data_1kmg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kmg _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.702 0.287 . . . . 3.9100000000000001 111.288 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.97 144.75 25.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.651 -1.24 . . . . 1.54 107.651 163.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 t -110.61 142.28 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.747 -0.835 . . . . 2.2599999999999998 108.747 167.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.01 97.47 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.069 -1.086 . . . . 1.75 108.069 156.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.14 107.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.723 -1.584 . . . . 1.8300000000000001 106.723 161.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.22 124.46 38.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.081 -1.081 . . . . 1.8899999999999999 108.081 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -135.22 -52.05 0.77 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.213 0.605 . . . . 5.0700000000000003 109.822 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.73 -121.97 4.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.811 -1.315 . . . . 0.79000000000000004 109.811 -170.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.89 -37.63 1.51 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.18 0.592 . . . . 3.0699999999999998 111.553 -162.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.27 162.3 18.98 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 110.972 -0.851 . . . . 0.81999999999999995 110.972 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.86 58.95 6.23 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.15 3.234 . . . . 1.78 111.22 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -132.71 152.63 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 127.353 2.261 . . . . 1.8400000000000001 107.269 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -155.04 133.77 12.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.49 -1.3 . . . . 2.9300000000000002 107.49 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.41 168.83 40.21 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.789 -0.72 . . . . 0.5 112.785 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.86 125.67 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 2.21 107.345 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.7 136.55 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.883 -1.525 . . . . 1.8100000000000001 106.883 161.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -116.26 106.99 14.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.7 -1.593 . . . . 2.2200000000000002 106.7 165.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.74 120.11 32.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 3.71 106.877 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.62 163.17 33.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.102 0.953 . . . . 3.46 109.935 163.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -156.85 153.82 28.85 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.979 2.112 . . . . 3.1899999999999999 105.405 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -63.42 -62.43 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.323 0.965 . . . . 6.5499999999999998 110.375 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 6.0 mp0 -90.9 -162.38 0.9 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 126.802 2.041 . . . . 4.4100000000000001 111.282 -167.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 m -101.69 -68.55 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.643 1.577 . . . . 3.1499999999999999 107.215 158.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -73.58 76.55 1.48 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.526 1.131 . . . . 5.8499999999999996 110.72 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.36 179.35 43.2 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 110.343 -1.103 . . . . 1.4399999999999999 110.343 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.21 126.06 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.776 2.984 . . . . 1.22 112.123 -170.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.19 140.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.427 -0.583 . . . . 1.9299999999999999 109.427 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -103.74 99.04 8.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.547 -1.649 . . . . 3.6600000000000001 106.547 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.44 120.91 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.006 -1.479 . . . . 1.9199999999999999 107.006 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -130.92 140.34 50.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.8 -1.185 . . . . 1.0600000000000001 107.8 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.21 23.71 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.088 -1.205 . . . . 0.75 110.088 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 p -130.04 67.59 1.46 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.088 1.355 . . . . 2.5099999999999998 107.726 -163.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -81.6 139.53 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.541 -1.209 . . . . 1.6899999999999999 108.323 -175.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -134.94 169.53 17.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.452 1.279 . . . . 5.2300000000000004 114.452 170.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 -1.68 79.1 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 114.227 -1.351 . . . . 1.04 113.803 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -56.09 158.83 3.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.668 1.234 . . . . 1.8200000000000001 110.31 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.82 160.55 11.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.375 -0.972 . . . . 2.4500000000000002 108.375 154.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -60.88 174.04 0.68 Allowed 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.57 -0.706 . . . . 2.6000000000000001 110.822 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.26 -162.19 54.48 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.993 -0.549 . . . . 0.52000000000000002 112.541 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.17 146.69 47.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.37 0.668 . . . . 3.27 111.973 -171.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -144.74 119.3 9.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.486 1.515 . . . . 0.68000000000000005 109.408 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.15 147.83 8.96 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.155 -1.178 . . . . 0.34999999999999998 110.155 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.29 96.04 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.502 -1.295 . . . . 4.0800000000000001 107.502 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -130.91 146.6 52.38 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.99 -1.115 . . . . 0.80000000000000004 107.99 -162.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.75 104.91 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 122.09 0.948 . . . . 2.6800000000000002 109.542 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.71 161.87 18.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.245 -1.391 . . . . 0.82999999999999996 107.245 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -51.3 -103.39 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.124 1.77 . . . . 5.46 112.76 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 123.366 0.666 . . . . 2.9700000000000002 112.784 170.226 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.22 0.533 . . . . 2.6000000000000001 110.658 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.86 -88.32 1.27 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.152 -1.579 . . . . 1.3500000000000001 109.152 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.57 179.0 4.47 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.948 3.099 . . . . 1.4099999999999999 114.06 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -84.84 59.05 5.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.308 -1.315 . . . . 1.75 109.47 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.5 t80 50.17 68.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.828 . . . . 3.5099999999999998 109.818 -172.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -83.21 115.17 57.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.218 -0.896 . . . . 3.29 108.759 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.18 -37.12 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.148 1.898 . . . . 1.75 111.157 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 tt -155.84 -65.7 0.11 Allowed 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.945 -1.131 . . . . 3.8399999999999999 107.945 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -154.95 71.45 0.8 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.705 0.802 . . . . 2.27 109.379 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.56 161.34 27.08 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.946 -0.761 . . . . 5.3499999999999996 108.946 165.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 28.2 mttt -109.71 155.72 21.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.809 -1.552 . . . . 4.1399999999999997 106.809 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -74.85 164.06 26.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0700000000000001 110.587 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.01 148.46 9.28 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 105.447 -3.061 . . . . 2.5699999999999998 105.447 169.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.26 -155.46 4.99 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.444 -1.062 . . . . 1.95 110.444 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.71 -46.87 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.728 1.618 . . . . 1.4399999999999999 108.756 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.62 -36.26 75.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.265 1.426 . . . . 5.1799999999999997 113.039 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.95 165.93 1.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.927 0.491 . . . . 2.6600000000000001 110.737 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -79.61 -46.96 16.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.884 1.674 . . . . 4.2699999999999996 109.512 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 44.7 mt-10 -93.47 177.1 6.14 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.209 1.404 . . . . 3.1499999999999999 110.812 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 177.33 160.57 0.44 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 128.55 2.74 . . . . 4.25 106.82 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 51.0 m80 -71.51 152.14 43.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.241 -1.763 . . . . 0.70999999999999996 106.241 162.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.49 39.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.4 1.095 . . . . 2.2799999999999998 111.128 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.51 37.27 0.29 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 128.331 2.872 . . . . 1.2 110.62 166.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.05 140.57 50.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.427 1.614 . . . . 2.29 110.451 157.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.31 -51.22 4.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.708 -1.219 . . . . 2.7000000000000002 107.708 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.45 -103.41 0.23 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.649 -0.98 . . . . 0.68000000000000005 110.649 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -152.16 169.28 22.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.305 1.842 . . . . 2.6600000000000001 110.461 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.06 176.04 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.649 1.58 . . . . 1.6200000000000001 107.034 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.4 m -125.33 126.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.934 -1.135 . . . . 2.7999999999999998 107.934 174.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.17 141.4 29.58 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.127 0.971 . . . . 1.77 111.818 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.11 -90.38 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.153 0.908 . . . . 2.6499999999999999 110.855 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 93' ' ' GLY . 5.6 tttp -158.23 -34.37 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.243 0.831 . . . . 4.8399999999999999 113.243 -161.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -79.34 17.93 0.76 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 123.797 1.761 . . . . 3.4300000000000002 110.178 158.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 63.78 17.22 60.24 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 125.189 1.376 . . . . 0.96999999999999997 111.808 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.38 119.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.515 -1.291 . . . . 1.75 107.515 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.51 174.24 6.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.444 1.098 . . . . 1.74 109.292 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -132.49 91.24 2.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.196 -2.15 . . . . 3.6899999999999999 105.196 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.1 59.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.775 -0.824 . . . . 2.3199999999999998 108.775 -168.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m -96.56 104.15 16.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.758 1.223 . . . . 1.3700000000000001 109.453 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.02 153.31 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.393 -0.965 . . . . 2.9100000000000001 108.393 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -140.14 82.16 1.85 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.302 0.641 . . . . 2.7799999999999998 109.914 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.52 160.36 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.851 0.46 . . . . 2.1000000000000001 110.969 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.4 p -121.11 4.39 10.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.573 1.549 . . . . 1.9299999999999999 113.16 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.66 -50.43 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.28 0.945 . . . . 2.1899999999999999 109.065 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pp -77.57 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.425 0.631 . . . . 2.0800000000000001 111.043 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -153.66 175.1 13.64 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.746 1.618 . . . . 2.6200000000000001 107.502 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.87 38.72 4.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.726 0.811 . . . . 3.52 111.144 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 124.716 1.206 . . . . 3.5099999999999998 109.782 -176.257 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.454 0.168 . . . . 3.0099999999999998 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.257 1.3 pp -95.97 -7.84 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.266 0.469 . . . . 2.6499999999999999 112.266 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.7 tt -45.57 137.03 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.503 0.721 . . . . 3.0600000000000001 110.494 167.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.07 -30.78 6.4 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.727 0.679 . . . . 1.5600000000000001 112.253 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -81.1 166.23 20.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.734 1.267 . . . . 6.5300000000000002 109.897 -168.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.0 m -93.06 108.61 20.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.085 0.469 . . . . 1.8200000000000001 110.586 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -68.45 148.74 50.19 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.704 -0.85 . . . . 2.6200000000000001 108.704 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.98 137.77 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.894 1.677 . . . . 1.6299999999999999 108.342 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.37 128.33 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.017 -1.105 . . . . 2.6099999999999999 108.017 166.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -104.8 160.85 14.66 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.121 2.267 . . . . 0.41999999999999998 117.121 -169.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -50.82 -71.96 0.06 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.833 2.053 . . . . 3.3399999999999999 111.902 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -94.3 -178.22 4.53 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.174 0.897 . . . . 3.73 110.239 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.97 151.08 27.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.643 -0.873 . . . . 1.5800000000000001 108.643 161.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.53 169.02 18.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.434 -0.58 . . . . 1.97 109.434 163.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.08 -25.78 63.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.471 0.915 . . . . 3.9399999999999999 113.471 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 72.63 -13.71 0.63 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.111 2.164 . . . . 2.6099999999999999 113.006 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.54 5.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.949 1.25 . . . . 2.2000000000000002 110.666 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -91.57 -31.38 15.93 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.501 1.12 . . . . 6.4900000000000002 109.212 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.67 62.78 3.09 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.784 -1.326 . . . . 3.46 109.784 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.52 -31.42 57.29 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.563 -1.015 . . . . 4.5800000000000001 110.563 164.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 132' ' ' GLU . 1.3 p-10 -141.42 -78.54 0.27 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.421 0.611 . . . . 2.6499999999999999 111.622 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.421 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 13.5 tt0 179.56 -54.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.335 1.454 . . . . 3.5899999999999999 109.624 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -45.9 -31.4 2.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.7 0.8 . . . . 4.4000000000000004 110.735 167.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -29.57 -77.13 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.821 2.048 . . . . 2.0699999999999998 113.534 155.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 p -71.63 -39.38 70.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 120.884 -1.135 . . . . 2.1899999999999999 109.447 -175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -55.28 -51.37 66.88 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.104 0.411 . . . . 4.4800000000000004 111.463 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.496 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.337 1.0 OUTLIER -128.9 -47.92 1.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.361 0.874 . . . . 2.25 113.361 175.175 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.15 -5.46 0.39 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.577 1.08 . . . . 0.91000000000000003 115.366 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.3 t30 36.25 57.13 1.05 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.274 1.83 . . . . 2.54 113.549 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.55 -32.75 74.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.339 0.866 . . . . 2.2599999999999998 113.339 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.53 174.47 50.01 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.312 -1.515 . . . . 1.0600000000000001 109.312 -159.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 m -54.92 154.09 5.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.274 1.43 . . . . 2.0499999999999998 113.961 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -77.41 142.69 39.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 3.8500000000000001 109.897 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 mt -120.32 -72.64 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.694 -0.854 . . . . 1.53 108.694 -174.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.77 149.25 41.1 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.042 0.937 . . . . 1.9199999999999999 108.494 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.04 170.48 20.43 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.054 1.471 . . . . 1.55 109.178 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.43 147.19 6.36 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.642 -1.383 . . . . 0.88 109.642 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.46 135.25 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.27 1.028 . . . . 1.6000000000000001 109.065 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.1 tt -92.63 140.03 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.144 0.424 . . . . 1.76 112.144 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.68 7.42 1.03 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.579 1.085 . . . . 0.62 114.315 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.3 mm -98.65 57.0 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.229 -0.025 0 CA-C-N 119.55 1.675 . . . . 2.02 109.917 -154.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.65 176.93 11.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.823 0.849 . . . . 2.71 109.452 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 103.267 -2.864 . . . . 4.8300000000000001 103.267 154.184 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.8 pttp . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.777 0.322 . . . . 3.3199999999999998 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.27 147.18 24.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.257 -1.016 . . . . 1.77 108.257 163.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.49 152.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 106.164 -1.791 . . . . 1.99 106.164 157.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.2 96.3 3.25 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.9 -0.778 . . . . 1.5600000000000001 108.9 160.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.26 110.32 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.352 -1.351 . . . . 2.2200000000000002 107.352 168.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.4 mt -93.85 122.84 36.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.919 -0.771 . . . . 2.23 108.919 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.77 -47.97 0.46 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.857 0.863 . . . . 4.9400000000000004 110.578 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.83 -123.47 1.97 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.744 1.164 . . . . 0.92000000000000004 112.779 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -59.52 1.85 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 3.7599999999999998 108.52 -172.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.03 172.19 1.77 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.074 2.274 . . . . 1.04 114.518 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.43 -25.68 48.39 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.606 2.871 . . . . 1.48 111.906 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.6 t -51.33 141.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.225 1.01 . . . . 1.6899999999999999 110.851 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -152.25 92.75 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.83 1.652 . . . . 2.5600000000000001 107.432 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.77 21.17 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.031 0.824 . . . . 0.79000000000000004 111.867 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.41 131.91 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.294 -1.002 . . . . 2.4399999999999999 108.294 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 mm -102.2 147.59 8.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.632 1.573 . . . . 1.97 107.954 165.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.64 118.51 24.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.57 -2.011 . . . . 1.71 105.57 162.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -127.95 116.53 20.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.876 -1.898 . . . . 4.9500000000000002 105.876 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 163.88 39.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.274 0.559 . . . . 3.6499999999999999 111.971 -170.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 -177.84 6.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.69 -1.596 . . . . 3.8300000000000001 106.69 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -77.73 -63.22 1.43 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.861 -0.792 . . . . 7.2599999999999998 108.861 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.33 165.62 14.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.828 1.251 . . . . 4.9400000000000004 109.569 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -81.0 -0.78 41.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.765 0.654 . . . . 3.5299999999999998 112.765 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -161.47 83.04 0.61 Allowed 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 121.723 -0.611 . . . . 4.7400000000000002 110.225 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.18 169.74 42.43 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 105.827 -2.909 . . . . 1.6599999999999999 105.827 171.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.42 114.82 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.587 2.858 . . . . 1.8400000000000001 112.584 -165.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.32 142.65 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.82 -0.627 . . . . 1.75 109.951 -168.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -95.66 122.46 38.45 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.736 -0.839 . . . . 3.2400000000000002 108.736 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.72 97.39 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.705 1.602 . . . . 1.98 107.727 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -113.76 148.81 35.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.273 -0.64 . . . . 0.91000000000000003 109.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.87 160.46 34.06 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 120.991 -1.068 . . . . 0.73999999999999999 110.964 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.2 p -129.77 113.51 14.8 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 105.486 -2.042 . . . . 2.2400000000000002 105.486 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.74 142.1 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.844 -1.91 . . . . 2.0800000000000001 105.844 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.56 153.49 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.875 -0.516 . . . . 6.4000000000000004 110.368 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.94 21.01 51.98 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.914 1.245 . . . . 0.64000000000000001 112.401 -171.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.14 -168.16 0.37 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.335 1.064 . . . . 1.95 108.753 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.0 m -135.93 166.32 23.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 103.814 -2.662 . . . . 3.9900000000000002 103.814 159.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.24 175.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.763 1.625 . . . . 2.8999999999999999 114.649 -166.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.04 -170.66 54.72 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 114.975 -1.011 . . . . 1.51 112.284 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.37 152.52 27.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.379 1.071 . . . . 3.6400000000000001 110.528 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -145.51 112.83 6.18 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.835 1.254 . . . . 0.65000000000000002 109.277 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.26 150.37 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.835 -0.906 . . . . 0.54000000000000004 110.835 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -142.95 94.49 2.64 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.917 -1.512 . . . . 4.1200000000000001 106.917 -171.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -131.98 162.72 30.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.533 -1.284 . . . . 1.27 107.533 -164.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 m -134.97 115.26 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.721 0.691 . . . . 3.6600000000000001 109.624 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -104.69 150.77 24.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.894 1.277 . . . . 1.1599999999999999 110.561 -164.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.78 66.83 0.37 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.071 1.748 . . . . 5.0700000000000003 112.414 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 106.577 -1.638 . . . . 3.3399999999999999 106.577 171.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.061 0 CA-C-O 120.027 -0.035 . . . . 3.3999999999999999 111.02 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.96 -178.35 44.76 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.389 -1.084 . . . . 3.1899999999999999 110.389 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.73 179.35 5.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.085 3.857 . . . . 1.79 113.331 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -62.17 57.57 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.189 2.596 . . . . 2.0699999999999998 113.299 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.0 t80 35.88 77.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.341 1.056 . . . . 3.73 111.016 -160.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -93.74 106.02 19.45 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 108.457 -0.942 . . . . 3.02 108.457 171.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.69 -33.37 10.5 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.286 1.99 . . . . 1.55 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -155.33 -66.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.537 -0.912 . . . . 4.3200000000000003 108.537 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.6 m -154.4 74.71 0.97 Allowed 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.63 -0.669 . . . . 2.0699999999999998 110.36 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -78.31 161.29 27.33 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.699 -0.852 . . . . 6.1600000000000001 108.699 166.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -107.62 148.53 29.21 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.452 1.101 . . . . 5.3600000000000003 108.326 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -78.18 159.64 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.767 -0.373 . . . . 1.1699999999999999 110.691 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.52 160.72 33.02 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 107.448 -2.261 . . . . 2.3300000000000001 107.448 161.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.33 -176.86 29.11 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 117.715 0.758 . . . . 2.4100000000000001 111.342 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.49 -29.2 37.7 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.104 1.869 . . . . 3.1400000000000001 110.43 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -64.81 -43.45 93.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.329 0.651 . . . . 6.21 111.202 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -63.48 147.77 50.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.299 1.047 . . . . 2.5899999999999999 112.183 -168.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.27 -50.78 71.82 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.819 -1.082 . . . . 4.4900000000000002 108.242 167.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -78.02 164.98 24.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.155 0.982 . . . . 3.8500000000000001 110.574 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.37 147.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 C-N-CA 129.255 3.022 . . . . 4.3399999999999999 108.751 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -65.44 152.51 43.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 119.504 -0.878 . . . . 0.96999999999999997 109.986 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.12 -5.98 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 O-C-N 121.894 -0.504 . . . . 2.3399999999999999 112.307 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.2 50.96 0.77 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.058 -1.026 . . . . 1.3899999999999999 111.772 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.25 123.06 1.88 Allowed 'General case' 0 C--O 1.227 -0.087 0 O-C-N 120.811 -1.406 . . . . 2.96 110.089 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.13 -52.45 4.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.652 -0.499 . . . . 3.2999999999999998 109.652 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.39 -101.41 0.19 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.068 -1.063 . . . . 0.89000000000000001 111.99 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -155.11 166.03 34.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.084 1.353 . . . . 3.0800000000000001 111.327 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.9 179.71 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.308 1.843 . . . . 1.8400000000000001 106.165 162.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 t -134.32 145.17 48.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.568 -1.271 . . . . 3.3799999999999999 107.568 163.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.22 143.18 35.58 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.601 0.563 . . . . 1.98 109.618 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.76 -69.64 0.23 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.474 0.709 . . . . 3.3300000000000001 109.918 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -168.35 -55.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.789 2.036 . . . . 5.1299999999999999 108.53 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.21 29.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.922 1.344 . . . . 4.8200000000000003 110.244 -170.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.13 17.61 72.14 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.59 1.091 . . . . 1.0800000000000001 112.386 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.4 152.33 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.461 -1.311 . . . . 1.95 107.461 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.26 167.22 22.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.495 -1.298 . . . . 1.7 107.495 161.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.05 148.95 51.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.668 -2.345 . . . . 2.8399999999999999 104.668 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.6 136.48 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 107.614 -1.254 . . . . 2.1000000000000001 107.614 164.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.0 m -156.95 70.4 0.63 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.545 1.538 . . . . 1.3899999999999999 108.168 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.58 155.3 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.942 0.897 . . . . 2.98 109.088 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.6 134.71 29.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.393 -0.595 . . . . 2.71 109.393 145.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -128.64 165.31 21.07 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.332 1.053 . . . . 2.8500000000000001 109.539 170.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 p -104.08 8.0 36.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.078 1.751 . . . . 2.1899999999999999 112.287 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.4 t -90.53 -49.15 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.368 -0.975 . . . . 2.4399999999999999 108.368 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.259 0.4 OUTLIER -84.19 175.82 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.05 0.452 . . . . 2.6000000000000001 111.574 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -160.97 169.12 23.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.325 1.05 . . . . 3.4399999999999999 109.25 -166.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.7 mp -85.67 -25.79 26.35 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.483 1.113 . . . . 3.9700000000000002 111.907 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.326 -0.449 0 C-N-CA 125.951 1.7 . . . . 4.6600000000000001 107.47 171.667 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.0 p . . . . . 0 N--CA 1.445 -0.685 0 CA-C-O 122.082 0.944 . . . . 1.8799999999999999 113.409 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 pp -91.02 -6.3 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.018 -1.446 . . . . 2.5499999999999998 109.825 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 tp -43.86 123.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.897 0.879 . . . . 2.6800000000000002 109.465 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.9 32.53 84.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.926 -0.654 . . . . 1.49 113.093 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -98.32 174.96 6.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.282 -1.007 . . . . 6.4199999999999999 108.282 152.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 m -105.58 117.16 33.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.778 1.231 . . . . 2.0299999999999998 108.283 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.3 150.62 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.008 -0.738 . . . . 3.7799999999999998 109.008 171.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -140.7 134.6 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.918 1.287 . . . . 1.6399999999999999 107.702 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.33 128.37 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.865 -1.531 . . . . 2.73 106.865 164.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -98.32 160.02 14.56 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 115.182 1.549 . . . . 0.60999999999999999 115.182 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.16 -72.15 0.06 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.138 1.775 . . . . 4.2800000000000002 111.787 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -101.21 -177.71 3.53 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.441 0.696 . . . . 3.8599999999999999 110.038 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.89 151.35 18.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.043 -0.725 . . . . 1.9299999999999999 109.043 165.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.14 176.33 4.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.321 -0.992 . . . . 1.9199999999999999 108.321 159.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.65 -28.38 66.83 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 3.98 114.351 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 81.55 -7.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.244 2.618 . . . . 3.27 113.475 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.12 31.64 11.7 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.82 1.191 . . . . 2.6600000000000001 110.477 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -35.36 32.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 128.224 2.61 . . . . 7.8700000000000001 108.229 168.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.13 41.88 30.6 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.655 1.122 . . . . 4.25 111.253 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.64 35.64 1.61 Allowed Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.538 1.169 . . . . 3.9100000000000001 114.299 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.6 p30 177.64 -89.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.455 1.902 . . . . 3.21 108.703 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.38 -57.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.296 1.838 . . . . 2.9399999999999999 107.137 -173.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -56.42 -34.37 66.71 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.745 1.218 . . . . 3.8599999999999999 110.883 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.1 m -41.84 -68.77 0.16 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.898 1.279 . . . . 2.1899999999999999 112.087 167.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -43.78 69.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.3 -0.875 . . . . 2.7999999999999998 110.059 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -57.81 -42.86 85.12 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.104 0.962 . . . . 3.21 111.647 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . 0.255 4.2 p -132.53 -52.28 0.94 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.676 0.621 . . . . 2.75 112.676 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.52 -25.13 0.66 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 124.092 0.854 . . . . 0.91000000000000003 112.171 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t30 41.55 56.2 3.32 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.92 1.688 . . . . 2.4700000000000002 111.06 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 -50.55 18.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.293 -0.963 . . . . 1.8400000000000001 108.992 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 132.11 -151.95 20.02 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 107.427 -2.269 . . . . 1.6200000000000001 107.427 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 t -67.76 -179.71 1.21 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.326 1.06 . . . . 3.6200000000000001 111.98 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -105.44 152.23 23.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.611 2.364 . . . . 4.21 111.405 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.5 -85.27 0.66 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.371 -1.344 . . . . 1.8600000000000001 107.371 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.17 155.23 17.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.173 -1.047 . . . . 2.0899999999999999 108.173 164.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 18.5 p -146.93 168.09 22.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.107 -1.406 . . . . 2.02 107.776 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.99 140.93 4.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.126 -1.19 . . . . 0.75 110.126 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.93 137.98 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.897 0.879 . . . . 1.9299999999999999 108.96 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.0 tt -101.43 125.43 55.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.205 0.526 . . . . 2.0800000000000001 111.231 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.21 8.87 0.42 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.539 1.066 . . . . 0.66000000000000003 114.306 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.11 55.39 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 120.116 1.958 . . . . 1.96 110.19 -161.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.87 176.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.563 1.145 . . . . 2.0499999999999998 109.412 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 102.844 -3.021 . . . . 5.2599999999999998 102.844 150.895 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.8 pttm . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 109.505 -0.554 . . . . 3.4100000000000001 109.505 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.5 153.41 48.78 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.909 2.083 . . . . 1.8 108.148 167.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -118.87 143.12 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.412 -1.329 . . . . 1.76 107.412 170.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.95 99.83 6.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.141 1.376 . . . . 1.6599999999999999 108.996 156.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 113.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.573 -1.269 . . . . 1.76 107.573 159.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.71 125.12 49.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.359 1.064 . . . . 2.0099999999999998 109.056 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -132.23 -53.2 0.96 Allowed 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.409 0.684 . . . . 4.8799999999999999 110.215 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.43 -124.14 13.86 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.036 0.827 . . . . 0.93000000000000005 113.832 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -114.12 -52.47 2.73 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.867 1.267 . . . . 3.7999999999999998 108.859 -158.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.05 160.52 26.45 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 110.295 -1.122 . . . . 0.96999999999999997 110.295 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.52 40.59 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.72 2.946 . . . . 1.01 112.711 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.04 156.18 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.807 1.643 . . . . 2.0 108.934 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -153.63 93.0 1.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.523 -0.917 . . . . 3.3300000000000001 108.523 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.91 162.53 14.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 124.03 0.824 . . . . 0.79000000000000004 111.462 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.8 mt -130.95 120.56 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 106.532 -1.655 . . . . 2.3199999999999998 106.532 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.4 mm -84.23 146.37 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.319 1.048 . . . . 1.8999999999999999 108.221 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -124.85 101.18 6.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.244 -1.761 . . . . 2.4700000000000002 106.244 166.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.66 91.09 5.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.245 -2.132 . . . . 3.3700000000000001 105.245 166.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.39 140.84 31.28 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.824 -1.547 . . . . 3.6600000000000001 106.824 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -157.96 151.36 23.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.759 -1.941 . . . . 3.8999999999999999 105.759 167.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.91 -65.31 1.18 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.072 0.851 . . . . 7.9400000000000004 108.769 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -78.97 119.23 21.83 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.583 -0.895 . . . . 5.1799999999999997 108.583 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 m -35.4 -64.11 0.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.403 2.681 . . . . 3.0 113.815 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.0 37.21 0.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.582 -0.699 . . . . 4.5099999999999998 111.114 177.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.67 167.34 22.17 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.322 0.963 . . . . 1.75 111.291 -174.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.7 139.21 51.92 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.458 2.772 . . . . 1.71 112.019 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -89.32 126.71 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.305 -0.998 . . . . 1.96 108.305 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -83.6 98.86 9.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.436 -1.69 . . . . 3.54 106.436 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.25 85.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.746 1.618 . . . . 2.3100000000000001 107.387 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -98.61 162.13 13.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.204 -0.665 . . . . 1.3 109.204 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.41 153.57 23.15 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.834 -0.906 . . . . 0.83999999999999997 110.834 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 p -121.98 79.43 1.58 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.245 1.418 . . . . 3.0299999999999998 107.488 -171.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -96.99 125.2 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.69 1.196 . . . . 1.96 108.934 -170.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.73 158.58 43.77 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.711 -0.477 . . . . 5.8799999999999999 109.711 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.52 19.52 48.53 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.675 1.607 . . . . 0.69999999999999996 113.34 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.83 170.28 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.648 -0.913 . . . . 1.72 108.962 170.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.1 163.39 27.98 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.711 -1.218 . . . . 2.4100000000000001 107.711 149.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -61.63 175.91 0.57 Allowed 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.382 -0.824 . . . . 3.3500000000000001 111.03 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.62 -165.54 52.2 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.272 0.939 . . . . 0.55000000000000004 112.607 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.52 141.99 58.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.802 1.241 . . . . 2.9700000000000002 113.045 -174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -143.12 118.38 10.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.756 1.622 . . . . 0.66000000000000003 108.592 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.46 149.3 2.14 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.751 -0.939 . . . . 0.40999999999999998 110.751 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -139.91 94.16 2.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.327 -1.731 . . . . 4.4500000000000002 106.327 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.438 ' ND1' ' CD2' ' A' ' 120' ' ' HIS . 26.5 m80 -138.86 153.49 48.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.723 -1.584 . . . . 1.21 106.723 -166.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.24 121.76 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.637 0.732 . . . . 2.6699999999999999 109.792 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -96.19 144.2 26.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.154 2.182 . . . . 0.84999999999999998 109.548 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -33.97 -90.87 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.539 2.736 . . . . 5.3799999999999999 112.671 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 C--N 1.331 -0.198 0 N-CA-C 115.103 1.52 . . . . 3.6899999999999999 115.103 170.192 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 114.645 1.35 . . . . 2.9500000000000002 114.645 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.82 -167.58 30.52 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.887 -1.685 . . . . 1.8799999999999999 108.887 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 178.75 4.34 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.315 3.343 . . . . 1.5 113.142 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -47.61 123.48 5.89 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.338 1.455 . . . . 1.25 110.182 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -45.86 122.92 4.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.724 0.809 . . . . 4.0300000000000002 111.027 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -155.4 152.84 25.56 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 106.679 -1.601 . . . . 3.54 106.679 171.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.22 -20.33 24.81 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.228 1.952 . . . . 1.54 113.806 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.81 -70.08 0.11 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.463 1.029 . . . . 4.2300000000000004 111.195 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.9 t -157.43 69.53 0.56 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.254 0.622 . . . . 2.8900000000000001 109.488 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -79.21 175.04 10.95 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.379 0.609 . . . . 6.1799999999999997 110.374 168.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -118.55 161.24 20.36 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 106.33 -1.73 . . . . 3.9300000000000002 106.33 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -85.9 165.21 16.97 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.639 0.654 . . . . 1.0600000000000001 109.382 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.53 -65.84 0.02 OUTLIER Glycine 0 C--O 1.223 -0.591 0 N-CA-C 108.201 -1.959 . . . . 2.9199999999999999 108.201 169.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.15 -171.27 27.87 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.604 1.097 . . . . 1.9199999999999999 111.978 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.14 -46.85 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.743 2.295 . . . . 1.6100000000000001 109.796 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.66 -36.41 82.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.611 0.764 . . . . 4.9199999999999999 112.017 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.1 176.95 0.66 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.277 1.031 . . . . 1.8 112.042 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.69 -48.3 11.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.052 1.341 . . . . 4.6100000000000003 109.71 165.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -98.4 156.58 16.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.311 1.044 . . . . 3.5099999999999998 112.68 -166.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.69 150.0 0.64 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.768 1.627 . . . . 4.7800000000000002 110.0 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.416 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 44.5 m80 -55.84 136.6 51.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 104.979 -2.23 . . . . 0.75 104.979 156.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -58.98 -23.17 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.185 -0.606 . . . . 2.2799999999999998 109.947 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.87 39.24 2.8 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.372 1.463 . . . . 0.80000000000000004 115.083 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -102.9 136.63 42.37 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.772 1.786 . . . . 2.4500000000000002 106.831 153.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.6 -52.74 3.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.469 -0.938 . . . . 2.9399999999999999 108.469 147.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.38 -106.72 0.29 Allowed Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.964 -0.854 . . . . 0.78000000000000003 110.964 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.69 165.66 31.69 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.261 1.425 . . . . 2.3999999999999999 109.524 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.38 175.38 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 106.174 -1.788 . . . . 1.6899999999999999 106.174 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -120.67 141.72 50.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.769 -1.197 . . . . 2.7000000000000002 107.769 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.3 138.84 34.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.398 0.679 . . . . 1.6599999999999999 109.979 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.45 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.571 0.544 . . . . 3.3599999999999999 110.134 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -53.79 1.52 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.928 0.891 . . . . 5.3700000000000001 111.52 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.05 26.61 2.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 123.368 1.556 . . . . 2.7999999999999998 110.78 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.8 17.9 67.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 114.524 -1.217 . . . . 0.67000000000000004 111.596 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.6 t -89.02 122.63 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 125.378 1.471 . . . . 1.79 107.306 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.16 175.99 5.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.894 1.277 . . . . 1.6200000000000001 107.662 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -133.67 148.21 51.48 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 103.62 -2.733 . . . . 2.9100000000000001 103.62 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.01 139.79 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.874 -1.528 . . . . 2.2799999999999998 106.874 160.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.1 m -158.16 59.69 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.303 1.841 . . . . 1.3400000000000001 108.078 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.08 151.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 107.638 -1.245 . . . . 2.6499999999999999 107.638 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -124.99 90.06 3.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.853 -0.795 . . . . 3.5899999999999999 108.853 166.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.63 152.89 31.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.461 0.573 . . . . 2.7000000000000002 110.637 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -132.07 41.9 3.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.779 1.232 . . . . 1.9299999999999999 110.295 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -127.57 -54.33 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.596 1.158 . . . . 2.3900000000000001 108.197 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -86.42 173.02 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.224 0.535 . . . . 2.6299999999999999 110.566 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.2 m -140.86 173.95 10.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.324 1.85 . . . . 2.9900000000000002 106.835 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.6 -3.37 46.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.137 0.421 . . . . 4.8399999999999999 112.137 170.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 106.881 -1.526 . . . . 3.8399999999999999 106.881 171.734 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 108.738 -0.838 . . . . 1.5 108.738 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.27 -12.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.534 -0.466 . . . . 2.8199999999999998 110.794 -169.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.9 tp -16.85 119.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 127.877 2.471 . . . . 2.96 113.353 164.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.59 -17.39 59.18 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.181 -1.344 . . . . 1.54 113.386 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.3 169.07 18.25 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.951 1.875 . . . . 4.8099999999999996 111.735 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.4 m -96.17 110.38 22.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.213 1.005 . . . . 2.02 109.472 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.29 144.28 54.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.222 0.919 . . . . 2.5699999999999998 108.705 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.7 t -130.79 136.41 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.87 1.268 . . . . 1.8899999999999999 109.087 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -103.39 126.9 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.794 -1.558 . . . . 2.5499999999999998 106.794 163.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.438 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 61.6 m-70 -100.97 161.0 13.9 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 116.358 1.985 . . . . 0.38 116.358 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -39.61 -70.33 0.11 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.949 2.9 . . . . 3.0 112.273 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -112.72 -172.49 2.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.426 1.012 . . . . 3.3999999999999999 108.848 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.12 160.59 9.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.917 -0.771 . . . . 1.6399999999999999 108.917 162.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.3 167.11 21.86 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.721 0.772 . . . . 1.8899999999999999 109.808 158.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.7 -6.98 57.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.463 1.905 . . . . 3.4100000000000001 111.282 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 36.06 20.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.886 2.074 . . . . 2.7999999999999998 111.068 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.49 27.43 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.44 -0.788 . . . . 1.9199999999999999 112.65 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -111.67 -34.03 6.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.063 1.345 . . . . 6.8099999999999996 109.623 -171.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -48.39 126.76 16.38 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.247 -1.141 . . . . 3.6600000000000001 110.247 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.62 64.43 2.94 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.341 0.972 . . . . 3.0299999999999998 111.69 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -163.58 117.44 1.55 Allowed 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 106.619 -1.623 . . . . 2.6200000000000001 106.619 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.15 -54.53 0.61 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.814 1.646 . . . . 3.4399999999999999 113.786 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -27.54 -49.64 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.791 2.836 . . . . 4.4699999999999998 113.983 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -44.47 -60.22 2.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.399 1.88 . . . . 2.6099999999999999 110.435 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.7 p -72.99 -42.51 63.19 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.091 -0.381 . . . . 1.98 110.579 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -51.99 -53.69 38.57 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.353 1.061 . . . . 4.4800000000000004 110.862 -172.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.416 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.3 p -123.39 -42.31 2.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.27 0.228 . . . . 1.9099999999999999 111.567 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 141.19 -27.51 2.41 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.447 -1.061 . . . . 0.98999999999999999 110.447 -169.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.3 t30 55.23 54.41 8.78 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 122.665 1.222 . . . . 2.2599999999999998 110.463 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.69 -27.83 69.19 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.812 1.245 . . . . 2.04 112.812 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.18 179.42 52.52 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 108.514 -1.834 . . . . 1.04 108.514 -160.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.4 m -59.21 148.94 29.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.286 1.217 . . . . 1.8400000000000001 114.286 -164.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -51.38 126.09 16.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.652 2.381 . . . . 3.8700000000000001 109.346 166.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.7 mt -109.26 -71.16 0.77 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-N 120.098 1.317 . . . . 1.6000000000000001 108.669 170.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.89 154.52 18.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.565 -0.532 . . . . 2.0499999999999998 109.565 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.81 160.16 16.76 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.676 0.61 . . . . 1.45 111.391 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.89 144.84 4.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 128.382 2.896 . . . . 1.3100000000000001 105.954 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.23 143.36 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 118.023 0.911 . . . . 2.0099999999999998 110.671 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 tt -92.92 139.83 17.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.555 0.742 . . . . 1.75 112.71 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.06 -4.83 1.2 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.192 0.901 . . . . 0.60999999999999999 114.777 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -90.55 58.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.715 1.258 . . . . 2.4900000000000002 109.101 -156.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.6 143.69 30.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.518 -0.739 . . . . 2.8700000000000001 112.263 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 103.511 -2.774 . . . . 6.6200000000000001 103.511 141.554 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp . . . . . 0 N--CA 1.441 -0.895 0 N-CA-C 107.858 -1.164 . . . . 4.4500000000000002 107.858 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.64 138.39 34.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.338 -0.986 . . . . 1.6499999999999999 108.338 163.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 t -99.79 136.27 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 106.885 -1.524 . . . . 2.1099999999999999 106.885 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.88 94.5 4.54 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 124.329 1.052 . . . . 1.51 108.236 158.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -65.84 102.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.45 -1.315 . . . . 2.0499999999999998 107.45 165.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.3 134.68 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.037 0.535 . . . . 2.1800000000000002 109.889 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -149.65 -50.31 0.14 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.657 0.383 . . . . 4.8799999999999999 111.618 166.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.43 -123.8 16.57 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.72 1.152 . . . . 1.0700000000000001 112.971 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.12 -51.77 2.92 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.47 1.108 . . . . 3.9900000000000002 108.621 -159.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.22 172.75 16.39 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.663 1.601 . . . . 0.97999999999999998 111.851 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 27.69 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.433 2.755 . . . . 1.05 112.674 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.4 t -82.1 165.38 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 1.78 109.11 -175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -156.33 139.1 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.937 1.695 . . . . 3.52 106.729 168.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.77 43.39 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.21 -0.995 . . . . 0.94999999999999996 111.651 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.21 126.45 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.071 -1.455 . . . . 3.3300000000000001 107.071 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.1 mm -92.51 129.24 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.269 -1.382 . . . . 2.23 107.269 165.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.75 108.7 21.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.875 -1.528 . . . . 2.3599999999999999 106.875 159.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.1 131.97 33.98 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.705 -1.961 . . . . 3.4700000000000002 105.705 162.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.39 165.16 36.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.226 0.921 . . . . 3.4700000000000002 111.49 158.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -155.26 145.46 21.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 104.714 -2.328 . . . . 3.1699999999999999 104.714 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -81.46 -36.91 28.78 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.875 -1.157 . . . . 8.2400000000000002 107.875 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -77.81 -167.4 0.97 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.721 2.808 . . . . 4.6299999999999999 110.037 171.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -139.83 26.56 2.27 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.877 1.271 . . . . 3.1499999999999999 109.425 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 179.03 35.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.485 1.114 . . . . 6.7800000000000002 110.202 -152.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.44 -162.27 9.73 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.628 -1.389 . . . . 1.3 109.628 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.35 144.95 29.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.294 2.663 . . . . 1.3 110.104 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -88.11 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.523 -0.917 . . . . 2.0299999999999998 108.523 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -111.08 124.01 51.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.568 -1.641 . . . . 3.4500000000000002 106.568 165.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -120.57 124.51 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.95 -1.5 . . . . 2.4399999999999999 106.95 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -140.64 138.0 34.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.609 -0.515 . . . . 1.25 109.609 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.67 139.4 4.66 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.525 -1.43 . . . . 1.21 109.525 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.6 m -119.17 91.16 3.49 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.34 1.056 . . . . 3.21 108.987 -167.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.2 mm -87.47 152.74 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.091 2.156 . . . . 2.7200000000000002 109.332 -165.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.89 146.69 33.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.329 0.651 . . . . 5.1399999999999997 109.66 -172.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.65 18.99 42.47 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.008 1.289 . . . . 0.60999999999999999 112.703 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 162.58 28.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.566 -0.902 . . . . 1.99 108.566 168.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.48 163.84 27.29 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.991 -1.114 . . . . 2.3199999999999998 107.991 155.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.53 176.39 0.5 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.435 -0.791 . . . . 2.3599999999999999 111.133 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.5 -165.95 46.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.659 0.647 . . . . 0.54000000000000004 113.648 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.87 147.94 52.59 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.649 0.78 . . . . 3.52 112.023 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -142.52 119.91 11.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.859 1.664 . . . . 0.80000000000000004 108.059 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.99 148.0 6.8 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.719 -1.352 . . . . 0.47999999999999998 109.719 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -141.72 95.79 2.87 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.488 -1.301 . . . . 3.8599999999999999 107.488 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -133.67 161.75 33.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.624 -1.25 . . . . 0.90000000000000002 107.624 -163.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.83 137.72 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 108.932 -0.766 . . . . 2.98 108.932 165.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -98.8 151.11 21.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.579 1.151 . . . . 0.84999999999999998 109.422 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -36.23 -59.62 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.371 1.868 . . . . 4.7699999999999996 112.37 -174.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 CA--C 1.53 0.198 0 C-N-CA 130.041 3.337 . . . . 3.3500000000000001 116.706 171.387 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.279 0 N-CA-C 109.527 -0.546 . . . . 2.3599999999999999 109.527 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.17 -85.17 0.84 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.079 -1.209 . . . . 1.71 110.079 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.61 175.4 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.309 2.673 . . . . 1.22 116.118 -161.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -83.55 57.22 3.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 113.695 -1.593 . . . . 2.04 110.996 -170.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 59.79 75.44 0.4 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.345 0.658 . . . . 2.8900000000000001 109.353 -172.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.21 87.91 0.52 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 3.6699999999999999 108.939 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -62.81 -43.67 19.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.246 1.297 . . . . 2.0600000000000001 110.136 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.49 -93.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.783 -0.821 . . . . 3.3399999999999999 108.783 165.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.1 p -137.37 60.7 1.64 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.794 0.838 . . . . 4.2599999999999998 110.399 -161.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -82.16 161.64 22.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.769 -1.196 . . . . 5.9699999999999998 107.769 159.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -128.94 175.28 8.78 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.728 -1.582 . . . . 5.3200000000000003 106.728 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -106.08 132.6 51.96 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.251 -1.018 . . . . 1.3500000000000001 108.251 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -124.06 -48.88 0.22 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.437 -1.465 . . . . 3.46 109.437 173.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.54 176.14 21.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.31 1.91 . . . . 2.1299999999999999 109.029 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -57.86 -43.71 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.42 2.08 . . . . 2.0600000000000001 110.614 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -70.47 -47.47 60.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.846 1.658 . . . . 5.0300000000000002 111.817 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.44 152.46 34.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.464 0.705 . . . . 1.78 111.573 -168.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -50.99 -51.43 52.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.582 1.553 . . . . 3.9399999999999999 111.837 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.94 146.42 26.16 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 122.924 1.345 . . . . 3.4500000000000002 111.444 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -170.84 134.69 1.02 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.931 -1.486 . . . . 5.0300000000000002 107.002 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.2 m80 -51.46 140.74 17.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.219 -1.4 . . . . 0.63 107.219 158.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.69 -14.1 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.988 -0.551 . . . . 2.04 110.291 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.22 35.22 4.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.071 0.843 . . . . 0.83999999999999997 115.143 165.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -94.89 117.85 30.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.818 1.809 . . . . 2.3700000000000001 106.619 158.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.39 -61.35 2.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.11 -1.441 . . . . 3.8900000000000001 107.11 158.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.41 -106.42 0.25 Allowed Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.387 -0.685 . . . . 0.93999999999999995 111.387 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -152.45 169.84 21.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.493 1.517 . . . . 1.75 109.427 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.03 169.99 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.131 -1.433 . . . . 1.6599999999999999 107.131 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.4 m -122.7 120.27 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.618 -1.253 . . . . 3.0299999999999998 107.618 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 141.85 35.85 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.109 0.564 . . . . 1.6299999999999999 109.888 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.51 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.309 2.244 . . . . 3.9300000000000002 110.459 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -172.88 -45.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.205 1.402 . . . . 4.5 108.855 -161.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -77.5 8.43 4.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.234 1.016 . . . . 2.73 110.929 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.46 19.44 78.13 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.123 -0.985 . . . . 0.79000000000000004 110.728 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.6 t -86.39 137.64 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.087 . . . . 1.52 108.064 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.12 167.25 21.31 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.931 -1.507 . . . . 1.5700000000000001 106.931 167.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -148.28 138.41 22.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.176 -1.416 . . . . 3.8700000000000001 107.176 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.35 56.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 124.331 1.019 . . . . 1.9099999999999999 111.349 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.8 m -70.3 88.51 0.64 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.981 0.512 . . . . 1.8300000000000001 109.962 166.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.8 mm -127.56 160.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.104 0.961 . . . . 3.4100000000000001 109.611 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -146.66 76.41 1.43 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.397 0.679 . . . . 2.46 111.177 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.1 143.73 35.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.935 0.398 . . . . 2.1299999999999999 110.156 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -106.35 -4.21 20.25 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.033 1.733 . . . . 1.8400000000000001 112.843 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.06 -46.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.701 1.2 . . . . 2.21 107.963 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.95 168.82 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.02 0.438 . . . . 2.3999999999999999 110.507 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 m -146.2 167.52 23.26 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.803 1.641 . . . . 2.1000000000000001 106.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 pp -99.01 -0.35 42.19 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.597 0.592 . . . . 3.1499999999999999 112.597 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.454 -0.266 0 C-N-CA 125.189 1.395 . . . . 3.3500000000000001 108.055 177.107 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.2 p . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 115.276 1.584 . . . . 1.3500000000000001 115.276 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.271 2.0 pp -95.34 -4.53 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 113.335 -1.757 . . . . 2.6499999999999999 111.207 174.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tp -39.08 131.42 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.892 0.877 . . . . 2.7599999999999998 109.824 162.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.63 49.54 72.89 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.232 -0.747 . . . . 1.9399999999999999 111.232 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -137.1 163.83 29.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.58 -1.637 . . . . 4.8499999999999996 106.58 164.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 m -90.61 111.84 23.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 118.691 -0.671 . . . . 1.73 110.121 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.36 143.16 57.32 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.556 -0.905 . . . . 2.75 108.556 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.6 t -134.67 139.58 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.337 1.855 . . . . 1.8 108.294 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.96 125.11 68.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.253 -1.017 . . . . 2.8500000000000001 108.253 162.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -94.45 163.46 13.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 115.355 1.613 . . . . 0.45000000000000001 115.355 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.78 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.201 1.4 . . . . 3.8799999999999999 112.357 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -92.54 -177.85 4.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.775 0.716 . . . . 3.79 110.601 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 151.6 16.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.447 -0.946 . . . . 1.8400000000000001 108.447 157.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.78 162.32 29.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.99 -0.744 . . . . 2.0600000000000001 108.99 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.65 -7.2 58.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.43 1.092 . . . . 3.3999999999999999 112.043 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 49.6 40.28 19.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.648 1.179 . . . . 2.5499999999999998 109.307 -168.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 51.78 34.12 36.37 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.453 -0.794 . . . . 2.0600000000000001 113.396 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -130.21 49.99 2.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.492 1.146 . . . . 5.4699999999999998 108.982 -177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.76 132.65 8.78 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.849 -1.7 . . . . 3.29 108.849 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.59 -37.38 67.41 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.713 -0.955 . . . . 3.0699999999999998 110.713 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -50.45 103.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.694 1.198 . . . . 2.52 109.593 159.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -35.19 10.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.246 1.018 . . . . 3.4300000000000002 111.948 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -28.08 -44.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.157 2.583 . . . . 3.8399999999999999 112.671 167.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.8 p -49.62 -73.16 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 2.8199999999999998 110.292 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.6 p -61.66 -40.73 95.95 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.298 -0.876 . . . . 1.9099999999999999 110.818 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.72 -53.27 59.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.392 1.477 . . . . 3.8700000000000001 110.783 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.502 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.33 1.3 p -126.07 -45.66 1.7 Allowed 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.96 0.726 . . . . 2.2999999999999998 112.96 172.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.72 -25.43 0.74 Allowed Glycine 0 N--CA 1.463 0.455 0 CA-C-N 118.965 0.802 . . . . 0.93999999999999995 112.029 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 t30 47.51 52.34 12.54 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.412 1.485 . . . . 2.1699999999999999 110.987 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.37 -47.95 31.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.77 -1.196 . . . . 2.25 107.77 162.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.22 -146.06 16.8 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 108.271 -1.932 . . . . 1.51 108.271 164.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.1 m -58.41 156.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.861 1.264 . . . . 2.6200000000000001 112.77 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -60.73 141.9 56.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.109 -1.405 . . . . 3.5099999999999998 109.608 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.3 mt -107.73 -71.52 0.75 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 105.992 -1.855 . . . . 1.98 105.992 156.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.93 151.79 19.91 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.439 -0.949 . . . . 2.2599999999999998 108.439 174.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 67.0 m -139.43 156.69 46.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.604 -1.999 . . . . 2.0 105.604 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.16 130.69 1.79 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.809 -0.916 . . . . 0.82999999999999996 110.809 163.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.55 130.22 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.405 0.682 . . . . 1.77 109.578 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 tt -98.76 135.9 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.311 -0.404 . . . . 1.78 111.592 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.68 -4.9 0.94 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.11 0.804 . . . . 0.69999999999999996 115.11 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -89.04 58.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.888 1.344 . . . . 2.4300000000000002 109.559 -159.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.96 151.54 23.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.744 -0.662 . . . . 3.3900000000000001 109.553 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 . . . . . 0 C--O 1.256 1.425 0 N-CA-C 104.48 -2.415 . . . . 6.9500000000000002 104.48 166.005 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.124 -0.324 . . . . 3.73 110.124 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.81 141.21 29.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.31 1.044 . . . . 1.78 108.885 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 t -102.61 144.37 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.437 -0.949 . . . . 2.1000000000000001 108.437 162.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.02 100.26 6.65 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 108.615 -0.883 . . . . 1.9199999999999999 108.615 153.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 101.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.971 -1.122 . . . . 2.02 107.971 164.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.44 130.84 36.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.288 -0.634 . . . . 2.1200000000000001 109.288 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -134.58 -57.37 0.83 Allowed 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.747 -0.835 . . . . 5.4199999999999999 108.747 165.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.83 -143.07 48.42 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.263 0.935 . . . . 1.6200000000000001 113.518 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.51 -46.69 5.65 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.841 1.656 . . . . 4.0300000000000002 108.495 -165.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.45 158.69 22.21 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 109.968 -1.253 . . . . 1.4199999999999999 109.968 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.38 46.77 2.21 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.513 2.808 . . . . 1.2 111.83 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.2 159.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.613 1.565 . . . . 1.9399999999999999 109.524 -173.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.51 129.05 7.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.698 1.599 . . . . 2.96 106.798 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.89 175.19 47.0 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.165 -0.774 . . . . 0.97999999999999998 111.165 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.4 mt -126.26 119.18 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.595 -1.632 . . . . 3.0800000000000001 106.595 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.29 134.06 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.197 -1.779 . . . . 1.9299999999999999 106.197 160.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -108.99 121.36 44.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.259 -2.126 . . . . 2.6699999999999999 105.259 162.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.47 114.72 26.95 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.944 1.698 . . . . 4.1699999999999999 106.647 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -131.33 156.2 45.9 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.294 0.952 . . . . 3.0699999999999998 109.367 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -153.99 146.8 24.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.721 -1.955 . . . . 4.2300000000000004 105.721 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -84.97 -90.26 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.905 -0.776 . . . . 5.3899999999999997 108.905 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.1 mp0 -77.06 149.8 35.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.831 -1.174 . . . . 3.8700000000000001 107.831 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -73.65 -2.17 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.132 -0.98 . . . . 2.7799999999999998 113.001 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -119.12 24.91 10.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.307 1.843 . . . . 5.8399999999999999 109.482 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.42 169.04 18.08 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 108.654 -1.778 . . . . 2.0099999999999998 108.654 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -65.63 139.48 58.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.681 1.587 . . . . 1.73 110.563 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.74 153.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.75 -1.204 . . . . 2.23 107.75 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -129.21 131.67 47.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.417 -1.697 . . . . 3.6899999999999999 106.417 172.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.45 139.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.208 1.403 . . . . 2.4100000000000001 107.755 -169.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.22 138.75 21.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.274 -1.01 . . . . 1.3200000000000001 108.274 168.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.93 130.74 2.24 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.388 -1.885 . . . . 1.03 108.388 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.4 p -105.92 85.99 2.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.698 -1.964 . . . . 3.0299999999999998 105.698 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mm -88.1 153.29 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.309 -1.367 . . . . 2.7200000000000002 107.309 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -147.54 158.19 43.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.128 1.158 . . . . 4.2800000000000002 114.128 168.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.24 9.96 43.28 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.87 2.176 . . . . 0.62 112.481 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.84 160.86 16.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.588 0.755 . . . . 2.3300000000000001 109.369 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.57 159.2 26.94 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 107.468 -1.308 . . . . 2.29 107.468 155.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.47 177.9 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.947 0.879 . . . . 3.0699999999999998 111.681 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.65 -164.55 54.05 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.02 -0.536 . . . . 0.58999999999999997 112.036 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.81 148.4 40.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.895 1.678 . . . . 2.9399999999999999 112.305 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -150.59 111.35 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.239 1.416 . . . . 0.63 110.29 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.25 147.4 2.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.549 -0.62 . . . . 0.42999999999999999 111.549 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.36 96.71 3.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.875 -1.157 . . . . 4.0899999999999999 107.875 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -133.28 156.53 47.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.813 -1.551 . . . . 0.89000000000000001 106.813 -167.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.7 119.46 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.434 1.016 . . . . 2.9300000000000002 109.491 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -91.25 138.46 31.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.659 -1.608 . . . . 0.84999999999999998 106.659 -174.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -40.76 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.684 1.594 . . . . 4.4100000000000001 110.935 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 N--CA 1.454 -0.234 0 C-N-CA 124.18 0.992 . . . . 3.2400000000000002 112.457 152.794 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.719 0.295 . . . . 2.1400000000000001 110.486 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.63 -86.5 1.75 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.288 -1.925 . . . . 1.6299999999999999 108.288 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.25 177.42 8.8 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.621 2.881 . . . . 1.0800000000000001 113.326 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -64.8 134.81 54.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.821 -1.536 . . . . 1.47 108.136 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -37.89 106.66 0.05 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.301 1.041 . . . . 2.73 111.129 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -127.14 143.54 47.41 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 130.817 3.647 . . . . 3.7599999999999998 108.037 -175.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.14 -51.82 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.644 1.563 . . . . 1.46 109.256 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -143.53 -82.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.891 1.276 . . . . 3.96 108.08 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -123.59 60.53 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.494 1.118 . . . . 2.6099999999999999 109.751 -164.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -79.01 166.35 22.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.469 0.652 . . . . 4.29 110.354 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -118.67 159.29 23.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.644 1.578 . . . . 3.9700000000000002 107.906 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.4 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 40.7 t60 -86.94 168.47 13.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.023 0.529 . . . . 0.96999999999999997 112.064 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.7 -126.59 1.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.431 -3.068 . . . . 1.8600000000000001 105.431 165.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.49 -176.74 45.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.929 -2.068 . . . . 1.99 107.929 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.01 -40.43 84.03 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.012 2.475 . . . . 2.8300000000000001 111.463 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -32.61 71.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.166 0.586 . . . . 5.96 112.474 174.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -89.09 177.66 6.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.716 0.769 . . . . 2.8599999999999999 112.66 -164.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.453 ' CG ' ' H ' ' A' ' 78' ' ' GLU . 3.4 pt-20 -55.75 -66.41 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.619 1.168 . . . . 7.2999999999999998 111.405 169.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.453 ' H ' ' CG ' ' A' ' 77' ' ' GLU . 50.0 mt-10 -118.23 179.6 4.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.663 2.385 . . . . 3.1099999999999999 112.263 -166.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.83 157.45 1.96 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.7 2.4 . . . . 5.29 108.231 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -63.56 153.89 34.33 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.844 -1.169 . . . . 0.54000000000000004 107.844 170.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.76 -37.48 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 119.902 -0.719 . . . . 2.0099999999999998 110.464 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.03 71.7 0.24 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 112.026 -0.43 . . . . 1.04 112.026 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -165.8 113.55 0.94 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.331 -0.988 . . . . 2.7000000000000002 108.331 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.13 -61.39 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.094 -0.706 . . . . 3.0 109.094 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.3 -107.05 0.27 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.139 -1.184 . . . . 0.87 110.139 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -147.2 163.25 36.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 125.107 1.363 . . . . 2.21 110.93 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.24 -178.58 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.027 2.131 . . . . 1.6299999999999999 105.867 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.8 t -129.47 171.54 12.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.827 -1.175 . . . . 2.98 107.827 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.11 144.58 50.81 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.308 1.043 . . . . 1.6599999999999999 110.669 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.47 -90.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.386 2.274 . . . . 4.2400000000000002 110.89 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -174.23 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.278 1.031 . . . . 3.96 110.271 -158.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.04 5.0 8.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.118 0.961 . . . . 2.7799999999999998 110.183 165.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.53 23.03 71.38 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.124 -1.19 . . . . 0.85999999999999999 110.124 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.2 t -85.36 136.65 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.364 1.466 . . . . 1.6599999999999999 107.895 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.18 166.22 21.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.691 1.596 . . . . 2.1600000000000001 109.748 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -142.14 118.45 10.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.038 -2.579 . . . . 2.71 104.038 -158.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.95 55.54 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 123.691 0.62 . . . . 2.1000000000000001 111.225 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.4 m -77.18 87.86 3.64 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.642 -0.661 . . . . 1.47 109.771 168.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.5 mm -125.39 157.16 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.163 0.985 . . . . 2.8900000000000001 108.352 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -151.32 99.0 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.637 0.375 . . . . 2.5899999999999999 111.494 166.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -92.17 159.1 15.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.178 0.591 . . . . 2.3999999999999999 110.595 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 p -116.23 -17.52 10.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.62 1.968 . . . . 2.1099999999999999 113.296 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.75 -50.91 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 119.151 0.887 . . . . 2.6200000000000001 108.656 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.55 175.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.45 0.643 . . . . 2.5699999999999998 110.915 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.1 p -146.33 178.26 8.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.425 2.69 . . . . 2.96 105.231 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 44.84 2.9 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.767 1.167 . . . . 3.9700000000000002 111.68 167.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 112.976 0.732 . . . . 4.0999999999999996 112.976 -169.106 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.891 0.853 . . . . 1.4099999999999999 112.327 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.08 -8.65 10.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 CA-C-N 115.327 -0.851 . . . . 2.8199999999999998 111.001 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 tp -33.63 127.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.258 1.423 . . . . 3.3100000000000001 110.569 159.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.74 -19.52 24.4 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.037 -0.868 . . . . 1.6399999999999999 113.479 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.3 mtt-85 -86.54 168.94 13.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.604 1.702 . . . . 5.1799999999999997 109.281 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.7 m -101.82 115.4 30.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.018 -0.427 . . . . 1.9299999999999999 110.353 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 149.42 45.15 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.65 -0.87 . . . . 3.5099999999999998 108.65 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.0 t -133.78 128.55 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.454 1.102 . . . . 1.8700000000000001 109.246 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.1 t -99.81 116.24 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 C-N-CA 126.346 1.858 . . . . 3.4700000000000002 106.275 168.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -94.26 160.47 14.67 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.164 1.913 . . . . 0.54000000000000004 116.164 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -41.27 -77.53 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.265 2.626 . . . . 3.2799999999999998 112.481 170.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -97.29 -179.52 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.627 1.571 . . . . 3.2400000000000002 111.147 -168.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.81 153.72 32.11 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.019 -0.734 . . . . 1.73 109.019 158.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -85.05 153.36 22.77 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.306 0.574 . . . . 2.02 109.729 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -81.97 -3.93 55.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.617 1.567 . . . . 3.0899999999999999 113.542 -168.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 53.85 32.9 15.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.377 1.071 . . . . 3.9900000000000002 110.773 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.79 14.5 30.22 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 121.08 -1.013 . . . . 2.2200000000000002 113.567 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -127.97 -27.48 2.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.926 1.291 . . . . 7.5499999999999998 110.728 -168.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.05 134.5 40.62 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.547 -1.421 . . . . 3.71 109.547 164.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.62 -24.75 33.18 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.152 0.882 . . . . 2.9399999999999999 114.872 -166.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -55.91 125.86 23.27 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 118.295 -0.86 . . . . 2.9199999999999999 109.267 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -47.38 -40.99 18.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.833 1.197 . . . . 3.6899999999999999 111.192 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -47.43 -31.3 4.0 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.56 1.544 . . . . 3.8599999999999999 111.624 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.99 -72.16 0.07 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.369 -0.604 . . . . 2.4700000000000002 109.369 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 t -63.44 -41.11 98.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 121.621 -0.674 . . . . 3.7999999999999998 109.485 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.53 -45.41 94.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.75 -0.643 . . . . 4.8899999999999997 112.27 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.44 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.339 0.2 OUTLIER -128.68 -53.08 1.24 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.476 1.034 . . . . 1.9199999999999999 113.181 173.723 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.4 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.71 -22.5 0.4 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.241 0.924 . . . . 1.03 112.201 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.1 t30 49.61 54.53 10.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.651 1.18 . . . . 2.6499999999999999 111.001 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.42 -3.45 58.34 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.672 -0.811 . . . . 2.46 111.021 162.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.35 -155.34 45.45 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.249 -1.54 . . . . 0.96999999999999997 109.249 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.8 m -65.45 150.9 47.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.444 -1.378 . . . . 2.0299999999999998 113.537 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -59.2 135.72 57.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.581 1.552 . . . . 4.0700000000000003 108.812 170.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 mt -116.55 -76.88 0.57 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.05 -1.092 . . . . 2.04 108.05 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.47 145.86 29.69 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.755 -0.831 . . . . 2.3100000000000001 108.755 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.3 163.81 30.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 123.862 0.726 . . . . 1.6899999999999999 110.221 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.47 145.87 6.01 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.456 1.979 . . . . 0.88 109.035 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.37 139.02 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.875 1.27 . . . . 2.1400000000000001 108.65 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.6 tt -101.96 139.15 23.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 123.239 0.616 . . . . 2.2400000000000002 112.22 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.35 1.63 1.92 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.395 0.998 . . . . 0.62 114.482 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.0 mm -93.61 56.91 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.214 1.507 . . . . 2.0299999999999998 110.3 -156.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.99 168.4 27.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.148 0.579 . . . . 2.5299999999999998 110.461 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 . . . . . 0 C--O 1.256 1.412 0 N-CA-C 101.995 -3.335 . . . . 5.2400000000000002 101.995 162.117 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 108.641 -0.874 . . . . 4.8399999999999999 108.641 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.95 21.77 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.49 -0.93 . . . . 1.9299999999999999 108.49 167.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.0 t -107.58 150.68 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 106.666 -1.605 . . . . 2.3100000000000001 106.666 161.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.1 96.2 3.85 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.706 -0.85 . . . . 1.52 108.706 158.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 109.32 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.876 -1.527 . . . . 2.0 106.876 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.83 125.03 39.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.571 -1.27 . . . . 1.8799999999999999 107.571 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -49.27 0.14 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 110.575 -0.157 . . . . 5.4699999999999998 110.575 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.86 -117.21 0.8 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.958 1.266 . . . . 0.76000000000000001 111.247 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.75 -60.15 1.59 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.181 -1.044 . . . . 3.2999999999999998 108.181 -164.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.01 168.24 0.43 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 127.089 2.28 . . . . 0.73999999999999999 113.96 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.79 -21.08 69.49 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.315 2.677 . . . . 1.23 111.657 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.4 141.41 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.736 1.214 . . . . 1.8600000000000001 110.937 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.0 122.31 5.6 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.119 -1.438 . . . . 2.52 107.119 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.14 168.68 36.51 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.67 -0.572 . . . . 0.71999999999999997 111.67 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.76 131.3 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.623 -0.88 . . . . 2.4100000000000001 108.623 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.3 mm -97.21 146.63 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.747 -1.575 . . . . 1.8999999999999999 106.747 161.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.86 144.51 50.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.472 -1.677 . . . . 2.1299999999999999 106.472 159.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.93 161.51 41.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.535 -0.466 . . . . 5.1200000000000001 111.758 167.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.23 170.64 15.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.541 1.136 . . . . 3.5099999999999998 108.166 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.76 165.41 36.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 104.878 -2.267 . . . . 3.4399999999999999 104.878 165.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.65 -66.14 0.85 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.326 -0.62 . . . . 5.54 109.326 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -89.38 166.12 13.93 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.219 1.007 . . . . 3.7400000000000002 110.52 -164.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -78.31 2.26 19.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.402 0.681 . . . . 3.8900000000000001 111.652 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -153.34 85.4 1.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.205 1.402 . . . . 4.6699999999999999 108.406 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.83 169.74 37.8 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 109.816 -1.313 . . . . 1.5600000000000001 109.816 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.41 133.61 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.723 2.949 . . . . 1.3 112.934 -166.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -106.93 139.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.568 0.747 . . . . 2.02 110.115 -171.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -99.5 89.71 4.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.713 0.805 . . . . 7.3899999999999997 109.223 -170.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.2 t -76.82 105.13 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 2.1800000000000002 106.878 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -113.66 140.9 47.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.817 -0.808 . . . . 1.1799999999999999 108.817 166.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.45 156.95 28.77 Favored Glycine 0 N--CA 1.448 -0.528 0 O-C-N 121.472 -0.768 . . . . 0.66000000000000003 112.008 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 p -130.36 104.38 7.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.505 -2.035 . . . . 2.7400000000000002 105.505 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.01 143.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.381 -1.34 . . . . 1.8600000000000001 107.381 -168.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -147.78 174.06 12.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.581 0.705 . . . . 4.54 112.729 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 22.26 72.38 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 114.868 -1.06 . . . . 0.66000000000000003 112.107 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -76.58 -155.38 0.06 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.475 -1.306 . . . . 1.8100000000000001 107.475 168.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -146.99 146.15 29.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.848 -2.278 . . . . 3.5499999999999998 104.848 166.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -34.19 132.96 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.719 2.408 . . . . 3.3100000000000001 113.223 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.63 -172.3 20.94 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.284 0.468 . . . . 0.68999999999999995 112.612 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.28 149.03 49.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.667 1.187 . . . . 3.4300000000000002 112.831 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.34 120.22 9.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 126.279 1.832 . . . . 0.66000000000000003 108.455 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.0 150.06 6.65 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 110.393 -1.083 . . . . 0.41999999999999998 110.393 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.87 95.83 2.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.417 -1.327 . . . . 4.0899999999999999 107.417 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.427 ' ND1' ' CE1' ' A' ' 63' ' ' HIS . 24.0 m170 -134.2 147.16 50.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.264 -1.013 . . . . 0.83999999999999997 108.264 -161.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.294 0.7 OUTLIER -99.43 126.46 52.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.194 0.997 . . . . 3.0699999999999998 109.993 168.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -85.38 -172.97 4.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.233 -1.395 . . . . 1.74 107.233 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -112.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.105 -1.443 . . . . 4.9500000000000002 107.105 161.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.213 -1.032 . . . . 2.9900000000000002 108.213 -177.197 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 107.777 -1.194 . . . . 2.3100000000000001 107.777 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.22 -88.03 0.07 OUTLIER Glycine 0 CA--C 1.522 0.485 0 N-CA-C 108.661 -1.776 . . . . 1.6699999999999999 108.661 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -71.88 179.13 5.08 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 125.057 3.838 . . . . 1.1899999999999999 112.585 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.427 ' CE1' ' ND1' ' A' ' 46' ' ' HIS . 15.4 m170 -74.23 152.7 39.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.143 -0.935 . . . . 1.5700000000000001 109.327 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -50.82 108.09 0.22 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.382 0.512 . . . . 3.0800000000000001 112.382 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -121.48 135.32 24.97 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 126.246 1.818 . . . . 3.5 109.147 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.5 -50.43 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.739 1.626 . . . . 1.3600000000000001 108.991 171.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.48 -84.09 0.25 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.94 1.296 . . . . 3.29 107.652 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.8 m -132.71 60.88 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.406 1.082 . . . . 2.4199999999999999 110.787 -168.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -77.44 158.7 29.89 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.526 -1.287 . . . . 5.0700000000000003 107.526 162.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -120.41 163.44 17.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.433 1.493 . . . . 3.8399999999999999 107.713 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -81.58 157.04 24.89 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.22 0.533 . . . . 0.75 111.043 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.88 -155.84 16.54 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 104.469 -3.453 . . . . 2.3999999999999999 104.469 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.63 -131.65 1.24 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.274 -1.53 . . . . 2.1400000000000001 109.274 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.7 -40.67 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.308 2.005 . . . . 2.1299999999999999 111.872 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.29 -46.17 42.94 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.786 0.291 . . . . 5.6200000000000001 111.786 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.95 176.69 6.93 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.505 -0.554 . . . . 2.4300000000000002 109.505 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.62 -33.55 10.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 5.1399999999999997 111.736 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 162.89 26.74 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 119.111 -1.036 . . . . 3.6200000000000001 110.183 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 133.05 0.05 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.782 2.033 . . . . 4.6600000000000001 108.864 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 46.5 m80 -50.01 144.61 6.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.177 -1.786 . . . . 0.78000000000000003 106.177 155.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.304 5.1 p -83.55 44.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 123.304 1.526 . . . . 2.27 110.795 -170.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -154.63 3.68 0.24 Allowed Glycine 0 CA--C 1.545 1.926 1 C-N-CA 131.364 4.316 . . . . 1.8400000000000001 113.125 169.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.19 99.39 8.54 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 121.651 2.726 . . . . 2.4100000000000001 107.753 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.5 mt -77.31 -44.96 27.77 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.064 0.847 . . . . 4.0199999999999996 109.103 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.58 -107.82 0.34 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.688 -0.767 . . . . 0.84999999999999998 111.216 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -149.69 171.13 17.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.648 1.579 . . . . 1.8300000000000001 109.366 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.82 172.27 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.74 -1.578 . . . . 1.8500000000000001 106.74 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.5 m -122.02 124.28 43.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.523 -1.288 . . . . 2.77 107.523 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.88 138.78 38.29 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.642 -0.503 . . . . 1.8200000000000001 109.642 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.72 -89.69 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 124.272 0.982 . . . . 2.7799999999999998 110.228 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 -57.84 1.0 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.295 1.038 . . . . 4.1799999999999997 110.085 -164.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.36 25.04 1.48 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 123.352 1.549 . . . . 2.96 110.911 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 62.91 19.71 61.4 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.917 -1.038 . . . . 0.93000000000000005 111.51 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.72 139.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.13 -1.433 . . . . 1.8799999999999999 107.13 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.99 166.18 23.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.856 1.263 . . . . 1.8600000000000001 107.887 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -128.0 143.23 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.766 -2.679 . . . . 2.8900000000000001 103.766 -173.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.39 121.7 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.381 -1.711 . . . . 1.8799999999999999 106.381 173.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -150.59 91.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.947 1.299 . . . . 1.21 108.604 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.48 144.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 107.951 -1.129 . . . . 2.9100000000000001 107.951 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -112.51 83.44 1.81 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.656 -1.609 . . . . 3.7400000000000002 106.656 161.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.28 146.29 33.06 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.1 p -108.06 -7.95 15.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.764 2.025 . . . . 2.4300000000000002 112.28 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.59 -55.53 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.78 -1.193 . . . . 2.3399999999999999 107.78 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.8 pt -70.35 176.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 122.312 1.053 . . . . 2.6699999999999999 112.008 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 m -153.4 176.96 11.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.663 1.985 . . . . 2.4199999999999999 106.233 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 -19.61 25.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.319 0.963 . . . . 4.1399999999999997 113.434 -169.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 CA--C 1.532 0.255 0 O-C-N 121.034 -1.041 . . . . 4.6600000000000001 111.857 -168.292 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.5 p . . . . . 0 N--CA 1.445 -0.686 0 CA-C-O 121.194 0.521 . . . . 1.53 111.113 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.38 -5.89 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.389 -0.823 . . . . 2.8599999999999999 110.553 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -51.49 120.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.094 -0.706 . . . . 2.5499999999999998 109.094 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.85 39.61 95.14 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.61 -0.55 . . . . 1.77 112.8 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -120.79 167.94 11.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.265 -1.383 . . . . 6.8700000000000001 107.265 158.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.7 m -91.69 118.3 30.53 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.846 0.458 . . . . 1.77 111.043 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 144.4 45.56 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.145 -1.057 . . . . 2.54 108.145 164.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.0 t -131.54 140.33 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.189 1.796 . . . . 1.4299999999999999 107.818 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.63 127.44 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.129 -1.063 . . . . 2.75 108.129 164.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -97.08 159.61 14.81 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.474 2.028 . . . . 0.40999999999999998 116.474 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -47.57 -73.4 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.257 1.823 . . . . 3.02 112.243 172.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -97.35 179.87 4.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.002 0.921 . . . . 5.1399999999999997 110.264 -172.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.61 147.96 39.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.031 -0.729 . . . . 1.75 109.031 160.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -77.32 162.73 27.07 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.278 -0.638 . . . . 1.97 109.278 167.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.13 -8.47 59.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.424 1.268 . . . . 3.0800000000000001 114.424 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 48.97 30.3 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.695 1.134 . . . . 2.27 110.89 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.56 28.18 72.85 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.152 0.882 . . . . 1.8500000000000001 112.502 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -130.41 29.48 4.84 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.034 0.917 . . . . 6.2300000000000004 111.226 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -96.44 135.2 12.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 108.467 -1.853 . . . . 3.3300000000000001 108.467 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.08 66.27 2.88 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 117.63 0.715 . . . . 2.79 112.43 -171.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -168.84 170.72 8.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 125.085 1.354 . . . . 3.3999999999999999 108.092 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -52.09 -71.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.062 0.545 . . . . 3.6099999999999999 110.897 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -47.72 -41.96 24.13 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.868 2.067 . . . . 4.6399999999999997 111.947 -162.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.2 m -46.09 -58.54 3.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.994 0.917 . . . . 3.02 112.071 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -73.07 -40.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.792 -1.193 . . . . 2.21 112.511 173.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -66.25 -36.29 82.62 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.376 1.07 . . . . 6.6699999999999999 110.549 -165.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.502 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.377 13.1 t -133.47 -46.27 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.604 0.762 . . . . 2.9500000000000002 111.562 172.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.37 -18.45 1.33 Allowed Glycine 0 N--CA 1.467 0.752 0 CA-C-N 119.886 1.221 . . . . 0.89000000000000001 112.877 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 34.36 56.28 0.66 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.077 2.551 . . . . 2.6400000000000001 112.347 -174.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.44 -1.61 27.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.417 -0.513 . . . . 2.1600000000000001 111.994 167.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.81 -163.23 45.64 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.017 -1.633 . . . . 0.94999999999999996 109.017 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.4 m -60.86 148.79 38.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.026 -1.587 . . . . 2.1299999999999999 113.822 -161.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -57.47 130.82 48.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.392 -1.277 . . . . 3.6899999999999999 107.799 165.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.7 mt -106.64 -73.1 0.7 Allowed 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 107.746 -1.205 . . . . 1.6499999999999999 107.746 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.25 144.45 34.04 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.705 -1.22 . . . . 1.72 107.705 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 85.8 m -126.87 160.58 30.53 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.522 -2.029 . . . . 2.1299999999999999 105.522 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.8 131.19 1.85 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.013 -0.835 . . . . 0.79000000000000004 111.013 169.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.6 t -62.94 134.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.669 0.788 . . . . 1.53 109.404 169.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.6 tt -95.67 134.81 31.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.714 0.293 . . . . 2.0499999999999998 111.116 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.54 3.81 0.49 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.062 0.839 . . . . 0.81000000000000005 115.033 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.8 mm -92.77 57.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.52 1.66 . . . . 2.02 110.91 -155.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.57 170.92 20.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.488 0.715 . . . . 2.6899999999999999 110.792 167.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 83.9 mt-30 . . . . . 0 C--O 1.255 1.359 0 N-CA-C 103.065 -2.939 . . . . 5.21 103.065 163.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.721 0.296 . . . . 4.75 110.643 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.26 41.71 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.003 1.321 . . . . 1.78 107.562 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.92 143.74 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 106.701 -1.592 . . . . 2.0099999999999998 106.701 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.4 93.34 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.698 . . . . 1.51 109.114 156.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.68 100.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.246 -1.39 . . . . 2.1600000000000001 107.246 164.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.9 mt -89.13 143.16 27.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.996 0.518 . . . . 2.1099999999999999 109.767 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -143.73 -64.2 0.38 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.206 -1.035 . . . . 4.9299999999999997 108.206 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.36 -122.9 13.14 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.748 -0.66 . . . . 1.1499999999999999 113.14 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -126.43 -55.98 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.387 0.613 . . . . 2.98 110.014 -152.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.31 164.15 25.07 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 110.049 -1.22 . . . . 0.82999999999999996 110.049 164.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.74 34.25 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.674 2.916 . . . . 1.1200000000000001 113.586 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.5 155.1 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.722 1.609 . . . . 2.25 109.69 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.03 125.69 9.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.799 -1.926 . . . . 2.7999999999999998 105.799 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.61 164.15 31.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.194 -0.763 . . . . 0.82999999999999996 111.194 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.636 -1.616 . . . . 2.0 106.636 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.48 144.06 9.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.432 -1.692 . . . . 3.25 106.432 161.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.5 102.72 7.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.395 1.478 . . . . 2.1800000000000002 107.104 167.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.77 118.76 21.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.615 -1.995 . . . . 3.52 105.615 169.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -142.67 145.84 33.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.52 1.055 . . . . 3.2799999999999998 108.902 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -157.18 146.06 19.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.223 -0.444 . . . . 4.5099999999999998 109.919 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -68.43 -61.26 1.91 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.275 1.03 . . . . 5.8799999999999999 109.755 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -78.48 -175.92 4.52 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 119.018 0.827 . . . . 4.1299999999999999 110.194 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -81.0 -68.68 0.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.035 -1.468 . . . . 3.0800000000000001 107.035 165.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -90.56 106.02 18.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.907 0.883 . . . . 5.5999999999999996 109.293 171.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.08 176.17 45.88 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 107.94 -2.064 . . . . 1.51 107.94 166.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.84 116.84 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.317 2.678 . . . . 1.49 110.635 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.8 t -78.62 147.39 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.312 -0.625 . . . . 1.98 109.312 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -98.14 113.37 25.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.809 -1.552 . . . . 3.9700000000000002 106.809 171.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.6 t -115.25 82.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.996 1.718 . . . . 2.29 106.974 -169.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -98.07 158.84 15.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.078 -0.712 . . . . 0.85999999999999999 109.078 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.72 158.94 29.36 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.769 -0.933 . . . . 0.72999999999999998 110.769 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.9 p -129.16 104.07 7.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.762 -1.94 . . . . 3.4900000000000002 105.762 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.7 141.95 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.082 -1.451 . . . . 1.8100000000000001 107.082 -168.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.11 159.9 41.69 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.593 1.331 . . . . 4.0899999999999999 114.593 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.4 22.84 25.79 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.957 1.742 . . . . 1.1200000000000001 111.81 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.33 -156.05 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.105 -1.072 . . . . 1.8600000000000001 108.105 166.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 m -146.27 152.17 38.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.749 -2.315 . . . . 3.7599999999999998 104.749 165.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -37.98 141.39 0.21 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.273 2.229 . . . . 2.8599999999999999 113.77 -170.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.66 -171.87 26.76 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.238 -0.437 . . . . 0.89000000000000001 112.323 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 151.47 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.286 1.035 . . . . 3.6299999999999999 112.804 -168.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -146.66 118.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.194 1.797 . . . . 1.05 108.154 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.01 154.25 3.89 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.035 -1.226 . . . . 0.64000000000000001 110.035 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -145.47 89.79 1.96 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.612 -1.255 . . . . 4.0800000000000001 107.612 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -128.72 164.58 22.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.156 -1.053 . . . . 1.22 108.156 -160.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 134.0 66.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 122.055 0.931 . . . . 3.1600000000000001 110.488 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -110.05 132.82 53.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.371 1.469 . . . . 0.96999999999999997 107.241 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -74.11 65.95 1.18 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.876 1.27 . . . . 5.7699999999999996 111.19 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.429 -1.521 0 CA-C-N 113.516 -1.675 . . . . 5.6500000000000004 107.446 168.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 110.614 -0.143 . . . . 3.0099999999999998 110.614 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.25 -126.45 3.2 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.069 -1.213 . . . . 1.54 110.069 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.15 178.68 6.63 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.894 3.062 . . . . 0.94999999999999996 112.629 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.66 126.02 28.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.519 -1.229 . . . . 1.23 108.031 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -5.56 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.243 2.217 . . . . 3.5099999999999998 113.394 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -125.81 130.51 24.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 127.318 2.247 . . . . 3.5699999999999998 108.719 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.73 -43.77 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.8 1.666 . . . . 1.3799999999999999 109.729 173.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.54 -73.11 0.42 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.718 1.207 . . . . 3.5299999999999998 107.923 172.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.5 m -154.0 83.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.423 -0.798 . . . . 3.0 109.767 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -79.5 168.52 19.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.399 -0.593 . . . . 6.0899999999999999 109.399 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -102.93 152.93 20.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 107.264 -1.384 . . . . 4.1600000000000001 107.264 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -75.41 163.21 27.66 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.114 0.87 . . . . 0.93000000000000005 110.349 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.6 -103.54 0.17 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.846 -2.502 . . . . 1.9299999999999999 106.846 167.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.26 -121.21 2.51 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.496 1.148 . . . . 2.8199999999999998 111.547 167.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -86.58 -42.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.541 2.161 . . . . 1.6200000000000001 111.306 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -64.15 0.96 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.095 -1.076 . . . . 5.7300000000000004 108.095 174.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.87 143.09 54.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.265 -0.879 . . . . 2.0699999999999998 109.34 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -54.87 -46.93 74.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 126.449 1.899 . . . . 5.21 111.667 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.59 176.57 6.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.246 1.018 . . . . 3.4700000000000002 110.924 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 154.86 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.616 1.166 . . . . 5.7699999999999996 110.995 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.457 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.6 m80 -54.53 141.86 29.77 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.682 -1.97 . . . . 0.66000000000000003 105.682 155.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.08 -17.81 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.298 -0.561 . . . . 1.79 110.973 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.4 52.37 0.75 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.506 -0.608 . . . . 1.01 114.574 162.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -96.71 124.51 40.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 105.463 -2.051 . . . . 2.3100000000000001 105.463 143.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.06 -51.64 6.52 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.33 0.968 . . . . 3.5 108.399 161.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.49 -115.35 0.64 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.713 -1.355 . . . . 1.0700000000000001 109.713 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -148.63 166.56 27.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.359 1.463 . . . . 2.2400000000000002 109.362 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.3 174.28 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.648 -1.612 . . . . 1.95 106.648 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.4 m -129.02 129.67 45.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 2.75 107.306 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 135.49 37.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.324 -0.621 . . . . 1.8200000000000001 109.324 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.84 -69.91 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.725 1.266 . . . . 4.0199999999999996 110.356 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -168.87 -53.94 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.95 2.1 . . . . 6.25 108.528 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.44 23.29 1.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.934 1.293 . . . . 3.5899999999999999 110.563 -167.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.26 4.97 75.36 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.52 1.057 . . . . 1.1799999999999999 112.182 -174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.85 154.34 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.022 -1.103 . . . . 1.8400000000000001 108.022 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.64 171.32 14.21 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.525 1.13 . . . . 1.8700000000000001 108.079 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.41 151.45 38.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 104.266 -2.494 . . . . 2.75 104.266 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.07 134.19 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 107.788 -1.19 . . . . 2.3100000000000001 107.788 145.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.3 m -155.42 61.35 0.62 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.012 1.725 . . . . 1.1200000000000001 107.748 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -105.91 155.56 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 108.036 -1.098 . . . . 2.3799999999999999 108.036 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.06 118.64 14.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.135 -0.691 . . . . 2.7000000000000002 109.135 150.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.46 -174.4 5.17 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.59 0.71 . . . . 4.0999999999999996 109.664 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.6 p -144.75 51.41 1.25 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.197 -1.038 . . . . 2.4300000000000002 108.197 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.4 -54.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.329 1.452 . . . . 2.6400000000000001 108.957 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -96.32 179.76 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.165 0.986 . . . . 2.3900000000000001 109.928 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.1 m -152.31 176.82 11.22 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.192 -1.41 . . . . 2.5899999999999999 107.192 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.65 47.96 1.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.733 1.254 . . . . 3.79 110.712 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 126.742 2.017 . . . . 4.4699999999999998 112.937 -169.862 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 111.647 0.24 . . . . 1.3999999999999999 111.647 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 15.2 pt -78.05 -10.28 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.538 -0.744 . . . . 2.8900000000000001 111.904 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.4 mm -40.6 123.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 2.9199999999999999 110.68 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.14 50.89 6.02 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.558 -0.617 . . . . 2.0699999999999998 111.558 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -136.62 153.52 50.92 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.535 1.134 . . . . 4.6600000000000001 109.264 168.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 98.7 m -79.63 115.95 19.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 124.326 1.016 . . . . 2.0099999999999998 108.397 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tt -86.03 136.5 33.22 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 118.901 0.773 . . . . 3.1499999999999999 109.427 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -124.86 120.21 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.958 -1.127 . . . . 1.5700000000000001 107.958 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.94 118.59 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 105.523 -2.029 . . . . 2.8900000000000001 105.523 161.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -90.07 162.83 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.249 1.574 . . . . 0.55000000000000004 115.249 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -38.78 -69.13 0.13 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.068 2.547 . . . . 3.23 111.907 170.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -120.75 -177.71 3.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.622 1.169 . . . . 3.3799999999999999 110.624 -167.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.62 57.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.274 -0.639 . . . . 1.4399999999999999 109.274 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -81.07 156.28 25.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.056 -0.72 . . . . 2.23 109.056 158.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -22.93 60.08 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.332 0.653 . . . . 3.5099999999999998 111.664 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.98 56.77 2.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.823 0.82 . . . . 3.4500000000000002 109.573 -168.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.87 73.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.156 -0.929 . . . . 1.6100000000000001 113.438 157.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -77.3 -23.31 51.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.932 -0.746 . . . . 7.4100000000000001 110.217 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 71.76 -118.66 7.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.415 -1.474 . . . . 4.2400000000000002 109.415 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.72 -68.44 1.57 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.334 -1.506 . . . . 3.8300000000000001 109.334 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -94.41 161.61 14.16 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.79 -1.189 . . . . 2.7599999999999998 107.79 160.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 136' ' ' LYS . 18.2 tt0 -64.62 -53.53 46.16 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.242 -0.286 . . . . 3.5299999999999998 110.649 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -49.03 -40.94 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.818 1.647 . . . . 2.9399999999999999 113.45 -169.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.9 m -47.16 -54.27 11.03 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.77 0.828 . . . . 2.6299999999999999 112.004 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -44.6 60.96 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.46 -0.775 . . . . 2.4199999999999999 111.78 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 132' ' ' GLU . 25.2 tttt -59.62 -50.84 72.33 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.976 0.911 . . . . 3.4300000000000002 111.207 -166.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.457 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.35 0.1 OUTLIER -124.7 -46.39 1.87 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.568 -0.73 . . . . 2.0 111.56 175.086 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.35 -2.1 0.67 Allowed Glycine 0 C--O 1.222 -0.652 0 CA-C-O 118.009 -1.439 . . . . 1.03 115.531 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 27.63 52.72 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.151 2.181 . . . . 4.2800000000000002 114.589 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.21 -16.42 60.48 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.416 -0.803 . . . . 2.0099999999999998 111.93 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.67 -171.32 36.08 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 109.142 -1.583 . . . . 0.95999999999999996 109.142 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -62.46 156.01 23.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.639 -1.28 . . . . 2.0699999999999998 113.564 -164.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -73.1 148.05 44.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.959 -1.019 . . . . 3.3399999999999999 111.14 173.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mt -128.73 -69.43 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.537 -1.283 . . . . 2.0 107.537 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.02 163.58 12.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.918 -0.771 . . . . 2.1000000000000001 108.918 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.9 p -165.07 160.45 18.86 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.678 -1.601 . . . . 1.9099999999999999 106.678 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.49 143.16 3.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 105.766 -2.933 . . . . 1.2 105.766 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.5 t -81.37 139.85 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 117.901 0.851 . . . . 2.1800000000000002 110.213 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.8 tt -86.49 131.88 33.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.899 0.38 . . . . 1.9399999999999999 110.484 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.83 -8.62 0.97 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.048 0.833 . . . . 0.93000000000000005 115.002 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mm -90.56 57.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.662 1.231 . . . . 2.0899999999999999 110.546 -157.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.92 175.87 5.79 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.556 0.742 . . . . 3.4399999999999999 110.465 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 C--O 1.257 1.451 0 N-CA-C 104.113 -2.551 . . . . 4.6799999999999997 104.113 164.814 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 109.972 -0.381 . . . . 4.4199999999999999 109.972 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.85 148.41 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.866 1.666 . . . . 1.8400000000000001 108.367 169.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.92 144.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.39 -0.967 . . . . 1.8500000000000001 108.39 165.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.93 97.03 5.3 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.841 -0.8 . . . . 1.6100000000000001 108.841 155.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.26 106.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.992 -1.485 . . . . 1.78 106.992 161.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -90.31 133.91 34.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 1.97 108.456 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -149.45 -50.99 0.15 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.413 0.685 . . . . 4.04 110.527 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.06 -117.5 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.352 0.977 . . . . 0.92000000000000004 113.501 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -114.33 -54.82 2.55 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.661 1.184 . . . . 4.0700000000000003 109.69 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.77 159.73 21.42 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 110.336 -1.106 . . . . 0.89000000000000001 110.336 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.11 40.6 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.342 2.695 . . . . 1.03 112.179 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.59 159.47 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.003 1.721 . . . . 1.95 108.616 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.81 135.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.948 -1.501 . . . . 2.8100000000000001 106.948 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 169.31 42.27 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.916 -1.274 . . . . 0.75 109.916 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.87 110.16 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.115 -1.439 . . . . 1.9399999999999999 107.115 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.2 125.34 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.756 -1.572 . . . . 1.9099999999999999 106.756 168.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -99.36 109.56 22.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.699 -1.963 . . . . 2.6000000000000001 105.699 166.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.01 105.56 17.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.554 -2.017 . . . . 3.6800000000000002 105.554 171.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.25 138.31 49.14 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.948 1.249 . . . . 3.6600000000000001 110.264 169.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -156.67 105.71 2.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.159 -1.052 . . . . 4.1399999999999997 108.159 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -89.36 36.38 0.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.89 0.476 . . . . 8.4399999999999995 111.33 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -125.63 -138.06 0.27 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.221 -1.4 . . . . 4.8499999999999996 107.221 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -130.3 -76.62 0.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.349 0.66 . . . . 3.7400000000000002 109.345 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -101.8 86.04 2.84 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.184 -1.784 . . . . 5.9100000000000001 106.184 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.64 34.68 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.597 -1.001 . . . . 1.95 110.597 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.92 132.11 29.27 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.512 2.808 . . . . 1.8100000000000001 112.297 -170.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.6 t -91.89 149.24 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.307 -0.997 . . . . 2.0899999999999999 108.307 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 121.67 44.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.729 -1.582 . . . . 3.73 106.729 163.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.86 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.245 1.818 . . . . 2.1699999999999999 107.25 -170.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -127.23 126.88 43.52 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 123.507 0.505 . . . . 1.4299999999999999 110.743 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.2 137.02 5.06 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.56 -1.416 . . . . 0.89000000000000001 109.56 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -116.53 110.25 18.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.929 -1.878 . . . . 3.5899999999999999 105.929 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 mm -103.1 152.81 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.595 1.958 . . . . 2.54 108.866 -164.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -149.55 156.17 41.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.28 0.844 . . . . 4.21 113.28 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.52 15.11 33.06 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.782 2.134 . . . . 0.60999999999999999 112.458 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.54 162.49 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.18 0.992 . . . . 2.5600000000000001 110.035 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.49 161.63 24.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.927 -1.138 . . . . 2.2000000000000002 107.927 157.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -56.87 174.85 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.786 0.803 . . . . 2.4399999999999999 111.775 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.8 -169.52 52.4 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.986 0.803 . . . . 0.96999999999999997 113.687 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.82 153.02 44.54 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.892 1.277 . . . . 3.3900000000000001 111.754 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -149.36 117.72 6.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.869 1.667 . . . . 0.60999999999999999 108.365 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.37 150.44 4.32 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.712 -0.955 . . . . 0.37 110.712 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -140.85 95.66 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.827 -1.545 . . . . 4.0099999999999998 106.827 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -134.11 155.97 49.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.033 -1.469 . . . . 0.81999999999999995 107.033 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.27 126.84 67.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.091 -0.707 . . . . 2.6099999999999999 109.091 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -95.2 142.58 27.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.883 1.673 . . . . 0.75 108.376 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -46.49 -64.8 0.67 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.726 1.211 . . . . 4.2599999999999998 110.935 -171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 127.706 2.403 . . . . 3.2000000000000002 114.73 155.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.188 -0.671 . . . . 2.3500000000000001 109.188 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.74 -89.11 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 107.945 -2.062 . . . . 1.73 107.945 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.56 177.65 8.25 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 124.823 3.682 . . . . 1.1200000000000001 112.948 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -66.43 142.02 57.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.921 1.688 . . . . 1.4199999999999999 107.551 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -49.49 115.66 1.43 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.402 0.681 . . . . 2.6600000000000001 110.95 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.58 111.88 9.82 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.995 1.718 . . . . 2.8500000000000001 108.819 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.6 -10.9 29.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.85 1.7 . . . . 2.0099999999999998 113.46 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -146.52 -72.64 0.23 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.745 -0.835 . . . . 3.1600000000000001 108.745 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -161.74 92.7 0.88 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.758 -1.201 . . . . 3.2000000000000002 107.758 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.29 175.53 5.68 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.048 1.739 . . . . 6.4900000000000002 108.202 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 9.9 mtpm? -133.8 153.27 51.84 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.575 1.55 . . . . 4.8700000000000001 107.397 -174.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -87.87 136.98 32.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.807 0.843 . . . . 1.28 109.908 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.68 -66.53 0.14 Allowed Glycine 0 C--O 1.222 -0.636 0 N-CA-C 107.519 -2.232 . . . . 2.7599999999999998 107.519 163.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.0 -170.21 35.37 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.007 1.289 . . . . 1.96 111.595 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.02 -42.61 5.9 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.789 2.326 . . . . 1.6799999999999999 110.343 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.35 -54.08 7.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.546 0.738 . . . . 5.5599999999999996 111.107 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.05 149.31 50.1 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.439 -0.948 . . . . 2.02 108.439 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -49.53 -51.92 33.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.058 0.943 . . . . 3.9500000000000002 110.532 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 59.5 mt-10 -76.11 152.5 36.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.751 1.262 . . . . 3.75 110.694 -163.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -175.05 134.66 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.394 1.478 . . . . 4.3099999999999996 108.177 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.448 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 34.4 m80 -50.87 137.75 20.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.154 -2.165 . . . . 0.77000000000000002 105.154 147.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.44 -24.76 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 119.342 -0.943 . . . . 1.95 109.73 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.65 33.94 4.75 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.133 -1.371 . . . . 0.93000000000000005 116.504 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -102.81 112.95 25.98 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 120.72 2.26 . . . . 2.4100000000000001 107.937 161.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.66 -57.58 3.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.449 -1.315 . . . . 2.5 107.449 160.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.85 -110.63 0.43 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.806 -0.918 . . . . 0.71999999999999997 110.806 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -146.72 169.31 19.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.666 1.186 . . . . 1.8600000000000001 109.898 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.5 176.56 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 105.998 -1.853 . . . . 1.8500000000000001 105.998 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.3 m -140.27 132.71 28.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.363 -2.088 . . . . 2.9399999999999999 105.363 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.666 0.604 . . . . 1.75 110.127 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.72 -80.98 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.119 0.968 . . . . 2.9700000000000002 109.407 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 93' ' ' GLY . 28.2 tttm -160.2 -43.54 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.563 1.145 . . . . 4.8899999999999997 111.878 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -81.99 30.61 0.38 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 123.739 1.733 . . . . 3.2599999999999998 110.833 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 64.72 17.73 63.02 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.002 1.763 . . . . 1.0700000000000001 112.571 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.52 147.82 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.54 -1.281 . . . . 2.0499999999999998 107.54 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.06 175.02 11.35 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.114 -1.439 . . . . 2.0899999999999999 107.114 166.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.31 149.95 29.22 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.386 -1.338 . . . . 3.2400000000000002 107.386 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.37 103.41 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 C-N-CA 125.621 1.569 . . . . 1.9199999999999999 106.791 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.5 m -121.48 87.52 2.77 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.377 1.471 . . . . 1.1499999999999999 107.789 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.8 mt -126.45 160.51 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.555 0.742 . . . . 2.4199999999999999 109.034 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.33 95.78 2.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.194 -0.457 . . . . 2.4100000000000001 111.503 157.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.35 154.46 25.25 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.311 0.577 . . . . 2.0499999999999998 110.243 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.1 p -107.76 -17.54 14.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.224 2.21 . . . . 2.1000000000000001 112.386 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.33 -51.3 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.259 0.936 . . . . 2.1299999999999999 109.426 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -71.81 176.23 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.858 0.837 . . . . 1.9299999999999999 111.051 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -156.85 173.7 16.6 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.877 -1.157 . . . . 2.3500000000000001 107.877 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -43.69 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.761 0.824 . . . . 3.8999999999999999 110.558 169.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.534 0.327 0 O-C-N 121.424 -0.797 . . . . 4.7000000000000002 112.389 -158.76 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.936 0 CA-C-O 121.542 0.687 . . . . 1.4199999999999999 112.829 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.4 pt -90.53 -5.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.085 0.954 . . . . 3.23 111.218 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 tp -26.55 126.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.889 1.675 . . . . 3.2200000000000002 111.876 163.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.26 -19.09 37.26 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.827 -0.985 . . . . 1.5700000000000001 113.433 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -88.81 164.08 15.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.576 1.688 . . . . 5.8300000000000001 110.807 -169.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.2 m -89.06 106.17 18.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 119.226 -0.416 . . . . 1.6699999999999999 110.603 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 mt -65.72 146.37 54.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.613 -0.835 . . . . 2.6400000000000001 108.775 166.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 80.6 t -135.47 135.46 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.443 1.897 . . . . 1.76 109.046 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.1 t -102.25 119.62 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.153 1.781 . . . . 3.5899999999999999 106.412 166.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -92.96 159.32 15.38 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 116.839 2.163 . . . . 0.42999999999999999 116.839 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -33.3 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.501 3.121 . . . . 3.3700000000000001 112.364 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -107.14 -175.98 2.95 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.059 0.845 . . . . 3.6200000000000001 110.458 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.86 142.53 45.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.504 -0.924 . . . . 1.73 108.504 158.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.21 165.95 24.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.242 -0.651 . . . . 2.2200000000000002 109.242 159.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -88.45 -7.13 57.08 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.396 1.478 . . . . 3.3500000000000001 111.227 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.28 46.16 27.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.346 1.458 . . . . 2.8100000000000001 110.2 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.27 24.06 58.45 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.644 -0.531 . . . . 1.7 113.627 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -78.34 -13.66 59.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.441 1.121 . . . . 5.8200000000000003 110.633 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.0 -133.34 11.74 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.588 -1.005 . . . . 3.8500000000000001 110.588 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.95 -68.32 1.33 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.221 -1.552 . . . . 3.3199999999999998 109.221 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.09 150.97 19.61 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.222 -1.029 . . . . 2.6499999999999999 108.222 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.24 -48.76 79.99 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.81 -0.556 . . . . 3.5 111.248 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -51.94 -33.46 37.56 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.114 1.366 . . . . 3.8500000000000001 111.777 -168.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.2 t -39.39 -62.56 0.65 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.386 1.474 . . . . 2.6899999999999999 110.466 167.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.3 p -73.77 -46.46 45.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.762 0.425 . . . . 2.0800000000000001 110.757 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -42.92 86.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.026 0.53 . . . . 3.6400000000000001 110.858 -167.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.448 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.6 p -128.33 -48.07 1.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.355 0.662 . . . . 1.99 112.127 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.31 -31.85 0.71 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.103 1.335 . . . . 1.1299999999999999 111.038 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 52.99 54.68 10.06 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.628 1.971 . . . . 3.6499999999999999 112.606 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.54 -43.11 33.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.12 0.962 . . . . 2.29 108.875 162.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 116.05 -143.42 18.07 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 107.986 -2.046 . . . . 1.25 107.986 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.5 m -60.61 149.6 34.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.574 1.149 . . . . 1.8100000000000001 112.459 -169.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -60.5 135.01 57.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 3.6499999999999999 108.878 168.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -112.19 -82.27 0.59 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.887 -1.153 . . . . 1.75 107.887 165.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.04 145.42 29.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.672 -1.233 . . . . 2.2999999999999998 107.672 171.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 77.7 m -141.24 154.29 45.7 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.137 -1.431 . . . . 2.21 107.137 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.06 128.64 1.5 Allowed Glycine 0 CA--C 1.527 0.796 0 O-C-N 123.614 0.571 . . . . 0.88 111.735 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.95 132.28 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.676 1.19 . . . . 1.49 109.223 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.1 tt -95.7 138.79 20.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 111.688 0.255 . . . . 1.8400000000000001 111.688 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.69 0.03 1.6 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.062 0.839 . . . . 0.57999999999999996 115.048 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.62 57.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 119.11 1.455 . . . . 1.8999999999999999 110.914 -157.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.39 169.07 25.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.196 0.598 . . . . 2.0899999999999999 110.547 168.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 . . . . . 0 C--O 1.253 1.272 0 N-CA-C 102.057 -3.312 . . . . 4.9199999999999999 102.057 162.701 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 108.369 -0.975 . . . . 3.8900000000000001 108.369 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.79 139.9 34.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.933 -1.506 . . . . 1.9099999999999999 106.933 153.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -98.2 147.26 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.132 -1.803 . . . . 1.9099999999999999 106.132 159.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.77 96.13 3.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.404 -0.962 . . . . 1.79 108.404 160.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.06 109.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.381 -1.34 . . . . 1.98 107.381 168.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.52 128.77 42.65 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.176 0.591 . . . . 1.8700000000000001 109.901 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -140.15 -65.05 0.47 Allowed 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.848 0.859 . . . . 4.9199999999999999 110.858 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.58 -122.74 5.81 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.791 1.186 . . . . 1.05 112.94 -170.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -118.89 -49.81 2.41 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.179 0.991 . . . . 3.0800000000000001 109.67 -155.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.3 154.96 8.06 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 108.803 -1.719 . . . . 0.96999999999999997 108.803 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.33 42.8 1.29 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.175 2.583 . . . . 1.1000000000000001 113.385 -165.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -84.98 153.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.191 1.396 . . . . 2.3199999999999998 110.298 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.61 75.69 1.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.37 -0.974 . . . . 3.52 108.37 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 165.27 16.89 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.65000000000000002 112.522 -171.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.51 133.22 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.11 0.964 . . . . 2.4300000000000002 109.546 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.6 mm -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.513 1.525 . . . . 2.0099999999999998 107.708 161.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -121.45 119.09 31.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.554 -1.646 . . . . 1.8999999999999999 106.554 158.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -128.07 120.54 27.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.442 -1.318 . . . . 4.5099999999999998 107.442 -169.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.81 165.07 37.62 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.45 0.643 . . . . 4.3700000000000001 112.191 -166.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -153.84 157.04 38.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.501 -2.037 . . . . 3.0600000000000001 105.501 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.26 -29.77 64.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.043 0.383 . . . . 5.8899999999999997 110.894 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.52 -150.5 0.43 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.946 -1.501 . . . . 5.6200000000000001 106.946 174.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.0 m -146.17 1.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.708 -1.245 . . . . 4.9800000000000004 113.866 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -124.26 39.93 3.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.067 1.747 . . . . 4.0499999999999998 109.728 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.84 -162.23 10.81 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.377 -1.089 . . . . 1.8899999999999999 110.377 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.98 114.5 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.155 2.57 . . . . 1.5700000000000001 111.139 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.1 158.54 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.089 -0.708 . . . . 1.99 109.089 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -106.37 112.54 25.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.18 -1.045 . . . . 3.2200000000000002 108.18 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -80.55 122.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.198 -1.778 . . . . 2.5899999999999999 106.198 164.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -125.98 145.54 50.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.675 -0.861 . . . . 1.29 108.675 154.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.41 155.4 26.68 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.673 -0.971 . . . . 0.76000000000000001 110.673 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -134.62 108.19 7.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.099 -2.186 . . . . 2.8500000000000001 105.099 -173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.3 149.01 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.014 -1.476 . . . . 2.1099999999999999 107.014 -167.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -155.32 157.28 36.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.957 -0.464 . . . . 4.6600000000000001 110.509 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.38 22.08 30.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.832 1.682 . . . . 0.90000000000000002 111.909 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.02 168.11 19.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.109 -1.071 . . . . 1.5800000000000001 108.109 168.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -74.85 169.17 18.45 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.216 -1.031 . . . . 2.8199999999999998 108.216 153.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.11 174.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.275 1.43 . . . . 3.9100000000000001 111.044 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -162.83 37.14 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.822 -0.626 . . . . 0.60999999999999999 113.531 167.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.67 141.23 57.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.929 1.292 . . . . 2.98 113.27 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.3 114.64 7.53 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.486 1.514 . . . . 0.73999999999999999 109.751 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.46 145.14 2.81 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.497 1.046 . . . . 0.48999999999999999 110.665 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.18 93.57 3.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 3.75 106.972 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -131.35 154.48 48.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.24 -0.437 . . . . 0.94999999999999996 109.862 -161.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.02 116.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.375 -1.342 . . . . 3.3300000000000001 107.375 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -103.84 139.67 38.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.24 -1.393 . . . . 1.1000000000000001 107.24 170.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.35 35.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.802 1.408 . . . . 5.3399999999999999 114.802 -171.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.7 mt-10 . . . . . 0 C--O 1.234 0.278 0 O-C-N 120.507 -1.371 . . . . 3.3700000000000001 112.365 -159.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.058 0 N-CA-C 108.284 -1.006 . . . . 2.9199999999999999 108.284 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.15 -91.84 1.63 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.726 -1.75 . . . . 1.6699999999999999 108.726 173.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.74 -179.06 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 125.843 4.362 . . . . 1.27 112.7 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -53.1 131.6 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.615 1.566 . . . . 1.4399999999999999 110.236 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -42.44 114.03 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.771 1.228 . . . . 4.2000000000000002 109.712 170.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -156.29 165.95 17.51 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 106.671 -1.603 . . . . 3.2400000000000002 106.671 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.39 -35.09 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.549 1.499 . . . . 1.47 111.487 -167.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -147.22 -82.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.876 0.87 . . . . 3.8999999999999999 109.194 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.4 m -139.03 64.94 1.46 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.383 1.073 . . . . 2.5699999999999998 110.617 -168.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -77.67 175.27 10.07 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.532 0.682 . . . . 4.8700000000000001 109.3 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -120.83 146.47 46.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.473 1.509 . . . . 3.9300000000000002 107.189 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -72.31 167.31 20.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.568 0.747 . . . . 1.29 110.873 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.03 -138.45 2.68 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 106.699 -2.56 . . . . 2.0099999999999998 106.699 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.75 -144.26 4.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.882 -2.087 . . . . 2.2400000000000002 107.882 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.57 -41.24 6.47 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.176 1.988 . . . . 2.1000000000000001 109.901 174.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -58.03 7.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.724 0.81 . . . . 6.4800000000000004 111.802 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.16 145.44 37.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.576 -0.528 . . . . 2.04 109.576 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -55.97 -44.54 78.6 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.77 1.628 . . . . 4.1200000000000001 111.156 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -78.92 179.45 7.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.012 0.925 . . . . 2.8700000000000001 111.243 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 157.67 144.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.391 3.076 . . . . 3.8300000000000001 106.369 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.439 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.4 m80 -59.96 141.23 55.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 105.536 -2.024 . . . . 0.55000000000000004 105.536 156.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.68 71.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 123.117 1.437 . . . . 2.4300000000000002 108.165 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.26 26.73 0.26 Allowed Glycine 0 CA--C 1.542 1.774 0 C-N-CA 126.779 2.133 . . . . 2.1200000000000001 113.59 -155.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -130.51 145.75 51.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 120.518 2.159 . . . . 2.5099999999999998 108.032 146.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -104.95 -42.36 5.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.794 0.837 . . . . 2.71 108.79 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.28 -121.82 1.11 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 109.076 -1.61 . . . . 0.68000000000000005 109.076 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -139.82 169.22 18.12 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.381 1.473 . . . . 2.3799999999999999 109.076 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.34 175.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 1.73 106.653 163.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -106.68 142.63 36.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.967 -1.494 . . . . 3.2999999999999998 106.967 156.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.75 152.05 31.7 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.24 -1.022 . . . . 1.53 108.24 152.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.32 -78.9 0.09 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.666 0.786 . . . . 2.8599999999999999 110.303 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -154.39 -52.43 0.09 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.716 1.606 . . . . 5.54 107.948 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.63 4.03 17.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.084 1.754 . . . . 5.0099999999999998 111.748 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.07 10.16 72.25 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.907 1.241 . . . . 0.84999999999999998 111.682 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -79.17 147.38 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 1.75 107.694 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.05 167.76 21.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.244 1.018 . . . . 1.99 108.755 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -130.64 144.59 51.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 103.901 -2.629 . . . . 2.7000000000000002 103.901 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.06 111.04 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 106.704 -1.591 . . . . 1.97 106.704 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -140.17 104.82 4.9 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.952 0.901 . . . . 1.54 108.773 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.04 151.9 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.662 -0.866 . . . . 2.7799999999999998 108.662 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.32 98.55 3.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.626 0.37 . . . . 2.5899999999999999 110.152 158.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.58 160.12 20.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.512 0.325 . . . . 2.6400000000000001 110.155 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -116.95 57.18 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.353 1.461 . . . . 2.5099999999999998 109.312 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -139.56 -64.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 108.025 -1.102 . . . . 1.97 108.025 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -75.88 175.58 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.345 0.593 . . . . 2.73 110.905 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -153.94 176.0 12.7 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.554 1.541 . . . . 2.52 107.01 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 11.78 33.63 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.676 1.58 . . . . 3.1699999999999999 114.486 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.464 0.261 0 CA-C-N 118.362 0.528 . . . . 3.23 111.654 -170.919 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 110.528 -0.175 . . . . 2.04 110.528 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.5 pt -78.96 -7.05 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.208 -0.308 . . . . 3.0299999999999998 110.28 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -44.98 129.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.267 0.627 . . . . 2.4100000000000001 109.744 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.21 -5.36 84.47 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 118.143 -1.365 . . . . 1.3400000000000001 113.839 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -98.26 162.3 13.26 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 120.199 2.0 . . . . 4.9299999999999997 111.655 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.0 m -94.65 107.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.059 0.943 . . . . 2.0800000000000001 109.319 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.83 133.52 45.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.398 -0.964 . . . . 2.5699999999999998 108.398 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.94 134.23 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 126.846 2.058 . . . . 1.72 106.516 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -101.47 128.84 53.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.624 -1.621 . . . . 2.6600000000000001 106.624 165.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -104.86 161.13 14.45 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 116.037 1.865 . . . . 0.56999999999999995 116.037 -169.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -37.32 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.41 2.684 . . . . 3.4100000000000001 112.06 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -101.27 -174.85 2.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.599 0.636 . . . . 3.4500000000000002 109.905 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.11 156.94 11.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.722 -0.844 . . . . 1.6799999999999999 108.722 157.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -80.4 164.59 22.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.902 0.858 . . . . 2.1600000000000001 109.14 152.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.418 ' CB ' ' HG ' ' A' ' 134' ' ' SER . 73.5 m-20 -88.06 -4.61 58.76 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.321 1.448 . . . . 3.2400000000000002 112.354 -172.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 56.16 33.79 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.638 1.175 . . . . 2.5 110.561 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.98 25.33 65.93 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.392 -0.671 . . . . 1.4399999999999999 112.46 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -131.97 21.11 4.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.261 1.031 . . . . 6.0199999999999996 111.731 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.32 147.04 18.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.707 -0.957 . . . . 3.4700000000000002 110.707 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.73 60.07 2.95 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.874 -0.89 . . . . 3.2200000000000002 110.874 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -176.67 106.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 105.232 -2.136 . . . . 2.8300000000000001 105.232 -169.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -31.92 46.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.021 0.749 . . . . 3.8199999999999998 113.021 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -36.01 -43.61 0.33 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.076 1.75 . . . . 2.9399999999999999 112.783 166.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.418 ' HG ' ' CB ' ' A' ' 125' ' ' ASP . 20.9 t -43.78 -63.91 0.76 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.954 1.701 . . . . 3.2799999999999998 110.205 173.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.39 -46.11 61.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.818 -0.551 . . . . 3.0099999999999998 110.988 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -56.06 -45.75 79.18 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 123.642 0.777 . . . . 4.0499999999999998 110.875 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.439 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 2.7 p -130.81 -47.88 1.04 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 119.127 -0.463 . . . . 2.4700000000000002 112.022 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.41 -31.2 0.86 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.699 0.682 . . . . 1.0 112.647 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.41 54.21 5.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.098 1.359 . . . . 2.3100000000000001 110.09 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.83 -36.03 81.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.23 1.412 . . . . 2.4199999999999999 112.792 174.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 -174.05 49.77 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.396 -1.882 . . . . 0.91000000000000003 108.396 -160.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.1 m -59.53 151.61 23.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.439 1.495 . . . . 2.0699999999999998 113.385 -166.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 50' ' ' GLU . 4.8 mmt-85 -60.6 135.0 57.63 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.114 1.366 . . . . 4.0499999999999998 108.522 168.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.4 mt -112.19 -68.93 0.9 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.618 -1.253 . . . . 1.6100000000000001 107.618 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.6 166.41 11.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.185 -0.461 . . . . 2.0099999999999998 110.209 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.2 p -146.81 161.12 41.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.953 -1.021 . . . . 2.5299999999999998 108.507 165.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.94 131.62 1.57 Allowed Glycine 0 CA--C 1.526 0.779 0 O-C-N 125.07 1.481 . . . . 0.79000000000000004 110.288 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.13 134.6 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 123.743 0.817 . . . . 2.1400000000000001 109.433 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.4 tt -91.8 126.37 44.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 C-N-CA 123.236 0.615 . . . . 1.9399999999999999 111.439 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.74 -5.75 0.84 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.467 1.032 . . . . 0.70999999999999996 114.911 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.82 59.54 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.816 1.308 . . . . 2.46 110.297 -155.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.49 175.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.866 0.841 . . . . 2.2799999999999998 113.181 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 C--O 1.248 1.001 0 N-CA-C 104.555 -2.387 . . . . 6.7000000000000002 104.555 160.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 pttt . . . . . 0 N--CA 1.457 -0.098 0 N-CA-C 112.002 0.371 . . . . 5.2300000000000004 112.002 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.42 155.09 19.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.718 1.207 . . . . 1.8200000000000001 109.043 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.24 151.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.614 -1.254 . . . . 1.78 107.614 162.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.75 102.39 6.07 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.86 0.864 . . . . 1.96 108.765 157.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.61 105.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.149 -1.426 . . . . 1.8999999999999999 107.149 161.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -86.18 129.7 34.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.005 -1.109 . . . . 2.0299999999999998 108.005 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -151.58 -51.69 0.12 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.958 0.408 . . . . 4.0 110.552 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.24 -111.16 1.06 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.472 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.99 -48.44 2.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.483 1.113 . . . . 3.6299999999999999 109.429 -161.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.65 171.65 33.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.212 1.387 . . . . 0.84999999999999998 112.048 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -69.64 -19.05 37.2 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.587 2.858 . . . . 1.3799999999999999 111.961 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.68 146.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.203 1.401 . . . . 1.9399999999999999 111.072 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.11 122.05 5.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.783 -0.821 . . . . 2.6000000000000001 108.783 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.41 169.75 32.79 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.843 -0.503 . . . . 0.72999999999999998 111.843 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.84 113.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.059 -1.089 . . . . 2.4300000000000002 108.059 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -79.49 137.16 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.936 -1.135 . . . . 1.9399999999999999 107.936 167.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -109.66 118.46 36.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.008 -1.849 . . . . 1.9199999999999999 106.008 157.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.04 98.04 7.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.575 1.55 . . . . 4.2800000000000002 106.89 176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -109.13 137.13 47.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.441 -0.948 . . . . 5.1699999999999999 108.441 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -147.42 -62.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.54 -0.911 . . . . 4.0599999999999996 108.54 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 tttp 72.82 -48.41 0.68 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.834 1.654 . . . . 9.5 112.243 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 99.75 5.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.69 -1.226 . . . . 3.7799999999999998 107.69 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.4 t -19.36 -66.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.854 2.461 . . . . 3.5499999999999998 114.954 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -109.61 27.16 9.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.564 0.746 . . . . 4.4500000000000002 110.579 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.42 171.49 33.67 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.562 -1.015 . . . . 1.6399999999999999 110.562 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.13 139.5 66.99 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.948 1.766 . . . . 1.3100000000000001 110.257 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.81 159.86 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.274 -1.01 . . . . 2.4199999999999999 108.274 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 110.85 13.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.28 -1.378 . . . . 4.2300000000000004 107.28 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.73 118.04 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 127.124 2.17 . . . . 2.1099999999999999 107.139 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -139.03 167.22 22.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.935 -0.395 . . . . 1.2 109.935 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.15 175.31 38.95 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.699 -1.76 . . . . 1.01 108.699 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.1 p -130.15 113.84 14.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.807 -2.294 . . . . 2.5699999999999998 104.807 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.31 109.81 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.283 -2.117 . . . . 2.21 105.283 -166.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -111.38 162.61 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.731 0.645 . . . . 4.5800000000000001 111.731 -166.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.55 80.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.219 -0.901 . . . . 0.78000000000000003 112.95 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -69.44 160.51 31.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.588 1.194 . . . . 1.6499999999999999 108.488 172.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.42 163.88 17.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.949 -1.13 . . . . 2.6299999999999999 107.949 154.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -58.61 170.11 0.82 Allowed 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.443 -0.786 . . . . 2.8900000000000001 111.295 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.58 -158.87 53.66 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.655 -0.702 . . . . 0.77000000000000002 112.693 165.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -70.86 144.44 50.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.849 1.259 . . . . 3.8500000000000001 112.59 -171.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -146.36 118.5 8.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.909 1.684 . . . . 0.85999999999999999 109.294 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.99 149.86 4.18 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.923 -0.871 . . . . 0.35999999999999999 110.923 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -142.84 94.91 2.69 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.834 -1.543 . . . . 3.6499999999999999 106.834 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -136.6 144.82 44.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.704 -1.221 . . . . 0.81999999999999995 107.704 -164.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.2 p -99.63 127.03 52.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 119.17 0.896 . . . . 2.8900000000000001 109.894 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -97.1 136.23 37.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.356 -1.35 . . . . 0.77000000000000002 107.356 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.76 -32.29 59.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.169 0.988 . . . . 4.3200000000000003 112.111 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 CA--C 1.535 0.382 0 C-N-CA 128.525 2.73 . . . . 3.0299999999999998 113.068 158.352 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.612 0.244 . . . . 2.4900000000000002 110.606 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.55 -85.31 1.15 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.684 -1.767 . . . . 1.49 108.684 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.1 178.88 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.607 1 C-N-CA 125.774 4.316 . . . . 1.01 113.308 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -67.96 132.88 48.13 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.572 1.549 . . . . 1.3100000000000001 110.106 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -44.99 114.03 0.66 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.942 0.897 . . . . 4.4900000000000002 111.68 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.92 157.36 31.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.634 1.574 . . . . 3.48 106.875 168.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.06 -24.13 13.03 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.958 1.772 . . . . 1.5600000000000001 113.609 -168.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.0 tp -156.2 -72.32 0.11 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.03 0.832 . . . . 4.4699999999999998 110.856 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.6 m -154.09 63.21 0.7 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.266 0.555 . . . . 2.75 110.21 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -78.09 168.76 19.38 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.353 -0.98 . . . . 4.7199999999999998 108.353 162.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -128.76 165.11 21.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.026 1.331 . . . . 5.5499999999999998 108.214 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -94.66 132.25 39.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.665 -0.865 . . . . 1.1699999999999999 108.665 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.92 -56.84 0.08 OUTLIER Glycine 0 C--O 1.224 -0.522 0 N-CA-C 108.095 -2.002 . . . . 2.96 108.095 171.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 140.33 173.41 13.34 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.457 1.503 . . . . 2.0299999999999998 110.083 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.04 -31.13 66.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.902 2.402 . . . . 2.1600000000000001 111.037 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -73.84 -40.63 63.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.099 0.96 . . . . 4.7800000000000002 111.059 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -70.42 176.12 4.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.91 0.884 . . . . 1.8500000000000001 111.288 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.48 -48.96 20.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.386 1.074 . . . . 4.4299999999999997 109.734 168.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.38 149.85 26.45 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.654 1.216 . . . . 3.4700000000000002 112.185 -171.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -168.1 129.28 1.38 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.977 2.111 . . . . 6.6100000000000003 107.488 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.459 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 50.1 m80 -51.62 131.58 29.88 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.463 -2.421 . . . . 0.63 104.463 145.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.09 -35.47 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.933 -0.765 . . . . 2.4300000000000002 108.933 -169.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.76 38.95 2.98 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.537 1.065 . . . . 0.87 115.289 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -90.16 129.21 36.46 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.206 -2.146 . . . . 2.3799999999999999 105.206 152.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.67 -51.75 6.25 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.735 -1.209 . . . . 3.0 107.735 156.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.35 -104.63 0.26 Allowed Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.977 -1.249 . . . . 0.62 109.977 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -148.49 170.64 17.59 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.799 1.64 . . . . 2.1899999999999999 109.57 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.81 162.32 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.069 -1.456 . . . . 1.78 107.069 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.6 m -109.4 129.79 55.53 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 108.012 -1.107 . . . . 3.1800000000000002 108.012 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.51 139.26 34.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.744 0.818 . . . . 1.8799999999999999 111.513 168.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.13 -90.67 0.08 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 124.045 0.841 . . . . 3.0800000000000001 110.574 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 93' ' ' GLY . 1.1 tpmt? -141.2 -34.38 0.49 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.395 0.887 . . . . 5.0499999999999998 113.395 -162.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -78.81 14.75 1.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.911 1.339 . . . . 3.6699999999999999 110.385 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 62.33 20.88 61.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.115 -1.194 . . . . 0.72999999999999998 110.115 -166.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -92.24 117.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 123.995 0.918 . . . . 2.4199999999999999 108.573 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.21 143.81 26.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.899 -1.889 . . . . 2.0800000000000001 105.899 149.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.35 108.1 8.97 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 105.44 -2.059 . . . . 5.21 105.44 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.85 141.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.84 -1.073 . . . . 2.5800000000000001 110.601 -148.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.7 t -146.13 113.29 6.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.188 -1.412 . . . . 4.29 107.188 162.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.4 mt -137.15 144.86 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 105.88 -1.896 . . . . 2.5499999999999998 105.88 166.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -125.71 96.36 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.945 0.35 . . . . 2.46 111.945 165.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.9 145.39 34.13 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.274 0.559 . . . . 2.6299999999999999 110.719 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.6 p -98.35 -20.52 17.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.394 1.878 . . . . 2.1699999999999999 111.27 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.42 -49.6 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.305 0.502 . . . . 1.8600000000000001 109.875 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.2 pt -75.43 177.74 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.761 0.791 . . . . 2.73 111.438 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.8 m -157.41 175.76 13.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.78 1.632 . . . . 2.23 107.417 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.1 mt -124.31 54.99 1.32 Allowed 'General case' 0 C--N 1.338 0.08 0 C-N-CA 124.534 1.133 . . . . 5.2300000000000004 108.754 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 126.203 1.801 . . . . 3.6200000000000001 107.351 174.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.2 m . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 108.591 -0.892 . . . . 2.6400000000000001 108.591 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 pp -78.78 -24.36 13.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.693 -0.403 . . . . 3.1299999999999999 110.449 -163.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 tp -1.79 113.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.33 2.652 . . . . 3.02 114.099 161.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.59 37.62 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.971 0.796 . . . . 1.74 113.183 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -83.0 169.48 15.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.542 1.171 . . . . 4.71 110.24 -171.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.2 m -95.45 108.81 21.05 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.735 -0.603 . . . . 2.02 110.459 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.84 131.32 44.3 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.368 -1.345 . . . . 2.5299999999999998 107.368 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.09 139.89 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 127.265 2.226 . . . . 1.6200000000000001 107.845 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 m -108.86 130.19 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.85 -0.796 . . . . 2.9100000000000001 108.85 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -99.09 159.79 14.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 116.01 1.856 . . . . 0.40000000000000002 116.01 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -40.65 -74.66 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.302 2.241 . . . . 3.0899999999999999 112.562 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -97.13 -179.34 4.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.198 1.399 . . . . 3.3100000000000001 110.637 -171.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.38 149.96 5.2 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 1.75 109.473 156.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.5 149.04 26.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.152 -1.055 . . . . 2.1400000000000001 108.152 162.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.72 -8.6 59.34 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.233 0.827 . . . . 3.4199999999999999 113.233 -164.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 47.48 38.12 7.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.169 0.985 . . . . 3.2999999999999998 110.413 -165.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.25 25.48 57.42 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.533 -0.758 . . . . 2.0 113.001 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -113.85 40.38 2.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.22 1.01 . . . . 6.1100000000000003 108.655 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.0 134.6 9.0 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.895 -1.682 . . . . 3.1499999999999999 108.895 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.67 -35.51 92.13 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 117.509 0.655 . . . . 2.79 111.756 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -58.71 107.94 0.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.961 0.904 . . . . 2.6400000000000001 108.719 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -41.93 -42.65 2.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 3.8999999999999999 112.817 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -36.43 -41.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.73 2.012 . . . . 3.5800000000000001 113.978 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.5 m -54.93 -48.26 73.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.452 0.701 . . . . 2.73 111.631 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.7 p -73.08 -46.33 52.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.361 -0.837 . . . . 2.0 110.482 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -51.83 -49.74 62.23 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.685 1.194 . . . . 3.3599999999999999 111.264 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.459 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.9 OUTLIER -125.0 -46.52 1.82 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.607 0.763 . . . . 1.9399999999999999 111.142 175.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.91 2.02 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 119.086 0.857 . . . . 0.93999999999999995 112.197 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.64 54.28 9.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.187 1.795 . . . . 2.1800000000000002 111.181 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.01 -5.36 58.28 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.26 -0.9 . . . . 2.2799999999999998 111.804 169.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.74 -165.23 45.71 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.083 -1.607 . . . . 0.93999999999999995 109.083 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.1 m -57.94 150.85 19.56 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.554 1.542 . . . . 1.8 113.678 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.1 mmt-85 -54.7 135.79 46.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.082 -1.417 . . . . 3.6299999999999999 108.275 164.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.5 mt -106.89 -76.63 0.61 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.953 -1.499 . . . . 1.74 106.953 166.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 144.98 32.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.477 -0.934 . . . . 1.72 108.477 170.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.46 150.36 48.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.119 -1.808 . . . . 1.71 106.119 172.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.48 119.94 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.424 -1.07 . . . . 0.93999999999999995 110.424 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.47 130.21 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.046 1.338 . . . . 2.2200000000000002 108.923 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.7 tt -105.65 133.12 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.962 0.727 . . . . 2.4300000000000002 112.962 -169.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.87 8.43 0.47 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.313 0.959 . . . . 0.82999999999999996 114.205 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.7 mm -91.88 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 120.045 1.922 . . . . 2.3199999999999998 109.867 -162.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.7 176.83 12.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.952 1.301 . . . . 2.1200000000000001 108.333 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--O 1.254 1.331 0 N-CA-C 107.014 -1.476 . . . . 5.3600000000000003 107.014 166.703 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 108.502 -0.925 . . . . 4.6600000000000001 108.502 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.63 141.19 49.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.948 -1.131 . . . . 1.6699999999999999 107.948 159.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.0 t -103.81 142.83 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.195 -1.409 . . . . 1.6299999999999999 107.195 163.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.35 96.9 5.22 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.13 0.972 . . . . 1.54 108.418 158.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.41 106.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.083 -1.451 . . . . 1.77 107.083 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 mt -99.17 133.95 42.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.166 0.986 . . . . 2.0600000000000001 109.196 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -143.47 -52.27 0.35 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.108 0.563 . . . . 4.1600000000000001 110.066 172.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.7 -121.67 27.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.878 0.751 . . . . 0.88 113.286 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -120.28 -54.66 2.09 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 125.128 1.371 . . . . 3.9900000000000002 110.008 -164.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.5 162.96 13.66 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.756 -1.338 . . . . 0.83999999999999997 109.756 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.52 33.54 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.389 2.726 . . . . 0.95999999999999996 113.141 -172.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.17 155.79 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.784 1.234 . . . . 2.1000000000000001 108.956 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -154.98 122.21 5.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.507 1.523 . . . . 3.3199999999999998 107.243 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.41 169.09 38.36 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.883 -0.887 . . . . 0.57999999999999996 110.883 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.06 109.07 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.784 -1.562 . . . . 2.1000000000000001 106.784 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.0 mm -79.03 126.45 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.531 -1.655 . . . . 1.8 106.531 168.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -101.99 109.08 20.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.63 -1.618 . . . . 1.6499999999999999 106.63 160.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.31 96.43 10.66 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.028 -1.842 . . . . 4.0099999999999998 106.028 168.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.58 165.37 15.51 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.425 -0.954 . . . . 3.23 108.425 163.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -157.24 -50.39 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.279 0.632 . . . . 3.9399999999999999 109.411 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt 70.99 -61.33 0.48 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 127.594 2.358 . . . . 4.8499999999999996 111.156 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -80.89 118.86 22.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.083 -0.71 . . . . 4.1600000000000001 109.083 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 m -20.24 -66.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.233 3.013 . . . . 3.8799999999999999 116.05 -172.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -123.9 52.55 1.45 Allowed 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 107.623 -1.251 . . . . 4.6299999999999999 107.623 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.98 178.09 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.761 -1.336 . . . . 1.8400000000000001 109.761 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.01 132.7 30.92 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.107 1.871 . . . . 1.8700000000000001 111.283 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.6 124.2 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 108.747 -0.834 . . . . 2.2799999999999998 108.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -99.3 89.99 4.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.434 2.694 . . . . 6.2199999999999998 105.538 -170.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 t -83.54 126.1 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.138 1.775 . . . . 2.1899999999999999 107.161 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -140.69 140.23 34.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.715 -0.846 . . . . 0.90000000000000002 108.715 158.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.48 145.75 8.75 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 105.806 -2.918 . . . . 0.82999999999999996 105.806 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.4 m -127.13 78.49 1.81 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.2 -1.778 . . . . 3.5800000000000001 106.2 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.38 134.15 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 128.38 2.672 . . . . 1.8899999999999999 108.48 -162.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -129.48 163.01 26.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 118.741 0.701 . . . . 5.2400000000000002 111.475 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.09 24.27 52.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.113 0.863 . . . . 0.89000000000000001 111.993 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.16 -150.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.497 -1.297 . . . . 1.6299999999999999 107.497 163.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 m -147.34 152.35 38.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.36 -2.459 . . . . 3.8199999999999998 104.36 164.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -32.8 138.1 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.484 2.314 . . . . 2.7999999999999998 113.862 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.77 -166.4 28.92 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.212 0.434 . . . . 0.78000000000000003 112.995 167.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.29 147.24 53.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.091 1.356 . . . . 3.3100000000000001 112.829 -166.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -149.39 115.57 5.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.796 1.639 . . . . 0.65000000000000002 109.002 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.23 155.83 2.51 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.749 0.704 . . . . 0.58999999999999997 111.449 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -149.25 100.6 3.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.69 -0.855 . . . . 4.0599999999999996 108.69 -169.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -137.59 175.42 9.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.596 -1.261 . . . . 0.87 107.596 -166.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.76 137.73 56.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.837 0.827 . . . . 2.8999999999999999 109.135 165.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -101.3 178.76 4.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.673 1.589 . . . . 0.93000000000000005 107.224 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -107.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.251 -1.018 . . . . 5.54 108.251 174.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 CA--C 1.529 0.163 0 C-N-CA 125.194 1.397 . . . . 3.2000000000000002 111.591 174.25 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 121.586 0.708 . . . . 2.52 110.723 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.44 -89.56 0.97 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.356 -1.898 . . . . 1.9399999999999999 108.356 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.87 179.02 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 125.136 3.89 . . . . 1.4399999999999999 112.919 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -65.46 138.4 58.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.16 1.784 . . . . 1.53 111.694 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -45.18 108.45 0.12 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.085 1.754 . . . . 3.48 111.993 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -150.24 154.82 36.73 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 125.727 1.611 . . . . 3.3999999999999999 107.454 166.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.51 -42.0 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.17 1.913 . . . . 1.54 112.667 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -142.33 -68.07 0.37 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.029 0.531 . . . . 4.4500000000000002 110.937 -175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -154.12 64.92 0.7 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.632 -0.668 . . . . 2.8199999999999998 111.532 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -78.02 166.25 23.05 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.952 -1.129 . . . . 4.8200000000000003 107.952 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -123.71 176.93 5.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.26 1.824 . . . . 6.1399999999999997 106.846 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -101.63 148.62 25.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.982 -0.449 . . . . 1.1599999999999999 111.515 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.58 -61.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.465 -1.054 . . . . 2.9700000000000002 110.465 173.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.23 -172.55 29.28 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.904 1.24 . . . . 2.1899999999999999 114.206 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 -41.49 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.769 2.313 . . . . 1.95 109.787 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -70.64 -47.55 59.47 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.735 0.814 . . . . 6.0700000000000003 111.239 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.84 175.21 1.56 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.108 -0.496 . . . . 2.5600000000000001 109.681 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.6 -39.92 21.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.986 -0.746 . . . . 8.0 108.986 165.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 147.14 39.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 117.237 -1.785 . . . . 3.8100000000000001 110.576 -165.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 167.58 127.89 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.548 2.339 . . . . 3.98 108.262 -167.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 53.7 m80 -49.25 127.63 15.2 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 106.815 -1.55 . . . . 1.1000000000000001 106.815 163.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 p -52.69 -34.62 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.544 0.572 . . . . 2.3500000000000001 112.544 -154.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.76 83.42 0.77 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.967 -0.853 . . . . 1.25 110.967 166.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -161.98 111.74 1.54 Allowed 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.789 -0.83 . . . . 2.4399999999999999 108.84 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -90.02 -53.01 4.67 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.883 0.473 . . . . 3.3999999999999999 110.743 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.62 -102.74 0.22 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.572 -0.823 . . . . 0.81000000000000005 111.998 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.18 166.79 27.77 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.92 1.288 . . . . 2.1000000000000001 110.176 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.62 175.58 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.865 1.666 . . . . 1.73 106.612 167.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 t -127.36 134.43 49.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.624 -0.88 . . . . 2.6800000000000002 108.624 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.74 135.99 36.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 123.227 0.611 . . . . 1.6799999999999999 110.411 165.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.19 -92.16 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.795 1.638 . . . . 3.1899999999999999 110.238 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -115.03 -67.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.616 0.767 . . . . 6.8600000000000003 110.864 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.3 -32.44 49.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 122.062 0.934 . . . . 3.4700000000000002 110.262 -168.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.24 46.41 0.07 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.597 -2.201 . . . . 1.3100000000000001 107.597 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.51 111.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.36 1.864 . . . . 1.8200000000000001 106.901 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.33 174.29 5.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.091 -1.078 . . . . 1.9399999999999999 108.091 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -145.52 149.61 34.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.787 -1.56 . . . . 3.1000000000000001 106.787 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.16 54.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.288 0.992 . . . . 2.04 111.293 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.3 m -70.07 91.8 0.71 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.839 -0.538 . . . . 1.76 110.717 165.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.62 149.83 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.926 0.89 . . . . 2.7200000000000002 108.646 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -113.23 89.6 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.729 -0.841 . . . . 3.7400000000000002 108.729 160.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -77.88 148.54 34.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.224 0.92 . . . . 2.3500000000000001 109.77 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.3 p -115.01 -6.69 12.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.926 1.69 . . . . 2.71 112.729 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.4 t -78.79 -54.73 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 119.546 1.066 . . . . 2.6699999999999999 109.615 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -86.85 176.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.977 0.894 . . . . 1.98 111.403 178.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -145.17 160.94 40.66 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.093 -1.817 . . . . 2.5 106.093 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.93 24.9 7.9 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.064 0.946 . . . . 3.48 111.644 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 CA--C 1.534 0.349 0 C-N-CA 123.069 0.548 . . . . 3.3700000000000001 109.657 -178.239 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 121.786 0.803 . . . . 1.46 112.408 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.2 pt -84.12 -5.72 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.961 -0.563 . . . . 3.2799999999999998 111.429 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -51.0 136.59 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 O-C-N 122.016 -0.427 . . . . 3.1000000000000001 110.207 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.88 30.01 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.614 -1.103 . . . . 1.76 112.45 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -89.59 166.06 13.87 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.8 1.8 . . . . 5.46 112.614 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 m -85.54 104.09 14.98 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.537 0.735 . . . . 2.1000000000000001 109.878 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tt -69.42 147.8 50.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.585 -0.894 . . . . 3.1099999999999999 108.585 170.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.56 128.85 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.339 1.056 . . . . 1.5700000000000001 109.088 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -100.66 125.7 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 106.429 -1.693 . . . . 3.3300000000000001 106.429 162.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -98.29 174.17 6.63 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.316 1.846 . . . . 0.51000000000000001 115.035 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.497 -1.229 . . . . 4.96 111.984 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -178.42 6.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 121.079 1.763 . . . . 4.4199999999999999 110.98 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.38 156.25 13.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.213 -0.903 . . . . 1.9099999999999999 109.671 164.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.39 151.24 28.02 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.256 1.023 . . . . 2.9199999999999999 110.027 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.55 -10.64 58.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.623 0.769 . . . . 3.1499999999999999 112.679 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 49.06 35.57 7.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.394 1.478 . . . . 3.0699999999999998 110.904 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.96 22.28 54.54 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 121.494 -0.754 . . . . 1.99 112.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -116.88 -33.5 4.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.871 0.836 . . . . 6.0300000000000002 110.967 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.64 137.15 39.64 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.474 -0.65 . . . . 3.7000000000000002 111.474 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.04 69.31 1.6 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.082 0.849 . . . . 3.1200000000000001 112.27 -170.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -162.33 155.47 20.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.74 1.616 . . . . 2.6800000000000002 107.096 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.42 -40.8 97.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.227 0.467 . . . . 3.21 112.237 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -57.55 -30.94 65.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.032 0.533 . . . . 2.77 111.37 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -49.44 -69.68 0.11 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.965 0.906 . . . . 2.6499999999999999 110.277 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.2 p -69.28 -42.42 75.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.461 -0.774 . . . . 2.04 110.422 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -61.42 -35.62 78.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.31 0.505 . . . . 4.2699999999999996 111.892 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.416 1.3 t -139.11 -58.3 0.6 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.919 -1.039 . . . . 3.2000000000000002 113.203 177.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.06 -18.19 0.47 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 120.194 1.361 . . . . 1.05 111.8 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.6 t30 51.09 54.64 10.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.654 1.582 . . . . 2.6299999999999999 111.107 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.88 -52.62 5.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.531 0.682 . . . . 2.4300000000000002 110.473 170.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.63 -169.46 32.89 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.836 -1.706 . . . . 1.3100000000000001 108.836 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -58.4 161.55 4.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.744 1.618 . . . . 3.0 111.293 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmt-85 -58.66 137.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.938 -1.028 . . . . 3.9399999999999999 108.356 166.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.82 -70.65 0.8 Allowed 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.134 -1.432 . . . . 1.6699999999999999 107.134 163.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.32 157.22 16.55 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.672 -0.695 . . . . 2.1099999999999999 109.322 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.65 159.53 16.54 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 124.02 0.825 . . . . 1.5 109.129 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.58 141.39 3.42 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 107.068 -2.413 . . . . 1.03 107.068 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.7 133.15 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 123.999 0.919 . . . . 2.0 110.174 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.8 tt -89.17 138.68 18.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 122.766 0.426 . . . . 1.8899999999999999 110.903 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.85 1.39 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.15 0.881 . . . . 0.69999999999999996 114.687 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.93 59.42 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.062 1.431 . . . . 1.97 110.686 -161.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.08 177.64 8.43 Favored 'General case' 0 C--N 1.335 -0.022 0 N-CA-C 113.502 0.927 . . . . 2.5800000000000001 113.502 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.255 1.384 0 N-CA-C 103.098 -2.927 . . . . 6.3799999999999999 103.098 150.787 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 108.595 -0.891 . . . . 4.96 108.595 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.9 154.8 36.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.453 -1.314 . . . . 1.8300000000000001 107.453 163.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.78 144.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 104.883 -2.266 . . . . 2.0 104.883 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.69 94.53 4.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.129 0.893 . . . . 1.52 108.887 159.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.55 108.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.162 -1.421 . . . . 1.8 107.162 164.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.13 125.06 36.65 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.416 -0.587 . . . . 2.0299999999999998 109.416 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -143.7 -55.5 0.38 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.067 0.547 . . . . 4.5 110.263 165.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.7 -110.57 0.85 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.783 -0.927 . . . . 1.1399999999999999 110.783 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.76 -48.11 1.92 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.45 1.1 . . . . 3.6699999999999999 109.9 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.54 161.43 12.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 112.086 -0.406 . . . . 1.0900000000000001 112.086 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.37 29.98 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.097 3.198 . . . . 1.1899999999999999 114.215 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.04 160.88 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.142 1.377 . . . . 2.2599999999999998 108.787 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 97.8 1.93 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.786 -1.931 . . . . 3.0800000000000001 105.786 168.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.45 167.17 24.84 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.933 -0.467 . . . . 0.53000000000000003 111.933 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.33 121.44 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.555 -0.906 . . . . 2.04 108.555 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.3 mm -87.7 142.35 13.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 107.413 -1.328 . . . . 2.0600000000000001 107.413 162.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.48 129.73 47.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.92 1.288 . . . . 1.8600000000000001 107.525 169.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.0 131.03 53.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.226 1.81 . . . . 4.1399999999999997 107.197 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 153.98 48.9 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.522 -0.918 . . . . 4.0700000000000003 108.522 162.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.71 81.5 0.88 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.424 1.89 . . . . 4.0 107.486 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -40.44 -57.21 1.85 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.261 1.425 . . . . 5.3200000000000003 112.437 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.07 126.53 35.15 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.43 1.092 . . . . 3.8700000000000001 109.271 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -19.49 -66.68 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.277 2.631 . . . . 3.8300000000000001 114.57 174.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -118.5 42.2 2.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.391 1.076 . . . . 4.7000000000000002 109.214 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 175.29 48.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.333 -1.507 . . . . 1.72 109.333 168.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.66 142.9 72.61 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.024 1.816 . . . . 1.29 109.592 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.31 151.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.096 -1.075 . . . . 2.27 108.096 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -126.75 120.4 29.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.599 -1.26 . . . . 5.0099999999999998 107.599 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.02 134.28 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.613 1.965 . . . . 2.27 107.261 -171.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -133.22 156.02 48.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.415 -2.068 . . . . 0.94999999999999996 105.415 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 145.78 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.939 -1.664 . . . . 0.75 108.939 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -122.96 94.46 4.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.823 -2.288 . . . . 2.46 104.823 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.71 142.03 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.765 -1.198 . . . . 1.75 107.765 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -152.3 147.59 26.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 115.112 1.523 . . . . 4.2000000000000002 115.112 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.65 23.17 8.97 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.834 2.159 . . . . 0.93000000000000005 111.999 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -74.6 166.49 23.46 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.851 -1.166 . . . . 1.8100000000000001 107.851 167.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.24 165.45 20.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.889 -1.152 . . . . 2.7400000000000002 107.889 152.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.04 173.73 0.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.412 -0.805 . . . . 2.3399999999999999 110.513 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.14 -161.37 53.22 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.251 -0.431 . . . . 0.67000000000000004 113.053 165.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.29 140.27 58.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.481 1.112 . . . . 3.0899999999999999 113.357 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -144.24 116.03 8.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.543 1.537 . . . . 0.72999999999999998 109.85 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.7 148.57 4.63 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.685 0.659 . . . . 0.56000000000000005 111.792 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 100.01 4.67 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.891 1.676 . . . . 4.5 107.334 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -133.98 160.49 37.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.396 -2.076 . . . . 1.01 105.396 -169.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.11 125.92 74.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.482 -0.933 . . . . 2.8599999999999999 108.482 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.39 -161.35 0.73 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.316 1.046 . . . . 1.55 108.819 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -73.75 -129.01 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.083 0.953 . . . . 3.75 109.917 163.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.451 -0.407 0 C-N-CA 124.727 1.211 . . . . 3.0600000000000001 112.723 168.523 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 110.267 -0.271 . . . . 3.6200000000000001 110.267 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.53 -173.81 25.77 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 106.733 -2.547 . . . . 2.52 106.733 -158.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.92 178.27 6.67 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.658 3.572 . . . . 1.4399999999999999 113.958 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -74.01 58.22 0.66 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.145 1.778 . . . . 2.1600000000000001 111.606 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 51.92 69.02 0.72 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.255 1.022 . . . . 2.6800000000000002 109.639 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -90.85 115.31 64.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.016 -0.992 . . . . 2.9500000000000002 108.482 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.29 -43.8 1.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.842 1.695 . . . . 1.48 110.685 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -146.22 -67.25 0.28 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.232 1.013 . . . . 3.2200000000000002 108.884 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.5 m -153.39 63.99 0.75 Allowed 'General case' 0 N--CA 1.457 -0.125 0 O-C-N 121.524 -0.735 . . . . 2.2599999999999998 110.488 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -78.19 165.47 23.89 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.253 -0.647 . . . . 4.3700000000000001 109.253 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -133.66 154.26 51.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.148 1.379 . . . . 3.9399999999999999 109.012 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -89.53 169.64 11.18 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.124 . . . . 0.81999999999999995 110.245 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.93 -40.21 0.17 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 107.761 -2.136 . . . . 2.6600000000000001 107.761 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.29 -175.63 54.54 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.706 1.622 . . . . 2.2200000000000002 110.842 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.05 -8.9 23.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.584 2.856 . . . . 2.3399999999999999 114.167 -171.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -27.07 42.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.779 0.718 . . . . 7.4199999999999999 111.435 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.26 176.6 5.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.77 1.628 . . . . 2.7000000000000002 109.428 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.9 -47.04 40.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.962 -0.755 . . . . 4.7999999999999998 108.962 162.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -78.43 138.35 38.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.674 1.226 . . . . 3.0499999999999998 111.536 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -160.45 154.35 22.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.36 -2.83 . . . . 6.1900000000000004 103.36 173.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.1 m80 -64.92 159.66 22.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 117.794 -1.563 . . . . 0.75 106.88 162.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.08 40.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 122.984 1.373 . . . . 2.1099999999999999 110.876 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -170.73 42.2 0.19 Allowed Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 128.257 2.837 . . . . 1.5 108.563 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -126.12 109.07 11.95 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.795 -1.187 . . . . 2.46 107.795 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.82 -50.3 10.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.419 -0.956 . . . . 2.8199999999999998 108.419 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.8 -120.69 0.99 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.43 -1.068 . . . . 1.1699999999999999 110.43 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -155.19 166.3 34.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.127 1.371 . . . . 2.3300000000000001 108.672 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.98 171.77 16.38 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 N-CA-C 108.206 -1.035 . . . . 1.8400000000000001 108.206 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 m -114.87 118.57 33.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.477 -1.305 . . . . 3.02 107.477 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.81 140.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.375 0.534 . . . . 1.6899999999999999 110.319 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.2 -80.93 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.309 1.044 . . . . 3.0299999999999998 111.739 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -157.39 -48.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.107 1.363 . . . . 4.4900000000000002 109.898 -170.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.76 13.78 1.56 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.012 1.325 . . . . 2.79 111.214 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.02 14.64 76.21 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.197 0.903 . . . . 0.75 111.256 -175.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.4 145.18 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.226 1.41 . . . . 2.0600000000000001 107.73 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.67 164.83 29.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.652 1.181 . . . . 1.8 108.516 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.12 143.85 51.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.959 -2.608 . . . . 2.73 103.959 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.99 56.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 123.801 0.688 . . . . 1.72 112.096 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.0 m -74.39 91.61 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.712 -0.617 . . . . 1.4299999999999999 110.935 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.2 mt -129.46 159.05 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.588 0.755 . . . . 2.5099999999999998 108.984 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.76 93.66 2.54 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 3.0299999999999998 111.392 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.9 126.09 30.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.717 0.807 . . . . 2.54 109.582 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 p -95.54 1.73 53.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.249 1.42 . . . . 2.29 112.567 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.54 -44.82 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.519 0.727 . . . . 2.4100000000000001 109.795 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pt -74.65 175.75 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.845 -0.742 . . . . 2.3999999999999999 109.762 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 p -151.96 176.94 10.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.918 1.287 . . . . 2.7400000000000002 107.784 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.0 mt -131.95 57.8 1.76 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.374 1.87 . . . . 5.1500000000000004 110.725 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.722 0.638 . . . . 3.6499999999999999 112.722 174.829 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 120.237 0.065 . . . . 1.3200000000000001 111.157 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.3 pt -77.95 -6.47 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.841 0.682 . . . . 3.0499999999999998 112.841 -174.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.3 mm -32.01 116.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.1 1.36 . . . . 2.9900000000000002 110.323 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.49 10.87 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 112.12 -0.392 . . . . 1.75 112.12 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -136.1 164.6 27.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.499 -1.667 . . . . 7.3799999999999999 106.499 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.01 113.23 23.44 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.602 1.092 . . . . 2.6299999999999999 109.558 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.35 145.09 53.24 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.267 -1.753 . . . . 3.3799999999999999 106.267 167.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.5 t -130.98 135.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.137 1.775 . . . . 1.8799999999999999 109.066 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -101.79 123.65 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.756 1.223 . . . . 2.8199999999999998 107.711 164.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -95.96 165.69 12.14 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 117.378 2.362 . . . . 0.81999999999999995 117.378 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.47 -66.43 0.56 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.16 -1.836 . . . . 3.4700000000000002 110.971 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -90.28 -179.5 5.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.958 0.885 . . . . 4.9000000000000004 110.566 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.87 46.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.073 -1.454 . . . . 1.49 107.073 153.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -83.05 162.49 21.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.894 -0.78 . . . . 2.0699999999999998 108.894 161.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.74 -8.28 59.62 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.484 0.714 . . . . 3.0099999999999998 112.106 -169.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 51.18 38.78 22.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.014 0.926 . . . . 2.5299999999999998 109.101 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 48.78 33.04 11.98 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.529 1.062 . . . . 1.4399999999999999 112.798 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -77.48 -25.33 50.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.095 0.948 . . . . 5.71 110.039 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 133.25 -130.28 5.68 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.964 -0.854 . . . . 3.9700000000000002 110.964 161.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.49 -73.72 0.02 OUTLIER Glycine 0 C--N 1.34 0.772 0 C-N-CA 126.372 1.939 . . . . 3.0099999999999998 111.414 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.21 165.46 24.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.834 1.654 . . . . 3.0299999999999998 108.286 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -79.06 -52.02 8.78 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.874 -0.787 . . . . 3.8100000000000001 108.874 162.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.18 -40.69 11.61 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.992 2.117 . . . . 4.3600000000000003 111.49 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.8 p -39.16 -64.46 0.46 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.798 2.039 . . . . 2.3999999999999999 111.003 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.7 p -71.66 -45.86 60.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.717 -0.674 . . . . 2.3199999999999998 110.497 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -58.09 -50.13 74.54 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.403 0.681 . . . . 3.73 111.313 -165.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.514 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.384 1.3 p -125.63 -45.76 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.678 -0.677 . . . . 2.6899999999999999 112.665 168.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.44 0.13 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.428 1.013 . . . . 0.95999999999999996 114.803 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 54.28 55.53 8.04 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.628 1.571 . . . . 2.7200000000000002 111.557 -167.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.12 -3.07 9.22 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.453 0.909 . . . . 2.1899999999999999 113.453 169.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.47 -64.8 4.21 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 120.549 -1.344 . . . . 3.2400000000000002 111.127 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -165.2 168.18 17.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.163 0.985 . . . . 2.46 111.808 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.33 133.86 34.94 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.242 2.217 . . . . 3.4300000000000002 107.33 172.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.35 -77.93 0.56 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.158 -1.052 . . . . 1.72 108.158 166.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.19 154.01 42.21 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.901 -1.148 . . . . 2.2799999999999998 107.901 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 16.6 p -142.8 171.51 13.95 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.352 -1.295 . . . . 1.99 108.959 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.16 142.71 5.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.744 -1.342 . . . . 0.69999999999999996 109.744 174.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.34 126.91 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 108.735 -0.839 . . . . 2.0600000000000001 108.735 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.3 126.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.722 -0.844 . . . . 3.79 108.722 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.46 -5.97 1.42 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 115.014 0.766 . . . . 0.76000000000000001 115.014 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.3 59.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 118.638 1.219 . . . . 1.8600000000000001 110.627 -156.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.39 172.07 7.2 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.661 0.743 . . . . 2.5899999999999999 111.643 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.25 1.083 0 N-CA-C 103.44 -2.8 . . . . 5.9900000000000002 103.44 144.599 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.2 0 N-CA-C 110.803 -0.073 . . . . 3.46 110.803 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.48 131.9 34.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.586 -1.265 . . . . 1.98 107.586 163.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -98.52 142.12 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.688 -0.856 . . . . 1.6799999999999999 108.688 165.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.63 97.57 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.581 -0.896 . . . . 1.74 108.581 154.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.02 107.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.207 -1.405 . . . . 1.9199999999999999 107.207 163.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.3 mt -93.96 133.19 37.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.911 -0.774 . . . . 2.1200000000000001 108.911 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -138.08 -56.52 0.66 Allowed 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.541 -0.911 . . . . 5.2699999999999996 108.541 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.04 -121.34 24.89 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.789 -1.096 . . . . 0.88 111.957 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.08 -49.27 1.71 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.903 0.881 . . . . 3.48 109.497 -155.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.36 164.19 20.27 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 109.841 -1.303 . . . . 0.87 109.841 167.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.61 40.92 0.9 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.614 2.876 . . . . 1.0700000000000001 112.617 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.2 t -94.51 155.11 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.539 1.535 . . . . 1.6399999999999999 109.846 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.38 123.24 8.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.231 -1.396 . . . . 2.9500000000000002 107.231 168.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.94 167.32 33.73 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.543 -1.023 . . . . 0.71999999999999997 110.543 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.19 118.28 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.767 -1.568 . . . . 2.1600000000000001 106.767 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -85.02 128.55 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.259 -1.756 . . . . 1.9099999999999999 106.259 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -111.59 113.68 26.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.366 -1.716 . . . . 2.8599999999999999 106.366 166.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.88 115.6 30.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.613 -1.625 . . . . 3.9300000000000002 106.613 173.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -139.14 160.37 39.96 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.054 0.843 . . . . 3.3700000000000001 109.609 170.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -155.26 145.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.594 -2.002 . . . . 3.1699999999999999 105.594 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -45.5 44.25 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.008 -0.738 . . . . 5.7300000000000004 109.008 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -78.73 178.2 8.07 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.118 1.767 . . . . 3.8100000000000001 109.189 168.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.3 p -123.8 21.47 9.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.98 0.912 . . . . 3.21 111.382 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -167.41 38.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.593 0.633 . . . . 4.0999999999999996 111.557 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.69 -157.84 7.66 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.042 -1.623 . . . . 1.48 109.042 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.36 135.41 33.9 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.161 2.574 . . . . 1.3700000000000001 110.348 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -78.97 164.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.394 -0.965 . . . . 1.9399999999999999 108.394 173.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -115.57 125.21 52.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.634 -1.987 . . . . 3.6899999999999999 105.634 167.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.1 114.75 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.586 1.554 . . . . 2.1099999999999999 107.352 -171.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -125.9 133.53 51.87 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.189 0.93 . . . . 0.92000000000000004 110.408 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.2 160.16 33.73 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.385 -1.086 . . . . 0.82999999999999996 110.385 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 p -135.29 107.17 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.229 -1.397 . . . . 2.6200000000000001 107.229 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.78 119.91 59.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.559 -1.645 . . . . 2.04 106.559 -159.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -124.35 152.21 43.43 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.946 0.498 . . . . 5.8799999999999999 110.062 -160.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.58 27.04 64.0 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.444 -0.344 . . . . 0.82999999999999996 113.823 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -67.0 -169.41 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.581 -0.952 . . . . 1.8200000000000001 108.478 157.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.51 165.94 10.81 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 105.518 -2.03 . . . . 4.46 105.518 146.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 178.9 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.83 2.052 . . . . 3.3599999999999999 112.43 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.58 -169.45 53.38 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.357 -0.838 . . . . 0.55000000000000004 111.933 169.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.77 147.17 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.475 0.71 . . . . 3.0800000000000001 111.493 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -143.92 121.16 11.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.945 1.698 . . . . 0.58999999999999997 108.473 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.07 149.03 7.59 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.519 -1.433 . . . . 0.48999999999999999 109.519 169.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -143.25 83.48 1.79 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.644 -1.243 . . . . 3.6299999999999999 107.644 -169.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -124.64 146.38 49.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.885 -1.052 . . . . 1.1699999999999999 109.071 -160.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.22 106.44 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.436 -0.95 . . . . 3.5899999999999999 108.436 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -82.35 150.21 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.903 -0.777 . . . . 0.89000000000000001 108.903 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.26 19.84 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.376 1.471 . . . . 3.96 113.374 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 CA--C 1.53 0.201 0 O-C-N 120.648 -1.283 . . . . 3.1600000000000001 110.138 -167.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.409 0 CA-C-O 121.29 0.567 . . . . 2.5800000000000001 110.589 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.9 -65.89 3.14 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.987 -0.896 . . . . 1.5600000000000001 111.661 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.85 172.72 2.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.771 1.647 . . . . 2.2999999999999998 115.016 -166.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -83.01 56.68 3.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 113.121 -1.854 . . . . 2.1299999999999999 110.559 -172.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 53.32 80.09 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.406 0.682 . . . . 2.9300000000000002 109.476 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -107.85 103.85 51.1 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.181 0.993 . . . . 3.1200000000000001 110.425 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.82 -30.98 39.95 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.997 1.798 . . . . 1.3500000000000001 112.251 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.0 tp -155.93 -67.4 0.11 Allowed 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.554 0.616 . . . . 3.98 110.038 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 p -151.99 60.72 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.21 0.529 . . . . 2.79 110.621 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -77.51 165.99 23.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.384 -0.598 . . . . 4.8799999999999999 109.384 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -137.83 162.68 33.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.068 1.347 . . . . 8.4100000000000001 107.819 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -94.27 153.23 18.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.135 1.374 . . . . 0.79000000000000004 113.374 -158.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.48 171.93 45.0 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 107.763 -2.135 . . . . 2.4399999999999999 107.763 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.84 -171.23 30.75 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.165 0.412 . . . . 2.02 112.832 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.49 -31.18 51.64 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.515 2.144 . . . . 1.8400000000000001 109.582 172.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.63 -43.1 73.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.915 0.486 . . . . 5.29 111.496 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -69.22 161.96 28.12 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.673 0.749 . . . . 2.4300000000000002 112.144 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -75.5 -46.89 29.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.896 2.078 . . . . 4.3200000000000003 109.33 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -77.05 159.45 29.86 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.1 -1.074 . . . . 4.3099999999999996 108.1 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 158.98 127.1 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.463 2.305 . . . . 3.9700000000000002 106.441 -163.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 45.4 m80 -62.29 150.8 38.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.963 -1.495 . . . . 0.56000000000000005 106.963 163.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.82 -16.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 120.255 -0.578 . . . . 1.6699999999999999 110.38 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.56 56.58 0.46 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.959 0.79 . . . . 0.84999999999999998 113.336 161.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -123.59 117.99 26.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.022 1.411 . . . . 2.4199999999999999 108.771 158.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.6 -56.66 3.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.068 -1.086 . . . . 2.6099999999999999 108.068 164.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.65 -121.95 1.05 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.319 -0.712 . . . . 0.81999999999999995 111.319 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -143.11 165.28 27.83 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.895 1.678 . . . . 2.4900000000000002 108.112 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.31 166.74 28.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.699 -1.223 . . . . 1.75 107.699 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.3 m -123.41 116.42 23.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.234 1.014 . . . . 2.75 108.67 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.58 139.3 35.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.033 0.379 . . . . 1.55 111.076 171.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.07 -84.16 0.12 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.956 0.502 . . . . 4.0999999999999996 111.053 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 -53.19 0.93 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.231 0.612 . . . . 5.4000000000000004 112.082 -161.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.18 30.12 1.0 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 124.53 2.11 . . . . 3.3100000000000001 109.972 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 57.69 27.66 59.16 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 113.619 -1.628 . . . . 0.77000000000000002 110.833 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.27 103.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.56 1.144 . . . . 1.95 108.101 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.92 166.77 12.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.336 1.054 . . . . 1.75 108.267 160.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.7 141.82 47.73 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.452 -2.425 . . . . 2.8500000000000001 104.452 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.16 116.6 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.881 -1.525 . . . . 2.0699999999999998 106.881 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -137.46 80.29 1.8 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.068 1.747 . . . . 1.1699999999999999 106.738 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.2 mm -125.75 156.95 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.135 0.574 . . . . 3.5600000000000001 109.57 -170.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -151.36 71.54 1.01 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.733 0.813 . . . . 2.8900000000000001 110.93 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.96 119.23 22.52 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.126 -0.359 . . . . 3.29 111.738 -168.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.6 p -79.4 65.19 4.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.159 0.984 . . . . 2.8900000000000001 110.391 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.3 t -141.56 -52.32 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.622 1.169 . . . . 2.27 109.083 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -102.96 168.7 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.079 0.952 . . . . 2.3100000000000001 111.321 -172.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.2 m -137.91 168.92 18.71 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.077 1.351 . . . . 2.6699999999999999 109.217 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.84 17.04 23.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.477 1.511 . . . . 3.6000000000000001 113.068 -178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 C--O 1.233 0.231 0 C-N-CA 124.148 0.979 . . . . 3.6800000000000002 108.737 179.372 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 122.381 1.086 . . . . 1.55 111.345 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -18.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.684 -1.144 . . . . 4.0199999999999996 111.782 174.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.1 mm -47.0 119.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.174 0.99 . . . . 3.3100000000000001 110.758 -162.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.46 -32.47 5.2 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.519 0.58 . . . . 1.99 112.553 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -76.52 177.01 7.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.547 1.673 . . . . 11.6 114.031 -163.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 m -104.15 120.99 42.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.436 1.095 . . . . 2.0899999999999999 110.322 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.71 138.25 39.87 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.465 -1.309 . . . . 2.6600000000000001 107.465 164.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.48 127.84 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.272 1.429 . . . . 1.6799999999999999 107.88 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.47 122.45 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.125 -1.806 . . . . 2.6699999999999999 106.125 162.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -93.97 158.19 15.75 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 115.319 1.6 . . . . 0.59999999999999998 115.319 -171.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -25.56 -83.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.183 2.993 . . . . 3.5800000000000001 112.388 162.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -106.73 -177.34 3.33 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.819 0.848 . . . . 3.4700000000000002 110.215 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.1 157.44 3.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.498 -0.774 . . . . 1.8600000000000001 109.987 162.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.26 176.58 5.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.951 -0.759 . . . . 1.95 108.951 160.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.53 -9.59 59.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 3.9500000000000002 111.183 -167.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.7 11.93 4.29 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.694 1.598 . . . . 2.98 111.928 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.86 102.03 1.0 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 108.538 -1.825 . . . . 3.4399999999999999 108.538 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.55 -56.49 0.08 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.953 -1.499 . . . . 5.4500000000000002 106.953 174.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.47 50.49 0.97 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.165 -1.174 . . . . 3.7999999999999998 110.165 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.52 37.29 0.84 Allowed Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.165 0.982 . . . . 3.96 112.984 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.3 p30 175.66 -108.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.862 2.865 . . . . 2.8999999999999999 106.266 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -153.13 -39.61 0.1 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.456 1.102 . . . . 4.29 109.07 161.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -44.09 -37.63 3.17 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.423 1.489 . . . . 2.8900000000000001 111.784 170.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.9 t -45.71 -58.25 3.6 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.417 1.087 . . . . 2.5800000000000001 110.903 168.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -44.63 67.63 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.101 -1.0 . . . . 2.1200000000000001 110.015 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -55.68 -50.65 69.69 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.355 1.062 . . . . 3.6600000000000001 112.239 -172.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.474 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.309 2.0 p -124.33 -50.33 1.78 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.834 -0.603 . . . . 2.2599999999999998 111.759 171.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 157.27 -26.81 0.49 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.139 -0.784 . . . . 0.98999999999999999 111.139 -173.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 49.41 53.93 11.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.876 1.27 . . . . 3.6699999999999999 110.338 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.62 -51.93 13.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.858 0.837 . . . . 2.1099999999999999 109.53 170.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.32 -157.84 22.18 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.623 -2.191 . . . . 1.0 107.623 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.1 m -61.0 151.35 30.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.307 1.443 . . . . 1.8899999999999999 113.217 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -61.33 138.23 58.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.101 1.36 . . . . 4.0700000000000003 109.046 168.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.9 mt -112.17 -67.35 1.0 Allowed 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.44 -0.948 . . . . 1.6399999999999999 108.44 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.37 156.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.072 0.549 . . . . 2.0899999999999999 110.384 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.2 p -165.0 162.21 20.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.018 0.927 . . . . 1.4399999999999999 110.17 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.27 140.96 3.33 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.861 2.172 . . . . 0.97999999999999998 107.688 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.79 134.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.668 1.187 . . . . 2.0600000000000001 109.756 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.5 tt -91.1 136.59 23.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 C-N-CA 123.101 0.561 . . . . 1.99 112.512 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.9 4.56 0.83 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.839 1.209 . . . . 0.65000000000000002 114.078 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.7 mm -102.24 57.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 119.192 1.496 . . . . 2.0499999999999998 110.147 -150.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.96 175.41 13.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.146 0.498 . . . . 2.4199999999999999 111.142 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.439 0 N-CA-C 102.962 -2.977 . . . . 5.8399999999999999 102.962 160.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.048 -0.723 . . . . 4.4100000000000001 109.048 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.68 139.31 33.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.884 -1.525 . . . . 1.8100000000000001 106.884 164.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.79 144.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.547 -2.02 . . . . 1.8500000000000001 105.547 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.74 93.55 3.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.271 -1.011 . . . . 1.5 108.271 161.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.91 104.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.22 -1.03 . . . . 1.73 108.22 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -87.98 136.71 32.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.56 0.344 . . . . 2.1499999999999999 110.213 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -149.82 -54.72 0.17 Allowed 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.322 0.649 . . . . 5.2199999999999998 110.49 168.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.32 -126.55 27.87 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.603 0.621 . . . . 1.0 113.815 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.09 -53.99 2.63 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.672 1.189 . . . . 4.2199999999999998 110.138 -165.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.19 154.28 10.95 Favored Glycine 0 CA--C 1.536 1.353 0 N-CA-C 110.008 -1.237 . . . . 1.03 110.008 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.24 52.04 3.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.84 3.027 . . . . 1.3400000000000001 112.279 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.78 156.65 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.302 2.241 . . . . 1.79 107.875 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -155.84 136.48 13.36 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.621 -0.881 . . . . 3.4500000000000002 108.621 166.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.57 176.49 46.16 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.175 -0.77 . . . . 0.78000000000000003 111.175 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.68 123.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.494 -1.298 . . . . 2.1000000000000001 107.494 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.66 136.65 22.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.66 -1.978 . . . . 2.9300000000000002 105.66 161.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -120.6 119.24 32.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.444 -2.058 . . . . 2.0600000000000001 105.444 161.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -132.57 126.96 34.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.385 -0.969 . . . . 4.5 108.385 -166.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -148.07 158.83 44.28 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.074 0.949 . . . . 4.3399999999999999 110.321 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -152.44 142.52 22.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.36 1.864 . . . . 3.1699999999999999 106.964 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -44.94 -74.07 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.14 0.576 . . . . 5.3399999999999999 111.342 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -81.47 -172.9 4.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.1 1.36 . . . . 3.7400000000000002 110.929 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.7 m -83.43 -64.67 1.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.232 1.413 . . . . 2.9199999999999999 111.133 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -102.97 75.62 1.4 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.065 1.346 . . . . 4.7199999999999998 110.229 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.04 -167.15 12.85 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.585 -1.406 . . . . 1.3899999999999999 109.585 166.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.02 113.58 3.82 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.242 1.962 . . . . 1.3300000000000001 111.32 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.17 138.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.312 -0.403 . . . . 2.1200000000000001 110.556 -172.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -94.11 116.48 28.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.929 -1.137 . . . . 3.1499999999999999 107.929 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.72 132.71 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.703 -1.962 . . . . 2.4500000000000002 105.703 162.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -133.53 151.8 51.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.986 -1.487 . . . . 1.1000000000000001 106.986 156.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.76 134.54 2.91 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.131 -1.188 . . . . 0.92000000000000004 110.131 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.5 p -109.57 94.75 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.54 -1.652 . . . . 2.98 106.54 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 mm -96.99 148.59 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.623 -1.251 . . . . 2.6600000000000001 107.623 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.36 165.39 22.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.298 0.571 . . . . 5.25 111.45 165.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.19 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 114.462 -1.245 . . . . 0.60999999999999999 114.171 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.88 158.92 17.82 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.266 1.533 . . . . 1.9199999999999999 108.861 167.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.36 158.01 24.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.2 -1.407 . . . . 2.46 107.2 154.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.94 174.31 0.51 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.952 1.251 . . . . 3.2799999999999998 112.327 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.14 -160.65 52.5 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.956 -1.02 . . . . 0.81999999999999995 112.29 168.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.7 140.69 57.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.956 1.303 . . . . 3.2000000000000002 113.105 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -144.41 117.69 9.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.647 1.579 . . . . 0.66000000000000003 109.257 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.19 145.91 5.56 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.362 -1.095 . . . . 0.5 110.362 172.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.6 102.08 5.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.776 -1.565 . . . . 4.3099999999999996 106.776 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -133.48 168.22 19.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.156 -1.794 . . . . 0.95999999999999996 106.156 -173.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.88 130.2 48.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.867 -0.79 . . . . 2.8799999999999999 108.867 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -114.62 147.34 39.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.466 1.507 . . . . 0.84999999999999998 110.413 -160.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.14 -9.35 0.26 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.059 1.744 . . . . 4.25 114.638 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.442 ' CD ' HH21 ' A' ' 143' ' ' ARG . 4.5 mt-10 . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.47 1.108 . . . . 3.3300000000000001 109.794 164.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 107.48 -1.304 . . . . 2.4300000000000002 107.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.92 -87.63 0.08 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.322 -1.511 . . . . 1.71 109.322 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.91 176.84 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.965 3.777 . . . . 1.4199999999999999 113.569 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -75.48 58.49 1.02 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.885 1.674 . . . . 2.29 111.615 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.84 80.3 0.16 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.994 0.917 . . . . 3.0600000000000001 108.628 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -112.88 86.66 9.18 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.55 1.14 . . . . 3.0699999999999998 109.415 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.13 -17.95 45.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.3 2.0 . . . . 2.77 112.7 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 tt -154.28 -68.0 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.676 0.671 . . . . 2.9199999999999999 109.838 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -162.92 96.0 0.89 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.757 -1.201 . . . . 2.46 107.757 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.27 173.68 6.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.147 1.379 . . . . 6.2199999999999998 109.703 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -137.3 151.33 48.53 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 125.61 1.564 . . . . 4.5300000000000002 108.032 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -91.24 139.97 30.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.828 0.677 . . . . 0.80000000000000004 112.828 -170.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.02 -88.75 0.07 OUTLIER Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.539 -2.625 . . . . 1.8600000000000001 106.539 163.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.67 -102.58 0.38 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.973 -0.904 . . . . 2.46 112.289 159.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -90.63 -47.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.508 2.139 . . . . 1.8200000000000001 110.774 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.27 -46.01 10.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.233 1.413 . . . . 5.6399999999999997 110.388 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.03 175.58 10.24 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.889 -1.05 . . . . 2.7599999999999998 111.424 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.06 -55.22 8.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.399 1.479 . . . . 3.79 109.596 -174.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.89 175.28 10.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.462 -0.79 . . . . 3.8100000000000001 110.967 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.36 141.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.248 2.219 . . . . 4.46 107.876 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -64.21 160.72 17.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 118.468 -1.293 . . . . 0.60999999999999999 108.669 162.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -28.66 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 121.289 -0.882 . . . . 2.1800000000000002 110.69 -177.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.56 70.11 0.22 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.85999999999999999 110.973 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -163.3 104.74 0.98 Allowed 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.782 -0.834 . . . . 2.3399999999999999 108.914 -169.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.54 -54.81 3.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.686 -0.688 . . . . 2.8399999999999999 109.156 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 -108.38 0.34 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.603 -0.999 . . . . 0.71999999999999997 110.603 -176.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -152.06 167.5 28.26 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.938 1.695 . . . . 2.1800000000000002 109.874 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -123.35 175.78 5.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.476 -1.675 . . . . 1.78 106.476 164.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 t -116.76 149.76 39.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.377 -0.971 . . . . 2.7999999999999998 108.377 167.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.68 140.48 45.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.174 1.39 . . . . 1.8300000000000001 112.333 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.01 -90.17 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 O-C-N 124.46 1.1 . . . . 2.5899999999999999 111.11 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -156.22 -31.75 0.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.652 2.093 . . . . 5.4000000000000004 116.652 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -8.96 58.14 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.993 0.901 . . . . 3.7200000000000002 109.119 164.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.57 23.16 10.4 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.701 1.62 . . . . 1.1100000000000001 109.593 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.2 t -78.0 123.39 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.289 -1.375 . . . . 1.8100000000000001 107.289 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.19 159.32 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.055 0.942 . . . . 1.8799999999999999 109.231 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.77 95.59 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.763 -1.569 . . . . 2.8500000000000001 106.763 -159.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.36 57.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.715 -0.476 . . . . 2.1699999999999999 109.715 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.2 m -85.49 91.66 8.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.813 0.845 . . . . 1.1399999999999999 109.231 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 mt -124.33 148.19 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.893 -0.78 . . . . 3.04 108.893 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -134.39 101.97 5.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.279 -0.638 . . . . 2.98 109.279 164.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.16 140.74 31.21 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.918 0.887 . . . . 2.27 109.073 173.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 t -110.85 19.23 18.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.407 1.083 . . . . 3.04 112.406 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.99 -48.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 108.098 -1.075 . . . . 2.6000000000000001 108.098 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.35 177.01 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 122.813 0.445 . . . . 2.2000000000000002 111.289 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.5 p -155.4 178.8 9.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.429 1.892 . . . . 2.8599999999999999 108.23 -164.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.14 69.9 1.44 Allowed 'General case' 0 C--N 1.339 0.151 0 CA-C-O 122.917 1.342 . . . . 3.1699999999999999 110.466 162.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.326 -0.428 0 C-N-CA 126.721 2.008 . . . . 4.9400000000000004 110.348 -177.849 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 123.213 1.482 . . . . 1.53 113.682 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.839 -1.528 . . . . 3.0099999999999998 111.112 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mm -49.03 118.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.795 0.725 . . . . 3.1000000000000001 109.118 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.53 -20.32 34.83 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.468 1.508 . . . . 1.5700000000000001 112.759 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.59 165.34 18.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.416 1.608 . . . . 5.4500000000000002 110.279 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -86.95 117.9 25.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.801 0.841 . . . . 2.0699999999999998 109.159 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 140.33 58.28 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.393 -1.336 . . . . 3.6800000000000002 107.393 167.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -128.26 126.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.945 -1.132 . . . . 1.54 107.945 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 p -99.17 116.95 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.219 -1.771 . . . . 2.9500000000000002 106.219 166.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -89.54 160.11 16.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 115.808 1.781 . . . . 0.58999999999999997 115.808 -172.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.53 ' CD ' ' HZ1' ' A' ' 122' ' ' LYS . 2.0 tm-20 -44.87 -72.27 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.708 2.003 . . . . 3.3900000000000001 112.362 174.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.53 ' HZ1' ' CD ' ' A' ' 121' ' ' GLU . 40.4 mttm -98.26 -177.19 3.63 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.33 1.052 . . . . 3.96 111.097 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.08 157.56 7.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.375 0.67 . . . . 2.0 109.703 162.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.24 175.67 8.8 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.484 -0.561 . . . . 2.1200000000000001 109.484 164.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.03 -35.61 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.989 0.916 . . . . 3.3100000000000001 112.669 -152.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp 66.72 32.77 6.7 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.894 1.678 . . . . 4.7699999999999996 111.402 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.37 45.82 92.3 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.227 0.917 . . . . 1.76 112.255 163.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -127.07 -28.82 2.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.234 2.213 . . . . 5.9900000000000002 111.493 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.34 126.22 33.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.812 -0.915 . . . . 3.02 110.812 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.1 -30.58 76.05 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.327 0.489 . . . . 3.1400000000000001 111.88 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -55.6 115.29 2.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.843 0.857 . . . . 2.7999999999999998 109.26 170.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -38.29 -48.23 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.814 1.246 . . . . 3.5 113.217 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -46.93 -33.84 4.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.244 1.418 . . . . 3.1800000000000002 112.647 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 m -62.49 -56.88 13.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.976 0.51 . . . . 2.5 111.976 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -71.21 -45.81 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.0 -1.687 . . . . 2.0699999999999998 110.215 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -58.08 -39.4 78.45 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.052 0.941 . . . . 4.0099999999999998 111.728 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 p -128.95 -54.92 1.21 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.762 0.71 . . . . 2.5299999999999998 112.632 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 140.48 -18.55 2.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 125.936 1.732 . . . . 0.89000000000000001 111.385 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.76 56.95 2.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.333 1.453 . . . . 2.3500000000000001 111.757 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.66 -5.02 48.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.226 -0.59 . . . . 2.4399999999999999 111.435 171.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.6 -173.68 40.54 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 108.899 -1.681 . . . . 1.03 108.899 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -55.82 153.33 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.752 1.621 . . . . 1.73 114.086 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.442 HH21 ' CD ' ' A' ' 50' ' ' GLU . 6.4 mmt-85 -60.02 139.8 57.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.775 -1.557 . . . . 4.1299999999999999 107.963 166.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.07 -74.74 0.59 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.047 -1.094 . . . . 1.6299999999999999 108.047 173.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.47 151.18 23.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.334 -1.358 . . . . 1.72 107.334 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 p -151.45 160.54 43.67 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.042 0.839 . . . . 1.8300000000000001 109.246 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.09 140.75 3.25 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 125.596 1.81 . . . . 0.68999999999999995 109.61 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -77.88 134.67 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.044 1.338 . . . . 1.8700000000000001 109.878 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.6 tt -90.66 131.28 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.081 0.553 . . . . 1.79 111.342 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.08 -8.17 2.68 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 124.377 0.989 . . . . 0.56999999999999995 113.762 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.4 mm -91.07 59.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 118.026 0.913 . . . . 2.4199999999999999 111.448 -154.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.68 168.09 9.48 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.218 0.533 . . . . 2.5600000000000001 111.587 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 . . . . . 0 C--O 1.256 1.397 0 N-CA-C 101.643 -3.465 . . . . 4.9699999999999998 101.643 139.824 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.011 0.434 . . . . 4.0599999999999996 110.416 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.72 136.6 48.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.547 -2.02 . . . . 1.6699999999999999 105.547 152.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.94 140.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.378 -1.712 . . . . 2.23 106.378 169.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.56 96.61 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.371 -0.974 . . . . 1.6399999999999999 108.371 156.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.83 108.26 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.656 -1.609 . . . . 1.77 106.656 161.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.7 mt -97.37 127.97 43.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.204 -1.036 . . . . 1.8100000000000001 108.204 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -149.39 -56.13 0.19 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.191 -1.04 . . . . 4.2599999999999998 108.191 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.49 -117.61 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.504 -1.225 . . . . 0.93000000000000005 111.19 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -123.37 -41.17 2.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.883 0.873 . . . . 3.7000000000000002 110.056 -163.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.72 161.42 51.36 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.732 -0.605 . . . . 0.90000000000000002 111.762 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.86 30.82 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.984 3.123 . . . . 1.0600000000000001 113.436 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.1 t -99.24 155.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.575 1.95 . . . . 1.6799999999999999 107.424 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 129.37 9.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.739 -0.837 . . . . 3.3900000000000001 108.739 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.27 171.07 41.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.793 -0.718 . . . . 0.53000000000000003 114.383 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.6 118.64 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.477 1.111 . . . . 1.9299999999999999 108.482 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -83.84 129.57 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.459 -1.312 . . . . 1.8100000000000001 107.459 164.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -106.13 115.68 30.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.328 -1.36 . . . . 2.3799999999999999 107.328 160.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.9 112.64 24.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.126 -1.805 . . . . 3.77 106.126 171.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -124.94 144.79 50.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.668 0.747 . . . . 3.4500000000000002 109.436 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -156.99 158.68 37.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.155 1.382 . . . . 4.1799999999999997 109.15 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.01 -74.95 0.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.134 0.973 . . . . 5.5499999999999998 109.634 170.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -90.83 130.08 36.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.539 1.136 . . . . 3.8300000000000001 110.377 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 p -66.43 1.28 1.72 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.931 1.456 . . . . 3.3300000000000001 114.931 -169.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -140.19 54.18 1.64 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 126.518 1.927 . . . . 5.4299999999999997 107.161 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.64 175.07 32.87 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 107.509 -2.237 . . . . 1.4099999999999999 107.509 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.08 134.62 46.87 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.728 2.285 . . . . 1.4399999999999999 110.63 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.86 141.5 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.124 -0.695 . . . . 2.04 109.124 -171.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -97.34 107.2 19.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.419 -1.326 . . . . 3.2999999999999998 107.419 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.8 t -96.25 116.09 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.532 -1.655 . . . . 2.1899999999999999 106.532 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -123.4 107.11 11.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.131 -1.062 . . . . 1.3300000000000001 108.131 164.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.76 152.95 16.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.88 111.805 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -132.06 85.39 2.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.737 2.015 . . . . 3.4700000000000002 106.575 -165.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 mp -111.31 126.02 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 107.017 -1.475 . . . . 1.8500000000000001 107.017 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 162.69 16.51 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.327 1.051 . . . . 4.6699999999999999 110.973 171.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.24 1.8 74.91 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.341 -0.7 . . . . 0.70999999999999996 114.768 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -53.35 157.22 2.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.099 1.449 . . . . 2.0600000000000001 110.815 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.68 163.37 9.26 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.124 -1.065 . . . . 2.3799999999999999 108.124 156.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.34 173.74 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 2.3700000000000001 111.038 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.71 -159.73 34.6 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.049 0.833 . . . . 0.58999999999999997 113.843 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.57 145.12 55.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.246 1.818 . . . . 2.8900000000000001 113.79 -171.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -147.34 118.55 7.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.326 1.85 . . . . 0.62 109.777 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.66 147.6 8.14 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.515 -1.034 . . . . 0.42999999999999999 110.515 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -136.39 91.23 2.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.268 -1.382 . . . . 3.6299999999999999 107.268 -174.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -125.8 172.36 9.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.015 -0.735 . . . . 0.89000000000000001 109.015 -163.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.4 133.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.527 -1.286 . . . . 3.3999999999999999 107.527 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -119.43 140.97 49.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.152 1.381 . . . . 0.95999999999999996 107.738 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -45.16 -58.15 3.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.767 2.027 . . . . 5.0999999999999996 111.107 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 127.082 2.153 . . . . 3.4100000000000001 116.153 164.477 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 106.078 -1.823 . . . . 2.3599999999999999 106.078 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.12 -91.58 0.08 OUTLIER Glycine 0 CA--C 1.524 0.605 0 CA-C-O 117.86 -1.522 . . . . 1.5 111.756 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.03 -177.47 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 1 C-N-CA 126.911 5.074 . . . . 1.29 113.351 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -89.33 62.39 6.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.916 1.286 . . . . 1.8100000000000001 111.363 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 56.41 64.29 1.73 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.45 -0.944 . . . . 2.8500000000000001 108.45 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -90.45 113.8 58.86 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 3.3300000000000001 110.4 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.66 -37.39 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.134 1.889 . . . . 1.53 111.294 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 tp -156.17 -64.74 0.11 Allowed 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.376 -0.601 . . . . 4.3200000000000003 109.376 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -153.81 69.47 0.8 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 2.3999999999999999 109.68 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -76.92 166.49 23.26 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.49 -0.559 . . . . 4.4299999999999997 109.49 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.8 156.2 33.7 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.647 1.579 . . . . 4.5999999999999996 107.008 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -92.79 153.81 18.66 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.657 0.614 . . . . 1.03 112.657 -172.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.3 38.79 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 108.95 -1.66 . . . . 2.5800000000000001 108.95 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.82 -156.06 9.87 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 108.662 -1.775 . . . . 1.8100000000000001 108.662 170.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.33 -35.06 92.76 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.987 1.791 . . . . 2.0499999999999998 110.853 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -51.63 68.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.066 0.946 . . . . 7.9199999999999999 110.944 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.88 156.57 20.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.594 1.702 . . . . 2.4500000000000002 115.594 -145.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.64 -48.84 74.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.716 2.006 . . . . 6.4100000000000001 112.367 -169.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -135.51 162.42 32.72 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.049 1.34 . . . . 5.5800000000000001 107.759 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -163.4 161.2 24.26 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.4 0.68 . . . . 4.4299999999999997 111.081 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.416 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 62.6 m80 -68.16 141.5 56.0 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 107.949 -1.13 . . . . 0.72999999999999998 107.949 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.41 -30.23 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.625 -0.262 . . . . 2.2000000000000002 110.716 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 57.37 0.43 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.745 -0.475 . . . . 0.84999999999999998 113.802 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.4 146.75 33.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.918 1.859 . . . . 2.3999999999999999 110.226 149.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 mt -97.1 -51.83 4.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.572 -0.899 . . . . 3.5699999999999998 108.572 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.04 -107.92 0.31 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.5 -1.04 . . . . 0.69999999999999996 110.5 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -147.08 171.98 14.46 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.184 1.794 . . . . 2.3799999999999999 109.493 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -132.78 171.4 18.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 106.644 -1.614 . . . . 2.1499999999999999 106.644 166.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -103.99 144.48 31.49 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.404 -0.961 . . . . 3.1600000000000001 108.404 163.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.05 159.51 27.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.983 0.913 . . . . 1.6200000000000001 110.004 158.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.37 -92.06 0.05 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.033 1.733 . . . . 4.3799999999999999 108.858 162.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 93' ' ' GLY . 13.7 tttt -176.07 -31.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.619 1.168 . . . . 4.5199999999999996 112.0 -159.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -76.84 15.49 0.65 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 124.243 1.973 . . . . 3.3500000000000001 109.477 151.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 63.05 24.75 67.33 Favored Glycine 0 N--CA 1.44 -1.069 0 O-C-N 119.933 -1.729 . . . . 1.1100000000000001 110.347 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.0 t -83.89 118.88 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.306 -0.998 . . . . 2.1699999999999999 108.306 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.79 153.26 17.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.331 -0.989 . . . . 2.1400000000000001 108.331 166.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -112.32 83.72 1.85 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 104.16 -2.533 . . . . 3.7400000000000002 104.16 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.96 60.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.722 -0.844 . . . . 2.1200000000000001 108.722 -167.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -96.43 86.93 4.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.694 1.597 . . . . 1.3100000000000001 108.027 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.76 150.69 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.894 -0.78 . . . . 2.7999999999999998 108.894 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.47 134.27 33.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.218 -1.771 . . . . 3.1099999999999999 106.218 158.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -145.77 164.25 32.44 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.603 -1.258 . . . . 3.8199999999999998 107.603 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.3 p -112.59 -5.31 14.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.741 2.016 . . . . 2.2200000000000002 111.915 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.24 -37.06 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 119.065 0.848 . . . . 3.0600000000000001 109.26 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -96.02 177.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.586 0.754 . . . . 2.3500000000000001 110.655 176.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.6 m -158.53 175.96 13.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.702 1.601 . . . . 2.77 108.3 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.34 14.18 31.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.214 1.405 . . . . 3.6400000000000001 111.546 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.455 -0.201 0 O-C-N 120.738 -1.226 . . . . 3.5600000000000001 109.632 -179.643 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 121.882 0.848 . . . . 2.4199999999999999 112.034 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 pp -81.0 -8.14 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 113.537 0.94 . . . . 2.4700000000000002 113.537 -166.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 mm -50.79 120.12 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.922 0.889 . . . . 3.3900000000000001 109.175 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.16 22.05 66.32 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.916 -0.935 . . . . 1.5800000000000001 113.498 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 174.28 5.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.139 1.469 . . . . 6.5800000000000001 107.982 160.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -86.61 126.74 34.71 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 118.086 -0.959 . . . . 2.1299999999999999 108.943 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.56 137.17 34.65 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.557 -1.275 . . . . 3.0299999999999998 107.557 159.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.86 135.16 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.733 1.613 . . . . 1.73 108.082 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.32 130.48 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.178 -1.045 . . . . 3.0600000000000001 108.178 165.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -106.79 160.51 15.43 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 117.632 2.456 . . . . 0.48999999999999999 117.632 -167.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -33.84 -84.51 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.265 3.026 . . . . 3.6200000000000001 112.736 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -99.4 -174.67 2.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.292 0.951 . . . . 3.6800000000000002 109.592 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.24 157.95 2.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.087 0.555 . . . . 1.6799999999999999 110.11 164.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 152.17 35.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.675 -1.232 . . . . 2.1000000000000001 107.675 158.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -77.16 -6.81 54.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.439 0.903 . . . . 3.3599999999999999 113.439 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 68.65 -9.37 0.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.34 1.456 . . . . 3.4399999999999999 112.851 -167.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.72 6.1 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.935 0.789 . . . . 1.98 111.537 168.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.37 38.78 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.2 -0.667 . . . . 7.9500000000000002 109.2 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -103.73 160.62 16.21 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.497 -0.641 . . . . 2.98 111.497 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.79 59.51 3.0 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.156 0.884 . . . . 2.7000000000000002 110.972 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -178.42 109.22 0.05 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 105.254 -2.128 . . . . 2.6600000000000001 105.254 -170.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -33.51 66.34 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.164 -0.335 . . . . 3.3799999999999999 111.637 -171.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -34.47 -44.4 0.2 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.355 1.862 . . . . 4.1600000000000001 113.18 165.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.84 -63.38 1.17 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.868 -0.79 . . . . 2.5499999999999998 108.868 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 p -60.14 -46.59 89.16 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.904 -0.497 . . . . 2.1899999999999999 110.946 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.67 -43.72 75.55 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.826 0.851 . . . . 3.6600000000000001 112.181 -167.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.416 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.288 1.1 p -124.72 -52.83 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.239 -0.886 . . . . 2.3599999999999999 111.734 172.333 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 146.53 -14.31 1.6 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.528 1.058 . . . . 0.90000000000000002 113.598 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.95 54.86 9.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.535 1.134 . . . . 2.2400000000000002 110.649 173.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.21 -40.85 81.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.172 0.987 . . . . 2.0299999999999998 110.665 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.92 -168.66 30.36 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 108.407 -1.877 . . . . 1.01 108.407 -159.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -55.42 148.23 15.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.111 1.764 . . . . 1.8300000000000001 113.924 -167.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.1 mmt-85 -59.52 134.57 57.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.361 1.464 . . . . 3.98 107.972 165.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -110.51 -80.01 0.58 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.016 1.28 . . . . 1.6499999999999999 109.837 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.48 149.42 36.37 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.548 -0.908 . . . . 1.99 108.548 172.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.96 160.43 12.16 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.729 -2.032 . . . . 1.8 107.013 -163.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.07 156.12 13.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.748 -2.141 . . . . 1.04 107.748 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.14 140.07 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 117.75 0.775 . . . . 1.9099999999999999 109.646 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.6 tt -97.04 132.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.839 -0.619 . . . . 1.8300000000000001 111.126 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 140.52 -6.66 2.73 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 123.902 0.763 . . . . 0.58999999999999997 114.519 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.33 59.83 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 118.487 1.144 . . . . 2.6400000000000001 109.873 -157.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.69 149.2 24.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.268 -0.878 . . . . 2.6600000000000001 112.411 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 . . . . . 0 C--O 1.256 1.409 0 N-CA-C 102.691 -3.077 . . . . 5.9500000000000002 102.691 129.612 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 109.805 -0.442 . . . . 4.2300000000000004 109.805 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.57 154.85 17.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.426 -1.694 . . . . 1.9299999999999999 106.426 153.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.99 147.89 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 104.859 -2.274 . . . . 2.0299999999999998 104.859 161.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.39 102.59 5.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.08 -1.822 . . . . 1.5600000000000001 106.08 166.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.57 99.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.907 -1.146 . . . . 1.99 107.907 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.79 120.68 28.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.777 -1.194 . . . . 3.75 107.777 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -139.99 -50.17 0.48 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 122.888 0.475 . . . . 4.54 110.811 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.37 -117.35 2.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.113 0.864 . . . . 0.88 112.667 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.14 -50.65 1.68 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.977 0.911 . . . . 3.3799999999999999 110.165 -155.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.85 165.13 11.85 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 110.667 -0.973 . . . . 0.93999999999999995 110.667 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.23 41.91 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.911 3.074 . . . . 1.3400000000000001 112.063 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.2 t -110.89 150.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 126.79 2.036 . . . . 1.9099999999999999 108.154 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.12 129.4 8.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.892 -1.151 . . . . 3.3900000000000001 107.892 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.85 172.18 44.54 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.027 -0.829 . . . . 0.65000000000000002 111.027 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.87 126.67 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.061 -1.088 . . . . 2.8300000000000001 108.061 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mm -86.31 132.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.268 -1.753 . . . . 2.6800000000000002 106.268 159.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -112.16 124.62 52.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.741 -1.948 . . . . 1.99 105.741 159.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -133.42 103.82 6.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.576 -2.009 . . . . 5.1200000000000001 105.576 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.52 161.28 29.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.396 0.679 . . . . 3.4500000000000002 112.114 -169.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -154.97 147.15 23.78 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.972 -1.122 . . . . 3.02 107.972 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -79.5 -35.56 39.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.415 -1.266 . . . . 7.8700000000000001 110.134 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -85.37 -144.94 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.063 -1.828 . . . . 6.3700000000000001 106.063 158.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 p -147.72 -1.87 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.634 1.106 . . . . 4.1699999999999999 112.984 162.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -123.57 49.76 1.68 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.217 1.007 . . . . 4.0599999999999996 109.612 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.69 -162.81 12.55 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.007 -1.237 . . . . 1.6599999999999999 110.007 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.19 111.9 2.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.256 1.97 . . . . 1.54 112.434 -168.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.66 150.15 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.959 0.904 . . . . 2.1000000000000001 109.535 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -105.69 106.62 17.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.532 -1.655 . . . . 4.8899999999999997 106.532 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -104.24 116.98 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.079 -1.452 . . . . 2.1800000000000002 107.079 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -130.08 142.39 50.61 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.133 -0.691 . . . . 1.0700000000000001 109.133 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.85 159.45 32.68 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.65 -1.78 . . . . 0.69999999999999996 108.65 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -140.14 108.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.841 -2.281 . . . . 3.2400000000000002 104.841 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.28 142.46 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.961 -1.866 . . . . 1.78 105.961 -163.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.453 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -140.31 159.06 43.02 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 115.328 1.603 . . . . 5.2199999999999998 115.328 173.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.98 53.87 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.828 1.68 . . . . 0.90000000000000002 112.815 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.44 159.98 9.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.187 0.993 . . . . 2.0 109.568 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.59 162.02 13.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.597 -1.261 . . . . 2.54 107.597 156.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.47 172.44 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.172 0.897 . . . . 2.5899999999999999 110.757 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.5 -163.29 54.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 116.079 -0.51 . . . . 0.57999999999999996 113.122 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.77 146.59 47.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.959 0.904 . . . . 3.3300000000000001 111.913 -172.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -146.56 119.97 9.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.729 1.612 . . . . 0.79000000000000004 109.145 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.81 152.12 4.99 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.405 -0.678 . . . . 0.40999999999999998 111.405 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -146.04 101.84 3.57 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.329 -1.36 . . . . 3.71 107.329 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.455 ' ND1' ' CD2' ' A' ' 120' ' ' HIS . 26.5 m80 -143.15 160.22 40.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.322 -0.992 . . . . 1.2 108.322 -163.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.62 127.83 75.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 CA-C-O 121.899 0.857 . . . . 2.8300000000000001 110.058 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -99.68 137.49 38.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.715 1.606 . . . . 0.78000000000000003 107.627 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.02 -38.21 56.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.409 1.084 . . . . 4.3099999999999996 111.749 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 N--CA 1.454 -0.274 0 C-N-CA 128.596 2.759 . . . . 3.0899999999999999 113.199 156.252 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.066 0.46 . . . . 2.4100000000000001 111.347 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.62 -95.67 2.42 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.125 -1.375 . . . . 1.3700000000000001 109.767 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.69 -179.87 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.545 4.163 . . . . 1.3200000000000001 113.833 -175.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -52.01 126.3 18.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.514 1.526 . . . . 1.3999999999999999 108.793 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -39.7 117.3 0.72 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.353 1.061 . . . . 3.96 111.742 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -124.71 143.28 43.08 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 130.397 3.479 . . . . 3.5099999999999998 107.578 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.99 -36.21 3.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.124 2.55 . . . . 1.6399999999999999 110.148 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 tt -151.42 -66.72 0.18 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.254 -1.387 . . . . 3.7599999999999998 107.254 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.4 m -154.39 84.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.091 -1.005 . . . . 3.1000000000000001 109.848 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -79.39 174.99 11.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.182 0.515 . . . . 5.8300000000000001 110.131 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -127.79 163.84 23.48 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.521 1.928 . . . . 7.79 106.951 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -102.9 152.9 20.76 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 123.707 0.803 . . . . 0.97999999999999998 110.881 -172.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 -35.56 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.777 -0.529 . . . . 2.8199999999999998 111.777 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.52 -150.5 20.12 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.682 1.611 . . . . 1.9399999999999999 111.386 167.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.1 -26.98 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.566 2.844 . . . . 2.2400000000000002 110.374 -176.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -48.35 82.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.585 -0.524 . . . . 7.1100000000000003 109.585 170.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.83 175.55 6.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.29 113.41 -166.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.34 -43.73 60.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.299 1.439 . . . . 4.6399999999999997 108.401 164.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.95 157.73 31.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.639 -0.71 . . . . 3.27 111.344 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 164.66 147.93 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.89 2.076 . . . . 4.2800000000000002 111.777 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.418 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 18.4 m80 -62.79 153.61 32.4 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.319 -0.993 . . . . 0.70999999999999996 108.319 167.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.06 -36.64 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 119.794 -0.762 . . . . 1.99 109.3 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.98 60.87 1.38 Allowed Glycine 0 CA--C 1.529 0.969 0 O-C-N 122.003 -0.436 . . . . 0.91000000000000003 113.175 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.84 96.71 1.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.367 -0.975 . . . . 2.4199999999999999 108.367 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.37 -52.28 8.3 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.319 -0.993 . . . . 3.1000000000000001 108.319 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.53 -109.06 0.35 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.834 -0.698 . . . . 0.63 112.645 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -155.49 170.18 22.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.599 1.56 . . . . 2.25 109.758 -168.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.8 169.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.004 -1.48 . . . . 1.6799999999999999 107.004 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.2 m -123.87 123.47 40.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.58 -1.267 . . . . 2.8100000000000001 107.58 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.36 141.4 31.79 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.568 0.347 . . . . 1.5900000000000001 111.149 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.25 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.348 1.03 . . . . 2.71 109.277 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.4 tttt -155.29 -34.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.102 1.519 . . . . 4.6900000000000004 115.102 -172.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 24.7 t0 -89.19 40.05 0.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.216 1.96 . . . . 2.8599999999999999 109.284 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 56.58 20.58 31.76 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 129.15 3.262 . . . . 0.88 112.562 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.49 119.92 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.947 0.899 . . . . 2.1099999999999999 108.928 -168.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.46 156.87 27.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.568 1.147 . . . . 1.8400000000000001 108.591 168.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.61 147.42 33.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.485 -2.413 . . . . 3.2799999999999998 104.485 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.67 59.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.827 0.704 . . . . 1.77 112.024 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.5 m -86.62 96.02 9.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.371 1.068 . . . . 1.1499999999999999 110.429 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.51 152.17 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.546 1.138 . . . . 3.3399999999999999 109.931 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.37 141.9 51.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.324 -0.991 . . . . 3.4399999999999999 108.324 150.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -135.14 163.76 29.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.133 -0.691 . . . . 2.0600000000000001 109.133 162.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -111.24 -16.04 13.5 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.463 2.305 . . . . 1.8600000000000001 112.781 -173.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.37 -36.29 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.888 0.767 . . . . 2.4399999999999999 109.478 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -91.56 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.767 0.827 . . . . 2.21 110.477 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.2 p -159.28 176.95 11.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.654 1.981 . . . . 3.25 106.967 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.87 37.74 4.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.918 1.235 . . . . 3.1800000000000002 112.498 166.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 108.968 -0.753 . . . . 3.3799999999999999 108.968 178.293 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.8 p . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 109.179 -0.675 . . . . 1.9099999999999999 109.179 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.9 pt -78.61 -5.13 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.044 -0.503 . . . . 2.8999999999999999 111.918 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 mm -32.01 127.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.762 1.225 . . . . 2.8300000000000001 110.716 170.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.78 33.3 83.79 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.378 -0.679 . . . . 1.5600000000000001 112.928 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -116.29 169.13 9.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.088 0.944 . . . . 4.7800000000000002 108.487 166.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m -100.88 110.4 22.46 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-N 118.867 0.758 . . . . 2.6699999999999999 110.247 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt -68.04 148.98 50.26 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.427 -0.953 . . . . 2.8900000000000001 108.427 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.71 138.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.103 1.761 . . . . 1.46 108.135 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -109.15 129.1 64.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.147 -1.057 . . . . 2.7200000000000002 108.147 162.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.455 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 50.5 m-70 -101.98 160.18 14.71 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 116.366 1.987 . . . . 0.39000000000000001 116.366 -168.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 7.3 tt0 -44.05 -75.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.68 2.392 . . . . 3.0299999999999998 112.228 172.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -94.24 179.0 5.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.222 0.534 . . . . 3.6000000000000001 110.353 -168.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.13 142.62 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.382 -1.34 . . . . 1.6599999999999999 107.382 155.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -82.25 164.23 21.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.207 1.003 . . . . 2.0099999999999998 109.094 165.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -28.12 47.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.0 -1.0 . . . . 2.8399999999999999 111.722 -160.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.16 46.4 21.51 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.876 0.87 . . . . 3.0099999999999998 109.793 -168.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.71 34.63 64.99 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 124.696 1.141 . . . . 1.6299999999999999 113.04 165.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -78.45 -17.18 56.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.409 0.604 . . . . 6.9500000000000002 109.712 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.28 -118.25 5.25 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.593 -1.003 . . . . 3.8199999999999998 110.593 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.36 -69.52 0.68 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.503 -1.439 . . . . 3.3500000000000001 109.503 -168.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -92.6 160.34 15.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.19 0.996 . . . . 2.79 108.453 164.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -72.94 -47.97 40.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.253 -0.88 . . . . 5.1100000000000003 110.819 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -44.22 -39.78 4.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.795 1.634 . . . . 2.9500000000000002 114.463 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 t -39.41 -64.16 0.5 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.944 1.298 . . . . 2.4900000000000002 111.035 166.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.271 1.6 t -73.38 -44.53 58.37 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.6 0.76 . . . . 3.4100000000000001 111.1 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -55.03 -49.64 71.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 119.495 1.043 . . . . 3.29 111.921 -174.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.418 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 19.5 p -127.62 -45.98 1.46 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 119.08 -0.486 . . . . 2.6400000000000001 111.403 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.42 -14.56 1.25 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.191 0.9 . . . . 0.98999999999999999 114.327 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.265 0.3 OUTLIER 28.24 56.05 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.041 1.337 . . . . 4.0700000000000003 113.944 -156.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.65 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.603 1.161 . . . . 2.2400000000000002 112.337 167.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.86 -176.55 45.95 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.751 -1.74 . . . . 0.94999999999999996 108.751 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 m -61.21 154.28 23.84 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.612 1.165 . . . . 1.8100000000000001 113.809 -166.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -56.18 136.56 52.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.126 1.37 . . . . 3.54 109.022 168.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.5 mt -111.13 -76.24 0.6 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.294 -1.002 . . . . 1.6799999999999999 108.294 168.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.79 150.85 26.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.821 -1.177 . . . . 1.9299999999999999 107.821 170.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.5 p -153.34 156.68 38.8 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.301 -1.318 . . . . 1.53 108.49 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 136.68 4.31 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 125.036 1.46 . . . . 0.76000000000000001 112.091 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.51 125.06 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 125.192 1.397 . . . . 2.1499999999999999 109.544 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.6 tt -90.29 128.74 42.02 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.227 0.537 . . . . 1.97 111.233 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 152.08 -11.62 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.151 0.881 . . . . 0.83999999999999997 114.901 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.76 59.43 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 122.557 1.17 . . . . 2.6099999999999999 109.275 -152.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.28 148.53 25.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.71 -0.677 . . . . 2.79 111.6 172.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 C--O 1.252 1.195 0 N-CA-C 101.967 -3.345 . . . . 7.5599999999999996 101.967 142.32 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 pttp . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.086 -0.709 . . . . 5.3899999999999997 109.086 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.06 168.93 16.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.253 1.025 . . . . 2.6299999999999999 111.428 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 t -128.78 147.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.532 -2.396 . . . . 2.4900000000000002 104.532 155.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.43 99.18 4.02 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 108.525 -0.916 . . . . 1.76 108.525 153.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.4 t -68.58 94.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.868 -1.16 . . . . 2.1499999999999999 107.868 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -79.52 122.96 27.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.597 -0.89 . . . . 2.8999999999999999 108.597 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -136.33 -60.01 0.72 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.242 -1.022 . . . . 4.9400000000000004 108.242 174.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.83 -139.79 9.73 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.894 -1.682 . . . . 1.23 108.894 -156.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.83 21.78 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.142 0.577 . . . . 5.9400000000000004 111.534 168.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.32 165.57 46.37 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 107.97 -2.052 . . . . 0.95999999999999996 107.97 148.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.62 72.42 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.798 2.332 . . . . 2.6299999999999999 109.845 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.0 t -139.64 144.64 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.818 0.847 . . . . 1.98 109.287 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -145.44 120.61 10.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.575 -1.268 . . . . 3.52 107.575 166.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.88 163.56 32.78 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.588 -0.695 . . . . 0.57999999999999996 111.941 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.1 mt -127.16 127.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.474 -1.306 . . . . 2.5899999999999999 107.474 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -87.85 142.6 12.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 N-CA-C 106.383 -1.71 . . . . 1.8 106.383 158.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -139.04 82.25 1.89 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.165 -1.05 . . . . 3.2999999999999998 108.165 168.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.407 ' CD1' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -77.85 152.53 33.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 118.641 -1.224 . . . . 6.7300000000000004 108.992 175.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -139.3 148.22 42.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.905 -1.887 . . . . 3.5600000000000001 105.905 166.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -156.94 116.96 3.51 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.208 1.403 . . . . 4.0700000000000003 108.173 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -63.6 -60.23 3.6 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.274 0.63 . . . . 5.4900000000000002 110.681 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -77.9 107.02 10.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.244 -0.91 . . . . 4.0499999999999998 108.919 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -57.76 6.08 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.593 2.357 . . . . 4.3099999999999996 116.922 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.44 60.85 0.75 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.116 -1.068 . . . . 4.3700000000000001 108.116 168.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.79 179.97 19.37 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 108.389 -1.884 . . . . 1.24 108.389 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.67 116.78 3.57 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 1.1699999999999999 111.302 -171.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 20' ' ' PHE . 7.8 t -80.95 135.37 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.367 -0.825 . . . . 2.3999999999999999 109.958 -169.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.83 88.03 4.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.293 0.951 . . . . 5.1299999999999999 109.855 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.96 88.66 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.634 1.174 . . . . 2.5299999999999998 109.03 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -102.62 157.3 17.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 123.52 0.513 . . . . 1.02 111.581 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.17 164.24 35.37 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.652 -0.579 . . . . 0.68000000000000005 111.652 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -130.08 70.44 1.44 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.161 1.384 . . . . 2.8900000000000001 108.999 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.0 132.59 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.191 0.996 . . . . 1.76 110.124 -168.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -130.91 163.03 28.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.618 0.767 . . . . 4.75 111.494 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.6 -16.89 59.82 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.077 -0.846 . . . . 1.3899999999999999 113.862 173.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.41 159.25 2.09 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.55 1.175 . . . . 1.8400000000000001 111.389 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 154.67 23.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.722 -1.214 . . . . 2.3300000000000001 107.722 153.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.2 171.42 0.27 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.065 0.935 . . . . 3.3100000000000001 111.302 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.05 -161.58 54.32 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.307 -0.86 . . . . 0.88 112.75 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.92 136.24 52.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.085 1.354 . . . . 3.2000000000000002 112.401 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -140.6 121.75 14.76 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.581 1.552 . . . . 0.76000000000000001 108.86 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.66 149.98 9.87 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.73 -0.948 . . . . 0.48999999999999999 110.73 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.11 96.62 3.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.487 -1.672 . . . . 3.9300000000000002 106.487 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -134.86 161.52 34.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.997 -1.112 . . . . 1.1499999999999999 107.997 -169.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 t -114.09 128.05 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.845 -1.169 . . . . 3.5099999999999998 107.845 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -112.47 137.98 49.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.099 -1.445 . . . . 0.96999999999999997 107.099 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -72.34 63.95 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.418 0.687 . . . . 4.1600000000000001 112.725 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 107.228 -1.397 . . . . 3.5099999999999998 107.228 171.463 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 N-CA-C 108.949 -0.759 . . . . 2.4199999999999999 108.949 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.01 -94.38 0.9 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.393 -1.483 . . . . 1.55 109.393 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.17 178.25 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.902 3.068 . . . . 1.3999999999999999 112.819 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -63.85 130.0 42.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.693 -1.14 . . . . 1.3799999999999999 110.608 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -31.92 113.83 0.13 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.196 1.184 . . . . 2.96 114.196 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.47 154.86 49.39 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 126.517 1.927 . . . . 3.02 106.722 160.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.9 -42.33 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.61 1.54 . . . . 1.53 111.666 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 -71.95 0.43 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.257 0.623 . . . . 3.6699999999999999 109.556 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 m -145.47 72.56 1.32 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.562 0.745 . . . . 2.1400000000000001 111.512 -164.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -79.43 175.5 10.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.599 -1.26 . . . . 5.6600000000000001 107.599 153.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -128.89 174.97 9.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.333 1.453 . . . . 5.0899999999999999 107.224 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -108.02 129.85 55.1 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.285 1.034 . . . . 1.3899999999999999 112.658 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.79 21.71 1.29 Allowed Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.68 -0.568 . . . . 3.0 111.68 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.58 -169.71 4.02 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.074 0.845 . . . . 2.6600000000000001 113.348 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.94 -6.13 12.12 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.056 3.171 . . . . 1.6100000000000001 114.256 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.04 -50.06 5.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.916 -1.115 . . . . 6.8399999999999999 110.612 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.81 169.46 18.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.989 0.899 . . . . 2.5099999999999998 111.552 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.26 -37.84 84.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 5.21 109.51 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.343 12.1 pt-20 -78.57 149.68 32.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.028 0.918 . . . . 4.9299999999999997 110.915 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 151.87 127.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 131.405 3.882 . . . . 3.73 104.03 -162.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.0 m80 -60.62 152.34 26.61 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.649 -1.241 . . . . 0.68999999999999995 107.649 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -30.25 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 120.117 -0.633 . . . . 2.1200000000000001 110.239 -167.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.52 59.56 0.5 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.385 -0.675 . . . . 0.85999999999999999 112.756 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -123.03 108.67 13.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.682 1.241 . . . . 2.6400000000000001 109.049 165.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.82 -47.46 15.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.088 -0.708 . . . . 2.5600000000000001 109.088 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.52 -104.17 0.25 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.916 0.78 . . . . 0.79000000000000004 112.677 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -155.66 167.42 30.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.484 1.914 . . . . 2.3399999999999999 108.629 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.4 160.19 40.26 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.205 -1.035 . . . . 1.75 108.205 171.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -109.32 111.93 23.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 2.9300000000000002 108.669 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.38 139.37 37.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.304 0.502 . . . . 1.95 110.802 169.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.02 -90.31 0.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.532 0.52 . . . . 3.9300000000000002 110.649 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -129.3 -56.95 1.16 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.844 0.857 . . . . 5.5099999999999998 112.142 -159.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.7 21.16 0.85 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.074 1.749 . . . . 3.2999999999999998 110.155 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 67.08 18.47 69.03 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 124.593 1.092 . . . . 0.78000000000000003 111.597 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -79.74 110.14 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.534 -1.284 . . . . 1.8500000000000001 107.534 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.75 175.71 6.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.873 -1.158 . . . . 1.6799999999999999 107.873 161.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -131.34 136.39 48.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 102.67 -3.085 . . . . 2.9100000000000001 102.67 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.83 131.86 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.784 -1.932 . . . . 1.8 105.784 167.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.6 m -160.78 61.04 0.31 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.868 1.667 . . . . 1.5 108.245 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -108.22 152.78 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.414 0.686 . . . . 3.0800000000000001 109.705 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -137.64 142.83 41.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.308 -0.627 . . . . 3.27 109.308 149.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -124.6 145.21 49.74 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.614 -1.625 . . . . 2.5499999999999998 106.614 166.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -79.58 -18.11 52.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.036 2.134 . . . . 2.0800000000000001 111.394 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.4 t -77.17 -39.91 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.772 -0.455 . . . . 2.1299999999999999 109.772 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -77.46 176.79 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.672 0.749 . . . . 2.3100000000000001 110.985 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 t -161.51 179.89 7.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.613 1.965 . . . . 3.1400000000000001 105.871 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.54 41.86 3.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.846 1.259 . . . . 4.2199999999999998 110.74 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 C--N 1.332 -0.166 0 N-CA-C 109.015 -0.735 . . . . 4.1399999999999997 109.015 -174.779 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 N--CA 1.44 -0.935 0 CA-C-O 123.01 1.386 . . . . 1.6699999999999999 111.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -8.68 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 113.695 -1.593 . . . . 3.3100000000000001 111.98 169.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.1 mm -49.75 123.85 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 119.471 1.032 . . . . 2.8900000000000001 110.34 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.75 -9.46 55.92 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.614 -1.103 . . . . 1.6799999999999999 112.974 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -88.6 164.54 15.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.519 1.659 . . . . 5.4400000000000004 110.171 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 m -94.11 118.41 31.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.233 -0.292 . . . . 2.1000000000000001 110.698 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.76 142.53 54.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.356 -0.979 . . . . 3.7599999999999998 108.356 163.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.6 t -127.91 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.24 1.416 . . . . 1.5700000000000001 107.648 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.39 120.95 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 106.187 -1.783 . . . . 3.54 106.187 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -98.29 159.42 14.95 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.751 2.13 . . . . 0.47999999999999998 116.751 -174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -29.59 -83.44 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.363 3.065 . . . . 3.71 112.352 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -96.98 -175.35 3.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.472 1.109 . . . . 4.5 109.728 -175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.15 157.6 3.37 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.701 -0.481 . . . . 2.04 109.701 159.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.27 160.79 23.65 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.44 -0.578 . . . . 2.1899999999999999 109.44 161.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.05 -25.21 59.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.96 1.096 . . . . 3.0800000000000001 113.96 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.78 13.11 2.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.839 0.856 . . . . 2.5299999999999998 113.127 -165.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.39 47.49 42.92 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.831 1.196 . . . . 1.55 111.554 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -142.03 -22.71 0.7 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.807 2.043 . . . . 5.6900000000000004 112.925 -173.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.2 136.72 40.2 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 120.315 1.416 . . . . 3.54 111.02 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.28 67.68 0.92 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.691 1.139 . . . . 3.0600000000000001 111.26 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -144.07 -179.22 6.36 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.025 2.13 . . . . 3.1400000000000001 105.424 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -39.47 15.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.387 -0.968 . . . . 4.2000000000000002 108.387 159.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -47.48 -28.25 2.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.336 2.254 . . . . 5.0899999999999999 113.622 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.6 p -58.21 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.734 1.214 . . . . 2.8700000000000001 109.116 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.5 t -60.83 -31.74 71.15 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.23 -0.919 . . . . 4.0300000000000002 111.592 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -59.09 -49.36 78.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.281 -0.887 . . . . 4.2800000000000002 111.948 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.496 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.335 9.9 t -134.08 -51.81 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.325 -0.845 . . . . 2.8500000000000001 111.343 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.54 30.0 0.07 OUTLIER Glycine 0 C--N 1.336 0.579 0 CA-C-O 116.989 -2.006 . . . . 1.1699999999999999 115.572 168.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 9.03 57.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.683 2.393 . . . . 2.6800000000000002 114.674 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.34 88.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.2 1.0 . . . . 2.0299999999999998 108.998 166.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.73 36.44 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 108.074 -2.011 . . . . 1.04 108.074 -165.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 158.81 20.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.985 0.914 . . . . 2.6899999999999999 113.106 -166.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -63.15 132.02 50.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.243 1.817 . . . . 4.21 108.487 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.84 -63.23 1.37 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.256 -1.016 . . . . 1.8700000000000001 108.256 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.45 158.66 16.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.15 -0.932 . . . . 2.2000000000000002 109.716 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 139.36 23.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.356 -1.72 . . . . 1.78 106.356 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.12 131.05 2.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.553 -1.819 . . . . 0.81999999999999995 108.553 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.42 139.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.722 -0.844 . . . . 1.75 108.722 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.8 tt -102.31 142.68 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.779 0.831 . . . . 1.99 112.692 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.23 6.72 8.8 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.016 1.294 . . . . 0.97999999999999998 112.658 172.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.33 58.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.685 1.242 . . . . 1.8700000000000001 111.315 -163.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.57 175.54 13.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.052 0.941 . . . . 2.6600000000000001 108.79 164.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.501 0 C-N-CA 126.361 1.864 . . . . 5.3600000000000003 106.127 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 108.648 -0.871 . . . . 4.1799999999999997 108.648 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.58 139.99 37.32 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.873 -1.529 . . . . 1.6799999999999999 106.873 156.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -99.46 146.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.373 -1.714 . . . . 1.72 106.373 161.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.2 92.76 3.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.875 -0.787 . . . . 2.0099999999999998 108.875 163.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.24 110.22 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.163 -1.051 . . . . 1.8200000000000001 108.163 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.42 140.31 30.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.04 0.536 . . . . 1.95 110.355 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -144.94 -54.45 0.31 Allowed 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.204 1.002 . . . . 6.9500000000000002 109.877 165.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.46 -134.93 51.6 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.421 1.01 . . . . 0.98999999999999999 114.185 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.79 -51.32 2.92 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.79 1.236 . . . . 4.0099999999999998 109.481 -166.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.14 156.1 15.14 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 109.192 -1.563 . . . . 0.90000000000000002 109.192 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.72 46.38 2.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 1.02 112.045 -172.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 t -89.91 158.16 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 125.353 1.461 . . . . 1.8899999999999999 108.643 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.62 120.85 4.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.536 -1.653 . . . . 3.1200000000000001 106.536 173.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.06 40.38 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.528 -0.844 . . . . 0.68000000000000005 111.864 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.11 128.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.035 -1.098 . . . . 1.99 108.035 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.91 141.94 14.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.009 -1.849 . . . . 2.8700000000000001 106.009 162.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.32 115.65 20.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.414 -2.069 . . . . 1.99 105.414 163.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -129.91 107.45 9.38 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.445 -2.057 . . . . 4.5599999999999996 105.445 -163.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -136.1 153.72 51.23 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.422 0.63 . . . . 3.3199999999999998 110.58 -166.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -140.18 143.63 36.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.18 -1.785 . . . . 4.1500000000000004 106.18 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -85.31 -35.87 21.18 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.932 0.893 . . . . 5.8899999999999997 110.675 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -137.24 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.437 1.095 . . . . 5.25 108.52 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 t -129.61 -69.53 0.68 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.95 1.7 . . . . 3.3999999999999999 108.715 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -109.68 61.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.93 1.292 . . . . 5.4199999999999999 107.865 -172.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.11 175.07 21.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.961 -1.256 . . . . 1.4099999999999999 109.961 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 115.35 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.789 2.993 . . . . 1.3799999999999999 111.259 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -78.51 150.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.921 -0.77 . . . . 1.9399999999999999 108.921 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -100.13 113.79 26.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.311 -1.366 . . . . 4.4800000000000004 107.311 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.54 128.59 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.131 -1.433 . . . . 2.0699999999999998 107.131 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -130.41 146.54 51.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.851 -1.907 . . . . 1.26 105.851 162.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.23 20.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.046 -1.622 . . . . 0.68999999999999995 109.046 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 p -132.12 118.22 19.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.574 -1.639 . . . . 2.4900000000000002 106.574 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.36 148.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 125.588 1.555 . . . . 2.3100000000000001 108.462 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.439 ' HZ3' ' CG ' ' A' ' 92' ' ' ASP . 9.7 ptmm? -141.09 176.45 8.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 119.017 -1.073 . . . . 6.5800000000000001 112.548 149.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.99 13.89 57.08 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.203 1.858 . . . . 0.69999999999999996 113.191 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -65.25 166.01 10.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 117.713 0.757 . . . . 2.6499999999999999 109.968 166.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 164.95 23.65 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.988 -1.115 . . . . 2.8199999999999998 107.988 156.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -58.92 174.11 0.38 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.266 0.939 . . . . 2.4300000000000002 111.476 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.08 -166.38 54.85 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.677 0.656 . . . . 0.70999999999999996 113.756 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.05 153.26 40.93 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.241 1.017 . . . . 3.3300000000000001 110.41 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -146.55 118.62 8.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.945 1.298 . . . . 0.65000000000000002 108.878 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.96 151.58 5.5 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.335 -1.106 . . . . 0.45000000000000001 110.335 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -145.85 102.27 3.64 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 117.977 0.889 . . . . 3.5499999999999998 108.716 -171.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -143.34 155.21 44.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.248 -1.39 . . . . 0.93000000000000005 107.248 -158.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.1 140.35 30.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 119.643 1.111 . . . . 2.9300000000000002 109.784 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -113.25 140.33 48.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.971 1.308 . . . . 1.0 107.691 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.1 74.1 0.65 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.387 1.089 . . . . 4.4699999999999998 112.193 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 104.753 -2.314 . . . . 3.3100000000000001 104.753 -171.978 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.474 0.654 . . . . 2.04 109.472 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.68 -91.92 1.92 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 107.879 -2.088 . . . . 1.73 107.879 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.95 178.09 6.91 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.759 2.972 . . . . 1.3 113.281 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.31 131.74 45.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.584 -1.644 . . . . 1.47 109.868 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -35.42 109.84 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.834 1.254 . . . . 3.1299999999999999 111.907 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.38 150.7 21.17 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 126.038 1.735 . . . . 3.3199999999999998 107.199 165.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.15 -29.02 33.72 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.368 2.045 . . . . 1.47 114.14 -170.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.93 -64.38 0.11 Allowed 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.07 0.85 . . . . 4.2699999999999996 112.152 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.6 m -154.23 83.3 1.13 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.102 -0.703 . . . . 2.6800000000000002 109.102 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 168.06 11.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.462 -0.94 . . . . 6.3799999999999999 108.462 162.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -114.7 163.16 15.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.635 -1.246 . . . . 3.8100000000000001 107.635 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -82.58 160.77 22.46 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.082 0.553 . . . . 0.80000000000000004 110.293 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.54 176.72 41.64 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 106.302 -2.719 . . . . 2.02 106.302 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.19 -168.92 23.99 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 118.927 1.364 . . . . 1.9199999999999999 112.913 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -62.36 -30.9 81.31 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.851 1.7 . . . . 1.72 109.957 163.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -78.11 -42.39 32.12 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.617 0.767 . . . . 6.3200000000000003 112.561 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.1 163.55 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.456 0.571 . . . . 2.2999999999999998 111.267 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -78.5 -50.9 10.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.638 1.575 . . . . 4.2000000000000002 109.936 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.259 16.9 pt-20 -90.48 176.82 6.56 Favored 'General case' 0 C--N 1.337 0.055 0 C-N-CA 122.554 0.342 . . . . 3.4100000000000001 111.812 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 165.05 159.06 0.02 OUTLIER 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.674 1.989 . . . . 5.75 108.552 -166.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.454 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 55.7 m80 -61.52 139.39 58.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.094 -1.817 . . . . 0.75 106.094 161.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.11 -32.23 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.723 -0.391 . . . . 2.21 110.653 -163.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.62 53.32 0.65 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.123 0.392 . . . . 1.0800000000000001 113.007 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -107.9 130.14 55.04 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 2.5899999999999999 107.733 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.71 -58.75 2.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.166 -1.05 . . . . 2.77 108.166 159.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.12 -93.14 0.13 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.701 -0.96 . . . . 0.70999999999999996 110.701 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -155.09 166.52 33.33 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.945 1.698 . . . . 2.3900000000000001 111.234 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.09 178.06 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 127.31 2.244 . . . . 1.8700000000000001 105.961 165.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -136.49 145.73 45.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.921 -1.881 . . . . 2.75 105.921 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.52 145.49 34.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.733 0.813 . . . . 1.55 110.862 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -70.39 -84.25 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.873 0.869 . . . . 2.9500000000000002 110.79 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 93' ' ' GLY . 61.5 tttt -158.69 -47.3 0.06 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.317 1.047 . . . . 4.2300000000000004 111.226 -171.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.439 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 19.3 t0 -82.44 29.62 0.43 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 124.659 2.171 . . . . 3.0699999999999998 110.277 173.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 60.07 21.31 55.94 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 113.583 -1.644 . . . . 0.91000000000000003 111.611 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.56 138.14 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.716 -1.587 . . . . 1.9199999999999999 106.716 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.73 169.37 19.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.103 -1.073 . . . . 1.78 108.103 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.64 141.61 29.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.956 -1.868 . . . . 2.7200000000000002 105.956 -165.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.8 56.59 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 124.048 0.843 . . . . 2.1099999999999999 112.415 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.8 m -78.15 97.45 5.47 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.27 1.028 . . . . 1.5700000000000001 109.846 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 mm -136.44 153.62 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.964 0.906 . . . . 2.9900000000000002 110.455 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -132.81 97.08 3.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.243 1.817 . . . . 4.0300000000000002 108.77 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.98 174.4 11.59 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.601 -0.518 . . . . 2.3199999999999998 109.601 169.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.2 m -147.84 26.52 1.01 Allowed 'General case' 0 CA--C 1.53 0.211 0 O-C-N 120.839 -1.163 . . . . 3.3500000000000001 112.069 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.15 -52.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.543 1.537 . . . . 2.0099999999999998 108.532 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.21 173.22 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.107 0.48 . . . . 2.3599999999999999 111.338 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.3 t -154.43 176.48 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.679 0.792 . . . . 3.0699999999999998 110.257 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -86.88 -13.67 44.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 3.5499999999999998 111.073 160.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 124.568 1.147 . . . . 3.6400000000000001 111.349 -172.184 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.44 -0.963 0 CA-C-O 121.375 0.607 . . . . 1.76 112.413 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.7 pt -86.04 -6.39 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 2.9100000000000001 110.855 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.6 tp -33.22 123.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 125.369 1.468 . . . . 3.5499999999999998 110.69 166.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.81 57.11 20.5 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.858 -0.897 . . . . 1.8600000000000001 110.858 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -135.56 157.93 45.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.883 -1.525 . . . . 4.96 106.883 163.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -82.58 120.75 25.93 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.543 -1.28 . . . . 1.8700000000000001 107.543 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.44 141.69 44.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.602 -1.258 . . . . 3.6899999999999999 107.602 168.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.04 134.1 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.446 -1.316 . . . . 1.5900000000000001 107.446 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.33 130.43 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 106.337 -1.727 . . . . 3.4100000000000001 106.337 162.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -104.51 163.66 12.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.773 1.397 . . . . 0.38 114.773 -168.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.72 -71.47 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.281 -0.866 . . . . 3.7599999999999998 112.287 176.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -79.56 176.68 9.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.643 1.111 . . . . 3.96 109.08 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.3 158.66 16.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.779 -0.822 . . . . 1.8200000000000001 108.779 162.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -76.64 170.57 16.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.481 -0.562 . . . . 2.0 109.481 166.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.78 -20.84 59.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.254 1.205 . . . . 4.1500000000000004 114.254 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 66.48 -6.21 0.53 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.119 1.368 . . . . 2.54 113.471 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.84 9.34 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 120.122 1.328 . . . . 1.95 109.904 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.09 -31.09 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 6.7599999999999998 109.384 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.64 -106.73 2.12 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.761 . . . . 4.0700000000000003 111.196 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.44 -72.19 0.47 Allowed Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.544 -0.974 . . . . 3.7799999999999998 112.117 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -83.23 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.688 0.744 . . . . 3.1699999999999999 110.933 -172.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 178.77 -71.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.597 1.959 . . . . 3.2200000000000002 106.908 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -40.28 -40.39 1.14 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.857 2.063 . . . . 4.6799999999999997 112.042 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.47 0.09 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.549 2.339 . . . . 2.48 112.076 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -39.53 74.27 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.409 -1.432 . . . . 2.8500000000000001 110.787 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -55.66 -48.42 75.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.78 1.232 . . . . 3.9300000000000002 111.566 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.454 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -127.7 -48.26 1.39 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.691 0.796 . . . . 2.0299999999999998 111.987 177.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.3 -11.9 0.9 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.797 -1.002 . . . . 0.89000000000000001 114.097 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 30.51 54.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.943 2.097 . . . . 3.9300000000000002 112.911 -168.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.8 80.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.519 1.127 . . . . 2.2200000000000002 111.014 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.96 -165.75 30.72 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 108.895 -1.682 . . . . 1.05 108.895 -166.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -58.57 154.83 13.44 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 127.751 2.421 . . . . 1.8700000000000001 113.102 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -57.01 139.03 53.47 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.816 -1.084 . . . . 3.1800000000000002 108.964 166.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.73 -78.48 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.014 -1.106 . . . . 1.74 108.014 160.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.7 159.8 16.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.019 -0.734 . . . . 1.8999999999999999 109.019 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 72.8 m -148.01 157.84 43.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.825 -1.546 . . . . 2.1800000000000002 106.825 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.14 139.96 3.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.212 -1.955 . . . . 0.73999999999999999 108.212 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.42 138.08 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.714 0.806 . . . . 2.0 109.552 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 tt -94.82 131.03 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.104 0.478 . . . . 1.9099999999999999 111.828 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.45 0.52 0.98 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.942 1.258 . . . . 0.66000000000000003 114.689 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.96 57.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.19 1.495 . . . . 1.9099999999999999 111.54 -153.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.72 174.58 15.25 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.027 0.531 . . . . 2.0 110.914 163.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 . . . . . 0 C--O 1.255 1.347 0 N-CA-C 102.731 -3.063 . . . . 6.8300000000000001 102.731 160.668 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.1 pttt . . . . . 0 C--O 1.229 -0.017 0 N-CA-C 113.295 0.85 . . . . 4.4400000000000004 113.295 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.97 155.82 23.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.39 1.076 . . . . 2.0099999999999998 109.573 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -124.18 150.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 107.981 -1.118 . . . . 2.1099999999999999 107.981 165.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.36 95.37 4.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.194 0.998 . . . . 1.71 109.206 161.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.67 112.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.359 -1.348 . . . . 1.8100000000000001 107.359 161.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.48 131.83 51.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.153 0.981 . . . . 2.2200000000000002 109.769 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.63 -47.92 0.29 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.785 1.234 . . . . 5.71 109.886 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.61 -125.05 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.543 1.068 . . . . 0.84999999999999998 111.989 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.47 -58.27 1.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.696 -0.853 . . . . 4.21 108.696 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.72 165.92 3.8 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.788 1.661 . . . . 0.75 114.146 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.62 37.46 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 124.516 3.477 . . . . 1.4299999999999999 111.95 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.2 t -110.97 143.61 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.167 2.187 . . . . 2.0699999999999998 106.795 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -137.38 131.22 31.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.786 -1.931 . . . . 3.23 105.786 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.96 165.75 33.27 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 121.687 -0.633 . . . . 0.69999999999999996 111.84 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.65 127.65 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.979 -1.86 . . . . 2.3900000000000001 105.979 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.5 mm -98.46 138.14 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.748 -1.575 . . . . 1.8999999999999999 106.748 165.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -109.38 124.86 51.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.57 -1.641 . . . . 2.1699999999999999 106.57 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.21 95.99 6.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.882 -1.895 . . . . 3.54 105.882 171.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -113.52 136.66 52.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.879 -1.526 . . . . 5.54 106.879 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -153.69 153.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.913 -1.514 . . . . 4.29 106.913 -166.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -105.5 -79.06 0.56 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 5.5599999999999996 110.121 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.46 137.07 37.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.098 0.959 . . . . 4.0 109.051 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -52.52 -68.08 0.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.02 1.728 . . . . 2.8900000000000001 112.446 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -79.7 68.54 5.79 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.814 -1.18 . . . . 4.6399999999999997 107.814 170.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 167.46 31.42 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.604 -0.999 . . . . 1.5800000000000001 110.604 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.4 142.32 44.84 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.523 2.816 . . . . 1.5900000000000001 111.834 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.3 165.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.617 -1.253 . . . . 2.3399999999999999 107.617 171.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.37 95.09 4.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.866 -1.901 . . . . 4.1399999999999997 105.866 157.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.83 113.49 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.524 -1.658 . . . . 2.0899999999999999 106.524 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -124.85 142.5 51.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.177 -1.045 . . . . 0.96999999999999997 108.177 166.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.1 152.23 23.67 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.446 -0.661 . . . . 0.73999999999999999 111.446 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 p -125.33 64.56 1.16 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.484 1.514 . . . . 2.8599999999999999 108.599 -165.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -80.72 142.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.525 -1.216 . . . . 1.8 109.099 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -149.99 161.88 41.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.324 0.861 . . . . 4.2300000000000004 113.324 174.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.81 9.1 61.43 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.702 1.62 . . . . 0.82999999999999996 112.617 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.87 162.41 16.35 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.751 -0.853 . . . . 1.6399999999999999 109.542 172.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.18 162.21 14.91 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.571 -1.27 . . . . 2.73 107.571 152.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.69 177.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.962 0.801 . . . . 3.0699999999999998 110.959 174.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.98 -163.51 37.51 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.922 0.772 . . . . 0.68999999999999995 113.512 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.7 142.92 58.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.393 1.477 . . . . 2.8799999999999999 113.355 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -145.68 116.88 7.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 126.104 1.762 . . . . 0.68999999999999995 109.359 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.58 150.02 6.13 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.301 0.953 . . . . 0.40000000000000002 111.081 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -141.25 99.61 3.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.66 -1.237 . . . . 4.3200000000000003 107.66 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -140.02 161.95 36.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.714 -1.217 . . . . 1.1000000000000001 107.714 -165.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.89 130.0 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 119.07 0.85 . . . . 3.1299999999999999 109.41 172.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -106.99 134.09 50.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.479 1.911 . . . . 1.3 105.947 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 60.64 0.61 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.16 1.541 . . . . 4.6900000000000004 115.16 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 107.878 -1.156 . . . . 3.1800000000000002 107.878 168.543 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.453 -0.573 . . . . 2.0299999999999998 109.453 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.49 -85.5 1.85 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.819 -1.312 . . . . 1.5600000000000001 109.819 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.63 176.66 9.82 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.215 2.61 . . . . 1.05 113.217 -174.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 m170 -66.31 123.4 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.107 -1.406 . . . . 1.45 108.119 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -37.19 113.5 0.26 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.092 1.357 . . . . 4.3700000000000001 111.608 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.5 154.55 25.63 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 124.957 1.303 . . . . 3.3300000000000001 107.604 168.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.36 -48.6 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.861 1.708 . . . . 1.3600000000000001 111.643 -168.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.38 -79.71 0.62 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.898 0.879 . . . . 4.2199999999999998 109.074 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.3 m -150.8 68.86 0.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.801 0.841 . . . . 2.27 110.384 -166.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.426 HH11 ' CD ' ' A' ' 78' ' ' GLU . 9.4 mmt180 -78.95 174.92 11.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.338 0.589 . . . . 5.0 109.417 166.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -124.8 156.01 38.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.376 -1.342 . . . . 3.8199999999999998 107.376 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -83.15 162.05 21.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.099 0.476 . . . . 0.79000000000000004 111.155 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.41 -126.28 0.87 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.173 -2.771 . . . . 2.0499999999999998 106.173 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.02 -134.22 2.02 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 106.403 -2.679 . . . . 1.8200000000000001 106.403 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.14 -54.18 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 120.288 2.044 . . . . 1.8500000000000001 109.869 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -60.14 -44.42 94.95 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.952 1.301 . . . . 5.9699999999999998 113.841 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.8 175.75 2.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.905 0.383 . . . . 2.0600000000000001 111.06 -170.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -77.36 -46.85 21.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.048 1.339 . . . . 5.0099999999999998 108.889 167.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.426 ' CD ' HH11 ' A' ' 69' ' ' ARG . 2.0 mm-40 -79.85 172.22 14.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.81 0.844 . . . . 3.1499999999999999 112.144 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 172.17 145.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.234 2.213 . . . . 4.9699999999999998 109.757 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -56.18 138.64 49.64 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.905 -1.517 . . . . 0.77000000000000002 106.905 161.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.55 -32.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.293 -0.632 . . . . 2.0899999999999999 109.293 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.87 34.45 5.34 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 116.395 1.318 . . . . 1.0600000000000001 116.395 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -107.1 148.08 29.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.861 1.83 . . . . 2.4399999999999999 107.402 157.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.62 -49.95 4.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.27 -1.011 . . . . 2.6899999999999999 108.27 141.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.82 -97.16 0.17 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.794 -1.322 . . . . 0.85999999999999999 109.794 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -152.81 169.49 22.65 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.784 1.634 . . . . 2.3700000000000001 109.574 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.7 175.2 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.331 -1.729 . . . . 1.79 106.331 163.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -109.47 143.7 38.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.733 -1.21 . . . . 2.9399999999999999 107.733 162.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.25 151.32 29.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.548 -0.908 . . . . 1.8600000000000001 108.548 151.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.39 -87.28 0.06 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.328 0.651 . . . . 2.8599999999999999 109.388 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -150.72 -43.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.12 1.368 . . . . 4.5599999999999996 110.848 -170.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.24 8.09 5.45 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.204 1.002 . . . . 2.6699999999999999 111.268 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.29 8.16 87.59 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.169 0.89 . . . . 1.01 111.536 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -78.67 135.91 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.015 -1.476 . . . . 1.8300000000000001 107.015 173.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.1 174.42 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.086 0.955 . . . . 1.5700000000000001 109.424 170.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -130.0 117.56 20.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 103.241 -2.874 . . . . 3.6400000000000001 103.241 -174.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.58 112.03 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 105.039 -2.208 . . . . 1.9199999999999999 105.039 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -148.89 97.23 2.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.816 1.246 . . . . 1.47 108.433 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.1 mp -145.28 147.41 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 108.929 -0.767 . . . . 2.9100000000000001 108.929 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.22 68.49 1.28 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.066 0.946 . . . . 4.21 111.964 173.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.99 157.66 31.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.375 -0.828 . . . . 2.4199999999999999 111.078 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 p -110.36 -11.8 14.49 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.775 2.03 . . . . 2.0 113.508 -177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.05 -50.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.923 -1.14 . . . . 2.3300000000000001 107.923 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.78 158.95 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 122.357 1.075 . . . . 3.6400000000000001 109.808 171.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.8 p -152.17 174.68 13.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.762 2.425 . . . . 2.3599999999999999 107.553 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -42.61 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.344 1.458 . . . . 3.8700000000000001 109.45 173.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 125.301 1.44 . . . . 5.1100000000000003 110.899 178.127 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.806 0 N-CA-C 110.824 -0.065 . . . . 1.4299999999999999 110.824 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.8 pt -79.58 -7.73 10.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 119.295 -0.962 . . . . 3.1600000000000001 111.339 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 tt -44.46 140.91 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.095 1.146 . . . . 3.27 114.095 -167.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 56.59 9.32 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.4 -1.08 . . . . 1.8 110.4 -178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.48 175.78 13.51 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.861 2.065 . . . . 5.0099999999999998 105.706 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -123.35 106.39 10.63 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.501 1.046 . . . . 2.1600000000000001 112.488 -169.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.69 150.02 42.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.194 -0.457 . . . . 2.73 110.133 168.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.33 134.45 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.995 1.718 . . . . 1.8600000000000001 107.124 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 m -103.71 124.66 58.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.265 -1.383 . . . . 2.7200000000000002 107.265 165.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -97.81 159.42 14.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 116.859 2.17 . . . . 0.47999999999999998 116.859 -168.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -40.62 -69.52 0.13 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.143 2.577 . . . . 3.1099999999999999 111.651 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -113.44 -176.23 2.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.66 0.664 . . . . 4.1900000000000004 109.985 -169.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.7 146.33 41.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.528 -0.545 . . . . 1.5 109.528 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 154.47 41.61 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.244 -1.021 . . . . 2.0800000000000001 108.244 157.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -90.81 -6.02 54.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 3.54 113.663 -170.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 65.84 14.49 9.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.365 1.466 . . . . 2.5299999999999998 113.44 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 39.01 3.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.94 1.257 . . . . 1.6399999999999999 110.999 167.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -141.68 -82.36 0.21 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.346 1.459 . . . . 6.2000000000000002 108.525 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.06 -46.42 0.98 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.66 1.124 . . . . 3.98 114.285 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.53 7.76 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.349 -1.5 . . . . 2.6200000000000001 109.349 -165.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -166.18 -170.39 1.69 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.138 1.775 . . . . 3.48 107.347 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -92.87 -47.61 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.831 0.853 . . . . 3.3199999999999998 110.493 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -53.3 -33.76 54.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.929 2.092 . . . . 4.9800000000000004 112.085 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 p -49.73 -70.68 0.08 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.47 1.508 . . . . 2.54 110.705 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.6 p -60.06 -45.65 92.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 2.1099999999999999 110.207 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.8 -48.26 75.7 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.373 1.069 . . . . 4.9400000000000004 111.577 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 54.5 p -132.07 -54.73 0.98 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.386 0.513 . . . . 2.6600000000000001 112.386 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 126.99 106.96 1.45 Allowed Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 104.783 -3.327 . . . . 3.02 104.783 -167.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.45 57.55 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.679 1.592 . . . . 2.54 108.984 -172.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.75 -30.84 67.81 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.458 1.503 . . . . 1.9299999999999999 113.438 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.08 50.62 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 107.953 -2.059 . . . . 1.05 107.953 -160.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 t -64.69 162.78 15.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.927 0.891 . . . . 2.3599999999999999 113.289 -165.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -65.75 138.03 57.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.337 1.855 . . . . 4.04 109.144 172.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.7 mt -110.75 -78.31 0.59 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.773 1.169 . . . . 1.76 108.91 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.4 151.7 26.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.878 0.871 . . . . 2.0099999999999998 109.175 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.0 p -160.57 173.24 15.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.426 1.89 . . . . 1.49 107.367 -177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 167.11 170.88 32.54 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.844 -2.902 . . . . 1.45 105.844 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.6 t -87.49 143.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 119.624 1.712 . . . . 1.9299999999999999 109.082 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.8 tt -93.65 127.63 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.92 0.488 . . . . 2.0800000000000001 111.592 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.54 14.95 0.11 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.38 1.467 . . . . 1.1000000000000001 114.292 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 mm -101.99 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 120.178 1.989 . . . . 2.25 109.331 -159.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.73 175.11 14.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 2.23 109.278 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 104.351 -2.463 . . . . 4.8899999999999997 104.351 162.377 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.749 0.309 . . . . 4.5 111.181 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.06 138.36 34.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 1.6399999999999999 108.108 165.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.59 142.36 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.953 -1.129 . . . . 2.1600000000000001 107.953 166.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.34 96.07 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.444 -0.947 . . . . 1.6699999999999999 108.444 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.84 107.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.763 -1.569 . . . . 2.23 106.763 159.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -95.21 125.0 39.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.969 -1.123 . . . . 1.96 107.969 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -49.68 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.16 0.584 . . . . 5.7599999999999998 109.872 175.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 36.38 -120.5 0.6 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.42 1.486 . . . . 1.22 112.918 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -93.47 -59.67 1.96 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.342 -0.984 . . . . 3.4100000000000001 108.342 -173.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.39 164.2 5.43 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.512 1.53 . . . . 1.1200000000000001 114.897 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -79.06 33.48 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.399 3.399 . . . . 1.3999999999999999 112.208 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 t -111.2 141.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 127.171 2.189 . . . . 2.0299999999999998 105.997 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -139.61 128.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.776 -1.564 . . . . 3.1800000000000002 106.776 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.17 164.88 31.59 Favored Glycine 0 N--CA 1.45 -0.395 0 O-C-N 121.905 -0.497 . . . . 0.81999999999999995 112.064 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.98 124.57 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.863 -1.162 . . . . 2.3799999999999999 107.863 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.0 mm -89.39 155.33 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.504 1.122 . . . . 2.1099999999999999 109.061 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 126.57 43.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.516 -0.92 . . . . 2.46 108.516 153.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.65 123.25 47.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.462 -2.051 . . . . 3.6200000000000001 105.462 168.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -148.98 139.51 22.56 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.098 -0.705 . . . . 3.4199999999999999 109.098 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 164.91 37.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.618 -1.993 . . . . 3.8999999999999999 105.618 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -54.3 2.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.774 1.23 . . . . 5.0800000000000001 110.34 -177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -79.28 118.74 21.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.257 -1.386 . . . . 4.1699999999999999 107.257 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -76.02 46.09 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.738 1.154 . . . . 2.79 112.7 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.8 t30 179.85 58.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.822 2.449 . . . . 4.6799999999999997 107.971 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.59 170.59 35.2 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.41 -1.076 . . . . 1.3 110.41 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.45 140.24 86.49 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.315 2.677 . . . . 1.47 111.626 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 t -93.67 158.12 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.12 -1.067 . . . . 2.3799999999999999 108.12 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -107.71 111.75 24.09 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.38 -1.711 . . . . 6.4699999999999998 106.38 162.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -79.61 135.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.507 -2.034 . . . . 2.02 105.507 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -139.13 159.64 41.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.644 -1.984 . . . . 0.93999999999999995 105.644 159.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.1 -166.29 14.75 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.201 -1.0 . . . . 1.9199999999999999 110.61 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.0 m -148.22 109.73 4.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.626 -1.99 . . . . 2.1699999999999999 105.626 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -114.81 146.18 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.703 -1.592 . . . . 2.0499999999999998 106.703 -170.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -154.79 170.63 21.17 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 114.127 1.158 . . . . 4.5999999999999996 114.127 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.89 80.45 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.626 1.584 . . . . 0.65000000000000002 112.616 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.1 155.77 26.93 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.833 -0.804 . . . . 1.79 110.232 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 165.01 17.71 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.66 -1.237 . . . . 2.3999999999999999 107.66 156.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.66 175.69 0.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.013 0.824 . . . . 2.6099999999999999 111.59 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.34 -162.12 37.22 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.129 0.871 . . . . 0.60999999999999999 113.576 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.49 146.48 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.051 1.74 . . . . 2.98 112.962 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -146.97 113.53 5.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.872 1.669 . . . . 0.64000000000000001 109.428 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.92 147.84 4.16 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.745 -0.942 . . . . 0.41999999999999998 110.745 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.54 95.32 2.85 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.791 -1.559 . . . . 3.48 106.791 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -132.18 158.37 41.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.354 -1.721 . . . . 0.89000000000000001 106.354 -165.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.302 0.8 OUTLIER -117.81 115.94 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.546 1.165 . . . . 2.7799999999999998 110.681 175.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -79.78 158.95 26.72 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.113 1.365 . . . . 0.92000000000000004 109.15 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -28.62 -93.39 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.638 2.775 . . . . 4.9400000000000004 114.998 -158.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.517 -0.301 0 C-N-CA 123.1 0.56 . . . . 12.24 110.273 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 113.188 0.81 . . . . 3.3199999999999998 113.188 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.82 -91.98 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.955 -0.914 . . . . 1.96 112.204 -161.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.4 177.51 8.25 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.607 2.872 . . . . 1.6399999999999999 112.925 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -62.3 123.42 18.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.219 -1.4 . . . . 1.28 107.219 168.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -37.9 109.63 0.11 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.422 1.089 . . . . 2.8100000000000001 112.255 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -126.12 145.06 51.0 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 130.792 3.637 . . . . 3.5 107.712 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 -43.0 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.277 1.985 . . . . 1.5800000000000001 109.028 168.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -155.24 -73.44 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.368 -0.975 . . . . 3.9199999999999999 108.368 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 p -129.49 58.88 1.61 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.471 1.108 . . . . 3.3599999999999999 110.906 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -79.8 159.84 26.37 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.818 -0.552 . . . . 5.79 109.559 168.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.46 163.02 17.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.375 1.47 . . . . 4.8799999999999999 107.792 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -90.2 153.39 20.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.912 0.885 . . . . 0.82999999999999996 110.329 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.66 -52.4 0.01 OUTLIER Glycine 0 C--O 1.224 -0.521 0 N-CA-C 109.639 -1.384 . . . . 2.77 109.639 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.9 -166.31 21.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.948 1.261 . . . . 1.9199999999999999 111.488 171.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.91 -41.31 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.786 2.324 . . . . 1.5700000000000001 109.155 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -58.78 -58.11 10.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.267 1.427 . . . . 5.7300000000000004 109.91 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.66 152.88 29.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.036 -0.983 . . . . 1.9299999999999999 111.269 -167.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -52.18 -45.42 65.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.77 1.628 . . . . 4.0999999999999996 111.479 173.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -77.64 145.67 36.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.505 1.145 . . . . 2.6499999999999999 110.256 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.27 151.56 2.07 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.369 1.868 . . . . 3.8599999999999999 108.848 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.4 m80 -60.94 143.63 54.72 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.785 -1.561 . . . . 0.55000000000000004 106.785 163.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.97 -30.73 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.167 -0.613 . . . . 1.8200000000000001 110.947 -165.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.69 67.51 0.31 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 112.157 -0.377 . . . . 1.1200000000000001 112.157 167.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.29 114.37 3.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.419 -1.048 . . . . 2.6600000000000001 108.862 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.03 -53.93 3.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.248 0.619 . . . . 3.3399999999999999 110.121 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.76 -110.41 0.42 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.112 -0.566 . . . . 0.64000000000000001 111.822 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -148.58 167.58 25.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.04 1.736 . . . . 2.25 109.479 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.5 m -117.63 175.23 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.362 -1.718 . . . . 1.74 106.362 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.9 t -109.43 150.48 28.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.264 -1.384 . . . . 3.21 107.264 159.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.03 152.83 32.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.64 -0.874 . . . . 1.74 108.64 157.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -79.88 -83.47 0.1 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.781 1.232 . . . . 3.7200000000000002 108.984 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 93' ' ' GLY . 1.0 OUTLIER -151.29 -48.47 0.12 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.175 0.99 . . . . 4.96 110.968 -178.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.37 24.91 0.65 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.439 1.59 . . . . 2.7200000000000002 111.13 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 66.36 14.39 61.94 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.063 1.316 . . . . 0.70999999999999996 111.889 -173.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.88 152.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 125.193 1.397 . . . . 1.8999999999999999 107.749 175.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.41 172.35 15.07 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.16 1.384 . . . . 1.6699999999999999 107.729 168.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -132.85 162.66 30.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.89 -2.263 . . . . 3.3999999999999999 104.89 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.54 55.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 O-C-N 124.184 0.928 . . . . 1.97 112.423 174.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.3 m -70.4 101.29 1.92 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.741 -0.599 . . . . 1.3799999999999999 110.845 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.07 157.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.835 -0.802 . . . . 2.7400000000000002 108.835 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -139.09 129.16 25.19 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.613 -0.884 . . . . 3.6200000000000001 108.613 159.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -134.68 151.48 51.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.695 1.598 . . . . 2.3599999999999999 108.492 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 p -107.59 -3.51 19.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.275 1.83 . . . . 1.9199999999999999 113.28 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.94 -42.56 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.364 -1.347 . . . . 2.1899999999999999 107.364 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.69 177.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.519 0.676 . . . . 2.77 111.546 172.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.9 m -161.21 179.32 8.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.833 2.453 . . . . 2.3799999999999999 106.434 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 70.4 1.08 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.118 -2.179 . . . . 3.9399999999999999 105.118 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 115.638 -0.71 . . . . 3.96 110.513 170.019 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.445 -0.692 0 CA-C-O 122.486 1.136 . . . . 2.48 112.887 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.95 -6.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.065 -0.971 . . . . 2.73 112.081 -170.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.2 mm -59.38 124.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.455 -0.943 . . . . 3.8599999999999999 108.455 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.79 3.56 76.91 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.447 1.022 . . . . 1.3200000000000001 113.256 -172.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -113.03 163.48 14.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.285 1.543 . . . . 5.1799999999999997 109.771 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -93.15 89.79 6.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.833 1.253 . . . . 2.9399999999999999 110.252 -157.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.33 143.98 56.27 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.329 -0.857 . . . . 3.0699999999999998 109.848 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -135.19 133.45 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.281 1.832 . . . . 1.52 109.046 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -94.38 121.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 125.858 1.663 . . . . 3.6400000000000001 107.706 163.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -98.56 167.28 10.91 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 117.608 2.447 . . . . 0.58999999999999997 117.608 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -81.3 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.325 1.85 . . . . 4.0199999999999996 110.314 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -178.26 6.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.595 0.634 . . . . 5.7199999999999998 109.878 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.63 151.03 30.07 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.141 -1.429 . . . . 1.6599999999999999 107.141 153.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -76.74 151.7 35.93 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.473 -1.306 . . . . 1.99 107.473 158.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.424 ' CB ' ' HG ' ' A' ' 134' ' ' SER . 56.4 m-20 -70.27 -25.56 63.41 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.0 -0.437 . . . . 3.1400000000000001 111.529 -169.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 50.0 7.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.043 0.937 . . . . 3.1600000000000001 109.93 -159.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 52.53 39.72 53.73 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.306 0.955 . . . . 1.6000000000000001 113.263 167.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -80.01 -18.61 49.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.681 0.792 . . . . 6.1699999999999999 111.394 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.44 -143.09 16.3 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.83 -0.508 . . . . 3.6600000000000001 111.83 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.77 -77.05 0.4 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.577 -1.409 . . . . 3.2000000000000002 109.577 -172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.86 104.03 14.46 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.012 -1.477 . . . . 2.8399999999999999 107.012 167.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.56 -33.55 22.23 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.763 1.165 . . . . 5.1600000000000001 112.986 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -37.07 -36.71 0.13 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.319 1.048 . . . . 3.02 113.694 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.424 ' HG ' ' CB ' ' A' ' 125' ' ' ASP . 5.8 t -36.35 -66.99 0.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.903 2.081 . . . . 2.4900000000000002 111.023 167.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.28 -46.15 51.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.145 0.978 . . . . 2.3900000000000001 110.583 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -53.01 -52.27 58.96 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.585 0.754 . . . . 3.7799999999999998 111.328 -168.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.278 5.4 p -126.51 -48.51 1.54 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.675 -0.679 . . . . 2.2999999999999998 112.277 174.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 159.42 -21.06 0.28 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 120.052 1.296 . . . . 1.01 114.039 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.17 56.32 5.96 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.796 1.238 . . . . 2.8100000000000001 111.349 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.28 0.49 2.78 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.509 0.929 . . . . 2.1699999999999999 113.509 169.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -71.13 2.99 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.297 -1.502 . . . . 3.3799999999999999 110.315 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 t -166.33 -174.41 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.529 0.732 . . . . 2.6400000000000001 110.975 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.31 139.06 31.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.496 2.718 . . . . 4.0899999999999999 109.522 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.4 mt -113.26 -88.28 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.298 0.954 . . . . 1.6699999999999999 109.685 169.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.31 154.43 21.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.598 -0.89 . . . . 2.1899999999999999 108.598 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.6 p -157.58 170.98 21.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 123.753 0.658 . . . . 1.76 110.598 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.62 155.42 11.31 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.484 -1.446 . . . . 1.3500000000000001 109.484 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.0 137.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.611 0.705 . . . . 2.4500000000000002 109.459 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.1 tt -86.45 143.65 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.228 -0.442 . . . . 1.8 110.935 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.04 5.56 3.03 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.62 1.105 . . . . 0.57999999999999996 114.219 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.4 mm -96.05 56.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 119.289 1.544 . . . . 2.0 109.926 -156.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.49 176.52 12.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.547 0.739 . . . . 2.4900000000000002 110.578 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.313 0 N-CA-C 103.999 -2.593 . . . . 5.9900000000000002 103.999 154.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 pttm . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 107.798 -1.186 . . . . 3.9199999999999999 107.798 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.39 144.8 43.26 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.055 -1.461 . . . . 1.6000000000000001 107.055 164.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.9 t -119.91 141.38 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 107.571 -1.27 . . . . 1.76 107.571 171.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.19 99.82 6.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.173 1.389 . . . . 1.8700000000000001 108.286 159.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.83 98.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.65 -1.241 . . . . 1.8 107.65 163.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.0 mt -84.61 126.82 33.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.188 0.595 . . . . 1.77 109.564 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -143.72 -48.3 0.29 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.72 0.808 . . . . 4.6200000000000001 110.91 170.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.43 -123.68 5.24 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.432 -1.067 . . . . 0.82999999999999996 110.432 -171.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -107.1 -52.57 2.74 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.712 0.756 . . . . 4.0199999999999996 110.707 -173.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.56 156.58 5.71 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.913 1.244 . . . . 0.81000000000000005 111.702 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.14 39.65 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.372 3.381 . . . . 1.1899999999999999 113.23 -170.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.5 t -101.47 155.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.761 2.025 . . . . 1.9399999999999999 107.644 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.12 125.02 9.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.967 -1.494 . . . . 3.2599999999999998 106.967 175.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.81 165.91 35.33 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.268 -0.733 . . . . 0.59999999999999998 111.268 177.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.09 115.18 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.009 -1.849 . . . . 2.71 106.009 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.4 mm -78.65 145.83 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.273 -1.38 . . . . 1.8799999999999999 107.273 168.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -123.41 107.62 11.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.878 -1.897 . . . . 2.0299999999999998 105.878 163.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -89.55 93.16 9.39 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.265 -2.124 . . . . 3.9900000000000002 105.265 164.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -96.11 134.87 38.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.106 -0.702 . . . . 3.5600000000000001 109.106 177.483 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -145.95 83.31 1.63 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.104 -0.953 . . . . 3.71 110.931 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -50.39 -45.13 55.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.721 -0.672 . . . . 7.7699999999999996 111.012 157.036 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -85.33 73.48 10.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.852 -1.166 . . . . 4.7400000000000002 107.852 -175.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 79.78 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.473 0.709 . . . . 5.0199999999999996 109.614 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -162.72 -53.69 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.61 1.564 . . . . 6.3899999999999997 109.513 -162.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.08 -85.31 0.06 OUTLIER Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.762 -1.209 . . . . 3.4100000000000001 112.761 -170.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.21 115.64 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.363 2.708 . . . . 2.1800000000000002 111.593 -174.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 t -87.5 165.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.861 -1.162 . . . . 2.1200000000000001 107.861 172.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.162 -1.792 . . . . 4.54 106.162 168.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 t -89.67 131.49 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.96 -1.496 . . . . 1.97 106.96 174.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -136.93 161.9 34.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.26 -1.385 . . . . 0.94999999999999996 107.26 153.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.09 146.16 7.06 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.998 . . . . 0.84999999999999998 108.105 178.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -119.81 66.94 0.81 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.672 1.989 . . . . 2.4100000000000001 107.16 -171.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.73 115.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.47 -1.241 . . . . 1.95 107.96 -167.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -110.27 154.36 23.56 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.424 0.69 . . . . 4.4699999999999998 111.616 -173.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.64 68.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.641 -0.709 . . . . 0.85999999999999999 114.31 172.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -59.28 164.28 3.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.945 1.373 . . . . 1.6100000000000001 109.078 163.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.28 160.22 19.18 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.719 -1.238 . . . . 2.4100000000000001 107.836 154.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -58.85 171.33 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.367 -0.833 . . . . 2.6000000000000001 110.289 175.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.0 -157.27 48.42 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 121.94 -0.475 . . . . 0.54000000000000004 112.96 167.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.98 141.92 38.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.207 1.003 . . . . 3.3300000000000001 111.059 -167.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -143.99 119.62 10.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.241 1.016 . . . . 0.62 110.537 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.3 147.9 16.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.708 -0.957 . . . . 0.51000000000000001 110.708 172.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.41 91.85 2.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.361 1.064 . . . . 3.71 108.167 -173.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -130.86 158.27 40.64 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.017 -0.538 . . . . 1.1399999999999999 109.828 -160.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.42 117.0 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.295 -0.632 . . . . 3.7400000000000002 109.295 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -107.6 139.57 41.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.959 -1.126 . . . . 1.05 107.959 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -73.01 66.16 0.79 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.242 0.83 . . . . 5.1900000000000004 113.242 -171.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' CD ' HH22 ' A' ' 143' ' ' ARG . 2.4 mt-10 . . . . . 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 3.0 110.541 -173.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.367 0 N-CA-C 106.634 -1.617 . . . . 2.1200000000000001 106.634 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.5 -96.27 2.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.485 -1.846 . . . . 1.5900000000000001 108.485 -177.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.47 177.8 6.34 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.281 2.654 . . . . 1.1100000000000001 113.23 -177.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -69.07 131.77 45.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 115.968 -1.968 . . . . 1.6499999999999999 105.852 170.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -33.93 107.91 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.865 1.666 . . . . 4.1699999999999999 114.337 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.41 127.73 30.89 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 126.521 1.928 . . . . 3.1699999999999999 107.31 167.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.49 -40.68 13.45 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.595 1.53 . . . . 2.04 109.133 173.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 tt -146.69 -60.56 0.3 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.159 -1.793 . . . . 4.5099999999999998 106.159 164.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.6 p -151.38 80.28 1.3 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.49 0.716 . . . . 3.8199999999999998 109.948 -178.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -80.03 163.58 24.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 5.6799999999999997 108.392 158.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.14 166.21 10.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.32 -1.363 . . . . 4.2999999999999998 107.32 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.408 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 46.0 t60 -80.1 160.95 25.58 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.81999999999999995 110.148 175.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.19 -149.33 7.98 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 104.769 -3.332 . . . . 2.1299999999999999 104.769 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.69 -146.45 4.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.462 1.631 . . . . 1.8500000000000001 109.041 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.9 -36.88 21.59 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.321 2.014 . . . . 1.71 111.132 -177.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.61 -44.05 91.8 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.627 0.371 . . . . 5.4900000000000002 111.104 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.43 164.13 26.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.625 0.726 . . . . 1.9299999999999999 112.042 -169.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -77.74 -45.63 24.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.158 1.383 . . . . 4.1500000000000004 108.971 165.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -78.27 168.59 19.6 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.987 0.899 . . . . 3.25 109.84 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 153.62 142.75 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 130.524 3.53 . . . . 3.9199999999999999 105.454 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.443 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.0 m80 -59.58 151.02 25.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.649 -0.82 . . . . 0.78000000000000003 109.313 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -71.31 -4.77 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.258 -0.901 . . . . 1.9099999999999999 111.121 -172.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.99 70.2 0.44 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.995 1.283 . . . . 1.1200000000000001 109.947 159.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.92 122.28 0.7 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.64 -1.244 . . . . 2.8399999999999999 107.64 -177.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.33 -38.06 8.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.772 0.829 . . . . 2.9300000000000002 110.204 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.87 -129.29 3.24 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.086 -2.006 . . . . 0.93999999999999995 108.086 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -131.05 170.6 14.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.134 1.374 . . . . 2.4199999999999999 110.382 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.09 175.71 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.352 1.461 . . . . 2.0800000000000001 107.244 171.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -124.89 126.76 46.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.937 -1.135 . . . . 3.0600000000000001 107.937 175.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.48 139.53 31.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.754 0.822 . . . . 1.8700000000000001 111.337 171.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -74.26 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 O-C-N 124.305 1.003 . . . . 3.0899999999999999 110.508 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 93' ' ' GLY . 46.6 tttt -149.84 -35.44 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.786 1.032 . . . . 4.1200000000000001 113.786 -164.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -80.89 22.17 0.63 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 124.047 1.879 . . . . 3.9300000000000002 110.191 165.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 57.9 25.83 56.95 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 125.124 1.345 . . . . 1.0900000000000001 111.069 -170.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.9 t -83.78 106.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.396 1.079 . . . . 2.3999999999999999 108.169 -175.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.8 167.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.977 -1.12 . . . . 2.2799999999999998 107.977 158.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -128.07 139.6 52.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 103.399 -2.815 . . . . 3.0899999999999999 103.399 176.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.08 55.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 123.861 0.726 . . . . 2.02 111.775 179.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -74.89 101.57 4.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.389 0.676 . . . . 1.1599999999999999 110.767 170.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.1 mt -140.94 156.01 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.93 0.786 . . . . 2.8500000000000001 109.626 177.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.27 72.22 1.37 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.345 1.458 . . . . 4.96 111.22 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.49 134.68 37.29 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.403 -0.811 . . . . 2.1699999999999999 109.454 177.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 p -92.72 -9.97 38.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.424 1.49 . . . . 2.1499999999999999 112.894 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.4 t -85.63 -46.09 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.404 -0.962 . . . . 2.4199999999999999 108.404 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -70.8 177.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.097 0.475 . . . . 2.1400000000000001 111.922 176.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.5 t -153.12 175.07 13.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.609 1.964 . . . . 3.6000000000000001 105.808 172.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.45 0.68 17.9 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.036 0.935 . . . . 3.4700000000000002 111.399 162.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 CA--C 1.53 0.184 0 C-N-CA 125.246 1.418 . . . . 4.1299999999999999 110.74 -173.243 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 p . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 115.509 1.67 . . . . 1.51 115.509 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.66 -14.54 12.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 114.122 -1.399 . . . . 3.7599999999999998 112.392 170.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.2 tp -50.04 123.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 124.066 0.946 . . . . 2.9900000000000002 110.297 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.9 86.77 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.215 -0.769 . . . . 1.3600000000000001 114.198 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.7 175.99 9.41 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.148 1.974 . . . . 7.0899999999999999 109.341 178.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.85 123.69 50.89 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.578 1.081 . . . . 2.6099999999999999 108.594 167.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.85 144.92 40.95 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.301 -1.37 . . . . 2.5299999999999998 107.301 167.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -129.75 134.93 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.195 1.798 . . . . 1.6499999999999999 107.59 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.82 128.44 58.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.729 -1.212 . . . . 2.6800000000000002 107.729 167.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -104.3 158.13 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.827 2.158 . . . . 0.63 116.827 -171.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -41.33 -68.87 0.16 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.724 2.81 . . . . 3.04 111.355 172.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -111.27 -175.06 2.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.1 -0.704 . . . . 3.5099999999999998 109.1 -171.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.97 141.04 47.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.053 -1.091 . . . . 1.8500000000000001 108.053 165.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.66 165.46 14.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.994 -0.682 . . . . 2.5600000000000001 109.604 154.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.53 -48.66 74.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.525 -0.761 . . . . 3.54 113.048 -173.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 77.08 52.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.289 1.836 . . . . 2.4199999999999999 111.021 -159.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 27.16 64.42 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.408 1.004 . . . . 1.6399999999999999 114.889 152.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -85.35 -33.14 22.1 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.081 1.352 . . . . 6.5899999999999999 108.673 169.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.43 -80.67 1.6 Allowed Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.633 -1.787 . . . . 3.8700000000000001 108.633 -178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.85 -73.92 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.294 0.95 . . . . 3.23 110.861 -175.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -75.46 -116.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.097 -1.446 . . . . 2.8900000000000001 107.097 157.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.15 -40.3 0.06 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.069 1.304 . . . . 4.2400000000000002 112.912 173.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -43.21 -43.61 4.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.806 1.242 . . . . 3.8399999999999999 111.504 175.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.9 m -33.28 -63.66 0.23 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.095 2.558 . . . . 2.6499999999999999 113.483 163.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.08 -46.28 57.44 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.119 -0.988 . . . . 2.3300000000000001 112.052 175.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -53.03 -49.46 66.25 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.395 0.543 . . . . 4.3499999999999996 110.821 -173.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.443 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -129.67 -46.21 1.17 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.662 0.785 . . . . 2.0600000000000001 110.991 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.408 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.21 -31.74 0.79 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.241 0.448 . . . . 1.1699999999999999 112.12 -175.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 48.19 54.66 9.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.926 1.29 . . . . 4.04 110.259 -165.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.46 -35.35 39.34 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.921 1.688 . . . . 2.7000000000000002 113.71 174.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.52 -179.04 49.1 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 108.464 -1.854 . . . . 1.02 108.464 -159.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -62.43 153.3 31.77 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.263 1.425 . . . . 2.3900000000000001 112.736 -164.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.419 HH22 ' CD ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -77.07 133.71 38.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.8 1.24 . . . . 3.7400000000000002 108.664 179.137 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.0 mt -111.02 -70.39 0.82 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.093 -1.077 . . . . 1.6499999999999999 108.093 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.97 148.37 52.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.614 0.766 . . . . 2.1600000000000001 110.047 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.3 p -160.28 173.79 15.17 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 125.191 1.557 . . . . 1.75 109.415 -176.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.64 135.04 2.5 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.71 -2.156 . . . . 0.78000000000000003 107.71 -176.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.1 t -60.5 133.79 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.495 0.718 . . . . 2.1099999999999999 109.074 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.22 136.08 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.28 0.562 . . . . 1.9199999999999999 112.204 -174.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 137.25 -3.02 3.28 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.812 1.196 . . . . 0.55000000000000004 114.029 175.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.3 61.26 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 122.784 1.278 . . . . 2.8100000000000001 107.832 -157.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.25 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.93 -1.032 . . . . 2.6400000000000001 112.696 -173.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 C--O 1.25 1.104 0 N-CA-C 101.813 -3.403 . . . . 8.6500000000000004 101.813 150.662 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 107.946 -1.131 . . . . 5.7000000000000002 107.946 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.53 149.12 47.27 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.856 -0.794 . . . . 1.77 108.856 157.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 t -119.59 145.48 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.856 -1.164 . . . . 2.2200000000000002 107.856 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.11 97.14 5.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.648 -0.871 . . . . 1.6899999999999999 108.648 159.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.43 105.33 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.264 -1.384 . . . . 1.79 107.264 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.22 124.48 37.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.99 -0.745 . . . . 1.8400000000000001 108.99 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -137.97 -60.16 0.64 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.75 0.42 . . . . 4.04 110.001 174.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.78 -122.1 6.43 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.201 0.905 . . . . 0.79000000000000004 111.989 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -115.14 -50.48 2.75 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 124.932 1.293 . . . . 3.02 109.475 -163.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.31 153.95 9.18 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.735 -1.346 . . . . 0.71999999999999997 109.735 171.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.69 41.91 1.15 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.425 2.75 . . . . 0.98999999999999999 113.279 -166.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.62 155.91 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.329 1.852 . . . . 2.23 108.945 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.39 81.57 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.133 -1.432 . . . . 2.9100000000000001 107.133 172.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.23 163.66 13.96 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.398 -0.681 . . . . 0.58999999999999997 111.398 -173.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.75 124.56 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.417 -0.957 . . . . 2.1899999999999999 108.417 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -88.82 135.31 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.421 1.089 . . . . 2.21 108.326 164.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.48 110.38 22.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.801 1.64 . . . . 2.9199999999999999 108.086 159.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.42 111.88 23.57 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.11 -1.811 . . . . 3.52 106.11 166.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -117.41 140.13 49.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.852 0.72 . . . . 2.9399999999999999 110.167 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -156.62 141.57 17.13 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.781 0.832 . . . . 4.4900000000000002 110.569 170.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -70.42 -67.06 0.52 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.44 0.696 . . . . 5.4699999999999998 109.529 170.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -76.85 -178.7 5.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 120.076 1.307 . . . . 3.8100000000000001 111.854 -170.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -65.57 -65.95 0.61 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.882 1.273 . . . . 2.8100000000000001 110.401 172.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -125.65 92.52 3.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.892 0.877 . . . . 5.1799999999999997 109.526 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.25 177.35 27.5 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 108.28 -1.928 . . . . 1.3100000000000001 108.28 170.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.44 111.59 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.51 2.806 . . . . 1.3100000000000001 112.094 -175.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.31 132.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.075 -1.083 . . . . 1.8100000000000001 108.075 -169.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -87.23 101.17 13.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.201 -1.777 . . . . 4.5899999999999999 106.201 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.1 124.37 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.282 -1.747 . . . . 2.0299999999999998 106.282 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -131.83 136.35 47.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.047 -1.834 . . . . 1.21 106.047 159.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.28 150.97 23.21 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.539 -1.824 . . . . 0.90000000000000002 108.539 -174.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.1 m -128.95 101.43 6.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.73 -2.322 . . . . 2.5699999999999998 104.73 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.97 144.59 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.074 -1.454 . . . . 1.9199999999999999 107.074 -169.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -154.83 143.73 20.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.475 0.546 . . . . 4.7999999999999998 112.475 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.89 25.79 8.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.877 2.179 . . . . 0.98999999999999999 112.712 -177.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.31 -155.78 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.431 -0.952 . . . . 1.8200000000000001 108.431 164.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -135.65 168.43 19.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.622 -2.733 . . . . 3.3199999999999998 103.622 165.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.16 169.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.277 1.399 . . . . 3.1899999999999999 114.099 -172.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.36 -165.98 48.9 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.592 -1.185 . . . . 0.63 113.195 169.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.51 143.7 57.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.403 1.481 . . . . 2.7799999999999998 113.104 -174.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -143.15 114.82 8.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.074 1.749 . . . . 0.63 108.69 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.61 145.16 2.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.33 -1.108 . . . . 0.39000000000000001 110.33 169.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -137.58 95.11 3.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.738 -1.579 . . . . 3.8599999999999999 106.738 -176.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -134.98 154.51 51.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.362 -1.347 . . . . 1.02 107.362 -164.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.264 2.6 p -107.08 108.66 25.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 CA-C-O 122.396 1.093 . . . . 3.0299999999999998 108.782 172.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -77.47 156.44 31.05 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.39 -1.707 . . . . 0.98999999999999999 106.39 172.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -81.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.908 0.483 . . . . 5.5099999999999998 110.261 -178.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 C--O 1.233 0.203 0 C-N-CA 127.853 2.461 . . . . 4.4900000000000002 114.403 -169.313 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 N-CA-C 118.556 2.799 . . . . 3.21 118.556 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -177.66 14.05 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 114.235 -1.348 . . . . 3.0099999999999998 110.914 164.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.61 -179.99 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.977 3.785 . . . . 1.1499999999999999 113.612 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -47.07 107.19 0.1 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.844 1.258 . . . . 1.1499999999999999 109.063 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -34.27 104.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.278 1.431 . . . . 3.8999999999999999 111.935 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -122.79 141.58 35.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 129.55 3.14 . . . . 3.48 108.197 -174.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.91 -51.71 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.017 1.811 . . . . 1.22 109.085 173.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.19 -75.4 0.37 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.299 1.04 . . . . 3.8500000000000001 108.558 169.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -136.32 60.63 1.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.006 0.522 . . . . 2.25 111.613 -159.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -78.74 164.04 24.89 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.702 -1.222 . . . . 5.0499999999999998 107.702 162.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -127.66 173.62 9.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.643 . . . . 5.54 107.142 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.464 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 35.8 t60 -93.85 157.69 16.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.97 0.73 . . . . 0.81999999999999995 112.97 -167.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.41 -147.77 7.79 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 105.734 -2.946 . . . . 2.1099999999999999 105.734 166.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.89 -170.4 30.77 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.051 -2.42 . . . . 2.0299999999999998 107.051 176.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.29 -23.84 71.62 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.092 2.528 . . . . 2.6899999999999999 113.667 -176.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -70.37 -34.37 72.52 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.963 -0.461 . . . . 5.8300000000000001 111.264 173.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.52 176.65 8.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.562 1.545 . . . . 1.8899999999999999 110.585 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -83.93 -47.91 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.926 1.29 . . . . 4.3200000000000003 109.145 164.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -88.69 166.39 14.11 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.592 1.157 . . . . 3.46 111.073 -166.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 168.95 146.1 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.51 2.324 . . . . 6.7699999999999996 108.773 -173.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 42.1 m80 -63.25 148.75 47.31 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 106.278 -1.749 . . . . 0.55000000000000004 106.278 166.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 -45.84 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 119.224 -0.99 . . . . 1.9099999999999999 108.389 -176.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.6 59.71 4.8 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.618 -0.677 . . . . 1.1499999999999999 113.187 171.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -168.94 120.22 0.75 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.656 -1.238 . . . . 2.6699999999999999 107.656 -172.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.39 -51.56 3.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.18 0.992 . . . . 3.5499999999999998 109.186 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.95 -116.49 0.71 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.642 -0.983 . . . . 0.67000000000000004 110.642 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -144.66 167.5 22.4 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.876 1.27 . . . . 2.46 109.677 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 175.54 5.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 N-CA-C 106.522 -1.659 . . . . 1.6399999999999999 106.522 167.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -106.97 147.25 30.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.264 -1.384 . . . . 3.1800000000000002 107.264 158.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.01 30.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.639 -0.875 . . . . 1.54 108.639 155.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -73.2 -78.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.227 1.011 . . . . 3.3199999999999998 109.736 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -152.95 -52.37 0.11 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.532 1.533 . . . . 5.4900000000000002 108.491 178.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.48 17.7 1.68 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.903 1.681 . . . . 4.4800000000000004 111.541 -171.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.98 15.11 81.95 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.084 1.326 . . . . 0.79000000000000004 111.337 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.77 149.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.21 -1.404 . . . . 1.77 107.21 171.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.77 24.85 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.232 1.013 . . . . 1.73 108.343 169.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.33 145.91 50.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.027 -2.212 . . . . 2.79 105.027 -174.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.13 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.841 0.713 . . . . 1.8400000000000001 111.3 178.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.5 m -76.07 96.78 3.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.387 1.075 . . . . 1.27 110.85 170.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.7 mt -132.45 153.94 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 2.6600000000000001 109.064 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -126.08 84.01 2.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.103 0.561 . . . . 3.0499999999999998 110.47 166.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -79.5 121.76 25.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.89 0.476 . . . . 2.9900000000000002 109.728 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.5 p -84.6 -17.33 39.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.286 1.834 . . . . 2.0800000000000001 112.57 178.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.2 t -83.64 -51.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.908 0.776 . . . . 2.0299999999999998 110.05 -170.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -75.55 177.04 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.261 0.553 . . . . 2.2200000000000002 110.863 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.0 m -155.97 175.84 13.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.898 1.279 . . . . 2.4100000000000001 108.1 171.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 47.66 2.09 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.891 1.276 . . . . 3.6099999999999999 111.705 -175.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 105.856 -1.905 . . . . 3.2799999999999998 105.856 171.808 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 p . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 122.375 1.083 . . . . 1.51 113.007 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -79.69 -27.41 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.943 -1.026 . . . . 3.0299999999999998 110.443 172.142 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -32.12 108.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.133 2.173 . . . . 3.48 111.247 177.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.88 -20.13 10.91 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.419 1.485 . . . . 1.55 112.816 -174.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -103.06 160.13 14.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.961 1.881 . . . . 5.46 113.002 -165.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -75.81 102.09 5.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.354 1.062 . . . . 2.2400000000000002 111.028 -172.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -68.71 144.96 54.25 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.335 -0.853 . . . . 2.7999999999999998 108.938 168.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -136.1 140.59 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.703 1.601 . . . . 1.5900000000000001 108.99 -172.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 m -111.38 125.45 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.203 1.401 . . . . 2.9399999999999999 107.445 166.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.408 ' CG ' ' HB3' ' A' ' 140' ' ' ALA . 60.1 m-70 -101.63 165.25 11.33 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.727 1.751 . . . . 0.41999999999999998 115.727 -172.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.403 ' CG ' ' HD3' ' A' ' 122' ' ' LYS . 8.1 pt-20 -67.86 -53.41 26.94 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.469 1.108 . . . . 3.4300000000000002 112.444 -174.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HD3' ' CG ' ' A' ' 121' ' ' GLU . 1.9 mppt? -101.09 -176.17 3.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.227 1.376 . . . . 3.5299999999999998 109.039 175.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.11 165.97 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.838 -0.801 . . . . 1.79 108.838 156.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -84.39 167.06 16.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.421 0.688 . . . . 1.98 109.383 156.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.29 -7.15 59.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.627 1.171 . . . . 3.0299999999999998 111.881 -175.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 53.14 33.18 14.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.351 1.06 . . . . 2.3500000000000001 110.241 -170.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.57 20.52 52.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.798 0.713 . . . . 1.5900000000000001 112.635 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -135.14 50.3 2.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.292 1.437 . . . . 7.0800000000000001 107.446 -173.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.38 147.23 19.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 106.94 -2.464 . . . . 3.46 106.94 173.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.4 60.3 4.3 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.435 0.618 . . . . 2.9100000000000001 112.631 -167.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.88 163.22 35.76 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 107.325 -1.361 . . . . 2.8300000000000001 107.325 172.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.26 -52.37 62.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.004 -0.739 . . . . 3.2400000000000002 109.004 168.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -46.65 -42.57 16.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.518 1.527 . . . . 3.6800000000000002 111.847 -171.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 m -40.17 -63.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.866 2.066 . . . . 2.2799999999999998 112.113 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.2 t -74.95 -45.74 40.29 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.867 -0.521 . . . . 3.6200000000000001 111.598 175.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.85 -48.22 67.21 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.713 1.605 . . . . 3.4500000000000002 111.492 -169.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.42 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.0 p -127.77 -46.73 1.41 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.778 0.431 . . . . 2.2999999999999998 111.493 174.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.464 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.54 -27.73 0.48 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 123.169 0.414 . . . . 1.0800000000000001 113.71 -178.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 51.6 t30 48.71 53.77 11.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 2.5699999999999998 110.216 -165.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.408 ' HB3' ' CG ' ' A' ' 120' ' ' HIS . . . -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.576 1.15 . . . . 2.1200000000000001 112.012 167.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.09 179.02 51.73 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 108.765 -1.734 . . . . 1.0 108.765 -161.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -53.79 155.72 3.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.791 -1.204 . . . . 2.3300000000000001 112.04 -175.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.93 144.49 25.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.615 1.966 . . . . 4.8200000000000003 109.519 -177.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt -114.43 -69.28 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.814 -1.18 . . . . 1.6200000000000001 107.814 -173.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 165.21 12.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.865 -0.607 . . . . 2.0 110.133 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.1 p -151.07 154.9 37.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.248 -0.887 . . . . 1.76 109.234 164.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.11 131.45 2.29 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.111 -1.996 . . . . 0.67000000000000004 108.111 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.94 125.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.433 -0.951 . . . . 2.1299999999999999 108.433 175.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.02 138.07 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 120.381 0.134 . . . . 2.0899999999999999 111.088 178.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.19 6.87 1.16 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.622 1.106 . . . . 0.67000000000000004 114.409 174.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.5 58.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 119.584 1.692 . . . . 1.73 110.635 -160.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.94 175.67 12.68 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.891 0.876 . . . . 2.0299999999999998 108.646 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 103.603 -2.74 . . . . 4.7699999999999996 103.603 161.815 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 108.534 -0.913 . . . . 4.6799999999999997 108.534 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.63 154.95 19.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.198 -1.408 . . . . 2.2999999999999998 107.198 154.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.1 t -123.39 142.81 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.788 -0.819 . . . . 1.6499999999999999 108.788 169.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.38 93.14 4.26 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.114 -0.698 . . . . 1.54 109.114 158.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.62 103.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.73 -1.211 . . . . 1.8799999999999999 107.73 158.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.86 134.71 34.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.974 -0.751 . . . . 1.76 108.974 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -145.81 -57.64 0.31 Allowed 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.602 1.161 . . . . 3.8300000000000001 108.824 169.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.63 -124.3 31.25 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.804 0.716 . . . . 0.96999999999999997 112.432 -176.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -113.18 -54.15 2.64 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.618 1.167 . . . . 4.25 109.939 -164.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.02 160.55 7.07 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.202 -1.159 . . . . 0.98999999999999999 110.202 173.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.21 40.63 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.441 2.761 . . . . 1.04 112.349 -172.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.48 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.441 1.897 . . . . 1.8600000000000001 108.848 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.5 128.84 8.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.085 -1.82 . . . . 3.0299999999999998 106.085 170.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.43 171.12 41.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.798 . . . . 0.54000000000000004 111.57 -177.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 mm -128.92 129.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.143 -1.428 . . . . 3.0800000000000001 107.143 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.3 mm -101.07 137.29 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 N-CA-C 107.126 -1.435 . . . . 1.8400000000000001 107.126 161.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 127.15 45.23 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.274 -1.38 . . . . 1.97 107.274 160.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.25 91.82 5.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.619 -1.993 . . . . 3.2999999999999998 105.619 158.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -122.03 134.76 54.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.119 -1.067 . . . . 4.1399999999999997 108.119 175.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.39 -62.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.512 -1.222 . . . . 3.5299999999999998 108.193 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? 58.79 48.89 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.299 1.44 . . . . 9.9499999999999993 112.958 169.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -147.67 160.76 42.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.042 0.937 . . . . 5.4199999999999999 109.387 160.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.3 p -75.93 56.23 0.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.216 -0.661 . . . . 5.8300000000000001 109.216 167.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -110.59 -56.91 2.29 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.527 1.531 . . . . 10.9 107.688 176.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.65 0.35 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 117.974 -1.459 . . . . 3.8300000000000001 110.161 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -50.65 122.93 10.49 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.912 3.075 . . . . 3.23 113.869 -168.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.23 143.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.623 -0.717 . . . . 2.1600000000000001 110.25 -165.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -92.16 83.81 5.16 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.082 -1.822 . . . . 3.5 106.082 171.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.43 83.52 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.945 -1.132 . . . . 1.95 107.945 -172.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -92.49 135.18 34.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.267 0.556 . . . . 1.1299999999999999 110.03 169.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.27 164.61 35.04 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.079 -1.609 . . . . 0.80000000000000004 109.079 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -154.09 129.22 9.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.369 -1.345 . . . . 3.1000000000000001 107.369 -174.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -128.78 147.92 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 125.689 1.596 . . . . 2.1899999999999999 108.932 -163.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -136.86 156.2 48.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.291 0.496 . . . . 4.7800000000000002 112.202 164.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.83 13.09 41.41 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.382 1.944 . . . . 0.57999999999999996 112.916 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.69 157.15 36.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.709 -0.848 . . . . 1.97 108.709 168.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -78.55 157.02 28.91 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.984 -1.487 . . . . 3.1699999999999999 106.984 156.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.36 174.2 0.1 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.951 . . . . 3.1899999999999999 112.637 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.75 -169.19 53.12 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.623 -0.717 . . . . 0.58999999999999997 112.564 169.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 tp -75.18 146.82 40.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.351 1.06 . . . . 3.6699999999999999 110.753 -177.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.59 116.26 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.331 1.452 . . . . 0.76000000000000001 108.468 -178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.72 146.72 7.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.63 -1.388 . . . . 0.63 109.63 172.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -139.1 93.75 2.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.541 -1.652 . . . . 3.9300000000000002 106.541 -171.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -131.83 150.95 52.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.719 -1.585 . . . . 1.0800000000000001 106.719 -162.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.738 0.78 . . . . 2.7200000000000002 109.07 174.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -78.7 149.28 32.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.416 -1.698 . . . . 0.97999999999999998 106.416 170.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.55 -100.23 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.388 2.275 . . . . 5.1799999999999997 113.543 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 112.82 0.674 . . . . 3.52 112.82 174.806 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 111.224 0.083 . . . . 2.7999999999999998 111.224 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.42 -143.9 15.47 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.44 1.495 . . . . 1.77 111.394 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.47 -179.43 5.42 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.798 3.665 . . . . 1.3400000000000001 113.76 -170.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -52.57 64.57 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 129.498 3.119 . . . . 1.6200000000000001 115.402 -174.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.2 t80 42.97 68.22 0.53 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.074 1.75 . . . . 3.3399999999999999 110.504 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -85.09 114.82 58.2 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.241 -0.885 . . . . 3.2799999999999998 109.808 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.84 -32.99 10.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.271 1.981 . . . . 1.47 111.593 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.43 -64.57 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.239 -0.652 . . . . 4.21 109.239 177.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.7 t -158.94 65.34 0.41 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.062 -0.718 . . . . 3.5800000000000001 109.062 178.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 -79.23 163.39 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.931 -0.396 . . . . 6.6100000000000003 109.931 169.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.96 144.16 49.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.091 1.356 . . . . 4.6200000000000001 109.114 -169.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -77.09 155.66 32.27 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.831 0.853 . . . . 0.78000000000000003 111.707 -173.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.79 -98.27 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.499 -1.44 . . . . 2.2400000000000002 109.499 161.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.34 -146.93 9.55 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.577 -1.809 . . . . 1.73 108.577 178.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.83 -58.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.536 2.157 . . . . 1.4099999999999999 109.724 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -20.54 64.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.906 1.283 . . . . 7.46 112.176 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 2.7 t70 -64.41 175.91 1.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.528 0.731 . . . . 3.4500000000000002 111.255 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.04 -50.97 7.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.917 1.287 . . . . 5.6299999999999999 108.551 164.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.12 174.39 8.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.954 0.502 . . . . 4.29 111.606 -173.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 164.58 136.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.309 3.044 . . . . 4.9400000000000004 107.78 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.478 ' C ' ' H ' ' A' ' 82' ' ' GLY . 32.4 m80 -66.9 156.52 35.57 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.195 -1.78 . . . . 0.84999999999999998 106.195 165.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.265 13.0 p -78.51 45.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 123.25 1.5 . . . . 2.4500000000000002 110.832 173.102 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.16 33.25 0.27 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 128.74 3.067 . . . . 1.3500000000000001 111.331 165.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -137.48 131.9 32.53 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.312 2.056 . . . . 2.4300000000000002 110.37 161.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.28 -56.38 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.114 1.365 . . . . 3.3799999999999999 109.201 176.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.34 -123.58 0.94 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.238 -0.745 . . . . 0.98999999999999999 111.238 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -139.26 172.32 13.0 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 125.28 1.432 . . . . 2.1800000000000002 110.077 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.5 163.68 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.993 1.317 . . . . 1.78 107.453 164.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.2 m -110.59 133.42 53.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.999 -1.482 . . . . 3.0800000000000001 106.999 174.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.76 137.41 32.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.766 0.426 . . . . 1.53 110.535 169.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -73.98 -75.57 0.15 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.307 1.043 . . . . 3.3900000000000001 111.645 -166.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.37 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.668 1.187 . . . . 5.6699999999999999 110.841 -168.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.18 8.44 4.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.278 1.431 . . . . 2.77 110.936 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.82 16.45 76.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.365 -1.094 . . . . 0.98999999999999999 110.365 -171.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -78.24 149.01 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.788 -1.56 . . . . 1.72 106.788 172.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.72 165.73 26.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.774 -1.195 . . . . 1.75 107.774 165.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.28 140.25 51.5 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.364 -2.828 . . . . 3.0600000000000001 103.364 -172.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.61 78.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 123.971 0.795 . . . . 1.77 110.144 160.025 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.7 m -98.54 77.87 2.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.14 0.976 . . . . 1.3 108.952 166.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.58 159.11 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.554 -0.906 . . . . 2.6899999999999999 108.554 176.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.32 147.29 49.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.352 -0.981 . . . . 2.52 108.352 152.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -137.62 150.56 47.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.332 1.053 . . . . 2.0800000000000001 108.218 172.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 p -110.17 -4.45 15.76 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.942 1.697 . . . . 1.78 113.418 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.55 -47.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.745 -1.206 . . . . 1.9099999999999999 107.745 175.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.11 176.27 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.131 0.967 . . . . 2.4100000000000001 111.388 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.2 m -163.1 175.54 10.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.987 2.515 . . . . 2.21 104.469 -175.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.78 -1.93 45.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.896 0.771 . . . . 3.4500000000000002 112.587 173.165 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.535 0.399 0 C-N-CA 124.578 1.151 . . . . 4.2699999999999996 108.848 -173.852 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 121.948 0.88 . . . . 1.5700000000000001 111.931 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.2 pt -88.61 -5.72 10.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.011 -0.995 . . . . 2.9199999999999999 110.738 -178.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -37.8 122.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.874 1.67 . . . . 2.8700000000000001 110.446 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.99 -21.24 40.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.895 -0.947 . . . . 1.6899999999999999 113.989 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -83.92 165.2 18.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.475 1.637 . . . . 6.6600000000000001 110.961 -170.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -89.56 108.15 19.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.699 0.4 . . . . 1.77 111.351 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.08 148.15 52.17 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.8 -0.815 . . . . 3.6000000000000001 108.8 168.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.16 141.47 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.525 1.53 . . . . 1.74 108.045 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.01 132.77 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.087 -1.079 . . . . 2.6499999999999999 108.087 162.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -102.97 168.98 8.85 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.621 1.568 . . . . 0.68000000000000005 114.018 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -72.06 0.17 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.493 -0.776 . . . . 5.4000000000000004 111.078 177.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -79.78 178.09 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.284 0.947 . . . . 5.5599999999999996 109.498 -178.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.13 173.76 0.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.433 1.093 . . . . 2.25 111.442 172.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -70.39 165.52 22.28 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.812 0.815 . . . . 2.9399999999999999 108.94 163.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.74 -21.38 15.21 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.128 -0.942 . . . . 3.9100000000000001 112.36 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 54.69 14.36 0.85 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.904 1.282 . . . . 2.98 112.232 -173.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.61 61.67 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.11 1.338 . . . . 2.4100000000000001 111.285 -176.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 11.3 mttt -129.94 19.08 5.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.267 1.027 . . . . 6.8600000000000003 110.874 -172.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.01 139.04 22.22 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.942 -2.063 . . . . 3.6299999999999999 107.942 164.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.36 67.13 1.88 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 117.764 0.782 . . . . 3.2599999999999998 111.682 -175.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -172.99 156.27 3.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.46 1.504 . . . . 3.0699999999999998 108.195 -177.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -52.24 52.78 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.263 -0.398 . . . . 3.6200000000000001 111.28 -178.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -29.49 -46.13 0.05 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 3.1200000000000001 113.751 171.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 t -53.16 -61.74 2.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.174 0.989 . . . . 2.4700000000000002 111.548 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -71.26 -43.4 67.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.237 -0.914 . . . . 2.0600000000000001 109.743 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -54.4 -39.14 66.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.337 2.255 . . . . 4.6699999999999999 112.539 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.412 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.4 t -138.1 -53.81 0.63 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.41 1.084 . . . . 2.8500000000000001 112.011 176.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 79.45 1.0 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 103.714 -3.755 . . . . 3.3599999999999999 103.714 -162.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -71.07 57.5 0.22 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.325 1.85 . . . . 3.7599999999999998 110.681 -178.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -26.1 67.78 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.928 -0.483 . . . . 2.4100000000000001 111.432 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 134.28 -177.34 19.24 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.397 -1.881 . . . . 0.93000000000000005 108.397 175.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -53.51 153.99 3.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.821 1.249 . . . . 2.0499999999999998 111.775 175.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.24 131.16 49.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.002 -0.999 . . . . 4.1399999999999997 108.468 168.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -102.51 -74.14 0.64 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.576 -1.639 . . . . 1.8799999999999999 106.576 164.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.16 154.44 19.76 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.424 -0.954 . . . . 2.2000000000000002 108.424 173.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.0 m -144.46 156.05 44.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.909 -1.886 . . . . 2.1099999999999999 105.909 170.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.39 130.1 1.62 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.101 -0.8 . . . . 0.83999999999999997 111.101 169.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.9 131.24 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.898 0.879 . . . . 2.0600000000000001 109.004 173.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.8 tt -91.91 133.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.722 0.296 . . . . 1.75 111.533 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.06 2.78 0.83 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.135 0.874 . . . . 1.1100000000000001 115.104 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.4 mm -95.4 57.86 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-N 119.325 1.562 . . . . 2.2400000000000002 109.92 -157.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.62 176.62 12.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.668 0.787 . . . . 2.73 109.773 171.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.256 1.435 0 N-CA-C 104.068 -2.568 . . . . 5.0599999999999996 104.068 170.225 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 106.943 -1.503 . . . . 5.5800000000000001 106.943 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.22 142.46 46.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.773 0.829 . . . . 1.95 108.909 158.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -111.87 145.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.654 -1.61 . . . . 2.0899999999999999 106.654 166.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.47 97.62 5.85 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 1.79 108.941 155.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.64 98.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.561 1.144 . . . . 1.8700000000000001 108.768 164.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.69 130.4 35.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.958 0.903 . . . . 3.6800000000000002 108.784 172.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -151.69 -52.12 0.12 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 122.767 0.427 . . . . 4.3499999999999996 110.961 166.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.45 -116.6 1.43 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.261 0.934 . . . . 1.1599999999999999 112.998 -175.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -117.2 -46.04 2.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.169 0.988 . . . . 3.3500000000000001 109.729 -158.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 172.36 16.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.567 1.08 . . . . 1.03 111.747 177.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.47 -24.06 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.139 2.559 . . . . 1.3100000000000001 111.594 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.2 t -49.89 139.36 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 2.0299999999999998 110.92 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.89 130.26 8.88 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.751 -1.203 . . . . 2.3199999999999998 107.751 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.14 170.06 41.79 Favored Glycine 0 N--CA 1.449 -0.437 0 O-C-N 121.732 -0.605 . . . . 0.67000000000000004 111.691 -177.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 mm -123.83 126.14 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.287 -1.375 . . . . 3.0299999999999998 107.287 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mp -95.65 147.62 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.019 -1.474 . . . . 2.6800000000000002 107.019 163.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.53 121.39 36.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.032 1.333 . . . . 1.9099999999999999 107.494 167.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.73 99.03 10.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.978 -2.23 . . . . 3.4700000000000002 104.978 162.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -113.69 128.31 56.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.6 -0.889 . . . . 3.8999999999999999 108.6 174.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -157.22 -77.82 0.08 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.54 -1.664 . . . . 3.9300000000000002 108.963 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.2 59.85 3.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.47 -0.937 . . . . 7.5199999999999996 108.47 -174.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -113.83 -103.48 0.41 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.59 -2.374 . . . . 3.8599999999999999 104.59 168.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 t -153.03 -69.97 0.15 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.111 -1.44 . . . . 3.4900000000000002 107.111 157.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -124.19 97.85 5.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.84 -1.541 . . . . 4.9699999999999998 106.84 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.89 37.43 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.345 -0.702 . . . . 1.3200000000000001 111.345 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.74 115.62 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.366 3.378 . . . . 1.51 112.065 -172.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.02 164.44 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.562 0.745 . . . . 2.2000000000000002 109.157 -172.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -115.1 99.18 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.938 -1.504 . . . . 3.8700000000000001 106.938 166.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -92.31 88.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.08 1.752 . . . . 2.2200000000000002 107.566 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -98.31 151.43 20.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.419 -0.586 . . . . 1.05 109.419 169.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.9 159.04 32.18 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.369 -1.493 . . . . 0.84999999999999998 109.369 176.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.4 m -136.82 110.25 7.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.6 -1.63 . . . . 3.0499999999999998 106.6 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -119.16 148.83 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.013 1.325 . . . . 2.1200000000000001 107.893 -163.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -148.33 166.26 28.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.978 0.732 . . . . 4.4199999999999999 112.978 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.44 19.35 62.35 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 0.67000000000000004 113.208 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -75.49 165.32 25.3 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.373 1.086 . . . . 1.7 109.32 174.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.13 163.01 28.38 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.67 -1.233 . . . . 2.5699999999999998 107.67 155.342 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.89 165.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.79 0.805 . . . . 2.52 112.216 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 -158.31 53.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.086 -0.961 . . . . 0.73999999999999999 113.402 167.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 130.02 42.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.926 1.29 . . . . 2.8799999999999999 111.176 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -136.49 110.08 8.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.919 1.688 . . . . 2.29 109.527 -174.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.91 149.42 11.06 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.852 1.692 . . . . 0.64000000000000001 111.563 -177.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -146.4 100.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.463 -0.94 . . . . 4.2599999999999998 108.463 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -139.56 154.21 47.58 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.137 -1.06 . . . . 1.05 108.137 -166.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -113.61 129.23 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 119.571 1.078 . . . . 2.9100000000000001 108.82 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -105.81 146.83 29.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.64 -1.615 . . . . 0.79000000000000004 106.64 -176.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -53.77 -61.24 2.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.591 0.557 . . . . 4.0499999999999998 110.751 -165.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 . . . . . 0 CA--C 1.54 0.568 0 C-N-CA 125.598 1.559 . . . . 3.3799999999999999 111.535 159.205 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 107.497 -1.297 . . . . 3.3900000000000001 107.497 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.89 -94.52 0.34 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.256 -1.938 . . . . 1.8100000000000001 108.256 173.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.76 177.07 9.17 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.311 2.674 . . . . 0.96999999999999997 113.736 -176.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -60.93 130.94 48.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.582 -1.645 . . . . 1.3600000000000001 108.517 171.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -48.22 117.11 1.79 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.085 0.469 . . . . 2.6600000000000001 110.487 176.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.22 152.57 25.28 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 126.536 1.934 . . . . 3.4100000000000001 107.158 173.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -24.69 12.37 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.418 2.079 . . . . 1.45 113.529 -167.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.36 -68.74 0.12 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.952 0.796 . . . . 3.7400000000000002 109.57 -176.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.7 m -155.99 77.96 0.96 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.484 0.714 . . . . 2.6200000000000001 109.67 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -77.99 169.82 17.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.785 -0.82 . . . . 6.0899999999999999 108.785 163.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -118.41 158.47 25.23 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.701 1.6 . . . . 4.3300000000000001 106.734 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 55.0 t60 -86.0 154.06 21.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.566 0.58 . . . . 0.85999999999999999 112.566 -175.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.41 -178.58 43.48 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 106.613 -2.595 . . . . 2.1699999999999999 106.613 160.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.49 -160.83 26.04 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 117.462 0.631 . . . . 2.2400000000000002 112.616 -170.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.85 -43.19 3.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.951 1.768 . . . . 1.6100000000000001 109.301 173.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.4 -46.57 76.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 5.9000000000000004 111.659 -176.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.68 174.45 1.79 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.425 -0.807 . . . . 2.4399999999999999 109.754 176.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.09 -37.44 11.61 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.224 1.01 . . . . 5.7300000000000004 111.082 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -75.71 155.53 35.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.04 -1.096 . . . . 4.0199999999999996 108.04 -174.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 165.57 145.46 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.905 2.082 . . . . 4.1500000000000004 112.002 -170.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.2 m80 -66.57 149.7 50.09 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 107.564 -1.273 . . . . 0.65000000000000002 107.564 164.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.69 -37.43 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.94 -0.704 . . . . 2.2599999999999998 109.714 -171.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.17 60.86 1.59 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.611 0.624 . . . . 0.84999999999999998 112.029 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -168.29 114.94 0.67 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.523 -0.917 . . . . 2.6600000000000001 108.523 -172.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.13 -45.06 8.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.249 -0.648 . . . . 3.46 109.249 176.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.76 -94.11 0.15 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.289 -1.124 . . . . 1.4299999999999999 110.289 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -150.62 164.84 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.478 1.511 . . . . 2.21 110.573 -177.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.0 m -110.0 176.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.284 -1.747 . . . . 1.6200000000000001 106.284 156.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 t -112.49 144.3 42.2 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.444 -1.317 . . . . 2.8100000000000001 107.444 160.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.35 153.25 29.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.289 -1.004 . . . . 1.9099999999999999 108.289 154.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.47 -89.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.781 -0.822 . . . . 2.8399999999999999 108.781 173.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 93' ' ' GLY . 28.5 ttpp -140.25 -57.67 0.54 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.584 1.554 . . . . 5.2400000000000002 108.981 -171.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -87.8 30.39 0.83 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.042 1.337 . . . . 5.0700000000000003 110.062 -170.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 69.63 10.65 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.205 1.86 . . . . 1.04 112.956 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.71 138.3 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.393 -1.336 . . . . 1.95 107.393 176.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.55 170.79 15.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.063 1.345 . . . . 1.79 107.953 173.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -143.9 147.76 34.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.998 -2.223 . . . . 2.7999999999999998 104.998 -171.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.85 132.64 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.407 -1.701 . . . . 2.1000000000000001 106.407 166.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.9 m -153.02 73.19 0.98 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.013 1.325 . . . . 1.5600000000000001 107.603 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.6 mm -115.85 152.51 17.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.638 -0.875 . . . . 3.6800000000000002 108.638 -177.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -145.53 91.47 2.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.522 0.729 . . . . 2.4500000000000002 109.48 167.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.42 -178.02 6.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.904 0.882 . . . . 3.5800000000000001 109.931 177.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.4 p -133.33 48.97 2.34 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.201 1.0 . . . . 2.2599999999999998 109.146 170.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.22 -55.86 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.918 1.287 . . . . 2.3399999999999999 108.486 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pp -88.08 177.68 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.89 0.852 . . . . 2.2799999999999998 111.451 -177.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -161.64 177.88 9.56 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.921 2.088 . . . . 2.5 107.077 -176.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.86 -3.8 24.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.888 1.07 . . . . 4.25 113.888 -175.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 125.091 1.357 . . . . 4.8300000000000001 109.125 176.836 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.276 0.56 . . . . 1.4199999999999999 111.07 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.3 pt -78.64 -17.32 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.553 -0.737 . . . . 3.0299999999999998 109.257 174.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 tp -36.91 133.06 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.606 1.562 . . . . 2.7200000000000002 113.775 -170.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.53 37.82 45.67 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.85 -0.5 . . . . 1.51 111.85 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -134.99 160.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.894 1.278 . . . . 4.7400000000000002 107.559 172.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.4 m -94.29 112.71 24.52 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.693 0.397 . . . . 2.3799999999999999 111.022 -170.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.92 149.55 50.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.117 -0.698 . . . . 2.8599999999999999 109.117 172.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t -135.47 128.93 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.346 1.459 . . . . 1.78 107.467 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.53 120.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.046 -1.835 . . . . 2.6699999999999999 106.046 163.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -94.28 175.65 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.019 1.727 . . . . 0.69999999999999996 112.247 -174.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -72.67 -76.93 0.11 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 113.041 0.756 . . . . 6.0599999999999996 113.041 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -81.11 -176.79 6.14 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.21 0.913 . . . . 4.21 110.084 -167.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.6 148.89 36.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.89 -0.782 . . . . 1.75 108.89 167.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -67.9 170.17 8.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.051 -0.722 . . . . 1.99 109.051 159.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.32 -23.58 62.86 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.699 1.37 . . . . 3.9100000000000001 114.699 -176.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 67.03 2.01 2.56 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.811 1.244 . . . . 2.6400000000000001 113.636 -170.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.21 10.09 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 120.54 1.518 . . . . 1.77 112.676 166.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -106.92 -20.77 13.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.508 2.323 . . . . 5.9299999999999997 109.639 -178.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.8 -77.01 1.94 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 124.492 1.044 . . . . 3.5600000000000001 112.939 167.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.77 -70.35 0.12 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.118 -0.793 . . . . 2.8999999999999999 111.118 -163.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' A' ' 132' ' ' GLU . 5.9 p-10 -90.76 -92.98 0.13 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.449 1.5 . . . . 3.4500000000000002 112.473 -176.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.429 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 3.8 tm-20 -165.39 -81.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.144 0.978 . . . . 3.25 108.693 -164.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -29.09 -45.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.282 2.633 . . . . 3.2000000000000002 113.146 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.2 m -53.65 -50.49 65.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.305 1.842 . . . . 3.0499999999999998 112.744 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 52.2 p -71.7 -48.35 47.86 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.881 -1.137 . . . . 2.3700000000000001 110.615 170.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -53.25 -48.15 68.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.091 2.156 . . . . 4.3300000000000001 111.022 -168.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.408 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.1 p -128.08 -50.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.154 0.982 . . . . 2.1800000000000002 110.691 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.405 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.83 -18.53 0.66 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-O 119.268 -0.74 . . . . 0.91000000000000003 114.556 -176.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 45.47 54.12 7.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.294 1.438 . . . . 2.6800000000000002 110.803 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.93 75.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.075 1.35 . . . . 2.1299999999999999 113.213 177.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.86 173.67 31.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.404 -1.878 . . . . 1.25 108.404 -159.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 p -61.12 153.62 25.25 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.116 1.366 . . . . 3.2200000000000002 112.426 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -81.1 147.43 30.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.151 1.78 . . . . 3.3500000000000001 110.437 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.5 mt -127.33 -76.3 0.57 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.528 -0.916 . . . . 1.7 108.528 -168.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.82 151.54 21.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.192 -0.669 . . . . 1.9199999999999999 109.192 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.1 p -136.71 167.36 21.57 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.521 1.528 . . . . 2.4700000000000002 107.879 174.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.95 133.88 1.64 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 114.46 -1.246 . . . . 0.85999999999999999 110.195 -177.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.38 138.87 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.817 -0.808 . . . . 1.74 108.817 175.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.5 tt -93.79 127.48 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 123.42 0.45 . . . . 1.8600000000000001 111.166 175.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.04 -2.1 0.82 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.106 1.336 . . . . 0.54000000000000004 115.692 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -89.36 60.59 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.25 1.525 . . . . 2.6099999999999999 109.589 -160.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -131.13 175.68 8.89 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.386 -0.821 . . . . 1.97 110.881 164.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 . . . . . 0 C--O 1.254 1.334 0 N-CA-C 103.187 -2.894 . . . . 4.8600000000000003 103.187 163.458 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 110.478 -0.193 . . . . 3.8599999999999999 110.478 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.95 14.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.375 0.67 . . . . 2.6899999999999999 110.359 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.8 t -122.2 152.08 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.104 1.761 . . . . 1.71 106.399 159.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.25 99.15 4.03 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.986 -0.746 . . . . 1.73 108.986 154.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.7 t -66.15 111.88 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.221 -1.4 . . . . 2.04 107.221 166.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -92.07 133.05 36.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.469 -0.937 . . . . 2.1400000000000001 108.469 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -149.12 -50.27 0.15 Allowed 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.487 0.551 . . . . 4.5800000000000001 112.487 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.18 -113.64 1.15 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.092 -0.838 . . . . 0.82999999999999996 113.942 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -124.09 -55.59 1.67 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.207 1.003 . . . . 3.5800000000000001 110.909 -164.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.32 165.58 12.76 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.041 -0.823 . . . . 0.80000000000000004 111.041 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.77 27.14 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.807 3.005 . . . . 1.05 113.59 -173.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.6 t -91.89 143.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.895 1.678 . . . . 1.8300000000000001 107.649 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -154.79 116.83 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.179 -1.045 . . . . 3.0800000000000001 108.179 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.02 171.74 32.02 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.692 -0.563 . . . . 0.68999999999999995 111.692 -172.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -127.99 126.65 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.46 0.704 . . . . 2.3999999999999999 109.243 178.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.5 151.47 3.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 125.53 1.532 . . . . 1.9299999999999999 107.005 165.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.92 154.23 48.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.592 -1.633 . . . . 1.74 106.592 164.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.8 160.11 40.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.81 -0.756 . . . . 6.6600000000000001 109.131 158.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -127.82 139.51 52.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.056 2.143 . . . . 4.7300000000000004 105.386 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -143.65 146.82 33.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.949 -1.871 . . . . 4.8200000000000003 105.949 154.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -73.9 -68.8 0.48 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.151 -0.685 . . . . 5.1100000000000003 109.151 170.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -78.19 165.25 24.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.769 0.828 . . . . 3.8999999999999999 111.618 -173.038 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -77.92 2.26 17.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.548 0.739 . . . . 3.3100000000000001 112.513 173.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -161.32 78.22 0.57 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.877 0.762 . . . . 5.0599999999999996 109.856 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.61 164.81 30.38 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.375 -2.29 . . . . 1.72 107.375 165.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.02 118.41 5.27 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.983 2.455 . . . . 1.6499999999999999 110.524 -176.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -76.69 176.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.769 -0.826 . . . . 2.9300000000000002 108.769 -165.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -131.24 81.06 1.97 Allowed 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.577 -0.897 . . . . 5.9500000000000002 108.577 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.58 100.95 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.988 -1.116 . . . . 2.54 107.988 -177.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -114.02 170.39 8.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.934 0.493 . . . . 1.25 110.081 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.21 165.72 34.74 Favored Glycine 0 N--CA 1.449 -0.463 0 O-C-N 120.974 -1.079 . . . . 0.67000000000000004 112.088 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -131.18 106.66 8.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.509 -2.034 . . . . 2.5899999999999999 105.509 -177.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.64 146.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.626 -1.25 . . . . 2.1600000000000001 107.626 -166.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 161.84 41.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.485 0.92 . . . . 4.3899999999999997 113.485 168.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.85 15.56 45.27 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.758 1.647 . . . . 0.65000000000000002 113.467 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.83 -173.47 0.63 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.524 1.162 . . . . 1.55 108.85 169.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -85.29 -100.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.077 -1.083 . . . . 2.7799999999999998 108.077 164.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -149.2 162.04 40.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.389 1.475 . . . . 2.6600000000000001 108.049 -175.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.57 -161.54 50.91 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.209 0.433 . . . . 0.83999999999999997 112.443 167.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.17 132.78 53.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.735 0.814 . . . . 3.04 112.521 -175.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.18 114.94 9.52 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.132 1.773 . . . . 2.0099999999999998 109.131 -177.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.23 152.27 6.91 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.918 1.247 . . . . 0.70999999999999996 113.753 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 103.84 4.3 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.209 1.803 . . . . 4.3399999999999999 108.138 -177.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.478 ' ND1' ' CD2' ' A' ' 120' ' ' HIS . 41.9 m80 -142.06 162.07 36.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.729 . . . . 1.9099999999999999 109.033 -169.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.43 130.43 74.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 3.5 108.73 -178.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -113.51 154.52 26.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.116 0.967 . . . . 0.81999999999999995 108.838 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.61 33.09 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.197 1.399 . . . . 4.4199999999999999 113.495 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 106.598 -1.63 . . . . 3.1200000000000001 106.598 178.744 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 108.636 -0.875 . . . . 2.1800000000000002 108.636 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.98 -99.18 2.16 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.79 -1.324 . . . . 1.3500000000000001 109.79 -173.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.92 178.39 5.34 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.692 2.928 . . . . 1.23 112.524 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -61.73 136.68 58.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.432 -1.27 . . . . 1.48 108.365 172.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -23.06 105.41 0.02 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.975 1.71 . . . . 4.0300000000000002 113.814 -177.123 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -130.16 90.59 41.58 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.815 1.646 . . . . 3.1200000000000001 109.621 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.64 -36.93 13.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.836 1.69 . . . . 2.0 111.115 -178.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -135.49 -75.06 0.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.977 0.911 . . . . 3.6899999999999999 109.557 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.6 m -156.97 81.06 0.93 Allowed 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.312 -0.868 . . . . 2.27 109.468 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -85.35 170.93 12.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.322 0.582 . . . . 5.75 110.598 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -125.82 161.63 26.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.944 1.698 . . . . 4.1100000000000003 107.265 177.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -104.24 115.95 31.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.774 0.83 . . . . 1.01 110.914 173.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.87 12.9 6.48 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 124.76 1.171 . . . . 3.1400000000000001 110.621 164.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.92 -164.11 23.24 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.44 -1.035 . . . . 2.6099999999999999 112.296 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.92 -23.69 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.34 2.027 . . . . 2.4199999999999999 111.545 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -71.89 -53.84 11.94 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.739 0.816 . . . . 7.4000000000000004 111.45 -176.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.5 171.16 7.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.73 -0.841 . . . . 4.0700000000000003 108.73 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.96 -51.11 68.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.974 -1.121 . . . . 6.2300000000000004 107.974 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -76.81 143.47 39.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.738 0.78 . . . . 3.3100000000000001 110.6 -163.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -176.3 150.89 0.95 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.388 -1.338 . . . . 3.9399999999999999 107.388 -166.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.486 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.1 m80 -63.67 147.46 51.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.848 -1.538 . . . . 0.72999999999999998 106.848 163.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.71 -15.22 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 120.625 -0.43 . . . . 2.2999999999999998 110.672 -175.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.2 67.42 0.28 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.088 1.328 . . . . 0.92000000000000004 110.747 166.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -132.8 110.75 10.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.868 1.334 . . . . 2.4500000000000002 109.781 168.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -39.59 16.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.068 0.547 . . . . 2.8300000000000001 109.94 169.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 138.59 -106.34 0.52 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.108 -0.797 . . . . 0.79000000000000004 111.108 172.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.09 159.8 40.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.467 1.507 . . . . 2.25 109.373 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.2 176.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 125.695 1.598 . . . . 2.0699999999999998 107.078 166.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -114.91 139.76 49.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.799 -1.185 . . . . 2.7400000000000002 107.799 163.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.25 141.25 31.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.242 1.417 . . . . 1.78 110.801 169.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.25 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.194 0.998 . . . . 2.5299999999999998 111.08 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 93' ' ' GLY . 84.7 tttt -159.38 -46.55 0.05 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.923 1.289 . . . . 4.7199999999999998 110.496 -173.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.79 19.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.419 1.488 . . . . 3.3100000000000001 111.134 178.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 73.65 9.28 78.39 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.6 -1.111 . . . . 1.01 111.997 -177.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.0 t -77.52 141.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.59 -1.263 . . . . 2.1600000000000001 107.59 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.36 168.2 21.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.531 1.132 . . . . 1.8899999999999999 108.407 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.54 144.24 50.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 103.452 -2.796 . . . . 2.9199999999999999 103.452 -174.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.89 136.06 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.055 -1.831 . . . . 1.8200000000000001 106.055 169.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -159.98 67.39 0.37 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.141 1.376 . . . . 1.4199999999999999 107.613 -177.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 mm -112.64 146.66 17.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 108.485 -0.931 . . . . 3.0899999999999999 108.485 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.82 74.96 1.49 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.258 0.623 . . . . 3.4500000000000002 109.805 177.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -77.84 151.17 34.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.599 0.714 . . . . 2.48 110.356 -177.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -98.71 -26.28 14.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.018 2.127 . . . . 2.1899999999999999 110.844 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.2 -48.77 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 118.91 -0.567 . . . . 2.6200000000000001 110.162 -173.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.24 162.97 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.291 0.95 . . . . 2.73 109.97 171.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 m -143.13 179.85 6.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.604 1.561 . . . . 2.8700000000000001 108.316 -175.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.06 31.88 3.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.295 1.438 . . . . 5.4900000000000002 113.857 -173.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.536 0.429 0 O-C-N 121.128 -0.983 . . . . 3.2999999999999998 110.863 178.261 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 106.128 -1.805 . . . . 1.96 106.128 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.3 pt -76.94 -13.83 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 118.419 -1.312 . . . . 3.4900000000000002 113.598 -168.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.4 mm -43.21 115.72 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.283 0.947 . . . . 3.0299999999999998 111.183 176.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.7 25.35 74.22 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.076 -0.847 . . . . 1.3300000000000001 112.389 178.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.84 159.45 16.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 120.051 1.926 . . . . 6.0099999999999998 110.548 170.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 m -92.06 104.56 16.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 1.8600000000000001 109.592 -172.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.06 147.44 53.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.055 -1.091 . . . . 2.7799999999999998 108.055 166.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -134.72 133.72 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 127.356 2.263 . . . . 1.76 106.222 177.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.23 120.81 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.024 -1.472 . . . . 2.8199999999999998 107.024 165.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.478 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 45.7 m-70 -95.56 176.1 6.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.58 1.552 . . . . 0.79000000000000004 112.343 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -77.58 -65.58 0.94 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.558 0.947 . . . . 6.0999999999999996 113.558 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -88.42 174.32 8.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.206 0.912 . . . . 6.9299999999999997 110.675 -175.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.84 143.29 17.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.363 -1.289 . . . . 2.04 107.91 157.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.48 155.74 38.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.614 -0.884 . . . . 2.1099999999999999 108.614 158.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -78.76 -5.58 53.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.163 0.985 . . . . 3.3900000000000001 112.092 -172.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 54.46 30.59 13.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.418 1.087 . . . . 2.71 110.542 -173.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.84 16.48 68.22 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.403 -0.665 . . . . 1.8300000000000001 112.796 177.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -98.83 -23.6 15.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.334 1.067 . . . . 6.25 110.782 -176.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.1 131.22 45.28 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.019 -0.832 . . . . 3.2599999999999998 111.019 -176.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.03 -40.22 72.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 117.731 0.766 . . . . 2.6400000000000001 111.514 179.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -50.72 109.29 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.87 1.268 . . . . 2.3999999999999999 109.46 164.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -61.87 -21.7 64.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.6 -0.688 . . . . 3.77 112.308 -170.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -41.13 -38.2 1.02 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.949 1.7 . . . . 4.9500000000000002 111.018 169.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.9 p -46.15 -67.12 0.31 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.264 1.026 . . . . 2.3700000000000001 109.909 172.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.8 p -66.13 -46.84 76.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.045 0.938 . . . . 2.27 111.119 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -60.26 -38.95 85.07 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.182 0.993 . . . . 5.9199999999999999 111.633 -172.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.486 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.317 7.3 t -136.91 -55.25 0.72 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 3.1400000000000001 111.095 175.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.88 -25.21 0.21 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.059 0.845 . . . . 0.96999999999999997 112.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 47.79 55.53 8.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.208 1.403 . . . . 2.4700000000000002 110.996 -170.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.1 -8.89 58.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.218 0.821 . . . . 2.0099999999999998 113.218 173.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.56 173.28 49.51 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.247 -1.541 . . . . 1.1599999999999999 109.247 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 m -56.36 155.13 7.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.797 1.639 . . . . 2.1000000000000001 113.344 -173.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.91 142.37 45.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.24 1.416 . . . . 4.1200000000000001 110.34 177.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 mt -122.39 -74.83 0.6 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.897 -1.149 . . . . 1.7 107.897 -174.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.6 144.32 33.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.063 -1.088 . . . . 1.99 108.063 166.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 25.7 p -123.36 169.03 11.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.401 1.48 . . . . 2.1499999999999999 107.863 168.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.98 142.6 6.13 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 124.362 1.039 . . . . 0.82999999999999996 111.234 166.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.76 133.57 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.996 0.918 . . . . 1.9299999999999999 108.692 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.0 tt -96.7 139.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.303 0.483 . . . . 2.0 112.303 -178.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 134.22 6.3 2.48 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.127 1.346 . . . . 1.1899999999999999 113.992 174.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -91.8 57.26 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.328 1.564 . . . . 2.0800000000000001 110.691 -159.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.15 176.02 13.22 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.567 0.747 . . . . 2.3700000000000001 110.552 169.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.251 1.168 0 N-CA-C 105.821 -1.918 . . . . 5.4900000000000002 105.821 167.689 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.561 -0.533 . . . . 3.8300000000000001 109.561 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.42 158.89 15.24 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.804 -0.813 . . . . 1.8999999999999999 108.804 163.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 t -124.79 150.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.36 -1.291 . . . . 2.0299999999999998 108.058 165.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.84 97.98 5.18 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.39 1.076 . . . . 1.8100000000000001 108.624 158.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.58 114.84 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.511 -1.292 . . . . 1.8700000000000001 107.511 165.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.8 mt -96.66 137.0 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.685 0.794 . . . . 2.3399999999999999 109.91 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -150.0 -52.68 0.15 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.84 0.856 . . . . 3.9500000000000002 109.358 169.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.59 -124.99 28.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.979 -1.01 . . . . 1.0800000000000001 111.622 -175.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.05 -48.2 2.84 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.339 1.055 . . . . 3.6499999999999999 109.365 -162.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.83 166.06 23.9 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.99 -0.844 . . . . 0.81999999999999995 110.99 174.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.11 36.78 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.822 3.015 . . . . 0.97999999999999998 112.785 -173.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.51 159.38 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.693 1.597 . . . . 1.8400000000000001 108.98 -176.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 132.19 9.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.082 -1.451 . . . . 2.9300000000000002 107.082 176.242 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.47 179.36 44.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.623 -0.799 . . . . 0.88 111.575 178.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.77 119.54 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.212 -1.403 . . . . 2.0499999999999998 107.212 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -79.07 146.44 7.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.389 -1.337 . . . . 2.0099999999999998 107.389 163.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -120.24 137.1 54.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.094 -1.817 . . . . 2.2000000000000002 106.094 163.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.93 112.82 18.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.966 1.706 . . . . 3.3599999999999999 107.452 177.277 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.55 135.27 54.06 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.67 1.188 . . . . 4.0999999999999996 108.832 177.092 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -151.45 152.63 33.3 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.541 1.537 . . . . 3.9100000000000001 108.753 170.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -120.31 -46.56 2.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.472 2.709 . . . . 7.2999999999999998 107.556 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.77 96.41 6.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.496 -1.298 . . . . 5.0300000000000002 107.496 173.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -21.13 -66.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.446 2.298 . . . . 3.2799999999999998 114.748 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -114.51 54.55 0.77 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.849 0.859 . . . . 4.9800000000000004 110.153 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.54 -179.71 18.73 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.328 1.442 . . . . 1.27 110.407 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.96 115.45 3.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.536 2.824 . . . . 1.24 111.086 -178.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.0 t -78.73 153.24 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.02 0.528 . . . . 2.1099999999999999 109.626 -170.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -108.34 126.03 52.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.618 -0.882 . . . . 3.4500000000000002 108.618 174.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.0 t -125.63 140.84 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 125.489 1.516 . . . . 2.1099999999999999 107.593 -169.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -155.17 164.54 38.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.689 -0.486 . . . . 1.0800000000000001 109.689 167.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.19 137.14 3.21 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.363 -0.446 . . . . 1.2 112.027 175.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 p -102.22 77.3 1.65 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.78 1.232 . . . . 2.2599999999999998 109.577 -172.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.13 142.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.028 -0.73 . . . . 2.8399999999999999 109.028 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -137.6 157.16 47.1 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.243 0.617 . . . . 4.75 110.256 -176.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.95 12.42 66.11 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.68000000000000005 112.709 -176.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.85 157.33 30.77 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.177 0.991 . . . . 2.1200000000000001 109.308 170.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -74.6 156.45 36.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.114 -1.069 . . . . 2.9100000000000001 108.114 154.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.89 171.79 0.32 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.124 0.97 . . . . 2.3100000000000001 111.839 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.45 -165.13 54.76 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.614 -0.721 . . . . 0.57999999999999996 113.031 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.95 147.92 44.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.7 0.8 . . . . 3.0099999999999998 111.288 -173.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -145.31 123.54 12.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.504 1.522 . . . . 0.63 109.429 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.37 149.18 18.95 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.812 -0.915 . . . . 0.46999999999999997 110.812 170.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -138.66 95.64 3.01 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.089 -1.448 . . . . 4.3399999999999999 107.089 -174.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -133.87 160.34 37.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.754 -1.202 . . . . 1.3100000000000001 107.754 -160.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.42 128.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 122.307 1.051 . . . . 3.5499999999999998 109.933 175.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -104.61 142.64 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.656 -1.609 . . . . 1.1100000000000001 106.656 -177.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 74.31 0.59 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.325 -1.731 . . . . 4.8799999999999999 106.325 170.368 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.444 -0.737 0 CA-C-N 115.871 -0.604 . . . . 3.6099999999999999 109.559 -165.823 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 104.87 -2.27 . . . . 2.4199999999999999 104.87 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.45 -115.37 1.11 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.72 -1.6 . . . . 1.4299999999999999 110.666 178.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 -179.22 5.03 Favored 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.808 4.339 . . . . 1.24 113.933 -173.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -53.39 134.3 40.11 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.038 -0.983 . . . . 1.6899999999999999 111.111 176.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -50.54 117.9 2.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 123.74 0.65 . . . . 2.79 109.567 172.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.8 156.54 30.74 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 106.757 -1.571 . . . . 3.1899999999999999 106.757 169.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.14 -38.65 2.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.176 1.917 . . . . 1.6799999999999999 111.55 -165.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 mt -144.52 -74.54 0.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.858 0.863 . . . . 3.29 109.347 176.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.3 m -142.51 64.85 1.36 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.47 0.708 . . . . 2.6000000000000001 111.062 -165.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.3 170.68 16.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.377 0.608 . . . . 5.8899999999999997 109.555 163.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -111.9 162.34 15.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.67 -1.974 . . . . 4.3200000000000003 105.67 172.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -77.33 168.67 19.64 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.979 0.419 . . . . 1.1699999999999999 110.325 169.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.93 161.08 34.75 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 105.802 -2.919 . . . . 2.0299999999999998 105.802 156.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.86 -172.54 7.83 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 117.17 0.485 . . . . 2.5499999999999998 112.509 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 -18.77 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.133 2.555 . . . . 2.1699999999999999 111.376 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.2 -26.76 18.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.312 1.045 . . . . 6.6299999999999999 111.584 173.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.53 159.89 23.54 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.061 0.458 . . . . 2.0099999999999998 109.914 175.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -74.13 -51.43 15.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.387 1.475 . . . . 4.8700000000000001 108.03 170.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -80.25 168.3 19.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.87 0.843 . . . . 3.54 110.98 -175.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.28 150.2 0.07 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.936 2.095 . . . . 5.6900000000000004 106.53 -167.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.484 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 71.4 m80 -65.58 155.8 34.66 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.278 -2.119 . . . . 0.85999999999999999 105.278 162.335 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.61 48.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 123.355 1.55 . . . . 2.5600000000000001 109.618 170.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . 178.73 34.97 0.06 OUTLIER Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.953 2.216 . . . . 1.8300000000000001 111.512 -175.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.42 136.41 37.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.333 -1.358 . . . . 2.6299999999999999 107.333 157.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.36 -54.72 4.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.649 -1.612 . . . . 2.5499999999999998 106.649 168.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.97 -114.92 0.63 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.514 -1.434 . . . . 0.72999999999999998 109.514 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -140.75 162.03 36.37 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.942 1.697 . . . . 2.2000000000000002 109.329 -177.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.11 175.65 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.354 1.462 . . . . 2.1800000000000002 107.162 175.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.8 m -129.6 134.29 47.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.365 -0.976 . . . . 2.73 108.365 -178.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.61 137.28 34.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.35 1.06 . . . . 1.8400000000000001 109.731 169.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -87.83 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.857 2.463 . . . . 3.9100000000000001 110.736 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -173.34 -46.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.794 1.238 . . . . 7.2300000000000004 108.745 -156.997 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.403 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 2.3 m-20 -79.16 11.35 2.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.887 1.275 . . . . 4.46 110.407 172.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.25 64.39 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 110.789 -0.925 . . . . 1.05 110.789 -178.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.37 128.31 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 1.73 108.464 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.2 114.93 22.66 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.595 -1.631 . . . . 1.6399999999999999 106.595 168.334 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -113.44 93.99 4.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.859 -1.534 . . . . 5.3399999999999999 106.859 -169.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.77 149.34 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.147 -0.933 . . . . 2.98 110.359 -162.19 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.8 m -151.12 126.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.383 1.473 . . . . 1.74 107.413 168.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mt -143.22 155.13 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.306 1.043 . . . . 3.6000000000000001 108.306 -174.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.3 101.06 3.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.573 0.225 . . . . 2.3500000000000001 110.811 157.198 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -89.25 159.71 17.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.941 0.896 . . . . 2.25 108.823 173.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 p -107.65 -15.76 14.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.303 1.841 . . . . 1.8 112.283 -175.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.81 -41.09 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.513 0.597 . . . . 2.1099999999999999 109.894 -171.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pp -98.19 170.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.312 0.645 . . . . 2.1899999999999999 111.72 -173.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.6 m -151.34 174.61 13.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.706 1.202 . . . . 2.2799999999999998 110.265 -176.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -126.49 29.9 5.66 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.957 0.903 . . . . 3.1400000000000001 112.243 170.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.634 -0.876 . . . . 3.46 108.634 165.805 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.426 -1.641 0 CA-C-O 122.835 1.302 . . . . 2.1699999999999999 112.88 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.23 -4.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.231 -1.804 . . . . 3.4900000000000002 111.466 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -38.32 129.87 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.453 1.101 . . . . 3.4900000000000002 110.211 170.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.7 23.72 74.32 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 118.095 0.407 . . . . 1.52 114.042 -174.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.69 176.99 8.99 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.249 1.525 . . . . 9.9700000000000006 108.517 159.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -109.31 120.88 43.84 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.072 -0.714 . . . . 1.77 109.072 153.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -73.02 142.39 47.69 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 106.029 -1.841 . . . . 4.3300000000000001 106.029 168.181 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.6 134.17 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.354 1.862 . . . . 1.51 106.94 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.19 133.82 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.309 -1.367 . . . . 3.3500000000000001 107.309 164.314 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -109.14 161.62 15.03 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 115.992 1.849 . . . . 0.42999999999999999 115.992 -161.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -34.47 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.896 2.878 . . . . 3.29 112.813 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -80.57 174.99 11.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.611 1.164 . . . . 6.2400000000000002 110.482 -170.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.97 142.88 49.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.631 -1.622 . . . . 1.8 108.234 150.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.04 152.15 20.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.317 0.647 . . . . 2.8199999999999998 109.296 170.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.83 -4.86 53.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.488 0.586 . . . . 3.6600000000000001 112.506 -179.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 59.82 28.93 18.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.168 1.387 . . . . 2.96 109.607 -177.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.46 25.78 68.96 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.695 0.664 . . . . 2.0499999999999998 111.598 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -145.5 45.14 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.718 0.759 . . . . 6.2599999999999998 109.365 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.93 159.97 27.03 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.152 -1.179 . . . . 3.5699999999999998 110.152 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.35 61.43 3.13 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.353 -1.499 . . . . 3.8900000000000001 109.353 171.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -177.36 164.77 2.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.487 1.515 . . . . 2.9700000000000002 107.678 -167.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -83.15 -38.39 22.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.775 0.83 . . . . 3.9399999999999999 109.389 173.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -42.18 -39.05 1.9 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.413 1.485 . . . . 3.2400000000000002 112.774 -176.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.8 p -57.22 -61.85 2.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.707 1.203 . . . . 2.5099999999999998 111.25 178.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.4 p -67.68 -42.59 81.86 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.478 -0.764 . . . . 1.97 110.187 178.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -57.35 -44.08 84.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.972 1.709 . . . . 3.8900000000000001 111.841 -177.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.484 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.424 8.9 t -138.23 -56.85 0.65 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 2.6800000000000002 111.839 177.918 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.19 -22.44 0.2 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 119.415 1.007 . . . . 0.87 112.231 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 45.79 55.6 6.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.064 1.746 . . . . 2.1899999999999999 111.258 -177.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.61 58.2 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 118.953 -1.099 . . . . 2.1400000000000001 111.934 167.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.36 -161.01 33.71 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 109.063 -1.615 . . . . 0.96999999999999997 109.063 179.283 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.5 p -59.89 151.49 25.71 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.942 1.297 . . . . 2.3900000000000001 112.752 -169.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.4 mmt-85 -68.01 130.67 43.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.864 2.066 . . . . 4.4900000000000002 108.177 176.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.94 -83.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.552 1.069 . . . . 1.76 108.663 174.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.98 146.29 25.64 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.296 -1.372 . . . . 1.98 107.296 176.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.8 m -147.43 160.56 42.43 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 124.663 1.227 . . . . 2.2200000000000002 107.991 178.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.03 142.18 7.06 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.752 -0.939 . . . . 0.92000000000000004 110.752 172.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.31 139.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.152 1.381 . . . . 1.5700000000000001 108.999 172.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.2 tt -105.65 132.49 52.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.193 0.812 . . . . 2.1800000000000002 113.193 -178.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.76 13.1 0.15 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.482 1.515 . . . . 0.70999999999999996 113.99 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.2 mm -107.72 58.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.836 1.818 . . . . 1.9299999999999999 110.081 -152.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 175.35 14.1 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.745 -0.661 . . . . 2.3900000000000001 110.255 171.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.259 1.586 0 C-N-CA 125.09 1.356 . . . . 6.3499999999999996 108.691 177.052 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.898 -0.408 . . . . 3.73 109.898 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.32 137.63 51.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.778 -0.823 . . . . 1.6100000000000001 108.778 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -96.94 144.25 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.32 -0.993 . . . . 1.5800000000000001 108.32 167.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.08 111.57 15.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.929 -1.508 . . . . 1.8 106.929 148.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.34 108.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.972 -1.492 . . . . 1.9199999999999999 106.972 156.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.9 125.18 31.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.765 -1.198 . . . . 3.2999999999999998 107.765 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -153.97 -45.31 0.09 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.063 0.545 . . . . 4.4199999999999999 111.561 170.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.35 -109.25 0.39 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.237 0.922 . . . . 1.1599999999999999 113.04 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.1 -55.24 2.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.817 1.247 . . . . 3.3300000000000001 110.245 -172.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 164.48 11.4 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.459 1.028 . . . . 1.03 112.339 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.83 -19.54 58.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.567 2.845 . . . . 1.4299999999999999 112.476 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.57 143.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.945 1.298 . . . . 1.8200000000000001 110.634 175.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -155.39 128.4 8.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.467 -0.568 . . . . 2.5499999999999998 109.467 -176.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.11 177.28 39.91 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.17 -0.331 . . . . 0.57999999999999996 112.354 -177.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.09 133.91 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.882 -1.155 . . . . 2.1299999999999999 107.882 172.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.1 mm -102.79 136.33 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.92 1.688 . . . . 2.1899999999999999 106.866 164.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.26 112.17 22.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.35 1.46 . . . . 1.74 108.22 163.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -77.57 140.72 39.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.469 1.508 . . . . 3.73 108.698 164.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -149.13 168.29 23.62 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.464 -1.68 . . . . 4.5700000000000003 106.464 148.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -151.29 159.32 44.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.739 -1.948 . . . . 3.8799999999999999 105.739 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -64.08 -73.78 0.11 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.998 -1.112 . . . . 7.2699999999999996 107.998 166.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -79.85 -165.66 0.86 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.046 2.538 . . . . 4.8799999999999999 111.138 -169.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -106.61 3.82 27.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.112 1.765 . . . . 2.9199999999999999 110.59 162.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -160.73 78.46 0.62 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.267 2.227 . . . . 4.7300000000000004 108.681 -170.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.68 -170.4 41.16 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 110.258 -1.137 . . . . 2.1899999999999999 110.258 -170.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.79 120.74 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.157 2.571 . . . . 1.27 114.108 -167.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.8 t -79.14 147.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.499 -0.773 . . . . 2.3199999999999998 109.335 175.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -116.51 110.54 18.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.836 -1.172 . . . . 3.46 107.836 159.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 m -95.27 132.22 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.234 -1.395 . . . . 3.4300000000000002 107.234 169.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -126.83 145.09 50.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.116 -1.438 . . . . 1.05 107.116 168.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.09 156.87 29.02 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.36 -0.924 . . . . 0.65000000000000002 112.165 -173.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 m -131.71 83.49 2.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.706 1.602 . . . . 2.4399999999999999 107.389 -162.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.19 139.09 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.2 1.0 . . . . 2.2400000000000002 109.13 -168.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 166.67 22.8 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.4 0.619 . . . . 4.75 112.26 176.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.13 15.52 69.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.761 1.172 . . . . 0.64000000000000001 113.492 174.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.41 165.03 21.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.603 1.201 . . . . 1.79 108.837 172.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -72.58 166.39 22.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.596 -1.261 . . . . 2.3999999999999999 107.596 150.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.9 175.45 0.5 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.167 0.987 . . . . 3.3300000000000001 110.696 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.65 -156.04 51.61 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.865 -0.607 . . . . 0.60999999999999999 111.643 169.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.56 145.18 33.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.793 1.637 . . . . 2.8700000000000001 112.48 -171.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -147.73 113.18 5.62 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.032 1.333 . . . . 0.62 110.434 -179.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.0 146.26 2.91 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.493 1.044 . . . . 0.68000000000000005 111.316 173.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.76 96.74 3.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.909 -1.886 . . . . 3.4399999999999999 105.909 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -133.43 171.94 13.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.322 -1.362 . . . . 1.22 107.322 -164.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 0.3 OUTLIER -130.54 133.44 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 122.147 0.975 . . . . 2.8100000000000001 109.938 173.163 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -109.79 145.64 36.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.051 2.141 . . . . 0.98999999999999999 106.876 -175.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -72.31 31.52 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.981 1.474 . . . . 4.5700000000000003 114.981 -168.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 143' ' ' ARG . 5.1 mt-10 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 108.075 -1.083 . . . . 3.0800000000000001 108.075 -170.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 N-CA-C 107.53 -1.285 . . . . 2.73 107.53 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.04 -92.43 2.03 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.636 -1.386 . . . . 1.4199999999999999 109.636 -178.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.08 -178.84 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 126.337 4.692 . . . . 1.1799999999999999 113.21 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -52.52 128.47 26.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.031 1.332 . . . . 1.4199999999999999 109.627 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -45.46 120.24 2.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.753 1.221 . . . . 2.8799999999999999 111.273 175.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 69' ' ' ARG . 79.0 m-20 -118.46 163.12 26.95 Favored Pre-proline 0 C--O 1.227 -0.1 0 C-N-CA 127.314 2.246 . . . . 3.8999999999999999 109.747 164.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.45 -53.01 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.194 1.263 . . . . 1.8200000000000001 108.85 154.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.66 -77.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.281 1.032 . . . . 4.3300000000000001 109.998 169.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -135.5 71.03 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.306 1.042 . . . . 2.6200000000000001 110.459 -165.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.419 ' H ' ' ND2' ' A' ' 65' ' ' ASN . 15.9 mmt85 -79.38 172.21 14.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.715 -1.216 . . . . 6.1799999999999997 107.715 156.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 162.89 26.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 127.019 2.128 . . . . 3.6699999999999999 105.946 177.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -76.6 162.91 27.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.693 0.797 . . . . 1.1599999999999999 110.933 -169.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.14 -123.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 105.518 -3.033 . . . . 1.99 105.518 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.24 -140.48 3.06 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 107.957 -2.057 . . . . 2.2400000000000002 107.957 169.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.31 -47.78 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 120.091 1.946 . . . . 1.8700000000000001 109.011 168.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -59.18 -42.15 90.17 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 126.133 1.773 . . . . 6.2199999999999998 112.987 -171.058 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.8 176.93 2.28 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.756 -1.566 . . . . 1.98 111.467 -168.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.07 -52.46 6.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.004 1.322 . . . . 5.1100000000000003 108.21 164.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -80.33 175.91 10.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.693 0.797 . . . . 2.75 111.424 -177.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 161.04 143.15 0.01 OUTLIER 'General case' 0 C--O 1.239 0.535 0 C-N-CA 129.958 3.303 . . . . 3.8900000000000001 106.498 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.406 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.2 m80 -60.06 153.26 22.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.335 -1.357 . . . . 0.71999999999999997 107.335 166.154 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.0 -37.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 117.796 -1.562 . . . . 2.3900000000000001 109.991 -169.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.82 73.11 0.87 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.229 -0.748 . . . . 1.28 111.229 167.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -168.14 103.37 0.46 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.786 -0.82 . . . . 2.7200000000000002 108.786 -175.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.86 -51.39 8.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.195 0.598 . . . . 2.71 109.541 176.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.83 -119.86 0.94 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.404 -1.478 . . . . 0.67000000000000004 109.404 -177.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -137.91 166.5 23.89 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 124.407 1.083 . . . . 2.3100000000000001 110.291 174.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.12 177.14 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.462 -1.681 . . . . 1.77 106.462 166.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -122.51 155.26 36.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.695 -0.854 . . . . 3.1099999999999999 108.695 164.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.86 141.76 48.35 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.45 1.1 . . . . 1.8200000000000001 110.352 164.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.83 -75.28 0.12 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.1 0.96 . . . . 2.9399999999999999 111.389 -171.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -153.94 -44.26 0.09 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.321 1.048 . . . . 4.5800000000000001 110.973 -169.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.84 7.77 6.56 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.297 1.046 . . . . 2.6000000000000001 111.39 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.71 8.12 84.05 Favored Glycine 0 CA--C 1.524 0.636 0 O-C-N 121.266 -0.896 . . . . 0.77000000000000002 111.75 -175.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.54 128.61 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.218 1.407 . . . . 1.79 107.713 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.89 175.24 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.213 1.405 . . . . 1.5600000000000001 109.169 173.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -121.88 145.28 48.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.964 -2.606 . . . . 3.3599999999999999 103.964 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.21 58.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.331 -0.548 . . . . 1.8500000000000001 111.391 167.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.4 m -90.08 88.03 7.12 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.607 1.163 . . . . 1.2 109.098 172.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.1 mm -125.67 156.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.942 -0.762 . . . . 3.27 108.942 -177.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -140.12 142.15 36.06 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.658 0.383 . . . . 2.6499999999999999 110.616 164.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.23 148.52 44.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.475 1.51 . . . . 2.2799999999999998 109.259 176.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.5 p -102.74 -4.26 25.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.789 2.036 . . . . 1.8700000000000001 113.249 -173.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.97 -45.77 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.658 1.183 . . . . 2.1000000000000001 108.807 -178.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -76.49 176.14 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.473 0.654 . . . . 2.5800000000000001 110.969 176.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -165.7 176.58 7.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.592 1.957 . . . . 2.3999999999999999 107.208 177.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -6.3 57.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.963 . . . . 4.4400000000000004 112.928 175.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 127.157 2.183 . . . . 3.5899999999999999 108.498 -172.782 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.445 -0.716 0 CA-C-O 121.005 0.431 . . . . 2.04 112.055 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.277 1.8 pp -111.8 -6.2 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.144 -0.934 . . . . 2.73 111.833 -177.362 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.86 133.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.914 -0.773 . . . . 3.1600000000000001 108.914 162.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.06 47.44 81.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.58 -1.008 . . . . 2.25 110.58 -173.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -142.42 168.92 18.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.906 -1.887 . . . . 5.46 105.906 165.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 m -101.02 115.42 30.44 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.579 -0.526 . . . . 2.0 109.579 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.8 148.73 51.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.845 -0.798 . . . . 3.21 108.845 165.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -134.01 137.9 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.94 2.096 . . . . 1.8 106.588 175.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 m -113.0 129.52 68.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.74 -1.207 . . . . 3.0 107.74 169.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -107.29 159.94 15.99 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 117.361 2.356 . . . . 0.65000000000000002 117.361 -163.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -32.02 -76.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.55 3.14 . . . . 3.5699999999999998 112.908 168.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.69 -174.36 2.44 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.913 0.885 . . . . 3.6800000000000002 110.491 -171.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.58 148.79 18.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.987 -0.745 . . . . 1.55 108.987 157.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.04 168.65 18.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.738 -0.838 . . . . 2.1899999999999999 108.738 154.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.46 -38.81 48.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.066 0.765 . . . . 4.2800000000000002 113.066 -168.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 82.2 46.05 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.835 2.854 . . . . 2.6200000000000001 110.691 -169.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.94 43.53 98.76 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.472 1.034 . . . . 1.8600000000000001 112.051 165.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -155.11 -16.37 0.11 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.806 1.409 . . . . 6.0999999999999996 114.806 -170.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.3 146.18 47.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 120.496 1.498 . . . . 2.96 110.928 -178.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.54 -24.3 69.34 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.791 0.71 . . . . 2.6499999999999999 114.202 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 159.85 14.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.227 -1.027 . . . . 2.52 108.227 174.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -46.82 76.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 3.8900000000000001 107.646 167.677 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -40.39 -48.49 2.73 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.374 2.67 . . . . 4.2300000000000004 111.64 -175.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -63.38 0.83 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.535 1.534 . . . . 2.5299999999999998 110.702 176.093 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -71.62 -41.99 68.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.052 -1.03 . . . . 2.3199999999999998 111.597 177.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.57 -37.26 84.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.334 1.454 . . . . 4.4500000000000002 110.924 -166.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.406 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.257 0.7 OUTLIER -133.3 -51.97 0.88 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.232 1.013 . . . . 2.0899999999999999 111.545 173.218 . . . . . . . . 4 4 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.05 -22.49 0.52 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.715 0.689 . . . . 0.93000000000000005 114.287 -177.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 44.71 54.42 6.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.302 1.441 . . . . 2.5099999999999998 111.561 -163.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.12 -39.38 82.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.568 1.147 . . . . 2.3700000000000001 111.217 166.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.89 -171.33 44.7 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 108.682 -1.767 . . . . 0.98999999999999999 108.682 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.7 m -59.17 153.07 19.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 126.028 1.731 . . . . 1.8799999999999999 114.091 -166.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 50' ' ' GLU . 2.4 mmt-85 -59.55 137.22 58.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.21 1.804 . . . . 3.48 108.83 168.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.9 mt -114.84 -85.26 0.61 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.775 -1.195 . . . . 1.5900000000000001 107.775 169.536 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.16 154.77 18.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.522 -0.918 . . . . 2.0099999999999998 108.522 172.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.2 m -146.22 165.11 30.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.603 -1.18 . . . . 1.96 108.408 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.39 134.46 3.09 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.498 -1.041 . . . . 0.79000000000000004 110.498 173.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.97 130.85 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.575 -1.269 . . . . 1.5900000000000001 107.575 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.2 tt -102.22 129.87 52.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.244 0.545 . . . . 2.0 111.897 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.59 3.99 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.603 1.097 . . . . 0.56000000000000005 115.429 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -98.28 56.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 119.989 1.894 . . . . 1.96 109.917 -156.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.24 173.57 16.76 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.27 0.628 . . . . 2.1600000000000001 110.305 169.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 C--O 1.255 1.378 0 N-CA-C 102.5 -3.148 . . . . 5.5 102.5 159.919 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.297 -0.631 . . . . 4.6399999999999997 109.297 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.85 18.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.875 -0.787 . . . . 2.1000000000000001 108.875 168.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.71 152.61 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 105.585 -2.005 . . . . 2.3199999999999998 105.585 158.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.61 93.52 3.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.516 -0.92 . . . . 1.9399999999999999 108.516 158.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.66 107.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.926 -1.509 . . . . 1.9099999999999999 106.926 169.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 mt -92.46 128.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.368 0.667 . . . . 2.0099999999999998 109.712 178.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 -48.21 0.15 Allowed 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.155 1.382 . . . . 5.4100000000000001 109.863 172.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.55 -120.47 2.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.084 1.326 . . . . 1.22 112.808 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -97.07 -59.0 1.88 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.647 -1.242 . . . . 3.9500000000000002 107.647 -169.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.98 176.65 2.41 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.66 2.076 . . . . 1.3600000000000001 115.15 -173.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.81 -25.95 16.35 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.742 2.961 . . . . 1.6100000000000001 111.817 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.81 141.99 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.719 1.208 . . . . 2.4100000000000001 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -153.71 121.99 6.17 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.319 -0.993 . . . . 2.4900000000000002 108.319 -171.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.58 172.06 37.69 Favored Glycine 0 C--N 1.333 0.372 0 O-C-N 121.832 -0.542 . . . . 0.65000000000000002 112.514 -174.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.38 125.1 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.946 -0.761 . . . . 2.6000000000000001 108.946 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.9 mm -88.71 139.65 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 107.029 -1.471 . . . . 1.96 107.029 160.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -129.61 108.07 9.93 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.903 -1.517 . . . . 2.8399999999999999 106.903 171.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -130.67 120.8 24.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.879 -1.156 . . . . 5.0599999999999996 107.879 -155.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.15 159.93 41.18 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.785 0.721 . . . . 3.5600000000000001 111.35 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -145.61 141.76 28.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.018 -2.586 . . . . 4.0199999999999996 104.018 -175.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -107.35 -29.84 9.04 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.25 1.02 . . . . 7.0099999999999998 109.444 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -77.99 164.76 24.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 128.72 2.808 . . . . 4.8200000000000003 109.433 -178.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -77.97 -67.79 0.69 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.158 0.983 . . . . 5.1699999999999999 109.176 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -111.88 85.47 2.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.346 -1.724 . . . . 4.5599999999999996 106.346 170.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.17 174.47 32.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.388 -1.485 . . . . 1.46 109.388 178.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 140.97 47.83 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.191 2.594 . . . . 1.3899999999999999 111.647 -167.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 t -91.2 140.46 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.22 -0.659 . . . . 2.2599999999999998 109.22 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -95.12 105.59 17.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.54 -1.652 . . . . 5.9100000000000001 106.54 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.5 85.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.378 1.471 . . . . 2.3700000000000001 108.689 -169.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -99.24 145.16 27.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.206 -0.665 . . . . 1.01 109.206 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.73 149.82 18.15 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.172 -1.171 . . . . 0.91000000000000003 110.172 -177.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 p -130.15 105.23 7.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.677 -1.972 . . . . 2.6200000000000001 105.677 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.68 143.75 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 106.888 -1.523 . . . . 2.1600000000000001 106.888 -169.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -143.7 -178.73 6.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.944 1.461 . . . . 5.8399999999999999 114.944 167.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.91 76.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 113.94 -1.482 . . . . 0.69999999999999996 112.322 -179.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -72.61 163.14 28.54 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.264 1.032 . . . . 1.98 108.31 172.248 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.86 163.66 25.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.701 -1.222 . . . . 2.5 107.701 153.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.91 171.09 0.54 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.702 0.763 . . . . 2.5699999999999998 111.227 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.92 -158.61 53.43 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.747 -0.661 . . . . 0.58999999999999997 113.038 166.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.23 143.86 46.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.232 0.613 . . . . 3.1299999999999999 111.396 -171.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -139.42 127.0 21.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.392 1.477 . . . . 0.69999999999999996 108.697 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.51 152.04 7.51 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.344 -1.102 . . . . 0.54000000000000004 110.344 171.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -144.0 90.88 2.16 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.067 -1.457 . . . . 4.2199999999999998 107.067 -173.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -137.28 143.77 42.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.674 -1.232 . . . . 0.96999999999999997 107.674 -162.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.2 m -98.93 129.15 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.49 1.041 . . . . 3.2599999999999998 110.39 178.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -109.8 155.22 21.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.375 1.07 . . . . 1.2 108.712 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 11.77 0.39 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.795 1.638 . . . . 5.2699999999999996 113.655 -167.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 CA--C 1.534 0.352 0 CA-C-N 119.417 1.008 . . . . 3.48 109.855 -173.943 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 N-CA-C 107.476 -1.305 . . . . 2.2799999999999998 107.476 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.2 -127.75 3.88 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 119.244 0.929 . . . . 2.0699999999999998 112.048 -171.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.35 -179.7 5.43 Favored 'Trans proline' 0 N--CA 1.457 -0.667 1 C-N-CA 125.378 4.052 . . . . 1.6200000000000001 111.597 -176.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -44.8 125.92 5.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 118.856 -0.592 . . . . 1.27 109.946 171.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -46.62 119.58 2.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.71 0.631 . . . . 4.2599999999999998 109.939 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -156.37 157.04 30.91 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 126.544 1.938 . . . . 3.4500000000000002 106.888 174.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.26 -27.42 13.57 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.148 1.898 . . . . 1.72 113.502 -170.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.21 -63.93 0.11 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.133 0.879 . . . . 5.0499999999999998 111.569 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.5 m -158.87 81.45 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.468 1.107 . . . . 2.7000000000000002 109.287 171.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -74.73 167.65 21.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.26 -1.755 . . . . 6.0800000000000001 106.26 157.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -119.3 166.08 13.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.952 -1.499 . . . . 5.5199999999999996 106.952 -176.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -93.95 149.98 20.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 111.81 0.3 . . . . 1.0900000000000001 111.81 -175.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.37 176.74 39.51 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.31 -3.116 . . . . 1.8300000000000001 105.31 158.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.42 -172.32 47.78 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 117.856 0.828 . . . . 2.8399999999999999 111.268 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.89 -24.36 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.101 2.534 . . . . 1.78 110.624 172.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -65.84 -44.12 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.522 0.729 . . . . 6.1799999999999997 109.822 171.152 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.65 163.21 27.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.418 -0.81 . . . . 2.0299999999999998 109.716 175.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.06 -37.92 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.749 0.82 . . . . 5.5 108.925 163.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.18 152.15 41.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.543 -0.91 . . . . 3.02 108.543 -173.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 166.04 143.8 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.782 2.033 . . . . 4.2999999999999998 111.129 -167.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -65.24 154.5 37.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.489 -0.93 . . . . 0.98999999999999999 108.489 166.762 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.43 -40.57 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.948 -0.76 . . . . 2.6400000000000001 108.948 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.42 62.14 1.75 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.627 0.632 . . . . 0.85999999999999999 111.849 173.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -165.67 97.93 0.67 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.398 -0.964 . . . . 2.2999999999999998 108.398 -172.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.38 -43.48 15.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.998 -0.547 . . . . 3.2999999999999998 109.634 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.2 -100.87 0.19 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.474 -0.87 . . . . 0.77000000000000002 112.864 177.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -155.53 166.33 33.87 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.747 1.619 . . . . 2.1899999999999999 109.954 -169.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.49 155.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.713 1.205 . . . . 1.79 108.34 173.44 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.9 p -107.26 109.16 20.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.772 1.629 . . . . 3.7000000000000002 108.83 -176.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.71 138.8 37.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.717 0.689 . . . . 1.6299999999999999 111.127 171.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.14 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.207 0.942 . . . . 2.6200000000000001 109.536 177.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.5 tttt -157.48 -30.23 0.08 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.827 1.417 . . . . 4.8099999999999996 114.827 -170.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -80.25 21.92 0.57 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.757 1.741 . . . . 2.8700000000000001 110.665 164.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 64.12 12.96 51.9 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 125.458 1.504 . . . . 0.83999999999999997 111.739 -175.089 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -78.65 133.05 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.796 -1.187 . . . . 1.8999999999999999 107.796 -176.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.54 155.23 46.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.447 1.499 . . . . 1.8 107.157 168.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -120.44 143.23 48.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.718 -2.327 . . . . 2.7999999999999998 104.718 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.39 131.69 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.339 -1.356 . . . . 2.3900000000000001 107.339 165.263 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.5 m -148.32 73.47 1.25 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.046 1.338 . . . . 1.54 107.962 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -111.72 152.51 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.974 0.909 . . . . 3.5099999999999998 108.723 -175.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -132.39 88.23 2.51 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.635 -0.876 . . . . 4.1799999999999997 108.635 164.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.62 152.87 29.78 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.6 0.36 . . . . 2.5699999999999998 110.303 176.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -124.2 34.53 5.02 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.022 1.329 . . . . 2.1800000000000002 111.325 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.36 -52.0 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.434 1.093 . . . . 2.52 108.395 175.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -74.54 174.59 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.255 0.55 . . . . 2.1600000000000001 110.772 176.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -149.44 171.71 16.13 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.411 -1.329 . . . . 2.8900000000000001 107.411 170.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -101.8 5.44 41.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.525 0.73 . . . . 3.52 111.944 169.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 CA--C 1.537 0.476 0 C-N-CA 126.124 1.77 . . . . 3.54 111.022 -177.876 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.44 -0.962 0 CA-C-O 121.735 0.778 . . . . 1.8500000000000001 111.931 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -6.4 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.212 1.005 . . . . 3.48 111.024 -178.575 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.0 tp -19.99 117.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.718 2.007 . . . . 3.02 111.69 163.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.4 -32.34 7.64 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 119.519 -0.601 . . . . 2.4700000000000002 113.785 -177.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.424 ' HE ' ' C ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -77.81 177.36 8.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.752 1.776 . . . . 12.140000000000001 114.672 -153.964 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.3 123.53 35.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.362 1.065 . . . . 2.5600000000000001 111.277 169.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.25 132.11 35.79 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.513 -1.291 . . . . 4.7699999999999996 107.513 162.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.26 117.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 107.274 -1.38 . . . . 2.0899999999999999 107.274 170.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.07 114.98 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 104.685 -2.339 . . . . 3.1099999999999999 104.685 164.459 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -90.13 161.52 15.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 115.828 1.788 . . . . 0.69999999999999996 115.828 -164.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -40.81 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.244 2.618 . . . . 3.1800000000000002 112.532 169.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -89.2 -179.2 5.83 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.306 0.957 . . . . 3.8999999999999999 109.723 179.268 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 155.4 16.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.703 -0.851 . . . . 1.8799999999999999 108.703 157.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -74.66 165.9 24.46 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.233 -0.655 . . . . 2.4500000000000002 109.233 167.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.405 ' CB ' ' HG ' ' A' ' 134' ' ' SER . 22.0 m-20 -70.85 -19.5 62.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 117.829 -1.081 . . . . 3.4100000000000001 112.389 -175.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 59.16 39.63 22.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.664 1.12 . . . . 2.8900000000000001 109.816 -160.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.18 42.66 82.69 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.025 0.821 . . . . 1.9399999999999999 111.533 172.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.94 -22.01 43.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.057 0.943 . . . . 8.5899999999999999 110.73 -171.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.3 -155.51 26.21 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.976 -0.85 . . . . 4.0499999999999998 110.976 177.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.41 -68.12 1.2 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.935 -1.666 . . . . 4.04 108.935 -170.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.12 118.0 14.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.327 -1.731 . . . . 3.1400000000000001 106.327 167.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -49.83 -45.33 50.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.306 1.412 . . . . 3.5299999999999998 109.602 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -35.74 -41.24 0.21 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.593 2.757 . . . . 3.1000000000000001 112.657 170.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.405 ' HG ' ' CB ' ' A' ' 125' ' ' ASP . 7.8 t -49.37 -65.19 0.61 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.684 1.594 . . . . 2.0699999999999998 109.024 179.038 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 -41.95 69.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.36 1.064 . . . . 2.2000000000000002 110.819 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -67.12 -32.31 73.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.989 0.516 . . . . 7.0800000000000001 111.556 -169.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.44 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.382 13.5 t -139.54 -58.57 0.58 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 118.132 -0.937 . . . . 3.0299999999999998 111.398 174.482 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.99 -21.26 0.2 Allowed Glycine 0 N--CA 1.463 0.436 0 CA-C-N 119.556 1.071 . . . . 0.96999999999999997 113.309 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 52.5 54.84 9.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.848 1.259 . . . . 2.1899999999999999 111.256 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.72 59.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.159 0.8 . . . . 2.2599999999999998 113.159 168.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 -159.35 34.22 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 108.526 -1.83 . . . . 0.93000000000000005 108.526 -177.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.4 m -62.54 151.67 36.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.959 -1.12 . . . . 2.1200000000000001 113.639 -163.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -61.44 141.36 57.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.712 -1.585 . . . . 4.4500000000000002 108.896 166.152 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.8 mt -111.97 -82.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.728 -0.841 . . . . 1.72 108.728 169.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.56 167.31 10.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.134 0.574 . . . . 1.99 110.411 177.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.2 p -154.54 170.64 20.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.653 1.181 . . . . 2.5800000000000001 109.451 173.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.6 143.75 4.18 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 124.417 1.073 . . . . 0.82999999999999996 111.189 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.39 134.08 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.752 1.221 . . . . 2.77 109.549 174.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.4 tt -89.55 126.97 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.326 -0.62 . . . . 2.3500000000000001 109.326 161.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.38 -4.32 0.49 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.785 -0.643 . . . . 0.89000000000000001 114.562 176.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.92 57.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 118.778 1.289 . . . . 2.52 111.298 -157.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.98 168.91 26.08 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.739 0.816 . . . . 2.3999999999999999 110.578 160.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 101.658 -3.46 . . . . 7.8300000000000001 101.658 159.494 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.505 -0.924 . . . . 3.7599999999999998 108.505 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.01 143.78 42.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.977 -1.49 . . . . 1.6499999999999999 106.977 159.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.9 t -105.85 144.23 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.434 -1.691 . . . . 2.0 106.434 165.153 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.51 97.09 5.04 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.702 -0.851 . . . . 1.6599999999999999 108.702 156.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.55 109.41 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.981 -1.489 . . . . 1.9199999999999999 106.981 164.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -93.73 122.5 36.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.564 -0.902 . . . . 1.8200000000000001 108.564 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -139.42 -53.25 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.651 -1.24 . . . . 5.2800000000000002 107.651 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.52 -113.12 2.46 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.193 0.901 . . . . 1.1899999999999999 110.88 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -109.68 -65.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.524 -1.288 . . . . 3.8100000000000001 107.524 -163.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.56 2.03 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 129.318 3.342 . . . . 1.45 115.068 -172.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.7 -26.16 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.797 2.998 . . . . 1.71 112.094 -176.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.18 143.67 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.753 1.221 . . . . 2.0099999999999998 110.601 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -155.18 132.19 10.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.328 -0.99 . . . . 2.6299999999999999 108.328 -175.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.97 172.72 42.77 Favored Glycine 0 N--CA 1.451 -0.36 0 O-C-N 121.86 -0.525 . . . . 0.56000000000000005 112.464 -175.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.11 129.78 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.54 -1.281 . . . . 2.0699999999999998 107.54 176.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mm -96.93 137.84 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.218 1.407 . . . . 1.8799999999999999 107.44 164.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -113.7 122.75 48.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.274 -1.38 . . . . 1.8799999999999999 107.274 160.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.1 130.6 53.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.407 1.883 . . . . 3.6299999999999999 106.222 172.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -135.75 148.21 48.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.986 0.812 . . . . 3.9500000000000002 109.906 168.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -155.3 133.63 11.72 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.255 -1.016 . . . . 3.25 108.255 166.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -44.17 71.7 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.572 -0.899 . . . . 4.8099999999999996 108.572 177.09 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -77.33 -177.16 4.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.438 1.495 . . . . 4.0899999999999999 109.597 -170.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.4 p -82.86 -67.92 0.75 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.502 1.521 . . . . 4.2400000000000002 107.86 169.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -117.1 109.65 17.22 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.168 1.387 . . . . 4.6600000000000001 107.643 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.87 -155.01 7.01 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 108.511 -1.836 . . . . 1.6799999999999999 108.511 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.5 114.11 2.96 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.385 2.056 . . . . 2.4199999999999999 109.515 173.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.14 146.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.232 -0.655 . . . . 2.0299999999999998 109.232 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -100.27 118.53 36.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.28 -1.748 . . . . 3.4399999999999999 106.28 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 t -117.1 122.19 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 107.794 -1.187 . . . . 2.1299999999999999 107.794 177.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -141.04 142.14 34.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.024 0.375 . . . . 0.94999999999999996 110.174 169.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.84 -178.22 38.01 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.535 -1.826 . . . . 0.92000000000000004 108.535 175.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.6 p -148.12 108.68 4.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.263 -2.125 . . . . 2.25 105.263 169.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.28 126.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.128 -2.175 . . . . 2.1899999999999999 105.128 -176.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 157.84 24.03 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.486 0.66 . . . . 5.8600000000000003 111.45 -175.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 15.5 62.51 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 114.583 -1.19 . . . . 0.67000000000000004 114.079 176.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.98 159.08 23.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.293 1.547 . . . . 1.6399999999999999 109.57 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.18 166.61 13.71 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.288 -1.005 . . . . 2.4100000000000001 108.288 155.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -63.79 177.85 0.69 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.104 -0.998 . . . . 2.5 111.56 -175.041 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.78 -159.53 52.21 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.759 0.695 . . . . 0.63 114.076 167.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.91 150.05 41.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.193 0.997 . . . . 3.2799999999999998 110.493 -177.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -143.58 116.92 9.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.336 1.054 . . . . 0.71999999999999997 110.086 178.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.13 141.71 19.92 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.538 -1.425 . . . . 0.45000000000000001 109.538 169.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -140.09 96.7 3.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.468 -1.308 . . . . 3.9300000000000002 107.468 -172.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -131.79 146.42 52.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.503 -1.295 . . . . 0.80000000000000004 107.503 -160.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.83 113.66 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.263 1.03 . . . . 2.6899999999999999 108.446 172.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -79.63 -174.28 4.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.137 -1.392 . . . . 1.3300000000000001 108.446 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -115.84 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 118.317 -0.849 . . . . 5.3700000000000001 109.071 166.362 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 124.613 1.165 . . . . 5.0199999999999996 112.794 -179.146 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 116.303 1.964 . . . . 3.98 116.303 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 42.2 -150.04 0.35 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.42 1.486 . . . . 2.3300000000000001 114.223 173.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.43 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.863 3.042 . . . . 1.52 111.142 173.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -66.27 59.79 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.721 2.009 . . . . 1.9099999999999999 112.252 -178.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 48.82 58.53 5.22 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.194 0.998 . . . . 2.79 109.186 -176.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -87.62 114.95 61.25 Favored Pre-proline 0 C--N 1.34 0.153 0 CA-C-O 118.066 -0.969 . . . . 3.73 108.481 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.16 -34.67 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.654 1.569 . . . . 1.4199999999999999 111.425 -178.45 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -156.32 -76.63 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.526 -0.916 . . . . 3.5099999999999998 108.526 177.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.2 m -138.79 59.03 1.64 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.101 0.961 . . . . 2.5 110.599 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -77.94 163.51 25.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.63 -0.878 . . . . 5.1200000000000001 108.63 162.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -125.58 153.78 43.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.299 1.839 . . . . 4.4199999999999999 107.718 -171.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -76.97 164.68 25.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.032 0.444 . . . . 1.03 110.827 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.55 156.5 22.1 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 106.133 -2.787 . . . . 2.2799999999999998 106.133 168.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.18 -156.44 12.6 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 109.915 -1.274 . . . . 2.1200000000000001 109.915 173.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.35 -44.49 4.69 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.541 1.494 . . . . 1.7 108.936 165.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -59.01 -43.84 91.59 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.549 1.54 . . . . 6.25 112.308 -173.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -55.91 166.89 0.66 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.424 1.09 . . . . 2.48 111.328 -177.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -82.32 -47.86 11.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.436 1.894 . . . . 4.71 109.665 170.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 175.9 10.19 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.374 1.07 . . . . 3.98 110.112 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 170.28 148.08 0.03 OUTLIER 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.422 3.089 . . . . 4.5899999999999999 107.191 168.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.479 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 40.0 m80 -61.73 148.58 42.41 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 117.614 -1.634 . . . . 0.63 106.791 171.132 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 p -53.58 -23.04 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 2.3199999999999998 110.665 174.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.97 43.09 1.8 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.805 1.082 . . . . 0.83999999999999997 115.805 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.66 138.69 34.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.984 1.892 . . . . 2.48 111.385 153.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.7 -44.09 7.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.972 1.309 . . . . 4.1699999999999999 108.119 166.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.85 -103.13 0.23 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.608 -1.397 . . . . 1.1599999999999999 109.608 177.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -145.29 170.88 15.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.805 1.642 . . . . 2.2799999999999998 111.516 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.07 170.95 18.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 127.055 2.142 . . . . 1.7 107.877 174.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.77 109.67 15.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.726 1.61 . . . . 3.9100000000000001 109.718 -170.62 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.55 139.54 38.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.548 -0.72 . . . . 1.78 111.496 174.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.02 -92.14 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.38 1.472 . . . . 4.25 109.886 172.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -175.28 -32.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.878 1.271 . . . . 4.4299999999999997 111.795 -163.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.91 8.12 4.1 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 123.39 1.567 . . . . 3.3999999999999999 109.64 153.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.84 72.74 Favored Glycine 0 N--CA 1.442 -0.935 0 O-C-N 120.639 -1.288 . . . . 0.95999999999999996 110.217 177.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.3 t -82.93 111.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.943 1.297 . . . . 1.9199999999999999 107.611 -177.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.53 155.15 21.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.535 1.134 . . . . 1.9099999999999999 110.041 172.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -102.0 57.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.859 2.464 . . . . 6.2400000000000002 107.502 -165.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.07 85.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.996 -0.742 . . . . 2.54 108.996 -163.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.1 m -143.76 119.41 10.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.124 -0.695 . . . . 2.1000000000000001 109.124 173.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.31 152.69 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.173 -1.047 . . . . 3.52 108.173 -173.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -131.72 92.45 3.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.705 -1.22 . . . . 2.8799999999999999 107.705 167.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.6 151.3 21.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.259 0.624 . . . . 2.3700000000000001 110.569 176.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -121.06 -0.48 9.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.224 1.81 . . . . 3.8300000000000001 112.651 173.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -78.56 -51.21 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.752 -1.203 . . . . 2.73 107.752 174.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.13 168.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.299 0.571 . . . . 2.4199999999999999 110.319 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.8 m -131.66 178.53 6.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.127 2.171 . . . . 2.3399999999999999 106.509 174.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.01 9.74 42.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.21 0.914 . . . . 4.1900000000000004 112.453 171.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.451 -0.392 0 C-N-CA 124.918 1.287 . . . . 5.2699999999999996 109.312 -166.189 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 123.082 1.42 . . . . 2.3999999999999999 112.83 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -7.55 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 113.534 -1.666 . . . . 2.8100000000000001 110.893 179.453 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.74 131.79 23.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.413 0 CA-C-N 119.823 1.192 . . . . 3.52 107.969 171.292 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.07 23.67 68.29 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.24 -0.755 . . . . 1.79 111.687 -170.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.41 168.82 16.35 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.085 1.443 . . . . 5.6399999999999997 109.173 167.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.9 m -100.06 110.57 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.583 0.753 . . . . 1.79 112.681 -169.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mt -67.05 141.9 57.36 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.219 -1.03 . . . . 2.5499999999999998 108.219 170.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.6 t -132.31 140.23 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.889 2.475 . . . . 1.73 107.148 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 p -112.5 127.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.663 1.185 . . . . 2.9300000000000002 108.204 167.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -105.25 163.35 12.66 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.785 1.634 . . . . 0.52000000000000002 113.611 -171.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . 0.28 8.7 tt0 -76.71 -53.52 7.87 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 115.035 1.494 . . . . 6.1699999999999999 115.035 -178.005 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -78.93 177.46 8.75 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 120.476 1.489 . . . . 4.8399999999999999 108.713 -179.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.29 37.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.429 -0.952 . . . . 1.71 108.429 160.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 164.26 20.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.039 . . . . 1.9399999999999999 108.193 156.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -10.47 59.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.217 1.191 . . . . 4.1299999999999999 114.217 -171.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 58.93 34.19 23.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 2.6800000000000002 111.706 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.0 60.41 6.88 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.723 -0.611 . . . . 2.1800000000000002 112.712 168.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -138.7 -59.47 0.61 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.422 1.489 . . . . 6.0999999999999996 109.937 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 64.28 -72.06 0.06 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.844 1.688 . . . . 2.8599999999999999 116.152 173.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.19 40.26 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 111.184 -0.766 . . . . 3.3100000000000001 111.184 -157.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -170.68 160.69 7.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.077 1.751 . . . . 3.0699999999999998 107.085 -178.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -55.13 -64.88 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.015 1.117 . . . . 3.1800000000000002 114.015 -173.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -45.12 66.37 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.874 0.87 . . . . 5.0300000000000002 110.617 -156.421 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -58.85 1.99 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.039 1.735 . . . . 2.75 111.515 170.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -70.9 -48.03 55.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.195 -0.941 . . . . 2.1000000000000001 110.788 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -67.33 -36.68 81.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.052 -0.499 . . . . 3.4399999999999999 112.304 -169.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.479 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.404 0.0 OUTLIER -129.49 -53.89 1.17 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.681 -1.152 . . . . 2.1899999999999999 113.518 168.428 . . . . . . . . 4 4 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.68 -10.25 0.27 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 120.408 1.458 . . . . 0.88 115.995 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 46.84 53.62 10.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.216 1.406 . . . . 2.9300000000000002 111.791 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.18 -30.22 71.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.366 1.467 . . . . 2.2200000000000002 113.452 177.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.62 173.15 49.54 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.865 -1.294 . . . . 1.1599999999999999 109.865 -160.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 m -56.4 152.25 11.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.167 1.387 . . . . 2.1800000000000002 113.148 -172.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -77.61 162.85 26.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.713 -1.585 . . . . 6.0899999999999999 111.614 176.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 mt -138.83 -72.92 0.4 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.836 -1.913 . . . . 1.6699999999999999 105.836 -172.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.68 155.69 30.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.425 0.631 . . . . 2.0099999999999998 109.321 172.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -157.23 172.12 19.19 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.543 -1.662 . . . . 1.99 108.642 175.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.24 146.08 6.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.034 -0.985 . . . . 0.90000000000000002 111.932 176.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.4 t -63.32 133.49 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.489 1.116 . . . . 1.9399999999999999 109.118 175.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.6 tt -96.41 136.05 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.151 -0.477 . . . . 1.8400000000000001 110.478 176.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.96 -1.27 2.5 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.883 0.754 . . . . 0.80000000000000004 114.427 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -89.38 58.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.906 1.353 . . . . 2.1299999999999999 110.367 -160.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.46 176.14 7.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.431 1.093 . . . . 2.6200000000000001 110.972 176.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 102.047 -3.316 . . . . 5.2300000000000004 102.047 143.817 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 107.567 -1.272 . . . . 6.8399999999999999 107.567 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.92 125.74 53.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.252 -1.388 . . . . 1.5800000000000001 107.252 160.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.78 140.91 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 105.837 -1.912 . . . . 2.1699999999999999 105.837 164.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.96 92.52 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.27 -1.011 . . . . 1.75 108.27 160.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.09 103.19 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 107.077 -1.453 . . . . 2.0 107.077 165.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.73 129.96 34.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.402 -0.962 . . . . 2.0299999999999998 108.402 176.274 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -154.98 -53.86 0.09 Allowed 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.411 -0.588 . . . . 4.5199999999999996 109.411 170.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.72 -107.04 0.61 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.421 -0.809 . . . . 1.3500000000000001 113.005 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -116.37 -57.23 2.22 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.949 1.3 . . . . 2.9700000000000002 110.005 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 164.81 10.15 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.674 0.654 . . . . 1.1599999999999999 112.289 -177.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.72 -19.46 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.593 2.862 . . . . 1.47 112.336 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.88 143.24 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 124.712 1.205 . . . . 2.0899999999999999 110.562 174.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -155.65 126.28 6.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.732 -1.21 . . . . 2.3700000000000001 107.732 -174.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.7 170.8 42.51 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.957 -0.639 . . . . 0.56999999999999995 112.369 -174.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.4 128.17 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.491 -0.929 . . . . 2.75 108.491 -179.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.29 134.71 30.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.651 -1.611 . . . . 2.21 106.651 161.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.42 59.85 1.02 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.863 0.865 . . . . 3.3300000000000001 108.69 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.77 144.28 25.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.237 1.415 . . . . 4.5199999999999996 110.916 -163.277 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -153.44 163.39 40.03 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.872 0.844 . . . . 3.2599999999999998 111.27 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -145.55 153.79 41.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.041 -2.207 . . . . 3.2000000000000002 105.041 157.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -70.71 -56.06 7.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.373 -0.602 . . . . 5.3600000000000003 109.373 172.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -83.08 166.46 18.71 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.798 1.239 . . . . 3.5899999999999999 109.324 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 p -90.79 -0.16 57.63 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.887 -0.508 . . . . 3.0299999999999998 111.949 176.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -144.29 47.72 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.325 0.966 . . . . 5.7400000000000002 111.843 -159.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.56 -164.87 12.75 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.823 -1.311 . . . . 1.3700000000000001 109.823 171.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.4 146.78 45.58 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.594 2.196 . . . . 1.21 110.799 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.54 143.77 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 123.849 0.718 . . . . 2.1200000000000001 110.826 -171.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -95.97 96.98 9.26 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.354 -0.609 . . . . 3.3999999999999999 109.354 -175.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.1 t -83.78 88.94 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.096 -1.076 . . . . 2.29 108.096 177.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -104.55 137.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.778 0.674 . . . . 1.25 109.798 164.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.85 156.83 27.86 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.957 -0.857 . . . . 0.83999999999999997 110.957 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 p -132.21 106.74 8.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.664 -1.976 . . . . 2.6600000000000001 105.664 -171.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.62 150.25 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.627 -1.249 . . . . 1.8200000000000001 107.627 -167.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.75 -179.54 6.86 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.271 1.211 . . . . 6.0 114.271 161.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.92 64.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.854 1.692 . . . . 0.59999999999999998 112.204 179.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.16 162.2 29.7 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.139 0.97 . . . . 1.74 108.811 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.21 164.61 23.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.884 -1.154 . . . . 2.4500000000000002 107.884 153.412 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.01 175.21 0.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.63 0.728 . . . . 2.4100000000000001 111.048 176.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.07 -163.67 50.63 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.295 0.474 . . . . 0.77000000000000002 113.395 170.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.06 147.08 47.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.131 . . . . 3.54 112.284 -172.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.36 117.22 8.22 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.822 1.649 . . . . 0.63 108.987 177.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.16 152.61 5.09 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.917 -0.873 . . . . 0.38 110.917 171.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.84 95.62 2.76 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.559 1.143 . . . . 3.7000000000000002 108.053 -174.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -135.24 160.61 37.86 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 108.383 -0.969 . . . . 0.78000000000000003 108.383 -160.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.37 115.94 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.98 1.264 . . . . 2.9199999999999999 110.686 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -86.9 162.42 17.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.766 -0.652 . . . . 0.87 109.564 -169.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.73 47.27 0.13 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.683 1.993 . . . . 4.5199999999999996 111.345 178.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 106.074 -1.824 . . . . 3.0899999999999999 106.074 -171.998 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.403 -0.591 . . . . 2.3999999999999999 109.403 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.93 -95.25 1.68 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 109.683 -1.367 . . . . 1.54 109.683 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.83 178.61 6.59 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.392 3.394 . . . . 1.0700000000000001 114.236 -173.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -73.03 125.35 27.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.309 -1.314 . . . . 1.52 109.226 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -4.04 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.465 2.306 . . . . 3.7200000000000002 113.754 168.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -123.78 99.84 38.13 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.27 1.028 . . . . 3.1400000000000001 109.105 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.81 -37.02 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.668 1.578 . . . . 1.25 110.03 -179.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.41 -86.02 0.54 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.59 -1.263 . . . . 3.98 107.59 160.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -140.32 72.87 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.434 1.094 . . . . 2.5099999999999998 109.71 -166.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -77.75 164.31 25.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.8 -0.815 . . . . 5.5899999999999999 108.8 170.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -125.07 148.02 48.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.059 1.343 . . . . 4.1200000000000001 108.386 -178.974 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.426 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 44.2 t60 -81.48 156.22 25.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.719 0.407 . . . . 0.89000000000000001 111.828 -176.211 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.57 -97.78 0.13 Allowed Glycine 0 C--O 1.219 -0.784 0 N-CA-C 107.334 -2.306 . . . . 2.3300000000000001 107.334 159.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.09 -154.55 25.48 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 120.575 -1.544 . . . . 1.9099999999999999 110.344 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.34 -55.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.932 2.421 . . . . 2.0499999999999998 110.394 -168.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -39.82 82.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.737 0.779 . . . . 6.4900000000000002 110.067 171.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -57.29 153.09 12.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.725 -1.579 . . . . 3.1299999999999999 112.861 -164.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -49.2 -47.24 46.26 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 128.144 2.578 . . . . 6.5700000000000003 109.576 170.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 21.6 pt-20 -133.93 178.52 6.89 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.762 1.023 . . . . 3.6600000000000001 113.762 -171.145 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 175.73 153.55 0.16 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.147 2.179 . . . . 3.8599999999999999 108.579 -173.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 58.4 m80 -62.6 156.24 23.82 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.072 -0.714 . . . . 0.82999999999999996 109.072 170.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.94 -34.24 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.45 -0.782 . . . . 1.8999999999999999 110.489 -174.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.46 59.98 0.49 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.39 0.995 . . . . 0.90000000000000002 110.65 175.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -169.68 115.93 0.56 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.22 -1.4 . . . . 2.75 107.22 -170.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -106.79 -48.43 3.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.37 0.668 . . . . 3.52 110.978 -173.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.76 -121.69 0.93 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 119.647 -1.263 . . . . 0.87 112.333 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -151.03 172.02 16.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.085 1.354 . . . . 1.8899999999999999 108.925 -171.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 167.23 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.016 -1.476 . . . . 1.76 107.016 167.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 m -120.09 123.42 43.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.217 -1.401 . . . . 3.0 107.217 172.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.94 33.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.979 0.354 . . . . 2.0099999999999998 110.977 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -69.19 -84.05 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.567 1.147 . . . . 2.8799999999999999 110.449 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 93' ' ' GLY . 75.4 tttt -159.12 -46.33 0.06 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.735 1.214 . . . . 4.2000000000000002 111.308 -175.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.41 32.98 0.45 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 124.337 2.018 . . . . 2.73 110.38 176.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 58.39 18.67 37.3 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 126.504 2.002 . . . . 0.78000000000000003 112.228 -176.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.62 142.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.844 -1.539 . . . . 1.9199999999999999 106.844 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.04 163.34 33.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.89 -1.152 . . . . 1.9399999999999999 107.89 171.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -129.99 141.53 50.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.815 -2.661 . . . . 2.6499999999999999 103.815 -174.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.38 126.25 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 105.439 -2.06 . . . . 1.8999999999999999 105.439 170.299 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.8 m -145.81 71.34 1.27 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.375 1.47 . . . . 1.6799999999999999 107.974 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mm -108.56 151.16 10.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.654 0.782 . . . . 2.6200000000000001 109.208 -178.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -137.67 133.96 34.88 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.737 -1.579 . . . . 3.5499999999999998 106.737 160.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.06 161.94 37.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.522 -1.659 . . . . 2.4900000000000002 106.522 175.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 p -113.17 -9.2 13.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.981 2.113 . . . . 2.2999999999999998 112.487 -172.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.1 t -77.5 -41.85 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.339 -0.985 . . . . 2.6099999999999999 108.339 -177.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.68 162.75 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 123.774 0.83 . . . . 3.7599999999999998 108.996 172.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 p -164.29 169.54 17.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.728 1.611 . . . . 2.3500000000000001 108.086 -175.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.5 42.52 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.733 1.213 . . . . 3.8599999999999999 110.046 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 107.575 -1.269 . . . . 4.21 107.575 166.409 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 113.026 0.75 . . . . 1.5700000000000001 113.026 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.3 pp -85.64 -8.86 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.91 -0.494 . . . . 2.4199999999999999 112.05 -177.012 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mm -47.6 123.88 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.835 0.854 . . . . 3.5 109.235 169.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.12 -27.72 17.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.036 0.827 . . . . 2.0299999999999998 112.645 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.85 160.4 26.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.837 1.318 . . . . 5.9900000000000002 110.936 -168.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.8 m -87.35 100.46 12.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.042 1.337 . . . . 2.02 109.904 -176.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.9 146.77 54.48 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.139 -1.06 . . . . 2.8900000000000001 108.139 169.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.9 t -134.41 140.8 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 127.898 2.479 . . . . 1.5700000000000001 107.175 -177.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.64 127.19 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.265 -1.383 . . . . 2.8500000000000001 107.265 165.327 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -98.71 162.99 12.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.573 2.064 . . . . 0.39000000000000001 116.573 -169.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -66.36 0.4 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.754 2.022 . . . . 2.9500000000000002 112.054 176.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -107.68 -178.58 3.66 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.187 0.995 . . . . 3.7999999999999998 111.549 -173.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.79 147.36 42.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.292 -0.867 . . . . 1.73 108.798 158.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.95 164.23 23.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.578 0.704 . . . . 2.1699999999999999 109.776 161.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.19 -4.69 58.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.473 1.509 . . . . 3.1400000000000001 112.927 -172.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 57.08 30.36 18.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.597 1.159 . . . . 2.2999999999999998 110.583 -170.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.45 20.69 59.2 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.872 -0.518 . . . . 1.97 112.587 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -131.24 50.76 2.2 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.221 -1.4 . . . . 7.0700000000000003 107.221 -173.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.46 139.71 11.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.713 -1.755 . . . . 2.96 108.713 177.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.23 -37.28 79.75 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.67 0.735 . . . . 2.7599999999999998 112.604 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -56.15 109.63 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.519 1.127 . . . . 2.6499999999999999 108.995 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -38.91 20.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.163 0.985 . . . . 3.54 112.105 -178.212 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -35.36 -37.87 0.09 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 128.022 2.529 . . . . 3.71 113.227 171.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.7 p -47.7 -69.2 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.285 1.034 . . . . 2.6800000000000002 109.69 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -63.96 -43.35 96.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.334 0.654 . . . . 2.27 110.417 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -52.2 -49.83 63.1 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 126.1 1.76 . . . . 3.75 110.703 -171.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.379 10.2 t -136.2 -48.19 0.65 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 117.801 -1.095 . . . . 2.8799999999999999 111.629 175.459 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.426 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 162.38 -31.32 0.3 Allowed Glycine 0 N--CA 1.463 0.483 0 CA-C-N 119.564 1.074 . . . . 0.91000000000000003 112.578 178.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.99 53.4 10.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.498 1.519 . . . . 2.2999999999999998 109.778 -174.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.18 -7.27 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.352 -0.842 . . . . 2.1299999999999999 112.085 166.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.53 -167.57 50.55 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 108.88 -1.688 . . . . 0.95999999999999996 108.88 -174.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -54.39 151.35 7.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.087 1.755 . . . . 1.8300000000000001 113.836 -167.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -64.93 141.46 58.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.333 1.453 . . . . 4.0099999999999998 108.083 170.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.7 mt -108.92 -89.66 0.47 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.058 -1.089 . . . . 1.72 108.058 169.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.74 158.08 15.85 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.953 -1.129 . . . . 1.9199999999999999 107.953 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.6 p -143.64 174.84 10.43 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.214 -1.357 . . . . 1.96 108.413 166.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.1 139.72 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 123.943 0.777 . . . . 0.79000000000000004 111.551 176.439 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.21 129.76 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.556 1.143 . . . . 1.9099999999999999 108.861 174.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.9 tt -90.74 131.88 36.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 122.665 0.386 . . . . 1.9299999999999999 110.76 176.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.54 3.2 0.62 Allowed Glycine 0 CA--C 1.523 0.532 0 CA-C-O 119.389 -0.673 . . . . 0.77000000000000002 114.639 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.19 56.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.193 1.497 . . . . 2.3999999999999999 110.917 -164.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.36 175.51 13.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.061 1.344 . . . . 2.3300000000000001 108.268 160.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 103.858 -2.645 . . . . 5.6299999999999999 103.858 163.615 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 110.302 -0.259 . . . . 3.3799999999999999 110.302 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.41 153.64 21.01 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.51 -0.922 . . . . 1.7 108.51 164.102 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.96 148.62 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 123.799 0.84 . . . . 1.8400000000000001 108.939 164.395 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.18 101.64 6.35 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.067 1.347 . . . . 1.6799999999999999 108.937 159.007 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.7 98.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.204 -1.035 . . . . 1.95 108.204 164.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 mt -81.76 123.77 29.05 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.812 0.845 . . . . 3.0099999999999998 109.564 175.05 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.76 -56.73 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.82 1.248 . . . . 5.3700000000000001 108.29 178.88 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.54 -116.16 1.58 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.043 1.306 . . . . 0.93000000000000005 112.47 -177.549 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.05 -62.03 1.33 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.642 0.721 . . . . 3.46 109.605 -173.138 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.58 161.94 1.13 Allowed Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.825 1.678 . . . . 0.84999999999999998 112.554 -178.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.34 38.6 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.001 3.134 . . . . 0.96999999999999997 112.75 -172.207 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.3 155.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.341 1.856 . . . . 2.1499999999999999 109.013 -177.436 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.53 116.76 4.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.892 -1.151 . . . . 3.0299999999999998 107.892 171.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 163.68 33.02 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.969 -0.852 . . . . 0.72999999999999998 110.969 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.77 114.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.826 -1.916 . . . . 3.1000000000000001 105.826 -177.607 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -78.2 148.44 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.191 -1.411 . . . . 1.97 107.191 170.252 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -122.7 118.23 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.183 -2.154 . . . . 2.1600000000000001 105.183 163.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.405 ' CD2' HG11 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -106.54 99.94 9.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.175 -1.787 . . . . 3.8399999999999999 106.175 175.606 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -103.78 136.84 42.72 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.693 0.797 . . . . 4.6900000000000004 109.246 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -155.94 86.97 1.05 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.626 1.17 . . . . 3.8100000000000001 109.591 172.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.98 -52.02 59.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.377 1.071 . . . . 5.6799999999999997 110.125 174.036 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -83.56 92.46 7.64 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.265 -1.013 . . . . 4.2300000000000004 108.265 175.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -54.57 3.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 118.287 2.699 . . . . 3.79 118.287 -162.831 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -159.04 64.76 0.41 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 120.004 1.275 . . . . 4.3600000000000003 109.566 170.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.94 -145.85 6.84 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 107.578 -2.209 . . . . 1.49 107.578 164.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.72 142.51 16.08 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.555 2.17 . . . . 1.3 110.693 169.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' ' 20' ' ' PHE . 59.5 t -90.39 152.11 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 122.818 0.447 . . . . 2.02 110.128 -175.559 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.6 125.76 48.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.388 -1.708 . . . . 5.0499999999999998 106.388 170.219 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.14 129.91 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.581 -1.266 . . . . 1.8600000000000001 107.581 175.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -144.07 150.32 37.98 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.543 -1.28 . . . . 0.82999999999999996 107.543 162.444 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.28 142.88 5.71 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 107.748 -2.141 . . . . 1.0900000000000001 107.748 173.625 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -116.92 98.57 6.56 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.444 -1.317 . . . . 3.3900000000000001 107.444 -169.261 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.69 143.44 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.512 1.525 . . . . 2.3999999999999999 108.54 -169.119 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 160.65 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.515 -0.474 . . . . 5.6799999999999997 110.619 170.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.57 25.16 63.62 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.796 1.665 . . . . 0.97999999999999998 113.99 -179.121 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.58 171.56 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.297 -1.001 . . . . 1.75 108.297 160.333 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -74.45 168.47 19.65 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.995 -1.113 . . . . 3.3199999999999998 107.995 152.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.47 172.55 0.85 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.73 1.212 . . . . 4.71 110.9 179.516 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.28 -158.75 38.33 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 115.967 -0.561 . . . . 0.96999999999999997 114.023 167.63 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.13 141.35 56.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.228 1.411 . . . . 3.3799999999999999 111.997 -168.17 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -142.48 115.86 9.02 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.168 0.987 . . . . 0.75 110.804 176.457 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.11 146.88 9.77 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.997 -0.841 . . . . 0.38 110.997 170.515 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.26 105.68 5.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.848 1.259 . . . . 3.9100000000000001 107.778 -175.889 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.431 ' ND1' ' CD2' ' A' ' 120' ' ' HIS . 31.0 m80 -138.66 162.09 35.52 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.291 -1.003 . . . . 1.03 108.291 -166.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.45 126.18 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.472 0.654 . . . . 2.73 109.385 176.319 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -104.94 147.75 27.44 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.75 2.02 . . . . 0.80000000000000004 109.215 -173.314 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 67.87 0.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.681 1.192 . . . . 4.3700000000000001 111.095 177.716 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 107.383 -1.339 . . . . 3.1800000000000002 107.383 -176.254 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.386 0 N-CA-C 106.867 -1.531 . . . . 2.5299999999999998 106.867 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.78 -122.89 2.94 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.076 -0.847 . . . . 1.51 111.98 -158.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.89 179.12 6.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.416 2.744 . . . . 1.0700000000000001 113.289 -172.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -58.82 115.74 3.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.893 -1.503 . . . . 1.29 107.19 171.534 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -21.89 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.967 1.707 . . . . 3.3500000000000001 113.902 176.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -130.29 146.23 60.75 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.08 . . . . 3.2200000000000002 107.929 -173.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.58 -54.69 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.778 1.652 . . . . 2.2000000000000002 108.655 169.076 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -144.63 -70.37 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.449 1.499 . . . . 3.5899999999999999 107.333 171.244 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.9 p -135.29 71.92 1.44 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.042 1.337 . . . . 3.6800000000000002 109.369 -168.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -78.82 175.13 10.77 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.233 -1.025 . . . . 5.21 108.233 162.488 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -117.16 149.08 40.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.561 -2.015 . . . . 4.9100000000000001 105.561 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -66.93 146.25 54.58 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.543 -0.863 . . . . 0.83999999999999997 111.048 178.487 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.36 130.28 3.29 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 106.751 -2.54 . . . . 2.73 106.751 172.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.1 -155.28 12.36 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.231 -1.148 . . . . 2.1800000000000002 110.231 174.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.52 -33.0 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.26 1.974 . . . . 2.7000000000000002 110.786 178.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -44.23 90.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.437 0.637 . . . . 8.8900000000000006 110.817 175.637 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.18 139.69 56.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.218 1.562 . . . . 3.0299999999999998 115.218 -159.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -53.57 -59.45 4.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.752 2.421 . . . . 5.4199999999999999 110.167 170.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.64 -178.72 6.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 130.221 3.409 . . . . 3.8199999999999998 110.406 178.029 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 172.68 161.01 0.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.206 1.802 . . . . 3.7200000000000002 111.685 164.74 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.7 m80 -50.25 136.84 19.14 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.685 -1.968 . . . . 0.71999999999999997 105.685 154.256 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.78 -20.6 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 120.072 -0.651 . . . . 1.9299999999999999 109.82 -179.96 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.91 43.29 1.75 Allowed Glycine 0 CA--C 1.535 1.338 0 N-CA-C 116.717 1.447 . . . . 0.94999999999999996 116.717 164.56 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -98.09 136.8 37.81 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 105.757 -1.942 . . . . 2.4100000000000001 105.757 147.681 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.55 -52.29 4.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.72 -0.844 . . . . 2.4300000000000002 108.72 148.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.92 -108.6 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 119.597 -1.287 . . . . 0.65000000000000002 112.321 178.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -155.63 168.18 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.512 1.525 . . . . 3.21 109.224 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.98 178.05 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.565 -1.643 . . . . 1.8300000000000001 106.565 163.21 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.5 t -113.07 146.22 39.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.562 -1.644 . . . . 3.4199999999999999 106.562 151.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.46 156.43 20.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.106 -1.072 . . . . 1.78 108.106 150.755 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.57 -90.11 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.967 -0.753 . . . . 3.1299999999999999 108.967 172.314 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -139.22 -48.79 0.49 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.467 1.507 . . . . 4.7400000000000002 110.091 -167.497 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -81.88 17.0 1.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.964 1.364 . . . . 3.0800000000000001 111.343 -176.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.84 10.11 76.42 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.344 -0.847 . . . . 1.1000000000000001 111.7 -175.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.38 124.65 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.493 1.517 . . . . 2.1400000000000001 107.475 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.34 171.62 14.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.269 1.828 . . . . 1.8100000000000001 108.086 175.12 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.31 144.74 26.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.787 -1.19 . . . . 3.5899999999999999 107.787 -179.583 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.21 55.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 123.866 0.866 . . . . 2.04 111.153 -172.797 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.6 m -72.67 102.3 3.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.768 -0.634 . . . . 1.2 110.193 169.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.4 mt -137.4 157.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.192 0.906 . . . . 2.7999999999999998 110.147 179.077 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -137.94 123.72 19.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.659 -1.237 . . . . 3.6600000000000001 107.659 158.514 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -117.15 156.82 26.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.466 -0.939 . . . . 2.4500000000000002 108.466 164.095 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.9 p -102.03 -12.64 18.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.282 2.233 . . . . 1.8 111.937 176.432 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.35 -25.87 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.764 0.711 . . . . 2.1899999999999999 110.872 -173.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.88 166.6 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.704 0.683 . . . . 2.5699999999999998 111.686 177.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -136.41 176.81 8.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.596 2.359 . . . . 2.4900000000000002 107.618 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.42 57.37 1.09 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.802 0.728 . . . . 3.3999999999999999 112.11 167.352 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 123.328 0.651 . . . . 3.4100000000000001 111.743 165.509 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.443 -0.776 0 CA-C-O 122.695 1.236 . . . . 1.4099999999999999 112.516 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -8.53 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 4.1299999999999999 111.942 176.066 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 33.9 mm -54.85 120.4 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.926 1.239 . . . . 2.8599999999999999 109.491 -174.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.25 73.81 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.617 -0.546 . . . . 1.49 112.338 -177.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -102.39 177.21 4.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.313 -1.736 . . . . 5.3099999999999996 106.313 167.611 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -119.4 122.14 41.11 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.596 1.089 . . . . 1.9299999999999999 111.314 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.8 mt -74.16 146.43 43.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.239 -0.652 . . . . 2.7000000000000002 109.239 166.144 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.91 136.06 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.416 1.886 . . . . 1.73 107.919 177.511 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.3 t -100.47 122.23 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 126.044 1.738 . . . . 3.4500000000000002 106.9 167.005 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.431 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 65.0 m-70 -98.48 158.69 15.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.369 1.989 . . . . 0.44 116.369 -174.653 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 2.7 tt0 -46.72 -74.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.219 2.208 . . . . 2.96 112.018 174.292 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -93.76 -176.88 4.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.851 0.75 . . . . 3.5299999999999998 110.275 -171.748 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.32 152.08 30.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.588 -0.893 . . . . 1.8100000000000001 108.588 157.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.13 177.34 6.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.94 0.876 . . . . 2.1099999999999999 109.087 161.92 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.53 -27.4 67.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.498 1.119 . . . . 4.3899999999999997 113.83 177.824 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.288 2.9 mm? 88.73 -17.58 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 128.47 2.708 . . . . 3.6200000000000001 113.172 -175.127 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.27 3.33 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.647 -1.381 . . . . 3.6000000000000001 109.647 -171.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -95.44 -38.97 10.23 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 128.264 2.626 . . . . 7.0300000000000002 108.87 160.403 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.35 62.63 5.8 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 125.401 1.477 . . . . 4.6600000000000001 110.112 -167.294 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.19 -16.02 25.05 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.694 -0.503 . . . . 3.96 113.741 178.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -176.68 -179.98 1.05 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.49 1.516 . . . . 3.0600000000000001 108.236 -169.507 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -42.83 -82.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.772 2.029 . . . . 3.4900000000000002 113.562 178.681 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -53.18 -33.54 53.07 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.827 -0.546 . . . . 3.9500000000000002 111.709 -172.796 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.3 m -61.42 -52.78 63.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.005 1.322 . . . . 2.6299999999999999 111.161 179.266 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.9 t -71.04 -45.07 64.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.767 1.167 . . . . 3.6000000000000001 110.791 173.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.17 -43.13 99.36 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.175 0.59 . . . . 4.75 111.58 -170.063 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -128.21 -47.98 1.33 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.225 0.466 . . . . 2.1600000000000001 112.107 177.104 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.65 -14.99 1.4 Allowed Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.786 0.721 . . . . 0.91000000000000003 114.097 -178.417 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.11 54.85 6.73 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.035 1.334 . . . . 2.3900000000000001 110.601 -174.755 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.5 -31.26 71.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.77 1.228 . . . . 2.1699999999999999 112.087 172.848 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.52 178.43 50.48 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 108.64 -1.784 . . . . 0.93999999999999995 108.64 -163.262 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 m -58.23 153.76 14.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.556 1.142 . . . . 2.1899999999999999 113.648 -167.229 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -59.72 134.58 57.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.082 1.353 . . . . 4.1299999999999999 108.465 170.254 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.6 mt -110.32 -72.48 0.72 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.955 -1.498 . . . . 1.76 106.955 168.37 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.35 155.03 16.94 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.409 -0.96 . . . . 2.1000000000000001 108.409 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 73.9 m -135.96 150.51 49.3 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 106.196 -1.779 . . . . 2.1000000000000001 106.196 163.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.09 116.45 0.75 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.8 -1.72 . . . . 1.3300000000000001 108.8 172.03 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.68 132.88 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.095 -1.446 . . . . 1.97 107.095 168.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.59 138.96 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.206 0.527 . . . . 1.75 112.385 -172.537 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 137.78 5.84 1.62 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.328 1.442 . . . . 0.59999999999999998 114.221 177.563 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.75 57.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-N 119.351 1.575 . . . . 1.9099999999999999 109.89 -154.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 165.33 36.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.367 0.603 . . . . 2.1400000000000001 111.236 171.669 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 C--O 1.255 1.353 0 N-CA-C 102.699 -3.075 . . . . 5.1600000000000001 102.699 156.139 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HZ3' ' C ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.747 0.308 . . . . 3.96 110.845 . . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.76 37.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.551 -2.018 . . . . 2.04 105.551 156.147 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -100.6 142.85 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 105.558 -2.016 . . . . 1.8799999999999999 105.558 162.725 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.79 93.16 3.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.645 -1.243 . . . . 1.4099999999999999 107.645 166.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.09 98.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.299 -1.371 . . . . 1.9199999999999999 107.299 169.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.89 123.06 27.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.038 -0.727 . . . . 3.0099999999999998 109.038 177.741 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -150.69 -48.07 0.12 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.824 -0.625 . . . . 4.3399999999999999 111.065 167.623 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.32 -117.8 3.52 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.61 -0.996 . . . . 1.1200000000000001 110.61 -174.898 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.85 -35.04 6.07 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.319 1.048 . . . . 3.7400000000000002 110.131 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.44 168.8 30.15 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-O 121.63 0.572 . . . . 1.1799999999999999 112.577 -177.466 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.47 -26.29 47.58 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.571 2.847 . . . . 1.8700000000000001 111.758 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.0 t -48.04 151.61 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.639 1.976 . . . . 1.6299999999999999 111.025 -178.603 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -156.01 118.32 4.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.396 0.678 . . . . 2.5800000000000001 109.254 -175.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.77 167.72 35.35 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.868 -0.52 . . . . 0.55000000000000004 112.286 -178.838 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.8 mt -129.95 119.95 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.736 -1.209 . . . . 2.5299999999999998 107.736 177.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 mm -81.27 140.51 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.903 -1.147 . . . . 2.1600000000000001 107.903 164.592 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -120.38 93.5 4.07 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 105.396 -2.075 . . . . 1.9399999999999999 105.396 159.299 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.3 118.93 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.881 -1.896 . . . . 4.7699999999999996 105.881 -173.481 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -155.65 175.07 14.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.028 0.918 . . . . 3.9199999999999999 113.404 -173.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.84 169.87 23.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.807 -1.553 . . . . 3.1099999999999999 106.807 -173.51 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -93.79 -64.66 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.596 1.558 . . . . 5.5599999999999996 108.601 171.779 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -79.95 -178.58 6.55 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.458 1.103 . . . . 4.3099999999999996 111.375 178.368 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -87.7 -66.87 0.87 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.906 -1.146 . . . . 3.3100000000000001 107.906 155.69 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -75.74 63.23 1.6 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.045 1.338 . . . . 4.4100000000000001 111.723 -173.219 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.09 -177.48 27.55 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.319 -1.912 . . . . 2.2400000000000002 108.319 169.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.35 152.82 44.72 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.1 2.534 . . . . 1.77 110.412 174.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -82.65 158.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.547 -0.908 . . . . 2.1000000000000001 108.547 176.743 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -111.57 104.88 13.3 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.382 1.087 . . . . 3.4199999999999999 108.601 162.297 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.26 105.22 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.883 1.673 . . . . 2.3599999999999999 108.206 -175.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -128.01 164.27 22.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.693 0.627 . . . . 1.1100000000000001 112.693 176.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.5 42.69 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.516 -1.034 . . . . 0.70999999999999996 110.516 179.267 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -138.74 109.32 6.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.427 -1.694 . . . . 2.7999999999999998 106.427 179.025 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.53 115.87 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.865 -1.531 . . . . 2.1299999999999999 106.865 -161.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -105.36 162.38 13.49 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.64 0.733 . . . . 4.5300000000000002 111.954 -173.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.65 79.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.201 -0.908 . . . . 0.57999999999999996 113.662 168.398 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.77 165.85 9.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.82 1.31 . . . . 1.73 108.839 167.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.93 160.75 25.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.188 -1.412 . . . . 2.3599999999999999 107.188 152.804 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.55 173.68 0.52 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.397 -0.814 . . . . 2.73 110.6 177.359 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.92 -159.26 46.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 123.747 0.689 . . . . 0.93999999999999995 112.465 170.028 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.49 141.49 55.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.609 1.564 . . . . 3.1800000000000002 114.543 -169.493 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -145.29 119.62 9.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.97 1.708 . . . . 0.71999999999999997 109.703 177.24 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.37 150.44 5.57 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.883 -0.887 . . . . 0.46000000000000002 110.883 171.699 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.58 93.12 2.53 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.939 -1.504 . . . . 3.8599999999999999 106.939 -173.292 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -130.39 173.39 10.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.217 -1.031 . . . . 0.85999999999999999 108.217 -165.475 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.9 t -124.42 118.27 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.39 -0.967 . . . . 3.4399999999999999 108.39 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -100.2 149.61 23.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.415 1.486 . . . . 0.88 107.912 175.847 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.45 34.24 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.931 0.892 . . . . 4.7300000000000004 112.445 177.743 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.3 tt0 . . . . . 0 N--CA 1.456 -0.151 0 O-C-N 120.579 -1.326 . . . . 3.4900000000000002 110.817 -159.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 121.256 0.55 . . . . 2.46 109.809 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.83 -119.66 4.2 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.698 -0.961 . . . . 1.55 110.698 -172.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.64 178.65 7.35 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.014 3.143 . . . . 1.02 112.333 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -54.26 124.97 17.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.977 1.311 . . . . 1.25 108.898 174.582 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -30.73 113.88 0.11 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.653 1.581 . . . . 3.52 112.23 174.499 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.7 151.73 46.99 Favored Pre-proline 0 N--CA 1.446 -0.625 0 C-N-CA 124.675 1.19 . . . . 2.98 109.152 167.369 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.48 -30.91 52.15 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.42 2.08 . . . . 1.6200000000000001 111.621 -178.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 tp -154.54 -69.72 0.13 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.145 0.429 . . . . 4.8700000000000001 109.954 173.331 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -145.94 76.41 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.144 0.978 . . . . 2.5299999999999998 110.411 -172.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -79.67 176.55 9.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.964 -0.754 . . . . 5.5800000000000001 108.964 165.28 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.978 -1.49 . . . . 3.9399999999999999 106.978 -179.558 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -106.64 126.9 52.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.132 0.573 . . . . 1.0600000000000001 111.495 175.017 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.25 3.95 8.3 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.683 1.611 . . . . 3.2200000000000002 111.461 173.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 -173.29 4.25 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.468 -1.019 . . . . 2.3999999999999999 111.291 -169.546 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.09 -9.43 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.641 2.227 . . . . 1.6699999999999999 111.872 173.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -54.51 5.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.469 0.577 . . . . 4.6699999999999999 111.397 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.26 176.58 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.033 0.444 . . . . 2.6600000000000001 110.382 -179.335 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.54 -63.12 1.21 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.684 1.194 . . . . 5.6500000000000004 109.923 -179.885 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.49 148.5 33.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.573 -0.739 . . . . 3.3100000000000001 111.333 -161.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -159.29 147.01 17.41 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.095 -1.003 . . . . 4.7400000000000002 108.396 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.2 m80 -54.69 135.22 47.17 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.721 -1.955 . . . . 0.72999999999999998 105.721 157.462 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -62.09 -22.02 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.788 -0.449 . . . . 2.1400000000000001 109.788 -178.13 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.83 44.93 1.57 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.809 0.719 . . . . 0.93999999999999995 114.337 162.709 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.72 121.77 45.96 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 106.643 -1.614 . . . . 2.3900000000000001 106.643 158.058 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.24 -71.13 0.46 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.422 -1.696 . . . . 2.7999999999999998 106.422 154.399 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.32 -110.76 0.35 Allowed Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.536 -0.626 . . . . 0.82999999999999996 111.536 -176.575 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.66 167.35 26.66 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.848 1.659 . . . . 2.3300000000000001 109.086 175.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.03 175.06 10.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 106.848 -1.538 . . . . 1.5600000000000001 106.848 170.553 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -122.89 142.93 50.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.936 -1.135 . . . . 3.02 107.936 169.104 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 142.13 40.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.921 1.288 . . . . 2.0499999999999998 112.629 173.525 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.31 -88.15 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.158 0.983 . . . . 2.5099999999999998 111.688 -178.652 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 93' ' ' GLY . 1.7 tpmt? -146.08 -42.32 0.21 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.595 0.591 . . . . 4.4900000000000002 112.595 -158.251 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -83.49 23.27 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 124.059 1.885 . . . . 4.0599999999999996 110.163 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 58.42 24.94 57.08 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.563 -1.199 . . . . 1.05 110.479 -168.7 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.15 107.5 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.221 -1.029 . . . . 2.54 108.221 -175.599 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.83 154.72 18.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.904 -1.147 . . . . 1.8200000000000001 107.904 156.187 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.57 139.11 50.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 102.218 -3.252 . . . . 2.8700000000000001 102.218 174.01 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.85 131.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.041 -1.466 . . . . 2.1099999999999999 107.041 170.678 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -158.22 61.73 0.45 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.649 1.98 . . . . 1.21 107.678 178.39 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.0 mm -105.29 157.55 6.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.904 -1.146 . . . . 3.48 107.904 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.2 102.94 4.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.187 -0.321 . . . . 2.3199999999999998 111.617 165.397 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.46 144.75 25.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.314 1.046 . . . . 2.0299999999999998 111.045 -178.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -105.63 -9.14 17.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.04 2.136 . . . . 2.0 113.142 -176.213 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.41 -43.4 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.148 -1.056 . . . . 2.25 108.148 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 pt -86.67 176.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.714 0.768 . . . . 2.5299999999999998 111.446 175.001 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.1 m -157.16 177.67 11.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.1 2.16 . . . . 2.5499999999999998 105.78 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.76 54.83 1.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.909 1.231 . . . . 3.3500000000000001 111.995 172.844 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 124.646 1.178 . . . . 4.5199999999999996 108.524 175.083 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.437 -1.121 0 CA-C-O 122.498 1.142 . . . . 1.47 112.654 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.1 pp -93.78 -6.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.001 -1.454 . . . . 3.3100000000000001 113.228 177.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.9 mm -43.81 119.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.973 . . . . 2.9500000000000002 110.371 -179.214 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.63 25.54 73.83 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.707 -0.496 . . . . 1.4199999999999999 113.089 177.055 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -104.06 -178.86 3.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.405 -1.702 . . . . 5.1399999999999997 106.405 166.244 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 m -116.02 118.79 33.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.082 0.401 . . . . 2.1200000000000001 110.108 178.119 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 tt -73.34 143.46 46.89 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.506 -1.294 . . . . 3.25 107.506 170.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -127.24 136.81 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.808 2.043 . . . . 1.73 107.577 177.974 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.19 127.15 58.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.444 -0.947 . . . . 2.7599999999999998 108.444 164.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.24 160.29 14.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 116.066 1.876 . . . . 0.40000000000000002 116.066 -171.217 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -36.2 -68.03 0.15 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.579 2.352 . . . . 3.1200000000000001 112.522 172.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -126.09 -173.8 2.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.683 1.193 . . . . 3.1400000000000001 110.188 -170.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.78 141.76 43.17 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.468 -0.567 . . . . 1.73 109.468 169.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.19 160.96 28.1 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.288 -1.005 . . . . 2.0 108.288 161.502 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.53 -22.34 62.63 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.715 -0.659 . . . . 2.9900000000000002 112.189 -176.042 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 56.36 51.96 10.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.137 1.335 . . . . 2.21 109.68 -161.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 50.58 44.11 46.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.334 0.969 . . . . 1.5700000000000001 113.793 169.116 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -79.5 -30.87 42.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.235 1.014 . . . . 6.6900000000000004 111.088 179.147 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.38 -146.01 25.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.259 -1.136 . . . . 3.8100000000000001 110.259 -170.369 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.37 -72.37 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.444 -1.862 . . . . 3.3900000000000001 108.444 -169.075 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 109.81 8.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 104.488 -2.412 . . . . 3.0099999999999998 104.488 161.592 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -35.9 66.87 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.559 . . . . 3.6499999999999999 110.391 178.654 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -28.6 -44.96 0.03 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.58 2.752 . . . . 3.5800000000000001 113.248 162.366 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -45.68 -60.92 1.93 Allowed 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.979 1.312 . . . . 3.3700000000000001 109.489 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -72.26 -43.56 64.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.499 0.32 . . . . 2.25 110.152 178.829 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -52.91 -53.02 55.41 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.822 1.649 . . . . 3.23 110.85 -170.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.251 1.0 OUTLIER -125.0 -47.71 1.78 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.067 0.547 . . . . 1.97 111.207 173.483 . . . . . . . . 4 4 . 1 . 032 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.66 -26.29 1.06 Allowed Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.533 -0.627 . . . . 1.0900000000000001 111.533 -170.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.64 56.51 6.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.303 1.041 . . . . 2.7799999999999998 111.249 178.281 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.22 -5.96 57.24 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.389 0.514 . . . . 2.3399999999999999 112.389 168.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.05 -170.84 43.82 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.054 -1.619 . . . . 1.04 109.054 -173.847 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -68.48 171.22 7.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.108 -1.046 . . . . 3.1400000000000001 113.016 -167.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.469 HH21 ' CD ' ' A' ' 50' ' ' GLU . 5.8 mmt-85 -66.79 142.17 57.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.171 2.188 . . . . 3.9199999999999999 109.316 175.126 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.9 -78.95 0.58 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.466 -1.309 . . . . 1.5900000000000001 107.466 166.501 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.71 150.23 28.6 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.651 -0.87 . . . . 1.95 108.651 171.624 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 3.3 m -137.12 150.05 47.73 Favored 'General case' 0 N--CA 1.436 -1.135 0 O-C-N 125.462 1.727 . . . . 2.0800000000000001 106.66 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.67 123.5 1.67 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 109.454 -1.459 . . . . 1.1699999999999999 109.454 178.263 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.08 128.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.575 -1.269 . . . . 2.0099999999999998 107.575 168.562 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.5 tt -103.92 117.06 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.645 0.736 . . . . 1.8899999999999999 110.95 -172.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.24 2.63 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-N 114.954 -1.021 . . . . 0.53000000000000003 115.388 178.133 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.8 mm -94.45 58.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.732 1.766 . . . . 1.96 111.589 -155.031 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.89 176.4 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.678 0.791 . . . . 2.3199999999999998 110.024 167.84 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.494 ' C ' ' HZ3' ' A' ' 3' ' ' LYS . 84.2 mt-30 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 104.148 -2.538 . . . . 4.9699999999999998 104.148 162.294 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 pttm . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 111.272 0.101 . . . . 3.2200000000000002 111.272 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.15 133.13 33.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.03 -1.1 . . . . 1.72 108.03 165.57 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.12 146.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 106.852 -1.536 . . . . 1.9399999999999999 106.852 158.013 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.86 94.77 3.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.017 -1.105 . . . . 1.77 108.017 162.55 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.67 96.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.407 1.083 . . . . 1.9199999999999999 108.284 170.469 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -91.71 121.55 33.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.431 -0.581 . . . . 2.1099999999999999 109.431 -179.212 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -130.84 -62.12 0.92 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.822 -0.807 . . . . 4.0800000000000001 108.822 174.268 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.26 -123.83 10.33 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 114.34 -1.3 . . . . 1.02 112.22 -170.296 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.22 -43.19 1.8 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.247 0.619 . . . . 3.4300000000000002 109.974 -150.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.99 165.61 8.43 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 109.439 -1.464 . . . . 0.91000000000000003 109.439 164.386 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.53 35.14 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.515 2.81 . . . . 1.0 112.954 -173.681 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -93.16 153.73 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.578 1.551 . . . . 1.6299999999999999 109.992 -171.962 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -155.08 107.16 2.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.217 1.407 . . . . 3.4100000000000001 107.543 175.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.0 166.03 29.35 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.664 -0.574 . . . . 0.53000000000000003 111.664 179.1 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 mm -132.17 117.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.934 -1.876 . . . . 3.0 105.934 -178.368 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 mm -85.28 140.6 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.856 -1.535 . . . . 1.8 106.856 165.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -120.88 105.1 10.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.518 -2.03 . . . . 2.04 105.518 164.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -115.76 110.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.482 -2.044 . . . . 4.8700000000000001 105.482 -171.397 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.33 167.42 30.43 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.659 0.742 . . . . 3.98 112.057 -174.672 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.96 -156.7 0.71 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.181 -2.526 . . . . 4.4000000000000004 104.181 169.493 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -110.67 -62.78 1.48 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.485 1.039 . . . . 4.9199999999999999 109.497 168.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.17 101.45 12.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.927 -1.509 . . . . 4.6100000000000003 106.927 -171.286 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 p -73.99 53.18 0.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.177 1.391 . . . . 3.5899999999999999 111.946 -177.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -156.08 34.74 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.199 1.8 . . . . 4.5999999999999996 108.196 165.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.72 -173.26 14.36 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.042 -1.623 . . . . 1.3999999999999999 109.042 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.04 169.9 6.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.346 2.698 . . . . 1.55 111.765 177.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.83 154.38 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.863 -0.608 . . . . 1.8300000000000001 109.622 -178.842 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -104.46 113.5 27.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.209 -1.775 . . . . 3.5800000000000001 106.209 171.662 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.25 90.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.786 -1.19 . . . . 2.1800000000000002 107.786 -168.798 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -109.59 150.66 27.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 123.457 0.473 . . . . 0.79000000000000004 110.067 -179.613 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.74 168.25 41.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.221 -1.151 . . . . 0.77000000000000002 110.221 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.6 m -139.63 107.5 5.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.281 -1.748 . . . . 3.02 106.281 -179.387 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -115.77 123.02 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.89 -1.893 . . . . 1.8799999999999999 105.89 -161.047 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 162.83 20.74 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 118.651 0.659 . . . . 5.4000000000000004 110.966 -174.371 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.91 74.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.878 0.751 . . . . 0.71999999999999997 113.692 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -69.94 164.04 24.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.48 1.14 . . . . 1.76 109.151 167.633 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.85 156.78 19.81 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.098 -1.075 . . . . 2.5600000000000001 108.098 149.02 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.78 -180.0 0.31 Allowed 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.004 -1.06 . . . . 3.9399999999999999 110.4 176.1 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.11 -158.6 51.13 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.818 -0.551 . . . . 0.85999999999999999 112.1 168.087 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.43 146.86 30.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.948 1.299 . . . . 3.6800000000000002 110.219 -170.149 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.9 121.09 10.83 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.178 0.991 . . . . 0.66000000000000003 110.213 -177.257 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.15 147.58 26.45 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.914 -1.275 . . . . 0.42999999999999999 109.914 170.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -136.26 97.07 3.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.63 -1.619 . . . . 4.5 106.63 -174.084 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -129.31 174.88 9.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.548 -1.278 . . . . 0.82999999999999996 107.548 -169.281 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 p -134.33 115.91 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.177 -1.416 . . . . 2.8799999999999999 107.177 170.203 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -82.28 -175.74 5.84 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.836 -1.542 . . . . 1.1499999999999999 106.836 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -70.92 -106.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.433 -0.951 . . . . 4.1299999999999999 108.433 172.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 . . . . . 0 CA--C 1.532 0.253 0 C-N-CA 123.75 0.82 . . . . 3.3700000000000001 110.513 -175.976 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 107.544 -1.28 . . . . 2.2599999999999998 107.544 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -94.44 0.18 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.785 -0.926 . . . . 1.6599999999999999 110.785 -179.59 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -81.54 178.28 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.12 2.546 . . . . 1.1399999999999999 115.405 -166.226 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -65.86 64.86 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.613 2.365 . . . . 1.6899999999999999 112.46 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.6 t80 37.77 70.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.411 1.884 . . . . 3.8599999999999999 111.025 -177.275 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -96.33 105.26 21.18 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 118.271 -0.871 . . . . 3.79 109.338 -176.727 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.2 -36.15 17.38 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.058 1.838 . . . . 1.8200000000000001 111.655 -175.094 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -141.71 -75.4 0.3 Allowed 'General case' 0 C--N 1.339 0.134 0 N-CA-C 108.687 -0.857 . . . . 3.98 108.687 177.825 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.6 p -156.55 58.34 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.68 0.753 . . . . 3.7599999999999998 110.512 -171.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -77.41 160.57 28.64 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.163 -1.421 . . . . 5.6200000000000001 107.163 162.133 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -133.84 152.01 51.73 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.242 1.417 . . . . 4.2400000000000002 108.178 -172.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -76.18 153.75 35.91 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.804 0.668 . . . . 0.92000000000000004 112.804 -169.245 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.13 163.88 36.24 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.964 -2.454 . . . . 2.2799999999999998 106.964 159.086 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.5 -170.35 11.76 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 117.524 0.662 . . . . 2.1899999999999999 112.493 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.98 -39.77 30.76 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.656 2.237 . . . . 1.6799999999999999 109.797 178.158 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -66.87 -51.06 60.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.083 1.353 . . . . 5.8099999999999996 111.258 175.401 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -61.5 157.55 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.516 0.932 . . . . 2.1299999999999999 113.516 -161.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.13 -49.77 73.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.418 1.087 . . . . 4.4100000000000001 110.333 -179.313 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -78.1 170.04 17.26 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.845 -0.428 . . . . 3.29 109.845 177.488 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 165.24 133.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.927 2.491 . . . . 4.1299999999999999 106.584 -171.882 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.528 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.8 m80 -68.31 161.37 27.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 118.594 -1.242 . . . . 0.73999999999999999 107.947 167.962 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.54 44.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 122.985 1.374 . . . . 2.6200000000000001 110.498 165.303 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -169.0 36.72 0.2 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 124.816 1.198 . . . . 1.3999999999999999 110.984 167.458 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 133.72 28.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.33 -1.1 . . . . 2.46 108.712 163.337 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.9 mt -99.74 -46.02 5.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.014 -1.106 . . . . 3.0800000000000001 108.014 168.757 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.24 -111.41 0.46 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.511 -0.852 . . . . 0.68999999999999995 111.347 178.28 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -155.11 158.41 38.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.164 1.386 . . . . 2.8300000000000001 109.375 -169.83 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.66 178.14 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.686 1.995 . . . . 1.73 106.384 172.353 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -138.32 145.92 41.76 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.562 -0.903 . . . . 3.3199999999999998 108.562 171.301 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.83 139.79 39.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.446 1.099 . . . . 1.8899999999999999 110.885 170.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.76 -79.77 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 123.784 0.678 . . . . 2.9100000000000001 111.309 -174.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.65 -46.33 0.15 Allowed 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.744 0.817 . . . . 4.4100000000000001 111.151 -164.739 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.02 13.58 2.19 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.803 1.287 . . . . 2.6699999999999999 111.529 177.693 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.63 16.85 74.35 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.235 -0.916 . . . . 0.67000000000000004 111.224 -173.341 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -89.06 115.21 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.051 1.34 . . . . 1.8300000000000001 108.262 -179.53 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.59 168.09 9.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.906 1.683 . . . . 1.6799999999999999 108.367 162.242 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -126.8 149.13 49.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.202 -2.888 . . . . 2.98 103.202 -179.369 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.68 135.19 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 107.197 -1.408 . . . . 2.1299999999999999 107.197 166.742 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.9 m -157.59 58.75 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.298 1.839 . . . . 1.24 107.229 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.0 mt -101.88 154.04 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 123.886 0.875 . . . . 2.5800000000000001 108.861 -174.424 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -133.45 137.98 45.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.364 -1.347 . . . . 2.8300000000000001 107.364 161.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.42 159.74 41.64 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.151 -1.426 . . . . 2.5 107.151 170.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -121.74 -1.96 9.4 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.808 2.043 . . . . 3.9900000000000002 113.199 -177.549 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.02 -31.2 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.458 1.027 . . . . 2.3199999999999998 108.236 176.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -99.94 175.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.683 1.193 . . . . 2.4399999999999999 109.286 171.129 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.1 t -158.1 179.55 9.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.347 1.859 . . . . 3.0499999999999998 106.058 175.339 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -106.2 27.74 8.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.946 0.898 . . . . 3.77 111.922 177.9 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 124.371 1.068 . . . . 4.8899999999999997 110.887 -170.922 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.9 p . . . . . 0 C--O 1.237 0.428 0 CA-C-O 122.248 1.023 . . . . 1.6799999999999999 112.232 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.8 pt -100.29 -5.31 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.348 -1.296 . . . . 3.1499999999999999 111.056 171.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 tp -46.73 128.81 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.725 0.81 . . . . 2.8199999999999998 109.383 176.906 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.79 -14.12 62.53 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.597 -1.113 . . . . 1.4299999999999999 113.744 -178.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -94.11 163.24 13.55 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.875 1.837 . . . . 4.7800000000000002 111.561 -169.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -88.74 108.74 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.898 0.479 . . . . 1.77 111.184 -177.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.75 143.25 48.04 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.927 -0.768 . . . . 3.0 108.927 174.281 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.1 t -130.27 127.78 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.687 1.195 . . . . 1.6499999999999999 109.212 -179.105 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.67 128.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 106.48 -1.674 . . . . 3.5800000000000001 106.48 161.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -101.87 158.45 16.12 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 114.627 1.343 . . . . 0.40000000000000002 114.627 -175.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.8 -71.73 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.397 -0.819 . . . . 5.5300000000000002 111.152 176.835 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -79.6 -179.5 6.9 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.025 0.83 . . . . 5.0999999999999996 109.353 -177.247 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.43 157.31 26.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.041 -0.527 . . . . 1.8100000000000001 109.818 169.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.83 160.49 5.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.043 -0.526 . . . . 2.8500000000000001 110.326 162.324 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.01 -33.02 74.65 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.921 0.711 . . . . 3.5099999999999998 112.921 176.181 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 73.34 -9.68 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.72 2.408 . . . . 2.77 112.532 -168.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.52 43.42 8.5 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.142 -1.983 . . . . 2.3700000000000001 108.142 -168.197 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.26 -20.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.575 0.954 . . . . 6.9500000000000002 113.575 -175.0 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.9 -46.21 92.18 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 108.276 -1.93 . . . . 3.4700000000000002 108.276 169.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.55 36.01 57.84 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.583 0.611 . . . . 4.8399999999999999 111.64 175.926 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -69.64 -61.62 1.71 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.246 -1.39 . . . . 2.8100000000000001 107.246 -179.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 27.5 tt0 178.96 -55.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.694 2.798 . . . . 3.2999999999999998 105.124 166.795 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -48.01 -37.7 15.39 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.937 2.095 . . . . 2.8399999999999999 111.212 173.619 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.7 m -38.09 -65.18 0.35 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.87 1.668 . . . . 2.1899999999999999 110.754 164.302 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.9 p -71.73 -42.74 66.92 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.378 -0.826 . . . . 2.2799999999999998 110.77 -176.138 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 132' ' ' GLU . 60.9 mttm -52.78 -51.34 61.08 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 123.528 0.731 . . . . 3.5600000000000001 110.837 -175.248 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.528 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 15.2 t -136.92 -48.34 0.61 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.246 -1.359 . . . . 2.75 111.906 176.162 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.11 25.7 0.08 OUTLIER Glycine 0 N--CA 1.473 1.119 0 CA-C-N 120.52 1.509 . . . . 1.21 115.642 177.107 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.28 0.4 OUTLIER 3.37 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.54 2.336 . . . . 4.6900000000000004 116.601 -167.693 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.86 70.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.55 1.54 . . . . 2.0 113.965 -177.605 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.79 171.55 44.85 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.055 -1.618 . . . . 1.1000000000000001 109.055 -160.119 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m -53.03 147.92 8.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.538 1.535 . . . . 2.0499999999999998 113.923 -170.342 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -54.79 136.62 46.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.844 1.258 . . . . 3.7799999999999998 108.645 166.79 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.2 mt -107.88 -64.88 1.16 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.335 -0.987 . . . . 1.8500000000000001 108.335 167.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.95 162.39 13.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.057 -0.974 . . . . 2.1899999999999999 110.847 -173.691 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.57 156.3 34.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.166 0.986 . . . . 1.9199999999999999 109.552 169.119 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.82 138.95 3.53 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 106.613 -2.595 . . . . 0.81999999999999995 106.613 172.909 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.63 132.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.551 -0.907 . . . . 2.0800000000000001 108.551 177.554 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.7 tt -86.17 134.12 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 122.832 0.453 . . . . 1.8400000000000001 111.252 -178.765 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 140.0 5.84 1.15 Allowed Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.166 0.889 . . . . 0.56999999999999995 114.236 175.796 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.75 55.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.713 1.757 . . . . 1.8100000000000001 110.062 -158.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.76 177.82 10.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.43 1.092 . . . . 2.23 109.873 170.089 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 103.449 -2.797 . . . . 6.2599999999999998 103.449 146.837 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.9 tttt . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 109.529 -0.545 . . . . 5.2999999999999998 109.529 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.42 156.09 44.65 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.168 0.987 . . . . 1.8999999999999999 108.945 154.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.45 150.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 106.674 -1.602 . . . . 1.9099999999999999 106.674 158.435 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.64 102.08 4.65 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 108.446 -0.946 . . . . 1.6899999999999999 108.446 157.102 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.15 102.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.208 -1.404 . . . . 1.9199999999999999 107.208 167.354 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -87.36 126.26 34.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.882 -1.155 . . . . 2.2999999999999998 107.882 177.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -150.92 -53.4 0.14 Allowed 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.481 0.312 . . . . 4.1900000000000004 110.629 -175.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.62 -114.33 1.05 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.763 1.173 . . . . 0.72999999999999998 112.986 -177.163 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -122.54 -52.45 1.92 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.496 1.118 . . . . 3.8100000000000001 110.724 -168.489 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.78 163.76 13.84 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.705 0.669 . . . . 0.84999999999999998 112.225 -175.067 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.45 64.35 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.271 3.314 . . . . 2.1299999999999999 110.864 -176.603 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t -141.64 146.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.752 2.021 . . . . 1.8500000000000001 106.4 -171.633 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -155.59 136.75 13.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.656 -0.868 . . . . 5.5199999999999996 108.656 176.812 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.77 174.58 44.63 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.129 -0.557 . . . . 0.59999999999999998 111.92 175.374 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.84 118.3 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.082 -1.081 . . . . 2.3399999999999999 108.082 -179.119 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.1 137.49 22.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 105.804 -1.925 . . . . 2.0600000000000001 105.804 165.065 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.33 58.73 1.66 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.742 -0.836 . . . . 2.8700000000000001 108.742 178.004 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.55 168.42 19.81 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.18 -1.008 . . . . 4.9100000000000001 112.162 -168.597 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -144.72 150.31 37.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.706 -1.133 . . . . 3.98 108.146 177.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.444 ' NE2' ' H ' ' A' ' 27' ' ' GLY . 32.6 tt0 -151.26 93.89 1.96 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.448 -1.251 . . . . 3.6200000000000001 108.229 167.506 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -49.21 -39.85 31.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.588 1.329 . . . . 6.0599999999999996 114.588 -178.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -87.21 148.89 24.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.461 1.104 . . . . 5.1100000000000003 110.239 -176.356 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -0.53 18.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.203 1.801 . . . . 3.6899999999999999 114.935 -173.678 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -170.13 53.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.844 1.656 . . . . 5.75 111.218 170.96 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' H ' ' NE2' ' A' ' 22' ' ' GLN . . . -108.42 -157.7 19.12 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.116 1.341 . . . . 1.48 110.722 178.193 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -89.34 141.37 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.06 3.84 . . . . 1.6399999999999999 111.053 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.17 136.18 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.916 -0.401 . . . . 2.21 109.916 -175.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -90.29 91.92 8.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.452 -0.944 . . . . 3.4500000000000002 108.452 173.815 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.4 t -90.57 86.0 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.764 0.826 . . . . 2.2000000000000002 110.419 -170.41 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -102.96 139.51 38.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.148 0.499 . . . . 0.93999999999999995 111.572 173.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.04 41.35 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.066 1.793 . . . . 0.68000000000000005 108.799 170.384 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.8 m -139.54 80.43 1.77 Allowed 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 107.702 -1.221 . . . . 2.9300000000000002 107.702 -176.752 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.78 119.42 33.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.908 -1.145 . . . . 1.8200000000000001 107.908 -169.091 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.92 162.02 13.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.395 0.678 . . . . 4.5099999999999998 110.705 -175.218 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.59 -10.77 64.85 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.819 0.687 . . . . 1.4399999999999999 114.819 167.276 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.3 154.94 4.09 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.868 1.334 . . . . 1.5900000000000001 110.87 176.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -65.59 153.13 42.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.94 -1.1 . . . . 2.25 108.231 158.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -52.74 156.24 2.01 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.344 1.057 . . . . 2.7999999999999998 112.073 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 -158.2 31.69 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.276 -0.874 . . . . 0.68000000000000005 112.683 167.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.91 142.54 36.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.882 0.873 . . . . 3.3399999999999999 110.891 -165.492 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -142.04 130.35 22.3 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.775 1.23 . . . . 0.83999999999999997 110.594 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 148.23 36.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.91 -0.876 . . . . 0.51000000000000001 110.91 170.783 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -146.91 96.72 2.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.275 1.43 . . . . 4.0700000000000003 107.798 -171.453 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.435 ' ND1' ' CD2' ' A' ' 120' ' ' HIS . 40.6 m80 -131.32 170.93 13.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.227 -0.657 . . . . 1.0900000000000001 109.227 -164.564 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.58 108.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.767 -1.198 . . . . 3.6899999999999999 107.767 173.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -81.52 168.0 18.72 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.0 -1.111 . . . . 1.1000000000000001 108.0 168.57 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.02 -96.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.642 -1.244 . . . . 4.7199999999999998 107.642 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 60' ' ' ALA . 4.1 mt-10 . . . . . 0 CA--C 1.533 0.32 0 C-N-CA 123.354 0.662 . . . . 3.2400000000000002 112.581 160.326 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.937 0.399 . . . . 3.5 111.921 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.31 -116.22 4.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 116.954 -2.025 . . . . 2.3300000000000001 109.142 -172.417 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.99 179.95 4.42 Favored 'Trans proline' 0 C--N 1.348 0.516 1 C-N-CA 125.337 4.025 . . . . 1.3100000000000001 115.359 -170.576 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -67.74 99.27 0.79 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.384 1.474 . . . . 1.4299999999999999 108.722 -179.231 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -9.52 102.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.127 2.171 . . . . 2.8199999999999998 113.744 172.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -124.47 136.8 28.23 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 127.458 2.303 . . . . 3.1000000000000001 108.13 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.51 -47.43 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.101 1.868 . . . . 1.26 109.218 174.812 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.0 -70.97 0.47 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.571 -1.27 . . . . 3.6499999999999999 107.571 170.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.2 t -154.6 90.79 1.34 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.345 -0.613 . . . . 3.2999999999999998 109.345 -178.552 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -84.64 165.66 17.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.39 -1.337 . . . . 5.5700000000000003 107.39 146.669 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -116.93 170.46 8.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.579 -1.637 . . . . 3.6800000000000002 106.579 174.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -84.33 157.17 21.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.083 0.468 . . . . 0.81000000000000005 110.808 -179.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.62 158.5 31.47 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 104.702 -3.359 . . . . 1.97 104.702 160.83 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.91 174.59 8.54 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.325 -1.11 . . . . 2.79 110.325 170.821 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.15 -29.7 89.7 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.045 1.83 . . . . 1.6399999999999999 110.176 169.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.87 -52.11 66.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.653 0.781 . . . . 4.6500000000000004 110.98 171.305 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -73.83 164.81 26.15 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.718 0.636 . . . . 2.1600000000000001 111.177 -178.169 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -89.48 -36.09 15.6 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.457 1.103 . . . . 5.54 112.674 -171.607 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -75.19 166.04 24.25 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.498 -1.297 . . . . 3.04 107.498 165.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 152.21 127.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.387 2.675 . . . . 4.3899999999999997 104.811 -161.142 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.0 m80 -58.48 149.92 23.98 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.863 -1.162 . . . . 0.58999999999999997 107.863 174.627 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.46 -32.79 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.07 -0.652 . . . . 1.79 109.848 -175.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.5 52.53 2.07 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.308 -0.718 . . . . 0.93000000000000005 113.114 165.642 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -127.42 117.17 21.64 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.186 1.493 . . . . 2.4199999999999999 108.275 164.201 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.39 -53.17 6.54 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.655 -0.869 . . . . 2.6099999999999999 108.655 161.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.62 -105.25 0.27 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.81 -0.71 . . . . 0.69999999999999996 112.95 175.218 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.36 155.52 32.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.876 1.271 . . . . 3.6600000000000001 109.059 -166.317 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.97 163.1 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.477 1.111 . . . . 1.97 110.41 -175.836 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 m -116.49 103.02 10.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.967 2.107 . . . . 3.8100000000000001 109.632 -169.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.11 135.38 36.83 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.669 -0.644 . . . . 1.71 112.225 176.4 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.58 -92.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.741 1.616 . . . . 4.0499999999999998 110.438 175.505 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -177.21 -26.71 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.658 1.983 . . . . 4.3300000000000001 112.548 -165.112 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -76.06 9.06 2.68 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.831 1.777 . . . . 3.7999999999999998 108.442 148.599 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.67 26.63 72.98 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 119.782 -1.824 . . . . 1.1100000000000001 109.996 178.154 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -84.11 108.48 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.219 -1.4 . . . . 2.48 107.219 -175.795 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.46 155.31 28.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.022 1.329 . . . . 1.95 109.129 171.636 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -102.81 58.49 0.78 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.325 2.25 . . . . 6.5199999999999996 107.765 -164.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.98 68.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.397 -0.819 . . . . 2.5899999999999999 110.792 -161.256 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -121.45 75.45 1.18 Allowed 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.79 1.636 . . . . 1.3799999999999999 108.796 179.099 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.0 mm -106.18 155.31 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.26 1.024 . . . . 2.8799999999999999 109.476 -174.613 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -146.5 122.89 10.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.13 -1.434 . . . . 3.3700000000000001 107.13 168.375 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.88 158.45 25.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.424 1.089 . . . . 2.1000000000000001 109.241 173.14 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -127.6 29.67 5.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.069 1.348 . . . . 1.8700000000000001 111.785 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.18 -49.3 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.667 -1.234 . . . . 2.0600000000000001 107.667 171.312 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.95 174.11 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.558 0.694 . . . . 1.9099999999999999 110.178 171.255 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -156.83 -179.89 8.64 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.178 -1.786 . . . . 2.9700000000000002 106.178 175.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.77 14.4 22.23 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 3.6800000000000002 112.197 173.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.455 -0.186 0 C-N-CA 124.509 1.124 . . . . 3.2599999999999998 108.929 -166.7 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.442 -0.83 0 CA-C-O 122.919 1.342 . . . . 2.2799999999999998 112.586 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.89 -6.94 10.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 114.702 -1.136 . . . . 3.0899999999999999 111.094 175.309 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 tp -44.26 131.65 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.331 1.052 . . . . 2.9100000000000001 110.386 172.088 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.87 -25.23 7.72 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.909 0.766 . . . . 1.5900000000000001 112.65 -176.441 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -87.18 162.93 17.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.758 1.279 . . . . 5.2000000000000002 110.333 -166.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -94.01 113.61 25.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.087 0.555 . . . . 2.1200000000000001 110.758 -172.544 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.21 141.28 52.56 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.385 -1.339 . . . . 3.0600000000000001 107.385 167.403 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.37 133.1 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 126.125 1.77 . . . . 1.71 109.211 175.653 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.1 t -98.13 122.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 125.799 1.64 . . . . 3.4500000000000002 106.929 165.213 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.435 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 64.9 m-70 -97.45 156.76 16.33 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 116.284 1.957 . . . . 0.44 116.284 -174.508 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -34.18 -90.39 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 130.232 3.413 . . . . 3.7000000000000002 112.211 168.06 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -174.49 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.873 0.845 . . . . 5.4800000000000004 109.418 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.54 154.93 10.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.556 -1.202 . . . . 2.3999999999999999 110.099 164.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.06 161.47 8.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.974 -1.012 . . . . 2.8900000000000001 108.93 158.182 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -86.64 -30.49 21.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.988 1.715 . . . . 3.0 111.081 177.183 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 76.16 -1.93 2.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.693 2.397 . . . . 2.79 112.982 -172.8 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.61 30.48 4.61 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.866 1.212 . . . . 1.4399999999999999 113.123 163.151 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -129.56 -16.62 3.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.881 1.272 . . . . 5.6699999999999999 112.823 -173.946 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.91 124.85 31.27 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.33 0.968 . . . . 3.0099999999999998 111.885 175.704 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.02 -29.83 62.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.604 0.621 . . . . 2.77 111.81 175.805 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -53.24 98.63 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.268 1.027 . . . . 2.4399999999999999 109.531 163.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -35.61 -43.26 0.27 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 127.013 2.125 . . . . 4.0199999999999996 113.458 -178.711 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -37.88 -37.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.107 1.763 . . . . 2.8199999999999998 112.668 175.31 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.2 t -50.72 -77.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.159 0.984 . . . . 2.9100000000000001 110.709 169.726 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 t -58.4 -38.32 77.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.771 -1.205 . . . . 3.52 110.959 -177.01 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -59.38 -51.43 69.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.323 1.049 . . . . 6.1600000000000001 110.887 -177.445 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.45 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.281 0.1 OUTLIER -129.72 -54.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.891 0.477 . . . . 2.1600000000000001 112.156 174.504 . . . . . . . . 4 4 . 1 . 034 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.64 -16.24 0.26 Allowed Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.073 0.851 . . . . 0.91000000000000003 113.252 179.078 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.87 52.22 9.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.316 . . . . 2.4500000000000002 110.718 -176.651 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.45 71.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.039 0.936 . . . . 2.0899999999999999 109.921 169.356 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 115.46 -172.09 14.04 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 106.99 -2.444 . . . . 0.93999999999999995 106.99 -168.419 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.6 m -60.93 155.35 20.07 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.388 1.475 . . . . 1.8400000000000001 113.049 -171.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -61.1 135.57 57.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.323 1.449 . . . . 4.0 108.867 169.538 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.2 mt -111.01 -76.57 0.6 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.678 1.126 . . . . 1.6100000000000001 108.753 168.859 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.05 140.41 37.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.205 -1.406 . . . . 1.6200000000000001 107.205 173.444 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 66.7 m -127.3 159.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.738 -1.578 . . . . 2.1099999999999999 106.738 173.285 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.93 132.85 2.59 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.81000000000000005 110.951 168.201 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.89 136.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.619 1.167 . . . . 1.8300000000000001 109.037 171.228 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.89 144.15 14.66 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.115 0 C-N-CA 123.222 0.609 . . . . 2.1499999999999999 111.653 -179.01 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.28 0.8 5.81 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.737 0.684 . . . . 0.80000000000000004 113.451 175.116 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.8 mm -87.82 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.499 1.149 . . . . 1.98 110.91 -161.187 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.28 175.06 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.335 1.054 . . . . 2.8199999999999998 110.22 171.489 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 104.271 -2.492 . . . . 5.21 104.271 167.244 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 111.353 0.131 . . . . 4.21 111.353 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.81 25.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.591 -1.262 . . . . 1.6799999999999999 107.591 161.058 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.9 t -103.88 145.11 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.778 -1.193 . . . . 1.8 107.778 165.206 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.95 97.65 5.04 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.77 -0.826 . . . . 1.55 108.77 155.696 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.06 107.81 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.925 -1.509 . . . . 1.8400000000000001 106.925 162.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.1 128.21 35.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.939 -1.134 . . . . 1.97 107.939 175.813 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -149.34 -52.02 0.16 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.965 0.412 . . . . 4.4100000000000001 110.663 172.278 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.71 -119.22 4.86 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.52 -0.764 . . . . 0.93000000000000005 111.526 -175.648 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.38 -42.66 2.65 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.806 1.242 . . . . 3.1000000000000001 110.353 -165.821 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.49 166.99 10.69 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 123.825 0.726 . . . . 0.83999999999999997 111.309 177.411 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.38 -21.65 53.62 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.407 2.738 . . . . 1.1599999999999999 111.993 179.584 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.6 t -50.01 141.77 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.828 1.251 . . . . 1.95 110.822 177.112 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.56 125.09 6.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.909 -1.145 . . . . 2.2999999999999998 107.909 -175.752 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.65 172.67 40.44 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 121.764 -0.585 . . . . 0.55000000000000004 112.52 -177.106 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.31 130.96 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.775 0.83 . . . . 2.52 108.877 176.577 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.24 137.9 23.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.497 -1.298 . . . . 1.9299999999999999 107.497 163.543 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -119.43 99.98 7.02 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.574 -1.269 . . . . 2.0099999999999998 107.574 166.952 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.66 118.02 26.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.698 1.199 . . . . 3.6099999999999999 108.566 -178.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -148.28 164.72 33.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.014 0.824 . . . . 3.6000000000000001 109.419 167.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.66 164.5 38.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.255 1.422 . . . . 4.6500000000000004 107.273 177.265 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -51.22 -46.72 62.33 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.987 0.915 . . . . 5.4800000000000004 112.076 178.728 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -114.31 164.02 14.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.715 -1.217 . . . . 5.8600000000000003 107.715 179.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.0 p -69.2 55.14 0.1 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.023 1.329 . . . . 4.0999999999999996 109.158 163.466 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 179.4 -153.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.578 1.951 . . . . 4.8099999999999996 106.619 -165.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.25 -178.09 0.4 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 127.191 2.329 . . . . 1.6399999999999999 115.268 175.022 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.72 110.23 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.601 2.867 . . . . 1.5600000000000001 109.917 -175.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.63 133.03 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.818 -0.353 . . . . 1.73 111.161 -164.655 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -95.97 101.76 13.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.99 -1.485 . . . . 4.25 106.99 -174.381 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.0 90.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.77 1.228 . . . . 2.0600000000000001 107.877 -173.287 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -97.77 131.41 44.32 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 123.738 0.649 . . . . 1.6599999999999999 109.271 169.425 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 163.21 30.79 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.177 -0.769 . . . . 0.78000000000000003 111.177 -179.422 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -133.4 99.82 4.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 2.9100000000000001 106.522 -171.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.15 140.59 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.534 1.134 . . . . 2.27 108.647 -169.775 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -145.0 -178.02 5.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.709 0.766 . . . . 4.5899999999999999 112.967 169.56 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.24 75.44 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.922 1.249 . . . . 0.58999999999999997 112.598 -179.025 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -77.62 -157.63 0.1 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.615 -0.883 . . . . 1.98 108.615 173.185 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.6 m -143.82 144.43 31.77 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.126 -2.546 . . . . 3.5099999999999998 104.126 168.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -40.87 138.04 1.11 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.723 2.409 . . . . 2.6899999999999999 112.857 -168.772 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.32 -171.38 29.45 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.128 -0.487 . . . . 0.69999999999999996 111.979 174.243 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.28 153.19 40.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.663 0.986 . . . . 3.4700000000000002 113.663 -163.155 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.99 126.55 14.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.218 1.807 . . . . 0.69999999999999996 109.323 -179.261 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.65 155.58 10.98 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.658 -0.977 . . . . 0.39000000000000001 110.658 165.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.38 92.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.143 1.377 . . . . 3.71 107.655 -170.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -134.45 161.91 33.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.785 -0.82 . . . . 0.80000000000000004 108.785 -161.03 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.3 m -113.58 140.75 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.906 0.775 . . . . 3.1000000000000001 109.11 168.99 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -111.52 172.06 7.11 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.282 1.033 . . . . 1.28 111.252 -168.825 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -58.02 -21.59 45.88 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.763 0.825 . . . . 5.9299999999999997 113.019 173.209 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 N--CA 1.452 -0.364 0 C-N-CA 126.655 1.982 . . . . 3.3700000000000001 111.133 -179.246 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 110.456 -0.201 . . . . 2.54 110.456 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.25 -91.39 1.56 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.312 -2.315 . . . . 1.8999999999999999 107.312 169.676 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 179.71 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 124.898 3.732 . . . . 1.3700000000000001 115.066 -176.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -82.25 60.64 5.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.297 1.439 . . . . 2.0099999999999998 110.44 -170.701 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.4 t80 53.6 72.69 0.42 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.048 1.339 . . . . 4.7300000000000004 108.323 -170.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -97.73 98.32 5.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 108.997 -0.742 . . . . 3.1600000000000001 108.997 175.22 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.06 -38.37 7.24 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.196 1.93 . . . . 2.3999999999999999 111.468 -173.559 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.72 -65.34 0.56 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.712 0.805 . . . . 4.2199999999999998 109.456 173.409 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 m -163.22 100.45 0.95 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.108 -1.441 . . . . 2.1400000000000001 107.108 -171.303 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.6 mmt-85 -126.23 163.0 24.15 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.18 0.992 . . . . 7.29 109.86 170.228 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -116.25 149.53 39.05 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.38 1.472 . . . . 4.0999999999999996 108.362 -172.527 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -78.43 153.57 31.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 112.509 -172.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.64 152.26 10.58 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 105.563 -3.015 . . . . 3.02 105.563 172.081 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.89 -133.99 7.05 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.067 -1.613 . . . . 2.1600000000000001 109.067 177.294 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.6 -52.3 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.768 1.646 . . . . 1.9399999999999999 110.212 173.706 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.94 -34.76 78.16 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.081 1.141 . . . . 5.8899999999999997 114.081 -167.072 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.73 175.83 2.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.698 0.285 . . . . 1.99 110.884 -174.582 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.83 -48.13 11.12 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 4.4000000000000004 109.102 168.074 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -79.64 171.04 15.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.804 0.842 . . . . 3.6699999999999999 110.439 -176.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 174.05 145.37 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.41 2.284 . . . . 4.2800000000000002 110.037 171.54 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.507 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.2 m80 -57.83 143.16 43.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.204 -1.776 . . . . 0.64000000000000001 106.204 160.113 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -52.59 -27.29 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.369 -0.378 . . . . 2.2200000000000002 110.589 174.545 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.55 28.76 12.38 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.49 -1.172 . . . . 0.92000000000000004 115.071 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -94.79 127.81 41.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.455 2.128 . . . . 2.3999999999999999 107.421 159.653 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.85 -54.34 4.95 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.113 -1.44 . . . . 2.8999999999999999 107.113 151.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 153.24 -116.44 0.74 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.394 -1.482 . . . . 0.80000000000000004 109.394 173.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -139.46 160.51 39.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.249 1.02 . . . . 2.4399999999999999 110.34 -174.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.86 178.09 5.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.451 -1.685 . . . . 1.78 106.451 171.245 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -129.99 147.1 51.7 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.559 -0.534 . . . . 3.0899999999999999 109.559 164.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.93 146.6 32.02 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.46 -0.941 . . . . 1.99 108.46 162.092 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.15 -88.47 0.09 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.524 1.14 . . . . 2.8900000000000001 109.619 177.187 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -137.54 -51.18 0.63 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.949 1.3 . . . . 5.0700000000000003 110.542 -174.399 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.92 15.49 1.79 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.846 1.308 . . . . 2.7000000000000002 111.635 -174.265 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.3 10.11 69.18 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.358 -0.838 . . . . 0.83999999999999997 111.309 -171.625 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.6 140.69 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.036 -1.468 . . . . 1.8600000000000001 107.036 173.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.86 175.9 7.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.073 0.949 . . . . 1.6299999999999999 109.262 174.267 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -110.59 148.42 32.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 103.732 -2.692 . . . . 3.9399999999999999 103.732 176.315 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.46 94.58 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.143 -1.058 . . . . 1.8400000000000001 108.143 153.16 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.7 m -122.04 76.99 1.34 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.217 1.407 . . . . 1.0800000000000001 109.287 170.818 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.42 157.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.574 -0.528 . . . . 2.5600000000000001 109.574 179.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -144.68 89.41 1.98 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.149 0.58 . . . . 3.0699999999999998 110.654 166.684 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.84 162.37 26.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.896 -0.409 . . . . 2.2000000000000002 109.896 172.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 p -124.67 7.17 8.18 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.019 1.328 . . . . 2.2400000000000002 113.159 179.321 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.88 -51.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 119.076 0.853 . . . . 2.1499999999999999 108.773 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.39 159.54 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.407 0.623 . . . . 2.0800000000000001 111.23 -177.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.1 p -120.06 177.4 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.266 2.226 . . . . 3.8500000000000001 107.632 175.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -112.26 27.62 9.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.36 0.664 . . . . 3.5299999999999998 110.944 166.767 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.409 -0.589 . . . . 3.3900000000000001 109.409 177.89 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 122.776 1.274 . . . . 1.9199999999999999 111.709 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -7.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.443 -1.708 . . . . 3.1800000000000002 110.836 170.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.8 mm -61.06 128.55 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 119.978 1.263 . . . . 3.3399999999999999 108.404 -177.481 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.38 33.38 84.39 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 112.036 -0.426 . . . . 1.6799999999999999 112.036 -171.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 163.94 12.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.262 -1.755 . . . . 5.6900000000000004 106.262 149.814 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.2 m -92.59 123.88 36.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.406 1.083 . . . . 1.8799999999999999 108.434 171.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -80.47 145.99 31.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.102 -1.073 . . . . 3.48 108.102 167.087 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.73 133.47 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 127.549 2.34 . . . . 1.6899999999999999 107.107 -177.62 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.41 118.34 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.564 -1.643 . . . . 2.8300000000000001 106.564 167.367 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -90.99 159.43 16.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.1 1.889 . . . . 0.34999999999999998 116.1 -168.572 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -33.01 -83.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.693 2.797 . . . . 3.3500000000000001 112.617 166.145 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -105.27 -179.23 3.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.542 0.737 . . . . 3.4300000000000002 109.591 -170.231 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.0 137.76 55.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.553 -0.906 . . . . 1.8300000000000001 108.553 167.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 160.95 30.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.622 -0.881 . . . . 2.1800000000000002 108.622 163.436 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -15.24 54.07 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.863 1.06 . . . . 3.5800000000000001 113.863 -170.353 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 64.45 4.23 2.16 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.739 -1.226 . . . . 2.4399999999999999 113.836 -173.022 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.28 60.39 1.06 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 121.242 1.837 . . . . 1.8799999999999999 111.434 167.208 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.82 -51.76 0.37 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.345 1.858 . . . . 6.4900000000000002 110.308 -175.592 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -43.84 122.69 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.619 1.58 . . . . 2.8399999999999999 113.181 -177.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.04 -22.99 65.47 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.365 0.507 . . . . 3.2400000000000002 112.79 179.234 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -65.43 102.83 0.74 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.982 0.891 . . . . 2.5 109.055 174.775 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -19.31 -64.34 0.02 OUTLIER 'General case' 0 C--N 1.341 0.236 0 C-N-CA 127.857 2.463 . . . . 3.48 113.899 -172.264 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -37.72 -42.98 0.61 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.549 2.34 . . . . 4.2999999999999998 112.568 -177.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.3 m -55.45 -55.1 35.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.198 0.999 . . . . 2.5099999999999998 111.685 177.14 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -71.18 -48.26 52.76 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.024 -1.048 . . . . 2.2999999999999998 110.231 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -65.97 -28.88 69.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.856 1.262 . . . . 5.5700000000000003 111.909 -170.241 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.507 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 1.2 t -137.45 -53.89 0.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.589 -1.196 . . . . 2.77 113.14 174.143 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.38 -18.52 1.33 Allowed Glycine 0 N--CA 1.468 0.83 0 CA-C-N 120.126 1.33 . . . . 0.97999999999999998 112.562 -179.88 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 46.6 54.12 9.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.199 1.8 . . . . 3.52 111.751 175.376 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.93 -36.74 56.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.377 0.608 . . . . 2.2200000000000002 110.591 168.728 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 -150.53 17.85 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 108.52 -1.832 . . . . 1.02 108.52 176.105 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.9 p -65.77 151.47 46.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.061 0.763 . . . . 3.3100000000000001 113.061 -164.035 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -60.81 139.46 57.93 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.809 -1.182 . . . . 3.8199999999999998 107.809 166.86 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -115.49 -77.41 0.57 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.749 -1.204 . . . . 1.54 107.749 173.504 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.91 157.9 17.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.197 -1.409 . . . . 2.0499999999999998 107.197 165.745 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.6 p -156.83 163.27 39.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.169 -1.832 . . . . 1.48 107.102 179.601 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.24 138.39 5.05 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.476 -1.05 . . . . 0.68999999999999995 110.476 179.418 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.06 133.9 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.368 1.067 . . . . 1.99 108.54 172.6 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.7 tt -100.11 132.84 44.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 122.769 0.428 . . . . 1.8899999999999999 111.508 -177.051 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.68 2.99 1.01 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.466 1.032 . . . . 0.63 114.675 179.379 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.6 mm -92.63 57.04 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 119.541 1.671 . . . . 1.8400000000000001 110.832 -157.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.1 173.45 16.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.804 . . . . 2.3799999999999999 109.518 166.305 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 C--O 1.255 1.388 0 N-CA-C 102.892 -3.003 . . . . 4.4100000000000001 102.892 162.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 105.385 -2.08 . . . . 6.6900000000000004 105.385 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.9 m 92.53 121.38 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 126.656 1.982 . . . . 3.6000000000000001 105.887 -162.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.32 144.97 26.57 Favored 'General case' 0 N--CA 1.458 -0.068 0 CA-C-N 118.149 0.431 . . . . 3.9100000000000001 111.288 -173.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.97 144.75 25.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.651 -1.24 . . . . 1.54 107.651 163.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 t -110.61 142.28 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.747 -0.835 . . . . 2.2599999999999998 108.747 167.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.01 97.47 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.069 -1.086 . . . . 1.75 108.069 156.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.14 107.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.723 -1.584 . . . . 1.8300000000000001 106.723 161.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.22 124.46 38.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.081 -1.081 . . . . 1.8899999999999999 108.081 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -135.22 -52.05 0.77 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.213 0.605 . . . . 5.0700000000000003 109.822 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.73 -121.97 4.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.811 -1.315 . . . . 0.79000000000000004 109.811 -170.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.89 -37.63 1.51 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.18 0.592 . . . . 3.0699999999999998 111.553 -162.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.27 162.3 18.98 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 110.972 -0.851 . . . . 0.81999999999999995 110.972 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.86 58.95 6.23 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.15 3.234 . . . . 1.78 111.22 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -132.71 152.63 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 127.353 2.261 . . . . 1.8400000000000001 107.269 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -155.04 133.77 12.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.49 -1.3 . . . . 2.9300000000000002 107.49 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.41 168.83 40.21 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.789 -0.72 . . . . 0.5 112.785 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.86 125.67 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 2.21 107.345 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.7 136.55 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.883 -1.525 . . . . 1.8100000000000001 106.883 161.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -116.26 106.99 14.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.7 -1.593 . . . . 2.2200000000000002 106.7 165.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.74 120.11 32.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 3.71 106.877 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.62 163.17 33.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.102 0.953 . . . . 3.46 109.935 163.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -156.85 153.82 28.85 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.979 2.112 . . . . 3.1899999999999999 105.405 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -63.42 -62.43 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.323 0.965 . . . . 6.5499999999999998 110.375 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 6.0 mp0 -90.9 -162.38 0.9 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 126.802 2.041 . . . . 4.4100000000000001 111.282 -167.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 m -101.69 -68.55 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.643 1.577 . . . . 3.1499999999999999 107.215 158.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -73.58 76.55 1.48 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.526 1.131 . . . . 5.8499999999999996 110.72 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.36 179.35 43.2 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 110.343 -1.103 . . . . 1.4399999999999999 110.343 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.21 126.06 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.776 2.984 . . . . 1.22 112.123 -170.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.19 140.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.427 -0.583 . . . . 1.9299999999999999 109.427 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -103.74 99.04 8.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.547 -1.649 . . . . 3.6600000000000001 106.547 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.44 120.91 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.006 -1.479 . . . . 1.9199999999999999 107.006 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -130.92 140.34 50.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.8 -1.185 . . . . 1.0600000000000001 107.8 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.21 23.71 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.088 -1.205 . . . . 0.75 110.088 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 p -130.04 67.59 1.46 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.088 1.355 . . . . 2.5099999999999998 107.726 -163.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -81.6 139.53 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.541 -1.209 . . . . 1.6899999999999999 108.323 -175.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -134.94 169.53 17.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.452 1.279 . . . . 5.2300000000000004 114.452 170.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 -1.68 79.1 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 114.227 -1.351 . . . . 1.04 113.803 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -56.09 158.83 3.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.668 1.234 . . . . 1.8200000000000001 110.31 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.82 160.55 11.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.375 -0.972 . . . . 2.4500000000000002 108.375 154.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -60.88 174.04 0.68 Allowed 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.57 -0.706 . . . . 2.6000000000000001 110.822 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.26 -162.19 54.48 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.993 -0.549 . . . . 0.52000000000000002 112.541 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.17 146.69 47.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.37 0.668 . . . . 3.27 111.973 -171.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -144.74 119.3 9.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.486 1.515 . . . . 0.68000000000000005 109.408 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.15 147.83 8.96 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.155 -1.178 . . . . 0.34999999999999998 110.155 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.29 96.04 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.502 -1.295 . . . . 4.0800000000000001 107.502 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -130.91 146.6 52.38 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.99 -1.115 . . . . 0.80000000000000004 107.99 -162.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.75 104.91 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 122.09 0.948 . . . . 2.6800000000000002 109.542 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.71 161.87 18.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.245 -1.391 . . . . 0.82999999999999996 107.245 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -51.3 -103.39 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.124 1.77 . . . . 5.46 112.76 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 50.21 67.11 0.97 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.366 0.666 . . . . 2.9700000000000002 112.784 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -73.99 -107.39 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.48 1.112 . . . . 5.1299999999999999 111.138 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -85.12 59.37 5.58 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.135 1.774 . . . . 6.4400000000000004 110.482 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.01 -53.91 6.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.435 0.636 . . . . 5.3200000000000003 110.13 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -170.22 -55.21 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.321 2.248 . . . . 4.9500000000000002 106.783 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -170.37 -53.01 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.16 1.384 . . . . 6.4000000000000004 109.632 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.25 -148.89 12.91 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.328 -1.109 . . . . 4.96 110.328 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.5 m -58.4 149.1 25.77 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.084 0.954 . . . . 3.0499999999999998 110.406 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.41 7.74 0.2 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.117 1.525 . . . . 5.9800000000000004 115.117 161.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.4 m -176.0 -40.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 118.54 2.793 . . . . 2.8599999999999999 118.54 -126.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.16 154.13 20.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.215 1.006 . . . . 2.6000000000000001 110.658 -170.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.86 -88.32 1.27 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.152 -1.579 . . . . 1.3500000000000001 109.152 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.57 179.0 4.47 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.948 3.099 . . . . 1.4099999999999999 114.06 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -84.84 59.05 5.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.308 -1.315 . . . . 1.75 109.47 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.5 t80 50.17 68.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.828 . . . . 3.5099999999999998 109.818 -172.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -83.21 115.17 57.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.218 -0.896 . . . . 3.29 108.759 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.18 -37.12 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.148 1.898 . . . . 1.75 111.157 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 tt -155.84 -65.7 0.11 Allowed 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.945 -1.131 . . . . 3.8399999999999999 107.945 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -154.95 71.45 0.8 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.705 0.802 . . . . 2.27 109.379 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.56 161.34 27.08 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.946 -0.761 . . . . 5.3499999999999996 108.946 165.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 28.2 mttt -109.71 155.72 21.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.809 -1.552 . . . . 4.1399999999999997 106.809 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -74.85 164.06 26.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0700000000000001 110.587 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.01 148.46 9.28 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 105.447 -3.061 . . . . 2.5699999999999998 105.447 169.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.26 -155.46 4.99 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.444 -1.062 . . . . 1.95 110.444 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.71 -46.87 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.728 1.618 . . . . 1.4399999999999999 108.756 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.62 -36.26 75.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.265 1.426 . . . . 5.1799999999999997 113.039 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.95 165.93 1.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.927 0.491 . . . . 2.6600000000000001 110.737 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -79.61 -46.96 16.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.884 1.674 . . . . 4.2699999999999996 109.512 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 44.7 mt-10 -93.47 177.1 6.14 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.209 1.404 . . . . 3.1499999999999999 110.812 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 177.33 160.57 0.44 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 128.55 2.74 . . . . 4.25 106.82 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 51.0 m80 -71.51 152.14 43.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.241 -1.763 . . . . 0.70999999999999996 106.241 162.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.49 39.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.4 1.095 . . . . 2.2799999999999998 111.128 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.51 37.27 0.29 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 128.331 2.872 . . . . 1.2 110.62 166.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.05 140.57 50.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.427 1.614 . . . . 2.29 110.451 157.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.31 -51.22 4.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.708 -1.219 . . . . 2.7000000000000002 107.708 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.45 -103.41 0.23 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.649 -0.98 . . . . 0.68000000000000005 110.649 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -152.16 169.28 22.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.305 1.842 . . . . 2.6600000000000001 110.461 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.06 176.04 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.649 1.58 . . . . 1.6200000000000001 107.034 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.4 m -125.33 126.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.934 -1.135 . . . . 2.7999999999999998 107.934 174.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.17 141.4 29.58 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.127 0.971 . . . . 1.77 111.818 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.11 -90.38 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.153 0.908 . . . . 2.6499999999999999 110.855 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 93' ' ' GLY . 5.6 tttp -158.23 -34.37 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.243 0.831 . . . . 4.8399999999999999 113.243 -161.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -79.34 17.93 0.76 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 123.797 1.761 . . . . 3.4300000000000002 110.178 158.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 63.78 17.22 60.24 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 125.189 1.376 . . . . 0.96999999999999997 111.808 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.38 119.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.515 -1.291 . . . . 1.75 107.515 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.51 174.24 6.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.444 1.098 . . . . 1.74 109.292 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -132.49 91.24 2.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.196 -2.15 . . . . 3.6899999999999999 105.196 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.1 59.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.775 -0.824 . . . . 2.3199999999999998 108.775 -168.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m -96.56 104.15 16.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.758 1.223 . . . . 1.3700000000000001 109.453 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.02 153.31 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.393 -0.965 . . . . 2.9100000000000001 108.393 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -140.14 82.16 1.85 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.302 0.641 . . . . 2.7799999999999998 109.914 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.52 160.36 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.851 0.46 . . . . 2.1000000000000001 110.969 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.4 p -121.11 4.39 10.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.573 1.549 . . . . 1.9299999999999999 113.16 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.66 -50.43 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.28 0.945 . . . . 2.1899999999999999 109.065 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pp -77.57 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.425 0.631 . . . . 2.0800000000000001 111.043 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -153.66 175.1 13.64 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.746 1.618 . . . . 2.6200000000000001 107.502 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.87 38.72 4.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.726 0.811 . . . . 3.52 111.144 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 t -99.1 -58.39 1.95 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.716 1.206 . . . . 3.5099999999999998 109.782 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.53 -176.72 40.36 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 108.42 -1.872 . . . . 3.7400000000000002 108.42 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 55.1 -105.6 0.28 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 117.882 0.841 . . . . 3.7000000000000002 110.93 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -76.9 -13.38 59.99 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.753 1.16 . . . . 6.0099999999999998 111.814 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.6 m -53.35 158.36 1.7 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 119.092 0.86 . . . . 3.0099999999999998 111.279 167.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.257 1.3 pp -95.97 -7.84 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.266 0.469 . . . . 2.6499999999999999 112.266 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.7 tt -45.57 137.03 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.503 0.721 . . . . 3.0600000000000001 110.494 167.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.07 -30.78 6.4 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.727 0.679 . . . . 1.5600000000000001 112.253 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -81.1 166.23 20.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.734 1.267 . . . . 6.5300000000000002 109.897 -168.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.0 m -93.06 108.61 20.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.085 0.469 . . . . 1.8200000000000001 110.586 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -68.45 148.74 50.19 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.704 -0.85 . . . . 2.6200000000000001 108.704 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.98 137.77 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.894 1.677 . . . . 1.6299999999999999 108.342 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.37 128.33 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.017 -1.105 . . . . 2.6099999999999999 108.017 166.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -104.8 160.85 14.66 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.121 2.267 . . . . 0.41999999999999998 117.121 -169.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -50.82 -71.96 0.06 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.833 2.053 . . . . 3.3399999999999999 111.902 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -94.3 -178.22 4.53 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.174 0.897 . . . . 3.73 110.239 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.97 151.08 27.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.643 -0.873 . . . . 1.5800000000000001 108.643 161.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.53 169.02 18.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.434 -0.58 . . . . 1.97 109.434 163.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.08 -25.78 63.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.471 0.915 . . . . 3.9399999999999999 113.471 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 72.63 -13.71 0.63 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.111 2.164 . . . . 2.6099999999999999 113.006 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.54 5.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.949 1.25 . . . . 2.2000000000000002 110.666 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -91.57 -31.38 15.93 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.501 1.12 . . . . 6.4900000000000002 109.212 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.67 62.78 3.09 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.784 -1.326 . . . . 3.46 109.784 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.52 -31.42 57.29 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.563 -1.015 . . . . 4.5800000000000001 110.563 164.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 132' ' ' GLU . 1.3 p-10 -141.42 -78.54 0.27 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.421 0.611 . . . . 2.6499999999999999 111.622 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.421 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 13.5 tt0 179.56 -54.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.335 1.454 . . . . 3.5899999999999999 109.624 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -45.9 -31.4 2.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.7 0.8 . . . . 4.4000000000000004 110.735 167.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -29.57 -77.13 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.821 2.048 . . . . 2.0699999999999998 113.534 155.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 p -71.63 -39.38 70.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 120.884 -1.135 . . . . 2.1899999999999999 109.447 -175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -55.28 -51.37 66.88 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.104 0.411 . . . . 4.4800000000000004 111.463 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.496 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.337 1.0 OUTLIER -128.9 -47.92 1.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.361 0.874 . . . . 2.25 113.361 175.175 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.15 -5.46 0.39 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.577 1.08 . . . . 0.91000000000000003 115.366 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.3 t30 36.25 57.13 1.05 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.274 1.83 . . . . 2.54 113.549 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.55 -32.75 74.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.339 0.866 . . . . 2.2599999999999998 113.339 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.53 174.47 50.01 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.312 -1.515 . . . . 1.0600000000000001 109.312 -159.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 m -54.92 154.09 5.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.274 1.43 . . . . 2.0499999999999998 113.961 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -77.41 142.69 39.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 3.8500000000000001 109.897 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 mt -120.32 -72.64 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.694 -0.854 . . . . 1.53 108.694 -174.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.77 149.25 41.1 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.042 0.937 . . . . 1.9199999999999999 108.494 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.04 170.48 20.43 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.054 1.471 . . . . 1.55 109.178 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.43 147.19 6.36 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.642 -1.383 . . . . 0.88 109.642 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.46 135.25 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.27 1.028 . . . . 1.6000000000000001 109.065 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.1 tt -92.63 140.03 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.144 0.424 . . . . 1.76 112.144 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.68 7.42 1.03 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.579 1.085 . . . . 0.62 114.315 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.3 mm -98.65 57.0 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.229 -0.025 0 CA-C-N 119.55 1.675 . . . . 2.02 109.917 -154.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.65 176.93 11.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.823 0.849 . . . . 2.71 109.452 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 103.267 -2.864 . . . . 4.8300000000000001 103.267 154.184 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 108.426 -0.953 . . . . 6.7400000000000002 108.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m -59.45 133.01 55.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.64 -0.874 . . . . 3.46 108.64 170.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -125.63 141.41 52.04 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.917 0.887 . . . . 3.3199999999999998 111.09 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.27 147.18 24.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.257 -1.016 . . . . 1.77 108.257 163.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.49 152.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 106.164 -1.791 . . . . 1.99 106.164 157.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.2 96.3 3.25 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.9 -0.778 . . . . 1.5600000000000001 108.9 160.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.26 110.32 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.352 -1.351 . . . . 2.2200000000000002 107.352 168.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.4 mt -93.85 122.84 36.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.919 -0.771 . . . . 2.23 108.919 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.77 -47.97 0.46 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.857 0.863 . . . . 4.9400000000000004 110.578 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.83 -123.47 1.97 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.744 1.164 . . . . 0.92000000000000004 112.779 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -59.52 1.85 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 3.7599999999999998 108.52 -172.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.03 172.19 1.77 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.074 2.274 . . . . 1.04 114.518 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.43 -25.68 48.39 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.606 2.871 . . . . 1.48 111.906 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.6 t -51.33 141.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.225 1.01 . . . . 1.6899999999999999 110.851 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -152.25 92.75 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.83 1.652 . . . . 2.5600000000000001 107.432 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.77 21.17 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.031 0.824 . . . . 0.79000000000000004 111.867 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.41 131.91 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.294 -1.002 . . . . 2.4399999999999999 108.294 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 mm -102.2 147.59 8.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.632 1.573 . . . . 1.97 107.954 165.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.64 118.51 24.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.57 -2.011 . . . . 1.71 105.57 162.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -127.95 116.53 20.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.876 -1.898 . . . . 4.9500000000000002 105.876 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 163.88 39.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.274 0.559 . . . . 3.6499999999999999 111.971 -170.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 -177.84 6.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.69 -1.596 . . . . 3.8300000000000001 106.69 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -77.73 -63.22 1.43 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.861 -0.792 . . . . 7.2599999999999998 108.861 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.33 165.62 14.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.828 1.251 . . . . 4.9400000000000004 109.569 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -81.0 -0.78 41.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.765 0.654 . . . . 3.5299999999999998 112.765 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -161.47 83.04 0.61 Allowed 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 121.723 -0.611 . . . . 4.7400000000000002 110.225 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.18 169.74 42.43 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 105.827 -2.909 . . . . 1.6599999999999999 105.827 171.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.42 114.82 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.587 2.858 . . . . 1.8400000000000001 112.584 -165.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.32 142.65 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.82 -0.627 . . . . 1.75 109.951 -168.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -95.66 122.46 38.45 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.736 -0.839 . . . . 3.2400000000000002 108.736 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.72 97.39 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.705 1.602 . . . . 1.98 107.727 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -113.76 148.81 35.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.273 -0.64 . . . . 0.91000000000000003 109.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.87 160.46 34.06 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 120.991 -1.068 . . . . 0.73999999999999999 110.964 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.2 p -129.77 113.51 14.8 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 105.486 -2.042 . . . . 2.2400000000000002 105.486 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.74 142.1 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.844 -1.91 . . . . 2.0800000000000001 105.844 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.56 153.49 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.875 -0.516 . . . . 6.4000000000000004 110.368 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.94 21.01 51.98 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.914 1.245 . . . . 0.64000000000000001 112.401 -171.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.14 -168.16 0.37 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.335 1.064 . . . . 1.95 108.753 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.0 m -135.93 166.32 23.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 103.814 -2.662 . . . . 3.9900000000000002 103.814 159.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.24 175.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.763 1.625 . . . . 2.8999999999999999 114.649 -166.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.04 -170.66 54.72 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 114.975 -1.011 . . . . 1.51 112.284 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.37 152.52 27.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.379 1.071 . . . . 3.6400000000000001 110.528 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -145.51 112.83 6.18 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.835 1.254 . . . . 0.65000000000000002 109.277 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.26 150.37 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.835 -0.906 . . . . 0.54000000000000004 110.835 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -142.95 94.49 2.64 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.917 -1.512 . . . . 4.1200000000000001 106.917 -171.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -131.98 162.72 30.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.533 -1.284 . . . . 1.27 107.533 -164.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 m -134.97 115.26 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.721 0.691 . . . . 3.6600000000000001 109.624 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -104.69 150.77 24.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.894 1.277 . . . . 1.1599999999999999 110.561 -164.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.78 66.83 0.37 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.071 1.748 . . . . 5.0700000000000003 112.414 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.5 110.51 11.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.577 -1.638 . . . . 3.3399999999999999 106.577 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -153.31 0.09 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.31 0.644 . . . . 5.8799999999999999 109.753 171.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -88.84 115.22 26.23 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.825 1.193 . . . . 7.4699999999999998 110.035 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -152.79 -84.15 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.066 0.946 . . . . 6.0199999999999996 111.245 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.8 m -145.31 133.5 21.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.314 -1.365 . . . . 5.1100000000000003 107.314 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 127.94 34.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.184 -0.672 . . . . 5.5800000000000001 109.184 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.01 52.0 0.05 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.566 -1.413 . . . . 5.1100000000000003 109.566 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.5 m -74.79 29.49 0.09 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.034 0.934 . . . . 3.3599999999999999 113.313 -164.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -79.3 -12.32 59.94 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 119.859 -1.775 . . . . 6.3300000000000001 113.69 -175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.3 m 177.69 68.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 118.861 -1.135 . . . . 6.4699999999999998 112.288 -115.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.61 -86.49 0.17 Allowed 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 122.588 0.355 . . . . 3.3999999999999999 111.02 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.96 -178.35 44.76 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.389 -1.084 . . . . 3.1899999999999999 110.389 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.73 179.35 5.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.085 3.857 . . . . 1.79 113.331 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -62.17 57.57 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.189 2.596 . . . . 2.0699999999999998 113.299 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.0 t80 35.88 77.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.341 1.056 . . . . 3.73 111.016 -160.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -93.74 106.02 19.45 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 108.457 -0.942 . . . . 3.02 108.457 171.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.69 -33.37 10.5 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.286 1.99 . . . . 1.55 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -155.33 -66.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.537 -0.912 . . . . 4.3200000000000003 108.537 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.6 m -154.4 74.71 0.97 Allowed 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.63 -0.669 . . . . 2.0699999999999998 110.36 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -78.31 161.29 27.33 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.699 -0.852 . . . . 6.1600000000000001 108.699 166.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -107.62 148.53 29.21 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.452 1.101 . . . . 5.3600000000000003 108.326 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -78.18 159.64 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.767 -0.373 . . . . 1.1699999999999999 110.691 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.52 160.72 33.02 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 107.448 -2.261 . . . . 2.3300000000000001 107.448 161.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.33 -176.86 29.11 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 117.715 0.758 . . . . 2.4100000000000001 111.342 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.49 -29.2 37.7 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.104 1.869 . . . . 3.1400000000000001 110.43 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -64.81 -43.45 93.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.329 0.651 . . . . 6.21 111.202 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -63.48 147.77 50.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.299 1.047 . . . . 2.5899999999999999 112.183 -168.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.27 -50.78 71.82 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.819 -1.082 . . . . 4.4900000000000002 108.242 167.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -78.02 164.98 24.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.155 0.982 . . . . 3.8500000000000001 110.574 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.37 147.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 C-N-CA 129.255 3.022 . . . . 4.3399999999999999 108.751 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -65.44 152.51 43.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 119.504 -0.878 . . . . 0.96999999999999997 109.986 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.12 -5.98 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 O-C-N 121.894 -0.504 . . . . 2.3399999999999999 112.307 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.2 50.96 0.77 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.058 -1.026 . . . . 1.3899999999999999 111.772 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.25 123.06 1.88 Allowed 'General case' 0 C--O 1.227 -0.087 0 O-C-N 120.811 -1.406 . . . . 2.96 110.089 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.13 -52.45 4.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.652 -0.499 . . . . 3.2999999999999998 109.652 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.39 -101.41 0.19 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.068 -1.063 . . . . 0.89000000000000001 111.99 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -155.11 166.03 34.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.084 1.353 . . . . 3.0800000000000001 111.327 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.9 179.71 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.308 1.843 . . . . 1.8400000000000001 106.165 162.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 t -134.32 145.17 48.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.568 -1.271 . . . . 3.3799999999999999 107.568 163.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.22 143.18 35.58 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.601 0.563 . . . . 1.98 109.618 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.76 -69.64 0.23 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.474 0.709 . . . . 3.3300000000000001 109.918 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -168.35 -55.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.789 2.036 . . . . 5.1299999999999999 108.53 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.21 29.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.922 1.344 . . . . 4.8200000000000003 110.244 -170.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.13 17.61 72.14 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.59 1.091 . . . . 1.0800000000000001 112.386 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.4 152.33 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.461 -1.311 . . . . 1.95 107.461 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.26 167.22 22.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.495 -1.298 . . . . 1.7 107.495 161.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.05 148.95 51.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.668 -2.345 . . . . 2.8399999999999999 104.668 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.6 136.48 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 107.614 -1.254 . . . . 2.1000000000000001 107.614 164.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.0 m -156.95 70.4 0.63 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.545 1.538 . . . . 1.3899999999999999 108.168 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.58 155.3 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.942 0.897 . . . . 2.98 109.088 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.6 134.71 29.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.393 -0.595 . . . . 2.71 109.393 145.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -128.64 165.31 21.07 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.332 1.053 . . . . 2.8500000000000001 109.539 170.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 p -104.08 8.0 36.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.078 1.751 . . . . 2.1899999999999999 112.287 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.4 t -90.53 -49.15 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.368 -0.975 . . . . 2.4399999999999999 108.368 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.259 0.4 OUTLIER -84.19 175.82 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.05 0.452 . . . . 2.6000000000000001 111.574 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -160.97 169.12 23.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.325 1.05 . . . . 3.4399999999999999 109.25 -166.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.7 mp -85.67 -25.79 26.35 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.483 1.113 . . . . 3.9700000000000002 111.907 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.0 t -154.98 -176.18 5.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.951 1.7 . . . . 4.6600000000000001 107.47 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.86 168.06 24.61 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.969 0.795 . . . . 4.1399999999999997 111.696 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -32.27 -53.45 0.3 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 128.828 2.851 . . . . 5.2999999999999998 114.676 -169.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -79.13 -23.27 44.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.575 -0.726 . . . . 4.75 112.608 -171.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.0 p -51.3 147.01 6.15 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 122.082 0.944 . . . . 1.8799999999999999 113.409 -165.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 pp -91.02 -6.3 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.018 -1.446 . . . . 2.5499999999999998 109.825 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 tp -43.86 123.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.897 0.879 . . . . 2.6800000000000002 109.465 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.9 32.53 84.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.926 -0.654 . . . . 1.49 113.093 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -98.32 174.96 6.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.282 -1.007 . . . . 6.4199999999999999 108.282 152.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 m -105.58 117.16 33.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.778 1.231 . . . . 2.0299999999999998 108.283 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.3 150.62 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.008 -0.738 . . . . 3.7799999999999998 109.008 171.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -140.7 134.6 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.918 1.287 . . . . 1.6399999999999999 107.702 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.33 128.37 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.865 -1.531 . . . . 2.73 106.865 164.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -98.32 160.02 14.56 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 115.182 1.549 . . . . 0.60999999999999999 115.182 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.16 -72.15 0.06 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.138 1.775 . . . . 4.2800000000000002 111.787 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -101.21 -177.71 3.53 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.441 0.696 . . . . 3.8599999999999999 110.038 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.89 151.35 18.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.043 -0.725 . . . . 1.9299999999999999 109.043 165.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.14 176.33 4.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.321 -0.992 . . . . 1.9199999999999999 108.321 159.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.65 -28.38 66.83 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 3.98 114.351 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 81.55 -7.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.244 2.618 . . . . 3.27 113.475 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.12 31.64 11.7 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.82 1.191 . . . . 2.6600000000000001 110.477 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -35.36 32.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 128.224 2.61 . . . . 7.8700000000000001 108.229 168.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.13 41.88 30.6 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.655 1.122 . . . . 4.25 111.253 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.64 35.64 1.61 Allowed Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.538 1.169 . . . . 3.9100000000000001 114.299 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.6 p30 177.64 -89.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.455 1.902 . . . . 3.21 108.703 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.38 -57.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.296 1.838 . . . . 2.9399999999999999 107.137 -173.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -56.42 -34.37 66.71 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.745 1.218 . . . . 3.8599999999999999 110.883 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.1 m -41.84 -68.77 0.16 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.898 1.279 . . . . 2.1899999999999999 112.087 167.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -43.78 69.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.3 -0.875 . . . . 2.7999999999999998 110.059 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -57.81 -42.86 85.12 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.104 0.962 . . . . 3.21 111.647 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . 0.255 4.2 p -132.53 -52.28 0.94 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.676 0.621 . . . . 2.75 112.676 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.52 -25.13 0.66 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 124.092 0.854 . . . . 0.91000000000000003 112.171 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t30 41.55 56.2 3.32 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.92 1.688 . . . . 2.4700000000000002 111.06 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 -50.55 18.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.293 -0.963 . . . . 1.8400000000000001 108.992 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 132.11 -151.95 20.02 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 107.427 -2.269 . . . . 1.6200000000000001 107.427 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 t -67.76 -179.71 1.21 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.326 1.06 . . . . 3.6200000000000001 111.98 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -105.44 152.23 23.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.611 2.364 . . . . 4.21 111.405 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.5 -85.27 0.66 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.371 -1.344 . . . . 1.8600000000000001 107.371 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.17 155.23 17.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.173 -1.047 . . . . 2.0899999999999999 108.173 164.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 18.5 p -146.93 168.09 22.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.107 -1.406 . . . . 2.02 107.776 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.99 140.93 4.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.126 -1.19 . . . . 0.75 110.126 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.93 137.98 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.897 0.879 . . . . 1.9299999999999999 108.96 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.0 tt -101.43 125.43 55.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.205 0.526 . . . . 2.0800000000000001 111.231 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.21 8.87 0.42 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.539 1.066 . . . . 0.66000000000000003 114.306 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.11 55.39 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 120.116 1.958 . . . . 1.96 110.19 -161.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.87 176.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.563 1.145 . . . . 2.0499999999999998 109.412 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 102.844 -3.021 . . . . 5.2599999999999998 102.844 150.895 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 118.736 -0.649 . . . . 9.1099999999999994 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.3 p -70.85 -177.05 1.48 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.566 1.146 . . . . 4.7699999999999996 110.279 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.8 pttm -78.51 175.09 10.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.505 -0.554 . . . . 3.4100000000000001 109.505 158.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.5 153.41 48.78 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.909 2.083 . . . . 1.8 108.148 167.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -118.87 143.12 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.412 -1.329 . . . . 1.76 107.412 170.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.95 99.83 6.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.141 1.376 . . . . 1.6599999999999999 108.996 156.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 113.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.573 -1.269 . . . . 1.76 107.573 159.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.71 125.12 49.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.359 1.064 . . . . 2.0099999999999998 109.056 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -132.23 -53.2 0.96 Allowed 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.409 0.684 . . . . 4.8799999999999999 110.215 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.43 -124.14 13.86 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.036 0.827 . . . . 0.93000000000000005 113.832 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -114.12 -52.47 2.73 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.867 1.267 . . . . 3.7999999999999998 108.859 -158.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.05 160.52 26.45 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 110.295 -1.122 . . . . 0.96999999999999997 110.295 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.52 40.59 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.72 2.946 . . . . 1.01 112.711 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.04 156.18 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.807 1.643 . . . . 2.0 108.934 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -153.63 93.0 1.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.523 -0.917 . . . . 3.3300000000000001 108.523 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.91 162.53 14.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 124.03 0.824 . . . . 0.79000000000000004 111.462 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.8 mt -130.95 120.56 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 106.532 -1.655 . . . . 2.3199999999999998 106.532 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.4 mm -84.23 146.37 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.319 1.048 . . . . 1.8999999999999999 108.221 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -124.85 101.18 6.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.244 -1.761 . . . . 2.4700000000000002 106.244 166.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.66 91.09 5.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.245 -2.132 . . . . 3.3700000000000001 105.245 166.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.39 140.84 31.28 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.824 -1.547 . . . . 3.6600000000000001 106.824 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -157.96 151.36 23.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.759 -1.941 . . . . 3.8999999999999999 105.759 167.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.91 -65.31 1.18 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.072 0.851 . . . . 7.9400000000000004 108.769 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -78.97 119.23 21.83 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.583 -0.895 . . . . 5.1799999999999997 108.583 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 m -35.4 -64.11 0.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.403 2.681 . . . . 3.0 113.815 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.0 37.21 0.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.582 -0.699 . . . . 4.5099999999999998 111.114 177.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.67 167.34 22.17 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.322 0.963 . . . . 1.75 111.291 -174.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.7 139.21 51.92 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.458 2.772 . . . . 1.71 112.019 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -89.32 126.71 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.305 -0.998 . . . . 1.96 108.305 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -83.6 98.86 9.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.436 -1.69 . . . . 3.54 106.436 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.25 85.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.746 1.618 . . . . 2.3100000000000001 107.387 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -98.61 162.13 13.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.204 -0.665 . . . . 1.3 109.204 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.41 153.57 23.15 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.834 -0.906 . . . . 0.83999999999999997 110.834 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 p -121.98 79.43 1.58 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.245 1.418 . . . . 3.0299999999999998 107.488 -171.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -96.99 125.2 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.69 1.196 . . . . 1.96 108.934 -170.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.73 158.58 43.77 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.711 -0.477 . . . . 5.8799999999999999 109.711 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.52 19.52 48.53 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.675 1.607 . . . . 0.69999999999999996 113.34 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.83 170.28 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.648 -0.913 . . . . 1.72 108.962 170.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.1 163.39 27.98 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.711 -1.218 . . . . 2.4100000000000001 107.711 149.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -61.63 175.91 0.57 Allowed 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.382 -0.824 . . . . 3.3500000000000001 111.03 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.62 -165.54 52.2 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.272 0.939 . . . . 0.55000000000000004 112.607 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.52 141.99 58.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.802 1.241 . . . . 2.9700000000000002 113.045 -174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -143.12 118.38 10.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.756 1.622 . . . . 0.66000000000000003 108.592 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.46 149.3 2.14 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.751 -0.939 . . . . 0.40999999999999998 110.751 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -139.91 94.16 2.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.327 -1.731 . . . . 4.4500000000000002 106.327 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.438 ' ND1' ' CD2' ' A' ' 120' ' ' HIS . 26.5 m80 -138.86 153.49 48.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.723 -1.584 . . . . 1.21 106.723 -166.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.24 121.76 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.637 0.732 . . . . 2.6699999999999999 109.792 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -96.19 144.2 26.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.154 2.182 . . . . 0.84999999999999998 109.548 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -33.97 -90.87 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.539 2.736 . . . . 5.3799999999999999 112.671 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 43.34 56.1 4.44 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.103 1.52 . . . . 3.6899999999999999 115.103 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -78.71 43.69 0.5 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.73 -0.606 . . . . 5.1500000000000004 110.35 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 t70 179.1 135.37 0.09 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 129.556 3.142 . . . . 4.8300000000000001 105.451 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.41 48.6 2.04 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.054 -1.091 . . . . 4.9299999999999997 108.054 165.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.3 t -62.34 -46.2 89.76 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.544 -0.722 . . . . 5.5999999999999996 111.395 -171.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.59 -47.19 13.37 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.751 0.82 . . . . 6.3099999999999996 109.3 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.9 -171.27 37.79 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 106.289 -2.724 . . . . 4.2300000000000004 106.289 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.8 p -74.05 154.87 39.04 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 117.805 0.802 . . . . 3.27 111.133 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.2 p -134.0 163.14 30.21 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.058 1.343 . . . . 5.6900000000000004 111.381 -166.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.421 0.7 OUTLIER 45.18 -96.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 118.041 2.608 . . . . 4.9299999999999997 118.041 105.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 28.67 -118.42 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.04 2.536 . . . . 2.9500000000000002 114.645 -173.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.82 -167.58 30.52 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.887 -1.685 . . . . 1.8799999999999999 108.887 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 178.75 4.34 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.315 3.343 . . . . 1.5 113.142 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -47.61 123.48 5.89 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.338 1.455 . . . . 1.25 110.182 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -45.86 122.92 4.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.724 0.809 . . . . 4.0300000000000002 111.027 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -155.4 152.84 25.56 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 106.679 -1.601 . . . . 3.54 106.679 171.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.22 -20.33 24.81 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.228 1.952 . . . . 1.54 113.806 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.81 -70.08 0.11 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.463 1.029 . . . . 4.2300000000000004 111.195 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.9 t -157.43 69.53 0.56 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.254 0.622 . . . . 2.8900000000000001 109.488 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -79.21 175.04 10.95 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.379 0.609 . . . . 6.1799999999999997 110.374 168.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -118.55 161.24 20.36 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 106.33 -1.73 . . . . 3.9300000000000002 106.33 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -85.9 165.21 16.97 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.639 0.654 . . . . 1.0600000000000001 109.382 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.53 -65.84 0.02 OUTLIER Glycine 0 C--O 1.223 -0.591 0 N-CA-C 108.201 -1.959 . . . . 2.9199999999999999 108.201 169.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.15 -171.27 27.87 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.604 1.097 . . . . 1.9199999999999999 111.978 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.14 -46.85 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.743 2.295 . . . . 1.6100000000000001 109.796 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.66 -36.41 82.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.611 0.764 . . . . 4.9199999999999999 112.017 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.1 176.95 0.66 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.277 1.031 . . . . 1.8 112.042 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.69 -48.3 11.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.052 1.341 . . . . 4.6100000000000003 109.71 165.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -98.4 156.58 16.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.311 1.044 . . . . 3.5099999999999998 112.68 -166.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.69 150.0 0.64 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.768 1.627 . . . . 4.7800000000000002 110.0 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.416 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 44.5 m80 -55.84 136.6 51.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 104.979 -2.23 . . . . 0.75 104.979 156.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -58.98 -23.17 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.185 -0.606 . . . . 2.2799999999999998 109.947 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.87 39.24 2.8 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.372 1.463 . . . . 0.80000000000000004 115.083 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -102.9 136.63 42.37 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.772 1.786 . . . . 2.4500000000000002 106.831 153.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.6 -52.74 3.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.469 -0.938 . . . . 2.9399999999999999 108.469 147.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.38 -106.72 0.29 Allowed Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.964 -0.854 . . . . 0.78000000000000003 110.964 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.69 165.66 31.69 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.261 1.425 . . . . 2.3999999999999999 109.524 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.38 175.38 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 106.174 -1.788 . . . . 1.6899999999999999 106.174 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -120.67 141.72 50.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.769 -1.197 . . . . 2.7000000000000002 107.769 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.3 138.84 34.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.398 0.679 . . . . 1.6599999999999999 109.979 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.45 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.571 0.544 . . . . 3.3599999999999999 110.134 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -53.79 1.52 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.928 0.891 . . . . 5.3700000000000001 111.52 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.05 26.61 2.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 123.368 1.556 . . . . 2.7999999999999998 110.78 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.8 17.9 67.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 114.524 -1.217 . . . . 0.67000000000000004 111.596 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.6 t -89.02 122.63 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 125.378 1.471 . . . . 1.79 107.306 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.16 175.99 5.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.894 1.277 . . . . 1.6200000000000001 107.662 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -133.67 148.21 51.48 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 103.62 -2.733 . . . . 2.9100000000000001 103.62 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.01 139.79 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.874 -1.528 . . . . 2.2799999999999998 106.874 160.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.1 m -158.16 59.69 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.303 1.841 . . . . 1.3400000000000001 108.078 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.08 151.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 107.638 -1.245 . . . . 2.6499999999999999 107.638 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -124.99 90.06 3.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.853 -0.795 . . . . 3.5899999999999999 108.853 166.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.63 152.89 31.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.461 0.573 . . . . 2.7000000000000002 110.637 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -132.07 41.9 3.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.779 1.232 . . . . 1.9299999999999999 110.295 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -127.57 -54.33 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.596 1.158 . . . . 2.3900000000000001 108.197 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -86.42 173.02 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.224 0.535 . . . . 2.6299999999999999 110.566 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.2 m -140.86 173.95 10.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.324 1.85 . . . . 2.9900000000000002 106.835 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.6 -3.37 46.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.137 0.421 . . . . 4.8399999999999999 112.137 170.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t -150.87 153.14 34.78 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.881 -1.526 . . . . 3.8399999999999999 106.881 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.41 -155.78 22.08 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 107.412 -2.275 . . . . 3.79 107.412 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.71 -73.74 0.42 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.382 -0.97 . . . . 4.2599999999999998 108.382 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.15 4.73 9.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.645 1.178 . . . . 5.9699999999999998 113.141 -173.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 p -49.96 137.56 16.78 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 119.233 0.924 . . . . 1.5 108.738 167.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.27 -12.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.534 -0.466 . . . . 2.8199999999999998 110.794 -169.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.9 tp -16.85 119.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 127.877 2.471 . . . . 2.96 113.353 164.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.59 -17.39 59.18 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.181 -1.344 . . . . 1.54 113.386 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.3 169.07 18.25 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.951 1.875 . . . . 4.8099999999999996 111.735 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.4 m -96.17 110.38 22.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.213 1.005 . . . . 2.02 109.472 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.29 144.28 54.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.222 0.919 . . . . 2.5699999999999998 108.705 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.7 t -130.79 136.41 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.87 1.268 . . . . 1.8899999999999999 109.087 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -103.39 126.9 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.794 -1.558 . . . . 2.5499999999999998 106.794 163.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.438 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 61.6 m-70 -100.97 161.0 13.9 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 116.358 1.985 . . . . 0.38 116.358 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -39.61 -70.33 0.11 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.949 2.9 . . . . 3.0 112.273 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -112.72 -172.49 2.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.426 1.012 . . . . 3.3999999999999999 108.848 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.12 160.59 9.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.917 -0.771 . . . . 1.6399999999999999 108.917 162.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.3 167.11 21.86 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.721 0.772 . . . . 1.8899999999999999 109.808 158.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.7 -6.98 57.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.463 1.905 . . . . 3.4100000000000001 111.282 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 36.06 20.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.886 2.074 . . . . 2.7999999999999998 111.068 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.49 27.43 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.44 -0.788 . . . . 1.9199999999999999 112.65 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -111.67 -34.03 6.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.063 1.345 . . . . 6.8099999999999996 109.623 -171.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -48.39 126.76 16.38 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.247 -1.141 . . . . 3.6600000000000001 110.247 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.62 64.43 2.94 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.341 0.972 . . . . 3.0299999999999998 111.69 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -163.58 117.44 1.55 Allowed 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 106.619 -1.623 . . . . 2.6200000000000001 106.619 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.15 -54.53 0.61 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.814 1.646 . . . . 3.4399999999999999 113.786 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -27.54 -49.64 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.791 2.836 . . . . 4.4699999999999998 113.983 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -44.47 -60.22 2.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.399 1.88 . . . . 2.6099999999999999 110.435 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.7 p -72.99 -42.51 63.19 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.091 -0.381 . . . . 1.98 110.579 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -51.99 -53.69 38.57 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.353 1.061 . . . . 4.4800000000000004 110.862 -172.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.416 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.3 p -123.39 -42.31 2.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.27 0.228 . . . . 1.9099999999999999 111.567 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 141.19 -27.51 2.41 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.447 -1.061 . . . . 0.98999999999999999 110.447 -169.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.3 t30 55.23 54.41 8.78 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 122.665 1.222 . . . . 2.2599999999999998 110.463 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.69 -27.83 69.19 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.812 1.245 . . . . 2.04 112.812 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.18 179.42 52.52 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 108.514 -1.834 . . . . 1.04 108.514 -160.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.4 m -59.21 148.94 29.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.286 1.217 . . . . 1.8400000000000001 114.286 -164.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -51.38 126.09 16.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.652 2.381 . . . . 3.8700000000000001 109.346 166.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.7 mt -109.26 -71.16 0.77 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-N 120.098 1.317 . . . . 1.6000000000000001 108.669 170.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.89 154.52 18.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.565 -0.532 . . . . 2.0499999999999998 109.565 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.81 160.16 16.76 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.676 0.61 . . . . 1.45 111.391 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.89 144.84 4.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 128.382 2.896 . . . . 1.3100000000000001 105.954 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.23 143.36 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 118.023 0.911 . . . . 2.0099999999999998 110.671 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 tt -92.92 139.83 17.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.555 0.742 . . . . 1.75 112.71 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.06 -4.83 1.2 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.192 0.901 . . . . 0.60999999999999999 114.777 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -90.55 58.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.715 1.258 . . . . 2.4900000000000002 109.101 -156.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.6 143.69 30.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.518 -0.739 . . . . 2.8700000000000001 112.263 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 103.511 -2.774 . . . . 6.6200000000000001 103.511 141.554 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 117.819 -1.086 . . . . 7.2800000000000002 108.085 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.02 141.74 3.99 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.182 1.393 . . . . 4.9400000000000004 112.024 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.93 175.51 9.98 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.858 -1.164 . . . . 4.4500000000000002 107.858 170.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.64 138.39 34.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.338 -0.986 . . . . 1.6499999999999999 108.338 163.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 t -99.79 136.27 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 106.885 -1.524 . . . . 2.1099999999999999 106.885 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.88 94.5 4.54 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 124.329 1.052 . . . . 1.51 108.236 158.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -65.84 102.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.45 -1.315 . . . . 2.0499999999999998 107.45 165.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.3 134.68 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.037 0.535 . . . . 2.1800000000000002 109.889 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -149.65 -50.31 0.14 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.657 0.383 . . . . 4.8799999999999999 111.618 166.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.43 -123.8 16.57 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.72 1.152 . . . . 1.0700000000000001 112.971 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.12 -51.77 2.92 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.47 1.108 . . . . 3.9900000000000002 108.621 -159.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.22 172.75 16.39 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.663 1.601 . . . . 0.97999999999999998 111.851 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 27.69 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.433 2.755 . . . . 1.05 112.674 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.4 t -82.1 165.38 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 1.78 109.11 -175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -156.33 139.1 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.937 1.695 . . . . 3.52 106.729 168.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.77 43.39 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.21 -0.995 . . . . 0.94999999999999996 111.651 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.21 126.45 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.071 -1.455 . . . . 3.3300000000000001 107.071 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.1 mm -92.51 129.24 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.269 -1.382 . . . . 2.23 107.269 165.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.75 108.7 21.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.875 -1.528 . . . . 2.3599999999999999 106.875 159.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.1 131.97 33.98 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.705 -1.961 . . . . 3.4700000000000002 105.705 162.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.39 165.16 36.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.226 0.921 . . . . 3.4700000000000002 111.49 158.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -155.26 145.46 21.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 104.714 -2.328 . . . . 3.1699999999999999 104.714 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -81.46 -36.91 28.78 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.875 -1.157 . . . . 8.2400000000000002 107.875 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -77.81 -167.4 0.97 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.721 2.808 . . . . 4.6299999999999999 110.037 171.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -139.83 26.56 2.27 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.877 1.271 . . . . 3.1499999999999999 109.425 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 179.03 35.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.485 1.114 . . . . 6.7800000000000002 110.202 -152.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.44 -162.27 9.73 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.628 -1.389 . . . . 1.3 109.628 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.35 144.95 29.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.294 2.663 . . . . 1.3 110.104 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -88.11 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.523 -0.917 . . . . 2.0299999999999998 108.523 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -111.08 124.01 51.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.568 -1.641 . . . . 3.4500000000000002 106.568 165.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -120.57 124.51 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.95 -1.5 . . . . 2.4399999999999999 106.95 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -140.64 138.0 34.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.609 -0.515 . . . . 1.25 109.609 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.67 139.4 4.66 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.525 -1.43 . . . . 1.21 109.525 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.6 m -119.17 91.16 3.49 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.34 1.056 . . . . 3.21 108.987 -167.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.2 mm -87.47 152.74 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.091 2.156 . . . . 2.7200000000000002 109.332 -165.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.89 146.69 33.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.329 0.651 . . . . 5.1399999999999997 109.66 -172.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.65 18.99 42.47 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.008 1.289 . . . . 0.60999999999999999 112.703 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 162.58 28.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.566 -0.902 . . . . 1.99 108.566 168.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.48 163.84 27.29 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.991 -1.114 . . . . 2.3199999999999998 107.991 155.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.53 176.39 0.5 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.435 -0.791 . . . . 2.3599999999999999 111.133 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.5 -165.95 46.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.659 0.647 . . . . 0.54000000000000004 113.648 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.87 147.94 52.59 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.649 0.78 . . . . 3.52 112.023 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -142.52 119.91 11.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.859 1.664 . . . . 0.80000000000000004 108.059 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.99 148.0 6.8 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.719 -1.352 . . . . 0.47999999999999998 109.719 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -141.72 95.79 2.87 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.488 -1.301 . . . . 3.8599999999999999 107.488 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -133.67 161.75 33.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.624 -1.25 . . . . 0.90000000000000002 107.624 -163.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.83 137.72 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 108.932 -0.766 . . . . 2.98 108.932 165.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -98.8 151.11 21.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.579 1.151 . . . . 0.84999999999999998 109.422 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -36.23 -59.62 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.371 1.868 . . . . 4.7699999999999996 112.37 -174.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 2.21 87.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.041 3.337 . . . . 3.3500000000000001 116.706 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.66 -51.72 68.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.12 0.418 . . . . 4.7300000000000004 111.431 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 t0 178.69 92.85 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 126.021 1.729 . . . . 5.25 109.121 167.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -40.28 71.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.377 -0.829 . . . . 5.1500000000000004 112.754 165.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 t 178.47 -42.31 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.014 1.326 . . . . 4.79 110.292 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 169.34 -46.93 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 126.712 2.005 . . . . 7.3300000000000001 109.753 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.31 -106.65 0.23 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 125.045 1.307 . . . . 4.5700000000000003 111.546 -172.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 20.5 p -169.06 -129.37 0.01 OUTLIER 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.006 0.743 . . . . 2.8199999999999998 113.006 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p 52.47 68.19 0.86 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.361 2.264 . . . . 5.2300000000000004 111.892 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.2 t -172.33 -10.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 117.32 2.341 . . . . 3.9700000000000002 117.32 -141.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.9 155.6 10.24 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.488 1.04 . . . . 2.3599999999999999 109.527 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.17 -85.17 0.84 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.079 -1.209 . . . . 1.71 110.079 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.61 175.4 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.309 2.673 . . . . 1.22 116.118 -161.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -83.55 57.22 3.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 113.695 -1.593 . . . . 2.04 110.996 -170.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 59.79 75.44 0.4 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.345 0.658 . . . . 2.8900000000000001 109.353 -172.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.21 87.91 0.52 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 3.6699999999999999 108.939 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -62.81 -43.67 19.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.246 1.297 . . . . 2.0600000000000001 110.136 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.49 -93.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.783 -0.821 . . . . 3.3399999999999999 108.783 165.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.1 p -137.37 60.7 1.64 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.794 0.838 . . . . 4.2599999999999998 110.399 -161.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -82.16 161.64 22.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.769 -1.196 . . . . 5.9699999999999998 107.769 159.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -128.94 175.28 8.78 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.728 -1.582 . . . . 5.3200000000000003 106.728 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -106.08 132.6 51.96 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.251 -1.018 . . . . 1.3500000000000001 108.251 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -124.06 -48.88 0.22 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.437 -1.465 . . . . 3.46 109.437 173.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.54 176.14 21.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.31 1.91 . . . . 2.1299999999999999 109.029 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -57.86 -43.71 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.42 2.08 . . . . 2.0600000000000001 110.614 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -70.47 -47.47 60.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.846 1.658 . . . . 5.0300000000000002 111.817 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.44 152.46 34.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.464 0.705 . . . . 1.78 111.573 -168.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -50.99 -51.43 52.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.582 1.553 . . . . 3.9399999999999999 111.837 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.94 146.42 26.16 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 122.924 1.345 . . . . 3.4500000000000002 111.444 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -170.84 134.69 1.02 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.931 -1.486 . . . . 5.0300000000000002 107.002 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.2 m80 -51.46 140.74 17.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.219 -1.4 . . . . 0.63 107.219 158.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.69 -14.1 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.988 -0.551 . . . . 2.04 110.291 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.22 35.22 4.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.071 0.843 . . . . 0.83999999999999997 115.143 165.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -94.89 117.85 30.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.818 1.809 . . . . 2.3700000000000001 106.619 158.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.39 -61.35 2.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.11 -1.441 . . . . 3.8900000000000001 107.11 158.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.41 -106.42 0.25 Allowed Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.387 -0.685 . . . . 0.93999999999999995 111.387 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -152.45 169.84 21.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.493 1.517 . . . . 1.75 109.427 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.03 169.99 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.131 -1.433 . . . . 1.6599999999999999 107.131 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.4 m -122.7 120.27 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.618 -1.253 . . . . 3.0299999999999998 107.618 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 141.85 35.85 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.109 0.564 . . . . 1.6299999999999999 109.888 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.51 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.309 2.244 . . . . 3.9300000000000002 110.459 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -172.88 -45.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.205 1.402 . . . . 4.5 108.855 -161.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -77.5 8.43 4.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.234 1.016 . . . . 2.73 110.929 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.46 19.44 78.13 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.123 -0.985 . . . . 0.79000000000000004 110.728 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.6 t -86.39 137.64 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.087 . . . . 1.52 108.064 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.12 167.25 21.31 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.931 -1.507 . . . . 1.5700000000000001 106.931 167.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -148.28 138.41 22.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.176 -1.416 . . . . 3.8700000000000001 107.176 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.35 56.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 124.331 1.019 . . . . 1.9099999999999999 111.349 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.8 m -70.3 88.51 0.64 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.981 0.512 . . . . 1.8300000000000001 109.962 166.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.8 mm -127.56 160.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.104 0.961 . . . . 3.4100000000000001 109.611 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -146.66 76.41 1.43 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.397 0.679 . . . . 2.46 111.177 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.1 143.73 35.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.935 0.398 . . . . 2.1299999999999999 110.156 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -106.35 -4.21 20.25 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.033 1.733 . . . . 1.8400000000000001 112.843 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.06 -46.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.701 1.2 . . . . 2.21 107.963 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.95 168.82 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.02 0.438 . . . . 2.3999999999999999 110.507 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 m -146.2 167.52 23.26 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.803 1.641 . . . . 2.1000000000000001 106.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 pp -99.01 -0.35 42.19 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.597 0.592 . . . . 3.1499999999999999 112.597 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p -155.04 167.41 30.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.189 1.395 . . . . 3.3500000000000001 108.055 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.34 155.12 15.86 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.403 -0.679 . . . . 3.8100000000000001 111.403 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.43 55.57 0.23 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.314 2.645 . . . . 4.2400000000000002 112.192 -169.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -158.4 -36.05 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 128.336 2.655 . . . . 5.7599999999999998 109.6 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.2 p -44.47 155.03 0.1 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.276 1.584 . . . . 1.3500000000000001 115.276 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.271 2.0 pp -95.34 -4.53 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 113.335 -1.757 . . . . 2.6499999999999999 111.207 174.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tp -39.08 131.42 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.892 0.877 . . . . 2.7599999999999998 109.824 162.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.63 49.54 72.89 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.232 -0.747 . . . . 1.9399999999999999 111.232 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -137.1 163.83 29.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.58 -1.637 . . . . 4.8499999999999996 106.58 164.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 m -90.61 111.84 23.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 118.691 -0.671 . . . . 1.73 110.121 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.36 143.16 57.32 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.556 -0.905 . . . . 2.75 108.556 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.6 t -134.67 139.58 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.337 1.855 . . . . 1.8 108.294 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.96 125.11 68.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.253 -1.017 . . . . 2.8500000000000001 108.253 162.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -94.45 163.46 13.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 115.355 1.613 . . . . 0.45000000000000001 115.355 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.78 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.201 1.4 . . . . 3.8799999999999999 112.357 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -92.54 -177.85 4.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.775 0.716 . . . . 3.79 110.601 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 151.6 16.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.447 -0.946 . . . . 1.8400000000000001 108.447 157.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.78 162.32 29.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.99 -0.744 . . . . 2.0600000000000001 108.99 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.65 -7.2 58.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.43 1.092 . . . . 3.3999999999999999 112.043 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 49.6 40.28 19.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.648 1.179 . . . . 2.5499999999999998 109.307 -168.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 51.78 34.12 36.37 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.453 -0.794 . . . . 2.0600000000000001 113.396 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -130.21 49.99 2.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.492 1.146 . . . . 5.4699999999999998 108.982 -177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.76 132.65 8.78 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.849 -1.7 . . . . 3.29 108.849 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.59 -37.38 67.41 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.713 -0.955 . . . . 3.0699999999999998 110.713 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -50.45 103.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.694 1.198 . . . . 2.52 109.593 159.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -35.19 10.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.246 1.018 . . . . 3.4300000000000002 111.948 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -28.08 -44.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.157 2.583 . . . . 3.8399999999999999 112.671 167.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.8 p -49.62 -73.16 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 2.8199999999999998 110.292 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.6 p -61.66 -40.73 95.95 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.298 -0.876 . . . . 1.9099999999999999 110.818 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.72 -53.27 59.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.392 1.477 . . . . 3.8700000000000001 110.783 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.502 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.33 1.3 p -126.07 -45.66 1.7 Allowed 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.96 0.726 . . . . 2.2999999999999998 112.96 172.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.72 -25.43 0.74 Allowed Glycine 0 N--CA 1.463 0.455 0 CA-C-N 118.965 0.802 . . . . 0.93999999999999995 112.029 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 t30 47.51 52.34 12.54 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.412 1.485 . . . . 2.1699999999999999 110.987 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.37 -47.95 31.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.77 -1.196 . . . . 2.25 107.77 162.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.22 -146.06 16.8 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 108.271 -1.932 . . . . 1.51 108.271 164.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.1 m -58.41 156.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.861 1.264 . . . . 2.6200000000000001 112.77 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -60.73 141.9 56.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.109 -1.405 . . . . 3.5099999999999998 109.608 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.3 mt -107.73 -71.52 0.75 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 105.992 -1.855 . . . . 1.98 105.992 156.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.93 151.79 19.91 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.439 -0.949 . . . . 2.2599999999999998 108.439 174.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 67.0 m -139.43 156.69 46.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.604 -1.999 . . . . 2.0 105.604 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.16 130.69 1.79 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.809 -0.916 . . . . 0.82999999999999996 110.809 163.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.55 130.22 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.405 0.682 . . . . 1.77 109.578 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 tt -98.76 135.9 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.311 -0.404 . . . . 1.78 111.592 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.68 -4.9 0.94 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.11 0.804 . . . . 0.69999999999999996 115.11 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -89.04 58.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.888 1.344 . . . . 2.4300000000000002 109.559 -159.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.96 151.54 23.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.744 -0.662 . . . . 3.3900000000000001 109.553 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 . . . . . 0 C--O 1.256 1.425 0 N-CA-C 104.48 -2.415 . . . . 6.9500000000000002 104.48 166.005 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.521 -0.918 . . . . 5.6299999999999999 108.521 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 m -70.77 81.09 0.62 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.877 0.871 . . . . 4.0499999999999998 109.935 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 146.82 38.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 3.73 110.124 -175.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.81 141.21 29.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.31 1.044 . . . . 1.78 108.885 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 t -102.61 144.37 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.437 -0.949 . . . . 2.1000000000000001 108.437 162.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.02 100.26 6.65 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 108.615 -0.883 . . . . 1.9199999999999999 108.615 153.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 101.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.971 -1.122 . . . . 2.02 107.971 164.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.44 130.84 36.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.288 -0.634 . . . . 2.1200000000000001 109.288 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -134.58 -57.37 0.83 Allowed 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.747 -0.835 . . . . 5.4199999999999999 108.747 165.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.83 -143.07 48.42 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.263 0.935 . . . . 1.6200000000000001 113.518 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.51 -46.69 5.65 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.841 1.656 . . . . 4.0300000000000002 108.495 -165.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.45 158.69 22.21 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 109.968 -1.253 . . . . 1.4199999999999999 109.968 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.38 46.77 2.21 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.513 2.808 . . . . 1.2 111.83 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.2 159.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.613 1.565 . . . . 1.9399999999999999 109.524 -173.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.51 129.05 7.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.698 1.599 . . . . 2.96 106.798 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.89 175.19 47.0 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.165 -0.774 . . . . 0.97999999999999998 111.165 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.4 mt -126.26 119.18 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.595 -1.632 . . . . 3.0800000000000001 106.595 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.29 134.06 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.197 -1.779 . . . . 1.9299999999999999 106.197 160.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -108.99 121.36 44.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.259 -2.126 . . . . 2.6699999999999999 105.259 162.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.47 114.72 26.95 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.944 1.698 . . . . 4.1699999999999999 106.647 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -131.33 156.2 45.9 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.294 0.952 . . . . 3.0699999999999998 109.367 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -153.99 146.8 24.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.721 -1.955 . . . . 4.2300000000000004 105.721 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -84.97 -90.26 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.905 -0.776 . . . . 5.3899999999999997 108.905 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.1 mp0 -77.06 149.8 35.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.831 -1.174 . . . . 3.8700000000000001 107.831 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -73.65 -2.17 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.132 -0.98 . . . . 2.7799999999999998 113.001 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -119.12 24.91 10.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.307 1.843 . . . . 5.8399999999999999 109.482 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.42 169.04 18.08 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 108.654 -1.778 . . . . 2.0099999999999998 108.654 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -65.63 139.48 58.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.681 1.587 . . . . 1.73 110.563 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.74 153.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.75 -1.204 . . . . 2.23 107.75 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -129.21 131.67 47.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.417 -1.697 . . . . 3.6899999999999999 106.417 172.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.45 139.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.208 1.403 . . . . 2.4100000000000001 107.755 -169.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.22 138.75 21.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.274 -1.01 . . . . 1.3200000000000001 108.274 168.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.93 130.74 2.24 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.388 -1.885 . . . . 1.03 108.388 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.4 p -105.92 85.99 2.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.698 -1.964 . . . . 3.0299999999999998 105.698 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mm -88.1 153.29 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.309 -1.367 . . . . 2.7200000000000002 107.309 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -147.54 158.19 43.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.128 1.158 . . . . 4.2800000000000002 114.128 168.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.24 9.96 43.28 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.87 2.176 . . . . 0.62 112.481 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.84 160.86 16.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.588 0.755 . . . . 2.3300000000000001 109.369 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.57 159.2 26.94 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 107.468 -1.308 . . . . 2.29 107.468 155.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.47 177.9 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.947 0.879 . . . . 3.0699999999999998 111.681 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.65 -164.55 54.05 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.02 -0.536 . . . . 0.58999999999999997 112.036 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.81 148.4 40.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.895 1.678 . . . . 2.9399999999999999 112.305 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -150.59 111.35 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.239 1.416 . . . . 0.63 110.29 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.25 147.4 2.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.549 -0.62 . . . . 0.42999999999999999 111.549 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.36 96.71 3.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.875 -1.157 . . . . 4.0899999999999999 107.875 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -133.28 156.53 47.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.813 -1.551 . . . . 0.89000000000000001 106.813 -167.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.7 119.46 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.434 1.016 . . . . 2.9300000000000002 109.491 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -91.25 138.46 31.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.659 -1.608 . . . . 0.84999999999999998 106.659 -174.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -40.76 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.684 1.594 . . . . 4.4100000000000001 110.935 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 45.62 56.71 5.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.18 0.992 . . . . 3.2400000000000002 112.457 152.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -83.61 15.85 2.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.656 -1.156 . . . . 4.5099999999999998 110.762 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.42 81.71 0.56 Allowed 'General case' 0 C--N 1.342 0.271 0 CA-C-O 122.699 1.237 . . . . 5.5999999999999996 108.705 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -80.09 23.43 0.47 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.727 1.211 . . . . 7.7999999999999998 110.54 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -106.58 -55.56 2.31 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.906 0.882 . . . . 6.1200000000000001 109.162 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.97 -16.98 12.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.209 1.404 . . . . 5.46 112.665 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.5 -116.57 5.49 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 118.817 0.735 . . . . 5.9400000000000004 112.58 167.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.4 t -84.11 60.04 5.67 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.72 0.808 . . . . 3.3300000000000001 111.092 -163.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 p -112.38 0.24 15.58 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.085 1.513 . . . . 6.6399999999999997 115.085 -162.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -177.76 40.25 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 116.831 -1.948 . . . . 4.46 115.191 -119.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.83 158.74 6.04 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.487 -0.758 . . . . 2.1400000000000001 110.486 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.63 -86.5 1.75 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.288 -1.925 . . . . 1.6299999999999999 108.288 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.25 177.42 8.8 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.621 2.881 . . . . 1.0800000000000001 113.326 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -64.8 134.81 54.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.821 -1.536 . . . . 1.47 108.136 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -37.89 106.66 0.05 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.301 1.041 . . . . 2.73 111.129 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -127.14 143.54 47.41 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 130.817 3.647 . . . . 3.7599999999999998 108.037 -175.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.14 -51.82 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.644 1.563 . . . . 1.46 109.256 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -143.53 -82.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.891 1.276 . . . . 3.96 108.08 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -123.59 60.53 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.494 1.118 . . . . 2.6099999999999999 109.751 -164.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -79.01 166.35 22.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.469 0.652 . . . . 4.29 110.354 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -118.67 159.29 23.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.644 1.578 . . . . 3.9700000000000002 107.906 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.4 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 40.7 t60 -86.94 168.47 13.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.023 0.529 . . . . 0.96999999999999997 112.064 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.7 -126.59 1.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.431 -3.068 . . . . 1.8600000000000001 105.431 165.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.49 -176.74 45.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.929 -2.068 . . . . 1.99 107.929 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.01 -40.43 84.03 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.012 2.475 . . . . 2.8300000000000001 111.463 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -32.61 71.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.166 0.586 . . . . 5.96 112.474 174.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -89.09 177.66 6.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.716 0.769 . . . . 2.8599999999999999 112.66 -164.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.453 ' CG ' ' H ' ' A' ' 78' ' ' GLU . 3.4 pt-20 -55.75 -66.41 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.619 1.168 . . . . 7.2999999999999998 111.405 169.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.453 ' H ' ' CG ' ' A' ' 77' ' ' GLU . 50.0 mt-10 -118.23 179.6 4.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.663 2.385 . . . . 3.1099999999999999 112.263 -166.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.83 157.45 1.96 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.7 2.4 . . . . 5.29 108.231 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -63.56 153.89 34.33 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.844 -1.169 . . . . 0.54000000000000004 107.844 170.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.76 -37.48 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 119.902 -0.719 . . . . 2.0099999999999998 110.464 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.03 71.7 0.24 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 112.026 -0.43 . . . . 1.04 112.026 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -165.8 113.55 0.94 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.331 -0.988 . . . . 2.7000000000000002 108.331 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.13 -61.39 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.094 -0.706 . . . . 3.0 109.094 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.3 -107.05 0.27 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.139 -1.184 . . . . 0.87 110.139 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -147.2 163.25 36.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 125.107 1.363 . . . . 2.21 110.93 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.24 -178.58 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.027 2.131 . . . . 1.6299999999999999 105.867 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.8 t -129.47 171.54 12.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.827 -1.175 . . . . 2.98 107.827 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.11 144.58 50.81 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.308 1.043 . . . . 1.6599999999999999 110.669 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.47 -90.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.386 2.274 . . . . 4.2400000000000002 110.89 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -174.23 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.278 1.031 . . . . 3.96 110.271 -158.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.04 5.0 8.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.118 0.961 . . . . 2.7799999999999998 110.183 165.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.53 23.03 71.38 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.124 -1.19 . . . . 0.85999999999999999 110.124 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.2 t -85.36 136.65 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.364 1.466 . . . . 1.6599999999999999 107.895 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.18 166.22 21.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.691 1.596 . . . . 2.1600000000000001 109.748 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -142.14 118.45 10.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.038 -2.579 . . . . 2.71 104.038 -158.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.95 55.54 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 123.691 0.62 . . . . 2.1000000000000001 111.225 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.4 m -77.18 87.86 3.64 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.642 -0.661 . . . . 1.47 109.771 168.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.5 mm -125.39 157.16 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.163 0.985 . . . . 2.8900000000000001 108.352 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -151.32 99.0 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.637 0.375 . . . . 2.5899999999999999 111.494 166.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -92.17 159.1 15.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.178 0.591 . . . . 2.3999999999999999 110.595 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 p -116.23 -17.52 10.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.62 1.968 . . . . 2.1099999999999999 113.296 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.75 -50.91 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 119.151 0.887 . . . . 2.6200000000000001 108.656 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.55 175.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.45 0.643 . . . . 2.5699999999999998 110.915 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.1 p -146.33 178.26 8.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.425 2.69 . . . . 2.96 105.231 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 44.84 2.9 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.767 1.167 . . . . 3.9700000000000002 111.68 167.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 p -156.87 38.6 0.31 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.976 0.732 . . . . 4.0999999999999996 112.976 -169.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.6 174.96 39.86 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.989 -0.845 . . . . 2.98 110.989 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.56 -44.86 62.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.409 1.483 . . . . 5.8600000000000003 110.741 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -78.61 -23.38 45.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.463 1.105 . . . . 4.1900000000000004 112.53 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.08 176.76 1.17 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.891 0.853 . . . . 1.4099999999999999 112.327 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.08 -8.65 10.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 CA-C-N 115.327 -0.851 . . . . 2.8199999999999998 111.001 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 tp -33.63 127.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.258 1.423 . . . . 3.3100000000000001 110.569 159.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.74 -19.52 24.4 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.037 -0.868 . . . . 1.6399999999999999 113.479 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.3 mtt-85 -86.54 168.94 13.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.604 1.702 . . . . 5.1799999999999997 109.281 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.7 m -101.82 115.4 30.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.018 -0.427 . . . . 1.9299999999999999 110.353 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 149.42 45.15 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.65 -0.87 . . . . 3.5099999999999998 108.65 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.0 t -133.78 128.55 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.454 1.102 . . . . 1.8700000000000001 109.246 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.1 t -99.81 116.24 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 C-N-CA 126.346 1.858 . . . . 3.4700000000000002 106.275 168.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -94.26 160.47 14.67 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.164 1.913 . . . . 0.54000000000000004 116.164 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -41.27 -77.53 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.265 2.626 . . . . 3.2799999999999998 112.481 170.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -97.29 -179.52 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.627 1.571 . . . . 3.2400000000000002 111.147 -168.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.81 153.72 32.11 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.019 -0.734 . . . . 1.73 109.019 158.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -85.05 153.36 22.77 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.306 0.574 . . . . 2.02 109.729 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -81.97 -3.93 55.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.617 1.567 . . . . 3.0899999999999999 113.542 -168.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 53.85 32.9 15.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.377 1.071 . . . . 3.9900000000000002 110.773 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.79 14.5 30.22 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 121.08 -1.013 . . . . 2.2200000000000002 113.567 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -127.97 -27.48 2.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.926 1.291 . . . . 7.5499999999999998 110.728 -168.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.05 134.5 40.62 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.547 -1.421 . . . . 3.71 109.547 164.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.62 -24.75 33.18 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.152 0.882 . . . . 2.9399999999999999 114.872 -166.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -55.91 125.86 23.27 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 118.295 -0.86 . . . . 2.9199999999999999 109.267 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -47.38 -40.99 18.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.833 1.197 . . . . 3.6899999999999999 111.192 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -47.43 -31.3 4.0 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.56 1.544 . . . . 3.8599999999999999 111.624 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.99 -72.16 0.07 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.369 -0.604 . . . . 2.4700000000000002 109.369 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 t -63.44 -41.11 98.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 121.621 -0.674 . . . . 3.7999999999999998 109.485 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.53 -45.41 94.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.75 -0.643 . . . . 4.8899999999999997 112.27 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.44 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.339 0.2 OUTLIER -128.68 -53.08 1.24 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.476 1.034 . . . . 1.9199999999999999 113.181 173.723 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.4 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.71 -22.5 0.4 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.241 0.924 . . . . 1.03 112.201 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.1 t30 49.61 54.53 10.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.651 1.18 . . . . 2.6499999999999999 111.001 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.42 -3.45 58.34 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.672 -0.811 . . . . 2.46 111.021 162.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.35 -155.34 45.45 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.249 -1.54 . . . . 0.96999999999999997 109.249 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.8 m -65.45 150.9 47.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.444 -1.378 . . . . 2.0299999999999998 113.537 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -59.2 135.72 57.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.581 1.552 . . . . 4.0700000000000003 108.812 170.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 mt -116.55 -76.88 0.57 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.05 -1.092 . . . . 2.04 108.05 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.47 145.86 29.69 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.755 -0.831 . . . . 2.3100000000000001 108.755 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.3 163.81 30.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 123.862 0.726 . . . . 1.6899999999999999 110.221 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.47 145.87 6.01 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.456 1.979 . . . . 0.88 109.035 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.37 139.02 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.875 1.27 . . . . 2.1400000000000001 108.65 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.6 tt -101.96 139.15 23.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 123.239 0.616 . . . . 2.2400000000000002 112.22 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.35 1.63 1.92 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.395 0.998 . . . . 0.62 114.482 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.0 mm -93.61 56.91 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.214 1.507 . . . . 2.0299999999999998 110.3 -156.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.99 168.4 27.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.148 0.579 . . . . 2.5299999999999998 110.461 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 . . . . . 0 C--O 1.256 1.412 0 N-CA-C 101.995 -3.335 . . . . 5.2400000000000002 101.995 162.117 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 107.102 -1.444 . . . . 6.1299999999999999 107.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.3 p -54.54 138.32 40.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.991 -1.115 . . . . 3.3599999999999999 107.991 161.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER -140.65 153.92 46.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.091 0.956 . . . . 4.8399999999999999 108.641 -175.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.95 21.77 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.49 -0.93 . . . . 1.9299999999999999 108.49 167.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.0 t -107.58 150.68 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 106.666 -1.605 . . . . 2.3100000000000001 106.666 161.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.1 96.2 3.85 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.706 -0.85 . . . . 1.52 108.706 158.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 109.32 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.876 -1.527 . . . . 2.0 106.876 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.83 125.03 39.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.571 -1.27 . . . . 1.8799999999999999 107.571 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -49.27 0.14 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 110.575 -0.157 . . . . 5.4699999999999998 110.575 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.86 -117.21 0.8 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.958 1.266 . . . . 0.76000000000000001 111.247 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.75 -60.15 1.59 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.181 -1.044 . . . . 3.2999999999999998 108.181 -164.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.01 168.24 0.43 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 127.089 2.28 . . . . 0.73999999999999999 113.96 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.79 -21.08 69.49 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.315 2.677 . . . . 1.23 111.657 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.4 141.41 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.736 1.214 . . . . 1.8600000000000001 110.937 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.0 122.31 5.6 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.119 -1.438 . . . . 2.52 107.119 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.14 168.68 36.51 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.67 -0.572 . . . . 0.71999999999999997 111.67 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.76 131.3 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.623 -0.88 . . . . 2.4100000000000001 108.623 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.3 mm -97.21 146.63 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.747 -1.575 . . . . 1.8999999999999999 106.747 161.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.86 144.51 50.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.472 -1.677 . . . . 2.1299999999999999 106.472 159.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.93 161.51 41.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.535 -0.466 . . . . 5.1200000000000001 111.758 167.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.23 170.64 15.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.541 1.136 . . . . 3.5099999999999998 108.166 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.76 165.41 36.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 104.878 -2.267 . . . . 3.4399999999999999 104.878 165.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.65 -66.14 0.85 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.326 -0.62 . . . . 5.54 109.326 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -89.38 166.12 13.93 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.219 1.007 . . . . 3.7400000000000002 110.52 -164.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -78.31 2.26 19.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.402 0.681 . . . . 3.8900000000000001 111.652 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -153.34 85.4 1.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.205 1.402 . . . . 4.6699999999999999 108.406 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.83 169.74 37.8 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 109.816 -1.313 . . . . 1.5600000000000001 109.816 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.41 133.61 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.723 2.949 . . . . 1.3 112.934 -166.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -106.93 139.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.568 0.747 . . . . 2.02 110.115 -171.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -99.5 89.71 4.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.713 0.805 . . . . 7.3899999999999997 109.223 -170.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.2 t -76.82 105.13 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 2.1800000000000002 106.878 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -113.66 140.9 47.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.817 -0.808 . . . . 1.1799999999999999 108.817 166.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.45 156.95 28.77 Favored Glycine 0 N--CA 1.448 -0.528 0 O-C-N 121.472 -0.768 . . . . 0.66000000000000003 112.008 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 p -130.36 104.38 7.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.505 -2.035 . . . . 2.7400000000000002 105.505 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.01 143.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.381 -1.34 . . . . 1.8600000000000001 107.381 -168.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -147.78 174.06 12.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.581 0.705 . . . . 4.54 112.729 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 22.26 72.38 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 114.868 -1.06 . . . . 0.66000000000000003 112.107 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -76.58 -155.38 0.06 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.475 -1.306 . . . . 1.8100000000000001 107.475 168.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -146.99 146.15 29.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.848 -2.278 . . . . 3.5499999999999998 104.848 166.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -34.19 132.96 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.719 2.408 . . . . 3.3100000000000001 113.223 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.63 -172.3 20.94 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.284 0.468 . . . . 0.68999999999999995 112.612 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.28 149.03 49.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.667 1.187 . . . . 3.4300000000000002 112.831 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.34 120.22 9.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 126.279 1.832 . . . . 0.66000000000000003 108.455 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.0 150.06 6.65 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 110.393 -1.083 . . . . 0.41999999999999998 110.393 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.87 95.83 2.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.417 -1.327 . . . . 4.0899999999999999 107.417 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.427 ' ND1' ' CE1' ' A' ' 63' ' ' HIS . 24.0 m170 -134.2 147.16 50.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.264 -1.013 . . . . 0.83999999999999997 108.264 -161.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.294 0.7 OUTLIER -99.43 126.46 52.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.194 0.997 . . . . 3.0699999999999998 109.993 168.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -85.38 -172.97 4.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.233 -1.395 . . . . 1.74 107.233 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -112.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.105 -1.443 . . . . 4.9500000000000002 107.105 161.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 54.4 63.61 2.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.213 -1.032 . . . . 2.9900000000000002 108.213 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -48.63 -48.07 39.8 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.895 -1.048 . . . . 4.4299999999999997 110.412 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -175.91 95.88 0.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.197 1.799 . . . . 5.1900000000000004 109.224 163.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.404 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 2.2 p30 -60.55 -40.82 92.99 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.027 1.731 . . . . 5.04 111.941 166.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m 177.48 -49.99 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.321 2.248 . . . . 4.8899999999999997 107.255 -163.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 179.44 -41.09 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.466 1.507 . . . . 7.2300000000000004 111.011 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.11 -105.6 2.72 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.264 -1.134 . . . . 5.1200000000000001 110.264 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.3 p -161.59 147.23 13.74 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.535 1.534 . . . . 3.3799999999999999 107.098 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.96 8.58 0.08 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.142 1.164 . . . . 4.5999999999999996 114.142 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 p -167.9 -43.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 117.672 2.471 . . . . 3.5899999999999999 117.672 -121.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.06 -145.04 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.777 -1.194 . . . . 2.3100000000000001 107.777 167.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.22 -88.03 0.07 OUTLIER Glycine 0 CA--C 1.522 0.485 0 N-CA-C 108.661 -1.776 . . . . 1.6699999999999999 108.661 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -71.88 179.13 5.08 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 125.057 3.838 . . . . 1.1899999999999999 112.585 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.427 ' CE1' ' ND1' ' A' ' 46' ' ' HIS . 15.4 m170 -74.23 152.7 39.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.143 -0.935 . . . . 1.5700000000000001 109.327 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -50.82 108.09 0.22 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.382 0.512 . . . . 3.0800000000000001 112.382 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -121.48 135.32 24.97 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 126.246 1.818 . . . . 3.5 109.147 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.5 -50.43 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.739 1.626 . . . . 1.3600000000000001 108.991 171.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.48 -84.09 0.25 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.94 1.296 . . . . 3.29 107.652 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.8 m -132.71 60.88 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.406 1.082 . . . . 2.4199999999999999 110.787 -168.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -77.44 158.7 29.89 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.526 -1.287 . . . . 5.0700000000000003 107.526 162.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -120.41 163.44 17.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.433 1.493 . . . . 3.8399999999999999 107.713 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -81.58 157.04 24.89 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.22 0.533 . . . . 0.75 111.043 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.88 -155.84 16.54 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 104.469 -3.453 . . . . 2.3999999999999999 104.469 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.63 -131.65 1.24 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.274 -1.53 . . . . 2.1400000000000001 109.274 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.7 -40.67 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.308 2.005 . . . . 2.1299999999999999 111.872 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.29 -46.17 42.94 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.786 0.291 . . . . 5.6200000000000001 111.786 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.95 176.69 6.93 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.505 -0.554 . . . . 2.4300000000000002 109.505 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.62 -33.55 10.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 5.1399999999999997 111.736 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 162.89 26.74 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 119.111 -1.036 . . . . 3.6200000000000001 110.183 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 133.05 0.05 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.782 2.033 . . . . 4.6600000000000001 108.864 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 46.5 m80 -50.01 144.61 6.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.177 -1.786 . . . . 0.78000000000000003 106.177 155.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.304 5.1 p -83.55 44.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 123.304 1.526 . . . . 2.27 110.795 -170.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -154.63 3.68 0.24 Allowed Glycine 0 CA--C 1.545 1.926 1 C-N-CA 131.364 4.316 . . . . 1.8400000000000001 113.125 169.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.19 99.39 8.54 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 121.651 2.726 . . . . 2.4100000000000001 107.753 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.5 mt -77.31 -44.96 27.77 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.064 0.847 . . . . 4.0199999999999996 109.103 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.58 -107.82 0.34 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.688 -0.767 . . . . 0.84999999999999998 111.216 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -149.69 171.13 17.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.648 1.579 . . . . 1.8300000000000001 109.366 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.82 172.27 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.74 -1.578 . . . . 1.8500000000000001 106.74 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.5 m -122.02 124.28 43.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.523 -1.288 . . . . 2.77 107.523 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.88 138.78 38.29 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.642 -0.503 . . . . 1.8200000000000001 109.642 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.72 -89.69 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 124.272 0.982 . . . . 2.7799999999999998 110.228 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 -57.84 1.0 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.295 1.038 . . . . 4.1799999999999997 110.085 -164.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.36 25.04 1.48 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 123.352 1.549 . . . . 2.96 110.911 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 62.91 19.71 61.4 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.917 -1.038 . . . . 0.93000000000000005 111.51 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.72 139.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.13 -1.433 . . . . 1.8799999999999999 107.13 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.99 166.18 23.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.856 1.263 . . . . 1.8600000000000001 107.887 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -128.0 143.23 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.766 -2.679 . . . . 2.8900000000000001 103.766 -173.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.39 121.7 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.381 -1.711 . . . . 1.8799999999999999 106.381 173.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -150.59 91.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.947 1.299 . . . . 1.21 108.604 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.48 144.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 107.951 -1.129 . . . . 2.9100000000000001 107.951 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -112.51 83.44 1.81 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.656 -1.609 . . . . 3.7400000000000002 106.656 161.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.28 146.29 33.06 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.1 p -108.06 -7.95 15.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.764 2.025 . . . . 2.4300000000000002 112.28 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.59 -55.53 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.78 -1.193 . . . . 2.3399999999999999 107.78 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.8 pt -70.35 176.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 122.312 1.053 . . . . 2.6699999999999999 112.008 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 m -153.4 176.96 11.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.663 1.985 . . . . 2.4199999999999999 106.233 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 -19.61 25.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.319 0.963 . . . . 4.1399999999999997 113.434 -169.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 m -159.7 90.32 0.93 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.034 -1.041 . . . . 4.6600000000000001 111.857 -168.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 167.63 179.06 40.14 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.148 -1.181 . . . . 3.25 110.148 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -36.14 -52.7 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.601 1.191 . . . . 5.6100000000000003 111.761 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -76.96 -23.78 52.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.503 -1.226 . . . . 6.3499999999999996 110.428 -169.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.5 p -63.95 151.1 43.61 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.542 0.61 . . . . 1.53 111.113 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.38 -5.89 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.389 -0.823 . . . . 2.8599999999999999 110.553 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -51.49 120.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.094 -0.706 . . . . 2.5499999999999998 109.094 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.85 39.61 95.14 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.61 -0.55 . . . . 1.77 112.8 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -120.79 167.94 11.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.265 -1.383 . . . . 6.8700000000000001 107.265 158.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.7 m -91.69 118.3 30.53 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.846 0.458 . . . . 1.77 111.043 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 144.4 45.56 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.145 -1.057 . . . . 2.54 108.145 164.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.0 t -131.54 140.33 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.189 1.796 . . . . 1.4299999999999999 107.818 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.63 127.44 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.129 -1.063 . . . . 2.75 108.129 164.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -97.08 159.61 14.81 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.474 2.028 . . . . 0.40999999999999998 116.474 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -47.57 -73.4 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.257 1.823 . . . . 3.02 112.243 172.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -97.35 179.87 4.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.002 0.921 . . . . 5.1399999999999997 110.264 -172.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.61 147.96 39.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.031 -0.729 . . . . 1.75 109.031 160.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -77.32 162.73 27.07 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.278 -0.638 . . . . 1.97 109.278 167.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.13 -8.47 59.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.424 1.268 . . . . 3.0800000000000001 114.424 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 48.97 30.3 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.695 1.134 . . . . 2.27 110.89 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.56 28.18 72.85 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.152 0.882 . . . . 1.8500000000000001 112.502 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -130.41 29.48 4.84 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.034 0.917 . . . . 6.2300000000000004 111.226 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -96.44 135.2 12.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 108.467 -1.853 . . . . 3.3300000000000001 108.467 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.08 66.27 2.88 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 117.63 0.715 . . . . 2.79 112.43 -171.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -168.84 170.72 8.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 125.085 1.354 . . . . 3.3999999999999999 108.092 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -52.09 -71.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.062 0.545 . . . . 3.6099999999999999 110.897 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -47.72 -41.96 24.13 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.868 2.067 . . . . 4.6399999999999997 111.947 -162.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.2 m -46.09 -58.54 3.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.994 0.917 . . . . 3.02 112.071 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -73.07 -40.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.792 -1.193 . . . . 2.21 112.511 173.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -66.25 -36.29 82.62 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.376 1.07 . . . . 6.6699999999999999 110.549 -165.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.502 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.377 13.1 t -133.47 -46.27 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.604 0.762 . . . . 2.9500000000000002 111.562 172.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.37 -18.45 1.33 Allowed Glycine 0 N--CA 1.467 0.752 0 CA-C-N 119.886 1.221 . . . . 0.89000000000000001 112.877 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 34.36 56.28 0.66 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.077 2.551 . . . . 2.6400000000000001 112.347 -174.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.44 -1.61 27.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.417 -0.513 . . . . 2.1600000000000001 111.994 167.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.81 -163.23 45.64 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.017 -1.633 . . . . 0.94999999999999996 109.017 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.4 m -60.86 148.79 38.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.026 -1.587 . . . . 2.1299999999999999 113.822 -161.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -57.47 130.82 48.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.392 -1.277 . . . . 3.6899999999999999 107.799 165.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.7 mt -106.64 -73.1 0.7 Allowed 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 107.746 -1.205 . . . . 1.6499999999999999 107.746 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.25 144.45 34.04 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.705 -1.22 . . . . 1.72 107.705 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 85.8 m -126.87 160.58 30.53 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.522 -2.029 . . . . 2.1299999999999999 105.522 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.8 131.19 1.85 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.013 -0.835 . . . . 0.79000000000000004 111.013 169.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.6 t -62.94 134.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.669 0.788 . . . . 1.53 109.404 169.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.6 tt -95.67 134.81 31.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.714 0.293 . . . . 2.0499999999999998 111.116 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.54 3.81 0.49 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.062 0.839 . . . . 0.81000000000000005 115.033 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.8 mm -92.77 57.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.52 1.66 . . . . 2.02 110.91 -155.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.57 170.92 20.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.488 0.715 . . . . 2.6899999999999999 110.792 167.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 83.9 mt-30 . . . . . 0 C--O 1.255 1.359 0 N-CA-C 103.065 -2.939 . . . . 5.21 103.065 163.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 107.352 -1.351 . . . . 8.2200000000000006 107.352 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 m -45.25 141.86 2.29 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.313 1.445 . . . . 4.3099999999999996 111.906 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -78.57 174.93 10.85 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.474 0.31 . . . . 4.75 110.643 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.26 41.71 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.003 1.321 . . . . 1.78 107.562 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.92 143.74 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 106.701 -1.592 . . . . 2.0099999999999998 106.701 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.4 93.34 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.698 . . . . 1.51 109.114 156.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.68 100.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.246 -1.39 . . . . 2.1600000000000001 107.246 164.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.9 mt -89.13 143.16 27.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.996 0.518 . . . . 2.1099999999999999 109.767 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -143.73 -64.2 0.38 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.206 -1.035 . . . . 4.9299999999999997 108.206 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.36 -122.9 13.14 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.748 -0.66 . . . . 1.1499999999999999 113.14 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -126.43 -55.98 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.387 0.613 . . . . 2.98 110.014 -152.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.31 164.15 25.07 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 110.049 -1.22 . . . . 0.82999999999999996 110.049 164.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.74 34.25 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.674 2.916 . . . . 1.1200000000000001 113.586 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.5 155.1 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.722 1.609 . . . . 2.25 109.69 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.03 125.69 9.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.799 -1.926 . . . . 2.7999999999999998 105.799 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.61 164.15 31.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.194 -0.763 . . . . 0.82999999999999996 111.194 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.636 -1.616 . . . . 2.0 106.636 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.48 144.06 9.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.432 -1.692 . . . . 3.25 106.432 161.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.5 102.72 7.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.395 1.478 . . . . 2.1800000000000002 107.104 167.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.77 118.76 21.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.615 -1.995 . . . . 3.52 105.615 169.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -142.67 145.84 33.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.52 1.055 . . . . 3.2799999999999998 108.902 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -157.18 146.06 19.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.223 -0.444 . . . . 4.5099999999999998 109.919 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -68.43 -61.26 1.91 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.275 1.03 . . . . 5.8799999999999999 109.755 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -78.48 -175.92 4.52 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 119.018 0.827 . . . . 4.1299999999999999 110.194 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -81.0 -68.68 0.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.035 -1.468 . . . . 3.0800000000000001 107.035 165.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -90.56 106.02 18.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.907 0.883 . . . . 5.5999999999999996 109.293 171.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.08 176.17 45.88 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 107.94 -2.064 . . . . 1.51 107.94 166.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.84 116.84 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.317 2.678 . . . . 1.49 110.635 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.8 t -78.62 147.39 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.312 -0.625 . . . . 1.98 109.312 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -98.14 113.37 25.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.809 -1.552 . . . . 3.9700000000000002 106.809 171.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.6 t -115.25 82.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.996 1.718 . . . . 2.29 106.974 -169.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -98.07 158.84 15.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.078 -0.712 . . . . 0.85999999999999999 109.078 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.72 158.94 29.36 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.769 -0.933 . . . . 0.72999999999999998 110.769 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.9 p -129.16 104.07 7.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.762 -1.94 . . . . 3.4900000000000002 105.762 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.7 141.95 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.082 -1.451 . . . . 1.8100000000000001 107.082 -168.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.11 159.9 41.69 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.593 1.331 . . . . 4.0899999999999999 114.593 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.4 22.84 25.79 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.957 1.742 . . . . 1.1200000000000001 111.81 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.33 -156.05 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.105 -1.072 . . . . 1.8600000000000001 108.105 166.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 m -146.27 152.17 38.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.749 -2.315 . . . . 3.7599999999999998 104.749 165.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -37.98 141.39 0.21 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.273 2.229 . . . . 2.8599999999999999 113.77 -170.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.66 -171.87 26.76 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.238 -0.437 . . . . 0.89000000000000001 112.323 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 151.47 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.286 1.035 . . . . 3.6299999999999999 112.804 -168.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -146.66 118.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.194 1.797 . . . . 1.05 108.154 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.01 154.25 3.89 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.035 -1.226 . . . . 0.64000000000000001 110.035 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -145.47 89.79 1.96 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.612 -1.255 . . . . 4.0800000000000001 107.612 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -128.72 164.58 22.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.156 -1.053 . . . . 1.22 108.156 -160.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 134.0 66.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 122.055 0.931 . . . . 3.1600000000000001 110.488 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -110.05 132.82 53.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.371 1.469 . . . . 0.96999999999999997 107.241 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -74.11 65.95 1.18 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.876 1.27 . . . . 5.7699999999999996 111.19 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.4 171.58 14.16 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.516 -1.675 . . . . 5.6500000000000004 107.446 168.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -105.73 35.73 2.78 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 128.486 2.714 . . . . 6.3399999999999999 109.681 169.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.86 75.14 0.62 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.778 2.031 . . . . 9.9299999999999997 107.863 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -90.05 -52.19 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.206 -0.934 . . . . 6.3600000000000003 110.132 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -56.55 136.15 54.43 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.715 1.206 . . . . 6.5199999999999996 111.495 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.32 145.4 6.27 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.16 -0.682 . . . . 8.4100000000000001 109.16 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.36 56.0 4.87 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.784 -1.727 . . . . 7.0199999999999996 108.784 -162.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.6 m -75.08 59.75 0.97 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.119 1.367 . . . . 3.3999999999999999 109.475 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -118.78 75.55 1.04 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.926 0.891 . . . . 5.6200000000000001 108.666 -154.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 t 179.29 -68.07 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.455 -0.793 . . . . 3.2400000000000002 111.043 -142.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 134.4 57.01 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.945 -0.472 . . . . 3.0099999999999998 110.614 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.25 -126.45 3.2 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.069 -1.213 . . . . 1.54 110.069 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.15 178.68 6.63 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.894 3.062 . . . . 0.94999999999999996 112.629 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.66 126.02 28.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.519 -1.229 . . . . 1.23 108.031 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -5.56 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.243 2.217 . . . . 3.5099999999999998 113.394 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -125.81 130.51 24.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 127.318 2.247 . . . . 3.5699999999999998 108.719 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.73 -43.77 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.8 1.666 . . . . 1.3799999999999999 109.729 173.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.54 -73.11 0.42 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.718 1.207 . . . . 3.5299999999999998 107.923 172.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.5 m -154.0 83.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.423 -0.798 . . . . 3.0 109.767 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -79.5 168.52 19.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.399 -0.593 . . . . 6.0899999999999999 109.399 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -102.93 152.93 20.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 107.264 -1.384 . . . . 4.1600000000000001 107.264 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -75.41 163.21 27.66 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.114 0.87 . . . . 0.93000000000000005 110.349 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.6 -103.54 0.17 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.846 -2.502 . . . . 1.9299999999999999 106.846 167.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.26 -121.21 2.51 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.496 1.148 . . . . 2.8199999999999998 111.547 167.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -86.58 -42.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.541 2.161 . . . . 1.6200000000000001 111.306 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -64.15 0.96 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.095 -1.076 . . . . 5.7300000000000004 108.095 174.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.87 143.09 54.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.265 -0.879 . . . . 2.0699999999999998 109.34 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -54.87 -46.93 74.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 126.449 1.899 . . . . 5.21 111.667 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.59 176.57 6.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.246 1.018 . . . . 3.4700000000000002 110.924 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 154.86 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.616 1.166 . . . . 5.7699999999999996 110.995 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.457 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.6 m80 -54.53 141.86 29.77 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.682 -1.97 . . . . 0.66000000000000003 105.682 155.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.08 -17.81 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.298 -0.561 . . . . 1.79 110.973 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.4 52.37 0.75 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.506 -0.608 . . . . 1.01 114.574 162.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -96.71 124.51 40.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 105.463 -2.051 . . . . 2.3100000000000001 105.463 143.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.06 -51.64 6.52 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.33 0.968 . . . . 3.5 108.399 161.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.49 -115.35 0.64 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.713 -1.355 . . . . 1.0700000000000001 109.713 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -148.63 166.56 27.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.359 1.463 . . . . 2.2400000000000002 109.362 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.3 174.28 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.648 -1.612 . . . . 1.95 106.648 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.4 m -129.02 129.67 45.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 2.75 107.306 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 135.49 37.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.324 -0.621 . . . . 1.8200000000000001 109.324 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.84 -69.91 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.725 1.266 . . . . 4.0199999999999996 110.356 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -168.87 -53.94 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.95 2.1 . . . . 6.25 108.528 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.44 23.29 1.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.934 1.293 . . . . 3.5899999999999999 110.563 -167.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.26 4.97 75.36 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.52 1.057 . . . . 1.1799999999999999 112.182 -174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.85 154.34 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.022 -1.103 . . . . 1.8400000000000001 108.022 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.64 171.32 14.21 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.525 1.13 . . . . 1.8700000000000001 108.079 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.41 151.45 38.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 104.266 -2.494 . . . . 2.75 104.266 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.07 134.19 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 107.788 -1.19 . . . . 2.3100000000000001 107.788 145.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.3 m -155.42 61.35 0.62 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.012 1.725 . . . . 1.1200000000000001 107.748 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -105.91 155.56 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 108.036 -1.098 . . . . 2.3799999999999999 108.036 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.06 118.64 14.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.135 -0.691 . . . . 2.7000000000000002 109.135 150.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.46 -174.4 5.17 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.59 0.71 . . . . 4.0999999999999996 109.664 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.6 p -144.75 51.41 1.25 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.197 -1.038 . . . . 2.4300000000000002 108.197 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.4 -54.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.329 1.452 . . . . 2.6400000000000001 108.957 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -96.32 179.76 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.165 0.986 . . . . 2.3900000000000001 109.928 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.1 m -152.31 176.82 11.22 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.192 -1.41 . . . . 2.5899999999999999 107.192 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.65 47.96 1.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.733 1.254 . . . . 3.79 110.712 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p -95.95 -29.95 13.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.742 2.017 . . . . 4.4699999999999998 112.937 -169.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.55 -179.52 30.55 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 108.008 -2.037 . . . . 3.1899999999999999 108.008 -152.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.0 t70 55.52 -106.9 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.533 1.133 . . . . 4.0899999999999999 110.518 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.01 -11.55 59.97 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.869 0.868 . . . . 5.46 111.409 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -58.5 156.95 9.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.277 -0.889 . . . . 1.3999999999999999 111.647 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 15.2 pt -78.05 -10.28 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.538 -0.744 . . . . 2.8900000000000001 111.904 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.4 mm -40.6 123.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 2.9199999999999999 110.68 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.14 50.89 6.02 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.558 -0.617 . . . . 2.0699999999999998 111.558 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -136.62 153.52 50.92 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.535 1.134 . . . . 4.6600000000000001 109.264 168.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 98.7 m -79.63 115.95 19.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 124.326 1.016 . . . . 2.0099999999999998 108.397 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tt -86.03 136.5 33.22 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 118.901 0.773 . . . . 3.1499999999999999 109.427 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -124.86 120.21 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.958 -1.127 . . . . 1.5700000000000001 107.958 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.94 118.59 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 105.523 -2.029 . . . . 2.8900000000000001 105.523 161.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -90.07 162.83 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.249 1.574 . . . . 0.55000000000000004 115.249 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -38.78 -69.13 0.13 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.068 2.547 . . . . 3.23 111.907 170.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -120.75 -177.71 3.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.622 1.169 . . . . 3.3799999999999999 110.624 -167.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.62 57.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.274 -0.639 . . . . 1.4399999999999999 109.274 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -81.07 156.28 25.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.056 -0.72 . . . . 2.23 109.056 158.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -22.93 60.08 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.332 0.653 . . . . 3.5099999999999998 111.664 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.98 56.77 2.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.823 0.82 . . . . 3.4500000000000002 109.573 -168.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.87 73.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.156 -0.929 . . . . 1.6100000000000001 113.438 157.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -77.3 -23.31 51.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.932 -0.746 . . . . 7.4100000000000001 110.217 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 71.76 -118.66 7.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.415 -1.474 . . . . 4.2400000000000002 109.415 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.72 -68.44 1.57 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.334 -1.506 . . . . 3.8300000000000001 109.334 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -94.41 161.61 14.16 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.79 -1.189 . . . . 2.7599999999999998 107.79 160.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 136' ' ' LYS . 18.2 tt0 -64.62 -53.53 46.16 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.242 -0.286 . . . . 3.5299999999999998 110.649 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -49.03 -40.94 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.818 1.647 . . . . 2.9399999999999999 113.45 -169.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.9 m -47.16 -54.27 11.03 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.77 0.828 . . . . 2.6299999999999999 112.004 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -44.6 60.96 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.46 -0.775 . . . . 2.4199999999999999 111.78 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 132' ' ' GLU . 25.2 tttt -59.62 -50.84 72.33 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.976 0.911 . . . . 3.4300000000000002 111.207 -166.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.457 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.35 0.1 OUTLIER -124.7 -46.39 1.87 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.568 -0.73 . . . . 2.0 111.56 175.086 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.35 -2.1 0.67 Allowed Glycine 0 C--O 1.222 -0.652 0 CA-C-O 118.009 -1.439 . . . . 1.03 115.531 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 27.63 52.72 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.151 2.181 . . . . 4.2800000000000002 114.589 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.21 -16.42 60.48 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.416 -0.803 . . . . 2.0099999999999998 111.93 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.67 -171.32 36.08 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 109.142 -1.583 . . . . 0.95999999999999996 109.142 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -62.46 156.01 23.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.639 -1.28 . . . . 2.0699999999999998 113.564 -164.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -73.1 148.05 44.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.959 -1.019 . . . . 3.3399999999999999 111.14 173.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mt -128.73 -69.43 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.537 -1.283 . . . . 2.0 107.537 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.02 163.58 12.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.918 -0.771 . . . . 2.1000000000000001 108.918 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.9 p -165.07 160.45 18.86 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.678 -1.601 . . . . 1.9099999999999999 106.678 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.49 143.16 3.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 105.766 -2.933 . . . . 1.2 105.766 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.5 t -81.37 139.85 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 117.901 0.851 . . . . 2.1800000000000002 110.213 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.8 tt -86.49 131.88 33.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.899 0.38 . . . . 1.9399999999999999 110.484 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.83 -8.62 0.97 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.048 0.833 . . . . 0.93000000000000005 115.002 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mm -90.56 57.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.662 1.231 . . . . 2.0899999999999999 110.546 -157.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.92 175.87 5.79 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.556 0.742 . . . . 3.4399999999999999 110.465 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 C--O 1.257 1.451 0 N-CA-C 104.113 -2.551 . . . . 4.6799999999999997 104.113 164.814 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.333 -0.365 . . . . 8.2400000000000002 110.856 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 p -70.25 177.58 3.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.08 0.952 . . . . 4.6699999999999999 110.538 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 148.77 23.98 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.584 0.754 . . . . 4.4199999999999999 109.972 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.85 148.41 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.866 1.666 . . . . 1.8400000000000001 108.367 169.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.92 144.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.39 -0.967 . . . . 1.8500000000000001 108.39 165.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.93 97.03 5.3 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.841 -0.8 . . . . 1.6100000000000001 108.841 155.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.26 106.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.992 -1.485 . . . . 1.78 106.992 161.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -90.31 133.91 34.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 1.97 108.456 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -149.45 -50.99 0.15 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.413 0.685 . . . . 4.04 110.527 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.06 -117.5 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.352 0.977 . . . . 0.92000000000000004 113.501 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -114.33 -54.82 2.55 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.661 1.184 . . . . 4.0700000000000003 109.69 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.77 159.73 21.42 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 110.336 -1.106 . . . . 0.89000000000000001 110.336 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.11 40.6 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.342 2.695 . . . . 1.03 112.179 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.59 159.47 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.003 1.721 . . . . 1.95 108.616 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.81 135.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.948 -1.501 . . . . 2.8100000000000001 106.948 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 169.31 42.27 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.916 -1.274 . . . . 0.75 109.916 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.87 110.16 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.115 -1.439 . . . . 1.9399999999999999 107.115 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.2 125.34 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.756 -1.572 . . . . 1.9099999999999999 106.756 168.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -99.36 109.56 22.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.699 -1.963 . . . . 2.6000000000000001 105.699 166.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.01 105.56 17.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.554 -2.017 . . . . 3.6800000000000002 105.554 171.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.25 138.31 49.14 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.948 1.249 . . . . 3.6600000000000001 110.264 169.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -156.67 105.71 2.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.159 -1.052 . . . . 4.1399999999999997 108.159 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -89.36 36.38 0.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.89 0.476 . . . . 8.4399999999999995 111.33 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -125.63 -138.06 0.27 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.221 -1.4 . . . . 4.8499999999999996 107.221 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -130.3 -76.62 0.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.349 0.66 . . . . 3.7400000000000002 109.345 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -101.8 86.04 2.84 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.184 -1.784 . . . . 5.9100000000000001 106.184 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.64 34.68 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.597 -1.001 . . . . 1.95 110.597 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.92 132.11 29.27 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.512 2.808 . . . . 1.8100000000000001 112.297 -170.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.6 t -91.89 149.24 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.307 -0.997 . . . . 2.0899999999999999 108.307 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 121.67 44.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.729 -1.582 . . . . 3.73 106.729 163.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.86 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.245 1.818 . . . . 2.1699999999999999 107.25 -170.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -127.23 126.88 43.52 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 123.507 0.505 . . . . 1.4299999999999999 110.743 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.2 137.02 5.06 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.56 -1.416 . . . . 0.89000000000000001 109.56 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -116.53 110.25 18.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.929 -1.878 . . . . 3.5899999999999999 105.929 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 mm -103.1 152.81 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.595 1.958 . . . . 2.54 108.866 -164.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -149.55 156.17 41.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.28 0.844 . . . . 4.21 113.28 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.52 15.11 33.06 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.782 2.134 . . . . 0.60999999999999999 112.458 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.54 162.49 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.18 0.992 . . . . 2.5600000000000001 110.035 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.49 161.63 24.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.927 -1.138 . . . . 2.2000000000000002 107.927 157.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -56.87 174.85 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.786 0.803 . . . . 2.4399999999999999 111.775 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.8 -169.52 52.4 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.986 0.803 . . . . 0.96999999999999997 113.687 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.82 153.02 44.54 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.892 1.277 . . . . 3.3900000000000001 111.754 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -149.36 117.72 6.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.869 1.667 . . . . 0.60999999999999999 108.365 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.37 150.44 4.32 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.712 -0.955 . . . . 0.37 110.712 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -140.85 95.66 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.827 -1.545 . . . . 4.0099999999999998 106.827 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -134.11 155.97 49.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.033 -1.469 . . . . 0.81999999999999995 107.033 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.27 126.84 67.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.091 -0.707 . . . . 2.6099999999999999 109.091 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -95.2 142.58 27.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.883 1.673 . . . . 0.75 108.376 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -46.49 -64.8 0.67 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.726 1.211 . . . . 4.2599999999999998 110.935 -171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 38.91 54.6 2.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.706 2.403 . . . . 3.2000000000000002 114.73 155.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -50.0 -59.42 3.9 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 127.142 2.177 . . . . 5.6699999999999999 112.787 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -141.71 55.88 1.5 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.741 1.616 . . . . 6.9699999999999998 108.812 -156.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -77.96 -66.64 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.803 -1.09 . . . . 5.1699999999999999 110.767 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.5 t 179.47 -47.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.976 1.71 . . . . 5.6200000000000001 109.781 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 177.25 -48.28 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.322 1.849 . . . . 7.0800000000000001 109.494 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.18 -118.11 2.92 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.549 -1.02 . . . . 5.4500000000000002 110.549 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.1 p -126.85 155.68 42.54 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.307 2.243 . . . . 3.3599999999999999 105.675 172.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.75 -1.81 0.07 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.033 1.494 . . . . 4.5099999999999998 115.033 164.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.2 t -160.3 -48.18 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 116.405 -2.118 . . . . 3.7400000000000002 114.245 -110.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.04 -114.19 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.188 -0.671 . . . . 2.3500000000000001 109.188 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.74 -89.11 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 107.945 -2.062 . . . . 1.73 107.945 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.56 177.65 8.25 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 124.823 3.682 . . . . 1.1200000000000001 112.948 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -66.43 142.02 57.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.921 1.688 . . . . 1.4199999999999999 107.551 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -49.49 115.66 1.43 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.402 0.681 . . . . 2.6600000000000001 110.95 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.58 111.88 9.82 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.995 1.718 . . . . 2.8500000000000001 108.819 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.6 -10.9 29.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.85 1.7 . . . . 2.0099999999999998 113.46 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -146.52 -72.64 0.23 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.745 -0.835 . . . . 3.1600000000000001 108.745 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -161.74 92.7 0.88 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.758 -1.201 . . . . 3.2000000000000002 107.758 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.29 175.53 5.68 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.048 1.739 . . . . 6.4900000000000002 108.202 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 9.9 mtpm? -133.8 153.27 51.84 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.575 1.55 . . . . 4.8700000000000001 107.397 -174.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -87.87 136.98 32.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.807 0.843 . . . . 1.28 109.908 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.68 -66.53 0.14 Allowed Glycine 0 C--O 1.222 -0.636 0 N-CA-C 107.519 -2.232 . . . . 2.7599999999999998 107.519 163.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.0 -170.21 35.37 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.007 1.289 . . . . 1.96 111.595 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.02 -42.61 5.9 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.789 2.326 . . . . 1.6799999999999999 110.343 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.35 -54.08 7.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.546 0.738 . . . . 5.5599999999999996 111.107 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.05 149.31 50.1 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.439 -0.948 . . . . 2.02 108.439 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -49.53 -51.92 33.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.058 0.943 . . . . 3.9500000000000002 110.532 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 59.5 mt-10 -76.11 152.5 36.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.751 1.262 . . . . 3.75 110.694 -163.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -175.05 134.66 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.394 1.478 . . . . 4.3099999999999996 108.177 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.448 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 34.4 m80 -50.87 137.75 20.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.154 -2.165 . . . . 0.77000000000000002 105.154 147.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.44 -24.76 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 119.342 -0.943 . . . . 1.95 109.73 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.65 33.94 4.75 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.133 -1.371 . . . . 0.93000000000000005 116.504 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -102.81 112.95 25.98 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 120.72 2.26 . . . . 2.4100000000000001 107.937 161.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.66 -57.58 3.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.449 -1.315 . . . . 2.5 107.449 160.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.85 -110.63 0.43 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.806 -0.918 . . . . 0.71999999999999997 110.806 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -146.72 169.31 19.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.666 1.186 . . . . 1.8600000000000001 109.898 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.5 176.56 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 105.998 -1.853 . . . . 1.8500000000000001 105.998 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.3 m -140.27 132.71 28.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.363 -2.088 . . . . 2.9399999999999999 105.363 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.666 0.604 . . . . 1.75 110.127 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.72 -80.98 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.119 0.968 . . . . 2.9700000000000002 109.407 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 93' ' ' GLY . 28.2 tttm -160.2 -43.54 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.563 1.145 . . . . 4.8899999999999997 111.878 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -81.99 30.61 0.38 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 123.739 1.733 . . . . 3.2599999999999998 110.833 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 64.72 17.73 63.02 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.002 1.763 . . . . 1.0700000000000001 112.571 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.52 147.82 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.54 -1.281 . . . . 2.0499999999999998 107.54 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.06 175.02 11.35 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.114 -1.439 . . . . 2.0899999999999999 107.114 166.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.31 149.95 29.22 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.386 -1.338 . . . . 3.2400000000000002 107.386 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.37 103.41 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 C-N-CA 125.621 1.569 . . . . 1.9199999999999999 106.791 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.5 m -121.48 87.52 2.77 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.377 1.471 . . . . 1.1499999999999999 107.789 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.8 mt -126.45 160.51 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.555 0.742 . . . . 2.4199999999999999 109.034 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.33 95.78 2.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.194 -0.457 . . . . 2.4100000000000001 111.503 157.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.35 154.46 25.25 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.311 0.577 . . . . 2.0499999999999998 110.243 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.1 p -107.76 -17.54 14.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.224 2.21 . . . . 2.1000000000000001 112.386 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.33 -51.3 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.259 0.936 . . . . 2.1299999999999999 109.426 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -71.81 176.23 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.858 0.837 . . . . 1.9299999999999999 111.051 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -156.85 173.7 16.6 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.877 -1.157 . . . . 2.3500000000000001 107.877 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -43.69 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.761 0.824 . . . . 3.8999999999999999 110.558 169.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.0 t -101.72 35.25 2.37 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.424 -0.797 . . . . 4.7000000000000002 112.389 -158.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -149.65 -137.53 2.78 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 118.805 0.729 . . . . 4.0700000000000003 112.232 -169.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -100.14 -67.97 0.83 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.177 0.991 . . . . 5.9199999999999999 109.338 -166.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -79.87 2.76 22.02 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.24 1.016 . . . . 4.4800000000000004 111.684 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.64 157.42 0.77 Allowed 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.651 1.58 . . . . 1.4199999999999999 112.829 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.4 pt -90.53 -5.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.085 0.954 . . . . 3.23 111.218 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 tp -26.55 126.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.889 1.675 . . . . 3.2200000000000002 111.876 163.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.26 -19.09 37.26 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.827 -0.985 . . . . 1.5700000000000001 113.433 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -88.81 164.08 15.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.576 1.688 . . . . 5.8300000000000001 110.807 -169.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.2 m -89.06 106.17 18.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 119.226 -0.416 . . . . 1.6699999999999999 110.603 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 mt -65.72 146.37 54.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.613 -0.835 . . . . 2.6400000000000001 108.775 166.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 80.6 t -135.47 135.46 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.443 1.897 . . . . 1.76 109.046 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.1 t -102.25 119.62 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.153 1.781 . . . . 3.5899999999999999 106.412 166.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -92.96 159.32 15.38 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 116.839 2.163 . . . . 0.42999999999999999 116.839 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -33.3 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.501 3.121 . . . . 3.3700000000000001 112.364 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -107.14 -175.98 2.95 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.059 0.845 . . . . 3.6200000000000001 110.458 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.86 142.53 45.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.504 -0.924 . . . . 1.73 108.504 158.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.21 165.95 24.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.242 -0.651 . . . . 2.2200000000000002 109.242 159.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -88.45 -7.13 57.08 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.396 1.478 . . . . 3.3500000000000001 111.227 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.28 46.16 27.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.346 1.458 . . . . 2.8100000000000001 110.2 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.27 24.06 58.45 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.644 -0.531 . . . . 1.7 113.627 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -78.34 -13.66 59.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.441 1.121 . . . . 5.8200000000000003 110.633 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.0 -133.34 11.74 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.588 -1.005 . . . . 3.8500000000000001 110.588 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.95 -68.32 1.33 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.221 -1.552 . . . . 3.3199999999999998 109.221 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.09 150.97 19.61 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.222 -1.029 . . . . 2.6499999999999999 108.222 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.24 -48.76 79.99 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.81 -0.556 . . . . 3.5 111.248 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -51.94 -33.46 37.56 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.114 1.366 . . . . 3.8500000000000001 111.777 -168.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.2 t -39.39 -62.56 0.65 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.386 1.474 . . . . 2.6899999999999999 110.466 167.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.3 p -73.77 -46.46 45.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.762 0.425 . . . . 2.0800000000000001 110.757 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -42.92 86.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.026 0.53 . . . . 3.6400000000000001 110.858 -167.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.448 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.6 p -128.33 -48.07 1.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.355 0.662 . . . . 1.99 112.127 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.31 -31.85 0.71 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.103 1.335 . . . . 1.1299999999999999 111.038 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 52.99 54.68 10.06 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.628 1.971 . . . . 3.6499999999999999 112.606 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.54 -43.11 33.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.12 0.962 . . . . 2.29 108.875 162.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 116.05 -143.42 18.07 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 107.986 -2.046 . . . . 1.25 107.986 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.5 m -60.61 149.6 34.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.574 1.149 . . . . 1.8100000000000001 112.459 -169.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -60.5 135.01 57.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 3.6499999999999999 108.878 168.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -112.19 -82.27 0.59 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.887 -1.153 . . . . 1.75 107.887 165.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.04 145.42 29.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.672 -1.233 . . . . 2.2999999999999998 107.672 171.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 77.7 m -141.24 154.29 45.7 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.137 -1.431 . . . . 2.21 107.137 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.06 128.64 1.5 Allowed Glycine 0 CA--C 1.527 0.796 0 O-C-N 123.614 0.571 . . . . 0.88 111.735 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.95 132.28 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.676 1.19 . . . . 1.49 109.223 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.1 tt -95.7 138.79 20.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 111.688 0.255 . . . . 1.8400000000000001 111.688 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.69 0.03 1.6 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.062 0.839 . . . . 0.57999999999999996 115.048 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.62 57.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 119.11 1.455 . . . . 1.8999999999999999 110.914 -157.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.39 169.07 25.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.196 0.598 . . . . 2.0899999999999999 110.547 168.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 . . . . . 0 C--O 1.253 1.272 0 N-CA-C 102.057 -3.312 . . . . 4.9199999999999999 102.057 162.701 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 107.664 -1.236 . . . . 8.6099999999999994 107.664 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.99 86.84 2.17 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.796 0.839 . . . . 4.4500000000000002 109.805 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.11 177.35 8.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.753 1.221 . . . . 3.8900000000000001 108.369 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.79 139.9 34.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.933 -1.506 . . . . 1.9099999999999999 106.933 153.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -98.2 147.26 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.132 -1.803 . . . . 1.9099999999999999 106.132 159.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.77 96.13 3.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.404 -0.962 . . . . 1.79 108.404 160.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.06 109.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.381 -1.34 . . . . 1.98 107.381 168.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.52 128.77 42.65 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.176 0.591 . . . . 1.8700000000000001 109.901 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -140.15 -65.05 0.47 Allowed 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.848 0.859 . . . . 4.9199999999999999 110.858 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.58 -122.74 5.81 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.791 1.186 . . . . 1.05 112.94 -170.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -118.89 -49.81 2.41 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.179 0.991 . . . . 3.0800000000000001 109.67 -155.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.3 154.96 8.06 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 108.803 -1.719 . . . . 0.96999999999999997 108.803 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.33 42.8 1.29 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.175 2.583 . . . . 1.1000000000000001 113.385 -165.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -84.98 153.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.191 1.396 . . . . 2.3199999999999998 110.298 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.61 75.69 1.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.37 -0.974 . . . . 3.52 108.37 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 165.27 16.89 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.65000000000000002 112.522 -171.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.51 133.22 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.11 0.964 . . . . 2.4300000000000002 109.546 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.6 mm -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.513 1.525 . . . . 2.0099999999999998 107.708 161.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -121.45 119.09 31.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.554 -1.646 . . . . 1.8999999999999999 106.554 158.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -128.07 120.54 27.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.442 -1.318 . . . . 4.5099999999999998 107.442 -169.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.81 165.07 37.62 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.45 0.643 . . . . 4.3700000000000001 112.191 -166.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -153.84 157.04 38.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.501 -2.037 . . . . 3.0600000000000001 105.501 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.26 -29.77 64.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.043 0.383 . . . . 5.8899999999999997 110.894 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.52 -150.5 0.43 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.946 -1.501 . . . . 5.6200000000000001 106.946 174.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.0 m -146.17 1.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.708 -1.245 . . . . 4.9800000000000004 113.866 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -124.26 39.93 3.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.067 1.747 . . . . 4.0499999999999998 109.728 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.84 -162.23 10.81 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.377 -1.089 . . . . 1.8899999999999999 110.377 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.98 114.5 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.155 2.57 . . . . 1.5700000000000001 111.139 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.1 158.54 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.089 -0.708 . . . . 1.99 109.089 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -106.37 112.54 25.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.18 -1.045 . . . . 3.2200000000000002 108.18 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -80.55 122.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.198 -1.778 . . . . 2.5899999999999999 106.198 164.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -125.98 145.54 50.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.675 -0.861 . . . . 1.29 108.675 154.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.41 155.4 26.68 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.673 -0.971 . . . . 0.76000000000000001 110.673 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -134.62 108.19 7.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.099 -2.186 . . . . 2.8500000000000001 105.099 -173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.3 149.01 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.014 -1.476 . . . . 2.1099999999999999 107.014 -167.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -155.32 157.28 36.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.957 -0.464 . . . . 4.6600000000000001 110.509 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.38 22.08 30.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.832 1.682 . . . . 0.90000000000000002 111.909 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.02 168.11 19.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.109 -1.071 . . . . 1.5800000000000001 108.109 168.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -74.85 169.17 18.45 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.216 -1.031 . . . . 2.8199999999999998 108.216 153.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.11 174.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.275 1.43 . . . . 3.9100000000000001 111.044 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -162.83 37.14 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.822 -0.626 . . . . 0.60999999999999999 113.531 167.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.67 141.23 57.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.929 1.292 . . . . 2.98 113.27 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.3 114.64 7.53 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.486 1.514 . . . . 0.73999999999999999 109.751 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.46 145.14 2.81 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.497 1.046 . . . . 0.48999999999999999 110.665 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.18 93.57 3.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 3.75 106.972 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -131.35 154.48 48.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.24 -0.437 . . . . 0.94999999999999996 109.862 -161.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.02 116.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.375 -1.342 . . . . 3.3300000000000001 107.375 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -103.84 139.67 38.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.24 -1.393 . . . . 1.1000000000000001 107.24 170.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.35 35.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.802 1.408 . . . . 5.3399999999999999 114.802 -171.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.7 mt-10 -90.78 59.98 4.32 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.507 -1.371 . . . . 3.3700000000000001 112.365 -159.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.74 73.23 7.73 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.266 -0.642 . . . . 6.8300000000000001 109.266 173.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 58' ' ' THR . 16.4 p-10 -123.0 56.8 1.15 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.228 -1.027 . . . . 7.54 108.228 162.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -51.98 -40.23 60.6 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.594 -0.691 . . . . 6.2599999999999998 110.956 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -77.3 43.58 0.38 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.873 0.869 . . . . 6.3200000000000003 112.105 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -172.98 -53.57 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 125.951 1.7 . . . . 6.8799999999999999 108.038 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.28 -100.84 0.14 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.918 -1.273 . . . . 4.2300000000000004 109.918 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.5 p 178.92 54.22 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.721 2.008 . . . . 4.3300000000000001 107.088 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.423 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 0.6 OUTLIER -151.73 70.53 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.188 0.595 . . . . 4.7599999999999998 109.628 -142.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.8 t -175.82 5.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 117.14 2.274 . . . . 4.9900000000000002 117.14 -143.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -134.98 168.76 18.53 Favored 'General case' 0 C--O 1.228 -0.058 0 N-CA-C 108.284 -1.006 . . . . 2.9199999999999999 108.284 160.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.15 -91.84 1.63 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.726 -1.75 . . . . 1.6699999999999999 108.726 173.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.74 -179.06 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 125.843 4.362 . . . . 1.27 112.7 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -53.1 131.6 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.615 1.566 . . . . 1.4399999999999999 110.236 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -42.44 114.03 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.771 1.228 . . . . 4.2000000000000002 109.712 170.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -156.29 165.95 17.51 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 106.671 -1.603 . . . . 3.2400000000000002 106.671 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.39 -35.09 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.549 1.499 . . . . 1.47 111.487 -167.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -147.22 -82.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.876 0.87 . . . . 3.8999999999999999 109.194 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.4 m -139.03 64.94 1.46 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.383 1.073 . . . . 2.5699999999999998 110.617 -168.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -77.67 175.27 10.07 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.532 0.682 . . . . 4.8700000000000001 109.3 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -120.83 146.47 46.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.473 1.509 . . . . 3.9300000000000002 107.189 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -72.31 167.31 20.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.568 0.747 . . . . 1.29 110.873 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.03 -138.45 2.68 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 106.699 -2.56 . . . . 2.0099999999999998 106.699 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.75 -144.26 4.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.882 -2.087 . . . . 2.2400000000000002 107.882 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.57 -41.24 6.47 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.176 1.988 . . . . 2.1000000000000001 109.901 174.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -58.03 7.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.724 0.81 . . . . 6.4800000000000004 111.802 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.16 145.44 37.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.576 -0.528 . . . . 2.04 109.576 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -55.97 -44.54 78.6 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.77 1.628 . . . . 4.1200000000000001 111.156 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -78.92 179.45 7.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.012 0.925 . . . . 2.8700000000000001 111.243 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 157.67 144.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.391 3.076 . . . . 3.8300000000000001 106.369 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.439 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.4 m80 -59.96 141.23 55.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 105.536 -2.024 . . . . 0.55000000000000004 105.536 156.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.68 71.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 123.117 1.437 . . . . 2.4300000000000002 108.165 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.26 26.73 0.26 Allowed Glycine 0 CA--C 1.542 1.774 0 C-N-CA 126.779 2.133 . . . . 2.1200000000000001 113.59 -155.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -130.51 145.75 51.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 120.518 2.159 . . . . 2.5099999999999998 108.032 146.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -104.95 -42.36 5.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.794 0.837 . . . . 2.71 108.79 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.28 -121.82 1.11 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 109.076 -1.61 . . . . 0.68000000000000005 109.076 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -139.82 169.22 18.12 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.381 1.473 . . . . 2.3799999999999999 109.076 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.34 175.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 1.73 106.653 163.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -106.68 142.63 36.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.967 -1.494 . . . . 3.2999999999999998 106.967 156.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.75 152.05 31.7 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.24 -1.022 . . . . 1.53 108.24 152.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.32 -78.9 0.09 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.666 0.786 . . . . 2.8599999999999999 110.303 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -154.39 -52.43 0.09 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.716 1.606 . . . . 5.54 107.948 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.63 4.03 17.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.084 1.754 . . . . 5.0099999999999998 111.748 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.07 10.16 72.25 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.907 1.241 . . . . 0.84999999999999998 111.682 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -79.17 147.38 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 1.75 107.694 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.05 167.76 21.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.244 1.018 . . . . 1.99 108.755 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -130.64 144.59 51.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 103.901 -2.629 . . . . 2.7000000000000002 103.901 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.06 111.04 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 106.704 -1.591 . . . . 1.97 106.704 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -140.17 104.82 4.9 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.952 0.901 . . . . 1.54 108.773 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.04 151.9 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.662 -0.866 . . . . 2.7799999999999998 108.662 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.32 98.55 3.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.626 0.37 . . . . 2.5899999999999999 110.152 158.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.58 160.12 20.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.512 0.325 . . . . 2.6400000000000001 110.155 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -116.95 57.18 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.353 1.461 . . . . 2.5099999999999998 109.312 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -139.56 -64.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 108.025 -1.102 . . . . 1.97 108.025 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -75.88 175.58 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.345 0.593 . . . . 2.73 110.905 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -153.94 176.0 12.7 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.554 1.541 . . . . 2.52 107.01 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 11.78 33.63 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.676 1.58 . . . . 3.1699999999999999 114.486 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.3 t -73.99 -73.28 0.23 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.362 0.528 . . . . 3.23 111.654 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -171.15 171.94 44.18 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.665 -0.974 . . . . 3.46 110.665 -172.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 51.87 -80.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.164 0 C-N-CA 128.273 2.629 . . . . 5.25 113.162 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -77.43 -25.4 50.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.275 1.83 . . . . 5.2599999999999998 110.304 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -53.83 160.24 1.46 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.891 0.477 . . . . 2.04 110.528 171.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.5 pt -78.96 -7.05 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.208 -0.308 . . . . 3.0299999999999998 110.28 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -44.98 129.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.267 0.627 . . . . 2.4100000000000001 109.744 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.21 -5.36 84.47 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 118.143 -1.365 . . . . 1.3400000000000001 113.839 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -98.26 162.3 13.26 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 120.199 2.0 . . . . 4.9299999999999997 111.655 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.0 m -94.65 107.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.059 0.943 . . . . 2.0800000000000001 109.319 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.83 133.52 45.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.398 -0.964 . . . . 2.5699999999999998 108.398 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.94 134.23 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 126.846 2.058 . . . . 1.72 106.516 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -101.47 128.84 53.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.624 -1.621 . . . . 2.6600000000000001 106.624 165.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -104.86 161.13 14.45 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 116.037 1.865 . . . . 0.56999999999999995 116.037 -169.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -37.32 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.41 2.684 . . . . 3.4100000000000001 112.06 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -101.27 -174.85 2.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.599 0.636 . . . . 3.4500000000000002 109.905 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.11 156.94 11.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.722 -0.844 . . . . 1.6799999999999999 108.722 157.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -80.4 164.59 22.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.902 0.858 . . . . 2.1600000000000001 109.14 152.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.418 ' CB ' ' HG ' ' A' ' 134' ' ' SER . 73.5 m-20 -88.06 -4.61 58.76 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.321 1.448 . . . . 3.2400000000000002 112.354 -172.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 56.16 33.79 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.638 1.175 . . . . 2.5 110.561 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.98 25.33 65.93 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.392 -0.671 . . . . 1.4399999999999999 112.46 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -131.97 21.11 4.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.261 1.031 . . . . 6.0199999999999996 111.731 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.32 147.04 18.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.707 -0.957 . . . . 3.4700000000000002 110.707 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.73 60.07 2.95 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.874 -0.89 . . . . 3.2200000000000002 110.874 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -176.67 106.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 105.232 -2.136 . . . . 2.8300000000000001 105.232 -169.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -31.92 46.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.021 0.749 . . . . 3.8199999999999998 113.021 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -36.01 -43.61 0.33 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.076 1.75 . . . . 2.9399999999999999 112.783 166.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.418 ' HG ' ' CB ' ' A' ' 125' ' ' ASP . 20.9 t -43.78 -63.91 0.76 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.954 1.701 . . . . 3.2799999999999998 110.205 173.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.39 -46.11 61.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.818 -0.551 . . . . 3.0099999999999998 110.988 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -56.06 -45.75 79.18 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 123.642 0.777 . . . . 4.0499999999999998 110.875 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.439 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 2.7 p -130.81 -47.88 1.04 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 119.127 -0.463 . . . . 2.4700000000000002 112.022 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.41 -31.2 0.86 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.699 0.682 . . . . 1.0 112.647 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.41 54.21 5.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.098 1.359 . . . . 2.3100000000000001 110.09 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.83 -36.03 81.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.23 1.412 . . . . 2.4199999999999999 112.792 174.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 -174.05 49.77 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.396 -1.882 . . . . 0.91000000000000003 108.396 -160.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.1 m -59.53 151.61 23.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.439 1.495 . . . . 2.0699999999999998 113.385 -166.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 50' ' ' GLU . 4.8 mmt-85 -60.6 135.0 57.63 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.114 1.366 . . . . 4.0499999999999998 108.522 168.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.4 mt -112.19 -68.93 0.9 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.618 -1.253 . . . . 1.6100000000000001 107.618 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.6 166.41 11.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.185 -0.461 . . . . 2.0099999999999998 110.209 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.2 p -146.81 161.12 41.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.953 -1.021 . . . . 2.5299999999999998 108.507 165.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.94 131.62 1.57 Allowed Glycine 0 CA--C 1.526 0.779 0 O-C-N 125.07 1.481 . . . . 0.79000000000000004 110.288 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.13 134.6 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 123.743 0.817 . . . . 2.1400000000000001 109.433 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.4 tt -91.8 126.37 44.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 C-N-CA 123.236 0.615 . . . . 1.9399999999999999 111.439 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.74 -5.75 0.84 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.467 1.032 . . . . 0.70999999999999996 114.911 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.82 59.54 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.816 1.308 . . . . 2.46 110.297 -155.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.49 175.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.866 0.841 . . . . 2.2799999999999998 113.181 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 C--O 1.248 1.001 0 N-CA-C 104.555 -2.387 . . . . 6.7000000000000002 104.555 160.571 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 112.989 0.737 . . . . 7.75 112.989 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 153' ' ' GLN . 1.5 m 66.82 58.87 0.59 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.52 1.928 . . . . 3.8900000000000001 110.223 -162.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -139.16 167.74 21.39 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.826 0.45 . . . . 5.2300000000000004 112.002 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.42 155.09 19.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.718 1.207 . . . . 1.8200000000000001 109.043 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.24 151.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.614 -1.254 . . . . 1.78 107.614 162.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.75 102.39 6.07 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.86 0.864 . . . . 1.96 108.765 157.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.61 105.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.149 -1.426 . . . . 1.8999999999999999 107.149 161.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -86.18 129.7 34.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.005 -1.109 . . . . 2.0299999999999998 108.005 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -151.58 -51.69 0.12 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.958 0.408 . . . . 4.0 110.552 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.24 -111.16 1.06 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.472 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.99 -48.44 2.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.483 1.113 . . . . 3.6299999999999999 109.429 -161.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.65 171.65 33.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.212 1.387 . . . . 0.84999999999999998 112.048 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -69.64 -19.05 37.2 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.587 2.858 . . . . 1.3799999999999999 111.961 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.68 146.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.203 1.401 . . . . 1.9399999999999999 111.072 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.11 122.05 5.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.783 -0.821 . . . . 2.6000000000000001 108.783 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.41 169.75 32.79 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.843 -0.503 . . . . 0.72999999999999998 111.843 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.84 113.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.059 -1.089 . . . . 2.4300000000000002 108.059 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -79.49 137.16 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.936 -1.135 . . . . 1.9399999999999999 107.936 167.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -109.66 118.46 36.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.008 -1.849 . . . . 1.9199999999999999 106.008 157.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.04 98.04 7.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.575 1.55 . . . . 4.2800000000000002 106.89 176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -109.13 137.13 47.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.441 -0.948 . . . . 5.1699999999999999 108.441 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -147.42 -62.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.54 -0.911 . . . . 4.0599999999999996 108.54 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 tttp 72.82 -48.41 0.68 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.834 1.654 . . . . 9.5 112.243 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 99.75 5.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.69 -1.226 . . . . 3.7799999999999998 107.69 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.4 t -19.36 -66.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.854 2.461 . . . . 3.5499999999999998 114.954 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -109.61 27.16 9.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.564 0.746 . . . . 4.4500000000000002 110.579 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.42 171.49 33.67 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.562 -1.015 . . . . 1.6399999999999999 110.562 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.13 139.5 66.99 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.948 1.766 . . . . 1.3100000000000001 110.257 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.81 159.86 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.274 -1.01 . . . . 2.4199999999999999 108.274 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 110.85 13.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.28 -1.378 . . . . 4.2300000000000004 107.28 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.73 118.04 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 127.124 2.17 . . . . 2.1099999999999999 107.139 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -139.03 167.22 22.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.935 -0.395 . . . . 1.2 109.935 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.15 175.31 38.95 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.699 -1.76 . . . . 1.01 108.699 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.1 p -130.15 113.84 14.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.807 -2.294 . . . . 2.5699999999999998 104.807 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.31 109.81 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.283 -2.117 . . . . 2.21 105.283 -166.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -111.38 162.61 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.731 0.645 . . . . 4.5800000000000001 111.731 -166.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.55 80.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.219 -0.901 . . . . 0.78000000000000003 112.95 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -69.44 160.51 31.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.588 1.194 . . . . 1.6499999999999999 108.488 172.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.42 163.88 17.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.949 -1.13 . . . . 2.6299999999999999 107.949 154.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -58.61 170.11 0.82 Allowed 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.443 -0.786 . . . . 2.8900000000000001 111.295 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.58 -158.87 53.66 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.655 -0.702 . . . . 0.77000000000000002 112.693 165.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -70.86 144.44 50.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.849 1.259 . . . . 3.8500000000000001 112.59 -171.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -146.36 118.5 8.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.909 1.684 . . . . 0.85999999999999999 109.294 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.99 149.86 4.18 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.923 -0.871 . . . . 0.35999999999999999 110.923 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -142.84 94.91 2.69 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.834 -1.543 . . . . 3.6499999999999999 106.834 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -136.6 144.82 44.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.704 -1.221 . . . . 0.81999999999999995 107.704 -164.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.2 p -99.63 127.03 52.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 119.17 0.896 . . . . 2.8900000000000001 109.894 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -97.1 136.23 37.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.356 -1.35 . . . . 0.77000000000000002 107.356 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.76 -32.29 59.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.169 0.988 . . . . 4.3200000000000003 112.111 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -4.58 100.64 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.525 2.73 . . . . 3.0299999999999998 113.068 158.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.63 178.44 6.04 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.067 1.747 . . . . 5.54 112.348 -163.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -80.19 58.64 3.09 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.553 1.941 . . . . 7.0899999999999999 110.19 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.92 -18.36 22.02 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.452 1.901 . . . . 5.6200000000000001 111.83 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.0 t -169.92 -163.16 0.35 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.414 -1.699 . . . . 5.3799999999999999 106.414 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.63 -53.99 6.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.357 0.663 . . . . 7.9400000000000004 110.605 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.13 -166.19 39.36 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.87 0.748 . . . . 4.8600000000000003 112.546 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 65.1 m -59.2 151.86 21.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.377 0.671 . . . . 2.98 109.818 173.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 m -151.38 -8.56 0.23 Allowed 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 114.018 1.118 . . . . 6.9199999999999999 114.018 163.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.298 2.4 p -173.8 2.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 119.497 3.147 . . . . 4.9500000000000002 119.497 -117.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.31 178.72 9.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.322 0.965 . . . . 2.4900000000000002 110.606 164.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.55 -85.31 1.15 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.684 -1.767 . . . . 1.49 108.684 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.1 178.88 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.607 1 C-N-CA 125.774 4.316 . . . . 1.01 113.308 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -67.96 132.88 48.13 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.572 1.549 . . . . 1.3100000000000001 110.106 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -44.99 114.03 0.66 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.942 0.897 . . . . 4.4900000000000002 111.68 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.92 157.36 31.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.634 1.574 . . . . 3.48 106.875 168.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.06 -24.13 13.03 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.958 1.772 . . . . 1.5600000000000001 113.609 -168.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.0 tp -156.2 -72.32 0.11 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.03 0.832 . . . . 4.4699999999999998 110.856 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.6 m -154.09 63.21 0.7 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.266 0.555 . . . . 2.75 110.21 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -78.09 168.76 19.38 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.353 -0.98 . . . . 4.7199999999999998 108.353 162.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -128.76 165.11 21.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.026 1.331 . . . . 5.5499999999999998 108.214 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -94.66 132.25 39.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.665 -0.865 . . . . 1.1699999999999999 108.665 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.92 -56.84 0.08 OUTLIER Glycine 0 C--O 1.224 -0.522 0 N-CA-C 108.095 -2.002 . . . . 2.96 108.095 171.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 140.33 173.41 13.34 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.457 1.503 . . . . 2.0299999999999998 110.083 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.04 -31.13 66.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.902 2.402 . . . . 2.1600000000000001 111.037 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -73.84 -40.63 63.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.099 0.96 . . . . 4.7800000000000002 111.059 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -70.42 176.12 4.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.91 0.884 . . . . 1.8500000000000001 111.288 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.48 -48.96 20.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.386 1.074 . . . . 4.4299999999999997 109.734 168.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.38 149.85 26.45 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.654 1.216 . . . . 3.4700000000000002 112.185 -171.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -168.1 129.28 1.38 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.977 2.111 . . . . 6.6100000000000003 107.488 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.459 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 50.1 m80 -51.62 131.58 29.88 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.463 -2.421 . . . . 0.63 104.463 145.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.09 -35.47 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.933 -0.765 . . . . 2.4300000000000002 108.933 -169.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.76 38.95 2.98 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.537 1.065 . . . . 0.87 115.289 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -90.16 129.21 36.46 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.206 -2.146 . . . . 2.3799999999999999 105.206 152.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.67 -51.75 6.25 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.735 -1.209 . . . . 3.0 107.735 156.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.35 -104.63 0.26 Allowed Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.977 -1.249 . . . . 0.62 109.977 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -148.49 170.64 17.59 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.799 1.64 . . . . 2.1899999999999999 109.57 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.81 162.32 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.069 -1.456 . . . . 1.78 107.069 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.6 m -109.4 129.79 55.53 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 108.012 -1.107 . . . . 3.1800000000000002 108.012 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.51 139.26 34.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.744 0.818 . . . . 1.8799999999999999 111.513 168.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.13 -90.67 0.08 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 124.045 0.841 . . . . 3.0800000000000001 110.574 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 93' ' ' GLY . 1.1 tpmt? -141.2 -34.38 0.49 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.395 0.887 . . . . 5.0499999999999998 113.395 -162.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -78.81 14.75 1.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.911 1.339 . . . . 3.6699999999999999 110.385 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 62.33 20.88 61.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.115 -1.194 . . . . 0.72999999999999998 110.115 -166.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -92.24 117.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 123.995 0.918 . . . . 2.4199999999999999 108.573 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.21 143.81 26.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.899 -1.889 . . . . 2.0800000000000001 105.899 149.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.35 108.1 8.97 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 105.44 -2.059 . . . . 5.21 105.44 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.85 141.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.84 -1.073 . . . . 2.5800000000000001 110.601 -148.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.7 t -146.13 113.29 6.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.188 -1.412 . . . . 4.29 107.188 162.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.4 mt -137.15 144.86 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 105.88 -1.896 . . . . 2.5499999999999998 105.88 166.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -125.71 96.36 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.945 0.35 . . . . 2.46 111.945 165.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.9 145.39 34.13 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.274 0.559 . . . . 2.6299999999999999 110.719 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.6 p -98.35 -20.52 17.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.394 1.878 . . . . 2.1699999999999999 111.27 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.42 -49.6 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.305 0.502 . . . . 1.8600000000000001 109.875 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.2 pt -75.43 177.74 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.761 0.791 . . . . 2.73 111.438 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.8 m -157.41 175.76 13.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.78 1.632 . . . . 2.23 107.417 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.1 mt -124.31 54.99 1.32 Allowed 'General case' 0 C--N 1.338 0.08 0 C-N-CA 124.534 1.133 . . . . 5.2300000000000004 108.754 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t -134.72 -127.12 0.16 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.203 1.801 . . . . 3.6200000000000001 107.351 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.75 156.89 48.41 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 114.498 0.559 . . . . 3.4100000000000001 114.498 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.2 t70 52.76 -88.66 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.642 2.377 . . . . 4.5700000000000003 114.521 155.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -73.54 -20.85 60.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.49 1.116 . . . . 7.4100000000000001 110.448 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.2 m -50.43 130.81 24.2 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.591 -0.892 . . . . 2.6400000000000001 108.591 167.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 pp -78.78 -24.36 13.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.693 -0.403 . . . . 3.1299999999999999 110.449 -163.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 tp -1.79 113.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.33 2.652 . . . . 3.02 114.099 161.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.59 37.62 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.971 0.796 . . . . 1.74 113.183 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -83.0 169.48 15.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.542 1.171 . . . . 4.71 110.24 -171.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.2 m -95.45 108.81 21.05 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.735 -0.603 . . . . 2.02 110.459 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.84 131.32 44.3 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.368 -1.345 . . . . 2.5299999999999998 107.368 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.09 139.89 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 127.265 2.226 . . . . 1.6200000000000001 107.845 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 m -108.86 130.19 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.85 -0.796 . . . . 2.9100000000000001 108.85 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -99.09 159.79 14.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 116.01 1.856 . . . . 0.40000000000000002 116.01 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -40.65 -74.66 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.302 2.241 . . . . 3.0899999999999999 112.562 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -97.13 -179.34 4.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.198 1.399 . . . . 3.3100000000000001 110.637 -171.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.38 149.96 5.2 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 1.75 109.473 156.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.5 149.04 26.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.152 -1.055 . . . . 2.1400000000000001 108.152 162.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.72 -8.6 59.34 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.233 0.827 . . . . 3.4199999999999999 113.233 -164.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 47.48 38.12 7.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.169 0.985 . . . . 3.2999999999999998 110.413 -165.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.25 25.48 57.42 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.533 -0.758 . . . . 2.0 113.001 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -113.85 40.38 2.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.22 1.01 . . . . 6.1100000000000003 108.655 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.0 134.6 9.0 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.895 -1.682 . . . . 3.1499999999999999 108.895 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.67 -35.51 92.13 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 117.509 0.655 . . . . 2.79 111.756 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -58.71 107.94 0.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.961 0.904 . . . . 2.6400000000000001 108.719 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -41.93 -42.65 2.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 3.8999999999999999 112.817 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -36.43 -41.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.73 2.012 . . . . 3.5800000000000001 113.978 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.5 m -54.93 -48.26 73.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.452 0.701 . . . . 2.73 111.631 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.7 p -73.08 -46.33 52.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.361 -0.837 . . . . 2.0 110.482 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -51.83 -49.74 62.23 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.685 1.194 . . . . 3.3599999999999999 111.264 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.459 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.9 OUTLIER -125.0 -46.52 1.82 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.607 0.763 . . . . 1.9399999999999999 111.142 175.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.91 2.02 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 119.086 0.857 . . . . 0.93999999999999995 112.197 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.64 54.28 9.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.187 1.795 . . . . 2.1800000000000002 111.181 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.01 -5.36 58.28 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.26 -0.9 . . . . 2.2799999999999998 111.804 169.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.74 -165.23 45.71 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.083 -1.607 . . . . 0.93999999999999995 109.083 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.1 m -57.94 150.85 19.56 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.554 1.542 . . . . 1.8 113.678 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.1 mmt-85 -54.7 135.79 46.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.082 -1.417 . . . . 3.6299999999999999 108.275 164.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.5 mt -106.89 -76.63 0.61 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.953 -1.499 . . . . 1.74 106.953 166.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 144.98 32.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.477 -0.934 . . . . 1.72 108.477 170.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.46 150.36 48.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.119 -1.808 . . . . 1.71 106.119 172.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.48 119.94 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.424 -1.07 . . . . 0.93999999999999995 110.424 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.47 130.21 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.046 1.338 . . . . 2.2200000000000002 108.923 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.7 tt -105.65 133.12 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.962 0.727 . . . . 2.4300000000000002 112.962 -169.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.87 8.43 0.47 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.313 0.959 . . . . 0.82999999999999996 114.205 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.7 mm -91.88 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 120.045 1.922 . . . . 2.3199999999999998 109.867 -162.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.7 176.83 12.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.952 1.301 . . . . 2.1200000000000001 108.333 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.413 ' C ' ' H ' ' A' ' 2' ' ' THR . 38.4 mt-30 . . . . . 0 C--O 1.254 1.331 0 N-CA-C 107.014 -1.476 . . . . 5.3600000000000003 107.014 166.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 108.146 -1.057 . . . . 5.6399999999999997 108.146 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 m 54.76 56.04 7.17 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.928 -1.878 . . . . 5.0199999999999996 105.928 -161.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -89.96 173.51 8.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.155 -1.384 . . . . 4.6600000000000001 108.502 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.63 141.19 49.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.948 -1.131 . . . . 1.6699999999999999 107.948 159.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.0 t -103.81 142.83 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.195 -1.409 . . . . 1.6299999999999999 107.195 163.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.35 96.9 5.22 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.13 0.972 . . . . 1.54 108.418 158.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.41 106.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.083 -1.451 . . . . 1.77 107.083 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 mt -99.17 133.95 42.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.166 0.986 . . . . 2.0600000000000001 109.196 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -143.47 -52.27 0.35 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.108 0.563 . . . . 4.1600000000000001 110.066 172.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.7 -121.67 27.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.878 0.751 . . . . 0.88 113.286 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -120.28 -54.66 2.09 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 125.128 1.371 . . . . 3.9900000000000002 110.008 -164.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.5 162.96 13.66 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.756 -1.338 . . . . 0.83999999999999997 109.756 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.52 33.54 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.389 2.726 . . . . 0.95999999999999996 113.141 -172.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.17 155.79 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.784 1.234 . . . . 2.1000000000000001 108.956 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -154.98 122.21 5.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.507 1.523 . . . . 3.3199999999999998 107.243 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.41 169.09 38.36 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.883 -0.887 . . . . 0.57999999999999996 110.883 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.06 109.07 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.784 -1.562 . . . . 2.1000000000000001 106.784 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.0 mm -79.03 126.45 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.531 -1.655 . . . . 1.8 106.531 168.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -101.99 109.08 20.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.63 -1.618 . . . . 1.6499999999999999 106.63 160.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.31 96.43 10.66 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.028 -1.842 . . . . 4.0099999999999998 106.028 168.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.58 165.37 15.51 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.425 -0.954 . . . . 3.23 108.425 163.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -157.24 -50.39 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.279 0.632 . . . . 3.9399999999999999 109.411 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt 70.99 -61.33 0.48 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 127.594 2.358 . . . . 4.8499999999999996 111.156 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -80.89 118.86 22.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.083 -0.71 . . . . 4.1600000000000001 109.083 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 m -20.24 -66.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.233 3.013 . . . . 3.8799999999999999 116.05 -172.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -123.9 52.55 1.45 Allowed 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 107.623 -1.251 . . . . 4.6299999999999999 107.623 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.98 178.09 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.761 -1.336 . . . . 1.8400000000000001 109.761 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.01 132.7 30.92 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.107 1.871 . . . . 1.8700000000000001 111.283 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.6 124.2 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 108.747 -0.834 . . . . 2.2799999999999998 108.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -99.3 89.99 4.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.434 2.694 . . . . 6.2199999999999998 105.538 -170.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 t -83.54 126.1 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.138 1.775 . . . . 2.1899999999999999 107.161 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -140.69 140.23 34.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.715 -0.846 . . . . 0.90000000000000002 108.715 158.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.48 145.75 8.75 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 105.806 -2.918 . . . . 0.82999999999999996 105.806 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.4 m -127.13 78.49 1.81 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.2 -1.778 . . . . 3.5800000000000001 106.2 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.38 134.15 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 128.38 2.672 . . . . 1.8899999999999999 108.48 -162.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -129.48 163.01 26.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 118.741 0.701 . . . . 5.2400000000000002 111.475 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.09 24.27 52.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.113 0.863 . . . . 0.89000000000000001 111.993 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.16 -150.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.497 -1.297 . . . . 1.6299999999999999 107.497 163.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 m -147.34 152.35 38.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.36 -2.459 . . . . 3.8199999999999998 104.36 164.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -32.8 138.1 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.484 2.314 . . . . 2.7999999999999998 113.862 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.77 -166.4 28.92 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.212 0.434 . . . . 0.78000000000000003 112.995 167.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.29 147.24 53.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.091 1.356 . . . . 3.3100000000000001 112.829 -166.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -149.39 115.57 5.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.796 1.639 . . . . 0.65000000000000002 109.002 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.23 155.83 2.51 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.749 0.704 . . . . 0.58999999999999997 111.449 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -149.25 100.6 3.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.69 -0.855 . . . . 4.0599999999999996 108.69 -169.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -137.59 175.42 9.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.596 -1.261 . . . . 0.87 107.596 -166.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.76 137.73 56.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.837 0.827 . . . . 2.8999999999999999 109.135 165.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -101.3 178.76 4.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.673 1.589 . . . . 0.93000000000000005 107.224 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -107.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.251 -1.018 . . . . 5.54 108.251 174.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 46.61 59.29 3.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.194 1.397 . . . . 3.2000000000000002 111.591 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.76 -105.89 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.132 0.973 . . . . 5.1399999999999997 110.8 -177.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -84.06 63.61 7.72 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.523 -1.361 . . . . 6.7199999999999998 110.786 -169.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -60.17 1.61 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.83 0.852 . . . . 5.3899999999999997 109.674 -174.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.6 m -159.09 -56.45 0.06 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.959 0.904 . . . . 4.4199999999999999 109.532 -173.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -165.35 -43.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.453 1.101 . . . . 6.5099999999999998 110.716 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.14 -138.99 2.6 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.391 -1.084 . . . . 5.54 110.391 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 71.0 m -47.16 128.19 11.35 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 124.927 1.291 . . . . 3.2400000000000002 111.27 -172.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.99 0.34 0.22 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.19 1.552 . . . . 6.6200000000000001 115.19 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.7 m -172.33 -59.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 118.653 2.834 . . . . 2.9100000000000001 118.653 -123.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.49 -179.39 4.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.586 0.708 . . . . 2.52 110.723 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.44 -89.56 0.97 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.356 -1.898 . . . . 1.9399999999999999 108.356 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.87 179.02 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 125.136 3.89 . . . . 1.4399999999999999 112.919 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -65.46 138.4 58.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.16 1.784 . . . . 1.53 111.694 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -45.18 108.45 0.12 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.085 1.754 . . . . 3.48 111.993 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -150.24 154.82 36.73 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 125.727 1.611 . . . . 3.3999999999999999 107.454 166.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.51 -42.0 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.17 1.913 . . . . 1.54 112.667 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -142.33 -68.07 0.37 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.029 0.531 . . . . 4.4500000000000002 110.937 -175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -154.12 64.92 0.7 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.632 -0.668 . . . . 2.8199999999999998 111.532 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -78.02 166.25 23.05 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.952 -1.129 . . . . 4.8200000000000003 107.952 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -123.71 176.93 5.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.26 1.824 . . . . 6.1399999999999997 106.846 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -101.63 148.62 25.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.982 -0.449 . . . . 1.1599999999999999 111.515 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.58 -61.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.465 -1.054 . . . . 2.9700000000000002 110.465 173.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.23 -172.55 29.28 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.904 1.24 . . . . 2.1899999999999999 114.206 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 -41.49 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.769 2.313 . . . . 1.95 109.787 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -70.64 -47.55 59.47 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.735 0.814 . . . . 6.0700000000000003 111.239 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.84 175.21 1.56 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.108 -0.496 . . . . 2.5600000000000001 109.681 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.6 -39.92 21.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.986 -0.746 . . . . 8.0 108.986 165.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 147.14 39.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 117.237 -1.785 . . . . 3.8100000000000001 110.576 -165.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 167.58 127.89 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.548 2.339 . . . . 3.98 108.262 -167.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 53.7 m80 -49.25 127.63 15.2 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 106.815 -1.55 . . . . 1.1000000000000001 106.815 163.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 p -52.69 -34.62 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.544 0.572 . . . . 2.3500000000000001 112.544 -154.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.76 83.42 0.77 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.967 -0.853 . . . . 1.25 110.967 166.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -161.98 111.74 1.54 Allowed 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.789 -0.83 . . . . 2.4399999999999999 108.84 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -90.02 -53.01 4.67 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.883 0.473 . . . . 3.3999999999999999 110.743 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.62 -102.74 0.22 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.572 -0.823 . . . . 0.81000000000000005 111.998 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.18 166.79 27.77 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.92 1.288 . . . . 2.1000000000000001 110.176 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.62 175.58 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.865 1.666 . . . . 1.73 106.612 167.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 t -127.36 134.43 49.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.624 -0.88 . . . . 2.6800000000000002 108.624 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.74 135.99 36.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 123.227 0.611 . . . . 1.6799999999999999 110.411 165.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.19 -92.16 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.795 1.638 . . . . 3.1899999999999999 110.238 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -115.03 -67.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.616 0.767 . . . . 6.8600000000000003 110.864 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.3 -32.44 49.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 122.062 0.934 . . . . 3.4700000000000002 110.262 -168.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.24 46.41 0.07 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.597 -2.201 . . . . 1.3100000000000001 107.597 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.51 111.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.36 1.864 . . . . 1.8200000000000001 106.901 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.33 174.29 5.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.091 -1.078 . . . . 1.9399999999999999 108.091 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -145.52 149.61 34.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.787 -1.56 . . . . 3.1000000000000001 106.787 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.16 54.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.288 0.992 . . . . 2.04 111.293 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.3 m -70.07 91.8 0.71 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.839 -0.538 . . . . 1.76 110.717 165.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.62 149.83 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.926 0.89 . . . . 2.7200000000000002 108.646 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -113.23 89.6 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.729 -0.841 . . . . 3.7400000000000002 108.729 160.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -77.88 148.54 34.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.224 0.92 . . . . 2.3500000000000001 109.77 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.3 p -115.01 -6.69 12.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.926 1.69 . . . . 2.71 112.729 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.4 t -78.79 -54.73 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 119.546 1.066 . . . . 2.6699999999999999 109.615 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -86.85 176.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.977 0.894 . . . . 1.98 111.403 178.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -145.17 160.94 40.66 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.093 -1.817 . . . . 2.5 106.093 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.93 24.9 7.9 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.064 0.946 . . . . 3.48 111.644 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 t -76.8 -162.97 0.3 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.069 0.548 . . . . 3.3700000000000001 109.657 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.75 67.75 0.23 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.859 -1.696 . . . . 3.98 108.859 172.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -142.44 -129.49 0.09 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.852 -1.166 . . . . 4.79 107.852 -172.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -79.19 2.23 21.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.122 1.369 . . . . 5.8899999999999997 111.155 171.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p -50.48 158.01 0.66 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.836 2.454 . . . . 1.46 112.408 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.2 pt -84.12 -5.72 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.961 -0.563 . . . . 3.2799999999999998 111.429 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -51.0 136.59 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 O-C-N 122.016 -0.427 . . . . 3.1000000000000001 110.207 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.88 30.01 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.614 -1.103 . . . . 1.76 112.45 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -89.59 166.06 13.87 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.8 1.8 . . . . 5.46 112.614 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 m -85.54 104.09 14.98 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.537 0.735 . . . . 2.1000000000000001 109.878 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tt -69.42 147.8 50.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.585 -0.894 . . . . 3.1099999999999999 108.585 170.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.56 128.85 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.339 1.056 . . . . 1.5700000000000001 109.088 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -100.66 125.7 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 106.429 -1.693 . . . . 3.3300000000000001 106.429 162.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -98.29 174.17 6.63 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.316 1.846 . . . . 0.51000000000000001 115.035 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.497 -1.229 . . . . 4.96 111.984 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -178.42 6.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 121.079 1.763 . . . . 4.4199999999999999 110.98 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.38 156.25 13.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.213 -0.903 . . . . 1.9099999999999999 109.671 164.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.39 151.24 28.02 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.256 1.023 . . . . 2.9199999999999999 110.027 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.55 -10.64 58.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.623 0.769 . . . . 3.1499999999999999 112.679 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 49.06 35.57 7.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.394 1.478 . . . . 3.0699999999999998 110.904 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.96 22.28 54.54 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 121.494 -0.754 . . . . 1.99 112.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -116.88 -33.5 4.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.871 0.836 . . . . 6.0300000000000002 110.967 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.64 137.15 39.64 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.474 -0.65 . . . . 3.7000000000000002 111.474 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.04 69.31 1.6 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.082 0.849 . . . . 3.1200000000000001 112.27 -170.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -162.33 155.47 20.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.74 1.616 . . . . 2.6800000000000002 107.096 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.42 -40.8 97.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.227 0.467 . . . . 3.21 112.237 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -57.55 -30.94 65.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.032 0.533 . . . . 2.77 111.37 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -49.44 -69.68 0.11 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.965 0.906 . . . . 2.6499999999999999 110.277 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.2 p -69.28 -42.42 75.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.461 -0.774 . . . . 2.04 110.422 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -61.42 -35.62 78.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.31 0.505 . . . . 4.2699999999999996 111.892 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.416 1.3 t -139.11 -58.3 0.6 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.919 -1.039 . . . . 3.2000000000000002 113.203 177.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.06 -18.19 0.47 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 120.194 1.361 . . . . 1.05 111.8 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.6 t30 51.09 54.64 10.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.654 1.582 . . . . 2.6299999999999999 111.107 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.88 -52.62 5.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.531 0.682 . . . . 2.4300000000000002 110.473 170.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.63 -169.46 32.89 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.836 -1.706 . . . . 1.3100000000000001 108.836 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -58.4 161.55 4.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.744 1.618 . . . . 3.0 111.293 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmt-85 -58.66 137.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.938 -1.028 . . . . 3.9399999999999999 108.356 166.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.82 -70.65 0.8 Allowed 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.134 -1.432 . . . . 1.6699999999999999 107.134 163.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.32 157.22 16.55 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.672 -0.695 . . . . 2.1099999999999999 109.322 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.65 159.53 16.54 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 124.02 0.825 . . . . 1.5 109.129 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.58 141.39 3.42 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 107.068 -2.413 . . . . 1.03 107.068 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.7 133.15 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 123.999 0.919 . . . . 2.0 110.174 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.8 tt -89.17 138.68 18.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 122.766 0.426 . . . . 1.8899999999999999 110.903 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.85 1.39 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.15 0.881 . . . . 0.69999999999999996 114.687 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.93 59.42 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.062 1.431 . . . . 1.97 110.686 -161.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.08 177.64 8.43 Favored 'General case' 0 C--N 1.335 -0.022 0 N-CA-C 113.502 0.927 . . . . 2.5800000000000001 113.502 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.255 1.384 0 N-CA-C 103.098 -2.927 . . . . 6.3799999999999999 103.098 150.787 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 107.481 -1.303 . . . . 6.2699999999999996 107.481 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.9 m -74.5 114.9 13.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.931 -1.137 . . . . 3.5499999999999998 107.931 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 166.99 22.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.595 -0.891 . . . . 4.96 108.595 177.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.9 154.8 36.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.453 -1.314 . . . . 1.8300000000000001 107.453 163.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.78 144.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 104.883 -2.266 . . . . 2.0 104.883 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.69 94.53 4.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.129 0.893 . . . . 1.52 108.887 159.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.55 108.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.162 -1.421 . . . . 1.8 107.162 164.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.13 125.06 36.65 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.416 -0.587 . . . . 2.0299999999999998 109.416 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -143.7 -55.5 0.38 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.067 0.547 . . . . 4.5 110.263 165.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.7 -110.57 0.85 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.783 -0.927 . . . . 1.1399999999999999 110.783 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.76 -48.11 1.92 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.45 1.1 . . . . 3.6699999999999999 109.9 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.54 161.43 12.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 112.086 -0.406 . . . . 1.0900000000000001 112.086 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.37 29.98 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.097 3.198 . . . . 1.1899999999999999 114.215 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.04 160.88 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.142 1.377 . . . . 2.2599999999999998 108.787 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 97.8 1.93 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.786 -1.931 . . . . 3.0800000000000001 105.786 168.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.45 167.17 24.84 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.933 -0.467 . . . . 0.53000000000000003 111.933 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.33 121.44 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.555 -0.906 . . . . 2.04 108.555 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.3 mm -87.7 142.35 13.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 107.413 -1.328 . . . . 2.0600000000000001 107.413 162.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.48 129.73 47.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.92 1.288 . . . . 1.8600000000000001 107.525 169.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.0 131.03 53.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.226 1.81 . . . . 4.1399999999999997 107.197 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 153.98 48.9 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.522 -0.918 . . . . 4.0700000000000003 108.522 162.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.71 81.5 0.88 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.424 1.89 . . . . 4.0 107.486 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -40.44 -57.21 1.85 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.261 1.425 . . . . 5.3200000000000003 112.437 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.07 126.53 35.15 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.43 1.092 . . . . 3.8700000000000001 109.271 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -19.49 -66.68 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.277 2.631 . . . . 3.8300000000000001 114.57 174.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -118.5 42.2 2.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.391 1.076 . . . . 4.7000000000000002 109.214 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 175.29 48.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.333 -1.507 . . . . 1.72 109.333 168.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.66 142.9 72.61 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.024 1.816 . . . . 1.29 109.592 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.31 151.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.096 -1.075 . . . . 2.27 108.096 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -126.75 120.4 29.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.599 -1.26 . . . . 5.0099999999999998 107.599 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.02 134.28 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.613 1.965 . . . . 2.27 107.261 -171.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -133.22 156.02 48.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.415 -2.068 . . . . 0.94999999999999996 105.415 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 145.78 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.939 -1.664 . . . . 0.75 108.939 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -122.96 94.46 4.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.823 -2.288 . . . . 2.46 104.823 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.71 142.03 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.765 -1.198 . . . . 1.75 107.765 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -152.3 147.59 26.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 115.112 1.523 . . . . 4.2000000000000002 115.112 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.65 23.17 8.97 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.834 2.159 . . . . 0.93000000000000005 111.999 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -74.6 166.49 23.46 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.851 -1.166 . . . . 1.8100000000000001 107.851 167.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.24 165.45 20.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.889 -1.152 . . . . 2.7400000000000002 107.889 152.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.04 173.73 0.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.412 -0.805 . . . . 2.3399999999999999 110.513 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.14 -161.37 53.22 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.251 -0.431 . . . . 0.67000000000000004 113.053 165.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.29 140.27 58.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.481 1.112 . . . . 3.0899999999999999 113.357 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -144.24 116.03 8.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.543 1.537 . . . . 0.72999999999999998 109.85 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.7 148.57 4.63 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.685 0.659 . . . . 0.56000000000000005 111.792 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 100.01 4.67 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.891 1.676 . . . . 4.5 107.334 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -133.98 160.49 37.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.396 -2.076 . . . . 1.01 105.396 -169.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.11 125.92 74.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.482 -0.933 . . . . 2.8599999999999999 108.482 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.39 -161.35 0.73 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.316 1.046 . . . . 1.55 108.819 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -73.75 -129.01 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.083 0.953 . . . . 3.75 109.917 163.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 59.05 65.84 1.14 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.727 1.211 . . . . 3.0600000000000001 112.723 168.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -51.63 -42.51 62.08 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.797 0.839 . . . . 4.5800000000000001 110.652 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -125.59 128.12 47.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.511 -1.292 . . . . 4.8700000000000001 107.511 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.76 29.14 2.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.814 2.046 . . . . 4.8300000000000001 109.702 170.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 m -74.08 72.63 1.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.905 0.882 . . . . 5.6500000000000004 110.322 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -173.92 -44.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.096 1.758 . . . . 5.6200000000000001 108.924 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.84 144.42 3.91 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 107.339 -2.305 . . . . 4.1799999999999997 107.339 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.02 41.81 0.99 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.31 1.055 . . . . 2.6499999999999999 109.968 -171.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -86.28 50.27 1.95 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.446 1.098 . . . . 5.5899999999999999 111.488 -161.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.2 p 166.58 172.93 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.035 -1.098 . . . . 4.8300000000000001 108.035 -133.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 134.94 -112.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 130.523 3.529 . . . . 3.6200000000000001 110.267 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.53 -173.81 25.77 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 106.733 -2.547 . . . . 2.52 106.733 -158.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.92 178.27 6.67 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.658 3.572 . . . . 1.4399999999999999 113.958 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -74.01 58.22 0.66 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.145 1.778 . . . . 2.1600000000000001 111.606 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 51.92 69.02 0.72 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.255 1.022 . . . . 2.6800000000000002 109.639 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -90.85 115.31 64.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.016 -0.992 . . . . 2.9500000000000002 108.482 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.29 -43.8 1.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.842 1.695 . . . . 1.48 110.685 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -146.22 -67.25 0.28 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.232 1.013 . . . . 3.2200000000000002 108.884 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.5 m -153.39 63.99 0.75 Allowed 'General case' 0 N--CA 1.457 -0.125 0 O-C-N 121.524 -0.735 . . . . 2.2599999999999998 110.488 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -78.19 165.47 23.89 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.253 -0.647 . . . . 4.3700000000000001 109.253 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -133.66 154.26 51.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.148 1.379 . . . . 3.9399999999999999 109.012 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -89.53 169.64 11.18 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.124 . . . . 0.81999999999999995 110.245 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.93 -40.21 0.17 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 107.761 -2.136 . . . . 2.6600000000000001 107.761 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.29 -175.63 54.54 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.706 1.622 . . . . 2.2200000000000002 110.842 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.05 -8.9 23.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.584 2.856 . . . . 2.3399999999999999 114.167 -171.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -27.07 42.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.779 0.718 . . . . 7.4199999999999999 111.435 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.26 176.6 5.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.77 1.628 . . . . 2.7000000000000002 109.428 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.9 -47.04 40.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.962 -0.755 . . . . 4.7999999999999998 108.962 162.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -78.43 138.35 38.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.674 1.226 . . . . 3.0499999999999998 111.536 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -160.45 154.35 22.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.36 -2.83 . . . . 6.1900000000000004 103.36 173.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.1 m80 -64.92 159.66 22.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 117.794 -1.563 . . . . 0.75 106.88 162.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.08 40.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 122.984 1.373 . . . . 2.1099999999999999 110.876 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -170.73 42.2 0.19 Allowed Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 128.257 2.837 . . . . 1.5 108.563 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -126.12 109.07 11.95 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.795 -1.187 . . . . 2.46 107.795 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.82 -50.3 10.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.419 -0.956 . . . . 2.8199999999999998 108.419 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.8 -120.69 0.99 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.43 -1.068 . . . . 1.1699999999999999 110.43 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -155.19 166.3 34.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.127 1.371 . . . . 2.3300000000000001 108.672 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.98 171.77 16.38 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 N-CA-C 108.206 -1.035 . . . . 1.8400000000000001 108.206 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 m -114.87 118.57 33.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.477 -1.305 . . . . 3.02 107.477 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.81 140.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.375 0.534 . . . . 1.6899999999999999 110.319 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.2 -80.93 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.309 1.044 . . . . 3.0299999999999998 111.739 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -157.39 -48.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.107 1.363 . . . . 4.4900000000000002 109.898 -170.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.76 13.78 1.56 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.012 1.325 . . . . 2.79 111.214 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.02 14.64 76.21 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.197 0.903 . . . . 0.75 111.256 -175.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.4 145.18 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.226 1.41 . . . . 2.0600000000000001 107.73 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.67 164.83 29.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.652 1.181 . . . . 1.8 108.516 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.12 143.85 51.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.959 -2.608 . . . . 2.73 103.959 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.99 56.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 123.801 0.688 . . . . 1.72 112.096 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.0 m -74.39 91.61 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.712 -0.617 . . . . 1.4299999999999999 110.935 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.2 mt -129.46 159.05 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.588 0.755 . . . . 2.5099999999999998 108.984 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.76 93.66 2.54 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 3.0299999999999998 111.392 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.9 126.09 30.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.717 0.807 . . . . 2.54 109.582 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 p -95.54 1.73 53.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.249 1.42 . . . . 2.29 112.567 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.54 -44.82 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.519 0.727 . . . . 2.4100000000000001 109.795 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pt -74.65 175.75 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.845 -0.742 . . . . 2.3999999999999999 109.762 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 p -151.96 176.94 10.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.918 1.287 . . . . 2.7400000000000002 107.784 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.0 mt -131.95 57.8 1.76 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.374 1.87 . . . . 5.1500000000000004 110.725 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.6 m -96.04 -22.04 17.61 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.722 0.638 . . . . 3.6499999999999999 112.722 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.86 38.76 10.05 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.113 -1.195 . . . . 4.4699999999999998 110.113 -169.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.94 -120.91 0.3 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.803 2.041 . . . . 4.0899999999999999 106.049 172.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -78.14 -2.81 39.34 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.39 0.995 . . . . 6.0 111.117 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.0 p -48.14 151.26 1.02 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.351 1.46 . . . . 1.3200000000000001 111.157 167.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.3 pt -77.95 -6.47 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.841 0.682 . . . . 3.0499999999999998 112.841 -174.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.3 mm -32.01 116.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.1 1.36 . . . . 2.9900000000000002 110.323 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.49 10.87 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 112.12 -0.392 . . . . 1.75 112.12 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -136.1 164.6 27.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.499 -1.667 . . . . 7.3799999999999999 106.499 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.01 113.23 23.44 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.602 1.092 . . . . 2.6299999999999999 109.558 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.35 145.09 53.24 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.267 -1.753 . . . . 3.3799999999999999 106.267 167.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.5 t -130.98 135.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.137 1.775 . . . . 1.8799999999999999 109.066 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -101.79 123.65 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.756 1.223 . . . . 2.8199999999999998 107.711 164.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -95.96 165.69 12.14 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 117.378 2.362 . . . . 0.81999999999999995 117.378 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.47 -66.43 0.56 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.16 -1.836 . . . . 3.4700000000000002 110.971 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -90.28 -179.5 5.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.958 0.885 . . . . 4.9000000000000004 110.566 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.87 46.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.073 -1.454 . . . . 1.49 107.073 153.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -83.05 162.49 21.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.894 -0.78 . . . . 2.0699999999999998 108.894 161.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.74 -8.28 59.62 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.484 0.714 . . . . 3.0099999999999998 112.106 -169.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 51.18 38.78 22.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.014 0.926 . . . . 2.5299999999999998 109.101 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 48.78 33.04 11.98 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.529 1.062 . . . . 1.4399999999999999 112.798 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -77.48 -25.33 50.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.095 0.948 . . . . 5.71 110.039 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 133.25 -130.28 5.68 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.964 -0.854 . . . . 3.9700000000000002 110.964 161.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.49 -73.72 0.02 OUTLIER Glycine 0 C--N 1.34 0.772 0 C-N-CA 126.372 1.939 . . . . 3.0099999999999998 111.414 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.21 165.46 24.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.834 1.654 . . . . 3.0299999999999998 108.286 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -79.06 -52.02 8.78 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.874 -0.787 . . . . 3.8100000000000001 108.874 162.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.18 -40.69 11.61 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.992 2.117 . . . . 4.3600000000000003 111.49 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.8 p -39.16 -64.46 0.46 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.798 2.039 . . . . 2.3999999999999999 111.003 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.7 p -71.66 -45.86 60.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.717 -0.674 . . . . 2.3199999999999998 110.497 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -58.09 -50.13 74.54 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.403 0.681 . . . . 3.73 111.313 -165.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.514 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.384 1.3 p -125.63 -45.76 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.678 -0.677 . . . . 2.6899999999999999 112.665 168.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.44 0.13 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.428 1.013 . . . . 0.95999999999999996 114.803 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 54.28 55.53 8.04 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.628 1.571 . . . . 2.7200000000000002 111.557 -167.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.12 -3.07 9.22 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.453 0.909 . . . . 2.1899999999999999 113.453 169.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.47 -64.8 4.21 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 120.549 -1.344 . . . . 3.2400000000000002 111.127 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -165.2 168.18 17.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.163 0.985 . . . . 2.46 111.808 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.33 133.86 34.94 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.242 2.217 . . . . 3.4300000000000002 107.33 172.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.35 -77.93 0.56 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.158 -1.052 . . . . 1.72 108.158 166.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.19 154.01 42.21 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.901 -1.148 . . . . 2.2799999999999998 107.901 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 16.6 p -142.8 171.51 13.95 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.352 -1.295 . . . . 1.99 108.959 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.16 142.71 5.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.744 -1.342 . . . . 0.69999999999999996 109.744 174.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.34 126.91 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 108.735 -0.839 . . . . 2.0600000000000001 108.735 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.3 126.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.722 -0.844 . . . . 3.79 108.722 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.46 -5.97 1.42 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 115.014 0.766 . . . . 0.76000000000000001 115.014 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.3 59.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 118.638 1.219 . . . . 1.8600000000000001 110.627 -156.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.39 172.07 7.2 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.661 0.743 . . . . 2.5899999999999999 111.643 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.25 1.083 0 N-CA-C 103.44 -2.8 . . . . 5.9900000000000002 103.44 144.599 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 106.217 -1.771 . . . . 7.4699999999999998 106.217 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.58 56.39 0.17 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.842 -1.54 . . . . 5.0199999999999996 106.842 -157.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 138.09 51.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.56 -0.745 . . . . 3.46 110.803 -173.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.48 131.9 34.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.586 -1.265 . . . . 1.98 107.586 163.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -98.52 142.12 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.688 -0.856 . . . . 1.6799999999999999 108.688 165.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.63 97.57 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.581 -0.896 . . . . 1.74 108.581 154.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.02 107.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.207 -1.405 . . . . 1.9199999999999999 107.207 163.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.3 mt -93.96 133.19 37.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.911 -0.774 . . . . 2.1200000000000001 108.911 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -138.08 -56.52 0.66 Allowed 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.541 -0.911 . . . . 5.2699999999999996 108.541 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.04 -121.34 24.89 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.789 -1.096 . . . . 0.88 111.957 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.08 -49.27 1.71 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.903 0.881 . . . . 3.48 109.497 -155.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.36 164.19 20.27 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 109.841 -1.303 . . . . 0.87 109.841 167.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.61 40.92 0.9 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.614 2.876 . . . . 1.0700000000000001 112.617 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.2 t -94.51 155.11 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.539 1.535 . . . . 1.6399999999999999 109.846 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.38 123.24 8.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.231 -1.396 . . . . 2.9500000000000002 107.231 168.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.94 167.32 33.73 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.543 -1.023 . . . . 0.71999999999999997 110.543 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.19 118.28 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.767 -1.568 . . . . 2.1600000000000001 106.767 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -85.02 128.55 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.259 -1.756 . . . . 1.9099999999999999 106.259 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -111.59 113.68 26.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.366 -1.716 . . . . 2.8599999999999999 106.366 166.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.88 115.6 30.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.613 -1.625 . . . . 3.9300000000000002 106.613 173.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -139.14 160.37 39.96 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.054 0.843 . . . . 3.3700000000000001 109.609 170.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -155.26 145.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.594 -2.002 . . . . 3.1699999999999999 105.594 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -45.5 44.25 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.008 -0.738 . . . . 5.7300000000000004 109.008 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -78.73 178.2 8.07 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.118 1.767 . . . . 3.8100000000000001 109.189 168.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.3 p -123.8 21.47 9.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.98 0.912 . . . . 3.21 111.382 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -167.41 38.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.593 0.633 . . . . 4.0999999999999996 111.557 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.69 -157.84 7.66 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.042 -1.623 . . . . 1.48 109.042 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.36 135.41 33.9 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.161 2.574 . . . . 1.3700000000000001 110.348 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -78.97 164.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.394 -0.965 . . . . 1.9399999999999999 108.394 173.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -115.57 125.21 52.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.634 -1.987 . . . . 3.6899999999999999 105.634 167.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.1 114.75 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.586 1.554 . . . . 2.1099999999999999 107.352 -171.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -125.9 133.53 51.87 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.189 0.93 . . . . 0.92000000000000004 110.408 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.2 160.16 33.73 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.385 -1.086 . . . . 0.82999999999999996 110.385 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 p -135.29 107.17 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.229 -1.397 . . . . 2.6200000000000001 107.229 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.78 119.91 59.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.559 -1.645 . . . . 2.04 106.559 -159.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -124.35 152.21 43.43 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.946 0.498 . . . . 5.8799999999999999 110.062 -160.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.58 27.04 64.0 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.444 -0.344 . . . . 0.82999999999999996 113.823 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -67.0 -169.41 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.581 -0.952 . . . . 1.8200000000000001 108.478 157.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.51 165.94 10.81 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 105.518 -2.03 . . . . 4.46 105.518 146.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 178.9 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.83 2.052 . . . . 3.3599999999999999 112.43 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.58 -169.45 53.38 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.357 -0.838 . . . . 0.55000000000000004 111.933 169.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.77 147.17 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.475 0.71 . . . . 3.0800000000000001 111.493 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -143.92 121.16 11.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.945 1.698 . . . . 0.58999999999999997 108.473 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.07 149.03 7.59 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.519 -1.433 . . . . 0.48999999999999999 109.519 169.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -143.25 83.48 1.79 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.644 -1.243 . . . . 3.6299999999999999 107.644 -169.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -124.64 146.38 49.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.885 -1.052 . . . . 1.1699999999999999 109.071 -160.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.22 106.44 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.436 -0.95 . . . . 3.5899999999999999 108.436 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -82.35 150.21 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.903 -0.777 . . . . 0.89000000000000001 108.903 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.26 19.84 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.376 1.471 . . . . 3.96 113.374 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -88.57 67.09 8.41 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.648 -1.283 . . . . 3.1600000000000001 110.138 -167.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -75.3 60.18 1.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.498 0.666 . . . . 4.9100000000000001 109.514 160.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.7 t0 178.42 155.09 0.39 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.456 2.302 . . . . 5.2999999999999998 106.512 164.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -158.37 34.99 0.24 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.83 1.652 . . . . 5.3399999999999999 111.985 157.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.6 t -74.59 33.28 0.09 Allowed 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.971 -1.081 . . . . 5.5700000000000003 113.759 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -168.82 -50.39 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.089 1.756 . . . . 7.3700000000000001 107.839 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -169.47 157.72 29.65 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.488 -1.845 . . . . 4.8600000000000003 108.488 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.8 t -76.53 56.41 1.11 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.937 1.295 . . . . 2.8999999999999999 109.582 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.5 m -148.49 78.68 1.42 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.478 -0.489 . . . . 4.5700000000000003 111.402 -152.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -174.28 -51.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.709 1.744 . . . . 2.6899999999999999 115.709 -146.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.17 100.31 10.52 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.622 1.169 . . . . 2.5800000000000001 110.589 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.9 -65.89 3.14 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.987 -0.896 . . . . 1.5600000000000001 111.661 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.85 172.72 2.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.771 1.647 . . . . 2.2999999999999998 115.016 -166.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -83.01 56.68 3.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 113.121 -1.854 . . . . 2.1299999999999999 110.559 -172.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 53.32 80.09 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.406 0.682 . . . . 2.9300000000000002 109.476 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -107.85 103.85 51.1 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.181 0.993 . . . . 3.1200000000000001 110.425 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.82 -30.98 39.95 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.997 1.798 . . . . 1.3500000000000001 112.251 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.0 tp -155.93 -67.4 0.11 Allowed 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.554 0.616 . . . . 3.98 110.038 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 p -151.99 60.72 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.21 0.529 . . . . 2.79 110.621 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -77.51 165.99 23.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.384 -0.598 . . . . 4.8799999999999999 109.384 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -137.83 162.68 33.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.068 1.347 . . . . 8.4100000000000001 107.819 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -94.27 153.23 18.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.135 1.374 . . . . 0.79000000000000004 113.374 -158.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.48 171.93 45.0 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 107.763 -2.135 . . . . 2.4399999999999999 107.763 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.84 -171.23 30.75 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.165 0.412 . . . . 2.02 112.832 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.49 -31.18 51.64 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.515 2.144 . . . . 1.8400000000000001 109.582 172.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.63 -43.1 73.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.915 0.486 . . . . 5.29 111.496 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -69.22 161.96 28.12 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.673 0.749 . . . . 2.4300000000000002 112.144 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -75.5 -46.89 29.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.896 2.078 . . . . 4.3200000000000003 109.33 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -77.05 159.45 29.86 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.1 -1.074 . . . . 4.3099999999999996 108.1 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 158.98 127.1 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.463 2.305 . . . . 3.9700000000000002 106.441 -163.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 45.4 m80 -62.29 150.8 38.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.963 -1.495 . . . . 0.56000000000000005 106.963 163.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.82 -16.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 120.255 -0.578 . . . . 1.6699999999999999 110.38 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.56 56.58 0.46 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.959 0.79 . . . . 0.84999999999999998 113.336 161.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -123.59 117.99 26.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.022 1.411 . . . . 2.4199999999999999 108.771 158.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.6 -56.66 3.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.068 -1.086 . . . . 2.6099999999999999 108.068 164.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.65 -121.95 1.05 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.319 -0.712 . . . . 0.81999999999999995 111.319 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -143.11 165.28 27.83 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.895 1.678 . . . . 2.4900000000000002 108.112 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.31 166.74 28.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.699 -1.223 . . . . 1.75 107.699 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.3 m -123.41 116.42 23.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.234 1.014 . . . . 2.75 108.67 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.58 139.3 35.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.033 0.379 . . . . 1.55 111.076 171.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.07 -84.16 0.12 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.956 0.502 . . . . 4.0999999999999996 111.053 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 -53.19 0.93 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.231 0.612 . . . . 5.4000000000000004 112.082 -161.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.18 30.12 1.0 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 124.53 2.11 . . . . 3.3100000000000001 109.972 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 57.69 27.66 59.16 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 113.619 -1.628 . . . . 0.77000000000000002 110.833 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.27 103.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.56 1.144 . . . . 1.95 108.101 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.92 166.77 12.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.336 1.054 . . . . 1.75 108.267 160.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.7 141.82 47.73 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.452 -2.425 . . . . 2.8500000000000001 104.452 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.16 116.6 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.881 -1.525 . . . . 2.0699999999999998 106.881 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -137.46 80.29 1.8 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.068 1.747 . . . . 1.1699999999999999 106.738 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.2 mm -125.75 156.95 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.135 0.574 . . . . 3.5600000000000001 109.57 -170.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -151.36 71.54 1.01 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.733 0.813 . . . . 2.8900000000000001 110.93 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.96 119.23 22.52 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.126 -0.359 . . . . 3.29 111.738 -168.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.6 p -79.4 65.19 4.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.159 0.984 . . . . 2.8900000000000001 110.391 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.3 t -141.56 -52.32 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.622 1.169 . . . . 2.27 109.083 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -102.96 168.7 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.079 0.952 . . . . 2.3100000000000001 111.321 -172.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.2 m -137.91 168.92 18.71 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.077 1.351 . . . . 2.6699999999999999 109.217 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.84 17.04 23.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.477 1.511 . . . . 3.6000000000000001 113.068 -178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.9 t -157.78 162.84 38.49 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.148 0.979 . . . . 3.6800000000000002 108.737 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.45 157.29 14.96 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.02 -0.832 . . . . 3.5 111.02 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.22 -43.11 42.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.175 1.79 . . . . 5.1299999999999999 112.182 -172.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -79.27 0.64 27.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.15 0.98 . . . . 4.6200000000000001 112.364 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.4 p -66.94 174.31 3.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.589 -1.32 . . . . 1.55 111.345 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -18.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.684 -1.144 . . . . 4.0199999999999996 111.782 174.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.1 mm -47.0 119.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.174 0.99 . . . . 3.3100000000000001 110.758 -162.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.46 -32.47 5.2 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.519 0.58 . . . . 1.99 112.553 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -76.52 177.01 7.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.547 1.673 . . . . 11.6 114.031 -163.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 m -104.15 120.99 42.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.436 1.095 . . . . 2.0899999999999999 110.322 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.71 138.25 39.87 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.465 -1.309 . . . . 2.6600000000000001 107.465 164.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.48 127.84 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.272 1.429 . . . . 1.6799999999999999 107.88 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.47 122.45 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.125 -1.806 . . . . 2.6699999999999999 106.125 162.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -93.97 158.19 15.75 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 115.319 1.6 . . . . 0.59999999999999998 115.319 -171.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -25.56 -83.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.183 2.993 . . . . 3.5800000000000001 112.388 162.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -106.73 -177.34 3.33 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.819 0.848 . . . . 3.4700000000000002 110.215 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.1 157.44 3.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.498 -0.774 . . . . 1.8600000000000001 109.987 162.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.26 176.58 5.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.951 -0.759 . . . . 1.95 108.951 160.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.53 -9.59 59.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 3.9500000000000002 111.183 -167.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.7 11.93 4.29 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.694 1.598 . . . . 2.98 111.928 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.86 102.03 1.0 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 108.538 -1.825 . . . . 3.4399999999999999 108.538 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.55 -56.49 0.08 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.953 -1.499 . . . . 5.4500000000000002 106.953 174.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.47 50.49 0.97 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.165 -1.174 . . . . 3.7999999999999998 110.165 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.52 37.29 0.84 Allowed Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.165 0.982 . . . . 3.96 112.984 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.3 p30 175.66 -108.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.862 2.865 . . . . 2.8999999999999999 106.266 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -153.13 -39.61 0.1 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.456 1.102 . . . . 4.29 109.07 161.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -44.09 -37.63 3.17 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.423 1.489 . . . . 2.8900000000000001 111.784 170.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.9 t -45.71 -58.25 3.6 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.417 1.087 . . . . 2.5800000000000001 110.903 168.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -44.63 67.63 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.101 -1.0 . . . . 2.1200000000000001 110.015 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -55.68 -50.65 69.69 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.355 1.062 . . . . 3.6600000000000001 112.239 -172.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.474 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.309 2.0 p -124.33 -50.33 1.78 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.834 -0.603 . . . . 2.2599999999999998 111.759 171.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 157.27 -26.81 0.49 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.139 -0.784 . . . . 0.98999999999999999 111.139 -173.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 49.41 53.93 11.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.876 1.27 . . . . 3.6699999999999999 110.338 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.62 -51.93 13.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.858 0.837 . . . . 2.1099999999999999 109.53 170.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.32 -157.84 22.18 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.623 -2.191 . . . . 1.0 107.623 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.1 m -61.0 151.35 30.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.307 1.443 . . . . 1.8899999999999999 113.217 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -61.33 138.23 58.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.101 1.36 . . . . 4.0700000000000003 109.046 168.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.9 mt -112.17 -67.35 1.0 Allowed 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.44 -0.948 . . . . 1.6399999999999999 108.44 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.37 156.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.072 0.549 . . . . 2.0899999999999999 110.384 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.2 p -165.0 162.21 20.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.018 0.927 . . . . 1.4399999999999999 110.17 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.27 140.96 3.33 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.861 2.172 . . . . 0.97999999999999998 107.688 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.79 134.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.668 1.187 . . . . 2.0600000000000001 109.756 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.5 tt -91.1 136.59 23.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 C-N-CA 123.101 0.561 . . . . 1.99 112.512 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.9 4.56 0.83 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.839 1.209 . . . . 0.65000000000000002 114.078 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.7 mm -102.24 57.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 119.192 1.496 . . . . 2.0499999999999998 110.147 -150.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.96 175.41 13.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.146 0.498 . . . . 2.4199999999999999 111.142 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.439 0 N-CA-C 102.962 -2.977 . . . . 5.8399999999999999 102.962 160.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 121.083 0.468 . . . . 6.7999999999999998 109.754 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -165.42 105.54 0.75 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.261 -2.126 . . . . 3.5899999999999999 105.261 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 143.46 35.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.048 -0.723 . . . . 4.4100000000000001 109.048 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.68 139.31 33.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.884 -1.525 . . . . 1.8100000000000001 106.884 164.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.79 144.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.547 -2.02 . . . . 1.8500000000000001 105.547 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.74 93.55 3.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.271 -1.011 . . . . 1.5 108.271 161.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.91 104.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.22 -1.03 . . . . 1.73 108.22 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -87.98 136.71 32.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.56 0.344 . . . . 2.1499999999999999 110.213 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -149.82 -54.72 0.17 Allowed 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.322 0.649 . . . . 5.2199999999999998 110.49 168.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.32 -126.55 27.87 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.603 0.621 . . . . 1.0 113.815 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.09 -53.99 2.63 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.672 1.189 . . . . 4.2199999999999998 110.138 -165.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.19 154.28 10.95 Favored Glycine 0 CA--C 1.536 1.353 0 N-CA-C 110.008 -1.237 . . . . 1.03 110.008 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.24 52.04 3.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.84 3.027 . . . . 1.3400000000000001 112.279 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.78 156.65 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.302 2.241 . . . . 1.79 107.875 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -155.84 136.48 13.36 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.621 -0.881 . . . . 3.4500000000000002 108.621 166.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.57 176.49 46.16 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.175 -0.77 . . . . 0.78000000000000003 111.175 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.68 123.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.494 -1.298 . . . . 2.1000000000000001 107.494 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.66 136.65 22.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.66 -1.978 . . . . 2.9300000000000002 105.66 161.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -120.6 119.24 32.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.444 -2.058 . . . . 2.0600000000000001 105.444 161.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -132.57 126.96 34.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.385 -0.969 . . . . 4.5 108.385 -166.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -148.07 158.83 44.28 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.074 0.949 . . . . 4.3399999999999999 110.321 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -152.44 142.52 22.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.36 1.864 . . . . 3.1699999999999999 106.964 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -44.94 -74.07 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.14 0.576 . . . . 5.3399999999999999 111.342 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -81.47 -172.9 4.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.1 1.36 . . . . 3.7400000000000002 110.929 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.7 m -83.43 -64.67 1.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.232 1.413 . . . . 2.9199999999999999 111.133 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -102.97 75.62 1.4 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.065 1.346 . . . . 4.7199999999999998 110.229 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.04 -167.15 12.85 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.585 -1.406 . . . . 1.3899999999999999 109.585 166.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.02 113.58 3.82 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.242 1.962 . . . . 1.3300000000000001 111.32 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.17 138.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.312 -0.403 . . . . 2.1200000000000001 110.556 -172.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -94.11 116.48 28.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.929 -1.137 . . . . 3.1499999999999999 107.929 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.72 132.71 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.703 -1.962 . . . . 2.4500000000000002 105.703 162.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -133.53 151.8 51.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.986 -1.487 . . . . 1.1000000000000001 106.986 156.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.76 134.54 2.91 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.131 -1.188 . . . . 0.92000000000000004 110.131 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.5 p -109.57 94.75 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.54 -1.652 . . . . 2.98 106.54 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 mm -96.99 148.59 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.623 -1.251 . . . . 2.6600000000000001 107.623 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.36 165.39 22.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.298 0.571 . . . . 5.25 111.45 165.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.19 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 114.462 -1.245 . . . . 0.60999999999999999 114.171 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.88 158.92 17.82 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.266 1.533 . . . . 1.9199999999999999 108.861 167.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.36 158.01 24.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.2 -1.407 . . . . 2.46 107.2 154.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.94 174.31 0.51 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.952 1.251 . . . . 3.2799999999999998 112.327 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.14 -160.65 52.5 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.956 -1.02 . . . . 0.81999999999999995 112.29 168.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.7 140.69 57.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.956 1.303 . . . . 3.2000000000000002 113.105 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -144.41 117.69 9.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.647 1.579 . . . . 0.66000000000000003 109.257 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.19 145.91 5.56 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.362 -1.095 . . . . 0.5 110.362 172.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.6 102.08 5.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.776 -1.565 . . . . 4.3099999999999996 106.776 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -133.48 168.22 19.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.156 -1.794 . . . . 0.95999999999999996 106.156 -173.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.88 130.2 48.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.867 -0.79 . . . . 2.8799999999999999 108.867 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -114.62 147.34 39.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.466 1.507 . . . . 0.84999999999999998 110.413 -160.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.14 -9.35 0.26 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.059 1.744 . . . . 4.25 114.638 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' CD ' HH21 ' A' ' 143' ' ' ARG . 4.5 mt-10 -52.28 89.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.47 1.108 . . . . 3.3300000000000001 109.794 164.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -100.07 -45.89 5.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.422 1.489 . . . . 4.8300000000000001 111.356 169.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.32 56.42 2.1 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.278 -0.889 . . . . 6.3099999999999996 111.666 -167.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -90.5 44.57 1.21 Allowed 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.426 -1.421 . . . . 4.7800000000000002 112.004 -163.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 t -81.62 42.92 0.72 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.249 0.619 . . . . 5.0300000000000002 111.12 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 177.12 -54.87 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.321 1.449 . . . . 5.8799999999999999 109.992 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.41 -163.58 22.63 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.764 -1.334 . . . . 3.6400000000000001 109.764 -171.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.6 p -151.75 72.11 1.01 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 124.347 1.059 . . . . 2.7000000000000002 109.136 -167.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -155.03 71.67 0.8 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.024 -1.473 . . . . 5.9000000000000004 107.024 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.8 m -167.19 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.63 1.344 . . . . 3.0 114.63 -136.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.1 -116.05 0.08 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.48 -1.304 . . . . 2.4300000000000002 107.48 166.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.92 -87.63 0.08 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.322 -1.511 . . . . 1.71 109.322 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.91 176.84 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.965 3.777 . . . . 1.4199999999999999 113.569 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -75.48 58.49 1.02 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.885 1.674 . . . . 2.29 111.615 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.84 80.3 0.16 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.994 0.917 . . . . 3.0600000000000001 108.628 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -112.88 86.66 9.18 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.55 1.14 . . . . 3.0699999999999998 109.415 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.13 -17.95 45.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.3 2.0 . . . . 2.77 112.7 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 tt -154.28 -68.0 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.676 0.671 . . . . 2.9199999999999999 109.838 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -162.92 96.0 0.89 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.757 -1.201 . . . . 2.46 107.757 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.27 173.68 6.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.147 1.379 . . . . 6.2199999999999998 109.703 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -137.3 151.33 48.53 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 125.61 1.564 . . . . 4.5300000000000002 108.032 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -91.24 139.97 30.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.828 0.677 . . . . 0.80000000000000004 112.828 -170.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.02 -88.75 0.07 OUTLIER Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.539 -2.625 . . . . 1.8600000000000001 106.539 163.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.67 -102.58 0.38 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.973 -0.904 . . . . 2.46 112.289 159.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -90.63 -47.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.508 2.139 . . . . 1.8200000000000001 110.774 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.27 -46.01 10.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.233 1.413 . . . . 5.6399999999999997 110.388 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.03 175.58 10.24 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.889 -1.05 . . . . 2.7599999999999998 111.424 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.06 -55.22 8.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.399 1.479 . . . . 3.79 109.596 -174.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.89 175.28 10.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.462 -0.79 . . . . 3.8100000000000001 110.967 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.36 141.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.248 2.219 . . . . 4.46 107.876 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -64.21 160.72 17.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 118.468 -1.293 . . . . 0.60999999999999999 108.669 162.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -28.66 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 121.289 -0.882 . . . . 2.1800000000000002 110.69 -177.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.56 70.11 0.22 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.85999999999999999 110.973 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -163.3 104.74 0.98 Allowed 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.782 -0.834 . . . . 2.3399999999999999 108.914 -169.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.54 -54.81 3.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.686 -0.688 . . . . 2.8399999999999999 109.156 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 -108.38 0.34 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.603 -0.999 . . . . 0.71999999999999997 110.603 -176.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -152.06 167.5 28.26 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.938 1.695 . . . . 2.1800000000000002 109.874 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -123.35 175.78 5.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.476 -1.675 . . . . 1.78 106.476 164.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 t -116.76 149.76 39.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.377 -0.971 . . . . 2.7999999999999998 108.377 167.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.68 140.48 45.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.174 1.39 . . . . 1.8300000000000001 112.333 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.01 -90.17 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 O-C-N 124.46 1.1 . . . . 2.5899999999999999 111.11 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -156.22 -31.75 0.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.652 2.093 . . . . 5.4000000000000004 116.652 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -8.96 58.14 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.993 0.901 . . . . 3.7200000000000002 109.119 164.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.57 23.16 10.4 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.701 1.62 . . . . 1.1100000000000001 109.593 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.2 t -78.0 123.39 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.289 -1.375 . . . . 1.8100000000000001 107.289 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.19 159.32 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.055 0.942 . . . . 1.8799999999999999 109.231 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.77 95.59 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.763 -1.569 . . . . 2.8500000000000001 106.763 -159.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.36 57.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.715 -0.476 . . . . 2.1699999999999999 109.715 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.2 m -85.49 91.66 8.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.813 0.845 . . . . 1.1399999999999999 109.231 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 mt -124.33 148.19 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.893 -0.78 . . . . 3.04 108.893 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -134.39 101.97 5.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.279 -0.638 . . . . 2.98 109.279 164.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.16 140.74 31.21 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.918 0.887 . . . . 2.27 109.073 173.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 t -110.85 19.23 18.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.407 1.083 . . . . 3.04 112.406 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.99 -48.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 108.098 -1.075 . . . . 2.6000000000000001 108.098 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.35 177.01 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 122.813 0.445 . . . . 2.2000000000000002 111.289 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.5 p -155.4 178.8 9.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.429 1.892 . . . . 2.8599999999999999 108.23 -164.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.14 69.9 1.44 Allowed 'General case' 0 C--N 1.339 0.151 0 CA-C-O 122.917 1.342 . . . . 3.1699999999999999 110.466 162.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p -119.19 156.14 30.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.721 2.008 . . . . 4.9400000000000004 110.348 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.28 62.68 2.2 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.652 -1.379 . . . . 3.9900000000000002 109.652 168.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -148.26 -124.87 0.05 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.143 1.777 . . . . 4.7999999999999998 107.054 -172.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -78.67 -9.01 59.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.445 1.02 . . . . 6.7800000000000002 113.085 -176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.2 p -60.37 163.89 4.79 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 123.213 1.482 . . . . 1.53 113.682 -165.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.839 -1.528 . . . . 3.0099999999999998 111.112 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mm -49.03 118.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.795 0.725 . . . . 3.1000000000000001 109.118 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.53 -20.32 34.83 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.468 1.508 . . . . 1.5700000000000001 112.759 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.59 165.34 18.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.416 1.608 . . . . 5.4500000000000002 110.279 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -86.95 117.9 25.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.801 0.841 . . . . 2.0699999999999998 109.159 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 140.33 58.28 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.393 -1.336 . . . . 3.6800000000000002 107.393 167.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -128.26 126.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.945 -1.132 . . . . 1.54 107.945 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 p -99.17 116.95 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.219 -1.771 . . . . 2.9500000000000002 106.219 166.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -89.54 160.11 16.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 115.808 1.781 . . . . 0.58999999999999997 115.808 -172.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.53 ' CD ' ' HZ1' ' A' ' 122' ' ' LYS . 2.0 tm-20 -44.87 -72.27 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.708 2.003 . . . . 3.3900000000000001 112.362 174.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.53 ' HZ1' ' CD ' ' A' ' 121' ' ' GLU . 40.4 mttm -98.26 -177.19 3.63 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.33 1.052 . . . . 3.96 111.097 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.08 157.56 7.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.375 0.67 . . . . 2.0 109.703 162.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.24 175.67 8.8 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.484 -0.561 . . . . 2.1200000000000001 109.484 164.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.03 -35.61 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.989 0.916 . . . . 3.3100000000000001 112.669 -152.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp 66.72 32.77 6.7 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.894 1.678 . . . . 4.7699999999999996 111.402 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.37 45.82 92.3 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.227 0.917 . . . . 1.76 112.255 163.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -127.07 -28.82 2.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.234 2.213 . . . . 5.9900000000000002 111.493 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.34 126.22 33.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.812 -0.915 . . . . 3.02 110.812 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.1 -30.58 76.05 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.327 0.489 . . . . 3.1400000000000001 111.88 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -55.6 115.29 2.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.843 0.857 . . . . 2.7999999999999998 109.26 170.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -38.29 -48.23 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.814 1.246 . . . . 3.5 113.217 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -46.93 -33.84 4.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.244 1.418 . . . . 3.1800000000000002 112.647 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 m -62.49 -56.88 13.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.976 0.51 . . . . 2.5 111.976 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -71.21 -45.81 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.0 -1.687 . . . . 2.0699999999999998 110.215 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -58.08 -39.4 78.45 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.052 0.941 . . . . 4.0099999999999998 111.728 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 p -128.95 -54.92 1.21 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.762 0.71 . . . . 2.5299999999999998 112.632 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 140.48 -18.55 2.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 125.936 1.732 . . . . 0.89000000000000001 111.385 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.76 56.95 2.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.333 1.453 . . . . 2.3500000000000001 111.757 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.66 -5.02 48.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.226 -0.59 . . . . 2.4399999999999999 111.435 171.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.6 -173.68 40.54 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 108.899 -1.681 . . . . 1.03 108.899 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -55.82 153.33 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.752 1.621 . . . . 1.73 114.086 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.442 HH21 ' CD ' ' A' ' 50' ' ' GLU . 6.4 mmt-85 -60.02 139.8 57.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.775 -1.557 . . . . 4.1299999999999999 107.963 166.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.07 -74.74 0.59 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.047 -1.094 . . . . 1.6299999999999999 108.047 173.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.47 151.18 23.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.334 -1.358 . . . . 1.72 107.334 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 p -151.45 160.54 43.67 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.042 0.839 . . . . 1.8300000000000001 109.246 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.09 140.75 3.25 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 125.596 1.81 . . . . 0.68999999999999995 109.61 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -77.88 134.67 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.044 1.338 . . . . 1.8700000000000001 109.878 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.6 tt -90.66 131.28 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.081 0.553 . . . . 1.79 111.342 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.08 -8.17 2.68 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 124.377 0.989 . . . . 0.56999999999999995 113.762 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.4 mm -91.07 59.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 118.026 0.913 . . . . 2.4199999999999999 111.448 -154.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.68 168.09 9.48 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.218 0.533 . . . . 2.5600000000000001 111.587 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 . . . . . 0 C--O 1.256 1.397 0 N-CA-C 101.643 -3.465 . . . . 4.9699999999999998 101.643 139.824 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.53 ' H1 ' ' CD ' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 106.89 -1.522 . . . . 6.7199999999999998 106.89 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 m -81.17 94.21 6.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.491 -1.3 . . . . 3.3900000000000001 107.491 167.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 161.4 27.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.012 -0.54 . . . . 4.0599999999999996 110.416 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.72 136.6 48.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.547 -2.02 . . . . 1.6699999999999999 105.547 152.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.94 140.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.378 -1.712 . . . . 2.23 106.378 169.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.56 96.61 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.371 -0.974 . . . . 1.6399999999999999 108.371 156.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.83 108.26 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.656 -1.609 . . . . 1.77 106.656 161.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.7 mt -97.37 127.97 43.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.204 -1.036 . . . . 1.8100000000000001 108.204 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -149.39 -56.13 0.19 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.191 -1.04 . . . . 4.2599999999999998 108.191 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.49 -117.61 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.504 -1.225 . . . . 0.93000000000000005 111.19 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -123.37 -41.17 2.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.883 0.873 . . . . 3.7000000000000002 110.056 -163.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.72 161.42 51.36 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.732 -0.605 . . . . 0.90000000000000002 111.762 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.86 30.82 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.984 3.123 . . . . 1.0600000000000001 113.436 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.1 t -99.24 155.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.575 1.95 . . . . 1.6799999999999999 107.424 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 129.37 9.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.739 -0.837 . . . . 3.3900000000000001 108.739 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.27 171.07 41.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.793 -0.718 . . . . 0.53000000000000003 114.383 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.6 118.64 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.477 1.111 . . . . 1.9299999999999999 108.482 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -83.84 129.57 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.459 -1.312 . . . . 1.8100000000000001 107.459 164.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -106.13 115.68 30.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.328 -1.36 . . . . 2.3799999999999999 107.328 160.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.9 112.64 24.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.126 -1.805 . . . . 3.77 106.126 171.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.53 ' CD ' ' H1 ' ' A' ' 1' ' ' ALA . 2.8 mm-40 -124.94 144.79 50.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.668 0.747 . . . . 3.4500000000000002 109.436 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -156.99 158.68 37.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.155 1.382 . . . . 4.1799999999999997 109.15 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.01 -74.95 0.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.134 0.973 . . . . 5.5499999999999998 109.634 170.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -90.83 130.08 36.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.539 1.136 . . . . 3.8300000000000001 110.377 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 p -66.43 1.28 1.72 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.931 1.456 . . . . 3.3300000000000001 114.931 -169.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -140.19 54.18 1.64 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 126.518 1.927 . . . . 5.4299999999999997 107.161 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.64 175.07 32.87 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 107.509 -2.237 . . . . 1.4099999999999999 107.509 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.08 134.62 46.87 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.728 2.285 . . . . 1.4399999999999999 110.63 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.86 141.5 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.124 -0.695 . . . . 2.04 109.124 -171.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -97.34 107.2 19.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.419 -1.326 . . . . 3.2999999999999998 107.419 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.8 t -96.25 116.09 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.532 -1.655 . . . . 2.1899999999999999 106.532 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -123.4 107.11 11.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.131 -1.062 . . . . 1.3300000000000001 108.131 164.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.76 152.95 16.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.88 111.805 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -132.06 85.39 2.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.737 2.015 . . . . 3.4700000000000002 106.575 -165.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 mp -111.31 126.02 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 107.017 -1.475 . . . . 1.8500000000000001 107.017 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 162.69 16.51 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.327 1.051 . . . . 4.6699999999999999 110.973 171.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.24 1.8 74.91 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.341 -0.7 . . . . 0.70999999999999996 114.768 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -53.35 157.22 2.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.099 1.449 . . . . 2.0600000000000001 110.815 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.68 163.37 9.26 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.124 -1.065 . . . . 2.3799999999999999 108.124 156.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.34 173.74 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 2.3700000000000001 111.038 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.71 -159.73 34.6 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.049 0.833 . . . . 0.58999999999999997 113.843 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.57 145.12 55.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.246 1.818 . . . . 2.8900000000000001 113.79 -171.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -147.34 118.55 7.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.326 1.85 . . . . 0.62 109.777 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.66 147.6 8.14 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.515 -1.034 . . . . 0.42999999999999999 110.515 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -136.39 91.23 2.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.268 -1.382 . . . . 3.6299999999999999 107.268 -174.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -125.8 172.36 9.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.015 -0.735 . . . . 0.89000000000000001 109.015 -163.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.4 133.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.527 -1.286 . . . . 3.3999999999999999 107.527 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -119.43 140.97 49.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.152 1.381 . . . . 0.95999999999999996 107.738 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -45.16 -58.15 3.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.767 2.027 . . . . 5.0999999999999996 111.107 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 25.41 66.49 0.05 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.082 2.153 . . . . 3.4100000000000001 116.153 164.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -49.27 -53.21 22.82 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.283 1.833 . . . . 5.5899999999999999 112.322 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -124.62 118.58 26.84 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.79 0.836 . . . . 5.3099999999999996 109.667 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.22 42.17 2.4 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.052 1.741 . . . . 5.0599999999999996 109.117 166.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.3 m -63.44 -40.83 98.22 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.15 0.5 . . . . 5.1100000000000003 111.066 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.94 -42.9 62.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.807 0.843 . . . . 5.8799999999999999 111.69 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.73 173.55 42.41 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 106.041 -2.824 . . . . 3.8599999999999999 106.041 -174.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 85.3 m -75.62 83.17 2.64 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 119.169 1.485 . . . . 2.6400000000000001 112.246 -171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 m -29.47 94.28 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.208 1.403 . . . . 6.8600000000000003 113.063 157.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.296 1.4 m 51.78 16.49 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 118.539 2.792 . . . . 5.6399999999999997 118.539 82.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.33 -118.33 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.078 -1.823 . . . . 2.3599999999999999 106.078 165.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.12 -91.58 0.08 OUTLIER Glycine 0 CA--C 1.524 0.605 0 CA-C-O 117.86 -1.522 . . . . 1.5 111.756 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.03 -177.47 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 1 C-N-CA 126.911 5.074 . . . . 1.29 113.351 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -89.33 62.39 6.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.916 1.286 . . . . 1.8100000000000001 111.363 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 56.41 64.29 1.73 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.45 -0.944 . . . . 2.8500000000000001 108.45 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -90.45 113.8 58.86 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 3.3300000000000001 110.4 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.66 -37.39 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.134 1.889 . . . . 1.53 111.294 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 tp -156.17 -64.74 0.11 Allowed 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.376 -0.601 . . . . 4.3200000000000003 109.376 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -153.81 69.47 0.8 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 2.3999999999999999 109.68 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -76.92 166.49 23.26 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.49 -0.559 . . . . 4.4299999999999997 109.49 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.8 156.2 33.7 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.647 1.579 . . . . 4.5999999999999996 107.008 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -92.79 153.81 18.66 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.657 0.614 . . . . 1.03 112.657 -172.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.3 38.79 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 108.95 -1.66 . . . . 2.5800000000000001 108.95 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.82 -156.06 9.87 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 108.662 -1.775 . . . . 1.8100000000000001 108.662 170.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.33 -35.06 92.76 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.987 1.791 . . . . 2.0499999999999998 110.853 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -51.63 68.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.066 0.946 . . . . 7.9199999999999999 110.944 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.88 156.57 20.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.594 1.702 . . . . 2.4500000000000002 115.594 -145.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.64 -48.84 74.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.716 2.006 . . . . 6.4100000000000001 112.367 -169.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -135.51 162.42 32.72 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.049 1.34 . . . . 5.5800000000000001 107.759 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -163.4 161.2 24.26 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.4 0.68 . . . . 4.4299999999999997 111.081 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.416 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 62.6 m80 -68.16 141.5 56.0 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 107.949 -1.13 . . . . 0.72999999999999998 107.949 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.41 -30.23 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.625 -0.262 . . . . 2.2000000000000002 110.716 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 57.37 0.43 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.745 -0.475 . . . . 0.84999999999999998 113.802 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.4 146.75 33.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.918 1.859 . . . . 2.3999999999999999 110.226 149.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 mt -97.1 -51.83 4.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.572 -0.899 . . . . 3.5699999999999998 108.572 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.04 -107.92 0.31 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.5 -1.04 . . . . 0.69999999999999996 110.5 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -147.08 171.98 14.46 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.184 1.794 . . . . 2.3799999999999999 109.493 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -132.78 171.4 18.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 106.644 -1.614 . . . . 2.1499999999999999 106.644 166.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -103.99 144.48 31.49 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.404 -0.961 . . . . 3.1600000000000001 108.404 163.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.05 159.51 27.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.983 0.913 . . . . 1.6200000000000001 110.004 158.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.37 -92.06 0.05 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.033 1.733 . . . . 4.3799999999999999 108.858 162.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 93' ' ' GLY . 13.7 tttt -176.07 -31.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.619 1.168 . . . . 4.5199999999999996 112.0 -159.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -76.84 15.49 0.65 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 124.243 1.973 . . . . 3.3500000000000001 109.477 151.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 63.05 24.75 67.33 Favored Glycine 0 N--CA 1.44 -1.069 0 O-C-N 119.933 -1.729 . . . . 1.1100000000000001 110.347 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.0 t -83.89 118.88 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.306 -0.998 . . . . 2.1699999999999999 108.306 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.79 153.26 17.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.331 -0.989 . . . . 2.1400000000000001 108.331 166.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -112.32 83.72 1.85 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 104.16 -2.533 . . . . 3.7400000000000002 104.16 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.96 60.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.722 -0.844 . . . . 2.1200000000000001 108.722 -167.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -96.43 86.93 4.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.694 1.597 . . . . 1.3100000000000001 108.027 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.76 150.69 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.894 -0.78 . . . . 2.7999999999999998 108.894 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.47 134.27 33.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.218 -1.771 . . . . 3.1099999999999999 106.218 158.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -145.77 164.25 32.44 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.603 -1.258 . . . . 3.8199999999999998 107.603 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.3 p -112.59 -5.31 14.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.741 2.016 . . . . 2.2200000000000002 111.915 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.24 -37.06 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 119.065 0.848 . . . . 3.0600000000000001 109.26 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -96.02 177.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.586 0.754 . . . . 2.3500000000000001 110.655 176.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.6 m -158.53 175.96 13.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.702 1.601 . . . . 2.77 108.3 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.34 14.18 31.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.214 1.405 . . . . 3.6400000000000001 111.546 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m -84.5 135.79 34.09 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 120.738 -1.226 . . . . 3.5600000000000001 109.632 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.13 65.7 1.24 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 109.414 -1.475 . . . . 5.0499999999999998 109.414 170.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -144.33 -127.04 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.053 1.741 . . . . 3.9100000000000001 107.421 -169.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -79.13 -19.87 50.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.245 0.93 . . . . 4.7000000000000002 111.04 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.83 172.77 0.49 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.13 0.972 . . . . 2.4199999999999999 112.034 172.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 pp -81.0 -8.14 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 113.537 0.94 . . . . 2.4700000000000002 113.537 -166.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 mm -50.79 120.12 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.922 0.889 . . . . 3.3900000000000001 109.175 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.16 22.05 66.32 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.916 -0.935 . . . . 1.5800000000000001 113.498 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 174.28 5.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.139 1.469 . . . . 6.5800000000000001 107.982 160.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -86.61 126.74 34.71 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 118.086 -0.959 . . . . 2.1299999999999999 108.943 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.56 137.17 34.65 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.557 -1.275 . . . . 3.0299999999999998 107.557 159.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.86 135.16 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.733 1.613 . . . . 1.73 108.082 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.32 130.48 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.178 -1.045 . . . . 3.0600000000000001 108.178 165.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -106.79 160.51 15.43 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 117.632 2.456 . . . . 0.48999999999999999 117.632 -167.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -33.84 -84.51 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.265 3.026 . . . . 3.6200000000000001 112.736 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -99.4 -174.67 2.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.292 0.951 . . . . 3.6800000000000002 109.592 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.24 157.95 2.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.087 0.555 . . . . 1.6799999999999999 110.11 164.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 152.17 35.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.675 -1.232 . . . . 2.1000000000000001 107.675 158.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -77.16 -6.81 54.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.439 0.903 . . . . 3.3599999999999999 113.439 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 68.65 -9.37 0.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.34 1.456 . . . . 3.4399999999999999 112.851 -167.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.72 6.1 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.935 0.789 . . . . 1.98 111.537 168.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.37 38.78 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.2 -0.667 . . . . 7.9500000000000002 109.2 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -103.73 160.62 16.21 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.497 -0.641 . . . . 2.98 111.497 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.79 59.51 3.0 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.156 0.884 . . . . 2.7000000000000002 110.972 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -178.42 109.22 0.05 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 105.254 -2.128 . . . . 2.6600000000000001 105.254 -170.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -33.51 66.34 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.164 -0.335 . . . . 3.3799999999999999 111.637 -171.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -34.47 -44.4 0.2 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.355 1.862 . . . . 4.1600000000000001 113.18 165.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.84 -63.38 1.17 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.868 -0.79 . . . . 2.5499999999999998 108.868 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 p -60.14 -46.59 89.16 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.904 -0.497 . . . . 2.1899999999999999 110.946 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.67 -43.72 75.55 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.826 0.851 . . . . 3.6600000000000001 112.181 -167.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.416 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.288 1.1 p -124.72 -52.83 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.239 -0.886 . . . . 2.3599999999999999 111.734 172.333 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 146.53 -14.31 1.6 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.528 1.058 . . . . 0.90000000000000002 113.598 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.95 54.86 9.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.535 1.134 . . . . 2.2400000000000002 110.649 173.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.21 -40.85 81.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.172 0.987 . . . . 2.0299999999999998 110.665 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.92 -168.66 30.36 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 108.407 -1.877 . . . . 1.01 108.407 -159.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -55.42 148.23 15.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.111 1.764 . . . . 1.8300000000000001 113.924 -167.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.1 mmt-85 -59.52 134.57 57.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.361 1.464 . . . . 3.98 107.972 165.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -110.51 -80.01 0.58 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.016 1.28 . . . . 1.6499999999999999 109.837 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.48 149.42 36.37 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.548 -0.908 . . . . 1.99 108.548 172.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.96 160.43 12.16 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.729 -2.032 . . . . 1.8 107.013 -163.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.07 156.12 13.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.748 -2.141 . . . . 1.04 107.748 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.14 140.07 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 117.75 0.775 . . . . 1.9099999999999999 109.646 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.6 tt -97.04 132.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.839 -0.619 . . . . 1.8300000000000001 111.126 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 140.52 -6.66 2.73 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 123.902 0.763 . . . . 0.58999999999999997 114.519 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.33 59.83 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 118.487 1.144 . . . . 2.6400000000000001 109.873 -157.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.69 149.2 24.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.268 -0.878 . . . . 2.6600000000000001 112.411 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 . . . . . 0 C--O 1.256 1.409 0 N-CA-C 102.691 -3.077 . . . . 5.9500000000000002 102.691 129.612 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 109.915 -0.402 . . . . 6.9000000000000004 109.915 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.7 155.55 30.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.178 -1.416 . . . . 3.6299999999999999 107.178 -167.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.3 153.63 30.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 124.315 1.009 . . . . 4.2300000000000004 109.805 167.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.57 154.85 17.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.426 -1.694 . . . . 1.9299999999999999 106.426 153.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.99 147.89 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 104.859 -2.274 . . . . 2.0299999999999998 104.859 161.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.39 102.59 5.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.08 -1.822 . . . . 1.5600000000000001 106.08 166.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.57 99.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.907 -1.146 . . . . 1.99 107.907 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.79 120.68 28.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.777 -1.194 . . . . 3.75 107.777 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -139.99 -50.17 0.48 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 122.888 0.475 . . . . 4.54 110.811 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.37 -117.35 2.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.113 0.864 . . . . 0.88 112.667 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.14 -50.65 1.68 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.977 0.911 . . . . 3.3799999999999999 110.165 -155.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.85 165.13 11.85 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 110.667 -0.973 . . . . 0.93999999999999995 110.667 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.23 41.91 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.911 3.074 . . . . 1.3400000000000001 112.063 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.2 t -110.89 150.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 126.79 2.036 . . . . 1.9099999999999999 108.154 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.12 129.4 8.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.892 -1.151 . . . . 3.3900000000000001 107.892 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.85 172.18 44.54 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.027 -0.829 . . . . 0.65000000000000002 111.027 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.87 126.67 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.061 -1.088 . . . . 2.8300000000000001 108.061 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mm -86.31 132.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.268 -1.753 . . . . 2.6800000000000002 106.268 159.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -112.16 124.62 52.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.741 -1.948 . . . . 1.99 105.741 159.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -133.42 103.82 6.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.576 -2.009 . . . . 5.1200000000000001 105.576 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.52 161.28 29.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.396 0.679 . . . . 3.4500000000000002 112.114 -169.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -154.97 147.15 23.78 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.972 -1.122 . . . . 3.02 107.972 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -79.5 -35.56 39.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.415 -1.266 . . . . 7.8700000000000001 110.134 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -85.37 -144.94 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.063 -1.828 . . . . 6.3700000000000001 106.063 158.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 p -147.72 -1.87 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.634 1.106 . . . . 4.1699999999999999 112.984 162.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -123.57 49.76 1.68 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.217 1.007 . . . . 4.0599999999999996 109.612 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.69 -162.81 12.55 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.007 -1.237 . . . . 1.6599999999999999 110.007 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.19 111.9 2.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.256 1.97 . . . . 1.54 112.434 -168.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.66 150.15 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.959 0.904 . . . . 2.1000000000000001 109.535 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -105.69 106.62 17.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.532 -1.655 . . . . 4.8899999999999997 106.532 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -104.24 116.98 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.079 -1.452 . . . . 2.1800000000000002 107.079 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -130.08 142.39 50.61 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.133 -0.691 . . . . 1.0700000000000001 109.133 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.85 159.45 32.68 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.65 -1.78 . . . . 0.69999999999999996 108.65 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -140.14 108.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.841 -2.281 . . . . 3.2400000000000002 104.841 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.28 142.46 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.961 -1.866 . . . . 1.78 105.961 -163.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -140.31 159.06 43.02 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 115.328 1.603 . . . . 5.2199999999999998 115.328 173.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.98 53.87 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.828 1.68 . . . . 0.90000000000000002 112.815 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.44 159.98 9.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.187 0.993 . . . . 2.0 109.568 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.59 162.02 13.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.597 -1.261 . . . . 2.54 107.597 156.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.47 172.44 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.172 0.897 . . . . 2.5899999999999999 110.757 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.5 -163.29 54.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 116.079 -0.51 . . . . 0.57999999999999996 113.122 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.77 146.59 47.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.959 0.904 . . . . 3.3300000000000001 111.913 -172.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -146.56 119.97 9.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.729 1.612 . . . . 0.79000000000000004 109.145 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.81 152.12 4.99 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.405 -0.678 . . . . 0.40999999999999998 111.405 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -146.04 101.84 3.57 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.329 -1.36 . . . . 3.71 107.329 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.455 ' ND1' ' CD2' ' A' ' 120' ' ' HIS . 26.5 m80 -143.15 160.22 40.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.322 -0.992 . . . . 1.2 108.322 -163.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.62 127.83 75.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 CA-C-O 121.899 0.857 . . . . 2.8300000000000001 110.058 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -99.68 137.49 38.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.715 1.606 . . . . 0.78000000000000003 107.627 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.02 -38.21 56.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.409 1.084 . . . . 4.3099999999999996 111.749 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 0.1 103.53 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.596 2.759 . . . . 3.0899999999999999 113.199 156.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.77 -177.82 0.08 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 129.833 3.253 . . . . 6.8600000000000003 113.305 -162.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -74.52 59.65 0.83 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.46 1.504 . . . . 7.4800000000000004 109.808 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -55.21 -59.3 4.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.941 1.696 . . . . 5.1799999999999997 111.246 -171.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m 179.5 -52.25 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 127.539 2.336 . . . . 6.3600000000000003 106.573 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.33 -65.16 0.09 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.943 -1.026 . . . . 7.6799999999999997 110.215 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.59 170.75 53.67 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 121.278 0.376 . . . . 4.3499999999999996 113.879 -170.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.7 p -91.45 137.47 32.34 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 126.381 1.872 . . . . 3.1200000000000001 107.123 167.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -159.92 20.45 0.16 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.134 0.879 . . . . 5.2000000000000002 113.029 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.272 66.5 m -169.0 -21.59 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 118.043 2.608 . . . . 2.98 118.043 -128.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -132.72 176.75 8.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.229 0.922 . . . . 2.4100000000000001 111.347 168.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.62 -95.67 2.42 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.125 -1.375 . . . . 1.3700000000000001 109.767 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.69 -179.87 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.545 4.163 . . . . 1.3200000000000001 113.833 -175.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -52.01 126.3 18.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.514 1.526 . . . . 1.3999999999999999 108.793 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -39.7 117.3 0.72 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.353 1.061 . . . . 3.96 111.742 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -124.71 143.28 43.08 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 130.397 3.479 . . . . 3.5099999999999998 107.578 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.99 -36.21 3.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.124 2.55 . . . . 1.6399999999999999 110.148 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 tt -151.42 -66.72 0.18 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.254 -1.387 . . . . 3.7599999999999998 107.254 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.4 m -154.39 84.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.091 -1.005 . . . . 3.1000000000000001 109.848 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -79.39 174.99 11.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.182 0.515 . . . . 5.8300000000000001 110.131 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -127.79 163.84 23.48 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.521 1.928 . . . . 7.79 106.951 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -102.9 152.9 20.76 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 123.707 0.803 . . . . 0.97999999999999998 110.881 -172.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 -35.56 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.777 -0.529 . . . . 2.8199999999999998 111.777 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.52 -150.5 20.12 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.682 1.611 . . . . 1.9399999999999999 111.386 167.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.1 -26.98 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.566 2.844 . . . . 2.2400000000000002 110.374 -176.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -48.35 82.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.585 -0.524 . . . . 7.1100000000000003 109.585 170.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.83 175.55 6.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.29 113.41 -166.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.34 -43.73 60.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.299 1.439 . . . . 4.6399999999999997 108.401 164.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.95 157.73 31.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.639 -0.71 . . . . 3.27 111.344 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 164.66 147.93 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.89 2.076 . . . . 4.2800000000000002 111.777 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.418 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 18.4 m80 -62.79 153.61 32.4 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.319 -0.993 . . . . 0.70999999999999996 108.319 167.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.06 -36.64 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 119.794 -0.762 . . . . 1.99 109.3 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.98 60.87 1.38 Allowed Glycine 0 CA--C 1.529 0.969 0 O-C-N 122.003 -0.436 . . . . 0.91000000000000003 113.175 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.84 96.71 1.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.367 -0.975 . . . . 2.4199999999999999 108.367 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.37 -52.28 8.3 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.319 -0.993 . . . . 3.1000000000000001 108.319 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.53 -109.06 0.35 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.834 -0.698 . . . . 0.63 112.645 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -155.49 170.18 22.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.599 1.56 . . . . 2.25 109.758 -168.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.8 169.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.004 -1.48 . . . . 1.6799999999999999 107.004 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.2 m -123.87 123.47 40.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.58 -1.267 . . . . 2.8100000000000001 107.58 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.36 141.4 31.79 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.568 0.347 . . . . 1.5900000000000001 111.149 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.25 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.348 1.03 . . . . 2.71 109.277 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.4 tttt -155.29 -34.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.102 1.519 . . . . 4.6900000000000004 115.102 -172.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 24.7 t0 -89.19 40.05 0.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.216 1.96 . . . . 2.8599999999999999 109.284 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 56.58 20.58 31.76 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 129.15 3.262 . . . . 0.88 112.562 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.49 119.92 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.947 0.899 . . . . 2.1099999999999999 108.928 -168.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.46 156.87 27.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.568 1.147 . . . . 1.8400000000000001 108.591 168.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.61 147.42 33.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.485 -2.413 . . . . 3.2799999999999998 104.485 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.67 59.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.827 0.704 . . . . 1.77 112.024 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.5 m -86.62 96.02 9.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.371 1.068 . . . . 1.1499999999999999 110.429 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.51 152.17 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.546 1.138 . . . . 3.3399999999999999 109.931 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.37 141.9 51.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.324 -0.991 . . . . 3.4399999999999999 108.324 150.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -135.14 163.76 29.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.133 -0.691 . . . . 2.0600000000000001 109.133 162.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -111.24 -16.04 13.5 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.463 2.305 . . . . 1.8600000000000001 112.781 -173.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.37 -36.29 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.888 0.767 . . . . 2.4399999999999999 109.478 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -91.56 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.767 0.827 . . . . 2.21 110.477 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.2 p -159.28 176.95 11.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.654 1.981 . . . . 3.25 106.967 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.87 37.74 4.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.918 1.235 . . . . 3.1800000000000002 112.498 166.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 m -94.56 -63.44 1.18 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.968 -0.753 . . . . 3.3799999999999999 108.968 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.58 167.3 37.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.218 -0.753 . . . . 3.3100000000000001 111.218 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.96 -78.59 0.02 OUTLIER 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.045 2.138 . . . . 4.6799999999999997 112.831 165.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -79.54 -24.98 41.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.478 1.111 . . . . 5.1100000000000003 110.443 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.8 p -55.85 151.95 10.66 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.179 -0.675 . . . . 1.9099999999999999 109.179 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.9 pt -78.61 -5.13 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.044 -0.503 . . . . 2.8999999999999999 111.918 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 mm -32.01 127.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.762 1.225 . . . . 2.8300000000000001 110.716 170.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.78 33.3 83.79 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.378 -0.679 . . . . 1.5600000000000001 112.928 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -116.29 169.13 9.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.088 0.944 . . . . 4.7800000000000002 108.487 166.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m -100.88 110.4 22.46 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-N 118.867 0.758 . . . . 2.6699999999999999 110.247 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt -68.04 148.98 50.26 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.427 -0.953 . . . . 2.8900000000000001 108.427 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.71 138.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.103 1.761 . . . . 1.46 108.135 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -109.15 129.1 64.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.147 -1.057 . . . . 2.7200000000000002 108.147 162.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.455 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 50.5 m-70 -101.98 160.18 14.71 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 116.366 1.987 . . . . 0.39000000000000001 116.366 -168.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 7.3 tt0 -44.05 -75.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.68 2.392 . . . . 3.0299999999999998 112.228 172.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -94.24 179.0 5.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.222 0.534 . . . . 3.6000000000000001 110.353 -168.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.13 142.62 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.382 -1.34 . . . . 1.6599999999999999 107.382 155.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -82.25 164.23 21.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.207 1.003 . . . . 2.0099999999999998 109.094 165.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -28.12 47.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.0 -1.0 . . . . 2.8399999999999999 111.722 -160.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.16 46.4 21.51 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.876 0.87 . . . . 3.0099999999999998 109.793 -168.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.71 34.63 64.99 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 124.696 1.141 . . . . 1.6299999999999999 113.04 165.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -78.45 -17.18 56.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.409 0.604 . . . . 6.9500000000000002 109.712 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.28 -118.25 5.25 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.593 -1.003 . . . . 3.8199999999999998 110.593 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.36 -69.52 0.68 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.503 -1.439 . . . . 3.3500000000000001 109.503 -168.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -92.6 160.34 15.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.19 0.996 . . . . 2.79 108.453 164.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -72.94 -47.97 40.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.253 -0.88 . . . . 5.1100000000000003 110.819 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -44.22 -39.78 4.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.795 1.634 . . . . 2.9500000000000002 114.463 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 t -39.41 -64.16 0.5 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.944 1.298 . . . . 2.4900000000000002 111.035 166.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.271 1.6 t -73.38 -44.53 58.37 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.6 0.76 . . . . 3.4100000000000001 111.1 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -55.03 -49.64 71.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 119.495 1.043 . . . . 3.29 111.921 -174.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.418 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 19.5 p -127.62 -45.98 1.46 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 119.08 -0.486 . . . . 2.6400000000000001 111.403 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.42 -14.56 1.25 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.191 0.9 . . . . 0.98999999999999999 114.327 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.265 0.3 OUTLIER 28.24 56.05 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.041 1.337 . . . . 4.0700000000000003 113.944 -156.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.65 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.603 1.161 . . . . 2.2400000000000002 112.337 167.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.86 -176.55 45.95 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.751 -1.74 . . . . 0.94999999999999996 108.751 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 m -61.21 154.28 23.84 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.612 1.165 . . . . 1.8100000000000001 113.809 -166.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -56.18 136.56 52.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.126 1.37 . . . . 3.54 109.022 168.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.5 mt -111.13 -76.24 0.6 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.294 -1.002 . . . . 1.6799999999999999 108.294 168.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.79 150.85 26.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.821 -1.177 . . . . 1.9299999999999999 107.821 170.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.5 p -153.34 156.68 38.8 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.301 -1.318 . . . . 1.53 108.49 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 136.68 4.31 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 125.036 1.46 . . . . 0.76000000000000001 112.091 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.51 125.06 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 125.192 1.397 . . . . 2.1499999999999999 109.544 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.6 tt -90.29 128.74 42.02 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.227 0.537 . . . . 1.97 111.233 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 152.08 -11.62 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.151 0.881 . . . . 0.83999999999999997 114.901 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.76 59.43 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 122.557 1.17 . . . . 2.6099999999999999 109.275 -152.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.28 148.53 25.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.71 -0.677 . . . . 2.79 111.6 172.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 C--O 1.252 1.195 0 N-CA-C 101.967 -3.345 . . . . 7.5599999999999996 101.967 142.32 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 113.733 1.012 . . . . 9.4900000000000002 113.733 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m 52.53 58.8 5.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.626 1.17 . . . . 5.25 113.031 157.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -154.99 163.74 39.88 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.14 0.976 . . . . 5.3899999999999997 109.086 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.06 168.93 16.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.253 1.025 . . . . 2.6299999999999999 111.428 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 t -128.78 147.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.532 -2.396 . . . . 2.4900000000000002 104.532 155.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.43 99.18 4.02 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 108.525 -0.916 . . . . 1.76 108.525 153.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.4 t -68.58 94.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.868 -1.16 . . . . 2.1499999999999999 107.868 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -79.52 122.96 27.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.597 -0.89 . . . . 2.8999999999999999 108.597 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -136.33 -60.01 0.72 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.242 -1.022 . . . . 4.9400000000000004 108.242 174.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.83 -139.79 9.73 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.894 -1.682 . . . . 1.23 108.894 -156.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.83 21.78 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.142 0.577 . . . . 5.9400000000000004 111.534 168.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.32 165.57 46.37 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 107.97 -2.052 . . . . 0.95999999999999996 107.97 148.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.62 72.42 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.798 2.332 . . . . 2.6299999999999999 109.845 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.0 t -139.64 144.64 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.818 0.847 . . . . 1.98 109.287 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -145.44 120.61 10.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.575 -1.268 . . . . 3.52 107.575 166.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.88 163.56 32.78 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.588 -0.695 . . . . 0.57999999999999996 111.941 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.1 mt -127.16 127.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.474 -1.306 . . . . 2.5899999999999999 107.474 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -87.85 142.6 12.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 N-CA-C 106.383 -1.71 . . . . 1.8 106.383 158.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -139.04 82.25 1.89 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.165 -1.05 . . . . 3.2999999999999998 108.165 168.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.407 ' CD1' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -77.85 152.53 33.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 118.641 -1.224 . . . . 6.7300000000000004 108.992 175.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -139.3 148.22 42.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.905 -1.887 . . . . 3.5600000000000001 105.905 166.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -156.94 116.96 3.51 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.208 1.403 . . . . 4.0700000000000003 108.173 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -63.6 -60.23 3.6 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.274 0.63 . . . . 5.4900000000000002 110.681 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -77.9 107.02 10.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.244 -0.91 . . . . 4.0499999999999998 108.919 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -57.76 6.08 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.593 2.357 . . . . 4.3099999999999996 116.922 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.44 60.85 0.75 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.116 -1.068 . . . . 4.3700000000000001 108.116 168.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.79 179.97 19.37 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 108.389 -1.884 . . . . 1.24 108.389 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.67 116.78 3.57 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 1.1699999999999999 111.302 -171.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 20' ' ' PHE . 7.8 t -80.95 135.37 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.367 -0.825 . . . . 2.3999999999999999 109.958 -169.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.83 88.03 4.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.293 0.951 . . . . 5.1299999999999999 109.855 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.96 88.66 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.634 1.174 . . . . 2.5299999999999998 109.03 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -102.62 157.3 17.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 123.52 0.513 . . . . 1.02 111.581 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.17 164.24 35.37 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.652 -0.579 . . . . 0.68000000000000005 111.652 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -130.08 70.44 1.44 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.161 1.384 . . . . 2.8900000000000001 108.999 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.0 132.59 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.191 0.996 . . . . 1.76 110.124 -168.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -130.91 163.03 28.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.618 0.767 . . . . 4.75 111.494 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.6 -16.89 59.82 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.077 -0.846 . . . . 1.3899999999999999 113.862 173.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.41 159.25 2.09 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.55 1.175 . . . . 1.8400000000000001 111.389 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 154.67 23.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.722 -1.214 . . . . 2.3300000000000001 107.722 153.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.2 171.42 0.27 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.065 0.935 . . . . 3.3100000000000001 111.302 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.05 -161.58 54.32 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.307 -0.86 . . . . 0.88 112.75 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.92 136.24 52.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.085 1.354 . . . . 3.2000000000000002 112.401 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -140.6 121.75 14.76 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.581 1.552 . . . . 0.76000000000000001 108.86 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.66 149.98 9.87 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.73 -0.948 . . . . 0.48999999999999999 110.73 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.11 96.62 3.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.487 -1.672 . . . . 3.9300000000000002 106.487 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -134.86 161.52 34.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.997 -1.112 . . . . 1.1499999999999999 107.997 -169.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 t -114.09 128.05 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.845 -1.169 . . . . 3.5099999999999998 107.845 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -112.47 137.98 49.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.099 -1.445 . . . . 0.96999999999999997 107.099 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -72.34 63.95 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.418 0.687 . . . . 4.1600000000000001 112.725 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -113.29 115.32 27.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.228 -1.397 . . . . 3.5099999999999998 107.228 171.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -72.62 -173.65 1.22 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 127.381 2.272 . . . . 4.6399999999999997 111.861 -167.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -76.66 70.71 3.19 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.376 1.87 . . . . 8.2200000000000006 110.709 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.58 -25.26 0.57 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.856 1.058 . . . . 6.1399999999999997 113.856 -175.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -161.33 -167.18 1.7 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.318 -1.364 . . . . 5.7300000000000004 107.318 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.45 84.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.053 0.541 . . . . 7.5999999999999996 109.758 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.48 65.63 0.81 Allowed Glycine 0 CA--C 1.523 0.553 0 CA-C-O 123.707 1.726 . . . . 6.6799999999999997 111.512 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 p -151.76 56.31 0.85 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.706 -1.22 . . . . 3.1899999999999999 107.706 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -148.78 32.61 0.77 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.065 0.765 . . . . 4.6600000000000001 113.065 171.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.298 15.1 m -170.06 -50.99 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 117.309 2.337 . . . . 3.0600000000000001 117.309 -144.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.09 134.2 49.59 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.659 0.784 . . . . 2.4199999999999999 108.949 176.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.01 -94.38 0.9 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.393 -1.483 . . . . 1.55 109.393 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.17 178.25 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.902 3.068 . . . . 1.3999999999999999 112.819 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -63.85 130.0 42.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.693 -1.14 . . . . 1.3799999999999999 110.608 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -31.92 113.83 0.13 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.196 1.184 . . . . 2.96 114.196 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.47 154.86 49.39 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 126.517 1.927 . . . . 3.02 106.722 160.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.9 -42.33 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.61 1.54 . . . . 1.53 111.666 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 -71.95 0.43 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.257 0.623 . . . . 3.6699999999999999 109.556 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 m -145.47 72.56 1.32 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.562 0.745 . . . . 2.1400000000000001 111.512 -164.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -79.43 175.5 10.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.599 -1.26 . . . . 5.6600000000000001 107.599 153.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -128.89 174.97 9.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.333 1.453 . . . . 5.0899999999999999 107.224 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -108.02 129.85 55.1 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.285 1.034 . . . . 1.3899999999999999 112.658 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.79 21.71 1.29 Allowed Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.68 -0.568 . . . . 3.0 111.68 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.58 -169.71 4.02 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.074 0.845 . . . . 2.6600000000000001 113.348 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.94 -6.13 12.12 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.056 3.171 . . . . 1.6100000000000001 114.256 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.04 -50.06 5.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.916 -1.115 . . . . 6.8399999999999999 110.612 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.81 169.46 18.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.989 0.899 . . . . 2.5099999999999998 111.552 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.26 -37.84 84.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 5.21 109.51 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.343 12.1 pt-20 -78.57 149.68 32.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.028 0.918 . . . . 4.9299999999999997 110.915 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 151.87 127.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 131.405 3.882 . . . . 3.73 104.03 -162.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.0 m80 -60.62 152.34 26.61 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.649 -1.241 . . . . 0.68999999999999995 107.649 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -30.25 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 120.117 -0.633 . . . . 2.1200000000000001 110.239 -167.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.52 59.56 0.5 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.385 -0.675 . . . . 0.85999999999999999 112.756 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -123.03 108.67 13.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.682 1.241 . . . . 2.6400000000000001 109.049 165.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.82 -47.46 15.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.088 -0.708 . . . . 2.5600000000000001 109.088 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.52 -104.17 0.25 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.916 0.78 . . . . 0.79000000000000004 112.677 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -155.66 167.42 30.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.484 1.914 . . . . 2.3399999999999999 108.629 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.4 160.19 40.26 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.205 -1.035 . . . . 1.75 108.205 171.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -109.32 111.93 23.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 2.9300000000000002 108.669 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.38 139.37 37.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.304 0.502 . . . . 1.95 110.802 169.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.02 -90.31 0.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.532 0.52 . . . . 3.9300000000000002 110.649 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -129.3 -56.95 1.16 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.844 0.857 . . . . 5.5099999999999998 112.142 -159.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.7 21.16 0.85 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.074 1.749 . . . . 3.2999999999999998 110.155 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 67.08 18.47 69.03 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 124.593 1.092 . . . . 0.78000000000000003 111.597 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -79.74 110.14 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.534 -1.284 . . . . 1.8500000000000001 107.534 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.75 175.71 6.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.873 -1.158 . . . . 1.6799999999999999 107.873 161.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -131.34 136.39 48.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 102.67 -3.085 . . . . 2.9100000000000001 102.67 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.83 131.86 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.784 -1.932 . . . . 1.8 105.784 167.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.6 m -160.78 61.04 0.31 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.868 1.667 . . . . 1.5 108.245 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -108.22 152.78 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.414 0.686 . . . . 3.0800000000000001 109.705 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -137.64 142.83 41.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.308 -0.627 . . . . 3.27 109.308 149.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -124.6 145.21 49.74 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.614 -1.625 . . . . 2.5499999999999998 106.614 166.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -79.58 -18.11 52.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.036 2.134 . . . . 2.0800000000000001 111.394 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.4 t -77.17 -39.91 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.772 -0.455 . . . . 2.1299999999999999 109.772 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -77.46 176.79 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.672 0.749 . . . . 2.3100000000000001 110.985 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 t -161.51 179.89 7.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.613 1.965 . . . . 3.1400000000000001 105.871 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.54 41.86 3.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.846 1.259 . . . . 4.2199999999999998 110.74 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.4 t -155.92 -64.73 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.015 -0.735 . . . . 4.1399999999999997 109.015 -174.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.75 157.14 48.53 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.147 -0.781 . . . . 4.29 111.147 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -45.44 -43.02 11.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.128 0.964 . . . . 6.5499999999999998 112.135 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -74.76 1.79 11.6 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.987 -0.445 . . . . 6.0700000000000003 111.721 -172.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.0 p -57.14 164.41 1.71 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 123.01 1.386 . . . . 1.6699999999999999 111.533 158.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -8.68 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 113.695 -1.593 . . . . 3.3100000000000001 111.98 169.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.1 mm -49.75 123.85 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 119.471 1.032 . . . . 2.8900000000000001 110.34 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.75 -9.46 55.92 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.614 -1.103 . . . . 1.6799999999999999 112.974 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -88.6 164.54 15.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.519 1.659 . . . . 5.4400000000000004 110.171 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 m -94.11 118.41 31.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.233 -0.292 . . . . 2.1000000000000001 110.698 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.76 142.53 54.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.356 -0.979 . . . . 3.7599999999999998 108.356 163.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.6 t -127.91 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.24 1.416 . . . . 1.5700000000000001 107.648 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.39 120.95 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 106.187 -1.783 . . . . 3.54 106.187 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -98.29 159.42 14.95 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.751 2.13 . . . . 0.47999999999999998 116.751 -174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -29.59 -83.44 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.363 3.065 . . . . 3.71 112.352 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -96.98 -175.35 3.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.472 1.109 . . . . 4.5 109.728 -175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.15 157.6 3.37 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.701 -0.481 . . . . 2.04 109.701 159.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.27 160.79 23.65 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.44 -0.578 . . . . 2.1899999999999999 109.44 161.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.05 -25.21 59.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.96 1.096 . . . . 3.0800000000000001 113.96 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.78 13.11 2.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.839 0.856 . . . . 2.5299999999999998 113.127 -165.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.39 47.49 42.92 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.831 1.196 . . . . 1.55 111.554 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -142.03 -22.71 0.7 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.807 2.043 . . . . 5.6900000000000004 112.925 -173.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.2 136.72 40.2 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 120.315 1.416 . . . . 3.54 111.02 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.28 67.68 0.92 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.691 1.139 . . . . 3.0600000000000001 111.26 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -144.07 -179.22 6.36 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.025 2.13 . . . . 3.1400000000000001 105.424 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -39.47 15.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.387 -0.968 . . . . 4.2000000000000002 108.387 159.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -47.48 -28.25 2.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.336 2.254 . . . . 5.0899999999999999 113.622 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.6 p -58.21 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.734 1.214 . . . . 2.8700000000000001 109.116 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.5 t -60.83 -31.74 71.15 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.23 -0.919 . . . . 4.0300000000000002 111.592 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -59.09 -49.36 78.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.281 -0.887 . . . . 4.2800000000000002 111.948 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.496 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.335 9.9 t -134.08 -51.81 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.325 -0.845 . . . . 2.8500000000000001 111.343 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.54 30.0 0.07 OUTLIER Glycine 0 C--N 1.336 0.579 0 CA-C-O 116.989 -2.006 . . . . 1.1699999999999999 115.572 168.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 9.03 57.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.683 2.393 . . . . 2.6800000000000002 114.674 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.34 88.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.2 1.0 . . . . 2.0299999999999998 108.998 166.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.73 36.44 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 108.074 -2.011 . . . . 1.04 108.074 -165.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 158.81 20.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.985 0.914 . . . . 2.6899999999999999 113.106 -166.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -63.15 132.02 50.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.243 1.817 . . . . 4.21 108.487 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.84 -63.23 1.37 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.256 -1.016 . . . . 1.8700000000000001 108.256 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.45 158.66 16.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.15 -0.932 . . . . 2.2000000000000002 109.716 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 139.36 23.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.356 -1.72 . . . . 1.78 106.356 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.12 131.05 2.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.553 -1.819 . . . . 0.81999999999999995 108.553 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.42 139.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.722 -0.844 . . . . 1.75 108.722 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.8 tt -102.31 142.68 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.779 0.831 . . . . 1.99 112.692 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.23 6.72 8.8 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.016 1.294 . . . . 0.97999999999999998 112.658 172.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.33 58.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.685 1.242 . . . . 1.8700000000000001 111.315 -163.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.57 175.54 13.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.052 0.941 . . . . 2.6600000000000001 108.79 164.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.501 0 C-N-CA 126.361 1.864 . . . . 5.3600000000000003 106.127 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 120.8 0.333 . . . . 5.5700000000000003 110.654 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.65 78.34 3.31 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.872 1.269 . . . . 3.1600000000000001 110.655 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.24 145.67 37.4 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.648 -0.871 . . . . 4.1799999999999997 108.648 168.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.58 139.99 37.32 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.873 -1.529 . . . . 1.6799999999999999 106.873 156.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -99.46 146.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.373 -1.714 . . . . 1.72 106.373 161.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.2 92.76 3.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.875 -0.787 . . . . 2.0099999999999998 108.875 163.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.24 110.22 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.163 -1.051 . . . . 1.8200000000000001 108.163 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.42 140.31 30.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.04 0.536 . . . . 1.95 110.355 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -144.94 -54.45 0.31 Allowed 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.204 1.002 . . . . 6.9500000000000002 109.877 165.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.46 -134.93 51.6 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.421 1.01 . . . . 0.98999999999999999 114.185 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.79 -51.32 2.92 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.79 1.236 . . . . 4.0099999999999998 109.481 -166.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.14 156.1 15.14 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 109.192 -1.563 . . . . 0.90000000000000002 109.192 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.72 46.38 2.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 1.02 112.045 -172.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 t -89.91 158.16 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 125.353 1.461 . . . . 1.8899999999999999 108.643 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.62 120.85 4.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.536 -1.653 . . . . 3.1200000000000001 106.536 173.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.06 40.38 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.528 -0.844 . . . . 0.68000000000000005 111.864 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.11 128.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.035 -1.098 . . . . 1.99 108.035 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.91 141.94 14.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.009 -1.849 . . . . 2.8700000000000001 106.009 162.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.32 115.65 20.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.414 -2.069 . . . . 1.99 105.414 163.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -129.91 107.45 9.38 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.445 -2.057 . . . . 4.5599999999999996 105.445 -163.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -136.1 153.72 51.23 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.422 0.63 . . . . 3.3199999999999998 110.58 -166.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -140.18 143.63 36.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.18 -1.785 . . . . 4.1500000000000004 106.18 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -85.31 -35.87 21.18 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.932 0.893 . . . . 5.8899999999999997 110.675 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -137.24 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.437 1.095 . . . . 5.25 108.52 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 t -129.61 -69.53 0.68 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.95 1.7 . . . . 3.3999999999999999 108.715 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -109.68 61.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.93 1.292 . . . . 5.4199999999999999 107.865 -172.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.11 175.07 21.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.961 -1.256 . . . . 1.4099999999999999 109.961 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 115.35 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.789 2.993 . . . . 1.3799999999999999 111.259 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -78.51 150.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.921 -0.77 . . . . 1.9399999999999999 108.921 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -100.13 113.79 26.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.311 -1.366 . . . . 4.4800000000000004 107.311 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.54 128.59 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.131 -1.433 . . . . 2.0699999999999998 107.131 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -130.41 146.54 51.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.851 -1.907 . . . . 1.26 105.851 162.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.23 20.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.046 -1.622 . . . . 0.68999999999999995 109.046 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 p -132.12 118.22 19.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.574 -1.639 . . . . 2.4900000000000002 106.574 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.36 148.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 125.588 1.555 . . . . 2.3100000000000001 108.462 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.439 ' HZ3' ' CG ' ' A' ' 92' ' ' ASP . 9.7 ptmm? -141.09 176.45 8.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 119.017 -1.073 . . . . 6.5800000000000001 112.548 149.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.99 13.89 57.08 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.203 1.858 . . . . 0.69999999999999996 113.191 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -65.25 166.01 10.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 117.713 0.757 . . . . 2.6499999999999999 109.968 166.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 164.95 23.65 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.988 -1.115 . . . . 2.8199999999999998 107.988 156.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -58.92 174.11 0.38 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.266 0.939 . . . . 2.4300000000000002 111.476 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.08 -166.38 54.85 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.677 0.656 . . . . 0.70999999999999996 113.756 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.05 153.26 40.93 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.241 1.017 . . . . 3.3300000000000001 110.41 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -146.55 118.62 8.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.945 1.298 . . . . 0.65000000000000002 108.878 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.96 151.58 5.5 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.335 -1.106 . . . . 0.45000000000000001 110.335 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -145.85 102.27 3.64 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 117.977 0.889 . . . . 3.5499999999999998 108.716 -171.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -143.34 155.21 44.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.248 -1.39 . . . . 0.93000000000000005 107.248 -158.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.1 140.35 30.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 119.643 1.111 . . . . 2.9300000000000002 109.784 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -113.25 140.33 48.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.971 1.308 . . . . 1.0 107.691 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.1 74.1 0.65 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.387 1.089 . . . . 4.4699999999999998 112.193 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -148.56 80.94 1.45 Allowed 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 104.753 -2.314 . . . . 3.3100000000000001 104.753 -171.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -152.25 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.124 1.37 . . . . 5.04 110.698 172.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -84.58 63.84 8.13 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 120.422 -1.424 . . . . 6.6100000000000003 109.814 -174.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.24 -28.96 12.72 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 126.227 1.811 . . . . 5.8700000000000001 110.373 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -171.34 157.94 5.15 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.072 0.949 . . . . 6.2699999999999996 108.588 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.65 -22.23 29.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.579 0.752 . . . . 5.8700000000000001 110.161 163.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.99 71.95 1.38 Allowed Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.353 -1.499 . . . . 4.7000000000000002 109.353 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.0 t -48.39 109.61 0.26 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.009 1.723 . . . . 2.9700000000000002 112.387 -171.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 m -149.7 -117.57 0.05 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.604 -1.258 . . . . 4.7599999999999998 107.604 -173.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.3 m 69.97 -73.34 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.823 2.157 . . . . 2.9300000000000002 116.823 139.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.22 142.83 27.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.891 1.277 . . . . 2.04 109.472 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.68 -91.92 1.92 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 107.879 -2.088 . . . . 1.73 107.879 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.95 178.09 6.91 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.759 2.972 . . . . 1.3 113.281 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.31 131.74 45.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.584 -1.644 . . . . 1.47 109.868 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -35.42 109.84 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.834 1.254 . . . . 3.1299999999999999 111.907 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.38 150.7 21.17 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 126.038 1.735 . . . . 3.3199999999999998 107.199 165.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.15 -29.02 33.72 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.368 2.045 . . . . 1.47 114.14 -170.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.93 -64.38 0.11 Allowed 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.07 0.85 . . . . 4.2699999999999996 112.152 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.6 m -154.23 83.3 1.13 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.102 -0.703 . . . . 2.6800000000000002 109.102 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 168.06 11.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.462 -0.94 . . . . 6.3799999999999999 108.462 162.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -114.7 163.16 15.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.635 -1.246 . . . . 3.8100000000000001 107.635 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -82.58 160.77 22.46 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.082 0.553 . . . . 0.80000000000000004 110.293 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.54 176.72 41.64 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 106.302 -2.719 . . . . 2.02 106.302 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.19 -168.92 23.99 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 118.927 1.364 . . . . 1.9199999999999999 112.913 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -62.36 -30.9 81.31 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.851 1.7 . . . . 1.72 109.957 163.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -78.11 -42.39 32.12 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.617 0.767 . . . . 6.3200000000000003 112.561 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.1 163.55 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.456 0.571 . . . . 2.2999999999999998 111.267 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -78.5 -50.9 10.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.638 1.575 . . . . 4.2000000000000002 109.936 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.259 16.9 pt-20 -90.48 176.82 6.56 Favored 'General case' 0 C--N 1.337 0.055 0 C-N-CA 122.554 0.342 . . . . 3.4100000000000001 111.812 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 165.05 159.06 0.02 OUTLIER 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.674 1.989 . . . . 5.75 108.552 -166.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.454 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 55.7 m80 -61.52 139.39 58.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.094 -1.817 . . . . 0.75 106.094 161.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.11 -32.23 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.723 -0.391 . . . . 2.21 110.653 -163.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.62 53.32 0.65 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.123 0.392 . . . . 1.0800000000000001 113.007 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -107.9 130.14 55.04 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 2.5899999999999999 107.733 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.71 -58.75 2.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.166 -1.05 . . . . 2.77 108.166 159.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.12 -93.14 0.13 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.701 -0.96 . . . . 0.70999999999999996 110.701 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -155.09 166.52 33.33 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.945 1.698 . . . . 2.3900000000000001 111.234 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.09 178.06 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 127.31 2.244 . . . . 1.8700000000000001 105.961 165.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -136.49 145.73 45.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.921 -1.881 . . . . 2.75 105.921 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.52 145.49 34.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.733 0.813 . . . . 1.55 110.862 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -70.39 -84.25 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.873 0.869 . . . . 2.9500000000000002 110.79 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 93' ' ' GLY . 61.5 tttt -158.69 -47.3 0.06 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.317 1.047 . . . . 4.2300000000000004 111.226 -171.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.439 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 19.3 t0 -82.44 29.62 0.43 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 124.659 2.171 . . . . 3.0699999999999998 110.277 173.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 60.07 21.31 55.94 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 113.583 -1.644 . . . . 0.91000000000000003 111.611 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.56 138.14 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.716 -1.587 . . . . 1.9199999999999999 106.716 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.73 169.37 19.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.103 -1.073 . . . . 1.78 108.103 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.64 141.61 29.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.956 -1.868 . . . . 2.7200000000000002 105.956 -165.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.8 56.59 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 124.048 0.843 . . . . 2.1099999999999999 112.415 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.8 m -78.15 97.45 5.47 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.27 1.028 . . . . 1.5700000000000001 109.846 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 mm -136.44 153.62 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.964 0.906 . . . . 2.9900000000000002 110.455 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -132.81 97.08 3.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.243 1.817 . . . . 4.0300000000000002 108.77 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.98 174.4 11.59 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.601 -0.518 . . . . 2.3199999999999998 109.601 169.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.2 m -147.84 26.52 1.01 Allowed 'General case' 0 CA--C 1.53 0.211 0 O-C-N 120.839 -1.163 . . . . 3.3500000000000001 112.069 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.15 -52.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.543 1.537 . . . . 2.0099999999999998 108.532 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.21 173.22 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.107 0.48 . . . . 2.3599999999999999 111.338 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.3 t -154.43 176.48 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.679 0.792 . . . . 3.0699999999999998 110.257 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -86.88 -13.67 44.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 3.5499999999999998 111.073 160.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.1 t -126.64 177.21 6.67 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.568 1.147 . . . . 3.6400000000000001 111.349 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.42 -96.96 2.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.848 -1.301 . . . . 4.6399999999999997 109.848 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -162.8 -60.47 0.04 OUTLIER 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.483 1.113 . . . . 4.2199999999999998 108.989 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -75.39 2.65 10.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.064 0.946 . . . . 6.5499999999999998 111.516 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -41.96 156.48 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.147 1.779 . . . . 1.76 112.413 165.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.7 pt -86.04 -6.39 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 2.9100000000000001 110.855 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.6 tp -33.22 123.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 125.369 1.468 . . . . 3.5499999999999998 110.69 166.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.81 57.11 20.5 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.858 -0.897 . . . . 1.8600000000000001 110.858 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -135.56 157.93 45.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.883 -1.525 . . . . 4.96 106.883 163.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -82.58 120.75 25.93 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.543 -1.28 . . . . 1.8700000000000001 107.543 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.44 141.69 44.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.602 -1.258 . . . . 3.6899999999999999 107.602 168.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.04 134.1 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.446 -1.316 . . . . 1.5900000000000001 107.446 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.33 130.43 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 106.337 -1.727 . . . . 3.4100000000000001 106.337 162.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -104.51 163.66 12.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.773 1.397 . . . . 0.38 114.773 -168.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.72 -71.47 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.281 -0.866 . . . . 3.7599999999999998 112.287 176.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -79.56 176.68 9.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.643 1.111 . . . . 3.96 109.08 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.3 158.66 16.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.779 -0.822 . . . . 1.8200000000000001 108.779 162.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -76.64 170.57 16.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.481 -0.562 . . . . 2.0 109.481 166.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.78 -20.84 59.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.254 1.205 . . . . 4.1500000000000004 114.254 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 66.48 -6.21 0.53 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.119 1.368 . . . . 2.54 113.471 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.84 9.34 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 120.122 1.328 . . . . 1.95 109.904 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.09 -31.09 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 6.7599999999999998 109.384 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.64 -106.73 2.12 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.761 . . . . 4.0700000000000003 111.196 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.44 -72.19 0.47 Allowed Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.544 -0.974 . . . . 3.7799999999999998 112.117 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -83.23 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.688 0.744 . . . . 3.1699999999999999 110.933 -172.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 178.77 -71.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.597 1.959 . . . . 3.2200000000000002 106.908 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -40.28 -40.39 1.14 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.857 2.063 . . . . 4.6799999999999997 112.042 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.47 0.09 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.549 2.339 . . . . 2.48 112.076 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -39.53 74.27 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.409 -1.432 . . . . 2.8500000000000001 110.787 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -55.66 -48.42 75.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.78 1.232 . . . . 3.9300000000000002 111.566 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.454 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -127.7 -48.26 1.39 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.691 0.796 . . . . 2.0299999999999998 111.987 177.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.3 -11.9 0.9 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.797 -1.002 . . . . 0.89000000000000001 114.097 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 30.51 54.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.943 2.097 . . . . 3.9300000000000002 112.911 -168.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.8 80.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.519 1.127 . . . . 2.2200000000000002 111.014 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.96 -165.75 30.72 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 108.895 -1.682 . . . . 1.05 108.895 -166.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -58.57 154.83 13.44 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 127.751 2.421 . . . . 1.8700000000000001 113.102 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -57.01 139.03 53.47 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.816 -1.084 . . . . 3.1800000000000002 108.964 166.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.73 -78.48 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.014 -1.106 . . . . 1.74 108.014 160.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.7 159.8 16.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.019 -0.734 . . . . 1.8999999999999999 109.019 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 72.8 m -148.01 157.84 43.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.825 -1.546 . . . . 2.1800000000000002 106.825 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.14 139.96 3.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.212 -1.955 . . . . 0.73999999999999999 108.212 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.42 138.08 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.714 0.806 . . . . 2.0 109.552 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 tt -94.82 131.03 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.104 0.478 . . . . 1.9099999999999999 111.828 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.45 0.52 0.98 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.942 1.258 . . . . 0.66000000000000003 114.689 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.96 57.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.19 1.495 . . . . 1.9099999999999999 111.54 -153.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.72 174.58 15.25 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.027 0.531 . . . . 2.0 110.914 163.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 . . . . . 0 C--O 1.255 1.347 0 N-CA-C 102.731 -3.063 . . . . 6.8300000000000001 102.731 160.668 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 107.932 -1.136 . . . . 8.3599999999999994 107.932 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -165.89 56.24 0.1 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.304 1.441 . . . . 3.9399999999999999 109.375 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -151.55 166.54 30.86 Favored 'General case' 0 C--N 1.335 -0.055 0 O-C-N 121.183 -0.948 . . . . 4.4400000000000004 113.295 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.97 155.82 23.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.39 1.076 . . . . 2.0099999999999998 109.573 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -124.18 150.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 107.981 -1.118 . . . . 2.1099999999999999 107.981 165.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.36 95.37 4.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.194 0.998 . . . . 1.71 109.206 161.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.67 112.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.359 -1.348 . . . . 1.8100000000000001 107.359 161.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.48 131.83 51.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.153 0.981 . . . . 2.2200000000000002 109.769 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.63 -47.92 0.29 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.785 1.234 . . . . 5.71 109.886 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.61 -125.05 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.543 1.068 . . . . 0.84999999999999998 111.989 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.47 -58.27 1.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.696 -0.853 . . . . 4.21 108.696 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.72 165.92 3.8 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.788 1.661 . . . . 0.75 114.146 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.62 37.46 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 124.516 3.477 . . . . 1.4299999999999999 111.95 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.2 t -110.97 143.61 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.167 2.187 . . . . 2.0699999999999998 106.795 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -137.38 131.22 31.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.786 -1.931 . . . . 3.23 105.786 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.96 165.75 33.27 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 121.687 -0.633 . . . . 0.69999999999999996 111.84 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.65 127.65 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.979 -1.86 . . . . 2.3900000000000001 105.979 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.5 mm -98.46 138.14 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.748 -1.575 . . . . 1.8999999999999999 106.748 165.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -109.38 124.86 51.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.57 -1.641 . . . . 2.1699999999999999 106.57 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.21 95.99 6.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.882 -1.895 . . . . 3.54 105.882 171.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -113.52 136.66 52.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.879 -1.526 . . . . 5.54 106.879 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -153.69 153.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.913 -1.514 . . . . 4.29 106.913 -166.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -105.5 -79.06 0.56 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 5.5599999999999996 110.121 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.46 137.07 37.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.098 0.959 . . . . 4.0 109.051 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -52.52 -68.08 0.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.02 1.728 . . . . 2.8900000000000001 112.446 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -79.7 68.54 5.79 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.814 -1.18 . . . . 4.6399999999999997 107.814 170.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 167.46 31.42 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.604 -0.999 . . . . 1.5800000000000001 110.604 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.4 142.32 44.84 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.523 2.816 . . . . 1.5900000000000001 111.834 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.3 165.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.617 -1.253 . . . . 2.3399999999999999 107.617 171.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.37 95.09 4.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.866 -1.901 . . . . 4.1399999999999997 105.866 157.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.83 113.49 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.524 -1.658 . . . . 2.0899999999999999 106.524 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -124.85 142.5 51.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.177 -1.045 . . . . 0.96999999999999997 108.177 166.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.1 152.23 23.67 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.446 -0.661 . . . . 0.73999999999999999 111.446 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 p -125.33 64.56 1.16 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.484 1.514 . . . . 2.8599999999999999 108.599 -165.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -80.72 142.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.525 -1.216 . . . . 1.8 109.099 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -149.99 161.88 41.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.324 0.861 . . . . 4.2300000000000004 113.324 174.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.81 9.1 61.43 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.702 1.62 . . . . 0.82999999999999996 112.617 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.87 162.41 16.35 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.751 -0.853 . . . . 1.6399999999999999 109.542 172.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.18 162.21 14.91 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.571 -1.27 . . . . 2.73 107.571 152.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.69 177.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.962 0.801 . . . . 3.0699999999999998 110.959 174.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.98 -163.51 37.51 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.922 0.772 . . . . 0.68999999999999995 113.512 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.7 142.92 58.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.393 1.477 . . . . 2.8799999999999999 113.355 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -145.68 116.88 7.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 126.104 1.762 . . . . 0.68999999999999995 109.359 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.58 150.02 6.13 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.301 0.953 . . . . 0.40000000000000002 111.081 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -141.25 99.61 3.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.66 -1.237 . . . . 4.3200000000000003 107.66 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -140.02 161.95 36.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.714 -1.217 . . . . 1.1000000000000001 107.714 -165.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.89 130.0 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 119.07 0.85 . . . . 3.1299999999999999 109.41 172.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -106.99 134.09 50.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.479 1.911 . . . . 1.3 105.947 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 60.64 0.61 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.16 1.541 . . . . 4.6900000000000004 115.16 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -95.75 112.12 23.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.878 -1.156 . . . . 3.1800000000000002 107.878 168.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -88.53 39.31 0.91 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.683 -1.229 . . . . 4.1600000000000001 107.683 160.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -73.9 84.88 1.72 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 122.42 1.105 . . . . 6.8799999999999999 109.009 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -101.45 38.08 1.67 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.933 -1.485 . . . . 7.3600000000000003 107.847 171.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -128.55 -47.81 1.29 Allowed 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.059 0.543 . . . . 5.71 111.784 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.35 -63.8 1.2 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.267 1.027 . . . . 5.4400000000000004 109.165 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.72 -47.44 0.36 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.343 -0.703 . . . . 5.1699999999999999 111.343 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 32.2 m -147.31 135.05 21.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 104.077 -2.564 . . . . 3.29 104.077 164.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 m -140.43 -13.81 1.0 Allowed 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 114.281 1.215 . . . . 5.96 114.281 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.3 t -179.8 55.48 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 116.697 2.11 . . . . 3.9399999999999999 116.697 -115.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -167.28 148.54 5.69 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.395 0.678 . . . . 2.0299999999999998 109.453 158.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.49 -85.5 1.85 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.819 -1.312 . . . . 1.5600000000000001 109.819 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.63 176.66 9.82 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.215 2.61 . . . . 1.05 113.217 -174.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 m170 -66.31 123.4 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.107 -1.406 . . . . 1.45 108.119 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -37.19 113.5 0.26 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.092 1.357 . . . . 4.3700000000000001 111.608 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.5 154.55 25.63 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 124.957 1.303 . . . . 3.3300000000000001 107.604 168.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.36 -48.6 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.861 1.708 . . . . 1.3600000000000001 111.643 -168.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.38 -79.71 0.62 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.898 0.879 . . . . 4.2199999999999998 109.074 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.3 m -150.8 68.86 0.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.801 0.841 . . . . 2.27 110.384 -166.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.426 HH11 ' CD ' ' A' ' 78' ' ' GLU . 9.4 mmt180 -78.95 174.92 11.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.338 0.589 . . . . 5.0 109.417 166.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -124.8 156.01 38.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.376 -1.342 . . . . 3.8199999999999998 107.376 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -83.15 162.05 21.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.099 0.476 . . . . 0.79000000000000004 111.155 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.41 -126.28 0.87 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.173 -2.771 . . . . 2.0499999999999998 106.173 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.02 -134.22 2.02 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 106.403 -2.679 . . . . 1.8200000000000001 106.403 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.14 -54.18 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 120.288 2.044 . . . . 1.8500000000000001 109.869 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -60.14 -44.42 94.95 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.952 1.301 . . . . 5.9699999999999998 113.841 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.8 175.75 2.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.905 0.383 . . . . 2.0600000000000001 111.06 -170.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -77.36 -46.85 21.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.048 1.339 . . . . 5.0099999999999998 108.889 167.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.426 ' CD ' HH11 ' A' ' 69' ' ' ARG . 2.0 mm-40 -79.85 172.22 14.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.81 0.844 . . . . 3.1499999999999999 112.144 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 172.17 145.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.234 2.213 . . . . 4.9699999999999998 109.757 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -56.18 138.64 49.64 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.905 -1.517 . . . . 0.77000000000000002 106.905 161.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.55 -32.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.293 -0.632 . . . . 2.0899999999999999 109.293 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.87 34.45 5.34 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 116.395 1.318 . . . . 1.0600000000000001 116.395 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -107.1 148.08 29.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.861 1.83 . . . . 2.4399999999999999 107.402 157.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.62 -49.95 4.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.27 -1.011 . . . . 2.6899999999999999 108.27 141.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.82 -97.16 0.17 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.794 -1.322 . . . . 0.85999999999999999 109.794 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -152.81 169.49 22.65 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.784 1.634 . . . . 2.3700000000000001 109.574 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.7 175.2 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.331 -1.729 . . . . 1.79 106.331 163.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -109.47 143.7 38.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.733 -1.21 . . . . 2.9399999999999999 107.733 162.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.25 151.32 29.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.548 -0.908 . . . . 1.8600000000000001 108.548 151.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.39 -87.28 0.06 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.328 0.651 . . . . 2.8599999999999999 109.388 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -150.72 -43.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.12 1.368 . . . . 4.5599999999999996 110.848 -170.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.24 8.09 5.45 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.204 1.002 . . . . 2.6699999999999999 111.268 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.29 8.16 87.59 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.169 0.89 . . . . 1.01 111.536 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -78.67 135.91 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.015 -1.476 . . . . 1.8300000000000001 107.015 173.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.1 174.42 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.086 0.955 . . . . 1.5700000000000001 109.424 170.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -130.0 117.56 20.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 103.241 -2.874 . . . . 3.6400000000000001 103.241 -174.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.58 112.03 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 105.039 -2.208 . . . . 1.9199999999999999 105.039 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -148.89 97.23 2.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.816 1.246 . . . . 1.47 108.433 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.1 mp -145.28 147.41 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 108.929 -0.767 . . . . 2.9100000000000001 108.929 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.22 68.49 1.28 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.066 0.946 . . . . 4.21 111.964 173.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.99 157.66 31.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.375 -0.828 . . . . 2.4199999999999999 111.078 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 p -110.36 -11.8 14.49 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.775 2.03 . . . . 2.0 113.508 -177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.05 -50.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.923 -1.14 . . . . 2.3300000000000001 107.923 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.78 158.95 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 122.357 1.075 . . . . 3.6400000000000001 109.808 171.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.8 p -152.17 174.68 13.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.762 2.425 . . . . 2.3599999999999999 107.553 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -42.61 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.344 1.458 . . . . 3.8700000000000001 109.45 173.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.5 m -119.02 72.21 0.88 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.301 1.44 . . . . 5.1100000000000003 110.899 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -166.63 60.14 0.23 Allowed Glycine 0 CA--C 1.526 0.724 0 CA-C-N 118.616 0.644 . . . . 5.0300000000000002 111.769 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.9 t70 56.49 -76.75 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.671 1.989 . . . . 3.8700000000000001 113.476 172.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -78.07 1.38 21.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.664 1.186 . . . . 6.0300000000000002 111.232 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.17 146.01 0.33 Allowed 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.122 0.969 . . . . 1.4299999999999999 110.824 163.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.8 pt -79.58 -7.73 10.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 119.295 -0.962 . . . . 3.1600000000000001 111.339 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 tt -44.46 140.91 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.095 1.146 . . . . 3.27 114.095 -167.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 56.59 9.32 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.4 -1.08 . . . . 1.8 110.4 -178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.48 175.78 13.51 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.861 2.065 . . . . 5.0099999999999998 105.706 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -123.35 106.39 10.63 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.501 1.046 . . . . 2.1600000000000001 112.488 -169.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.69 150.02 42.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.194 -0.457 . . . . 2.73 110.133 168.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.33 134.45 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.995 1.718 . . . . 1.8600000000000001 107.124 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 m -103.71 124.66 58.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.265 -1.383 . . . . 2.7200000000000002 107.265 165.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -97.81 159.42 14.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 116.859 2.17 . . . . 0.47999999999999998 116.859 -168.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -40.62 -69.52 0.13 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.143 2.577 . . . . 3.1099999999999999 111.651 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -113.44 -176.23 2.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.66 0.664 . . . . 4.1900000000000004 109.985 -169.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.7 146.33 41.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.528 -0.545 . . . . 1.5 109.528 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 154.47 41.61 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.244 -1.021 . . . . 2.0800000000000001 108.244 157.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -90.81 -6.02 54.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 3.54 113.663 -170.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 65.84 14.49 9.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.365 1.466 . . . . 2.5299999999999998 113.44 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 39.01 3.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.94 1.257 . . . . 1.6399999999999999 110.999 167.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -141.68 -82.36 0.21 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.346 1.459 . . . . 6.2000000000000002 108.525 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.06 -46.42 0.98 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.66 1.124 . . . . 3.98 114.285 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.53 7.76 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.349 -1.5 . . . . 2.6200000000000001 109.349 -165.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -166.18 -170.39 1.69 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.138 1.775 . . . . 3.48 107.347 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -92.87 -47.61 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.831 0.853 . . . . 3.3199999999999998 110.493 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -53.3 -33.76 54.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.929 2.092 . . . . 4.9800000000000004 112.085 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 p -49.73 -70.68 0.08 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.47 1.508 . . . . 2.54 110.705 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.6 p -60.06 -45.65 92.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 2.1099999999999999 110.207 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.8 -48.26 75.7 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.373 1.069 . . . . 4.9400000000000004 111.577 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 54.5 p -132.07 -54.73 0.98 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.386 0.513 . . . . 2.6600000000000001 112.386 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 126.99 106.96 1.45 Allowed Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 104.783 -3.327 . . . . 3.02 104.783 -167.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.45 57.55 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.679 1.592 . . . . 2.54 108.984 -172.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.75 -30.84 67.81 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.458 1.503 . . . . 1.9299999999999999 113.438 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.08 50.62 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 107.953 -2.059 . . . . 1.05 107.953 -160.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 t -64.69 162.78 15.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.927 0.891 . . . . 2.3599999999999999 113.289 -165.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -65.75 138.03 57.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.337 1.855 . . . . 4.04 109.144 172.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.7 mt -110.75 -78.31 0.59 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.773 1.169 . . . . 1.76 108.91 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.4 151.7 26.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.878 0.871 . . . . 2.0099999999999998 109.175 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.0 p -160.57 173.24 15.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.426 1.89 . . . . 1.49 107.367 -177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 167.11 170.88 32.54 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.844 -2.902 . . . . 1.45 105.844 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.6 t -87.49 143.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 119.624 1.712 . . . . 1.9299999999999999 109.082 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.8 tt -93.65 127.63 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.92 0.488 . . . . 2.0800000000000001 111.592 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.54 14.95 0.11 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.38 1.467 . . . . 1.1000000000000001 114.292 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 mm -101.99 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 120.178 1.989 . . . . 2.25 109.331 -159.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.73 175.11 14.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 2.23 109.278 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 104.351 -2.463 . . . . 4.8899999999999997 104.351 162.377 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 106.984 -1.487 . . . . 5.9199999999999999 106.984 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.0 p -71.98 95.33 1.57 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.064 0.946 . . . . 3.2000000000000002 108.568 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 149.46 26.6 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.656 0.662 . . . . 4.5 111.181 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.06 138.36 34.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 1.6399999999999999 108.108 165.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.59 142.36 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.953 -1.129 . . . . 2.1600000000000001 107.953 166.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.34 96.07 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.444 -0.947 . . . . 1.6699999999999999 108.444 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.84 107.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.763 -1.569 . . . . 2.23 106.763 159.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -95.21 125.0 39.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.969 -1.123 . . . . 1.96 107.969 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -49.68 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.16 0.584 . . . . 5.7599999999999998 109.872 175.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 36.38 -120.5 0.6 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.42 1.486 . . . . 1.22 112.918 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -93.47 -59.67 1.96 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.342 -0.984 . . . . 3.4100000000000001 108.342 -173.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.39 164.2 5.43 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.512 1.53 . . . . 1.1200000000000001 114.897 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -79.06 33.48 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.399 3.399 . . . . 1.3999999999999999 112.208 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 t -111.2 141.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 127.171 2.189 . . . . 2.0299999999999998 105.997 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -139.61 128.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.776 -1.564 . . . . 3.1800000000000002 106.776 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.17 164.88 31.59 Favored Glycine 0 N--CA 1.45 -0.395 0 O-C-N 121.905 -0.497 . . . . 0.81999999999999995 112.064 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.98 124.57 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.863 -1.162 . . . . 2.3799999999999999 107.863 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.0 mm -89.39 155.33 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.504 1.122 . . . . 2.1099999999999999 109.061 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 126.57 43.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.516 -0.92 . . . . 2.46 108.516 153.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.65 123.25 47.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.462 -2.051 . . . . 3.6200000000000001 105.462 168.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -148.98 139.51 22.56 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.098 -0.705 . . . . 3.4199999999999999 109.098 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 164.91 37.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.618 -1.993 . . . . 3.8999999999999999 105.618 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -54.3 2.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.774 1.23 . . . . 5.0800000000000001 110.34 -177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -79.28 118.74 21.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.257 -1.386 . . . . 4.1699999999999999 107.257 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -76.02 46.09 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.738 1.154 . . . . 2.79 112.7 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.8 t30 179.85 58.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.822 2.449 . . . . 4.6799999999999997 107.971 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.59 170.59 35.2 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.41 -1.076 . . . . 1.3 110.41 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.45 140.24 86.49 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.315 2.677 . . . . 1.47 111.626 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 t -93.67 158.12 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.12 -1.067 . . . . 2.3799999999999999 108.12 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -107.71 111.75 24.09 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.38 -1.711 . . . . 6.4699999999999998 106.38 162.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -79.61 135.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.507 -2.034 . . . . 2.02 105.507 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -139.13 159.64 41.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.644 -1.984 . . . . 0.93999999999999995 105.644 159.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.1 -166.29 14.75 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.201 -1.0 . . . . 1.9199999999999999 110.61 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.0 m -148.22 109.73 4.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.626 -1.99 . . . . 2.1699999999999999 105.626 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -114.81 146.18 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.703 -1.592 . . . . 2.0499999999999998 106.703 -170.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -154.79 170.63 21.17 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 114.127 1.158 . . . . 4.5999999999999996 114.127 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.89 80.45 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.626 1.584 . . . . 0.65000000000000002 112.616 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.1 155.77 26.93 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.833 -0.804 . . . . 1.79 110.232 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 165.01 17.71 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.66 -1.237 . . . . 2.3999999999999999 107.66 156.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.66 175.69 0.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.013 0.824 . . . . 2.6099999999999999 111.59 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.34 -162.12 37.22 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.129 0.871 . . . . 0.60999999999999999 113.576 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.49 146.48 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.051 1.74 . . . . 2.98 112.962 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -146.97 113.53 5.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.872 1.669 . . . . 0.64000000000000001 109.428 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.92 147.84 4.16 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.745 -0.942 . . . . 0.41999999999999998 110.745 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.54 95.32 2.85 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.791 -1.559 . . . . 3.48 106.791 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -132.18 158.37 41.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.354 -1.721 . . . . 0.89000000000000001 106.354 -165.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.302 0.8 OUTLIER -117.81 115.94 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.546 1.165 . . . . 2.7799999999999998 110.681 175.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -79.78 158.95 26.72 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.113 1.365 . . . . 0.92000000000000004 109.15 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -28.62 -93.39 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.638 2.775 . . . . 4.9400000000000004 114.998 -158.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.69 74.13 0.05 Allowed 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.1 0.56 . . . . 12.24 110.273 -171.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -149.1 125.41 10.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.428 -0.509 . . . . 8.8800000000000008 111.82 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -90.45 134.46 34.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.64 1.576 . . . . 4.8499999999999996 109.325 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -173.0 53.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.048 1.339 . . . . 4.7199999999999998 107.997 -163.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -77.31 59.4 1.81 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.715 1.206 . . . . 7.9699999999999998 112.861 -166.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 175.14 -65.33 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.925 2.49 . . . . 5.9299999999999997 105.339 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.36 57.29 5.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.722 -1.351 . . . . 5.25 109.722 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.3 t -79.62 65.95 4.95 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.219 0.51 . . . . 3.54 112.209 -165.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.6 m -165.04 134.38 3.54 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.345 2.258 . . . . 5.3399999999999999 105.881 167.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.6 m 119.82 152.86 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 104.232 -2.507 . . . . 3.7000000000000002 104.232 -101.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 53.6 93.21 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.258 1.823 . . . . 3.3199999999999998 113.188 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.82 -91.98 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.955 -0.914 . . . . 1.96 112.204 -161.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.4 177.51 8.25 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.607 2.872 . . . . 1.6399999999999999 112.925 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -62.3 123.42 18.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.219 -1.4 . . . . 1.28 107.219 168.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -37.9 109.63 0.11 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.422 1.089 . . . . 2.8100000000000001 112.255 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -126.12 145.06 51.0 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 130.792 3.637 . . . . 3.5 107.712 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 -43.0 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.277 1.985 . . . . 1.5800000000000001 109.028 168.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -155.24 -73.44 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.368 -0.975 . . . . 3.9199999999999999 108.368 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 p -129.49 58.88 1.61 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.471 1.108 . . . . 3.3599999999999999 110.906 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -79.8 159.84 26.37 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.818 -0.552 . . . . 5.79 109.559 168.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.46 163.02 17.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.375 1.47 . . . . 4.8799999999999999 107.792 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -90.2 153.39 20.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.912 0.885 . . . . 0.82999999999999996 110.329 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.66 -52.4 0.01 OUTLIER Glycine 0 C--O 1.224 -0.521 0 N-CA-C 109.639 -1.384 . . . . 2.77 109.639 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.9 -166.31 21.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.948 1.261 . . . . 1.9199999999999999 111.488 171.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.91 -41.31 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.786 2.324 . . . . 1.5700000000000001 109.155 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -58.78 -58.11 10.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.267 1.427 . . . . 5.7300000000000004 109.91 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.66 152.88 29.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.036 -0.983 . . . . 1.9299999999999999 111.269 -167.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -52.18 -45.42 65.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.77 1.628 . . . . 4.0999999999999996 111.479 173.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -77.64 145.67 36.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.505 1.145 . . . . 2.6499999999999999 110.256 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.27 151.56 2.07 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.369 1.868 . . . . 3.8599999999999999 108.848 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.4 m80 -60.94 143.63 54.72 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.785 -1.561 . . . . 0.55000000000000004 106.785 163.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.97 -30.73 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.167 -0.613 . . . . 1.8200000000000001 110.947 -165.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.69 67.51 0.31 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 112.157 -0.377 . . . . 1.1200000000000001 112.157 167.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.29 114.37 3.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.419 -1.048 . . . . 2.6600000000000001 108.862 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.03 -53.93 3.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.248 0.619 . . . . 3.3399999999999999 110.121 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.76 -110.41 0.42 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.112 -0.566 . . . . 0.64000000000000001 111.822 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -148.58 167.58 25.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.04 1.736 . . . . 2.25 109.479 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.5 m -117.63 175.23 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.362 -1.718 . . . . 1.74 106.362 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.9 t -109.43 150.48 28.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.264 -1.384 . . . . 3.21 107.264 159.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.03 152.83 32.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.64 -0.874 . . . . 1.74 108.64 157.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -79.88 -83.47 0.1 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.781 1.232 . . . . 3.7200000000000002 108.984 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 93' ' ' GLY . 1.0 OUTLIER -151.29 -48.47 0.12 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.175 0.99 . . . . 4.96 110.968 -178.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.37 24.91 0.65 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.439 1.59 . . . . 2.7200000000000002 111.13 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 66.36 14.39 61.94 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.063 1.316 . . . . 0.70999999999999996 111.889 -173.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.88 152.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 125.193 1.397 . . . . 1.8999999999999999 107.749 175.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.41 172.35 15.07 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.16 1.384 . . . . 1.6699999999999999 107.729 168.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -132.85 162.66 30.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.89 -2.263 . . . . 3.3999999999999999 104.89 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.54 55.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 O-C-N 124.184 0.928 . . . . 1.97 112.423 174.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.3 m -70.4 101.29 1.92 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.741 -0.599 . . . . 1.3799999999999999 110.845 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.07 157.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.835 -0.802 . . . . 2.7400000000000002 108.835 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -139.09 129.16 25.19 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.613 -0.884 . . . . 3.6200000000000001 108.613 159.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -134.68 151.48 51.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.695 1.598 . . . . 2.3599999999999999 108.492 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 p -107.59 -3.51 19.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.275 1.83 . . . . 1.9199999999999999 113.28 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.94 -42.56 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.364 -1.347 . . . . 2.1899999999999999 107.364 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.69 177.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.519 0.676 . . . . 2.77 111.546 172.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.9 m -161.21 179.32 8.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.833 2.453 . . . . 2.3799999999999999 106.434 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 70.4 1.08 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.118 -2.179 . . . . 3.9399999999999999 105.118 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 t -145.4 -72.12 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.638 -0.71 . . . . 3.96 110.513 170.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 167.37 -146.09 10.39 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 106.924 -2.47 . . . . 4.5700000000000003 106.924 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.1 t70 55.1 -101.77 0.13 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.21 1.004 . . . . 3.8599999999999999 110.417 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -76.51 -34.88 58.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.108 0.963 . . . . 5.3099999999999996 110.736 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.5 p -72.75 176.56 5.47 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.486 1.136 . . . . 2.48 112.887 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.95 -6.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.065 -0.971 . . . . 2.73 112.081 -170.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.2 mm -59.38 124.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.455 -0.943 . . . . 3.8599999999999999 108.455 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.79 3.56 76.91 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.447 1.022 . . . . 1.3200000000000001 113.256 -172.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -113.03 163.48 14.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.285 1.543 . . . . 5.1799999999999997 109.771 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -93.15 89.79 6.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.833 1.253 . . . . 2.9399999999999999 110.252 -157.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.33 143.98 56.27 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.329 -0.857 . . . . 3.0699999999999998 109.848 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -135.19 133.45 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.281 1.832 . . . . 1.52 109.046 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -94.38 121.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 125.858 1.663 . . . . 3.6400000000000001 107.706 163.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -98.56 167.28 10.91 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 117.608 2.447 . . . . 0.58999999999999997 117.608 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -81.3 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.325 1.85 . . . . 4.0199999999999996 110.314 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -178.26 6.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.595 0.634 . . . . 5.7199999999999998 109.878 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.63 151.03 30.07 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.141 -1.429 . . . . 1.6599999999999999 107.141 153.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -76.74 151.7 35.93 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.473 -1.306 . . . . 1.99 107.473 158.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.424 ' CB ' ' HG ' ' A' ' 134' ' ' SER . 56.4 m-20 -70.27 -25.56 63.41 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.0 -0.437 . . . . 3.1400000000000001 111.529 -169.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 50.0 7.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.043 0.937 . . . . 3.1600000000000001 109.93 -159.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 52.53 39.72 53.73 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.306 0.955 . . . . 1.6000000000000001 113.263 167.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -80.01 -18.61 49.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.681 0.792 . . . . 6.1699999999999999 111.394 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.44 -143.09 16.3 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.83 -0.508 . . . . 3.6600000000000001 111.83 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.77 -77.05 0.4 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.577 -1.409 . . . . 3.2000000000000002 109.577 -172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.86 104.03 14.46 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.012 -1.477 . . . . 2.8399999999999999 107.012 167.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.56 -33.55 22.23 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.763 1.165 . . . . 5.1600000000000001 112.986 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -37.07 -36.71 0.13 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.319 1.048 . . . . 3.02 113.694 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.424 ' HG ' ' CB ' ' A' ' 125' ' ' ASP . 5.8 t -36.35 -66.99 0.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.903 2.081 . . . . 2.4900000000000002 111.023 167.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.28 -46.15 51.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.145 0.978 . . . . 2.3900000000000001 110.583 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -53.01 -52.27 58.96 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.585 0.754 . . . . 3.7799999999999998 111.328 -168.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.278 5.4 p -126.51 -48.51 1.54 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.675 -0.679 . . . . 2.2999999999999998 112.277 174.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 159.42 -21.06 0.28 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 120.052 1.296 . . . . 1.01 114.039 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.17 56.32 5.96 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.796 1.238 . . . . 2.8100000000000001 111.349 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.28 0.49 2.78 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.509 0.929 . . . . 2.1699999999999999 113.509 169.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -71.13 2.99 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.297 -1.502 . . . . 3.3799999999999999 110.315 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 t -166.33 -174.41 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.529 0.732 . . . . 2.6400000000000001 110.975 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.31 139.06 31.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.496 2.718 . . . . 4.0899999999999999 109.522 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.4 mt -113.26 -88.28 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.298 0.954 . . . . 1.6699999999999999 109.685 169.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.31 154.43 21.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.598 -0.89 . . . . 2.1899999999999999 108.598 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.6 p -157.58 170.98 21.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 123.753 0.658 . . . . 1.76 110.598 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.62 155.42 11.31 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.484 -1.446 . . . . 1.3500000000000001 109.484 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.0 137.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.611 0.705 . . . . 2.4500000000000002 109.459 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.1 tt -86.45 143.65 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.228 -0.442 . . . . 1.8 110.935 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.04 5.56 3.03 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.62 1.105 . . . . 0.57999999999999996 114.219 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.4 mm -96.05 56.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 119.289 1.544 . . . . 2.0 109.926 -156.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.49 176.52 12.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.547 0.739 . . . . 2.4900000000000002 110.578 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.313 0 N-CA-C 103.999 -2.593 . . . . 5.9900000000000002 103.999 154.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 107.171 -1.418 . . . . 8.6699999999999999 107.171 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.9 p -151.85 -178.16 6.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.934 1.294 . . . . 5.4000000000000004 107.654 -176.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -75.73 176.18 7.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.798 -1.186 . . . . 3.9199999999999999 107.798 157.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.39 144.8 43.26 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.055 -1.461 . . . . 1.6000000000000001 107.055 164.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.9 t -119.91 141.38 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 107.571 -1.27 . . . . 1.76 107.571 171.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.19 99.82 6.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.173 1.389 . . . . 1.8700000000000001 108.286 159.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.83 98.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.65 -1.241 . . . . 1.8 107.65 163.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.0 mt -84.61 126.82 33.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.188 0.595 . . . . 1.77 109.564 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -143.72 -48.3 0.29 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.72 0.808 . . . . 4.6200000000000001 110.91 170.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.43 -123.68 5.24 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.432 -1.067 . . . . 0.82999999999999996 110.432 -171.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -107.1 -52.57 2.74 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.712 0.756 . . . . 4.0199999999999996 110.707 -173.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.56 156.58 5.71 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.913 1.244 . . . . 0.81000000000000005 111.702 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.14 39.65 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.372 3.381 . . . . 1.1899999999999999 113.23 -170.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.5 t -101.47 155.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.761 2.025 . . . . 1.9399999999999999 107.644 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.12 125.02 9.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.967 -1.494 . . . . 3.2599999999999998 106.967 175.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.81 165.91 35.33 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.268 -0.733 . . . . 0.59999999999999998 111.268 177.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.09 115.18 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.009 -1.849 . . . . 2.71 106.009 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.4 mm -78.65 145.83 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.273 -1.38 . . . . 1.8799999999999999 107.273 168.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -123.41 107.62 11.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.878 -1.897 . . . . 2.0299999999999998 105.878 163.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -89.55 93.16 9.39 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.265 -2.124 . . . . 3.9900000000000002 105.265 164.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -96.11 134.87 38.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.106 -0.702 . . . . 3.5600000000000001 109.106 177.483 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -145.95 83.31 1.63 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.104 -0.953 . . . . 3.71 110.931 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -50.39 -45.13 55.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.721 -0.672 . . . . 7.7699999999999996 111.012 157.036 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -85.33 73.48 10.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.852 -1.166 . . . . 4.7400000000000002 107.852 -175.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 79.78 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.473 0.709 . . . . 5.0199999999999996 109.614 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -162.72 -53.69 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.61 1.564 . . . . 6.3899999999999997 109.513 -162.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.08 -85.31 0.06 OUTLIER Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.762 -1.209 . . . . 3.4100000000000001 112.761 -170.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.21 115.64 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.363 2.708 . . . . 2.1800000000000002 111.593 -174.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 t -87.5 165.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.861 -1.162 . . . . 2.1200000000000001 107.861 172.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.162 -1.792 . . . . 4.54 106.162 168.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 t -89.67 131.49 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.96 -1.496 . . . . 1.97 106.96 174.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -136.93 161.9 34.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.26 -1.385 . . . . 0.94999999999999996 107.26 153.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.09 146.16 7.06 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.998 . . . . 0.84999999999999998 108.105 178.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -119.81 66.94 0.81 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.672 1.989 . . . . 2.4100000000000001 107.16 -171.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.73 115.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.47 -1.241 . . . . 1.95 107.96 -167.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -110.27 154.36 23.56 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.424 0.69 . . . . 4.4699999999999998 111.616 -173.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.64 68.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.641 -0.709 . . . . 0.85999999999999999 114.31 172.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -59.28 164.28 3.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.945 1.373 . . . . 1.6100000000000001 109.078 163.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.28 160.22 19.18 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.719 -1.238 . . . . 2.4100000000000001 107.836 154.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -58.85 171.33 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.367 -0.833 . . . . 2.6000000000000001 110.289 175.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.0 -157.27 48.42 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 121.94 -0.475 . . . . 0.54000000000000004 112.96 167.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.98 141.92 38.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.207 1.003 . . . . 3.3300000000000001 111.059 -167.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -143.99 119.62 10.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.241 1.016 . . . . 0.62 110.537 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.3 147.9 16.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.708 -0.957 . . . . 0.51000000000000001 110.708 172.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.41 91.85 2.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.361 1.064 . . . . 3.71 108.167 -173.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -130.86 158.27 40.64 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.017 -0.538 . . . . 1.1399999999999999 109.828 -160.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.42 117.0 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.295 -0.632 . . . . 3.7400000000000002 109.295 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -107.6 139.57 41.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.959 -1.126 . . . . 1.05 107.959 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -73.01 66.16 0.79 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.242 0.83 . . . . 5.1900000000000004 113.242 -171.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' CD ' HH22 ' A' ' 143' ' ' ARG . 2.4 mt-10 -119.7 78.25 1.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 3.0 110.541 -173.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -80.93 -85.85 0.09 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.062 0.545 . . . . 5.1100000000000003 110.19 171.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -82.24 70.81 9.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.834 0.826 . . . . 6.0300000000000002 110.834 -170.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -104.67 -60.05 1.65 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.336 1.054 . . . . 4.8399999999999999 109.381 169.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 t -178.86 -46.4 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.349 1.46 . . . . 5.2800000000000002 109.935 -175.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -179.18 -42.51 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.814 1.246 . . . . 7.0 110.83 -174.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.09 -93.18 2.11 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.04 0.829 . . . . 5.21 111.747 -174.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m -148.43 148.75 30.66 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 117.982 -1.008 . . . . 2.6800000000000002 108.442 -167.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 p -152.7 -4.91 0.22 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.522 1.304 . . . . 5.4699999999999998 114.522 164.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.1 t 173.15 40.92 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.297 -1.502 . . . . 3.6800000000000002 113.28 -115.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.91 146.91 16.35 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.634 -1.617 . . . . 2.1200000000000001 106.634 166.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.5 -96.27 2.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.485 -1.846 . . . . 1.5900000000000001 108.485 -177.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.47 177.8 6.34 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.281 2.654 . . . . 1.1100000000000001 113.23 -177.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -69.07 131.77 45.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 115.968 -1.968 . . . . 1.6499999999999999 105.852 170.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -33.93 107.91 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.865 1.666 . . . . 4.1699999999999999 114.337 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.41 127.73 30.89 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 126.521 1.928 . . . . 3.1699999999999999 107.31 167.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.49 -40.68 13.45 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.595 1.53 . . . . 2.04 109.133 173.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 tt -146.69 -60.56 0.3 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.159 -1.793 . . . . 4.5099999999999998 106.159 164.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.6 p -151.38 80.28 1.3 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.49 0.716 . . . . 3.8199999999999998 109.948 -178.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -80.03 163.58 24.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 5.6799999999999997 108.392 158.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.14 166.21 10.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.32 -1.363 . . . . 4.2999999999999998 107.32 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.408 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 46.0 t60 -80.1 160.95 25.58 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.81999999999999995 110.148 175.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.19 -149.33 7.98 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 104.769 -3.332 . . . . 2.1299999999999999 104.769 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.69 -146.45 4.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.462 1.631 . . . . 1.8500000000000001 109.041 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.9 -36.88 21.59 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.321 2.014 . . . . 1.71 111.132 -177.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.61 -44.05 91.8 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.627 0.371 . . . . 5.4900000000000002 111.104 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.43 164.13 26.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.625 0.726 . . . . 1.9299999999999999 112.042 -169.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -77.74 -45.63 24.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.158 1.383 . . . . 4.1500000000000004 108.971 165.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -78.27 168.59 19.6 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.987 0.899 . . . . 3.25 109.84 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 153.62 142.75 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 130.524 3.53 . . . . 3.9199999999999999 105.454 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.443 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.0 m80 -59.58 151.02 25.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.649 -0.82 . . . . 0.78000000000000003 109.313 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -71.31 -4.77 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.258 -0.901 . . . . 1.9099999999999999 111.121 -172.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.99 70.2 0.44 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.995 1.283 . . . . 1.1200000000000001 109.947 159.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.92 122.28 0.7 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.64 -1.244 . . . . 2.8399999999999999 107.64 -177.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.33 -38.06 8.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.772 0.829 . . . . 2.9300000000000002 110.204 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.87 -129.29 3.24 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.086 -2.006 . . . . 0.93999999999999995 108.086 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -131.05 170.6 14.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.134 1.374 . . . . 2.4199999999999999 110.382 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.09 175.71 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.352 1.461 . . . . 2.0800000000000001 107.244 171.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -124.89 126.76 46.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.937 -1.135 . . . . 3.0600000000000001 107.937 175.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.48 139.53 31.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.754 0.822 . . . . 1.8700000000000001 111.337 171.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -74.26 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 O-C-N 124.305 1.003 . . . . 3.0899999999999999 110.508 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 93' ' ' GLY . 46.6 tttt -149.84 -35.44 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.786 1.032 . . . . 4.1200000000000001 113.786 -164.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -80.89 22.17 0.63 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 124.047 1.879 . . . . 3.9300000000000002 110.191 165.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 57.9 25.83 56.95 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 125.124 1.345 . . . . 1.0900000000000001 111.069 -170.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.9 t -83.78 106.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.396 1.079 . . . . 2.3999999999999999 108.169 -175.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.8 167.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.977 -1.12 . . . . 2.2799999999999998 107.977 158.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -128.07 139.6 52.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 103.399 -2.815 . . . . 3.0899999999999999 103.399 176.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.08 55.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 123.861 0.726 . . . . 2.02 111.775 179.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -74.89 101.57 4.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.389 0.676 . . . . 1.1599999999999999 110.767 170.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.1 mt -140.94 156.01 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.93 0.786 . . . . 2.8500000000000001 109.626 177.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.27 72.22 1.37 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.345 1.458 . . . . 4.96 111.22 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.49 134.68 37.29 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.403 -0.811 . . . . 2.1699999999999999 109.454 177.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 p -92.72 -9.97 38.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.424 1.49 . . . . 2.1499999999999999 112.894 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.4 t -85.63 -46.09 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.404 -0.962 . . . . 2.4199999999999999 108.404 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -70.8 177.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.097 0.475 . . . . 2.1400000000000001 111.922 176.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.5 t -153.12 175.07 13.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.609 1.964 . . . . 3.6000000000000001 105.808 172.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.45 0.68 17.9 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.036 0.935 . . . . 3.4700000000000002 111.399 162.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.9 m -121.94 -49.71 2.08 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.246 1.418 . . . . 4.1299999999999999 110.74 -173.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.08 158.73 37.6 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.739 -0.544 . . . . 4.3700000000000001 111.739 -174.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.46 -49.5 5.28 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.176 1.79 . . . . 4.8399999999999999 112.229 -177.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.65 4.07 19.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.108 1.363 . . . . 6.4199999999999999 113.516 -174.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 p -50.32 175.38 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.509 1.67 . . . . 1.51 115.509 -173.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.66 -14.54 12.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 114.122 -1.399 . . . . 3.7599999999999998 112.392 170.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.2 tp -50.04 123.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 124.066 0.946 . . . . 2.9900000000000002 110.297 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.9 86.77 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.215 -0.769 . . . . 1.3600000000000001 114.198 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.7 175.99 9.41 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.148 1.974 . . . . 7.0899999999999999 109.341 178.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.85 123.69 50.89 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.578 1.081 . . . . 2.6099999999999999 108.594 167.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.85 144.92 40.95 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.301 -1.37 . . . . 2.5299999999999998 107.301 167.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -129.75 134.93 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.195 1.798 . . . . 1.6499999999999999 107.59 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.82 128.44 58.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.729 -1.212 . . . . 2.6800000000000002 107.729 167.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -104.3 158.13 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.827 2.158 . . . . 0.63 116.827 -171.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -41.33 -68.87 0.16 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.724 2.81 . . . . 3.04 111.355 172.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -111.27 -175.06 2.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.1 -0.704 . . . . 3.5099999999999998 109.1 -171.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.97 141.04 47.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.053 -1.091 . . . . 1.8500000000000001 108.053 165.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.66 165.46 14.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.994 -0.682 . . . . 2.5600000000000001 109.604 154.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.53 -48.66 74.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.525 -0.761 . . . . 3.54 113.048 -173.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 77.08 52.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.289 1.836 . . . . 2.4199999999999999 111.021 -159.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 27.16 64.42 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.408 1.004 . . . . 1.6399999999999999 114.889 152.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -85.35 -33.14 22.1 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.081 1.352 . . . . 6.5899999999999999 108.673 169.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.43 -80.67 1.6 Allowed Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.633 -1.787 . . . . 3.8700000000000001 108.633 -178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.85 -73.92 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.294 0.95 . . . . 3.23 110.861 -175.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -75.46 -116.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.097 -1.446 . . . . 2.8900000000000001 107.097 157.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.15 -40.3 0.06 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.069 1.304 . . . . 4.2400000000000002 112.912 173.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -43.21 -43.61 4.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.806 1.242 . . . . 3.8399999999999999 111.504 175.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.9 m -33.28 -63.66 0.23 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.095 2.558 . . . . 2.6499999999999999 113.483 163.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.08 -46.28 57.44 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.119 -0.988 . . . . 2.3300000000000001 112.052 175.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -53.03 -49.46 66.25 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.395 0.543 . . . . 4.3499999999999996 110.821 -173.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.443 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -129.67 -46.21 1.17 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.662 0.785 . . . . 2.0600000000000001 110.991 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.408 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.21 -31.74 0.79 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.241 0.448 . . . . 1.1699999999999999 112.12 -175.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 48.19 54.66 9.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.926 1.29 . . . . 4.04 110.259 -165.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.46 -35.35 39.34 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.921 1.688 . . . . 2.7000000000000002 113.71 174.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.52 -179.04 49.1 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 108.464 -1.854 . . . . 1.02 108.464 -159.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -62.43 153.3 31.77 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.263 1.425 . . . . 2.3900000000000001 112.736 -164.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.419 HH22 ' CD ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -77.07 133.71 38.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.8 1.24 . . . . 3.7400000000000002 108.664 179.137 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.0 mt -111.02 -70.39 0.82 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.093 -1.077 . . . . 1.6499999999999999 108.093 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.97 148.37 52.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.614 0.766 . . . . 2.1600000000000001 110.047 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.3 p -160.28 173.79 15.17 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 125.191 1.557 . . . . 1.75 109.415 -176.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.64 135.04 2.5 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.71 -2.156 . . . . 0.78000000000000003 107.71 -176.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.1 t -60.5 133.79 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.495 0.718 . . . . 2.1099999999999999 109.074 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.22 136.08 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.28 0.562 . . . . 1.9199999999999999 112.204 -174.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 137.25 -3.02 3.28 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.812 1.196 . . . . 0.55000000000000004 114.029 175.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.3 61.26 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 122.784 1.278 . . . . 2.8100000000000001 107.832 -157.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.25 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.93 -1.032 . . . . 2.6400000000000001 112.696 -173.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 C--O 1.25 1.104 0 N-CA-C 101.813 -3.403 . . . . 8.6500000000000004 101.813 150.662 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.375 -0.602 . . . . 8.3699999999999992 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.1 m -100.04 159.02 15.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.957 -1.497 . . . . 4.7999999999999998 106.957 171.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -78.13 154.28 31.38 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.946 -1.131 . . . . 5.7000000000000002 107.946 167.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.53 149.12 47.27 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.856 -0.794 . . . . 1.77 108.856 157.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 t -119.59 145.48 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.856 -1.164 . . . . 2.2200000000000002 107.856 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.11 97.14 5.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.648 -0.871 . . . . 1.6899999999999999 108.648 159.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.43 105.33 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.264 -1.384 . . . . 1.79 107.264 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.22 124.48 37.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.99 -0.745 . . . . 1.8400000000000001 108.99 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -137.97 -60.16 0.64 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.75 0.42 . . . . 4.04 110.001 174.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.78 -122.1 6.43 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.201 0.905 . . . . 0.79000000000000004 111.989 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -115.14 -50.48 2.75 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 124.932 1.293 . . . . 3.02 109.475 -163.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.31 153.95 9.18 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.735 -1.346 . . . . 0.71999999999999997 109.735 171.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.69 41.91 1.15 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.425 2.75 . . . . 0.98999999999999999 113.279 -166.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.62 155.91 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.329 1.852 . . . . 2.23 108.945 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.39 81.57 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.133 -1.432 . . . . 2.9100000000000001 107.133 172.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.23 163.66 13.96 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.398 -0.681 . . . . 0.58999999999999997 111.398 -173.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.75 124.56 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.417 -0.957 . . . . 2.1899999999999999 108.417 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -88.82 135.31 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.421 1.089 . . . . 2.21 108.326 164.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.48 110.38 22.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.801 1.64 . . . . 2.9199999999999999 108.086 159.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.42 111.88 23.57 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.11 -1.811 . . . . 3.52 106.11 166.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -117.41 140.13 49.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.852 0.72 . . . . 2.9399999999999999 110.167 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -156.62 141.57 17.13 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.781 0.832 . . . . 4.4900000000000002 110.569 170.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -70.42 -67.06 0.52 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.44 0.696 . . . . 5.4699999999999998 109.529 170.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -76.85 -178.7 5.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 120.076 1.307 . . . . 3.8100000000000001 111.854 -170.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -65.57 -65.95 0.61 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.882 1.273 . . . . 2.8100000000000001 110.401 172.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -125.65 92.52 3.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.892 0.877 . . . . 5.1799999999999997 109.526 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.25 177.35 27.5 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 108.28 -1.928 . . . . 1.3100000000000001 108.28 170.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.44 111.59 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.51 2.806 . . . . 1.3100000000000001 112.094 -175.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.31 132.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.075 -1.083 . . . . 1.8100000000000001 108.075 -169.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -87.23 101.17 13.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.201 -1.777 . . . . 4.5899999999999999 106.201 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.1 124.37 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.282 -1.747 . . . . 2.0299999999999998 106.282 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -131.83 136.35 47.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.047 -1.834 . . . . 1.21 106.047 159.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.28 150.97 23.21 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.539 -1.824 . . . . 0.90000000000000002 108.539 -174.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.1 m -128.95 101.43 6.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.73 -2.322 . . . . 2.5699999999999998 104.73 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.97 144.59 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.074 -1.454 . . . . 1.9199999999999999 107.074 -169.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -154.83 143.73 20.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.475 0.546 . . . . 4.7999999999999998 112.475 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.89 25.79 8.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.877 2.179 . . . . 0.98999999999999999 112.712 -177.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.31 -155.78 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.431 -0.952 . . . . 1.8200000000000001 108.431 164.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -135.65 168.43 19.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.622 -2.733 . . . . 3.3199999999999998 103.622 165.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.16 169.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.277 1.399 . . . . 3.1899999999999999 114.099 -172.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.36 -165.98 48.9 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.592 -1.185 . . . . 0.63 113.195 169.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.51 143.7 57.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.403 1.481 . . . . 2.7799999999999998 113.104 -174.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -143.15 114.82 8.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.074 1.749 . . . . 0.63 108.69 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.61 145.16 2.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.33 -1.108 . . . . 0.39000000000000001 110.33 169.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -137.58 95.11 3.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.738 -1.579 . . . . 3.8599999999999999 106.738 -176.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -134.98 154.51 51.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.362 -1.347 . . . . 1.02 107.362 -164.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.264 2.6 p -107.08 108.66 25.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 CA-C-O 122.396 1.093 . . . . 3.0299999999999998 108.782 172.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -77.47 156.44 31.05 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.39 -1.707 . . . . 0.98999999999999999 106.39 172.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -81.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.908 0.483 . . . . 5.5099999999999998 110.261 -178.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 11.25 76.66 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 C-N-CA 127.853 2.461 . . . . 4.4900000000000002 114.403 -169.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -80.75 57.25 2.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.175 0.99 . . . . 4.2599999999999998 109.438 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -159.72 153.99 23.68 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.536 1.534 . . . . 5.29 108.46 166.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.75 -3.85 4.68 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.246 1.419 . . . . 6.25 113.283 165.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.43 -40.53 61.9 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 120.546 1.521 . . . . 5.25 111.19 -177.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.67 78.8 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.252 0.621 . . . . 6.7800000000000002 111.623 -177.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.91 98.75 2.37 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 107.138 -2.385 . . . . 4.2800000000000002 107.138 -167.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.83 114.79 4.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.715 0.257 . . . . 4.3099999999999996 110.787 -171.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 m -149.73 -77.09 0.15 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.225 -0.922 . . . . 5.1900000000000004 110.826 177.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.378 0.4 OUTLIER 26.73 -61.99 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 1 N-CA-C 123.074 4.472 . . . . 3.1899999999999999 123.074 143.463 . . . . . . . . 4 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -36.42 142.49 0.09 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 118.556 2.799 . . . . 3.21 118.556 -157.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -177.66 14.05 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 114.235 -1.348 . . . . 3.0099999999999998 110.914 164.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.61 -179.99 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.977 3.785 . . . . 1.1499999999999999 113.612 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -47.07 107.19 0.1 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.844 1.258 . . . . 1.1499999999999999 109.063 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -34.27 104.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.278 1.431 . . . . 3.8999999999999999 111.935 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -122.79 141.58 35.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 129.55 3.14 . . . . 3.48 108.197 -174.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.91 -51.71 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.017 1.811 . . . . 1.22 109.085 173.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.19 -75.4 0.37 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.299 1.04 . . . . 3.8500000000000001 108.558 169.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -136.32 60.63 1.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.006 0.522 . . . . 2.25 111.613 -159.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -78.74 164.04 24.89 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.702 -1.222 . . . . 5.0499999999999998 107.702 162.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -127.66 173.62 9.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.643 . . . . 5.54 107.142 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.464 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 35.8 t60 -93.85 157.69 16.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.97 0.73 . . . . 0.81999999999999995 112.97 -167.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.41 -147.77 7.79 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 105.734 -2.946 . . . . 2.1099999999999999 105.734 166.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.89 -170.4 30.77 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.051 -2.42 . . . . 2.0299999999999998 107.051 176.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.29 -23.84 71.62 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.092 2.528 . . . . 2.6899999999999999 113.667 -176.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -70.37 -34.37 72.52 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.963 -0.461 . . . . 5.8300000000000001 111.264 173.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.52 176.65 8.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.562 1.545 . . . . 1.8899999999999999 110.585 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -83.93 -47.91 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.926 1.29 . . . . 4.3200000000000003 109.145 164.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -88.69 166.39 14.11 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.592 1.157 . . . . 3.46 111.073 -166.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 168.95 146.1 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.51 2.324 . . . . 6.7699999999999996 108.773 -173.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 42.1 m80 -63.25 148.75 47.31 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 106.278 -1.749 . . . . 0.55000000000000004 106.278 166.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 -45.84 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 119.224 -0.99 . . . . 1.9099999999999999 108.389 -176.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.6 59.71 4.8 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.618 -0.677 . . . . 1.1499999999999999 113.187 171.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -168.94 120.22 0.75 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.656 -1.238 . . . . 2.6699999999999999 107.656 -172.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.39 -51.56 3.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.18 0.992 . . . . 3.5499999999999998 109.186 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.95 -116.49 0.71 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.642 -0.983 . . . . 0.67000000000000004 110.642 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -144.66 167.5 22.4 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.876 1.27 . . . . 2.46 109.677 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 175.54 5.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 N-CA-C 106.522 -1.659 . . . . 1.6399999999999999 106.522 167.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -106.97 147.25 30.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.264 -1.384 . . . . 3.1800000000000002 107.264 158.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.01 30.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.639 -0.875 . . . . 1.54 108.639 155.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -73.2 -78.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.227 1.011 . . . . 3.3199999999999998 109.736 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -152.95 -52.37 0.11 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.532 1.533 . . . . 5.4900000000000002 108.491 178.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.48 17.7 1.68 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.903 1.681 . . . . 4.4800000000000004 111.541 -171.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.98 15.11 81.95 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.084 1.326 . . . . 0.79000000000000004 111.337 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.77 149.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.21 -1.404 . . . . 1.77 107.21 171.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.77 24.85 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.232 1.013 . . . . 1.73 108.343 169.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.33 145.91 50.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.027 -2.212 . . . . 2.79 105.027 -174.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.13 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.841 0.713 . . . . 1.8400000000000001 111.3 178.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.5 m -76.07 96.78 3.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.387 1.075 . . . . 1.27 110.85 170.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.7 mt -132.45 153.94 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 2.6600000000000001 109.064 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -126.08 84.01 2.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.103 0.561 . . . . 3.0499999999999998 110.47 166.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -79.5 121.76 25.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.89 0.476 . . . . 2.9900000000000002 109.728 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.5 p -84.6 -17.33 39.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.286 1.834 . . . . 2.0800000000000001 112.57 178.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.2 t -83.64 -51.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.908 0.776 . . . . 2.0299999999999998 110.05 -170.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -75.55 177.04 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.261 0.553 . . . . 2.2200000000000002 110.863 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.0 m -155.97 175.84 13.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.898 1.279 . . . . 2.4100000000000001 108.1 171.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 47.66 2.09 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.891 1.276 . . . . 3.6099999999999999 111.705 -175.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -121.38 155.88 33.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.856 -1.905 . . . . 3.2799999999999998 105.856 171.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.09 63.95 2.42 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.281 0.946 . . . . 4.25 112.175 -171.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -128.27 -113.18 0.27 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.373 1.469 . . . . 6.21 108.515 -169.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -87.22 0.9 54.64 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.644 1.978 . . . . 7.25 111.662 176.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 p -62.35 166.32 5.16 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.094 1.358 . . . . 1.51 113.007 -166.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -79.69 -27.41 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.943 -1.026 . . . . 3.0299999999999998 110.443 172.142 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -32.12 108.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.133 2.173 . . . . 3.48 111.247 177.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.88 -20.13 10.91 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.419 1.485 . . . . 1.55 112.816 -174.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -103.06 160.13 14.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.961 1.881 . . . . 5.46 113.002 -165.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -75.81 102.09 5.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.354 1.062 . . . . 2.2400000000000002 111.028 -172.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -68.71 144.96 54.25 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.335 -0.853 . . . . 2.7999999999999998 108.938 168.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -136.1 140.59 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.703 1.601 . . . . 1.5900000000000001 108.99 -172.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 m -111.38 125.45 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.203 1.401 . . . . 2.9399999999999999 107.445 166.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.408 ' CG ' ' HB3' ' A' ' 140' ' ' ALA . 60.1 m-70 -101.63 165.25 11.33 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.727 1.751 . . . . 0.41999999999999998 115.727 -172.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.403 ' CG ' ' HD3' ' A' ' 122' ' ' LYS . 8.1 pt-20 -67.86 -53.41 26.94 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.469 1.108 . . . . 3.4300000000000002 112.444 -174.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HD3' ' CG ' ' A' ' 121' ' ' GLU . 1.9 mppt? -101.09 -176.17 3.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.227 1.376 . . . . 3.5299999999999998 109.039 175.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.11 165.97 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.838 -0.801 . . . . 1.79 108.838 156.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -84.39 167.06 16.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.421 0.688 . . . . 1.98 109.383 156.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.29 -7.15 59.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.627 1.171 . . . . 3.0299999999999998 111.881 -175.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 53.14 33.18 14.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.351 1.06 . . . . 2.3500000000000001 110.241 -170.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.57 20.52 52.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.798 0.713 . . . . 1.5900000000000001 112.635 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -135.14 50.3 2.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.292 1.437 . . . . 7.0800000000000001 107.446 -173.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.38 147.23 19.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 106.94 -2.464 . . . . 3.46 106.94 173.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.4 60.3 4.3 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.435 0.618 . . . . 2.9100000000000001 112.631 -167.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.88 163.22 35.76 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 107.325 -1.361 . . . . 2.8300000000000001 107.325 172.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.26 -52.37 62.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.004 -0.739 . . . . 3.2400000000000002 109.004 168.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -46.65 -42.57 16.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.518 1.527 . . . . 3.6800000000000002 111.847 -171.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 m -40.17 -63.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.866 2.066 . . . . 2.2799999999999998 112.113 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.2 t -74.95 -45.74 40.29 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.867 -0.521 . . . . 3.6200000000000001 111.598 175.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.85 -48.22 67.21 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.713 1.605 . . . . 3.4500000000000002 111.492 -169.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.42 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.0 p -127.77 -46.73 1.41 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.778 0.431 . . . . 2.2999999999999998 111.493 174.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.464 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.54 -27.73 0.48 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 123.169 0.414 . . . . 1.0800000000000001 113.71 -178.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 51.6 t30 48.71 53.77 11.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 2.5699999999999998 110.216 -165.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.408 ' HB3' ' CG ' ' A' ' 120' ' ' HIS . . . -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.576 1.15 . . . . 2.1200000000000001 112.012 167.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.09 179.02 51.73 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 108.765 -1.734 . . . . 1.0 108.765 -161.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -53.79 155.72 3.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.791 -1.204 . . . . 2.3300000000000001 112.04 -175.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.93 144.49 25.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.615 1.966 . . . . 4.8200000000000003 109.519 -177.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt -114.43 -69.28 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.814 -1.18 . . . . 1.6200000000000001 107.814 -173.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 165.21 12.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.865 -0.607 . . . . 2.0 110.133 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.1 p -151.07 154.9 37.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.248 -0.887 . . . . 1.76 109.234 164.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.11 131.45 2.29 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.111 -1.996 . . . . 0.67000000000000004 108.111 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.94 125.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.433 -0.951 . . . . 2.1299999999999999 108.433 175.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.02 138.07 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 120.381 0.134 . . . . 2.0899999999999999 111.088 178.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.19 6.87 1.16 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.622 1.106 . . . . 0.67000000000000004 114.409 174.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.5 58.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 119.584 1.692 . . . . 1.73 110.635 -160.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.94 175.67 12.68 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.891 0.876 . . . . 2.0299999999999998 108.646 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 103.603 -2.74 . . . . 4.7699999999999996 103.603 161.815 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 112.861 0.689 . . . . 9.6500000000000004 112.861 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m 46.04 59.44 3.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.007 1.723 . . . . 5.4900000000000002 114.319 172.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 161.75 29.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.534 -0.913 . . . . 4.6799999999999997 108.534 158.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.63 154.95 19.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.198 -1.408 . . . . 2.2999999999999998 107.198 154.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.1 t -123.39 142.81 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.788 -0.819 . . . . 1.6499999999999999 108.788 169.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.38 93.14 4.26 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.114 -0.698 . . . . 1.54 109.114 158.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.62 103.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.73 -1.211 . . . . 1.8799999999999999 107.73 158.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.86 134.71 34.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.974 -0.751 . . . . 1.76 108.974 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -145.81 -57.64 0.31 Allowed 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.602 1.161 . . . . 3.8300000000000001 108.824 169.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.63 -124.3 31.25 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.804 0.716 . . . . 0.96999999999999997 112.432 -176.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -113.18 -54.15 2.64 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.618 1.167 . . . . 4.25 109.939 -164.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.02 160.55 7.07 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.202 -1.159 . . . . 0.98999999999999999 110.202 173.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.21 40.63 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.441 2.761 . . . . 1.04 112.349 -172.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.48 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.441 1.897 . . . . 1.8600000000000001 108.848 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.5 128.84 8.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.085 -1.82 . . . . 3.0299999999999998 106.085 170.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.43 171.12 41.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.798 . . . . 0.54000000000000004 111.57 -177.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 mm -128.92 129.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.143 -1.428 . . . . 3.0800000000000001 107.143 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.3 mm -101.07 137.29 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 N-CA-C 107.126 -1.435 . . . . 1.8400000000000001 107.126 161.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 127.15 45.23 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.274 -1.38 . . . . 1.97 107.274 160.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.25 91.82 5.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.619 -1.993 . . . . 3.2999999999999998 105.619 158.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -122.03 134.76 54.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.119 -1.067 . . . . 4.1399999999999997 108.119 175.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.39 -62.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.512 -1.222 . . . . 3.5299999999999998 108.193 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? 58.79 48.89 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.299 1.44 . . . . 9.9499999999999993 112.958 169.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -147.67 160.76 42.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.042 0.937 . . . . 5.4199999999999999 109.387 160.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.3 p -75.93 56.23 0.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.216 -0.661 . . . . 5.8300000000000001 109.216 167.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -110.59 -56.91 2.29 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.527 1.531 . . . . 10.9 107.688 176.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.65 0.35 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 117.974 -1.459 . . . . 3.8300000000000001 110.161 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -50.65 122.93 10.49 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.912 3.075 . . . . 3.23 113.869 -168.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.23 143.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.623 -0.717 . . . . 2.1600000000000001 110.25 -165.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -92.16 83.81 5.16 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.082 -1.822 . . . . 3.5 106.082 171.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.43 83.52 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.945 -1.132 . . . . 1.95 107.945 -172.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -92.49 135.18 34.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.267 0.556 . . . . 1.1299999999999999 110.03 169.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.27 164.61 35.04 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.079 -1.609 . . . . 0.80000000000000004 109.079 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -154.09 129.22 9.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.369 -1.345 . . . . 3.1000000000000001 107.369 -174.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -128.78 147.92 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 125.689 1.596 . . . . 2.1899999999999999 108.932 -163.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -136.86 156.2 48.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.291 0.496 . . . . 4.7800000000000002 112.202 164.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.83 13.09 41.41 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.382 1.944 . . . . 0.57999999999999996 112.916 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.69 157.15 36.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.709 -0.848 . . . . 1.97 108.709 168.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -78.55 157.02 28.91 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.984 -1.487 . . . . 3.1699999999999999 106.984 156.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.36 174.2 0.1 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.951 . . . . 3.1899999999999999 112.637 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.75 -169.19 53.12 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.623 -0.717 . . . . 0.58999999999999997 112.564 169.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 tp -75.18 146.82 40.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.351 1.06 . . . . 3.6699999999999999 110.753 -177.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.59 116.26 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.331 1.452 . . . . 0.76000000000000001 108.468 -178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.72 146.72 7.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.63 -1.388 . . . . 0.63 109.63 172.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -139.1 93.75 2.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.541 -1.652 . . . . 3.9300000000000002 106.541 -171.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -131.83 150.95 52.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.719 -1.585 . . . . 1.0800000000000001 106.719 -162.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.738 0.78 . . . . 2.7200000000000002 109.07 174.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -78.7 149.28 32.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.416 -1.698 . . . . 0.97999999999999998 106.416 170.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.55 -100.23 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.388 2.275 . . . . 5.1799999999999997 113.543 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 50.97 58.53 5.45 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.82 0.674 . . . . 3.52 112.82 174.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -62.45 -27.09 68.87 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 113.635 0.976 . . . . 6.3700000000000001 113.635 -174.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -174.64 95.52 0.08 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.507 1.123 . . . . 5.9500000000000002 108.988 -175.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -153.14 -57.29 0.13 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.464 0.542 . . . . 5.5800000000000001 112.464 -177.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 t -163.79 164.4 23.65 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 119.328 0.967 . . . . 6.3700000000000001 109.458 176.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.12 -18.54 60.21 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.791 0.836 . . . . 7.7999999999999998 110.703 167.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.13 -126.52 0.5 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 108.745 -1.742 . . . . 4.2199999999999998 108.745 170.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.0 p 179.98 138.8 0.12 Allowed 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.253 1.021 . . . . 2.73 109.786 174.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.19 -158.82 0.75 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 104.156 -2.535 . . . . 4.4000000000000004 104.156 160.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.6 m 69.13 23.75 6.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 116.392 -2.123 . . . . 3.7200000000000002 116.121 143.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.09 150.44 24.06 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.593 0.633 . . . . 2.7999999999999998 111.224 -166.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.42 -143.9 15.47 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.44 1.495 . . . . 1.77 111.394 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.47 -179.43 5.42 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.798 3.665 . . . . 1.3400000000000001 113.76 -170.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -52.57 64.57 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 129.498 3.119 . . . . 1.6200000000000001 115.402 -174.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.2 t80 42.97 68.22 0.53 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.074 1.75 . . . . 3.3399999999999999 110.504 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -85.09 114.82 58.2 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.241 -0.885 . . . . 3.2799999999999998 109.808 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.84 -32.99 10.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.271 1.981 . . . . 1.47 111.593 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.43 -64.57 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.239 -0.652 . . . . 4.21 109.239 177.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.7 t -158.94 65.34 0.41 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.062 -0.718 . . . . 3.5800000000000001 109.062 178.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 -79.23 163.39 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.931 -0.396 . . . . 6.6100000000000003 109.931 169.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.96 144.16 49.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.091 1.356 . . . . 4.6200000000000001 109.114 -169.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -77.09 155.66 32.27 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.831 0.853 . . . . 0.78000000000000003 111.707 -173.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.79 -98.27 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.499 -1.44 . . . . 2.2400000000000002 109.499 161.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.34 -146.93 9.55 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.577 -1.809 . . . . 1.73 108.577 178.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.83 -58.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.536 2.157 . . . . 1.4099999999999999 109.724 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -20.54 64.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.906 1.283 . . . . 7.46 112.176 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 2.7 t70 -64.41 175.91 1.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.528 0.731 . . . . 3.4500000000000002 111.255 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.04 -50.97 7.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.917 1.287 . . . . 5.6299999999999999 108.551 164.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.12 174.39 8.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.954 0.502 . . . . 4.29 111.606 -173.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 164.58 136.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.309 3.044 . . . . 4.9400000000000004 107.78 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.478 ' C ' ' H ' ' A' ' 82' ' ' GLY . 32.4 m80 -66.9 156.52 35.57 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.195 -1.78 . . . . 0.84999999999999998 106.195 165.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.265 13.0 p -78.51 45.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 123.25 1.5 . . . . 2.4500000000000002 110.832 173.102 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.16 33.25 0.27 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 128.74 3.067 . . . . 1.3500000000000001 111.331 165.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -137.48 131.9 32.53 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.312 2.056 . . . . 2.4300000000000002 110.37 161.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.28 -56.38 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.114 1.365 . . . . 3.3799999999999999 109.201 176.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.34 -123.58 0.94 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.238 -0.745 . . . . 0.98999999999999999 111.238 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -139.26 172.32 13.0 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 125.28 1.432 . . . . 2.1800000000000002 110.077 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.5 163.68 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.993 1.317 . . . . 1.78 107.453 164.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.2 m -110.59 133.42 53.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.999 -1.482 . . . . 3.0800000000000001 106.999 174.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.76 137.41 32.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.766 0.426 . . . . 1.53 110.535 169.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -73.98 -75.57 0.15 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.307 1.043 . . . . 3.3900000000000001 111.645 -166.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.37 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.668 1.187 . . . . 5.6699999999999999 110.841 -168.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.18 8.44 4.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.278 1.431 . . . . 2.77 110.936 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.82 16.45 76.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.365 -1.094 . . . . 0.98999999999999999 110.365 -171.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -78.24 149.01 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.788 -1.56 . . . . 1.72 106.788 172.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.72 165.73 26.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.774 -1.195 . . . . 1.75 107.774 165.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.28 140.25 51.5 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.364 -2.828 . . . . 3.0600000000000001 103.364 -172.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.61 78.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 123.971 0.795 . . . . 1.77 110.144 160.025 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.7 m -98.54 77.87 2.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.14 0.976 . . . . 1.3 108.952 166.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.58 159.11 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.554 -0.906 . . . . 2.6899999999999999 108.554 176.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.32 147.29 49.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.352 -0.981 . . . . 2.52 108.352 152.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -137.62 150.56 47.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.332 1.053 . . . . 2.0800000000000001 108.218 172.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 p -110.17 -4.45 15.76 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.942 1.697 . . . . 1.78 113.418 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.55 -47.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.745 -1.206 . . . . 1.9099999999999999 107.745 175.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.11 176.27 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.131 0.967 . . . . 2.4100000000000001 111.388 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.2 m -163.1 175.54 10.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.987 2.515 . . . . 2.21 104.469 -175.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.78 -1.93 45.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.896 0.771 . . . . 3.4500000000000002 112.587 173.165 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.2 m -155.71 -150.25 0.29 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.578 1.151 . . . . 4.2699999999999996 108.848 -173.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.15 -90.76 0.81 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.249 -1.141 . . . . 4.5499999999999998 110.249 -178.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -160.56 -63.52 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.385 0.674 . . . . 4.1600000000000001 110.883 -175.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.02 1.11 18.84 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.809 -0.557 . . . . 5.1500000000000004 112.472 -172.069 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.1 p -53.98 155.36 3.5 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.056 1.343 . . . . 1.5700000000000001 111.931 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.2 pt -88.61 -5.72 10.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.011 -0.995 . . . . 2.9199999999999999 110.738 -178.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -37.8 122.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.874 1.67 . . . . 2.8700000000000001 110.446 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.99 -21.24 40.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.895 -0.947 . . . . 1.6899999999999999 113.989 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -83.92 165.2 18.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.475 1.637 . . . . 6.6600000000000001 110.961 -170.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -89.56 108.15 19.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.699 0.4 . . . . 1.77 111.351 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.08 148.15 52.17 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.8 -0.815 . . . . 3.6000000000000001 108.8 168.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.16 141.47 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.525 1.53 . . . . 1.74 108.045 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.01 132.77 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.087 -1.079 . . . . 2.6499999999999999 108.087 162.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -102.97 168.98 8.85 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.621 1.568 . . . . 0.68000000000000005 114.018 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -72.06 0.17 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.493 -0.776 . . . . 5.4000000000000004 111.078 177.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -79.78 178.09 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.284 0.947 . . . . 5.5599999999999996 109.498 -178.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.13 173.76 0.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.433 1.093 . . . . 2.25 111.442 172.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -70.39 165.52 22.28 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.812 0.815 . . . . 2.9399999999999999 108.94 163.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.74 -21.38 15.21 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.128 -0.942 . . . . 3.9100000000000001 112.36 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 54.69 14.36 0.85 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.904 1.282 . . . . 2.98 112.232 -173.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.61 61.67 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.11 1.338 . . . . 2.4100000000000001 111.285 -176.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 11.3 mttt -129.94 19.08 5.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.267 1.027 . . . . 6.8600000000000003 110.874 -172.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.01 139.04 22.22 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.942 -2.063 . . . . 3.6299999999999999 107.942 164.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.36 67.13 1.88 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 117.764 0.782 . . . . 3.2599999999999998 111.682 -175.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -172.99 156.27 3.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.46 1.504 . . . . 3.0699999999999998 108.195 -177.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -52.24 52.78 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.263 -0.398 . . . . 3.6200000000000001 111.28 -178.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -29.49 -46.13 0.05 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 3.1200000000000001 113.751 171.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 t -53.16 -61.74 2.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.174 0.989 . . . . 2.4700000000000002 111.548 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -71.26 -43.4 67.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.237 -0.914 . . . . 2.0600000000000001 109.743 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -54.4 -39.14 66.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.337 2.255 . . . . 4.6699999999999999 112.539 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.412 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.4 t -138.1 -53.81 0.63 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.41 1.084 . . . . 2.8500000000000001 112.011 176.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 79.45 1.0 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 103.714 -3.755 . . . . 3.3599999999999999 103.714 -162.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -71.07 57.5 0.22 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.325 1.85 . . . . 3.7599999999999998 110.681 -178.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -26.1 67.78 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.928 -0.483 . . . . 2.4100000000000001 111.432 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 134.28 -177.34 19.24 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.397 -1.881 . . . . 0.93000000000000005 108.397 175.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -53.51 153.99 3.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.821 1.249 . . . . 2.0499999999999998 111.775 175.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.24 131.16 49.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.002 -0.999 . . . . 4.1399999999999997 108.468 168.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -102.51 -74.14 0.64 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.576 -1.639 . . . . 1.8799999999999999 106.576 164.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.16 154.44 19.76 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.424 -0.954 . . . . 2.2000000000000002 108.424 173.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.0 m -144.46 156.05 44.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.909 -1.886 . . . . 2.1099999999999999 105.909 170.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.39 130.1 1.62 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.101 -0.8 . . . . 0.83999999999999997 111.101 169.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.9 131.24 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.898 0.879 . . . . 2.0600000000000001 109.004 173.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.8 tt -91.91 133.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.722 0.296 . . . . 1.75 111.533 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.06 2.78 0.83 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.135 0.874 . . . . 1.1100000000000001 115.104 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.4 mm -95.4 57.86 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-N 119.325 1.562 . . . . 2.2400000000000002 109.92 -157.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.62 176.62 12.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.668 0.787 . . . . 2.73 109.773 171.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.256 1.435 0 N-CA-C 104.068 -2.568 . . . . 5.0599999999999996 104.068 170.225 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.496 ' H3 ' ' C ' ' A' ' 153' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 109.797 -0.446 . . . . 8.7699999999999996 109.797 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.3 p 47.92 60.02 3.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.658 1.583 . . . . 4.9199999999999999 112.818 169.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -122.33 168.85 11.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.82 1.648 . . . . 5.5800000000000001 106.943 172.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.22 142.46 46.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.773 0.829 . . . . 1.95 108.909 158.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -111.87 145.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.654 -1.61 . . . . 2.0899999999999999 106.654 166.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.47 97.62 5.85 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 1.79 108.941 155.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.64 98.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.561 1.144 . . . . 1.8700000000000001 108.768 164.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.69 130.4 35.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.958 0.903 . . . . 3.6800000000000002 108.784 172.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -151.69 -52.12 0.12 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 122.767 0.427 . . . . 4.3499999999999996 110.961 166.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.45 -116.6 1.43 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.261 0.934 . . . . 1.1599999999999999 112.998 -175.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -117.2 -46.04 2.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.169 0.988 . . . . 3.3500000000000001 109.729 -158.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 172.36 16.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.567 1.08 . . . . 1.03 111.747 177.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.47 -24.06 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.139 2.559 . . . . 1.3100000000000001 111.594 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.2 t -49.89 139.36 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 2.0299999999999998 110.92 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.89 130.26 8.88 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.751 -1.203 . . . . 2.3199999999999998 107.751 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.14 170.06 41.79 Favored Glycine 0 N--CA 1.449 -0.437 0 O-C-N 121.732 -0.605 . . . . 0.67000000000000004 111.691 -177.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 mm -123.83 126.14 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.287 -1.375 . . . . 3.0299999999999998 107.287 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mp -95.65 147.62 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.019 -1.474 . . . . 2.6800000000000002 107.019 163.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.53 121.39 36.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.032 1.333 . . . . 1.9099999999999999 107.494 167.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.73 99.03 10.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.978 -2.23 . . . . 3.4700000000000002 104.978 162.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -113.69 128.31 56.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.6 -0.889 . . . . 3.8999999999999999 108.6 174.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -157.22 -77.82 0.08 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.54 -1.664 . . . . 3.9300000000000002 108.963 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.2 59.85 3.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.47 -0.937 . . . . 7.5199999999999996 108.47 -174.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -113.83 -103.48 0.41 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.59 -2.374 . . . . 3.8599999999999999 104.59 168.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 t -153.03 -69.97 0.15 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.111 -1.44 . . . . 3.4900000000000002 107.111 157.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -124.19 97.85 5.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.84 -1.541 . . . . 4.9699999999999998 106.84 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.89 37.43 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.345 -0.702 . . . . 1.3200000000000001 111.345 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.74 115.62 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.366 3.378 . . . . 1.51 112.065 -172.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.02 164.44 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.562 0.745 . . . . 2.2000000000000002 109.157 -172.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -115.1 99.18 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.938 -1.504 . . . . 3.8700000000000001 106.938 166.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -92.31 88.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.08 1.752 . . . . 2.2200000000000002 107.566 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -98.31 151.43 20.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.419 -0.586 . . . . 1.05 109.419 169.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.9 159.04 32.18 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.369 -1.493 . . . . 0.84999999999999998 109.369 176.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.4 m -136.82 110.25 7.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.6 -1.63 . . . . 3.0499999999999998 106.6 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -119.16 148.83 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.013 1.325 . . . . 2.1200000000000001 107.893 -163.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -148.33 166.26 28.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.978 0.732 . . . . 4.4199999999999999 112.978 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.44 19.35 62.35 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 0.67000000000000004 113.208 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -75.49 165.32 25.3 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.373 1.086 . . . . 1.7 109.32 174.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.13 163.01 28.38 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.67 -1.233 . . . . 2.5699999999999998 107.67 155.342 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.89 165.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.79 0.805 . . . . 2.52 112.216 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 -158.31 53.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.086 -0.961 . . . . 0.73999999999999999 113.402 167.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 130.02 42.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.926 1.29 . . . . 2.8799999999999999 111.176 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -136.49 110.08 8.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.919 1.688 . . . . 2.29 109.527 -174.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.91 149.42 11.06 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.852 1.692 . . . . 0.64000000000000001 111.563 -177.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -146.4 100.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.463 -0.94 . . . . 4.2599999999999998 108.463 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -139.56 154.21 47.58 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.137 -1.06 . . . . 1.05 108.137 -166.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -113.61 129.23 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 119.571 1.078 . . . . 2.9100000000000001 108.82 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -105.81 146.83 29.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.64 -1.615 . . . . 0.79000000000000004 106.64 -176.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -53.77 -61.24 2.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.591 0.557 . . . . 4.0499999999999998 110.751 -165.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 39.12 71.54 0.16 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.598 1.559 . . . . 3.3799999999999999 111.535 159.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -73.27 -77.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.277 0.56 . . . . 4.9199999999999999 111.195 -171.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -80.24 126.66 31.41 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.139 -1.43 . . . . 5.2800000000000002 107.139 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -126.61 20.55 7.2 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.382 1.073 . . . . 4.5199999999999996 109.709 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -78.67 46.39 0.65 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.952 -1.093 . . . . 5.96 111.981 -172.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -174.53 -45.89 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 125.105 1.362 . . . . 6.5899999999999999 109.584 -173.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.54 -163.39 27.05 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.566 -2.214 . . . . 4.0899999999999999 107.566 -178.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.01 161.46 40.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.59 -1.633 . . . . 3.7599999999999998 106.59 -177.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m 101.3 79.89 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.843 2.057 . . . . 6.5199999999999996 107.85 -178.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 t 179.77 39.68 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.641 0.734 . . . . 3.48 111.021 -137.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.11 -69.92 0.05 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.542 1.537 . . . . 3.3900000000000001 107.497 -178.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.89 -94.52 0.34 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.256 -1.938 . . . . 1.8100000000000001 108.256 173.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.76 177.07 9.17 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.311 2.674 . . . . 0.96999999999999997 113.736 -176.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -60.93 130.94 48.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.582 -1.645 . . . . 1.3600000000000001 108.517 171.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -48.22 117.11 1.79 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.085 0.469 . . . . 2.6600000000000001 110.487 176.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.22 152.57 25.28 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 126.536 1.934 . . . . 3.4100000000000001 107.158 173.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -24.69 12.37 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.418 2.079 . . . . 1.45 113.529 -167.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.36 -68.74 0.12 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.952 0.796 . . . . 3.7400000000000002 109.57 -176.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.7 m -155.99 77.96 0.96 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.484 0.714 . . . . 2.6200000000000001 109.67 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -77.99 169.82 17.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.785 -0.82 . . . . 6.0899999999999999 108.785 163.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -118.41 158.47 25.23 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.701 1.6 . . . . 4.3300000000000001 106.734 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 55.0 t60 -86.0 154.06 21.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.566 0.58 . . . . 0.85999999999999999 112.566 -175.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.41 -178.58 43.48 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 106.613 -2.595 . . . . 2.1699999999999999 106.613 160.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.49 -160.83 26.04 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 117.462 0.631 . . . . 2.2400000000000002 112.616 -170.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.85 -43.19 3.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.951 1.768 . . . . 1.6100000000000001 109.301 173.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.4 -46.57 76.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 5.9000000000000004 111.659 -176.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.68 174.45 1.79 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.425 -0.807 . . . . 2.4399999999999999 109.754 176.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.09 -37.44 11.61 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.224 1.01 . . . . 5.7300000000000004 111.082 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -75.71 155.53 35.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.04 -1.096 . . . . 4.0199999999999996 108.04 -174.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 165.57 145.46 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.905 2.082 . . . . 4.1500000000000004 112.002 -170.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.2 m80 -66.57 149.7 50.09 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 107.564 -1.273 . . . . 0.65000000000000002 107.564 164.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.69 -37.43 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.94 -0.704 . . . . 2.2599999999999998 109.714 -171.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.17 60.86 1.59 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.611 0.624 . . . . 0.84999999999999998 112.029 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -168.29 114.94 0.67 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.523 -0.917 . . . . 2.6600000000000001 108.523 -172.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.13 -45.06 8.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.249 -0.648 . . . . 3.46 109.249 176.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.76 -94.11 0.15 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.289 -1.124 . . . . 1.4299999999999999 110.289 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -150.62 164.84 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.478 1.511 . . . . 2.21 110.573 -177.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.0 m -110.0 176.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.284 -1.747 . . . . 1.6200000000000001 106.284 156.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 t -112.49 144.3 42.2 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.444 -1.317 . . . . 2.8100000000000001 107.444 160.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.35 153.25 29.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.289 -1.004 . . . . 1.9099999999999999 108.289 154.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.47 -89.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.781 -0.822 . . . . 2.8399999999999999 108.781 173.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 93' ' ' GLY . 28.5 ttpp -140.25 -57.67 0.54 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.584 1.554 . . . . 5.2400000000000002 108.981 -171.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -87.8 30.39 0.83 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.042 1.337 . . . . 5.0700000000000003 110.062 -170.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 69.63 10.65 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.205 1.86 . . . . 1.04 112.956 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.71 138.3 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.393 -1.336 . . . . 1.95 107.393 176.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.55 170.79 15.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.063 1.345 . . . . 1.79 107.953 173.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -143.9 147.76 34.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.998 -2.223 . . . . 2.7999999999999998 104.998 -171.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.85 132.64 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.407 -1.701 . . . . 2.1000000000000001 106.407 166.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.9 m -153.02 73.19 0.98 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.013 1.325 . . . . 1.5600000000000001 107.603 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.6 mm -115.85 152.51 17.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.638 -0.875 . . . . 3.6800000000000002 108.638 -177.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -145.53 91.47 2.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.522 0.729 . . . . 2.4500000000000002 109.48 167.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.42 -178.02 6.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.904 0.882 . . . . 3.5800000000000001 109.931 177.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.4 p -133.33 48.97 2.34 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.201 1.0 . . . . 2.2599999999999998 109.146 170.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.22 -55.86 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.918 1.287 . . . . 2.3399999999999999 108.486 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pp -88.08 177.68 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.89 0.852 . . . . 2.2799999999999998 111.451 -177.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -161.64 177.88 9.56 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.921 2.088 . . . . 2.5 107.077 -176.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.86 -3.8 24.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.888 1.07 . . . . 4.25 113.888 -175.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m -155.79 166.66 32.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.091 1.357 . . . . 4.8300000000000001 109.125 176.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.58 130.14 0.37 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 109.228 -1.549 . . . . 3.1800000000000002 109.228 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -72.05 74.48 0.92 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 123.6 1.667 . . . . 5.5800000000000001 112.336 -169.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -158.0 -39.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.577 1 C-N-CA 132.115 4.166 . . . . 4.5099999999999998 105.978 174.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.1 p -42.25 147.4 0.25 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.276 0.56 . . . . 1.4199999999999999 111.07 156.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.3 pt -78.64 -17.32 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.553 -0.737 . . . . 3.0299999999999998 109.257 174.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 tp -36.91 133.06 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.606 1.562 . . . . 2.7200000000000002 113.775 -170.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.53 37.82 45.67 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.85 -0.5 . . . . 1.51 111.85 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -134.99 160.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.894 1.278 . . . . 4.7400000000000002 107.559 172.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.4 m -94.29 112.71 24.52 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.693 0.397 . . . . 2.3799999999999999 111.022 -170.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.92 149.55 50.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.117 -0.698 . . . . 2.8599999999999999 109.117 172.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t -135.47 128.93 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.346 1.459 . . . . 1.78 107.467 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.53 120.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.046 -1.835 . . . . 2.6699999999999999 106.046 163.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -94.28 175.65 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.019 1.727 . . . . 0.69999999999999996 112.247 -174.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -72.67 -76.93 0.11 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 113.041 0.756 . . . . 6.0599999999999996 113.041 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -81.11 -176.79 6.14 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.21 0.913 . . . . 4.21 110.084 -167.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.6 148.89 36.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.89 -0.782 . . . . 1.75 108.89 167.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -67.9 170.17 8.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.051 -0.722 . . . . 1.99 109.051 159.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.32 -23.58 62.86 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.699 1.37 . . . . 3.9100000000000001 114.699 -176.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 67.03 2.01 2.56 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.811 1.244 . . . . 2.6400000000000001 113.636 -170.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.21 10.09 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 120.54 1.518 . . . . 1.77 112.676 166.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -106.92 -20.77 13.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.508 2.323 . . . . 5.9299999999999997 109.639 -178.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.8 -77.01 1.94 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 124.492 1.044 . . . . 3.5600000000000001 112.939 167.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.77 -70.35 0.12 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.118 -0.793 . . . . 2.8999999999999999 111.118 -163.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' A' ' 132' ' ' GLU . 5.9 p-10 -90.76 -92.98 0.13 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.449 1.5 . . . . 3.4500000000000002 112.473 -176.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.429 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 3.8 tm-20 -165.39 -81.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.144 0.978 . . . . 3.25 108.693 -164.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -29.09 -45.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.282 2.633 . . . . 3.2000000000000002 113.146 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.2 m -53.65 -50.49 65.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.305 1.842 . . . . 3.0499999999999998 112.744 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 52.2 p -71.7 -48.35 47.86 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.881 -1.137 . . . . 2.3700000000000001 110.615 170.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -53.25 -48.15 68.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.091 2.156 . . . . 4.3300000000000001 111.022 -168.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.408 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.1 p -128.08 -50.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.154 0.982 . . . . 2.1800000000000002 110.691 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.405 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.83 -18.53 0.66 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-O 119.268 -0.74 . . . . 0.91000000000000003 114.556 -176.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 45.47 54.12 7.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.294 1.438 . . . . 2.6800000000000002 110.803 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.83 -34.93 75.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.075 1.35 . . . . 2.1299999999999999 113.213 177.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.86 173.67 31.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.404 -1.878 . . . . 1.25 108.404 -159.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 p -61.12 153.62 25.25 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.116 1.366 . . . . 3.2200000000000002 112.426 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -81.1 147.43 30.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.151 1.78 . . . . 3.3500000000000001 110.437 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.5 mt -127.33 -76.3 0.57 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.528 -0.916 . . . . 1.7 108.528 -168.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.82 151.54 21.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.192 -0.669 . . . . 1.9199999999999999 109.192 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.1 p -136.71 167.36 21.57 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.521 1.528 . . . . 2.4700000000000002 107.879 174.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.95 133.88 1.64 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 114.46 -1.246 . . . . 0.85999999999999999 110.195 -177.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.38 138.87 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.817 -0.808 . . . . 1.74 108.817 175.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.5 tt -93.79 127.48 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 123.42 0.45 . . . . 1.8600000000000001 111.166 175.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.04 -2.1 0.82 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.106 1.336 . . . . 0.54000000000000004 115.692 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -89.36 60.59 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.25 1.525 . . . . 2.6099999999999999 109.589 -160.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -131.13 175.68 8.89 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.386 -0.821 . . . . 1.97 110.881 164.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.496 ' C ' ' H3 ' ' A' ' 1' ' ' ALA . 86.2 mt-30 . . . . . 0 C--O 1.254 1.334 0 N-CA-C 103.187 -2.894 . . . . 4.8600000000000003 103.187 163.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 109.454 -0.572 . . . . 7.2800000000000002 109.454 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 p -73.56 173.73 9.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.109 1.364 . . . . 3.8599999999999999 110.599 173.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.19 152.82 21.7 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.223 0.609 . . . . 3.8599999999999999 110.478 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.95 14.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.375 0.67 . . . . 2.6899999999999999 110.359 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.8 t -122.2 152.08 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.104 1.761 . . . . 1.71 106.399 159.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.25 99.15 4.03 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.986 -0.746 . . . . 1.73 108.986 154.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.7 t -66.15 111.88 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.221 -1.4 . . . . 2.04 107.221 166.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -92.07 133.05 36.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.469 -0.937 . . . . 2.1400000000000001 108.469 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -149.12 -50.27 0.15 Allowed 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.487 0.551 . . . . 4.5800000000000001 112.487 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.18 -113.64 1.15 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.092 -0.838 . . . . 0.82999999999999996 113.942 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -124.09 -55.59 1.67 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.207 1.003 . . . . 3.5800000000000001 110.909 -164.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.32 165.58 12.76 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.041 -0.823 . . . . 0.80000000000000004 111.041 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.77 27.14 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.807 3.005 . . . . 1.05 113.59 -173.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.6 t -91.89 143.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.895 1.678 . . . . 1.8300000000000001 107.649 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -154.79 116.83 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.179 -1.045 . . . . 3.0800000000000001 108.179 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.02 171.74 32.02 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.692 -0.563 . . . . 0.68999999999999995 111.692 -172.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -127.99 126.65 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.46 0.704 . . . . 2.3999999999999999 109.243 178.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.5 151.47 3.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 125.53 1.532 . . . . 1.9299999999999999 107.005 165.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.92 154.23 48.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.592 -1.633 . . . . 1.74 106.592 164.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.8 160.11 40.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.81 -0.756 . . . . 6.6600000000000001 109.131 158.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -127.82 139.51 52.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.056 2.143 . . . . 4.7300000000000004 105.386 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -143.65 146.82 33.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.949 -1.871 . . . . 4.8200000000000003 105.949 154.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -73.9 -68.8 0.48 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.151 -0.685 . . . . 5.1100000000000003 109.151 170.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -78.19 165.25 24.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.769 0.828 . . . . 3.8999999999999999 111.618 -173.038 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -77.92 2.26 17.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.548 0.739 . . . . 3.3100000000000001 112.513 173.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -161.32 78.22 0.57 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.877 0.762 . . . . 5.0599999999999996 109.856 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.61 164.81 30.38 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.375 -2.29 . . . . 1.72 107.375 165.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.02 118.41 5.27 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.983 2.455 . . . . 1.6499999999999999 110.524 -176.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -76.69 176.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.769 -0.826 . . . . 2.9300000000000002 108.769 -165.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -131.24 81.06 1.97 Allowed 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.577 -0.897 . . . . 5.9500000000000002 108.577 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.58 100.95 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.988 -1.116 . . . . 2.54 107.988 -177.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -114.02 170.39 8.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.934 0.493 . . . . 1.25 110.081 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.21 165.72 34.74 Favored Glycine 0 N--CA 1.449 -0.463 0 O-C-N 120.974 -1.079 . . . . 0.67000000000000004 112.088 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -131.18 106.66 8.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.509 -2.034 . . . . 2.5899999999999999 105.509 -177.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.64 146.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.626 -1.25 . . . . 2.1600000000000001 107.626 -166.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 161.84 41.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.485 0.92 . . . . 4.3899999999999997 113.485 168.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.85 15.56 45.27 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.758 1.647 . . . . 0.65000000000000002 113.467 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.83 -173.47 0.63 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.524 1.162 . . . . 1.55 108.85 169.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -85.29 -100.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.077 -1.083 . . . . 2.7799999999999998 108.077 164.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -149.2 162.04 40.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.389 1.475 . . . . 2.6600000000000001 108.049 -175.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.57 -161.54 50.91 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.209 0.433 . . . . 0.83999999999999997 112.443 167.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.17 132.78 53.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.735 0.814 . . . . 3.04 112.521 -175.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.18 114.94 9.52 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.132 1.773 . . . . 2.0099999999999998 109.131 -177.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.23 152.27 6.91 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.918 1.247 . . . . 0.70999999999999996 113.753 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 103.84 4.3 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.209 1.803 . . . . 4.3399999999999999 108.138 -177.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.478 ' ND1' ' CD2' ' A' ' 120' ' ' HIS . 41.9 m80 -142.06 162.07 36.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.729 . . . . 1.9099999999999999 109.033 -169.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.43 130.43 74.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 3.5 108.73 -178.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -113.51 154.52 26.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.116 0.967 . . . . 0.81999999999999995 108.838 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.61 33.09 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.197 1.399 . . . . 4.4199999999999999 113.495 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -83.4 95.59 8.28 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.598 -1.63 . . . . 3.1200000000000001 106.598 178.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.69 -82.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.451 1.5 . . . . 4.2000000000000002 108.528 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -78.52 126.66 31.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.163 -1.421 . . . . 5.0999999999999996 107.163 174.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -122.6 14.09 10.16 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.972 1.309 . . . . 4.5499999999999998 110.479 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.0 t -59.31 -39.94 84.68 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.733 0.697 . . . . 5.2800000000000002 111.447 -174.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.46 -55.5 7.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.414 0.685 . . . . 7.1299999999999999 109.816 175.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.75 163.6 21.95 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.975 -1.25 . . . . 3.8999999999999999 109.975 176.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 90.7 m -76.57 62.2 1.89 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.719 1.207 . . . . 2.7999999999999998 110.042 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -141.49 66.11 1.37 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.423 1.106 . . . . 5.0999999999999996 110.849 -172.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.5 m -168.95 -37.4 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.459 1.651 . . . . 2.7400000000000002 115.459 -141.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.57 149.29 30.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.625 1.57 . . . . 2.1800000000000002 108.636 168.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.98 -99.18 2.16 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.79 -1.324 . . . . 1.3500000000000001 109.79 -173.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.92 178.39 5.34 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.692 2.928 . . . . 1.23 112.524 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -61.73 136.68 58.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.432 -1.27 . . . . 1.48 108.365 172.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -23.06 105.41 0.02 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.975 1.71 . . . . 4.0300000000000002 113.814 -177.123 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -130.16 90.59 41.58 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.815 1.646 . . . . 3.1200000000000001 109.621 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.64 -36.93 13.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.836 1.69 . . . . 2.0 111.115 -178.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -135.49 -75.06 0.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.977 0.911 . . . . 3.6899999999999999 109.557 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.6 m -156.97 81.06 0.93 Allowed 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.312 -0.868 . . . . 2.27 109.468 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -85.35 170.93 12.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.322 0.582 . . . . 5.75 110.598 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -125.82 161.63 26.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.944 1.698 . . . . 4.1100000000000003 107.265 177.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -104.24 115.95 31.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.774 0.83 . . . . 1.01 110.914 173.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.87 12.9 6.48 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 124.76 1.171 . . . . 3.1400000000000001 110.621 164.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.92 -164.11 23.24 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.44 -1.035 . . . . 2.6099999999999999 112.296 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.92 -23.69 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.34 2.027 . . . . 2.4199999999999999 111.545 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -71.89 -53.84 11.94 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.739 0.816 . . . . 7.4000000000000004 111.45 -176.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.5 171.16 7.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.73 -0.841 . . . . 4.0700000000000003 108.73 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.96 -51.11 68.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.974 -1.121 . . . . 6.2300000000000004 107.974 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -76.81 143.47 39.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.738 0.78 . . . . 3.3100000000000001 110.6 -163.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -176.3 150.89 0.95 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.388 -1.338 . . . . 3.9399999999999999 107.388 -166.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.486 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.1 m80 -63.67 147.46 51.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.848 -1.538 . . . . 0.72999999999999998 106.848 163.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.71 -15.22 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 120.625 -0.43 . . . . 2.2999999999999998 110.672 -175.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.2 67.42 0.28 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.088 1.328 . . . . 0.92000000000000004 110.747 166.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -132.8 110.75 10.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.868 1.334 . . . . 2.4500000000000002 109.781 168.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -39.59 16.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.068 0.547 . . . . 2.8300000000000001 109.94 169.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 138.59 -106.34 0.52 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.108 -0.797 . . . . 0.79000000000000004 111.108 172.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.09 159.8 40.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.467 1.507 . . . . 2.25 109.373 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.2 176.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 125.695 1.598 . . . . 2.0699999999999998 107.078 166.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -114.91 139.76 49.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.799 -1.185 . . . . 2.7400000000000002 107.799 163.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.25 141.25 31.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.242 1.417 . . . . 1.78 110.801 169.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.25 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.194 0.998 . . . . 2.5299999999999998 111.08 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 93' ' ' GLY . 84.7 tttt -159.38 -46.55 0.05 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.923 1.289 . . . . 4.7199999999999998 110.496 -173.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.79 19.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.419 1.488 . . . . 3.3100000000000001 111.134 178.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 73.65 9.28 78.39 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.6 -1.111 . . . . 1.01 111.997 -177.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.0 t -77.52 141.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.59 -1.263 . . . . 2.1600000000000001 107.59 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.36 168.2 21.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.531 1.132 . . . . 1.8899999999999999 108.407 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.54 144.24 50.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 103.452 -2.796 . . . . 2.9199999999999999 103.452 -174.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.89 136.06 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.055 -1.831 . . . . 1.8200000000000001 106.055 169.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -159.98 67.39 0.37 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.141 1.376 . . . . 1.4199999999999999 107.613 -177.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 mm -112.64 146.66 17.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 108.485 -0.931 . . . . 3.0899999999999999 108.485 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.82 74.96 1.49 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.258 0.623 . . . . 3.4500000000000002 109.805 177.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -77.84 151.17 34.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.599 0.714 . . . . 2.48 110.356 -177.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -98.71 -26.28 14.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.018 2.127 . . . . 2.1899999999999999 110.844 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.2 -48.77 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 118.91 -0.567 . . . . 2.6200000000000001 110.162 -173.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.24 162.97 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.291 0.95 . . . . 2.73 109.97 171.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 m -143.13 179.85 6.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.604 1.561 . . . . 2.8700000000000001 108.316 -175.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.06 31.88 3.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.295 1.438 . . . . 5.4900000000000002 113.857 -173.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t -153.48 69.67 0.82 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.128 -0.983 . . . . 3.2999999999999998 110.863 178.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 167.22 172.53 34.51 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.932 -0.48 . . . . 3.6499999999999999 112.56 174.242 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.23 -46.95 46.64 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.405 1.882 . . . . 5.6600000000000001 112.507 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -95.76 0.5 52.48 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.75 1.62 . . . . 7.7400000000000002 111.878 -178.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p -75.71 161.98 28.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.128 -1.805 . . . . 1.96 106.128 168.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.3 pt -76.94 -13.83 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 118.419 -1.312 . . . . 3.4900000000000002 113.598 -168.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.4 mm -43.21 115.72 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.283 0.947 . . . . 3.0299999999999998 111.183 176.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.7 25.35 74.22 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.076 -0.847 . . . . 1.3300000000000001 112.389 178.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.84 159.45 16.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 120.051 1.926 . . . . 6.0099999999999998 110.548 170.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 m -92.06 104.56 16.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 1.8600000000000001 109.592 -172.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.06 147.44 53.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.055 -1.091 . . . . 2.7799999999999998 108.055 166.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -134.72 133.72 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 127.356 2.263 . . . . 1.76 106.222 177.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.23 120.81 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.024 -1.472 . . . . 2.8199999999999998 107.024 165.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.478 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 45.7 m-70 -95.56 176.1 6.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.58 1.552 . . . . 0.79000000000000004 112.343 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -77.58 -65.58 0.94 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.558 0.947 . . . . 6.0999999999999996 113.558 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -88.42 174.32 8.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.206 0.912 . . . . 6.9299999999999997 110.675 -175.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.84 143.29 17.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.363 -1.289 . . . . 2.04 107.91 157.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.48 155.74 38.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.614 -0.884 . . . . 2.1099999999999999 108.614 158.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -78.76 -5.58 53.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.163 0.985 . . . . 3.3900000000000001 112.092 -172.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 54.46 30.59 13.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.418 1.087 . . . . 2.71 110.542 -173.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.84 16.48 68.22 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.403 -0.665 . . . . 1.8300000000000001 112.796 177.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -98.83 -23.6 15.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.334 1.067 . . . . 6.25 110.782 -176.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.1 131.22 45.28 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.019 -0.832 . . . . 3.2599999999999998 111.019 -176.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.03 -40.22 72.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 117.731 0.766 . . . . 2.6400000000000001 111.514 179.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -50.72 109.29 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.87 1.268 . . . . 2.3999999999999999 109.46 164.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -61.87 -21.7 64.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.6 -0.688 . . . . 3.77 112.308 -170.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -41.13 -38.2 1.02 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.949 1.7 . . . . 4.9500000000000002 111.018 169.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.9 p -46.15 -67.12 0.31 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.264 1.026 . . . . 2.3700000000000001 109.909 172.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.8 p -66.13 -46.84 76.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.045 0.938 . . . . 2.27 111.119 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -60.26 -38.95 85.07 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.182 0.993 . . . . 5.9199999999999999 111.633 -172.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.486 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.317 7.3 t -136.91 -55.25 0.72 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 3.1400000000000001 111.095 175.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.88 -25.21 0.21 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.059 0.845 . . . . 0.96999999999999997 112.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 47.79 55.53 8.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.208 1.403 . . . . 2.4700000000000002 110.996 -170.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.1 -8.89 58.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.218 0.821 . . . . 2.0099999999999998 113.218 173.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.56 173.28 49.51 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.247 -1.541 . . . . 1.1599999999999999 109.247 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 m -56.36 155.13 7.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.797 1.639 . . . . 2.1000000000000001 113.344 -173.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.91 142.37 45.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.24 1.416 . . . . 4.1200000000000001 110.34 177.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 mt -122.39 -74.83 0.6 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.897 -1.149 . . . . 1.7 107.897 -174.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.6 144.32 33.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.063 -1.088 . . . . 1.99 108.063 166.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 25.7 p -123.36 169.03 11.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.401 1.48 . . . . 2.1499999999999999 107.863 168.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.98 142.6 6.13 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 124.362 1.039 . . . . 0.82999999999999996 111.234 166.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.76 133.57 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.996 0.918 . . . . 1.9299999999999999 108.692 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.0 tt -96.7 139.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.303 0.483 . . . . 2.0 112.303 -178.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 134.22 6.3 2.48 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.127 1.346 . . . . 1.1899999999999999 113.992 174.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -91.8 57.26 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.328 1.564 . . . . 2.0800000000000001 110.691 -159.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.15 176.02 13.22 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.567 0.747 . . . . 2.3700000000000001 110.552 169.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.251 1.168 0 N-CA-C 105.821 -1.918 . . . . 5.4900000000000002 105.821 167.689 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.429 ' N ' ' OXT' ' A' ' 153' ' ' GLN . . . . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 109.834 -0.432 . . . . 8.2100000000000009 109.834 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.5 p -71.3 79.29 0.73 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.292 0.637 . . . . 4.54 109.366 177.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -140.79 146.55 37.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.994 0.918 . . . . 3.8300000000000001 109.561 178.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.42 158.89 15.24 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.804 -0.813 . . . . 1.8999999999999999 108.804 163.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 t -124.79 150.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.36 -1.291 . . . . 2.0299999999999998 108.058 165.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.84 97.98 5.18 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.39 1.076 . . . . 1.8100000000000001 108.624 158.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.58 114.84 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.511 -1.292 . . . . 1.8700000000000001 107.511 165.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.8 mt -96.66 137.0 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.685 0.794 . . . . 2.3399999999999999 109.91 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -150.0 -52.68 0.15 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.84 0.856 . . . . 3.9500000000000002 109.358 169.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.59 -124.99 28.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.979 -1.01 . . . . 1.0800000000000001 111.622 -175.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.05 -48.2 2.84 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.339 1.055 . . . . 3.6499999999999999 109.365 -162.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.83 166.06 23.9 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.99 -0.844 . . . . 0.81999999999999995 110.99 174.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.11 36.78 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.822 3.015 . . . . 0.97999999999999998 112.785 -173.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.51 159.38 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.693 1.597 . . . . 1.8400000000000001 108.98 -176.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 132.19 9.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.082 -1.451 . . . . 2.9300000000000002 107.082 176.242 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.47 179.36 44.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.623 -0.799 . . . . 0.88 111.575 178.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.77 119.54 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.212 -1.403 . . . . 2.0499999999999998 107.212 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -79.07 146.44 7.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.389 -1.337 . . . . 2.0099999999999998 107.389 163.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -120.24 137.1 54.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.094 -1.817 . . . . 2.2000000000000002 106.094 163.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.93 112.82 18.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.966 1.706 . . . . 3.3599999999999999 107.452 177.277 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.55 135.27 54.06 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.67 1.188 . . . . 4.0999999999999996 108.832 177.092 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -151.45 152.63 33.3 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.541 1.537 . . . . 3.9100000000000001 108.753 170.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -120.31 -46.56 2.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.472 2.709 . . . . 7.2999999999999998 107.556 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.77 96.41 6.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.496 -1.298 . . . . 5.0300000000000002 107.496 173.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -21.13 -66.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.446 2.298 . . . . 3.2799999999999998 114.748 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -114.51 54.55 0.77 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.849 0.859 . . . . 4.9800000000000004 110.153 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.54 -179.71 18.73 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.328 1.442 . . . . 1.27 110.407 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.96 115.45 3.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.536 2.824 . . . . 1.24 111.086 -178.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.0 t -78.73 153.24 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.02 0.528 . . . . 2.1099999999999999 109.626 -170.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -108.34 126.03 52.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.618 -0.882 . . . . 3.4500000000000002 108.618 174.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.0 t -125.63 140.84 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 125.489 1.516 . . . . 2.1099999999999999 107.593 -169.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -155.17 164.54 38.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.689 -0.486 . . . . 1.0800000000000001 109.689 167.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.19 137.14 3.21 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.363 -0.446 . . . . 1.2 112.027 175.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 p -102.22 77.3 1.65 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.78 1.232 . . . . 2.2599999999999998 109.577 -172.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.13 142.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.028 -0.73 . . . . 2.8399999999999999 109.028 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -137.6 157.16 47.1 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.243 0.617 . . . . 4.75 110.256 -176.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.95 12.42 66.11 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.68000000000000005 112.709 -176.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.85 157.33 30.77 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.177 0.991 . . . . 2.1200000000000001 109.308 170.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -74.6 156.45 36.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.114 -1.069 . . . . 2.9100000000000001 108.114 154.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.89 171.79 0.32 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.124 0.97 . . . . 2.3100000000000001 111.839 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.45 -165.13 54.76 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.614 -0.721 . . . . 0.57999999999999996 113.031 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.95 147.92 44.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.7 0.8 . . . . 3.0099999999999998 111.288 -173.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -145.31 123.54 12.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.504 1.522 . . . . 0.63 109.429 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.37 149.18 18.95 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.812 -0.915 . . . . 0.46999999999999997 110.812 170.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -138.66 95.64 3.01 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.089 -1.448 . . . . 4.3399999999999999 107.089 -174.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -133.87 160.34 37.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.754 -1.202 . . . . 1.3100000000000001 107.754 -160.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.42 128.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 122.307 1.051 . . . . 3.5499999999999998 109.933 175.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -104.61 142.64 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.656 -1.609 . . . . 1.1100000000000001 106.656 -177.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 74.31 0.59 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.325 -1.731 . . . . 4.8799999999999999 106.325 170.368 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -141.62 39.31 1.69 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.871 -0.604 . . . . 3.6099999999999999 109.559 -165.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -58.74 78.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.212 1.005 . . . . 5.1600000000000001 112.736 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -146.08 140.95 27.12 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 127.147 2.179 . . . . 7.4400000000000004 106.076 169.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -141.58 60.63 1.48 Allowed 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 106.57 -1.641 . . . . 7.0800000000000001 106.57 152.268 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.257 8.7 t -142.08 -43.48 0.34 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.752 1.221 . . . . 5.25 110.749 176.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.95 -47.36 85.23 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.659 -0.867 . . . . 7.04 108.659 154.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.71 -70.6 0.39 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.648 1.594 . . . . 3.7000000000000002 109.511 172.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.4 t -179.08 176.3 0.89 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 129.231 3.012 . . . . 2.8799999999999999 104.839 -179.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m 71.55 73.62 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.167 1.349 . . . . 6.9400000000000004 110.079 167.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.0 t 177.85 33.99 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.233 1.016 . . . . 3.1899999999999999 110.013 -137.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 179.09 -148.04 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 128.666 2.786 . . . . 2.4199999999999999 104.87 -172.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.45 -115.37 1.11 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.72 -1.6 . . . . 1.4299999999999999 110.666 178.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 -179.22 5.03 Favored 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.808 4.339 . . . . 1.24 113.933 -173.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -53.39 134.3 40.11 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.038 -0.983 . . . . 1.6899999999999999 111.111 176.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -50.54 117.9 2.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 123.74 0.65 . . . . 2.79 109.567 172.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.8 156.54 30.74 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 106.757 -1.571 . . . . 3.1899999999999999 106.757 169.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.14 -38.65 2.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.176 1.917 . . . . 1.6799999999999999 111.55 -165.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 mt -144.52 -74.54 0.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.858 0.863 . . . . 3.29 109.347 176.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.3 m -142.51 64.85 1.36 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.47 0.708 . . . . 2.6000000000000001 111.062 -165.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.3 170.68 16.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.377 0.608 . . . . 5.8899999999999997 109.555 163.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -111.9 162.34 15.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.67 -1.974 . . . . 4.3200000000000003 105.67 172.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -77.33 168.67 19.64 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.979 0.419 . . . . 1.1699999999999999 110.325 169.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.93 161.08 34.75 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 105.802 -2.919 . . . . 2.0299999999999998 105.802 156.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.86 -172.54 7.83 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 117.17 0.485 . . . . 2.5499999999999998 112.509 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 -18.77 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.133 2.555 . . . . 2.1699999999999999 111.376 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.2 -26.76 18.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.312 1.045 . . . . 6.6299999999999999 111.584 173.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.53 159.89 23.54 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.061 0.458 . . . . 2.0099999999999998 109.914 175.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -74.13 -51.43 15.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.387 1.475 . . . . 4.8700000000000001 108.03 170.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -80.25 168.3 19.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.87 0.843 . . . . 3.54 110.98 -175.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.28 150.2 0.07 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.936 2.095 . . . . 5.6900000000000004 106.53 -167.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.484 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 71.4 m80 -65.58 155.8 34.66 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.278 -2.119 . . . . 0.85999999999999999 105.278 162.335 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.61 48.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 123.355 1.55 . . . . 2.5600000000000001 109.618 170.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . 178.73 34.97 0.06 OUTLIER Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.953 2.216 . . . . 1.8300000000000001 111.512 -175.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.42 136.41 37.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.333 -1.358 . . . . 2.6299999999999999 107.333 157.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.36 -54.72 4.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.649 -1.612 . . . . 2.5499999999999998 106.649 168.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.97 -114.92 0.63 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.514 -1.434 . . . . 0.72999999999999998 109.514 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -140.75 162.03 36.37 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.942 1.697 . . . . 2.2000000000000002 109.329 -177.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.11 175.65 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.354 1.462 . . . . 2.1800000000000002 107.162 175.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.8 m -129.6 134.29 47.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.365 -0.976 . . . . 2.73 108.365 -178.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.61 137.28 34.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.35 1.06 . . . . 1.8400000000000001 109.731 169.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -87.83 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.857 2.463 . . . . 3.9100000000000001 110.736 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -173.34 -46.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.794 1.238 . . . . 7.2300000000000004 108.745 -156.997 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.403 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 2.3 m-20 -79.16 11.35 2.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.887 1.275 . . . . 4.46 110.407 172.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.25 64.39 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 110.789 -0.925 . . . . 1.05 110.789 -178.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.37 128.31 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 1.73 108.464 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.2 114.93 22.66 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.595 -1.631 . . . . 1.6399999999999999 106.595 168.334 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -113.44 93.99 4.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.859 -1.534 . . . . 5.3399999999999999 106.859 -169.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.77 149.34 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.147 -0.933 . . . . 2.98 110.359 -162.19 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.8 m -151.12 126.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.383 1.473 . . . . 1.74 107.413 168.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mt -143.22 155.13 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.306 1.043 . . . . 3.6000000000000001 108.306 -174.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.3 101.06 3.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.573 0.225 . . . . 2.3500000000000001 110.811 157.198 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -89.25 159.71 17.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.941 0.896 . . . . 2.25 108.823 173.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 p -107.65 -15.76 14.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.303 1.841 . . . . 1.8 112.283 -175.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.81 -41.09 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.513 0.597 . . . . 2.1099999999999999 109.894 -171.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pp -98.19 170.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.312 0.645 . . . . 2.1899999999999999 111.72 -173.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.6 m -151.34 174.61 13.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.706 1.202 . . . . 2.2799999999999998 110.265 -176.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -126.49 29.9 5.66 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.957 0.903 . . . . 3.1400000000000001 112.243 170.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 t -81.16 -149.49 0.07 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.634 -0.876 . . . . 3.46 108.634 165.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -127.61 69.67 0.52 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.955 1.264 . . . . 4.1299999999999999 109.969 175.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -159.89 -109.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.357 1.063 . . . . 5.6799999999999997 108.318 -175.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -77.44 3.14 14.07 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.22 1.408 . . . . 5.2199999999999998 110.787 173.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p -59.25 162.61 4.44 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 122.835 1.302 . . . . 2.1699999999999999 112.88 177.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.23 -4.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.231 -1.804 . . . . 3.4900000000000002 111.466 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -38.32 129.87 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.453 1.101 . . . . 3.4900000000000002 110.211 170.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.7 23.72 74.32 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 118.095 0.407 . . . . 1.52 114.042 -174.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.69 176.99 8.99 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.249 1.525 . . . . 9.9700000000000006 108.517 159.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -109.31 120.88 43.84 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.072 -0.714 . . . . 1.77 109.072 153.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -73.02 142.39 47.69 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 106.029 -1.841 . . . . 4.3300000000000001 106.029 168.181 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.6 134.17 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.354 1.862 . . . . 1.51 106.94 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.19 133.82 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.309 -1.367 . . . . 3.3500000000000001 107.309 164.314 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -109.14 161.62 15.03 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 115.992 1.849 . . . . 0.42999999999999999 115.992 -161.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -34.47 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.896 2.878 . . . . 3.29 112.813 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -80.57 174.99 11.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.611 1.164 . . . . 6.2400000000000002 110.482 -170.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.97 142.88 49.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.631 -1.622 . . . . 1.8 108.234 150.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.04 152.15 20.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.317 0.647 . . . . 2.8199999999999998 109.296 170.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.83 -4.86 53.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.488 0.586 . . . . 3.6600000000000001 112.506 -179.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 59.82 28.93 18.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.168 1.387 . . . . 2.96 109.607 -177.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.46 25.78 68.96 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.695 0.664 . . . . 2.0499999999999998 111.598 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -145.5 45.14 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.718 0.759 . . . . 6.2599999999999998 109.365 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.93 159.97 27.03 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.152 -1.179 . . . . 3.5699999999999998 110.152 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.35 61.43 3.13 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.353 -1.499 . . . . 3.8900000000000001 109.353 171.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -177.36 164.77 2.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.487 1.515 . . . . 2.9700000000000002 107.678 -167.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -83.15 -38.39 22.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.775 0.83 . . . . 3.9399999999999999 109.389 173.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -42.18 -39.05 1.9 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.413 1.485 . . . . 3.2400000000000002 112.774 -176.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.8 p -57.22 -61.85 2.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.707 1.203 . . . . 2.5099999999999998 111.25 178.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.4 p -67.68 -42.59 81.86 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.478 -0.764 . . . . 1.97 110.187 178.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -57.35 -44.08 84.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.972 1.709 . . . . 3.8900000000000001 111.841 -177.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.484 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.424 8.9 t -138.23 -56.85 0.65 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 2.6800000000000002 111.839 177.918 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.19 -22.44 0.2 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 119.415 1.007 . . . . 0.87 112.231 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 45.79 55.6 6.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.064 1.746 . . . . 2.1899999999999999 111.258 -177.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.61 58.2 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 118.953 -1.099 . . . . 2.1400000000000001 111.934 167.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.36 -161.01 33.71 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 109.063 -1.615 . . . . 0.96999999999999997 109.063 179.283 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.5 p -59.89 151.49 25.71 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.942 1.297 . . . . 2.3900000000000001 112.752 -169.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.4 mmt-85 -68.01 130.67 43.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.864 2.066 . . . . 4.4900000000000002 108.177 176.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.94 -83.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.552 1.069 . . . . 1.76 108.663 174.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.98 146.29 25.64 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.296 -1.372 . . . . 1.98 107.296 176.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.8 m -147.43 160.56 42.43 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 124.663 1.227 . . . . 2.2200000000000002 107.991 178.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.03 142.18 7.06 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.752 -0.939 . . . . 0.92000000000000004 110.752 172.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.31 139.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.152 1.381 . . . . 1.5700000000000001 108.999 172.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.2 tt -105.65 132.49 52.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.193 0.812 . . . . 2.1800000000000002 113.193 -178.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.76 13.1 0.15 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.482 1.515 . . . . 0.70999999999999996 113.99 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.2 mm -107.72 58.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.836 1.818 . . . . 1.9299999999999999 110.081 -152.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 175.35 14.1 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.745 -0.661 . . . . 2.3900000000000001 110.255 171.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.429 ' OXT' ' N ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.259 1.586 0 C-N-CA 125.09 1.356 . . . . 6.3499999999999996 108.691 177.052 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.275 0.102 . . . . 7.5800000000000001 111.275 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m -159.58 105.47 1.64 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.291 -1.744 . . . . 4.0899999999999999 106.291 173.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -77.8 143.57 37.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.898 -0.408 . . . . 3.73 109.898 -171.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.32 137.63 51.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.778 -0.823 . . . . 1.6100000000000001 108.778 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -96.94 144.25 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.32 -0.993 . . . . 1.5800000000000001 108.32 167.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.08 111.57 15.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.929 -1.508 . . . . 1.8 106.929 148.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.34 108.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.972 -1.492 . . . . 1.9199999999999999 106.972 156.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.9 125.18 31.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.765 -1.198 . . . . 3.2999999999999998 107.765 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -153.97 -45.31 0.09 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.063 0.545 . . . . 4.4199999999999999 111.561 170.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.35 -109.25 0.39 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.237 0.922 . . . . 1.1599999999999999 113.04 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.1 -55.24 2.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.817 1.247 . . . . 3.3300000000000001 110.245 -172.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 164.48 11.4 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.459 1.028 . . . . 1.03 112.339 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.83 -19.54 58.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.567 2.845 . . . . 1.4299999999999999 112.476 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.57 143.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.945 1.298 . . . . 1.8200000000000001 110.634 175.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -155.39 128.4 8.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.467 -0.568 . . . . 2.5499999999999998 109.467 -176.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.11 177.28 39.91 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.17 -0.331 . . . . 0.57999999999999996 112.354 -177.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.09 133.91 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.882 -1.155 . . . . 2.1299999999999999 107.882 172.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.1 mm -102.79 136.33 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.92 1.688 . . . . 2.1899999999999999 106.866 164.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.26 112.17 22.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.35 1.46 . . . . 1.74 108.22 163.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -77.57 140.72 39.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.469 1.508 . . . . 3.73 108.698 164.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -149.13 168.29 23.62 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.464 -1.68 . . . . 4.5700000000000003 106.464 148.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -151.29 159.32 44.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.739 -1.948 . . . . 3.8799999999999999 105.739 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -64.08 -73.78 0.11 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.998 -1.112 . . . . 7.2699999999999996 107.998 166.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -79.85 -165.66 0.86 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.046 2.538 . . . . 4.8799999999999999 111.138 -169.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -106.61 3.82 27.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.112 1.765 . . . . 2.9199999999999999 110.59 162.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -160.73 78.46 0.62 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.267 2.227 . . . . 4.7300000000000004 108.681 -170.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.68 -170.4 41.16 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 110.258 -1.137 . . . . 2.1899999999999999 110.258 -170.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.79 120.74 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.157 2.571 . . . . 1.27 114.108 -167.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.8 t -79.14 147.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.499 -0.773 . . . . 2.3199999999999998 109.335 175.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -116.51 110.54 18.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.836 -1.172 . . . . 3.46 107.836 159.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 m -95.27 132.22 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.234 -1.395 . . . . 3.4300000000000002 107.234 169.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -126.83 145.09 50.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.116 -1.438 . . . . 1.05 107.116 168.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.09 156.87 29.02 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.36 -0.924 . . . . 0.65000000000000002 112.165 -173.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 m -131.71 83.49 2.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.706 1.602 . . . . 2.4399999999999999 107.389 -162.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.19 139.09 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.2 1.0 . . . . 2.2400000000000002 109.13 -168.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 166.67 22.8 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.4 0.619 . . . . 4.75 112.26 176.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.13 15.52 69.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.761 1.172 . . . . 0.64000000000000001 113.492 174.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.41 165.03 21.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.603 1.201 . . . . 1.79 108.837 172.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -72.58 166.39 22.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.596 -1.261 . . . . 2.3999999999999999 107.596 150.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.9 175.45 0.5 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.167 0.987 . . . . 3.3300000000000001 110.696 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.65 -156.04 51.61 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.865 -0.607 . . . . 0.60999999999999999 111.643 169.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.56 145.18 33.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.793 1.637 . . . . 2.8700000000000001 112.48 -171.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -147.73 113.18 5.62 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.032 1.333 . . . . 0.62 110.434 -179.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.0 146.26 2.91 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.493 1.044 . . . . 0.68000000000000005 111.316 173.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.76 96.74 3.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.909 -1.886 . . . . 3.4399999999999999 105.909 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -133.43 171.94 13.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.322 -1.362 . . . . 1.22 107.322 -164.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 0.3 OUTLIER -130.54 133.44 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 122.147 0.975 . . . . 2.8100000000000001 109.938 173.163 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -109.79 145.64 36.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.051 2.141 . . . . 0.98999999999999999 106.876 -175.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -72.31 31.52 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.981 1.474 . . . . 4.5700000000000003 114.981 -168.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 143' ' ' ARG . 5.1 mt-10 -85.97 62.21 7.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.075 -1.083 . . . . 3.0800000000000001 108.075 -170.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -58.88 -26.96 64.75 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.736 0.643 . . . . 4.4900000000000002 112.736 -171.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -129.46 149.31 51.29 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 105.387 -2.079 . . . . 4.75 105.387 151.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -163.32 42.66 0.11 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 128.158 2.583 . . . . 4.8200000000000003 110.191 170.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.6 t -65.96 57.45 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.005 1.722 . . . . 4.3899999999999997 113.875 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -170.46 -44.15 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.37 1.868 . . . . 6.4500000000000002 109.238 -173.445 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.73 146.5 6.35 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.042 -1.623 . . . . 4.3200000000000003 109.042 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.7 t -75.74 54.9 0.83 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.579 1.552 . . . . 2.9199999999999999 111.98 -170.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.8 p -149.38 80.38 1.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.302 -0.629 . . . . 5.1100000000000003 109.302 -158.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.7 m -170.8 -43.3 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.248 1.203 . . . . 2.7799999999999998 114.248 -144.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.87 170.5 7.9 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.53 -1.285 . . . . 2.73 107.53 151.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.04 -92.43 2.03 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.636 -1.386 . . . . 1.4199999999999999 109.636 -178.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.08 -178.84 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 126.337 4.692 . . . . 1.1799999999999999 113.21 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -52.52 128.47 26.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.031 1.332 . . . . 1.4199999999999999 109.627 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -45.46 120.24 2.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.753 1.221 . . . . 2.8799999999999999 111.273 175.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 69' ' ' ARG . 79.0 m-20 -118.46 163.12 26.95 Favored Pre-proline 0 C--O 1.227 -0.1 0 C-N-CA 127.314 2.246 . . . . 3.8999999999999999 109.747 164.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.45 -53.01 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.194 1.263 . . . . 1.8200000000000001 108.85 154.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.66 -77.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.281 1.032 . . . . 4.3300000000000001 109.998 169.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -135.5 71.03 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.306 1.042 . . . . 2.6200000000000001 110.459 -165.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.419 ' H ' ' ND2' ' A' ' 65' ' ' ASN . 15.9 mmt85 -79.38 172.21 14.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.715 -1.216 . . . . 6.1799999999999997 107.715 156.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 162.89 26.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 127.019 2.128 . . . . 3.6699999999999999 105.946 177.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -76.6 162.91 27.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.693 0.797 . . . . 1.1599999999999999 110.933 -169.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.14 -123.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 105.518 -3.033 . . . . 1.99 105.518 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.24 -140.48 3.06 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 107.957 -2.057 . . . . 2.2400000000000002 107.957 169.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.31 -47.78 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 120.091 1.946 . . . . 1.8700000000000001 109.011 168.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -59.18 -42.15 90.17 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 126.133 1.773 . . . . 6.2199999999999998 112.987 -171.058 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.8 176.93 2.28 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.756 -1.566 . . . . 1.98 111.467 -168.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.07 -52.46 6.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.004 1.322 . . . . 5.1100000000000003 108.21 164.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -80.33 175.91 10.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.693 0.797 . . . . 2.75 111.424 -177.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 161.04 143.15 0.01 OUTLIER 'General case' 0 C--O 1.239 0.535 0 C-N-CA 129.958 3.303 . . . . 3.8900000000000001 106.498 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.406 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.2 m80 -60.06 153.26 22.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.335 -1.357 . . . . 0.71999999999999997 107.335 166.154 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.0 -37.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 117.796 -1.562 . . . . 2.3900000000000001 109.991 -169.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.82 73.11 0.87 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.229 -0.748 . . . . 1.28 111.229 167.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -168.14 103.37 0.46 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.786 -0.82 . . . . 2.7200000000000002 108.786 -175.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.86 -51.39 8.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.195 0.598 . . . . 2.71 109.541 176.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.83 -119.86 0.94 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.404 -1.478 . . . . 0.67000000000000004 109.404 -177.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -137.91 166.5 23.89 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 124.407 1.083 . . . . 2.3100000000000001 110.291 174.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.12 177.14 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.462 -1.681 . . . . 1.77 106.462 166.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -122.51 155.26 36.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.695 -0.854 . . . . 3.1099999999999999 108.695 164.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.86 141.76 48.35 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.45 1.1 . . . . 1.8200000000000001 110.352 164.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.83 -75.28 0.12 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.1 0.96 . . . . 2.9399999999999999 111.389 -171.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -153.94 -44.26 0.09 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.321 1.048 . . . . 4.5800000000000001 110.973 -169.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.84 7.77 6.56 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.297 1.046 . . . . 2.6000000000000001 111.39 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.71 8.12 84.05 Favored Glycine 0 CA--C 1.524 0.636 0 O-C-N 121.266 -0.896 . . . . 0.77000000000000002 111.75 -175.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.54 128.61 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.218 1.407 . . . . 1.79 107.713 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.89 175.24 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.213 1.405 . . . . 1.5600000000000001 109.169 173.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -121.88 145.28 48.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.964 -2.606 . . . . 3.3599999999999999 103.964 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.21 58.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.331 -0.548 . . . . 1.8500000000000001 111.391 167.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.4 m -90.08 88.03 7.12 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.607 1.163 . . . . 1.2 109.098 172.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.1 mm -125.67 156.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.942 -0.762 . . . . 3.27 108.942 -177.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -140.12 142.15 36.06 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.658 0.383 . . . . 2.6499999999999999 110.616 164.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.23 148.52 44.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.475 1.51 . . . . 2.2799999999999998 109.259 176.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.5 p -102.74 -4.26 25.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.789 2.036 . . . . 1.8700000000000001 113.249 -173.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.97 -45.77 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.658 1.183 . . . . 2.1000000000000001 108.807 -178.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -76.49 176.14 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.473 0.654 . . . . 2.5800000000000001 110.969 176.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -165.7 176.58 7.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.592 1.957 . . . . 2.3999999999999999 107.208 177.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -6.3 57.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.963 . . . . 4.4400000000000004 112.928 175.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m -154.63 161.01 41.78 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.157 2.183 . . . . 3.5899999999999999 108.498 -172.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.09 -159.13 14.08 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.673 1.13 . . . . 4.3899999999999997 111.117 178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.44 -52.62 6.7 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.297 1.439 . . . . 5.6799999999999997 108.347 -179.147 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -80.68 -10.24 59.74 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.132 1.373 . . . . 5.0999999999999996 112.563 -170.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.1 p -60.22 154.91 18.69 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.837 0.855 . . . . 2.04 112.055 -178.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.277 1.8 pp -111.8 -6.2 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.144 -0.934 . . . . 2.73 111.833 -177.362 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.86 133.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.914 -0.773 . . . . 3.1600000000000001 108.914 162.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.06 47.44 81.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.58 -1.008 . . . . 2.25 110.58 -173.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -142.42 168.92 18.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.906 -1.887 . . . . 5.46 105.906 165.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 m -101.02 115.42 30.44 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.579 -0.526 . . . . 2.0 109.579 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.8 148.73 51.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.845 -0.798 . . . . 3.21 108.845 165.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -134.01 137.9 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.94 2.096 . . . . 1.8 106.588 175.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 m -113.0 129.52 68.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.74 -1.207 . . . . 3.0 107.74 169.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -107.29 159.94 15.99 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 117.361 2.356 . . . . 0.65000000000000002 117.361 -163.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -32.02 -76.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.55 3.14 . . . . 3.5699999999999998 112.908 168.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.69 -174.36 2.44 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.913 0.885 . . . . 3.6800000000000002 110.491 -171.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.58 148.79 18.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.987 -0.745 . . . . 1.55 108.987 157.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.04 168.65 18.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.738 -0.838 . . . . 2.1899999999999999 108.738 154.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.46 -38.81 48.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.066 0.765 . . . . 4.2800000000000002 113.066 -168.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 82.2 46.05 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.835 2.854 . . . . 2.6200000000000001 110.691 -169.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.94 43.53 98.76 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.472 1.034 . . . . 1.8600000000000001 112.051 165.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -155.11 -16.37 0.11 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.806 1.409 . . . . 6.0999999999999996 114.806 -170.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.3 146.18 47.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 120.496 1.498 . . . . 2.96 110.928 -178.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.54 -24.3 69.34 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.791 0.71 . . . . 2.6499999999999999 114.202 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 159.85 14.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.227 -1.027 . . . . 2.52 108.227 174.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -46.82 76.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 3.8900000000000001 107.646 167.677 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -40.39 -48.49 2.73 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.374 2.67 . . . . 4.2300000000000004 111.64 -175.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -63.38 0.83 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.535 1.534 . . . . 2.5299999999999998 110.702 176.093 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -71.62 -41.99 68.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.052 -1.03 . . . . 2.3199999999999998 111.597 177.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.57 -37.26 84.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.334 1.454 . . . . 4.4500000000000002 110.924 -166.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.406 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.257 0.7 OUTLIER -133.3 -51.97 0.88 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.232 1.013 . . . . 2.0899999999999999 111.545 173.218 . . . . . . . . 4 4 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.05 -22.49 0.52 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.715 0.689 . . . . 0.93000000000000005 114.287 -177.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 44.71 54.42 6.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.302 1.441 . . . . 2.5099999999999998 111.561 -163.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.12 -39.38 82.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.568 1.147 . . . . 2.3700000000000001 111.217 166.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.89 -171.33 44.7 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 108.682 -1.767 . . . . 0.98999999999999999 108.682 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.7 m -59.17 153.07 19.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 126.028 1.731 . . . . 1.8799999999999999 114.091 -166.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 50' ' ' GLU . 2.4 mmt-85 -59.55 137.22 58.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.21 1.804 . . . . 3.48 108.83 168.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.9 mt -114.84 -85.26 0.61 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.775 -1.195 . . . . 1.5900000000000001 107.775 169.536 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.16 154.77 18.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.522 -0.918 . . . . 2.0099999999999998 108.522 172.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.2 m -146.22 165.11 30.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.603 -1.18 . . . . 1.96 108.408 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.39 134.46 3.09 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.498 -1.041 . . . . 0.79000000000000004 110.498 173.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.97 130.85 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.575 -1.269 . . . . 1.5900000000000001 107.575 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.2 tt -102.22 129.87 52.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.244 0.545 . . . . 2.0 111.897 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.59 3.99 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.603 1.097 . . . . 0.56000000000000005 115.429 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -98.28 56.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 119.989 1.894 . . . . 1.96 109.917 -156.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.24 173.57 16.76 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.27 0.628 . . . . 2.1600000000000001 110.305 169.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 C--O 1.255 1.378 0 N-CA-C 102.5 -3.148 . . . . 5.5 102.5 159.919 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 108.199 -1.038 . . . . 5.5700000000000003 108.199 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 p -64.63 82.35 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.836 1.254 . . . . 3.6099999999999999 109.1 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 140.76 40.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.297 -0.631 . . . . 4.6399999999999997 109.297 179.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.85 18.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.875 -0.787 . . . . 2.1000000000000001 108.875 168.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.71 152.61 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 105.585 -2.005 . . . . 2.3199999999999998 105.585 158.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.61 93.52 3.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.516 -0.92 . . . . 1.9399999999999999 108.516 158.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.66 107.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.926 -1.509 . . . . 1.9099999999999999 106.926 169.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 mt -92.46 128.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.368 0.667 . . . . 2.0099999999999998 109.712 178.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 -48.21 0.15 Allowed 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.155 1.382 . . . . 5.4100000000000001 109.863 172.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.55 -120.47 2.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.084 1.326 . . . . 1.22 112.808 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -97.07 -59.0 1.88 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.647 -1.242 . . . . 3.9500000000000002 107.647 -169.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.98 176.65 2.41 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.66 2.076 . . . . 1.3600000000000001 115.15 -173.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.81 -25.95 16.35 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.742 2.961 . . . . 1.6100000000000001 111.817 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.81 141.99 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.719 1.208 . . . . 2.4100000000000001 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -153.71 121.99 6.17 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.319 -0.993 . . . . 2.4900000000000002 108.319 -171.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.58 172.06 37.69 Favored Glycine 0 C--N 1.333 0.372 0 O-C-N 121.832 -0.542 . . . . 0.65000000000000002 112.514 -174.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.38 125.1 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.946 -0.761 . . . . 2.6000000000000001 108.946 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.9 mm -88.71 139.65 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 107.029 -1.471 . . . . 1.96 107.029 160.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -129.61 108.07 9.93 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.903 -1.517 . . . . 2.8399999999999999 106.903 171.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -130.67 120.8 24.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.879 -1.156 . . . . 5.0599999999999996 107.879 -155.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.15 159.93 41.18 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.785 0.721 . . . . 3.5600000000000001 111.35 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -145.61 141.76 28.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.018 -2.586 . . . . 4.0199999999999996 104.018 -175.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -107.35 -29.84 9.04 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.25 1.02 . . . . 7.0099999999999998 109.444 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -77.99 164.76 24.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 128.72 2.808 . . . . 4.8200000000000003 109.433 -178.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -77.97 -67.79 0.69 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.158 0.983 . . . . 5.1699999999999999 109.176 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -111.88 85.47 2.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.346 -1.724 . . . . 4.5599999999999996 106.346 170.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.17 174.47 32.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.388 -1.485 . . . . 1.46 109.388 178.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 140.97 47.83 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.191 2.594 . . . . 1.3899999999999999 111.647 -167.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 t -91.2 140.46 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.22 -0.659 . . . . 2.2599999999999998 109.22 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -95.12 105.59 17.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.54 -1.652 . . . . 5.9100000000000001 106.54 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.5 85.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.378 1.471 . . . . 2.3700000000000001 108.689 -169.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -99.24 145.16 27.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.206 -0.665 . . . . 1.01 109.206 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.73 149.82 18.15 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.172 -1.171 . . . . 0.91000000000000003 110.172 -177.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 p -130.15 105.23 7.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.677 -1.972 . . . . 2.6200000000000001 105.677 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.68 143.75 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 106.888 -1.523 . . . . 2.1600000000000001 106.888 -169.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -143.7 -178.73 6.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.944 1.461 . . . . 5.8399999999999999 114.944 167.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.91 76.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 113.94 -1.482 . . . . 0.69999999999999996 112.322 -179.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -72.61 163.14 28.54 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.264 1.032 . . . . 1.98 108.31 172.248 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.86 163.66 25.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.701 -1.222 . . . . 2.5 107.701 153.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.91 171.09 0.54 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.702 0.763 . . . . 2.5699999999999998 111.227 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.92 -158.61 53.43 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.747 -0.661 . . . . 0.58999999999999997 113.038 166.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.23 143.86 46.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.232 0.613 . . . . 3.1299999999999999 111.396 -171.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -139.42 127.0 21.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.392 1.477 . . . . 0.69999999999999996 108.697 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.51 152.04 7.51 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.344 -1.102 . . . . 0.54000000000000004 110.344 171.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -144.0 90.88 2.16 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.067 -1.457 . . . . 4.2199999999999998 107.067 -173.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -137.28 143.77 42.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.674 -1.232 . . . . 0.96999999999999997 107.674 -162.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.2 m -98.93 129.15 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.49 1.041 . . . . 3.2599999999999998 110.39 178.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -109.8 155.22 21.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.375 1.07 . . . . 1.2 108.712 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 11.77 0.39 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.795 1.638 . . . . 5.2699999999999996 113.655 -167.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.14 66.13 2.88 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.417 1.008 . . . . 3.48 109.855 -173.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -61.12 -52.99 62.54 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.882 -0.785 . . . . 4.7300000000000004 108.882 176.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -76.17 126.16 30.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.101 -1.074 . . . . 5.5800000000000001 108.101 166.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -145.05 42.77 1.31 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.406 1.883 . . . . 5.0300000000000002 107.278 168.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.7 m -63.11 -50.11 71.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.197 0.599 . . . . 4.6200000000000001 110.755 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -111.73 110.07 20.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.71 0.804 . . . . 6.5499999999999998 109.617 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.04 -166.41 1.39 Allowed Glycine 0 CA--C 1.532 1.151 0 CA-C-N 114.461 -1.245 . . . . 4.8799999999999999 111.636 -172.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.23 -164.05 1.59 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.178 -0.675 . . . . 3.1000000000000001 109.178 170.628 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.4 m 70.67 81.1 0.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.205 -1.035 . . . . 6.8899999999999997 108.205 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.7 m -177.29 30.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.232 0.826 . . . . 4.2599999999999998 113.232 -134.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -167.39 -172.55 1.99 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.696 1.598 . . . . 2.2799999999999998 107.476 166.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.2 -127.75 3.88 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 119.244 0.929 . . . . 2.0699999999999998 112.048 -171.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.35 -179.7 5.43 Favored 'Trans proline' 0 N--CA 1.457 -0.667 1 C-N-CA 125.378 4.052 . . . . 1.6200000000000001 111.597 -176.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -44.8 125.92 5.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 118.856 -0.592 . . . . 1.27 109.946 171.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -46.62 119.58 2.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.71 0.631 . . . . 4.2599999999999998 109.939 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -156.37 157.04 30.91 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 126.544 1.938 . . . . 3.4500000000000002 106.888 174.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.26 -27.42 13.57 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.148 1.898 . . . . 1.72 113.502 -170.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.21 -63.93 0.11 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.133 0.879 . . . . 5.0499999999999998 111.569 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.5 m -158.87 81.45 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.468 1.107 . . . . 2.7000000000000002 109.287 171.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -74.73 167.65 21.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.26 -1.755 . . . . 6.0800000000000001 106.26 157.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -119.3 166.08 13.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.952 -1.499 . . . . 5.5199999999999996 106.952 -176.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -93.95 149.98 20.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 111.81 0.3 . . . . 1.0900000000000001 111.81 -175.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.37 176.74 39.51 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.31 -3.116 . . . . 1.8300000000000001 105.31 158.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.42 -172.32 47.78 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 117.856 0.828 . . . . 2.8399999999999999 111.268 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.89 -24.36 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.101 2.534 . . . . 1.78 110.624 172.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -65.84 -44.12 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.522 0.729 . . . . 6.1799999999999997 109.822 171.152 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.65 163.21 27.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.418 -0.81 . . . . 2.0299999999999998 109.716 175.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.06 -37.92 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.749 0.82 . . . . 5.5 108.925 163.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.18 152.15 41.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.543 -0.91 . . . . 3.02 108.543 -173.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 166.04 143.8 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.782 2.033 . . . . 4.2999999999999998 111.129 -167.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -65.24 154.5 37.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.489 -0.93 . . . . 0.98999999999999999 108.489 166.762 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.43 -40.57 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.948 -0.76 . . . . 2.6400000000000001 108.948 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.42 62.14 1.75 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.627 0.632 . . . . 0.85999999999999999 111.849 173.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -165.67 97.93 0.67 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.398 -0.964 . . . . 2.2999999999999998 108.398 -172.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.38 -43.48 15.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.998 -0.547 . . . . 3.2999999999999998 109.634 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.2 -100.87 0.19 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.474 -0.87 . . . . 0.77000000000000002 112.864 177.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -155.53 166.33 33.87 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.747 1.619 . . . . 2.1899999999999999 109.954 -169.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.49 155.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.713 1.205 . . . . 1.79 108.34 173.44 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.9 p -107.26 109.16 20.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.772 1.629 . . . . 3.7000000000000002 108.83 -176.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.71 138.8 37.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.717 0.689 . . . . 1.6299999999999999 111.127 171.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.14 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.207 0.942 . . . . 2.6200000000000001 109.536 177.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.5 tttt -157.48 -30.23 0.08 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.827 1.417 . . . . 4.8099999999999996 114.827 -170.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -80.25 21.92 0.57 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.757 1.741 . . . . 2.8700000000000001 110.665 164.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 64.12 12.96 51.9 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 125.458 1.504 . . . . 0.83999999999999997 111.739 -175.089 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -78.65 133.05 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.796 -1.187 . . . . 1.8999999999999999 107.796 -176.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.54 155.23 46.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.447 1.499 . . . . 1.8 107.157 168.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -120.44 143.23 48.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.718 -2.327 . . . . 2.7999999999999998 104.718 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.39 131.69 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.339 -1.356 . . . . 2.3900000000000001 107.339 165.263 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.5 m -148.32 73.47 1.25 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.046 1.338 . . . . 1.54 107.962 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -111.72 152.51 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.974 0.909 . . . . 3.5099999999999998 108.723 -175.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -132.39 88.23 2.51 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.635 -0.876 . . . . 4.1799999999999997 108.635 164.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.62 152.87 29.78 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.6 0.36 . . . . 2.5699999999999998 110.303 176.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -124.2 34.53 5.02 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.022 1.329 . . . . 2.1800000000000002 111.325 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.36 -52.0 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.434 1.093 . . . . 2.52 108.395 175.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -74.54 174.59 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.255 0.55 . . . . 2.1600000000000001 110.772 176.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -149.44 171.71 16.13 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.411 -1.329 . . . . 2.8900000000000001 107.411 170.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -101.8 5.44 41.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.525 0.73 . . . . 3.52 111.944 169.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 m -70.28 -160.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.124 1.77 . . . . 3.54 111.022 -177.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -113.23 74.67 0.23 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.397 -1.481 . . . . 3.9900000000000002 109.397 175.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -147.62 -126.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.619 -1.252 . . . . 5.1399999999999997 107.619 -176.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -79.33 4.0 16.53 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.037 1.335 . . . . 5.4299999999999997 111.371 171.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 p -46.48 151.86 0.51 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.71 2.004 . . . . 1.8500000000000001 111.931 175.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -6.4 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.212 1.005 . . . . 3.48 111.024 -178.575 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.0 tp -19.99 117.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.718 2.007 . . . . 3.02 111.69 163.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.4 -32.34 7.64 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 119.519 -0.601 . . . . 2.4700000000000002 113.785 -177.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.424 ' HE ' ' C ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -77.81 177.36 8.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.752 1.776 . . . . 12.140000000000001 114.672 -153.964 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.3 123.53 35.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.362 1.065 . . . . 2.5600000000000001 111.277 169.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.25 132.11 35.79 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.513 -1.291 . . . . 4.7699999999999996 107.513 162.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.26 117.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 107.274 -1.38 . . . . 2.0899999999999999 107.274 170.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.07 114.98 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 104.685 -2.339 . . . . 3.1099999999999999 104.685 164.459 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -90.13 161.52 15.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 115.828 1.788 . . . . 0.69999999999999996 115.828 -164.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -40.81 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.244 2.618 . . . . 3.1800000000000002 112.532 169.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -89.2 -179.2 5.83 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.306 0.957 . . . . 3.8999999999999999 109.723 179.268 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 155.4 16.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.703 -0.851 . . . . 1.8799999999999999 108.703 157.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -74.66 165.9 24.46 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.233 -0.655 . . . . 2.4500000000000002 109.233 167.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.405 ' CB ' ' HG ' ' A' ' 134' ' ' SER . 22.0 m-20 -70.85 -19.5 62.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 117.829 -1.081 . . . . 3.4100000000000001 112.389 -175.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 59.16 39.63 22.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.664 1.12 . . . . 2.8900000000000001 109.816 -160.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.18 42.66 82.69 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.025 0.821 . . . . 1.9399999999999999 111.533 172.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.94 -22.01 43.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.057 0.943 . . . . 8.5899999999999999 110.73 -171.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.3 -155.51 26.21 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.976 -0.85 . . . . 4.0499999999999998 110.976 177.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.41 -68.12 1.2 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.935 -1.666 . . . . 4.04 108.935 -170.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.12 118.0 14.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.327 -1.731 . . . . 3.1400000000000001 106.327 167.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -49.83 -45.33 50.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.306 1.412 . . . . 3.5299999999999998 109.602 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -35.74 -41.24 0.21 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.593 2.757 . . . . 3.1000000000000001 112.657 170.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.405 ' HG ' ' CB ' ' A' ' 125' ' ' ASP . 7.8 t -49.37 -65.19 0.61 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.684 1.594 . . . . 2.0699999999999998 109.024 179.038 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 -41.95 69.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.36 1.064 . . . . 2.2000000000000002 110.819 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -67.12 -32.31 73.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.989 0.516 . . . . 7.0800000000000001 111.556 -169.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.44 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.382 13.5 t -139.54 -58.57 0.58 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 118.132 -0.937 . . . . 3.0299999999999998 111.398 174.482 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.99 -21.26 0.2 Allowed Glycine 0 N--CA 1.463 0.436 0 CA-C-N 119.556 1.071 . . . . 0.96999999999999997 113.309 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 52.5 54.84 9.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.848 1.259 . . . . 2.1899999999999999 111.256 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.72 59.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.159 0.8 . . . . 2.2599999999999998 113.159 168.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 -159.35 34.22 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 108.526 -1.83 . . . . 0.93000000000000005 108.526 -177.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.4 m -62.54 151.67 36.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.959 -1.12 . . . . 2.1200000000000001 113.639 -163.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -61.44 141.36 57.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.712 -1.585 . . . . 4.4500000000000002 108.896 166.152 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.8 mt -111.97 -82.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.728 -0.841 . . . . 1.72 108.728 169.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.56 167.31 10.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.134 0.574 . . . . 1.99 110.411 177.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.2 p -154.54 170.64 20.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.653 1.181 . . . . 2.5800000000000001 109.451 173.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.6 143.75 4.18 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 124.417 1.073 . . . . 0.82999999999999996 111.189 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.39 134.08 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.752 1.221 . . . . 2.77 109.549 174.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.4 tt -89.55 126.97 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.326 -0.62 . . . . 2.3500000000000001 109.326 161.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.38 -4.32 0.49 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.785 -0.643 . . . . 0.89000000000000001 114.562 176.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.92 57.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 118.778 1.289 . . . . 2.52 111.298 -157.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.98 168.91 26.08 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.739 0.816 . . . . 2.3999999999999999 110.578 160.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 101.658 -3.46 . . . . 7.8300000000000001 101.658 159.494 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.662 -0.125 . . . . 8.2300000000000004 110.662 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.96 156.19 17.18 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.114 -1.439 . . . . 4.0700000000000003 107.114 -177.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -93.73 165.38 12.73 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.505 -0.924 . . . . 3.7599999999999998 108.505 166.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.01 143.78 42.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.977 -1.49 . . . . 1.6499999999999999 106.977 159.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.9 t -105.85 144.23 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.434 -1.691 . . . . 2.0 106.434 165.153 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.51 97.09 5.04 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.702 -0.851 . . . . 1.6599999999999999 108.702 156.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.55 109.41 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.981 -1.489 . . . . 1.9199999999999999 106.981 164.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -93.73 122.5 36.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.564 -0.902 . . . . 1.8200000000000001 108.564 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -139.42 -53.25 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.651 -1.24 . . . . 5.2800000000000002 107.651 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.52 -113.12 2.46 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.193 0.901 . . . . 1.1899999999999999 110.88 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -109.68 -65.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.524 -1.288 . . . . 3.8100000000000001 107.524 -163.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.56 2.03 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 129.318 3.342 . . . . 1.45 115.068 -172.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.7 -26.16 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.797 2.998 . . . . 1.71 112.094 -176.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.18 143.67 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.753 1.221 . . . . 2.0099999999999998 110.601 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -155.18 132.19 10.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.328 -0.99 . . . . 2.6299999999999999 108.328 -175.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.97 172.72 42.77 Favored Glycine 0 N--CA 1.451 -0.36 0 O-C-N 121.86 -0.525 . . . . 0.56000000000000005 112.464 -175.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.11 129.78 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.54 -1.281 . . . . 2.0699999999999998 107.54 176.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mm -96.93 137.84 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.218 1.407 . . . . 1.8799999999999999 107.44 164.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -113.7 122.75 48.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.274 -1.38 . . . . 1.8799999999999999 107.274 160.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.1 130.6 53.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.407 1.883 . . . . 3.6299999999999999 106.222 172.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -135.75 148.21 48.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.986 0.812 . . . . 3.9500000000000002 109.906 168.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -155.3 133.63 11.72 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.255 -1.016 . . . . 3.25 108.255 166.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -44.17 71.7 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.572 -0.899 . . . . 4.8099999999999996 108.572 177.09 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -77.33 -177.16 4.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.438 1.495 . . . . 4.0899999999999999 109.597 -170.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.4 p -82.86 -67.92 0.75 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.502 1.521 . . . . 4.2400000000000002 107.86 169.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -117.1 109.65 17.22 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.168 1.387 . . . . 4.6600000000000001 107.643 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.87 -155.01 7.01 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 108.511 -1.836 . . . . 1.6799999999999999 108.511 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.5 114.11 2.96 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.385 2.056 . . . . 2.4199999999999999 109.515 173.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.14 146.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.232 -0.655 . . . . 2.0299999999999998 109.232 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -100.27 118.53 36.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.28 -1.748 . . . . 3.4399999999999999 106.28 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 t -117.1 122.19 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 107.794 -1.187 . . . . 2.1299999999999999 107.794 177.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -141.04 142.14 34.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.024 0.375 . . . . 0.94999999999999996 110.174 169.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.84 -178.22 38.01 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.535 -1.826 . . . . 0.92000000000000004 108.535 175.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.6 p -148.12 108.68 4.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.263 -2.125 . . . . 2.25 105.263 169.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.28 126.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.128 -2.175 . . . . 2.1899999999999999 105.128 -176.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 157.84 24.03 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.486 0.66 . . . . 5.8600000000000003 111.45 -175.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 15.5 62.51 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 114.583 -1.19 . . . . 0.67000000000000004 114.079 176.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.98 159.08 23.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.293 1.547 . . . . 1.6399999999999999 109.57 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.18 166.61 13.71 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.288 -1.005 . . . . 2.4100000000000001 108.288 155.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -63.79 177.85 0.69 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.104 -0.998 . . . . 2.5 111.56 -175.041 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.78 -159.53 52.21 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.759 0.695 . . . . 0.63 114.076 167.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.91 150.05 41.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.193 0.997 . . . . 3.2799999999999998 110.493 -177.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -143.58 116.92 9.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.336 1.054 . . . . 0.71999999999999997 110.086 178.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.13 141.71 19.92 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.538 -1.425 . . . . 0.45000000000000001 109.538 169.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -140.09 96.7 3.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.468 -1.308 . . . . 3.9300000000000002 107.468 -172.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -131.79 146.42 52.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.503 -1.295 . . . . 0.80000000000000004 107.503 -160.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.83 113.66 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.263 1.03 . . . . 2.6899999999999999 108.446 172.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -79.63 -174.28 4.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.137 -1.392 . . . . 1.3300000000000001 108.446 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -115.84 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 118.317 -0.849 . . . . 5.3700000000000001 109.071 166.362 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 54.63 98.41 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.613 1.165 . . . . 5.0199999999999996 112.794 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -84.95 -158.7 0.38 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.818 0.818 . . . . 4.1900000000000004 110.882 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -86.15 83.38 7.75 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.037 1.335 . . . . 7.04 110.734 -164.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.57 -32.1 0.25 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.928 0.714 . . . . 6.0899999999999999 112.928 -173.118 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.9 t -161.87 173.52 14.41 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 119.758 1.163 . . . . 5.8499999999999996 109.15 168.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.65 -29.7 22.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.166 0.987 . . . . 7.4199999999999999 109.698 163.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.17 66.99 3.09 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.173 -0.793 . . . . 4.0099999999999998 111.922 -171.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.3 m -20.04 96.79 0.01 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.265 2.626 . . . . 3.0299999999999998 113.317 179.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.61 -4.98 58.93 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.533 0.938 . . . . 5.6399999999999997 113.533 -159.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 m 172.03 -6.45 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.653 2.094 . . . . 3.3700000000000001 116.653 -117.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.59 18.28 0.34 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.303 1.964 . . . . 3.98 116.303 -145.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 42.2 -150.04 0.35 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.42 1.486 . . . . 2.3300000000000001 114.223 173.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.43 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.863 3.042 . . . . 1.52 111.142 173.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -66.27 59.79 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.721 2.009 . . . . 1.9099999999999999 112.252 -178.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 48.82 58.53 5.22 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.194 0.998 . . . . 2.79 109.186 -176.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -87.62 114.95 61.25 Favored Pre-proline 0 C--N 1.34 0.153 0 CA-C-O 118.066 -0.969 . . . . 3.73 108.481 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.16 -34.67 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.654 1.569 . . . . 1.4199999999999999 111.425 -178.45 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -156.32 -76.63 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.526 -0.916 . . . . 3.5099999999999998 108.526 177.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.2 m -138.79 59.03 1.64 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.101 0.961 . . . . 2.5 110.599 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -77.94 163.51 25.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.63 -0.878 . . . . 5.1200000000000001 108.63 162.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -125.58 153.78 43.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.299 1.839 . . . . 4.4199999999999999 107.718 -171.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -76.97 164.68 25.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.032 0.444 . . . . 1.03 110.827 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.55 156.5 22.1 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 106.133 -2.787 . . . . 2.2799999999999998 106.133 168.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.18 -156.44 12.6 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 109.915 -1.274 . . . . 2.1200000000000001 109.915 173.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.35 -44.49 4.69 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.541 1.494 . . . . 1.7 108.936 165.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -59.01 -43.84 91.59 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.549 1.54 . . . . 6.25 112.308 -173.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -55.91 166.89 0.66 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.424 1.09 . . . . 2.48 111.328 -177.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -82.32 -47.86 11.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.436 1.894 . . . . 4.71 109.665 170.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 175.9 10.19 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.374 1.07 . . . . 3.98 110.112 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 170.28 148.08 0.03 OUTLIER 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.422 3.089 . . . . 4.5899999999999999 107.191 168.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.479 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 40.0 m80 -61.73 148.58 42.41 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 117.614 -1.634 . . . . 0.63 106.791 171.132 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 p -53.58 -23.04 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 2.3199999999999998 110.665 174.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.97 43.09 1.8 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.805 1.082 . . . . 0.83999999999999997 115.805 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.66 138.69 34.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.984 1.892 . . . . 2.48 111.385 153.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.7 -44.09 7.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.972 1.309 . . . . 4.1699999999999999 108.119 166.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.85 -103.13 0.23 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.608 -1.397 . . . . 1.1599999999999999 109.608 177.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -145.29 170.88 15.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.805 1.642 . . . . 2.2799999999999998 111.516 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.07 170.95 18.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 127.055 2.142 . . . . 1.7 107.877 174.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.77 109.67 15.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.726 1.61 . . . . 3.9100000000000001 109.718 -170.62 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.55 139.54 38.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.548 -0.72 . . . . 1.78 111.496 174.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.02 -92.14 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.38 1.472 . . . . 4.25 109.886 172.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -175.28 -32.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.878 1.271 . . . . 4.4299999999999997 111.795 -163.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.91 8.12 4.1 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 123.39 1.567 . . . . 3.3999999999999999 109.64 153.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.84 72.74 Favored Glycine 0 N--CA 1.442 -0.935 0 O-C-N 120.639 -1.288 . . . . 0.95999999999999996 110.217 177.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.3 t -82.93 111.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.943 1.297 . . . . 1.9199999999999999 107.611 -177.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.53 155.15 21.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.535 1.134 . . . . 1.9099999999999999 110.041 172.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -102.0 57.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.859 2.464 . . . . 6.2400000000000002 107.502 -165.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.07 85.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.996 -0.742 . . . . 2.54 108.996 -163.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.1 m -143.76 119.41 10.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.124 -0.695 . . . . 2.1000000000000001 109.124 173.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.31 152.69 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.173 -1.047 . . . . 3.52 108.173 -173.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -131.72 92.45 3.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.705 -1.22 . . . . 2.8799999999999999 107.705 167.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.6 151.3 21.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.259 0.624 . . . . 2.3700000000000001 110.569 176.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -121.06 -0.48 9.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.224 1.81 . . . . 3.8300000000000001 112.651 173.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -78.56 -51.21 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.752 -1.203 . . . . 2.73 107.752 174.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.13 168.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.299 0.571 . . . . 2.4199999999999999 110.319 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.8 m -131.66 178.53 6.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.127 2.171 . . . . 2.3399999999999999 106.509 174.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.01 9.74 42.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.21 0.914 . . . . 4.1900000000000004 112.453 171.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 p -76.68 110.41 11.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.918 1.287 . . . . 5.2699999999999996 109.312 -166.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.29 72.56 0.14 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.867 1.222 . . . . 5.4199999999999999 112.393 -176.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -162.3 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.615 2.366 . . . . 4.0300000000000002 105.066 -172.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -77.57 -31.58 53.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.725 1.21 . . . . 4.4400000000000004 110.919 178.071 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 p -66.06 179.54 0.91 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.082 1.42 . . . . 2.3999999999999999 112.83 -175.132 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -7.55 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 113.534 -1.666 . . . . 2.8100000000000001 110.893 179.453 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.74 131.79 23.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.413 0 CA-C-N 119.823 1.192 . . . . 3.52 107.969 171.292 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.07 23.67 68.29 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.24 -0.755 . . . . 1.79 111.687 -170.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.41 168.82 16.35 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.085 1.443 . . . . 5.6399999999999997 109.173 167.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.9 m -100.06 110.57 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.583 0.753 . . . . 1.79 112.681 -169.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mt -67.05 141.9 57.36 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.219 -1.03 . . . . 2.5499999999999998 108.219 170.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.6 t -132.31 140.23 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.889 2.475 . . . . 1.73 107.148 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 p -112.5 127.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.663 1.185 . . . . 2.9300000000000002 108.204 167.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -105.25 163.35 12.66 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.785 1.634 . . . . 0.52000000000000002 113.611 -171.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . 0.28 8.7 tt0 -76.71 -53.52 7.87 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 115.035 1.494 . . . . 6.1699999999999999 115.035 -178.005 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -78.93 177.46 8.75 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 120.476 1.489 . . . . 4.8399999999999999 108.713 -179.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.29 37.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.429 -0.952 . . . . 1.71 108.429 160.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 164.26 20.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.039 . . . . 1.9399999999999999 108.193 156.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -10.47 59.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.217 1.191 . . . . 4.1299999999999999 114.217 -171.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 58.93 34.19 23.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 2.6800000000000002 111.706 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.0 60.41 6.88 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.723 -0.611 . . . . 2.1800000000000002 112.712 168.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -138.7 -59.47 0.61 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.422 1.489 . . . . 6.0999999999999996 109.937 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 64.28 -72.06 0.06 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.844 1.688 . . . . 2.8599999999999999 116.152 173.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.19 40.26 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 111.184 -0.766 . . . . 3.3100000000000001 111.184 -157.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -170.68 160.69 7.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.077 1.751 . . . . 3.0699999999999998 107.085 -178.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -55.13 -64.88 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.015 1.117 . . . . 3.1800000000000002 114.015 -173.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -45.12 66.37 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.874 0.87 . . . . 5.0300000000000002 110.617 -156.421 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -58.85 1.99 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.039 1.735 . . . . 2.75 111.515 170.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -70.9 -48.03 55.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.195 -0.941 . . . . 2.1000000000000001 110.788 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -67.33 -36.68 81.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.052 -0.499 . . . . 3.4399999999999999 112.304 -169.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.479 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.404 0.0 OUTLIER -129.49 -53.89 1.17 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.681 -1.152 . . . . 2.1899999999999999 113.518 168.428 . . . . . . . . 4 4 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.68 -10.25 0.27 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 120.408 1.458 . . . . 0.88 115.995 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 46.84 53.62 10.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.216 1.406 . . . . 2.9300000000000002 111.791 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.18 -30.22 71.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.366 1.467 . . . . 2.2200000000000002 113.452 177.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.62 173.15 49.54 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.865 -1.294 . . . . 1.1599999999999999 109.865 -160.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 m -56.4 152.25 11.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.167 1.387 . . . . 2.1800000000000002 113.148 -172.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -77.61 162.85 26.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.713 -1.585 . . . . 6.0899999999999999 111.614 176.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 mt -138.83 -72.92 0.4 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.836 -1.913 . . . . 1.6699999999999999 105.836 -172.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.68 155.69 30.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.425 0.631 . . . . 2.0099999999999998 109.321 172.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -157.23 172.12 19.19 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.543 -1.662 . . . . 1.99 108.642 175.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.24 146.08 6.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.034 -0.985 . . . . 0.90000000000000002 111.932 176.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.4 t -63.32 133.49 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.489 1.116 . . . . 1.9399999999999999 109.118 175.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.6 tt -96.41 136.05 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.151 -0.477 . . . . 1.8400000000000001 110.478 176.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.96 -1.27 2.5 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.883 0.754 . . . . 0.80000000000000004 114.427 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -89.38 58.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.906 1.353 . . . . 2.1299999999999999 110.367 -160.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.46 176.14 7.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.431 1.093 . . . . 2.6200000000000001 110.972 176.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 102.047 -3.316 . . . . 5.2300000000000004 102.047 143.817 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.547 ' H3 ' ' C ' ' A' ' 153' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 110.587 -0.153 . . . . 7.75 110.587 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 p 53.19 66.15 1.31 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.068 1.347 . . . . 4.3499999999999996 111.416 173.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -134.67 148.86 50.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.96 1.304 . . . . 6.8399999999999999 107.567 178.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.92 125.74 53.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.252 -1.388 . . . . 1.5800000000000001 107.252 160.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.78 140.91 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 105.837 -1.912 . . . . 2.1699999999999999 105.837 164.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.96 92.52 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.27 -1.011 . . . . 1.75 108.27 160.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.09 103.19 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 107.077 -1.453 . . . . 2.0 107.077 165.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.73 129.96 34.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.402 -0.962 . . . . 2.0299999999999998 108.402 176.274 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -154.98 -53.86 0.09 Allowed 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.411 -0.588 . . . . 4.5199999999999996 109.411 170.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.72 -107.04 0.61 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.421 -0.809 . . . . 1.3500000000000001 113.005 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -116.37 -57.23 2.22 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.949 1.3 . . . . 2.9700000000000002 110.005 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 164.81 10.15 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.674 0.654 . . . . 1.1599999999999999 112.289 -177.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.72 -19.46 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.593 2.862 . . . . 1.47 112.336 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.88 143.24 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 124.712 1.205 . . . . 2.0899999999999999 110.562 174.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -155.65 126.28 6.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.732 -1.21 . . . . 2.3700000000000001 107.732 -174.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.7 170.8 42.51 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.957 -0.639 . . . . 0.56999999999999995 112.369 -174.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.4 128.17 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.491 -0.929 . . . . 2.75 108.491 -179.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.29 134.71 30.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.651 -1.611 . . . . 2.21 106.651 161.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.42 59.85 1.02 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.863 0.865 . . . . 3.3300000000000001 108.69 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.77 144.28 25.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.237 1.415 . . . . 4.5199999999999996 110.916 -163.277 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -153.44 163.39 40.03 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.872 0.844 . . . . 3.2599999999999998 111.27 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -145.55 153.79 41.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.041 -2.207 . . . . 3.2000000000000002 105.041 157.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -70.71 -56.06 7.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.373 -0.602 . . . . 5.3600000000000003 109.373 172.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -83.08 166.46 18.71 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.798 1.239 . . . . 3.5899999999999999 109.324 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 p -90.79 -0.16 57.63 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.887 -0.508 . . . . 3.0299999999999998 111.949 176.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -144.29 47.72 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.325 0.966 . . . . 5.7400000000000002 111.843 -159.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.56 -164.87 12.75 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.823 -1.311 . . . . 1.3700000000000001 109.823 171.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.4 146.78 45.58 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.594 2.196 . . . . 1.21 110.799 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.54 143.77 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 123.849 0.718 . . . . 2.1200000000000001 110.826 -171.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -95.97 96.98 9.26 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.354 -0.609 . . . . 3.3999999999999999 109.354 -175.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.1 t -83.78 88.94 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.096 -1.076 . . . . 2.29 108.096 177.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -104.55 137.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.778 0.674 . . . . 1.25 109.798 164.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.85 156.83 27.86 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.957 -0.857 . . . . 0.83999999999999997 110.957 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 p -132.21 106.74 8.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.664 -1.976 . . . . 2.6600000000000001 105.664 -171.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.62 150.25 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.627 -1.249 . . . . 1.8200000000000001 107.627 -167.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.75 -179.54 6.86 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.271 1.211 . . . . 6.0 114.271 161.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.92 64.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.854 1.692 . . . . 0.59999999999999998 112.204 179.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.16 162.2 29.7 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.139 0.97 . . . . 1.74 108.811 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.21 164.61 23.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.884 -1.154 . . . . 2.4500000000000002 107.884 153.412 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.01 175.21 0.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.63 0.728 . . . . 2.4100000000000001 111.048 176.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.07 -163.67 50.63 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.295 0.474 . . . . 0.77000000000000002 113.395 170.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.06 147.08 47.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.131 . . . . 3.54 112.284 -172.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.36 117.22 8.22 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.822 1.649 . . . . 0.63 108.987 177.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.16 152.61 5.09 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.917 -0.873 . . . . 0.38 110.917 171.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.84 95.62 2.76 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.559 1.143 . . . . 3.7000000000000002 108.053 -174.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -135.24 160.61 37.86 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 108.383 -0.969 . . . . 0.78000000000000003 108.383 -160.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.37 115.94 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.98 1.264 . . . . 2.9199999999999999 110.686 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -86.9 162.42 17.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.766 -0.652 . . . . 0.87 109.564 -169.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.73 47.27 0.13 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.683 1.993 . . . . 4.5199999999999996 111.345 178.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -123.77 129.02 50.41 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.074 -1.824 . . . . 3.0899999999999999 106.074 -171.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.405 ' CD ' HH21 ' A' ' 115' ' ' ARG . 3.6 tt0 -137.88 -70.28 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.859 1.264 . . . . 4.6699999999999999 107.999 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -79.28 61.03 3.26 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.381 2.272 . . . . 6.1299999999999999 109.673 178.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.81 43.6 2.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.359 0.599 . . . . 4.9800000000000004 112.291 -169.548 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 m -51.54 -22.81 3.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.072 1.349 . . . . 4.6600000000000001 113.084 174.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -46.97 -37.06 8.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.925 1.29 . . . . 6.4500000000000002 112.327 170.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.04 -90.73 0.11 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.275 -1.13 . . . . 3.5499999999999998 110.275 173.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.1 m -151.6 31.06 0.58 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.524 1.529 . . . . 3.1200000000000001 107.853 -176.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 m -131.22 56.35 1.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.015 -1.074 . . . . 4.3799999999999999 111.856 -138.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.6 m -167.61 -38.91 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.962 1.838 . . . . 2.7799999999999998 115.962 -143.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.27 154.5 26.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.637 1.575 . . . . 2.3999999999999999 109.403 167.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.93 -95.25 1.68 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 109.683 -1.367 . . . . 1.54 109.683 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.83 178.61 6.59 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.392 3.394 . . . . 1.0700000000000001 114.236 -173.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -73.03 125.35 27.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.309 -1.314 . . . . 1.52 109.226 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -4.04 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.465 2.306 . . . . 3.7200000000000002 113.754 168.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -123.78 99.84 38.13 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.27 1.028 . . . . 3.1400000000000001 109.105 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.81 -37.02 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.668 1.578 . . . . 1.25 110.03 -179.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.41 -86.02 0.54 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.59 -1.263 . . . . 3.98 107.59 160.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -140.32 72.87 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.434 1.094 . . . . 2.5099999999999998 109.71 -166.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -77.75 164.31 25.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.8 -0.815 . . . . 5.5899999999999999 108.8 170.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -125.07 148.02 48.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.059 1.343 . . . . 4.1200000000000001 108.386 -178.974 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.426 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 44.2 t60 -81.48 156.22 25.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.719 0.407 . . . . 0.89000000000000001 111.828 -176.211 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.57 -97.78 0.13 Allowed Glycine 0 C--O 1.219 -0.784 0 N-CA-C 107.334 -2.306 . . . . 2.3300000000000001 107.334 159.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.09 -154.55 25.48 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 120.575 -1.544 . . . . 1.9099999999999999 110.344 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.34 -55.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.932 2.421 . . . . 2.0499999999999998 110.394 -168.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -39.82 82.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.737 0.779 . . . . 6.4900000000000002 110.067 171.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -57.29 153.09 12.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.725 -1.579 . . . . 3.1299999999999999 112.861 -164.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -49.2 -47.24 46.26 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 128.144 2.578 . . . . 6.5700000000000003 109.576 170.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 21.6 pt-20 -133.93 178.52 6.89 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.762 1.023 . . . . 3.6600000000000001 113.762 -171.145 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 175.73 153.55 0.16 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.147 2.179 . . . . 3.8599999999999999 108.579 -173.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 58.4 m80 -62.6 156.24 23.82 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.072 -0.714 . . . . 0.82999999999999996 109.072 170.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.94 -34.24 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.45 -0.782 . . . . 1.8999999999999999 110.489 -174.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.46 59.98 0.49 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.39 0.995 . . . . 0.90000000000000002 110.65 175.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -169.68 115.93 0.56 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.22 -1.4 . . . . 2.75 107.22 -170.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -106.79 -48.43 3.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.37 0.668 . . . . 3.52 110.978 -173.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.76 -121.69 0.93 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 119.647 -1.263 . . . . 0.87 112.333 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -151.03 172.02 16.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.085 1.354 . . . . 1.8899999999999999 108.925 -171.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 167.23 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.016 -1.476 . . . . 1.76 107.016 167.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 m -120.09 123.42 43.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.217 -1.401 . . . . 3.0 107.217 172.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.94 33.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.979 0.354 . . . . 2.0099999999999998 110.977 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -69.19 -84.05 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.567 1.147 . . . . 2.8799999999999999 110.449 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 93' ' ' GLY . 75.4 tttt -159.12 -46.33 0.06 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.735 1.214 . . . . 4.2000000000000002 111.308 -175.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.41 32.98 0.45 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 124.337 2.018 . . . . 2.73 110.38 176.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 58.39 18.67 37.3 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 126.504 2.002 . . . . 0.78000000000000003 112.228 -176.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.62 142.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.844 -1.539 . . . . 1.9199999999999999 106.844 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.04 163.34 33.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.89 -1.152 . . . . 1.9399999999999999 107.89 171.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -129.99 141.53 50.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.815 -2.661 . . . . 2.6499999999999999 103.815 -174.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.38 126.25 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 105.439 -2.06 . . . . 1.8999999999999999 105.439 170.299 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.8 m -145.81 71.34 1.27 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.375 1.47 . . . . 1.6799999999999999 107.974 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mm -108.56 151.16 10.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.654 0.782 . . . . 2.6200000000000001 109.208 -178.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -137.67 133.96 34.88 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.737 -1.579 . . . . 3.5499999999999998 106.737 160.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.06 161.94 37.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.522 -1.659 . . . . 2.4900000000000002 106.522 175.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 p -113.17 -9.2 13.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.981 2.113 . . . . 2.2999999999999998 112.487 -172.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.1 t -77.5 -41.85 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.339 -0.985 . . . . 2.6099999999999999 108.339 -177.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.68 162.75 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 123.774 0.83 . . . . 3.7599999999999998 108.996 172.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 p -164.29 169.54 17.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.728 1.611 . . . . 2.3500000000000001 108.086 -175.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.5 42.52 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.733 1.213 . . . . 3.8599999999999999 110.046 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 m -79.85 -171.51 2.91 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.575 -1.269 . . . . 4.21 107.575 166.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -141.13 64.95 0.51 Allowed Glycine 0 N--CA 1.465 0.582 0 O-C-N 120.519 -1.363 . . . . 4.1299999999999999 110.762 -169.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -166.54 -105.57 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.06 -0.348 . . . . 4.7800000000000002 110.06 -155.795 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -82.68 -21.9 34.74 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.314 2.246 . . . . 6.1200000000000001 108.858 171.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.7 p -42.14 156.92 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.271 1.428 . . . . 1.5700000000000001 113.026 167.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.3 pp -85.64 -8.86 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.91 -0.494 . . . . 2.4199999999999999 112.05 -177.012 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mm -47.6 123.88 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.835 0.854 . . . . 3.5 109.235 169.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.12 -27.72 17.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.036 0.827 . . . . 2.0299999999999998 112.645 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.405 HH21 ' CD ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -79.85 160.4 26.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.837 1.318 . . . . 5.9900000000000002 110.936 -168.143 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.8 m -87.35 100.46 12.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.042 1.337 . . . . 2.02 109.904 -176.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.9 146.77 54.48 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.139 -1.06 . . . . 2.8900000000000001 108.139 169.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.9 t -134.41 140.8 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 127.898 2.479 . . . . 1.5700000000000001 107.175 -177.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.64 127.19 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.265 -1.383 . . . . 2.8500000000000001 107.265 165.327 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -98.71 162.99 12.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.573 2.064 . . . . 0.39000000000000001 116.573 -169.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -66.36 0.4 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.754 2.022 . . . . 2.9500000000000002 112.054 176.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -107.68 -178.58 3.66 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.187 0.995 . . . . 3.7999999999999998 111.549 -173.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.79 147.36 42.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.292 -0.867 . . . . 1.73 108.798 158.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.95 164.23 23.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.578 0.704 . . . . 2.1699999999999999 109.776 161.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.19 -4.69 58.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.473 1.509 . . . . 3.1400000000000001 112.927 -172.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 57.08 30.36 18.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.597 1.159 . . . . 2.2999999999999998 110.583 -170.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.45 20.69 59.2 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.872 -0.518 . . . . 1.97 112.587 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -131.24 50.76 2.2 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.221 -1.4 . . . . 7.0700000000000003 107.221 -173.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.46 139.71 11.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.713 -1.755 . . . . 2.96 108.713 177.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.23 -37.28 79.75 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.67 0.735 . . . . 2.7599999999999998 112.604 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -56.15 109.63 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.519 1.127 . . . . 2.6499999999999999 108.995 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -38.91 20.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.163 0.985 . . . . 3.54 112.105 -178.212 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -35.36 -37.87 0.09 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 128.022 2.529 . . . . 3.71 113.227 171.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.7 p -47.7 -69.2 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.285 1.034 . . . . 2.6800000000000002 109.69 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -63.96 -43.35 96.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.334 0.654 . . . . 2.27 110.417 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -52.2 -49.83 63.1 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 126.1 1.76 . . . . 3.75 110.703 -171.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.379 10.2 t -136.2 -48.19 0.65 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 117.801 -1.095 . . . . 2.8799999999999999 111.629 175.459 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.426 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 162.38 -31.32 0.3 Allowed Glycine 0 N--CA 1.463 0.483 0 CA-C-N 119.564 1.074 . . . . 0.91000000000000003 112.578 178.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.99 53.4 10.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.498 1.519 . . . . 2.2999999999999998 109.778 -174.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.18 -7.27 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.352 -0.842 . . . . 2.1299999999999999 112.085 166.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.53 -167.57 50.55 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 108.88 -1.688 . . . . 0.95999999999999996 108.88 -174.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -54.39 151.35 7.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.087 1.755 . . . . 1.8300000000000001 113.836 -167.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -64.93 141.46 58.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.333 1.453 . . . . 4.0099999999999998 108.083 170.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.7 mt -108.92 -89.66 0.47 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.058 -1.089 . . . . 1.72 108.058 169.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.74 158.08 15.85 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.953 -1.129 . . . . 1.9199999999999999 107.953 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.6 p -143.64 174.84 10.43 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.214 -1.357 . . . . 1.96 108.413 166.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.1 139.72 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 123.943 0.777 . . . . 0.79000000000000004 111.551 176.439 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.21 129.76 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.556 1.143 . . . . 1.9099999999999999 108.861 174.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.9 tt -90.74 131.88 36.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 122.665 0.386 . . . . 1.9299999999999999 110.76 176.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.54 3.2 0.62 Allowed Glycine 0 CA--C 1.523 0.532 0 CA-C-O 119.389 -0.673 . . . . 0.77000000000000002 114.639 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.19 56.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.193 1.497 . . . . 2.3999999999999999 110.917 -164.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.36 175.51 13.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.061 1.344 . . . . 2.3300000000000001 108.268 160.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.547 ' C ' ' H3 ' ' A' ' 1' ' ' ALA . 4.3 mp0 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 103.858 -2.645 . . . . 5.6299999999999999 103.858 163.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 108.989 -0.745 . . . . 7.1900000000000004 108.989 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.82 68.77 7.2 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.716 0.636 . . . . 4.9000000000000004 112.716 -165.414 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 132.82 55.22 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.52 0.728 . . . . 3.3799999999999999 110.302 162.251 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.41 153.64 21.01 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.51 -0.922 . . . . 1.7 108.51 164.102 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.96 148.62 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 123.799 0.84 . . . . 1.8400000000000001 108.939 164.395 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.18 101.64 6.35 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.067 1.347 . . . . 1.6799999999999999 108.937 159.007 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.7 98.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.204 -1.035 . . . . 1.95 108.204 164.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 mt -81.76 123.77 29.05 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.812 0.845 . . . . 3.0099999999999998 109.564 175.05 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.76 -56.73 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.82 1.248 . . . . 5.3700000000000001 108.29 178.88 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.54 -116.16 1.58 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.043 1.306 . . . . 0.93000000000000005 112.47 -177.549 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.05 -62.03 1.33 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.642 0.721 . . . . 3.46 109.605 -173.138 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.58 161.94 1.13 Allowed Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.825 1.678 . . . . 0.84999999999999998 112.554 -178.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.34 38.6 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.001 3.134 . . . . 0.96999999999999997 112.75 -172.207 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.3 155.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.341 1.856 . . . . 2.1499999999999999 109.013 -177.436 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.53 116.76 4.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.892 -1.151 . . . . 3.0299999999999998 107.892 171.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 163.68 33.02 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.969 -0.852 . . . . 0.72999999999999998 110.969 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.77 114.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.826 -1.916 . . . . 3.1000000000000001 105.826 -177.607 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -78.2 148.44 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.191 -1.411 . . . . 1.97 107.191 170.252 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -122.7 118.23 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.183 -2.154 . . . . 2.1600000000000001 105.183 163.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.405 ' CD2' HG11 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -106.54 99.94 9.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.175 -1.787 . . . . 3.8399999999999999 106.175 175.606 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -103.78 136.84 42.72 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.693 0.797 . . . . 4.6900000000000004 109.246 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -155.94 86.97 1.05 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.626 1.17 . . . . 3.8100000000000001 109.591 172.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.98 -52.02 59.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.377 1.071 . . . . 5.6799999999999997 110.125 174.036 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -83.56 92.46 7.64 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.265 -1.013 . . . . 4.2300000000000004 108.265 175.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -54.57 3.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 118.287 2.699 . . . . 3.79 118.287 -162.831 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -159.04 64.76 0.41 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 120.004 1.275 . . . . 4.3600000000000003 109.566 170.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.94 -145.85 6.84 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 107.578 -2.209 . . . . 1.49 107.578 164.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.72 142.51 16.08 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.555 2.17 . . . . 1.3 110.693 169.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' ' 20' ' ' PHE . 59.5 t -90.39 152.11 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 122.818 0.447 . . . . 2.02 110.128 -175.559 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.6 125.76 48.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.388 -1.708 . . . . 5.0499999999999998 106.388 170.219 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.14 129.91 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.581 -1.266 . . . . 1.8600000000000001 107.581 175.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -144.07 150.32 37.98 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.543 -1.28 . . . . 0.82999999999999996 107.543 162.444 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.28 142.88 5.71 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 107.748 -2.141 . . . . 1.0900000000000001 107.748 173.625 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -116.92 98.57 6.56 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.444 -1.317 . . . . 3.3900000000000001 107.444 -169.261 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.69 143.44 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.512 1.525 . . . . 2.3999999999999999 108.54 -169.119 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 160.65 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.515 -0.474 . . . . 5.6799999999999997 110.619 170.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.57 25.16 63.62 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.796 1.665 . . . . 0.97999999999999998 113.99 -179.121 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.58 171.56 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.297 -1.001 . . . . 1.75 108.297 160.333 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -74.45 168.47 19.65 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.995 -1.113 . . . . 3.3199999999999998 107.995 152.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.47 172.55 0.85 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.73 1.212 . . . . 4.71 110.9 179.516 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.28 -158.75 38.33 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 115.967 -0.561 . . . . 0.96999999999999997 114.023 167.63 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.13 141.35 56.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.228 1.411 . . . . 3.3799999999999999 111.997 -168.17 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -142.48 115.86 9.02 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.168 0.987 . . . . 0.75 110.804 176.457 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.11 146.88 9.77 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.997 -0.841 . . . . 0.38 110.997 170.515 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.26 105.68 5.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.848 1.259 . . . . 3.9100000000000001 107.778 -175.889 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.431 ' ND1' ' CD2' ' A' ' 120' ' ' HIS . 31.0 m80 -138.66 162.09 35.52 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.291 -1.003 . . . . 1.03 108.291 -166.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.45 126.18 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.472 0.654 . . . . 2.73 109.385 176.319 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -104.94 147.75 27.44 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.75 2.02 . . . . 0.80000000000000004 109.215 -173.314 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 67.87 0.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.681 1.192 . . . . 4.3700000000000001 111.095 177.716 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -129.35 107.92 9.89 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.383 -1.339 . . . . 3.1800000000000002 107.383 -176.254 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.73 -29.78 29.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.391 1.076 . . . . 5.2699999999999996 110.999 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -118.02 123.75 46.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.917 0.887 . . . . 5.4500000000000002 109.528 -178.226 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -138.43 46.15 2.03 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.908 0.883 . . . . 6.0999999999999996 108.782 161.439 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 t -76.6 39.61 0.21 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.559 1.144 . . . . 5.29 112.812 -172.568 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.96 -51.93 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 124.477 1.111 . . . . 5.8899999999999997 109.551 -177.265 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.81 -168.77 35.94 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.817 -2.113 . . . . 4.54 107.817 -176.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.6 m -69.32 98.11 1.03 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.775 0.788 . . . . 3.6800000000000002 110.843 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.253 19.4 m -38.19 -93.37 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 127.295 2.238 . . . . 6.3099999999999996 114.66 167.252 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.384 5.5 m 141.53 69.58 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 121.677 2.035 . . . . 4.6600000000000001 114.206 -113.631 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -156.7 163.29 39.45 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.906 2.082 . . . . 2.5299999999999998 106.867 168.623 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.78 -122.89 2.94 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.076 -0.847 . . . . 1.51 111.98 -158.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.89 179.12 6.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.416 2.744 . . . . 1.0700000000000001 113.289 -172.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -58.82 115.74 3.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.893 -1.503 . . . . 1.29 107.19 171.534 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -21.89 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.967 1.707 . . . . 3.3500000000000001 113.902 176.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -130.29 146.23 60.75 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.08 . . . . 3.2200000000000002 107.929 -173.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.58 -54.69 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.778 1.652 . . . . 2.2000000000000002 108.655 169.076 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -144.63 -70.37 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.449 1.499 . . . . 3.5899999999999999 107.333 171.244 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.9 p -135.29 71.92 1.44 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.042 1.337 . . . . 3.6800000000000002 109.369 -168.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -78.82 175.13 10.77 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.233 -1.025 . . . . 5.21 108.233 162.488 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -117.16 149.08 40.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.561 -2.015 . . . . 4.9100000000000001 105.561 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -66.93 146.25 54.58 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.543 -0.863 . . . . 0.83999999999999997 111.048 178.487 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.36 130.28 3.29 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 106.751 -2.54 . . . . 2.73 106.751 172.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.1 -155.28 12.36 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.231 -1.148 . . . . 2.1800000000000002 110.231 174.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.52 -33.0 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.26 1.974 . . . . 2.7000000000000002 110.786 178.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -44.23 90.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.437 0.637 . . . . 8.8900000000000006 110.817 175.637 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.18 139.69 56.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.218 1.562 . . . . 3.0299999999999998 115.218 -159.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -53.57 -59.45 4.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.752 2.421 . . . . 5.4199999999999999 110.167 170.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.64 -178.72 6.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 130.221 3.409 . . . . 3.8199999999999998 110.406 178.029 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 172.68 161.01 0.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.206 1.802 . . . . 3.7200000000000002 111.685 164.74 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.7 m80 -50.25 136.84 19.14 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.685 -1.968 . . . . 0.71999999999999997 105.685 154.256 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.78 -20.6 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 120.072 -0.651 . . . . 1.9299999999999999 109.82 -179.96 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.91 43.29 1.75 Allowed Glycine 0 CA--C 1.535 1.338 0 N-CA-C 116.717 1.447 . . . . 0.94999999999999996 116.717 164.56 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -98.09 136.8 37.81 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 105.757 -1.942 . . . . 2.4100000000000001 105.757 147.681 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.55 -52.29 4.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.72 -0.844 . . . . 2.4300000000000002 108.72 148.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.92 -108.6 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 119.597 -1.287 . . . . 0.65000000000000002 112.321 178.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -155.63 168.18 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.512 1.525 . . . . 3.21 109.224 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.98 178.05 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.565 -1.643 . . . . 1.8300000000000001 106.565 163.21 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.5 t -113.07 146.22 39.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.562 -1.644 . . . . 3.4199999999999999 106.562 151.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.46 156.43 20.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.106 -1.072 . . . . 1.78 108.106 150.755 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.57 -90.11 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.967 -0.753 . . . . 3.1299999999999999 108.967 172.314 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -139.22 -48.79 0.49 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.467 1.507 . . . . 4.7400000000000002 110.091 -167.497 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -81.88 17.0 1.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.964 1.364 . . . . 3.0800000000000001 111.343 -176.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.84 10.11 76.42 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.344 -0.847 . . . . 1.1000000000000001 111.7 -175.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.38 124.65 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.493 1.517 . . . . 2.1400000000000001 107.475 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.34 171.62 14.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.269 1.828 . . . . 1.8100000000000001 108.086 175.12 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.31 144.74 26.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.787 -1.19 . . . . 3.5899999999999999 107.787 -179.583 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.21 55.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 123.866 0.866 . . . . 2.04 111.153 -172.797 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.6 m -72.67 102.3 3.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.768 -0.634 . . . . 1.2 110.193 169.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.4 mt -137.4 157.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.192 0.906 . . . . 2.7999999999999998 110.147 179.077 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -137.94 123.72 19.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.659 -1.237 . . . . 3.6600000000000001 107.659 158.514 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -117.15 156.82 26.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.466 -0.939 . . . . 2.4500000000000002 108.466 164.095 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.9 p -102.03 -12.64 18.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.282 2.233 . . . . 1.8 111.937 176.432 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.35 -25.87 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.764 0.711 . . . . 2.1899999999999999 110.872 -173.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.88 166.6 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.704 0.683 . . . . 2.5699999999999998 111.686 177.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -136.41 176.81 8.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.596 2.359 . . . . 2.4900000000000002 107.618 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.42 57.37 1.09 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.802 0.728 . . . . 3.3999999999999999 112.11 167.352 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.0 m -151.08 -59.63 0.17 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.328 0.651 . . . . 3.4100000000000001 111.743 165.509 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.89 165.13 30.33 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 122.149 -0.344 . . . . 3.8599999999999999 113.395 -170.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -36.77 -47.8 0.69 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.936 2.095 . . . . 4.79 114.022 179.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -75.22 -11.39 60.06 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.078 -0.51 . . . . 6.9800000000000004 111.221 -170.745 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.9 p -61.56 171.97 1.35 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 122.695 1.236 . . . . 1.4099999999999999 112.516 -170.229 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -8.53 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 4.1299999999999999 111.942 176.066 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 33.9 mm -54.85 120.4 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.926 1.239 . . . . 2.8599999999999999 109.491 -174.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.25 73.81 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.617 -0.546 . . . . 1.49 112.338 -177.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -102.39 177.21 4.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.313 -1.736 . . . . 5.3099999999999996 106.313 167.611 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -119.4 122.14 41.11 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.596 1.089 . . . . 1.9299999999999999 111.314 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.8 mt -74.16 146.43 43.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.239 -0.652 . . . . 2.7000000000000002 109.239 166.144 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.91 136.06 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.416 1.886 . . . . 1.73 107.919 177.511 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.3 t -100.47 122.23 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 126.044 1.738 . . . . 3.4500000000000002 106.9 167.005 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.431 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 65.0 m-70 -98.48 158.69 15.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.369 1.989 . . . . 0.44 116.369 -174.653 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 2.7 tt0 -46.72 -74.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.219 2.208 . . . . 2.96 112.018 174.292 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -93.76 -176.88 4.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.851 0.75 . . . . 3.5299999999999998 110.275 -171.748 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.32 152.08 30.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.588 -0.893 . . . . 1.8100000000000001 108.588 157.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.13 177.34 6.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.94 0.876 . . . . 2.1099999999999999 109.087 161.92 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.53 -27.4 67.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.498 1.119 . . . . 4.3899999999999997 113.83 177.824 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.288 2.9 mm? 88.73 -17.58 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 128.47 2.708 . . . . 3.6200000000000001 113.172 -175.127 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.27 3.33 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.647 -1.381 . . . . 3.6000000000000001 109.647 -171.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -95.44 -38.97 10.23 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 128.264 2.626 . . . . 7.0300000000000002 108.87 160.403 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.35 62.63 5.8 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 125.401 1.477 . . . . 4.6600000000000001 110.112 -167.294 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.19 -16.02 25.05 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.694 -0.503 . . . . 3.96 113.741 178.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -176.68 -179.98 1.05 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.49 1.516 . . . . 3.0600000000000001 108.236 -169.507 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -42.83 -82.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.772 2.029 . . . . 3.4900000000000002 113.562 178.681 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -53.18 -33.54 53.07 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.827 -0.546 . . . . 3.9500000000000002 111.709 -172.796 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.3 m -61.42 -52.78 63.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.005 1.322 . . . . 2.6299999999999999 111.161 179.266 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.9 t -71.04 -45.07 64.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.767 1.167 . . . . 3.6000000000000001 110.791 173.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.17 -43.13 99.36 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.175 0.59 . . . . 4.75 111.58 -170.063 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -128.21 -47.98 1.33 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.225 0.466 . . . . 2.1600000000000001 112.107 177.104 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.65 -14.99 1.4 Allowed Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.786 0.721 . . . . 0.91000000000000003 114.097 -178.417 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.11 54.85 6.73 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.035 1.334 . . . . 2.3900000000000001 110.601 -174.755 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.5 -31.26 71.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.77 1.228 . . . . 2.1699999999999999 112.087 172.848 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.52 178.43 50.48 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 108.64 -1.784 . . . . 0.93999999999999995 108.64 -163.262 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 m -58.23 153.76 14.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.556 1.142 . . . . 2.1899999999999999 113.648 -167.229 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -59.72 134.58 57.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.082 1.353 . . . . 4.1299999999999999 108.465 170.254 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.6 mt -110.32 -72.48 0.72 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.955 -1.498 . . . . 1.76 106.955 168.37 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.35 155.03 16.94 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.409 -0.96 . . . . 2.1000000000000001 108.409 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 73.9 m -135.96 150.51 49.3 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 106.196 -1.779 . . . . 2.1000000000000001 106.196 163.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.09 116.45 0.75 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.8 -1.72 . . . . 1.3300000000000001 108.8 172.03 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.68 132.88 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.095 -1.446 . . . . 1.97 107.095 168.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.59 138.96 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.206 0.527 . . . . 1.75 112.385 -172.537 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 137.78 5.84 1.62 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.328 1.442 . . . . 0.59999999999999998 114.221 177.563 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.75 57.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-N 119.351 1.575 . . . . 1.9099999999999999 109.89 -154.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 165.33 36.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.367 0.603 . . . . 2.1400000000000001 111.236 171.669 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 C--O 1.255 1.353 0 N-CA-C 102.699 -3.075 . . . . 5.1600000000000001 102.699 156.139 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.418 0.628 . . . . 6.4400000000000004 112.224 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 p -78.49 83.32 4.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.975 -1.12 . . . . 3.6800000000000002 107.975 177.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HZ3' ' C ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER -76.2 145.86 39.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.747 0.308 . . . . 3.96 110.845 -175.508 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.76 37.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.551 -2.018 . . . . 2.04 105.551 156.147 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -100.6 142.85 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 105.558 -2.016 . . . . 1.8799999999999999 105.558 162.725 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.79 93.16 3.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.645 -1.243 . . . . 1.4099999999999999 107.645 166.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.09 98.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.299 -1.371 . . . . 1.9199999999999999 107.299 169.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.89 123.06 27.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.038 -0.727 . . . . 3.0099999999999998 109.038 177.741 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -150.69 -48.07 0.12 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.824 -0.625 . . . . 4.3399999999999999 111.065 167.623 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.32 -117.8 3.52 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.61 -0.996 . . . . 1.1200000000000001 110.61 -174.898 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.85 -35.04 6.07 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.319 1.048 . . . . 3.7400000000000002 110.131 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.44 168.8 30.15 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-O 121.63 0.572 . . . . 1.1799999999999999 112.577 -177.466 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.47 -26.29 47.58 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.571 2.847 . . . . 1.8700000000000001 111.758 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.0 t -48.04 151.61 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.639 1.976 . . . . 1.6299999999999999 111.025 -178.603 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -156.01 118.32 4.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.396 0.678 . . . . 2.5800000000000001 109.254 -175.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.77 167.72 35.35 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.868 -0.52 . . . . 0.55000000000000004 112.286 -178.838 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.8 mt -129.95 119.95 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.736 -1.209 . . . . 2.5299999999999998 107.736 177.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 mm -81.27 140.51 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.903 -1.147 . . . . 2.1600000000000001 107.903 164.592 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -120.38 93.5 4.07 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 105.396 -2.075 . . . . 1.9399999999999999 105.396 159.299 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.3 118.93 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.881 -1.896 . . . . 4.7699999999999996 105.881 -173.481 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -155.65 175.07 14.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.028 0.918 . . . . 3.9199999999999999 113.404 -173.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.84 169.87 23.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.807 -1.553 . . . . 3.1099999999999999 106.807 -173.51 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -93.79 -64.66 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.596 1.558 . . . . 5.5599999999999996 108.601 171.779 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -79.95 -178.58 6.55 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.458 1.103 . . . . 4.3099999999999996 111.375 178.368 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -87.7 -66.87 0.87 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.906 -1.146 . . . . 3.3100000000000001 107.906 155.69 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -75.74 63.23 1.6 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.045 1.338 . . . . 4.4100000000000001 111.723 -173.219 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.09 -177.48 27.55 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.319 -1.912 . . . . 2.2400000000000002 108.319 169.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.35 152.82 44.72 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.1 2.534 . . . . 1.77 110.412 174.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -82.65 158.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.547 -0.908 . . . . 2.1000000000000001 108.547 176.743 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -111.57 104.88 13.3 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.382 1.087 . . . . 3.4199999999999999 108.601 162.297 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.26 105.22 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.883 1.673 . . . . 2.3599999999999999 108.206 -175.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -128.01 164.27 22.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.693 0.627 . . . . 1.1100000000000001 112.693 176.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.5 42.69 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.516 -1.034 . . . . 0.70999999999999996 110.516 179.267 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -138.74 109.32 6.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.427 -1.694 . . . . 2.7999999999999998 106.427 179.025 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.53 115.87 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.865 -1.531 . . . . 2.1299999999999999 106.865 -161.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -105.36 162.38 13.49 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.64 0.733 . . . . 4.5300000000000002 111.954 -173.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.65 79.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.201 -0.908 . . . . 0.57999999999999996 113.662 168.398 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.77 165.85 9.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.82 1.31 . . . . 1.73 108.839 167.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.93 160.75 25.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.188 -1.412 . . . . 2.3599999999999999 107.188 152.804 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.55 173.68 0.52 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.397 -0.814 . . . . 2.73 110.6 177.359 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.92 -159.26 46.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 123.747 0.689 . . . . 0.93999999999999995 112.465 170.028 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.49 141.49 55.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.609 1.564 . . . . 3.1800000000000002 114.543 -169.493 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -145.29 119.62 9.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.97 1.708 . . . . 0.71999999999999997 109.703 177.24 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.37 150.44 5.57 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.883 -0.887 . . . . 0.46000000000000002 110.883 171.699 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.58 93.12 2.53 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.939 -1.504 . . . . 3.8599999999999999 106.939 -173.292 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -130.39 173.39 10.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.217 -1.031 . . . . 0.85999999999999999 108.217 -165.475 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.9 t -124.42 118.27 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.39 -0.967 . . . . 3.4399999999999999 108.39 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -100.2 149.61 23.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.415 1.486 . . . . 0.88 107.912 175.847 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.45 34.24 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.931 0.892 . . . . 4.7300000000000004 112.445 177.743 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.3 tt0 -91.3 55.27 2.78 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 120.579 -1.326 . . . . 3.4900000000000002 110.817 -159.408 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -48.91 -41.79 34.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.348 1.459 . . . . 4.4900000000000002 111.906 -174.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -76.36 95.15 3.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.96 -1.126 . . . . 6.8099999999999996 107.96 174.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -119.36 47.32 1.72 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.641 -1.244 . . . . 6.04 107.641 155.188 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.8 t -112.72 32.0 5.96 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.787 0.835 . . . . 4.3399999999999999 109.309 168.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.88 -50.14 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.742 1.617 . . . . 5.9000000000000004 108.505 -178.122 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.58 -176.22 46.19 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.643 -1.783 . . . . 4.0899999999999999 108.643 179.429 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.4 t -113.01 64.76 0.64 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.762 1.225 . . . . 2.9199999999999999 109.474 179.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m -144.14 55.27 1.29 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.433 -0.951 . . . . 5.3099999999999996 108.433 -170.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 m -159.71 -26.62 0.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.467 1.654 . . . . 3.3700000000000001 115.467 -131.388 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.46 175.15 9.21 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.477 1.511 . . . . 2.46 109.809 167.233 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.83 -119.66 4.2 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.698 -0.961 . . . . 1.55 110.698 -172.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.64 178.65 7.35 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.014 3.143 . . . . 1.02 112.333 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -54.26 124.97 17.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.977 1.311 . . . . 1.25 108.898 174.582 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -30.73 113.88 0.11 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.653 1.581 . . . . 3.52 112.23 174.499 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.7 151.73 46.99 Favored Pre-proline 0 N--CA 1.446 -0.625 0 C-N-CA 124.675 1.19 . . . . 2.98 109.152 167.369 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.48 -30.91 52.15 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.42 2.08 . . . . 1.6200000000000001 111.621 -178.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 tp -154.54 -69.72 0.13 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.145 0.429 . . . . 4.8700000000000001 109.954 173.331 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -145.94 76.41 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.144 0.978 . . . . 2.5299999999999998 110.411 -172.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -79.67 176.55 9.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.964 -0.754 . . . . 5.5800000000000001 108.964 165.28 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.978 -1.49 . . . . 3.9399999999999999 106.978 -179.558 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -106.64 126.9 52.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.132 0.573 . . . . 1.0600000000000001 111.495 175.017 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.25 3.95 8.3 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.683 1.611 . . . . 3.2200000000000002 111.461 173.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 -173.29 4.25 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.468 -1.019 . . . . 2.3999999999999999 111.291 -169.546 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.09 -9.43 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.641 2.227 . . . . 1.6699999999999999 111.872 173.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -54.51 5.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.469 0.577 . . . . 4.6699999999999999 111.397 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.26 176.58 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.033 0.444 . . . . 2.6600000000000001 110.382 -179.335 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.54 -63.12 1.21 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.684 1.194 . . . . 5.6500000000000004 109.923 -179.885 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.49 148.5 33.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.573 -0.739 . . . . 3.3100000000000001 111.333 -161.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -159.29 147.01 17.41 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.095 -1.003 . . . . 4.7400000000000002 108.396 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.2 m80 -54.69 135.22 47.17 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.721 -1.955 . . . . 0.72999999999999998 105.721 157.462 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -62.09 -22.02 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.788 -0.449 . . . . 2.1400000000000001 109.788 -178.13 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.83 44.93 1.57 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.809 0.719 . . . . 0.93999999999999995 114.337 162.709 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.72 121.77 45.96 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 106.643 -1.614 . . . . 2.3900000000000001 106.643 158.058 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.24 -71.13 0.46 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.422 -1.696 . . . . 2.7999999999999998 106.422 154.399 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.32 -110.76 0.35 Allowed Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.536 -0.626 . . . . 0.82999999999999996 111.536 -176.575 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.66 167.35 26.66 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.848 1.659 . . . . 2.3300000000000001 109.086 175.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.03 175.06 10.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 106.848 -1.538 . . . . 1.5600000000000001 106.848 170.553 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -122.89 142.93 50.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.936 -1.135 . . . . 3.02 107.936 169.104 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 142.13 40.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.921 1.288 . . . . 2.0499999999999998 112.629 173.525 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.31 -88.15 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.158 0.983 . . . . 2.5099999999999998 111.688 -178.652 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 93' ' ' GLY . 1.7 tpmt? -146.08 -42.32 0.21 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.595 0.591 . . . . 4.4900000000000002 112.595 -158.251 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -83.49 23.27 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 124.059 1.885 . . . . 4.0599999999999996 110.163 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 58.42 24.94 57.08 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.563 -1.199 . . . . 1.05 110.479 -168.7 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.15 107.5 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.221 -1.029 . . . . 2.54 108.221 -175.599 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.83 154.72 18.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.904 -1.147 . . . . 1.8200000000000001 107.904 156.187 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.57 139.11 50.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 102.218 -3.252 . . . . 2.8700000000000001 102.218 174.01 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.85 131.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.041 -1.466 . . . . 2.1099999999999999 107.041 170.678 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -158.22 61.73 0.45 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.649 1.98 . . . . 1.21 107.678 178.39 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.0 mm -105.29 157.55 6.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.904 -1.146 . . . . 3.48 107.904 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.2 102.94 4.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.187 -0.321 . . . . 2.3199999999999998 111.617 165.397 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.46 144.75 25.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.314 1.046 . . . . 2.0299999999999998 111.045 -178.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -105.63 -9.14 17.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.04 2.136 . . . . 2.0 113.142 -176.213 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.41 -43.4 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.148 -1.056 . . . . 2.25 108.148 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 pt -86.67 176.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.714 0.768 . . . . 2.5299999999999998 111.446 175.001 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.1 m -157.16 177.67 11.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.1 2.16 . . . . 2.5499999999999998 105.78 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.76 54.83 1.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.909 1.231 . . . . 3.3500000000000001 111.995 172.844 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 p -91.07 -76.99 0.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.646 1.178 . . . . 4.5199999999999996 108.524 175.083 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.33 61.53 0.01 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.075 -1.61 . . . . 3.54 109.075 -174.118 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -162.53 -105.52 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.499 1.12 . . . . 4.9000000000000004 108.154 -167.42 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -76.98 0.09 22.43 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.043 1.337 . . . . 5.6299999999999999 110.223 174.542 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 p -74.44 172.45 11.93 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 127.028 2.131 . . . . 1.47 112.654 -175.786 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.1 pp -93.78 -6.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.001 -1.454 . . . . 3.3100000000000001 113.228 177.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.9 mm -43.81 119.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.973 . . . . 2.9500000000000002 110.371 -179.214 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.63 25.54 73.83 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.707 -0.496 . . . . 1.4199999999999999 113.089 177.055 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -104.06 -178.86 3.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.405 -1.702 . . . . 5.1399999999999997 106.405 166.244 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 m -116.02 118.79 33.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.082 0.401 . . . . 2.1200000000000001 110.108 178.119 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 tt -73.34 143.46 46.89 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.506 -1.294 . . . . 3.25 107.506 170.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -127.24 136.81 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.808 2.043 . . . . 1.73 107.577 177.974 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.19 127.15 58.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.444 -0.947 . . . . 2.7599999999999998 108.444 164.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.24 160.29 14.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 116.066 1.876 . . . . 0.40000000000000002 116.066 -171.217 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -36.2 -68.03 0.15 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.579 2.352 . . . . 3.1200000000000001 112.522 172.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -126.09 -173.8 2.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.683 1.193 . . . . 3.1400000000000001 110.188 -170.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.78 141.76 43.17 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.468 -0.567 . . . . 1.73 109.468 169.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.19 160.96 28.1 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.288 -1.005 . . . . 2.0 108.288 161.502 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.53 -22.34 62.63 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.715 -0.659 . . . . 2.9900000000000002 112.189 -176.042 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 56.36 51.96 10.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.137 1.335 . . . . 2.21 109.68 -161.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 50.58 44.11 46.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.334 0.969 . . . . 1.5700000000000001 113.793 169.116 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -79.5 -30.87 42.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.235 1.014 . . . . 6.6900000000000004 111.088 179.147 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.38 -146.01 25.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.259 -1.136 . . . . 3.8100000000000001 110.259 -170.369 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.37 -72.37 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.444 -1.862 . . . . 3.3900000000000001 108.444 -169.075 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 109.81 8.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 104.488 -2.412 . . . . 3.0099999999999998 104.488 161.592 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -35.9 66.87 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.559 . . . . 3.6499999999999999 110.391 178.654 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -28.6 -44.96 0.03 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.58 2.752 . . . . 3.5800000000000001 113.248 162.366 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -45.68 -60.92 1.93 Allowed 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.979 1.312 . . . . 3.3700000000000001 109.489 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -72.26 -43.56 64.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.499 0.32 . . . . 2.25 110.152 178.829 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -52.91 -53.02 55.41 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.822 1.649 . . . . 3.23 110.85 -170.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.251 1.0 OUTLIER -125.0 -47.71 1.78 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.067 0.547 . . . . 1.97 111.207 173.483 . . . . . . . . 4 4 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.66 -26.29 1.06 Allowed Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.533 -0.627 . . . . 1.0900000000000001 111.533 -170.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.64 56.51 6.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.303 1.041 . . . . 2.7799999999999998 111.249 178.281 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.22 -5.96 57.24 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.389 0.514 . . . . 2.3399999999999999 112.389 168.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.05 -170.84 43.82 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.054 -1.619 . . . . 1.04 109.054 -173.847 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -68.48 171.22 7.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.108 -1.046 . . . . 3.1400000000000001 113.016 -167.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.469 HH21 ' CD ' ' A' ' 50' ' ' GLU . 5.8 mmt-85 -66.79 142.17 57.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.171 2.188 . . . . 3.9199999999999999 109.316 175.126 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.9 -78.95 0.58 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.466 -1.309 . . . . 1.5900000000000001 107.466 166.501 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.71 150.23 28.6 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.651 -0.87 . . . . 1.95 108.651 171.624 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 3.3 m -137.12 150.05 47.73 Favored 'General case' 0 N--CA 1.436 -1.135 0 O-C-N 125.462 1.727 . . . . 2.0800000000000001 106.66 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.67 123.5 1.67 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 109.454 -1.459 . . . . 1.1699999999999999 109.454 178.263 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.08 128.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.575 -1.269 . . . . 2.0099999999999998 107.575 168.562 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.5 tt -103.92 117.06 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.645 0.736 . . . . 1.8899999999999999 110.95 -172.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.24 2.63 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-N 114.954 -1.021 . . . . 0.53000000000000003 115.388 178.133 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.8 mm -94.45 58.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.732 1.766 . . . . 1.96 111.589 -155.031 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.89 176.4 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.678 0.791 . . . . 2.3199999999999998 110.024 167.84 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.494 ' C ' ' HZ3' ' A' ' 3' ' ' LYS . 84.2 mt-30 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 104.148 -2.538 . . . . 4.9699999999999998 104.148 162.294 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 106.603 -1.628 . . . . 6.2699999999999996 106.603 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m 70.37 56.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 105.958 -1.867 . . . . 3.6400000000000001 105.958 -155.221 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -103.28 146.08 28.99 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.032 -0.985 . . . . 3.2200000000000002 111.272 -170.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.15 133.13 33.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.03 -1.1 . . . . 1.72 108.03 165.57 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.12 146.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 106.852 -1.536 . . . . 1.9399999999999999 106.852 158.013 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.86 94.77 3.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.017 -1.105 . . . . 1.77 108.017 162.55 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.67 96.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.407 1.083 . . . . 1.9199999999999999 108.284 170.469 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -91.71 121.55 33.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.431 -0.581 . . . . 2.1099999999999999 109.431 -179.212 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -130.84 -62.12 0.92 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.822 -0.807 . . . . 4.0800000000000001 108.822 174.268 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.26 -123.83 10.33 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 114.34 -1.3 . . . . 1.02 112.22 -170.296 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.22 -43.19 1.8 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.247 0.619 . . . . 3.4300000000000002 109.974 -150.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.99 165.61 8.43 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 109.439 -1.464 . . . . 0.91000000000000003 109.439 164.386 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.53 35.14 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.515 2.81 . . . . 1.0 112.954 -173.681 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -93.16 153.73 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.578 1.551 . . . . 1.6299999999999999 109.992 -171.962 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -155.08 107.16 2.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.217 1.407 . . . . 3.4100000000000001 107.543 175.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.0 166.03 29.35 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.664 -0.574 . . . . 0.53000000000000003 111.664 179.1 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 mm -132.17 117.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.934 -1.876 . . . . 3.0 105.934 -178.368 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 mm -85.28 140.6 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.856 -1.535 . . . . 1.8 106.856 165.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -120.88 105.1 10.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.518 -2.03 . . . . 2.04 105.518 164.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -115.76 110.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.482 -2.044 . . . . 4.8700000000000001 105.482 -171.397 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.33 167.42 30.43 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.659 0.742 . . . . 3.98 112.057 -174.672 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.96 -156.7 0.71 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.181 -2.526 . . . . 4.4000000000000004 104.181 169.493 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -110.67 -62.78 1.48 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.485 1.039 . . . . 4.9199999999999999 109.497 168.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.17 101.45 12.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.927 -1.509 . . . . 4.6100000000000003 106.927 -171.286 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 p -73.99 53.18 0.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.177 1.391 . . . . 3.5899999999999999 111.946 -177.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -156.08 34.74 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.199 1.8 . . . . 4.5999999999999996 108.196 165.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.72 -173.26 14.36 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.042 -1.623 . . . . 1.3999999999999999 109.042 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.04 169.9 6.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.346 2.698 . . . . 1.55 111.765 177.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.83 154.38 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.863 -0.608 . . . . 1.8300000000000001 109.622 -178.842 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -104.46 113.5 27.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.209 -1.775 . . . . 3.5800000000000001 106.209 171.662 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.25 90.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.786 -1.19 . . . . 2.1800000000000002 107.786 -168.798 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -109.59 150.66 27.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 123.457 0.473 . . . . 0.79000000000000004 110.067 -179.613 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.74 168.25 41.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.221 -1.151 . . . . 0.77000000000000002 110.221 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.6 m -139.63 107.5 5.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.281 -1.748 . . . . 3.02 106.281 -179.387 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -115.77 123.02 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.89 -1.893 . . . . 1.8799999999999999 105.89 -161.047 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 162.83 20.74 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 118.651 0.659 . . . . 5.4000000000000004 110.966 -174.371 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.91 74.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.878 0.751 . . . . 0.71999999999999997 113.692 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -69.94 164.04 24.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.48 1.14 . . . . 1.76 109.151 167.633 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.85 156.78 19.81 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.098 -1.075 . . . . 2.5600000000000001 108.098 149.02 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.78 -180.0 0.31 Allowed 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.004 -1.06 . . . . 3.9399999999999999 110.4 176.1 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.11 -158.6 51.13 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.818 -0.551 . . . . 0.85999999999999999 112.1 168.087 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.43 146.86 30.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.948 1.299 . . . . 3.6800000000000002 110.219 -170.149 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.9 121.09 10.83 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.178 0.991 . . . . 0.66000000000000003 110.213 -177.257 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.15 147.58 26.45 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.914 -1.275 . . . . 0.42999999999999999 109.914 170.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -136.26 97.07 3.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.63 -1.619 . . . . 4.5 106.63 -174.084 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -129.31 174.88 9.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.548 -1.278 . . . . 0.82999999999999996 107.548 -169.281 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 p -134.33 115.91 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.177 -1.416 . . . . 2.8799999999999999 107.177 170.203 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -82.28 -175.74 5.84 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.836 -1.542 . . . . 1.1499999999999999 106.836 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -70.92 -106.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.433 -0.951 . . . . 4.1299999999999999 108.433 172.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 44.5 66.07 0.94 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.75 0.82 . . . . 3.3700000000000001 110.513 -175.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -57.16 -22.8 42.97 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.698 1.199 . . . . 5.5899999999999999 110.896 170.074 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -118.15 115.06 24.03 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.158 1.783 . . . . 4.9299999999999997 108.556 -179.15 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -128.19 52.35 1.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.435 -1.32 . . . . 5.1900000000000004 107.435 159.267 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.6 m -62.52 -29.28 70.44 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.635 -0.666 . . . . 5.7999999999999998 111.577 -179.229 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.86 -57.51 0.13 Allowed 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.719 0.807 . . . . 6.1699999999999999 109.686 177.718 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.15 172.89 53.23 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.111 -0.796 . . . . 5.1100000000000003 111.111 175.427 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.4 t -162.88 160.57 25.14 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.071 -1.826 . . . . 3.73 106.071 173.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.321 18.1 p 101.23 65.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 128.759 2.824 . . . . 6.4800000000000004 110.993 166.229 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.4 m -164.85 27.51 0.06 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.674 -1.148 . . . . 3.3599999999999999 113.057 -134.058 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -161.56 146.95 13.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.85 1.66 . . . . 2.2599999999999998 107.544 170.311 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -94.44 0.18 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.785 -0.926 . . . . 1.6599999999999999 110.785 -179.59 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -81.54 178.28 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.12 2.546 . . . . 1.1399999999999999 115.405 -166.226 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -65.86 64.86 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.613 2.365 . . . . 1.6899999999999999 112.46 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.6 t80 37.77 70.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.411 1.884 . . . . 3.8599999999999999 111.025 -177.275 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -96.33 105.26 21.18 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 118.271 -0.871 . . . . 3.79 109.338 -176.727 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.2 -36.15 17.38 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.058 1.838 . . . . 1.8200000000000001 111.655 -175.094 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -141.71 -75.4 0.3 Allowed 'General case' 0 C--N 1.339 0.134 0 N-CA-C 108.687 -0.857 . . . . 3.98 108.687 177.825 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.6 p -156.55 58.34 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.68 0.753 . . . . 3.7599999999999998 110.512 -171.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -77.41 160.57 28.64 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.163 -1.421 . . . . 5.6200000000000001 107.163 162.133 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -133.84 152.01 51.73 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.242 1.417 . . . . 4.2400000000000002 108.178 -172.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -76.18 153.75 35.91 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.804 0.668 . . . . 0.92000000000000004 112.804 -169.245 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.13 163.88 36.24 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.964 -2.454 . . . . 2.2799999999999998 106.964 159.086 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.5 -170.35 11.76 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 117.524 0.662 . . . . 2.1899999999999999 112.493 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.98 -39.77 30.76 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.656 2.237 . . . . 1.6799999999999999 109.797 178.158 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -66.87 -51.06 60.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.083 1.353 . . . . 5.8099999999999996 111.258 175.401 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -61.5 157.55 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.516 0.932 . . . . 2.1299999999999999 113.516 -161.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.13 -49.77 73.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.418 1.087 . . . . 4.4100000000000001 110.333 -179.313 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -78.1 170.04 17.26 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.845 -0.428 . . . . 3.29 109.845 177.488 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 165.24 133.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.927 2.491 . . . . 4.1299999999999999 106.584 -171.882 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.528 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.8 m80 -68.31 161.37 27.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 118.594 -1.242 . . . . 0.73999999999999999 107.947 167.962 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.54 44.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 122.985 1.374 . . . . 2.6200000000000001 110.498 165.303 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -169.0 36.72 0.2 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 124.816 1.198 . . . . 1.3999999999999999 110.984 167.458 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 133.72 28.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.33 -1.1 . . . . 2.46 108.712 163.337 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.9 mt -99.74 -46.02 5.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.014 -1.106 . . . . 3.0800000000000001 108.014 168.757 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.24 -111.41 0.46 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.511 -0.852 . . . . 0.68999999999999995 111.347 178.28 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -155.11 158.41 38.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.164 1.386 . . . . 2.8300000000000001 109.375 -169.83 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.66 178.14 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.686 1.995 . . . . 1.73 106.384 172.353 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -138.32 145.92 41.76 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.562 -0.903 . . . . 3.3199999999999998 108.562 171.301 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.83 139.79 39.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.446 1.099 . . . . 1.8899999999999999 110.885 170.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.76 -79.77 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 123.784 0.678 . . . . 2.9100000000000001 111.309 -174.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.65 -46.33 0.15 Allowed 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.744 0.817 . . . . 4.4100000000000001 111.151 -164.739 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.02 13.58 2.19 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.803 1.287 . . . . 2.6699999999999999 111.529 177.693 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.63 16.85 74.35 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.235 -0.916 . . . . 0.67000000000000004 111.224 -173.341 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -89.06 115.21 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.051 1.34 . . . . 1.8300000000000001 108.262 -179.53 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.59 168.09 9.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.906 1.683 . . . . 1.6799999999999999 108.367 162.242 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -126.8 149.13 49.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.202 -2.888 . . . . 2.98 103.202 -179.369 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.68 135.19 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 107.197 -1.408 . . . . 2.1299999999999999 107.197 166.742 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.9 m -157.59 58.75 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.298 1.839 . . . . 1.24 107.229 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.0 mt -101.88 154.04 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 123.886 0.875 . . . . 2.5800000000000001 108.861 -174.424 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -133.45 137.98 45.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.364 -1.347 . . . . 2.8300000000000001 107.364 161.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.42 159.74 41.64 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.151 -1.426 . . . . 2.5 107.151 170.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -121.74 -1.96 9.4 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.808 2.043 . . . . 3.9900000000000002 113.199 -177.549 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.02 -31.2 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.458 1.027 . . . . 2.3199999999999998 108.236 176.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -99.94 175.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.683 1.193 . . . . 2.4399999999999999 109.286 171.129 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.1 t -158.1 179.55 9.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.347 1.859 . . . . 3.0499999999999998 106.058 175.339 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -106.2 27.74 8.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.946 0.898 . . . . 3.77 111.922 177.9 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 p -88.76 -74.72 0.46 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.371 1.068 . . . . 4.8899999999999997 110.887 -170.922 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 174.6 -163.05 33.38 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 106.0 -2.84 . . . . 3.29 106.0 -171.87 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t70 47.72 -107.91 0.21 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.92 1.36 . . . . 4.4800000000000004 112.028 172.048 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -76.55 -3.93 40.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.644 1.178 . . . . 5.5099999999999998 112.278 -173.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.9 p -62.02 172.7 1.3 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.248 1.023 . . . . 1.6799999999999999 112.232 173.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.8 pt -100.29 -5.31 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.348 -1.296 . . . . 3.1499999999999999 111.056 171.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 tp -46.73 128.81 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.725 0.81 . . . . 2.8199999999999998 109.383 176.906 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.79 -14.12 62.53 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.597 -1.113 . . . . 1.4299999999999999 113.744 -178.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -94.11 163.24 13.55 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.875 1.837 . . . . 4.7800000000000002 111.561 -169.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -88.74 108.74 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.898 0.479 . . . . 1.77 111.184 -177.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.75 143.25 48.04 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.927 -0.768 . . . . 3.0 108.927 174.281 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.1 t -130.27 127.78 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.687 1.195 . . . . 1.6499999999999999 109.212 -179.105 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.67 128.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 106.48 -1.674 . . . . 3.5800000000000001 106.48 161.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -101.87 158.45 16.12 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 114.627 1.343 . . . . 0.40000000000000002 114.627 -175.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.8 -71.73 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.397 -0.819 . . . . 5.5300000000000002 111.152 176.835 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -79.6 -179.5 6.9 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.025 0.83 . . . . 5.0999999999999996 109.353 -177.247 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.43 157.31 26.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.041 -0.527 . . . . 1.8100000000000001 109.818 169.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.83 160.49 5.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.043 -0.526 . . . . 2.8500000000000001 110.326 162.324 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.01 -33.02 74.65 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.921 0.711 . . . . 3.5099999999999998 112.921 176.181 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 73.34 -9.68 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.72 2.408 . . . . 2.77 112.532 -168.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.52 43.42 8.5 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.142 -1.983 . . . . 2.3700000000000001 108.142 -168.197 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.26 -20.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.575 0.954 . . . . 6.9500000000000002 113.575 -175.0 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.9 -46.21 92.18 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 108.276 -1.93 . . . . 3.4700000000000002 108.276 169.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.55 36.01 57.84 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.583 0.611 . . . . 4.8399999999999999 111.64 175.926 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -69.64 -61.62 1.71 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.246 -1.39 . . . . 2.8100000000000001 107.246 -179.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 27.5 tt0 178.96 -55.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.694 2.798 . . . . 3.2999999999999998 105.124 166.795 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -48.01 -37.7 15.39 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.937 2.095 . . . . 2.8399999999999999 111.212 173.619 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.7 m -38.09 -65.18 0.35 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.87 1.668 . . . . 2.1899999999999999 110.754 164.302 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.9 p -71.73 -42.74 66.92 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.378 -0.826 . . . . 2.2799999999999998 110.77 -176.138 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 132' ' ' GLU . 60.9 mttm -52.78 -51.34 61.08 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 123.528 0.731 . . . . 3.5600000000000001 110.837 -175.248 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.528 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 15.2 t -136.92 -48.34 0.61 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.246 -1.359 . . . . 2.75 111.906 176.162 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.11 25.7 0.08 OUTLIER Glycine 0 N--CA 1.473 1.119 0 CA-C-N 120.52 1.509 . . . . 1.21 115.642 177.107 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.28 0.4 OUTLIER 3.37 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.54 2.336 . . . . 4.6900000000000004 116.601 -167.693 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.86 70.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.55 1.54 . . . . 2.0 113.965 -177.605 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.79 171.55 44.85 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.055 -1.618 . . . . 1.1000000000000001 109.055 -160.119 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m -53.03 147.92 8.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.538 1.535 . . . . 2.0499999999999998 113.923 -170.342 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -54.79 136.62 46.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.844 1.258 . . . . 3.7799999999999998 108.645 166.79 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.2 mt -107.88 -64.88 1.16 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.335 -0.987 . . . . 1.8500000000000001 108.335 167.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.95 162.39 13.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.057 -0.974 . . . . 2.1899999999999999 110.847 -173.691 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.57 156.3 34.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.166 0.986 . . . . 1.9199999999999999 109.552 169.119 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.82 138.95 3.53 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 106.613 -2.595 . . . . 0.81999999999999995 106.613 172.909 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.63 132.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.551 -0.907 . . . . 2.0800000000000001 108.551 177.554 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.7 tt -86.17 134.12 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 122.832 0.453 . . . . 1.8400000000000001 111.252 -178.765 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 140.0 5.84 1.15 Allowed Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.166 0.889 . . . . 0.56999999999999995 114.236 175.796 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.75 55.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.713 1.757 . . . . 1.8100000000000001 110.062 -158.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.76 177.82 10.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.43 1.092 . . . . 2.23 109.873 170.089 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 103.449 -2.797 . . . . 6.2599999999999998 103.449 146.837 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 107.357 -1.349 . . . . 6.7800000000000002 107.357 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -158.1 120.02 3.64 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 119.39 0.996 . . . . 4.75 109.16 -178.083 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -102.97 161.67 13.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.124 1.369 . . . . 5.2999999999999998 109.529 178.563 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.42 156.09 44.65 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.168 0.987 . . . . 1.8999999999999999 108.945 154.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.45 150.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 106.674 -1.602 . . . . 1.9099999999999999 106.674 158.435 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.64 102.08 4.65 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 108.446 -0.946 . . . . 1.6899999999999999 108.446 157.102 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.15 102.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.208 -1.404 . . . . 1.9199999999999999 107.208 167.354 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -87.36 126.26 34.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.882 -1.155 . . . . 2.2999999999999998 107.882 177.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -150.92 -53.4 0.14 Allowed 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.481 0.312 . . . . 4.1900000000000004 110.629 -175.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.62 -114.33 1.05 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.763 1.173 . . . . 0.72999999999999998 112.986 -177.163 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -122.54 -52.45 1.92 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.496 1.118 . . . . 3.8100000000000001 110.724 -168.489 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.78 163.76 13.84 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.705 0.669 . . . . 0.84999999999999998 112.225 -175.067 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.45 64.35 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.271 3.314 . . . . 2.1299999999999999 110.864 -176.603 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t -141.64 146.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.752 2.021 . . . . 1.8500000000000001 106.4 -171.633 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -155.59 136.75 13.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.656 -0.868 . . . . 5.5199999999999996 108.656 176.812 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.77 174.58 44.63 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.129 -0.557 . . . . 0.59999999999999998 111.92 175.374 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.84 118.3 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.082 -1.081 . . . . 2.3399999999999999 108.082 -179.119 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.1 137.49 22.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 105.804 -1.925 . . . . 2.0600000000000001 105.804 165.065 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.33 58.73 1.66 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.742 -0.836 . . . . 2.8700000000000001 108.742 178.004 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.55 168.42 19.81 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.18 -1.008 . . . . 4.9100000000000001 112.162 -168.597 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -144.72 150.31 37.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.706 -1.133 . . . . 3.98 108.146 177.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.444 ' NE2' ' H ' ' A' ' 27' ' ' GLY . 32.6 tt0 -151.26 93.89 1.96 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.448 -1.251 . . . . 3.6200000000000001 108.229 167.506 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -49.21 -39.85 31.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.588 1.329 . . . . 6.0599999999999996 114.588 -178.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -87.21 148.89 24.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.461 1.104 . . . . 5.1100000000000003 110.239 -176.356 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -0.53 18.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.203 1.801 . . . . 3.6899999999999999 114.935 -173.678 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -170.13 53.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.844 1.656 . . . . 5.75 111.218 170.96 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' H ' ' NE2' ' A' ' 22' ' ' GLN . . . -108.42 -157.7 19.12 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.116 1.341 . . . . 1.48 110.722 178.193 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -89.34 141.37 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.06 3.84 . . . . 1.6399999999999999 111.053 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.17 136.18 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.916 -0.401 . . . . 2.21 109.916 -175.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -90.29 91.92 8.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.452 -0.944 . . . . 3.4500000000000002 108.452 173.815 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.4 t -90.57 86.0 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.764 0.826 . . . . 2.2000000000000002 110.419 -170.41 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -102.96 139.51 38.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.148 0.499 . . . . 0.93999999999999995 111.572 173.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.04 41.35 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.066 1.793 . . . . 0.68000000000000005 108.799 170.384 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.8 m -139.54 80.43 1.77 Allowed 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 107.702 -1.221 . . . . 2.9300000000000002 107.702 -176.752 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.78 119.42 33.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.908 -1.145 . . . . 1.8200000000000001 107.908 -169.091 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.92 162.02 13.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.395 0.678 . . . . 4.5099999999999998 110.705 -175.218 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.59 -10.77 64.85 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.819 0.687 . . . . 1.4399999999999999 114.819 167.276 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.3 154.94 4.09 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.868 1.334 . . . . 1.5900000000000001 110.87 176.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -65.59 153.13 42.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.94 -1.1 . . . . 2.25 108.231 158.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -52.74 156.24 2.01 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.344 1.057 . . . . 2.7999999999999998 112.073 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 -158.2 31.69 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.276 -0.874 . . . . 0.68000000000000005 112.683 167.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.91 142.54 36.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.882 0.873 . . . . 3.3399999999999999 110.891 -165.492 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -142.04 130.35 22.3 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.775 1.23 . . . . 0.83999999999999997 110.594 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 148.23 36.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.91 -0.876 . . . . 0.51000000000000001 110.91 170.783 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -146.91 96.72 2.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.275 1.43 . . . . 4.0700000000000003 107.798 -171.453 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.435 ' ND1' ' CD2' ' A' ' 120' ' ' HIS . 40.6 m80 -131.32 170.93 13.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.227 -0.657 . . . . 1.0900000000000001 109.227 -164.564 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.58 108.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.767 -1.198 . . . . 3.6899999999999999 107.767 173.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -81.52 168.0 18.72 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.0 -1.111 . . . . 1.1000000000000001 108.0 168.57 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.02 -96.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.642 -1.244 . . . . 4.7199999999999998 107.642 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 60' ' ' ALA . 4.1 mt-10 54.99 65.06 1.6 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.354 0.662 . . . . 3.2400000000000002 112.581 160.326 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.95 -95.93 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.499 -0.751 . . . . 4.7599999999999998 110.777 176.764 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -84.87 58.81 5.2 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.825 1.25 . . . . 5.7599999999999998 110.724 -168.522 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.25 -53.3 6.16 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.404 0.621 . . . . 5.1299999999999999 109.401 -173.146 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t 179.85 -51.09 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.428 1.891 . . . . 5.5199999999999996 108.463 -179.066 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.13 -58.12 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.304 1.441 . . . . 6.3099999999999996 109.165 176.939 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.56 -163.03 36.44 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.856 -0.898 . . . . 4.6500000000000004 110.856 176.308 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 96.0 m -66.97 154.16 41.81 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.317 1.047 . . . . 3.4399999999999999 109.982 175.187 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.08 15.12 0.13 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 115.214 1.561 . . . . 4.9199999999999999 115.214 167.756 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.7 m -172.82 -56.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 118.473 2.768 . . . . 2.8500000000000001 118.473 -127.891 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . -72.21 -41.62 66.69 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.953 -0.467 . . . . 3.5 111.921 -162.363 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.31 -116.22 4.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 116.954 -2.025 . . . . 2.3300000000000001 109.142 -172.417 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.99 179.95 4.42 Favored 'Trans proline' 0 C--N 1.348 0.516 1 C-N-CA 125.337 4.025 . . . . 1.3100000000000001 115.359 -170.576 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -67.74 99.27 0.79 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.384 1.474 . . . . 1.4299999999999999 108.722 -179.231 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -9.52 102.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.127 2.171 . . . . 2.8199999999999998 113.744 172.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -124.47 136.8 28.23 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 127.458 2.303 . . . . 3.1000000000000001 108.13 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.51 -47.43 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.101 1.868 . . . . 1.26 109.218 174.812 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.0 -70.97 0.47 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.571 -1.27 . . . . 3.6499999999999999 107.571 170.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.2 t -154.6 90.79 1.34 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.345 -0.613 . . . . 3.2999999999999998 109.345 -178.552 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -84.64 165.66 17.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.39 -1.337 . . . . 5.5700000000000003 107.39 146.669 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -116.93 170.46 8.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.579 -1.637 . . . . 3.6800000000000002 106.579 174.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -84.33 157.17 21.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.083 0.468 . . . . 0.81000000000000005 110.808 -179.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.62 158.5 31.47 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 104.702 -3.359 . . . . 1.97 104.702 160.83 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.91 174.59 8.54 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.325 -1.11 . . . . 2.79 110.325 170.821 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.15 -29.7 89.7 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.045 1.83 . . . . 1.6399999999999999 110.176 169.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.87 -52.11 66.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.653 0.781 . . . . 4.6500000000000004 110.98 171.305 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -73.83 164.81 26.15 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.718 0.636 . . . . 2.1600000000000001 111.177 -178.169 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -89.48 -36.09 15.6 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.457 1.103 . . . . 5.54 112.674 -171.607 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -75.19 166.04 24.25 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.498 -1.297 . . . . 3.04 107.498 165.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 152.21 127.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.387 2.675 . . . . 4.3899999999999997 104.811 -161.142 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.0 m80 -58.48 149.92 23.98 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.863 -1.162 . . . . 0.58999999999999997 107.863 174.627 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.46 -32.79 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.07 -0.652 . . . . 1.79 109.848 -175.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.5 52.53 2.07 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.308 -0.718 . . . . 0.93000000000000005 113.114 165.642 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -127.42 117.17 21.64 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.186 1.493 . . . . 2.4199999999999999 108.275 164.201 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.39 -53.17 6.54 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.655 -0.869 . . . . 2.6099999999999999 108.655 161.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.62 -105.25 0.27 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.81 -0.71 . . . . 0.69999999999999996 112.95 175.218 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.36 155.52 32.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.876 1.271 . . . . 3.6600000000000001 109.059 -166.317 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.97 163.1 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.477 1.111 . . . . 1.97 110.41 -175.836 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 m -116.49 103.02 10.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.967 2.107 . . . . 3.8100000000000001 109.632 -169.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.11 135.38 36.83 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.669 -0.644 . . . . 1.71 112.225 176.4 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.58 -92.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.741 1.616 . . . . 4.0499999999999998 110.438 175.505 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -177.21 -26.71 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.658 1.983 . . . . 4.3300000000000001 112.548 -165.112 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -76.06 9.06 2.68 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.831 1.777 . . . . 3.7999999999999998 108.442 148.599 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.67 26.63 72.98 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 119.782 -1.824 . . . . 1.1100000000000001 109.996 178.154 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -84.11 108.48 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.219 -1.4 . . . . 2.48 107.219 -175.795 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.46 155.31 28.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.022 1.329 . . . . 1.95 109.129 171.636 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -102.81 58.49 0.78 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.325 2.25 . . . . 6.5199999999999996 107.765 -164.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.98 68.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.397 -0.819 . . . . 2.5899999999999999 110.792 -161.256 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -121.45 75.45 1.18 Allowed 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.79 1.636 . . . . 1.3799999999999999 108.796 179.099 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.0 mm -106.18 155.31 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.26 1.024 . . . . 2.8799999999999999 109.476 -174.613 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -146.5 122.89 10.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.13 -1.434 . . . . 3.3700000000000001 107.13 168.375 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.88 158.45 25.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.424 1.089 . . . . 2.1000000000000001 109.241 173.14 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -127.6 29.67 5.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.069 1.348 . . . . 1.8700000000000001 111.785 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.18 -49.3 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.667 -1.234 . . . . 2.0600000000000001 107.667 171.312 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.95 174.11 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.558 0.694 . . . . 1.9099999999999999 110.178 171.255 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -156.83 -179.89 8.64 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.178 -1.786 . . . . 2.9700000000000002 106.178 175.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.77 14.4 22.23 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 3.6800000000000002 112.197 173.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.2 t -145.53 134.09 22.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.509 1.124 . . . . 3.2599999999999998 108.929 -166.7 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.67 132.96 0.28 Allowed Glycine 0 CA--C 1.533 1.196 0 N-CA-C 109.596 -1.402 . . . . 3.2400000000000002 109.596 -168.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -29.03 -60.5 0.13 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.179 1.792 . . . . 6.0999999999999996 113.134 -170.724 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -74.13 1.99 9.94 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.588 0.218 . . . . 4.7199999999999998 111.588 -161.672 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.7 m -47.36 173.47 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 122.919 1.342 . . . . 2.2799999999999998 112.586 149.434 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.89 -6.94 10.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 114.702 -1.136 . . . . 3.0899999999999999 111.094 175.309 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 tp -44.26 131.65 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.331 1.052 . . . . 2.9100000000000001 110.386 172.088 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.87 -25.23 7.72 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.909 0.766 . . . . 1.5900000000000001 112.65 -176.441 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -87.18 162.93 17.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.758 1.279 . . . . 5.2000000000000002 110.333 -166.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -94.01 113.61 25.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.087 0.555 . . . . 2.1200000000000001 110.758 -172.544 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.21 141.28 52.56 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.385 -1.339 . . . . 3.0600000000000001 107.385 167.403 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.37 133.1 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 126.125 1.77 . . . . 1.71 109.211 175.653 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.1 t -98.13 122.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 125.799 1.64 . . . . 3.4500000000000002 106.929 165.213 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.435 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 64.9 m-70 -97.45 156.76 16.33 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 116.284 1.957 . . . . 0.44 116.284 -174.508 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -34.18 -90.39 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 130.232 3.413 . . . . 3.7000000000000002 112.211 168.06 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -174.49 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.873 0.845 . . . . 5.4800000000000004 109.418 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.54 154.93 10.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.556 -1.202 . . . . 2.3999999999999999 110.099 164.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.06 161.47 8.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.974 -1.012 . . . . 2.8900000000000001 108.93 158.182 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -86.64 -30.49 21.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.988 1.715 . . . . 3.0 111.081 177.183 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 76.16 -1.93 2.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.693 2.397 . . . . 2.79 112.982 -172.8 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.61 30.48 4.61 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.866 1.212 . . . . 1.4399999999999999 113.123 163.151 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -129.56 -16.62 3.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.881 1.272 . . . . 5.6699999999999999 112.823 -173.946 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.91 124.85 31.27 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.33 0.968 . . . . 3.0099999999999998 111.885 175.704 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.02 -29.83 62.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.604 0.621 . . . . 2.77 111.81 175.805 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -53.24 98.63 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.268 1.027 . . . . 2.4399999999999999 109.531 163.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -35.61 -43.26 0.27 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 127.013 2.125 . . . . 4.0199999999999996 113.458 -178.711 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -37.88 -37.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.107 1.763 . . . . 2.8199999999999998 112.668 175.31 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.2 t -50.72 -77.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.159 0.984 . . . . 2.9100000000000001 110.709 169.726 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 t -58.4 -38.32 77.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.771 -1.205 . . . . 3.52 110.959 -177.01 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -59.38 -51.43 69.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.323 1.049 . . . . 6.1600000000000001 110.887 -177.445 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.45 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.281 0.1 OUTLIER -129.72 -54.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.891 0.477 . . . . 2.1600000000000001 112.156 174.504 . . . . . . . . 4 4 . 1 . 034 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.64 -16.24 0.26 Allowed Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.073 0.851 . . . . 0.91000000000000003 113.252 179.078 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.87 52.22 9.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.316 . . . . 2.4500000000000002 110.718 -176.651 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.45 71.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.039 0.936 . . . . 2.0899999999999999 109.921 169.356 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 115.46 -172.09 14.04 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 106.99 -2.444 . . . . 0.93999999999999995 106.99 -168.419 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.6 m -60.93 155.35 20.07 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.388 1.475 . . . . 1.8400000000000001 113.049 -171.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -61.1 135.57 57.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.323 1.449 . . . . 4.0 108.867 169.538 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.2 mt -111.01 -76.57 0.6 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.678 1.126 . . . . 1.6100000000000001 108.753 168.859 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.05 140.41 37.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.205 -1.406 . . . . 1.6200000000000001 107.205 173.444 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 66.7 m -127.3 159.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.738 -1.578 . . . . 2.1099999999999999 106.738 173.285 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.93 132.85 2.59 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.81000000000000005 110.951 168.201 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.89 136.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.619 1.167 . . . . 1.8300000000000001 109.037 171.228 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.89 144.15 14.66 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.115 0 C-N-CA 123.222 0.609 . . . . 2.1499999999999999 111.653 -179.01 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.28 0.8 5.81 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.737 0.684 . . . . 0.80000000000000004 113.451 175.116 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.8 mm -87.82 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.499 1.149 . . . . 1.98 110.91 -161.187 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.28 175.06 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.335 1.054 . . . . 2.8199999999999998 110.22 171.489 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 104.271 -2.492 . . . . 5.21 104.271 167.244 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.786 0.291 . . . . 7.1200000000000001 111.786 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.9 p -105.01 85.86 2.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.469 1.508 . . . . 4.0499999999999998 107.235 -179.248 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 153.01 29.9 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.886 0.741 . . . . 4.21 111.353 -171.572 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.81 25.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.591 -1.262 . . . . 1.6799999999999999 107.591 161.058 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.9 t -103.88 145.11 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.778 -1.193 . . . . 1.8 107.778 165.206 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.95 97.65 5.04 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.77 -0.826 . . . . 1.55 108.77 155.696 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.06 107.81 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.925 -1.509 . . . . 1.8400000000000001 106.925 162.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.1 128.21 35.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.939 -1.134 . . . . 1.97 107.939 175.813 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -149.34 -52.02 0.16 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.965 0.412 . . . . 4.4100000000000001 110.663 172.278 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.71 -119.22 4.86 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.52 -0.764 . . . . 0.93000000000000005 111.526 -175.648 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.38 -42.66 2.65 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.806 1.242 . . . . 3.1000000000000001 110.353 -165.821 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.49 166.99 10.69 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 123.825 0.726 . . . . 0.83999999999999997 111.309 177.411 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.38 -21.65 53.62 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.407 2.738 . . . . 1.1599999999999999 111.993 179.584 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.6 t -50.01 141.77 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.828 1.251 . . . . 1.95 110.822 177.112 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.56 125.09 6.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.909 -1.145 . . . . 2.2999999999999998 107.909 -175.752 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.65 172.67 40.44 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 121.764 -0.585 . . . . 0.55000000000000004 112.52 -177.106 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.31 130.96 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.775 0.83 . . . . 2.52 108.877 176.577 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.24 137.9 23.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.497 -1.298 . . . . 1.9299999999999999 107.497 163.543 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -119.43 99.98 7.02 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.574 -1.269 . . . . 2.0099999999999998 107.574 166.952 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.66 118.02 26.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.698 1.199 . . . . 3.6099999999999999 108.566 -178.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -148.28 164.72 33.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.014 0.824 . . . . 3.6000000000000001 109.419 167.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.66 164.5 38.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.255 1.422 . . . . 4.6500000000000004 107.273 177.265 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -51.22 -46.72 62.33 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.987 0.915 . . . . 5.4800000000000004 112.076 178.728 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -114.31 164.02 14.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.715 -1.217 . . . . 5.8600000000000003 107.715 179.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.0 p -69.2 55.14 0.1 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.023 1.329 . . . . 4.0999999999999996 109.158 163.466 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 179.4 -153.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.578 1.951 . . . . 4.8099999999999996 106.619 -165.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.25 -178.09 0.4 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 127.191 2.329 . . . . 1.6399999999999999 115.268 175.022 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.72 110.23 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.601 2.867 . . . . 1.5600000000000001 109.917 -175.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.63 133.03 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.818 -0.353 . . . . 1.73 111.161 -164.655 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -95.97 101.76 13.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.99 -1.485 . . . . 4.25 106.99 -174.381 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.0 90.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.77 1.228 . . . . 2.0600000000000001 107.877 -173.287 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -97.77 131.41 44.32 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 123.738 0.649 . . . . 1.6599999999999999 109.271 169.425 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 163.21 30.79 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.177 -0.769 . . . . 0.78000000000000003 111.177 -179.422 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -133.4 99.82 4.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 2.9100000000000001 106.522 -171.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.15 140.59 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.534 1.134 . . . . 2.27 108.647 -169.775 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -145.0 -178.02 5.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.709 0.766 . . . . 4.5899999999999999 112.967 169.56 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.24 75.44 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.922 1.249 . . . . 0.58999999999999997 112.598 -179.025 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -77.62 -157.63 0.1 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.615 -0.883 . . . . 1.98 108.615 173.185 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.6 m -143.82 144.43 31.77 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.126 -2.546 . . . . 3.5099999999999998 104.126 168.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -40.87 138.04 1.11 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.723 2.409 . . . . 2.6899999999999999 112.857 -168.772 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.32 -171.38 29.45 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.128 -0.487 . . . . 0.69999999999999996 111.979 174.243 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.28 153.19 40.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.663 0.986 . . . . 3.4700000000000002 113.663 -163.155 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.99 126.55 14.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.218 1.807 . . . . 0.69999999999999996 109.323 -179.261 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.65 155.58 10.98 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.658 -0.977 . . . . 0.39000000000000001 110.658 165.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.38 92.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.143 1.377 . . . . 3.71 107.655 -170.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -134.45 161.91 33.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.785 -0.82 . . . . 0.80000000000000004 108.785 -161.03 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.3 m -113.58 140.75 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.906 0.775 . . . . 3.1000000000000001 109.11 168.99 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -111.52 172.06 7.11 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.282 1.033 . . . . 1.28 111.252 -168.825 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -58.02 -21.59 45.88 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.763 0.825 . . . . 5.9299999999999997 113.019 173.209 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -50.99 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.655 1.982 . . . . 3.3700000000000001 111.133 -179.246 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.3 174.49 2.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 129.295 3.038 . . . . 6.0300000000000002 113.671 178.871 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -90.27 117.37 28.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.815 1.246 . . . . 7.3700000000000001 109.902 172.484 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -138.78 -63.74 0.53 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.903 1.681 . . . . 6.2999999999999998 109.734 176.679 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t -174.61 -51.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.575 1.55 . . . . 4.7699999999999996 109.386 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.64 -43.06 19.09 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.97 0.908 . . . . 5.4199999999999999 109.139 175.078 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.01 -72.21 2.11 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 124.439 1.019 . . . . 6.8799999999999999 111.082 173.564 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.9 t -78.5 56.54 1.8 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.52 1.528 . . . . 3.6800000000000002 111.37 -168.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -117.36 -0.08 12.08 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.286 1.217 . . . . 6.1799999999999997 114.286 -163.127 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.5 t 174.29 51.28 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.176 1.917 . . . . 4.4400000000000004 116.176 -120.401 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.6 164.24 16.92 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 121.249 -0.907 . . . . 2.54 110.456 176.052 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.25 -91.39 1.56 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.312 -2.315 . . . . 1.8999999999999999 107.312 169.676 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 179.71 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 124.898 3.732 . . . . 1.3700000000000001 115.066 -176.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -82.25 60.64 5.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.297 1.439 . . . . 2.0099999999999998 110.44 -170.701 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.4 t80 53.6 72.69 0.42 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.048 1.339 . . . . 4.7300000000000004 108.323 -170.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -97.73 98.32 5.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 108.997 -0.742 . . . . 3.1600000000000001 108.997 175.22 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.06 -38.37 7.24 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.196 1.93 . . . . 2.3999999999999999 111.468 -173.559 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.72 -65.34 0.56 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.712 0.805 . . . . 4.2199999999999998 109.456 173.409 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 m -163.22 100.45 0.95 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.108 -1.441 . . . . 2.1400000000000001 107.108 -171.303 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.6 mmt-85 -126.23 163.0 24.15 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.18 0.992 . . . . 7.29 109.86 170.228 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -116.25 149.53 39.05 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.38 1.472 . . . . 4.0999999999999996 108.362 -172.527 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -78.43 153.57 31.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 112.509 -172.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.64 152.26 10.58 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 105.563 -3.015 . . . . 3.02 105.563 172.081 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.89 -133.99 7.05 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.067 -1.613 . . . . 2.1600000000000001 109.067 177.294 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.6 -52.3 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.768 1.646 . . . . 1.9399999999999999 110.212 173.706 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.94 -34.76 78.16 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.081 1.141 . . . . 5.8899999999999997 114.081 -167.072 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.73 175.83 2.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.698 0.285 . . . . 1.99 110.884 -174.582 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.83 -48.13 11.12 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 4.4000000000000004 109.102 168.074 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -79.64 171.04 15.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.804 0.842 . . . . 3.6699999999999999 110.439 -176.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 174.05 145.37 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.41 2.284 . . . . 4.2800000000000002 110.037 171.54 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.507 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.2 m80 -57.83 143.16 43.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.204 -1.776 . . . . 0.64000000000000001 106.204 160.113 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -52.59 -27.29 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.369 -0.378 . . . . 2.2200000000000002 110.589 174.545 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.55 28.76 12.38 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.49 -1.172 . . . . 0.92000000000000004 115.071 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -94.79 127.81 41.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.455 2.128 . . . . 2.3999999999999999 107.421 159.653 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.85 -54.34 4.95 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.113 -1.44 . . . . 2.8999999999999999 107.113 151.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 153.24 -116.44 0.74 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.394 -1.482 . . . . 0.80000000000000004 109.394 173.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -139.46 160.51 39.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.249 1.02 . . . . 2.4399999999999999 110.34 -174.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.86 178.09 5.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.451 -1.685 . . . . 1.78 106.451 171.245 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -129.99 147.1 51.7 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.559 -0.534 . . . . 3.0899999999999999 109.559 164.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.93 146.6 32.02 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.46 -0.941 . . . . 1.99 108.46 162.092 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.15 -88.47 0.09 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.524 1.14 . . . . 2.8900000000000001 109.619 177.187 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -137.54 -51.18 0.63 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.949 1.3 . . . . 5.0700000000000003 110.542 -174.399 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.92 15.49 1.79 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.846 1.308 . . . . 2.7000000000000002 111.635 -174.265 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.3 10.11 69.18 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.358 -0.838 . . . . 0.83999999999999997 111.309 -171.625 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.6 140.69 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.036 -1.468 . . . . 1.8600000000000001 107.036 173.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.86 175.9 7.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.073 0.949 . . . . 1.6299999999999999 109.262 174.267 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -110.59 148.42 32.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 103.732 -2.692 . . . . 3.9399999999999999 103.732 176.315 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.46 94.58 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.143 -1.058 . . . . 1.8400000000000001 108.143 153.16 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.7 m -122.04 76.99 1.34 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.217 1.407 . . . . 1.0800000000000001 109.287 170.818 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.42 157.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.574 -0.528 . . . . 2.5600000000000001 109.574 179.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -144.68 89.41 1.98 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.149 0.58 . . . . 3.0699999999999998 110.654 166.684 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.84 162.37 26.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.896 -0.409 . . . . 2.2000000000000002 109.896 172.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 p -124.67 7.17 8.18 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.019 1.328 . . . . 2.2400000000000002 113.159 179.321 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.88 -51.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 119.076 0.853 . . . . 2.1499999999999999 108.773 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.39 159.54 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.407 0.623 . . . . 2.0800000000000001 111.23 -177.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.1 p -120.06 177.4 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.266 2.226 . . . . 3.8500000000000001 107.632 175.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -112.26 27.62 9.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.36 0.664 . . . . 3.5299999999999998 110.944 166.767 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.3 t -155.63 162.12 40.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.409 -0.589 . . . . 3.3900000000000001 109.409 177.89 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.56 148.05 0.19 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.64 1.114 . . . . 3.0 110.515 -169.235 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -70.6 -3.18 16.94 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.854 -1.38 . . . . 7.5999999999999996 113.362 -173.328 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -76.97 -16.61 59.29 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 120.826 -1.171 . . . . 4.4000000000000004 110.047 169.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.6 p -67.69 175.58 2.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.776 1.274 . . . . 1.9199999999999999 111.709 176.149 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -7.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.443 -1.708 . . . . 3.1800000000000002 110.836 170.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.8 mm -61.06 128.55 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 119.978 1.263 . . . . 3.3399999999999999 108.404 -177.481 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.38 33.38 84.39 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 112.036 -0.426 . . . . 1.6799999999999999 112.036 -171.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 163.94 12.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.262 -1.755 . . . . 5.6900000000000004 106.262 149.814 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.2 m -92.59 123.88 36.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.406 1.083 . . . . 1.8799999999999999 108.434 171.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -80.47 145.99 31.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.102 -1.073 . . . . 3.48 108.102 167.087 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.73 133.47 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 127.549 2.34 . . . . 1.6899999999999999 107.107 -177.62 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.41 118.34 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.564 -1.643 . . . . 2.8300000000000001 106.564 167.367 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -90.99 159.43 16.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.1 1.889 . . . . 0.34999999999999998 116.1 -168.572 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -33.01 -83.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.693 2.797 . . . . 3.3500000000000001 112.617 166.145 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -105.27 -179.23 3.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.542 0.737 . . . . 3.4300000000000002 109.591 -170.231 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.0 137.76 55.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.553 -0.906 . . . . 1.8300000000000001 108.553 167.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 160.95 30.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.622 -0.881 . . . . 2.1800000000000002 108.622 163.436 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -15.24 54.07 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.863 1.06 . . . . 3.5800000000000001 113.863 -170.353 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 64.45 4.23 2.16 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.739 -1.226 . . . . 2.4399999999999999 113.836 -173.022 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.28 60.39 1.06 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 121.242 1.837 . . . . 1.8799999999999999 111.434 167.208 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.82 -51.76 0.37 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.345 1.858 . . . . 6.4900000000000002 110.308 -175.592 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -43.84 122.69 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.619 1.58 . . . . 2.8399999999999999 113.181 -177.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.04 -22.99 65.47 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.365 0.507 . . . . 3.2400000000000002 112.79 179.234 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -65.43 102.83 0.74 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.982 0.891 . . . . 2.5 109.055 174.775 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -19.31 -64.34 0.02 OUTLIER 'General case' 0 C--N 1.341 0.236 0 C-N-CA 127.857 2.463 . . . . 3.48 113.899 -172.264 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -37.72 -42.98 0.61 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.549 2.34 . . . . 4.2999999999999998 112.568 -177.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.3 m -55.45 -55.1 35.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.198 0.999 . . . . 2.5099999999999998 111.685 177.14 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -71.18 -48.26 52.76 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.024 -1.048 . . . . 2.2999999999999998 110.231 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -65.97 -28.88 69.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.856 1.262 . . . . 5.5700000000000003 111.909 -170.241 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.507 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 1.2 t -137.45 -53.89 0.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.589 -1.196 . . . . 2.77 113.14 174.143 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.38 -18.52 1.33 Allowed Glycine 0 N--CA 1.468 0.83 0 CA-C-N 120.126 1.33 . . . . 0.97999999999999998 112.562 -179.88 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 46.6 54.12 9.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.199 1.8 . . . . 3.52 111.751 175.376 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.93 -36.74 56.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.377 0.608 . . . . 2.2200000000000002 110.591 168.728 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 -150.53 17.85 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 108.52 -1.832 . . . . 1.02 108.52 176.105 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.9 p -65.77 151.47 46.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.061 0.763 . . . . 3.3100000000000001 113.061 -164.035 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -60.81 139.46 57.93 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.809 -1.182 . . . . 3.8199999999999998 107.809 166.86 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -115.49 -77.41 0.57 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.749 -1.204 . . . . 1.54 107.749 173.504 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.91 157.9 17.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.197 -1.409 . . . . 2.0499999999999998 107.197 165.745 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.6 p -156.83 163.27 39.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.169 -1.832 . . . . 1.48 107.102 179.601 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.24 138.39 5.05 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.476 -1.05 . . . . 0.68999999999999995 110.476 179.418 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.06 133.9 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.368 1.067 . . . . 1.99 108.54 172.6 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.7 tt -100.11 132.84 44.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 122.769 0.428 . . . . 1.8899999999999999 111.508 -177.051 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.68 2.99 1.01 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.466 1.032 . . . . 0.63 114.675 179.379 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.6 mm -92.63 57.04 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 119.541 1.671 . . . . 1.8400000000000001 110.832 -157.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.1 173.45 16.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.804 . . . . 2.3799999999999999 109.518 166.305 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 C--O 1.255 1.388 0 N-CA-C 102.892 -3.003 . . . . 4.4100000000000001 102.892 162.918 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.702 0.287 . . . . 2.9900000000000002 111.288 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -94.97 144.75 25.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.651 -1.24 . . . . 0.67000000000000004 107.651 163.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 t -110.61 142.28 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.747 -0.835 . . . . 0.87 108.747 167.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.01 97.47 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.069 -1.086 . . . . 0.44 108.069 156.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.14 107.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.723 -1.584 . . . . 0.60999999999999999 106.723 161.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.22 124.46 38.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.081 -1.081 . . . . 0.84999999999999998 108.081 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -135.22 -52.05 0.77 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.213 0.605 . . . . 4.21 109.822 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.73 -121.97 4.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.811 -1.315 . . . . 0.78000000000000003 109.811 -170.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.89 -37.63 1.51 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.18 0.592 . . . . 3.0699999999999998 111.553 -162.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.27 162.3 18.98 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 110.972 -0.851 . . . . 0.81999999999999995 110.972 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.86 58.95 6.23 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.15 3.234 . . . . 1.78 111.22 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -132.71 152.63 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 127.353 2.261 . . . . 0.98999999999999999 107.269 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -155.04 133.77 12.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.49 -1.3 . . . . 2.5800000000000001 107.49 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.41 168.83 40.21 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.789 -0.72 . . . . 0.44 112.785 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.86 125.67 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 1.1200000000000001 107.345 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.7 136.55 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.883 -1.525 . . . . 0.68999999999999995 106.883 161.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -116.26 106.99 14.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.7 -1.593 . . . . 1.6299999999999999 106.7 165.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -92.74 120.11 32.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 2.6000000000000001 106.877 176.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.62 163.17 33.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.102 0.953 . . . . 3.46 109.935 163.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -156.85 153.82 28.85 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.979 2.112 . . . . 3.1899999999999999 105.405 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -63.42 -62.43 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.323 0.965 . . . . 5.6500000000000004 110.375 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -90.9 -162.38 0.9 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 126.802 2.041 . . . . 4.4100000000000001 111.282 -167.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 m -101.69 -68.55 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.643 1.577 . . . . 2.5899999999999999 107.215 158.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -73.58 76.55 1.48 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.526 1.131 . . . . 4.5800000000000001 110.72 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.36 179.35 43.2 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 110.343 -1.103 . . . . 1.01 110.343 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.21 126.06 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.776 2.984 . . . . 1.03 112.123 -170.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.19 140.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.427 -0.583 . . . . 0.87 109.427 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -103.74 99.04 8.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.547 -1.649 . . . . 2.8300000000000001 106.547 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG22 ' CE1' ' A' ' 20' ' ' PHE . 30.4 t -89.44 120.91 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.006 -1.479 . . . . 0.93000000000000005 107.006 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -130.92 140.34 50.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.8 -1.185 . . . . 0.93999999999999995 107.8 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.21 23.71 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.088 -1.205 . . . . 0.75 110.088 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 p -130.04 67.59 1.46 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.088 1.355 . . . . 1.8899999999999999 107.726 -163.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -81.6 139.53 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.541 -1.209 . . . . 0.82999999999999996 108.323 -175.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 7.0 ptpt -134.94 169.53 17.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.452 1.279 . . . . 4.2999999999999998 114.452 170.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 -1.68 79.1 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 114.227 -1.351 . . . . 1.04 113.803 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -56.09 158.83 3.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.668 1.234 . . . . 0.79000000000000004 110.31 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.82 160.55 11.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.375 -0.972 . . . . 1.79 108.375 154.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -60.88 174.04 0.68 Allowed 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.57 -0.706 . . . . 2.6000000000000001 110.822 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.26 -162.19 54.48 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.993 -0.549 . . . . 0.44 112.541 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.17 146.69 47.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.37 0.668 . . . . 2.1400000000000001 111.973 -171.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -144.74 119.3 9.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.486 1.515 . . . . 0.48999999999999999 109.408 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.15 147.83 8.96 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.155 -1.178 . . . . 0.32000000000000001 110.155 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.421 ' CZ ' HG12 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -140.29 96.04 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.502 -1.295 . . . . 2.6499999999999999 107.502 -174.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.773 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 33.3 m170 -130.91 146.6 52.38 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.99 -1.115 . . . . 0.56999999999999995 107.99 -162.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.75 104.91 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 122.09 0.948 . . . . 1.6799999999999999 109.542 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.71 161.87 18.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.245 -1.391 . . . . 0.82999999999999996 107.245 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 6.8 pm0 -51.3 -103.39 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.124 1.77 . . . . 5.46 112.76 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 123.366 0.666 . . . . 2.9700000000000002 112.784 170.226 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.22 0.533 . . . . 1.96 110.658 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.86 -88.32 1.27 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.152 -1.579 . . . . 1.02 109.152 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.57 179.0 4.47 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.948 3.099 . . . . 1.1299999999999999 114.06 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -84.84 59.05 5.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.308 -1.315 . . . . 1.75 109.47 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.5 t80 50.17 68.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.828 . . . . 2.3399999999999999 109.818 -172.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -83.21 115.17 57.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.218 -0.896 . . . . 2.5699999999999998 108.759 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.18 -37.12 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.148 1.898 . . . . 1.55 111.157 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 tt -155.84 -65.7 0.11 Allowed 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.945 -1.131 . . . . 3.0600000000000001 107.945 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -154.95 71.45 0.8 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.705 0.802 . . . . 1.8500000000000001 109.379 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.56 161.34 27.08 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.946 -0.761 . . . . 4.4199999999999999 108.946 165.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 28.2 mttt -109.71 155.72 21.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.809 -1.552 . . . . 3.54 106.809 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -74.85 164.06 26.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0700000000000001 110.587 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.01 148.46 9.28 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 105.447 -3.061 . . . . 2.5699999999999998 105.447 169.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.26 -155.46 4.99 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.444 -1.062 . . . . 1.1699999999999999 110.444 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.71 -46.87 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.728 1.618 . . . . 1.4399999999999999 108.756 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.62 -36.26 75.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.265 1.426 . . . . 4.4000000000000004 113.039 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.95 165.93 1.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.927 0.491 . . . . 2.6600000000000001 110.737 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -79.61 -46.96 16.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.884 1.674 . . . . 4.2699999999999996 109.512 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 44.7 mt-10 -93.47 177.1 6.14 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.209 1.404 . . . . 3.1499999999999999 110.812 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 177.33 160.57 0.44 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 128.55 2.74 . . . . 3.4900000000000002 106.82 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 51.0 m80 -71.51 152.14 43.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.241 -1.763 . . . . 0.56000000000000005 106.241 162.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.49 39.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.4 1.095 . . . . 2.2799999999999998 111.128 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.51 37.27 0.29 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 128.331 2.872 . . . . 0.64000000000000001 110.62 166.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.05 140.57 50.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.427 1.614 . . . . 2.1899999999999999 110.451 157.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.31 -51.22 4.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.708 -1.219 . . . . 1.6399999999999999 107.708 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.45 -103.41 0.23 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.649 -0.98 . . . . 0.56999999999999995 110.649 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -152.16 169.28 22.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.305 1.842 . . . . 1.71 110.461 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.06 176.04 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.649 1.58 . . . . 0.42999999999999999 107.034 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.4 m -125.33 126.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.934 -1.135 . . . . 2.0099999999999998 107.934 174.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.17 141.4 29.58 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.127 0.971 . . . . 0.66000000000000003 111.818 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.11 -90.38 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.153 0.908 . . . . 2.6499999999999999 110.855 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -158.23 -34.37 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.243 0.831 . . . . 4.0499999999999998 113.243 -161.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 38.6 t0 -79.34 17.93 0.76 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 123.797 1.761 . . . . 3.4300000000000002 110.178 158.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.78 17.22 60.24 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 125.189 1.376 . . . . 0.96999999999999997 111.808 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.38 119.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.515 -1.291 . . . . 0.84999999999999998 107.515 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.51 174.24 6.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.444 1.098 . . . . 1.01 109.292 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -132.49 91.24 2.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.196 -2.15 . . . . 3.6899999999999999 105.196 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.1 59.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.775 -0.824 . . . . 1.6100000000000001 108.775 -168.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m -96.56 104.15 16.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.758 1.223 . . . . 1.3700000000000001 109.453 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.02 153.31 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.393 -0.965 . . . . 1.8100000000000001 108.393 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -140.14 82.16 1.85 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.302 0.641 . . . . 2.4199999999999999 109.914 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.52 160.36 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.851 0.46 . . . . 2.1000000000000001 110.969 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.4 p -121.11 4.39 10.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.573 1.549 . . . . 1.3500000000000001 113.16 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.66 -50.43 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.28 0.945 . . . . 1.1599999999999999 109.065 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pp -77.57 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.425 0.631 . . . . 0.93999999999999995 111.043 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -153.66 175.1 13.64 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.746 1.618 . . . . 2.27 107.502 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.87 38.72 4.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.726 0.811 . . . . 2.54 111.144 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 124.716 1.206 . . . . 3.5099999999999998 109.782 -176.257 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.454 0.168 . . . . 2.1299999999999999 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.441 HD12 ' C ' ' A' ' 112' ' ' ILE 0.257 1.3 pp -95.97 -7.84 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.266 0.469 . . . . 1.5600000000000001 112.266 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' HG23 ' A' ' 149' ' ' ILE . 8.7 tt -45.57 137.03 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.503 0.721 . . . . 1.8999999999999999 110.494 167.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.07 -30.78 6.4 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.727 0.679 . . . . 1.5600000000000001 112.253 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.541 ' O ' HG22 ' A' ' 149' ' ' ILE . 82.8 mtt180 -81.1 166.23 20.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.734 1.267 . . . . 5.1500000000000004 109.897 -168.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.0 m -93.06 108.61 20.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.085 0.469 . . . . 0.87 110.586 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -68.45 148.74 50.19 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.704 -0.85 . . . . 1.6399999999999999 108.704 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.98 137.77 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.894 1.677 . . . . 0.38 108.342 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.421 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -108.37 128.33 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.017 -1.105 . . . . 1.6299999999999999 108.017 166.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.531 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 72.1 m-70 -104.8 160.85 14.66 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.121 2.267 . . . . 0.40000000000000002 117.121 -169.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -50.82 -71.96 0.06 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.833 2.053 . . . . 3.3399999999999999 111.902 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -94.3 -178.22 4.53 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.174 0.897 . . . . 2.9399999999999999 110.239 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.97 151.08 27.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.643 -0.873 . . . . 0.52000000000000002 108.643 161.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.53 169.02 18.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.434 -0.58 . . . . 1.97 109.434 163.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.08 -25.78 63.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.471 0.915 . . . . 3.9399999999999999 113.471 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 72.63 -13.71 0.63 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.111 2.164 . . . . 2.1899999999999999 113.006 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.54 5.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.949 1.25 . . . . 2.2000000000000002 110.666 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -91.57 -31.38 15.93 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.501 1.12 . . . . 5.6799999999999997 109.212 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.67 62.78 3.09 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.784 -1.326 . . . . 2.3500000000000001 109.784 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.52 -31.42 57.29 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.563 -1.015 . . . . 4.0499999999999998 110.563 164.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -141.42 -78.54 0.27 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.421 0.611 . . . . 2.52 111.622 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 179.56 -54.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.335 1.454 . . . . 3.5899999999999999 109.624 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -45.9 -31.4 2.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.7 0.8 . . . . 4.4000000000000004 110.735 167.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -29.57 -77.13 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.821 2.048 . . . . 1.75 113.534 155.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 p -71.63 -39.38 70.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 120.884 -1.135 . . . . 1.24 109.447 -175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -55.28 -51.37 66.88 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.104 0.411 . . . . 3.7000000000000002 111.463 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.543 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.337 1.0 OUTLIER -128.9 -47.92 1.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.361 0.874 . . . . 1.1699999999999999 113.361 175.175 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.15 -5.46 0.39 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.577 1.08 . . . . 0.91000000000000003 115.366 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 36.25 57.13 1.05 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.274 1.83 . . . . 2.0 113.549 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.773 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -63.55 -32.75 74.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.339 0.866 . . . . 1.04 113.339 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.53 174.47 50.01 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.312 -1.515 . . . . 1.0600000000000001 109.312 -159.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 m -54.92 154.09 5.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.274 1.43 . . . . 1.46 113.961 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -77.41 142.69 39.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 2.7799999999999998 109.897 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 mt -120.32 -72.64 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.694 -0.854 . . . . 0.54000000000000004 108.694 -174.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.77 149.25 41.1 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.042 0.937 . . . . 0.77000000000000002 108.494 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.04 170.48 20.43 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.054 1.471 . . . . 1.3600000000000001 109.178 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.43 147.19 6.36 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.642 -1.383 . . . . 0.70999999999999996 109.642 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.46 135.25 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.27 1.028 . . . . 0.72999999999999998 109.065 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 115' ' ' ARG . 10.1 tt -92.63 140.03 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.144 0.424 . . . . 0.76000000000000001 112.144 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.403 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 139.68 7.42 1.03 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.579 1.085 . . . . 0.62 114.315 171.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.3 mm -98.65 57.0 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.229 -0.025 0 CA-C-N 119.55 1.675 . . . . 0.76000000000000001 109.917 -154.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.65 176.93 11.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.823 0.849 . . . . 1.4399999999999999 109.452 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 103.267 -2.864 . . . . 4.2800000000000002 103.267 154.184 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.8 pttp . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.777 0.322 . . . . 2.6299999999999999 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.27 147.18 24.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.257 -1.016 . . . . 0.77000000000000002 108.257 163.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 152' ' ' ALA . 46.4 t -104.49 152.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 106.164 -1.791 . . . . 0.81000000000000005 106.164 157.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -137.2 96.3 3.25 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.9 -0.778 . . . . 0.68000000000000005 108.9 160.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.26 110.32 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.352 -1.351 . . . . 1.0 107.352 168.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.4 mt -93.85 122.84 36.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.919 -0.771 . . . . 0.93000000000000005 108.919 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.77 -47.97 0.46 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.857 0.863 . . . . 4.2000000000000002 110.578 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.83 -123.47 1.97 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.744 1.164 . . . . 0.92000000000000004 112.779 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -59.52 1.85 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 3.7599999999999998 108.52 -172.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.03 172.19 1.77 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.074 2.274 . . . . 1.02 114.518 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.43 -25.68 48.39 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.606 2.871 . . . . 1.48 111.906 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 62.6 t -51.33 141.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.225 1.01 . . . . 0.75 110.851 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -152.25 92.75 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.83 1.652 . . . . 2.0899999999999999 107.432 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.77 21.17 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.031 0.824 . . . . 0.63 111.867 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.41 131.91 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.294 -1.002 . . . . 1.45 108.294 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 33.7 mm -102.2 147.59 8.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.632 1.573 . . . . 0.81999999999999995 107.954 165.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.64 118.51 24.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.57 -2.011 . . . . 1.6299999999999999 105.57 162.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 31' ' ' VAL . 5.7 t80 -127.95 116.53 20.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.876 -1.898 . . . . 3.2799999999999998 105.876 -168.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 163.88 39.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.274 0.559 . . . . 3.6499999999999999 111.971 -170.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 -177.84 6.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.69 -1.596 . . . . 3.8300000000000001 106.69 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -77.73 -63.22 1.43 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.861 -0.792 . . . . 6.4900000000000002 108.861 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.33 165.62 14.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.828 1.251 . . . . 4.9400000000000004 109.569 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -81.0 -0.78 41.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.765 0.654 . . . . 2.6299999999999999 112.765 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -161.47 83.04 0.61 Allowed 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 121.723 -0.611 . . . . 4.0899999999999999 110.225 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.18 169.74 42.43 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 105.827 -2.909 . . . . 1.23 105.827 171.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.42 114.82 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.587 2.858 . . . . 1.5700000000000001 112.584 -165.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 19.5 t -84.32 142.65 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.82 -0.627 . . . . 0.94999999999999996 109.951 -168.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -95.66 122.46 38.45 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.736 -0.839 . . . . 2.6400000000000001 108.736 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 20' ' ' PHE . 16.1 t -121.72 97.39 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.705 1.602 . . . . 1.0700000000000001 107.727 -169.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -113.76 148.81 35.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.273 -0.64 . . . . 0.82999999999999996 109.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.87 160.46 34.06 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 120.991 -1.068 . . . . 0.73999999999999999 110.964 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.2 p -129.77 113.51 14.8 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 105.486 -2.042 . . . . 1.8200000000000001 105.486 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.74 142.1 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.844 -1.91 . . . . 1.1000000000000001 105.844 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.56 153.49 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.875 -0.516 . . . . 5.4900000000000002 110.368 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.94 21.01 51.98 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.914 1.245 . . . . 0.64000000000000001 112.401 -171.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.14 -168.16 0.37 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.335 1.064 . . . . 0.87 108.753 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.0 m -135.93 166.32 23.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 103.814 -2.662 . . . . 3.46 103.814 159.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.24 175.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.763 1.625 . . . . 2.8999999999999999 114.649 -166.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.04 -170.66 54.72 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 114.975 -1.011 . . . . 1.1499999999999999 112.284 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.37 152.52 27.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.379 1.071 . . . . 2.3300000000000001 110.528 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -145.51 112.83 6.18 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.835 1.254 . . . . 0.52000000000000002 109.277 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.26 150.37 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.835 -0.906 . . . . 0.5 110.835 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE1' HD11 ' A' ' 117' ' ' LEU . 39.1 t80 -142.95 94.49 2.64 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.917 -1.512 . . . . 2.7400000000000002 106.917 -171.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -131.98 162.72 30.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.533 -1.284 . . . . 0.92000000000000004 107.533 -164.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 m -134.97 115.26 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.721 0.691 . . . . 2.4900000000000002 109.624 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -104.69 150.77 24.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.894 1.277 . . . . 1.1599999999999999 110.561 -164.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.78 66.83 0.37 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.071 1.748 . . . . 5.0700000000000003 112.414 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 106.577 -1.638 . . . . 3.3399999999999999 106.577 171.91 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.061 0 CA-C-O 120.027 -0.035 . . . . 3.3399999999999999 111.02 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.96 -178.35 44.76 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.389 -1.084 . . . . 2.1899999999999999 110.389 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.73 179.35 5.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.085 3.857 . . . . 1.6799999999999999 113.331 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -62.17 57.57 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.189 2.596 . . . . 2.0699999999999998 113.299 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.539 ' CD2' HG13 ' A' ' 81' ' ' VAL . 6.0 t80 35.88 77.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.341 1.056 . . . . 2.9399999999999999 111.016 -160.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -93.74 106.02 19.45 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 108.457 -0.942 . . . . 2.75 108.457 171.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.69 -33.37 10.5 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.286 1.99 . . . . 1.5 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -155.33 -66.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.537 -0.912 . . . . 3.6099999999999999 108.537 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.6 m -154.4 74.71 0.97 Allowed 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.63 -0.669 . . . . 1.8700000000000001 110.36 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -78.31 161.29 27.33 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.699 -0.852 . . . . 5.1799999999999997 108.699 166.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -107.62 148.53 29.21 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.452 1.101 . . . . 4.8099999999999996 108.326 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.442 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 56.8 t60 -78.18 159.64 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.767 -0.373 . . . . 1.1699999999999999 110.691 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.52 160.72 33.02 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 107.448 -2.261 . . . . 2.3300000000000001 107.448 161.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.33 -176.86 29.11 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 117.715 0.758 . . . . 1.99 111.342 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.49 -29.2 37.7 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.104 1.869 . . . . 2.9300000000000002 110.43 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -64.81 -43.45 93.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.329 0.651 . . . . 5.4900000000000002 111.202 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -63.48 147.77 50.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.299 1.047 . . . . 2.5899999999999999 112.183 -168.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.27 -50.78 71.82 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.819 -1.082 . . . . 4.2000000000000002 108.242 167.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -78.02 164.98 24.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.155 0.982 . . . . 3.8500000000000001 110.574 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.37 147.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 C-N-CA 129.255 3.022 . . . . 3.3100000000000001 108.751 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 31.4 m80 -65.44 152.51 43.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 119.504 -0.878 . . . . 0.96999999999999997 109.986 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.539 HG13 ' CD2' ' A' ' 64' ' ' PHE . 7.7 p -67.12 -5.98 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 O-C-N 121.894 -0.504 . . . . 1.8400000000000001 112.307 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.2 50.96 0.77 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.058 -1.026 . . . . 1.1799999999999999 111.772 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.25 123.06 1.88 Allowed 'General case' 0 C--O 1.227 -0.087 0 O-C-N 120.811 -1.406 . . . . 2.0299999999999998 110.089 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.13 -52.45 4.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.652 -0.499 . . . . 2.0499999999999998 109.652 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.39 -101.41 0.19 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.068 -1.063 . . . . 0.82999999999999996 111.99 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -155.11 166.03 34.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.084 1.353 . . . . 1.9299999999999999 111.327 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.9 179.71 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.308 1.843 . . . . 0.67000000000000004 106.165 162.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 t -134.32 145.17 48.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.568 -1.271 . . . . 2.2200000000000002 107.568 163.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.22 143.18 35.58 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.601 0.563 . . . . 0.72999999999999998 109.618 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.76 -69.64 0.23 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.474 0.709 . . . . 3.3300000000000001 109.918 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -168.35 -55.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.789 2.036 . . . . 4.1299999999999999 108.53 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.21 29.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.922 1.344 . . . . 4.8200000000000003 110.244 -170.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.13 17.61 72.14 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.59 1.091 . . . . 1.0800000000000001 112.386 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.4 152.33 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.461 -1.311 . . . . 1.0 107.461 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.26 167.22 22.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.495 -1.298 . . . . 0.68000000000000005 107.495 161.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.05 148.95 51.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.668 -2.345 . . . . 2.8399999999999999 104.668 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.6 136.48 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 107.614 -1.254 . . . . 1.54 107.614 164.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.0 m -156.95 70.4 0.63 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.545 1.538 . . . . 0.96999999999999997 108.168 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.58 155.3 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.942 0.897 . . . . 1.8700000000000001 109.088 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.6 134.71 29.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.393 -0.595 . . . . 2.71 109.393 145.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -128.64 165.31 21.07 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.332 1.053 . . . . 2.8399999999999999 109.539 170.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 p -104.08 8.0 36.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.078 1.751 . . . . 1.72 112.287 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.4 t -90.53 -49.15 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.368 -0.975 . . . . 1.49 108.368 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.259 0.4 OUTLIER -84.19 175.82 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.05 0.452 . . . . 1.22 111.574 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -160.97 169.12 23.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.325 1.05 . . . . 2.98 109.25 -166.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.7 mp -85.67 -25.79 26.35 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.483 1.113 . . . . 2.8999999999999999 111.907 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.326 -0.449 0 C-N-CA 125.951 1.7 . . . . 4.0599999999999996 107.47 171.667 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.0 p . . . . . 0 N--CA 1.445 -0.685 0 CA-C-O 122.082 0.944 . . . . 1.48 113.409 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 pp -91.02 -6.3 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.018 -1.446 . . . . 1.55 109.825 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 tp -43.86 123.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.897 0.879 . . . . 1.6100000000000001 109.465 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.9 32.53 84.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.926 -0.654 . . . . 1.49 113.093 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -98.32 174.96 6.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.282 -1.007 . . . . 5.5099999999999998 108.282 152.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 m -105.58 117.16 33.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.778 1.231 . . . . 1.05 108.283 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.419 HD11 ' CE1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -61.3 150.62 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.008 -0.738 . . . . 2.3999999999999999 109.008 171.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -140.7 134.6 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.918 1.287 . . . . 0.46000000000000002 107.702 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.33 128.37 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.865 -1.531 . . . . 1.71 106.865 164.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -98.32 160.02 14.56 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 115.182 1.549 . . . . 0.48999999999999999 115.182 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.16 -72.15 0.06 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.138 1.775 . . . . 4.2800000000000002 111.787 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -101.21 -177.71 3.53 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.441 0.696 . . . . 2.9700000000000002 110.038 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.89 151.35 18.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.043 -0.725 . . . . 0.75 109.043 165.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.14 176.33 4.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.321 -0.992 . . . . 1.9199999999999999 108.321 159.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.65 -28.38 66.83 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 3.98 114.351 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 81.55 -7.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.244 2.618 . . . . 2.3100000000000001 113.475 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.12 31.64 11.7 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.82 1.191 . . . . 2.6600000000000001 110.477 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -35.36 32.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 128.224 2.61 . . . . 6.9699999999999998 108.229 168.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.13 41.88 30.6 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.655 1.122 . . . . 3.1699999999999999 111.253 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.64 35.64 1.61 Allowed Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.538 1.169 . . . . 3.75 114.299 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.6 p30 177.64 -89.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.455 1.902 . . . . 3.21 108.703 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -170.38 -57.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.296 1.838 . . . . 2.9399999999999999 107.137 -173.234 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -56.42 -34.37 66.71 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.745 1.218 . . . . 3.25 110.883 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.1 m -41.84 -68.77 0.16 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.898 1.279 . . . . 1.8999999999999999 112.087 167.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -43.78 69.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.3 -0.875 . . . . 1.6799999999999999 110.059 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 132' ' ' GLU . 20.9 ttmt -57.81 -42.86 85.12 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.104 0.962 . . . . 2.5899999999999999 111.647 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.255 4.2 p -132.53 -52.28 0.94 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.676 0.621 . . . . 1.54 112.676 178.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.442 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 154.52 -25.13 0.66 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 124.092 0.854 . . . . 0.91000000000000003 112.171 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t30 41.55 56.2 3.32 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.92 1.688 . . . . 2.4700000000000002 111.06 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 -50.55 18.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.293 -0.963 . . . . 1.49 108.992 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 132.11 -151.95 20.02 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 107.427 -2.269 . . . . 1.54 107.427 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 t -67.76 -179.71 1.21 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.326 1.06 . . . . 3.1699999999999999 111.98 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -105.44 152.23 23.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.611 2.364 . . . . 3.2400000000000002 111.405 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.5 -85.27 0.66 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.371 -1.344 . . . . 0.75 107.371 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.497 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -94.17 155.23 17.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.173 -1.047 . . . . 1.01 108.173 164.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 18.5 p -146.93 168.09 22.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.107 -1.406 . . . . 2.02 107.776 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.99 140.93 4.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.126 -1.19 . . . . 0.67000000000000004 110.126 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.93 137.98 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.897 0.879 . . . . 0.84999999999999998 108.96 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.0 tt -101.43 125.43 55.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.205 0.526 . . . . 0.91000000000000003 111.231 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.21 8.87 0.42 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.539 1.066 . . . . 0.62 114.306 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.11 55.39 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 120.116 1.958 . . . . 1.05 110.19 -161.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -158.87 176.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.563 1.145 . . . . 1.5800000000000001 109.412 168.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 102.844 -3.021 . . . . 4.9800000000000004 102.844 150.895 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.8 pttm . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 109.505 -0.554 . . . . 2.6899999999999999 109.505 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.5 153.41 48.78 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.909 2.083 . . . . 0.68000000000000005 108.148 167.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -118.87 143.12 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.412 -1.329 . . . . 0.75 107.412 170.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.95 99.83 6.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.141 1.376 . . . . 0.48999999999999999 108.996 156.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 113.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.573 -1.269 . . . . 0.56999999999999995 107.573 159.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.71 125.12 49.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.359 1.064 . . . . 1.01 109.056 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -132.23 -53.2 0.96 Allowed 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.409 0.684 . . . . 3.9500000000000002 110.215 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.43 -124.14 13.86 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.036 0.827 . . . . 0.93000000000000005 113.832 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -114.12 -52.47 2.73 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.867 1.267 . . . . 3.7999999999999998 108.859 -158.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.05 160.52 26.45 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 110.295 -1.122 . . . . 0.90000000000000002 110.295 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.52 40.59 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.72 2.946 . . . . 1.01 112.711 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.04 156.18 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.807 1.643 . . . . 0.79000000000000004 108.934 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -153.63 93.0 1.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.523 -0.917 . . . . 2.6200000000000001 108.523 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.91 162.53 14.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 124.03 0.824 . . . . 0.60999999999999999 111.462 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.8 mt -130.95 120.56 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 106.532 -1.655 . . . . 1.28 106.532 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.4 mm -84.23 146.37 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.319 1.048 . . . . 0.75 108.221 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -124.85 101.18 6.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.244 -1.761 . . . . 2.4700000000000002 106.244 166.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -79.66 91.09 5.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.245 -2.132 . . . . 2.2999999999999998 105.245 166.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.39 140.84 31.28 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.824 -1.547 . . . . 3.6600000000000001 106.824 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -157.96 151.36 23.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.759 -1.941 . . . . 3.8999999999999999 105.759 167.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.91 -65.31 1.18 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.072 0.851 . . . . 6.9400000000000004 108.769 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -78.97 119.23 21.83 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.583 -0.895 . . . . 5.1799999999999997 108.583 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 m -35.4 -64.11 0.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.403 2.681 . . . . 2.6099999999999999 113.815 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.0 37.21 0.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.582 -0.699 . . . . 3.6299999999999999 111.114 177.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.67 167.34 22.17 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.322 0.963 . . . . 1.4399999999999999 111.291 -174.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.7 139.21 51.92 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.458 2.772 . . . . 1.52 112.019 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -89.32 126.71 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.305 -0.998 . . . . 0.93000000000000005 108.305 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -83.6 98.86 9.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.436 -1.69 . . . . 2.8900000000000001 106.436 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' A' ' 20' ' ' PHE . 41.9 t -97.25 85.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.746 1.618 . . . . 1.3400000000000001 107.387 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -98.61 162.13 13.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.204 -0.665 . . . . 1.1200000000000001 109.204 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.41 153.57 23.15 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.834 -0.906 . . . . 0.67000000000000004 110.834 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 p -121.98 79.43 1.58 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.245 1.418 . . . . 2.4500000000000002 107.488 -171.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -96.99 125.2 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.69 1.196 . . . . 0.94999999999999996 108.934 -170.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.73 158.58 43.77 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.711 -0.477 . . . . 5.0599999999999996 109.711 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.52 19.52 48.53 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.675 1.607 . . . . 0.69999999999999996 113.34 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.83 170.28 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.648 -0.913 . . . . 0.59999999999999998 108.962 170.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.1 163.39 27.98 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.711 -1.218 . . . . 1.6899999999999999 107.711 149.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -61.63 175.91 0.57 Allowed 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.382 -0.824 . . . . 3.3500000000000001 111.03 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.62 -165.54 52.2 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.272 0.939 . . . . 0.46000000000000002 112.607 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.52 141.99 58.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.802 1.241 . . . . 1.9399999999999999 113.045 -174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -143.12 118.38 10.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.756 1.622 . . . . 0.45000000000000001 108.592 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.46 149.3 2.14 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.751 -0.939 . . . . 0.35999999999999999 110.751 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -139.91 94.16 2.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.327 -1.731 . . . . 3.0699999999999998 106.327 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.566 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 26.5 m80 -138.86 153.49 48.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.723 -1.584 . . . . 0.83999999999999997 106.723 -166.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.24 121.76 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.637 0.732 . . . . 1.5600000000000001 109.792 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.438 ' CD2' HG21 ' A' ' 118' ' ' VAL . 21.3 m-70 -96.19 144.2 26.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.154 2.182 . . . . 0.84999999999999998 109.548 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -33.97 -90.87 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.539 2.736 . . . . 5.3799999999999999 112.671 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HG2' ' HB2' ' A' ' 60' ' ' ALA . 5.1 mt-10 . . . . . 0 C--N 1.331 -0.198 0 N-CA-C 115.103 1.52 . . . . 3.6899999999999999 115.103 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 114.645 1.35 . . . . 2.7000000000000002 114.645 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.82 -167.58 30.52 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.887 -1.685 . . . . 1.27 108.887 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 178.75 4.34 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.315 3.343 . . . . 1.1599999999999999 113.142 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -47.61 123.48 5.89 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.338 1.455 . . . . 1.25 110.182 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -45.86 122.92 4.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.724 0.809 . . . . 2.46 111.027 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -155.4 152.84 25.56 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 106.679 -1.601 . . . . 2.54 106.679 171.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.22 -20.33 24.81 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.228 1.952 . . . . 1.3200000000000001 113.806 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.81 -70.08 0.11 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.463 1.029 . . . . 3.0 111.195 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.9 t -157.43 69.53 0.56 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.254 0.622 . . . . 2.1200000000000001 109.488 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -79.21 175.04 10.95 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.379 0.609 . . . . 4.7800000000000002 110.374 168.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -118.55 161.24 20.36 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 106.33 -1.73 . . . . 3.21 106.33 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -85.9 165.21 16.97 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.639 0.654 . . . . 1.0600000000000001 109.382 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.53 -65.84 0.02 OUTLIER Glycine 0 C--O 1.223 -0.591 0 N-CA-C 108.201 -1.959 . . . . 2.9199999999999999 108.201 169.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.15 -171.27 27.87 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.604 1.097 . . . . 1.45 111.978 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.14 -46.85 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.743 2.295 . . . . 1.6100000000000001 109.796 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.66 -36.41 82.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.611 0.764 . . . . 4.2800000000000002 112.017 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.1 176.95 0.66 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.277 1.031 . . . . 1.8 112.042 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.69 -48.3 11.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.052 1.341 . . . . 4.6100000000000003 109.71 165.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -98.4 156.58 16.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.311 1.044 . . . . 3.5099999999999998 112.68 -166.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.69 150.0 0.64 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.768 1.627 . . . . 4.0599999999999996 110.0 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 44.5 m80 -55.84 136.6 51.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 104.979 -2.23 . . . . 0.70999999999999996 104.979 156.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -58.98 -23.17 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.185 -0.606 . . . . 1.47 109.947 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.87 39.24 2.8 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.372 1.463 . . . . 0.72999999999999998 115.083 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -102.9 136.63 42.37 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.772 1.786 . . . . 1.9099999999999999 106.831 153.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.6 -52.74 3.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.469 -0.938 . . . . 1.8600000000000001 108.469 147.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.38 -106.72 0.29 Allowed Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.964 -0.854 . . . . 0.65000000000000002 110.964 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.69 165.66 31.69 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.261 1.425 . . . . 1.6599999999999999 109.524 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.38 175.38 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 106.174 -1.788 . . . . 0.5 106.174 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -120.67 141.72 50.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.769 -1.197 . . . . 2.0699999999999998 107.769 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.3 138.84 34.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.398 0.679 . . . . 0.63 109.979 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.45 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.571 0.544 . . . . 3.3599999999999999 110.134 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -53.79 1.52 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.928 0.891 . . . . 4.6299999999999999 111.52 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.05 26.61 2.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 123.368 1.556 . . . . 2.7999999999999998 110.78 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.8 17.9 67.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 114.524 -1.217 . . . . 0.59999999999999998 111.596 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.6 t -89.02 122.63 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 125.378 1.471 . . . . 0.76000000000000001 107.306 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.16 175.99 5.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.894 1.277 . . . . 0.83999999999999997 107.662 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -133.67 148.21 51.48 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 103.62 -2.733 . . . . 2.9100000000000001 103.62 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.01 139.79 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.874 -1.528 . . . . 1.76 106.874 160.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.1 m -158.16 59.69 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.303 1.841 . . . . 1.3400000000000001 108.078 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.08 151.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 107.638 -1.245 . . . . 1.52 107.638 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -124.99 90.06 3.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.853 -0.795 . . . . 3.5899999999999999 108.853 166.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.63 152.89 31.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.461 0.573 . . . . 2.7000000000000002 110.637 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -132.07 41.9 3.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.779 1.232 . . . . 1.6299999999999999 110.295 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -127.57 -54.33 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.596 1.158 . . . . 1.3600000000000001 108.197 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -86.42 173.02 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.224 0.535 . . . . 1.3899999999999999 110.566 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.2 m -140.86 173.95 10.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.324 1.85 . . . . 1.96 106.835 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.6 -3.37 46.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.137 0.421 . . . . 3.7400000000000002 112.137 170.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 106.881 -1.526 . . . . 3.48 106.881 171.734 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 108.738 -0.838 . . . . 1.5 108.738 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.27 -12.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.534 -0.466 . . . . 1.7 110.794 -169.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.9 tp -16.85 119.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 127.877 2.471 . . . . 1.8100000000000001 113.353 164.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.59 -17.39 59.18 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.181 -1.344 . . . . 1.54 113.386 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.3 169.07 18.25 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.951 1.875 . . . . 4.0199999999999996 111.735 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.4 m -96.17 110.38 22.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.213 1.005 . . . . 0.93999999999999995 109.472 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.29 144.28 54.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.222 0.919 . . . . 1.6799999999999999 108.705 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.438 HG21 ' CD2' ' A' ' 48' ' ' HIS . 98.7 t -130.79 136.41 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.87 1.268 . . . . 0.53000000000000003 109.087 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.3 m -103.39 126.9 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.794 -1.558 . . . . 1.53 106.794 163.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.488 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 61.6 m-70 -100.97 161.0 13.9 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 116.358 1.985 . . . . 0.38 116.358 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -39.61 -70.33 0.11 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.949 2.9 . . . . 3.0 112.273 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -112.72 -172.49 2.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.426 1.012 . . . . 2.7200000000000002 108.848 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.12 160.59 9.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.917 -0.771 . . . . 0.57999999999999996 108.917 162.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.3 167.11 21.86 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.721 0.772 . . . . 1.8899999999999999 109.808 158.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.7 -6.98 57.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.463 1.905 . . . . 3.4100000000000001 111.282 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 36.06 20.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.886 2.074 . . . . 1.6399999999999999 111.068 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.49 27.43 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.44 -0.788 . . . . 1.9199999999999999 112.65 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -111.67 -34.03 6.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.063 1.345 . . . . 5.9500000000000002 109.623 -171.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -48.39 126.76 16.38 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.247 -1.141 . . . . 2.7200000000000002 110.247 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.62 64.43 2.94 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.341 0.972 . . . . 2.4900000000000002 111.69 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -163.58 117.44 1.55 Allowed 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 106.619 -1.623 . . . . 2.6200000000000001 106.619 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.15 -54.53 0.61 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.814 1.646 . . . . 3.4399999999999999 113.786 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -27.54 -49.64 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.791 2.836 . . . . 3.5699999999999998 113.983 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -44.47 -60.22 2.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.399 1.88 . . . . 2.2200000000000002 110.435 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.7 p -72.99 -42.51 63.19 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.091 -0.381 . . . . 1.29 110.579 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -51.99 -53.69 38.57 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.353 1.061 . . . . 3.6899999999999999 110.862 -172.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.451 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.3 p -123.39 -42.31 2.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.27 0.228 . . . . 1.48 111.567 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 141.19 -27.51 2.41 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.447 -1.061 . . . . 0.98999999999999999 110.447 -169.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.3 t30 55.23 54.41 8.78 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 122.665 1.222 . . . . 1.6799999999999999 110.463 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -64.69 -27.83 69.19 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.812 1.245 . . . . 0.93000000000000005 112.812 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.18 179.42 52.52 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 108.514 -1.834 . . . . 1.04 108.514 -160.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.4 m -59.21 148.94 29.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.286 1.217 . . . . 1.27 114.286 -164.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -51.38 126.09 16.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.652 2.381 . . . . 3.0299999999999998 109.346 166.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.7 mt -109.26 -71.16 0.77 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-N 120.098 1.317 . . . . 0.5 108.669 170.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -100.89 154.52 18.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.565 -0.532 . . . . 0.83999999999999997 109.565 -175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.81 160.16 16.76 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.676 0.61 . . . . 1.45 111.391 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.89 144.84 4.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 128.382 2.896 . . . . 1.04 105.954 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.23 143.36 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 118.023 0.911 . . . . 0.81999999999999995 110.671 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 tt -92.92 139.83 17.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.555 0.742 . . . . 0.73999999999999999 112.71 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.06 -4.83 1.2 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.192 0.901 . . . . 0.60999999999999999 114.777 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -90.55 58.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.715 1.258 . . . . 1.1799999999999999 109.101 -156.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.6 143.69 30.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.518 -0.739 . . . . 1.8300000000000001 112.263 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 103.511 -2.774 . . . . 6.5999999999999996 103.511 141.554 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp . . . . . 0 N--CA 1.441 -0.895 0 N-CA-C 107.858 -1.164 . . . . 3.52 107.858 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.64 138.39 34.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.338 -0.986 . . . . 0.78000000000000003 108.338 163.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 t -99.79 136.27 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 106.885 -1.524 . . . . 1.22 106.885 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -117.88 94.5 4.54 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 124.329 1.052 . . . . 0.47999999999999998 108.236 158.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -65.84 102.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.45 -1.315 . . . . 1.01 107.45 165.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.3 134.68 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.037 0.535 . . . . 0.93999999999999995 109.889 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -149.65 -50.31 0.14 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.657 0.383 . . . . 4.1299999999999999 111.618 166.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.43 -123.8 16.57 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.72 1.152 . . . . 1.0700000000000001 112.971 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.12 -51.77 2.92 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.47 1.108 . . . . 3.9900000000000002 108.621 -159.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.22 172.75 16.39 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.663 1.601 . . . . 0.91000000000000003 111.851 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 27.69 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.433 2.755 . . . . 1.05 112.674 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 15' ' ' GLN . 25.4 t -82.1 165.38 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 1.05 109.11 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.401 ' N ' HG12 ' A' ' 14' ' ' VAL . 6.3 pt20 -156.33 139.1 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.937 1.695 . . . . 3.1600000000000001 106.729 168.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.77 43.39 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.21 -0.995 . . . . 0.78000000000000003 111.651 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.21 126.45 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.071 -1.455 . . . . 1.98 107.071 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.1 mm -92.51 129.24 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.269 -1.382 . . . . 0.90000000000000002 107.269 165.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.75 108.7 21.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.875 -1.528 . . . . 2.1699999999999999 106.875 159.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CZ ' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -87.1 131.97 33.98 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.705 -1.961 . . . . 2.3599999999999999 105.705 162.206 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.39 165.16 36.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.226 0.921 . . . . 3.4700000000000002 111.49 158.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -155.26 145.46 21.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 104.714 -2.328 . . . . 3.0899999999999999 104.714 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -81.46 -36.91 28.78 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.875 -1.157 . . . . 7.4500000000000002 107.875 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -77.81 -167.4 0.97 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.721 2.808 . . . . 4.6299999999999999 110.037 171.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -139.83 26.56 2.27 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.877 1.271 . . . . 2.3999999999999999 109.425 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 179.03 35.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.485 1.114 . . . . 5.7199999999999998 110.202 -152.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.44 -162.27 9.73 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.628 -1.389 . . . . 0.97999999999999998 109.628 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.35 144.95 29.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.294 2.663 . . . . 1.1200000000000001 110.104 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -88.11 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.523 -0.917 . . . . 1.02 108.523 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -111.08 124.01 51.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.568 -1.641 . . . . 2.8199999999999998 106.568 165.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -120.57 124.51 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.95 -1.5 . . . . 1.3600000000000001 106.95 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -140.64 138.0 34.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.609 -0.515 . . . . 1.25 109.609 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.67 139.4 4.66 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.525 -1.43 . . . . 0.98999999999999999 109.525 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.6 m -119.17 91.16 3.49 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.34 1.056 . . . . 2.4100000000000001 108.987 -167.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.2 mm -87.47 152.74 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.091 2.156 . . . . 1.3799999999999999 109.332 -165.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.89 146.69 33.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.329 0.651 . . . . 4.1699999999999999 109.66 -172.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.65 18.99 42.47 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.008 1.289 . . . . 0.60999999999999999 112.703 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 162.58 28.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.566 -0.902 . . . . 0.89000000000000001 108.566 168.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.48 163.84 27.29 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.991 -1.114 . . . . 1.9199999999999999 107.991 155.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.53 176.39 0.5 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.435 -0.791 . . . . 2.3599999999999999 111.133 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.5 -165.95 46.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.659 0.647 . . . . 0.46999999999999997 113.648 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.87 147.94 52.59 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.649 0.78 . . . . 2.3700000000000001 112.023 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -142.52 119.91 11.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.859 1.664 . . . . 0.63 108.059 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.99 148.0 6.8 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.719 -1.352 . . . . 0.44 109.719 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.437 ' CZ ' HG11 ' A' ' 97' ' ' VAL . 24.1 t80 -141.72 95.79 2.87 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.488 -1.301 . . . . 2.46 107.488 -172.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -133.67 161.75 33.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.624 -1.25 . . . . 0.62 107.624 -163.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.83 137.72 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 108.932 -0.766 . . . . 2.0099999999999998 108.932 165.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.415 ' CD2' HG21 ' A' ' 118' ' ' VAL . 22.8 m-70 -98.8 151.11 21.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.579 1.151 . . . . 0.84999999999999998 109.422 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -36.23 -59.62 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.371 1.868 . . . . 4.7699999999999996 112.37 -174.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 CA--C 1.53 0.198 0 C-N-CA 130.041 3.337 . . . . 3.3500000000000001 116.706 171.387 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.279 0 N-CA-C 109.527 -0.546 . . . . 2.04 109.527 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.17 -85.17 0.84 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.079 -1.209 . . . . 1.22 110.079 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.61 175.4 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.309 2.673 . . . . 1.0 116.118 -161.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -83.55 57.22 3.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 113.695 -1.593 . . . . 2.04 110.996 -170.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 59.79 75.44 0.4 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.345 0.658 . . . . 1.9199999999999999 109.353 -172.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.21 87.91 0.52 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 3.29 108.939 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -62.81 -43.67 19.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.246 1.297 . . . . 1.6499999999999999 110.136 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.49 -93.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.783 -0.821 . . . . 2.4900000000000002 108.783 165.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.1 p -137.37 60.7 1.64 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.794 0.838 . . . . 3.2599999999999998 110.399 -161.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -82.16 161.64 22.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.769 -1.196 . . . . 4.5599999999999996 107.769 159.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -128.94 175.28 8.78 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.728 -1.582 . . . . 4.3499999999999996 106.728 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -106.08 132.6 51.96 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.251 -1.018 . . . . 1.3500000000000001 108.251 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -124.06 -48.88 0.22 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.437 -1.465 . . . . 3.46 109.437 173.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.54 176.14 21.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.31 1.91 . . . . 1.6699999999999999 109.029 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -57.86 -43.71 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.42 2.08 . . . . 2.0600000000000001 110.614 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -70.47 -47.47 60.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.846 1.658 . . . . 4.2400000000000002 111.817 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.44 152.46 34.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.464 0.705 . . . . 1.78 111.573 -168.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -50.99 -51.43 52.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.582 1.553 . . . . 3.9399999999999999 111.837 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.94 146.42 26.16 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 122.924 1.345 . . . . 3.4500000000000002 111.444 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -170.84 134.69 1.02 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.931 -1.486 . . . . 4.0 107.002 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.2 m80 -51.46 140.74 17.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.219 -1.4 . . . . 0.55000000000000004 107.219 158.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.69 -14.1 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.988 -0.551 . . . . 1.1599999999999999 110.291 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.22 35.22 4.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.071 0.843 . . . . 0.68000000000000005 115.143 165.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -94.89 117.85 30.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.818 1.809 . . . . 1.9299999999999999 106.619 158.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.39 -61.35 2.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.11 -1.441 . . . . 2.7400000000000002 107.11 158.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.41 -106.42 0.25 Allowed Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.387 -0.685 . . . . 0.80000000000000004 111.387 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -152.45 169.84 21.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.493 1.517 . . . . 1.6799999999999999 109.427 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.03 169.99 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.131 -1.433 . . . . 0.45000000000000001 107.131 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.4 m -122.7 120.27 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.618 -1.253 . . . . 2.2599999999999998 107.618 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 141.85 35.85 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.109 0.564 . . . . 0.62 109.888 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.51 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.309 2.244 . . . . 3.9300000000000002 110.459 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -172.88 -45.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.205 1.402 . . . . 3.79 108.855 -161.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -77.5 8.43 4.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.234 1.016 . . . . 2.73 110.929 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.46 19.44 78.13 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.123 -0.985 . . . . 0.79000000000000004 110.728 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.6 t -86.39 137.64 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.087 . . . . 0.67000000000000004 108.064 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.12 167.25 21.31 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.931 -1.507 . . . . 0.78000000000000003 106.931 167.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -148.28 138.41 22.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.176 -1.416 . . . . 3.8700000000000001 107.176 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.437 HG11 ' CZ ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -116.35 56.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 124.331 1.019 . . . . 1.53 111.349 -173.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.8 m -70.3 88.51 0.64 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.981 0.512 . . . . 1.1599999999999999 109.962 166.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.8 mm -127.56 160.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.104 0.961 . . . . 2.1400000000000001 109.611 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -146.66 76.41 1.43 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.397 0.679 . . . . 2.3700000000000001 111.177 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.1 143.73 35.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.935 0.398 . . . . 2.1299999999999999 110.156 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -106.35 -4.21 20.25 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.033 1.733 . . . . 1.55 112.843 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.06 -46.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.701 1.2 . . . . 1.1200000000000001 107.963 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.95 168.82 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.02 0.438 . . . . 1.27 110.507 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 m -146.2 167.52 23.26 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.803 1.641 . . . . 1.78 106.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 pp -99.01 -0.35 42.19 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.597 0.592 . . . . 2.3199999999999998 112.597 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.454 -0.266 0 C-N-CA 125.189 1.395 . . . . 3.1899999999999999 108.055 177.107 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.2 p . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 115.276 1.584 . . . . 1.25 115.276 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.462 HD11 ' CZ ' ' A' ' 20' ' ' PHE 0.271 2.0 pp -95.34 -4.53 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 113.335 -1.757 . . . . 1.5600000000000001 111.207 174.511 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tp -39.08 131.42 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.892 0.877 . . . . 1.5600000000000001 109.824 162.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.63 49.54 72.89 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.232 -0.747 . . . . 1.9399999999999999 111.232 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -137.1 163.83 29.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.58 -1.637 . . . . 3.9700000000000002 106.58 164.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 m -90.61 111.84 23.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 118.691 -0.671 . . . . 0.97999999999999998 110.121 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.36 143.16 57.32 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.556 -0.905 . . . . 1.72 108.556 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 48' ' ' HIS . 76.6 t -134.67 139.58 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.337 1.855 . . . . 0.46000000000000002 108.294 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -110.96 125.11 68.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.253 -1.017 . . . . 1.5900000000000001 108.253 162.631 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -94.45 163.46 13.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 115.355 1.613 . . . . 0.44 115.355 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.78 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.201 1.4 . . . . 3.5699999999999998 112.357 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -92.54 -177.85 4.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.775 0.716 . . . . 3.0099999999999998 110.601 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 151.6 16.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.447 -0.946 . . . . 0.56999999999999995 108.447 157.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.78 162.32 29.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.99 -0.744 . . . . 2.0600000000000001 108.99 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.65 -7.2 58.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.43 1.092 . . . . 3.3999999999999999 112.043 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 49.6 40.28 19.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.648 1.179 . . . . 1.8700000000000001 109.307 -168.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 51.78 34.12 36.37 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.453 -0.794 . . . . 2.0600000000000001 113.396 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -130.21 49.99 2.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.492 1.146 . . . . 4.8799999999999999 108.982 -177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.76 132.65 8.78 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.849 -1.7 . . . . 2.4300000000000002 108.849 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.59 -37.38 67.41 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.713 -0.955 . . . . 2.9300000000000002 110.713 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -50.45 103.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.694 1.198 . . . . 2.0499999999999998 109.593 159.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -35.19 10.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.246 1.018 . . . . 3.4300000000000002 111.948 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -28.08 -44.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.157 2.583 . . . . 2.96 112.671 167.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.8 p -49.62 -73.16 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 2.2000000000000002 110.292 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.6 p -61.66 -40.73 95.95 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.298 -0.876 . . . . 1.25 110.818 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.72 -53.27 59.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.392 1.477 . . . . 3.1000000000000001 110.783 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.33 1.3 p -126.07 -45.66 1.7 Allowed 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.96 0.726 . . . . 1.1599999999999999 112.96 172.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.72 -25.43 0.74 Allowed Glycine 0 N--CA 1.463 0.455 0 CA-C-N 118.965 0.802 . . . . 0.93999999999999995 112.029 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 t30 47.51 52.34 12.54 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.412 1.485 . . . . 1.75 110.987 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.37 -47.95 31.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.77 -1.196 . . . . 1.1200000000000001 107.77 162.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.22 -146.06 16.8 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 108.271 -1.932 . . . . 1.23 108.271 164.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.1 m -58.41 156.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.861 1.264 . . . . 1.49 112.77 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -60.73 141.9 56.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.109 -1.405 . . . . 2.54 109.608 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.3 mt -107.73 -71.52 0.75 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 105.992 -1.855 . . . . 0.83999999999999997 105.992 156.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.434 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -97.93 151.79 19.91 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.439 -0.949 . . . . 1.04 108.439 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 67.0 m -139.43 156.69 46.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.604 -1.999 . . . . 2.0 105.604 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.16 130.69 1.79 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.809 -0.916 . . . . 0.72999999999999998 110.809 163.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.55 130.22 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.405 0.682 . . . . 0.96999999999999997 109.578 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 tt -98.76 135.9 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.311 -0.404 . . . . 0.78000000000000003 111.592 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.68 -4.9 0.94 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.11 0.804 . . . . 0.65000000000000002 115.11 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -89.04 58.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.888 1.344 . . . . 1.24 109.559 -159.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.96 151.54 23.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.744 -0.662 . . . . 2.1099999999999999 109.553 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 . . . . . 0 C--O 1.256 1.425 0 N-CA-C 104.48 -2.415 . . . . 6.9500000000000002 104.48 166.005 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.124 -0.324 . . . . 3.0 110.124 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.81 141.21 29.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.31 1.044 . . . . 0.83999999999999997 108.885 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 t -102.61 144.37 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.437 -0.949 . . . . 0.90000000000000002 108.437 162.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.02 100.26 6.65 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 108.615 -0.883 . . . . 0.75 108.615 153.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 101.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.971 -1.122 . . . . 0.81999999999999995 107.971 164.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.44 130.84 36.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.288 -0.634 . . . . 0.90000000000000002 109.288 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -134.58 -57.37 0.83 Allowed 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.747 -0.835 . . . . 4.46 108.747 165.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.83 -143.07 48.42 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.263 0.935 . . . . 1.6200000000000001 113.518 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.51 -46.69 5.65 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.841 1.656 . . . . 4.0300000000000002 108.495 -165.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.45 158.69 22.21 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 109.968 -1.253 . . . . 1.3400000000000001 109.968 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.38 46.77 2.21 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.513 2.808 . . . . 1.0900000000000001 111.83 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.42 ' CB ' ' HB2' ' A' ' 145' ' ' ALA . 38.3 t -100.2 159.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.613 1.565 . . . . 0.90000000000000002 109.524 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.51 129.05 7.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.698 1.599 . . . . 2.4500000000000002 106.798 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.89 175.19 47.0 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.165 -0.774 . . . . 0.79000000000000004 111.165 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.4 mt -126.26 119.18 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.595 -1.632 . . . . 1.9099999999999999 106.595 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.29 134.06 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.197 -1.779 . . . . 0.76000000000000001 106.197 160.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -108.99 121.36 44.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.259 -2.126 . . . . 2.1699999999999999 105.259 162.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -113.47 114.72 26.95 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.944 1.698 . . . . 3.0699999999999998 106.647 175.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -131.33 156.2 45.9 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.294 0.952 . . . . 3.0699999999999998 109.367 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -153.99 146.8 24.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.721 -1.955 . . . . 4.2300000000000004 105.721 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -84.97 -90.26 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.905 -0.776 . . . . 4.7599999999999998 108.905 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.1 mp0 -77.06 149.8 35.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.831 -1.174 . . . . 3.8700000000000001 107.831 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -73.65 -2.17 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.132 -0.98 . . . . 2.2799999999999998 113.001 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -119.12 24.91 10.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.307 1.843 . . . . 4.8099999999999996 109.482 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.42 169.04 18.08 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 108.654 -1.778 . . . . 1.4399999999999999 108.654 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -65.63 139.48 58.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.681 1.587 . . . . 1.45 110.563 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.74 153.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.75 -1.204 . . . . 1.1100000000000001 107.75 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -129.21 131.67 47.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.417 -1.697 . . . . 2.8399999999999999 106.417 172.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.45 139.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.208 1.403 . . . . 1.4399999999999999 107.755 -169.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.22 138.75 21.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.274 -1.01 . . . . 1.1399999999999999 108.274 168.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.93 130.74 2.24 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.388 -1.885 . . . . 1.03 108.388 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.4 p -105.92 85.99 2.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.698 -1.964 . . . . 1.99 105.698 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mm -88.1 153.29 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.309 -1.367 . . . . 1.3999999999999999 107.309 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -147.54 158.19 43.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.128 1.158 . . . . 3.6099999999999999 114.128 168.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.24 9.96 43.28 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.87 2.176 . . . . 0.62 112.481 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 119' ' ' VAL . 1.3 mm? -63.84 160.86 16.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.588 0.755 . . . . 1.1399999999999999 109.369 168.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.57 159.2 26.94 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 107.468 -1.308 . . . . 1.6899999999999999 107.468 155.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.47 177.9 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.947 0.879 . . . . 3.0699999999999998 111.681 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.65 -164.55 54.05 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.02 -0.536 . . . . 0.5 112.036 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.81 148.4 40.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.895 1.678 . . . . 1.95 112.305 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.414 ' CD2' HD12 ' A' ' 38' ' ' LEU . 82.5 m-70 -150.59 111.35 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.239 1.416 . . . . 0.47999999999999998 110.29 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.25 147.4 2.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.549 -0.62 . . . . 0.37 111.549 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.572 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -136.36 96.71 3.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.875 -1.157 . . . . 2.6299999999999999 107.875 -178.058 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -133.28 156.53 47.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.813 -1.551 . . . . 0.62 106.813 -167.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.7 119.46 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.434 1.016 . . . . 1.8200000000000001 109.491 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.43 ' CD2' HG21 ' A' ' 118' ' ' VAL . 16.4 m-70 -91.25 138.46 31.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.659 -1.608 . . . . 0.84999999999999998 106.659 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -40.76 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.684 1.594 . . . . 4.4100000000000001 110.935 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 6.1 tt0 . . . . . 0 N--CA 1.454 -0.234 0 C-N-CA 124.18 0.992 . . . . 3.2400000000000002 112.457 152.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.719 0.295 . . . . 2.04 110.486 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.63 -86.5 1.75 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.288 -1.925 . . . . 1.21 108.288 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.25 177.42 8.8 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.621 2.881 . . . . 0.93000000000000005 113.326 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -64.8 134.81 54.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.821 -1.536 . . . . 1.47 108.136 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -37.89 106.66 0.05 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.301 1.041 . . . . 1.77 111.129 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -127.14 143.54 47.41 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 130.817 3.647 . . . . 3.7599999999999998 108.037 -175.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.14 -51.82 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.644 1.563 . . . . 1.2 109.256 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -143.53 -82.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.891 1.276 . . . . 3.0899999999999999 108.08 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -123.59 60.53 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.494 1.118 . . . . 1.8999999999999999 109.751 -164.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -79.01 166.35 22.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.469 0.652 . . . . 3.4500000000000002 110.354 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -118.67 159.29 23.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.644 1.578 . . . . 3.3700000000000001 107.906 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 40.7 t60 -86.94 168.47 13.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.023 0.529 . . . . 0.96999999999999997 112.064 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.7 -126.59 1.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.431 -3.068 . . . . 1.8600000000000001 105.431 165.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.49 -176.74 45.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.929 -2.068 . . . . 1.73 107.929 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.01 -40.43 84.03 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.012 2.475 . . . . 2.3700000000000001 111.463 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -32.61 71.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.166 0.586 . . . . 4.9800000000000004 112.474 174.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -89.09 177.66 6.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.716 0.769 . . . . 2.8599999999999999 112.66 -164.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -55.75 -66.41 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.619 1.168 . . . . 7.2999999999999998 111.405 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -118.23 179.6 4.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.663 2.385 . . . . 3.1099999999999999 112.263 -166.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.83 157.45 1.96 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.7 2.4 . . . . 4.1500000000000004 108.231 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -63.56 153.89 34.33 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.844 -1.169 . . . . 0.54000000000000004 107.844 170.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.76 -37.48 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 119.902 -0.719 . . . . 1.24 110.464 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.03 71.7 0.24 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 112.026 -0.43 . . . . 0.76000000000000001 112.026 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -165.8 113.55 0.94 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.331 -0.988 . . . . 1.8300000000000001 108.331 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.13 -61.39 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.094 -0.706 . . . . 1.97 109.094 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.3 -107.05 0.27 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.139 -1.184 . . . . 0.78000000000000003 110.139 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -147.2 163.25 36.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 125.107 1.363 . . . . 1.48 110.93 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.24 -178.58 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.027 2.131 . . . . 0.51000000000000001 105.867 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.8 t -129.47 171.54 12.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.827 -1.175 . . . . 1.99 107.827 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.11 144.58 50.81 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.308 1.043 . . . . 0.56999999999999995 110.669 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.47 -90.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.386 2.274 . . . . 4.2400000000000002 110.89 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -174.23 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.278 1.031 . . . . 3.29 110.271 -158.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.04 5.0 8.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.118 0.961 . . . . 2.7799999999999998 110.183 165.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.53 23.03 71.38 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.124 -1.19 . . . . 0.85999999999999999 110.124 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.2 t -85.36 136.65 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.364 1.466 . . . . 0.68000000000000005 107.895 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.407 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . . . -131.18 166.22 21.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.691 1.596 . . . . 0.87 109.748 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -142.14 118.45 10.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.038 -2.579 . . . . 2.71 104.038 -158.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.95 55.54 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 123.691 0.62 . . . . 1.51 111.225 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.4 m -77.18 87.86 3.64 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.642 -0.661 . . . . 1.0 109.771 168.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.5 mm -125.39 157.16 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.163 0.985 . . . . 1.76 108.352 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -151.32 99.0 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.637 0.375 . . . . 2.4300000000000002 111.494 166.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -92.17 159.1 15.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.178 0.591 . . . . 2.3999999999999999 110.595 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 p -116.23 -17.52 10.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.62 1.968 . . . . 1.55 113.296 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.75 -50.91 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 119.151 0.887 . . . . 1.3500000000000001 108.656 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.55 175.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.45 0.643 . . . . 1.4299999999999999 110.915 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.1 p -146.33 178.26 8.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.425 2.69 . . . . 2.3300000000000001 105.231 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 44.84 2.9 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.767 1.167 . . . . 2.8799999999999999 111.68 167.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 112.976 0.732 . . . . 3.2400000000000002 112.976 -169.106 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.891 0.853 . . . . 1.25 112.327 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.403 HD11 ' CE2' ' A' ' 20' ' ' PHE . 1.4 pp -89.08 -8.65 10.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 CA-C-N 115.327 -0.851 . . . . 1.6799999999999999 111.001 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 tp -33.63 127.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.258 1.423 . . . . 1.98 110.569 159.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.74 -19.52 24.4 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.037 -0.868 . . . . 1.6399999999999999 113.479 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.3 mtt-85 -86.54 168.94 13.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.604 1.702 . . . . 4.1900000000000004 109.281 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 80.7 m -101.82 115.4 30.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.018 -0.427 . . . . 0.88 110.353 -172.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 149.42 45.15 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.65 -0.87 . . . . 2.4300000000000002 108.65 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 48' ' ' HIS . 76.0 t -133.78 128.55 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.454 1.102 . . . . 0.54000000000000004 109.246 171.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 45' ' ' PHE . 25.1 t -99.81 116.24 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 C-N-CA 126.346 1.858 . . . . 2.2799999999999998 106.275 168.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -94.26 160.47 14.67 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.164 1.913 . . . . 0.53000000000000003 116.164 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -41.27 -77.53 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.265 2.626 . . . . 3.2799999999999998 112.481 170.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -97.29 -179.52 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.627 1.571 . . . . 2.5899999999999999 111.147 -168.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.81 153.72 32.11 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.019 -0.734 . . . . 0.80000000000000004 109.019 158.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -85.05 153.36 22.77 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.306 0.574 . . . . 2.02 109.729 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -81.97 -3.93 55.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.617 1.567 . . . . 3.0899999999999999 113.542 -168.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 53.85 32.9 15.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.377 1.071 . . . . 2.6200000000000001 110.773 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.79 14.5 30.22 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 121.08 -1.013 . . . . 2.2200000000000002 113.567 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -127.97 -27.48 2.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.926 1.291 . . . . 6.6799999999999997 110.728 -168.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.05 134.5 40.62 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.547 -1.421 . . . . 2.6800000000000002 109.547 164.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.62 -24.75 33.18 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.152 0.882 . . . . 2.1699999999999999 114.872 -166.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -55.91 125.86 23.27 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 118.295 -0.86 . . . . 2.8500000000000001 109.267 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -47.38 -40.99 18.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.833 1.197 . . . . 3.6899999999999999 111.192 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -47.43 -31.3 4.0 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.56 1.544 . . . . 3.0 111.624 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.99 -72.16 0.07 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.369 -0.604 . . . . 2.21 109.369 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 t -63.44 -41.11 98.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 121.621 -0.674 . . . . 2.5099999999999998 109.485 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.53 -45.41 94.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.75 -0.643 . . . . 3.8599999999999999 112.27 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.467 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.339 0.2 OUTLIER -128.68 -53.08 1.24 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.476 1.034 . . . . 1.27 113.181 173.723 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.71 -22.5 0.4 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.241 0.924 . . . . 1.03 112.201 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.1 t30 49.61 54.53 10.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.651 1.18 . . . . 1.8899999999999999 111.001 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.42 -3.45 58.34 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.672 -0.811 . . . . 1.3300000000000001 111.021 162.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.35 -155.34 45.45 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.249 -1.54 . . . . 0.96999999999999997 109.249 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.8 m -65.45 150.9 47.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.444 -1.378 . . . . 1.55 113.537 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -59.2 135.72 57.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.581 1.552 . . . . 2.96 108.812 170.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 mt -116.55 -76.88 0.57 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.05 -1.092 . . . . 0.82999999999999996 108.05 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 14' ' ' VAL . . . -104.47 145.86 29.69 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.755 -0.831 . . . . 1.23 108.755 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.3 163.81 30.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 123.862 0.726 . . . . 1.53 110.221 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.47 145.87 6.01 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.456 1.979 . . . . 0.72999999999999998 109.035 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.37 139.02 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.875 1.27 . . . . 0.88 108.65 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.6 tt -101.96 139.15 23.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 123.239 0.616 . . . . 0.98999999999999999 112.22 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.35 1.63 1.92 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.395 0.998 . . . . 0.59999999999999998 114.482 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.0 mm -93.61 56.91 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.214 1.507 . . . . 0.80000000000000004 110.3 -156.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.99 168.4 27.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.148 0.579 . . . . 1.3200000000000001 110.461 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 . . . . . 0 C--O 1.256 1.412 0 N-CA-C 101.995 -3.335 . . . . 4.5999999999999996 101.995 162.117 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 108.641 -0.874 . . . . 4.0499999999999998 108.641 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.95 21.77 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.49 -0.93 . . . . 1.0700000000000001 108.49 167.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 152' ' ' ALA . 53.0 t -107.58 150.68 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 106.666 -1.605 . . . . 1.05 106.666 161.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.1 96.2 3.85 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.706 -0.85 . . . . 0.59999999999999998 108.706 158.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 109.32 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.876 -1.527 . . . . 0.79000000000000004 106.876 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.83 125.03 39.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.571 -1.27 . . . . 0.85999999999999999 107.571 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -49.27 0.14 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 110.575 -0.157 . . . . 4.75 110.575 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.86 -117.21 0.8 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.958 1.266 . . . . 0.69999999999999996 111.247 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.75 -60.15 1.59 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.181 -1.044 . . . . 3.2999999999999998 108.181 -164.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.01 168.24 0.43 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 127.089 2.28 . . . . 0.69999999999999996 113.96 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.79 -21.08 69.49 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.315 2.677 . . . . 1.23 111.657 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.4 141.41 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.736 1.214 . . . . 1.01 110.937 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.0 122.31 5.6 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.119 -1.438 . . . . 1.98 107.119 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.14 168.68 36.51 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.67 -0.572 . . . . 0.63 111.67 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.76 131.3 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.623 -0.88 . . . . 1.4299999999999999 108.623 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.3 mm -97.21 146.63 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.747 -1.575 . . . . 0.82999999999999996 106.747 161.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -131.86 144.51 50.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.472 -1.677 . . . . 2.1299999999999999 106.472 159.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.93 161.51 41.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.535 -0.466 . . . . 3.5499999999999998 111.758 167.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.23 170.64 15.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.541 1.136 . . . . 3.5099999999999998 108.166 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.76 165.41 36.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 104.878 -2.267 . . . . 3.4399999999999999 104.878 165.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.65 -66.14 0.85 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.326 -0.62 . . . . 4.8300000000000001 109.326 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -89.38 166.12 13.93 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.219 1.007 . . . . 3.7400000000000002 110.52 -164.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -78.31 2.26 19.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.402 0.681 . . . . 3.27 111.652 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -153.34 85.4 1.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.205 1.402 . . . . 3.7999999999999998 108.406 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.83 169.74 37.8 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.41 133.61 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.723 2.949 . . . . 1.1200000000000001 112.934 -166.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -106.93 139.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.568 0.747 . . . . 1.1299999999999999 110.115 -171.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -99.5 89.71 4.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.713 0.805 . . . . 6.1500000000000004 109.223 -170.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.2 t -76.82 105.13 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 1.0600000000000001 106.878 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -113.66 140.9 47.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.817 -0.808 . . . . 1.0900000000000001 108.817 166.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.45 156.95 28.77 Favored Glycine 0 N--CA 1.448 -0.528 0 O-C-N 121.472 -0.768 . . . . 0.66000000000000003 112.008 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 p -130.36 104.38 7.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.505 -2.035 . . . . 2.02 105.505 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.01 143.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.381 -1.34 . . . . 0.88 107.381 -168.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -147.78 174.06 12.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.581 0.705 . . . . 3.6400000000000001 112.729 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 22.26 72.38 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 114.868 -1.06 . . . . 0.66000000000000003 112.107 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -76.58 -155.38 0.06 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.475 -1.306 . . . . 0.88 107.475 168.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -146.99 146.15 29.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.848 -2.278 . . . . 3.0699999999999998 104.848 166.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -34.19 132.96 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.719 2.408 . . . . 3.3100000000000001 113.223 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.63 -172.3 20.94 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.284 0.468 . . . . 0.56000000000000005 112.612 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.28 149.03 49.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.667 1.187 . . . . 2.23 112.831 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.34 120.22 9.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 126.279 1.832 . . . . 0.46999999999999997 108.455 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.0 150.06 6.65 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 110.393 -1.083 . . . . 0.35999999999999999 110.393 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.87 95.83 2.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.417 -1.327 . . . . 2.6699999999999999 107.417 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.427 ' ND1' ' CE1' ' A' ' 63' ' ' HIS . 24.0 m170 -134.2 147.16 50.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.264 -1.013 . . . . 0.56000000000000005 108.264 -161.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.294 0.7 OUTLIER -99.43 126.46 52.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.194 0.997 . . . . 1.8600000000000001 109.993 168.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.404 ' CD2' HG21 ' A' ' 118' ' ' VAL . 30.3 m-70 -85.38 -172.97 4.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.233 -1.395 . . . . 1.74 107.233 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -112.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.105 -1.443 . . . . 4.9500000000000002 107.105 161.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.213 -1.032 . . . . 2.9900000000000002 108.213 -177.197 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 107.777 -1.194 . . . . 2.0600000000000001 107.777 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.22 -88.03 0.07 OUTLIER Glycine 0 CA--C 1.522 0.485 0 N-CA-C 108.661 -1.776 . . . . 1.2 108.661 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -71.88 179.13 5.08 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 125.057 3.838 . . . . 1.0600000000000001 112.585 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.427 ' CE1' ' ND1' ' A' ' 46' ' ' HIS . 15.4 m170 -74.23 152.7 39.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.143 -0.935 . . . . 1.5700000000000001 109.327 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -50.82 108.09 0.22 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.382 0.512 . . . . 1.99 112.382 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -121.48 135.32 24.97 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 126.246 1.818 . . . . 3.5 109.147 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.5 -50.43 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.739 1.626 . . . . 1.1599999999999999 108.991 171.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.48 -84.09 0.25 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.94 1.296 . . . . 2.3199999999999998 107.652 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.8 m -132.71 60.88 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.406 1.082 . . . . 1.5900000000000001 110.787 -168.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -77.44 158.7 29.89 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.526 -1.287 . . . . 4.0 107.526 162.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -120.41 163.44 17.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.433 1.493 . . . . 3.0099999999999998 107.713 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -81.58 157.04 24.89 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.22 0.533 . . . . 0.75 111.043 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.88 -155.84 16.54 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 104.469 -3.453 . . . . 2.3999999999999999 104.469 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.63 -131.65 1.24 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.274 -1.53 . . . . 1.5600000000000001 109.274 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.7 -40.67 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.308 2.005 . . . . 1.8400000000000001 111.872 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.29 -46.17 42.94 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.786 0.291 . . . . 4.96 111.786 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.95 176.69 6.93 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.505 -0.554 . . . . 2.4300000000000002 109.505 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.62 -33.55 10.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 5.1399999999999997 111.736 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 162.89 26.74 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 119.111 -1.036 . . . . 3.6200000000000001 110.183 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 133.05 0.05 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.782 2.033 . . . . 3.9100000000000001 108.864 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 46.5 m80 -50.01 144.61 6.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.177 -1.786 . . . . 0.70999999999999996 106.177 155.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.304 5.1 p -83.55 44.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 123.304 1.526 . . . . 1.6899999999999999 110.795 -170.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -154.63 3.68 0.24 Allowed Glycine 0 CA--C 1.545 1.926 1 C-N-CA 131.364 4.316 . . . . 1.8400000000000001 113.125 169.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.19 99.39 8.54 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 121.651 2.726 . . . . 2.0 107.753 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.5 mt -77.31 -44.96 27.77 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.064 0.847 . . . . 2.79 109.103 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.58 -107.82 0.34 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.688 -0.767 . . . . 0.73999999999999999 111.216 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -149.69 171.13 17.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.648 1.579 . . . . 1.52 109.366 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.82 172.27 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.74 -1.578 . . . . 0.55000000000000004 106.74 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.5 m -122.02 124.28 43.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.523 -1.288 . . . . 1.98 107.523 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.88 138.78 38.29 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.642 -0.503 . . . . 0.58999999999999997 109.642 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.72 -89.69 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 124.272 0.982 . . . . 2.7799999999999998 110.228 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 -57.84 1.0 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.295 1.038 . . . . 3.4300000000000002 110.085 -164.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.36 25.04 1.48 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 123.352 1.549 . . . . 2.96 110.911 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 62.91 19.71 61.4 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.917 -1.038 . . . . 0.82999999999999996 111.51 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.72 139.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.13 -1.433 . . . . 0.80000000000000004 107.13 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.99 166.18 23.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.856 1.263 . . . . 0.70999999999999996 107.887 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -128.0 143.23 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.766 -2.679 . . . . 2.8900000000000001 103.766 -173.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.39 121.7 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.381 -1.711 . . . . 1.4399999999999999 106.381 173.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -150.59 91.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.947 1.299 . . . . 0.82999999999999996 108.604 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.48 144.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 107.951 -1.129 . . . . 1.8700000000000001 107.951 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -112.51 83.44 1.81 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.656 -1.609 . . . . 3.7400000000000002 106.656 161.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.28 146.29 33.06 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.1 p -108.06 -7.95 15.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.764 2.025 . . . . 1.48 112.28 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.59 -55.53 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.78 -1.193 . . . . 1.3600000000000001 107.78 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.8 pt -70.35 176.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 122.312 1.053 . . . . 1.54 112.008 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 m -153.4 176.96 11.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.663 1.985 . . . . 2.04 106.233 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 -19.61 25.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.319 0.963 . . . . 3.04 113.434 -169.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 CA--C 1.532 0.255 0 O-C-N 121.034 -1.041 . . . . 3.8900000000000001 111.857 -168.292 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.5 p . . . . . 0 N--CA 1.445 -0.686 0 CA-C-O 121.194 0.521 . . . . 1.3799999999999999 111.113 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.38 -5.89 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.389 -0.823 . . . . 1.97 110.553 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -51.49 120.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.094 -0.706 . . . . 1.6200000000000001 109.094 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.85 39.61 95.14 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.61 -0.55 . . . . 1.77 112.8 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -120.79 167.94 11.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.265 -1.383 . . . . 5.4699999999999998 107.265 158.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.7 m -91.69 118.3 30.53 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.846 0.458 . . . . 0.95999999999999996 111.043 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 144.4 45.56 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.145 -1.057 . . . . 1.5800000000000001 108.145 164.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.404 HG21 ' CD2' ' A' ' 48' ' ' HIS . 75.0 t -131.54 140.33 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.189 1.796 . . . . 0.40000000000000002 107.818 174.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.63 127.44 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.129 -1.063 . . . . 1.55 108.129 164.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -97.08 159.61 14.81 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.474 2.028 . . . . 0.40999999999999998 116.474 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -47.57 -73.4 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.257 1.823 . . . . 3.02 112.243 172.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -97.35 179.87 4.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.002 0.921 . . . . 4.2800000000000002 110.264 -172.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.61 147.96 39.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.031 -0.729 . . . . 0.54000000000000004 109.031 160.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -77.32 162.73 27.07 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.278 -0.638 . . . . 1.97 109.278 167.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.13 -8.47 59.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.424 1.268 . . . . 3.0800000000000001 114.424 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 48.97 30.3 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.695 1.134 . . . . 1.4299999999999999 110.89 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.56 28.18 72.85 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.152 0.882 . . . . 1.8500000000000001 112.502 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -130.41 29.48 4.84 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.034 0.917 . . . . 5.4400000000000004 111.226 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -96.44 135.2 12.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 108.467 -1.853 . . . . 2.29 108.467 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.08 66.27 2.88 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 117.63 0.715 . . . . 2.25 112.43 -171.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -168.84 170.72 8.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 125.085 1.354 . . . . 3.3999999999999999 108.092 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -52.09 -71.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.062 0.545 . . . . 3.6099999999999999 110.897 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -47.72 -41.96 24.13 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.868 2.067 . . . . 3.8300000000000001 111.947 -162.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.2 m -46.09 -58.54 3.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.994 0.917 . . . . 2.5600000000000001 112.071 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -73.07 -40.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.792 -1.193 . . . . 1.49 112.511 173.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -66.25 -36.29 82.62 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.376 1.07 . . . . 5.8399999999999999 110.549 -165.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.377 13.1 t -133.47 -46.27 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.604 0.762 . . . . 2.0699999999999998 111.562 172.222 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.37 -18.45 1.33 Allowed Glycine 0 N--CA 1.467 0.752 0 CA-C-N 119.886 1.221 . . . . 0.89000000000000001 112.877 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 34.36 56.28 0.66 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.077 2.551 . . . . 2.5699999999999998 112.347 -174.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.44 -1.61 27.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.417 -0.513 . . . . 1.1000000000000001 111.994 167.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.81 -163.23 45.64 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.017 -1.633 . . . . 0.94999999999999996 109.017 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.4 m -60.86 148.79 38.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.026 -1.587 . . . . 1.28 113.822 -161.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -57.47 130.82 48.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.392 -1.277 . . . . 2.6699999999999999 107.799 165.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.7 mt -106.64 -73.1 0.7 Allowed 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 107.746 -1.205 . . . . 0.46999999999999997 107.746 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.25 144.45 34.04 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.705 -1.22 . . . . 0.67000000000000004 107.705 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 85.8 m -126.87 160.58 30.53 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.522 -2.029 . . . . 2.1299999999999999 105.522 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.8 131.19 1.85 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.013 -0.835 . . . . 0.68999999999999995 111.013 169.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.6 t -62.94 134.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.669 0.788 . . . . 0.69999999999999996 109.404 169.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.6 tt -95.67 134.81 31.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.714 0.293 . . . . 0.95999999999999996 111.116 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.54 3.81 0.49 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.062 0.839 . . . . 0.81000000000000005 115.033 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.8 mm -92.77 57.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.52 1.66 . . . . 1.01 110.91 -155.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.566 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -155.57 170.92 20.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.488 0.715 . . . . 1.46 110.792 167.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 83.9 mt-30 . . . . . 0 C--O 1.255 1.359 0 N-CA-C 103.065 -2.939 . . . . 4.6600000000000001 103.065 163.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.721 0.296 . . . . 3.8799999999999999 110.643 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.26 41.71 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.003 1.321 . . . . 0.92000000000000004 107.562 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.92 143.74 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 106.701 -1.592 . . . . 1.02 106.701 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.575 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -122.4 93.34 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.698 . . . . 0.56000000000000005 109.114 156.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.68 100.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.246 -1.39 . . . . 1.04 107.246 164.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.9 mt -89.13 143.16 27.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.996 0.518 . . . . 1.26 109.767 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -143.73 -64.2 0.38 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.206 -1.035 . . . . 4.0300000000000002 108.206 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.36 -122.9 13.14 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.748 -0.66 . . . . 0.96999999999999997 113.14 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -126.43 -55.98 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.387 0.613 . . . . 2.98 110.014 -152.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.31 164.15 25.07 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 110.049 -1.22 . . . . 0.73999999999999999 110.049 164.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.74 34.25 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.674 2.916 . . . . 1.1000000000000001 113.586 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.5 155.1 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.722 1.609 . . . . 1.1200000000000001 109.69 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.03 125.69 9.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.799 -1.926 . . . . 2.46 105.799 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.61 164.15 31.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.194 -0.763 . . . . 0.76000000000000001 111.194 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.636 -1.616 . . . . 1.01 106.636 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 3.0 mp -90.48 144.06 9.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.432 -1.692 . . . . 1.79 106.432 161.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.5 102.72 7.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.395 1.478 . . . . 1.78 107.104 167.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -79.77 118.76 21.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.615 -1.995 . . . . 2.46 105.615 169.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -142.67 145.84 33.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.52 1.055 . . . . 3.2799999999999998 108.902 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -157.18 146.06 19.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.223 -0.444 . . . . 4.4500000000000002 109.919 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -68.43 -61.26 1.91 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.275 1.03 . . . . 5.0099999999999998 109.755 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -78.48 -175.92 4.52 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 119.018 0.827 . . . . 4.1299999999999999 110.194 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -81.0 -68.68 0.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.035 -1.468 . . . . 2.6899999999999999 107.035 165.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -90.56 106.02 18.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.907 0.883 . . . . 4.5499999999999998 109.293 171.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.08 176.17 45.88 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 107.94 -2.064 . . . . 1.23 107.94 166.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.84 116.84 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.317 2.678 . . . . 1.46 110.635 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.8 t -78.62 147.39 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.312 -0.625 . . . . 0.98999999999999999 109.312 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -98.14 113.37 25.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.809 -1.552 . . . . 3.1899999999999999 106.809 171.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 20' ' ' PHE . 56.6 t -115.25 82.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.996 1.718 . . . . 1.1399999999999999 106.974 -169.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -98.07 158.84 15.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.078 -0.712 . . . . 0.85999999999999999 109.078 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.72 158.94 29.36 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.769 -0.933 . . . . 0.72999999999999998 110.769 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.9 p -129.16 104.07 7.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.762 -1.94 . . . . 2.52 105.762 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.7 141.95 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.082 -1.451 . . . . 0.92000000000000004 107.082 -168.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.11 159.9 41.69 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.593 1.331 . . . . 3.23 114.593 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.4 22.84 25.79 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.957 1.742 . . . . 1.1200000000000001 111.81 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.33 -156.05 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.105 -1.072 . . . . 1.27 108.105 166.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 m -146.27 152.17 38.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.749 -2.315 . . . . 3.21 104.749 165.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -37.98 141.39 0.21 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.273 2.229 . . . . 2.8599999999999999 113.77 -170.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.66 -171.87 26.76 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.238 -0.437 . . . . 0.63 112.323 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 151.47 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.286 1.035 . . . . 2.3500000000000001 112.804 -168.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -146.66 118.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.194 1.797 . . . . 0.87 108.154 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.01 154.25 3.89 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.035 -1.226 . . . . 0.57999999999999996 110.035 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -145.47 89.79 1.96 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.612 -1.255 . . . . 2.6800000000000002 107.612 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -128.72 164.58 22.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.156 -1.053 . . . . 0.84999999999999998 108.156 -160.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 134.0 66.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 122.055 0.931 . . . . 2.0499999999999998 110.488 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.497 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 21.5 m-70 -110.05 132.82 53.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.371 1.469 . . . . 0.96999999999999997 107.241 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HA ' ' HG2' ' A' ' 115' ' ' ARG . 13.4 mt-10 -74.11 65.95 1.18 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.876 1.27 . . . . 5.7699999999999996 111.19 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' CB ' ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.429 -1.521 0 CA-C-N 113.516 -1.675 . . . . 5.6500000000000004 107.446 168.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 48' ' ' HIS . . . . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 110.614 -0.143 . . . . 1.95 110.614 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.25 -126.45 3.2 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.069 -1.213 . . . . 1.0600000000000001 110.069 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.15 178.68 6.63 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.894 3.062 . . . . 0.82999999999999996 112.629 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.66 126.02 28.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.519 -1.229 . . . . 1.23 108.031 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -5.56 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.243 2.217 . . . . 2.5600000000000001 113.394 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -125.81 130.51 24.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 127.318 2.247 . . . . 3.5699999999999998 108.719 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.73 -43.77 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.8 1.666 . . . . 1.1699999999999999 109.729 173.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.54 -73.11 0.42 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.718 1.207 . . . . 2.46 107.923 172.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.5 m -154.0 83.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.423 -0.798 . . . . 2.2200000000000002 109.767 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -79.5 168.52 19.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.399 -0.593 . . . . 4.6900000000000004 109.399 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -102.93 152.93 20.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 107.264 -1.384 . . . . 3.6200000000000001 107.264 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -75.41 163.21 27.66 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.114 0.87 . . . . 0.93000000000000005 110.349 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.6 -103.54 0.17 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.846 -2.502 . . . . 1.9299999999999999 106.846 167.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.26 -121.21 2.51 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.496 1.148 . . . . 2.1000000000000001 111.547 167.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -86.58 -42.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.541 2.161 . . . . 1.6200000000000001 111.306 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -64.15 0.96 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.095 -1.076 . . . . 4.9400000000000004 108.095 174.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.87 143.09 54.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.265 -0.879 . . . . 2.0699999999999998 109.34 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -54.87 -46.93 74.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 126.449 1.899 . . . . 5.21 111.667 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.59 176.57 6.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.246 1.018 . . . . 3.4700000000000002 110.924 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 154.86 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.616 1.166 . . . . 4.5499999999999998 110.995 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.6 m80 -54.53 141.86 29.77 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.682 -1.97 . . . . 0.64000000000000001 105.682 155.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.08 -17.81 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.298 -0.561 . . . . 1.3600000000000001 110.973 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.4 52.37 0.75 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.506 -0.608 . . . . 0.76000000000000001 114.574 162.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -96.71 124.51 40.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 105.463 -2.051 . . . . 2.0699999999999998 105.463 143.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.06 -51.64 6.52 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.33 0.968 . . . . 2.4500000000000002 108.399 161.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.49 -115.35 0.64 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.713 -1.355 . . . . 0.93000000000000005 109.713 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -148.63 166.56 27.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.359 1.463 . . . . 1.8500000000000001 109.362 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.3 174.28 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.648 -1.612 . . . . 0.78000000000000003 106.648 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.4 m -129.02 129.67 45.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 2.0600000000000001 107.306 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 135.49 37.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.324 -0.621 . . . . 0.72999999999999998 109.324 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.84 -69.91 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.725 1.266 . . . . 4.0199999999999996 110.356 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -168.87 -53.94 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.95 2.1 . . . . 5.2800000000000002 108.528 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.44 23.29 1.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.934 1.293 . . . . 3.5899999999999999 110.563 -167.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.26 4.97 75.36 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.52 1.057 . . . . 1.1100000000000001 112.182 -174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.85 154.34 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.022 -1.103 . . . . 1.3999999999999999 108.022 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.64 171.32 14.21 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.525 1.13 . . . . 0.87 108.079 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.41 151.45 38.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 104.266 -2.494 . . . . 2.75 104.266 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.07 134.19 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 107.788 -1.19 . . . . 1.74 107.788 145.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.3 m -155.42 61.35 0.62 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.012 1.725 . . . . 1.1100000000000001 107.748 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -105.91 155.56 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 108.036 -1.098 . . . . 1.47 108.036 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.06 118.64 14.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.135 -0.691 . . . . 2.7000000000000002 109.135 150.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.46 -174.4 5.17 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.59 0.71 . . . . 4.0999999999999996 109.664 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.6 p -144.75 51.41 1.25 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.197 -1.038 . . . . 2.4300000000000002 108.197 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.4 -54.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.329 1.452 . . . . 1.52 108.957 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -96.32 179.76 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.165 0.986 . . . . 1.1200000000000001 109.928 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.1 m -152.31 176.82 11.22 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.192 -1.41 . . . . 2.1600000000000001 107.192 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.65 47.96 1.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.733 1.254 . . . . 2.71 110.712 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 126.742 2.017 . . . . 3.96 112.937 -169.862 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 111.647 0.24 . . . . 1.1699999999999999 111.647 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.415 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 15.2 pt -78.05 -10.28 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.538 -0.744 . . . . 1.73 111.904 174.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.4 mm -40.6 123.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 1.8200000000000001 110.68 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.14 50.89 6.02 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.558 -0.617 . . . . 2.0699999999999998 111.558 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.427 ' HG2' ' HA ' ' A' ' 49' ' ' GLU . 2.2 mtt85 -136.62 153.52 50.92 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.535 1.134 . . . . 3.8799999999999999 109.264 168.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 98.7 m -79.63 115.95 19.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 124.326 1.016 . . . . 1.1899999999999999 108.397 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tt -86.03 136.5 33.22 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 118.901 0.773 . . . . 2.1400000000000001 109.427 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -124.86 120.21 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.958 -1.127 . . . . 0.48999999999999999 107.958 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.94 118.59 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 105.523 -2.029 . . . . 1.6799999999999999 105.523 161.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -90.07 162.83 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.249 1.574 . . . . 0.53000000000000003 115.249 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -38.78 -69.13 0.13 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.068 2.547 . . . . 3.23 111.907 170.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -120.75 -177.71 3.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.622 1.169 . . . . 2.71 110.624 -167.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.62 57.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.274 -0.639 . . . . 0.54000000000000004 109.274 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -81.07 156.28 25.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.056 -0.72 . . . . 2.23 109.056 158.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -22.93 60.08 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.332 0.653 . . . . 3.5099999999999998 111.664 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.98 56.77 2.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.823 0.82 . . . . 2.3599999999999999 109.573 -168.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.87 73.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.156 -0.929 . . . . 1.6100000000000001 113.438 157.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -77.3 -23.31 51.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.932 -0.746 . . . . 6.7300000000000004 110.217 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 71.76 -118.66 7.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.415 -1.474 . . . . 3.1200000000000001 109.415 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.72 -68.44 1.57 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.334 -1.506 . . . . 2.46 109.334 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -94.41 161.61 14.16 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.79 -1.189 . . . . 2.7599999999999998 107.79 160.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.62 -53.53 46.16 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.242 -0.286 . . . . 3.5299999999999998 110.649 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -49.03 -40.94 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.818 1.647 . . . . 2.9399999999999999 113.45 -169.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.9 m -47.16 -54.27 11.03 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.77 0.828 . . . . 2.2000000000000002 112.004 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -44.6 60.96 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.46 -0.775 . . . . 1.53 111.78 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -59.62 -50.84 72.33 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.976 0.911 . . . . 2.7400000000000002 111.207 -166.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.464 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.35 0.1 OUTLIER -124.7 -46.39 1.87 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.568 -0.73 . . . . 1.1399999999999999 111.56 175.086 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.35 -2.1 0.67 Allowed Glycine 0 C--O 1.222 -0.652 0 CA-C-O 118.009 -1.439 . . . . 1.03 115.531 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 27.63 52.72 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.151 2.181 . . . . 4.2800000000000002 114.589 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.21 -16.42 60.48 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.416 -0.803 . . . . 0.89000000000000001 111.93 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.67 -171.32 36.08 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 109.142 -1.583 . . . . 0.95999999999999996 109.142 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -62.46 156.01 23.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.639 -1.28 . . . . 1.25 113.564 -164.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -73.1 148.05 44.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.959 -1.019 . . . . 2.4700000000000002 111.14 173.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mt -128.73 -69.43 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.537 -1.283 . . . . 0.78000000000000003 107.537 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.02 163.58 12.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.918 -0.771 . . . . 1.3100000000000001 108.918 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.9 p -165.07 160.45 18.86 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.678 -1.601 . . . . 1.9099999999999999 106.678 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.49 143.16 3.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 105.766 -2.933 . . . . 1.0800000000000001 105.766 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.5 t -81.37 139.85 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 117.901 0.851 . . . . 1.29 110.213 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.8 tt -86.49 131.88 33.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.899 0.38 . . . . 0.82999999999999996 110.484 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.83 -8.62 0.97 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.048 0.833 . . . . 0.93000000000000005 115.002 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mm -90.56 57.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.662 1.231 . . . . 1.03 110.546 -157.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.92 175.87 5.79 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.556 0.742 . . . . 2.04 110.465 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 C--O 1.257 1.451 0 N-CA-C 104.113 -2.551 . . . . 4.29 104.113 164.814 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 109.972 -0.381 . . . . 3.6600000000000001 109.972 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.85 148.41 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.866 1.666 . . . . 0.69999999999999996 108.367 169.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.92 144.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.39 -0.967 . . . . 0.63 108.39 165.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.93 97.03 5.3 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.841 -0.8 . . . . 0.42999999999999999 108.841 155.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.26 106.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.992 -1.485 . . . . 0.51000000000000001 106.992 161.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -90.31 133.91 34.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 0.91000000000000003 108.456 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -149.45 -50.99 0.15 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.413 0.685 . . . . 3.2200000000000002 110.527 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.06 -117.5 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.352 0.977 . . . . 0.92000000000000004 113.501 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -114.33 -54.82 2.55 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.661 1.184 . . . . 4.0700000000000003 109.69 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.77 159.73 21.42 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 110.336 -1.106 . . . . 0.85999999999999999 110.336 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.11 40.6 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.342 2.695 . . . . 1.0 112.179 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 40.6 t -92.59 159.47 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.003 1.721 . . . . 0.81000000000000005 108.616 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.81 135.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.948 -1.501 . . . . 2.3500000000000001 106.948 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 169.31 42.27 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.916 -1.274 . . . . 0.67000000000000004 109.916 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.87 110.16 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.115 -1.439 . . . . 0.97999999999999998 107.115 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.2 125.34 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.756 -1.572 . . . . 0.72999999999999998 106.756 168.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -99.36 109.56 22.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.699 -1.963 . . . . 2.0499999999999998 105.699 166.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CG ' HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -98.01 105.56 17.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.554 -2.017 . . . . 2.5499999999999998 105.554 171.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.25 138.31 49.14 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.948 1.249 . . . . 3.6600000000000001 110.264 169.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -156.67 105.71 2.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.159 -1.052 . . . . 3.7999999999999998 108.159 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -89.36 36.38 0.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.89 0.476 . . . . 7.2199999999999998 111.33 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -125.63 -138.06 0.27 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.221 -1.4 . . . . 4.8499999999999996 107.221 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -130.3 -76.62 0.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.349 0.66 . . . . 3.4300000000000002 109.345 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -101.8 86.04 2.84 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.184 -1.784 . . . . 5.0 106.184 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.64 34.68 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.597 -1.001 . . . . 1.71 110.597 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.92 132.11 29.27 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.512 2.808 . . . . 1.6200000000000001 112.297 -170.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.6 t -91.89 149.24 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.307 -0.997 . . . . 1.04 108.307 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 121.67 44.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.729 -1.582 . . . . 2.6400000000000001 106.729 163.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.412 HG22 ' CE1' ' A' ' 20' ' ' PHE . 48.8 t -115.86 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.245 1.818 . . . . 1.03 107.25 -170.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -127.23 126.88 43.52 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 123.507 0.505 . . . . 1.25 110.743 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.2 137.02 5.06 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.56 -1.416 . . . . 0.89000000000000001 109.56 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -116.53 110.25 18.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.929 -1.878 . . . . 2.77 105.929 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 mm -103.1 152.81 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.595 1.958 . . . . 1.22 108.866 -164.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -149.55 156.17 41.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.28 0.844 . . . . 3.46 113.28 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.52 15.11 33.06 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.782 2.134 . . . . 0.60999999999999999 112.458 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 43' ' ' HIS . 2.8 mm? -69.54 162.49 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.18 0.992 . . . . 1.25 110.035 170.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.49 161.63 24.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.927 -1.138 . . . . 1.6899999999999999 107.927 157.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -56.87 174.85 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.786 0.803 . . . . 2.4399999999999999 111.775 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.8 -169.52 52.4 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.986 0.803 . . . . 0.78000000000000003 113.687 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.82 153.02 44.54 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.892 1.277 . . . . 2.23 111.754 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.489 ' CD2' HD12 ' A' ' 38' ' ' LEU . 89.3 m-70 -149.36 117.72 6.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.869 1.667 . . . . 0.42999999999999999 108.365 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.37 150.44 4.32 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.712 -0.955 . . . . 0.34999999999999998 110.712 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -140.85 95.66 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.827 -1.545 . . . . 2.5699999999999998 106.827 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -134.11 155.97 49.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.033 -1.469 . . . . 0.54000000000000004 107.033 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.27 126.84 67.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.091 -0.707 . . . . 1.6299999999999999 109.091 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.453 ' CD2' HG21 ' A' ' 118' ' ' VAL . 25.7 m-70 -95.2 142.58 27.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.883 1.673 . . . . 0.75 108.376 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -46.49 -64.8 0.67 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.726 1.211 . . . . 4.2599999999999998 110.935 -171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 127.706 2.403 . . . . 3.2000000000000002 114.73 155.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.188 -0.671 . . . . 2.3500000000000001 109.188 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.74 -89.11 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 107.945 -2.062 . . . . 1.1399999999999999 107.945 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.56 177.65 8.25 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 124.823 3.682 . . . . 0.96999999999999997 112.948 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -66.43 142.02 57.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.921 1.688 . . . . 1.4199999999999999 107.551 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -49.49 115.66 1.43 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.402 0.681 . . . . 1.71 110.95 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.58 111.88 9.82 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.995 1.718 . . . . 2.8500000000000001 108.819 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.6 -10.9 29.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.85 1.7 . . . . 1.72 113.46 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -146.52 -72.64 0.23 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.745 -0.835 . . . . 2.2999999999999998 108.745 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -161.74 92.7 0.88 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.758 -1.201 . . . . 2.3900000000000001 107.758 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.29 175.53 5.68 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.048 1.739 . . . . 5.7400000000000002 108.202 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 9.9 mtpm? -133.8 153.27 51.84 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.575 1.55 . . . . 3.9700000000000002 107.397 -174.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -87.87 136.98 32.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.807 0.843 . . . . 1.28 109.908 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.68 -66.53 0.14 Allowed Glycine 0 C--O 1.222 -0.636 0 N-CA-C 107.519 -2.232 . . . . 2.7599999999999998 107.519 163.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.0 -170.21 35.37 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.007 1.289 . . . . 1.4099999999999999 111.595 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.02 -42.61 5.9 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.789 2.326 . . . . 1.6799999999999999 110.343 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.35 -54.08 7.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.546 0.738 . . . . 4.6600000000000001 111.107 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.05 149.31 50.1 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.439 -0.948 . . . . 2.02 108.439 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -49.53 -51.92 33.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.058 0.943 . . . . 3.9500000000000002 110.532 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 59.5 mt-10 -76.11 152.5 36.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.751 1.262 . . . . 3.75 110.694 -163.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -175.05 134.66 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.394 1.478 . . . . 3.3300000000000001 108.177 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 34.4 m80 -50.87 137.75 20.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.154 -2.165 . . . . 0.77000000000000002 105.154 147.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.44 -24.76 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 119.342 -0.943 . . . . 1.46 109.73 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.65 33.94 4.75 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.133 -1.371 . . . . 0.82999999999999996 116.504 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -102.81 112.95 25.98 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 120.72 2.26 . . . . 1.96 107.937 161.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 84' ' ' LEU . 4.0 mm? -78.66 -57.58 3.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.449 -1.315 . . . . 1.52 107.449 160.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.85 -110.63 0.43 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.806 -0.918 . . . . 0.58999999999999997 110.806 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -146.72 169.31 19.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.666 1.186 . . . . 1.3600000000000001 109.898 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.5 176.56 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 105.998 -1.853 . . . . 0.62 105.998 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.3 m -140.27 132.71 28.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.363 -2.088 . . . . 2.02 105.363 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.666 0.604 . . . . 0.68999999999999995 110.127 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.72 -80.98 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.119 0.968 . . . . 2.9700000000000002 109.407 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.2 tttm -160.2 -43.54 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.563 1.145 . . . . 3.96 111.878 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -81.99 30.61 0.38 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 123.739 1.733 . . . . 3.2599999999999998 110.833 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 64.72 17.73 63.02 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.002 1.763 . . . . 1.0700000000000001 112.571 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.52 147.82 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.54 -1.281 . . . . 1.1299999999999999 107.54 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.06 175.02 11.35 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.114 -1.439 . . . . 0.90000000000000002 107.114 166.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.31 149.95 29.22 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.386 -1.338 . . . . 3.2400000000000002 107.386 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.37 103.41 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 C-N-CA 125.621 1.569 . . . . 1.25 106.791 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.5 m -121.48 87.52 2.77 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.377 1.471 . . . . 1.0 107.789 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.8 mt -126.45 160.51 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.555 0.742 . . . . 1.3899999999999999 109.034 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.33 95.78 2.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.194 -0.457 . . . . 2.3300000000000001 111.503 157.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.35 154.46 25.25 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.311 0.577 . . . . 2.0499999999999998 110.243 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.1 p -107.76 -17.54 14.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.224 2.21 . . . . 1.73 112.386 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.33 -51.3 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.259 0.936 . . . . 1.02 109.426 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.415 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.4 pp -71.81 176.23 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.858 0.837 . . . . 1.0900000000000001 111.051 174.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -156.85 173.7 16.6 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.877 -1.157 . . . . 1.78 107.877 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -43.69 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.761 0.824 . . . . 2.7000000000000002 110.558 169.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.534 0.327 0 O-C-N 121.424 -0.797 . . . . 4.4500000000000002 112.389 -158.76 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.936 0 CA-C-O 121.542 0.687 . . . . 1.4199999999999999 112.829 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.4 pt -90.53 -5.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.085 0.954 . . . . 2.02 111.218 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 tp -26.55 126.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.889 1.675 . . . . 1.98 111.876 163.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.26 -19.09 37.26 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.827 -0.985 . . . . 1.5700000000000001 113.433 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -88.81 164.08 15.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.576 1.688 . . . . 4.6500000000000004 110.807 -169.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.2 m -89.06 106.17 18.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 119.226 -0.416 . . . . 0.95999999999999996 110.603 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 mt -65.72 146.37 54.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.613 -0.835 . . . . 1.6499999999999999 108.775 166.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.453 HG21 ' CD2' ' A' ' 48' ' ' HIS . 80.6 t -135.47 135.46 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.443 1.897 . . . . 0.40000000000000002 109.046 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 145' ' ' ALA . 55.1 t -102.25 119.62 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.153 1.781 . . . . 2.3700000000000001 106.412 166.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -92.96 159.32 15.38 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 116.839 2.163 . . . . 0.40000000000000002 116.839 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -33.3 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.501 3.121 . . . . 3.3700000000000001 112.364 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -107.14 -175.98 2.95 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.059 0.845 . . . . 2.8300000000000001 110.458 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.86 142.53 45.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.504 -0.924 . . . . 0.87 108.504 158.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.21 165.95 24.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.242 -0.651 . . . . 2.2200000000000002 109.242 159.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -88.45 -7.13 57.08 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.396 1.478 . . . . 3.3500000000000001 111.227 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.28 46.16 27.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.346 1.458 . . . . 1.8400000000000001 110.2 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.27 24.06 58.45 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.644 -0.531 . . . . 1.7 113.627 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -78.34 -13.66 59.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.441 1.121 . . . . 5.04 110.633 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.0 -133.34 11.74 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.588 -1.005 . . . . 2.6200000000000001 110.588 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.95 -68.32 1.33 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.221 -1.552 . . . . 2.29 109.221 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.09 150.97 19.61 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.222 -1.029 . . . . 2.6499999999999999 108.222 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.24 -48.76 79.99 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.81 -0.556 . . . . 3.5 111.248 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -51.94 -33.46 37.56 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.114 1.366 . . . . 3.1099999999999999 111.777 -168.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.2 t -39.39 -62.56 0.65 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.386 1.474 . . . . 2.1499999999999999 110.466 167.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.3 p -73.77 -46.46 45.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.762 0.425 . . . . 1.3999999999999999 110.757 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -42.92 86.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.026 0.53 . . . . 2.8999999999999999 110.858 -167.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.497 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.6 p -128.33 -48.07 1.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.355 0.662 . . . . 1.52 112.127 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.31 -31.85 0.71 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.103 1.335 . . . . 1.1299999999999999 111.038 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 52.99 54.68 10.06 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.628 1.971 . . . . 2.4100000000000001 112.606 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.54 -43.11 33.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.12 0.962 . . . . 1.1899999999999999 108.875 162.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 116.05 -143.42 18.07 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 107.986 -2.046 . . . . 1.0700000000000001 107.986 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.5 m -60.61 149.6 34.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.574 1.149 . . . . 1.1899999999999999 112.459 -169.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -60.5 135.01 57.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 2.6400000000000001 108.878 168.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -112.19 -82.27 0.59 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.887 -1.153 . . . . 0.71999999999999997 107.887 165.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . . . -83.04 145.42 29.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.672 -1.233 . . . . 1.1599999999999999 107.672 171.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 77.7 m -141.24 154.29 45.7 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.137 -1.431 . . . . 2.21 107.137 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.06 128.64 1.5 Allowed Glycine 0 CA--C 1.527 0.796 0 O-C-N 123.614 0.571 . . . . 0.72999999999999998 111.735 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.95 132.28 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.676 1.19 . . . . 0.68999999999999995 109.223 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.417 HD11 ' CG ' ' A' ' 20' ' ' PHE . 8.1 tt -95.7 138.79 20.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 111.688 0.255 . . . . 0.69999999999999996 111.688 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.69 0.03 1.6 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.062 0.839 . . . . 0.56999999999999995 115.048 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.62 57.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 119.11 1.455 . . . . 0.76000000000000001 110.914 -157.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.39 169.07 25.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.196 0.598 . . . . 1.29 110.547 168.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 . . . . . 0 C--O 1.253 1.272 0 N-CA-C 102.057 -3.312 . . . . 4.4000000000000004 102.057 162.701 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 108.369 -0.975 . . . . 2.9100000000000001 108.369 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.79 139.9 34.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.933 -1.506 . . . . 0.77000000000000002 106.933 153.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -98.2 147.26 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.132 -1.803 . . . . 0.67000000000000004 106.132 159.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.77 96.13 3.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.404 -0.962 . . . . 0.54000000000000004 108.404 160.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.06 109.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.381 -1.34 . . . . 0.70999999999999996 107.381 168.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.52 128.77 42.65 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.176 0.591 . . . . 0.84999999999999998 109.901 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -140.15 -65.05 0.47 Allowed 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.848 0.859 . . . . 3.9700000000000002 110.858 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.58 -122.74 5.81 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.791 1.186 . . . . 1.05 112.94 -170.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -118.89 -49.81 2.41 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.179 0.991 . . . . 3.0800000000000001 109.67 -155.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.3 154.96 8.06 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 108.803 -1.719 . . . . 0.83999999999999997 108.803 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.33 42.8 1.29 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.175 2.583 . . . . 1.0600000000000001 113.385 -165.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -84.98 153.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.191 1.396 . . . . 1.1799999999999999 110.298 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.61 75.69 1.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.37 -0.974 . . . . 3.0099999999999998 108.37 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 165.27 16.89 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.56999999999999995 112.522 -171.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.51 133.22 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.11 0.964 . . . . 1.1799999999999999 109.546 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 26.6 mm -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.513 1.525 . . . . 0.79000000000000004 107.708 161.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -121.45 119.09 31.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.554 -1.646 . . . . 1.76 106.554 158.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.461 ' CD1' HG22 ' A' ' 31' ' ' VAL . 9.4 t80 -128.07 120.54 27.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.442 -1.318 . . . . 2.9500000000000002 107.442 -169.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.81 165.07 37.62 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.45 0.643 . . . . 4.3700000000000001 112.191 -166.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -153.84 157.04 38.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.501 -2.037 . . . . 2.9100000000000001 105.501 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.26 -29.77 64.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.043 0.383 . . . . 5.1900000000000004 110.894 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.52 -150.5 0.43 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.946 -1.501 . . . . 5.6200000000000001 106.946 174.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.0 m -146.17 1.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.708 -1.245 . . . . 4.2699999999999996 113.866 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -124.26 39.93 3.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.067 1.747 . . . . 3.46 109.728 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.84 -162.23 10.81 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.377 -1.089 . . . . 1.3799999999999999 110.377 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.98 114.5 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.155 2.57 . . . . 1.3600000000000001 111.139 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.1 158.54 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.089 -0.708 . . . . 0.91000000000000003 109.089 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -106.37 112.54 25.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.18 -1.045 . . . . 2.6600000000000001 108.18 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 20' ' ' PHE . 60.0 t -80.55 122.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.198 -1.778 . . . . 1.23 106.198 164.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -125.98 145.54 50.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.675 -0.861 . . . . 1.1399999999999999 108.675 154.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.41 155.4 26.68 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.673 -0.971 . . . . 0.72999999999999998 110.673 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -134.62 108.19 7.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.099 -2.186 . . . . 2.04 105.099 -173.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.3 149.01 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.014 -1.476 . . . . 0.92000000000000004 107.014 -167.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -155.32 157.28 36.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.957 -0.464 . . . . 3.8399999999999999 110.509 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.38 22.08 30.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.832 1.682 . . . . 0.90000000000000002 111.909 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.02 168.11 19.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.109 -1.071 . . . . 0.65000000000000002 108.109 168.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -74.85 169.17 18.45 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.216 -1.031 . . . . 1.6699999999999999 108.216 153.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.11 174.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.275 1.43 . . . . 3.9100000000000001 111.044 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -162.83 37.14 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.822 -0.626 . . . . 0.56000000000000005 113.531 167.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.67 141.23 57.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.929 1.292 . . . . 2.0299999999999998 113.27 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.3 114.64 7.53 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.486 1.514 . . . . 0.53000000000000003 109.751 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.46 145.14 2.81 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.497 1.046 . . . . 0.42999999999999999 110.665 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.18 93.57 3.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 2.4399999999999999 106.972 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.669 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 23.4 m170 -131.35 154.48 48.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.24 -0.437 . . . . 0.63 109.862 -161.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.02 116.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.375 -1.342 . . . . 2.1200000000000001 107.375 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -103.84 139.67 38.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.24 -1.393 . . . . 1.1000000000000001 107.24 170.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.35 35.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.802 1.408 . . . . 5.3399999999999999 114.802 -171.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.7 mt-10 . . . . . 0 C--O 1.234 0.278 0 O-C-N 120.507 -1.371 . . . . 3.3700000000000001 112.365 -159.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.058 0 N-CA-C 108.284 -1.006 . . . . 1.8100000000000001 108.284 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.15 -91.84 1.63 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.726 -1.75 . . . . 1.01 108.726 173.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.74 -179.06 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 125.843 4.362 . . . . 1.0700000000000001 112.7 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -53.1 131.6 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.615 1.566 . . . . 1.4399999999999999 110.236 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -42.44 114.03 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.771 1.228 . . . . 2.6200000000000001 109.712 170.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -156.29 165.95 17.51 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 106.671 -1.603 . . . . 2.5299999999999998 106.671 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.39 -35.09 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.549 1.499 . . . . 1.1399999999999999 111.487 -167.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -147.22 -82.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.876 0.87 . . . . 2.7999999999999998 109.194 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.4 m -139.03 64.94 1.46 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.383 1.073 . . . . 2.04 110.617 -168.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -77.67 175.27 10.07 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.532 0.682 . . . . 4.0300000000000002 109.3 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 8.5 mttp -120.83 146.47 46.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.473 1.509 . . . . 3.2799999999999998 107.189 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -72.31 167.31 20.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.568 0.747 . . . . 1.29 110.873 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.03 -138.45 2.68 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 106.699 -2.56 . . . . 2.0099999999999998 106.699 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.75 -144.26 4.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.882 -2.087 . . . . 1.6699999999999999 107.882 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.57 -41.24 6.47 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.176 1.988 . . . . 1.8400000000000001 109.901 174.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -58.03 7.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.724 0.81 . . . . 5.5499999999999998 111.802 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.16 145.44 37.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.576 -0.528 . . . . 2.04 109.576 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -55.97 -44.54 78.6 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.77 1.628 . . . . 4.1200000000000001 111.156 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 7.1 mt-10 -78.92 179.45 7.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.012 0.925 . . . . 2.8700000000000001 111.243 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 157.67 144.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.391 3.076 . . . . 2.9300000000000002 106.369 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.478 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.4 m80 -59.96 141.23 55.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 105.536 -2.024 . . . . 0.53000000000000003 105.536 156.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.68 71.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 123.117 1.437 . . . . 2.4300000000000002 108.165 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.26 26.73 0.26 Allowed Glycine 0 CA--C 1.542 1.774 0 C-N-CA 126.779 2.133 . . . . 0.85999999999999999 113.59 -155.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -130.51 145.75 51.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 120.518 2.159 . . . . 2.27 108.032 146.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -104.95 -42.36 5.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.794 0.837 . . . . 1.79 108.79 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.28 -121.82 1.11 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 109.076 -1.61 . . . . 0.56999999999999995 109.076 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -139.82 169.22 18.12 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.381 1.473 . . . . 1.6399999999999999 109.076 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.34 175.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 0.58999999999999997 106.653 163.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -106.68 142.63 36.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.967 -1.494 . . . . 2.3900000000000001 106.967 156.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.75 152.05 31.7 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.24 -1.022 . . . . 0.66000000000000003 108.24 152.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.32 -78.9 0.09 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.666 0.786 . . . . 2.8599999999999999 110.303 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -154.39 -52.43 0.09 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.716 1.606 . . . . 4.6900000000000004 107.948 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.63 4.03 17.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.084 1.754 . . . . 5.0099999999999998 111.748 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.07 10.16 72.25 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.907 1.241 . . . . 0.84999999999999998 111.682 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -79.17 147.38 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 0.98999999999999999 107.694 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.05 167.76 21.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.244 1.018 . . . . 0.66000000000000003 108.755 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -130.64 144.59 51.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 103.901 -2.629 . . . . 2.7000000000000002 103.901 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.06 111.04 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 106.704 -1.591 . . . . 1.1499999999999999 106.704 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -140.17 104.82 4.9 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.952 0.901 . . . . 1.4099999999999999 108.773 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.04 151.9 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.662 -0.866 . . . . 1.6599999999999999 108.662 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.32 98.55 3.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.626 0.37 . . . . 2.5899999999999999 110.152 158.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.58 160.12 20.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.512 0.325 . . . . 2.6400000000000001 110.155 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -116.95 57.18 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.353 1.461 . . . . 2.5099999999999998 109.312 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -139.56 -64.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 108.025 -1.102 . . . . 1.1200000000000001 108.025 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.7 pp -75.88 175.58 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.345 0.593 . . . . 1.4199999999999999 110.905 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -153.94 176.0 12.7 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.554 1.541 . . . . 2.04 107.01 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 11.78 33.63 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.676 1.58 . . . . 2.3300000000000001 114.486 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.464 0.261 0 CA-C-N 118.362 0.528 . . . . 3.1600000000000001 111.654 -170.919 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 110.528 -0.175 . . . . 1.3700000000000001 110.528 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.5 pt -78.96 -7.05 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.208 -0.308 . . . . 1.8899999999999999 110.28 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -44.98 129.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.267 0.627 . . . . 1.46 109.744 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.21 -5.36 84.47 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 118.143 -1.365 . . . . 1.3400000000000001 113.839 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -98.26 162.3 13.26 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 120.199 2.0 . . . . 4.1100000000000003 111.655 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.0 m -94.65 107.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.059 0.943 . . . . 1.01 109.319 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.83 133.52 45.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.398 -0.964 . . . . 1.6499999999999999 108.398 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.94 134.23 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 126.846 2.058 . . . . 0.44 106.516 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -101.47 128.84 53.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.624 -1.621 . . . . 1.6599999999999999 106.624 165.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.529 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 48.3 m-70 -104.86 161.13 14.45 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 116.037 1.865 . . . . 0.52000000000000002 116.037 -169.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -37.32 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.41 2.684 . . . . 3.4100000000000001 112.06 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -101.27 -174.85 2.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.599 0.636 . . . . 2.6800000000000002 109.905 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.11 156.94 11.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.722 -0.844 . . . . 0.62 108.722 157.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -80.4 164.59 22.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.902 0.858 . . . . 2.1600000000000001 109.14 152.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -88.06 -4.61 58.76 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.321 1.448 . . . . 3.2400000000000002 112.354 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 56.16 33.79 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.638 1.175 . . . . 1.6299999999999999 110.561 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.98 25.33 65.93 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.392 -0.671 . . . . 1.4399999999999999 112.46 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -131.97 21.11 4.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.261 1.031 . . . . 5.1799999999999997 111.731 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.32 147.04 18.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.707 -0.957 . . . . 2.48 110.707 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.73 60.07 2.95 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.874 -0.89 . . . . 2.8799999999999999 110.874 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -176.67 106.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 105.232 -2.136 . . . . 2.8300000000000001 105.232 -169.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -31.92 46.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.021 0.749 . . . . 3.8199999999999998 113.021 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -36.01 -43.61 0.33 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.076 1.75 . . . . 2.9399999999999999 112.783 166.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t -43.78 -63.91 0.76 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.954 1.701 . . . . 2.7200000000000002 110.205 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.39 -46.11 61.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.818 -0.551 . . . . 1.6699999999999999 110.988 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -56.06 -45.75 79.18 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 123.642 0.777 . . . . 3.25 110.875 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.478 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 2.7 p -130.81 -47.88 1.04 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 119.127 -0.463 . . . . 1.49 112.022 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.41 -31.2 0.86 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.699 0.682 . . . . 1.0 112.647 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.41 54.21 5.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.098 1.359 . . . . 1.9399999999999999 110.09 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.83 -36.03 81.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.23 1.412 . . . . 1.1799999999999999 112.792 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 -174.05 49.77 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.396 -1.882 . . . . 0.91000000000000003 108.396 -160.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.1 m -59.53 151.61 23.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.439 1.495 . . . . 1.3200000000000001 113.385 -166.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 50' ' ' GLU . 4.8 mmt-85 -60.6 135.0 57.63 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.114 1.366 . . . . 3.0800000000000001 108.522 168.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.4 mt -112.19 -68.93 0.9 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.618 -1.253 . . . . 0.45000000000000001 107.618 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.6 166.41 11.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.185 -0.461 . . . . 1.1100000000000001 110.209 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.2 p -146.81 161.12 41.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.953 -1.021 . . . . 2.5299999999999998 108.507 165.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.94 131.62 1.57 Allowed Glycine 0 CA--C 1.526 0.779 0 O-C-N 125.07 1.481 . . . . 0.66000000000000003 110.288 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.13 134.6 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 123.743 0.817 . . . . 0.87 109.433 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.4 tt -91.8 126.37 44.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 C-N-CA 123.236 0.615 . . . . 0.90000000000000002 111.439 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.74 -5.75 0.84 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.467 1.032 . . . . 0.70999999999999996 114.911 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.5 mp -90.82 59.54 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.816 1.308 . . . . 1.1499999999999999 110.297 -155.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.49 175.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.866 0.841 . . . . 2.0699999999999998 113.181 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 C--O 1.248 1.001 0 N-CA-C 104.555 -2.387 . . . . 6.7000000000000002 104.555 160.571 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 pttt . . . . . 0 N--CA 1.457 -0.098 0 N-CA-C 112.002 0.371 . . . . 4.2800000000000002 112.002 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.42 155.09 19.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.718 1.207 . . . . 0.75 109.043 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.24 151.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.614 -1.254 . . . . 0.82999999999999996 107.614 162.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.75 102.39 6.07 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.86 0.864 . . . . 0.77000000000000002 108.765 157.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.61 105.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.149 -1.426 . . . . 0.80000000000000004 107.149 161.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -86.18 129.7 34.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.005 -1.109 . . . . 0.93000000000000005 108.005 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -151.58 -51.69 0.12 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.958 0.408 . . . . 3.1699999999999999 110.552 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.24 -111.16 1.06 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.472 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.99 -48.44 2.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.483 1.113 . . . . 3.6299999999999999 109.429 -161.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.65 171.65 33.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.212 1.387 . . . . 0.84999999999999998 112.048 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -69.64 -19.05 37.2 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.587 2.858 . . . . 1.3799999999999999 111.961 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.68 146.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.203 1.401 . . . . 1.0 111.072 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.11 122.05 5.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.783 -0.821 . . . . 2.0600000000000001 108.783 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.41 169.75 32.79 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.843 -0.503 . . . . 0.68000000000000005 111.843 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.84 113.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.059 -1.089 . . . . 1.4399999999999999 108.059 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -79.49 137.16 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.936 -1.135 . . . . 0.76000000000000001 107.936 167.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -109.66 118.46 36.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.008 -1.849 . . . . 1.4399999999999999 106.008 157.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.586 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -108.04 98.04 7.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.575 1.55 . . . . 3.23 106.89 176.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -109.13 137.13 47.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.441 -0.948 . . . . 5.1699999999999999 108.441 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -147.42 -62.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.54 -0.911 . . . . 4.0599999999999996 108.54 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 tttp 72.82 -48.41 0.68 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.834 1.654 . . . . 8.75 112.243 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 99.75 5.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.69 -1.226 . . . . 3.7799999999999998 107.69 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.4 t -19.36 -66.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.854 2.461 . . . . 2.8999999999999999 114.954 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -109.61 27.16 9.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.564 0.746 . . . . 3.5899999999999999 110.579 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.42 171.49 33.67 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.562 -1.015 . . . . 1.1799999999999999 110.562 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.13 139.5 66.99 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.948 1.766 . . . . 1.1200000000000001 110.257 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.81 159.86 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.274 -1.01 . . . . 1.26 108.274 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 110.85 13.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.28 -1.378 . . . . 3.2400000000000002 107.28 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.586 HG22 ' CE1' ' A' ' 20' ' ' PHE . 59.4 t -100.73 118.04 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 127.124 2.17 . . . . 1.1699999999999999 107.139 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -139.03 167.22 22.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.935 -0.395 . . . . 1.0800000000000001 109.935 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.15 175.31 38.95 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.699 -1.76 . . . . 0.88 108.699 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.1 p -130.15 113.84 14.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.807 -2.294 . . . . 2.46 104.807 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.31 109.81 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.283 -2.117 . . . . 1.51 105.283 -166.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -111.38 162.61 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.731 0.645 . . . . 3.7999999999999998 111.731 -166.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.55 80.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.219 -0.901 . . . . 0.78000000000000003 112.95 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -69.44 160.51 31.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.588 1.194 . . . . 0.83999999999999997 108.488 172.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.42 163.88 17.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.949 -1.13 . . . . 1.9399999999999999 107.949 154.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -58.61 170.11 0.82 Allowed 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.443 -0.786 . . . . 2.8900000000000001 111.295 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.58 -158.87 53.66 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.655 -0.702 . . . . 0.66000000000000003 112.693 165.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -70.86 144.44 50.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.849 1.259 . . . . 2.5600000000000001 112.59 -171.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -146.36 118.5 8.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.909 1.684 . . . . 0.63 109.294 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.99 149.86 4.18 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.923 -0.871 . . . . 0.34000000000000002 110.923 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -142.84 94.91 2.69 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.834 -1.543 . . . . 2.27 106.834 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -136.6 144.82 44.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.704 -1.221 . . . . 0.54000000000000004 107.704 -164.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.2 p -99.63 127.03 52.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 119.17 0.896 . . . . 1.8 109.894 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -97.1 136.23 37.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.356 -1.35 . . . . 0.77000000000000002 107.356 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.76 -32.29 59.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.169 0.988 . . . . 4.3200000000000003 112.111 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 7.3 tt0 . . . . . 0 CA--C 1.535 0.382 0 C-N-CA 128.525 2.73 . . . . 3.0299999999999998 113.068 158.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.612 0.244 . . . . 1.8500000000000001 110.606 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.55 -85.31 1.15 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.684 -1.767 . . . . 1.05 108.684 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.1 178.88 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.607 1 C-N-CA 125.774 4.316 . . . . 0.90000000000000002 113.308 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -67.96 132.88 48.13 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.572 1.549 . . . . 1.3100000000000001 110.106 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -44.99 114.03 0.66 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.942 0.897 . . . . 2.8999999999999999 111.68 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.92 157.36 31.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.634 1.574 . . . . 2.6000000000000001 106.875 168.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.06 -24.13 13.03 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.958 1.772 . . . . 1.3300000000000001 113.609 -168.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.0 tp -156.2 -72.32 0.11 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.03 0.832 . . . . 3.1800000000000002 110.856 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.6 m -154.09 63.21 0.7 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.266 0.555 . . . . 1.9199999999999999 110.21 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -78.09 168.76 19.38 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.353 -0.98 . . . . 3.8999999999999999 108.353 162.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -128.76 165.11 21.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.026 1.331 . . . . 4.6500000000000004 108.214 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -94.66 132.25 39.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.665 -0.865 . . . . 1.1699999999999999 108.665 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.92 -56.84 0.08 OUTLIER Glycine 0 C--O 1.224 -0.522 0 N-CA-C 108.095 -2.002 . . . . 2.96 108.095 171.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 140.33 173.41 13.34 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.457 1.503 . . . . 1.54 110.083 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.04 -31.13 66.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.902 2.402 . . . . 1.9199999999999999 111.037 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -73.84 -40.63 63.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.099 0.96 . . . . 4.0700000000000003 111.059 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -70.42 176.12 4.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.91 0.884 . . . . 1.8500000000000001 111.288 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.48 -48.96 20.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.386 1.074 . . . . 4.4299999999999997 109.734 168.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.38 149.85 26.45 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.654 1.216 . . . . 3.4700000000000002 112.185 -171.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -168.1 129.28 1.38 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.977 2.111 . . . . 5.71 107.488 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.491 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 50.1 m80 -51.62 131.58 29.88 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.463 -2.421 . . . . 0.59999999999999998 104.463 145.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.09 -35.47 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.933 -0.765 . . . . 1.9299999999999999 108.933 -169.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.76 38.95 2.98 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.537 1.065 . . . . 0.78000000000000003 115.289 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -90.16 129.21 36.46 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.206 -2.146 . . . . 1.8200000000000001 105.206 152.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.67 -51.75 6.25 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.735 -1.209 . . . . 1.8500000000000001 107.735 156.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.35 -104.63 0.26 Allowed Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.977 -1.249 . . . . 0.56999999999999995 109.977 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -148.49 170.64 17.59 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.799 1.64 . . . . 1.4099999999999999 109.57 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.81 162.32 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.069 -1.456 . . . . 0.56999999999999995 107.069 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.6 m -109.4 129.79 55.53 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 108.012 -1.107 . . . . 2.1600000000000001 108.012 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.51 139.26 34.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.744 0.818 . . . . 0.64000000000000001 111.513 168.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.13 -90.67 0.08 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 124.045 0.841 . . . . 3.0800000000000001 110.574 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -141.2 -34.38 0.49 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.395 0.887 . . . . 4.04 113.395 -162.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -78.81 14.75 1.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.911 1.339 . . . . 3.6699999999999999 110.385 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 62.33 20.88 61.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.115 -1.194 . . . . 0.72999999999999998 110.115 -166.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -92.24 117.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 123.995 0.918 . . . . 1.04 108.573 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.21 143.81 26.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.899 -1.889 . . . . 0.87 105.899 149.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.35 108.1 8.97 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 105.44 -2.059 . . . . 5.21 105.44 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.85 141.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.84 -1.073 . . . . 2.1600000000000001 110.601 -148.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.7 t -146.13 113.29 6.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.188 -1.412 . . . . 3.1800000000000002 107.188 162.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.4 mt -137.15 144.86 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 105.88 -1.896 . . . . 1.6299999999999999 105.88 166.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -125.71 96.36 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.945 0.35 . . . . 2.46 111.945 165.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.9 145.39 34.13 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.274 0.559 . . . . 2.6299999999999999 110.719 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.6 p -98.35 -20.52 17.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.394 1.878 . . . . 1.53 111.27 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.42 -49.6 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.305 0.502 . . . . 0.94999999999999996 109.875 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.2 pt -75.43 177.74 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.761 0.791 . . . . 1.4399999999999999 111.438 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.8 m -157.41 175.76 13.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.78 1.632 . . . . 1.76 107.417 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.417 HD21 ' HD2' ' A' ' 20' ' ' PHE . 77.1 mt -124.31 54.99 1.32 Allowed 'General case' 0 C--N 1.338 0.08 0 C-N-CA 124.534 1.133 . . . . 4.3300000000000001 108.754 174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 126.203 1.801 . . . . 3.0699999999999998 107.351 174.937 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.2 m . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 108.591 -0.892 . . . . 2.29 108.591 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.565 ' CD1' HG21 ' A' ' 149' ' ' ILE . 2.6 pp -78.78 -24.36 13.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.693 -0.403 . . . . 1.96 110.449 -163.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 tp -1.79 113.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.33 2.652 . . . . 1.8500000000000001 114.099 161.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.59 37.62 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.971 0.796 . . . . 1.74 113.183 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.485 ' O ' HG22 ' A' ' 149' ' ' ILE . 81.3 mtt85 -83.0 169.48 15.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.542 1.171 . . . . 4.0499999999999998 110.24 -171.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.2 m -95.45 108.81 21.05 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.735 -0.603 . . . . 0.92000000000000004 110.459 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.84 131.32 44.3 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.368 -1.345 . . . . 1.5700000000000001 107.368 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.09 139.89 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 127.265 2.226 . . . . 0.39000000000000001 107.845 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 m -108.86 130.19 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.85 -0.796 . . . . 1.6100000000000001 108.85 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -99.09 159.79 14.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 116.01 1.856 . . . . 0.38 116.01 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -40.65 -74.66 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.302 2.241 . . . . 3.0899999999999999 112.562 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -97.13 -179.34 4.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.198 1.399 . . . . 2.6099999999999999 110.637 -171.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.38 149.96 5.2 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 0.54000000000000004 109.473 156.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.5 149.04 26.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.152 -1.055 . . . . 2.1400000000000001 108.152 162.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.72 -8.6 59.34 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.233 0.827 . . . . 3.4199999999999999 113.233 -164.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 47.48 38.12 7.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.169 0.985 . . . . 2.2799999999999998 110.413 -165.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.25 25.48 57.42 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.533 -0.758 . . . . 2.0 113.001 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -113.85 40.38 2.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.22 1.01 . . . . 5.1799999999999997 108.655 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.0 134.6 9.0 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.895 -1.682 . . . . 2.23 108.895 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.67 -35.51 92.13 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 117.509 0.655 . . . . 2.4399999999999999 111.756 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -58.71 107.94 0.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.961 0.904 . . . . 2.1000000000000001 108.719 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -41.93 -42.65 2.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 3.8999999999999999 112.817 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -36.43 -41.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.73 2.012 . . . . 2.8100000000000001 113.978 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.5 m -54.93 -48.26 73.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.452 0.701 . . . . 2.4500000000000002 111.631 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.7 p -73.08 -46.33 52.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.361 -0.837 . . . . 1.23 110.482 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -51.83 -49.74 62.23 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.685 1.194 . . . . 2.54 111.264 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.491 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.9 OUTLIER -125.0 -46.52 1.82 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.607 0.763 . . . . 1.3100000000000001 111.142 175.489 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.91 2.02 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 119.086 0.857 . . . . 0.93999999999999995 112.197 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.64 54.28 9.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.187 1.795 . . . . 1.98 111.181 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.01 -5.36 58.28 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.26 -0.9 . . . . 1.1499999999999999 111.804 169.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.74 -165.23 45.71 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.083 -1.607 . . . . 0.93999999999999995 109.083 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.1 m -57.94 150.85 19.56 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.554 1.542 . . . . 1.22 113.678 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.1 mmt-85 -54.7 135.79 46.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.082 -1.417 . . . . 2.6600000000000001 108.275 164.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.5 mt -106.89 -76.63 0.61 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.953 -1.499 . . . . 0.52000000000000002 106.953 166.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 144.98 32.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.477 -0.934 . . . . 0.70999999999999996 108.477 170.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.46 150.36 48.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.119 -1.808 . . . . 1.71 106.119 172.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.48 119.94 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.424 -1.07 . . . . 0.75 110.424 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.47 130.21 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.046 1.338 . . . . 1.21 108.923 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.565 HG21 ' CD1' ' A' ' 112' ' ' ILE . 6.7 tt -105.65 133.12 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.962 0.727 . . . . 1.1399999999999999 112.962 -169.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.87 8.43 0.47 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.313 0.959 . . . . 0.82999999999999996 114.205 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.7 mm -91.88 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 120.045 1.922 . . . . 1.1299999999999999 109.867 -162.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.7 176.83 12.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.952 1.301 . . . . 1.3400000000000001 108.333 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--O 1.254 1.331 0 N-CA-C 107.014 -1.476 . . . . 4.7599999999999998 107.014 166.703 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 108.502 -0.925 . . . . 3.5299999999999998 108.502 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.63 141.19 49.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.948 -1.131 . . . . 0.88 107.948 159.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.581 HG23 ' HB2' ' A' ' 152' ' ' ALA . 71.0 t -103.81 142.83 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.195 -1.409 . . . . 0.70999999999999996 107.195 163.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -122.35 96.9 5.22 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.13 0.972 . . . . 0.51000000000000001 108.418 158.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.41 106.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.083 -1.451 . . . . 0.62 107.083 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 mt -99.17 133.95 42.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.166 0.986 . . . . 1.1000000000000001 109.196 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -143.47 -52.27 0.35 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.108 0.563 . . . . 3.3599999999999999 110.066 172.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.7 -121.67 27.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.878 0.751 . . . . 0.88 113.286 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -120.28 -54.66 2.09 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 125.128 1.371 . . . . 3.9900000000000002 110.008 -164.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.5 162.96 13.66 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.756 -1.338 . . . . 0.83999999999999997 109.756 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.52 33.54 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.389 2.726 . . . . 0.95999999999999996 113.141 -172.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 47.4 t -83.17 155.79 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.784 1.234 . . . . 0.83999999999999997 108.956 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -154.98 122.21 5.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.507 1.523 . . . . 2.5 107.243 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.41 169.09 38.36 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.883 -0.887 . . . . 0.47999999999999998 110.883 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.06 109.07 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.784 -1.562 . . . . 1.05 106.784 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 39.0 mm -79.03 126.45 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.531 -1.655 . . . . 0.73999999999999999 106.531 168.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -101.99 109.08 20.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.63 -1.618 . . . . 1.6299999999999999 106.63 160.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.42 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -90.31 96.43 10.66 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.028 -1.842 . . . . 2.8999999999999999 106.028 168.254 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.58 165.37 15.51 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.425 -0.954 . . . . 3.23 108.425 163.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -157.24 -50.39 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.279 0.632 . . . . 3.8999999999999999 109.411 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt 70.99 -61.33 0.48 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 127.594 2.358 . . . . 4.25 111.156 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -80.89 118.86 22.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.083 -0.71 . . . . 4.1600000000000001 109.083 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 m -20.24 -66.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.233 3.013 . . . . 3.3599999999999999 116.05 -172.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -123.9 52.55 1.45 Allowed 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 107.623 -1.251 . . . . 3.6899999999999999 107.623 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.98 178.09 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.761 -1.336 . . . . 1.46 109.761 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.01 132.7 30.92 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.107 1.871 . . . . 1.6399999999999999 111.283 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.6 124.2 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 108.747 -0.834 . . . . 1.1200000000000001 108.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -99.3 89.99 4.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.434 2.694 . . . . 5.04 105.538 -170.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 20' ' ' PHE . 12.6 t -83.54 126.1 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.138 1.775 . . . . 1.28 107.161 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -140.69 140.23 34.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.715 -0.846 . . . . 0.84999999999999998 108.715 158.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.48 145.75 8.75 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 105.806 -2.918 . . . . 0.82999999999999996 105.806 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.4 m -127.13 78.49 1.81 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.2 -1.778 . . . . 2.6899999999999999 106.2 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.38 134.15 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 128.38 2.672 . . . . 0.88 108.48 -162.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -129.48 163.01 26.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 118.741 0.701 . . . . 4.3600000000000003 111.475 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.09 24.27 52.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.113 0.863 . . . . 0.89000000000000001 111.993 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.16 -150.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.497 -1.297 . . . . 1.1399999999999999 107.497 163.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 m -147.34 152.35 38.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.36 -2.459 . . . . 3.3300000000000001 104.36 164.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -32.8 138.1 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.484 2.314 . . . . 2.7999999999999998 113.862 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.77 -166.4 28.92 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.212 0.434 . . . . 0.67000000000000004 112.995 167.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.29 147.24 53.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.091 1.356 . . . . 2.3399999999999999 112.829 -166.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -149.39 115.57 5.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.796 1.639 . . . . 0.46999999999999997 109.002 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.23 155.83 2.51 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.749 0.704 . . . . 0.54000000000000004 111.449 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.533 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 31.6 t80 -149.25 100.6 3.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.69 -0.855 . . . . 2.6899999999999999 108.69 -169.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -137.59 175.42 9.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.596 -1.261 . . . . 0.69999999999999996 107.596 -166.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.76 137.73 56.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.837 0.827 . . . . 1.8100000000000001 109.135 165.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -101.3 178.76 4.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.673 1.589 . . . . 0.93000000000000005 107.224 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -107.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.251 -1.018 . . . . 5.54 108.251 174.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 CA--C 1.529 0.163 0 C-N-CA 125.194 1.397 . . . . 3.2000000000000002 111.591 174.25 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 121.586 0.708 . . . . 1.99 110.723 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.44 -89.56 0.97 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.356 -1.898 . . . . 1.4299999999999999 108.356 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.87 179.02 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 125.136 3.89 . . . . 1.3300000000000001 112.919 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.416 ' HB2' ' CG ' ' A' ' 80' ' ' HIS . 24.2 m170 -65.46 138.4 58.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.16 1.784 . . . . 1.53 111.694 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -45.18 108.45 0.12 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.085 1.754 . . . . 2.5 111.993 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -150.24 154.82 36.73 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 125.727 1.611 . . . . 2.4300000000000002 107.454 166.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.51 -42.0 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.17 1.913 . . . . 1.29 112.667 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -142.33 -68.07 0.37 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.029 0.531 . . . . 3.3199999999999998 110.937 -175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -154.12 64.92 0.7 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.632 -0.668 . . . . 2.0499999999999998 111.532 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -78.02 166.25 23.05 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.952 -1.129 . . . . 4.0099999999999998 107.952 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -123.71 176.93 5.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.26 1.824 . . . . 5.2599999999999998 106.846 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -101.63 148.62 25.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.982 -0.449 . . . . 1.1599999999999999 111.515 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.58 -61.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.465 -1.054 . . . . 2.9700000000000002 110.465 173.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.23 -172.55 29.28 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.904 1.24 . . . . 1.6200000000000001 114.206 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 -41.49 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.769 2.313 . . . . 1.95 109.787 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -70.64 -47.55 59.47 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.735 0.814 . . . . 5.2199999999999998 111.239 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.84 175.21 1.56 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.108 -0.496 . . . . 2.5600000000000001 109.681 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.6 -39.92 21.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.986 -0.746 . . . . 8.0 108.986 165.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 147.14 39.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 117.237 -1.785 . . . . 3.8100000000000001 110.576 -165.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 167.58 127.89 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.548 2.339 . . . . 3.2799999999999998 108.262 -167.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 53.7 m80 -49.25 127.63 15.2 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 106.815 -1.55 . . . . 1.1000000000000001 106.815 163.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 p -52.69 -34.62 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.544 0.572 . . . . 1.55 112.544 -154.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.76 83.42 0.77 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.967 -0.853 . . . . 0.89000000000000001 110.967 166.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -161.98 111.74 1.54 Allowed 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.789 -0.83 . . . . 2.1200000000000001 108.84 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -90.02 -53.01 4.67 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.883 0.473 . . . . 2.1299999999999999 110.743 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.62 -102.74 0.22 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.572 -0.823 . . . . 0.73999999999999999 111.998 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.18 166.79 27.77 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.92 1.288 . . . . 1.8300000000000001 110.176 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.62 175.58 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.865 1.666 . . . . 0.48999999999999999 106.612 167.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 t -127.36 134.43 49.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.624 -0.88 . . . . 2.0699999999999998 108.624 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.74 135.99 36.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 123.227 0.611 . . . . 0.56999999999999995 110.411 165.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.19 -92.16 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.795 1.638 . . . . 3.1899999999999999 110.238 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -115.03 -67.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.616 0.767 . . . . 5.9100000000000001 110.864 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.3 -32.44 49.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 122.062 0.934 . . . . 3.4700000000000002 110.262 -168.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.24 46.41 0.07 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.597 -2.201 . . . . 0.83999999999999997 107.597 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.51 111.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.36 1.864 . . . . 0.83999999999999997 106.901 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.33 174.29 5.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.091 -1.078 . . . . 0.66000000000000003 108.091 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -145.52 149.61 34.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.787 -1.56 . . . . 3.1000000000000001 106.787 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG11 ' CZ ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -127.16 54.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.288 0.992 . . . . 1.6799999999999999 111.293 -178.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.3 m -70.07 91.8 0.71 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.839 -0.538 . . . . 1.1200000000000001 110.717 165.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.62 149.83 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.926 0.89 . . . . 1.45 108.646 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -113.23 89.6 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.729 -0.841 . . . . 3.2200000000000002 108.729 160.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -77.88 148.54 34.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.224 0.92 . . . . 2.3500000000000001 109.77 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.3 p -115.01 -6.69 12.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.926 1.69 . . . . 1.73 112.729 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.4 t -78.79 -54.73 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 119.546 1.066 . . . . 1.6899999999999999 109.615 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -86.85 176.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.977 0.894 . . . . 0.98999999999999999 111.403 178.217 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -145.17 160.94 40.66 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.093 -1.817 . . . . 1.8999999999999999 106.093 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.93 24.9 7.9 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.064 0.946 . . . . 2.5499999999999998 111.644 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 CA--C 1.534 0.349 0 C-N-CA 123.069 0.548 . . . . 3.02 109.657 -178.239 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 121.786 0.803 . . . . 1.3100000000000001 112.408 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.2 pt -84.12 -5.72 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.961 -0.563 . . . . 2.1800000000000002 111.429 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -51.0 136.59 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 O-C-N 122.016 -0.427 . . . . 1.75 110.207 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.88 30.01 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.614 -1.103 . . . . 1.76 112.45 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -89.59 166.06 13.87 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.8 1.8 . . . . 4.79 112.614 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 146' ' ' CYS . 1.8 m -85.54 104.09 14.98 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.537 0.735 . . . . 1.1299999999999999 109.878 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 2.3 tt -69.42 147.8 50.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.585 -0.894 . . . . 2.0699999999999998 108.585 170.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.56 128.85 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.339 1.056 . . . . 0.54000000000000004 109.088 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 1.3 p -100.66 125.7 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 106.429 -1.693 . . . . 2.1000000000000001 106.429 162.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -98.29 174.17 6.63 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.316 1.846 . . . . 0.44 115.035 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.497 -1.229 . . . . 4.96 111.984 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -178.42 6.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 121.079 1.763 . . . . 3.6600000000000001 110.98 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.38 156.25 13.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.213 -0.903 . . . . 0.92000000000000004 109.671 164.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.39 151.24 28.02 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.256 1.023 . . . . 2.6299999999999999 110.027 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.55 -10.64 58.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.623 0.769 . . . . 3.1499999999999999 112.679 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 49.06 35.57 7.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.394 1.478 . . . . 1.8200000000000001 110.904 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.96 22.28 54.54 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 121.494 -0.754 . . . . 1.99 112.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -116.88 -33.5 4.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.871 0.836 . . . . 5.0999999999999996 110.967 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.64 137.15 39.64 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.474 -0.65 . . . . 2.6899999999999999 111.474 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.04 69.31 1.6 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.082 0.849 . . . . 2.7000000000000002 112.27 -170.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -162.33 155.47 20.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.74 1.616 . . . . 2.6299999999999999 107.096 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.42 -40.8 97.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.227 0.467 . . . . 3.21 112.237 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -57.55 -30.94 65.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.032 0.533 . . . . 2.77 111.37 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -49.44 -69.68 0.11 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.965 0.906 . . . . 2.1899999999999999 110.277 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.2 p -69.28 -42.42 75.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.461 -0.774 . . . . 1.3300000000000001 110.422 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -61.42 -35.62 78.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.31 0.505 . . . . 3.3500000000000001 111.892 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.516 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.416 1.3 t -139.11 -58.3 0.6 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.919 -1.039 . . . . 1.8500000000000001 113.203 177.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.06 -18.19 0.47 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 120.194 1.361 . . . . 1.05 111.8 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.6 t30 51.09 54.64 10.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.654 1.582 . . . . 2.0 111.107 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.88 -52.62 5.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.531 0.682 . . . . 1.3799999999999999 110.473 170.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.63 -169.46 32.89 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.836 -1.706 . . . . 0.93999999999999995 108.836 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -58.4 161.55 4.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.744 1.618 . . . . 1.8899999999999999 111.293 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmt-85 -58.66 137.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.938 -1.028 . . . . 2.9199999999999999 108.356 166.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.82 -70.65 0.8 Allowed 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.134 -1.432 . . . . 0.45000000000000001 107.134 163.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -99.32 157.22 16.55 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.672 -0.695 . . . . 0.88 109.322 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.421 ' HB2' HG23 ' A' ' 116' ' ' THR . 0.7 OUTLIER -165.65 159.53 16.54 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 124.02 0.825 . . . . 1.5 109.129 171.436 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.58 141.39 3.42 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 107.068 -2.413 . . . . 0.88 107.068 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.7 133.15 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 123.999 0.919 . . . . 0.77000000000000002 110.174 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.8 tt -89.17 138.68 18.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 122.766 0.426 . . . . 0.79000000000000004 110.903 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.85 1.39 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.15 0.881 . . . . 0.69999999999999996 114.687 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.93 59.42 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.062 1.431 . . . . 0.84999999999999998 110.686 -161.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.581 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -144.08 177.64 8.43 Favored 'General case' 0 C--N 1.335 -0.022 0 N-CA-C 113.502 0.927 . . . . 1.6100000000000001 113.502 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.255 1.384 0 N-CA-C 103.098 -2.927 . . . . 6.3799999999999999 103.098 150.787 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 108.595 -0.891 . . . . 3.8100000000000001 108.595 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.9 154.8 36.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.453 -1.314 . . . . 0.78000000000000003 107.453 163.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.78 144.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 104.883 -2.266 . . . . 0.75 104.883 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -126.69 94.53 4.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.129 0.893 . . . . 0.5 108.887 159.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.55 108.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.162 -1.421 . . . . 0.65000000000000002 107.162 164.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.13 125.06 36.65 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.416 -0.587 . . . . 0.88 109.416 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -143.7 -55.5 0.38 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.067 0.547 . . . . 3.5699999999999998 110.263 165.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.7 -110.57 0.85 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.783 -0.927 . . . . 1.1399999999999999 110.783 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.76 -48.11 1.92 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.45 1.1 . . . . 3.6699999999999999 109.9 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.54 161.43 12.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 112.086 -0.406 . . . . 1.03 112.086 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.37 29.98 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.097 3.198 . . . . 1.04 114.215 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.04 160.88 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.142 1.377 . . . . 1.1599999999999999 108.787 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 97.8 1.93 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.786 -1.931 . . . . 3.0 105.786 168.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.45 167.17 24.84 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.933 -0.467 . . . . 0.5 111.933 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.33 121.44 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.555 -0.906 . . . . 1.1000000000000001 108.555 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 31.3 mm -87.7 142.35 13.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 107.413 -1.328 . . . . 0.81999999999999995 107.413 162.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.48 129.73 47.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.92 1.288 . . . . 1.5900000000000001 107.525 169.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -122.0 131.03 53.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.226 1.81 . . . . 3.0299999999999998 107.197 -172.367 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 153.98 48.9 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.522 -0.918 . . . . 4.0700000000000003 108.522 162.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.71 81.5 0.88 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.424 1.89 . . . . 3.98 107.486 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -40.44 -57.21 1.85 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.261 1.425 . . . . 4.6900000000000004 112.437 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.07 126.53 35.15 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.43 1.092 . . . . 3.8700000000000001 109.271 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -19.49 -66.68 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.277 2.631 . . . . 3.1299999999999999 114.57 174.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -118.5 42.2 2.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.391 1.076 . . . . 3.6099999999999999 109.214 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 175.29 48.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.333 -1.507 . . . . 1.1899999999999999 109.333 168.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.66 142.9 72.61 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.024 1.816 . . . . 1.0600000000000001 109.592 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.31 151.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.096 -1.075 . . . . 1.27 108.096 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -126.75 120.4 29.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.599 -1.26 . . . . 4.1699999999999999 107.599 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 20' ' ' PHE . 47.1 t -115.02 134.28 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.613 1.965 . . . . 1.22 107.261 -171.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -133.22 156.02 48.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.415 -2.068 . . . . 0.81999999999999995 105.415 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 145.78 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.939 -1.664 . . . . 0.70999999999999996 108.939 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -122.96 94.46 4.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.823 -2.288 . . . . 1.6799999999999999 104.823 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.71 142.03 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.765 -1.198 . . . . 0.77000000000000002 107.765 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -152.3 147.59 26.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 115.112 1.523 . . . . 3.4100000000000001 115.112 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.65 23.17 8.97 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.834 2.159 . . . . 0.93000000000000005 111.999 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -74.6 166.49 23.46 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.851 -1.166 . . . . 0.70999999999999996 107.851 167.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.24 165.45 20.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.889 -1.152 . . . . 1.8400000000000001 107.889 152.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.04 173.73 0.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.412 -0.805 . . . . 2.3399999999999999 110.513 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.14 -161.37 53.22 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.251 -0.431 . . . . 0.59999999999999998 113.053 165.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.29 140.27 58.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.481 1.112 . . . . 2.02 113.357 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -144.24 116.03 8.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.543 1.537 . . . . 0.54000000000000004 109.85 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.7 148.57 4.63 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.685 0.659 . . . . 0.55000000000000004 111.792 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 100.01 4.67 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.891 1.676 . . . . 3.04 107.334 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 12.6 m170 -133.98 160.49 37.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.396 -2.076 . . . . 0.68999999999999995 105.396 -169.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.11 125.92 74.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.482 -0.933 . . . . 1.8400000000000001 108.482 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.39 -161.35 0.73 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.316 1.046 . . . . 1.55 108.819 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -73.75 -129.01 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.083 0.953 . . . . 3.75 109.917 163.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.451 -0.407 0 C-N-CA 124.727 1.211 . . . . 3.0600000000000001 112.723 168.523 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 110.267 -0.271 . . . . 2.8399999999999999 110.267 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.53 -173.81 25.77 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 106.733 -2.547 . . . . 1.52 106.733 -158.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.92 178.27 6.67 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.658 3.572 . . . . 1.3400000000000001 113.958 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -74.01 58.22 0.66 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.145 1.778 . . . . 2.1600000000000001 111.606 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 51.92 69.02 0.72 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.255 1.022 . . . . 1.78 109.639 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -90.85 115.31 64.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.016 -0.992 . . . . 2.5899999999999999 108.482 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.29 -43.8 1.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.842 1.695 . . . . 1.3200000000000001 110.685 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -146.22 -67.25 0.28 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.232 1.013 . . . . 2.25 108.884 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.5 m -153.39 63.99 0.75 Allowed 'General case' 0 N--CA 1.457 -0.125 0 O-C-N 121.524 -0.735 . . . . 1.78 110.488 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -78.19 165.47 23.89 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.253 -0.647 . . . . 3.6099999999999999 109.253 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 6.7 mtmp? -133.66 154.26 51.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.148 1.379 . . . . 3.1200000000000001 109.012 -174.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -89.53 169.64 11.18 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.124 . . . . 0.81999999999999995 110.245 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.93 -40.21 0.17 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 107.761 -2.136 . . . . 2.6600000000000001 107.761 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.29 -175.63 54.54 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.706 1.622 . . . . 1.53 110.842 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.05 -8.9 23.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.584 2.856 . . . . 1.8300000000000001 114.167 -171.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -27.07 42.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.779 0.718 . . . . 6.4199999999999999 111.435 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.26 176.6 5.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.77 1.628 . . . . 2.7000000000000002 109.428 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.9 -47.04 40.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.962 -0.755 . . . . 4.7999999999999998 108.962 162.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 74.5 mt-10 -78.43 138.35 38.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.674 1.226 . . . . 3.0499999999999998 111.536 -169.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -160.45 154.35 22.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.36 -2.83 . . . . 5.1900000000000004 103.36 173.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.1 m80 -64.92 159.66 22.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 117.794 -1.563 . . . . 0.54000000000000004 106.88 162.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.08 40.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 122.984 1.373 . . . . 1.9199999999999999 110.876 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -170.73 42.2 0.19 Allowed Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 128.257 2.837 . . . . 0.59999999999999998 108.563 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -126.12 109.07 11.95 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.795 -1.187 . . . . 2.46 107.795 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.82 -50.3 10.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.419 -0.956 . . . . 1.8300000000000001 108.419 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.8 -120.69 0.99 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.43 -1.068 . . . . 0.96999999999999997 110.43 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -155.19 166.3 34.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.127 1.371 . . . . 1.5700000000000001 108.672 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.98 171.77 16.38 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 N-CA-C 108.206 -1.035 . . . . 0.69999999999999996 108.206 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 m -114.87 118.57 33.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.477 -1.305 . . . . 1.8899999999999999 107.477 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.81 140.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.375 0.534 . . . . 0.66000000000000003 110.319 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.2 -80.93 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.309 1.044 . . . . 3.0299999999999998 111.739 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -157.39 -48.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.107 1.363 . . . . 3.71 109.898 -170.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.76 13.78 1.56 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.012 1.325 . . . . 2.79 111.214 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.02 14.64 76.21 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.197 0.903 . . . . 0.75 111.256 -175.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.4 145.18 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.226 1.41 . . . . 0.93000000000000005 107.73 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.67 164.83 29.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.652 1.181 . . . . 0.71999999999999997 108.516 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.12 143.85 51.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.959 -2.608 . . . . 2.73 103.959 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.99 56.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 123.801 0.688 . . . . 1.6200000000000001 112.096 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.0 m -74.39 91.61 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.712 -0.617 . . . . 0.97999999999999998 110.935 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.2 mt -129.46 159.05 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.588 0.755 . . . . 1.6399999999999999 108.984 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.76 93.66 2.54 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 3.0299999999999998 111.392 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.9 126.09 30.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.717 0.807 . . . . 2.54 109.582 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 p -95.54 1.73 53.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.249 1.42 . . . . 1.8400000000000001 112.567 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.54 -44.82 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.519 0.727 . . . . 1.21 109.795 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pt -74.65 175.75 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.845 -0.742 . . . . 1.1799999999999999 109.762 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 p -151.96 176.94 10.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.918 1.287 . . . . 2.1499999999999999 107.784 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.0 mt -131.95 57.8 1.76 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.374 1.87 . . . . 4.1500000000000004 110.725 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.722 0.638 . . . . 3.4300000000000002 112.722 174.829 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 120.237 0.065 . . . . 1.3100000000000001 111.157 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.3 pt -77.95 -6.47 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.841 0.682 . . . . 1.97 112.841 -174.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.3 mm -32.01 116.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.1 1.36 . . . . 1.71 110.323 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.49 10.87 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 112.12 -0.392 . . . . 1.75 112.12 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -136.1 164.6 27.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.499 -1.667 . . . . 6.25 106.499 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.01 113.23 23.44 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.602 1.092 . . . . 1.8899999999999999 109.558 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 118' ' ' VAL . 2.0 tm? -69.35 145.09 53.24 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.267 -1.753 . . . . 2.3100000000000001 106.267 167.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 117' ' ' LEU . 71.5 t -130.98 135.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.137 1.775 . . . . 0.58999999999999997 109.066 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -101.79 123.65 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.756 1.223 . . . . 1.78 107.711 164.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.579 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 93.8 m-70 -95.96 165.69 12.14 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 117.378 2.362 . . . . 0.66000000000000003 117.378 -172.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.47 -66.43 0.56 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.16 -1.836 . . . . 3.4700000000000002 110.971 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -90.28 -179.5 5.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.958 0.885 . . . . 3.9700000000000002 110.566 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.87 46.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.073 -1.454 . . . . 0.54000000000000004 107.073 153.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -83.05 162.49 21.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.894 -0.78 . . . . 2.0699999999999998 108.894 161.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.74 -8.28 59.62 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.484 0.714 . . . . 3.0099999999999998 112.106 -169.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 51.18 38.78 22.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.014 0.926 . . . . 1.6299999999999999 109.101 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 48.78 33.04 11.98 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.529 1.062 . . . . 1.4399999999999999 112.798 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -77.48 -25.33 50.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.095 0.948 . . . . 4.9299999999999997 110.039 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 133.25 -130.28 5.68 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.964 -0.854 . . . . 2.6099999999999999 110.964 161.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.49 -73.72 0.02 OUTLIER Glycine 0 C--N 1.34 0.772 0 C-N-CA 126.372 1.939 . . . . 2.0699999999999998 111.414 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.21 165.46 24.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.834 1.654 . . . . 2.5699999999999998 108.286 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -79.06 -52.02 8.78 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.874 -0.787 . . . . 3.8100000000000001 108.874 162.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.18 -40.69 11.61 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.992 2.117 . . . . 4.2000000000000002 111.49 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.8 p -39.16 -64.46 0.46 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.798 2.039 . . . . 1.9299999999999999 111.003 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.7 p -71.66 -45.86 60.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.717 -0.674 . . . . 1.26 110.497 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -58.09 -50.13 74.54 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.403 0.681 . . . . 2.98 111.313 -165.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.384 1.3 p -125.63 -45.76 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.678 -0.677 . . . . 1.3799999999999999 112.665 168.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.44 0.13 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.428 1.013 . . . . 0.95999999999999996 114.803 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 54.28 55.53 8.04 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.628 1.571 . . . . 2.0899999999999999 111.557 -167.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -68.12 -3.07 9.22 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.453 0.909 . . . . 1.1799999999999999 113.453 169.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.47 -64.8 4.21 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 120.549 -1.344 . . . . 3.2400000000000002 111.127 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -165.2 168.18 17.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.163 0.985 . . . . 1.45 111.808 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.432 ' HD2' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -83.33 133.86 34.94 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.242 2.217 . . . . 2.6499999999999999 107.33 172.091 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.35 -77.93 0.56 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.158 -1.052 . . . . 0.85999999999999999 108.158 166.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.19 154.01 42.21 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.901 -1.148 . . . . 1.0700000000000001 107.901 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 16.6 p -142.8 171.51 13.95 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.352 -1.295 . . . . 1.99 108.959 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.16 142.71 5.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.744 -1.342 . . . . 0.62 109.744 174.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.34 126.91 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 108.735 -0.839 . . . . 0.94999999999999996 108.735 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.3 126.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.722 -0.844 . . . . 2.6699999999999999 108.722 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.46 -5.97 1.42 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 115.014 0.766 . . . . 0.76000000000000001 115.014 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.3 59.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 118.638 1.219 . . . . 0.78000000000000003 110.627 -156.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.39 172.07 7.2 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.661 0.743 . . . . 1.6499999999999999 111.643 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.25 1.083 0 N-CA-C 103.44 -2.8 . . . . 5.9900000000000002 103.44 144.599 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.2 0 N-CA-C 110.803 -0.073 . . . . 2.8100000000000001 110.803 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.48 131.9 34.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.586 -1.265 . . . . 0.82999999999999996 107.586 163.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -98.52 142.12 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.688 -0.856 . . . . 0.79000000000000004 108.688 165.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.63 97.57 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.581 -0.896 . . . . 0.48999999999999999 108.581 154.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.02 107.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.207 -1.405 . . . . 0.73999999999999999 107.207 163.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.3 mt -93.96 133.19 37.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.911 -0.774 . . . . 0.92000000000000004 108.911 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -138.08 -56.52 0.66 Allowed 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.541 -0.911 . . . . 4.1399999999999997 108.541 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.04 -121.34 24.89 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.789 -1.096 . . . . 0.83999999999999997 111.957 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.08 -49.27 1.71 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.903 0.881 . . . . 3.48 109.497 -155.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.36 164.19 20.27 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 109.841 -1.303 . . . . 0.80000000000000004 109.841 167.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.61 40.92 0.9 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.614 2.876 . . . . 1.0700000000000001 112.617 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.2 t -94.51 155.11 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.539 1.535 . . . . 0.92000000000000004 109.846 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.38 123.24 8.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.231 -1.396 . . . . 2.2200000000000002 107.231 168.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.94 167.32 33.73 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.543 -1.023 . . . . 0.60999999999999999 110.543 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.19 118.28 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.767 -1.568 . . . . 1.2 106.767 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -85.02 128.55 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.259 -1.756 . . . . 0.78000000000000003 106.259 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -111.59 113.68 26.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.366 -1.716 . . . . 2.2999999999999998 106.366 166.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CE1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -102.88 115.6 30.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.613 -1.625 . . . . 2.8100000000000001 106.613 173.279 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -139.14 160.37 39.96 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.054 0.843 . . . . 3.3700000000000001 109.609 170.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -155.26 145.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.594 -2.002 . . . . 3.1400000000000001 105.594 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -45.5 44.25 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.008 -0.738 . . . . 4.9000000000000004 109.008 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -78.73 178.2 8.07 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.118 1.767 . . . . 3.8100000000000001 109.189 168.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.3 p -123.8 21.47 9.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.98 0.912 . . . . 2.3799999999999999 111.382 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -167.41 38.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.593 0.633 . . . . 3.6000000000000001 111.557 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.69 -157.84 7.66 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.042 -1.623 . . . . 1.1299999999999999 109.042 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.36 135.41 33.9 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.161 2.574 . . . . 1.1699999999999999 110.348 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -78.97 164.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.394 -0.965 . . . . 0.84999999999999998 108.394 173.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -115.57 125.21 52.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.634 -1.987 . . . . 3.04 105.634 167.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG22 ' CE1' ' A' ' 20' ' ' PHE . 59.0 t -117.1 114.75 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.586 1.554 . . . . 0.93999999999999995 107.352 -171.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -125.9 133.53 51.87 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.189 0.93 . . . . 0.83999999999999997 110.408 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.2 160.16 33.73 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.385 -1.086 . . . . 0.79000000000000004 110.385 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 p -135.29 107.17 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.229 -1.397 . . . . 2.02 107.229 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.78 119.91 59.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.559 -1.645 . . . . 1.23 106.559 -159.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -124.35 152.21 43.43 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.946 0.498 . . . . 4.96 110.062 -160.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.58 27.04 64.0 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.444 -0.344 . . . . 0.82999999999999996 113.823 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -67.0 -169.41 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.581 -0.952 . . . . 0.97999999999999998 108.478 157.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.51 165.94 10.81 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 105.518 -2.03 . . . . 3.5600000000000001 105.518 146.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 178.9 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.83 2.052 . . . . 3.3599999999999999 112.43 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.58 -169.45 53.38 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.357 -0.838 . . . . 0.45000000000000001 111.933 169.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.77 147.17 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.475 0.71 . . . . 1.98 111.493 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -143.92 121.16 11.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.945 1.698 . . . . 0.48999999999999999 108.473 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.07 149.03 7.59 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.519 -1.433 . . . . 0.46000000000000002 109.519 169.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -143.25 83.48 1.79 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.644 -1.243 . . . . 2.2999999999999998 107.644 -169.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -124.64 146.38 49.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.885 -1.052 . . . . 0.82999999999999996 109.071 -160.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.22 106.44 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.436 -0.95 . . . . 2.3799999999999999 108.436 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -82.35 150.21 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.903 -0.777 . . . . 0.89000000000000001 108.903 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.26 19.84 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.376 1.471 . . . . 3.96 113.374 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.406 ' CD ' HH22 ' A' ' 143' ' ' ARG . 1.5 tt0 . . . . . 0 CA--C 1.53 0.201 0 O-C-N 120.648 -1.283 . . . . 3.1600000000000001 110.138 -167.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.409 0 CA-C-O 121.29 0.567 . . . . 2.5800000000000001 110.589 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.9 -65.89 3.14 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.987 -0.896 . . . . 1.02 111.661 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.85 172.72 2.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.771 1.647 . . . . 1.8999999999999999 115.016 -166.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -83.01 56.68 3.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 113.121 -1.854 . . . . 2.1299999999999999 110.559 -172.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 53.32 80.09 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.406 0.682 . . . . 1.96 109.476 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -107.85 103.85 51.1 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.181 0.993 . . . . 2.3799999999999999 110.425 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.82 -30.98 39.95 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.997 1.798 . . . . 1.1200000000000001 112.251 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.0 tp -155.93 -67.4 0.11 Allowed 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.554 0.616 . . . . 2.8999999999999999 110.038 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 p -151.99 60.72 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.21 0.529 . . . . 2.1899999999999999 110.621 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -77.51 165.99 23.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.384 -0.598 . . . . 3.8399999999999999 109.384 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -137.83 162.68 33.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.068 1.347 . . . . 7.2400000000000002 107.819 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -94.27 153.23 18.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.135 1.374 . . . . 0.79000000000000004 113.374 -158.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.48 171.93 45.0 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 107.763 -2.135 . . . . 2.4399999999999999 107.763 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.84 -171.23 30.75 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.165 0.412 . . . . 1.1499999999999999 112.832 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.49 -31.18 51.64 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.515 2.144 . . . . 1.6699999999999999 109.582 172.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.63 -43.1 73.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.915 0.486 . . . . 4.4500000000000002 111.496 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -69.22 161.96 28.12 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.673 0.749 . . . . 2.4300000000000002 112.144 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -75.5 -46.89 29.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.896 2.078 . . . . 4.3200000000000003 109.33 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -77.05 159.45 29.86 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.1 -1.074 . . . . 4.3099999999999996 108.1 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 158.98 127.1 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.463 2.305 . . . . 3.1099999999999999 106.441 -163.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 45.4 m80 -62.29 150.8 38.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.963 -1.495 . . . . 0.52000000000000002 106.963 163.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.82 -16.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 120.255 -0.578 . . . . 1.1499999999999999 110.38 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.56 56.58 0.46 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.959 0.79 . . . . 0.65000000000000002 113.336 161.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -123.59 117.99 26.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.022 1.411 . . . . 2.4199999999999999 108.771 158.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.6 -56.66 3.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.068 -1.086 . . . . 1.5700000000000001 108.068 164.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.65 -121.95 1.05 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.319 -0.712 . . . . 0.65000000000000002 111.319 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -143.11 165.28 27.83 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.895 1.678 . . . . 1.55 108.112 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.31 166.74 28.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.699 -1.223 . . . . 0.45000000000000001 107.699 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.3 m -123.41 116.42 23.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.234 1.014 . . . . 1.96 108.67 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.58 139.3 35.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.033 0.379 . . . . 0.62 111.076 171.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.07 -84.16 0.12 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.956 0.502 . . . . 4.0999999999999996 111.053 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 -53.19 0.93 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.231 0.612 . . . . 4.6100000000000003 112.082 -161.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.18 30.12 1.0 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 124.53 2.11 . . . . 3.3100000000000001 109.972 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 57.69 27.66 59.16 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 113.619 -1.628 . . . . 0.71999999999999997 110.833 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.27 103.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.56 1.144 . . . . 0.89000000000000001 108.101 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.92 166.77 12.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.336 1.054 . . . . 0.82999999999999996 108.267 160.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.7 141.82 47.73 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.452 -2.425 . . . . 2.8500000000000001 104.452 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.16 116.6 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.881 -1.525 . . . . 1.3899999999999999 106.881 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -137.46 80.29 1.8 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.068 1.747 . . . . 0.93999999999999995 106.738 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.2 mm -125.75 156.95 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.135 0.574 . . . . 2.2999999999999998 109.57 -170.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -151.36 71.54 1.01 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.733 0.813 . . . . 2.8900000000000001 110.93 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.96 119.23 22.52 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.126 -0.359 . . . . 3.29 111.738 -168.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.6 p -79.4 65.19 4.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.159 0.984 . . . . 2.8900000000000001 110.391 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.3 t -141.56 -52.32 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.622 1.169 . . . . 1.26 109.083 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -102.96 168.7 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.079 0.952 . . . . 1.0900000000000001 111.321 -172.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.2 m -137.91 168.92 18.71 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.077 1.351 . . . . 2.0299999999999998 109.217 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' H ' ' CD2' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -100.84 17.04 23.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.477 1.511 . . . . 2.71 113.068 -178.241 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 C--O 1.233 0.231 0 C-N-CA 124.148 0.979 . . . . 2.96 108.737 179.372 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 122.381 1.086 . . . . 1.49 111.345 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -18.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.684 -1.144 . . . . 2.8100000000000001 111.782 174.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.1 mm -47.0 119.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.174 0.99 . . . . 2.2400000000000002 110.758 -162.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.46 -32.47 5.2 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.519 0.58 . . . . 1.99 112.553 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -76.52 177.01 7.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.547 1.673 . . . . 10.15 114.031 -163.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 m -104.15 120.99 42.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.436 1.095 . . . . 1.1000000000000001 110.322 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.71 138.25 39.87 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.465 -1.309 . . . . 1.8600000000000001 107.465 164.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.48 127.84 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.272 1.429 . . . . 0.57999999999999996 107.88 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.6 m -97.47 122.45 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.125 -1.806 . . . . 1.55 106.125 162.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -93.97 158.19 15.75 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 115.319 1.6 . . . . 0.57999999999999996 115.319 -171.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -25.56 -83.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.183 2.993 . . . . 3.5800000000000001 112.388 162.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -106.73 -177.34 3.33 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.819 0.848 . . . . 2.6400000000000001 110.215 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.1 157.44 3.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.498 -0.774 . . . . 0.75 109.987 162.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.26 176.58 5.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.951 -0.759 . . . . 1.95 108.951 160.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.53 -9.59 59.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 3.9500000000000002 111.183 -167.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.7 11.93 4.29 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.694 1.598 . . . . 2.4300000000000002 111.928 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.86 102.03 1.0 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 108.538 -1.825 . . . . 3.4399999999999999 108.538 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.55 -56.49 0.08 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.953 -1.499 . . . . 4.7300000000000004 106.953 174.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.47 50.49 0.97 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.165 -1.174 . . . . 2.6400000000000001 110.165 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.52 37.29 0.84 Allowed Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.165 0.982 . . . . 3.96 112.984 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.3 p30 175.66 -108.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.862 2.865 . . . . 2.8999999999999999 106.266 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.416 ' OE1' ' NZ ' ' A' ' 136' ' ' LYS . 15.9 tm-20 -153.13 -39.61 0.1 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.456 1.102 . . . . 4.29 109.07 161.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -44.09 -37.63 3.17 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.423 1.489 . . . . 2.8900000000000001 111.784 170.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.9 t -45.71 -58.25 3.6 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.417 1.087 . . . . 2.25 110.903 168.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -44.63 67.63 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.101 -1.0 . . . . 1.3100000000000001 110.015 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.416 ' NZ ' ' OE1' ' A' ' 132' ' ' GLU . 1.5 ttmp? -55.68 -50.65 69.69 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.355 1.062 . . . . 2.7799999999999998 112.239 -172.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.502 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.309 2.0 p -124.33 -50.33 1.78 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.834 -0.603 . . . . 1.21 111.759 171.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 157.27 -26.81 0.49 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.139 -0.784 . . . . 0.98999999999999999 111.139 -173.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 49.41 53.93 11.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.876 1.27 . . . . 2.3700000000000001 110.338 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.62 -51.93 13.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.858 0.837 . . . . 1.53 109.53 170.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.32 -157.84 22.18 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.623 -2.191 . . . . 1.0 107.623 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.1 m -61.0 151.35 30.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.307 1.443 . . . . 1.28 113.217 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.406 HH22 ' CD ' ' A' ' 50' ' ' GLU . 13.1 mmt85 -61.33 138.23 58.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.101 1.36 . . . . 2.98 109.046 168.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.9 mt -112.17 -67.35 1.0 Allowed 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.44 -0.948 . . . . 0.64000000000000001 108.44 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -106.37 156.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.072 0.549 . . . . 0.89000000000000001 110.384 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.2 p -165.0 162.21 20.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.018 0.927 . . . . 1.4399999999999999 110.17 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.27 140.96 3.33 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.861 2.172 . . . . 0.88 107.688 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.79 134.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.668 1.187 . . . . 0.89000000000000001 109.756 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.5 tt -91.1 136.59 23.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 C-N-CA 123.101 0.561 . . . . 0.83999999999999997 112.512 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.9 4.56 0.83 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.839 1.209 . . . . 0.65000000000000002 114.078 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.7 mm -102.24 57.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 119.192 1.496 . . . . 1.01 110.147 -150.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.96 175.41 13.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.146 0.498 . . . . 1.6000000000000001 111.142 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.439 0 N-CA-C 102.962 -2.977 . . . . 5.0499999999999998 102.962 160.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.424 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.048 -0.723 . . . . 3.5299999999999998 109.048 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.68 139.31 33.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.884 -1.525 . . . . 0.67000000000000004 106.884 164.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.79 144.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.547 -2.02 . . . . 1.0 105.547 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.74 93.55 3.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.271 -1.011 . . . . 0.44 108.271 161.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.91 104.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.22 -1.03 . . . . 0.56999999999999995 108.22 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -87.98 136.71 32.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.56 0.344 . . . . 0.93999999999999995 110.213 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -149.82 -54.72 0.17 Allowed 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.322 0.649 . . . . 4.2999999999999998 110.49 168.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.32 -126.55 27.87 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.603 0.621 . . . . 1.0 113.815 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.09 -53.99 2.63 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.672 1.189 . . . . 4.2199999999999998 110.138 -165.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.19 154.28 10.95 Favored Glycine 0 CA--C 1.536 1.353 0 N-CA-C 110.008 -1.237 . . . . 0.92000000000000004 110.008 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.24 52.04 3.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.84 3.027 . . . . 1.3400000000000001 112.279 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 74.7 t -110.78 156.65 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.302 2.241 . . . . 0.75 107.875 -175.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -155.84 136.48 13.36 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.621 -0.881 . . . . 2.7599999999999998 108.621 166.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.57 176.49 46.16 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.175 -0.77 . . . . 0.62 111.175 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.68 123.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.494 -1.298 . . . . 1.01 107.494 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.621 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.8 mp -80.66 136.65 22.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.66 -1.978 . . . . 1.51 105.66 161.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -120.6 119.24 32.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.444 -2.058 . . . . 2.0600000000000001 105.444 161.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 5.9 t80 -132.57 126.96 34.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.385 -0.969 . . . . 2.9399999999999999 108.385 -166.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -148.07 158.83 44.28 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.074 0.949 . . . . 4.3399999999999999 110.321 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -152.44 142.52 22.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.36 1.864 . . . . 3.0 106.964 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -44.94 -74.07 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.14 0.576 . . . . 4.6299999999999999 111.342 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -81.47 -172.9 4.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.1 1.36 . . . . 3.7400000000000002 110.929 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.7 m -83.43 -64.67 1.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.232 1.413 . . . . 2.3500000000000001 111.133 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -102.97 75.62 1.4 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.065 1.346 . . . . 3.75 110.229 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.04 -167.15 12.85 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.585 -1.406 . . . . 1.1000000000000001 109.585 166.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.02 113.58 3.82 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.242 1.962 . . . . 1.1699999999999999 111.32 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 4.0 t -87.17 138.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.312 -0.403 . . . . 0.93000000000000005 110.556 -172.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -94.11 116.48 28.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.929 -1.137 . . . . 2.6299999999999999 107.929 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG22 ' CD1' ' A' ' 20' ' ' PHE . 11.6 t -89.72 132.71 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.703 -1.962 . . . . 1.25 105.703 162.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -133.53 151.8 51.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.986 -1.487 . . . . 0.94999999999999996 106.986 156.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.76 134.54 2.91 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.131 -1.188 . . . . 0.92000000000000004 110.131 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.5 p -109.57 94.75 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.54 -1.652 . . . . 1.9299999999999999 106.54 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 mm -96.99 148.59 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.623 -1.251 . . . . 1.3700000000000001 107.623 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.36 165.39 22.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.298 0.571 . . . . 4.2199999999999998 111.45 165.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.19 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 114.462 -1.245 . . . . 0.60999999999999999 114.171 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.88 158.92 17.82 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.266 1.533 . . . . 0.68999999999999995 108.861 167.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.36 158.01 24.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.2 -1.407 . . . . 1.6799999999999999 107.2 154.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.94 174.31 0.51 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.952 1.251 . . . . 3.2799999999999998 112.327 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.14 -160.65 52.5 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.956 -1.02 . . . . 0.67000000000000004 112.29 168.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.7 140.69 57.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.956 1.303 . . . . 2.1000000000000001 113.105 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -144.41 117.69 9.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.647 1.579 . . . . 0.44 109.257 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.19 145.91 5.56 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.362 -1.095 . . . . 0.46000000000000002 110.362 172.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.6 102.08 5.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.776 -1.565 . . . . 2.9100000000000001 106.776 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -133.48 168.22 19.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.156 -1.794 . . . . 0.69999999999999996 106.156 -173.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.88 130.2 48.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.867 -0.79 . . . . 1.77 108.867 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -114.62 147.34 39.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.466 1.507 . . . . 0.83999999999999997 110.413 -160.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.14 -9.35 0.26 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.059 1.744 . . . . 4.25 114.638 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.475 ' CD ' HH21 ' A' ' 143' ' ' ARG . 4.5 mt-10 . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.47 1.108 . . . . 3.3300000000000001 109.794 164.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 107.48 -1.304 . . . . 2.4300000000000002 107.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.92 -87.63 0.08 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.322 -1.511 . . . . 1.01 109.322 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.91 176.84 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.965 3.777 . . . . 1.2 113.569 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -75.48 58.49 1.02 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.885 1.674 . . . . 2.29 111.615 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.84 80.3 0.16 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.994 0.917 . . . . 2.0800000000000001 108.628 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -112.88 86.66 9.18 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.55 1.14 . . . . 2.4199999999999999 109.415 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.13 -17.95 45.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.3 2.0 . . . . 2.3100000000000001 112.7 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 tt -154.28 -68.0 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.676 0.671 . . . . 2.1000000000000001 109.838 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -162.92 96.0 0.89 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.757 -1.201 . . . . 1.72 107.757 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.27 173.68 6.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.147 1.379 . . . . 5.2800000000000002 109.703 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -137.3 151.33 48.53 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 125.61 1.564 . . . . 3.71 108.032 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -91.24 139.97 30.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.828 0.677 . . . . 0.80000000000000004 112.828 -170.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.02 -88.75 0.07 OUTLIER Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.539 -2.625 . . . . 1.8600000000000001 106.539 163.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.67 -102.58 0.38 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.973 -0.904 . . . . 1.8 112.289 159.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -90.63 -47.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.508 2.139 . . . . 1.47 110.774 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.27 -46.01 10.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.233 1.413 . . . . 4.96 110.388 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.03 175.58 10.24 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.889 -1.05 . . . . 2.7599999999999998 111.424 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.06 -55.22 8.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.399 1.479 . . . . 3.79 109.596 -174.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.89 175.28 10.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.462 -0.79 . . . . 3.8100000000000001 110.967 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.36 141.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.248 2.219 . . . . 3.52 107.876 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.411 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 16.0 m80 -64.21 160.72 17.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 118.468 -1.293 . . . . 0.60999999999999999 108.669 162.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -28.66 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 121.289 -0.882 . . . . 1.23 110.69 -177.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.56 70.11 0.22 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.65000000000000002 110.973 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -163.3 104.74 0.98 Allowed 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.782 -0.834 . . . . 2.0499999999999998 108.914 -169.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.54 -54.81 3.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.686 -0.688 . . . . 1.78 109.156 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 -108.38 0.34 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.603 -0.999 . . . . 0.65000000000000002 110.603 -176.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -152.06 167.5 28.26 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.938 1.695 . . . . 1.5700000000000001 109.874 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -123.35 175.78 5.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.476 -1.675 . . . . 0.64000000000000001 106.476 164.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 t -116.76 149.76 39.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.377 -0.971 . . . . 2.0800000000000001 108.377 167.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.68 140.48 45.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.174 1.39 . . . . 0.78000000000000003 112.333 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.01 -90.17 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 O-C-N 124.46 1.1 . . . . 2.5899999999999999 111.11 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -156.22 -31.75 0.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.652 2.093 . . . . 4.5300000000000002 116.652 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -8.96 58.14 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.993 0.901 . . . . 3.7200000000000002 109.119 164.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.57 23.16 10.4 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.701 1.62 . . . . 0.83999999999999997 109.593 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.2 t -78.0 123.39 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.289 -1.375 . . . . 0.83999999999999997 107.289 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.19 159.32 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.055 0.942 . . . . 0.91000000000000003 109.231 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.77 95.59 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.763 -1.569 . . . . 2.8500000000000001 106.763 -159.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.36 57.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.715 -0.476 . . . . 1.8100000000000001 109.715 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.2 m -85.49 91.66 8.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.813 0.845 . . . . 0.90000000000000002 109.231 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 mt -124.33 148.19 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.893 -0.78 . . . . 2.0099999999999998 108.893 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -134.39 101.97 5.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.279 -0.638 . . . . 2.9500000000000002 109.279 164.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.16 140.74 31.21 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.918 0.887 . . . . 2.27 109.073 173.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 t -110.85 19.23 18.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.407 1.083 . . . . 2.6699999999999999 112.406 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.99 -48.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 108.098 -1.075 . . . . 1.53 108.098 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.35 177.01 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 122.813 0.445 . . . . 1.1899999999999999 111.289 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.5 p -155.4 178.8 9.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.429 1.892 . . . . 2.29 108.23 -164.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.14 69.9 1.44 Allowed 'General case' 0 C--N 1.339 0.151 0 CA-C-O 122.917 1.342 . . . . 2.25 110.466 162.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.326 -0.428 0 C-N-CA 126.721 2.008 . . . . 4.1900000000000004 110.348 -177.849 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 123.213 1.482 . . . . 1.49 113.682 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.839 -1.528 . . . . 1.8400000000000001 111.112 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mm -49.03 118.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.795 0.725 . . . . 1.8300000000000001 109.118 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.53 -20.32 34.83 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.468 1.508 . . . . 1.5700000000000001 112.759 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.59 165.34 18.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.416 1.608 . . . . 4.7199999999999998 110.279 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -86.95 117.9 25.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.801 0.841 . . . . 1.0700000000000001 109.159 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 140.33 58.28 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.393 -1.336 . . . . 2.3599999999999999 107.393 167.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -128.26 126.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.945 -1.132 . . . . 0.42999999999999999 107.945 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.627 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 2.1 p -99.17 116.95 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.219 -1.771 . . . . 1.77 106.219 166.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -89.54 160.11 16.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 115.808 1.781 . . . . 0.58999999999999997 115.808 -172.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -44.87 -72.27 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.708 2.003 . . . . 3.3900000000000001 112.362 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -98.26 -177.19 3.63 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.33 1.052 . . . . 3.1200000000000001 111.097 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.08 157.56 7.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.375 0.67 . . . . 0.72999999999999998 109.703 162.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.24 175.67 8.8 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.484 -0.561 . . . . 2.1200000000000001 109.484 164.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.03 -35.61 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.989 0.916 . . . . 3.3100000000000001 112.669 -152.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp 66.72 32.77 6.7 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.894 1.678 . . . . 3.4199999999999999 111.402 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.37 45.82 92.3 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.227 0.917 . . . . 1.76 112.255 163.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -127.07 -28.82 2.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.234 2.213 . . . . 5.2300000000000004 111.493 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.34 126.22 33.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.812 -0.915 . . . . 2.0600000000000001 110.812 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.1 -30.58 76.05 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.327 0.489 . . . . 3.1400000000000001 111.88 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -55.6 115.29 2.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.843 0.857 . . . . 2.0299999999999998 109.26 170.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -38.29 -48.23 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.814 1.246 . . . . 3.5 113.217 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -46.93 -33.84 4.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.244 1.418 . . . . 3.1800000000000002 112.647 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 m -62.49 -56.88 13.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.976 0.51 . . . . 2.3300000000000001 111.976 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -71.21 -45.81 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.0 -1.687 . . . . 1.3500000000000001 110.215 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -58.08 -39.4 78.45 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.052 0.941 . . . . 3.1800000000000002 111.728 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.411 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 6.8 p -128.95 -54.92 1.21 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.762 0.71 . . . . 1.55 112.632 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 140.48 -18.55 2.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 125.936 1.732 . . . . 0.89000000000000001 111.385 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.76 56.95 2.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.333 1.453 . . . . 2.3500000000000001 111.757 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.66 -5.02 48.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.226 -0.59 . . . . 1.27 111.435 171.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.6 -173.68 40.54 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 108.899 -1.681 . . . . 1.03 108.899 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -55.82 153.33 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.752 1.621 . . . . 1.27 114.086 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.475 HH21 ' CD ' ' A' ' 50' ' ' GLU . 6.4 mmt-85 -60.02 139.8 57.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.775 -1.557 . . . . 3.0699999999999998 107.963 166.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.07 -74.74 0.59 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.047 -1.094 . . . . 0.51000000000000001 108.047 173.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -103.47 151.18 23.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.334 -1.358 . . . . 0.68999999999999995 107.334 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 p -151.45 160.54 43.67 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.042 0.839 . . . . 1.8300000000000001 109.246 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.09 140.75 3.25 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 125.596 1.81 . . . . 0.58999999999999997 109.61 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -77.88 134.67 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.044 1.338 . . . . 0.68000000000000005 109.878 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 16.6 tt -90.66 131.28 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.081 0.553 . . . . 0.78000000000000003 111.342 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.08 -8.17 2.68 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 124.377 0.989 . . . . 0.56999999999999995 113.762 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.4 mm -91.07 59.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 118.026 0.913 . . . . 1.0900000000000001 111.448 -154.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.68 168.09 9.48 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.218 0.533 . . . . 1.98 111.587 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.424 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 20.9 mm-40 . . . . . 0 C--O 1.256 1.397 0 N-CA-C 101.643 -3.465 . . . . 4.1699999999999999 101.643 139.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.011 0.434 . . . . 3.0899999999999999 110.416 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -109.72 136.6 48.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.547 -2.02 . . . . 0.69999999999999996 105.547 152.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.94 140.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.378 -1.712 . . . . 0.81000000000000005 106.378 169.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.56 96.61 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.371 -0.974 . . . . 0.41999999999999998 108.371 156.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.83 108.26 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.656 -1.609 . . . . 0.56000000000000005 106.656 161.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.7 mt -97.37 127.97 43.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.204 -1.036 . . . . 0.91000000000000003 108.204 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -149.39 -56.13 0.19 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.191 -1.04 . . . . 3.4199999999999999 108.191 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.49 -117.61 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.504 -1.225 . . . . 0.93000000000000005 111.19 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -123.37 -41.17 2.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.883 0.873 . . . . 3.7000000000000002 110.056 -163.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.72 161.42 51.36 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.732 -0.605 . . . . 0.84999999999999998 111.762 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.86 30.82 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.984 3.123 . . . . 1.04 113.436 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 52.1 t -99.24 155.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.575 1.95 . . . . 0.70999999999999996 107.424 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 129.37 9.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.739 -0.837 . . . . 3.3900000000000001 108.739 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.27 171.07 41.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.793 -0.718 . . . . 0.47999999999999998 114.383 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.6 118.64 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.477 1.111 . . . . 1.0 108.482 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -83.84 129.57 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.459 -1.312 . . . . 0.66000000000000003 107.459 164.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -106.13 115.68 30.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.328 -1.36 . . . . 1.6899999999999999 107.328 160.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -95.9 112.64 24.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.126 -1.805 . . . . 2.6400000000000001 106.126 171.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -124.94 144.79 50.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.668 0.747 . . . . 3.3399999999999999 109.436 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -156.99 158.68 37.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.155 1.382 . . . . 4.1799999999999997 109.15 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.01 -74.95 0.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.134 0.973 . . . . 4.7300000000000004 109.634 170.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -90.83 130.08 36.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.539 1.136 . . . . 3.8300000000000001 110.377 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 p -66.43 1.28 1.72 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.931 1.456 . . . . 2.4100000000000001 114.931 -169.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -140.19 54.18 1.64 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 126.518 1.927 . . . . 4.2699999999999996 107.161 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.64 175.07 32.87 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 107.509 -2.237 . . . . 1.0700000000000001 107.509 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.08 134.62 46.87 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.728 2.285 . . . . 1.23 110.63 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.86 141.5 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.124 -0.695 . . . . 0.90000000000000002 109.124 -171.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -97.34 107.2 19.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.419 -1.326 . . . . 2.6699999999999999 107.419 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.493 HG22 ' CE1' ' A' ' 20' ' ' PHE . 23.8 t -96.25 116.09 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.532 -1.655 . . . . 1.1299999999999999 106.532 -177.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -123.4 107.11 11.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.131 -1.062 . . . . 1.28 108.131 164.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.76 152.95 16.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.66000000000000003 111.805 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -132.06 85.39 2.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.737 2.015 . . . . 2.7599999999999998 106.575 -165.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 mp -111.31 126.02 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 107.017 -1.475 . . . . 0.83999999999999997 107.017 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 162.69 16.51 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.327 1.051 . . . . 3.8799999999999999 110.973 171.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.24 1.8 74.91 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.341 -0.7 . . . . 0.70999999999999996 114.768 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -53.35 157.22 2.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.099 1.449 . . . . 0.77000000000000002 110.815 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.68 163.37 9.26 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.124 -1.065 . . . . 1.8999999999999999 108.124 156.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.34 173.74 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 2.3700000000000001 111.038 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.71 -159.73 34.6 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.049 0.833 . . . . 0.44 113.843 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.57 145.12 55.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.246 1.818 . . . . 1.8999999999999999 113.79 -171.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -147.34 118.55 7.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.326 1.85 . . . . 0.42999999999999999 109.777 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.66 147.6 8.14 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.515 -1.034 . . . . 0.40000000000000002 110.515 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE2' HD21 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -136.39 91.23 2.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.268 -1.382 . . . . 2.3199999999999998 107.268 -174.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.75 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 40.2 m170 -125.8 172.36 9.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.015 -0.735 . . . . 0.81000000000000005 109.015 -163.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.4 133.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.527 -1.286 . . . . 2.1800000000000002 107.527 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -119.43 140.97 49.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.152 1.381 . . . . 0.81999999999999995 107.738 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -45.16 -58.15 3.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.767 2.027 . . . . 5.0999999999999996 111.107 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 127.082 2.153 . . . . 3.4100000000000001 116.153 164.477 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 106.078 -1.823 . . . . 2.3500000000000001 106.078 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.12 -91.58 0.08 OUTLIER Glycine 0 CA--C 1.524 0.605 0 CA-C-O 117.86 -1.522 . . . . 1.1100000000000001 111.756 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.03 -177.47 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 1 C-N-CA 126.911 5.074 . . . . 1.01 113.351 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -89.33 62.39 6.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.916 1.286 . . . . 1.8100000000000001 111.363 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 56.41 64.29 1.73 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.45 -0.944 . . . . 1.8899999999999999 108.45 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -90.45 113.8 58.86 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 2.3199999999999998 110.4 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.66 -37.39 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.134 1.889 . . . . 1.3400000000000001 111.294 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 tp -156.17 -64.74 0.11 Allowed 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.376 -0.601 . . . . 3.1600000000000001 109.376 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -153.81 69.47 0.8 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 1.77 109.68 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -76.92 166.49 23.26 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.49 -0.559 . . . . 3.6899999999999999 109.49 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.8 156.2 33.7 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.647 1.579 . . . . 3.7999999999999998 107.008 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -92.79 153.81 18.66 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.657 0.614 . . . . 1.03 112.657 -172.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.3 38.79 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 108.95 -1.66 . . . . 2.5800000000000001 108.95 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.82 -156.06 9.87 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 108.662 -1.775 . . . . 1.3400000000000001 108.662 170.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.33 -35.06 92.76 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.987 1.791 . . . . 1.74 110.853 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -51.63 68.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.066 0.946 . . . . 7.0 110.944 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.88 156.57 20.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.594 1.702 . . . . 2.4500000000000002 115.594 -145.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.64 -48.84 74.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.716 2.006 . . . . 6.4100000000000001 112.367 -169.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -135.51 162.42 32.72 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.049 1.34 . . . . 5.5800000000000001 107.759 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -163.4 161.2 24.26 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.4 0.68 . . . . 3.6299999999999999 111.081 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 62.6 m80 -68.16 141.5 56.0 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 107.949 -1.13 . . . . 0.66000000000000003 107.949 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.41 -30.23 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.625 -0.262 . . . . 1.21 110.716 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 57.37 0.43 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.745 -0.475 . . . . 0.64000000000000001 113.802 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.4 146.75 33.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.918 1.859 . . . . 2.3799999999999999 110.226 149.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 mt -97.1 -51.83 4.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.572 -0.899 . . . . 2.3300000000000001 108.572 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.04 -107.92 0.31 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.5 -1.04 . . . . 0.56999999999999995 110.5 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -147.08 171.98 14.46 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.184 1.794 . . . . 1.48 109.493 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -132.78 171.4 18.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 106.644 -1.614 . . . . 0.77000000000000002 106.644 166.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -103.99 144.48 31.49 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.404 -0.961 . . . . 2.2400000000000002 108.404 163.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.05 159.51 27.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.983 0.913 . . . . 0.88 110.004 158.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.37 -92.06 0.05 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.033 1.733 . . . . 4.3799999999999999 108.858 162.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 93' ' ' GLY . 13.7 tttt -176.07 -31.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.619 1.168 . . . . 3.5899999999999999 112.0 -159.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -76.84 15.49 0.65 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 124.243 1.973 . . . . 3.3500000000000001 109.477 151.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 63.05 24.75 67.33 Favored Glycine 0 N--CA 1.44 -1.069 0 O-C-N 119.933 -1.729 . . . . 1.1000000000000001 110.347 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.0 t -83.89 118.88 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.306 -0.998 . . . . 1.05 108.306 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.79 153.26 17.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.331 -0.989 . . . . 1.1299999999999999 108.331 166.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -112.32 83.72 1.85 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 104.16 -2.533 . . . . 3.7400000000000002 104.16 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.412 HG11 ' CE2' ' A' ' 45' ' ' PHE . 2.4 t -86.96 60.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.722 -0.844 . . . . 1.1899999999999999 108.722 -167.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -96.43 86.93 4.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.694 1.597 . . . . 1.01 108.027 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.76 150.69 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.894 -0.78 . . . . 1.8100000000000001 108.894 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.47 134.27 33.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.218 -1.771 . . . . 3.1099999999999999 106.218 158.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -145.77 164.25 32.44 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.603 -1.258 . . . . 3.8199999999999998 107.603 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.3 p -112.59 -5.31 14.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.741 2.016 . . . . 1.5800000000000001 111.915 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.24 -37.06 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 119.065 0.848 . . . . 2.1200000000000001 109.26 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.4 pp -96.02 177.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.586 0.754 . . . . 1.22 110.655 176.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.6 m -158.53 175.96 13.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.702 1.601 . . . . 2.25 108.3 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.34 14.18 31.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.214 1.405 . . . . 2.5299999999999998 111.546 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.455 -0.201 0 O-C-N 120.738 -1.226 . . . . 3.0800000000000001 109.632 -179.643 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 121.882 0.848 . . . . 2.4199999999999999 112.034 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.433 HD11 ' CE2' ' A' ' 20' ' ' PHE . 2.5 pp -81.0 -8.14 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 113.537 0.94 . . . . 1.47 113.537 -166.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 mm -50.79 120.12 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.922 0.889 . . . . 2.4500000000000002 109.175 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.16 22.05 66.32 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.916 -0.935 . . . . 1.5800000000000001 113.498 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 174.28 5.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.139 1.469 . . . . 5.5700000000000003 107.982 160.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -86.61 126.74 34.71 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 118.086 -0.959 . . . . 0.96999999999999997 108.943 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.454 HD21 ' CE2' ' A' ' 45' ' ' PHE . 5.0 tt -82.56 137.17 34.65 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.557 -1.275 . . . . 2.0600000000000001 107.557 159.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.86 135.16 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.733 1.613 . . . . 0.48999999999999999 108.082 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.32 130.48 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.178 -1.045 . . . . 1.8400000000000001 108.178 165.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.556 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 72.8 m-70 -106.79 160.51 15.43 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 117.632 2.456 . . . . 0.46999999999999997 117.632 -167.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -33.84 -84.51 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.265 3.026 . . . . 3.6200000000000001 112.736 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -99.4 -174.67 2.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.292 0.951 . . . . 2.71 109.592 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.24 157.95 2.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.087 0.555 . . . . 0.84999999999999998 110.11 164.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 152.17 35.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.675 -1.232 . . . . 2.1000000000000001 107.675 158.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -77.16 -6.81 54.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.439 0.903 . . . . 3.3599999999999999 113.439 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 68.65 -9.37 0.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.34 1.456 . . . . 2.2799999999999998 112.851 -167.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.72 6.1 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.935 0.789 . . . . 1.98 111.537 168.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.37 38.78 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.2 -0.667 . . . . 7.0599999999999996 109.2 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -103.73 160.62 16.21 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.497 -0.641 . . . . 1.96 111.497 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.79 59.51 3.0 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.156 0.884 . . . . 2.6499999999999999 110.972 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -178.42 109.22 0.05 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 105.254 -2.128 . . . . 2.6600000000000001 105.254 -170.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -33.51 66.34 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.164 -0.335 . . . . 3.3799999999999999 111.637 -171.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -34.47 -44.4 0.2 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.355 1.862 . . . . 3.2000000000000002 113.18 165.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.84 -63.38 1.17 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.868 -0.79 . . . . 2.1600000000000001 108.868 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 p -60.14 -46.59 89.16 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.904 -0.497 . . . . 1.22 110.946 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.67 -43.72 75.55 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.826 0.851 . . . . 2.6600000000000001 112.181 -167.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.288 1.1 p -124.72 -52.83 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.239 -0.886 . . . . 1.22 111.734 172.333 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 146.53 -14.31 1.6 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.528 1.058 . . . . 0.90000000000000002 113.598 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.95 54.86 9.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.535 1.134 . . . . 1.8899999999999999 110.649 173.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -68.21 -40.85 81.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.172 0.987 . . . . 1.01 110.665 173.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.92 -168.66 30.36 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 108.407 -1.877 . . . . 1.01 108.407 -159.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -55.42 148.23 15.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.111 1.764 . . . . 1.1699999999999999 113.924 -167.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.1 mmt-85 -59.52 134.57 57.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.361 1.464 . . . . 2.9199999999999999 107.972 165.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -110.51 -80.01 0.58 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.016 1.28 . . . . 0.59999999999999998 109.837 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.6 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -114.48 149.42 36.37 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.548 -0.908 . . . . 1.1699999999999999 108.548 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.96 160.43 12.16 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.729 -2.032 . . . . 1.75 107.013 -163.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.07 156.12 13.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.748 -2.141 . . . . 0.73999999999999999 107.748 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.14 140.07 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 117.75 0.775 . . . . 0.98999999999999999 109.646 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.6 tt -97.04 132.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.839 -0.619 . . . . 0.71999999999999997 111.126 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.413 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 140.52 -6.66 2.73 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 123.902 0.763 . . . . 0.56999999999999995 114.519 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -90.33 59.83 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 118.487 1.144 . . . . 1.29 109.873 -157.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.69 149.2 24.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.268 -0.878 . . . . 2.1000000000000001 112.411 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.404 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 85.2 mt-30 . . . . . 0 C--O 1.256 1.409 0 N-CA-C 102.691 -3.077 . . . . 5.7400000000000002 102.691 129.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 109.805 -0.442 . . . . 3.4100000000000001 109.805 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.57 154.85 17.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.426 -1.694 . . . . 0.82999999999999996 106.426 153.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.99 147.89 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 104.859 -2.274 . . . . 0.90000000000000002 104.859 161.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.447 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -134.39 102.59 5.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.08 -1.822 . . . . 0.54000000000000004 106.08 166.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.57 99.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.907 -1.146 . . . . 0.81999999999999995 107.907 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.447 HD22 ' O ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -86.79 120.68 28.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.777 -1.194 . . . . 2.6000000000000001 107.777 -178.417 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -139.99 -50.17 0.48 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 122.888 0.475 . . . . 3.54 110.811 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.37 -117.35 2.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.113 0.864 . . . . 0.84999999999999998 112.667 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.14 -50.65 1.68 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.977 0.911 . . . . 3.3799999999999999 110.165 -155.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.85 165.13 11.85 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 110.667 -0.973 . . . . 0.90000000000000002 110.667 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.23 41.91 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.911 3.074 . . . . 1.3400000000000001 112.063 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 72.2 t -110.89 150.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 126.79 2.036 . . . . 0.89000000000000001 108.154 -174.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.12 129.4 8.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.892 -1.151 . . . . 2.73 107.892 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.85 172.18 44.54 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.027 -0.829 . . . . 0.65000000000000002 111.027 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.87 126.67 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.061 -1.088 . . . . 1.4399999999999999 108.061 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 2.4 mm -86.31 132.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.268 -1.753 . . . . 1.48 106.268 159.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -112.16 124.62 52.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.741 -1.948 . . . . 1.99 105.741 159.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -133.42 103.82 6.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.576 -2.009 . . . . 3.46 105.576 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.52 161.28 29.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.396 0.679 . . . . 3.4500000000000002 112.114 -169.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.407 HE22 ' N ' ' A' ' 27' ' ' GLY . 16.5 tt0 -154.97 147.15 23.78 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.972 -1.122 . . . . 3.0 107.972 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -79.5 -35.56 39.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.415 -1.266 . . . . 6.7699999999999996 110.134 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -85.37 -144.94 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.063 -1.828 . . . . 6.3700000000000001 106.063 158.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 p -147.72 -1.87 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.634 1.106 . . . . 3.25 112.984 162.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -123.57 49.76 1.68 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.217 1.007 . . . . 3.4500000000000002 109.612 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' HE22 ' A' ' 22' ' ' GLN . . . -159.69 -162.81 12.55 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.007 -1.237 . . . . 1.25 110.007 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.19 111.9 2.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.256 1.97 . . . . 1.3200000000000001 112.434 -168.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.66 150.15 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.959 0.904 . . . . 1.04 109.535 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -105.69 106.62 17.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.532 -1.655 . . . . 3.9100000000000001 106.532 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -104.24 116.98 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -130.08 142.39 50.61 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.133 -0.691 . . . . 0.96999999999999997 109.133 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.85 159.45 32.68 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.65 -1.78 . . . . 0.69999999999999996 108.65 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -140.14 108.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.841 -2.281 . . . . 2.4199999999999999 104.841 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.28 142.46 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.961 -1.866 . . . . 0.81999999999999995 105.961 -163.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.455 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -140.31 159.06 43.02 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 115.328 1.603 . . . . 4.4900000000000002 115.328 173.065 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.98 53.87 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.828 1.68 . . . . 0.90000000000000002 112.815 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.44 159.98 9.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.187 0.993 . . . . 0.78000000000000003 109.568 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.59 162.02 13.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.597 -1.261 . . . . 1.6599999999999999 107.597 156.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.47 172.44 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.172 0.897 . . . . 2.5899999999999999 110.757 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.5 -163.29 54.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 116.079 -0.51 . . . . 0.47999999999999998 113.122 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.77 146.59 47.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.959 0.904 . . . . 2.1200000000000001 111.913 -172.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -146.56 119.97 9.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.729 1.612 . . . . 0.60999999999999999 109.145 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.81 152.12 4.99 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.405 -0.678 . . . . 0.37 111.405 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE2' HG12 ' A' ' 119' ' ' VAL . 16.7 t80 -146.04 101.84 3.57 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.329 -1.36 . . . . 2.3799999999999999 107.329 -174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 26.5 m80 -143.15 160.22 40.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.322 -0.992 . . . . 0.81000000000000005 108.322 -163.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.62 127.83 75.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 CA-C-O 121.899 0.857 . . . . 1.8 110.058 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -99.68 137.49 38.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.715 1.606 . . . . 0.78000000000000003 107.627 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.02 -38.21 56.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.409 1.084 . . . . 4.3099999999999996 111.749 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 2.8 tt0 . . . . . 0 N--CA 1.454 -0.274 0 C-N-CA 128.596 2.759 . . . . 3.0899999999999999 113.199 156.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.066 0.46 . . . . 1.8100000000000001 111.347 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.62 -95.67 2.42 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.125 -1.375 . . . . 1.01 109.767 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.69 -179.87 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.545 4.163 . . . . 1.1799999999999999 113.833 -175.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -52.01 126.3 18.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.514 1.526 . . . . 1.3999999999999999 108.793 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -39.7 117.3 0.72 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.353 1.061 . . . . 2.4199999999999999 111.742 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -124.71 143.28 43.08 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 130.397 3.479 . . . . 3.5099999999999998 107.578 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.99 -36.21 3.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.124 2.55 . . . . 1.27 110.148 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 tt -151.42 -66.72 0.18 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.254 -1.387 . . . . 2.9300000000000002 107.254 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.4 m -154.39 84.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.091 -1.005 . . . . 2.3700000000000001 109.848 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -79.39 174.99 11.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.182 0.515 . . . . 4.79 110.131 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -127.79 163.84 23.48 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.521 1.928 . . . . 6.75 106.951 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -102.9 152.9 20.76 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 123.707 0.803 . . . . 0.97999999999999998 110.881 -172.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 -35.56 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.777 -0.529 . . . . 2.8199999999999998 111.777 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.52 -150.5 20.12 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.682 1.611 . . . . 1.2 111.386 167.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.1 -26.98 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.566 2.844 . . . . 2.2400000000000002 110.374 -176.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -48.35 82.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.585 -0.524 . . . . 5.9100000000000001 109.585 170.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.83 175.55 6.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.29 113.41 -166.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.34 -43.73 60.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.299 1.439 . . . . 4.6399999999999997 108.401 164.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.95 157.73 31.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.639 -0.71 . . . . 3.27 111.344 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 164.66 147.93 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.89 2.076 . . . . 3.3500000000000001 111.777 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 18.4 m80 -62.79 153.61 32.4 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.319 -0.993 . . . . 0.65000000000000002 108.319 167.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.06 -36.64 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 119.794 -0.762 . . . . 1.3600000000000001 109.3 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.98 60.87 1.38 Allowed Glycine 0 CA--C 1.529 0.969 0 O-C-N 122.003 -0.436 . . . . 0.59999999999999998 113.175 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.84 96.71 1.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.367 -0.975 . . . . 2.1699999999999999 108.367 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.37 -52.28 8.3 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.319 -0.993 . . . . 2.1299999999999999 108.319 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.53 -109.06 0.35 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.834 -0.698 . . . . 0.53000000000000003 112.645 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -155.49 170.18 22.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.599 1.56 . . . . 1.52 109.758 -168.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.8 169.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.004 -1.48 . . . . 0.52000000000000002 107.004 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.2 m -123.87 123.47 40.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.58 -1.267 . . . . 2.0 107.58 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.36 141.4 31.79 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.568 0.347 . . . . 0.60999999999999999 111.149 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.25 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.348 1.03 . . . . 2.71 109.277 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.4 tttt -155.29 -34.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.102 1.519 . . . . 3.7599999999999998 115.102 -172.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.455 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 24.7 t0 -89.19 40.05 0.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.216 1.96 . . . . 2.8599999999999999 109.284 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 56.58 20.58 31.76 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 129.15 3.262 . . . . 0.88 112.562 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.49 119.92 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.947 0.899 . . . . 0.93999999999999995 108.928 -168.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.46 156.87 27.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.568 1.147 . . . . 0.67000000000000004 108.591 168.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.61 147.42 33.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.485 -2.413 . . . . 3.2799999999999998 104.485 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.67 59.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.827 0.704 . . . . 1.6599999999999999 112.024 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.5 m -86.62 96.02 9.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.371 1.068 . . . . 0.96999999999999997 110.429 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.51 152.17 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.546 1.138 . . . . 2.0099999999999998 109.931 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.37 141.9 51.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.324 -0.991 . . . . 2.8300000000000001 108.324 150.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -135.14 163.76 29.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.133 -0.691 . . . . 2.0600000000000001 109.133 162.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -111.24 -16.04 13.5 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.463 2.305 . . . . 1.8600000000000001 112.781 -173.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.37 -36.29 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.888 0.767 . . . . 1.28 109.478 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.8 pp -91.56 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.767 0.827 . . . . 1.1599999999999999 110.477 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.2 p -159.28 176.95 11.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.654 1.981 . . . . 2.6000000000000001 106.967 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.87 37.74 4.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.918 1.235 . . . . 2.3700000000000001 112.498 166.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 108.968 -0.753 . . . . 3.3799999999999999 108.968 178.293 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.8 p . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 109.179 -0.675 . . . . 1.3200000000000001 109.179 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.9 pt -78.61 -5.13 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.044 -0.503 . . . . 1.78 111.918 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 mm -32.01 127.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.762 1.225 . . . . 1.6599999999999999 110.716 170.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.78 33.3 83.79 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.378 -0.679 . . . . 1.5600000000000001 112.928 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -116.29 169.13 9.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.088 0.944 . . . . 4.1500000000000004 108.487 166.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m -100.88 110.4 22.46 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-N 118.867 0.758 . . . . 1.3300000000000001 110.247 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt -68.04 148.98 50.26 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.427 -0.953 . . . . 1.76 108.427 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.71 138.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.103 1.761 . . . . 0.40000000000000002 108.135 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.444 HG12 ' CE2' ' A' ' 45' ' ' PHE . 1.3 m -109.15 129.1 64.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.147 -1.057 . . . . 1.53 108.147 162.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.455 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 50.5 m-70 -101.98 160.18 14.71 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 116.366 1.987 . . . . 0.37 116.366 -168.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 7.3 tt0 -44.05 -75.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.68 2.392 . . . . 3.0299999999999998 112.228 172.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -94.24 179.0 5.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.222 0.534 . . . . 2.8399999999999999 110.353 -168.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.13 142.62 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.382 -1.34 . . . . 0.73999999999999999 107.382 155.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -82.25 164.23 21.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.207 1.003 . . . . 2.0099999999999998 109.094 165.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -28.12 47.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.0 -1.0 . . . . 2.8399999999999999 111.722 -160.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.16 46.4 21.51 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.876 0.87 . . . . 1.9399999999999999 109.793 -168.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.71 34.63 64.99 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 124.696 1.141 . . . . 1.6299999999999999 113.04 165.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -78.45 -17.18 56.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.409 0.604 . . . . 6.21 109.712 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.28 -118.25 5.25 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.593 -1.003 . . . . 2.5499999999999998 110.593 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.36 -69.52 0.68 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.503 -1.439 . . . . 2.48 109.503 -168.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -92.6 160.34 15.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.19 0.996 . . . . 2.79 108.453 164.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -72.94 -47.97 40.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.253 -0.88 . . . . 5.1100000000000003 110.819 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -44.22 -39.78 4.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.795 1.634 . . . . 2.7799999999999998 114.463 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 t -39.41 -64.16 0.5 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.944 1.298 . . . . 2.1099999999999999 111.035 166.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.271 1.6 t -73.38 -44.53 58.37 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.6 0.76 . . . . 2.0800000000000001 111.1 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -55.03 -49.64 71.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 119.495 1.043 . . . . 2.6600000000000001 111.921 -174.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 19.5 p -127.62 -45.98 1.46 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 119.08 -0.486 . . . . 1.72 111.403 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.42 -14.56 1.25 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.191 0.9 . . . . 0.98999999999999999 114.327 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.265 0.3 OUTLIER 28.24 56.05 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.041 1.337 . . . . 3.2599999999999998 113.944 -156.739 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.499 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -55.3 -35.65 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.603 1.161 . . . . 1.0600000000000001 112.337 167.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.86 -176.55 45.95 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.751 -1.74 . . . . 0.94999999999999996 108.751 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 m -61.21 154.28 23.84 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.612 1.165 . . . . 1.28 113.809 -166.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -56.18 136.56 52.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.126 1.37 . . . . 2.5699999999999998 109.022 168.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.5 mt -111.13 -76.24 0.6 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.294 -1.002 . . . . 0.55000000000000004 108.294 168.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.531 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.79 150.85 26.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.821 -1.177 . . . . 0.78000000000000003 107.821 170.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.5 p -153.34 156.68 38.8 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.301 -1.318 . . . . 1.3600000000000001 108.49 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 136.68 4.31 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 125.036 1.46 . . . . 0.60999999999999999 112.091 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.51 125.06 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 125.192 1.397 . . . . 0.90000000000000002 109.544 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.425 ' CB ' ' HB2' ' A' ' 6' ' ' ALA . 12.6 tt -90.29 128.74 42.02 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.227 0.537 . . . . 0.77000000000000002 111.233 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 152.08 -11.62 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.151 0.881 . . . . 0.76000000000000001 114.901 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -93.76 59.43 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 122.557 1.17 . . . . 1.5 109.275 -152.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.28 148.53 25.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.71 -0.677 . . . . 2.23 111.6 172.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 C--O 1.252 1.195 0 N-CA-C 101.967 -3.345 . . . . 6.8099999999999996 101.967 142.32 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 21.1 pttp . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.086 -0.709 . . . . 4.5300000000000002 109.086 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.06 168.93 16.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.253 1.025 . . . . 2.1600000000000001 111.428 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.644 HG23 ' HB2' ' A' ' 152' ' ' ALA . 27.3 t -128.78 147.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.532 -2.396 . . . . 1.6000000000000001 104.532 155.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.43 99.18 4.02 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 108.525 -0.916 . . . . 0.82999999999999996 108.525 153.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.4 t -68.58 94.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.868 -1.16 . . . . 1.02 107.868 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 147' ' ' GLY . 34.8 mt -79.52 122.96 27.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.597 -0.89 . . . . 1.8600000000000001 108.597 175.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -136.33 -60.01 0.72 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.242 -1.022 . . . . 4.0199999999999996 108.242 174.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.83 -139.79 9.73 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.894 -1.682 . . . . 1.23 108.894 -156.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.83 21.78 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.142 0.577 . . . . 5.9400000000000004 111.534 168.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.32 165.57 46.37 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 107.97 -2.052 . . . . 0.95999999999999996 107.97 148.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.62 72.42 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.798 2.332 . . . . 2.6299999999999999 109.845 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.0 t -139.64 144.64 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.818 0.847 . . . . 0.76000000000000001 109.287 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -145.44 120.61 10.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.575 -1.268 . . . . 3.0099999999999998 107.575 166.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.88 163.56 32.78 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.588 -0.695 . . . . 0.52000000000000002 111.941 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.1 mt -127.16 127.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.474 -1.306 . . . . 1.3400000000000001 107.474 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 30.2 mm -87.85 142.6 12.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 N-CA-C 106.383 -1.71 . . . . 0.77000000000000002 106.383 158.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -139.04 82.25 1.89 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.165 -1.05 . . . . 2.7000000000000002 108.165 168.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.407 ' CD1' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -77.85 152.53 33.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 118.641 -1.224 . . . . 5.29 108.992 175.147 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -139.3 148.22 42.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.905 -1.887 . . . . 3.5600000000000001 105.905 166.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -156.94 116.96 3.51 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.208 1.403 . . . . 4.0700000000000003 108.173 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -63.6 -60.23 3.6 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.274 0.63 . . . . 4.6699999999999999 110.681 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -77.9 107.02 10.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.244 -0.91 . . . . 4.0499999999999998 108.919 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -57.76 6.08 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.593 2.357 . . . . 3.29 116.922 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.44 60.85 0.75 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.116 -1.068 . . . . 3.6099999999999999 108.116 168.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.79 179.97 19.37 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 108.389 -1.884 . . . . 0.93999999999999995 108.389 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.67 116.78 3.57 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 1.02 111.302 -171.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 20' ' ' PHE . 7.8 t -80.95 135.37 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.367 -0.825 . . . . 1.4199999999999999 109.958 -169.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.83 88.03 4.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.293 0.951 . . . . 3.9700000000000002 109.855 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.96 88.66 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.634 1.174 . . . . 1.8400000000000001 109.03 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -102.62 157.3 17.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 123.52 0.513 . . . . 0.93999999999999995 111.581 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.17 164.24 35.37 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.652 -0.579 . . . . 0.67000000000000004 111.652 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -130.08 70.44 1.44 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.161 1.384 . . . . 2.2599999999999998 108.999 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.0 132.59 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.191 0.996 . . . . 0.75 110.124 -168.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -130.91 163.03 28.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.618 0.767 . . . . 3.7999999999999998 111.494 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.6 -16.89 59.82 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.077 -0.846 . . . . 1.3899999999999999 113.862 173.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.41 159.25 2.09 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.55 1.175 . . . . 0.79000000000000004 111.389 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 154.67 23.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.722 -1.214 . . . . 1.72 107.722 153.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.2 171.42 0.27 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.065 0.935 . . . . 3.3100000000000001 111.302 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.05 -161.58 54.32 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.307 -0.86 . . . . 0.73999999999999999 112.75 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.92 136.24 52.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.085 1.354 . . . . 1.99 112.401 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -140.6 121.75 14.76 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.581 1.552 . . . . 0.53000000000000003 108.86 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.66 149.98 9.87 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.73 -0.948 . . . . 0.48999999999999999 110.73 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.11 96.62 3.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.487 -1.672 . . . . 2.4700000000000002 106.487 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.624 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 27.9 m80 -134.86 161.52 34.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.997 -1.112 . . . . 0.68000000000000005 107.997 -169.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 t -114.09 128.05 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.845 -1.169 . . . . 2.1800000000000002 107.845 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -112.47 137.98 49.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.099 -1.445 . . . . 0.96999999999999997 107.099 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -72.34 63.95 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.418 0.687 . . . . 4.1600000000000001 112.725 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 107.228 -1.397 . . . . 3.5099999999999998 107.228 171.463 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 N-CA-C 108.949 -0.759 . . . . 1.9199999999999999 108.949 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.01 -94.38 0.9 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.393 -1.483 . . . . 1.02 109.393 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.17 178.25 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.902 3.068 . . . . 1.23 112.819 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -63.85 130.0 42.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.693 -1.14 . . . . 1.3799999999999999 110.608 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -31.92 113.83 0.13 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.196 1.184 . . . . 1.99 114.196 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.47 154.86 49.39 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 126.517 1.927 . . . . 2.6400000000000001 106.722 160.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.9 -42.33 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.61 1.54 . . . . 1.28 111.666 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 -71.95 0.43 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.257 0.623 . . . . 2.7400000000000002 109.556 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 m -145.47 72.56 1.32 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.562 0.745 . . . . 1.6599999999999999 111.512 -164.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -79.43 175.5 10.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.599 -1.26 . . . . 4.75 107.599 153.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -128.89 174.97 9.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.333 1.453 . . . . 4.0700000000000003 107.224 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -108.02 129.85 55.1 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.285 1.034 . . . . 1.3899999999999999 112.658 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.79 21.71 1.29 Allowed Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.68 -0.568 . . . . 3.0 111.68 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.58 -169.71 4.02 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.074 0.845 . . . . 1.3999999999999999 113.348 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.94 -6.13 12.12 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.056 3.171 . . . . 1.47 114.256 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.04 -50.06 5.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.916 -1.115 . . . . 6.0499999999999998 110.612 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.81 169.46 18.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.989 0.899 . . . . 2.5099999999999998 111.552 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.26 -37.84 84.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 5.21 109.51 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.343 12.1 pt-20 -78.57 149.68 32.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.028 0.918 . . . . 4.9299999999999997 110.915 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 151.87 127.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 131.405 3.882 . . . . 2.98 104.03 -162.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.523 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.0 m80 -60.62 152.34 26.61 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.649 -1.241 . . . . 0.64000000000000001 107.649 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -30.25 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 120.117 -0.633 . . . . 1.3500000000000001 110.239 -167.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.52 59.56 0.5 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.385 -0.675 . . . . 0.66000000000000003 112.756 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -123.03 108.67 13.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.682 1.241 . . . . 2.6400000000000001 109.049 165.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.82 -47.46 15.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.088 -0.708 . . . . 1.5600000000000001 109.088 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.52 -104.17 0.25 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.916 0.78 . . . . 0.70999999999999996 112.677 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -155.66 167.42 30.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.484 1.914 . . . . 1.5600000000000001 108.629 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.4 160.19 40.26 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.205 -1.035 . . . . 0.85999999999999999 108.205 171.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -109.32 111.93 23.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 2.1899999999999999 108.669 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.38 139.37 37.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.304 0.502 . . . . 0.62 110.802 169.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.02 -90.31 0.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.532 0.52 . . . . 3.9300000000000002 110.649 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 -56.95 1.16 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.844 0.857 . . . . 4.6299999999999999 112.142 -159.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.7 21.16 0.85 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.074 1.749 . . . . 3.2999999999999998 110.155 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.08 18.47 69.03 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 124.593 1.092 . . . . 0.78000000000000003 111.597 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -79.74 110.14 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.534 -1.284 . . . . 0.97999999999999998 107.534 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.75 175.71 6.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.873 -1.158 . . . . 0.80000000000000004 107.873 161.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -131.34 136.39 48.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 102.67 -3.085 . . . . 2.9100000000000001 102.67 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.83 131.86 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.784 -1.932 . . . . 1.5700000000000001 105.784 167.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.6 m -160.78 61.04 0.31 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.868 1.667 . . . . 1.3 108.245 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -108.22 152.78 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.414 0.686 . . . . 1.8500000000000001 109.705 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -137.64 142.83 41.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.308 -0.627 . . . . 3.27 109.308 149.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -124.6 145.21 49.74 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.614 -1.625 . . . . 2.5499999999999998 106.614 166.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -79.58 -18.11 52.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.036 2.134 . . . . 1.4199999999999999 111.394 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.4 t -77.17 -39.91 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.772 -0.455 . . . . 1.1100000000000001 109.772 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -77.46 176.79 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.672 0.749 . . . . 1.1200000000000001 110.985 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 t -161.51 179.89 7.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.613 1.965 . . . . 2.2999999999999998 105.871 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.54 41.86 3.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.846 1.259 . . . . 3.1899999999999999 110.74 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 C--N 1.332 -0.166 0 N-CA-C 109.015 -0.735 . . . . 3.27 109.015 -174.779 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 N--CA 1.44 -0.935 0 CA-C-O 123.01 1.386 . . . . 1.6699999999999999 111.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.628 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -83.52 -8.68 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 113.695 -1.593 . . . . 2.3399999999999999 111.98 169.298 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.1 mm -49.75 123.85 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 119.471 1.032 . . . . 1.6899999999999999 110.34 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.75 -9.46 55.92 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.614 -1.103 . . . . 1.6799999999999999 112.974 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.444 ' O ' HG22 ' A' ' 149' ' ' ILE . 90.5 mtt-85 -88.6 164.54 15.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.519 1.659 . . . . 4.2199999999999998 110.171 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 m -94.11 118.41 31.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.233 -0.292 . . . . 0.89000000000000001 110.698 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.76 142.53 54.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.356 -0.979 . . . . 2.4900000000000002 108.356 163.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.6 t -127.91 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.24 1.416 . . . . 0.38 107.648 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.39 120.95 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 106.187 -1.783 . . . . 2.2999999999999998 106.187 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.501 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 55.1 m-70 -98.29 159.42 14.95 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.751 2.13 . . . . 0.40999999999999998 116.751 -174.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -29.59 -83.44 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.363 3.065 . . . . 3.71 112.352 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -96.98 -175.35 3.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.472 1.109 . . . . 3.3300000000000001 109.728 -175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.15 157.6 3.37 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.701 -0.481 . . . . 0.94999999999999996 109.701 159.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.27 160.79 23.65 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.44 -0.578 . . . . 2.1899999999999999 109.44 161.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.05 -25.21 59.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.96 1.096 . . . . 3.0800000000000001 113.96 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.78 13.11 2.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.839 0.856 . . . . 1.4399999999999999 113.127 -165.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.39 47.49 42.92 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.831 1.196 . . . . 1.55 111.554 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -142.03 -22.71 0.7 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.807 2.043 . . . . 4.96 112.925 -173.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.2 136.72 40.2 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 120.315 1.416 . . . . 2.5600000000000001 111.02 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.28 67.68 0.92 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.691 1.139 . . . . 2.6400000000000001 111.26 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -144.07 -179.22 6.36 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.025 2.13 . . . . 3.1400000000000001 105.424 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -39.47 15.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.387 -0.968 . . . . 4.2000000000000002 108.387 159.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -47.48 -28.25 2.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.336 2.254 . . . . 4.9299999999999997 113.622 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.6 p -58.21 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.734 1.214 . . . . 2.3999999999999999 109.116 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.5 t -60.83 -31.74 71.15 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.23 -0.919 . . . . 2.79 111.592 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -59.09 -49.36 78.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.281 -0.887 . . . . 3.3900000000000001 111.948 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.523 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.335 9.9 t -134.08 -51.81 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.325 -0.845 . . . . 1.77 111.343 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.54 30.0 0.07 OUTLIER Glycine 0 C--N 1.336 0.579 0 CA-C-O 116.989 -2.006 . . . . 1.1699999999999999 115.572 168.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 9.03 57.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.683 2.393 . . . . 2.3100000000000001 114.674 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.624 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.25 -38.34 88.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.2 1.0 . . . . 1.0 108.998 166.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.73 36.44 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 108.074 -2.011 . . . . 1.04 108.074 -165.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 158.81 20.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.985 0.914 . . . . 2.21 113.106 -166.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -63.15 132.02 50.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.243 1.817 . . . . 3.0699999999999998 108.487 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.84 -63.23 1.37 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.256 -1.016 . . . . 0.64000000000000001 108.256 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.45 158.66 16.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.15 -0.932 . . . . 1.04 109.716 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 139.36 23.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.356 -1.72 . . . . 1.78 106.356 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.469 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -160.12 131.05 2.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.553 -1.819 . . . . 0.68999999999999995 108.553 170.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.42 139.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.722 -0.844 . . . . 0.80000000000000004 108.722 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.628 HG21 HG12 ' A' ' 112' ' ' ILE . 7.8 tt -102.31 142.68 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.779 0.831 . . . . 0.88 112.692 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.23 6.72 8.8 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.016 1.294 . . . . 0.76000000000000001 112.658 172.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.33 58.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.685 1.242 . . . . 0.78000000000000003 111.315 -163.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.644 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -155.57 175.54 13.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.052 0.941 . . . . 1.45 108.79 164.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.501 0 C-N-CA 126.361 1.864 . . . . 4.2999999999999998 106.127 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 108.648 -0.871 . . . . 3.3500000000000001 108.648 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.58 139.99 37.32 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.873 -1.529 . . . . 0.69999999999999996 106.873 156.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -99.46 146.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.373 -1.714 . . . . 0.75 106.373 161.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -133.2 92.76 3.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.875 -0.787 . . . . 0.58999999999999997 108.875 163.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.24 110.22 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.69999999999999996 108.163 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.42 140.31 30.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.04 0.536 . . . . 0.85999999999999999 110.355 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -144.94 -54.45 0.31 Allowed 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.204 1.002 . . . . 6.0199999999999996 109.877 165.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.46 -134.93 51.6 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.421 1.01 . . . . 0.98999999999999999 114.185 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.79 -51.32 2.92 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.79 1.236 . . . . 4.0099999999999998 109.481 -166.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.14 156.1 15.14 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 109.192 -1.563 . . . . 0.85999999999999999 109.192 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.72 46.38 2.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 0.96999999999999997 112.045 -172.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 30.3 t -89.91 158.16 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 125.353 1.461 . . . . 0.88 108.643 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.62 120.85 4.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.536 -1.653 . . . . 3.1200000000000001 106.536 173.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.06 40.38 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.528 -0.844 . . . . 0.59999999999999998 111.864 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.11 128.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.035 -1.098 . . . . 1.01 108.035 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.8 mp -93.91 141.94 14.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.009 -1.849 . . . . 1.47 106.009 162.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.32 115.65 20.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.414 -2.069 . . . . 1.6100000000000001 105.414 163.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.485 ' CD2' HG22 ' A' ' 31' ' ' VAL . 31.8 t80 -129.91 107.45 9.38 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.445 -2.057 . . . . 2.9500000000000002 105.445 -163.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -136.1 153.72 51.23 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.422 0.63 . . . . 3.3199999999999998 110.58 -166.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -140.18 143.63 36.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.18 -1.785 . . . . 3.75 106.18 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -85.31 -35.87 21.18 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.932 0.893 . . . . 5.1900000000000004 110.675 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -137.24 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.437 1.095 . . . . 5.25 108.52 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 t -129.61 -69.53 0.68 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.95 1.7 . . . . 2.7599999999999998 108.715 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.68 61.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.93 1.292 . . . . 4.2599999999999998 107.865 -172.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.11 175.07 21.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.961 -1.256 . . . . 1.0600000000000001 109.961 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 115.35 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.789 2.993 . . . . 1.2 111.259 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -78.51 150.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.921 -0.77 . . . . 0.80000000000000004 108.921 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -100.13 113.79 26.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.311 -1.366 . . . . 3.6899999999999999 107.311 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 20' ' ' PHE . 3.5 t -104.54 128.59 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.131 -1.433 . . . . 1.3300000000000001 107.131 175.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -130.41 146.54 51.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.851 -1.907 . . . . 1.0600000000000001 105.851 162.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.23 20.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.046 -1.622 . . . . 0.68999999999999995 109.046 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 p -132.12 118.22 19.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.574 -1.639 . . . . 1.9199999999999999 106.574 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.36 148.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 125.588 1.555 . . . . 1.1299999999999999 108.462 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -141.09 176.45 8.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 119.017 -1.073 . . . . 5.7000000000000002 112.548 149.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.99 13.89 57.08 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.203 1.858 . . . . 0.69999999999999996 113.191 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 119' ' ' VAL . 2.3 mm? -65.25 166.01 10.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 117.713 0.757 . . . . 1.3799999999999999 109.968 166.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 164.95 23.65 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.988 -1.115 . . . . 1.8999999999999999 107.988 156.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -58.92 174.11 0.38 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.266 0.939 . . . . 2.4300000000000002 111.476 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.08 -166.38 54.85 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.677 0.656 . . . . 0.56999999999999995 113.756 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.05 153.26 40.93 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.241 1.017 . . . . 2.1899999999999999 110.41 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CD2' HD12 ' A' ' 38' ' ' LEU . 80.5 m-70 -146.55 118.62 8.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.945 1.298 . . . . 0.46000000000000002 108.878 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.96 151.58 5.5 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.335 -1.106 . . . . 0.41999999999999998 110.335 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -145.85 102.27 3.64 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 117.977 0.889 . . . . 2.25 108.716 -171.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.648 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.5 m80 -143.34 155.21 44.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.248 -1.39 . . . . 0.56000000000000005 107.248 -158.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.1 140.35 30.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 119.643 1.111 . . . . 1.8899999999999999 109.784 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -113.25 140.33 48.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.971 1.308 . . . . 1.0 107.691 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.1 74.1 0.65 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.387 1.089 . . . . 4.4699999999999998 112.193 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 104.753 -2.314 . . . . 3.3100000000000001 104.753 -171.978 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.474 0.654 . . . . 2.04 109.472 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.68 -91.92 1.92 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 107.879 -2.088 . . . . 1.26 107.879 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.95 178.09 6.91 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.759 2.972 . . . . 1.1599999999999999 113.281 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.31 131.74 45.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.584 -1.644 . . . . 1.47 109.868 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -35.42 109.84 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.834 1.254 . . . . 2.1200000000000001 111.907 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.38 150.7 21.17 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 126.038 1.735 . . . . 2.3599999999999999 107.199 165.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.15 -29.02 33.72 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.368 2.045 . . . . 1.1499999999999999 114.14 -170.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.93 -64.38 0.11 Allowed 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.07 0.85 . . . . 3.1200000000000001 112.152 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.6 m -154.23 83.3 1.13 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.102 -0.703 . . . . 1.8799999999999999 109.102 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 168.06 11.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.462 -0.94 . . . . 5.6100000000000003 108.462 162.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -114.7 163.16 15.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.635 -1.246 . . . . 3.0899999999999999 107.635 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -82.58 160.77 22.46 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.082 0.553 . . . . 0.80000000000000004 110.293 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.54 176.72 41.64 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 106.302 -2.719 . . . . 2.02 106.302 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.19 -168.92 23.99 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 118.927 1.364 . . . . 1.3500000000000001 112.913 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -62.36 -30.9 81.31 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.851 1.7 . . . . 1.49 109.957 163.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -78.11 -42.39 32.12 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.617 0.767 . . . . 5.5899999999999999 112.561 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.1 163.55 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.456 0.571 . . . . 2.2999999999999998 111.267 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -78.5 -50.9 10.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.638 1.575 . . . . 4.2000000000000002 109.936 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.259 16.9 pt-20 -90.48 176.82 6.56 Favored 'General case' 0 C--N 1.337 0.055 0 C-N-CA 122.554 0.342 . . . . 2.9700000000000002 111.812 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 165.05 159.06 0.02 OUTLIER 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.674 1.989 . . . . 4.7800000000000002 108.552 -166.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 55.7 m80 -61.52 139.39 58.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.094 -1.817 . . . . 0.67000000000000004 106.094 161.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.11 -32.23 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.723 -0.391 . . . . 1.3400000000000001 110.653 -163.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.62 53.32 0.65 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.123 0.392 . . . . 0.96999999999999997 113.007 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -107.9 130.14 55.04 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 2.5899999999999999 107.733 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.71 -58.75 2.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.166 -1.05 . . . . 1.6699999999999999 108.166 159.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.12 -93.14 0.13 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.701 -0.96 . . . . 0.63 110.701 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -155.09 166.52 33.33 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.945 1.698 . . . . 1.8899999999999999 111.234 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.09 178.06 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 127.31 2.244 . . . . 0.69999999999999996 105.961 165.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -136.49 145.73 45.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.921 -1.881 . . . . 2.1200000000000001 105.921 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.52 145.49 34.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.733 0.813 . . . . 0.53000000000000003 110.862 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -70.39 -84.25 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.873 0.869 . . . . 2.9500000000000002 110.79 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 93' ' ' GLY . 61.5 tttt -158.69 -47.3 0.06 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.317 1.047 . . . . 3.48 111.226 -171.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -82.44 29.62 0.43 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 124.659 2.171 . . . . 3.0699999999999998 110.277 173.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 60.07 21.31 55.94 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 113.583 -1.644 . . . . 0.71999999999999997 111.611 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.56 138.14 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.716 -1.587 . . . . 0.79000000000000004 106.716 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.73 169.37 19.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.103 -1.073 . . . . 0.85999999999999999 108.103 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.64 141.61 29.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.956 -1.868 . . . . 2.7200000000000002 105.956 -165.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.8 56.59 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 124.048 0.843 . . . . 1.6299999999999999 112.415 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.8 m -78.15 97.45 5.47 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.27 1.028 . . . . 0.96999999999999997 109.846 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 mm -136.44 153.62 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.964 0.906 . . . . 1.77 110.455 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -132.81 97.08 3.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.243 1.817 . . . . 4.0300000000000002 108.77 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.98 174.4 11.59 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.601 -0.518 . . . . 2.3199999999999998 109.601 169.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.2 m -147.84 26.52 1.01 Allowed 'General case' 0 CA--C 1.53 0.211 0 O-C-N 120.839 -1.163 . . . . 2.4300000000000002 112.069 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.15 -52.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.543 1.537 . . . . 1.04 108.532 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.21 173.22 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.107 0.48 . . . . 1.1299999999999999 111.338 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.3 t -154.43 176.48 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.679 0.792 . . . . 2.5699999999999998 110.257 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -86.88 -13.67 44.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 2.4199999999999999 111.073 160.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 124.568 1.147 . . . . 3.6400000000000001 111.349 -172.184 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.44 -0.963 0 CA-C-O 121.375 0.607 . . . . 1.4199999999999999 112.413 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.7 pt -86.04 -6.39 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 1.9199999999999999 110.855 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.6 tp -33.22 123.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 125.369 1.468 . . . . 2.3900000000000001 110.69 166.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.81 57.11 20.5 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.858 -0.897 . . . . 1.8600000000000001 110.858 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -135.56 157.93 45.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.883 -1.525 . . . . 4.3300000000000001 106.883 163.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -82.58 120.75 25.93 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.543 -1.28 . . . . 1.21 107.543 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.44 141.69 44.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.602 -1.258 . . . . 2.4300000000000002 107.602 168.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.04 134.1 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.446 -1.316 . . . . 0.35999999999999999 107.446 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.656 HG21 HD11 ' A' ' 38' ' ' LEU . 5.6 p -107.33 130.43 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 106.337 -1.727 . . . . 2.21 106.337 162.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.506 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 49.7 m-70 -104.51 163.66 12.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.773 1.397 . . . . 0.38 114.773 -168.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.72 -71.47 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.281 -0.866 . . . . 3.7599999999999998 112.287 176.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -79.56 176.68 9.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.643 1.111 . . . . 3.3300000000000001 109.08 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.3 158.66 16.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.779 -0.822 . . . . 0.66000000000000003 108.779 162.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -76.64 170.57 16.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.481 -0.562 . . . . 2.0 109.481 166.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.78 -20.84 59.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.254 1.205 . . . . 4.1500000000000004 114.254 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 66.48 -6.21 0.53 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.119 1.368 . . . . 1.97 113.471 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.84 9.34 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 120.122 1.328 . . . . 1.95 109.904 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.09 -31.09 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 5.6600000000000001 109.384 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.64 -106.73 2.12 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.761 . . . . 2.96 111.196 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.44 -72.19 0.47 Allowed Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.544 -0.974 . . . . 2.6299999999999999 112.117 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -83.23 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.688 0.744 . . . . 3.1699999999999999 110.933 -172.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 178.77 -71.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.597 1.959 . . . . 3.2200000000000002 106.908 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -40.28 -40.39 1.14 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.857 2.063 . . . . 4.5599999999999996 112.042 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.47 0.09 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.549 2.339 . . . . 2.2200000000000002 112.076 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -39.53 74.27 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.409 -1.432 . . . . 1.79 110.787 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -55.66 -48.42 75.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.78 1.232 . . . . 3.1899999999999999 111.566 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.496 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -127.7 -48.26 1.39 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.691 0.796 . . . . 1.3200000000000001 111.987 177.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.3 -11.9 0.9 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.797 -1.002 . . . . 0.89000000000000001 114.097 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 30.51 54.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.943 2.097 . . . . 2.6499999999999999 112.911 -168.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.648 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.74 -35.8 80.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.519 1.127 . . . . 1.02 111.014 169.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.96 -165.75 30.72 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 108.895 -1.682 . . . . 1.05 108.895 -166.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -58.57 154.83 13.44 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 127.751 2.421 . . . . 1.21 113.102 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -57.01 139.03 53.47 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.816 -1.084 . . . . 2.3199999999999998 108.964 166.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.73 -78.48 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.014 -1.106 . . . . 0.5 108.014 160.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.566 ' HB3' HG12 ' A' ' 119' ' ' VAL . . . -89.7 159.8 16.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.019 -0.734 . . . . 0.79000000000000004 109.019 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 72.8 m -148.01 157.84 43.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.825 -1.546 . . . . 1.75 106.825 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.14 139.96 3.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.212 -1.955 . . . . 0.65000000000000002 108.212 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.42 138.08 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.714 0.806 . . . . 0.77000000000000002 109.552 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 tt -94.82 131.03 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.104 0.478 . . . . 0.77000000000000002 111.828 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.45 0.52 0.98 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.942 1.258 . . . . 0.66000000000000003 114.689 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.96 57.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.19 1.495 . . . . 0.82999999999999996 111.54 -153.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.72 174.58 15.25 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.027 0.531 . . . . 1.6000000000000001 110.914 163.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 . . . . . 0 C--O 1.255 1.347 0 N-CA-C 102.731 -3.063 . . . . 6.1799999999999997 102.731 160.668 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.1 pttt . . . . . 0 C--O 1.229 -0.017 0 N-CA-C 113.295 0.85 . . . . 3.4700000000000002 113.295 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.97 155.82 23.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.39 1.076 . . . . 0.85999999999999999 109.573 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -124.18 150.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 107.981 -1.118 . . . . 0.85999999999999999 107.981 165.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -124.36 95.37 4.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.194 0.998 . . . . 0.46999999999999997 109.206 161.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.67 112.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.359 -1.348 . . . . 0.56999999999999995 107.359 161.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.48 131.83 51.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.153 0.981 . . . . 1.1299999999999999 109.769 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.63 -47.92 0.29 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.785 1.234 . . . . 4.9100000000000001 109.886 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.61 -125.05 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.543 1.068 . . . . 0.84999999999999998 111.989 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.47 -58.27 1.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.696 -0.853 . . . . 4.21 108.696 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.72 165.92 3.8 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.788 1.661 . . . . 0.72999999999999998 114.146 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.62 37.46 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 124.516 3.477 . . . . 1.4299999999999999 111.95 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 55.2 t -110.97 143.61 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.167 2.187 . . . . 0.89000000000000001 106.795 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -137.38 131.22 31.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.786 -1.931 . . . . 2.8599999999999999 105.786 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.96 165.75 33.27 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 121.687 -0.633 . . . . 0.59999999999999998 111.84 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.65 127.65 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.979 -1.86 . . . . 1.25 105.979 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 35.5 mm -98.46 138.14 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.748 -1.575 . . . . 0.73999999999999999 106.748 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -109.38 124.86 51.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.57 -1.641 . . . . 2.1699999999999999 106.57 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.517 ' CG ' HD11 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -107.21 95.99 6.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.882 -1.895 . . . . 2.4700000000000002 105.882 171.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -113.52 136.66 52.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.879 -1.526 . . . . 5.54 106.879 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -153.69 153.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.913 -1.514 . . . . 4.29 106.913 -166.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -105.5 -79.06 0.56 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 4.8799999999999999 110.121 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.46 137.07 37.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.098 0.959 . . . . 4.0 109.051 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -52.52 -68.08 0.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.02 1.728 . . . . 2.3500000000000001 112.446 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -79.7 68.54 5.79 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.814 -1.18 . . . . 3.71 107.814 170.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 167.46 31.42 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.604 -0.999 . . . . 1.3500000000000001 110.604 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.4 142.32 44.84 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.523 2.816 . . . . 1.49 111.834 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.3 165.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.617 -1.253 . . . . 1.28 107.617 171.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.37 95.09 4.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.866 -1.901 . . . . 3.1499999999999999 105.866 157.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' CE1' ' A' ' 20' ' ' PHE . 38.3 t -79.83 113.49 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.524 -1.658 . . . . 0.84999999999999998 106.524 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -124.85 142.5 51.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.177 -1.045 . . . . 0.84999999999999998 108.177 166.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.1 152.23 23.67 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.446 -0.661 . . . . 0.67000000000000004 111.446 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 p -125.33 64.56 1.16 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.484 1.514 . . . . 2.2799999999999998 108.599 -165.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -80.72 142.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.525 -1.216 . . . . 0.81000000000000005 109.099 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -149.99 161.88 41.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.324 0.861 . . . . 3.4199999999999999 113.324 174.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.81 9.1 61.43 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.702 1.62 . . . . 0.82999999999999996 112.617 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.87 162.41 16.35 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.751 -0.853 . . . . 0.81999999999999995 109.542 172.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.18 162.21 14.91 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.571 -1.27 . . . . 1.5800000000000001 107.571 152.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.69 177.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.962 0.801 . . . . 3.0699999999999998 110.959 174.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.98 -163.51 37.51 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.922 0.772 . . . . 0.59999999999999998 113.512 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.7 142.92 58.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.393 1.477 . . . . 1.9199999999999999 113.355 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -145.68 116.88 7.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 126.104 1.762 . . . . 0.53000000000000003 109.359 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.58 150.02 6.13 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.301 0.953 . . . . 0.34999999999999998 111.081 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -141.25 99.61 3.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.66 -1.237 . . . . 2.8799999999999999 107.66 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.607 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 25.5 m80 -140.02 161.95 36.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.714 -1.217 . . . . 0.68000000000000005 107.714 -165.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.89 130.0 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 119.07 0.85 . . . . 2.04 109.41 172.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -106.99 134.09 50.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.479 1.911 . . . . 1.3 105.947 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 60.64 0.61 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.16 1.541 . . . . 4.6900000000000004 115.16 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 107.878 -1.156 . . . . 3.1800000000000002 107.878 168.543 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.453 -0.573 . . . . 2.0299999999999998 109.453 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.49 -85.5 1.85 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.819 -1.312 . . . . 1.1200000000000001 109.819 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.63 176.66 9.82 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.215 2.61 . . . . 0.89000000000000001 113.217 -174.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 m170 -66.31 123.4 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.107 -1.406 . . . . 1.45 108.119 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -37.19 113.5 0.26 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.092 1.357 . . . . 2.77 111.608 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.5 154.55 25.63 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 124.957 1.303 . . . . 2.5 107.604 168.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.36 -48.6 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.861 1.708 . . . . 1.1000000000000001 111.643 -168.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.38 -79.71 0.62 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.898 0.879 . . . . 3.1400000000000001 109.074 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.3 m -150.8 68.86 0.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.801 0.841 . . . . 1.6499999999999999 110.384 -166.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -78.95 174.92 11.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.338 0.589 . . . . 4.0999999999999996 109.417 166.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -124.8 156.01 38.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.376 -1.342 . . . . 3.04 107.376 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -83.15 162.05 21.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.099 0.476 . . . . 0.79000000000000004 111.155 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.41 -126.28 0.87 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.173 -2.771 . . . . 2.0499999999999998 106.173 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.02 -134.22 2.02 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 106.403 -2.679 . . . . 1.24 106.403 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.14 -54.18 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 120.288 2.044 . . . . 1.5600000000000001 109.869 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -60.14 -44.42 94.95 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.952 1.301 . . . . 5.2599999999999998 113.841 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.8 175.75 2.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.905 0.383 . . . . 2.0600000000000001 111.06 -170.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -77.36 -46.85 21.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.048 1.339 . . . . 5.0099999999999998 108.889 167.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.85 172.22 14.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.81 0.844 . . . . 3.1499999999999999 112.144 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 172.17 145.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.234 2.213 . . . . 4.1799999999999997 109.757 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 38.2 m80 -56.18 138.64 49.64 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.905 -1.517 . . . . 0.77000000000000002 106.905 161.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.55 -32.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.293 -0.632 . . . . 1.3799999999999999 109.293 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.87 34.45 5.34 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 116.395 1.318 . . . . 0.79000000000000004 116.395 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -107.1 148.08 29.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.861 1.83 . . . . 1.79 107.402 157.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.62 -49.95 4.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.27 -1.011 . . . . 1.5800000000000001 108.27 141.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.82 -97.16 0.17 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.794 -1.322 . . . . 0.69999999999999996 109.794 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -152.81 169.49 22.65 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.784 1.634 . . . . 1.47 109.574 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.7 175.2 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.331 -1.729 . . . . 0.60999999999999999 106.331 163.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -109.47 143.7 38.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.733 -1.21 . . . . 2.0099999999999998 107.733 162.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.25 151.32 29.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.548 -0.908 . . . . 1.01 108.548 151.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.39 -87.28 0.06 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.328 0.651 . . . . 2.8599999999999999 109.388 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -150.72 -43.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.12 1.368 . . . . 3.8700000000000001 110.848 -170.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.24 8.09 5.45 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.204 1.002 . . . . 2.6699999999999999 111.268 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.29 8.16 87.59 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.169 0.89 . . . . 0.89000000000000001 111.536 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -78.67 135.91 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.015 -1.476 . . . . 0.67000000000000004 107.015 173.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.1 174.42 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.086 0.955 . . . . 0.89000000000000001 109.424 170.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -130.0 117.56 20.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 103.241 -2.874 . . . . 3.6400000000000001 103.241 -174.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.58 112.03 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 105.039 -2.208 . . . . 1.25 105.039 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -148.89 97.23 2.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.816 1.246 . . . . 0.94999999999999996 108.433 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.1 mp -145.28 147.41 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 108.929 -0.767 . . . . 1.75 108.929 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.22 68.49 1.28 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.066 0.946 . . . . 4.21 111.964 173.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.99 157.66 31.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.375 -0.828 . . . . 2.4199999999999999 111.078 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 p -110.36 -11.8 14.49 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.775 2.03 . . . . 1.8899999999999999 113.508 -177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.05 -50.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.923 -1.14 . . . . 1.3200000000000001 107.923 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -77.78 158.95 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 122.357 1.075 . . . . 2.4199999999999999 109.808 171.469 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.8 p -152.17 174.68 13.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.762 2.425 . . . . 2.1499999999999999 107.553 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -42.61 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.344 1.458 . . . . 2.8599999999999999 109.45 173.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 125.301 1.44 . . . . 4.4299999999999997 110.899 178.127 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.806 0 N-CA-C 110.824 -0.065 . . . . 1.4299999999999999 110.824 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 115' ' ' ARG . 10.8 pt -79.58 -7.73 10.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 119.295 -0.962 . . . . 2.1899999999999999 111.339 -175.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 tt -44.46 140.91 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.095 1.146 . . . . 1.9399999999999999 114.095 -167.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 56.59 9.32 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.4 -1.08 . . . . 1.8 110.4 -178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 112' ' ' ILE . 0.2 OUTLIER -157.48 175.78 13.51 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.861 2.065 . . . . 4.29 105.706 -174.564 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -123.35 106.39 10.63 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.501 1.046 . . . . 0.94999999999999996 112.488 -169.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.69 150.02 42.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.194 -0.457 . . . . 1.6699999999999999 110.133 168.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.33 134.45 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.995 1.718 . . . . 0.44 107.124 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 m -103.71 124.66 58.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.265 -1.383 . . . . 1.6000000000000001 107.265 165.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.476 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 60.0 m-70 -97.81 159.42 14.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 116.859 2.17 . . . . 0.42999999999999999 116.859 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -40.62 -69.52 0.13 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.143 2.577 . . . . 3.1099999999999999 111.651 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -113.44 -176.23 2.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.66 0.664 . . . . 3.3900000000000001 109.985 -169.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.7 146.33 41.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.528 -0.545 . . . . 0.59999999999999998 109.528 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 154.47 41.61 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.244 -1.021 . . . . 2.0800000000000001 108.244 157.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -90.81 -6.02 54.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 3.54 113.663 -170.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 65.84 14.49 9.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.365 1.466 . . . . 1.5 113.44 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 39.01 3.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.94 1.257 . . . . 1.6399999999999999 110.999 167.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -141.68 -82.36 0.21 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.346 1.459 . . . . 5.3200000000000003 108.525 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.06 -46.42 0.98 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.66 1.124 . . . . 3.98 114.285 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.53 7.76 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.349 -1.5 . . . . 2.6200000000000001 109.349 -165.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -166.18 -170.39 1.69 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.138 1.775 . . . . 2.5899999999999999 107.347 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -92.87 -47.61 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.831 0.853 . . . . 3.3199999999999998 110.493 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -53.3 -33.76 54.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.929 2.092 . . . . 4.1699999999999999 112.085 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 p -49.73 -70.68 0.08 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.47 1.508 . . . . 2.1800000000000002 110.705 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.6 p -60.06 -45.65 92.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 1.4199999999999999 110.207 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.8 -48.26 75.7 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.373 1.069 . . . . 3.9100000000000001 111.577 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.45 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 54.5 p -132.07 -54.73 0.98 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.386 0.513 . . . . 1.6100000000000001 112.386 -172.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 126.99 106.96 1.45 Allowed Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 104.783 -3.327 . . . . 3.02 104.783 -167.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.45 57.55 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.679 1.592 . . . . 1.95 108.984 -172.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -58.75 -30.84 67.81 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.458 1.503 . . . . 0.89000000000000001 113.438 -176.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.08 50.62 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 107.953 -2.059 . . . . 1.05 107.953 -160.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 t -64.69 162.78 15.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.927 0.891 . . . . 1.8799999999999999 113.289 -165.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -65.75 138.03 57.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.337 1.855 . . . . 2.9300000000000002 109.144 172.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.7 mt -110.75 -78.31 0.59 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.773 1.169 . . . . 0.53000000000000003 108.91 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -109.4 151.7 26.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.878 0.871 . . . . 0.76000000000000001 109.175 174.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.0 p -160.57 173.24 15.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.426 1.89 . . . . 1.3899999999999999 107.367 -177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 167.11 170.88 32.54 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.844 -2.902 . . . . 1.45 105.844 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.6 t -87.49 143.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 119.624 1.712 . . . . 0.78000000000000003 109.082 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.517 HD11 ' CG ' ' A' ' 20' ' ' PHE . 12.8 tt -93.65 127.63 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.92 0.488 . . . . 0.78000000000000003 111.592 171.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.54 14.95 0.11 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.38 1.467 . . . . 1.1000000000000001 114.292 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 mm -101.99 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 120.178 1.989 . . . . 1.03 109.331 -159.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.73 175.11 14.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 1.24 109.278 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 104.351 -2.463 . . . . 4.2999999999999998 104.351 162.377 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.749 0.309 . . . . 3.6099999999999999 111.181 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.06 138.36 34.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 0.66000000000000003 108.108 165.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.59 142.36 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.953 -1.129 . . . . 0.76000000000000001 107.953 166.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.34 96.07 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.444 -0.947 . . . . 0.47999999999999998 108.444 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.84 107.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.763 -1.569 . . . . 0.87 106.763 159.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -95.21 125.0 39.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.969 -1.123 . . . . 1.01 107.969 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -49.68 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.16 0.584 . . . . 4.8499999999999996 109.872 175.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 36.38 -120.5 0.6 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.42 1.486 . . . . 1.04 112.918 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -93.47 -59.67 1.96 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.342 -0.984 . . . . 3.4100000000000001 108.342 -173.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.39 164.2 5.43 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.512 1.53 . . . . 1.01 114.897 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -79.06 33.48 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.399 3.399 . . . . 1.3200000000000001 112.208 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 27.7 t -111.2 141.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 127.171 2.189 . . . . 1.21 105.997 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -139.61 128.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.776 -1.564 . . . . 2.4300000000000002 106.776 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.17 164.88 31.59 Favored Glycine 0 N--CA 1.45 -0.395 0 O-C-N 121.905 -0.497 . . . . 0.77000000000000002 112.064 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.98 124.57 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.863 -1.162 . . . . 1.28 107.863 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.0 mm -89.39 155.33 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.504 1.122 . . . . 0.94999999999999996 109.061 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 126.57 43.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.516 -0.92 . . . . 2.3300000000000001 108.516 153.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.592 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -106.65 123.25 47.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.462 -2.051 . . . . 2.5299999999999998 105.462 168.542 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -148.98 139.51 22.56 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.098 -0.705 . . . . 3.4199999999999999 109.098 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 164.91 37.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.618 -1.993 . . . . 3.8999999999999999 105.618 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -54.3 2.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.774 1.23 . . . . 4.4100000000000001 110.34 -177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -79.28 118.74 21.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.257 -1.386 . . . . 4.1699999999999999 107.257 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -76.02 46.09 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.738 1.154 . . . . 2.79 112.7 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.8 t30 179.85 58.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.822 2.449 . . . . 3.79 107.971 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.59 170.59 35.2 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.41 -1.076 . . . . 0.96999999999999997 110.41 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.45 140.24 86.49 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.315 2.677 . . . . 1.2 111.626 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 20' ' ' PHE . 9.6 t -93.67 158.12 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.12 -1.067 . . . . 1.27 108.12 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -107.71 111.75 24.09 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.38 -1.711 . . . . 5.6200000000000001 106.38 162.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' CE1' ' A' ' 20' ' ' PHE . 5.0 t -79.61 135.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.507 -2.034 . . . . 1.1599999999999999 105.507 170.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -139.13 159.64 41.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.644 -1.984 . . . . 0.81000000000000005 105.644 159.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.1 -166.29 14.75 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.201 -1.0 . . . . 1.9199999999999999 110.61 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.0 m -148.22 109.73 4.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.626 -1.99 . . . . 1.6499999999999999 105.626 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -114.81 146.18 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.703 -1.592 . . . . 0.82999999999999996 106.703 -170.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -154.79 170.63 21.17 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 114.127 1.158 . . . . 3.7200000000000002 114.127 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.89 80.45 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.626 1.584 . . . . 0.65000000000000002 112.616 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.1 155.77 26.93 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.833 -0.804 . . . . 0.68999999999999995 110.232 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 165.01 17.71 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.66 -1.237 . . . . 1.6899999999999999 107.66 156.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.66 175.69 0.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.013 0.824 . . . . 2.6099999999999999 111.59 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.34 -162.12 37.22 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.129 0.871 . . . . 0.45000000000000001 113.576 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.49 146.48 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.051 1.74 . . . . 1.9199999999999999 112.962 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -146.97 113.53 5.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.872 1.669 . . . . 0.51000000000000001 109.428 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.92 147.84 4.16 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.745 -0.942 . . . . 0.40999999999999998 110.745 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.54 95.32 2.85 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.791 -1.559 . . . . 2.23 106.791 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.669 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 14.7 m170 -132.18 158.37 41.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.354 -1.721 . . . . 0.64000000000000001 106.354 -165.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.302 0.8 OUTLIER -117.81 115.94 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.546 1.165 . . . . 1.77 110.681 175.527 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -79.78 158.95 26.72 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.113 1.365 . . . . 0.92000000000000004 109.15 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -28.62 -93.39 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.638 2.775 . . . . 4.9400000000000004 114.998 -158.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.517 -0.301 0 C-N-CA 123.1 0.56 . . . . 12.24 110.273 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 113.188 0.81 . . . . 2.7999999999999998 113.188 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.82 -91.98 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.955 -0.914 . . . . 1.6000000000000001 112.204 -161.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.4 177.51 8.25 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.607 2.872 . . . . 1.3999999999999999 112.925 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -62.3 123.42 18.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.219 -1.4 . . . . 1.28 107.219 168.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -37.9 109.63 0.11 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.422 1.089 . . . . 1.8600000000000001 112.255 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -126.12 145.06 51.0 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 130.792 3.637 . . . . 3.5 107.712 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 -43.0 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.277 1.985 . . . . 1.27 109.028 168.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -155.24 -73.44 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.368 -0.975 . . . . 2.9500000000000002 108.368 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 p -129.49 58.88 1.61 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.471 1.108 . . . . 2.77 110.906 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -79.8 159.84 26.37 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.818 -0.552 . . . . 4.71 109.559 168.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.46 163.02 17.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.375 1.47 . . . . 3.8500000000000001 107.792 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -90.2 153.39 20.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.912 0.885 . . . . 0.82999999999999996 110.329 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.66 -52.4 0.01 OUTLIER Glycine 0 C--O 1.224 -0.521 0 N-CA-C 109.639 -1.384 . . . . 2.77 109.639 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.9 -166.31 21.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.948 1.261 . . . . 1.1699999999999999 111.488 171.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.91 -41.31 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.786 2.324 . . . . 1.3600000000000001 109.155 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -58.78 -58.11 10.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.267 1.427 . . . . 4.9000000000000004 109.91 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.66 152.88 29.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.036 -0.983 . . . . 1.9299999999999999 111.269 -167.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -52.18 -45.42 65.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.77 1.628 . . . . 4.0999999999999996 111.479 173.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -77.64 145.67 36.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.505 1.145 . . . . 2.6499999999999999 110.256 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.27 151.56 2.07 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.369 1.868 . . . . 3.1099999999999999 108.848 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.4 m80 -60.94 143.63 54.72 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.785 -1.561 . . . . 0.53000000000000003 106.785 163.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.97 -30.73 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.167 -0.613 . . . . 1.3700000000000001 110.947 -165.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.69 67.51 0.31 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 112.157 -0.377 . . . . 0.89000000000000001 112.157 167.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.29 114.37 3.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.419 -1.048 . . . . 2.1899999999999999 108.862 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.03 -53.93 3.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.248 0.619 . . . . 2.0600000000000001 110.121 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.76 -110.41 0.42 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.112 -0.566 . . . . 0.55000000000000004 111.822 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -148.58 167.58 25.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.04 1.736 . . . . 1.46 109.479 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.5 m -117.63 175.23 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.362 -1.718 . . . . 0.48999999999999999 106.362 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.9 t -109.43 150.48 28.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.264 -1.384 . . . . 2.2599999999999998 107.264 159.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.03 152.83 32.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.64 -0.874 . . . . 1.04 108.64 157.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -79.88 -83.47 0.1 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.781 1.232 . . . . 3.7200000000000002 108.984 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -151.29 -48.47 0.12 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.175 0.99 . . . . 3.9500000000000002 110.968 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.37 24.91 0.65 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.439 1.59 . . . . 2.7200000000000002 111.13 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.36 14.39 61.94 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.063 1.316 . . . . 0.70999999999999996 111.889 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.88 152.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 125.193 1.397 . . . . 0.92000000000000004 107.749 175.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.41 172.35 15.07 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.16 1.384 . . . . 0.88 107.729 168.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -132.85 162.66 30.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.89 -2.263 . . . . 3.3999999999999999 104.89 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.54 55.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 O-C-N 124.184 0.928 . . . . 1.8700000000000001 112.423 174.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.3 m -70.4 101.29 1.92 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.741 -0.599 . . . . 0.98999999999999999 110.845 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.07 157.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.835 -0.802 . . . . 1.76 108.835 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -139.09 129.16 25.19 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.613 -0.884 . . . . 3.6200000000000001 108.613 159.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -134.68 151.48 51.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.695 1.598 . . . . 2.3599999999999999 108.492 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 p -107.59 -3.51 19.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.275 1.83 . . . . 1.45 113.28 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.94 -42.56 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.364 -1.347 . . . . 1.1599999999999999 107.364 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.497 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.2 pp -74.69 177.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.519 0.676 . . . . 1.79 111.546 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.9 m -161.21 179.32 8.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.833 2.453 . . . . 1.9399999999999999 106.434 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 70.4 1.08 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.118 -2.179 . . . . 2.8399999999999999 105.118 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 115.638 -0.71 . . . . 3.96 110.513 170.019 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.445 -0.692 0 CA-C-O 122.486 1.136 . . . . 2.0699999999999998 112.887 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.507 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -86.95 -6.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.065 -0.971 . . . . 1.6899999999999999 112.081 -170.594 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.463 ' HA ' HG23 ' A' ' 149' ' ' ILE . 24.2 mm -59.38 124.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.455 -0.943 . . . . 2.6200000000000001 108.455 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.79 3.56 76.91 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.447 1.022 . . . . 1.3200000000000001 113.256 -172.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -113.03 163.48 14.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.285 1.543 . . . . 4.46 109.771 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -93.15 89.79 6.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.833 1.253 . . . . 2.54 110.252 -157.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.33 143.98 56.27 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.329 -0.857 . . . . 1.8100000000000001 109.848 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -135.19 133.45 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.281 1.832 . . . . 0.46000000000000002 109.046 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -94.38 121.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 125.858 1.663 . . . . 2.4500000000000002 107.706 163.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.568 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 90.3 m-70 -98.56 167.28 10.91 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 117.608 2.447 . . . . 0.48999999999999999 117.608 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -81.3 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.325 1.85 . . . . 4.0199999999999996 110.314 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -178.26 6.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.595 0.634 . . . . 4.6100000000000003 109.878 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.63 151.03 30.07 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.141 -1.429 . . . . 0.55000000000000004 107.141 153.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -76.74 151.7 35.93 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.473 -1.306 . . . . 1.99 107.473 158.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -70.27 -25.56 63.41 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.0 -0.437 . . . . 3.1400000000000001 111.529 -169.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 50.0 7.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.043 0.937 . . . . 2.0800000000000001 109.93 -159.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 52.53 39.72 53.73 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.306 0.955 . . . . 1.6000000000000001 113.263 167.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -80.01 -18.61 49.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.681 0.792 . . . . 5.3700000000000001 111.394 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.44 -143.09 16.3 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.83 -0.508 . . . . 2.4399999999999999 111.83 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.77 -77.05 0.4 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.577 -1.409 . . . . 2.27 109.577 -172.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.86 104.03 14.46 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.012 -1.477 . . . . 2.8399999999999999 107.012 167.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.56 -33.55 22.23 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.763 1.165 . . . . 5.1600000000000001 112.986 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -37.07 -36.71 0.13 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.319 1.048 . . . . 3.02 113.694 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.8 t -36.35 -66.99 0.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.903 2.081 . . . . 2.27 111.023 167.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.28 -46.15 51.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.145 0.978 . . . . 1.49 110.583 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -53.01 -52.27 58.96 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.585 0.754 . . . . 3.0099999999999998 111.328 -168.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.492 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.278 5.4 p -126.51 -48.51 1.54 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.675 -0.679 . . . . 1.3100000000000001 112.277 174.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 159.42 -21.06 0.28 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 120.052 1.296 . . . . 1.01 114.039 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.17 56.32 5.96 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.796 1.238 . . . . 2.1800000000000002 111.349 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -67.28 0.49 2.78 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.509 0.929 . . . . 1.0700000000000001 113.509 169.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -71.13 2.99 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.297 -1.502 . . . . 3.3799999999999999 110.315 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 t -166.33 -174.41 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.529 0.732 . . . . 1.8200000000000001 110.975 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.31 139.06 31.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.496 2.718 . . . . 2.8900000000000001 109.522 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.4 mt -113.26 -88.28 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.298 0.954 . . . . 0.93999999999999995 109.685 169.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.31 154.43 21.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.598 -0.89 . . . . 1.02 108.598 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.6 p -157.58 170.98 21.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 123.753 0.658 . . . . 1.51 110.598 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.62 155.42 11.31 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.484 -1.446 . . . . 1.0600000000000001 109.484 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.0 137.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.611 0.705 . . . . 1.48 109.459 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.507 HG21 HG12 ' A' ' 112' ' ' ILE . 13.1 tt -86.45 143.65 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.72999999999999998 110.935 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.04 5.56 3.03 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.62 1.105 . . . . 0.57999999999999996 114.219 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.4 mm -96.05 56.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 119.289 1.544 . . . . 0.94999999999999996 109.926 -156.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.49 176.52 12.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.547 0.739 . . . . 1.3 110.578 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.483 ' NE2' ' H ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.313 0 N-CA-C 103.999 -2.593 . . . . 5.0599999999999996 103.999 154.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 pttm . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 107.798 -1.186 . . . . 2.9900000000000002 107.798 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.414 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -115.39 144.8 43.26 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.055 -1.461 . . . . 0.78000000000000003 107.055 164.169 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.9 t -119.91 141.38 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 107.571 -1.27 . . . . 0.87 107.571 171.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.19 99.82 6.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.173 1.389 . . . . 0.55000000000000004 108.286 159.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.83 98.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.65 -1.241 . . . . 0.58999999999999997 107.65 163.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.0 mt -84.61 126.82 33.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.188 0.595 . . . . 0.81000000000000005 109.564 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -143.72 -48.3 0.29 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.72 0.808 . . . . 3.75 110.91 170.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.43 -123.68 5.24 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.432 -1.067 . . . . 0.82999999999999996 110.432 -171.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -107.1 -52.57 2.74 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.712 0.756 . . . . 4.0199999999999996 110.707 -173.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.56 156.58 5.71 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.913 1.244 . . . . 0.78000000000000003 111.702 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.14 39.65 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.372 3.381 . . . . 1.1899999999999999 113.23 -170.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 63.5 t -101.47 155.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.761 2.025 . . . . 0.80000000000000004 107.644 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.12 125.02 9.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.967 -1.494 . . . . 2.5 106.967 175.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.81 165.91 35.33 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.268 -0.733 . . . . 0.51000000000000001 111.268 177.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.09 115.18 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.009 -1.849 . . . . 1.6000000000000001 106.009 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.4 mm -78.65 145.83 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.273 -1.38 . . . . 0.75 107.273 168.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -123.41 107.62 11.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.878 -1.897 . . . . 2.0299999999999998 105.878 163.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CE1' HG22 ' A' ' 31' ' ' VAL . 1.3 m-85 -89.55 93.16 9.39 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.265 -2.124 . . . . 2.8999999999999999 105.265 164.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -96.11 134.87 38.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.106 -0.702 . . . . 3.5600000000000001 109.106 177.483 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -145.95 83.31 1.63 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.104 -0.953 . . . . 3.71 110.931 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -50.39 -45.13 55.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.721 -0.672 . . . . 6.7699999999999996 111.012 157.036 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -85.33 73.48 10.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.852 -1.166 . . . . 4.7400000000000002 107.852 -175.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 79.78 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.473 0.709 . . . . 4.1600000000000001 109.614 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -162.72 -53.69 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.61 1.564 . . . . 5.6299999999999999 109.513 -162.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.08 -85.31 0.06 OUTLIER Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.762 -1.209 . . . . 2.0899999999999999 112.761 -170.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.21 115.64 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.363 2.708 . . . . 1.8400000000000001 111.593 -174.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.51 HG11 ' CD2' ' A' ' 20' ' ' PHE . 23.2 t -87.5 165.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.861 -1.162 . . . . 1.0600000000000001 107.861 172.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.162 -1.792 . . . . 3.9399999999999999 106.162 168.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.525 HG22 ' CE1' ' A' ' 20' ' ' PHE . 10.0 t -89.67 131.49 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.96 -1.496 . . . . 1.0900000000000001 106.96 174.513 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -136.93 161.9 34.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.26 -1.385 . . . . 0.87 107.26 153.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.09 146.16 7.06 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.998 . . . . 0.84999999999999998 108.105 178.138 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -119.81 66.94 0.81 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.672 1.989 . . . . 1.6299999999999999 107.16 -171.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.73 115.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.47 -1.241 . . . . 1.21 107.96 -167.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -110.27 154.36 23.56 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.424 0.69 . . . . 3.7000000000000002 111.616 -173.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.64 68.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.641 -0.709 . . . . 0.73999999999999999 114.31 172.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -59.28 164.28 3.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.945 1.373 . . . . 0.68999999999999995 109.078 163.205 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.28 160.22 19.18 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.719 -1.238 . . . . 1.75 107.836 154.27 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -58.85 171.33 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.367 -0.833 . . . . 2.6000000000000001 110.289 175.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.0 -157.27 48.42 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 121.94 -0.475 . . . . 0.46000000000000002 112.96 167.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.98 141.92 38.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.207 1.003 . . . . 2.3999999999999999 111.059 -167.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -143.99 119.62 10.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.241 1.016 . . . . 0.45000000000000001 110.537 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.3 147.9 16.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.708 -0.957 . . . . 0.45000000000000001 110.708 172.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.41 91.85 2.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.361 1.064 . . . . 2.4100000000000001 108.167 -173.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.583 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 21.3 m170 -130.86 158.27 40.64 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.81999999999999995 109.828 -160.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.42 117.0 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.295 -0.632 . . . . 2.4700000000000002 109.295 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -107.6 139.57 41.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.959 -1.126 . . . . 1.05 107.959 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -73.01 66.16 0.79 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.242 0.83 . . . . 5.1900000000000004 113.242 -171.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' CD ' HH22 ' A' ' 143' ' ' ARG . 2.4 mt-10 . . . . . 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 3.0 110.541 -173.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.367 0 N-CA-C 106.634 -1.617 . . . . 1.9399999999999999 106.634 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.5 -96.27 2.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.485 -1.846 . . . . 1.1699999999999999 108.485 -177.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.47 177.8 6.34 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.281 2.654 . . . . 1.0 113.23 -177.17 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -69.07 131.77 45.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 115.968 -1.968 . . . . 1.6499999999999999 105.852 170.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -33.93 107.91 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.865 1.666 . . . . 3.1499999999999999 114.337 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.41 127.73 30.89 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 126.521 1.928 . . . . 3.1699999999999999 107.31 167.545 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.49 -40.68 13.45 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.595 1.53 . . . . 1.76 109.133 173.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 tt -146.69 -60.56 0.3 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.159 -1.793 . . . . 3.54 106.159 164.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.6 p -151.38 80.28 1.3 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.49 0.716 . . . . 2.6600000000000001 109.948 -178.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -80.03 163.58 24.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 4.7699999999999996 108.392 158.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.14 166.21 10.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.32 -1.363 . . . . 3.54 107.32 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.437 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 46.0 t60 -80.1 160.95 25.58 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.81999999999999995 110.148 175.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.19 -149.33 7.98 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 104.769 -3.332 . . . . 2.1299999999999999 104.769 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.69 -146.45 4.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.462 1.631 . . . . 1.3300000000000001 109.041 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.9 -36.88 21.59 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.321 2.014 . . . . 1.48 111.132 -177.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.61 -44.05 91.8 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.627 0.371 . . . . 4.8200000000000003 111.104 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.43 164.13 26.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.625 0.726 . . . . 1.9299999999999999 112.042 -169.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -77.74 -45.63 24.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.158 1.383 . . . . 4.1500000000000004 108.971 165.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -78.27 168.59 19.6 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.987 0.899 . . . . 3.25 109.84 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 153.62 142.75 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 130.524 3.53 . . . . 3.0 105.454 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.0 m80 -59.58 151.02 25.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.649 -0.82 . . . . 0.78000000000000003 109.313 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -71.31 -4.77 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.258 -0.901 . . . . 1.51 111.121 -172.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.99 70.2 0.44 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.995 1.283 . . . . 1.0 109.947 159.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.92 122.28 0.7 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.64 -1.244 . . . . 2.1400000000000001 107.64 -177.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.33 -38.06 8.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.772 0.829 . . . . 1.8100000000000001 110.204 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.87 -129.29 3.24 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.086 -2.006 . . . . 0.82999999999999996 108.086 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -131.05 170.6 14.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.134 1.374 . . . . 1.77 110.382 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.09 175.71 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.352 1.461 . . . . 0.79000000000000004 107.244 171.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -124.89 126.76 46.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.937 -1.135 . . . . 2.1200000000000001 107.937 175.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.48 139.53 31.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.754 0.822 . . . . 0.63 111.337 171.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -74.26 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 O-C-N 124.305 1.003 . . . . 3.0899999999999999 110.508 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 93' ' ' GLY . 46.6 tttt -149.84 -35.44 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.786 1.032 . . . . 3.23 113.786 -164.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -80.89 22.17 0.63 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 124.047 1.879 . . . . 3.9300000000000002 110.191 165.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 57.9 25.83 56.95 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 125.124 1.345 . . . . 1.0900000000000001 111.069 -170.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.9 t -83.78 106.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.396 1.079 . . . . 1.1599999999999999 108.169 -175.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.8 167.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.977 -1.12 . . . . 0.96999999999999997 107.977 158.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -128.07 139.6 52.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 103.399 -2.815 . . . . 3.0899999999999999 103.399 176.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.08 55.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 123.861 0.726 . . . . 2.02 111.775 179.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -74.89 101.57 4.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.389 0.676 . . . . 1.05 110.767 170.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.1 mt -140.94 156.01 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.93 0.786 . . . . 1.8700000000000001 109.626 177.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.27 72.22 1.37 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.345 1.458 . . . . 4.96 111.22 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.49 134.68 37.29 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.403 -0.811 . . . . 2.1699999999999999 109.454 177.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 p -92.72 -9.97 38.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.424 1.49 . . . . 1.6599999999999999 112.894 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.4 t -85.63 -46.09 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.404 -0.962 . . . . 1.48 108.404 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.6 pp -70.8 177.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.097 0.475 . . . . 1.1200000000000001 111.922 176.493 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.5 t -153.12 175.07 13.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.609 1.964 . . . . 2.98 105.808 172.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.45 0.68 17.9 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.036 0.935 . . . . 2.4100000000000001 111.399 162.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 CA--C 1.53 0.184 0 C-N-CA 125.246 1.418 . . . . 3.5899999999999999 110.74 -173.243 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 p . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 115.509 1.67 . . . . 1.49 115.509 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.66 -14.54 12.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 114.122 -1.399 . . . . 2.73 112.392 170.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.2 tp -50.04 123.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 124.066 0.946 . . . . 2.1499999999999999 110.297 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.9 86.77 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.215 -0.769 . . . . 1.3600000000000001 114.198 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.7 175.99 9.41 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.148 1.974 . . . . 5.6699999999999999 109.341 178.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.85 123.69 50.89 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.578 1.081 . . . . 1.9399999999999999 108.594 167.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.85 144.92 40.95 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.301 -1.37 . . . . 1.52 107.301 167.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -129.75 134.93 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.195 1.798 . . . . 0.41999999999999998 107.59 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.82 128.44 58.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.729 -1.212 . . . . 1.6899999999999999 107.729 167.582 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.497 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 53.6 m-70 -104.3 158.13 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.827 2.158 . . . . 0.63 116.827 -171.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -41.33 -68.87 0.16 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.724 2.81 . . . . 3.04 111.355 172.291 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -111.27 -175.06 2.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.1 -0.704 . . . . 2.8900000000000001 109.1 -171.053 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.97 141.04 47.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.053 -1.091 . . . . 0.89000000000000001 108.053 165.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.66 165.46 14.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.994 -0.682 . . . . 2.5600000000000001 109.604 154.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.53 -48.66 74.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.525 -0.761 . . . . 3.54 113.048 -173.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 77.08 52.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.289 1.836 . . . . 1.6799999999999999 111.021 -159.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 27.16 64.42 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.408 1.004 . . . . 1.6399999999999999 114.889 152.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -85.35 -33.14 22.1 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.081 1.352 . . . . 5.9199999999999999 108.673 169.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.43 -80.67 1.6 Allowed Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.633 -1.787 . . . . 2.7200000000000002 108.633 -178.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.85 -73.92 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.294 0.95 . . . . 2.7799999999999998 110.861 -175.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -75.46 -116.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.097 -1.446 . . . . 2.8900000000000001 107.097 157.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.15 -40.3 0.06 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.069 1.304 . . . . 4.2400000000000002 112.912 173.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -43.21 -43.61 4.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.806 1.242 . . . . 3.8399999999999999 111.504 175.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.9 m -33.28 -63.66 0.23 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.095 2.558 . . . . 2.5 113.483 163.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.08 -46.28 57.44 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.119 -0.988 . . . . 1.97 112.052 175.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -53.03 -49.46 66.25 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.395 0.543 . . . . 3.5600000000000001 110.821 -173.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -129.67 -46.21 1.17 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.662 0.785 . . . . 1.45 110.991 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.21 -31.74 0.79 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.241 0.448 . . . . 1.1699999999999999 112.12 -175.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 48.19 54.66 9.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.926 1.29 . . . . 2.7799999999999998 110.259 -165.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.583 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -51.46 -35.35 39.34 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.921 1.688 . . . . 1.3899999999999999 113.71 174.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.52 -179.04 49.1 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 108.464 -1.854 . . . . 0.98999999999999999 108.464 -159.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -62.43 153.3 31.77 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.263 1.425 . . . . 1.6200000000000001 112.736 -164.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.436 HH22 ' CD ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -77.07 133.71 38.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.8 1.24 . . . . 2.6800000000000002 108.664 179.137 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.0 mt -111.02 -70.39 0.82 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.093 -1.077 . . . . 0.53000000000000003 108.093 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -131.97 148.37 52.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.614 0.766 . . . . 0.88 110.047 -173.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.3 p -160.28 173.79 15.17 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 125.191 1.557 . . . . 1.55 109.415 -176.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.64 135.04 2.5 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.71 -2.156 . . . . 0.68999999999999995 107.71 -176.356 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.1 t -60.5 133.79 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.495 0.718 . . . . 0.80000000000000004 109.074 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.22 136.08 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.28 0.562 . . . . 0.80000000000000004 112.204 -174.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 137.25 -3.02 3.28 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.812 1.196 . . . . 0.55000000000000004 114.029 175.464 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -95.3 61.26 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 122.784 1.278 . . . . 1.45 107.832 -157.678 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.25 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.93 -1.032 . . . . 2.6400000000000001 112.696 -173.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 C--O 1.25 1.104 0 N-CA-C 101.813 -3.403 . . . . 8.6500000000000004 101.813 150.662 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 107.946 -1.131 . . . . 4.79 107.946 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.53 149.12 47.27 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.856 -0.794 . . . . 0.82999999999999996 108.856 157.295 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 t -119.59 145.48 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.856 -1.164 . . . . 1.0600000000000001 107.856 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.11 97.14 5.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.648 -0.871 . . . . 0.65000000000000002 108.648 159.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.43 105.33 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.264 -1.384 . . . . 0.67000000000000004 107.264 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.22 124.48 37.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.99 -0.745 . . . . 0.85999999999999999 108.99 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -137.97 -60.16 0.64 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.75 0.42 . . . . 3.3100000000000001 110.001 174.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.78 -122.1 6.43 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.201 0.905 . . . . 0.79000000000000004 111.989 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -115.14 -50.48 2.75 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 124.932 1.293 . . . . 3.02 109.475 -163.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.31 153.95 9.18 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.735 -1.346 . . . . 0.71999999999999997 109.735 171.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.69 41.91 1.15 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.425 2.75 . . . . 0.98999999999999999 113.279 -166.242 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.62 155.91 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.329 1.852 . . . . 1.1499999999999999 108.945 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.39 81.57 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.133 -1.432 . . . . 2.3900000000000001 107.133 172.086 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.23 163.66 13.96 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.398 -0.681 . . . . 0.46999999999999997 111.398 -173.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.75 124.56 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.417 -0.957 . . . . 1.1200000000000001 108.417 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -88.82 135.31 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.421 1.089 . . . . 0.91000000000000003 108.326 164.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.48 110.38 22.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.801 1.64 . . . . 2.9199999999999999 108.086 159.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.42 111.88 23.57 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.11 -1.811 . . . . 2.3999999999999999 106.11 166.595 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -117.41 140.13 49.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.852 0.72 . . . . 2.9399999999999999 110.167 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -156.62 141.57 17.13 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.781 0.832 . . . . 4.0899999999999999 110.569 170.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -70.42 -67.06 0.52 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.44 0.696 . . . . 4.79 109.529 170.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -76.85 -178.7 5.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 120.076 1.307 . . . . 3.8100000000000001 111.854 -170.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -65.57 -65.95 0.61 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.882 1.273 . . . . 2.4399999999999999 110.401 172.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -125.65 92.52 3.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.892 0.877 . . . . 4.1699999999999999 109.526 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.25 177.35 27.5 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 108.28 -1.928 . . . . 1.0600000000000001 108.28 170.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.44 111.59 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.51 2.806 . . . . 1.3 112.094 -175.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.31 132.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.075 -1.083 . . . . 0.83999999999999997 108.075 -169.181 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -87.23 101.17 13.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.201 -1.777 . . . . 3.6600000000000001 106.201 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.1 124.37 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.282 -1.747 . . . . 1.23 106.282 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -131.83 136.35 47.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.047 -1.834 . . . . 1.0700000000000001 106.047 159.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.28 150.97 23.21 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.539 -1.824 . . . . 0.71999999999999997 108.539 -174.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.1 m -128.95 101.43 6.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.73 -2.322 . . . . 1.8600000000000001 104.73 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.97 144.59 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.074 -1.454 . . . . 0.81000000000000005 107.074 -169.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -154.83 143.73 20.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.475 0.546 . . . . 3.8199999999999998 112.475 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.89 25.79 8.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.877 2.179 . . . . 0.98999999999999999 112.712 -177.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.31 -155.78 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.431 -0.952 . . . . 1.1899999999999999 108.431 164.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -135.65 168.43 19.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.622 -2.733 . . . . 2.5499999999999998 103.622 165.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.16 169.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.277 1.399 . . . . 3.1899999999999999 114.099 -172.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.36 -165.98 48.9 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.592 -1.185 . . . . 0.5 113.195 169.211 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.51 143.7 57.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.403 1.481 . . . . 1.8200000000000001 113.104 -174.384 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -143.15 114.82 8.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.074 1.749 . . . . 0.44 108.69 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.61 145.16 2.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.33 -1.108 . . . . 0.33000000000000002 110.33 169.497 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.456 ' CE2' HG12 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -137.58 95.11 3.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.738 -1.579 . . . . 2.46 106.738 -176.64 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.3 m80 -134.98 154.51 51.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.362 -1.347 . . . . 0.65000000000000002 107.362 -164.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.264 2.6 p -107.08 108.66 25.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 CA-C-O 122.396 1.093 . . . . 1.8899999999999999 108.782 172.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.515 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 12.4 m-70 -77.47 156.44 31.05 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.39 -1.707 . . . . 0.97999999999999998 106.39 172.245 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -81.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.908 0.483 . . . . 5.5099999999999998 110.261 -178.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . 30.5 tt0 . . . . . 0 C--O 1.233 0.203 0 C-N-CA 127.853 2.461 . . . . 4.4900000000000002 114.403 -169.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . . . . . . . . 0 C--O 1.232 0.137 0 N-CA-C 118.556 2.799 . . . . 2.3700000000000001 118.556 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -177.66 14.05 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 114.235 -1.348 . . . . 2.0899999999999999 110.914 164.088 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.61 -179.99 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.977 3.785 . . . . 1.1399999999999999 113.612 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -47.07 107.19 0.1 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.844 1.258 . . . . 1.1499999999999999 109.063 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -34.27 104.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.278 1.431 . . . . 2.4100000000000001 111.935 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -122.79 141.58 35.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 129.55 3.14 . . . . 3.48 108.197 -174.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.91 -51.71 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.017 1.811 . . . . 1.01 109.085 173.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.19 -75.4 0.37 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.299 1.04 . . . . 2.6000000000000001 108.558 169.04 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -136.32 60.63 1.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.006 0.522 . . . . 1.6299999999999999 111.613 -159.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -78.74 164.04 24.89 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.702 -1.222 . . . . 4.0300000000000002 107.702 162.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -127.66 173.62 9.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.643 . . . . 4.6100000000000003 107.142 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.518 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 35.8 t60 -93.85 157.69 16.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.97 0.73 . . . . 0.81999999999999995 112.97 -167.076 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.41 -147.77 7.79 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 105.734 -2.946 . . . . 2.1099999999999999 105.734 166.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.89 -170.4 30.77 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.051 -2.42 . . . . 1.8300000000000001 107.051 176.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.29 -23.84 71.62 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.092 2.528 . . . . 2.1499999999999999 113.667 -176.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -70.37 -34.37 72.52 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.963 -0.461 . . . . 5.2400000000000002 111.264 173.592 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.52 176.65 8.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.562 1.545 . . . . 1.8899999999999999 110.585 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -83.93 -47.91 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.926 1.29 . . . . 4.3200000000000003 109.145 164.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -88.69 166.39 14.11 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.592 1.157 . . . . 3.2400000000000002 111.073 -166.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 168.95 146.1 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.51 2.324 . . . . 5.7599999999999998 108.773 -173.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 42.1 m80 -63.25 148.75 47.31 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 106.278 -1.749 . . . . 0.52000000000000002 106.278 166.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 -45.84 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 119.224 -0.99 . . . . 1.5 108.389 -176.124 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.6 59.71 4.8 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.618 -0.677 . . . . 0.78000000000000003 113.187 171.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 80' ' ' HIS . 1.3 t0 -168.94 120.22 0.75 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.656 -1.238 . . . . 2.0 107.656 -172.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.39 -51.56 3.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.18 0.992 . . . . 2.2799999999999998 109.186 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.95 -116.49 0.71 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.642 -0.983 . . . . 0.56999999999999995 110.642 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -144.66 167.5 22.4 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.876 1.27 . . . . 1.71 109.677 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 175.54 5.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 N-CA-C 106.522 -1.659 . . . . 0.53000000000000003 106.522 167.342 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -106.97 147.25 30.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.264 -1.384 . . . . 2.27 107.264 158.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.01 30.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.639 -0.875 . . . . 0.88 108.639 155.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -73.2 -78.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.227 1.011 . . . . 3.3199999999999998 109.736 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -152.95 -52.37 0.11 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.532 1.533 . . . . 4.5700000000000003 108.491 178.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.48 17.7 1.68 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.903 1.681 . . . . 4.4800000000000004 111.541 -171.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.98 15.11 81.95 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.084 1.326 . . . . 0.70999999999999996 111.337 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.77 149.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.21 -1.404 . . . . 1.0 107.21 171.228 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.77 24.85 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.232 1.013 . . . . 0.69999999999999996 108.343 169.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.33 145.91 50.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.027 -2.212 . . . . 2.79 105.027 -174.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.13 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.841 0.713 . . . . 1.8 111.3 178.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.5 m -76.07 96.78 3.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.387 1.075 . . . . 0.81000000000000005 110.85 170.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.7 mt -132.45 153.94 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 1.5900000000000001 109.064 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -126.08 84.01 2.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.103 0.561 . . . . 3.0499999999999998 110.47 166.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -79.5 121.76 25.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.89 0.476 . . . . 2.9900000000000002 109.728 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.5 p -84.6 -17.33 39.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.286 1.834 . . . . 1.79 112.57 178.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.2 t -83.64 -51.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.908 0.776 . . . . 1.03 110.05 -170.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.435 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.9 pp -75.55 177.04 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.261 0.553 . . . . 1.03 110.863 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.0 m -155.97 175.84 13.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.898 1.279 . . . . 1.98 108.1 171.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 47.66 2.09 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.891 1.276 . . . . 2.5800000000000001 111.705 -175.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 105.856 -1.905 . . . . 2.77 105.856 171.808 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 p . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 122.375 1.083 . . . . 1.49 113.007 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -79.69 -27.41 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.943 -1.026 . . . . 1.97 110.443 172.142 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -32.12 108.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.133 2.173 . . . . 2.5600000000000001 111.247 177.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.88 -20.13 10.91 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.419 1.485 . . . . 1.55 112.816 -174.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -103.06 160.13 14.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.961 1.881 . . . . 4.6399999999999997 113.002 -165.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 146' ' ' CYS . 1.3 m -75.81 102.09 5.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.354 1.062 . . . . 1.1699999999999999 111.028 -172.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -68.71 144.96 54.25 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.335 -0.853 . . . . 1.6599999999999999 108.938 168.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -136.1 140.59 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.703 1.601 . . . . 0.44 108.99 -172.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 45' ' ' PHE . 2.2 m -111.38 125.45 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.203 1.401 . . . . 1.75 107.445 166.563 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.549 ' CD2' ' HD1' ' A' ' 46' ' ' HIS . 60.1 m-70 -101.63 165.25 11.33 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.727 1.751 . . . . 0.39000000000000001 115.727 -172.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' CG ' ' HD3' ' A' ' 122' ' ' LYS . 8.1 pt-20 -67.86 -53.41 26.94 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.469 1.108 . . . . 3.4300000000000002 112.444 -174.209 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.484 ' HD3' ' CG ' ' A' ' 121' ' ' GLU . 1.9 mppt? -101.09 -176.17 3.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.227 1.376 . . . . 2.8300000000000001 109.039 175.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.11 165.97 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.838 -0.801 . . . . 0.67000000000000004 108.838 156.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -84.39 167.06 16.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.421 0.688 . . . . 1.98 109.383 156.297 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.29 -7.15 59.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.627 1.171 . . . . 3.0299999999999998 111.881 -175.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 53.14 33.18 14.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.351 1.06 . . . . 1.3500000000000001 110.241 -170.087 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.57 20.52 52.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.798 0.713 . . . . 1.5900000000000001 112.635 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -135.14 50.3 2.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.292 1.437 . . . . 6.1500000000000004 107.446 -173.285 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.38 147.23 19.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 106.94 -2.464 . . . . 2.46 106.94 173.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.4 60.3 4.3 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.435 0.618 . . . . 2.2599999999999998 112.631 -167.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.88 163.22 35.76 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 107.325 -1.361 . . . . 2.8300000000000001 107.325 172.509 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.26 -52.37 62.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.004 -0.739 . . . . 3.1099999999999999 109.004 168.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -46.65 -42.57 16.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.518 1.527 . . . . 2.9300000000000002 111.847 -171.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 m -40.17 -63.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.866 2.066 . . . . 2.0299999999999998 112.113 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.2 t -74.95 -45.74 40.29 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.867 -0.521 . . . . 2.71 111.598 175.311 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.85 -48.22 67.21 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.713 1.605 . . . . 2.7999999999999998 111.492 -169.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.0 p -127.77 -46.73 1.41 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.778 0.431 . . . . 1.3899999999999999 111.493 174.763 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.518 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.54 -27.73 0.48 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 123.169 0.414 . . . . 1.0800000000000001 113.71 -178.412 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 51.6 t30 48.71 53.77 11.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 1.9199999999999999 110.216 -165.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.576 1.15 . . . . 1.0900000000000001 112.012 167.635 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.09 179.02 51.73 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 108.765 -1.734 . . . . 1.0 108.765 -161.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -53.79 155.72 3.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.791 -1.204 . . . . 1.6699999999999999 112.04 -175.398 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -92.93 144.49 25.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.615 1.966 . . . . 3.8500000000000001 109.519 -177.878 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt -114.43 -69.28 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.814 -1.18 . . . . 0.63 107.814 -173.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 165.21 12.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.865 -0.607 . . . . 1.28 110.133 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.532 ' HB2' HG23 ' A' ' 116' ' ' THR . 4.1 p -151.07 154.9 37.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.248 -0.887 . . . . 1.76 109.234 164.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.11 131.45 2.29 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.111 -1.996 . . . . 0.56000000000000005 108.111 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.94 125.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.433 -0.951 . . . . 0.81000000000000005 108.433 175.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.02 138.07 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 120.381 0.134 . . . . 0.93000000000000005 111.088 178.207 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.19 6.87 1.16 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.622 1.106 . . . . 0.67000000000000004 114.409 174.563 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.5 58.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 119.584 1.692 . . . . 0.92000000000000004 110.635 -160.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.94 175.67 12.68 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.891 0.876 . . . . 1.6100000000000001 108.646 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 103.603 -2.74 . . . . 4.7699999999999996 103.603 161.815 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 108.534 -0.913 . . . . 3.7200000000000002 108.534 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.457 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -88.63 154.95 19.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.198 -1.408 . . . . 0.97999999999999998 107.198 154.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.1 t -123.39 142.81 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.788 -0.819 . . . . 0.72999999999999998 108.788 169.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.38 93.14 4.26 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.114 -0.698 . . . . 0.5 109.114 158.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.62 103.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.73 -1.211 . . . . 0.68999999999999995 107.73 158.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.86 134.71 34.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.974 -0.751 . . . . 0.87 108.974 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -145.81 -57.64 0.31 Allowed 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.602 1.161 . . . . 3.1800000000000002 108.824 169.137 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.63 -124.3 31.25 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.804 0.716 . . . . 0.94999999999999996 112.432 -176.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -113.18 -54.15 2.64 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.618 1.167 . . . . 4.25 109.939 -164.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.02 160.55 7.07 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.202 -1.159 . . . . 0.95999999999999996 110.202 173.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.21 40.63 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.441 2.761 . . . . 1.04 112.349 -172.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.48 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.441 1.897 . . . . 0.68000000000000005 108.848 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.5 128.84 8.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.085 -1.82 . . . . 2.52 106.085 170.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.43 171.12 41.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.798 . . . . 0.46999999999999997 111.57 -177.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 mm -128.92 129.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.143 -1.428 . . . . 1.8999999999999999 107.143 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.3 mm -101.07 137.29 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 N-CA-C 107.126 -1.435 . . . . 0.71999999999999997 107.126 161.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 127.15 45.23 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.274 -1.38 . . . . 1.78 107.274 160.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.25 91.82 5.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.619 -1.993 . . . . 2.2400000000000002 105.619 158.658 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -122.03 134.76 54.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.119 -1.067 . . . . 4.1399999999999997 108.119 175.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.39 -62.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.512 -1.222 . . . . 3.5299999999999998 108.193 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? 58.79 48.89 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.299 1.44 . . . . 9.0099999999999998 112.958 169.397 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -147.67 160.76 42.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.042 0.937 . . . . 5.4199999999999999 109.387 160.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.3 p -75.93 56.23 0.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.216 -0.661 . . . . 5.8300000000000001 109.216 167.077 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -110.59 -56.91 2.29 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.527 1.531 . . . . 9.5899999999999999 107.688 176.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.65 0.35 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 117.974 -1.459 . . . . 2.0899999999999999 110.161 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -50.65 122.93 10.49 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.912 3.075 . . . . 2.0800000000000001 113.869 -168.402 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.23 143.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.623 -0.717 . . . . 1.0600000000000001 110.25 -165.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -92.16 83.81 5.16 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.082 -1.822 . . . . 2.77 106.082 171.404 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.43 83.52 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.945 -1.132 . . . . 1.05 107.945 -172.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -92.49 135.18 34.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.267 0.556 . . . . 1.02 110.03 169.379 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.27 164.61 35.04 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.079 -1.609 . . . . 0.80000000000000004 109.079 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -154.09 129.22 9.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.369 -1.345 . . . . 2.29 107.369 -174.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -128.78 147.92 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 125.689 1.596 . . . . 1.0800000000000001 108.932 -163.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -136.86 156.2 48.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.291 0.496 . . . . 3.96 112.202 164.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.83 13.09 41.41 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.382 1.944 . . . . 0.57999999999999996 112.916 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.69 157.15 36.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.709 -0.848 . . . . 0.76000000000000001 108.709 168.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -78.55 157.02 28.91 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.984 -1.487 . . . . 2.0499999999999998 106.984 156.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.36 174.2 0.1 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.951 . . . . 3.1899999999999999 112.637 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.75 -169.19 53.12 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.623 -0.717 . . . . 0.56000000000000005 112.564 169.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 42' ' ' LEU . 3.6 tp -75.18 146.82 40.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.351 1.06 . . . . 2.46 110.753 -177.057 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.59 116.26 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.331 1.452 . . . . 0.59999999999999998 108.468 -178.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.72 146.72 7.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.63 -1.388 . . . . 0.56000000000000005 109.63 172.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -139.1 93.75 2.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.541 -1.652 . . . . 2.5 106.541 -171.206 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -131.83 150.95 52.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.719 -1.585 . . . . 0.66000000000000003 106.719 -162.309 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.738 0.78 . . . . 1.6699999999999999 109.07 174.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -78.7 149.28 32.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.416 -1.698 . . . . 0.97999999999999998 106.416 170.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.55 -100.23 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.388 2.275 . . . . 5.1799999999999997 113.543 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 112.82 0.674 . . . . 3.52 112.82 174.806 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 111.224 0.083 . . . . 1.8100000000000001 111.224 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.42 -143.9 15.47 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.44 1.495 . . . . 1.4199999999999999 111.394 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.47 -179.43 5.42 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.798 3.665 . . . . 1.1299999999999999 113.76 -170.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -52.57 64.57 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 129.498 3.119 . . . . 1.6200000000000001 115.402 -174.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.2 t80 42.97 68.22 0.53 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.074 1.75 . . . . 2.2400000000000002 110.504 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -85.09 114.82 58.2 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.241 -0.885 . . . . 2.6400000000000001 109.808 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.84 -32.99 10.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.271 1.981 . . . . 1.3 111.593 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.43 -64.57 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.239 -0.652 . . . . 3.0899999999999999 109.239 177.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.7 t -158.94 65.34 0.41 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.062 -0.718 . . . . 2.6600000000000001 109.062 178.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 -79.23 163.39 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.931 -0.396 . . . . 5.2199999999999998 109.931 169.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.96 144.16 49.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.091 1.356 . . . . 3.8900000000000001 109.114 -169.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -77.09 155.66 32.27 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.831 0.853 . . . . 0.78000000000000003 111.707 -173.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.79 -98.27 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.499 -1.44 . . . . 2.2400000000000002 109.499 161.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.34 -146.93 9.55 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.577 -1.809 . . . . 1.2 108.577 178.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.83 -58.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.536 2.157 . . . . 1.4099999999999999 109.724 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -20.54 64.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.906 1.283 . . . . 6.4100000000000001 112.176 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 2.7 t70 -64.41 175.91 1.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.528 0.731 . . . . 3.4500000000000002 111.255 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.04 -50.97 7.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.917 1.287 . . . . 5.6299999999999999 108.551 164.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.12 174.39 8.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.954 0.502 . . . . 4.29 111.606 -173.057 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 164.58 136.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.309 3.044 . . . . 4.2199999999999998 107.78 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 32.4 m80 -66.9 156.52 35.57 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.195 -1.78 . . . . 0.68000000000000005 106.195 165.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.265 13.0 p -78.51 45.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 123.25 1.5 . . . . 2.3199999999999998 110.832 173.102 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.16 33.25 0.27 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 128.74 3.067 . . . . 0.76000000000000001 111.331 165.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -137.48 131.9 32.53 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.312 2.056 . . . . 2.1699999999999999 110.37 161.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.28 -56.38 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.114 1.365 . . . . 2.2999999999999998 109.201 176.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.34 -123.58 0.94 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.238 -0.745 . . . . 0.83999999999999997 111.238 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -139.26 172.32 13.0 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 125.28 1.432 . . . . 1.9199999999999999 110.077 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.5 163.68 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.993 1.317 . . . . 0.63 107.453 164.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.2 m -110.59 133.42 53.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.999 -1.482 . . . . 2.3199999999999998 106.999 174.034 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.76 137.41 32.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.766 0.426 . . . . 0.68999999999999995 110.535 169.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -73.98 -75.57 0.15 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.307 1.043 . . . . 3.3900000000000001 111.645 -166.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.37 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.668 1.187 . . . . 4.79 110.841 -168.525 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.18 8.44 4.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.278 1.431 . . . . 2.77 110.936 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.82 16.45 76.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.365 -1.094 . . . . 0.91000000000000003 110.365 -171.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -78.24 149.01 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.788 -1.56 . . . . 0.87 106.788 172.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.72 165.73 26.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.774 -1.195 . . . . 0.71999999999999997 107.774 165.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.28 140.25 51.5 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.364 -2.828 . . . . 3.0600000000000001 103.364 -172.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.61 78.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 123.971 0.795 . . . . 1.3 110.144 160.025 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.7 m -98.54 77.87 2.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.14 0.976 . . . . 1.02 108.952 166.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.58 159.11 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.554 -0.906 . . . . 1.78 108.554 176.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.32 147.29 49.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.352 -0.981 . . . . 2.52 108.352 152.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -137.62 150.56 47.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.332 1.053 . . . . 2.0800000000000001 108.218 172.348 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 p -110.17 -4.45 15.76 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.942 1.697 . . . . 1.3400000000000001 113.418 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.55 -47.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.745 -1.206 . . . . 1.0800000000000001 107.745 175.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.11 176.27 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.131 0.967 . . . . 1.1000000000000001 111.388 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.2 m -163.1 175.54 10.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.987 2.515 . . . . 1.72 104.469 -175.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.78 -1.93 45.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.896 0.771 . . . . 2.5899999999999999 112.587 173.165 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.535 0.399 0 C-N-CA 124.578 1.151 . . . . 3.4500000000000002 108.848 -173.852 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 121.948 0.88 . . . . 1.1399999999999999 111.931 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.2 pt -88.61 -5.72 10.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.011 -0.995 . . . . 1.99 110.738 -178.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -37.8 122.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.874 1.67 . . . . 1.6799999999999999 110.446 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.99 -21.24 40.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.895 -0.947 . . . . 1.6899999999999999 113.989 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -83.92 165.2 18.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.475 1.637 . . . . 5.29 110.961 -170.021 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -89.56 108.15 19.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.699 0.4 . . . . 0.93999999999999995 111.351 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.08 148.15 52.17 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.8 -0.815 . . . . 2.4399999999999999 108.8 168.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.16 141.47 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.525 1.53 . . . . 0.44 108.045 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.01 132.77 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.087 -1.079 . . . . 1.53 108.087 162.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -102.97 168.98 8.85 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.621 1.568 . . . . 0.66000000000000003 114.018 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -72.06 0.17 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.493 -0.776 . . . . 5.4000000000000004 111.078 177.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -79.78 178.09 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.284 0.947 . . . . 4.6100000000000003 109.498 -178.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.13 173.76 0.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.433 1.093 . . . . 1.5 111.442 172.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -70.39 165.52 22.28 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.812 0.815 . . . . 2.9399999999999999 108.94 163.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.74 -21.38 15.21 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.128 -0.942 . . . . 3.9100000000000001 112.36 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 54.69 14.36 0.85 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.904 1.282 . . . . 1.98 112.232 -173.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.61 61.67 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.11 1.338 . . . . 2.4100000000000001 111.285 -176.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 11.3 mttt -129.94 19.08 5.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.267 1.027 . . . . 5.96 110.874 -172.263 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.01 139.04 22.22 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.942 -2.063 . . . . 2.6000000000000001 107.942 164.745 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.36 67.13 1.88 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 117.764 0.782 . . . . 2.73 111.682 -175.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -172.99 156.27 3.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.46 1.504 . . . . 3.0699999999999998 108.195 -177.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -52.24 52.78 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.263 -0.398 . . . . 3.6200000000000001 111.28 -178.044 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -29.49 -46.13 0.05 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 3.0499999999999998 113.751 171.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 t -53.16 -61.74 2.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.174 0.989 . . . . 1.9099999999999999 111.548 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -71.26 -43.4 67.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.237 -0.914 . . . . 1.48 109.743 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -54.4 -39.14 66.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.337 2.255 . . . . 3.8900000000000001 112.539 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.4 t -138.1 -53.81 0.63 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.41 1.084 . . . . 1.6100000000000001 112.011 176.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 79.45 1.0 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 103.714 -3.755 . . . . 3.3599999999999999 103.714 -162.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -71.07 57.5 0.22 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.325 1.85 . . . . 3.48 110.681 -178.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -26.1 67.78 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.928 -0.483 . . . . 1.25 111.432 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 134.28 -177.34 19.24 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.397 -1.881 . . . . 0.93000000000000005 108.397 175.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -53.51 153.99 3.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.821 1.249 . . . . 1.25 111.775 175.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.24 131.16 49.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.002 -0.999 . . . . 3.0800000000000001 108.468 168.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -102.51 -74.14 0.64 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.576 -1.639 . . . . 0.67000000000000004 106.576 164.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.16 154.44 19.76 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.424 -0.954 . . . . 1.0800000000000001 108.424 173.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.0 m -144.46 156.05 44.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.909 -1.886 . . . . 2.0899999999999999 105.909 170.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.39 130.1 1.62 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.101 -0.8 . . . . 0.72999999999999998 111.101 169.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.9 131.24 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.898 0.879 . . . . 0.84999999999999998 109.004 173.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.8 tt -91.91 133.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.722 0.296 . . . . 0.70999999999999996 111.533 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.457 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 144.06 2.78 0.83 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.135 0.874 . . . . 1.1100000000000001 115.104 178.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.4 mm -95.4 57.86 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-N 119.325 1.562 . . . . 1.2 109.92 -157.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.62 176.62 12.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.668 0.787 . . . . 1.51 109.773 171.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.256 1.435 0 N-CA-C 104.068 -2.568 . . . . 4.4199999999999999 104.068 170.225 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.613 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 6.4 ttmm . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 106.943 -1.503 . . . . 4.4000000000000004 106.943 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -114.22 142.46 46.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.773 0.829 . . . . 0.69999999999999996 108.909 158.12 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' A' ' 152' ' ' ALA . 51.2 t -111.87 145.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.654 -1.61 . . . . 0.90000000000000002 106.654 166.232 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -118.47 97.62 5.85 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 0.54000000000000004 108.941 155.239 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.64 98.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.561 1.144 . . . . 0.71999999999999997 108.768 164.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.69 130.4 35.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.958 0.903 . . . . 2.3300000000000001 108.784 172.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -151.69 -52.12 0.12 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 122.767 0.427 . . . . 3.5800000000000001 110.961 166.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.45 -116.6 1.43 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.261 0.934 . . . . 1.1599999999999999 112.998 -175.076 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -117.2 -46.04 2.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.169 0.988 . . . . 3.3500000000000001 109.729 -158.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 172.36 16.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.567 1.08 . . . . 1.0 111.747 177.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.47 -24.06 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.139 2.559 . . . . 1.3100000000000001 111.594 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.2 t -49.89 139.36 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 0.97999999999999998 110.92 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.89 130.26 8.88 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.751 -1.203 . . . . 1.95 107.751 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.14 170.06 41.79 Favored Glycine 0 N--CA 1.449 -0.437 0 O-C-N 121.732 -0.605 . . . . 0.67000000000000004 111.691 -177.068 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 mm -123.83 126.14 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.287 -1.375 . . . . 1.6699999999999999 107.287 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.2 mp -95.65 147.62 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.019 -1.474 . . . . 1.3 107.019 163.234 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.53 121.39 36.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.032 1.333 . . . . 1.9099999999999999 107.494 167.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -96.73 99.03 10.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.978 -2.23 . . . . 2.4100000000000001 104.978 162.464 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -113.69 128.31 56.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.6 -0.889 . . . . 3.8999999999999999 108.6 174.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -157.22 -77.82 0.08 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.54 -1.664 . . . . 3.7799999999999998 108.963 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.2 59.85 3.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.47 -0.937 . . . . 6.5499999999999998 108.47 -174.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -113.83 -103.48 0.41 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.59 -2.374 . . . . 3.8599999999999999 104.59 168.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 t -153.03 -69.97 0.15 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.111 -1.44 . . . . 2.8999999999999999 107.111 157.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -124.19 97.85 5.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.84 -1.541 . . . . 4.04 106.84 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.89 37.43 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.345 -0.702 . . . . 1.02 111.345 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.74 115.62 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.366 3.378 . . . . 1.26 112.065 -172.661 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.02 164.44 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.562 0.745 . . . . 1.24 109.157 -172.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -115.1 99.18 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.938 -1.504 . . . . 3.0499999999999998 106.938 166.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -92.31 88.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.08 1.752 . . . . 1.1100000000000001 107.566 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -98.31 151.43 20.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.419 -0.586 . . . . 0.97999999999999998 109.419 169.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.9 159.04 32.18 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.369 -1.493 . . . . 0.82999999999999996 109.369 176.062 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.4 m -136.82 110.25 7.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.6 -1.63 . . . . 2.2200000000000002 106.6 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.411 HD11 HD12 ' A' ' 18' ' ' ILE . 1.1 mp -119.16 148.83 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.013 1.325 . . . . 0.95999999999999996 107.893 -163.338 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -148.33 166.26 28.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.978 0.732 . . . . 3.4900000000000002 112.978 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.44 19.35 62.35 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 0.67000000000000004 113.208 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -75.49 165.32 25.3 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.373 1.086 . . . . 0.79000000000000004 109.32 174.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.13 163.01 28.38 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.67 -1.233 . . . . 1.6599999999999999 107.67 155.342 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.89 165.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.79 0.805 . . . . 2.52 112.216 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 -158.31 53.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.086 -0.961 . . . . 0.58999999999999997 113.402 167.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 130.02 42.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.926 1.29 . . . . 1.9199999999999999 111.176 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -136.49 110.08 8.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.919 1.688 . . . . 1.3100000000000001 109.527 -174.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.91 149.42 11.06 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.852 1.692 . . . . 0.53000000000000003 111.563 -177.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -146.4 100.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.463 -0.94 . . . . 2.79 108.463 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.625 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.0 m80 -139.56 154.21 47.58 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.137 -1.06 . . . . 0.64000000000000001 108.137 -166.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -113.61 129.23 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 119.571 1.078 . . . . 1.8600000000000001 108.82 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -105.81 146.83 29.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.64 -1.615 . . . . 0.79000000000000004 106.64 -176.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -53.77 -61.24 2.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.591 0.557 . . . . 4.0499999999999998 110.751 -165.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 . . . . . 0 CA--C 1.54 0.568 0 C-N-CA 125.598 1.559 . . . . 2.98 111.535 159.205 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 107.497 -1.297 . . . . 3.3900000000000001 107.497 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.89 -94.52 0.34 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.256 -1.938 . . . . 0.95999999999999996 108.256 173.328 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.76 177.07 9.17 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.311 2.674 . . . . 0.82999999999999996 113.736 -176.384 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -60.93 130.94 48.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.582 -1.645 . . . . 1.3600000000000001 108.517 171.293 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -48.22 117.11 1.79 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.085 0.469 . . . . 1.71 110.487 176.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.22 152.57 25.28 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 126.536 1.934 . . . . 2.4500000000000002 107.158 173.052 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -24.69 12.37 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.418 2.079 . . . . 1.22 113.529 -167.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.36 -68.74 0.12 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.952 0.796 . . . . 2.9100000000000001 109.57 -176.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.7 m -155.99 77.96 0.96 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.484 0.714 . . . . 1.9199999999999999 109.67 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -77.99 169.82 17.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.785 -0.82 . . . . 5.0499999999999998 108.785 163.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -118.41 158.47 25.23 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.701 1.6 . . . . 3.4399999999999999 106.734 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.437 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 55.0 t60 -86.0 154.06 21.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.566 0.58 . . . . 0.85999999999999999 112.566 -175.252 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.41 -178.58 43.48 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 106.613 -2.595 . . . . 2.1699999999999999 106.613 160.062 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.49 -160.83 26.04 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 117.462 0.631 . . . . 1.45 112.616 -170.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.85 -43.19 3.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.951 1.768 . . . . 1.47 109.301 173.158 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.4 -46.57 76.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 5.1699999999999999 111.659 -176.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.68 174.45 1.79 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.425 -0.807 . . . . 2.4399999999999999 109.754 176.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.09 -37.44 11.61 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.224 1.01 . . . . 5.7300000000000004 111.082 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -75.71 155.53 35.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.04 -1.096 . . . . 2.7400000000000002 108.04 -174.108 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 165.57 145.46 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.905 2.082 . . . . 3.5099999999999998 112.002 -170.323 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.2 m80 -66.57 149.7 50.09 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 107.564 -1.273 . . . . 0.63 107.564 164.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.69 -37.43 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.94 -0.704 . . . . 1.5900000000000001 109.714 -171.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.17 60.86 1.59 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.611 0.624 . . . . 0.62 112.029 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 80' ' ' HIS . 1.2 t0 -168.29 114.94 0.67 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.523 -0.917 . . . . 2.0600000000000001 108.523 -172.506 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.13 -45.06 8.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.249 -0.648 . . . . 2.48 109.249 176.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.76 -94.11 0.15 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.289 -1.124 . . . . 1.1299999999999999 110.289 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -150.62 164.84 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.478 1.511 . . . . 1.5800000000000001 110.573 -177.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.0 m -110.0 176.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.284 -1.747 . . . . 0.52000000000000002 106.284 156.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 t -112.49 144.3 42.2 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.444 -1.317 . . . . 1.9099999999999999 107.444 160.295 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.35 153.25 29.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.289 -1.004 . . . . 1.1499999999999999 108.289 154.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.47 -89.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.781 -0.822 . . . . 2.8399999999999999 108.781 173.322 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -140.25 -57.67 0.54 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.584 1.554 . . . . 4.1799999999999997 108.981 -171.411 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -87.8 30.39 0.83 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.042 1.337 . . . . 5.0700000000000003 110.062 -170.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.63 10.65 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.205 1.86 . . . . 0.90000000000000002 112.956 179.137 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.71 138.3 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.393 -1.336 . . . . 0.95999999999999996 107.393 176.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.55 170.79 15.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.063 1.345 . . . . 0.60999999999999999 107.953 173.542 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -143.9 147.76 34.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.998 -2.223 . . . . 2.7999999999999998 104.998 -171.463 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.85 132.64 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.407 -1.701 . . . . 1.3799999999999999 106.407 166.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.9 m -153.02 73.19 0.98 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.013 1.325 . . . . 1.05 107.603 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.6 mm -115.85 152.51 17.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.638 -0.875 . . . . 2.5600000000000001 108.638 -177.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -145.53 91.47 2.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.522 0.729 . . . . 2.4500000000000002 109.48 167.533 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.42 -178.02 6.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.904 0.882 . . . . 3.5800000000000001 109.931 177.219 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.4 p -133.33 48.97 2.34 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.201 1.0 . . . . 1.6799999999999999 109.146 170.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.22 -55.86 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.918 1.287 . . . . 1.1799999999999999 108.486 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pp -88.08 177.68 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.89 0.852 . . . . 1.21 111.451 -177.075 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -161.64 177.88 9.56 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.921 2.088 . . . . 2.1400000000000001 107.077 -176.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.86 -3.8 24.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.888 1.07 . . . . 3.3900000000000001 113.888 -175.082 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 125.091 1.357 . . . . 4.1900000000000004 109.125 176.836 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.276 0.56 . . . . 1.27 111.07 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.3 pt -78.64 -17.32 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.553 -0.737 . . . . 1.96 109.257 174.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 tp -36.91 133.06 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.606 1.562 . . . . 1.78 113.775 -170.129 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.53 37.82 45.67 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.85 -0.5 . . . . 1.51 111.85 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -134.99 160.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.894 1.278 . . . . 4.0800000000000001 107.559 172.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.4 m -94.29 112.71 24.52 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.693 0.397 . . . . 1.2 111.022 -170.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.92 149.55 50.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.117 -0.698 . . . . 1.6399999999999999 109.117 172.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t -135.47 128.93 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.346 1.459 . . . . 0.38 107.467 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.53 120.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.046 -1.835 . . . . 1.6100000000000001 106.046 163.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.462 ' CD2' ' HD1' ' A' ' 46' ' ' HIS . 51.4 m-70 -94.28 175.65 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.019 1.727 . . . . 0.69999999999999996 112.247 -174.521 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -72.67 -76.93 0.11 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 113.041 0.756 . . . . 6.0599999999999996 113.041 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -81.11 -176.79 6.14 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.21 0.913 . . . . 3.2000000000000002 110.084 -167.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.6 148.89 36.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.89 -0.782 . . . . 0.56999999999999995 108.89 167.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -67.9 170.17 8.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.051 -0.722 . . . . 1.99 109.051 159.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.32 -23.58 62.86 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.699 1.37 . . . . 3.9100000000000001 114.699 -176.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 67.03 2.01 2.56 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.811 1.244 . . . . 1.6499999999999999 113.636 -170.259 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.21 10.09 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 120.54 1.518 . . . . 1.77 112.676 166.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -106.92 -20.77 13.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.508 2.323 . . . . 5.3799999999999999 109.639 -178.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.8 -77.01 1.94 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 124.492 1.044 . . . . 2.4199999999999999 112.939 167.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.77 -70.35 0.12 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.118 -0.793 . . . . 2.48 111.118 -163.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -90.76 -92.98 0.13 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.449 1.5 . . . . 2.96 112.473 -176.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -165.39 -81.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.144 0.978 . . . . 3.25 108.693 -164.37 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -29.09 -45.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.282 2.633 . . . . 3.2000000000000002 113.146 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.2 m -53.65 -50.49 65.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.305 1.842 . . . . 2.9900000000000002 112.744 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 52.2 p -71.7 -48.35 47.86 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.881 -1.137 . . . . 1.5 110.615 170.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -53.25 -48.15 68.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.091 2.156 . . . . 3.4399999999999999 111.022 -168.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.431 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.1 p -128.08 -50.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.154 0.982 . . . . 1.21 110.691 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.83 -18.53 0.66 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-O 119.268 -0.74 . . . . 0.91000000000000003 114.556 -176.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 45.47 54.12 7.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.294 1.438 . . . . 2.0 110.803 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -60.83 -34.93 75.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.075 1.35 . . . . 1.01 113.213 177.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.86 173.67 31.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.404 -1.878 . . . . 1.0600000000000001 108.404 -159.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 p -61.12 153.62 25.25 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.116 1.366 . . . . 2.2799999999999998 112.426 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -81.1 147.43 30.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.151 1.78 . . . . 2.4399999999999999 110.437 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.5 mt -127.33 -76.3 0.57 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.528 -0.916 . . . . 0.72999999999999998 108.528 -168.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.82 151.54 21.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.192 -0.669 . . . . 0.84999999999999998 109.192 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.1 p -136.71 167.36 21.57 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.521 1.528 . . . . 2.4700000000000002 107.879 174.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.95 133.88 1.64 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 114.46 -1.246 . . . . 0.64000000000000001 110.195 -177.411 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.38 138.87 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.817 -0.808 . . . . 0.82999999999999996 108.817 175.494 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 6' ' ' ALA . 21.5 tt -93.79 127.48 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 123.42 0.45 . . . . 0.79000000000000004 111.166 175.327 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.04 -2.1 0.82 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.106 1.336 . . . . 0.54000000000000004 115.692 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -89.36 60.59 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.25 1.525 . . . . 1.1499999999999999 109.589 -160.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -131.13 175.68 8.89 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.386 -0.821 . . . . 1.24 110.881 164.095 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 . . . . . 0 C--O 1.254 1.334 0 N-CA-C 103.187 -2.894 . . . . 4.3700000000000001 103.187 163.458 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 110.478 -0.193 . . . . 3.1099999999999999 110.478 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.95 14.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.375 0.67 . . . . 1.49 110.359 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 152' ' ' ALA . 37.8 t -122.2 152.08 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.104 1.761 . . . . 0.92000000000000004 106.399 159.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.25 99.15 4.03 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.986 -0.746 . . . . 0.71999999999999997 108.986 154.441 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.7 t -66.15 111.88 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.221 -1.4 . . . . 0.80000000000000004 107.221 166.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -92.07 133.05 36.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.469 -0.937 . . . . 0.95999999999999996 108.469 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -149.12 -50.27 0.15 Allowed 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.487 0.551 . . . . 3.7400000000000002 112.487 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.18 -113.64 1.15 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.092 -0.838 . . . . 0.82999999999999996 113.942 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -124.09 -55.59 1.67 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.207 1.003 . . . . 3.5800000000000001 110.909 -164.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.32 165.58 12.76 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.041 -0.823 . . . . 0.72999999999999998 111.041 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.77 27.14 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.807 3.005 . . . . 1.05 113.59 -173.396 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 91.6 t -91.89 143.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.895 1.678 . . . . 0.78000000000000003 107.649 177.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -154.79 116.83 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.179 -1.045 . . . . 2.8100000000000001 108.179 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.02 171.74 32.02 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.692 -0.563 . . . . 0.59999999999999998 111.692 -172.194 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -127.99 126.65 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.46 0.704 . . . . 1.3500000000000001 109.243 178.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.6 mm -94.5 151.47 3.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 125.53 1.532 . . . . 0.78000000000000003 107.005 165.153 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.92 154.23 48.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.592 -1.633 . . . . 1.5600000000000001 106.592 164.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.8 160.11 40.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.81 -0.756 . . . . 5.25 109.131 158.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -127.82 139.51 52.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.056 2.143 . . . . 4.7300000000000004 105.386 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -143.65 146.82 33.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.949 -1.871 . . . . 4.2999999999999998 105.949 154.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -73.9 -68.8 0.48 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.151 -0.685 . . . . 4.5300000000000002 109.151 170.617 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -78.19 165.25 24.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.769 0.828 . . . . 3.8999999999999999 111.618 -173.038 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -77.92 2.26 17.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.548 0.739 . . . . 2.6099999999999999 112.513 173.287 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -161.32 78.22 0.57 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.877 0.762 . . . . 4.2800000000000002 109.856 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.61 164.81 30.38 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.375 -2.29 . . . . 1.3899999999999999 107.375 165.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.02 118.41 5.27 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.983 2.455 . . . . 1.5800000000000001 110.524 -176.528 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.69 176.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.769 -0.826 . . . . 1.46 108.769 -165.871 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -131.24 81.06 1.97 Allowed 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.577 -0.897 . . . . 5.0300000000000002 108.577 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.58 100.95 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.988 -1.116 . . . . 1.75 107.988 -177.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -114.02 170.39 8.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.934 0.493 . . . . 1.24 110.081 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.21 165.72 34.74 Favored Glycine 0 N--CA 1.449 -0.463 0 O-C-N 120.974 -1.079 . . . . 0.67000000000000004 112.088 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -131.18 106.66 8.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.509 -2.034 . . . . 1.8400000000000001 105.509 -177.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.64 146.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.626 -1.25 . . . . 0.96999999999999997 107.626 -166.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 161.84 41.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.485 0.92 . . . . 3.6600000000000001 113.485 168.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.85 15.56 45.27 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.758 1.647 . . . . 0.65000000000000002 113.467 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.83 -173.47 0.63 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.524 1.162 . . . . 0.81000000000000005 108.85 169.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -85.29 -100.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.077 -1.083 . . . . 2.6000000000000001 108.077 164.065 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -149.2 162.04 40.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.389 1.475 . . . . 2.6600000000000001 108.049 -175.3 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.57 -161.54 50.91 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.209 0.433 . . . . 0.68999999999999995 112.443 167.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.17 132.78 53.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.735 0.814 . . . . 1.98 112.521 -175.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.18 114.94 9.52 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.132 1.773 . . . . 1.23 109.131 -177.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.23 152.27 6.91 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.918 1.247 . . . . 0.68000000000000005 113.753 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 103.84 4.3 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.209 1.803 . . . . 2.8599999999999999 108.138 -177.524 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 41.9 m80 -142.06 162.07 36.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.729 . . . . 1.26 109.033 -169.146 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.43 130.43 74.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 2.3700000000000001 108.73 -178.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -113.51 154.52 26.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.116 0.967 . . . . 0.81999999999999995 108.838 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.61 33.09 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.197 1.399 . . . . 4.4199999999999999 113.495 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 106.598 -1.63 . . . . 3.1200000000000001 106.598 178.744 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 108.636 -0.875 . . . . 1.8899999999999999 108.636 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.98 -99.18 2.16 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.79 -1.324 . . . . 0.94999999999999996 109.79 -173.379 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.92 178.39 5.34 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.692 2.928 . . . . 1.0700000000000001 112.524 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -61.73 136.68 58.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.432 -1.27 . . . . 1.48 108.365 172.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -23.06 105.41 0.02 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.975 1.71 . . . . 2.5099999999999998 113.814 -177.123 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -130.16 90.59 41.58 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.815 1.646 . . . . 2.5499999999999998 109.621 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.64 -36.93 13.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.836 1.69 . . . . 1.6599999999999999 111.115 -178.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -135.49 -75.06 0.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.977 0.911 . . . . 2.8399999999999999 109.557 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.6 m -156.97 81.06 0.93 Allowed 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.312 -0.868 . . . . 1.6299999999999999 109.468 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -85.35 170.93 12.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.322 0.582 . . . . 4.7800000000000002 110.598 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -125.82 161.63 26.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.944 1.698 . . . . 3.52 107.265 177.028 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -104.24 115.95 31.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.774 0.83 . . . . 1.01 110.914 173.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.87 12.9 6.48 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 124.76 1.171 . . . . 3.1400000000000001 110.621 164.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.92 -164.11 23.24 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.44 -1.035 . . . . 1.75 112.296 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.92 -23.69 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.34 2.027 . . . . 2.23 111.545 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -71.89 -53.84 11.94 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.739 0.816 . . . . 6.5 111.45 -176.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.5 171.16 7.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.73 -0.841 . . . . 4.0700000000000003 108.73 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.96 -51.11 68.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.974 -1.121 . . . . 6.2300000000000004 107.974 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -76.81 143.47 39.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.738 0.78 . . . . 3.3100000000000001 110.6 -163.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -176.3 150.89 0.95 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.388 -1.338 . . . . 3.1000000000000001 107.388 -166.309 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.1 m80 -63.67 147.46 51.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.848 -1.538 . . . . 0.65000000000000002 106.848 163.279 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.71 -15.22 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 120.625 -0.43 . . . . 1.3 110.672 -175.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.2 67.42 0.28 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.088 1.328 . . . . 0.68000000000000005 110.747 166.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -132.8 110.75 10.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.868 1.334 . . . . 2.4500000000000002 109.781 168.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -39.59 16.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.068 0.547 . . . . 1.78 109.94 169.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 138.59 -106.34 0.52 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.108 -0.797 . . . . 0.79000000000000004 111.108 172.015 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.09 159.8 40.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.467 1.507 . . . . 1.45 109.373 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.2 176.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 125.695 1.598 . . . . 0.77000000000000002 107.078 166.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -114.91 139.76 49.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.799 -1.185 . . . . 2.0299999999999998 107.799 163.347 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.25 141.25 31.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.242 1.417 . . . . 0.60999999999999999 110.801 169.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.25 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.194 0.998 . . . . 2.5299999999999998 111.08 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -159.38 -46.55 0.05 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.923 1.289 . . . . 3.75 110.496 -173.13 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.79 19.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.419 1.488 . . . . 3.3100000000000001 111.134 178.09 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.65 9.28 78.39 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.6 -1.111 . . . . 0.88 111.997 -177.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.0 t -77.52 141.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.59 -1.263 . . . . 1.01 107.59 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.36 168.2 21.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.531 1.132 . . . . 0.77000000000000002 108.407 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.54 144.24 50.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 103.452 -2.796 . . . . 2.9199999999999999 103.452 -174.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.89 136.06 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.055 -1.831 . . . . 1.54 106.055 169.666 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -159.98 67.39 0.37 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.141 1.376 . . . . 0.85999999999999999 107.613 -177.468 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 mm -112.64 146.66 17.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 108.485 -0.931 . . . . 2.0299999999999998 108.485 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.82 74.96 1.49 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.258 0.623 . . . . 3.4500000000000002 109.805 177.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -77.84 151.17 34.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.599 0.714 . . . . 2.48 110.356 -177.595 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -98.71 -26.28 14.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.018 2.127 . . . . 1.6299999999999999 110.844 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.2 -48.77 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 118.91 -0.567 . . . . 1.7 110.162 -173.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.24 162.97 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.291 0.95 . . . . 1.6899999999999999 109.97 171.395 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 m -143.13 179.85 6.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.604 1.561 . . . . 2.7400000000000002 108.316 -175.083 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -133.06 31.88 3.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.295 1.438 . . . . 4.4699999999999998 113.857 -173.648 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.536 0.429 0 O-C-N 121.128 -0.983 . . . . 3.2999999999999998 110.863 178.261 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 106.128 -1.805 . . . . 1.3200000000000001 106.128 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.3 pt -76.94 -13.83 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 118.419 -1.312 . . . . 2.27 113.598 -168.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.4 mm -43.21 115.72 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.283 0.947 . . . . 1.8500000000000001 111.183 176.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.7 25.35 74.22 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.076 -0.847 . . . . 1.3300000000000001 112.389 178.673 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.84 159.45 16.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 120.051 1.926 . . . . 4.8399999999999999 110.548 170.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 m -92.06 104.56 16.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 1.1499999999999999 109.592 -172.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.06 147.44 53.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.055 -1.091 . . . . 1.78 108.055 166.513 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -134.72 133.72 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 127.356 2.263 . . . . 0.40999999999999998 106.222 177.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.23 120.81 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.024 -1.472 . . . . 1.72 107.024 165.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.478 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 45.7 m-70 -95.56 176.1 6.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.58 1.552 . . . . 0.79000000000000004 112.343 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -77.58 -65.58 0.94 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.558 0.947 . . . . 6.0999999999999996 113.558 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -88.42 174.32 8.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.206 0.912 . . . . 5.9199999999999999 110.675 -175.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.84 143.29 17.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.363 -1.289 . . . . 0.96999999999999997 107.91 157.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.48 155.74 38.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.614 -0.884 . . . . 2.1099999999999999 108.614 158.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -78.76 -5.58 53.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.163 0.985 . . . . 3.3900000000000001 112.092 -172.426 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 54.46 30.59 13.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.418 1.087 . . . . 1.6699999999999999 110.542 -173.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.84 16.48 68.22 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.403 -0.665 . . . . 1.8300000000000001 112.796 177.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -98.83 -23.6 15.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.334 1.067 . . . . 5.2000000000000002 110.782 -176.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.1 131.22 45.28 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.019 -0.832 . . . . 2.2599999999999998 111.019 -176.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.03 -40.22 72.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 117.731 0.766 . . . . 2.52 111.514 179.145 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -50.72 109.29 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.87 1.268 . . . . 2.3799999999999999 109.46 164.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -61.87 -21.7 64.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.6 -0.688 . . . . 3.77 112.308 -170.215 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -41.13 -38.2 1.02 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.949 1.7 . . . . 4.3700000000000001 111.018 169.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.9 p -46.15 -67.12 0.31 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.264 1.026 . . . . 2.04 109.909 172.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.8 p -66.13 -46.84 76.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.045 0.938 . . . . 1.23 111.119 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -60.26 -38.95 85.07 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.182 0.993 . . . . 4.8200000000000003 111.633 -172.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.514 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.317 7.3 t -136.91 -55.25 0.72 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 1.8700000000000001 111.095 175.959 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.88 -25.21 0.21 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.059 0.845 . . . . 0.96999999999999997 112.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 47.79 55.53 8.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.208 1.403 . . . . 2.02 110.996 -170.238 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -78.1 -8.89 58.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.218 0.821 . . . . 1.1100000000000001 113.218 173.356 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.56 173.28 49.51 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.247 -1.541 . . . . 1.1599999999999999 109.247 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 m -56.36 155.13 7.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.797 1.639 . . . . 1.3600000000000001 113.344 -173.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.91 142.37 45.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.24 1.416 . . . . 3.04 110.34 177.254 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 mt -122.39 -74.83 0.6 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.897 -1.149 . . . . 0.54000000000000004 107.897 -174.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -106.6 144.32 33.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.063 -1.088 . . . . 0.78000000000000003 108.063 166.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 25.7 p -123.36 169.03 11.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.401 1.48 . . . . 2.1499999999999999 107.863 168.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.98 142.6 6.13 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 124.362 1.039 . . . . 0.75 111.234 166.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.76 133.57 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.996 0.918 . . . . 0.84999999999999998 108.692 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.466 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 8.0 tt -96.7 139.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.303 0.483 . . . . 1.0900000000000001 112.303 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 134.22 6.3 2.48 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.127 1.346 . . . . 1.0800000000000001 113.992 174.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -91.8 57.26 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.328 1.564 . . . . 1.0800000000000001 110.691 -159.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.15 176.02 13.22 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.567 0.747 . . . . 1.6799999999999999 110.552 169.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.409 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 17.6 tt0 . . . . . 0 C--O 1.251 1.168 0 N-CA-C 105.821 -1.918 . . . . 5.4900000000000002 105.821 167.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.561 -0.533 . . . . 3.0 109.561 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.42 158.89 15.24 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.804 -0.813 . . . . 0.92000000000000004 108.804 163.833 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 t -124.79 150.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.36 -1.291 . . . . 0.81999999999999995 108.058 165.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.84 97.98 5.18 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.39 1.076 . . . . 0.54000000000000004 108.624 158.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.58 114.84 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.511 -1.292 . . . . 0.65000000000000002 107.511 165.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.8 mt -96.66 137.0 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.685 0.794 . . . . 1.0700000000000001 109.91 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -150.0 -52.68 0.15 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.84 0.856 . . . . 3.2999999999999998 109.358 169.345 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.59 -124.99 28.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.979 -1.01 . . . . 0.96999999999999997 111.622 -175.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.05 -48.2 2.84 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.339 1.055 . . . . 3.6499999999999999 109.365 -162.311 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.83 166.06 23.9 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.99 -0.844 . . . . 0.80000000000000004 110.99 174.478 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.11 36.78 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.822 3.015 . . . . 0.97999999999999998 112.785 -173.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 57.2 t -94.51 159.38 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.693 1.597 . . . . 0.78000000000000003 108.98 -176.46 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 132.19 9.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.082 -1.451 . . . . 2.9300000000000002 107.082 176.242 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.47 179.36 44.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.623 -0.799 . . . . 0.77000000000000002 111.575 178.571 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.77 119.54 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.212 -1.403 . . . . 1.0 107.212 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -79.07 146.44 7.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.389 -1.337 . . . . 0.77000000000000002 107.389 163.639 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -120.24 137.1 54.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.094 -1.817 . . . . 2.2000000000000002 106.094 163.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -122.93 112.82 18.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.966 1.706 . . . . 2.2799999999999998 107.452 177.277 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.55 135.27 54.06 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.67 1.188 . . . . 4.0999999999999996 108.832 177.092 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.495 ' HB3' HD21 ' A' ' 106' ' ' LEU . 5.6 tp-100 -151.45 152.63 33.3 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.541 1.537 . . . . 3.7200000000000002 108.753 170.736 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -120.31 -46.56 2.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.472 2.709 . . . . 6.1699999999999999 107.556 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.77 96.41 6.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.496 -1.298 . . . . 5.0300000000000002 107.496 173.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -21.13 -66.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.446 2.298 . . . . 2.8300000000000001 114.748 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -114.51 54.55 0.77 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.849 0.859 . . . . 3.9900000000000002 110.153 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.54 -179.71 18.73 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.328 1.442 . . . . 0.93000000000000005 110.407 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.96 115.45 3.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.536 2.824 . . . . 1.04 111.086 -178.1 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.401 HG11 ' CD2' ' A' ' 20' ' ' PHE . 48.0 t -78.73 153.24 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.02 0.528 . . . . 0.96999999999999997 109.626 -170.685 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -108.34 126.03 52.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.618 -0.882 . . . . 2.6099999999999999 108.618 174.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 ' CE1' ' A' ' 20' ' ' PHE . 48.0 t -125.63 140.84 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 125.489 1.516 . . . . 1.1200000000000001 107.593 -169.549 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -155.17 164.54 38.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.689 -0.486 . . . . 0.98999999999999999 109.689 167.196 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.19 137.14 3.21 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.363 -0.446 . . . . 1.2 112.027 175.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 p -102.22 77.3 1.65 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.78 1.232 . . . . 1.8600000000000001 109.577 -172.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.13 142.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.028 -0.73 . . . . 1.54 109.028 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -137.6 157.16 47.1 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.243 0.617 . . . . 3.7999999999999998 110.256 -176.525 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.95 12.42 66.11 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.68000000000000005 112.709 -176.496 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.85 157.33 30.77 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.177 0.991 . . . . 0.96999999999999997 109.308 170.543 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -74.6 156.45 36.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.114 -1.069 . . . . 1.8700000000000001 108.114 154.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.89 171.79 0.32 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.124 0.97 . . . . 2.3100000000000001 111.839 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.45 -165.13 54.76 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.614 -0.721 . . . . 0.51000000000000001 113.031 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.95 147.92 44.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.7 0.8 . . . . 1.96 111.288 -173.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -145.31 123.54 12.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.504 1.522 . . . . 0.54000000000000004 109.429 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.37 149.18 18.95 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.812 -0.915 . . . . 0.44 110.812 170.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -138.66 95.64 3.01 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.089 -1.448 . . . . 2.9700000000000002 107.089 -174.547 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -133.87 160.34 37.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.754 -1.202 . . . . 0.88 107.754 -160.343 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.698 HG11 ' CZ ' ' A' ' 115' ' ' ARG . 33.8 m -119.42 128.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 122.307 1.051 . . . . 2.4500000000000002 109.933 175.327 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -104.61 142.64 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.656 -1.609 . . . . 0.88 106.656 -177.394 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 74.31 0.59 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.325 -1.731 . . . . 4.8799999999999999 106.325 170.368 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.444 -0.737 0 CA-C-N 115.871 -0.604 . . . . 3.6099999999999999 109.559 -165.823 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 104.87 -2.27 . . . . 2.4199999999999999 104.87 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.45 -115.37 1.11 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.72 -1.6 . . . . 1.0700000000000001 110.666 178.41 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 -179.22 5.03 Favored 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.808 4.339 . . . . 1.0900000000000001 113.933 -173.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -53.39 134.3 40.11 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.038 -0.983 . . . . 1.6899999999999999 111.111 176.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -50.54 117.9 2.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 123.74 0.65 . . . . 1.8700000000000001 109.567 172.179 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.8 156.54 30.74 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 106.757 -1.571 . . . . 2.79 106.757 169.632 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.14 -38.65 2.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.176 1.917 . . . . 1.4199999999999999 111.55 -165.459 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 mt -144.52 -74.54 0.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.858 0.863 . . . . 2.4100000000000001 109.347 176.616 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.3 m -142.51 64.85 1.36 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.47 0.708 . . . . 1.8100000000000001 111.062 -165.228 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.3 170.68 16.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.377 0.608 . . . . 4.9900000000000002 109.555 163.59 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.421 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 51.9 mttt -111.9 162.34 15.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.67 -1.974 . . . . 3.71 105.67 172.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -77.33 168.67 19.64 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.979 0.419 . . . . 1.1699999999999999 110.325 169.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.93 161.08 34.75 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 105.802 -2.919 . . . . 2.0299999999999998 105.802 156.187 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.86 -172.54 7.83 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 117.17 0.485 . . . . 1.8899999999999999 112.509 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 -18.77 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.133 2.555 . . . . 1.8700000000000001 111.376 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.2 -26.76 18.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.312 1.045 . . . . 5.9699999999999998 111.584 173.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.53 159.89 23.54 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.061 0.458 . . . . 2.0099999999999998 109.914 175.403 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -74.13 -51.43 15.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.387 1.475 . . . . 4.8700000000000001 108.03 170.07 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.421 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 34.9 mt-10 -80.25 168.3 19.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.87 0.843 . . . . 3.54 110.98 -175.007 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.28 150.2 0.07 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.936 2.095 . . . . 4.4900000000000002 106.53 -167.189 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 71.4 m80 -65.58 155.8 34.66 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.278 -2.119 . . . . 0.84999999999999998 105.278 162.335 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.61 48.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 123.355 1.55 . . . . 2.1099999999999999 109.618 170.637 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.73 34.97 0.06 OUTLIER Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.953 2.216 . . . . 0.85999999999999999 111.512 -175.31 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.42 136.41 37.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.333 -1.358 . . . . 2.6299999999999999 107.333 157.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.36 -54.72 4.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.649 -1.612 . . . . 1.52 106.649 168.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.97 -114.92 0.63 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.514 -1.434 . . . . 0.64000000000000001 109.514 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -140.75 162.03 36.37 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.942 1.697 . . . . 1.8500000000000001 109.329 -177.566 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.11 175.65 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.354 1.462 . . . . 0.83999999999999997 107.162 175.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.8 m -129.6 134.29 47.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.365 -0.976 . . . . 2.02 108.365 -178.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.61 137.28 34.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.35 1.06 . . . . 0.53000000000000003 109.731 169.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -87.83 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.857 2.463 . . . . 3.9100000000000001 110.736 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -173.34 -46.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.794 1.238 . . . . 6.1799999999999997 108.745 -156.997 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.403 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 2.3 m-20 -79.16 11.35 2.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.887 1.275 . . . . 4.46 110.407 172.522 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.25 64.39 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 110.789 -0.925 . . . . 1.05 110.789 -178.821 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.37 128.31 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 0.72999999999999998 108.464 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.2 114.93 22.66 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.595 -1.631 . . . . 1.3400000000000001 106.595 168.334 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -113.44 93.99 4.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.859 -1.534 . . . . 5.3399999999999999 106.859 -169.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.77 149.34 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.147 -0.933 . . . . 1.9099999999999999 110.359 -162.19 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.8 m -151.12 126.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.383 1.473 . . . . 1.28 107.413 168.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mt -143.22 155.13 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.306 1.043 . . . . 2.27 108.306 -174.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.3 101.06 3.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.573 0.225 . . . . 2.3500000000000001 110.811 157.198 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -89.25 159.71 17.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.941 0.896 . . . . 2.25 108.823 173.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 p -107.65 -15.76 14.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.303 1.841 . . . . 1.51 112.283 -175.745 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.81 -41.09 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.513 0.597 . . . . 1.05 109.894 -171.577 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.3 pp -98.19 170.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.312 0.645 . . . . 1.0 111.72 -173.521 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.6 m -151.34 174.61 13.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.706 1.202 . . . . 1.6000000000000001 110.265 -176.401 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 22' ' ' GLN . 1.9 pt? -126.49 29.9 5.66 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.957 0.903 . . . . 2.1600000000000001 112.243 170.046 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.634 -0.876 . . . . 3.0299999999999998 108.634 165.805 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.426 -1.641 0 CA-C-O 122.835 1.302 . . . . 1.97 112.88 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.23 -4.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.231 -1.804 . . . . 2.25 111.466 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -38.32 129.87 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.453 1.101 . . . . 2.4199999999999999 110.211 170.718 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.7 23.72 74.32 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 118.095 0.407 . . . . 1.52 114.042 -174.613 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.698 ' CZ ' HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.69 176.99 8.99 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.249 1.525 . . . . 8.5999999999999996 108.517 159.744 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -109.31 120.88 43.84 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.072 -0.714 . . . . 0.90000000000000002 109.072 153.215 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.61 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.6 tm? -73.02 142.39 47.69 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 106.029 -1.841 . . . . 3.2799999999999998 106.029 168.181 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.6 134.17 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.354 1.862 . . . . 0.56000000000000005 106.94 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.62 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 1.5 p -109.19 133.82 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.309 -1.367 . . . . 2.0899999999999999 107.309 164.314 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -109.14 161.62 15.03 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 115.992 1.849 . . . . 0.42999999999999999 115.992 -161.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -34.47 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.896 2.878 . . . . 3.29 112.813 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -80.57 174.99 11.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.611 1.164 . . . . 5.2400000000000002 110.482 -170.187 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.97 142.88 49.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.631 -1.622 . . . . 0.82999999999999996 108.234 150.309 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.04 152.15 20.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.317 0.647 . . . . 2.8199999999999998 109.296 170.155 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.83 -4.86 53.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.488 0.586 . . . . 3.6600000000000001 112.506 -179.449 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 59.82 28.93 18.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.168 1.387 . . . . 1.8400000000000001 109.607 -177.619 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.46 25.78 68.96 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.695 0.664 . . . . 2.0499999999999998 111.598 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -145.5 45.14 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.718 0.759 . . . . 5.25 109.365 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.93 159.97 27.03 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.152 -1.179 . . . . 2.6299999999999999 110.152 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.35 61.43 3.13 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.353 -1.499 . . . . 3.54 109.353 171.632 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -177.36 164.77 2.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.487 1.515 . . . . 2.9700000000000002 107.678 -167.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -83.15 -38.39 22.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.775 0.83 . . . . 3.9399999999999999 109.389 173.201 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -42.18 -39.05 1.9 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.413 1.485 . . . . 2.77 112.774 -176.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.8 p -57.22 -61.85 2.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.707 1.203 . . . . 1.8400000000000001 111.25 178.413 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.4 p -67.68 -42.59 81.86 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.478 -0.764 . . . . 1.3500000000000001 110.187 178.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -57.35 -44.08 84.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.972 1.709 . . . . 3.0299999999999998 111.841 -177.012 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.516 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.424 8.9 t -138.23 -56.85 0.65 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 2.1400000000000001 111.839 177.918 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.19 -22.44 0.2 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 119.415 1.007 . . . . 0.87 112.231 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 45.79 55.6 6.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.064 1.746 . . . . 2.0600000000000001 111.258 -177.805 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.61 58.2 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 118.953 -1.099 . . . . 1.01 111.934 167.21 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.36 -161.01 33.71 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 109.063 -1.615 . . . . 0.96999999999999997 109.063 179.283 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.5 p -59.89 151.49 25.71 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.942 1.297 . . . . 1.98 112.752 -169.104 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.4 mmt-85 -68.01 130.67 43.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.864 2.066 . . . . 3.3900000000000001 108.177 176.006 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.94 -83.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.552 1.069 . . . . 0.68000000000000005 108.663 174.007 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.669 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -97.98 146.29 25.64 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.296 -1.372 . . . . 0.98999999999999999 107.296 176.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.8 m -147.43 160.56 42.43 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 124.663 1.227 . . . . 2.2200000000000002 107.991 178.771 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.03 142.18 7.06 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.752 -0.939 . . . . 0.81999999999999995 110.752 172.638 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.31 139.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.152 1.381 . . . . 0.69999999999999996 108.999 172.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.2 tt -105.65 132.49 52.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.193 0.812 . . . . 1.1399999999999999 113.193 -178.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.76 13.1 0.15 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.482 1.515 . . . . 0.68000000000000005 113.99 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.2 mm -107.72 58.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.836 1.818 . . . . 0.82999999999999996 110.081 -152.237 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 175.35 14.1 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.745 -0.661 . . . . 1.26 110.255 171.057 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.259 1.586 0 C-N-CA 125.09 1.356 . . . . 5.21 108.691 177.052 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.898 -0.408 . . . . 3.0800000000000001 109.898 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.32 137.63 51.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.778 -0.823 . . . . 0.79000000000000004 108.778 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -96.94 144.25 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.32 -0.993 . . . . 0.73999999999999999 108.32 167.409 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.08 111.57 15.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.929 -1.508 . . . . 0.67000000000000004 106.929 148.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.34 108.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.972 -1.492 . . . . 0.78000000000000003 106.972 156.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.9 125.18 31.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.765 -1.198 . . . . 1.9299999999999999 107.765 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -153.97 -45.31 0.09 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.063 0.545 . . . . 3.6000000000000001 111.561 170.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.35 -109.25 0.39 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.237 0.922 . . . . 1.1599999999999999 113.04 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.1 -55.24 2.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.817 1.247 . . . . 3.3300000000000001 110.245 -172.79 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 164.48 11.4 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.459 1.028 . . . . 0.93999999999999995 112.339 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.83 -19.54 58.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.567 2.845 . . . . 1.4299999999999999 112.476 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.57 143.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.945 1.298 . . . . 0.89000000000000001 110.634 175.06 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -155.39 128.4 8.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.467 -0.568 . . . . 1.97 109.467 -176.577 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.11 177.28 39.91 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.17 -0.331 . . . . 0.53000000000000003 112.354 -177.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.09 133.91 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.882 -1.155 . . . . 1.1699999999999999 107.882 172.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.426 HD13 ' HA3' ' A' ' 33' ' ' GLY . 21.1 mm -102.79 136.33 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.92 1.688 . . . . 1.1599999999999999 106.866 164.076 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.26 112.17 22.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.35 1.46 . . . . 1.74 108.22 163.386 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -77.57 140.72 39.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.469 1.508 . . . . 2.8199999999999998 108.698 164.739 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -149.13 168.29 23.62 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.464 -1.68 . . . . 4.5700000000000003 106.464 148.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -151.29 159.32 44.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.739 -1.948 . . . . 3.8799999999999999 105.739 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -64.08 -73.78 0.11 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.998 -1.112 . . . . 6.2599999999999998 107.998 166.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -79.85 -165.66 0.86 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.046 2.538 . . . . 4.8799999999999999 111.138 -169.559 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -106.61 3.82 27.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.112 1.765 . . . . 2.4500000000000002 110.59 162.145 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -160.73 78.46 0.62 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.267 2.227 . . . . 3.8999999999999999 108.681 -170.128 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.68 -170.4 41.16 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 110.258 -1.137 . . . . 1.6599999999999999 110.258 -170.06 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.79 120.74 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.157 2.571 . . . . 1.0700000000000001 114.108 -167.301 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.8 t -79.14 147.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.499 -0.773 . . . . 1.3200000000000001 109.335 175.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 100' ' ' GLU . 65.9 mttm -116.51 110.54 18.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.836 -1.172 . . . . 2.9500000000000002 107.836 159.795 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 m -95.27 132.22 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.234 -1.395 . . . . 2.25 107.234 169.622 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -126.83 145.09 50.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.116 -1.438 . . . . 0.92000000000000004 107.116 168.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.09 156.87 29.02 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.36 -0.924 . . . . 0.65000000000000002 112.165 -173.597 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 m -131.71 83.49 2.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.706 1.602 . . . . 1.75 107.389 -162.542 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.19 139.09 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.2 1.0 . . . . 0.88 109.13 -168.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 166.67 22.8 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.4 0.619 . . . . 3.8599999999999999 112.26 176.502 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.13 15.52 69.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.761 1.172 . . . . 0.64000000000000001 113.492 174.423 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.41 165.03 21.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.603 1.201 . . . . 0.67000000000000004 108.837 172.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -72.58 166.39 22.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.596 -1.261 . . . . 1.72 107.596 150.557 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.9 175.45 0.5 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.167 0.987 . . . . 3.3300000000000001 110.696 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.65 -156.04 51.61 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.865 -0.607 . . . . 0.5 111.643 169.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.56 145.18 33.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.793 1.637 . . . . 1.9399999999999999 112.48 -171.291 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -147.73 113.18 5.62 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.032 1.333 . . . . 0.56999999999999995 110.434 -179.083 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.0 146.26 2.91 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.493 1.044 . . . . 0.57999999999999996 111.316 173.053 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.76 96.74 3.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.909 -1.886 . . . . 2.2000000000000002 105.909 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.1 m80 -133.43 171.94 13.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.322 -1.362 . . . . 0.85999999999999999 107.322 -164.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 0.3 OUTLIER -130.54 133.44 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 122.147 0.975 . . . . 1.8200000000000001 109.938 173.163 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.406 ' CD2' HG21 ' A' ' 118' ' ' VAL . 44.0 m-70 -109.79 145.64 36.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.051 2.141 . . . . 0.98999999999999999 106.876 -175.528 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -72.31 31.52 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.981 1.474 . . . . 4.5700000000000003 114.981 -168.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 108.075 -1.083 . . . . 3.0800000000000001 108.075 -170.487 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 N-CA-C 107.53 -1.285 . . . . 1.77 107.53 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.04 -92.43 2.03 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.636 -1.386 . . . . 0.98999999999999999 109.636 -178.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.08 -178.84 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 126.337 4.692 . . . . 1.02 113.21 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -52.52 128.47 26.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.031 1.332 . . . . 1.4199999999999999 109.627 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -45.46 120.24 2.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.753 1.221 . . . . 1.9099999999999999 111.273 175.154 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -118.46 163.12 26.95 Favored Pre-proline 0 C--O 1.227 -0.1 0 C-N-CA 127.314 2.246 . . . . 3.6499999999999999 109.747 164.848 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.45 -53.01 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.194 1.263 . . . . 1.6699999999999999 108.85 154.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.66 -77.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.281 1.032 . . . . 3.2200000000000002 109.998 169.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -135.5 71.03 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.306 1.042 . . . . 2.3100000000000001 110.459 -165.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -79.38 172.21 14.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.715 -1.216 . . . . 4.9800000000000004 107.715 156.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -129.11 162.89 26.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 127.019 2.128 . . . . 3.0 105.946 177.882 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -76.6 162.91 27.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.693 0.797 . . . . 1.1599999999999999 110.933 -169.452 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.14 -123.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 105.518 -3.033 . . . . 1.99 105.518 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.24 -140.48 3.06 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 107.957 -2.057 . . . . 1.8100000000000001 107.957 169.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.31 -47.78 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 120.091 1.946 . . . . 1.71 109.011 168.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -59.18 -42.15 90.17 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 126.133 1.773 . . . . 5.4299999999999997 112.987 -171.058 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.8 176.93 2.28 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.756 -1.566 . . . . 1.98 111.467 -168.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.07 -52.46 6.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.004 1.322 . . . . 5.1100000000000003 108.21 164.627 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 9.1 mt-10 -80.33 175.91 10.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.693 0.797 . . . . 2.75 111.424 -177.788 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 161.04 143.15 0.01 OUTLIER 'General case' 0 C--O 1.239 0.535 0 C-N-CA 129.958 3.303 . . . . 3.2200000000000002 106.498 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.2 m80 -60.06 153.26 22.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.335 -1.357 . . . . 0.69999999999999996 107.335 166.154 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.0 -37.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 117.796 -1.562 . . . . 1.3200000000000001 109.991 -169.789 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.82 73.11 0.87 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.229 -0.748 . . . . 0.90000000000000002 111.229 167.576 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -168.14 103.37 0.46 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.786 -0.82 . . . . 2.0899999999999999 108.786 -175.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.86 -51.39 8.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.195 0.598 . . . . 1.6699999999999999 109.541 176.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.83 -119.86 0.94 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.404 -1.478 . . . . 0.60999999999999999 109.404 -177.557 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -137.91 166.5 23.89 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 124.407 1.083 . . . . 1.5700000000000001 110.291 174.799 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.12 177.14 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.462 -1.681 . . . . 0.45000000000000001 106.462 166.393 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -122.51 155.26 36.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.695 -0.854 . . . . 2.0899999999999999 108.695 164.183 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.86 141.76 48.35 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.45 1.1 . . . . 0.80000000000000004 110.352 164.266 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.83 -75.28 0.12 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.1 0.96 . . . . 2.9399999999999999 111.389 -171.825 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -153.94 -44.26 0.09 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.321 1.048 . . . . 3.7200000000000002 110.973 -169.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.84 7.77 6.56 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.297 1.046 . . . . 2.6000000000000001 111.39 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.71 8.12 84.05 Favored Glycine 0 CA--C 1.524 0.636 0 O-C-N 121.266 -0.896 . . . . 0.68000000000000005 111.75 -175.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.54 128.61 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.218 1.407 . . . . 0.76000000000000001 107.713 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.89 175.24 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.213 1.405 . . . . 0.97999999999999998 109.169 173.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -121.88 145.28 48.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.964 -2.606 . . . . 3.3599999999999999 103.964 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.21 58.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.331 -0.548 . . . . 1.48 111.391 167.569 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.4 m -90.08 88.03 7.12 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.607 1.163 . . . . 0.84999999999999998 109.098 172.297 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.1 mm -125.67 156.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.942 -0.762 . . . . 2.1200000000000001 108.942 -177.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 30' ' ' LYS . 8.0 pt-20 -140.12 142.15 36.06 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.658 0.383 . . . . 2.6499999999999999 110.616 164.699 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.23 148.52 44.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.475 1.51 . . . . 2.2799999999999998 109.259 176.018 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.5 p -102.74 -4.26 25.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.789 2.036 . . . . 1.4299999999999999 113.249 -173.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.97 -45.77 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.658 1.183 . . . . 1.0800000000000001 108.807 -178.06 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -76.49 176.14 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.473 0.654 . . . . 1.3600000000000001 110.969 176.11 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -165.7 176.58 7.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.592 1.957 . . . . 1.9399999999999999 107.208 177.108 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -6.3 57.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.963 . . . . 3.3900000000000001 112.928 175.926 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 127.157 2.183 . . . . 3.5899999999999999 108.498 -172.782 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.445 -0.716 0 CA-C-O 121.005 0.431 . . . . 1.6899999999999999 112.055 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.277 1.8 pp -111.8 -6.2 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.144 -0.934 . . . . 1.6699999999999999 111.833 -177.362 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.86 133.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 162.255 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.06 47.44 81.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.58 -1.008 . . . . 2.25 110.58 -173.781 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -142.42 168.92 18.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.906 -1.887 . . . . 4.6799999999999997 105.906 165.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 m -101.02 115.42 30.44 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.579 -0.526 . . . . 1.04 109.579 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.8 148.73 51.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.845 -0.798 . . . . 1.97 108.845 165.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 48' ' ' HIS . 92.1 t -134.01 137.9 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.94 2.096 . . . . 0.59999999999999998 106.588 175.013 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 m -113.0 129.52 68.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.74 -1.207 . . . . 1.79 107.74 169.557 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.476 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 45.3 m-70 -107.29 159.94 15.99 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 117.361 2.356 . . . . 0.65000000000000002 117.361 -163.11 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -32.02 -76.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.55 3.14 . . . . 3.5699999999999998 112.908 168.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.69 -174.36 2.44 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.913 0.885 . . . . 2.75 110.491 -171.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.58 148.79 18.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.987 -0.745 . . . . 0.55000000000000004 108.987 157.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.04 168.65 18.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.738 -0.838 . . . . 2.1899999999999999 108.738 154.4 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.46 -38.81 48.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.066 0.765 . . . . 4.2800000000000002 113.066 -168.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 82.2 46.05 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.835 2.854 . . . . 1.55 110.691 -169.398 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.94 43.53 98.76 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.472 1.034 . . . . 1.8600000000000001 112.051 165.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -155.11 -16.37 0.11 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.806 1.409 . . . . 5.1900000000000004 114.806 -170.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.3 146.18 47.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 120.496 1.498 . . . . 1.99 110.928 -178.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.54 -24.3 69.34 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.791 0.71 . . . . 2.6499999999999999 114.202 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 159.85 14.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.227 -1.027 . . . . 2.52 108.227 174.499 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -46.82 76.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 3.8900000000000001 107.646 167.677 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -40.39 -48.49 2.73 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.374 2.67 . . . . 4.0499999999999998 111.64 -175.231 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -63.38 0.83 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.535 1.534 . . . . 1.9199999999999999 110.702 176.093 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -71.62 -41.99 68.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.052 -1.03 . . . . 1.1899999999999999 111.597 177.398 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.57 -37.26 84.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.334 1.454 . . . . 3.6299999999999999 110.924 -166.318 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.431 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.257 0.7 OUTLIER -133.3 -51.97 0.88 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.232 1.013 . . . . 1.29 111.545 173.218 . . . . . . . . 4 4 . 1 . 027 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.05 -22.49 0.52 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.715 0.689 . . . . 0.93000000000000005 114.287 -177.779 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 44.71 54.42 6.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.302 1.441 . . . . 2.2999999999999998 111.561 -163.441 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.598 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -59.12 -39.38 82.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.568 1.147 . . . . 1.1699999999999999 111.217 166.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.89 -171.33 44.7 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 108.682 -1.767 . . . . 0.98999999999999999 108.682 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.7 m -59.17 153.07 19.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 126.028 1.731 . . . . 1.1899999999999999 114.091 -166.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -59.55 137.22 58.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.21 1.804 . . . . 2.54 108.83 168.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.9 mt -114.84 -85.26 0.61 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.775 -1.195 . . . . 0.53000000000000003 107.775 169.536 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.16 154.77 18.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.522 -0.918 . . . . 0.89000000000000001 108.522 172.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.2 m -146.22 165.11 30.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.603 -1.18 . . . . 1.96 108.408 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.39 134.46 3.09 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.498 -1.041 . . . . 0.65000000000000002 110.498 173.516 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.97 130.85 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.575 -1.269 . . . . 0.70999999999999996 107.575 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.2 tt -102.22 129.87 52.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.244 0.545 . . . . 0.97999999999999998 111.897 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.59 3.99 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.603 1.097 . . . . 0.56000000000000005 115.429 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -98.28 56.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 119.989 1.894 . . . . 0.90000000000000002 109.917 -156.258 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.24 173.57 16.76 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.27 0.628 . . . . 1.5900000000000001 110.305 169.085 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 C--O 1.255 1.378 0 N-CA-C 102.5 -3.148 . . . . 4.8200000000000003 102.5 159.919 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.297 -0.631 . . . . 3.9300000000000002 109.297 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.85 18.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.875 -0.787 . . . . 1.01 108.875 168.051 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.575 HG23 ' HB2' ' A' ' 152' ' ' ALA . 60.4 t -106.71 152.61 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 105.585 -2.005 . . . . 0.93000000000000005 105.585 158.326 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.61 93.52 3.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.516 -0.92 . . . . 0.66000000000000003 108.516 158.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.66 107.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.926 -1.509 . . . . 0.73999999999999999 106.926 169.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.563 ' CD1' HD12 ' A' ' 117' ' ' LEU . 25.0 mt -92.46 128.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.368 0.667 . . . . 1.0 109.712 178.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 -48.21 0.15 Allowed 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.155 1.382 . . . . 4.6699999999999999 109.863 172.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.55 -120.47 2.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.084 1.326 . . . . 1.1399999999999999 112.808 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -97.07 -59.0 1.88 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.647 -1.242 . . . . 3.9500000000000002 107.647 -169.426 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.98 176.65 2.41 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.66 2.076 . . . . 1.27 115.15 -173.206 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.81 -25.95 16.35 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.742 2.961 . . . . 1.6100000000000001 111.817 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.81 141.99 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.719 1.208 . . . . 1.25 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -153.71 121.99 6.17 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.319 -0.993 . . . . 1.96 108.319 -171.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.58 172.06 37.69 Favored Glycine 0 C--N 1.333 0.372 0 O-C-N 121.832 -0.542 . . . . 0.56999999999999995 112.514 -174.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.38 125.1 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.946 -0.761 . . . . 1.29 108.946 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 17.9 mm -88.71 139.65 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 107.029 -1.471 . . . . 0.75 107.029 160.838 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -129.61 108.07 9.93 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.903 -1.517 . . . . 2.8399999999999999 106.903 171.863 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.521 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 35.9 t80 -130.67 120.8 24.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.879 -1.156 . . . . 3.4500000000000002 107.879 -155.93 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.15 159.93 41.18 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.785 0.721 . . . . 3.5600000000000001 111.35 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -145.61 141.76 28.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.018 -2.586 . . . . 3.8900000000000001 104.018 -175.374 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -107.35 -29.84 9.04 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.25 1.02 . . . . 6.0599999999999996 109.444 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -77.99 164.76 24.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 128.72 2.808 . . . . 4.8200000000000003 109.433 -178.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -77.97 -67.79 0.69 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.158 0.983 . . . . 4.54 109.176 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -111.88 85.47 2.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.346 -1.724 . . . . 3.7400000000000002 106.346 170.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.17 174.47 32.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.388 -1.485 . . . . 1.3600000000000001 109.388 178.281 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 140.97 47.83 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.191 2.594 . . . . 1.3500000000000001 111.647 -167.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 4.3 t -91.2 140.46 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.22 -0.659 . . . . 1.1699999999999999 109.22 -179.079 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -95.12 105.59 17.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.54 -1.652 . . . . 5.0099999999999998 106.54 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.5 85.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.378 1.471 . . . . 1.25 108.689 -169.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -99.24 145.16 27.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.206 -0.665 . . . . 0.90000000000000002 109.206 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.73 149.82 18.15 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.172 -1.171 . . . . 0.79000000000000004 110.172 -177.635 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 p -130.15 105.23 7.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.677 -1.972 . . . . 1.8999999999999999 105.677 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.68 143.75 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 106.888 -1.523 . . . . 0.90000000000000002 106.888 -169.242 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -143.7 -178.73 6.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.944 1.461 . . . . 4.79 114.944 167.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.91 76.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 113.94 -1.482 . . . . 0.69999999999999996 112.322 -179.313 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -72.61 163.14 28.54 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.264 1.032 . . . . 0.69999999999999996 108.31 172.248 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.86 163.66 25.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.701 -1.222 . . . . 1.8400000000000001 107.701 153.789 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.91 171.09 0.54 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.702 0.763 . . . . 2.5699999999999998 111.227 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.92 -158.61 53.43 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.747 -0.661 . . . . 0.48999999999999999 113.038 166.071 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.23 143.86 46.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.232 0.613 . . . . 2.0699999999999998 111.396 -171.228 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -139.42 127.0 21.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.392 1.477 . . . . 0.58999999999999997 108.697 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.51 152.04 7.51 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.344 -1.102 . . . . 0.48999999999999999 110.344 171.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -144.0 90.88 2.16 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.067 -1.457 . . . . 2.8500000000000001 107.067 -173.41 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -137.28 143.77 42.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.674 -1.232 . . . . 0.92000000000000004 107.674 -162.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.2 m -98.93 129.15 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.49 1.041 . . . . 2.1000000000000001 110.39 178.334 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -109.8 155.22 21.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.375 1.07 . . . . 1.02 108.712 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 11.77 0.39 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.795 1.638 . . . . 5.2699999999999996 113.655 -167.547 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HG2' ' HB3' ' A' ' 60' ' ' ALA . 1.2 mt-10 . . . . . 0 CA--C 1.534 0.352 0 CA-C-N 119.417 1.008 . . . . 3.3399999999999999 109.855 -173.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . . . . . . . . 0 C--O 1.235 0.317 0 N-CA-C 107.476 -1.305 . . . . 1.7 107.476 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.2 -127.75 3.88 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 119.244 0.929 . . . . 1.55 112.048 -171.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.35 -179.7 5.43 Favored 'Trans proline' 0 N--CA 1.457 -0.667 1 C-N-CA 125.378 4.052 . . . . 1.3100000000000001 111.597 -176.768 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -44.8 125.92 5.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 118.856 -0.592 . . . . 1.27 109.946 171.335 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -46.62 119.58 2.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.71 0.631 . . . . 2.6899999999999999 109.939 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -156.37 157.04 30.91 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 126.544 1.938 . . . . 2.6499999999999999 106.888 174.635 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.26 -27.42 13.57 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.148 1.898 . . . . 1.49 113.502 -170.049 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.21 -63.93 0.11 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.133 0.879 . . . . 3.8399999999999999 111.569 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.5 m -158.87 81.45 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.468 1.107 . . . . 2.4300000000000002 109.287 171.836 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -74.73 167.65 21.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.26 -1.755 . . . . 4.9699999999999998 106.26 157.198 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -119.3 166.08 13.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.952 -1.499 . . . . 4.6299999999999999 106.952 -176.682 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -93.95 149.98 20.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 111.81 0.3 . . . . 1.0900000000000001 111.81 -175.632 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.37 176.74 39.51 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.31 -3.116 . . . . 1.8300000000000001 105.31 158.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.42 -172.32 47.78 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 117.856 0.828 . . . . 1.8999999999999999 111.268 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.89 -24.36 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.101 2.534 . . . . 1.78 110.624 172.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -65.84 -44.12 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.522 0.729 . . . . 5.5800000000000001 109.822 171.152 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.65 163.21 27.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.418 -0.81 . . . . 2.0299999999999998 109.716 175.53 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.06 -37.92 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.749 0.82 . . . . 5.5 108.925 163.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.18 152.15 41.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.543 -0.91 . . . . 3.02 108.543 -173.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 166.04 143.8 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.782 2.033 . . . . 3.29 111.129 -167.603 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.462 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -65.24 154.5 37.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.489 -0.93 . . . . 0.98999999999999999 108.489 166.762 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.43 -40.57 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.948 -0.76 . . . . 1.8500000000000001 108.948 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.42 62.14 1.75 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.627 0.632 . . . . 0.69999999999999996 111.849 173.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -165.67 97.93 0.67 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.398 -0.964 . . . . 2.1600000000000001 108.398 -172.581 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.38 -43.48 15.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.998 -0.547 . . . . 2.3199999999999998 109.634 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.2 -100.87 0.19 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.474 -0.87 . . . . 0.67000000000000004 112.864 177.37 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -155.53 166.33 33.87 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.747 1.619 . . . . 1.54 109.954 -169.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.49 155.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.713 1.205 . . . . 0.54000000000000004 108.34 173.44 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.9 p -107.26 109.16 20.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.772 1.629 . . . . 3.1499999999999999 108.83 -176.068 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.71 138.8 37.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.717 0.689 . . . . 0.54000000000000004 111.127 171.368 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.14 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.207 0.942 . . . . 2.6200000000000001 109.536 177.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.5 tttt -157.48 -30.23 0.08 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.827 1.417 . . . . 3.8900000000000001 114.827 -170.753 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -80.25 21.92 0.57 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.757 1.741 . . . . 2.8700000000000001 110.665 164.453 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 64.12 12.96 51.9 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 125.458 1.504 . . . . 0.83999999999999997 111.739 -175.089 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -78.65 133.05 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.796 -1.187 . . . . 0.72999999999999998 107.796 -176.28 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.54 155.23 46.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.447 1.499 . . . . 0.81999999999999995 107.157 168.026 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -120.44 143.23 48.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.718 -2.327 . . . . 2.7999999999999998 104.718 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.39 131.69 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.339 -1.356 . . . . 1.3200000000000001 107.339 165.263 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.5 m -148.32 73.47 1.25 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.046 1.338 . . . . 1.47 107.962 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -111.72 152.51 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.974 0.909 . . . . 2.3199999999999998 108.723 -175.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -132.39 88.23 2.51 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.635 -0.876 . . . . 4.1799999999999997 108.635 164.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.62 152.87 29.78 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.6 0.36 . . . . 2.5699999999999998 110.303 176.416 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -124.2 34.53 5.02 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.022 1.329 . . . . 1.6299999999999999 111.325 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.36 -52.0 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.434 1.093 . . . . 1.45 108.395 175.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -74.54 174.59 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.255 0.55 . . . . 1.1399999999999999 110.772 176.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -149.44 171.71 16.13 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.411 -1.329 . . . . 2.5800000000000001 107.411 170.766 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -101.8 5.44 41.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.525 0.73 . . . . 2.52 111.944 169.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 CA--C 1.537 0.476 0 C-N-CA 126.124 1.77 . . . . 2.96 111.022 -177.876 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.44 -0.962 0 CA-C-O 121.735 0.778 . . . . 1.5900000000000001 111.931 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -6.4 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.212 1.005 . . . . 2.2200000000000002 111.024 -178.575 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.0 tp -19.99 117.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.718 2.007 . . . . 1.96 111.69 163.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.4 -32.34 7.64 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 119.519 -0.601 . . . . 2.4700000000000002 113.785 -177.844 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 177.36 8.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.752 1.776 . . . . 10.59 114.672 -153.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.489 HG23 ' HB2' ' A' ' 146' ' ' CYS . 0.9 OUTLIER -92.3 123.53 35.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.362 1.065 . . . . 1.54 111.277 169.483 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.563 HD12 ' CD1' ' A' ' 8' ' ' LEU . 3.2 tm? -80.25 132.11 35.79 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.513 -1.291 . . . . 3.8199999999999998 107.513 162.541 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.26 117.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 107.274 -1.38 . . . . 0.85999999999999999 107.274 170.252 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.07 114.98 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 104.685 -2.339 . . . . 1.8799999999999999 104.685 164.459 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -90.13 161.52 15.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 115.828 1.788 . . . . 0.64000000000000001 115.828 -164.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -40.81 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.244 2.618 . . . . 3.1800000000000002 112.532 169.486 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -89.2 -179.2 5.83 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.306 0.957 . . . . 3.3700000000000001 109.723 179.268 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 155.4 16.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.703 -0.851 . . . . 0.76000000000000001 108.703 157.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -74.66 165.9 24.46 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.233 -0.655 . . . . 2.4500000000000002 109.233 167.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -70.85 -19.5 62.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 117.829 -1.081 . . . . 3.4100000000000001 112.389 -175.73 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 59.16 39.63 22.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.664 1.12 . . . . 2.27 109.816 -160.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.18 42.66 82.69 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.025 0.821 . . . . 1.9399999999999999 111.533 172.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.94 -22.01 43.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.057 0.943 . . . . 7.4900000000000002 110.73 -171.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.3 -155.51 26.21 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.976 -0.85 . . . . 2.8799999999999999 110.976 177.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.41 -68.12 1.2 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.935 -1.666 . . . . 3.2599999999999998 108.935 -170.602 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.12 118.0 14.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.327 -1.731 . . . . 2.98 106.327 167.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -49.83 -45.33 50.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.306 1.412 . . . . 3.5299999999999998 109.602 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -35.74 -41.24 0.21 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.593 2.757 . . . . 3.1000000000000001 112.657 170.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -49.37 -65.19 0.61 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.684 1.594 . . . . 1.73 109.024 179.038 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 -41.95 69.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.36 1.064 . . . . 1.55 110.819 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -67.12 -32.31 73.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.989 0.516 . . . . 6.2300000000000004 111.556 -169.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.462 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.382 13.5 t -139.54 -58.57 0.58 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 118.132 -0.937 . . . . 2.0099999999999998 111.398 174.482 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.99 -21.26 0.2 Allowed Glycine 0 N--CA 1.463 0.436 0 CA-C-N 119.556 1.071 . . . . 0.96999999999999997 113.309 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 52.5 54.84 9.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.848 1.259 . . . . 1.8100000000000001 111.256 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.72 59.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.159 0.8 . . . . 1.1799999999999999 113.159 168.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 -159.35 34.22 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 108.526 -1.83 . . . . 0.93000000000000005 108.526 -177.316 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.4 m -62.54 151.67 36.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.959 -1.12 . . . . 1.26 113.639 -163.611 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -61.44 141.36 57.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.712 -1.585 . . . . 3.4300000000000002 108.896 166.152 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.8 mt -111.97 -82.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.728 -0.841 . . . . 0.69999999999999996 108.728 169.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.56 167.31 10.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.134 0.574 . . . . 0.88 110.411 177.093 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.489 ' HB2' HG23 ' A' ' 116' ' ' THR . 1.2 p -154.54 170.64 20.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.653 1.181 . . . . 2.5800000000000001 109.451 173.326 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.6 143.75 4.18 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 124.417 1.073 . . . . 0.77000000000000002 111.189 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.39 134.08 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.752 1.221 . . . . 1.8300000000000001 109.549 174.146 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 13.4 tt -89.55 126.97 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.326 -0.62 . . . . 0.93000000000000005 109.326 161.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.38 -4.32 0.49 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.785 -0.643 . . . . 0.82999999999999996 114.562 176.071 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.92 57.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 118.778 1.289 . . . . 1.1899999999999999 111.298 -157.093 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.575 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.98 168.91 26.08 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.739 0.816 . . . . 1.3700000000000001 110.578 160.709 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 101.658 -3.46 . . . . 6.3200000000000003 101.658 159.494 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.505 -0.924 . . . . 2.8599999999999999 108.505 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.01 143.78 42.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.977 -1.49 . . . . 0.68999999999999995 106.977 159.871 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 152' ' ' ALA . 93.9 t -105.85 144.23 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.434 -1.691 . . . . 0.90000000000000002 106.434 165.153 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.51 97.09 5.04 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.702 -0.851 . . . . 0.48999999999999999 108.702 156.039 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.55 109.41 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.981 -1.489 . . . . 0.68000000000000005 106.981 164.099 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -93.73 122.5 36.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.564 -0.902 . . . . 0.84999999999999998 108.564 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -139.42 -53.25 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.651 -1.24 . . . . 4.3600000000000003 107.651 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.52 -113.12 2.46 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.193 0.901 . . . . 1.1899999999999999 110.88 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -109.68 -65.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.524 -1.288 . . . . 3.8100000000000001 107.524 -163.356 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.56 2.03 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 129.318 3.342 . . . . 1.23 115.068 -172.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.7 -26.16 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.797 2.998 . . . . 1.71 112.094 -176.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.18 143.67 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.753 1.221 . . . . 0.87 110.601 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -155.18 132.19 10.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.328 -0.99 . . . . 2.0099999999999998 108.328 -175.749 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.97 172.72 42.77 Favored Glycine 0 N--CA 1.451 -0.36 0 O-C-N 121.86 -0.525 . . . . 0.5 112.464 -175.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.11 129.78 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.54 -1.281 . . . . 1.1000000000000001 107.54 176.883 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mm -96.93 137.84 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.218 1.407 . . . . 0.70999999999999996 107.44 164.274 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -113.7 122.75 48.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.274 -1.38 . . . . 1.8799999999999999 107.274 160.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.468 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -105.1 130.6 53.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.407 1.883 . . . . 2.5099999999999998 106.222 172.814 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -135.75 148.21 48.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.986 0.812 . . . . 3.9500000000000002 109.906 168.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -155.3 133.63 11.72 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.255 -1.016 . . . . 3.25 108.255 166.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -44.17 71.7 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.572 -0.899 . . . . 4.3099999999999996 108.572 177.09 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -77.33 -177.16 4.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.438 1.495 . . . . 4.0899999999999999 109.597 -170.857 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.4 p -82.86 -67.92 0.75 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.502 1.521 . . . . 3.77 107.86 169.476 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -117.1 109.65 17.22 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.168 1.387 . . . . 3.9500000000000002 107.643 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.87 -155.01 7.01 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 108.511 -1.836 . . . . 1.6799999999999999 108.511 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.5 114.11 2.96 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.385 2.056 . . . . 2.0099999999999998 109.515 173.702 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.14 146.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.232 -0.655 . . . . 1.02 109.232 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -100.27 118.53 36.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.28 -1.748 . . . . 2.6499999999999999 106.28 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.468 HG22 ' CE1' ' A' ' 20' ' ' PHE . 34.0 t -117.1 122.19 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 107.794 -1.187 . . . . 1.1599999999999999 107.794 177.705 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -141.04 142.14 34.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.024 0.375 . . . . 0.85999999999999999 110.174 169.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.84 -178.22 38.01 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.535 -1.826 . . . . 0.92000000000000004 108.535 175.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.6 p -148.12 108.68 4.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.263 -2.125 . . . . 2.0499999999999998 105.263 169.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.28 126.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.128 -2.175 . . . . 1.1699999999999999 105.128 -176.653 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 157.84 24.03 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.486 0.66 . . . . 4.9500000000000002 111.45 -175.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 15.5 62.51 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 114.583 -1.19 . . . . 0.67000000000000004 114.079 176.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.98 159.08 23.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.293 1.547 . . . . 0.71999999999999997 109.57 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.18 166.61 13.71 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.288 -1.005 . . . . 1.6499999999999999 108.288 155.297 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -63.79 177.85 0.69 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.104 -0.998 . . . . 2.5 111.56 -175.041 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.78 -159.53 52.21 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.759 0.695 . . . . 0.53000000000000003 114.076 167.116 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.91 150.05 41.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.193 0.997 . . . . 2.0800000000000001 110.493 -177.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -143.58 116.92 9.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.336 1.054 . . . . 0.51000000000000001 110.086 178.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.13 141.71 19.92 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.538 -1.425 . . . . 0.45000000000000001 109.538 169.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -140.09 96.7 3.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.468 -1.308 . . . . 2.54 107.468 -172.79 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.742 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 27.9 m170 -131.79 146.42 52.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.503 -1.295 . . . . 0.57999999999999996 107.503 -160.848 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.83 113.66 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.263 1.03 . . . . 1.6399999999999999 108.446 172.588 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -79.63 -174.28 4.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.137 -1.392 . . . . 1.3300000000000001 108.446 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -115.84 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 118.317 -0.849 . . . . 5.3700000000000001 109.071 166.362 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 124.613 1.165 . . . . 5.0199999999999996 112.794 -179.146 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 116.303 1.964 . . . . 3.3599999999999999 116.303 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 42.2 -150.04 0.35 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.42 1.486 . . . . 1.3300000000000001 114.223 173.025 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.43 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.863 3.042 . . . . 1.3 111.142 173.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -66.27 59.79 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.721 2.009 . . . . 1.9099999999999999 112.252 -178.443 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 48.82 58.53 5.22 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.194 0.998 . . . . 1.8899999999999999 109.186 -176.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -87.62 114.95 61.25 Favored Pre-proline 0 C--N 1.34 0.153 0 CA-C-O 118.066 -0.969 . . . . 2.7599999999999998 108.481 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.16 -34.67 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.654 1.569 . . . . 1.2 111.425 -178.45 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -156.32 -76.63 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.526 -0.916 . . . . 2.5600000000000001 108.526 177.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.2 m -138.79 59.03 1.64 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.101 0.961 . . . . 1.6299999999999999 110.599 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -77.94 163.51 25.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.63 -0.878 . . . . 4.2599999999999998 108.63 162.742 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -125.58 153.78 43.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.299 1.839 . . . . 3.73 107.718 -171.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -76.97 164.68 25.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.032 0.444 . . . . 1.03 110.827 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.55 156.5 22.1 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 106.133 -2.787 . . . . 2.2799999999999998 106.133 168.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.18 -156.44 12.6 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 109.915 -1.274 . . . . 1.3899999999999999 109.915 173.224 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.35 -44.49 4.69 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.541 1.494 . . . . 1.49 108.936 165.294 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -59.01 -43.84 91.59 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.549 1.54 . . . . 5.5800000000000001 112.308 -173.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -55.91 166.89 0.66 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.424 1.09 . . . . 2.48 111.328 -177.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -82.32 -47.86 11.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.436 1.894 . . . . 4.71 109.665 170.268 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 175.9 10.19 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.374 1.07 . . . . 3.98 110.112 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 170.28 148.08 0.03 OUTLIER 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.422 3.089 . . . . 3.73 107.191 168.684 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 40.0 m80 -61.73 148.58 42.41 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 117.614 -1.634 . . . . 0.56000000000000005 106.791 171.132 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 p -53.58 -23.04 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 1.3 110.665 174.934 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.97 43.09 1.8 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.805 1.082 . . . . 0.77000000000000002 115.805 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -140.66 138.69 34.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.984 1.892 . . . . 2.04 111.385 153.644 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.7 -44.09 7.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.972 1.309 . . . . 3.02 108.119 166.248 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.85 -103.13 0.23 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.608 -1.397 . . . . 0.88 109.608 177.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -145.29 170.88 15.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.805 1.642 . . . . 1.52 111.516 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.07 170.95 18.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 127.055 2.142 . . . . 0.57999999999999996 107.877 174.175 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.77 109.67 15.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.726 1.61 . . . . 2.9300000000000002 109.718 -170.62 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.55 139.54 38.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.548 -0.72 . . . . 0.59999999999999998 111.496 174.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.02 -92.14 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.38 1.472 . . . . 4.25 109.886 172.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -175.28 -32.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.878 1.271 . . . . 3.4700000000000002 111.795 -163.044 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.91 8.12 4.1 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 123.39 1.567 . . . . 3.3999999999999999 109.64 153.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.84 72.74 Favored Glycine 0 N--CA 1.442 -0.935 0 O-C-N 120.639 -1.288 . . . . 0.95999999999999996 110.217 177.081 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.3 t -82.93 111.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.943 1.297 . . . . 1.04 107.611 -177.169 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.53 155.15 21.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.535 1.134 . . . . 1.1299999999999999 110.041 172.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -102.0 57.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.859 2.464 . . . . 6.2400000000000002 107.502 -165.796 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.07 85.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.996 -0.742 . . . . 1.52 108.996 -163.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.1 m -143.76 119.41 10.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.124 -0.695 . . . . 1.47 109.124 173.098 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.31 152.69 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.173 -1.047 . . . . 2.1800000000000002 108.173 -173.466 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -131.72 92.45 3.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.705 -1.22 . . . . 2.8799999999999999 107.705 167.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.6 151.3 21.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.259 0.624 . . . . 2.3700000000000001 110.569 176.375 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -121.06 -0.48 9.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.224 1.81 . . . . 3.3399999999999999 112.651 173.27 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -78.56 -51.21 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.752 -1.203 . . . . 1.6499999999999999 107.752 174.472 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.13 168.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.299 0.571 . . . . 1.2 110.319 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.8 m -131.66 178.53 6.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.127 2.171 . . . . 1.96 106.509 174.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.44 ' HA ' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -100.01 9.74 42.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.21 0.914 . . . . 3.2000000000000002 112.453 171.871 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.451 -0.392 0 C-N-CA 124.918 1.287 . . . . 4.5099999999999998 109.312 -166.189 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 123.082 1.42 . . . . 2.2000000000000002 112.83 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -7.55 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 113.534 -1.666 . . . . 1.6699999999999999 110.893 179.453 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 106' ' ' LEU . 1.5 mp -58.74 131.79 23.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.413 0 CA-C-N 119.823 1.192 . . . . 2.6899999999999999 107.969 171.292 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.07 23.67 68.29 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.24 -0.755 . . . . 1.79 111.687 -170.72 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.528 ' O ' HG22 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -130.41 168.82 16.35 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.085 1.443 . . . . 5.0499999999999998 109.173 167.449 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.9 m -100.06 110.57 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.583 0.753 . . . . 0.93000000000000005 112.681 -169.065 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mt -67.05 141.9 57.36 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.219 -1.03 . . . . 1.5600000000000001 108.219 170.307 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.6 t -132.31 140.23 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.889 2.475 . . . . 0.39000000000000001 107.148 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 p -112.5 127.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.663 1.185 . . . . 1.75 108.204 167.736 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.531 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 56.9 m-70 -105.25 163.35 12.66 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.785 1.634 . . . . 0.46999999999999997 113.611 -171.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.471 ' HB2' HD21 ' A' ' 144' ' ' LEU 0.28 8.7 tt0 -76.71 -53.52 7.87 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 115.035 1.494 . . . . 6.1699999999999999 115.035 -178.005 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -78.93 177.46 8.75 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 120.476 1.489 . . . . 3.8900000000000001 108.713 -179.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.29 37.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.429 -0.952 . . . . 0.52000000000000002 108.429 160.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 164.26 20.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.039 . . . . 1.9399999999999999 108.193 156.654 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -10.47 59.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.217 1.191 . . . . 4.1299999999999999 114.217 -171.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 58.93 34.19 23.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 1.73 111.706 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.0 60.41 6.88 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.723 -0.611 . . . . 2.1800000000000002 112.712 168.138 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -138.7 -59.47 0.61 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.422 1.489 . . . . 5.1900000000000004 109.937 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 64.28 -72.06 0.06 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.844 1.688 . . . . 2.02 116.152 173.464 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.19 40.26 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 111.184 -0.766 . . . . 2.3500000000000001 111.184 -157.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -170.68 160.69 7.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.077 1.751 . . . . 2.8500000000000001 107.085 -178.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -55.13 -64.88 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.015 1.117 . . . . 3.1800000000000002 114.015 -173.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.59 -45.12 66.37 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.874 0.87 . . . . 4.2300000000000004 110.617 -156.421 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -58.85 1.99 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.039 1.735 . . . . 1.96 111.515 170.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -70.9 -48.03 55.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.195 -0.941 . . . . 1.52 110.788 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -67.33 -36.68 81.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.052 -0.499 . . . . 2.6600000000000001 112.304 -169.613 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.504 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.404 0.0 OUTLIER -129.49 -53.89 1.17 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.681 -1.152 . . . . 1.1499999999999999 113.518 168.428 . . . . . . . . 4 4 . 1 . 029 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.68 -10.25 0.27 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 120.408 1.458 . . . . 0.88 115.995 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 46.84 53.62 10.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.216 1.406 . . . . 1.98 111.791 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.742 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -65.18 -30.22 71.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.366 1.467 . . . . 1.0700000000000001 113.452 177.712 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.62 173.15 49.54 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.865 -1.294 . . . . 1.1599999999999999 109.865 -160.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 m -56.4 152.25 11.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.167 1.387 . . . . 1.5900000000000001 113.148 -172.454 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.44 ' O ' HD23 ' A' ' 144' ' ' LEU . 11.8 mtm105 -77.61 162.85 26.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.713 -1.585 . . . . 4.5599999999999996 111.614 176.648 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 121' ' ' GLU . 6.9 mt -138.83 -72.92 0.4 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.836 -1.913 . . . . 0.78000000000000003 105.836 -172.607 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.68 155.69 30.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.425 0.631 . . . . 0.87 109.321 172.551 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -157.23 172.12 19.19 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.543 -1.662 . . . . 1.6799999999999999 108.642 175.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.24 146.08 6.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.034 -0.985 . . . . 0.69999999999999996 111.932 176.567 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.4 t -63.32 133.49 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.489 1.116 . . . . 0.71999999999999997 109.118 175.229 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 115' ' ' ARG . 16.6 tt -96.41 136.05 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.76000000000000001 110.478 176.456 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.96 -1.27 2.5 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.883 0.754 . . . . 0.80000000000000004 114.427 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -89.38 58.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.906 1.353 . . . . 0.93000000000000005 110.367 -160.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.427 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -128.46 176.14 7.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.431 1.093 . . . . 1.52 110.972 176.304 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 102.047 -3.316 . . . . 4.8399999999999999 102.047 143.817 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 107.567 -1.272 . . . . 5.8099999999999996 107.567 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.92 125.74 53.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.252 -1.388 . . . . 0.78000000000000003 107.252 160.22 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 152' ' ' ALA . 59.5 t -90.78 140.91 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 105.837 -1.912 . . . . 1.05 105.837 164.711 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.96 92.52 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.27 -1.011 . . . . 0.75 108.27 160.456 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.09 103.19 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 107.077 -1.453 . . . . 0.81999999999999995 107.077 165.245 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.73 129.96 34.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.402 -0.962 . . . . 0.93999999999999995 108.402 176.274 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -154.98 -53.86 0.09 Allowed 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.411 -0.588 . . . . 3.6000000000000001 109.411 170.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.72 -107.04 0.61 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.421 -0.809 . . . . 1.3300000000000001 113.005 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -116.37 -57.23 2.22 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.949 1.3 . . . . 2.9700000000000002 110.005 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 164.81 10.15 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.674 0.654 . . . . 1.1200000000000001 112.289 -177.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.72 -19.46 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.593 2.862 . . . . 1.47 112.336 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.88 143.24 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 124.712 1.205 . . . . 0.91000000000000003 110.562 174.304 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -155.65 126.28 6.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.732 -1.21 . . . . 1.9299999999999999 107.732 -174.248 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.7 170.8 42.51 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.957 -0.639 . . . . 0.55000000000000004 112.369 -174.366 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.4 128.17 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.491 -0.929 . . . . 1.5800000000000001 108.491 -179.358 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.29 134.71 30.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.651 -1.611 . . . . 0.93999999999999995 106.651 161.315 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.42 59.85 1.02 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.863 0.865 . . . . 3.3300000000000001 108.69 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.491 ' CD2' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -90.77 144.28 25.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.237 1.415 . . . . 2.98 110.916 -163.277 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -153.44 163.39 40.03 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.872 0.844 . . . . 3.2599999999999998 111.27 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.416 HE22 ' N ' ' A' ' 27' ' ' GLY . 34.8 tt0 -145.55 153.79 41.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.041 -2.207 . . . . 2.9399999999999999 105.041 157.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -70.71 -56.06 7.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.373 -0.602 . . . . 4.5999999999999996 109.373 172.713 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -83.08 166.46 18.71 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.798 1.239 . . . . 3.5899999999999999 109.324 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 p -90.79 -0.16 57.63 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.887 -0.508 . . . . 2.3300000000000001 111.949 176.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -144.29 47.72 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.325 0.966 . . . . 4.8899999999999997 111.843 -159.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' N ' HE22 ' A' ' 22' ' ' GLN . . . -152.56 -164.87 12.75 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.823 -1.311 . . . . 1.01 109.823 171.876 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.4 146.78 45.58 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.594 2.196 . . . . 1.03 110.799 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.54 143.77 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 123.849 0.718 . . . . 0.90000000000000002 110.826 -171.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -95.97 96.98 9.26 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.354 -0.609 . . . . 2.5600000000000001 109.354 -175.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG22 ' CD2' ' A' ' 20' ' ' PHE . 44.1 t -83.78 88.94 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.096 -1.076 . . . . 1.22 108.096 177.423 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -104.55 137.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.778 0.674 . . . . 1.05 109.798 164.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.85 156.83 27.86 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.957 -0.857 . . . . 0.83999999999999997 110.957 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 p -132.21 106.74 8.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.664 -1.976 . . . . 1.71 105.664 -171.882 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.62 150.25 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.627 -1.249 . . . . 0.83999999999999997 107.627 -167.408 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.75 -179.54 6.86 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.271 1.211 . . . . 5.0899999999999999 114.271 161.796 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.92 64.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.854 1.692 . . . . 0.59999999999999998 112.204 179.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.16 162.2 29.7 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.139 0.97 . . . . 0.65000000000000002 108.811 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.21 164.61 23.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.884 -1.154 . . . . 1.78 107.884 153.412 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.01 175.21 0.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.63 0.728 . . . . 2.4100000000000001 111.048 176.898 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.07 -163.67 50.63 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.295 0.474 . . . . 0.58999999999999997 113.395 170.455 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.06 147.08 47.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.131 . . . . 2.2799999999999998 112.284 -172.786 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.36 117.22 8.22 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.822 1.649 . . . . 0.44 108.987 177.223 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.16 152.61 5.09 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.917 -0.873 . . . . 0.34000000000000002 110.917 171.546 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.84 95.62 2.76 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.559 1.143 . . . . 2.4100000000000001 108.053 -174.26 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -135.24 160.61 37.86 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 108.383 -0.969 . . . . 0.52000000000000002 108.383 -160.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.37 115.94 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.98 1.264 . . . . 1.8100000000000001 110.686 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -86.9 162.42 17.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.766 -0.652 . . . . 0.87 109.564 -169.792 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.73 47.27 0.13 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.683 1.993 . . . . 4.5199999999999996 111.345 178.094 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' CD ' HH22 ' A' ' 143' ' ' ARG . 4.7 mt-10 . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 106.074 -1.824 . . . . 3.0899999999999999 106.074 -171.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.403 -0.591 . . . . 1.8300000000000001 109.403 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.93 -95.25 1.68 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 109.683 -1.367 . . . . 1.04 109.683 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.83 178.61 6.59 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.392 3.394 . . . . 0.93999999999999995 114.236 -173.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -73.03 125.35 27.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.309 -1.314 . . . . 1.52 109.226 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -4.04 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.465 2.306 . . . . 2.3399999999999999 113.754 168.344 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -123.78 99.84 38.13 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.27 1.028 . . . . 3.1400000000000001 109.105 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.81 -37.02 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.668 1.578 . . . . 1.25 110.03 -179.004 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.41 -86.02 0.54 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.59 -1.263 . . . . 3.0099999999999998 107.59 160.366 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -140.32 72.87 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.434 1.094 . . . . 1.6100000000000001 109.71 -166.071 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -77.75 164.31 25.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.8 -0.815 . . . . 4.6699999999999999 108.8 170.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -125.07 148.02 48.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.059 1.343 . . . . 3.5099999999999998 108.386 -178.974 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.479 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 44.2 t60 -81.48 156.22 25.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.719 0.407 . . . . 0.89000000000000001 111.828 -176.211 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.57 -97.78 0.13 Allowed Glycine 0 C--O 1.219 -0.784 0 N-CA-C 107.334 -2.306 . . . . 2.3300000000000001 107.334 159.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.09 -154.55 25.48 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 120.575 -1.544 . . . . 1.51 110.344 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.34 -55.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.932 2.421 . . . . 1.8700000000000001 110.394 -168.08 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -39.82 82.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.737 0.779 . . . . 5.6100000000000003 110.067 171.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -57.29 153.09 12.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.725 -1.579 . . . . 3.1299999999999999 112.861 -164.417 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 77' ' ' GLU . 1.8 mp0 -49.2 -47.24 46.26 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 128.144 2.578 . . . . 6.5700000000000003 109.576 170.192 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 21.6 pt-20 -133.93 178.52 6.89 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.762 1.023 . . . . 3.4300000000000002 113.762 -171.145 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 175.73 153.55 0.16 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.147 2.179 . . . . 3.1000000000000001 108.579 -173.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 58.4 m80 -62.6 156.24 23.82 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.072 -0.714 . . . . 0.80000000000000004 109.072 170.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.94 -34.24 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.45 -0.782 . . . . 1.29 110.489 -174.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.46 59.98 0.49 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.39 0.995 . . . . 0.82999999999999996 110.65 175.461 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -169.68 115.93 0.56 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.22 -1.4 . . . . 2.0699999999999998 107.22 -170.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -106.79 -48.43 3.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.37 0.668 . . . . 2.5 110.978 -173.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.76 -121.69 0.93 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 119.647 -1.263 . . . . 0.67000000000000004 112.333 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -151.03 172.02 16.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.085 1.354 . . . . 1.3600000000000001 108.925 -171.599 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 167.23 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.016 -1.476 . . . . 0.67000000000000004 107.016 167.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 m -120.09 123.42 43.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.217 -1.401 . . . . 2.0299999999999998 107.217 172.683 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.94 33.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.979 0.354 . . . . 0.65000000000000002 110.977 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -69.19 -84.05 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.567 1.147 . . . . 2.8799999999999999 110.449 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 93' ' ' GLY . 75.4 tttt -159.12 -46.33 0.06 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.735 1.214 . . . . 3.52 111.308 -175.127 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.41 32.98 0.45 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 124.337 2.018 . . . . 2.73 110.38 176.217 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 58.39 18.67 37.3 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 126.504 2.002 . . . . 0.62 112.228 -176.925 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.62 142.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.844 -1.539 . . . . 0.76000000000000001 106.844 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.04 163.34 33.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.89 -1.152 . . . . 0.59999999999999998 107.89 171.127 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -129.99 141.53 50.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.815 -2.661 . . . . 2.6499999999999999 103.815 -174.634 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.38 126.25 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 105.439 -2.06 . . . . 1.3 105.439 170.299 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.8 m -145.81 71.34 1.27 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.375 1.47 . . . . 1.26 107.974 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mm -108.56 151.16 10.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.654 0.782 . . . . 1.73 109.208 -178.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -137.67 133.96 34.88 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.737 -1.579 . . . . 3.5499999999999998 106.737 160.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.06 161.94 37.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.522 -1.659 . . . . 2.4900000000000002 106.522 175.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 p -113.17 -9.2 13.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.981 2.113 . . . . 1.8 112.487 -172.389 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.1 t -77.5 -41.85 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.339 -0.985 . . . . 1.3799999999999999 108.339 -177.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -85.68 162.75 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 123.774 0.83 . . . . 2.3799999999999999 108.996 172.722 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.437 ' N ' HD13 ' A' ' 104' ' ' ILE . 49.2 p -164.29 169.54 17.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.728 1.611 . . . . 1.8200000000000001 108.086 -175.144 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.5 42.52 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.733 1.213 . . . . 2.7400000000000002 110.046 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 107.575 -1.269 . . . . 4.0800000000000001 107.575 166.409 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 113.026 0.75 . . . . 1.3500000000000001 113.026 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.489 HD12 HG21 ' A' ' 149' ' ' ILE . 1.3 pp -85.64 -8.86 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.91 -0.494 . . . . 1.48 112.05 -177.012 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mm -47.6 123.88 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.835 0.854 . . . . 2.2400000000000002 109.235 169.466 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.12 -27.72 17.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.036 0.827 . . . . 2.0299999999999998 112.645 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.85 160.4 26.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.837 1.318 . . . . 5.3300000000000001 110.936 -168.143 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.8 m -87.35 100.46 12.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.042 1.337 . . . . 1.1100000000000001 109.904 -176.253 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.9 146.77 54.48 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.139 -1.06 . . . . 1.76 108.139 169.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.9 t -134.41 140.8 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 127.898 2.479 . . . . 0.53000000000000003 107.175 -177.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.64 127.19 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.265 -1.383 . . . . 1.6200000000000001 107.265 165.327 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -98.71 162.99 12.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.573 2.064 . . . . 0.39000000000000001 116.573 -169.408 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -66.36 0.4 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.754 2.022 . . . . 2.9500000000000002 112.054 176.779 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -107.68 -178.58 3.66 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.187 0.995 . . . . 3.1899999999999999 111.549 -173.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.79 147.36 42.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.292 -0.867 . . . . 0.72999999999999998 108.798 158.093 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.95 164.23 23.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.578 0.704 . . . . 2.1699999999999999 109.776 161.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.19 -4.69 58.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.473 1.509 . . . . 3.1400000000000001 112.927 -172.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 57.08 30.36 18.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.597 1.159 . . . . 1.47 110.583 -170.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.45 20.69 59.2 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.872 -0.518 . . . . 1.97 112.587 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -131.24 50.76 2.2 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.221 -1.4 . . . . 6.21 107.221 -173.201 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.46 139.71 11.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.713 -1.755 . . . . 1.99 108.713 177.201 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.23 -37.28 79.75 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.67 0.735 . . . . 2.7599999999999998 112.604 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -56.15 109.63 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.519 1.127 . . . . 2.0800000000000001 108.995 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -38.91 20.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.163 0.985 . . . . 3.54 112.105 -178.212 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -35.36 -37.87 0.09 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 128.022 2.529 . . . . 3.0 113.227 171.208 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.7 p -47.7 -69.2 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.285 1.034 . . . . 2.1800000000000002 109.69 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -63.96 -43.35 96.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.334 0.654 . . . . 1.3 110.417 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -52.2 -49.83 63.1 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 126.1 1.76 . . . . 2.98 110.703 -171.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.492 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.379 10.2 t -136.2 -48.19 0.65 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 117.801 -1.095 . . . . 2.21 111.629 175.459 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.479 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 162.38 -31.32 0.3 Allowed Glycine 0 N--CA 1.463 0.483 0 CA-C-N 119.564 1.074 . . . . 0.91000000000000003 112.578 178.423 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.99 53.4 10.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.498 1.519 . . . . 1.9399999999999999 109.778 -174.724 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.18 -7.27 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.352 -0.842 . . . . 1.03 112.085 166.691 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.53 -167.57 50.55 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 108.88 -1.688 . . . . 0.95999999999999996 108.88 -174.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -54.39 151.35 7.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.087 1.755 . . . . 1.1899999999999999 113.836 -167.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.466 HH22 ' CD ' ' A' ' 50' ' ' GLU . 7.6 mmt85 -64.93 141.46 58.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.333 1.453 . . . . 2.9500000000000002 108.083 170.228 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.7 mt -108.92 -89.66 0.47 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.058 -1.089 . . . . 0.55000000000000004 108.058 169.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.74 158.08 15.85 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.953 -1.129 . . . . 0.87 107.953 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.6 p -143.64 174.84 10.43 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.214 -1.357 . . . . 1.96 108.413 166.017 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.1 139.72 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 123.943 0.777 . . . . 0.70999999999999996 111.551 176.439 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.21 129.76 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.556 1.143 . . . . 0.95999999999999996 108.861 174.006 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.489 HG21 HD12 ' A' ' 112' ' ' ILE . 7.9 tt -90.74 131.88 36.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 122.665 0.386 . . . . 0.84999999999999998 110.76 176.92 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.54 3.2 0.62 Allowed Glycine 0 CA--C 1.523 0.532 0 CA-C-O 119.389 -0.673 . . . . 0.77000000000000002 114.639 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.19 56.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.193 1.497 . . . . 1.29 110.917 -164.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.36 175.51 13.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.061 1.344 . . . . 1.3600000000000001 108.268 160.258 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 103.858 -2.645 . . . . 4.8499999999999996 103.858 163.615 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 110.302 -0.259 . . . . 2.6400000000000001 110.302 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.41 153.64 21.01 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.51 -0.922 . . . . 0.70999999999999996 108.51 164.102 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.96 148.62 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 123.799 0.84 . . . . 0.91000000000000003 108.939 164.395 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.18 101.64 6.35 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.067 1.347 . . . . 0.48999999999999999 108.937 159.007 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.7 98.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.204 -1.035 . . . . 0.69999999999999996 108.204 164.991 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 147' ' ' GLY . 44.3 mt -81.76 123.77 29.05 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.812 0.845 . . . . 1.6799999999999999 109.564 175.05 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.76 -56.73 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.82 1.248 . . . . 4.4699999999999998 108.29 178.88 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' H ' ' A' ' 146' ' ' CYS . . . 44.54 -116.16 1.58 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.043 1.306 . . . . 0.88 112.47 -177.549 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.05 -62.03 1.33 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.642 0.721 . . . . 3.46 109.605 -173.138 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.58 161.94 1.13 Allowed Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.825 1.678 . . . . 0.81000000000000005 112.554 -178.166 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.34 38.6 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.001 3.134 . . . . 0.96999999999999997 112.75 -172.207 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.3 155.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.341 1.856 . . . . 0.98999999999999999 109.013 -177.436 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.53 116.76 4.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.892 -1.151 . . . . 2.25 107.892 171.327 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 163.68 33.02 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.969 -0.852 . . . . 0.64000000000000001 110.969 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.77 114.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.826 -1.916 . . . . 1.72 105.826 -177.607 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -78.2 148.44 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.191 -1.411 . . . . 0.72999999999999998 107.191 170.252 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -122.7 118.23 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.183 -2.154 . . . . 2.1600000000000001 105.183 163.081 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -106.54 99.94 9.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.175 -1.787 . . . . 2.7400000000000002 106.175 175.606 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -103.78 136.84 42.72 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.693 0.797 . . . . 4.6900000000000004 109.246 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -155.94 86.97 1.05 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.626 1.17 . . . . 3.8100000000000001 109.591 172.717 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.98 -52.02 59.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.377 1.071 . . . . 4.9400000000000004 110.125 174.036 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -83.56 92.46 7.64 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.265 -1.013 . . . . 4.2300000000000004 108.265 175.434 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -54.57 3.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 118.287 2.699 . . . . 3.3599999999999999 118.287 -162.831 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -159.04 64.76 0.41 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 120.004 1.275 . . . . 3.6800000000000002 109.566 170.081 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.94 -145.85 6.84 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 107.578 -2.209 . . . . 1.49 107.578 164.717 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.72 142.51 16.08 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.555 2.17 . . . . 1.1299999999999999 110.693 169.922 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG11 ' CD2' ' A' ' 20' ' ' PHE . 59.5 t -90.39 152.11 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 122.818 0.447 . . . . 0.91000000000000003 110.128 -175.559 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.6 125.76 48.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.388 -1.708 . . . . 4.1600000000000001 106.388 170.219 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' CE1' ' A' ' 20' ' ' PHE . 16.1 t -116.14 129.91 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 175.442 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -144.07 150.32 37.98 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.543 -1.28 . . . . 0.73999999999999999 107.543 162.444 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.28 142.88 5.71 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 107.748 -2.141 . . . . 1.0900000000000001 107.748 173.625 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -116.92 98.57 6.56 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.444 -1.317 . . . . 2.5299999999999998 107.444 -169.261 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.69 143.44 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.512 1.525 . . . . 1.1000000000000001 108.54 -169.119 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 160.65 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.515 -0.474 . . . . 4.75 110.619 170.807 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.57 25.16 63.62 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.796 1.665 . . . . 0.97999999999999998 113.99 -179.121 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.58 171.56 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.297 -1.001 . . . . 0.95999999999999996 108.297 160.333 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -74.45 168.47 19.65 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.995 -1.113 . . . . 2.04 107.995 152.86 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.47 172.55 0.85 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.73 1.212 . . . . 4.71 110.9 179.516 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.28 -158.75 38.33 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 115.967 -0.561 . . . . 0.84999999999999998 114.023 167.63 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.13 141.35 56.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.228 1.411 . . . . 2.4900000000000002 111.997 -168.17 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -142.48 115.86 9.02 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.168 0.987 . . . . 0.57999999999999996 110.804 176.457 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.11 146.88 9.77 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.997 -0.841 . . . . 0.38 110.997 170.515 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -138.26 105.68 5.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.848 1.259 . . . . 2.5099999999999998 107.778 -175.889 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 31.0 m80 -138.66 162.09 35.52 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.291 -1.003 . . . . 0.64000000000000001 108.291 -166.055 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.45 126.18 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.472 0.654 . . . . 1.6899999999999999 109.385 176.319 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -104.94 147.75 27.44 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.75 2.02 . . . . 0.80000000000000004 109.215 -173.314 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 67.87 0.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.681 1.192 . . . . 4.3700000000000001 111.095 177.716 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 107.383 -1.339 . . . . 3.1800000000000002 107.383 -176.254 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.386 0 N-CA-C 106.867 -1.531 . . . . 1.79 106.867 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.78 -122.89 2.94 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.076 -0.847 . . . . 1.0700000000000001 111.98 -158.496 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.89 179.12 6.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.416 2.744 . . . . 0.90000000000000002 113.289 -172.356 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -58.82 115.74 3.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.893 -1.503 . . . . 1.29 107.19 171.534 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -21.89 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.967 1.707 . . . . 2.3900000000000001 113.902 176.94 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -130.29 146.23 60.75 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.08 . . . . 3.2200000000000002 107.929 -173.764 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.58 -54.69 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.778 1.652 . . . . 1.8700000000000001 108.655 169.076 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -144.63 -70.37 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.449 1.499 . . . . 2.54 107.333 171.244 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.9 p -135.29 71.92 1.44 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.042 1.337 . . . . 2.5600000000000001 109.369 -168.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -78.82 175.13 10.77 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.233 -1.025 . . . . 4.2400000000000002 108.233 162.488 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -117.16 149.08 40.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.561 -2.015 . . . . 4.3099999999999996 105.561 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.427 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 82.7 t60 -66.93 146.25 54.58 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.543 -0.863 . . . . 0.83999999999999997 111.048 178.487 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.36 130.28 3.29 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 106.751 -2.54 . . . . 2.73 106.751 172.495 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.1 -155.28 12.36 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.231 -1.148 . . . . 1.8200000000000001 110.231 174.732 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.52 -33.0 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.26 1.974 . . . . 2.4199999999999999 110.786 178.91 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -44.23 90.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.437 0.637 . . . . 7.8099999999999996 110.817 175.637 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.18 139.69 56.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.218 1.562 . . . . 3.0299999999999998 115.218 -159.401 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -53.57 -59.45 4.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.752 2.421 . . . . 5.4199999999999999 110.167 170.588 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.64 -178.72 6.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 130.221 3.409 . . . . 3.8199999999999998 110.406 178.029 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 172.68 161.01 0.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.206 1.802 . . . . 2.8700000000000001 111.685 164.74 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.7 m80 -50.25 136.84 19.14 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.685 -1.968 . . . . 0.64000000000000001 105.685 154.256 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.78 -20.6 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 120.072 -0.651 . . . . 1.24 109.82 -179.96 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.91 43.29 1.75 Allowed Glycine 0 CA--C 1.535 1.338 0 N-CA-C 116.717 1.447 . . . . 0.78000000000000003 116.717 164.56 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -98.09 136.8 37.81 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 105.757 -1.942 . . . . 1.9299999999999999 105.757 147.681 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 84' ' ' LEU . 3.9 mm? -93.55 -52.29 4.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.72 -0.844 . . . . 1.5700000000000001 108.72 148.464 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.92 -108.6 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 119.597 -1.287 . . . . 0.53000000000000003 112.321 178.783 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -155.63 168.18 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.512 1.525 . . . . 2.0800000000000001 109.224 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.98 178.05 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.565 -1.643 . . . . 0.56999999999999995 106.565 163.21 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.5 t -113.07 146.22 39.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.562 -1.644 . . . . 2.4900000000000002 106.562 151.913 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.46 156.43 20.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.106 -1.072 . . . . 0.78000000000000003 108.106 150.755 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.57 -90.11 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.967 -0.753 . . . . 3.1299999999999999 108.967 172.314 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -139.22 -48.79 0.49 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.467 1.507 . . . . 3.7599999999999998 110.091 -167.497 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -81.88 17.0 1.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.964 1.364 . . . . 3.0800000000000001 111.343 -176.545 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.84 10.11 76.42 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.344 -0.847 . . . . 0.93999999999999995 111.7 -175.87 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.38 124.65 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.493 1.517 . . . . 0.93000000000000005 107.475 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.34 171.62 14.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.269 1.828 . . . . 0.68000000000000005 108.086 175.12 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.31 144.74 26.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.787 -1.19 . . . . 3.5899999999999999 107.787 -179.583 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.21 55.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 123.866 0.866 . . . . 2.04 111.153 -172.797 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.6 m -72.67 102.3 3.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.768 -0.634 . . . . 1.1000000000000001 110.193 169.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 100' ' ' GLU . 16.4 mt -137.4 157.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.192 0.906 . . . . 1.8999999999999999 110.147 179.077 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 99' ' ' ILE . 34.7 tt0 -137.94 123.72 19.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.659 -1.237 . . . . 3.6600000000000001 107.659 158.514 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -117.15 156.82 26.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.466 -0.939 . . . . 2.4500000000000002 108.466 164.095 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.9 p -102.03 -12.64 18.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.282 2.233 . . . . 1.5700000000000001 111.937 176.432 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.35 -25.87 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.764 0.711 . . . . 1.3100000000000001 110.872 -173.726 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.88 166.6 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.704 0.683 . . . . 1.3999999999999999 111.686 177.32 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -136.41 176.81 8.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.596 2.359 . . . . 1.8200000000000001 107.618 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.42 57.37 1.09 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.802 0.728 . . . . 2.48 112.11 167.352 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 123.328 0.651 . . . . 2.8700000000000001 111.743 165.509 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.443 -0.776 0 CA-C-O 122.695 1.236 . . . . 1.4099999999999999 112.516 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -8.53 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 3.0800000000000001 111.942 176.066 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 33.9 mm -54.85 120.4 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.926 1.239 . . . . 1.96 109.491 -174.069 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.25 73.81 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.617 -0.546 . . . . 1.49 112.338 -177.965 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -102.39 177.21 4.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.313 -1.736 . . . . 4.2599999999999998 106.313 167.611 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -119.4 122.14 41.11 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.596 1.089 . . . . 1.01 111.314 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.8 mt -74.16 146.43 43.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.239 -0.652 . . . . 1.72 109.239 166.144 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.91 136.06 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.416 1.886 . . . . 0.39000000000000001 107.919 177.511 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.419 HG22 ' CE2' ' A' ' 45' ' ' PHE . 28.3 t -100.47 122.23 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 126.044 1.738 . . . . 2.27 106.9 167.005 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.486 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 65.0 m-70 -98.48 158.69 15.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.369 1.989 . . . . 0.44 116.369 -174.653 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 2.7 tt0 -46.72 -74.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.219 2.208 . . . . 2.96 112.018 174.292 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -93.76 -176.88 4.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.851 0.75 . . . . 2.8599999999999999 110.275 -171.748 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.32 152.08 30.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.588 -0.893 . . . . 0.60999999999999999 108.588 157.924 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.13 177.34 6.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.94 0.876 . . . . 2.1099999999999999 109.087 161.92 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.53 -27.4 67.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.498 1.119 . . . . 4.3899999999999997 113.83 177.824 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.288 2.9 mm? 88.73 -17.58 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 128.47 2.708 . . . . 2.8900000000000001 113.172 -175.127 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.27 3.33 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.647 -1.381 . . . . 3.6000000000000001 109.647 -171.969 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -95.44 -38.97 10.23 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 128.264 2.626 . . . . 6.1100000000000003 108.87 160.403 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.35 62.63 5.8 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 125.401 1.477 . . . . 3.6000000000000001 110.112 -167.294 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.19 -16.02 25.05 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.694 -0.503 . . . . 3.1099999999999999 113.741 178.845 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -176.68 -179.98 1.05 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.49 1.516 . . . . 2.25 108.236 -169.507 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -42.83 -82.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.772 2.029 . . . . 3.4900000000000002 113.562 178.681 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -53.18 -33.54 53.07 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.827 -0.546 . . . . 3.2000000000000002 111.709 -172.796 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.3 m -61.42 -52.78 63.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.005 1.322 . . . . 2.5099999999999998 111.161 179.266 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.9 t -71.04 -45.07 64.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.767 1.167 . . . . 2.4100000000000001 110.791 173.781 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.17 -43.13 99.36 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.175 0.59 . . . . 3.9500000000000002 111.58 -170.063 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -128.21 -47.98 1.33 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.225 0.466 . . . . 1.3600000000000001 112.107 177.104 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 147.65 -14.99 1.4 Allowed Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.786 0.721 . . . . 0.91000000000000003 114.097 -178.417 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.11 54.85 6.73 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.035 1.334 . . . . 1.8500000000000001 110.601 -174.755 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.5 -31.26 71.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.77 1.228 . . . . 1.1399999999999999 112.087 172.848 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.52 178.43 50.48 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 108.64 -1.784 . . . . 0.93999999999999995 108.64 -163.262 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 m -58.23 153.76 14.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.556 1.142 . . . . 1.28 113.648 -167.229 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -59.72 134.58 57.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.082 1.353 . . . . 3.0099999999999998 108.465 170.254 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.6 mt -110.32 -72.48 0.72 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.955 -1.498 . . . . 0.58999999999999997 106.955 168.37 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.35 155.03 16.94 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.409 -0.96 . . . . 0.93999999999999995 108.409 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.407 ' H ' ' HA3' ' A' ' 10' ' ' GLY . 73.9 m -135.96 150.51 49.3 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 106.196 -1.779 . . . . 1.8200000000000001 106.196 163.858 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.54 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -152.09 116.45 0.75 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.8 -1.72 . . . . 0.95999999999999996 108.8 172.03 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.68 132.88 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.095 -1.446 . . . . 0.77000000000000002 107.095 168.236 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.59 138.96 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.206 0.527 . . . . 0.69999999999999996 112.385 -172.537 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 137.78 5.84 1.62 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.328 1.442 . . . . 0.59999999999999998 114.221 177.563 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.75 57.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-N 119.351 1.575 . . . . 0.81000000000000005 109.89 -154.268 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 165.33 36.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.367 0.603 . . . . 1.5900000000000001 111.236 171.669 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 C--O 1.255 1.353 0 N-CA-C 102.699 -3.075 . . . . 4.5 102.699 156.139 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.747 0.308 . . . . 3.0800000000000001 110.845 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.76 37.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.551 -2.018 . . . . 0.87 105.551 156.147 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -100.6 142.85 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 105.558 -2.016 . . . . 0.65000000000000002 105.558 162.725 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -129.79 93.16 3.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.645 -1.243 . . . . 0.46000000000000002 107.645 166.889 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.09 98.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.299 -1.371 . . . . 0.78000000000000003 107.299 169.408 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 147' ' ' GLY . 18.2 mt -79.89 123.06 27.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.038 -0.727 . . . . 1.8300000000000001 109.038 177.741 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -150.69 -48.07 0.12 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.824 -0.625 . . . . 3.5299999999999998 111.065 167.623 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.32 -117.8 3.52 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.61 -0.996 . . . . 1.1200000000000001 110.61 -174.898 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.85 -35.04 6.07 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.319 1.048 . . . . 3.7400000000000002 110.131 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.44 168.8 30.15 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-O 121.63 0.572 . . . . 1.1200000000000001 112.577 -177.466 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.47 -26.29 47.58 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.571 2.847 . . . . 1.8700000000000001 111.758 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 56.0 t -48.04 151.61 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.639 1.976 . . . . 0.71999999999999997 111.025 -178.603 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -156.01 118.32 4.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.396 0.678 . . . . 2.02 109.254 -175.529 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.77 167.72 35.35 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.868 -0.52 . . . . 0.47999999999999998 112.286 -178.838 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.8 mt -129.95 119.95 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.736 -1.209 . . . . 1.4199999999999999 107.736 177.921 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 20.8 mm -81.27 140.51 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.903 -1.147 . . . . 0.87 107.903 164.592 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -120.38 93.5 4.07 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 105.396 -2.075 . . . . 1.71 105.396 159.299 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.665 ' CE1' HD11 ' A' ' 112' ' ' ILE . 1.1 t80 -100.3 118.93 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.881 -1.896 . . . . 3.1099999999999999 105.881 -173.481 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -155.65 175.07 14.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.028 0.918 . . . . 3.9199999999999999 113.404 -173.911 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.84 169.87 23.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.807 -1.553 . . . . 3.1099999999999999 106.807 -173.51 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -93.79 -64.66 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.596 1.558 . . . . 4.7699999999999996 108.601 171.779 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -79.95 -178.58 6.55 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.458 1.103 . . . . 4.3099999999999996 111.375 178.368 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -87.7 -66.87 0.87 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.906 -1.146 . . . . 3.3100000000000001 107.906 155.69 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -75.74 63.23 1.6 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.045 1.338 . . . . 4.4100000000000001 111.723 -173.219 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.09 -177.48 27.55 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.319 -1.912 . . . . 1.9199999999999999 108.319 169.794 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.35 152.82 44.72 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.1 2.534 . . . . 1.48 110.412 174.782 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -82.65 158.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.547 -0.908 . . . . 0.96999999999999997 108.547 176.743 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -111.57 104.88 13.3 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.382 1.087 . . . . 2.73 108.601 162.297 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.523 HG22 ' CD2' ' A' ' 20' ' ' PHE . 58.8 t -97.26 105.22 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.883 1.673 . . . . 1.24 108.206 -175.048 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -128.01 164.27 22.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.693 0.627 . . . . 0.97999999999999998 112.693 176.706 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.5 42.69 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.516 -1.034 . . . . 0.70999999999999996 110.516 179.267 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -138.74 109.32 6.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.427 -1.694 . . . . 1.96 106.427 179.025 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.53 115.87 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.865 -1.531 . . . . 1.0800000000000001 106.865 -161.934 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -105.36 162.38 13.49 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.64 0.733 . . . . 3.7200000000000002 111.954 -173.806 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.65 79.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.201 -0.908 . . . . 0.57999999999999996 113.662 168.398 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.77 165.85 9.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.82 1.31 . . . . 0.63 108.839 167.972 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.93 160.75 25.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.188 -1.412 . . . . 1.8600000000000001 107.188 152.804 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.55 173.68 0.52 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.397 -0.814 . . . . 2.73 110.6 177.359 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.92 -159.26 46.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 123.747 0.689 . . . . 0.76000000000000001 112.465 170.028 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.49 141.49 55.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.609 1.564 . . . . 2.02 114.543 -169.493 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -145.29 119.62 9.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.97 1.708 . . . . 0.5 109.703 177.24 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.37 150.44 5.57 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.883 -0.887 . . . . 0.41999999999999998 110.883 171.699 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CE2' HD21 ' A' ' 117' ' ' LEU . 1.0 OUTLIER -141.58 93.12 2.53 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.939 -1.504 . . . . 2.4300000000000002 106.939 -173.292 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -130.39 173.39 10.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.217 -1.031 . . . . 0.64000000000000001 108.217 -165.475 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.9 t -124.42 118.27 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.39 -0.967 . . . . 2.1200000000000001 108.39 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -100.2 149.61 23.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.415 1.486 . . . . 0.88 107.912 175.847 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.45 34.24 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.931 0.892 . . . . 4.7300000000000004 112.445 177.743 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.3 tt0 . . . . . 0 N--CA 1.456 -0.151 0 O-C-N 120.579 -1.326 . . . . 3.4900000000000002 110.817 -159.408 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 121.256 0.55 . . . . 1.6799999999999999 109.809 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.83 -119.66 4.2 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.698 -0.961 . . . . 1.1599999999999999 110.698 -172.269 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.64 178.65 7.35 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.014 3.143 . . . . 0.85999999999999999 112.333 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -54.26 124.97 17.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.977 1.311 . . . . 1.25 108.898 174.582 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -30.73 113.88 0.11 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.653 1.581 . . . . 2.5 112.23 174.499 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.7 151.73 46.99 Favored Pre-proline 0 N--CA 1.446 -0.625 0 C-N-CA 124.675 1.19 . . . . 2.29 109.152 167.369 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.48 -30.91 52.15 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.42 2.08 . . . . 1.3 111.621 -178.989 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 tp -154.54 -69.72 0.13 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.145 0.429 . . . . 3.71 109.954 173.331 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -145.94 76.41 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.144 0.978 . . . . 1.8 110.411 -172.649 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -79.67 176.55 9.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.964 -0.754 . . . . 4.4500000000000002 108.964 165.28 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.978 -1.49 . . . . 3.2799999999999998 106.978 -179.558 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -106.64 126.9 52.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.132 0.573 . . . . 1.0600000000000001 111.495 175.017 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.25 3.95 8.3 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.683 1.611 . . . . 3.2200000000000002 111.461 173.581 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 -173.29 4.25 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.468 -1.019 . . . . 1.3799999999999999 111.291 -169.546 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.09 -9.43 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.641 2.227 . . . . 1.45 111.872 173.12 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -54.51 5.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.469 0.577 . . . . 4.0599999999999996 111.397 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.26 176.58 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.033 0.444 . . . . 2.6600000000000001 110.382 -179.335 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.54 -63.12 1.21 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.684 1.194 . . . . 5.6500000000000004 109.923 -179.885 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.49 148.5 33.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.573 -0.739 . . . . 3.3100000000000001 111.333 -161.949 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -159.29 147.01 17.41 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.095 -1.003 . . . . 3.7999999999999998 108.396 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.455 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.2 m80 -54.69 135.22 47.17 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.721 -1.955 . . . . 0.69999999999999996 105.721 157.462 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -62.09 -22.02 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.788 -0.449 . . . . 1.25 109.788 -178.13 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.83 44.93 1.57 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.809 0.719 . . . . 0.56000000000000005 114.337 162.709 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.72 121.77 45.96 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 106.643 -1.614 . . . . 1.9399999999999999 106.643 158.058 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.24 -71.13 0.46 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.422 -1.696 . . . . 1.73 106.422 154.399 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.32 -110.76 0.35 Allowed Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.536 -0.626 . . . . 0.69999999999999996 111.536 -176.575 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.66 167.35 26.66 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.848 1.659 . . . . 1.49 109.086 175.967 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.03 175.06 10.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 106.848 -1.538 . . . . 0.46000000000000002 106.848 170.553 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -122.89 142.93 50.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.936 -1.135 . . . . 1.9099999999999999 107.936 169.104 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 142.13 40.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.921 1.288 . . . . 0.82999999999999996 112.629 173.525 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.31 -88.15 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.158 0.983 . . . . 2.5099999999999998 111.688 -178.652 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -146.08 -42.32 0.21 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.595 0.591 . . . . 3.52 112.595 -158.251 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -83.49 23.27 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 124.059 1.885 . . . . 4.0599999999999996 110.163 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.42 24.94 57.08 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.563 -1.199 . . . . 1.03 110.479 -168.7 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.15 107.5 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.221 -1.029 . . . . 1.1899999999999999 108.221 -175.599 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.83 154.72 18.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.904 -1.147 . . . . 0.70999999999999996 107.904 156.187 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.57 139.11 50.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 102.218 -3.252 . . . . 2.8700000000000001 102.218 174.01 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.85 131.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.041 -1.466 . . . . 1.6699999999999999 107.041 170.678 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -158.22 61.73 0.45 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.649 1.98 . . . . 1.0700000000000001 107.678 178.39 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.0 mm -105.29 157.55 6.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.904 -1.146 . . . . 2.4399999999999999 107.904 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.2 102.94 4.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.187 -0.321 . . . . 2.2000000000000002 111.617 165.397 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.46 144.75 25.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.314 1.046 . . . . 2.0299999999999998 111.045 -178.639 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -105.63 -9.14 17.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.04 2.136 . . . . 1.6699999999999999 113.142 -176.213 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.41 -43.4 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.148 -1.056 . . . . 1.1200000000000001 108.148 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 pt -86.67 176.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.714 0.768 . . . . 1.3100000000000001 111.446 175.001 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.1 m -157.16 177.67 11.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.1 2.16 . . . . 2.0899999999999999 105.78 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.76 54.83 1.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.909 1.231 . . . . 2.46 111.995 172.844 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 124.646 1.178 . . . . 3.6800000000000002 108.524 175.083 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.437 -1.121 0 CA-C-O 122.498 1.142 . . . . 1.1899999999999999 112.654 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.665 HD11 ' CE1' ' A' ' 20' ' ' PHE . 1.1 pp -93.78 -6.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.001 -1.454 . . . . 2.1499999999999999 113.228 177.994 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.9 mm -43.81 119.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.973 . . . . 1.6799999999999999 110.371 -179.214 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.63 25.54 73.83 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.707 -0.496 . . . . 1.4199999999999999 113.089 177.055 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 149' ' ' ILE . 63.1 mtt-85 -104.06 -178.86 3.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.405 -1.702 . . . . 4.1799999999999997 106.405 166.244 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 m -116.02 118.79 33.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.082 0.401 . . . . 1.0800000000000001 110.108 178.119 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.449 HD21 ' CE2' ' A' ' 45' ' ' PHE . 4.4 tt -73.34 143.46 46.89 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.506 -1.294 . . . . 2.27 107.506 170.804 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -127.24 136.81 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.808 2.043 . . . . 0.40000000000000002 107.577 177.974 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG12 ' CE1' ' A' ' 45' ' ' PHE . 1.5 m -104.19 127.15 58.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.444 -0.947 . . . . 1.6299999999999999 108.444 164.572 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.24 160.29 14.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 116.066 1.876 . . . . 0.40000000000000002 116.066 -171.217 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -36.2 -68.03 0.15 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.579 2.352 . . . . 3.1200000000000001 112.522 172.952 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -126.09 -173.8 2.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.683 1.193 . . . . 2.48 110.188 -170.462 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.78 141.76 43.17 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.468 -0.567 . . . . 0.62 109.468 169.594 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.19 160.96 28.1 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.288 -1.005 . . . . 2.0 108.288 161.502 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.53 -22.34 62.63 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.715 -0.659 . . . . 2.9900000000000002 112.189 -176.042 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 56.36 51.96 10.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.137 1.335 . . . . 1.6599999999999999 109.68 -161.607 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 50.58 44.11 46.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.334 0.969 . . . . 1.5700000000000001 113.793 169.116 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -79.5 -30.87 42.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.235 1.014 . . . . 5.8700000000000001 111.088 179.147 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.38 -146.01 25.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.259 -1.136 . . . . 2.6400000000000001 110.259 -170.369 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.37 -72.37 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.444 -1.862 . . . . 2.1400000000000001 108.444 -169.075 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 109.81 8.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 104.488 -2.412 . . . . 2.75 104.488 161.592 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -35.9 66.87 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.559 . . . . 3.6499999999999999 110.391 178.654 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -28.6 -44.96 0.03 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.58 2.752 . . . . 2.6299999999999999 113.248 162.366 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -45.68 -60.92 1.93 Allowed 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.979 1.312 . . . . 2.75 109.489 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -72.26 -43.56 64.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.499 0.32 . . . . 1.22 110.152 178.829 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -52.91 -53.02 55.41 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.822 1.649 . . . . 2.5800000000000001 110.85 -170.578 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.455 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.251 1.0 OUTLIER -125.0 -47.71 1.78 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.067 0.547 . . . . 1.3500000000000001 111.207 173.483 . . . . . . . . 4 4 . 1 . 032 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.66 -26.29 1.06 Allowed Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.533 -0.627 . . . . 1.0900000000000001 111.533 -170.916 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.64 56.51 6.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.303 1.041 . . . . 2.0299999999999998 111.249 178.281 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.22 -5.96 57.24 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.389 0.514 . . . . 1.27 112.389 168.613 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.05 -170.84 43.82 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.054 -1.619 . . . . 1.04 109.054 -173.847 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -68.48 171.22 7.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.108 -1.046 . . . . 2.6800000000000002 113.016 -167.577 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.498 HH21 ' CD ' ' A' ' 50' ' ' GLU . 5.8 mmt-85 -66.79 142.17 57.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.171 2.188 . . . . 2.8900000000000001 109.316 175.126 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.9 -78.95 0.58 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.466 -1.309 . . . . 0.46000000000000002 107.466 166.501 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.479 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -109.71 150.23 28.6 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.651 -0.87 . . . . 0.76000000000000001 108.651 171.624 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 3.3 m -137.12 150.05 47.73 Favored 'General case' 0 N--CA 1.436 -1.135 0 O-C-N 125.462 1.727 . . . . 2.0800000000000001 106.66 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.441 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -148.67 123.5 1.67 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 109.454 -1.459 . . . . 0.90000000000000002 109.454 178.263 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.08 128.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.575 -1.269 . . . . 0.83999999999999997 107.575 168.562 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 115' ' ' ARG . 10.5 tt -103.92 117.06 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.645 0.736 . . . . 0.89000000000000001 110.95 -172.012 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.24 2.63 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-N 114.954 -1.021 . . . . 0.51000000000000001 115.388 178.133 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.8 mm -94.45 58.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.732 1.766 . . . . 0.75 111.589 -155.031 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.89 176.4 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.678 0.791 . . . . 1.26 110.024 167.84 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 104.148 -2.538 . . . . 4.3899999999999997 104.148 162.294 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 pttm . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 111.272 0.101 . . . . 2.5800000000000001 111.272 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.15 133.13 33.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.03 -1.1 . . . . 0.78000000000000003 108.03 165.57 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.12 146.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 106.852 -1.536 . . . . 0.67000000000000004 106.852 158.013 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -128.86 94.77 3.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.017 -1.105 . . . . 0.42999999999999999 108.017 162.55 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.67 96.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.407 1.083 . . . . 0.69999999999999996 108.284 170.469 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -91.71 121.55 33.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.431 -0.581 . . . . 0.93000000000000005 109.431 -179.212 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -130.84 -62.12 0.92 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.822 -0.807 . . . . 3.3999999999999999 108.822 174.268 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.26 -123.83 10.33 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 114.34 -1.3 . . . . 1.02 112.22 -170.296 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.22 -43.19 1.8 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.247 0.619 . . . . 3.4300000000000002 109.974 -150.153 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.99 165.61 8.43 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 109.439 -1.464 . . . . 0.82999999999999996 109.439 164.386 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.53 35.14 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.515 2.81 . . . . 1.0 112.954 -173.681 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -93.16 153.73 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.578 1.551 . . . . 0.71999999999999997 109.992 -171.962 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -155.08 107.16 2.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.217 1.407 . . . . 2.8999999999999999 107.543 175.376 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.0 166.03 29.35 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.664 -0.574 . . . . 0.45000000000000001 111.664 179.1 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 mm -132.17 117.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.934 -1.876 . . . . 1.8600000000000001 105.934 -178.368 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.63 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 32.1 mm -85.28 140.6 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.856 -1.535 . . . . 0.69999999999999996 106.856 165.879 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -120.88 105.1 10.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.518 -2.03 . . . . 1.51 105.518 164.914 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.443 ' CD2' HG22 ' A' ' 31' ' ' VAL . 10.0 t80 -115.76 110.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.482 -2.044 . . . . 3.2200000000000002 105.482 -171.397 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.33 167.42 30.43 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.659 0.742 . . . . 3.98 112.057 -174.672 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.96 -156.7 0.71 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.181 -2.526 . . . . 4.4000000000000004 104.181 169.493 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -110.67 -62.78 1.48 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.485 1.039 . . . . 4.2400000000000002 109.497 168.899 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.17 101.45 12.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.927 -1.509 . . . . 4.6100000000000003 106.927 -171.286 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 p -73.99 53.18 0.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.177 1.391 . . . . 2.5899999999999999 111.946 -177.391 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -156.08 34.74 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.199 1.8 . . . . 3.7999999999999998 108.196 165.238 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.72 -173.26 14.36 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.042 -1.623 . . . . 1.05 109.042 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.04 169.9 6.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.346 2.698 . . . . 1.55 111.765 177.252 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.83 154.38 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.863 -0.608 . . . . 0.76000000000000001 109.622 -178.842 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -104.46 113.5 27.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.209 -1.775 . . . . 2.6600000000000001 106.209 171.662 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 20' ' ' PHE . 21.9 t -115.25 90.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.786 -1.19 . . . . 1.1899999999999999 107.786 -168.798 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -109.59 150.66 27.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 123.457 0.473 . . . . 0.70999999999999996 110.067 -179.613 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.74 168.25 41.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.221 -1.151 . . . . 0.77000000000000002 110.221 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.6 m -139.63 107.5 5.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.281 -1.748 . . . . 2.1800000000000002 106.281 -179.387 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -115.77 123.02 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.89 -1.893 . . . . 0.83999999999999997 105.89 -161.047 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 162.83 20.74 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 118.651 0.659 . . . . 4.4900000000000002 110.966 -174.371 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.91 74.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.878 0.751 . . . . 0.71999999999999997 113.692 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -69.94 164.04 24.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.48 1.14 . . . . 0.63 109.151 167.633 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.85 156.78 19.81 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.098 -1.075 . . . . 1.8799999999999999 108.098 149.02 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.78 -180.0 0.31 Allowed 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.004 -1.06 . . . . 3.9399999999999999 110.4 176.1 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.11 -158.6 51.13 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.818 -0.551 . . . . 0.71999999999999997 112.1 168.087 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.43 146.86 30.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.948 1.299 . . . . 2.6800000000000002 110.219 -170.149 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.9 121.09 10.83 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.178 0.991 . . . . 0.51000000000000001 110.213 -177.257 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.15 147.58 26.45 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.914 -1.275 . . . . 0.40000000000000002 109.914 170.71 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 38.3 t80 -136.26 97.07 3.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.63 -1.619 . . . . 3.1099999999999999 106.63 -174.084 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.1 m170 -129.31 174.88 9.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.548 -1.278 . . . . 0.82999999999999996 107.548 -169.281 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 p -134.33 115.91 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.177 -1.416 . . . . 1.6899999999999999 107.177 170.203 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -82.28 -175.74 5.84 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.836 -1.542 . . . . 1.1499999999999999 106.836 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -70.92 -106.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.433 -0.951 . . . . 4.1299999999999999 108.433 172.802 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 . . . . . 0 CA--C 1.532 0.253 0 C-N-CA 123.75 0.82 . . . . 3.3700000000000001 110.513 -175.976 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 107.544 -1.28 . . . . 2.04 107.544 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -94.44 0.18 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.785 -0.926 . . . . 1.1299999999999999 110.785 -179.59 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -81.54 178.28 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.12 2.546 . . . . 0.97999999999999998 115.405 -166.226 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -65.86 64.86 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.613 2.365 . . . . 1.6899999999999999 112.46 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.6 t80 37.77 70.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.411 1.884 . . . . 2.7999999999999998 111.025 -177.275 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -96.33 105.26 21.18 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 118.271 -0.871 . . . . 2.71 109.338 -176.727 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.2 -36.15 17.38 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.058 1.838 . . . . 1.48 111.655 -175.094 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -141.71 -75.4 0.3 Allowed 'General case' 0 C--N 1.339 0.134 0 N-CA-C 108.687 -0.857 . . . . 3.02 108.687 177.825 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.6 p -156.55 58.34 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.68 0.753 . . . . 3.2400000000000002 110.512 -171.548 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -77.41 160.57 28.64 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.163 -1.421 . . . . 4.8700000000000001 107.163 162.133 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -133.84 152.01 51.73 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.242 1.417 . . . . 3.3799999999999999 108.178 -172.62 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -76.18 153.75 35.91 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.804 0.668 . . . . 0.92000000000000004 112.804 -169.245 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.13 163.88 36.24 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.964 -2.454 . . . . 2.2799999999999998 106.964 159.086 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.5 -170.35 11.76 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 117.524 0.662 . . . . 1.3799999999999999 112.493 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.98 -39.77 30.76 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.656 2.237 . . . . 1.5 109.797 178.158 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -66.87 -51.06 60.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.083 1.353 . . . . 4.9400000000000004 111.258 175.401 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -61.5 157.55 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.516 0.932 . . . . 2.1299999999999999 113.516 -161.678 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.13 -49.77 73.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.418 1.087 . . . . 4.4100000000000001 110.333 -179.313 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -78.1 170.04 17.26 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.845 -0.428 . . . . 3.29 109.845 177.488 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 165.24 133.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.927 2.491 . . . . 3.3900000000000001 106.584 -171.882 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.552 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.8 m80 -68.31 161.37 27.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 118.594 -1.242 . . . . 0.64000000000000001 107.947 167.962 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.54 44.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 122.985 1.374 . . . . 2.6200000000000001 110.498 165.303 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -169.0 36.72 0.2 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 124.816 1.198 . . . . 0.93000000000000005 110.984 167.458 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 133.72 28.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.33 -1.1 . . . . 2.46 108.712 163.337 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.9 mt -99.74 -46.02 5.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.014 -1.106 . . . . 1.99 108.014 168.757 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.24 -111.41 0.46 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.511 -0.852 . . . . 0.60999999999999999 111.347 178.28 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -155.11 158.41 38.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.164 1.386 . . . . 1.9099999999999999 109.375 -169.83 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.66 178.14 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.686 1.995 . . . . 0.45000000000000001 106.384 172.353 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -138.32 145.92 41.76 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.562 -0.903 . . . . 2.2799999999999998 108.562 171.301 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.83 139.79 39.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.446 1.099 . . . . 0.93999999999999995 110.885 170.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.76 -79.77 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 123.784 0.678 . . . . 2.9100000000000001 111.309 -174.861 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.65 -46.33 0.15 Allowed 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.744 0.817 . . . . 3.6499999999999999 111.151 -164.739 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.02 13.58 2.19 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.803 1.287 . . . . 2.6699999999999999 111.529 177.693 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.63 16.85 74.35 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.235 -0.916 . . . . 0.60999999999999999 111.224 -173.341 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -89.06 115.21 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.051 1.34 . . . . 0.83999999999999997 108.262 -179.53 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.59 168.09 9.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.906 1.683 . . . . 0.68999999999999995 108.367 162.242 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -126.8 149.13 49.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.202 -2.888 . . . . 2.98 103.202 -179.369 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.68 135.19 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 107.197 -1.408 . . . . 1.74 107.197 166.742 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.9 m -157.59 58.75 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.298 1.839 . . . . 0.98999999999999999 107.229 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.0 mt -101.88 154.04 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 123.886 0.875 . . . . 1.71 108.861 -174.424 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -133.45 137.98 45.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.364 -1.347 . . . . 2.3900000000000001 107.364 161.393 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.42 159.74 41.64 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.151 -1.426 . . . . 2.5 107.151 170.995 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -121.74 -1.96 9.4 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.808 2.043 . . . . 3.1699999999999999 113.199 -177.549 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.02 -31.2 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.458 1.027 . . . . 1.5700000000000001 108.236 176.574 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -99.94 175.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.683 1.193 . . . . 1.22 109.286 171.129 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.1 t -158.1 179.55 9.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.347 1.859 . . . . 2.3100000000000001 106.058 175.339 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -106.2 27.74 8.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.946 0.898 . . . . 2.8399999999999999 111.922 177.9 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 124.371 1.068 . . . . 4.0999999999999996 110.887 -170.922 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.9 p . . . . . 0 C--O 1.237 0.428 0 CA-C-O 122.248 1.023 . . . . 1.51 112.232 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.8 pt -100.29 -5.31 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.348 -1.296 . . . . 2.0299999999999998 111.056 171.749 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 tp -46.73 128.81 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.725 0.81 . . . . 1.5900000000000001 109.383 176.906 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.79 -14.12 62.53 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.597 -1.113 . . . . 1.4299999999999999 113.744 -178.986 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -94.11 163.24 13.55 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.875 1.837 . . . . 4.0099999999999998 111.561 -169.745 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -88.74 108.74 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.898 0.479 . . . . 0.85999999999999999 111.184 -177.243 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.457 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -72.75 143.25 48.04 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.927 -0.768 . . . . 2.0600000000000001 108.927 174.281 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.1 t -130.27 127.78 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.687 1.195 . . . . 0.42999999999999999 109.212 -179.105 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.67 128.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 106.48 -1.674 . . . . 2.4199999999999999 106.48 161.643 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.458 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 76.6 m-70 -101.87 158.45 16.12 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 114.627 1.343 . . . . 0.39000000000000001 114.627 -175.782 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.8 -71.73 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.397 -0.819 . . . . 5.5300000000000002 111.152 176.835 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -79.6 -179.5 6.9 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.025 0.83 . . . . 3.9300000000000002 109.353 -177.247 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.43 157.31 26.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.75 109.818 169.631 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.83 160.49 5.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.043 -0.526 . . . . 2.6299999999999999 110.326 162.324 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.01 -33.02 74.65 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.921 0.711 . . . . 3.5099999999999998 112.921 176.181 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 73.34 -9.68 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.72 2.408 . . . . 1.9399999999999999 112.532 -168.92 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.52 43.42 8.5 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.142 -1.983 . . . . 2.3700000000000001 108.142 -168.197 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.26 -20.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.575 0.954 . . . . 5.8200000000000003 113.575 -175.0 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.9 -46.21 92.18 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 108.276 -1.93 . . . . 2.6499999999999999 108.276 169.898 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.55 36.01 57.84 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.583 0.611 . . . . 3.8999999999999999 111.64 175.926 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -69.64 -61.62 1.71 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.246 -1.39 . . . . 2.8100000000000001 107.246 -179.868 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 27.5 tt0 178.96 -55.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.694 2.798 . . . . 3.2999999999999998 105.124 166.795 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -48.01 -37.7 15.39 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.937 2.095 . . . . 2.8399999999999999 111.212 173.619 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.7 m -38.09 -65.18 0.35 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.87 1.668 . . . . 1.6299999999999999 110.754 164.302 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.9 p -71.73 -42.74 66.92 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.378 -0.826 . . . . 1.76 110.77 -176.138 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 132' ' ' GLU . 60.9 mttm -52.78 -51.34 61.08 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 123.528 0.731 . . . . 2.7999999999999998 110.837 -175.248 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.552 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 15.2 t -136.92 -48.34 0.61 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.246 -1.359 . . . . 2.5099999999999998 111.906 176.162 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.11 25.7 0.08 OUTLIER Glycine 0 N--CA 1.473 1.119 0 CA-C-N 120.52 1.509 . . . . 1.21 115.642 177.107 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.28 0.4 OUTLIER 3.37 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.54 2.336 . . . . 3.4199999999999999 116.601 -167.693 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -63.22 -28.86 70.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.55 1.54 . . . . 0.96999999999999997 113.965 -177.605 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.79 171.55 44.85 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.055 -1.618 . . . . 1.1000000000000001 109.055 -160.119 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m -53.03 147.92 8.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.538 1.535 . . . . 1.51 113.923 -170.342 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -54.79 136.62 46.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.844 1.258 . . . . 2.7400000000000002 108.645 166.79 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.2 mt -107.88 -64.88 1.16 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.335 -0.987 . . . . 0.68999999999999995 108.335 167.054 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.95 162.39 13.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.057 -0.974 . . . . 1.0800000000000001 110.847 -173.691 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.57 156.3 34.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.166 0.986 . . . . 1.9199999999999999 109.552 169.119 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.82 138.95 3.53 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 106.613 -2.595 . . . . 0.71999999999999997 106.613 172.909 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.63 132.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.551 -0.907 . . . . 0.75 108.551 177.554 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.7 tt -86.17 134.12 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 122.832 0.453 . . . . 0.81000000000000005 111.252 -178.765 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 140.0 5.84 1.15 Allowed Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.166 0.889 . . . . 0.53000000000000003 114.236 175.796 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.75 55.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.713 1.757 . . . . 0.73999999999999999 110.062 -158.321 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.76 177.82 10.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.43 1.092 . . . . 1.6299999999999999 109.873 170.089 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 103.449 -2.797 . . . . 6.2599999999999998 103.449 146.837 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.9 tttt . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 109.529 -0.545 . . . . 4.1699999999999999 109.529 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.42 156.09 44.65 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.168 0.987 . . . . 0.93000000000000005 108.945 154.867 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.45 150.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 106.674 -1.602 . . . . 0.90000000000000002 106.674 158.435 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.64 102.08 4.65 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 108.446 -0.946 . . . . 0.46999999999999997 108.446 157.102 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.15 102.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.208 -1.404 . . . . 0.60999999999999999 107.208 167.354 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -87.36 126.26 34.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.882 -1.155 . . . . 1.0 107.882 177.509 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -150.92 -53.4 0.14 Allowed 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.481 0.312 . . . . 3.3599999999999999 110.629 -175.872 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.62 -114.33 1.05 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.763 1.173 . . . . 0.72999999999999998 112.986 -177.163 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -122.54 -52.45 1.92 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.496 1.118 . . . . 3.8100000000000001 110.724 -168.489 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.78 163.76 13.84 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.705 0.669 . . . . 0.84999999999999998 112.225 -175.067 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.45 64.35 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.271 3.314 . . . . 2.1299999999999999 110.864 -176.603 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t -141.64 146.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.752 2.021 . . . . 0.80000000000000004 106.4 -171.633 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -155.59 136.75 13.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.656 -0.868 . . . . 4.0300000000000002 108.656 176.812 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.77 174.58 44.63 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.129 -0.557 . . . . 0.46999999999999997 111.92 175.374 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.84 118.3 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.082 -1.081 . . . . 1.1000000000000001 108.082 -179.119 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.1 137.49 22.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 105.804 -1.925 . . . . 0.85999999999999999 105.804 165.065 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.33 58.73 1.66 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.742 -0.836 . . . . 2.8700000000000001 108.742 178.004 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.55 168.42 19.81 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.18 -1.008 . . . . 3.6800000000000002 112.162 -168.597 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -144.72 150.31 37.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.706 -1.133 . . . . 3.98 108.146 177.912 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.427 ' NE2' ' H ' ' A' ' 27' ' ' GLY . 32.6 tt0 -151.26 93.89 1.96 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.448 -1.251 . . . . 3.5899999999999999 108.229 167.506 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -49.21 -39.85 31.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.588 1.329 . . . . 5.2000000000000002 114.588 -178.604 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -87.21 148.89 24.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.461 1.104 . . . . 5.1100000000000003 110.239 -176.356 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -0.53 18.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.203 1.801 . . . . 3.27 114.935 -173.678 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -170.13 53.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.844 1.656 . . . . 4.6900000000000004 111.218 170.96 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.427 ' H ' ' NE2' ' A' ' 22' ' ' GLN . . . -108.42 -157.7 19.12 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.116 1.341 . . . . 1.1200000000000001 110.722 178.193 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -89.34 141.37 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.06 3.84 . . . . 1.3500000000000001 111.053 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.17 136.18 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.916 -0.401 . . . . 1.1799999999999999 109.916 -175.965 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -90.29 91.92 8.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.452 -0.944 . . . . 2.54 108.452 173.815 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.4 t -90.57 86.0 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.764 0.826 . . . . 1.3500000000000001 110.419 -170.41 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -102.96 139.51 38.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.148 0.499 . . . . 0.81999999999999995 111.572 173.682 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.04 41.35 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.066 1.793 . . . . 0.68000000000000005 108.799 170.384 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.8 m -139.54 80.43 1.77 Allowed 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 107.702 -1.221 . . . . 2.3999999999999999 107.702 -176.752 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.78 119.42 33.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.908 -1.145 . . . . 1.22 107.908 -169.091 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.92 162.02 13.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.395 0.678 . . . . 3.6400000000000001 110.705 -175.218 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.59 -10.77 64.85 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.819 0.687 . . . . 1.4399999999999999 114.819 167.276 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.3 154.94 4.09 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.868 1.334 . . . . 1.1299999999999999 110.87 176.874 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -65.59 153.13 42.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.94 -1.1 . . . . 1.6399999999999999 108.231 158.927 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -52.74 156.24 2.01 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.344 1.057 . . . . 2.7999999999999998 112.073 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 -158.2 31.69 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.276 -0.874 . . . . 0.56999999999999995 112.683 167.964 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.91 142.54 36.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.882 0.873 . . . . 2.3799999999999999 110.891 -165.492 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -142.04 130.35 22.3 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.775 1.23 . . . . 0.56999999999999995 110.594 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 148.23 36.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.91 -0.876 . . . . 0.46999999999999997 110.91 170.783 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.427 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 52.0 t80 -146.91 96.72 2.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.275 1.43 . . . . 2.6699999999999999 107.798 -171.453 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.553 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 40.6 m80 -131.32 170.93 13.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.227 -0.657 . . . . 0.68999999999999995 109.227 -164.564 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.58 108.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.767 -1.198 . . . . 2.3500000000000001 107.767 173.919 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.421 ' CD2' HG21 ' A' ' 118' ' ' VAL . 67.6 m-70 -81.52 168.0 18.72 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.0 -1.111 . . . . 1.1000000000000001 108.0 168.57 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.02 -96.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.642 -1.244 . . . . 4.7199999999999998 107.642 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.533 0.32 0 C-N-CA 123.354 0.662 . . . . 3.2400000000000002 112.581 160.326 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.937 0.399 . . . . 3.5 111.921 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.31 -116.22 4.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 116.954 -2.025 . . . . 1.0600000000000001 109.142 -172.417 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.99 179.95 4.42 Favored 'Trans proline' 0 C--N 1.348 0.516 1 C-N-CA 125.337 4.025 . . . . 1.1499999999999999 115.359 -170.576 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -67.74 99.27 0.79 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.384 1.474 . . . . 1.4299999999999999 108.722 -179.231 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -9.52 102.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.127 2.171 . . . . 1.9199999999999999 113.744 172.932 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -124.47 136.8 28.23 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 127.458 2.303 . . . . 3.1000000000000001 108.13 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.51 -47.43 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.101 1.868 . . . . 1.0800000000000001 109.218 174.812 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.0 -70.97 0.47 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.571 -1.27 . . . . 2.6600000000000001 107.571 170.932 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.2 t -154.6 90.79 1.34 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.345 -0.613 . . . . 2.79 109.345 -178.552 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -84.64 165.66 17.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.39 -1.337 . . . . 4.6600000000000001 107.39 146.669 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -116.93 170.46 8.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.579 -1.637 . . . . 3.1000000000000001 106.579 174.303 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -84.33 157.17 21.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.083 0.468 . . . . 0.81000000000000005 110.808 -179.531 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.62 158.5 31.47 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 104.702 -3.359 . . . . 1.97 104.702 160.83 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.91 174.59 8.54 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.325 -1.11 . . . . 1.8200000000000001 110.325 170.821 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.15 -29.7 89.7 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.045 1.83 . . . . 1.3999999999999999 110.176 169.893 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.87 -52.11 66.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.653 0.781 . . . . 3.96 110.98 171.305 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -73.83 164.81 26.15 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.718 0.636 . . . . 2.1600000000000001 111.177 -178.169 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -89.48 -36.09 15.6 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.457 1.103 . . . . 5.54 112.674 -171.607 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -75.19 166.04 24.25 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.498 -1.297 . . . . 3.04 107.498 165.857 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 152.21 127.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.387 2.675 . . . . 3.5699999999999998 104.811 -161.142 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.477 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.0 m80 -58.48 149.92 23.98 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.863 -1.162 . . . . 0.57999999999999996 107.863 174.627 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.46 -32.79 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.07 -0.652 . . . . 1.25 109.848 -175.987 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.5 52.53 2.07 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.308 -0.718 . . . . 0.59999999999999998 113.114 165.642 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -127.42 117.17 21.64 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.186 1.493 . . . . 2.4199999999999999 108.275 164.201 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 84' ' ' LEU . 3.6 mm? -81.39 -53.17 6.54 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.655 -0.869 . . . . 1.5800000000000001 108.655 161.759 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.62 -105.25 0.27 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.81 -0.71 . . . . 0.65000000000000002 112.95 175.218 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.36 155.52 32.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.876 1.271 . . . . 3.6600000000000001 109.059 -166.317 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.97 163.1 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.477 1.111 . . . . 0.65000000000000002 110.41 -175.836 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 m -116.49 103.02 10.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.967 2.107 . . . . 2.79 109.632 -169.137 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.11 135.38 36.83 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.669 -0.644 . . . . 0.56000000000000005 112.225 176.4 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.58 -92.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.741 1.616 . . . . 4.0499999999999998 110.438 175.505 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -177.21 -26.71 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.658 1.983 . . . . 3.4199999999999999 112.548 -165.112 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -76.06 9.06 2.68 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.831 1.777 . . . . 3.7999999999999998 108.442 148.599 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.67 26.63 72.98 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 119.782 -1.824 . . . . 1.1100000000000001 109.996 178.154 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -84.11 108.48 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.219 -1.4 . . . . 1.3 107.219 -175.795 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.46 155.31 28.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.022 1.329 . . . . 1.4099999999999999 109.129 171.636 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -102.81 58.49 0.78 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.325 2.25 . . . . 6.5199999999999996 107.765 -164.994 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.98 68.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.397 -0.819 . . . . 1.46 110.792 -161.256 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -121.45 75.45 1.18 Allowed 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.79 1.636 . . . . 0.95999999999999996 108.796 179.099 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.0 mm -106.18 155.31 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.26 1.024 . . . . 1.8100000000000001 109.476 -174.613 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -146.5 122.89 10.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.13 -1.434 . . . . 3.3700000000000001 107.13 168.375 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.88 158.45 25.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.424 1.089 . . . . 2.1000000000000001 109.241 173.14 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -127.6 29.67 5.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.069 1.348 . . . . 1.3600000000000001 111.785 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.18 -49.3 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.667 -1.234 . . . . 1.0900000000000001 107.667 171.312 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.95 174.11 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.558 0.694 . . . . 0.93999999999999995 110.178 171.255 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -156.83 -179.89 8.64 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.178 -1.786 . . . . 2.3500000000000001 106.178 175.315 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.405 HD22 ' HB3' ' A' ' 22' ' ' GLN . 0.7 OUTLIER -110.77 14.4 22.23 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 2.46 112.197 173.963 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.455 -0.186 0 C-N-CA 124.509 1.124 . . . . 3.02 108.929 -166.7 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.442 -0.83 0 CA-C-O 122.919 1.342 . . . . 2.0800000000000001 112.586 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.89 -6.94 10.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 114.702 -1.136 . . . . 1.9099999999999999 111.094 175.309 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 tp -44.26 131.65 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.331 1.052 . . . . 1.6699999999999999 110.386 172.088 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.87 -25.23 7.72 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.909 0.766 . . . . 1.5900000000000001 112.65 -176.441 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -87.18 162.93 17.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.758 1.279 . . . . 4.1799999999999997 110.333 -166.855 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -94.01 113.61 25.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.087 0.555 . . . . 0.90000000000000002 110.758 -172.544 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.427 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -70.21 141.28 52.56 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.385 -1.339 . . . . 2.0699999999999998 107.385 167.403 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 48' ' ' HIS . 88.4 t -126.37 133.1 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 126.125 1.77 . . . . 0.35999999999999999 109.211 175.653 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.1 t -98.13 122.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 125.799 1.64 . . . . 2.2400000000000002 106.929 165.213 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.435 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 64.9 m-70 -97.45 156.76 16.33 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 116.284 1.957 . . . . 0.44 116.284 -174.508 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -34.18 -90.39 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 130.232 3.413 . . . . 3.7000000000000002 112.211 168.06 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -174.49 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.873 0.845 . . . . 4.5 109.418 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.54 154.93 10.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.556 -1.202 . . . . 0.97999999999999998 110.099 164.682 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.06 161.47 8.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.974 -1.012 . . . . 2.3500000000000001 108.93 158.182 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -86.64 -30.49 21.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.988 1.715 . . . . 3.0 111.081 177.183 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 76.16 -1.93 2.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.693 2.397 . . . . 1.9099999999999999 112.982 -172.8 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.61 30.48 4.61 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.866 1.212 . . . . 1.4399999999999999 113.123 163.151 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -129.56 -16.62 3.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.881 1.272 . . . . 4.96 112.823 -173.946 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.91 124.85 31.27 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.33 0.968 . . . . 2.0800000000000001 111.885 175.704 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.02 -29.83 62.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.604 0.621 . . . . 2.77 111.81 175.805 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -53.24 98.63 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.268 1.027 . . . . 2.4399999999999999 109.531 163.847 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -35.61 -43.26 0.27 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 127.013 2.125 . . . . 4.0199999999999996 113.458 -178.711 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -37.88 -37.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.107 1.763 . . . . 2.6400000000000001 112.668 175.31 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.2 t -50.72 -77.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.159 0.984 . . . . 2.52 110.709 169.726 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 t -58.4 -38.32 77.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.771 -1.205 . . . . 2.6099999999999999 110.959 -177.01 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -59.38 -51.43 69.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.323 1.049 . . . . 4.9900000000000002 110.887 -177.445 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.477 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.281 0.1 OUTLIER -129.72 -54.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.891 0.477 . . . . 1.1699999999999999 112.156 174.504 . . . . . . . . 4 4 . 1 . 034 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.64 -16.24 0.26 Allowed Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.073 0.851 . . . . 0.91000000000000003 113.252 179.078 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.87 52.22 9.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.316 . . . . 2.0899999999999999 110.718 -176.651 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.553 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.41 -50.45 71.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.039 0.936 . . . . 0.93000000000000005 109.921 169.356 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 115.46 -172.09 14.04 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 106.99 -2.444 . . . . 0.93999999999999995 106.99 -168.419 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.6 m -60.93 155.35 20.07 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.388 1.475 . . . . 1.26 113.049 -171.19 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -61.1 135.57 57.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.323 1.449 . . . . 2.98 108.867 169.538 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.2 mt -111.01 -76.57 0.6 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.678 1.126 . . . . 0.45000000000000001 108.753 168.859 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.05 140.41 37.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.205 -1.406 . . . . 0.68999999999999995 107.205 173.444 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 66.7 m -127.3 159.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.738 -1.578 . . . . 2.1099999999999999 106.738 173.285 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.93 132.85 2.59 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.69999999999999996 110.951 168.201 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.89 136.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.619 1.167 . . . . 0.63 109.037 171.228 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.89 144.15 14.66 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.115 0 C-N-CA 123.222 0.609 . . . . 0.92000000000000004 111.653 -179.01 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.28 0.8 5.81 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.737 0.684 . . . . 0.76000000000000001 113.451 175.116 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.8 mm -87.82 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.499 1.149 . . . . 0.83999999999999997 110.91 -161.187 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.28 175.06 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.335 1.054 . . . . 1.45 110.22 171.489 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 104.271 -2.492 . . . . 4.6299999999999999 104.271 167.244 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 111.353 0.131 . . . . 3.3999999999999999 111.353 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.81 25.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.591 -1.262 . . . . 0.69999999999999996 107.591 161.058 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.9 t -103.88 145.11 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.778 -1.193 . . . . 0.66000000000000003 107.778 165.206 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.95 97.65 5.04 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.77 -0.826 . . . . 0.40999999999999998 108.77 155.696 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.06 107.81 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.925 -1.509 . . . . 0.66000000000000003 106.925 162.735 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.1 128.21 35.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.939 -1.134 . . . . 0.98999999999999999 107.939 175.813 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -149.34 -52.02 0.16 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.965 0.412 . . . . 3.5600000000000001 110.663 172.278 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.71 -119.22 4.86 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.52 -0.764 . . . . 0.93000000000000005 111.526 -175.648 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.38 -42.66 2.65 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.806 1.242 . . . . 3.1000000000000001 110.353 -165.821 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.49 166.99 10.69 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 123.825 0.726 . . . . 0.82999999999999996 111.309 177.411 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.38 -21.65 53.62 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.407 2.738 . . . . 1.1599999999999999 111.993 179.584 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 89.6 t -50.01 141.77 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.828 1.251 . . . . 0.97999999999999998 110.822 177.112 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.56 125.09 6.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.909 -1.145 . . . . 2.0299999999999998 107.909 -175.752 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.65 172.67 40.44 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 121.764 -0.585 . . . . 0.52000000000000002 112.52 -177.106 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.31 130.96 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.775 0.83 . . . . 1.22 108.877 176.577 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.24 137.9 23.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.497 -1.298 . . . . 0.70999999999999996 107.497 163.543 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -119.43 99.98 7.02 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.574 -1.269 . . . . 1.8 107.574 166.952 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.569 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -87.66 118.02 26.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.698 1.199 . . . . 2.52 108.566 -178.981 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -148.28 164.72 33.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.014 0.824 . . . . 3.6000000000000001 109.419 167.609 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.66 164.5 38.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.255 1.422 . . . . 4.6500000000000004 107.273 177.265 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -51.22 -46.72 62.33 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.987 0.915 . . . . 4.6799999999999997 112.076 178.728 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -114.31 164.02 14.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.715 -1.217 . . . . 5.8600000000000003 107.715 179.847 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.0 p -69.2 55.14 0.1 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.023 1.329 . . . . 3.21 109.158 163.466 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 179.4 -153.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.578 1.951 . . . . 4.8099999999999996 106.619 -165.937 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.25 -178.09 0.4 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 127.191 2.329 . . . . 1.02 115.268 175.022 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.72 110.23 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.601 2.867 . . . . 1.5600000000000001 109.917 -175.446 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 20' ' ' PHE . 4.0 t -79.63 133.03 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.818 -0.353 . . . . 1.3999999999999999 111.161 -164.655 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -95.97 101.76 13.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.99 -1.485 . . . . 3.6099999999999999 106.99 -174.381 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.569 HG22 ' CE1' ' A' ' 20' ' ' PHE . 25.4 t -89.0 90.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.77 1.228 . . . . 1.1499999999999999 107.877 -173.287 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -97.77 131.41 44.32 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 123.738 0.649 . . . . 1.45 109.271 169.425 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 163.21 30.79 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.177 -0.769 . . . . 0.78000000000000003 111.177 -179.422 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -133.4 99.82 4.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 2.25 106.522 -171.805 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.15 140.59 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.534 1.134 . . . . 0.93000000000000005 108.647 -169.775 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -145.0 -178.02 5.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.709 0.766 . . . . 3.6800000000000002 112.967 169.56 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.24 75.44 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.922 1.249 . . . . 0.58999999999999997 112.598 -179.025 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -77.62 -157.63 0.1 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.615 -0.883 . . . . 0.81000000000000005 108.615 173.185 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.6 m -143.82 144.43 31.77 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.126 -2.546 . . . . 2.7000000000000002 104.126 168.78 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -40.87 138.04 1.11 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.723 2.409 . . . . 2.6899999999999999 112.857 -168.772 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.32 -171.38 29.45 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.128 -0.487 . . . . 0.59999999999999998 111.979 174.243 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.28 153.19 40.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.663 0.986 . . . . 2.2599999999999998 113.663 -163.155 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.99 126.55 14.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.218 1.807 . . . . 0.52000000000000002 109.323 -179.261 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.65 155.58 10.98 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.658 -0.977 . . . . 0.34999999999999998 110.658 165.78 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 117' ' ' LEU . 1.8 t80 -152.38 92.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.143 1.377 . . . . 2.4199999999999999 107.655 -170.657 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -134.45 161.91 33.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.785 -0.82 . . . . 0.53000000000000003 108.785 -161.03 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.3 m -113.58 140.75 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.906 0.775 . . . . 2.0 109.11 168.99 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -111.52 172.06 7.11 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.282 1.033 . . . . 1.28 111.252 -168.825 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -58.02 -21.59 45.88 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.763 0.825 . . . . 5.9299999999999997 113.019 173.209 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 N--CA 1.452 -0.364 0 C-N-CA 126.655 1.982 . . . . 3.3700000000000001 111.133 -179.246 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 110.456 -0.201 . . . . 1.95 110.456 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.25 -91.39 1.56 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.312 -2.315 . . . . 1.47 107.312 169.676 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 179.71 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 124.898 3.732 . . . . 1.1599999999999999 115.066 -176.872 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -82.25 60.64 5.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.297 1.439 . . . . 2.0099999999999998 110.44 -170.701 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.4 t80 53.6 72.69 0.42 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.048 1.339 . . . . 3.2599999999999998 108.323 -170.883 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -97.73 98.32 5.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 108.997 -0.742 . . . . 2.8199999999999998 108.997 175.22 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.06 -38.37 7.24 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.196 1.93 . . . . 2.0 111.468 -173.559 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.72 -65.34 0.56 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.712 0.805 . . . . 2.9900000000000002 109.456 173.409 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 m -163.22 100.45 0.95 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.108 -1.441 . . . . 1.5800000000000001 107.108 -171.303 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.6 mmt-85 -126.23 163.0 24.15 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.18 0.992 . . . . 5.8099999999999996 109.86 170.228 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -116.25 149.53 39.05 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.38 1.472 . . . . 3.48 108.362 -172.527 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -78.43 153.57 31.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 112.509 -172.57 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.64 152.26 10.58 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 105.563 -3.015 . . . . 3.02 105.563 172.081 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.89 -133.99 7.05 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.067 -1.613 . . . . 1.77 109.067 177.294 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.6 -52.3 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.768 1.646 . . . . 1.6799999999999999 110.212 173.706 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.94 -34.76 78.16 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.081 1.141 . . . . 4.9800000000000004 114.081 -167.072 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.73 175.83 2.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.698 0.285 . . . . 1.99 110.884 -174.582 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.83 -48.13 11.12 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 4.4000000000000004 109.102 168.074 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -79.64 171.04 15.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.804 0.842 . . . . 3.6699999999999999 110.439 -176.797 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 174.05 145.37 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.41 2.284 . . . . 3.5800000000000001 110.037 171.54 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.548 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.2 m80 -57.83 143.16 43.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.204 -1.776 . . . . 0.58999999999999997 106.204 160.113 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -52.59 -27.29 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.369 -0.378 . . . . 1.1499999999999999 110.589 174.545 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.55 28.76 12.38 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.49 -1.172 . . . . 0.64000000000000001 115.071 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -94.79 127.81 41.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.455 2.128 . . . . 1.8400000000000001 107.421 159.653 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.85 -54.34 4.95 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.113 -1.44 . . . . 1.8600000000000001 107.113 151.868 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 153.24 -116.44 0.74 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.394 -1.482 . . . . 0.70999999999999996 109.394 173.438 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -139.46 160.51 39.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.249 1.02 . . . . 1.9399999999999999 110.34 -174.945 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.86 178.09 5.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.451 -1.685 . . . . 0.46000000000000002 106.451 171.245 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -129.99 147.1 51.7 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.559 -0.534 . . . . 2.2400000000000002 109.559 164.897 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.93 146.6 32.02 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.46 -0.941 . . . . 0.72999999999999998 108.46 162.092 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.15 -88.47 0.09 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.524 1.14 . . . . 2.8900000000000001 109.619 177.187 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -137.54 -51.18 0.63 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.949 1.3 . . . . 4.2300000000000004 110.542 -174.399 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.92 15.49 1.79 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.846 1.308 . . . . 2.7000000000000002 111.635 -174.265 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.3 10.11 69.18 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.358 -0.838 . . . . 0.78000000000000003 111.309 -171.625 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.6 140.69 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.036 -1.468 . . . . 0.75 107.036 173.904 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.86 175.9 7.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.073 0.949 . . . . 1.0800000000000001 109.262 174.267 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -110.59 148.42 32.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 103.732 -2.692 . . . . 3.9399999999999999 103.732 176.315 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.46 94.58 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.143 -1.058 . . . . 1.1499999999999999 108.143 153.16 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.7 m -122.04 76.99 1.34 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.217 1.407 . . . . 0.88 109.287 170.818 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.42 157.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.574 -0.528 . . . . 1.5700000000000001 109.574 179.909 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -144.68 89.41 1.98 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.149 0.58 . . . . 3.0299999999999998 110.654 166.684 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.84 162.37 26.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.896 -0.409 . . . . 2.2000000000000002 109.896 172.852 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 p -124.67 7.17 8.18 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.019 1.328 . . . . 1.6499999999999999 113.159 179.321 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.88 -51.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 119.076 0.853 . . . . 1.1699999999999999 108.773 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.39 159.54 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.407 0.623 . . . . 1.01 111.23 -177.7 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.1 p -120.06 177.4 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.266 2.226 . . . . 2.9300000000000002 107.632 175.943 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -112.26 27.62 9.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.36 0.664 . . . . 2.5600000000000001 110.944 166.767 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.409 -0.589 . . . . 2.9100000000000001 109.409 177.89 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 122.776 1.274 . . . . 1.9199999999999999 111.709 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.59 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -77.48 -7.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.443 -1.708 . . . . 2.1400000000000001 110.836 170.971 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.8 mm -61.06 128.55 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 119.978 1.263 . . . . 2.0899999999999999 108.404 -177.481 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.38 33.38 84.39 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 112.036 -0.426 . . . . 1.6799999999999999 112.036 -171.373 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -105.94 163.94 12.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.262 -1.755 . . . . 4.9800000000000004 106.262 149.814 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.2 m -92.59 123.88 36.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.406 1.083 . . . . 0.88 108.434 171.795 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.532 HD21 ' CE2' ' A' ' 45' ' ' PHE . 5.6 tt -80.47 145.99 31.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.102 -1.073 . . . . 2.4199999999999999 108.102 167.087 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.73 133.47 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 127.549 2.34 . . . . 0.35999999999999999 107.107 -177.62 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.41 118.34 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.564 -1.643 . . . . 1.6699999999999999 106.564 167.367 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -90.99 159.43 16.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.1 1.889 . . . . 0.34999999999999998 116.1 -168.572 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -33.01 -83.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.693 2.797 . . . . 3.3500000000000001 112.617 166.145 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -105.27 -179.23 3.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.542 0.737 . . . . 2.73 109.591 -170.231 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.0 137.76 55.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.553 -0.906 . . . . 0.63 108.553 167.899 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 160.95 30.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.622 -0.881 . . . . 2.1800000000000002 108.622 163.436 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -15.24 54.07 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.863 1.06 . . . . 3.5800000000000001 113.863 -170.353 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 64.45 4.23 2.16 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.739 -1.226 . . . . 1.73 113.836 -173.022 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.28 60.39 1.06 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 121.242 1.837 . . . . 1.8799999999999999 111.434 167.208 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.82 -51.76 0.37 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.345 1.858 . . . . 5.7300000000000004 110.308 -175.592 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -43.84 122.69 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.619 1.58 . . . . 1.9399999999999999 113.181 -177.973 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.04 -22.99 65.47 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.365 0.507 . . . . 3.2400000000000002 112.79 179.234 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -65.43 102.83 0.74 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.982 0.891 . . . . 2.27 109.055 174.775 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -19.31 -64.34 0.02 OUTLIER 'General case' 0 C--N 1.341 0.236 0 C-N-CA 127.857 2.463 . . . . 3.48 113.899 -172.264 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -37.72 -42.98 0.61 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.549 2.34 . . . . 3.5299999999999998 112.568 -177.805 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.3 m -55.45 -55.1 35.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.198 0.999 . . . . 2.4300000000000002 111.685 177.14 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -71.18 -48.26 52.76 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.024 -1.048 . . . . 1.3 110.231 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -65.97 -28.88 69.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.856 1.262 . . . . 4.6699999999999999 111.909 -170.241 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.548 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 1.2 t -137.45 -53.89 0.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.589 -1.196 . . . . 1.51 113.14 174.143 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.38 -18.52 1.33 Allowed Glycine 0 N--CA 1.468 0.83 0 CA-C-N 120.126 1.33 . . . . 0.97999999999999998 112.562 -179.88 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 46.6 54.12 9.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.199 1.8 . . . . 2.2599999999999998 111.751 175.376 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.93 -36.74 56.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.377 0.608 . . . . 1.1000000000000001 110.591 168.728 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 -150.53 17.85 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 108.52 -1.832 . . . . 1.02 108.52 176.105 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.9 p -65.77 151.47 46.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.061 0.763 . . . . 2.2200000000000002 113.061 -164.035 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -60.81 139.46 57.93 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.809 -1.182 . . . . 2.7799999999999998 107.809 166.86 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -115.49 -77.41 0.57 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.749 -1.204 . . . . 0.60999999999999999 107.749 173.504 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.91 157.9 17.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.197 -1.409 . . . . 0.90000000000000002 107.197 165.745 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.6 p -156.83 163.27 39.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.169 -1.832 . . . . 1.3899999999999999 107.102 179.601 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.24 138.39 5.05 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.476 -1.05 . . . . 0.58999999999999997 110.476 179.418 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.06 133.9 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.368 1.067 . . . . 0.73999999999999999 108.54 172.6 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.59 HG21 HG12 ' A' ' 112' ' ' ILE . 14.7 tt -100.11 132.84 44.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 122.769 0.428 . . . . 0.72999999999999998 111.508 -177.051 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.68 2.99 1.01 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.466 1.032 . . . . 0.63 114.675 179.379 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.6 mm -92.63 57.04 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 119.541 1.671 . . . . 0.79000000000000004 110.832 -157.203 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.1 173.45 16.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.804 . . . . 1.29 109.518 166.305 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 C--O 1.255 1.388 0 N-CA-C 102.892 -3.003 . . . . 4.1299999999999999 102.892 162.918 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 105.385 -2.08 . . . . 5.7999999999999998 105.385 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.9 m 92.53 121.38 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 126.656 1.982 . . . . 2.7200000000000002 105.887 -162.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.32 144.97 26.57 Favored 'General case' 0 N--CA 1.458 -0.068 0 CA-C-N 118.149 0.431 . . . . 2.9900000000000002 111.288 -173.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -94.97 144.75 25.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.651 -1.24 . . . . 0.67000000000000004 107.651 163.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 t -110.61 142.28 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.747 -0.835 . . . . 0.87 108.747 167.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.01 97.47 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.069 -1.086 . . . . 0.44 108.069 156.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.14 107.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.723 -1.584 . . . . 0.60999999999999999 106.723 161.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.22 124.46 38.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.081 -1.081 . . . . 0.84999999999999998 108.081 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -135.22 -52.05 0.77 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.213 0.605 . . . . 4.21 109.822 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.73 -121.97 4.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.811 -1.315 . . . . 0.78000000000000003 109.811 -170.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.89 -37.63 1.51 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.18 0.592 . . . . 3.0699999999999998 111.553 -162.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.27 162.3 18.98 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 110.972 -0.851 . . . . 0.81999999999999995 110.972 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.86 58.95 6.23 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.15 3.234 . . . . 1.78 111.22 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -132.71 152.63 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 127.353 2.261 . . . . 0.98999999999999999 107.269 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -155.04 133.77 12.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.49 -1.3 . . . . 2.5800000000000001 107.49 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.41 168.83 40.21 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.789 -0.72 . . . . 0.44 112.785 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.86 125.67 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 1.1200000000000001 107.345 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.7 136.55 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.883 -1.525 . . . . 0.68999999999999995 106.883 161.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -116.26 106.99 14.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.7 -1.593 . . . . 1.6299999999999999 106.7 165.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -92.74 120.11 32.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 2.6000000000000001 106.877 176.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.62 163.17 33.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.102 0.953 . . . . 3.46 109.935 163.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -156.85 153.82 28.85 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.979 2.112 . . . . 3.1899999999999999 105.405 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -63.42 -62.43 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.323 0.965 . . . . 5.6500000000000004 110.375 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -90.9 -162.38 0.9 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 126.802 2.041 . . . . 4.4100000000000001 111.282 -167.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 m -101.69 -68.55 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.643 1.577 . . . . 2.5899999999999999 107.215 158.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -73.58 76.55 1.48 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.526 1.131 . . . . 4.5800000000000001 110.72 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.36 179.35 43.2 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 110.343 -1.103 . . . . 1.01 110.343 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.21 126.06 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.776 2.984 . . . . 1.03 112.123 -170.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.19 140.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.427 -0.583 . . . . 0.87 109.427 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -103.74 99.04 8.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.547 -1.649 . . . . 2.8300000000000001 106.547 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG22 ' CE1' ' A' ' 20' ' ' PHE . 30.4 t -89.44 120.91 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.006 -1.479 . . . . 0.93000000000000005 107.006 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -130.92 140.34 50.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.8 -1.185 . . . . 0.93999999999999995 107.8 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.21 23.71 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.088 -1.205 . . . . 0.75 110.088 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 p -130.04 67.59 1.46 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.088 1.355 . . . . 1.8899999999999999 107.726 -163.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -81.6 139.53 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.541 -1.209 . . . . 0.82999999999999996 108.323 -175.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 7.0 ptpt -134.94 169.53 17.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.452 1.279 . . . . 4.2999999999999998 114.452 170.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 -1.68 79.1 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 114.227 -1.351 . . . . 1.04 113.803 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -56.09 158.83 3.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.668 1.234 . . . . 0.79000000000000004 110.31 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.82 160.55 11.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.375 -0.972 . . . . 1.79 108.375 154.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -60.88 174.04 0.68 Allowed 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.57 -0.706 . . . . 2.6000000000000001 110.822 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.26 -162.19 54.48 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.993 -0.549 . . . . 0.44 112.541 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.17 146.69 47.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.37 0.668 . . . . 2.1400000000000001 111.973 -171.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -144.74 119.3 9.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.486 1.515 . . . . 0.48999999999999999 109.408 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.15 147.83 8.96 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.155 -1.178 . . . . 0.32000000000000001 110.155 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.421 ' CZ ' HG12 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -140.29 96.04 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.502 -1.295 . . . . 2.6499999999999999 107.502 -174.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.773 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 33.3 m170 -130.91 146.6 52.38 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.99 -1.115 . . . . 0.56999999999999995 107.99 -162.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.75 104.91 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 122.09 0.948 . . . . 1.6799999999999999 109.542 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.71 161.87 18.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.245 -1.391 . . . . 0.82999999999999996 107.245 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 6.8 pm0 -51.3 -103.39 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.124 1.77 . . . . 5.46 112.76 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 50.21 67.11 0.97 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.366 0.666 . . . . 2.9700000000000002 112.784 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -73.99 -107.39 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.48 1.112 . . . . 5.1299999999999999 111.138 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -85.12 59.37 5.58 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.135 1.774 . . . . 6.4400000000000004 110.482 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.01 -53.91 6.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.435 0.636 . . . . 5.3200000000000003 110.13 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -170.22 -55.21 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.321 2.248 . . . . 4.5599999999999996 106.783 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -170.37 -53.01 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.16 1.384 . . . . 6.3200000000000003 109.632 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.25 -148.89 12.91 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.328 -1.109 . . . . 4.1100000000000003 110.328 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.5 m -58.4 149.1 25.77 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.084 0.954 . . . . 3.0499999999999998 110.406 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.41 7.74 0.2 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.117 1.525 . . . . 4.8499999999999996 115.117 161.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.4 m -176.0 -40.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 118.54 2.793 . . . . 2.73 118.54 -126.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.16 154.13 20.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.215 1.006 . . . . 1.96 110.658 -170.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.86 -88.32 1.27 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.152 -1.579 . . . . 1.02 109.152 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.57 179.0 4.47 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.948 3.099 . . . . 1.1299999999999999 114.06 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -84.84 59.05 5.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.308 -1.315 . . . . 1.75 109.47 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.5 t80 50.17 68.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.828 . . . . 2.3399999999999999 109.818 -172.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -83.21 115.17 57.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.218 -0.896 . . . . 2.5699999999999998 108.759 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.18 -37.12 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.148 1.898 . . . . 1.55 111.157 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 tt -155.84 -65.7 0.11 Allowed 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.945 -1.131 . . . . 3.0600000000000001 107.945 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -154.95 71.45 0.8 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.705 0.802 . . . . 1.8500000000000001 109.379 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.56 161.34 27.08 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.946 -0.761 . . . . 4.4199999999999999 108.946 165.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 28.2 mttt -109.71 155.72 21.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.809 -1.552 . . . . 3.54 106.809 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -74.85 164.06 26.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0700000000000001 110.587 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.01 148.46 9.28 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 105.447 -3.061 . . . . 2.5699999999999998 105.447 169.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.26 -155.46 4.99 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.444 -1.062 . . . . 1.1699999999999999 110.444 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.71 -46.87 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.728 1.618 . . . . 1.4399999999999999 108.756 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.62 -36.26 75.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.265 1.426 . . . . 4.4000000000000004 113.039 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.95 165.93 1.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.927 0.491 . . . . 2.6600000000000001 110.737 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -79.61 -46.96 16.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.884 1.674 . . . . 4.2699999999999996 109.512 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 44.7 mt-10 -93.47 177.1 6.14 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.209 1.404 . . . . 3.1499999999999999 110.812 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 177.33 160.57 0.44 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 128.55 2.74 . . . . 3.4900000000000002 106.82 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 51.0 m80 -71.51 152.14 43.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.241 -1.763 . . . . 0.56000000000000005 106.241 162.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.49 39.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.4 1.095 . . . . 2.2799999999999998 111.128 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.51 37.27 0.29 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 128.331 2.872 . . . . 0.64000000000000001 110.62 166.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.05 140.57 50.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.427 1.614 . . . . 2.1899999999999999 110.451 157.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.31 -51.22 4.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.708 -1.219 . . . . 1.6399999999999999 107.708 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.45 -103.41 0.23 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.649 -0.98 . . . . 0.56999999999999995 110.649 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -152.16 169.28 22.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.305 1.842 . . . . 1.71 110.461 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.06 176.04 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.649 1.58 . . . . 0.42999999999999999 107.034 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.4 m -125.33 126.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.934 -1.135 . . . . 2.0099999999999998 107.934 174.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.17 141.4 29.58 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.127 0.971 . . . . 0.66000000000000003 111.818 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.11 -90.38 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.153 0.908 . . . . 2.6499999999999999 110.855 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -158.23 -34.37 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.243 0.831 . . . . 4.0499999999999998 113.243 -161.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 38.6 t0 -79.34 17.93 0.76 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 123.797 1.761 . . . . 3.4300000000000002 110.178 158.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.78 17.22 60.24 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 125.189 1.376 . . . . 0.96999999999999997 111.808 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.38 119.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.515 -1.291 . . . . 0.84999999999999998 107.515 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.51 174.24 6.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.444 1.098 . . . . 1.01 109.292 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -132.49 91.24 2.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.196 -2.15 . . . . 3.6899999999999999 105.196 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.1 59.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.775 -0.824 . . . . 1.6100000000000001 108.775 -168.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m -96.56 104.15 16.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.758 1.223 . . . . 1.3700000000000001 109.453 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.02 153.31 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.393 -0.965 . . . . 1.8100000000000001 108.393 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -140.14 82.16 1.85 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.302 0.641 . . . . 2.4199999999999999 109.914 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.52 160.36 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.851 0.46 . . . . 2.1000000000000001 110.969 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.4 p -121.11 4.39 10.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.573 1.549 . . . . 1.3500000000000001 113.16 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.66 -50.43 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.28 0.945 . . . . 1.1599999999999999 109.065 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pp -77.57 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.425 0.631 . . . . 0.93999999999999995 111.043 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -153.66 175.1 13.64 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.746 1.618 . . . . 2.27 107.502 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.87 38.72 4.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.726 0.811 . . . . 2.54 111.144 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 t -99.1 -58.39 1.95 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.716 1.206 . . . . 3.5099999999999998 109.782 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.53 -176.72 40.36 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 108.42 -1.872 . . . . 2.79 108.42 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 55.1 -105.6 0.28 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 117.882 0.841 . . . . 3.7000000000000002 110.93 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -76.9 -13.38 59.99 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.753 1.16 . . . . 4.5899999999999999 111.814 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.6 m -53.35 158.36 1.7 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 119.092 0.86 . . . . 2.1299999999999999 111.279 167.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.441 HD12 ' C ' ' A' ' 112' ' ' ILE 0.257 1.3 pp -95.97 -7.84 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.266 0.469 . . . . 1.5600000000000001 112.266 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' HG23 ' A' ' 149' ' ' ILE . 8.7 tt -45.57 137.03 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.503 0.721 . . . . 1.8999999999999999 110.494 167.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.07 -30.78 6.4 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.727 0.679 . . . . 1.5600000000000001 112.253 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.541 ' O ' HG22 ' A' ' 149' ' ' ILE . 82.8 mtt180 -81.1 166.23 20.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.734 1.267 . . . . 5.1500000000000004 109.897 -168.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.0 m -93.06 108.61 20.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.085 0.469 . . . . 0.87 110.586 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -68.45 148.74 50.19 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.704 -0.85 . . . . 1.6399999999999999 108.704 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.98 137.77 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.894 1.677 . . . . 0.38 108.342 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.421 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -108.37 128.33 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.017 -1.105 . . . . 1.6299999999999999 108.017 166.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.531 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 72.1 m-70 -104.8 160.85 14.66 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.121 2.267 . . . . 0.40000000000000002 117.121 -169.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -50.82 -71.96 0.06 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.833 2.053 . . . . 3.3399999999999999 111.902 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -94.3 -178.22 4.53 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.174 0.897 . . . . 2.9399999999999999 110.239 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.97 151.08 27.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.643 -0.873 . . . . 0.52000000000000002 108.643 161.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.53 169.02 18.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.434 -0.58 . . . . 1.97 109.434 163.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.08 -25.78 63.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.471 0.915 . . . . 3.9399999999999999 113.471 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 72.63 -13.71 0.63 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.111 2.164 . . . . 2.1899999999999999 113.006 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.54 5.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.949 1.25 . . . . 2.2000000000000002 110.666 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -91.57 -31.38 15.93 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.501 1.12 . . . . 5.6799999999999997 109.212 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.67 62.78 3.09 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.784 -1.326 . . . . 2.3500000000000001 109.784 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.52 -31.42 57.29 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.563 -1.015 . . . . 4.0499999999999998 110.563 164.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -141.42 -78.54 0.27 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.421 0.611 . . . . 2.52 111.622 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 179.56 -54.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.335 1.454 . . . . 3.5899999999999999 109.624 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -45.9 -31.4 2.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.7 0.8 . . . . 4.4000000000000004 110.735 167.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -29.57 -77.13 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.821 2.048 . . . . 1.75 113.534 155.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 p -71.63 -39.38 70.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 120.884 -1.135 . . . . 1.24 109.447 -175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -55.28 -51.37 66.88 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.104 0.411 . . . . 3.7000000000000002 111.463 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.543 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.337 1.0 OUTLIER -128.9 -47.92 1.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.361 0.874 . . . . 1.1699999999999999 113.361 175.175 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.15 -5.46 0.39 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.577 1.08 . . . . 0.91000000000000003 115.366 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 36.25 57.13 1.05 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.274 1.83 . . . . 2.0 113.549 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.773 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -63.55 -32.75 74.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.339 0.866 . . . . 1.04 113.339 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.53 174.47 50.01 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.312 -1.515 . . . . 1.0600000000000001 109.312 -159.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 m -54.92 154.09 5.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.274 1.43 . . . . 1.46 113.961 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -77.41 142.69 39.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 2.7799999999999998 109.897 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 mt -120.32 -72.64 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.694 -0.854 . . . . 0.54000000000000004 108.694 -174.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.77 149.25 41.1 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.042 0.937 . . . . 0.77000000000000002 108.494 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.04 170.48 20.43 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.054 1.471 . . . . 1.3600000000000001 109.178 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.43 147.19 6.36 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.642 -1.383 . . . . 0.70999999999999996 109.642 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.46 135.25 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.27 1.028 . . . . 0.72999999999999998 109.065 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 115' ' ' ARG . 10.1 tt -92.63 140.03 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.144 0.424 . . . . 0.76000000000000001 112.144 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.403 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 139.68 7.42 1.03 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.579 1.085 . . . . 0.62 114.315 171.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.3 mm -98.65 57.0 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.229 -0.025 0 CA-C-N 119.55 1.675 . . . . 0.76000000000000001 109.917 -154.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.65 176.93 11.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.823 0.849 . . . . 1.4399999999999999 109.452 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 103.267 -2.864 . . . . 4.2800000000000002 103.267 154.184 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 108.426 -0.953 . . . . 5.8200000000000003 108.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m -59.45 133.01 55.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.64 -0.874 . . . . 2.71 108.64 170.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -125.63 141.41 52.04 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.917 0.887 . . . . 2.6299999999999999 111.09 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.27 147.18 24.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.257 -1.016 . . . . 0.77000000000000002 108.257 163.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 152' ' ' ALA . 46.4 t -104.49 152.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 106.164 -1.791 . . . . 0.81000000000000005 106.164 157.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -137.2 96.3 3.25 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.9 -0.778 . . . . 0.68000000000000005 108.9 160.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.26 110.32 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.352 -1.351 . . . . 1.0 107.352 168.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.4 mt -93.85 122.84 36.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.919 -0.771 . . . . 0.93000000000000005 108.919 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.77 -47.97 0.46 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.857 0.863 . . . . 4.2000000000000002 110.578 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.83 -123.47 1.97 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.744 1.164 . . . . 0.92000000000000004 112.779 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -59.52 1.85 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 3.7599999999999998 108.52 -172.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.03 172.19 1.77 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.074 2.274 . . . . 1.02 114.518 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.43 -25.68 48.39 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.606 2.871 . . . . 1.48 111.906 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 62.6 t -51.33 141.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.225 1.01 . . . . 0.75 110.851 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -152.25 92.75 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.83 1.652 . . . . 2.0899999999999999 107.432 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.77 21.17 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.031 0.824 . . . . 0.63 111.867 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.41 131.91 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.294 -1.002 . . . . 1.45 108.294 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 33.7 mm -102.2 147.59 8.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.632 1.573 . . . . 0.81999999999999995 107.954 165.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.64 118.51 24.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.57 -2.011 . . . . 1.6299999999999999 105.57 162.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 31' ' ' VAL . 5.7 t80 -127.95 116.53 20.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.876 -1.898 . . . . 3.2799999999999998 105.876 -168.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 163.88 39.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.274 0.559 . . . . 3.6499999999999999 111.971 -170.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 -177.84 6.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.69 -1.596 . . . . 3.8300000000000001 106.69 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -77.73 -63.22 1.43 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.861 -0.792 . . . . 6.4900000000000002 108.861 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.33 165.62 14.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.828 1.251 . . . . 4.9400000000000004 109.569 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -81.0 -0.78 41.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.765 0.654 . . . . 2.6299999999999999 112.765 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -161.47 83.04 0.61 Allowed 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 121.723 -0.611 . . . . 4.0899999999999999 110.225 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.18 169.74 42.43 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 105.827 -2.909 . . . . 1.23 105.827 171.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.42 114.82 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.587 2.858 . . . . 1.5700000000000001 112.584 -165.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 19.5 t -84.32 142.65 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.82 -0.627 . . . . 0.94999999999999996 109.951 -168.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -95.66 122.46 38.45 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.736 -0.839 . . . . 2.6400000000000001 108.736 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 20' ' ' PHE . 16.1 t -121.72 97.39 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.705 1.602 . . . . 1.0700000000000001 107.727 -169.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -113.76 148.81 35.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.273 -0.64 . . . . 0.82999999999999996 109.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.87 160.46 34.06 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 120.991 -1.068 . . . . 0.73999999999999999 110.964 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.2 p -129.77 113.51 14.8 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 105.486 -2.042 . . . . 1.8200000000000001 105.486 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.74 142.1 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.844 -1.91 . . . . 1.1000000000000001 105.844 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.56 153.49 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.875 -0.516 . . . . 5.4900000000000002 110.368 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.94 21.01 51.98 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.914 1.245 . . . . 0.64000000000000001 112.401 -171.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.14 -168.16 0.37 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.335 1.064 . . . . 0.87 108.753 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.0 m -135.93 166.32 23.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 103.814 -2.662 . . . . 3.46 103.814 159.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.24 175.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.763 1.625 . . . . 2.8999999999999999 114.649 -166.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.04 -170.66 54.72 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 114.975 -1.011 . . . . 1.1499999999999999 112.284 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.37 152.52 27.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.379 1.071 . . . . 2.3300000000000001 110.528 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -145.51 112.83 6.18 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.835 1.254 . . . . 0.52000000000000002 109.277 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.26 150.37 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.835 -0.906 . . . . 0.5 110.835 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE1' HD11 ' A' ' 117' ' ' LEU . 39.1 t80 -142.95 94.49 2.64 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.917 -1.512 . . . . 2.7400000000000002 106.917 -171.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -131.98 162.72 30.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.533 -1.284 . . . . 0.92000000000000004 107.533 -164.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 m -134.97 115.26 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.721 0.691 . . . . 2.4900000000000002 109.624 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -104.69 150.77 24.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.894 1.277 . . . . 1.1599999999999999 110.561 -164.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.78 66.83 0.37 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.071 1.748 . . . . 5.0700000000000003 112.414 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.5 110.51 11.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.577 -1.638 . . . . 3.3399999999999999 106.577 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -153.31 0.09 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.31 0.644 . . . . 5.8799999999999999 109.753 171.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -88.84 115.22 26.23 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.825 1.193 . . . . 7.4699999999999998 110.035 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -152.79 -84.15 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.066 0.946 . . . . 5.3499999999999996 111.245 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.8 m -145.31 133.5 21.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.314 -1.365 . . . . 4.6699999999999999 107.314 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 127.94 34.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.184 -0.672 . . . . 4.9500000000000002 109.184 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.01 52.0 0.05 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.566 -1.413 . . . . 4.5999999999999996 109.566 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.5 m -74.79 29.49 0.09 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.034 0.934 . . . . 3.3599999999999999 113.313 -164.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -79.3 -12.32 59.94 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 119.859 -1.775 . . . . 5.3200000000000003 113.69 -175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.3 m 177.69 68.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 118.861 -1.135 . . . . 6.2800000000000002 112.288 -115.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.61 -86.49 0.17 Allowed 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 122.588 0.355 . . . . 3.3399999999999999 111.02 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.96 -178.35 44.76 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.389 -1.084 . . . . 2.1899999999999999 110.389 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.73 179.35 5.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.085 3.857 . . . . 1.6799999999999999 113.331 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -62.17 57.57 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.189 2.596 . . . . 2.0699999999999998 113.299 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.539 ' CD2' HG13 ' A' ' 81' ' ' VAL . 6.0 t80 35.88 77.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.341 1.056 . . . . 2.9399999999999999 111.016 -160.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -93.74 106.02 19.45 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 108.457 -0.942 . . . . 2.75 108.457 171.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.69 -33.37 10.5 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.286 1.99 . . . . 1.5 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -155.33 -66.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.537 -0.912 . . . . 3.6099999999999999 108.537 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.6 m -154.4 74.71 0.97 Allowed 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.63 -0.669 . . . . 1.8700000000000001 110.36 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -78.31 161.29 27.33 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.699 -0.852 . . . . 5.1799999999999997 108.699 166.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -107.62 148.53 29.21 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.452 1.101 . . . . 4.8099999999999996 108.326 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.442 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 56.8 t60 -78.18 159.64 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.767 -0.373 . . . . 1.1699999999999999 110.691 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.52 160.72 33.02 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 107.448 -2.261 . . . . 2.3300000000000001 107.448 161.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.33 -176.86 29.11 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 117.715 0.758 . . . . 1.99 111.342 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.49 -29.2 37.7 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.104 1.869 . . . . 2.9300000000000002 110.43 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -64.81 -43.45 93.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.329 0.651 . . . . 5.4900000000000002 111.202 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -63.48 147.77 50.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.299 1.047 . . . . 2.5899999999999999 112.183 -168.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.27 -50.78 71.82 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.819 -1.082 . . . . 4.2000000000000002 108.242 167.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -78.02 164.98 24.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.155 0.982 . . . . 3.8500000000000001 110.574 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.37 147.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 C-N-CA 129.255 3.022 . . . . 3.3100000000000001 108.751 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 31.4 m80 -65.44 152.51 43.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 119.504 -0.878 . . . . 0.96999999999999997 109.986 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.539 HG13 ' CD2' ' A' ' 64' ' ' PHE . 7.7 p -67.12 -5.98 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 O-C-N 121.894 -0.504 . . . . 1.8400000000000001 112.307 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.2 50.96 0.77 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.058 -1.026 . . . . 1.1799999999999999 111.772 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.25 123.06 1.88 Allowed 'General case' 0 C--O 1.227 -0.087 0 O-C-N 120.811 -1.406 . . . . 2.0299999999999998 110.089 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.13 -52.45 4.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.652 -0.499 . . . . 2.0499999999999998 109.652 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.39 -101.41 0.19 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.068 -1.063 . . . . 0.82999999999999996 111.99 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -155.11 166.03 34.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.084 1.353 . . . . 1.9299999999999999 111.327 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.9 179.71 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.308 1.843 . . . . 0.67000000000000004 106.165 162.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 t -134.32 145.17 48.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.568 -1.271 . . . . 2.2200000000000002 107.568 163.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.22 143.18 35.58 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.601 0.563 . . . . 0.72999999999999998 109.618 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.76 -69.64 0.23 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.474 0.709 . . . . 3.3300000000000001 109.918 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -168.35 -55.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.789 2.036 . . . . 4.1299999999999999 108.53 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.21 29.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.922 1.344 . . . . 4.8200000000000003 110.244 -170.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.13 17.61 72.14 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.59 1.091 . . . . 1.0800000000000001 112.386 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.4 152.33 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.461 -1.311 . . . . 1.0 107.461 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.26 167.22 22.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.495 -1.298 . . . . 0.68000000000000005 107.495 161.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.05 148.95 51.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.668 -2.345 . . . . 2.8399999999999999 104.668 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.6 136.48 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 107.614 -1.254 . . . . 1.54 107.614 164.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.0 m -156.95 70.4 0.63 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.545 1.538 . . . . 0.96999999999999997 108.168 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.58 155.3 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.942 0.897 . . . . 1.8700000000000001 109.088 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.6 134.71 29.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.393 -0.595 . . . . 2.71 109.393 145.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -128.64 165.31 21.07 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.332 1.053 . . . . 2.8399999999999999 109.539 170.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 p -104.08 8.0 36.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.078 1.751 . . . . 1.72 112.287 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.4 t -90.53 -49.15 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.368 -0.975 . . . . 1.49 108.368 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.259 0.4 OUTLIER -84.19 175.82 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.05 0.452 . . . . 1.22 111.574 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -160.97 169.12 23.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.325 1.05 . . . . 2.98 109.25 -166.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.7 mp -85.67 -25.79 26.35 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.483 1.113 . . . . 2.8999999999999999 111.907 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.0 t -154.98 -176.18 5.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.951 1.7 . . . . 4.0599999999999996 107.47 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.86 168.06 24.61 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.969 0.795 . . . . 3.4300000000000002 111.696 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -32.27 -53.45 0.3 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 128.828 2.851 . . . . 5.1500000000000004 114.676 -169.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -79.13 -23.27 44.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.575 -0.726 . . . . 3.8399999999999999 112.608 -171.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.0 p -51.3 147.01 6.15 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 122.082 0.944 . . . . 1.48 113.409 -165.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 pp -91.02 -6.3 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.018 -1.446 . . . . 1.55 109.825 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 tp -43.86 123.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.897 0.879 . . . . 1.6100000000000001 109.465 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.9 32.53 84.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.926 -0.654 . . . . 1.49 113.093 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -98.32 174.96 6.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.282 -1.007 . . . . 5.5099999999999998 108.282 152.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 m -105.58 117.16 33.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.778 1.231 . . . . 1.05 108.283 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.419 HD11 ' CE1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -61.3 150.62 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.008 -0.738 . . . . 2.3999999999999999 109.008 171.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -140.7 134.6 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.918 1.287 . . . . 0.46000000000000002 107.702 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.33 128.37 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.865 -1.531 . . . . 1.71 106.865 164.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -98.32 160.02 14.56 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 115.182 1.549 . . . . 0.48999999999999999 115.182 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.16 -72.15 0.06 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.138 1.775 . . . . 4.2800000000000002 111.787 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -101.21 -177.71 3.53 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.441 0.696 . . . . 2.9700000000000002 110.038 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.89 151.35 18.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.043 -0.725 . . . . 0.75 109.043 165.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.14 176.33 4.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.321 -0.992 . . . . 1.9199999999999999 108.321 159.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.65 -28.38 66.83 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 3.98 114.351 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 81.55 -7.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.244 2.618 . . . . 2.3100000000000001 113.475 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.12 31.64 11.7 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.82 1.191 . . . . 2.6600000000000001 110.477 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -35.36 32.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 128.224 2.61 . . . . 6.9699999999999998 108.229 168.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.13 41.88 30.6 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.655 1.122 . . . . 3.1699999999999999 111.253 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.64 35.64 1.61 Allowed Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.538 1.169 . . . . 3.75 114.299 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.6 p30 177.64 -89.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.455 1.902 . . . . 3.21 108.703 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -170.38 -57.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.296 1.838 . . . . 2.9399999999999999 107.137 -173.234 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -56.42 -34.37 66.71 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.745 1.218 . . . . 3.25 110.883 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.1 m -41.84 -68.77 0.16 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.898 1.279 . . . . 1.8999999999999999 112.087 167.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -43.78 69.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.3 -0.875 . . . . 1.6799999999999999 110.059 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 132' ' ' GLU . 20.9 ttmt -57.81 -42.86 85.12 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.104 0.962 . . . . 2.5899999999999999 111.647 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.255 4.2 p -132.53 -52.28 0.94 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.676 0.621 . . . . 1.54 112.676 178.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.442 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 154.52 -25.13 0.66 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 124.092 0.854 . . . . 0.91000000000000003 112.171 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t30 41.55 56.2 3.32 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.92 1.688 . . . . 2.4700000000000002 111.06 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 -50.55 18.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.293 -0.963 . . . . 1.49 108.992 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 132.11 -151.95 20.02 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 107.427 -2.269 . . . . 1.54 107.427 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 t -67.76 -179.71 1.21 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.326 1.06 . . . . 3.1699999999999999 111.98 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -105.44 152.23 23.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.611 2.364 . . . . 3.2400000000000002 111.405 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.5 -85.27 0.66 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.371 -1.344 . . . . 0.75 107.371 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.497 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -94.17 155.23 17.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.173 -1.047 . . . . 1.01 108.173 164.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 18.5 p -146.93 168.09 22.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.107 -1.406 . . . . 2.02 107.776 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.99 140.93 4.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.126 -1.19 . . . . 0.67000000000000004 110.126 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.93 137.98 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.897 0.879 . . . . 0.84999999999999998 108.96 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.0 tt -101.43 125.43 55.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.205 0.526 . . . . 0.91000000000000003 111.231 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.21 8.87 0.42 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.539 1.066 . . . . 0.62 114.306 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.11 55.39 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 120.116 1.958 . . . . 1.05 110.19 -161.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -158.87 176.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.563 1.145 . . . . 1.5800000000000001 109.412 168.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 102.844 -3.021 . . . . 4.9800000000000004 102.844 150.895 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 118.736 -0.649 . . . . 8.1500000000000004 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.3 p -70.85 -177.05 1.48 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.566 1.146 . . . . 4.0099999999999998 110.279 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.8 pttm -78.51 175.09 10.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.505 -0.554 . . . . 2.6899999999999999 109.505 158.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.5 153.41 48.78 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.909 2.083 . . . . 0.68000000000000005 108.148 167.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -118.87 143.12 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.412 -1.329 . . . . 0.75 107.412 170.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.95 99.83 6.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.141 1.376 . . . . 0.48999999999999999 108.996 156.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 113.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.573 -1.269 . . . . 0.56999999999999995 107.573 159.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.71 125.12 49.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.359 1.064 . . . . 1.01 109.056 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -132.23 -53.2 0.96 Allowed 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.409 0.684 . . . . 3.9500000000000002 110.215 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.43 -124.14 13.86 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.036 0.827 . . . . 0.93000000000000005 113.832 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -114.12 -52.47 2.73 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.867 1.267 . . . . 3.7999999999999998 108.859 -158.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.05 160.52 26.45 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 110.295 -1.122 . . . . 0.90000000000000002 110.295 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.52 40.59 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.72 2.946 . . . . 1.01 112.711 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.04 156.18 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.807 1.643 . . . . 0.79000000000000004 108.934 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -153.63 93.0 1.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.523 -0.917 . . . . 2.6200000000000001 108.523 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.91 162.53 14.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 124.03 0.824 . . . . 0.60999999999999999 111.462 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.8 mt -130.95 120.56 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 106.532 -1.655 . . . . 1.28 106.532 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.4 mm -84.23 146.37 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.319 1.048 . . . . 0.75 108.221 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -124.85 101.18 6.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.244 -1.761 . . . . 2.4700000000000002 106.244 166.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -79.66 91.09 5.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.245 -2.132 . . . . 2.2999999999999998 105.245 166.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.39 140.84 31.28 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.824 -1.547 . . . . 3.6600000000000001 106.824 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -157.96 151.36 23.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.759 -1.941 . . . . 3.8999999999999999 105.759 167.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.91 -65.31 1.18 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.072 0.851 . . . . 6.9400000000000004 108.769 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -78.97 119.23 21.83 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.583 -0.895 . . . . 5.1799999999999997 108.583 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 m -35.4 -64.11 0.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.403 2.681 . . . . 2.6099999999999999 113.815 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.0 37.21 0.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.582 -0.699 . . . . 3.6299999999999999 111.114 177.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.67 167.34 22.17 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.322 0.963 . . . . 1.4399999999999999 111.291 -174.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.7 139.21 51.92 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.458 2.772 . . . . 1.52 112.019 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -89.32 126.71 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.305 -0.998 . . . . 0.93000000000000005 108.305 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -83.6 98.86 9.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.436 -1.69 . . . . 2.8900000000000001 106.436 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' A' ' 20' ' ' PHE . 41.9 t -97.25 85.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.746 1.618 . . . . 1.3400000000000001 107.387 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -98.61 162.13 13.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.204 -0.665 . . . . 1.1200000000000001 109.204 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.41 153.57 23.15 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.834 -0.906 . . . . 0.67000000000000004 110.834 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 p -121.98 79.43 1.58 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.245 1.418 . . . . 2.4500000000000002 107.488 -171.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -96.99 125.2 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.69 1.196 . . . . 0.94999999999999996 108.934 -170.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.73 158.58 43.77 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.711 -0.477 . . . . 5.0599999999999996 109.711 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.52 19.52 48.53 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.675 1.607 . . . . 0.69999999999999996 113.34 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.83 170.28 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.648 -0.913 . . . . 0.59999999999999998 108.962 170.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.1 163.39 27.98 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.711 -1.218 . . . . 1.6899999999999999 107.711 149.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -61.63 175.91 0.57 Allowed 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.382 -0.824 . . . . 3.3500000000000001 111.03 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.62 -165.54 52.2 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.272 0.939 . . . . 0.46000000000000002 112.607 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.52 141.99 58.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.802 1.241 . . . . 1.9399999999999999 113.045 -174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -143.12 118.38 10.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.756 1.622 . . . . 0.45000000000000001 108.592 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.46 149.3 2.14 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.751 -0.939 . . . . 0.35999999999999999 110.751 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -139.91 94.16 2.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.327 -1.731 . . . . 3.0699999999999998 106.327 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.566 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 26.5 m80 -138.86 153.49 48.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.723 -1.584 . . . . 0.83999999999999997 106.723 -166.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.24 121.76 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.637 0.732 . . . . 1.5600000000000001 109.792 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.438 ' CD2' HG21 ' A' ' 118' ' ' VAL . 21.3 m-70 -96.19 144.2 26.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.154 2.182 . . . . 0.84999999999999998 109.548 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -33.97 -90.87 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.539 2.736 . . . . 5.3799999999999999 112.671 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HG2' ' HB2' ' A' ' 60' ' ' ALA . 5.1 mt-10 43.34 56.1 4.44 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.103 1.52 . . . . 3.6899999999999999 115.103 170.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -78.71 43.69 0.5 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.73 -0.606 . . . . 5.1500000000000004 110.35 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 t70 179.1 135.37 0.09 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 129.556 3.142 . . . . 4.8300000000000001 105.451 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.41 48.6 2.04 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.054 -1.091 . . . . 4.4500000000000002 108.054 165.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.3 t -62.34 -46.2 89.76 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.544 -0.722 . . . . 4.6699999999999999 111.395 -171.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.59 -47.19 13.37 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.751 0.82 . . . . 5.29 109.3 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.9 -171.27 37.79 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 106.289 -2.724 . . . . 3.4900000000000002 106.289 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.8 p -74.05 154.87 39.04 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 117.805 0.802 . . . . 2.6000000000000001 111.133 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.2 p -134.0 163.14 30.21 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.058 1.343 . . . . 4.7699999999999996 111.381 -166.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.421 0.7 OUTLIER 45.18 -96.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 118.041 2.608 . . . . 4.4900000000000002 118.041 105.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . . . 28.67 -118.42 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.04 2.536 . . . . 2.7000000000000002 114.645 -173.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.82 -167.58 30.52 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.887 -1.685 . . . . 1.27 108.887 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 178.75 4.34 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.315 3.343 . . . . 1.1599999999999999 113.142 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -47.61 123.48 5.89 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.338 1.455 . . . . 1.25 110.182 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -45.86 122.92 4.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.724 0.809 . . . . 2.46 111.027 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -155.4 152.84 25.56 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 106.679 -1.601 . . . . 2.54 106.679 171.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.22 -20.33 24.81 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.228 1.952 . . . . 1.3200000000000001 113.806 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.81 -70.08 0.11 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.463 1.029 . . . . 3.0 111.195 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.9 t -157.43 69.53 0.56 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.254 0.622 . . . . 2.1200000000000001 109.488 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -79.21 175.04 10.95 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.379 0.609 . . . . 4.7800000000000002 110.374 168.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -118.55 161.24 20.36 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 106.33 -1.73 . . . . 3.21 106.33 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -85.9 165.21 16.97 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.639 0.654 . . . . 1.0600000000000001 109.382 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.53 -65.84 0.02 OUTLIER Glycine 0 C--O 1.223 -0.591 0 N-CA-C 108.201 -1.959 . . . . 2.9199999999999999 108.201 169.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.15 -171.27 27.87 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.604 1.097 . . . . 1.45 111.978 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.14 -46.85 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.743 2.295 . . . . 1.6100000000000001 109.796 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.66 -36.41 82.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.611 0.764 . . . . 4.2800000000000002 112.017 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.1 176.95 0.66 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.277 1.031 . . . . 1.8 112.042 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.69 -48.3 11.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.052 1.341 . . . . 4.6100000000000003 109.71 165.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -98.4 156.58 16.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.311 1.044 . . . . 3.5099999999999998 112.68 -166.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.69 150.0 0.64 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.768 1.627 . . . . 4.0599999999999996 110.0 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 44.5 m80 -55.84 136.6 51.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 104.979 -2.23 . . . . 0.70999999999999996 104.979 156.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -58.98 -23.17 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.185 -0.606 . . . . 1.47 109.947 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.87 39.24 2.8 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.372 1.463 . . . . 0.72999999999999998 115.083 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -102.9 136.63 42.37 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.772 1.786 . . . . 1.9099999999999999 106.831 153.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.6 -52.74 3.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.469 -0.938 . . . . 1.8600000000000001 108.469 147.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.38 -106.72 0.29 Allowed Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.964 -0.854 . . . . 0.65000000000000002 110.964 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.69 165.66 31.69 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.261 1.425 . . . . 1.6599999999999999 109.524 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.38 175.38 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 106.174 -1.788 . . . . 0.5 106.174 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -120.67 141.72 50.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.769 -1.197 . . . . 2.0699999999999998 107.769 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.3 138.84 34.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.398 0.679 . . . . 0.63 109.979 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.45 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.571 0.544 . . . . 3.3599999999999999 110.134 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -53.79 1.52 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.928 0.891 . . . . 4.6299999999999999 111.52 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.05 26.61 2.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 123.368 1.556 . . . . 2.7999999999999998 110.78 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.8 17.9 67.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 114.524 -1.217 . . . . 0.59999999999999998 111.596 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.6 t -89.02 122.63 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 125.378 1.471 . . . . 0.76000000000000001 107.306 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.16 175.99 5.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.894 1.277 . . . . 0.83999999999999997 107.662 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -133.67 148.21 51.48 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 103.62 -2.733 . . . . 2.9100000000000001 103.62 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.01 139.79 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.874 -1.528 . . . . 1.76 106.874 160.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.1 m -158.16 59.69 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.303 1.841 . . . . 1.3400000000000001 108.078 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.08 151.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 107.638 -1.245 . . . . 1.52 107.638 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -124.99 90.06 3.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.853 -0.795 . . . . 3.5899999999999999 108.853 166.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.63 152.89 31.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.461 0.573 . . . . 2.7000000000000002 110.637 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -132.07 41.9 3.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.779 1.232 . . . . 1.6299999999999999 110.295 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -127.57 -54.33 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.596 1.158 . . . . 1.3600000000000001 108.197 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -86.42 173.02 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.224 0.535 . . . . 1.3899999999999999 110.566 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.2 m -140.86 173.95 10.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.324 1.85 . . . . 1.96 106.835 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.6 -3.37 46.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.137 0.421 . . . . 3.7400000000000002 112.137 170.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t -150.87 153.14 34.78 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.881 -1.526 . . . . 3.48 106.881 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.41 -155.78 22.08 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 107.412 -2.275 . . . . 2.6600000000000001 107.412 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.71 -73.74 0.42 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.382 -0.97 . . . . 4.2599999999999998 108.382 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.15 4.73 9.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.645 1.178 . . . . 4.5999999999999996 113.141 -173.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 p -49.96 137.56 16.78 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 119.233 0.924 . . . . 1.5 108.738 167.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.27 -12.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.534 -0.466 . . . . 1.7 110.794 -169.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.9 tp -16.85 119.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 127.877 2.471 . . . . 1.8100000000000001 113.353 164.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.59 -17.39 59.18 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.181 -1.344 . . . . 1.54 113.386 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.3 169.07 18.25 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.951 1.875 . . . . 4.0199999999999996 111.735 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.4 m -96.17 110.38 22.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.213 1.005 . . . . 0.93999999999999995 109.472 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.29 144.28 54.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.222 0.919 . . . . 1.6799999999999999 108.705 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.438 HG21 ' CD2' ' A' ' 48' ' ' HIS . 98.7 t -130.79 136.41 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.87 1.268 . . . . 0.53000000000000003 109.087 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.3 m -103.39 126.9 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.794 -1.558 . . . . 1.53 106.794 163.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.488 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 61.6 m-70 -100.97 161.0 13.9 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 116.358 1.985 . . . . 0.38 116.358 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -39.61 -70.33 0.11 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.949 2.9 . . . . 3.0 112.273 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -112.72 -172.49 2.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.426 1.012 . . . . 2.7200000000000002 108.848 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.12 160.59 9.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.917 -0.771 . . . . 0.57999999999999996 108.917 162.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.3 167.11 21.86 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.721 0.772 . . . . 1.8899999999999999 109.808 158.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.7 -6.98 57.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.463 1.905 . . . . 3.4100000000000001 111.282 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 36.06 20.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.886 2.074 . . . . 1.6399999999999999 111.068 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.49 27.43 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.44 -0.788 . . . . 1.9199999999999999 112.65 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -111.67 -34.03 6.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.063 1.345 . . . . 5.9500000000000002 109.623 -171.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -48.39 126.76 16.38 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.247 -1.141 . . . . 2.7200000000000002 110.247 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.62 64.43 2.94 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.341 0.972 . . . . 2.4900000000000002 111.69 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -163.58 117.44 1.55 Allowed 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 106.619 -1.623 . . . . 2.6200000000000001 106.619 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.15 -54.53 0.61 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.814 1.646 . . . . 3.4399999999999999 113.786 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -27.54 -49.64 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.791 2.836 . . . . 3.5699999999999998 113.983 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -44.47 -60.22 2.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.399 1.88 . . . . 2.2200000000000002 110.435 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.7 p -72.99 -42.51 63.19 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.091 -0.381 . . . . 1.29 110.579 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -51.99 -53.69 38.57 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.353 1.061 . . . . 3.6899999999999999 110.862 -172.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.451 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.3 p -123.39 -42.31 2.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.27 0.228 . . . . 1.48 111.567 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 141.19 -27.51 2.41 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.447 -1.061 . . . . 0.98999999999999999 110.447 -169.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.3 t30 55.23 54.41 8.78 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 122.665 1.222 . . . . 1.6799999999999999 110.463 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -64.69 -27.83 69.19 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.812 1.245 . . . . 0.93000000000000005 112.812 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.18 179.42 52.52 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 108.514 -1.834 . . . . 1.04 108.514 -160.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.4 m -59.21 148.94 29.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.286 1.217 . . . . 1.27 114.286 -164.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -51.38 126.09 16.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.652 2.381 . . . . 3.0299999999999998 109.346 166.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.7 mt -109.26 -71.16 0.77 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-N 120.098 1.317 . . . . 0.5 108.669 170.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -100.89 154.52 18.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.565 -0.532 . . . . 0.83999999999999997 109.565 -175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.81 160.16 16.76 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.676 0.61 . . . . 1.45 111.391 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.89 144.84 4.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 128.382 2.896 . . . . 1.04 105.954 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.23 143.36 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 118.023 0.911 . . . . 0.81999999999999995 110.671 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 tt -92.92 139.83 17.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.555 0.742 . . . . 0.73999999999999999 112.71 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.06 -4.83 1.2 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.192 0.901 . . . . 0.60999999999999999 114.777 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -90.55 58.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.715 1.258 . . . . 1.1799999999999999 109.101 -156.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.6 143.69 30.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.518 -0.739 . . . . 1.8300000000000001 112.263 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 103.511 -2.774 . . . . 6.5999999999999996 103.511 141.554 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 117.819 -1.086 . . . . 6.6100000000000003 108.085 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.02 141.74 3.99 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.182 1.393 . . . . 3.8599999999999999 112.024 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.93 175.51 9.98 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.858 -1.164 . . . . 3.52 107.858 170.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.64 138.39 34.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.338 -0.986 . . . . 0.78000000000000003 108.338 163.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 t -99.79 136.27 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 106.885 -1.524 . . . . 1.22 106.885 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -117.88 94.5 4.54 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 124.329 1.052 . . . . 0.47999999999999998 108.236 158.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -65.84 102.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.45 -1.315 . . . . 1.01 107.45 165.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.3 134.68 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.037 0.535 . . . . 0.93999999999999995 109.889 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -149.65 -50.31 0.14 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.657 0.383 . . . . 4.1299999999999999 111.618 166.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.43 -123.8 16.57 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.72 1.152 . . . . 1.0700000000000001 112.971 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.12 -51.77 2.92 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.47 1.108 . . . . 3.9900000000000002 108.621 -159.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.22 172.75 16.39 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.663 1.601 . . . . 0.91000000000000003 111.851 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 27.69 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.433 2.755 . . . . 1.05 112.674 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 15' ' ' GLN . 25.4 t -82.1 165.38 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 1.05 109.11 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.401 ' N ' HG12 ' A' ' 14' ' ' VAL . 6.3 pt20 -156.33 139.1 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.937 1.695 . . . . 3.1600000000000001 106.729 168.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.77 43.39 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.21 -0.995 . . . . 0.78000000000000003 111.651 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.21 126.45 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.071 -1.455 . . . . 1.98 107.071 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.1 mm -92.51 129.24 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.269 -1.382 . . . . 0.90000000000000002 107.269 165.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.75 108.7 21.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.875 -1.528 . . . . 2.1699999999999999 106.875 159.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CZ ' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -87.1 131.97 33.98 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.705 -1.961 . . . . 2.3599999999999999 105.705 162.206 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.39 165.16 36.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.226 0.921 . . . . 3.4700000000000002 111.49 158.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -155.26 145.46 21.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 104.714 -2.328 . . . . 3.0899999999999999 104.714 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -81.46 -36.91 28.78 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.875 -1.157 . . . . 7.4500000000000002 107.875 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -77.81 -167.4 0.97 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.721 2.808 . . . . 4.6299999999999999 110.037 171.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -139.83 26.56 2.27 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.877 1.271 . . . . 2.3999999999999999 109.425 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 179.03 35.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.485 1.114 . . . . 5.7199999999999998 110.202 -152.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.44 -162.27 9.73 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.628 -1.389 . . . . 0.97999999999999998 109.628 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.35 144.95 29.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.294 2.663 . . . . 1.1200000000000001 110.104 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -88.11 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.523 -0.917 . . . . 1.02 108.523 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -111.08 124.01 51.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.568 -1.641 . . . . 2.8199999999999998 106.568 165.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -120.57 124.51 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.95 -1.5 . . . . 1.3600000000000001 106.95 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -140.64 138.0 34.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.609 -0.515 . . . . 1.25 109.609 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.67 139.4 4.66 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.525 -1.43 . . . . 0.98999999999999999 109.525 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.6 m -119.17 91.16 3.49 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.34 1.056 . . . . 2.4100000000000001 108.987 -167.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.2 mm -87.47 152.74 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.091 2.156 . . . . 1.3799999999999999 109.332 -165.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.89 146.69 33.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.329 0.651 . . . . 4.1699999999999999 109.66 -172.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.65 18.99 42.47 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.008 1.289 . . . . 0.60999999999999999 112.703 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 162.58 28.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.566 -0.902 . . . . 0.89000000000000001 108.566 168.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.48 163.84 27.29 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.991 -1.114 . . . . 1.9199999999999999 107.991 155.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.53 176.39 0.5 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.435 -0.791 . . . . 2.3599999999999999 111.133 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.5 -165.95 46.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.659 0.647 . . . . 0.46999999999999997 113.648 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.87 147.94 52.59 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.649 0.78 . . . . 2.3700000000000001 112.023 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -142.52 119.91 11.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.859 1.664 . . . . 0.63 108.059 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.99 148.0 6.8 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.719 -1.352 . . . . 0.44 109.719 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.437 ' CZ ' HG11 ' A' ' 97' ' ' VAL . 24.1 t80 -141.72 95.79 2.87 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.488 -1.301 . . . . 2.46 107.488 -172.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -133.67 161.75 33.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.624 -1.25 . . . . 0.62 107.624 -163.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.83 137.72 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 108.932 -0.766 . . . . 2.0099999999999998 108.932 165.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.415 ' CD2' HG21 ' A' ' 118' ' ' VAL . 22.8 m-70 -98.8 151.11 21.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.579 1.151 . . . . 0.84999999999999998 109.422 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -36.23 -59.62 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.371 1.868 . . . . 4.7699999999999996 112.37 -174.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 2.21 87.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.041 3.337 . . . . 3.3500000000000001 116.706 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.66 -51.72 68.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.12 0.418 . . . . 4.7300000000000004 111.431 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 t0 178.69 92.85 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 126.021 1.729 . . . . 5.25 109.121 167.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -40.28 71.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.377 -0.829 . . . . 4.0899999999999999 112.754 165.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 t 178.47 -42.31 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.014 1.326 . . . . 4.3799999999999999 110.292 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 169.34 -46.93 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 126.712 2.005 . . . . 6.54 109.753 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.31 -106.65 0.23 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 125.045 1.307 . . . . 4.2400000000000002 111.546 -172.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 20.5 p -169.06 -129.37 0.01 OUTLIER 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.006 0.743 . . . . 2.79 113.006 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p 52.47 68.19 0.86 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.361 2.264 . . . . 4.4900000000000002 111.892 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.2 t -172.33 -10.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 117.32 2.341 . . . . 3.3900000000000001 117.32 -141.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.9 155.6 10.24 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.488 1.04 . . . . 2.04 109.527 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.17 -85.17 0.84 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.079 -1.209 . . . . 1.22 110.079 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.61 175.4 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.309 2.673 . . . . 1.0 116.118 -161.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -83.55 57.22 3.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 113.695 -1.593 . . . . 2.04 110.996 -170.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 59.79 75.44 0.4 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.345 0.658 . . . . 1.9199999999999999 109.353 -172.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.21 87.91 0.52 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 3.29 108.939 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -62.81 -43.67 19.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.246 1.297 . . . . 1.6499999999999999 110.136 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.49 -93.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.783 -0.821 . . . . 2.4900000000000002 108.783 165.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.1 p -137.37 60.7 1.64 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.794 0.838 . . . . 3.2599999999999998 110.399 -161.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -82.16 161.64 22.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.769 -1.196 . . . . 4.5599999999999996 107.769 159.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -128.94 175.28 8.78 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.728 -1.582 . . . . 4.3499999999999996 106.728 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -106.08 132.6 51.96 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.251 -1.018 . . . . 1.3500000000000001 108.251 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -124.06 -48.88 0.22 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.437 -1.465 . . . . 3.46 109.437 173.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.54 176.14 21.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.31 1.91 . . . . 1.6699999999999999 109.029 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -57.86 -43.71 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.42 2.08 . . . . 2.0600000000000001 110.614 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -70.47 -47.47 60.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.846 1.658 . . . . 4.2400000000000002 111.817 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.44 152.46 34.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.464 0.705 . . . . 1.78 111.573 -168.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -50.99 -51.43 52.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.582 1.553 . . . . 3.9399999999999999 111.837 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.94 146.42 26.16 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 122.924 1.345 . . . . 3.4500000000000002 111.444 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -170.84 134.69 1.02 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.931 -1.486 . . . . 4.0 107.002 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.2 m80 -51.46 140.74 17.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.219 -1.4 . . . . 0.55000000000000004 107.219 158.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.69 -14.1 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.988 -0.551 . . . . 1.1599999999999999 110.291 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.22 35.22 4.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.071 0.843 . . . . 0.68000000000000005 115.143 165.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -94.89 117.85 30.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.818 1.809 . . . . 1.9299999999999999 106.619 158.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.39 -61.35 2.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.11 -1.441 . . . . 2.7400000000000002 107.11 158.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.41 -106.42 0.25 Allowed Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.387 -0.685 . . . . 0.80000000000000004 111.387 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -152.45 169.84 21.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.493 1.517 . . . . 1.6799999999999999 109.427 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.03 169.99 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.131 -1.433 . . . . 0.45000000000000001 107.131 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.4 m -122.7 120.27 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.618 -1.253 . . . . 2.2599999999999998 107.618 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 141.85 35.85 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.109 0.564 . . . . 0.62 109.888 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.51 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.309 2.244 . . . . 3.9300000000000002 110.459 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -172.88 -45.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.205 1.402 . . . . 3.79 108.855 -161.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -77.5 8.43 4.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.234 1.016 . . . . 2.73 110.929 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.46 19.44 78.13 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.123 -0.985 . . . . 0.79000000000000004 110.728 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.6 t -86.39 137.64 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.087 . . . . 0.67000000000000004 108.064 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.12 167.25 21.31 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.931 -1.507 . . . . 0.78000000000000003 106.931 167.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -148.28 138.41 22.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.176 -1.416 . . . . 3.8700000000000001 107.176 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.437 HG11 ' CZ ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -116.35 56.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 124.331 1.019 . . . . 1.53 111.349 -173.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.8 m -70.3 88.51 0.64 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.981 0.512 . . . . 1.1599999999999999 109.962 166.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.8 mm -127.56 160.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.104 0.961 . . . . 2.1400000000000001 109.611 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -146.66 76.41 1.43 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.397 0.679 . . . . 2.3700000000000001 111.177 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.1 143.73 35.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.935 0.398 . . . . 2.1299999999999999 110.156 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -106.35 -4.21 20.25 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.033 1.733 . . . . 1.55 112.843 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.06 -46.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.701 1.2 . . . . 1.1200000000000001 107.963 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.95 168.82 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.02 0.438 . . . . 1.27 110.507 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 m -146.2 167.52 23.26 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.803 1.641 . . . . 1.78 106.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 pp -99.01 -0.35 42.19 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.597 0.592 . . . . 2.3199999999999998 112.597 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p -155.04 167.41 30.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.189 1.395 . . . . 3.1899999999999999 108.055 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.34 155.12 15.86 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.403 -0.679 . . . . 2.8300000000000001 111.403 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.43 55.57 0.23 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.314 2.645 . . . . 4.2400000000000002 112.192 -169.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -158.4 -36.05 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 128.336 2.655 . . . . 4.4900000000000002 109.6 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.2 p -44.47 155.03 0.1 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.276 1.584 . . . . 1.25 115.276 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.462 HD11 ' CZ ' ' A' ' 20' ' ' PHE 0.271 2.0 pp -95.34 -4.53 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 113.335 -1.757 . . . . 1.5600000000000001 111.207 174.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tp -39.08 131.42 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.892 0.877 . . . . 1.5600000000000001 109.824 162.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.63 49.54 72.89 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.232 -0.747 . . . . 1.9399999999999999 111.232 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -137.1 163.83 29.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.58 -1.637 . . . . 3.9700000000000002 106.58 164.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 m -90.61 111.84 23.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 118.691 -0.671 . . . . 0.97999999999999998 110.121 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.36 143.16 57.32 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.556 -0.905 . . . . 1.72 108.556 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 48' ' ' HIS . 76.6 t -134.67 139.58 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.337 1.855 . . . . 0.46000000000000002 108.294 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -110.96 125.11 68.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.253 -1.017 . . . . 1.5900000000000001 108.253 162.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -94.45 163.46 13.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 115.355 1.613 . . . . 0.44 115.355 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.78 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.201 1.4 . . . . 3.5699999999999998 112.357 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -92.54 -177.85 4.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.775 0.716 . . . . 3.0099999999999998 110.601 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 151.6 16.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.447 -0.946 . . . . 0.56999999999999995 108.447 157.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.78 162.32 29.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.99 -0.744 . . . . 2.0600000000000001 108.99 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.65 -7.2 58.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.43 1.092 . . . . 3.3999999999999999 112.043 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 49.6 40.28 19.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.648 1.179 . . . . 1.8700000000000001 109.307 -168.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 51.78 34.12 36.37 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.453 -0.794 . . . . 2.0600000000000001 113.396 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -130.21 49.99 2.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.492 1.146 . . . . 4.8799999999999999 108.982 -177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.76 132.65 8.78 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.849 -1.7 . . . . 2.4300000000000002 108.849 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.59 -37.38 67.41 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.713 -0.955 . . . . 2.9300000000000002 110.713 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -50.45 103.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.694 1.198 . . . . 2.0499999999999998 109.593 159.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -35.19 10.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.246 1.018 . . . . 3.4300000000000002 111.948 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -28.08 -44.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.157 2.583 . . . . 2.96 112.671 167.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.8 p -49.62 -73.16 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 2.2000000000000002 110.292 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.6 p -61.66 -40.73 95.95 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.298 -0.876 . . . . 1.25 110.818 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.72 -53.27 59.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.392 1.477 . . . . 3.1000000000000001 110.783 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.33 1.3 p -126.07 -45.66 1.7 Allowed 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.96 0.726 . . . . 1.1599999999999999 112.96 172.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.72 -25.43 0.74 Allowed Glycine 0 N--CA 1.463 0.455 0 CA-C-N 118.965 0.802 . . . . 0.93999999999999995 112.029 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 t30 47.51 52.34 12.54 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.412 1.485 . . . . 1.75 110.987 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.37 -47.95 31.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.77 -1.196 . . . . 1.1200000000000001 107.77 162.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.22 -146.06 16.8 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 108.271 -1.932 . . . . 1.23 108.271 164.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.1 m -58.41 156.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.861 1.264 . . . . 1.49 112.77 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -60.73 141.9 56.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.109 -1.405 . . . . 2.54 109.608 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.3 mt -107.73 -71.52 0.75 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 105.992 -1.855 . . . . 0.83999999999999997 105.992 156.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.434 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -97.93 151.79 19.91 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.439 -0.949 . . . . 1.04 108.439 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 67.0 m -139.43 156.69 46.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.604 -1.999 . . . . 2.0 105.604 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.16 130.69 1.79 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.809 -0.916 . . . . 0.72999999999999998 110.809 163.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.55 130.22 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.405 0.682 . . . . 0.96999999999999997 109.578 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 tt -98.76 135.9 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.311 -0.404 . . . . 0.78000000000000003 111.592 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.68 -4.9 0.94 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.11 0.804 . . . . 0.65000000000000002 115.11 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -89.04 58.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.888 1.344 . . . . 1.24 109.559 -159.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.96 151.54 23.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.744 -0.662 . . . . 2.1099999999999999 109.553 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 . . . . . 0 C--O 1.256 1.425 0 N-CA-C 104.48 -2.415 . . . . 6.9500000000000002 104.48 166.005 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.521 -0.918 . . . . 4.9100000000000001 108.521 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 m -70.77 81.09 0.62 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.877 0.871 . . . . 2.9199999999999999 109.935 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' CD ' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -76.14 146.82 38.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 3.0 110.124 -175.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.81 141.21 29.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.31 1.044 . . . . 0.83999999999999997 108.885 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 t -102.61 144.37 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.437 -0.949 . . . . 0.90000000000000002 108.437 162.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.02 100.26 6.65 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 108.615 -0.883 . . . . 0.75 108.615 153.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 101.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.971 -1.122 . . . . 0.81999999999999995 107.971 164.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.44 130.84 36.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.288 -0.634 . . . . 0.90000000000000002 109.288 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -134.58 -57.37 0.83 Allowed 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.747 -0.835 . . . . 4.46 108.747 165.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.83 -143.07 48.42 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.263 0.935 . . . . 1.6200000000000001 113.518 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.51 -46.69 5.65 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.841 1.656 . . . . 4.0300000000000002 108.495 -165.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.45 158.69 22.21 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 109.968 -1.253 . . . . 1.3400000000000001 109.968 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.38 46.77 2.21 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.513 2.808 . . . . 1.0900000000000001 111.83 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.42 ' CB ' ' HB2' ' A' ' 145' ' ' ALA . 38.3 t -100.2 159.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.613 1.565 . . . . 0.90000000000000002 109.524 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.51 129.05 7.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.698 1.599 . . . . 2.4500000000000002 106.798 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.89 175.19 47.0 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.165 -0.774 . . . . 0.79000000000000004 111.165 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.4 mt -126.26 119.18 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.595 -1.632 . . . . 1.9099999999999999 106.595 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.29 134.06 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.197 -1.779 . . . . 0.76000000000000001 106.197 160.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -108.99 121.36 44.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.259 -2.126 . . . . 2.1699999999999999 105.259 162.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -113.47 114.72 26.95 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.944 1.698 . . . . 3.0699999999999998 106.647 175.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -131.33 156.2 45.9 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.294 0.952 . . . . 3.0699999999999998 109.367 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -153.99 146.8 24.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.721 -1.955 . . . . 4.2300000000000004 105.721 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -84.97 -90.26 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.905 -0.776 . . . . 4.7599999999999998 108.905 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.1 mp0 -77.06 149.8 35.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.831 -1.174 . . . . 3.8700000000000001 107.831 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -73.65 -2.17 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.132 -0.98 . . . . 2.2799999999999998 113.001 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -119.12 24.91 10.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.307 1.843 . . . . 4.8099999999999996 109.482 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.42 169.04 18.08 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 108.654 -1.778 . . . . 1.4399999999999999 108.654 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -65.63 139.48 58.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.681 1.587 . . . . 1.45 110.563 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.74 153.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.75 -1.204 . . . . 1.1100000000000001 107.75 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -129.21 131.67 47.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.417 -1.697 . . . . 2.8399999999999999 106.417 172.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.45 139.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.208 1.403 . . . . 1.4399999999999999 107.755 -169.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.22 138.75 21.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.274 -1.01 . . . . 1.1399999999999999 108.274 168.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.93 130.74 2.24 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.388 -1.885 . . . . 1.03 108.388 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.4 p -105.92 85.99 2.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.698 -1.964 . . . . 1.99 105.698 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mm -88.1 153.29 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.309 -1.367 . . . . 1.3999999999999999 107.309 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -147.54 158.19 43.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.128 1.158 . . . . 3.6099999999999999 114.128 168.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.24 9.96 43.28 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.87 2.176 . . . . 0.62 112.481 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 119' ' ' VAL . 1.3 mm? -63.84 160.86 16.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.588 0.755 . . . . 1.1399999999999999 109.369 168.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.57 159.2 26.94 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 107.468 -1.308 . . . . 1.6899999999999999 107.468 155.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.47 177.9 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.947 0.879 . . . . 3.0699999999999998 111.681 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.65 -164.55 54.05 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.02 -0.536 . . . . 0.5 112.036 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.81 148.4 40.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.895 1.678 . . . . 1.95 112.305 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.414 ' CD2' HD12 ' A' ' 38' ' ' LEU . 82.5 m-70 -150.59 111.35 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.239 1.416 . . . . 0.47999999999999998 110.29 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.25 147.4 2.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.549 -0.62 . . . . 0.37 111.549 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.572 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -136.36 96.71 3.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.875 -1.157 . . . . 2.6299999999999999 107.875 -178.058 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -133.28 156.53 47.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.813 -1.551 . . . . 0.62 106.813 -167.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.7 119.46 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.434 1.016 . . . . 1.8200000000000001 109.491 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.43 ' CD2' HG21 ' A' ' 118' ' ' VAL . 16.4 m-70 -91.25 138.46 31.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.659 -1.608 . . . . 0.84999999999999998 106.659 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -40.76 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.684 1.594 . . . . 4.4100000000000001 110.935 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 6.1 tt0 45.62 56.71 5.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.18 0.992 . . . . 3.2400000000000002 112.457 152.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -83.61 15.85 2.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.656 -1.156 . . . . 4.5099999999999998 110.762 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.42 81.71 0.56 Allowed 'General case' 0 C--N 1.342 0.271 0 CA-C-O 122.699 1.237 . . . . 5.5999999999999996 108.705 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -80.09 23.43 0.47 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.727 1.211 . . . . 7.7999999999999998 110.54 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -106.58 -55.56 2.31 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.906 0.882 . . . . 5.8200000000000003 109.162 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.97 -16.98 12.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.209 1.404 . . . . 4.7699999999999996 112.665 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.5 -116.57 5.49 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 118.817 0.735 . . . . 4.79 112.58 167.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.4 t -84.11 60.04 5.67 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.72 0.808 . . . . 2.8900000000000001 111.092 -163.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 p -112.38 0.24 15.58 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.085 1.513 . . . . 5.5999999999999996 115.085 -162.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -177.76 40.25 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 116.831 -1.948 . . . . 3.6400000000000001 115.191 -119.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.83 158.74 6.04 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.487 -0.758 . . . . 2.04 110.486 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.63 -86.5 1.75 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.288 -1.925 . . . . 1.21 108.288 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.25 177.42 8.8 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.621 2.881 . . . . 0.93000000000000005 113.326 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -64.8 134.81 54.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.821 -1.536 . . . . 1.47 108.136 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -37.89 106.66 0.05 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.301 1.041 . . . . 1.77 111.129 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -127.14 143.54 47.41 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 130.817 3.647 . . . . 3.7599999999999998 108.037 -175.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.14 -51.82 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.644 1.563 . . . . 1.2 109.256 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -143.53 -82.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.891 1.276 . . . . 3.0899999999999999 108.08 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -123.59 60.53 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.494 1.118 . . . . 1.8999999999999999 109.751 -164.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -79.01 166.35 22.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.469 0.652 . . . . 3.4500000000000002 110.354 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -118.67 159.29 23.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.644 1.578 . . . . 3.3700000000000001 107.906 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 40.7 t60 -86.94 168.47 13.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.023 0.529 . . . . 0.96999999999999997 112.064 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.7 -126.59 1.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.431 -3.068 . . . . 1.8600000000000001 105.431 165.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.49 -176.74 45.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.929 -2.068 . . . . 1.73 107.929 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.01 -40.43 84.03 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.012 2.475 . . . . 2.3700000000000001 111.463 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -32.61 71.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.166 0.586 . . . . 4.9800000000000004 112.474 174.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -89.09 177.66 6.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.716 0.769 . . . . 2.8599999999999999 112.66 -164.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -55.75 -66.41 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.619 1.168 . . . . 7.2999999999999998 111.405 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -118.23 179.6 4.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.663 2.385 . . . . 3.1099999999999999 112.263 -166.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.83 157.45 1.96 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.7 2.4 . . . . 4.1500000000000004 108.231 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -63.56 153.89 34.33 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.844 -1.169 . . . . 0.54000000000000004 107.844 170.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.76 -37.48 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 119.902 -0.719 . . . . 1.24 110.464 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.03 71.7 0.24 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 112.026 -0.43 . . . . 0.76000000000000001 112.026 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -165.8 113.55 0.94 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.331 -0.988 . . . . 1.8300000000000001 108.331 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.13 -61.39 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.094 -0.706 . . . . 1.97 109.094 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.3 -107.05 0.27 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.139 -1.184 . . . . 0.78000000000000003 110.139 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -147.2 163.25 36.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 125.107 1.363 . . . . 1.48 110.93 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.24 -178.58 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.027 2.131 . . . . 0.51000000000000001 105.867 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.8 t -129.47 171.54 12.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.827 -1.175 . . . . 1.99 107.827 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.11 144.58 50.81 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.308 1.043 . . . . 0.56999999999999995 110.669 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.47 -90.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.386 2.274 . . . . 4.2400000000000002 110.89 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -174.23 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.278 1.031 . . . . 3.29 110.271 -158.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.04 5.0 8.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.118 0.961 . . . . 2.7799999999999998 110.183 165.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.53 23.03 71.38 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.124 -1.19 . . . . 0.85999999999999999 110.124 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.2 t -85.36 136.65 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.364 1.466 . . . . 0.68000000000000005 107.895 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.407 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . . . -131.18 166.22 21.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.691 1.596 . . . . 0.87 109.748 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -142.14 118.45 10.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.038 -2.579 . . . . 2.71 104.038 -158.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.95 55.54 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 123.691 0.62 . . . . 1.51 111.225 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.4 m -77.18 87.86 3.64 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.642 -0.661 . . . . 1.0 109.771 168.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.5 mm -125.39 157.16 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.163 0.985 . . . . 1.76 108.352 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -151.32 99.0 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.637 0.375 . . . . 2.4300000000000002 111.494 166.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -92.17 159.1 15.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.178 0.591 . . . . 2.3999999999999999 110.595 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 p -116.23 -17.52 10.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.62 1.968 . . . . 1.55 113.296 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.75 -50.91 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 119.151 0.887 . . . . 1.3500000000000001 108.656 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.55 175.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.45 0.643 . . . . 1.4299999999999999 110.915 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.1 p -146.33 178.26 8.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.425 2.69 . . . . 2.3300000000000001 105.231 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 44.84 2.9 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.767 1.167 . . . . 2.8799999999999999 111.68 167.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 p -156.87 38.6 0.31 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.976 0.732 . . . . 3.2400000000000002 112.976 -169.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.6 174.96 39.86 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.989 -0.845 . . . . 2.98 110.989 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.56 -44.86 62.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.409 1.483 . . . . 5.8600000000000003 110.741 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -78.61 -23.38 45.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.463 1.105 . . . . 3.1800000000000002 112.53 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.08 176.76 1.17 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.891 0.853 . . . . 1.25 112.327 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.403 HD11 ' CE2' ' A' ' 20' ' ' PHE . 1.4 pp -89.08 -8.65 10.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 CA-C-N 115.327 -0.851 . . . . 1.6799999999999999 111.001 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 tp -33.63 127.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.258 1.423 . . . . 1.98 110.569 159.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.74 -19.52 24.4 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.037 -0.868 . . . . 1.6399999999999999 113.479 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.3 mtt-85 -86.54 168.94 13.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.604 1.702 . . . . 4.1900000000000004 109.281 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 80.7 m -101.82 115.4 30.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.018 -0.427 . . . . 0.88 110.353 -172.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 149.42 45.15 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.65 -0.87 . . . . 2.4300000000000002 108.65 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 48' ' ' HIS . 76.0 t -133.78 128.55 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.454 1.102 . . . . 0.54000000000000004 109.246 171.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 45' ' ' PHE . 25.1 t -99.81 116.24 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 C-N-CA 126.346 1.858 . . . . 2.2799999999999998 106.275 168.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -94.26 160.47 14.67 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.164 1.913 . . . . 0.53000000000000003 116.164 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -41.27 -77.53 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.265 2.626 . . . . 3.2799999999999998 112.481 170.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -97.29 -179.52 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.627 1.571 . . . . 2.5899999999999999 111.147 -168.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.81 153.72 32.11 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.019 -0.734 . . . . 0.80000000000000004 109.019 158.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -85.05 153.36 22.77 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.306 0.574 . . . . 2.02 109.729 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -81.97 -3.93 55.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.617 1.567 . . . . 3.0899999999999999 113.542 -168.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 53.85 32.9 15.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.377 1.071 . . . . 2.6200000000000001 110.773 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.79 14.5 30.22 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 121.08 -1.013 . . . . 2.2200000000000002 113.567 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -127.97 -27.48 2.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.926 1.291 . . . . 6.6799999999999997 110.728 -168.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.05 134.5 40.62 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.547 -1.421 . . . . 2.6800000000000002 109.547 164.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.62 -24.75 33.18 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.152 0.882 . . . . 2.1699999999999999 114.872 -166.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -55.91 125.86 23.27 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 118.295 -0.86 . . . . 2.8500000000000001 109.267 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -47.38 -40.99 18.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.833 1.197 . . . . 3.6899999999999999 111.192 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -47.43 -31.3 4.0 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.56 1.544 . . . . 3.0 111.624 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.99 -72.16 0.07 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.369 -0.604 . . . . 2.21 109.369 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 t -63.44 -41.11 98.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 121.621 -0.674 . . . . 2.5099999999999998 109.485 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.53 -45.41 94.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.75 -0.643 . . . . 3.8599999999999999 112.27 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.467 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.339 0.2 OUTLIER -128.68 -53.08 1.24 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.476 1.034 . . . . 1.27 113.181 173.723 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.71 -22.5 0.4 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.241 0.924 . . . . 1.03 112.201 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.1 t30 49.61 54.53 10.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.651 1.18 . . . . 1.8899999999999999 111.001 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.42 -3.45 58.34 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.672 -0.811 . . . . 1.3300000000000001 111.021 162.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.35 -155.34 45.45 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.249 -1.54 . . . . 0.96999999999999997 109.249 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.8 m -65.45 150.9 47.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.444 -1.378 . . . . 1.55 113.537 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -59.2 135.72 57.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.581 1.552 . . . . 2.96 108.812 170.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 mt -116.55 -76.88 0.57 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.05 -1.092 . . . . 0.82999999999999996 108.05 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 14' ' ' VAL . . . -104.47 145.86 29.69 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.755 -0.831 . . . . 1.23 108.755 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.3 163.81 30.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 123.862 0.726 . . . . 1.53 110.221 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.47 145.87 6.01 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.456 1.979 . . . . 0.72999999999999998 109.035 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.37 139.02 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.875 1.27 . . . . 0.88 108.65 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.6 tt -101.96 139.15 23.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 123.239 0.616 . . . . 0.98999999999999999 112.22 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.35 1.63 1.92 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.395 0.998 . . . . 0.59999999999999998 114.482 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.0 mm -93.61 56.91 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.214 1.507 . . . . 0.80000000000000004 110.3 -156.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.99 168.4 27.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.148 0.579 . . . . 1.3200000000000001 110.461 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 . . . . . 0 C--O 1.256 1.412 0 N-CA-C 101.995 -3.335 . . . . 4.5999999999999996 101.995 162.117 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 107.102 -1.444 . . . . 5.3600000000000003 107.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.3 p -54.54 138.32 40.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.991 -1.115 . . . . 2.6000000000000001 107.991 161.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER -140.65 153.92 46.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.091 0.956 . . . . 4.0499999999999998 108.641 -175.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.95 21.77 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.49 -0.93 . . . . 1.0700000000000001 108.49 167.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 152' ' ' ALA . 53.0 t -107.58 150.68 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 106.666 -1.605 . . . . 1.05 106.666 161.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.1 96.2 3.85 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.706 -0.85 . . . . 0.59999999999999998 108.706 158.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 109.32 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.876 -1.527 . . . . 0.79000000000000004 106.876 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.83 125.03 39.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.571 -1.27 . . . . 0.85999999999999999 107.571 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -49.27 0.14 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 110.575 -0.157 . . . . 4.75 110.575 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.86 -117.21 0.8 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.958 1.266 . . . . 0.69999999999999996 111.247 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.75 -60.15 1.59 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.181 -1.044 . . . . 3.2999999999999998 108.181 -164.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.01 168.24 0.43 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 127.089 2.28 . . . . 0.69999999999999996 113.96 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.79 -21.08 69.49 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.315 2.677 . . . . 1.23 111.657 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.4 141.41 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.736 1.214 . . . . 1.01 110.937 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.0 122.31 5.6 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.119 -1.438 . . . . 1.98 107.119 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.14 168.68 36.51 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.67 -0.572 . . . . 0.63 111.67 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.76 131.3 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.623 -0.88 . . . . 1.4299999999999999 108.623 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.3 mm -97.21 146.63 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.747 -1.575 . . . . 0.82999999999999996 106.747 161.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -131.86 144.51 50.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.472 -1.677 . . . . 2.1299999999999999 106.472 159.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.93 161.51 41.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.535 -0.466 . . . . 3.5499999999999998 111.758 167.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.23 170.64 15.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.541 1.136 . . . . 3.5099999999999998 108.166 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.76 165.41 36.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 104.878 -2.267 . . . . 3.4399999999999999 104.878 165.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.65 -66.14 0.85 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.326 -0.62 . . . . 4.8300000000000001 109.326 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -89.38 166.12 13.93 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.219 1.007 . . . . 3.7400000000000002 110.52 -164.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -78.31 2.26 19.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.402 0.681 . . . . 3.27 111.652 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -153.34 85.4 1.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.205 1.402 . . . . 3.7999999999999998 108.406 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.83 169.74 37.8 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.41 133.61 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.723 2.949 . . . . 1.1200000000000001 112.934 -166.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -106.93 139.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.568 0.747 . . . . 1.1299999999999999 110.115 -171.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -99.5 89.71 4.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.713 0.805 . . . . 6.1500000000000004 109.223 -170.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.2 t -76.82 105.13 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 1.0600000000000001 106.878 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -113.66 140.9 47.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.817 -0.808 . . . . 1.0900000000000001 108.817 166.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.45 156.95 28.77 Favored Glycine 0 N--CA 1.448 -0.528 0 O-C-N 121.472 -0.768 . . . . 0.66000000000000003 112.008 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 p -130.36 104.38 7.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.505 -2.035 . . . . 2.02 105.505 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.01 143.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.381 -1.34 . . . . 0.88 107.381 -168.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -147.78 174.06 12.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.581 0.705 . . . . 3.6400000000000001 112.729 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 22.26 72.38 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 114.868 -1.06 . . . . 0.66000000000000003 112.107 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -76.58 -155.38 0.06 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.475 -1.306 . . . . 0.88 107.475 168.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -146.99 146.15 29.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.848 -2.278 . . . . 3.0699999999999998 104.848 166.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -34.19 132.96 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.719 2.408 . . . . 3.3100000000000001 113.223 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.63 -172.3 20.94 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.284 0.468 . . . . 0.56000000000000005 112.612 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.28 149.03 49.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.667 1.187 . . . . 2.23 112.831 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.34 120.22 9.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 126.279 1.832 . . . . 0.46999999999999997 108.455 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.0 150.06 6.65 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 110.393 -1.083 . . . . 0.35999999999999999 110.393 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.87 95.83 2.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.417 -1.327 . . . . 2.6699999999999999 107.417 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.427 ' ND1' ' CE1' ' A' ' 63' ' ' HIS . 24.0 m170 -134.2 147.16 50.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.264 -1.013 . . . . 0.56000000000000005 108.264 -161.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.294 0.7 OUTLIER -99.43 126.46 52.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.194 0.997 . . . . 1.8600000000000001 109.993 168.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.404 ' CD2' HG21 ' A' ' 118' ' ' VAL . 30.3 m-70 -85.38 -172.97 4.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.233 -1.395 . . . . 1.74 107.233 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -112.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.105 -1.443 . . . . 4.9500000000000002 107.105 161.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 54.4 63.61 2.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.213 -1.032 . . . . 2.9900000000000002 108.213 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -48.63 -48.07 39.8 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.895 -1.048 . . . . 4.4299999999999997 110.412 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -175.91 95.88 0.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.197 1.799 . . . . 5.1900000000000004 109.224 163.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.488 ' ND2' ' H ' ' A' ' 53' ' ' ASN . 2.2 p30 -60.55 -40.82 92.99 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.027 1.731 . . . . 4.2300000000000004 111.941 166.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m 177.48 -49.99 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.321 2.248 . . . . 3.96 107.255 -163.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 179.44 -41.09 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.466 1.507 . . . . 6.7599999999999998 111.011 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.11 -105.6 2.72 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.264 -1.134 . . . . 4.3499999999999996 110.264 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.3 p -161.59 147.23 13.74 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.535 1.534 . . . . 2.3199999999999998 107.098 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.96 8.58 0.08 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.142 1.164 . . . . 3.7599999999999998 114.142 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 p -167.9 -43.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 117.672 2.471 . . . . 2.7400000000000002 117.672 -121.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.06 -145.04 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.777 -1.194 . . . . 2.0600000000000001 107.777 167.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.22 -88.03 0.07 OUTLIER Glycine 0 CA--C 1.522 0.485 0 N-CA-C 108.661 -1.776 . . . . 1.2 108.661 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -71.88 179.13 5.08 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 125.057 3.838 . . . . 1.0600000000000001 112.585 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.427 ' CE1' ' ND1' ' A' ' 46' ' ' HIS . 15.4 m170 -74.23 152.7 39.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.143 -0.935 . . . . 1.5700000000000001 109.327 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -50.82 108.09 0.22 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.382 0.512 . . . . 1.99 112.382 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -121.48 135.32 24.97 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 126.246 1.818 . . . . 3.5 109.147 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.5 -50.43 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.739 1.626 . . . . 1.1599999999999999 108.991 171.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.48 -84.09 0.25 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.94 1.296 . . . . 2.3199999999999998 107.652 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.8 m -132.71 60.88 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.406 1.082 . . . . 1.5900000000000001 110.787 -168.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -77.44 158.7 29.89 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.526 -1.287 . . . . 4.0 107.526 162.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -120.41 163.44 17.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.433 1.493 . . . . 3.0099999999999998 107.713 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -81.58 157.04 24.89 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.22 0.533 . . . . 0.75 111.043 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.88 -155.84 16.54 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 104.469 -3.453 . . . . 2.3999999999999999 104.469 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.63 -131.65 1.24 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.274 -1.53 . . . . 1.5600000000000001 109.274 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.7 -40.67 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.308 2.005 . . . . 1.8400000000000001 111.872 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.29 -46.17 42.94 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.786 0.291 . . . . 4.96 111.786 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.95 176.69 6.93 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.505 -0.554 . . . . 2.4300000000000002 109.505 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.62 -33.55 10.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 5.1399999999999997 111.736 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 162.89 26.74 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 119.111 -1.036 . . . . 3.6200000000000001 110.183 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 133.05 0.05 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.782 2.033 . . . . 3.9100000000000001 108.864 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 46.5 m80 -50.01 144.61 6.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.177 -1.786 . . . . 0.70999999999999996 106.177 155.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.304 5.1 p -83.55 44.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 123.304 1.526 . . . . 1.6899999999999999 110.795 -170.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -154.63 3.68 0.24 Allowed Glycine 0 CA--C 1.545 1.926 1 C-N-CA 131.364 4.316 . . . . 1.8400000000000001 113.125 169.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.19 99.39 8.54 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 121.651 2.726 . . . . 2.0 107.753 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.5 mt -77.31 -44.96 27.77 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.064 0.847 . . . . 2.79 109.103 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.58 -107.82 0.34 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.688 -0.767 . . . . 0.73999999999999999 111.216 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -149.69 171.13 17.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.648 1.579 . . . . 1.52 109.366 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.82 172.27 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.74 -1.578 . . . . 0.55000000000000004 106.74 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.5 m -122.02 124.28 43.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.523 -1.288 . . . . 1.98 107.523 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.88 138.78 38.29 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.642 -0.503 . . . . 0.58999999999999997 109.642 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.72 -89.69 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 124.272 0.982 . . . . 2.7799999999999998 110.228 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 -57.84 1.0 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.295 1.038 . . . . 3.4300000000000002 110.085 -164.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.36 25.04 1.48 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 123.352 1.549 . . . . 2.96 110.911 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 62.91 19.71 61.4 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.917 -1.038 . . . . 0.82999999999999996 111.51 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.72 139.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.13 -1.433 . . . . 0.80000000000000004 107.13 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.99 166.18 23.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.856 1.263 . . . . 0.70999999999999996 107.887 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -128.0 143.23 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.766 -2.679 . . . . 2.8900000000000001 103.766 -173.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.39 121.7 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.381 -1.711 . . . . 1.4399999999999999 106.381 173.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -150.59 91.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.947 1.299 . . . . 0.82999999999999996 108.604 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.48 144.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 107.951 -1.129 . . . . 1.8700000000000001 107.951 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -112.51 83.44 1.81 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.656 -1.609 . . . . 3.7400000000000002 106.656 161.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.28 146.29 33.06 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.1 p -108.06 -7.95 15.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.764 2.025 . . . . 1.48 112.28 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.59 -55.53 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.78 -1.193 . . . . 1.3600000000000001 107.78 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.8 pt -70.35 176.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 122.312 1.053 . . . . 1.54 112.008 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 m -153.4 176.96 11.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.663 1.985 . . . . 2.04 106.233 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 -19.61 25.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.319 0.963 . . . . 3.04 113.434 -169.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 m -159.7 90.32 0.93 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.034 -1.041 . . . . 3.8900000000000001 111.857 -168.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 167.63 179.06 40.14 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.148 -1.181 . . . . 3.2200000000000002 110.148 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -36.14 -52.7 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.601 1.191 . . . . 5.6100000000000003 111.761 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -76.96 -23.78 52.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.503 -1.226 . . . . 5.0999999999999996 110.428 -169.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.5 p -63.95 151.1 43.61 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.542 0.61 . . . . 1.3799999999999999 111.113 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.38 -5.89 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.389 -0.823 . . . . 1.97 110.553 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -51.49 120.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.094 -0.706 . . . . 1.6200000000000001 109.094 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.85 39.61 95.14 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.61 -0.55 . . . . 1.77 112.8 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -120.79 167.94 11.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.265 -1.383 . . . . 5.4699999999999998 107.265 158.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.7 m -91.69 118.3 30.53 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.846 0.458 . . . . 0.95999999999999996 111.043 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 144.4 45.56 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.145 -1.057 . . . . 1.5800000000000001 108.145 164.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.404 HG21 ' CD2' ' A' ' 48' ' ' HIS . 75.0 t -131.54 140.33 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.189 1.796 . . . . 0.40000000000000002 107.818 174.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.63 127.44 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.129 -1.063 . . . . 1.55 108.129 164.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -97.08 159.61 14.81 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.474 2.028 . . . . 0.40999999999999998 116.474 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -47.57 -73.4 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.257 1.823 . . . . 3.02 112.243 172.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -97.35 179.87 4.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.002 0.921 . . . . 4.2800000000000002 110.264 -172.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.61 147.96 39.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.031 -0.729 . . . . 0.54000000000000004 109.031 160.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -77.32 162.73 27.07 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.278 -0.638 . . . . 1.97 109.278 167.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.13 -8.47 59.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.424 1.268 . . . . 3.0800000000000001 114.424 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 48.97 30.3 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.695 1.134 . . . . 1.4299999999999999 110.89 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.56 28.18 72.85 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.152 0.882 . . . . 1.8500000000000001 112.502 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -130.41 29.48 4.84 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.034 0.917 . . . . 5.4400000000000004 111.226 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -96.44 135.2 12.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 108.467 -1.853 . . . . 2.29 108.467 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.08 66.27 2.88 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 117.63 0.715 . . . . 2.25 112.43 -171.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -168.84 170.72 8.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 125.085 1.354 . . . . 3.3999999999999999 108.092 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -52.09 -71.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.062 0.545 . . . . 3.6099999999999999 110.897 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -47.72 -41.96 24.13 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.868 2.067 . . . . 3.8300000000000001 111.947 -162.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.2 m -46.09 -58.54 3.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.994 0.917 . . . . 2.5600000000000001 112.071 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -73.07 -40.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.792 -1.193 . . . . 1.49 112.511 173.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -66.25 -36.29 82.62 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.376 1.07 . . . . 5.8399999999999999 110.549 -165.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.377 13.1 t -133.47 -46.27 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.604 0.762 . . . . 2.0699999999999998 111.562 172.222 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.37 -18.45 1.33 Allowed Glycine 0 N--CA 1.467 0.752 0 CA-C-N 119.886 1.221 . . . . 0.89000000000000001 112.877 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 34.36 56.28 0.66 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.077 2.551 . . . . 2.5699999999999998 112.347 -174.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.44 -1.61 27.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.417 -0.513 . . . . 1.1000000000000001 111.994 167.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.81 -163.23 45.64 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.017 -1.633 . . . . 0.94999999999999996 109.017 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.4 m -60.86 148.79 38.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.026 -1.587 . . . . 1.28 113.822 -161.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -57.47 130.82 48.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.392 -1.277 . . . . 2.6699999999999999 107.799 165.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.7 mt -106.64 -73.1 0.7 Allowed 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 107.746 -1.205 . . . . 0.46999999999999997 107.746 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.25 144.45 34.04 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.705 -1.22 . . . . 0.67000000000000004 107.705 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 85.8 m -126.87 160.58 30.53 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.522 -2.029 . . . . 2.1299999999999999 105.522 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.8 131.19 1.85 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.013 -0.835 . . . . 0.68999999999999995 111.013 169.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.6 t -62.94 134.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.669 0.788 . . . . 0.69999999999999996 109.404 169.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.6 tt -95.67 134.81 31.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.714 0.293 . . . . 0.95999999999999996 111.116 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.54 3.81 0.49 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.062 0.839 . . . . 0.81000000000000005 115.033 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.8 mm -92.77 57.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.52 1.66 . . . . 1.01 110.91 -155.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.566 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -155.57 170.92 20.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.488 0.715 . . . . 1.46 110.792 167.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 83.9 mt-30 . . . . . 0 C--O 1.255 1.359 0 N-CA-C 103.065 -2.939 . . . . 4.6600000000000001 103.065 163.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 107.352 -1.351 . . . . 7.4500000000000002 107.352 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 m -45.25 141.86 2.29 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.313 1.445 . . . . 3.5899999999999999 111.906 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -78.57 174.93 10.85 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.474 0.31 . . . . 3.8799999999999999 110.643 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.26 41.71 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.003 1.321 . . . . 0.92000000000000004 107.562 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.92 143.74 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 106.701 -1.592 . . . . 1.02 106.701 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.575 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -122.4 93.34 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.698 . . . . 0.56000000000000005 109.114 156.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.68 100.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.246 -1.39 . . . . 1.04 107.246 164.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.9 mt -89.13 143.16 27.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.996 0.518 . . . . 1.26 109.767 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -143.73 -64.2 0.38 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.206 -1.035 . . . . 4.0300000000000002 108.206 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.36 -122.9 13.14 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.748 -0.66 . . . . 0.96999999999999997 113.14 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -126.43 -55.98 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.387 0.613 . . . . 2.98 110.014 -152.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.31 164.15 25.07 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 110.049 -1.22 . . . . 0.73999999999999999 110.049 164.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.74 34.25 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.674 2.916 . . . . 1.1000000000000001 113.586 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.5 155.1 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.722 1.609 . . . . 1.1200000000000001 109.69 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.03 125.69 9.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.799 -1.926 . . . . 2.46 105.799 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.61 164.15 31.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.194 -0.763 . . . . 0.76000000000000001 111.194 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.636 -1.616 . . . . 1.01 106.636 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 3.0 mp -90.48 144.06 9.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.432 -1.692 . . . . 1.79 106.432 161.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.5 102.72 7.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.395 1.478 . . . . 1.78 107.104 167.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -79.77 118.76 21.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.615 -1.995 . . . . 2.46 105.615 169.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -142.67 145.84 33.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.52 1.055 . . . . 3.2799999999999998 108.902 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -157.18 146.06 19.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.223 -0.444 . . . . 4.4500000000000002 109.919 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -68.43 -61.26 1.91 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.275 1.03 . . . . 5.0099999999999998 109.755 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -78.48 -175.92 4.52 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 119.018 0.827 . . . . 4.1299999999999999 110.194 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -81.0 -68.68 0.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.035 -1.468 . . . . 2.6899999999999999 107.035 165.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -90.56 106.02 18.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.907 0.883 . . . . 4.5499999999999998 109.293 171.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.08 176.17 45.88 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 107.94 -2.064 . . . . 1.23 107.94 166.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.84 116.84 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.317 2.678 . . . . 1.46 110.635 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.8 t -78.62 147.39 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.312 -0.625 . . . . 0.98999999999999999 109.312 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -98.14 113.37 25.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.809 -1.552 . . . . 3.1899999999999999 106.809 171.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 20' ' ' PHE . 56.6 t -115.25 82.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.996 1.718 . . . . 1.1399999999999999 106.974 -169.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -98.07 158.84 15.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.078 -0.712 . . . . 0.85999999999999999 109.078 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.72 158.94 29.36 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.769 -0.933 . . . . 0.72999999999999998 110.769 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.9 p -129.16 104.07 7.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.762 -1.94 . . . . 2.52 105.762 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.7 141.95 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.082 -1.451 . . . . 0.92000000000000004 107.082 -168.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.11 159.9 41.69 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.593 1.331 . . . . 3.23 114.593 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.4 22.84 25.79 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.957 1.742 . . . . 1.1200000000000001 111.81 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.33 -156.05 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.105 -1.072 . . . . 1.27 108.105 166.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 m -146.27 152.17 38.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.749 -2.315 . . . . 3.21 104.749 165.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -37.98 141.39 0.21 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.273 2.229 . . . . 2.8599999999999999 113.77 -170.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.66 -171.87 26.76 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.238 -0.437 . . . . 0.63 112.323 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 151.47 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.286 1.035 . . . . 2.3500000000000001 112.804 -168.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -146.66 118.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.194 1.797 . . . . 0.87 108.154 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.01 154.25 3.89 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.035 -1.226 . . . . 0.57999999999999996 110.035 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -145.47 89.79 1.96 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.612 -1.255 . . . . 2.6800000000000002 107.612 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -128.72 164.58 22.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.156 -1.053 . . . . 0.84999999999999998 108.156 -160.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 134.0 66.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 122.055 0.931 . . . . 2.0499999999999998 110.488 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.497 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 21.5 m-70 -110.05 132.82 53.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.371 1.469 . . . . 0.96999999999999997 107.241 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HA ' ' HG2' ' A' ' 115' ' ' ARG . 13.4 mt-10 -74.11 65.95 1.18 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.876 1.27 . . . . 5.7699999999999996 111.19 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' CB ' ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -138.4 171.58 14.16 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.516 -1.675 . . . . 5.6500000000000004 107.446 168.365 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -105.73 35.73 2.78 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 128.486 2.714 . . . . 6.3399999999999999 109.681 169.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.86 75.14 0.62 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.778 2.031 . . . . 9.9299999999999997 107.863 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -90.05 -52.19 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.206 -0.934 . . . . 6.2400000000000002 110.132 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -56.55 136.15 54.43 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.715 1.206 . . . . 6.4000000000000004 111.495 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.32 145.4 6.27 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.16 -0.682 . . . . 7.3399999999999999 109.16 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.36 56.0 4.87 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.784 -1.727 . . . . 5.9199999999999999 108.784 -162.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.6 m -75.08 59.75 0.97 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.119 1.367 . . . . 3.3900000000000001 109.475 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -118.78 75.55 1.04 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.926 0.891 . . . . 5.0599999999999996 108.666 -154.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 t 179.29 -68.07 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.455 -0.793 . . . . 2.6600000000000001 111.043 -142.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 48' ' ' HIS . . . -60.03 134.4 57.01 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.945 -0.472 . . . . 1.95 110.614 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.25 -126.45 3.2 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.069 -1.213 . . . . 1.0600000000000001 110.069 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.15 178.68 6.63 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.894 3.062 . . . . 0.82999999999999996 112.629 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.66 126.02 28.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.519 -1.229 . . . . 1.23 108.031 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -5.56 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.243 2.217 . . . . 2.5600000000000001 113.394 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -125.81 130.51 24.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 127.318 2.247 . . . . 3.5699999999999998 108.719 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.73 -43.77 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.8 1.666 . . . . 1.1699999999999999 109.729 173.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.54 -73.11 0.42 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.718 1.207 . . . . 2.46 107.923 172.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.5 m -154.0 83.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.423 -0.798 . . . . 2.2200000000000002 109.767 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -79.5 168.52 19.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.399 -0.593 . . . . 4.6900000000000004 109.399 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -102.93 152.93 20.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 107.264 -1.384 . . . . 3.6200000000000001 107.264 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -75.41 163.21 27.66 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.114 0.87 . . . . 0.93000000000000005 110.349 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.6 -103.54 0.17 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.846 -2.502 . . . . 1.9299999999999999 106.846 167.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.26 -121.21 2.51 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.496 1.148 . . . . 2.1000000000000001 111.547 167.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -86.58 -42.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.541 2.161 . . . . 1.6200000000000001 111.306 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -64.15 0.96 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.095 -1.076 . . . . 4.9400000000000004 108.095 174.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.87 143.09 54.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.265 -0.879 . . . . 2.0699999999999998 109.34 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -54.87 -46.93 74.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 126.449 1.899 . . . . 5.21 111.667 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.59 176.57 6.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.246 1.018 . . . . 3.4700000000000002 110.924 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 154.86 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.616 1.166 . . . . 4.5499999999999998 110.995 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.6 m80 -54.53 141.86 29.77 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.682 -1.97 . . . . 0.64000000000000001 105.682 155.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.08 -17.81 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.298 -0.561 . . . . 1.3600000000000001 110.973 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.4 52.37 0.75 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.506 -0.608 . . . . 0.76000000000000001 114.574 162.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -96.71 124.51 40.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 105.463 -2.051 . . . . 2.0699999999999998 105.463 143.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.06 -51.64 6.52 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.33 0.968 . . . . 2.4500000000000002 108.399 161.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.49 -115.35 0.64 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.713 -1.355 . . . . 0.93000000000000005 109.713 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -148.63 166.56 27.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.359 1.463 . . . . 1.8500000000000001 109.362 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.3 174.28 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.648 -1.612 . . . . 0.78000000000000003 106.648 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.4 m -129.02 129.67 45.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 2.0600000000000001 107.306 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 135.49 37.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.324 -0.621 . . . . 0.72999999999999998 109.324 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.84 -69.91 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.725 1.266 . . . . 4.0199999999999996 110.356 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -168.87 -53.94 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.95 2.1 . . . . 5.2800000000000002 108.528 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.44 23.29 1.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.934 1.293 . . . . 3.5899999999999999 110.563 -167.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.26 4.97 75.36 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.52 1.057 . . . . 1.1100000000000001 112.182 -174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.85 154.34 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.022 -1.103 . . . . 1.3999999999999999 108.022 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.64 171.32 14.21 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.525 1.13 . . . . 0.87 108.079 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.41 151.45 38.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 104.266 -2.494 . . . . 2.75 104.266 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.07 134.19 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 107.788 -1.19 . . . . 1.74 107.788 145.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.3 m -155.42 61.35 0.62 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.012 1.725 . . . . 1.1100000000000001 107.748 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -105.91 155.56 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 108.036 -1.098 . . . . 1.47 108.036 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.06 118.64 14.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.135 -0.691 . . . . 2.7000000000000002 109.135 150.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.46 -174.4 5.17 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.59 0.71 . . . . 4.0999999999999996 109.664 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.6 p -144.75 51.41 1.25 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.197 -1.038 . . . . 2.4300000000000002 108.197 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.4 -54.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.329 1.452 . . . . 1.52 108.957 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -96.32 179.76 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.165 0.986 . . . . 1.1200000000000001 109.928 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.1 m -152.31 176.82 11.22 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.192 -1.41 . . . . 2.1600000000000001 107.192 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.65 47.96 1.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.733 1.254 . . . . 2.71 110.712 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p -95.95 -29.95 13.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.742 2.017 . . . . 3.96 112.937 -169.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.55 -179.52 30.55 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 108.008 -2.037 . . . . 2.77 108.008 -152.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.0 t70 55.52 -106.9 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.533 1.133 . . . . 4.0899999999999999 110.518 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.01 -11.55 59.97 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.869 0.868 . . . . 4.1600000000000001 111.409 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -58.5 156.95 9.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.277 -0.889 . . . . 1.1699999999999999 111.647 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.415 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 15.2 pt -78.05 -10.28 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.538 -0.744 . . . . 1.73 111.904 174.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.4 mm -40.6 123.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 1.8200000000000001 110.68 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.14 50.89 6.02 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.558 -0.617 . . . . 2.0699999999999998 111.558 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.427 ' HG2' ' HA ' ' A' ' 49' ' ' GLU . 2.2 mtt85 -136.62 153.52 50.92 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.535 1.134 . . . . 3.8799999999999999 109.264 168.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 98.7 m -79.63 115.95 19.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 124.326 1.016 . . . . 1.1899999999999999 108.397 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tt -86.03 136.5 33.22 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 118.901 0.773 . . . . 2.1400000000000001 109.427 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -124.86 120.21 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.958 -1.127 . . . . 0.48999999999999999 107.958 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.94 118.59 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 105.523 -2.029 . . . . 1.6799999999999999 105.523 161.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -90.07 162.83 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.249 1.574 . . . . 0.53000000000000003 115.249 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -38.78 -69.13 0.13 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.068 2.547 . . . . 3.23 111.907 170.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -120.75 -177.71 3.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.622 1.169 . . . . 2.71 110.624 -167.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.62 57.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.274 -0.639 . . . . 0.54000000000000004 109.274 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -81.07 156.28 25.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.056 -0.72 . . . . 2.23 109.056 158.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -22.93 60.08 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.332 0.653 . . . . 3.5099999999999998 111.664 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.98 56.77 2.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.823 0.82 . . . . 2.3599999999999999 109.573 -168.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.87 73.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.156 -0.929 . . . . 1.6100000000000001 113.438 157.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -77.3 -23.31 51.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.932 -0.746 . . . . 6.7300000000000004 110.217 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 71.76 -118.66 7.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.415 -1.474 . . . . 3.1200000000000001 109.415 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.72 -68.44 1.57 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.334 -1.506 . . . . 2.46 109.334 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -94.41 161.61 14.16 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.79 -1.189 . . . . 2.7599999999999998 107.79 160.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.62 -53.53 46.16 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.242 -0.286 . . . . 3.5299999999999998 110.649 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -49.03 -40.94 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.818 1.647 . . . . 2.9399999999999999 113.45 -169.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.9 m -47.16 -54.27 11.03 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.77 0.828 . . . . 2.2000000000000002 112.004 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -44.6 60.96 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.46 -0.775 . . . . 1.53 111.78 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -59.62 -50.84 72.33 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.976 0.911 . . . . 2.7400000000000002 111.207 -166.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.464 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.35 0.1 OUTLIER -124.7 -46.39 1.87 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.568 -0.73 . . . . 1.1399999999999999 111.56 175.086 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.35 -2.1 0.67 Allowed Glycine 0 C--O 1.222 -0.652 0 CA-C-O 118.009 -1.439 . . . . 1.03 115.531 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 27.63 52.72 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.151 2.181 . . . . 4.2800000000000002 114.589 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.21 -16.42 60.48 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.416 -0.803 . . . . 0.89000000000000001 111.93 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.67 -171.32 36.08 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 109.142 -1.583 . . . . 0.95999999999999996 109.142 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -62.46 156.01 23.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.639 -1.28 . . . . 1.25 113.564 -164.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -73.1 148.05 44.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.959 -1.019 . . . . 2.4700000000000002 111.14 173.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mt -128.73 -69.43 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.537 -1.283 . . . . 0.78000000000000003 107.537 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.02 163.58 12.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.918 -0.771 . . . . 1.3100000000000001 108.918 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.9 p -165.07 160.45 18.86 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.678 -1.601 . . . . 1.9099999999999999 106.678 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.49 143.16 3.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 105.766 -2.933 . . . . 1.0800000000000001 105.766 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.5 t -81.37 139.85 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 117.901 0.851 . . . . 1.29 110.213 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.8 tt -86.49 131.88 33.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.899 0.38 . . . . 0.82999999999999996 110.484 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.83 -8.62 0.97 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.048 0.833 . . . . 0.93000000000000005 115.002 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mm -90.56 57.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.662 1.231 . . . . 1.03 110.546 -157.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.92 175.87 5.79 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.556 0.742 . . . . 2.04 110.465 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 C--O 1.257 1.451 0 N-CA-C 104.113 -2.551 . . . . 4.29 104.113 164.814 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.333 -0.365 . . . . 7.1500000000000004 110.856 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 p -70.25 177.58 3.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.08 0.952 . . . . 3.6800000000000002 110.538 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 148.77 23.98 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.584 0.754 . . . . 3.6600000000000001 109.972 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.85 148.41 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.866 1.666 . . . . 0.69999999999999996 108.367 169.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.92 144.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.39 -0.967 . . . . 0.63 108.39 165.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.93 97.03 5.3 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.841 -0.8 . . . . 0.42999999999999999 108.841 155.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.26 106.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.992 -1.485 . . . . 0.51000000000000001 106.992 161.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -90.31 133.91 34.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 0.91000000000000003 108.456 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -149.45 -50.99 0.15 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.413 0.685 . . . . 3.2200000000000002 110.527 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.06 -117.5 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.352 0.977 . . . . 0.92000000000000004 113.501 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -114.33 -54.82 2.55 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.661 1.184 . . . . 4.0700000000000003 109.69 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.77 159.73 21.42 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 110.336 -1.106 . . . . 0.85999999999999999 110.336 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.11 40.6 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.342 2.695 . . . . 1.0 112.179 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 40.6 t -92.59 159.47 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.003 1.721 . . . . 0.81000000000000005 108.616 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.81 135.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.948 -1.501 . . . . 2.3500000000000001 106.948 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 169.31 42.27 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.916 -1.274 . . . . 0.67000000000000004 109.916 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.87 110.16 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.115 -1.439 . . . . 0.97999999999999998 107.115 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.2 125.34 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.756 -1.572 . . . . 0.72999999999999998 106.756 168.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -99.36 109.56 22.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.699 -1.963 . . . . 2.0499999999999998 105.699 166.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CG ' HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -98.01 105.56 17.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.554 -2.017 . . . . 2.5499999999999998 105.554 171.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.25 138.31 49.14 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.948 1.249 . . . . 3.6600000000000001 110.264 169.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -156.67 105.71 2.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.159 -1.052 . . . . 3.7999999999999998 108.159 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -89.36 36.38 0.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.89 0.476 . . . . 7.2199999999999998 111.33 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -125.63 -138.06 0.27 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.221 -1.4 . . . . 4.8499999999999996 107.221 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -130.3 -76.62 0.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.349 0.66 . . . . 3.4300000000000002 109.345 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -101.8 86.04 2.84 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.184 -1.784 . . . . 5.0 106.184 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.64 34.68 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.597 -1.001 . . . . 1.71 110.597 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.92 132.11 29.27 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.512 2.808 . . . . 1.6200000000000001 112.297 -170.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.6 t -91.89 149.24 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.307 -0.997 . . . . 1.04 108.307 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 121.67 44.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.729 -1.582 . . . . 2.6400000000000001 106.729 163.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.412 HG22 ' CE1' ' A' ' 20' ' ' PHE . 48.8 t -115.86 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.245 1.818 . . . . 1.03 107.25 -170.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -127.23 126.88 43.52 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 123.507 0.505 . . . . 1.25 110.743 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.2 137.02 5.06 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.56 -1.416 . . . . 0.89000000000000001 109.56 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -116.53 110.25 18.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.929 -1.878 . . . . 2.77 105.929 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 mm -103.1 152.81 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.595 1.958 . . . . 1.22 108.866 -164.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -149.55 156.17 41.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.28 0.844 . . . . 3.46 113.28 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.52 15.11 33.06 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.782 2.134 . . . . 0.60999999999999999 112.458 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 43' ' ' HIS . 2.8 mm? -69.54 162.49 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.18 0.992 . . . . 1.25 110.035 170.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.49 161.63 24.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.927 -1.138 . . . . 1.6899999999999999 107.927 157.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -56.87 174.85 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.786 0.803 . . . . 2.4399999999999999 111.775 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.8 -169.52 52.4 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.986 0.803 . . . . 0.78000000000000003 113.687 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.82 153.02 44.54 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.892 1.277 . . . . 2.23 111.754 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.489 ' CD2' HD12 ' A' ' 38' ' ' LEU . 89.3 m-70 -149.36 117.72 6.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.869 1.667 . . . . 0.42999999999999999 108.365 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.37 150.44 4.32 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.712 -0.955 . . . . 0.34999999999999998 110.712 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -140.85 95.66 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.827 -1.545 . . . . 2.5699999999999998 106.827 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -134.11 155.97 49.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.033 -1.469 . . . . 0.54000000000000004 107.033 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.27 126.84 67.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.091 -0.707 . . . . 1.6299999999999999 109.091 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.453 ' CD2' HG21 ' A' ' 118' ' ' VAL . 25.7 m-70 -95.2 142.58 27.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.883 1.673 . . . . 0.75 108.376 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -46.49 -64.8 0.67 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.726 1.211 . . . . 4.2599999999999998 110.935 -171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 38.91 54.6 2.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.706 2.403 . . . . 3.2000000000000002 114.73 155.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -50.0 -59.42 3.9 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 127.142 2.177 . . . . 5.6699999999999999 112.787 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -141.71 55.88 1.5 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.741 1.616 . . . . 6.9699999999999998 108.812 -156.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -77.96 -66.64 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.803 -1.09 . . . . 4.4199999999999999 110.767 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.5 t 179.47 -47.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.976 1.71 . . . . 4.79 109.781 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 177.25 -48.28 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.322 1.849 . . . . 6.8600000000000003 109.494 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.18 -118.11 2.92 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.549 -1.02 . . . . 4.7000000000000002 110.549 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.1 p -126.85 155.68 42.54 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.307 2.243 . . . . 2.8599999999999999 105.675 172.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.75 -1.81 0.07 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.033 1.494 . . . . 3.7200000000000002 115.033 164.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.2 t -160.3 -48.18 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 116.405 -2.118 . . . . 2.9199999999999999 114.245 -110.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.04 -114.19 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.188 -0.671 . . . . 2.3500000000000001 109.188 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.74 -89.11 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 107.945 -2.062 . . . . 1.1399999999999999 107.945 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.56 177.65 8.25 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 124.823 3.682 . . . . 0.96999999999999997 112.948 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -66.43 142.02 57.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.921 1.688 . . . . 1.4199999999999999 107.551 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -49.49 115.66 1.43 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.402 0.681 . . . . 1.71 110.95 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.58 111.88 9.82 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.995 1.718 . . . . 2.8500000000000001 108.819 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.6 -10.9 29.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.85 1.7 . . . . 1.72 113.46 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -146.52 -72.64 0.23 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.745 -0.835 . . . . 2.2999999999999998 108.745 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -161.74 92.7 0.88 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.758 -1.201 . . . . 2.3900000000000001 107.758 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.29 175.53 5.68 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.048 1.739 . . . . 5.7400000000000002 108.202 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 9.9 mtpm? -133.8 153.27 51.84 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.575 1.55 . . . . 3.9700000000000002 107.397 -174.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -87.87 136.98 32.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.807 0.843 . . . . 1.28 109.908 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.68 -66.53 0.14 Allowed Glycine 0 C--O 1.222 -0.636 0 N-CA-C 107.519 -2.232 . . . . 2.7599999999999998 107.519 163.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.0 -170.21 35.37 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.007 1.289 . . . . 1.4099999999999999 111.595 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.02 -42.61 5.9 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.789 2.326 . . . . 1.6799999999999999 110.343 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.35 -54.08 7.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.546 0.738 . . . . 4.6600000000000001 111.107 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.05 149.31 50.1 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.439 -0.948 . . . . 2.02 108.439 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -49.53 -51.92 33.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.058 0.943 . . . . 3.9500000000000002 110.532 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 59.5 mt-10 -76.11 152.5 36.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.751 1.262 . . . . 3.75 110.694 -163.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -175.05 134.66 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.394 1.478 . . . . 3.3300000000000001 108.177 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 34.4 m80 -50.87 137.75 20.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.154 -2.165 . . . . 0.77000000000000002 105.154 147.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.44 -24.76 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 119.342 -0.943 . . . . 1.46 109.73 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.65 33.94 4.75 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.133 -1.371 . . . . 0.82999999999999996 116.504 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -102.81 112.95 25.98 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 120.72 2.26 . . . . 1.96 107.937 161.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 84' ' ' LEU . 4.0 mm? -78.66 -57.58 3.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.449 -1.315 . . . . 1.52 107.449 160.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.85 -110.63 0.43 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.806 -0.918 . . . . 0.58999999999999997 110.806 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -146.72 169.31 19.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.666 1.186 . . . . 1.3600000000000001 109.898 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.5 176.56 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 105.998 -1.853 . . . . 0.62 105.998 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.3 m -140.27 132.71 28.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.363 -2.088 . . . . 2.02 105.363 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.666 0.604 . . . . 0.68999999999999995 110.127 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.72 -80.98 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.119 0.968 . . . . 2.9700000000000002 109.407 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.2 tttm -160.2 -43.54 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.563 1.145 . . . . 3.96 111.878 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -81.99 30.61 0.38 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 123.739 1.733 . . . . 3.2599999999999998 110.833 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 64.72 17.73 63.02 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.002 1.763 . . . . 1.0700000000000001 112.571 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.52 147.82 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.54 -1.281 . . . . 1.1299999999999999 107.54 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.06 175.02 11.35 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.114 -1.439 . . . . 0.90000000000000002 107.114 166.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.31 149.95 29.22 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.386 -1.338 . . . . 3.2400000000000002 107.386 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.37 103.41 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 C-N-CA 125.621 1.569 . . . . 1.25 106.791 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.5 m -121.48 87.52 2.77 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.377 1.471 . . . . 1.0 107.789 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.8 mt -126.45 160.51 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.555 0.742 . . . . 1.3899999999999999 109.034 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.33 95.78 2.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.194 -0.457 . . . . 2.3300000000000001 111.503 157.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.35 154.46 25.25 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.311 0.577 . . . . 2.0499999999999998 110.243 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.1 p -107.76 -17.54 14.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.224 2.21 . . . . 1.73 112.386 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.33 -51.3 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.259 0.936 . . . . 1.02 109.426 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.415 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.4 pp -71.81 176.23 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.858 0.837 . . . . 1.0900000000000001 111.051 174.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -156.85 173.7 16.6 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.877 -1.157 . . . . 1.78 107.877 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -43.69 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.761 0.824 . . . . 2.7000000000000002 110.558 169.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.0 t -101.72 35.25 2.37 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.424 -0.797 . . . . 4.4500000000000002 112.389 -158.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -149.65 -137.53 2.78 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 118.805 0.729 . . . . 3.1499999999999999 112.232 -169.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -100.14 -67.97 0.83 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.177 0.991 . . . . 5.9199999999999999 109.338 -166.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -79.87 2.76 22.02 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.24 1.016 . . . . 3.3900000000000001 111.684 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.64 157.42 0.77 Allowed 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.651 1.58 . . . . 1.4199999999999999 112.829 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.4 pt -90.53 -5.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.085 0.954 . . . . 2.02 111.218 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 tp -26.55 126.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.889 1.675 . . . . 1.98 111.876 163.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.26 -19.09 37.26 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.827 -0.985 . . . . 1.5700000000000001 113.433 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -88.81 164.08 15.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.576 1.688 . . . . 4.6500000000000004 110.807 -169.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.2 m -89.06 106.17 18.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 119.226 -0.416 . . . . 0.95999999999999996 110.603 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 mt -65.72 146.37 54.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.613 -0.835 . . . . 1.6499999999999999 108.775 166.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.453 HG21 ' CD2' ' A' ' 48' ' ' HIS . 80.6 t -135.47 135.46 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.443 1.897 . . . . 0.40000000000000002 109.046 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 145' ' ' ALA . 55.1 t -102.25 119.62 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.153 1.781 . . . . 2.3700000000000001 106.412 166.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -92.96 159.32 15.38 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 116.839 2.163 . . . . 0.40000000000000002 116.839 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -33.3 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.501 3.121 . . . . 3.3700000000000001 112.364 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -107.14 -175.98 2.95 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.059 0.845 . . . . 2.8300000000000001 110.458 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.86 142.53 45.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.504 -0.924 . . . . 0.87 108.504 158.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.21 165.95 24.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.242 -0.651 . . . . 2.2200000000000002 109.242 159.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -88.45 -7.13 57.08 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.396 1.478 . . . . 3.3500000000000001 111.227 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.28 46.16 27.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.346 1.458 . . . . 1.8400000000000001 110.2 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.27 24.06 58.45 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.644 -0.531 . . . . 1.7 113.627 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -78.34 -13.66 59.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.441 1.121 . . . . 5.04 110.633 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.0 -133.34 11.74 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.588 -1.005 . . . . 2.6200000000000001 110.588 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.95 -68.32 1.33 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.221 -1.552 . . . . 2.29 109.221 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.09 150.97 19.61 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.222 -1.029 . . . . 2.6499999999999999 108.222 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.24 -48.76 79.99 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.81 -0.556 . . . . 3.5 111.248 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -51.94 -33.46 37.56 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.114 1.366 . . . . 3.1099999999999999 111.777 -168.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.2 t -39.39 -62.56 0.65 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.386 1.474 . . . . 2.1499999999999999 110.466 167.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.3 p -73.77 -46.46 45.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.762 0.425 . . . . 1.3999999999999999 110.757 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -42.92 86.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.026 0.53 . . . . 2.8999999999999999 110.858 -167.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.497 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.6 p -128.33 -48.07 1.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.355 0.662 . . . . 1.52 112.127 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.31 -31.85 0.71 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.103 1.335 . . . . 1.1299999999999999 111.038 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 52.99 54.68 10.06 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.628 1.971 . . . . 2.4100000000000001 112.606 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.54 -43.11 33.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.12 0.962 . . . . 1.1899999999999999 108.875 162.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 116.05 -143.42 18.07 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 107.986 -2.046 . . . . 1.0700000000000001 107.986 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.5 m -60.61 149.6 34.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.574 1.149 . . . . 1.1899999999999999 112.459 -169.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -60.5 135.01 57.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 2.6400000000000001 108.878 168.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -112.19 -82.27 0.59 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.887 -1.153 . . . . 0.71999999999999997 107.887 165.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . . . -83.04 145.42 29.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.672 -1.233 . . . . 1.1599999999999999 107.672 171.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 77.7 m -141.24 154.29 45.7 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.137 -1.431 . . . . 2.21 107.137 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.06 128.64 1.5 Allowed Glycine 0 CA--C 1.527 0.796 0 O-C-N 123.614 0.571 . . . . 0.72999999999999998 111.735 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.95 132.28 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.676 1.19 . . . . 0.68999999999999995 109.223 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.417 HD11 ' CG ' ' A' ' 20' ' ' PHE . 8.1 tt -95.7 138.79 20.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 111.688 0.255 . . . . 0.69999999999999996 111.688 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.69 0.03 1.6 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.062 0.839 . . . . 0.56999999999999995 115.048 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.62 57.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 119.11 1.455 . . . . 0.76000000000000001 110.914 -157.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.39 169.07 25.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.196 0.598 . . . . 1.29 110.547 168.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 . . . . . 0 C--O 1.253 1.272 0 N-CA-C 102.057 -3.312 . . . . 4.4000000000000004 102.057 162.701 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 107.664 -1.236 . . . . 7.5899999999999999 107.664 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.99 86.84 2.17 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.796 0.839 . . . . 3.8700000000000001 109.805 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.11 177.35 8.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.753 1.221 . . . . 2.9100000000000001 108.369 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.79 139.9 34.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.933 -1.506 . . . . 0.77000000000000002 106.933 153.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -98.2 147.26 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.132 -1.803 . . . . 0.67000000000000004 106.132 159.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.77 96.13 3.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.404 -0.962 . . . . 0.54000000000000004 108.404 160.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.06 109.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.381 -1.34 . . . . 0.70999999999999996 107.381 168.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.52 128.77 42.65 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.176 0.591 . . . . 0.84999999999999998 109.901 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -140.15 -65.05 0.47 Allowed 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.848 0.859 . . . . 3.9700000000000002 110.858 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.58 -122.74 5.81 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.791 1.186 . . . . 1.05 112.94 -170.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -118.89 -49.81 2.41 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.179 0.991 . . . . 3.0800000000000001 109.67 -155.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.3 154.96 8.06 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 108.803 -1.719 . . . . 0.83999999999999997 108.803 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.33 42.8 1.29 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.175 2.583 . . . . 1.0600000000000001 113.385 -165.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -84.98 153.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.191 1.396 . . . . 1.1799999999999999 110.298 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.61 75.69 1.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.37 -0.974 . . . . 3.0099999999999998 108.37 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 165.27 16.89 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.56999999999999995 112.522 -171.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.51 133.22 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.11 0.964 . . . . 1.1799999999999999 109.546 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 26.6 mm -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.513 1.525 . . . . 0.79000000000000004 107.708 161.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -121.45 119.09 31.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.554 -1.646 . . . . 1.76 106.554 158.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.461 ' CD1' HG22 ' A' ' 31' ' ' VAL . 9.4 t80 -128.07 120.54 27.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.442 -1.318 . . . . 2.9500000000000002 107.442 -169.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.81 165.07 37.62 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.45 0.643 . . . . 4.3700000000000001 112.191 -166.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -153.84 157.04 38.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.501 -2.037 . . . . 2.9100000000000001 105.501 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.26 -29.77 64.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.043 0.383 . . . . 5.1900000000000004 110.894 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.52 -150.5 0.43 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.946 -1.501 . . . . 5.6200000000000001 106.946 174.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.0 m -146.17 1.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.708 -1.245 . . . . 4.2699999999999996 113.866 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -124.26 39.93 3.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.067 1.747 . . . . 3.46 109.728 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.84 -162.23 10.81 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.377 -1.089 . . . . 1.3799999999999999 110.377 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.98 114.5 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.155 2.57 . . . . 1.3600000000000001 111.139 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.1 158.54 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.089 -0.708 . . . . 0.91000000000000003 109.089 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -106.37 112.54 25.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.18 -1.045 . . . . 2.6600000000000001 108.18 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 20' ' ' PHE . 60.0 t -80.55 122.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.198 -1.778 . . . . 1.23 106.198 164.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -125.98 145.54 50.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.675 -0.861 . . . . 1.1399999999999999 108.675 154.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.41 155.4 26.68 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.673 -0.971 . . . . 0.72999999999999998 110.673 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -134.62 108.19 7.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.099 -2.186 . . . . 2.04 105.099 -173.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.3 149.01 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.014 -1.476 . . . . 0.92000000000000004 107.014 -167.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -155.32 157.28 36.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.957 -0.464 . . . . 3.8399999999999999 110.509 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.38 22.08 30.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.832 1.682 . . . . 0.90000000000000002 111.909 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.02 168.11 19.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.109 -1.071 . . . . 0.65000000000000002 108.109 168.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -74.85 169.17 18.45 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.216 -1.031 . . . . 1.6699999999999999 108.216 153.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.11 174.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.275 1.43 . . . . 3.9100000000000001 111.044 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -162.83 37.14 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.822 -0.626 . . . . 0.56000000000000005 113.531 167.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.67 141.23 57.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.929 1.292 . . . . 2.0299999999999998 113.27 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.3 114.64 7.53 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.486 1.514 . . . . 0.53000000000000003 109.751 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.46 145.14 2.81 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.497 1.046 . . . . 0.42999999999999999 110.665 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.18 93.57 3.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 2.4399999999999999 106.972 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.669 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 23.4 m170 -131.35 154.48 48.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.24 -0.437 . . . . 0.63 109.862 -161.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.02 116.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.375 -1.342 . . . . 2.1200000000000001 107.375 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -103.84 139.67 38.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.24 -1.393 . . . . 1.1000000000000001 107.24 170.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.35 35.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.802 1.408 . . . . 5.3399999999999999 114.802 -171.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.7 mt-10 -90.78 59.98 4.32 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.507 -1.371 . . . . 3.3700000000000001 112.365 -159.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.74 73.23 7.73 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.266 -0.642 . . . . 6.8300000000000001 109.266 173.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -123.0 56.8 1.15 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.228 -1.027 . . . . 7.54 108.228 162.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -51.98 -40.23 60.6 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.594 -0.691 . . . . 6.0599999999999996 110.956 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -77.3 43.58 0.38 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.873 0.869 . . . . 5.8600000000000003 112.105 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -172.98 -53.57 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 125.951 1.7 . . . . 6.21 108.038 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.28 -100.84 0.14 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.918 -1.273 . . . . 3.73 109.918 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.5 p 178.92 54.22 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.721 2.008 . . . . 2.9300000000000002 107.088 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.73 70.53 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.188 0.595 . . . . 3.77 109.628 -142.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.8 t -175.82 5.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 117.14 2.274 . . . . 4.1699999999999999 117.14 -143.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -134.98 168.76 18.53 Favored 'General case' 0 C--O 1.228 -0.058 0 N-CA-C 108.284 -1.006 . . . . 1.8100000000000001 108.284 160.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.15 -91.84 1.63 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.726 -1.75 . . . . 1.01 108.726 173.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.74 -179.06 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 125.843 4.362 . . . . 1.0700000000000001 112.7 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -53.1 131.6 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.615 1.566 . . . . 1.4399999999999999 110.236 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -42.44 114.03 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.771 1.228 . . . . 2.6200000000000001 109.712 170.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -156.29 165.95 17.51 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 106.671 -1.603 . . . . 2.5299999999999998 106.671 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.39 -35.09 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.549 1.499 . . . . 1.1399999999999999 111.487 -167.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -147.22 -82.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.876 0.87 . . . . 2.7999999999999998 109.194 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.4 m -139.03 64.94 1.46 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.383 1.073 . . . . 2.04 110.617 -168.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -77.67 175.27 10.07 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.532 0.682 . . . . 4.0300000000000002 109.3 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 8.5 mttp -120.83 146.47 46.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.473 1.509 . . . . 3.2799999999999998 107.189 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -72.31 167.31 20.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.568 0.747 . . . . 1.29 110.873 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.03 -138.45 2.68 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 106.699 -2.56 . . . . 2.0099999999999998 106.699 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.75 -144.26 4.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.882 -2.087 . . . . 1.6699999999999999 107.882 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.57 -41.24 6.47 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.176 1.988 . . . . 1.8400000000000001 109.901 174.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -58.03 7.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.724 0.81 . . . . 5.5499999999999998 111.802 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.16 145.44 37.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.576 -0.528 . . . . 2.04 109.576 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -55.97 -44.54 78.6 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.77 1.628 . . . . 4.1200000000000001 111.156 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 7.1 mt-10 -78.92 179.45 7.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.012 0.925 . . . . 2.8700000000000001 111.243 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 157.67 144.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.391 3.076 . . . . 2.9300000000000002 106.369 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.478 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.4 m80 -59.96 141.23 55.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 105.536 -2.024 . . . . 0.53000000000000003 105.536 156.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.68 71.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 123.117 1.437 . . . . 2.4300000000000002 108.165 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.26 26.73 0.26 Allowed Glycine 0 CA--C 1.542 1.774 0 C-N-CA 126.779 2.133 . . . . 0.85999999999999999 113.59 -155.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -130.51 145.75 51.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 120.518 2.159 . . . . 2.27 108.032 146.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -104.95 -42.36 5.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.794 0.837 . . . . 1.79 108.79 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.28 -121.82 1.11 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 109.076 -1.61 . . . . 0.56999999999999995 109.076 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -139.82 169.22 18.12 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.381 1.473 . . . . 1.6399999999999999 109.076 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.34 175.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 0.58999999999999997 106.653 163.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -106.68 142.63 36.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.967 -1.494 . . . . 2.3900000000000001 106.967 156.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.75 152.05 31.7 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.24 -1.022 . . . . 0.66000000000000003 108.24 152.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.32 -78.9 0.09 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.666 0.786 . . . . 2.8599999999999999 110.303 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -154.39 -52.43 0.09 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.716 1.606 . . . . 4.6900000000000004 107.948 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.63 4.03 17.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.084 1.754 . . . . 5.0099999999999998 111.748 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.07 10.16 72.25 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.907 1.241 . . . . 0.84999999999999998 111.682 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -79.17 147.38 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 0.98999999999999999 107.694 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.05 167.76 21.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.244 1.018 . . . . 0.66000000000000003 108.755 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -130.64 144.59 51.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 103.901 -2.629 . . . . 2.7000000000000002 103.901 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.06 111.04 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 106.704 -1.591 . . . . 1.1499999999999999 106.704 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -140.17 104.82 4.9 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.952 0.901 . . . . 1.4099999999999999 108.773 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.04 151.9 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.662 -0.866 . . . . 1.6599999999999999 108.662 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.32 98.55 3.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.626 0.37 . . . . 2.5899999999999999 110.152 158.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.58 160.12 20.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.512 0.325 . . . . 2.6400000000000001 110.155 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -116.95 57.18 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.353 1.461 . . . . 2.5099999999999998 109.312 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -139.56 -64.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 108.025 -1.102 . . . . 1.1200000000000001 108.025 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.7 pp -75.88 175.58 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.345 0.593 . . . . 1.4199999999999999 110.905 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -153.94 176.0 12.7 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.554 1.541 . . . . 2.04 107.01 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 11.78 33.63 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.676 1.58 . . . . 2.3300000000000001 114.486 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.3 t -73.99 -73.28 0.23 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.362 0.528 . . . . 3.1600000000000001 111.654 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -171.15 171.94 44.18 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.665 -0.974 . . . . 2.5600000000000001 110.665 -172.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 51.87 -80.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.164 0 C-N-CA 128.273 2.629 . . . . 5.25 113.162 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -77.43 -25.4 50.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.275 1.83 . . . . 3.9500000000000002 110.304 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -53.83 160.24 1.46 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.891 0.477 . . . . 1.3700000000000001 110.528 171.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.5 pt -78.96 -7.05 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.208 -0.308 . . . . 1.8899999999999999 110.28 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -44.98 129.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.267 0.627 . . . . 1.46 109.744 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.21 -5.36 84.47 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 118.143 -1.365 . . . . 1.3400000000000001 113.839 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -98.26 162.3 13.26 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 120.199 2.0 . . . . 4.1100000000000003 111.655 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.0 m -94.65 107.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.059 0.943 . . . . 1.01 109.319 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.83 133.52 45.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.398 -0.964 . . . . 1.6499999999999999 108.398 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.94 134.23 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 126.846 2.058 . . . . 0.44 106.516 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -101.47 128.84 53.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.624 -1.621 . . . . 1.6599999999999999 106.624 165.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.529 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 48.3 m-70 -104.86 161.13 14.45 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 116.037 1.865 . . . . 0.52000000000000002 116.037 -169.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -37.32 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.41 2.684 . . . . 3.4100000000000001 112.06 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -101.27 -174.85 2.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.599 0.636 . . . . 2.6800000000000002 109.905 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.11 156.94 11.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.722 -0.844 . . . . 0.62 108.722 157.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -80.4 164.59 22.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.902 0.858 . . . . 2.1600000000000001 109.14 152.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -88.06 -4.61 58.76 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.321 1.448 . . . . 3.2400000000000002 112.354 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 56.16 33.79 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.638 1.175 . . . . 1.6299999999999999 110.561 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.98 25.33 65.93 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.392 -0.671 . . . . 1.4399999999999999 112.46 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -131.97 21.11 4.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.261 1.031 . . . . 5.1799999999999997 111.731 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.32 147.04 18.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.707 -0.957 . . . . 2.48 110.707 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.73 60.07 2.95 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.874 -0.89 . . . . 2.8799999999999999 110.874 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -176.67 106.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 105.232 -2.136 . . . . 2.8300000000000001 105.232 -169.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -31.92 46.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.021 0.749 . . . . 3.8199999999999998 113.021 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -36.01 -43.61 0.33 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.076 1.75 . . . . 2.9399999999999999 112.783 166.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t -43.78 -63.91 0.76 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.954 1.701 . . . . 2.7200000000000002 110.205 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.39 -46.11 61.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.818 -0.551 . . . . 1.6699999999999999 110.988 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -56.06 -45.75 79.18 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 123.642 0.777 . . . . 3.25 110.875 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.478 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 2.7 p -130.81 -47.88 1.04 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 119.127 -0.463 . . . . 1.49 112.022 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.41 -31.2 0.86 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.699 0.682 . . . . 1.0 112.647 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.41 54.21 5.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.098 1.359 . . . . 1.9399999999999999 110.09 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.83 -36.03 81.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.23 1.412 . . . . 1.1799999999999999 112.792 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 -174.05 49.77 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.396 -1.882 . . . . 0.91000000000000003 108.396 -160.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.1 m -59.53 151.61 23.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.439 1.495 . . . . 1.3200000000000001 113.385 -166.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 50' ' ' GLU . 4.8 mmt-85 -60.6 135.0 57.63 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.114 1.366 . . . . 3.0800000000000001 108.522 168.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.4 mt -112.19 -68.93 0.9 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.618 -1.253 . . . . 0.45000000000000001 107.618 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.6 166.41 11.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.185 -0.461 . . . . 1.1100000000000001 110.209 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.2 p -146.81 161.12 41.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.953 -1.021 . . . . 2.5299999999999998 108.507 165.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.94 131.62 1.57 Allowed Glycine 0 CA--C 1.526 0.779 0 O-C-N 125.07 1.481 . . . . 0.66000000000000003 110.288 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.13 134.6 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 123.743 0.817 . . . . 0.87 109.433 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.4 tt -91.8 126.37 44.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 C-N-CA 123.236 0.615 . . . . 0.90000000000000002 111.439 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.74 -5.75 0.84 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.467 1.032 . . . . 0.70999999999999996 114.911 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.5 mp -90.82 59.54 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.816 1.308 . . . . 1.1499999999999999 110.297 -155.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.49 175.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.866 0.841 . . . . 2.0699999999999998 113.181 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 C--O 1.248 1.001 0 N-CA-C 104.555 -2.387 . . . . 6.7000000000000002 104.555 160.571 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 112.989 0.737 . . . . 6.4800000000000004 112.989 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m 66.82 58.87 0.59 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.52 1.928 . . . . 2.9500000000000002 110.223 -162.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -139.16 167.74 21.39 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.826 0.45 . . . . 4.2800000000000002 112.002 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.42 155.09 19.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.718 1.207 . . . . 0.75 109.043 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.24 151.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.614 -1.254 . . . . 0.82999999999999996 107.614 162.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.75 102.39 6.07 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.86 0.864 . . . . 0.77000000000000002 108.765 157.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.61 105.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.149 -1.426 . . . . 0.80000000000000004 107.149 161.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -86.18 129.7 34.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.005 -1.109 . . . . 0.93000000000000005 108.005 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -151.58 -51.69 0.12 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.958 0.408 . . . . 3.1699999999999999 110.552 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.24 -111.16 1.06 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.472 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.99 -48.44 2.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.483 1.113 . . . . 3.6299999999999999 109.429 -161.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.65 171.65 33.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.212 1.387 . . . . 0.84999999999999998 112.048 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -69.64 -19.05 37.2 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.587 2.858 . . . . 1.3799999999999999 111.961 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.68 146.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.203 1.401 . . . . 1.0 111.072 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.11 122.05 5.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.783 -0.821 . . . . 2.0600000000000001 108.783 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.41 169.75 32.79 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.843 -0.503 . . . . 0.68000000000000005 111.843 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.84 113.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.059 -1.089 . . . . 1.4399999999999999 108.059 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -79.49 137.16 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.936 -1.135 . . . . 0.76000000000000001 107.936 167.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -109.66 118.46 36.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.008 -1.849 . . . . 1.4399999999999999 106.008 157.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.586 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -108.04 98.04 7.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.575 1.55 . . . . 3.23 106.89 176.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -109.13 137.13 47.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.441 -0.948 . . . . 5.1699999999999999 108.441 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -147.42 -62.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.54 -0.911 . . . . 4.0599999999999996 108.54 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 tttp 72.82 -48.41 0.68 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.834 1.654 . . . . 8.75 112.243 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 99.75 5.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.69 -1.226 . . . . 3.7799999999999998 107.69 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.4 t -19.36 -66.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.854 2.461 . . . . 2.8999999999999999 114.954 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -109.61 27.16 9.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.564 0.746 . . . . 3.5899999999999999 110.579 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.42 171.49 33.67 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.562 -1.015 . . . . 1.1799999999999999 110.562 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.13 139.5 66.99 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.948 1.766 . . . . 1.1200000000000001 110.257 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.81 159.86 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.274 -1.01 . . . . 1.26 108.274 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 110.85 13.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.28 -1.378 . . . . 3.2400000000000002 107.28 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.586 HG22 ' CE1' ' A' ' 20' ' ' PHE . 59.4 t -100.73 118.04 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 127.124 2.17 . . . . 1.1699999999999999 107.139 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -139.03 167.22 22.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.935 -0.395 . . . . 1.0800000000000001 109.935 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.15 175.31 38.95 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.699 -1.76 . . . . 0.88 108.699 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.1 p -130.15 113.84 14.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.807 -2.294 . . . . 2.46 104.807 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.31 109.81 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.283 -2.117 . . . . 1.51 105.283 -166.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -111.38 162.61 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.731 0.645 . . . . 3.7999999999999998 111.731 -166.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.55 80.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.219 -0.901 . . . . 0.78000000000000003 112.95 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -69.44 160.51 31.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.588 1.194 . . . . 0.83999999999999997 108.488 172.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.42 163.88 17.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.949 -1.13 . . . . 1.9399999999999999 107.949 154.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -58.61 170.11 0.82 Allowed 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.443 -0.786 . . . . 2.8900000000000001 111.295 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.58 -158.87 53.66 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.655 -0.702 . . . . 0.66000000000000003 112.693 165.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -70.86 144.44 50.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.849 1.259 . . . . 2.5600000000000001 112.59 -171.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -146.36 118.5 8.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.909 1.684 . . . . 0.63 109.294 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.99 149.86 4.18 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.923 -0.871 . . . . 0.34000000000000002 110.923 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -142.84 94.91 2.69 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.834 -1.543 . . . . 2.27 106.834 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -136.6 144.82 44.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.704 -1.221 . . . . 0.54000000000000004 107.704 -164.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.2 p -99.63 127.03 52.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 119.17 0.896 . . . . 1.8 109.894 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -97.1 136.23 37.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.356 -1.35 . . . . 0.77000000000000002 107.356 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.76 -32.29 59.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.169 0.988 . . . . 4.3200000000000003 112.111 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 7.3 tt0 -4.58 100.64 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.525 2.73 . . . . 3.0299999999999998 113.068 158.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.63 178.44 6.04 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.067 1.747 . . . . 5.54 112.348 -163.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -80.19 58.64 3.09 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.553 1.941 . . . . 7.0899999999999999 110.19 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.92 -18.36 22.02 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.452 1.901 . . . . 5.5199999999999996 111.83 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.0 t -169.92 -163.16 0.35 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.414 -1.699 . . . . 5.3799999999999999 106.414 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.63 -53.99 6.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.357 0.663 . . . . 6.8799999999999999 110.605 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.13 -166.19 39.36 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.87 0.748 . . . . 4.3399999999999999 112.546 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 65.1 m -59.2 151.86 21.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.377 0.671 . . . . 2.98 109.818 173.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 m -151.38 -8.56 0.23 Allowed 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 114.018 1.118 . . . . 5.9299999999999997 114.018 163.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.298 2.4 p -173.8 2.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 119.497 3.147 . . . . 3.8900000000000001 119.497 -117.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . . . -152.31 178.72 9.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.322 0.965 . . . . 1.8500000000000001 110.606 164.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.55 -85.31 1.15 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.684 -1.767 . . . . 1.05 108.684 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.1 178.88 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.607 1 C-N-CA 125.774 4.316 . . . . 0.90000000000000002 113.308 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -67.96 132.88 48.13 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.572 1.549 . . . . 1.3100000000000001 110.106 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -44.99 114.03 0.66 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.942 0.897 . . . . 2.8999999999999999 111.68 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.92 157.36 31.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.634 1.574 . . . . 2.6000000000000001 106.875 168.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.06 -24.13 13.03 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.958 1.772 . . . . 1.3300000000000001 113.609 -168.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.0 tp -156.2 -72.32 0.11 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.03 0.832 . . . . 3.1800000000000002 110.856 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.6 m -154.09 63.21 0.7 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.266 0.555 . . . . 1.9199999999999999 110.21 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -78.09 168.76 19.38 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.353 -0.98 . . . . 3.8999999999999999 108.353 162.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -128.76 165.11 21.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.026 1.331 . . . . 4.6500000000000004 108.214 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -94.66 132.25 39.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.665 -0.865 . . . . 1.1699999999999999 108.665 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.92 -56.84 0.08 OUTLIER Glycine 0 C--O 1.224 -0.522 0 N-CA-C 108.095 -2.002 . . . . 2.96 108.095 171.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 140.33 173.41 13.34 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.457 1.503 . . . . 1.54 110.083 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.04 -31.13 66.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.902 2.402 . . . . 1.9199999999999999 111.037 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -73.84 -40.63 63.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.099 0.96 . . . . 4.0700000000000003 111.059 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -70.42 176.12 4.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.91 0.884 . . . . 1.8500000000000001 111.288 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.48 -48.96 20.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.386 1.074 . . . . 4.4299999999999997 109.734 168.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.38 149.85 26.45 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.654 1.216 . . . . 3.4700000000000002 112.185 -171.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -168.1 129.28 1.38 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.977 2.111 . . . . 5.71 107.488 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.491 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 50.1 m80 -51.62 131.58 29.88 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.463 -2.421 . . . . 0.59999999999999998 104.463 145.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.09 -35.47 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.933 -0.765 . . . . 1.9299999999999999 108.933 -169.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.76 38.95 2.98 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.537 1.065 . . . . 0.78000000000000003 115.289 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -90.16 129.21 36.46 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.206 -2.146 . . . . 1.8200000000000001 105.206 152.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.67 -51.75 6.25 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.735 -1.209 . . . . 1.8500000000000001 107.735 156.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.35 -104.63 0.26 Allowed Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.977 -1.249 . . . . 0.56999999999999995 109.977 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -148.49 170.64 17.59 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.799 1.64 . . . . 1.4099999999999999 109.57 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.81 162.32 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.069 -1.456 . . . . 0.56999999999999995 107.069 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.6 m -109.4 129.79 55.53 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 108.012 -1.107 . . . . 2.1600000000000001 108.012 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.51 139.26 34.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.744 0.818 . . . . 0.64000000000000001 111.513 168.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.13 -90.67 0.08 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 124.045 0.841 . . . . 3.0800000000000001 110.574 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -141.2 -34.38 0.49 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.395 0.887 . . . . 4.04 113.395 -162.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -78.81 14.75 1.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.911 1.339 . . . . 3.6699999999999999 110.385 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 62.33 20.88 61.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.115 -1.194 . . . . 0.72999999999999998 110.115 -166.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -92.24 117.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 123.995 0.918 . . . . 1.04 108.573 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.21 143.81 26.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.899 -1.889 . . . . 0.87 105.899 149.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.35 108.1 8.97 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 105.44 -2.059 . . . . 5.21 105.44 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.85 141.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.84 -1.073 . . . . 2.1600000000000001 110.601 -148.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.7 t -146.13 113.29 6.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.188 -1.412 . . . . 3.1800000000000002 107.188 162.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.4 mt -137.15 144.86 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 105.88 -1.896 . . . . 1.6299999999999999 105.88 166.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -125.71 96.36 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.945 0.35 . . . . 2.46 111.945 165.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.9 145.39 34.13 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.274 0.559 . . . . 2.6299999999999999 110.719 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.6 p -98.35 -20.52 17.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.394 1.878 . . . . 1.53 111.27 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.42 -49.6 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.305 0.502 . . . . 0.94999999999999996 109.875 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.2 pt -75.43 177.74 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.761 0.791 . . . . 1.4399999999999999 111.438 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.8 m -157.41 175.76 13.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.78 1.632 . . . . 1.76 107.417 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.417 HD21 ' HD2' ' A' ' 20' ' ' PHE . 77.1 mt -124.31 54.99 1.32 Allowed 'General case' 0 C--N 1.338 0.08 0 C-N-CA 124.534 1.133 . . . . 4.3300000000000001 108.754 174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t -134.72 -127.12 0.16 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.203 1.801 . . . . 3.0699999999999998 107.351 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.75 156.89 48.41 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 114.498 0.559 . . . . 2.8799999999999999 114.498 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.2 t70 52.76 -88.66 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.642 2.377 . . . . 4.5700000000000003 114.521 155.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -73.54 -20.85 60.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.49 1.116 . . . . 5.8600000000000003 110.448 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.2 m -50.43 130.81 24.2 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.591 -0.892 . . . . 2.29 108.591 167.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.565 ' CD1' HG21 ' A' ' 149' ' ' ILE . 2.6 pp -78.78 -24.36 13.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.693 -0.403 . . . . 1.96 110.449 -163.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 tp -1.79 113.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.33 2.652 . . . . 1.8500000000000001 114.099 161.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.59 37.62 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.971 0.796 . . . . 1.74 113.183 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.485 ' O ' HG22 ' A' ' 149' ' ' ILE . 81.3 mtt85 -83.0 169.48 15.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.542 1.171 . . . . 4.0499999999999998 110.24 -171.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.2 m -95.45 108.81 21.05 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.735 -0.603 . . . . 0.92000000000000004 110.459 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.84 131.32 44.3 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.368 -1.345 . . . . 1.5700000000000001 107.368 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.09 139.89 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 127.265 2.226 . . . . 0.39000000000000001 107.845 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 m -108.86 130.19 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.85 -0.796 . . . . 1.6100000000000001 108.85 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -99.09 159.79 14.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 116.01 1.856 . . . . 0.38 116.01 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -40.65 -74.66 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.302 2.241 . . . . 3.0899999999999999 112.562 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -97.13 -179.34 4.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.198 1.399 . . . . 2.6099999999999999 110.637 -171.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.38 149.96 5.2 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 0.54000000000000004 109.473 156.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.5 149.04 26.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.152 -1.055 . . . . 2.1400000000000001 108.152 162.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.72 -8.6 59.34 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.233 0.827 . . . . 3.4199999999999999 113.233 -164.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 47.48 38.12 7.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.169 0.985 . . . . 2.2799999999999998 110.413 -165.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.25 25.48 57.42 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.533 -0.758 . . . . 2.0 113.001 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -113.85 40.38 2.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.22 1.01 . . . . 5.1799999999999997 108.655 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.0 134.6 9.0 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.895 -1.682 . . . . 2.23 108.895 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.67 -35.51 92.13 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 117.509 0.655 . . . . 2.4399999999999999 111.756 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -58.71 107.94 0.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.961 0.904 . . . . 2.1000000000000001 108.719 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -41.93 -42.65 2.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 3.8999999999999999 112.817 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -36.43 -41.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.73 2.012 . . . . 2.8100000000000001 113.978 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.5 m -54.93 -48.26 73.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.452 0.701 . . . . 2.4500000000000002 111.631 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.7 p -73.08 -46.33 52.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.361 -0.837 . . . . 1.23 110.482 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -51.83 -49.74 62.23 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.685 1.194 . . . . 2.54 111.264 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.491 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.9 OUTLIER -125.0 -46.52 1.82 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.607 0.763 . . . . 1.3100000000000001 111.142 175.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.91 2.02 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 119.086 0.857 . . . . 0.93999999999999995 112.197 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.64 54.28 9.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.187 1.795 . . . . 1.98 111.181 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.01 -5.36 58.28 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.26 -0.9 . . . . 1.1499999999999999 111.804 169.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.74 -165.23 45.71 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.083 -1.607 . . . . 0.93999999999999995 109.083 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.1 m -57.94 150.85 19.56 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.554 1.542 . . . . 1.22 113.678 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.1 mmt-85 -54.7 135.79 46.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.082 -1.417 . . . . 2.6600000000000001 108.275 164.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.5 mt -106.89 -76.63 0.61 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.953 -1.499 . . . . 0.52000000000000002 106.953 166.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 144.98 32.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.477 -0.934 . . . . 0.70999999999999996 108.477 170.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.46 150.36 48.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.119 -1.808 . . . . 1.71 106.119 172.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.48 119.94 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.424 -1.07 . . . . 0.75 110.424 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.47 130.21 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.046 1.338 . . . . 1.21 108.923 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.565 HG21 ' CD1' ' A' ' 112' ' ' ILE . 6.7 tt -105.65 133.12 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.962 0.727 . . . . 1.1399999999999999 112.962 -169.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.87 8.43 0.47 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.313 0.959 . . . . 0.82999999999999996 114.205 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.7 mm -91.88 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 120.045 1.922 . . . . 1.1299999999999999 109.867 -162.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.7 176.83 12.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.952 1.301 . . . . 1.3400000000000001 108.333 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--O 1.254 1.331 0 N-CA-C 107.014 -1.476 . . . . 4.7599999999999998 107.014 166.703 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 108.146 -1.057 . . . . 4.9100000000000001 108.146 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 m 54.76 56.04 7.17 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.928 -1.878 . . . . 3.9199999999999999 105.928 -161.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -89.96 173.51 8.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.155 -1.384 . . . . 3.5299999999999998 108.502 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.63 141.19 49.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.948 -1.131 . . . . 0.88 107.948 159.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.581 HG23 ' HB2' ' A' ' 152' ' ' ALA . 71.0 t -103.81 142.83 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.195 -1.409 . . . . 0.70999999999999996 107.195 163.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -122.35 96.9 5.22 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.13 0.972 . . . . 0.51000000000000001 108.418 158.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.41 106.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.083 -1.451 . . . . 0.62 107.083 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 mt -99.17 133.95 42.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.166 0.986 . . . . 1.1000000000000001 109.196 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -143.47 -52.27 0.35 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.108 0.563 . . . . 3.3599999999999999 110.066 172.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.7 -121.67 27.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.878 0.751 . . . . 0.88 113.286 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -120.28 -54.66 2.09 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 125.128 1.371 . . . . 3.9900000000000002 110.008 -164.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.5 162.96 13.66 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.756 -1.338 . . . . 0.83999999999999997 109.756 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.52 33.54 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.389 2.726 . . . . 0.95999999999999996 113.141 -172.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 47.4 t -83.17 155.79 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.784 1.234 . . . . 0.83999999999999997 108.956 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -154.98 122.21 5.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.507 1.523 . . . . 2.5 107.243 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.41 169.09 38.36 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.883 -0.887 . . . . 0.47999999999999998 110.883 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.06 109.07 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.784 -1.562 . . . . 1.05 106.784 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 39.0 mm -79.03 126.45 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.531 -1.655 . . . . 0.73999999999999999 106.531 168.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -101.99 109.08 20.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.63 -1.618 . . . . 1.6299999999999999 106.63 160.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.42 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -90.31 96.43 10.66 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.028 -1.842 . . . . 2.8999999999999999 106.028 168.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.58 165.37 15.51 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.425 -0.954 . . . . 3.23 108.425 163.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -157.24 -50.39 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.279 0.632 . . . . 3.8999999999999999 109.411 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt 70.99 -61.33 0.48 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 127.594 2.358 . . . . 4.25 111.156 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -80.89 118.86 22.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.083 -0.71 . . . . 4.1600000000000001 109.083 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 m -20.24 -66.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.233 3.013 . . . . 3.3599999999999999 116.05 -172.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -123.9 52.55 1.45 Allowed 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 107.623 -1.251 . . . . 3.6899999999999999 107.623 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.98 178.09 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.761 -1.336 . . . . 1.46 109.761 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.01 132.7 30.92 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.107 1.871 . . . . 1.6399999999999999 111.283 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.6 124.2 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 108.747 -0.834 . . . . 1.1200000000000001 108.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -99.3 89.99 4.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.434 2.694 . . . . 5.04 105.538 -170.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 20' ' ' PHE . 12.6 t -83.54 126.1 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.138 1.775 . . . . 1.28 107.161 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -140.69 140.23 34.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.715 -0.846 . . . . 0.84999999999999998 108.715 158.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.48 145.75 8.75 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 105.806 -2.918 . . . . 0.82999999999999996 105.806 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.4 m -127.13 78.49 1.81 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.2 -1.778 . . . . 2.6899999999999999 106.2 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.38 134.15 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 128.38 2.672 . . . . 0.88 108.48 -162.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -129.48 163.01 26.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 118.741 0.701 . . . . 4.3600000000000003 111.475 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.09 24.27 52.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.113 0.863 . . . . 0.89000000000000001 111.993 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.16 -150.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.497 -1.297 . . . . 1.1399999999999999 107.497 163.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 m -147.34 152.35 38.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.36 -2.459 . . . . 3.3300000000000001 104.36 164.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -32.8 138.1 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.484 2.314 . . . . 2.7999999999999998 113.862 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.77 -166.4 28.92 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.212 0.434 . . . . 0.67000000000000004 112.995 167.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.29 147.24 53.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.091 1.356 . . . . 2.3399999999999999 112.829 -166.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -149.39 115.57 5.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.796 1.639 . . . . 0.46999999999999997 109.002 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.23 155.83 2.51 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.749 0.704 . . . . 0.54000000000000004 111.449 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.533 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 31.6 t80 -149.25 100.6 3.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.69 -0.855 . . . . 2.6899999999999999 108.69 -169.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -137.59 175.42 9.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.596 -1.261 . . . . 0.69999999999999996 107.596 -166.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.76 137.73 56.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.837 0.827 . . . . 1.8100000000000001 109.135 165.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -101.3 178.76 4.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.673 1.589 . . . . 0.93000000000000005 107.224 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -107.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.251 -1.018 . . . . 5.54 108.251 174.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 46.61 59.29 3.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.194 1.397 . . . . 3.2000000000000002 111.591 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.76 -105.89 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.132 0.973 . . . . 5.1399999999999997 110.8 -177.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -84.06 63.61 7.72 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.523 -1.361 . . . . 6.7199999999999998 110.786 -169.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -60.17 1.61 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.83 0.852 . . . . 5.3899999999999997 109.674 -174.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.6 m -159.09 -56.45 0.06 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.959 0.904 . . . . 4.1399999999999997 109.532 -173.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -165.35 -43.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.453 1.101 . . . . 6.5099999999999998 110.716 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.14 -138.99 2.6 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.391 -1.084 . . . . 4.54 110.391 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 71.0 m -47.16 128.19 11.35 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 124.927 1.291 . . . . 2.54 111.27 -172.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.99 0.34 0.22 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.19 1.552 . . . . 5.3200000000000003 115.19 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.7 m -172.33 -59.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 118.653 2.834 . . . . 2.8399999999999999 118.653 -123.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.49 -179.39 4.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.586 0.708 . . . . 1.99 110.723 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.44 -89.56 0.97 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.356 -1.898 . . . . 1.4299999999999999 108.356 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.87 179.02 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 125.136 3.89 . . . . 1.3300000000000001 112.919 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.416 ' HB2' ' CG ' ' A' ' 80' ' ' HIS . 24.2 m170 -65.46 138.4 58.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.16 1.784 . . . . 1.53 111.694 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -45.18 108.45 0.12 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.085 1.754 . . . . 2.5 111.993 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -150.24 154.82 36.73 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 125.727 1.611 . . . . 2.4300000000000002 107.454 166.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.51 -42.0 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.17 1.913 . . . . 1.29 112.667 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -142.33 -68.07 0.37 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.029 0.531 . . . . 3.3199999999999998 110.937 -175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -154.12 64.92 0.7 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.632 -0.668 . . . . 2.0499999999999998 111.532 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -78.02 166.25 23.05 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.952 -1.129 . . . . 4.0099999999999998 107.952 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -123.71 176.93 5.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.26 1.824 . . . . 5.2599999999999998 106.846 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -101.63 148.62 25.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.982 -0.449 . . . . 1.1599999999999999 111.515 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.58 -61.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.465 -1.054 . . . . 2.9700000000000002 110.465 173.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.23 -172.55 29.28 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.904 1.24 . . . . 1.6200000000000001 114.206 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 -41.49 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.769 2.313 . . . . 1.95 109.787 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -70.64 -47.55 59.47 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.735 0.814 . . . . 5.2199999999999998 111.239 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.84 175.21 1.56 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.108 -0.496 . . . . 2.5600000000000001 109.681 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.6 -39.92 21.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.986 -0.746 . . . . 8.0 108.986 165.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 147.14 39.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 117.237 -1.785 . . . . 3.8100000000000001 110.576 -165.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 167.58 127.89 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.548 2.339 . . . . 3.2799999999999998 108.262 -167.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 53.7 m80 -49.25 127.63 15.2 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 106.815 -1.55 . . . . 1.1000000000000001 106.815 163.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 p -52.69 -34.62 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.544 0.572 . . . . 1.55 112.544 -154.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.76 83.42 0.77 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.967 -0.853 . . . . 0.89000000000000001 110.967 166.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -161.98 111.74 1.54 Allowed 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.789 -0.83 . . . . 2.1200000000000001 108.84 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -90.02 -53.01 4.67 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.883 0.473 . . . . 2.1299999999999999 110.743 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.62 -102.74 0.22 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.572 -0.823 . . . . 0.73999999999999999 111.998 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.18 166.79 27.77 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.92 1.288 . . . . 1.8300000000000001 110.176 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.62 175.58 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.865 1.666 . . . . 0.48999999999999999 106.612 167.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 t -127.36 134.43 49.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.624 -0.88 . . . . 2.0699999999999998 108.624 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.74 135.99 36.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 123.227 0.611 . . . . 0.56999999999999995 110.411 165.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.19 -92.16 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.795 1.638 . . . . 3.1899999999999999 110.238 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -115.03 -67.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.616 0.767 . . . . 5.9100000000000001 110.864 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.3 -32.44 49.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 122.062 0.934 . . . . 3.4700000000000002 110.262 -168.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.24 46.41 0.07 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.597 -2.201 . . . . 0.83999999999999997 107.597 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.51 111.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.36 1.864 . . . . 0.83999999999999997 106.901 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.33 174.29 5.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.091 -1.078 . . . . 0.66000000000000003 108.091 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -145.52 149.61 34.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.787 -1.56 . . . . 3.1000000000000001 106.787 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG11 ' CZ ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -127.16 54.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.288 0.992 . . . . 1.6799999999999999 111.293 -178.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.3 m -70.07 91.8 0.71 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.839 -0.538 . . . . 1.1200000000000001 110.717 165.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.62 149.83 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.926 0.89 . . . . 1.45 108.646 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -113.23 89.6 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.729 -0.841 . . . . 3.2200000000000002 108.729 160.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -77.88 148.54 34.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.224 0.92 . . . . 2.3500000000000001 109.77 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.3 p -115.01 -6.69 12.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.926 1.69 . . . . 1.73 112.729 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.4 t -78.79 -54.73 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 119.546 1.066 . . . . 1.6899999999999999 109.615 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -86.85 176.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.977 0.894 . . . . 0.98999999999999999 111.403 178.217 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -145.17 160.94 40.66 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.093 -1.817 . . . . 1.8999999999999999 106.093 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.93 24.9 7.9 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.064 0.946 . . . . 2.5499999999999998 111.644 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 t -76.8 -162.97 0.3 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.069 0.548 . . . . 3.02 109.657 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.75 67.75 0.23 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.859 -1.696 . . . . 3.4100000000000001 108.859 172.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -142.44 -129.49 0.09 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.852 -1.166 . . . . 4.79 107.852 -172.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -79.19 2.23 21.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.122 1.369 . . . . 4.5499999999999998 111.155 171.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p -50.48 158.01 0.66 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.836 2.454 . . . . 1.3100000000000001 112.408 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.2 pt -84.12 -5.72 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.961 -0.563 . . . . 2.1800000000000002 111.429 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -51.0 136.59 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 O-C-N 122.016 -0.427 . . . . 1.75 110.207 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.88 30.01 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.614 -1.103 . . . . 1.76 112.45 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -89.59 166.06 13.87 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.8 1.8 . . . . 4.79 112.614 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 146' ' ' CYS . 1.8 m -85.54 104.09 14.98 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.537 0.735 . . . . 1.1299999999999999 109.878 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 2.3 tt -69.42 147.8 50.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.585 -0.894 . . . . 2.0699999999999998 108.585 170.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.56 128.85 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.339 1.056 . . . . 0.54000000000000004 109.088 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 1.3 p -100.66 125.7 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 106.429 -1.693 . . . . 2.1000000000000001 106.429 162.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -98.29 174.17 6.63 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.316 1.846 . . . . 0.44 115.035 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.497 -1.229 . . . . 4.96 111.984 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -178.42 6.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 121.079 1.763 . . . . 3.6600000000000001 110.98 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.38 156.25 13.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.213 -0.903 . . . . 0.92000000000000004 109.671 164.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.39 151.24 28.02 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.256 1.023 . . . . 2.6299999999999999 110.027 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.55 -10.64 58.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.623 0.769 . . . . 3.1499999999999999 112.679 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 49.06 35.57 7.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.394 1.478 . . . . 1.8200000000000001 110.904 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.96 22.28 54.54 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 121.494 -0.754 . . . . 1.99 112.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -116.88 -33.5 4.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.871 0.836 . . . . 5.0999999999999996 110.967 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.64 137.15 39.64 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.474 -0.65 . . . . 2.6899999999999999 111.474 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.04 69.31 1.6 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.082 0.849 . . . . 2.7000000000000002 112.27 -170.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -162.33 155.47 20.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.74 1.616 . . . . 2.6299999999999999 107.096 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.42 -40.8 97.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.227 0.467 . . . . 3.21 112.237 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -57.55 -30.94 65.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.032 0.533 . . . . 2.77 111.37 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -49.44 -69.68 0.11 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.965 0.906 . . . . 2.1899999999999999 110.277 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.2 p -69.28 -42.42 75.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.461 -0.774 . . . . 1.3300000000000001 110.422 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -61.42 -35.62 78.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.31 0.505 . . . . 3.3500000000000001 111.892 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.516 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.416 1.3 t -139.11 -58.3 0.6 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.919 -1.039 . . . . 1.8500000000000001 113.203 177.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.06 -18.19 0.47 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 120.194 1.361 . . . . 1.05 111.8 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.6 t30 51.09 54.64 10.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.654 1.582 . . . . 2.0 111.107 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.88 -52.62 5.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.531 0.682 . . . . 1.3799999999999999 110.473 170.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.63 -169.46 32.89 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.836 -1.706 . . . . 0.93999999999999995 108.836 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -58.4 161.55 4.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.744 1.618 . . . . 1.8899999999999999 111.293 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmt-85 -58.66 137.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.938 -1.028 . . . . 2.9199999999999999 108.356 166.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.82 -70.65 0.8 Allowed 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.134 -1.432 . . . . 0.45000000000000001 107.134 163.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -99.32 157.22 16.55 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.672 -0.695 . . . . 0.88 109.322 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.421 ' HB2' HG23 ' A' ' 116' ' ' THR . 0.7 OUTLIER -165.65 159.53 16.54 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 124.02 0.825 . . . . 1.5 109.129 171.436 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.58 141.39 3.42 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 107.068 -2.413 . . . . 0.88 107.068 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.7 133.15 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 123.999 0.919 . . . . 0.77000000000000002 110.174 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.8 tt -89.17 138.68 18.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 122.766 0.426 . . . . 0.79000000000000004 110.903 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.85 1.39 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.15 0.881 . . . . 0.69999999999999996 114.687 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.93 59.42 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.062 1.431 . . . . 0.84999999999999998 110.686 -161.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.581 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -144.08 177.64 8.43 Favored 'General case' 0 C--N 1.335 -0.022 0 N-CA-C 113.502 0.927 . . . . 1.6100000000000001 113.502 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.255 1.384 0 N-CA-C 103.098 -2.927 . . . . 6.3799999999999999 103.098 150.787 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 107.481 -1.303 . . . . 5.5599999999999996 107.481 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.9 m -74.5 114.9 13.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.931 -1.137 . . . . 2.8700000000000001 107.931 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 166.99 22.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.595 -0.891 . . . . 3.8100000000000001 108.595 177.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.9 154.8 36.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.453 -1.314 . . . . 0.78000000000000003 107.453 163.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.78 144.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 104.883 -2.266 . . . . 0.75 104.883 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -126.69 94.53 4.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.129 0.893 . . . . 0.5 108.887 159.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.55 108.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.162 -1.421 . . . . 0.65000000000000002 107.162 164.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.13 125.06 36.65 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.416 -0.587 . . . . 0.88 109.416 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -143.7 -55.5 0.38 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.067 0.547 . . . . 3.5699999999999998 110.263 165.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.7 -110.57 0.85 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.783 -0.927 . . . . 1.1399999999999999 110.783 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.76 -48.11 1.92 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.45 1.1 . . . . 3.6699999999999999 109.9 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.54 161.43 12.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 112.086 -0.406 . . . . 1.03 112.086 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.37 29.98 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.097 3.198 . . . . 1.04 114.215 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.04 160.88 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.142 1.377 . . . . 1.1599999999999999 108.787 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 97.8 1.93 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.786 -1.931 . . . . 3.0 105.786 168.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.45 167.17 24.84 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.933 -0.467 . . . . 0.5 111.933 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.33 121.44 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.555 -0.906 . . . . 1.1000000000000001 108.555 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 31.3 mm -87.7 142.35 13.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 107.413 -1.328 . . . . 0.81999999999999995 107.413 162.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.48 129.73 47.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.92 1.288 . . . . 1.5900000000000001 107.525 169.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -122.0 131.03 53.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.226 1.81 . . . . 3.0299999999999998 107.197 -172.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 153.98 48.9 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.522 -0.918 . . . . 4.0700000000000003 108.522 162.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.71 81.5 0.88 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.424 1.89 . . . . 3.98 107.486 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -40.44 -57.21 1.85 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.261 1.425 . . . . 4.6900000000000004 112.437 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.07 126.53 35.15 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.43 1.092 . . . . 3.8700000000000001 109.271 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -19.49 -66.68 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.277 2.631 . . . . 3.1299999999999999 114.57 174.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -118.5 42.2 2.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.391 1.076 . . . . 3.6099999999999999 109.214 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 175.29 48.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.333 -1.507 . . . . 1.1899999999999999 109.333 168.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.66 142.9 72.61 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.024 1.816 . . . . 1.0600000000000001 109.592 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.31 151.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.096 -1.075 . . . . 1.27 108.096 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -126.75 120.4 29.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.599 -1.26 . . . . 4.1699999999999999 107.599 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 20' ' ' PHE . 47.1 t -115.02 134.28 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.613 1.965 . . . . 1.22 107.261 -171.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -133.22 156.02 48.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.415 -2.068 . . . . 0.81999999999999995 105.415 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 145.78 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.939 -1.664 . . . . 0.70999999999999996 108.939 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -122.96 94.46 4.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.823 -2.288 . . . . 1.6799999999999999 104.823 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.71 142.03 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.765 -1.198 . . . . 0.77000000000000002 107.765 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -152.3 147.59 26.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 115.112 1.523 . . . . 3.4100000000000001 115.112 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.65 23.17 8.97 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.834 2.159 . . . . 0.93000000000000005 111.999 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -74.6 166.49 23.46 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.851 -1.166 . . . . 0.70999999999999996 107.851 167.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.24 165.45 20.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.889 -1.152 . . . . 1.8400000000000001 107.889 152.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.04 173.73 0.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.412 -0.805 . . . . 2.3399999999999999 110.513 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.14 -161.37 53.22 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.251 -0.431 . . . . 0.59999999999999998 113.053 165.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.29 140.27 58.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.481 1.112 . . . . 2.02 113.357 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -144.24 116.03 8.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.543 1.537 . . . . 0.54000000000000004 109.85 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.7 148.57 4.63 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.685 0.659 . . . . 0.55000000000000004 111.792 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 100.01 4.67 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.891 1.676 . . . . 3.04 107.334 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 12.6 m170 -133.98 160.49 37.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.396 -2.076 . . . . 0.68999999999999995 105.396 -169.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.11 125.92 74.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.482 -0.933 . . . . 1.8400000000000001 108.482 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.39 -161.35 0.73 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.316 1.046 . . . . 1.55 108.819 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -73.75 -129.01 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.083 0.953 . . . . 3.75 109.917 163.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 59.05 65.84 1.14 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.727 1.211 . . . . 3.0600000000000001 112.723 168.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -51.63 -42.51 62.08 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.797 0.839 . . . . 4.5800000000000001 110.652 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -125.59 128.12 47.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.511 -1.292 . . . . 4.8700000000000001 107.511 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -136.76 29.14 2.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.814 2.046 . . . . 4.6299999999999999 109.702 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 m -74.08 72.63 1.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.905 0.882 . . . . 4.79 110.322 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -173.92 -44.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.096 1.758 . . . . 5.6200000000000001 108.924 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.84 144.42 3.91 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 107.339 -2.305 . . . . 3.7400000000000002 107.339 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.02 41.81 0.99 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.31 1.055 . . . . 2.6000000000000001 109.968 -171.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -86.28 50.27 1.95 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.446 1.098 . . . . 4.9100000000000001 111.488 -161.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.2 p 166.58 172.93 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.035 -1.098 . . . . 4.8300000000000001 108.035 -133.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 134.94 -112.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 130.523 3.529 . . . . 2.8399999999999999 110.267 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.53 -173.81 25.77 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 106.733 -2.547 . . . . 1.52 106.733 -158.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.92 178.27 6.67 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.658 3.572 . . . . 1.3400000000000001 113.958 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -74.01 58.22 0.66 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.145 1.778 . . . . 2.1600000000000001 111.606 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 51.92 69.02 0.72 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.255 1.022 . . . . 1.78 109.639 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -90.85 115.31 64.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.016 -0.992 . . . . 2.5899999999999999 108.482 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.29 -43.8 1.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.842 1.695 . . . . 1.3200000000000001 110.685 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -146.22 -67.25 0.28 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.232 1.013 . . . . 2.25 108.884 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.5 m -153.39 63.99 0.75 Allowed 'General case' 0 N--CA 1.457 -0.125 0 O-C-N 121.524 -0.735 . . . . 1.78 110.488 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -78.19 165.47 23.89 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.253 -0.647 . . . . 3.6099999999999999 109.253 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 6.7 mtmp? -133.66 154.26 51.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.148 1.379 . . . . 3.1200000000000001 109.012 -174.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -89.53 169.64 11.18 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.124 . . . . 0.81999999999999995 110.245 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.93 -40.21 0.17 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 107.761 -2.136 . . . . 2.6600000000000001 107.761 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.29 -175.63 54.54 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.706 1.622 . . . . 1.53 110.842 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.05 -8.9 23.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.584 2.856 . . . . 1.8300000000000001 114.167 -171.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -27.07 42.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.779 0.718 . . . . 6.4199999999999999 111.435 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.26 176.6 5.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.77 1.628 . . . . 2.7000000000000002 109.428 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.9 -47.04 40.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.962 -0.755 . . . . 4.7999999999999998 108.962 162.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 74.5 mt-10 -78.43 138.35 38.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.674 1.226 . . . . 3.0499999999999998 111.536 -169.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -160.45 154.35 22.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.36 -2.83 . . . . 5.1900000000000004 103.36 173.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.1 m80 -64.92 159.66 22.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 117.794 -1.563 . . . . 0.54000000000000004 106.88 162.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.08 40.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 122.984 1.373 . . . . 1.9199999999999999 110.876 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -170.73 42.2 0.19 Allowed Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 128.257 2.837 . . . . 0.59999999999999998 108.563 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -126.12 109.07 11.95 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.795 -1.187 . . . . 2.46 107.795 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.82 -50.3 10.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.419 -0.956 . . . . 1.8300000000000001 108.419 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.8 -120.69 0.99 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.43 -1.068 . . . . 0.96999999999999997 110.43 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -155.19 166.3 34.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.127 1.371 . . . . 1.5700000000000001 108.672 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.98 171.77 16.38 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 N-CA-C 108.206 -1.035 . . . . 0.69999999999999996 108.206 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 m -114.87 118.57 33.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.477 -1.305 . . . . 1.8899999999999999 107.477 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.81 140.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.375 0.534 . . . . 0.66000000000000003 110.319 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.2 -80.93 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.309 1.044 . . . . 3.0299999999999998 111.739 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -157.39 -48.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.107 1.363 . . . . 3.71 109.898 -170.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.76 13.78 1.56 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.012 1.325 . . . . 2.79 111.214 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.02 14.64 76.21 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.197 0.903 . . . . 0.75 111.256 -175.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.4 145.18 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.226 1.41 . . . . 0.93000000000000005 107.73 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.67 164.83 29.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.652 1.181 . . . . 0.71999999999999997 108.516 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.12 143.85 51.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.959 -2.608 . . . . 2.73 103.959 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.99 56.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 123.801 0.688 . . . . 1.6200000000000001 112.096 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.0 m -74.39 91.61 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.712 -0.617 . . . . 0.97999999999999998 110.935 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.2 mt -129.46 159.05 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.588 0.755 . . . . 1.6399999999999999 108.984 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.76 93.66 2.54 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 3.0299999999999998 111.392 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.9 126.09 30.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.717 0.807 . . . . 2.54 109.582 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 p -95.54 1.73 53.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.249 1.42 . . . . 1.8400000000000001 112.567 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.54 -44.82 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.519 0.727 . . . . 1.21 109.795 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pt -74.65 175.75 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.845 -0.742 . . . . 1.1799999999999999 109.762 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 p -151.96 176.94 10.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.918 1.287 . . . . 2.1499999999999999 107.784 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.0 mt -131.95 57.8 1.76 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.374 1.87 . . . . 4.1500000000000004 110.725 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.6 m -96.04 -22.04 17.61 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.722 0.638 . . . . 3.4300000000000002 112.722 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.86 38.76 10.05 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.113 -1.195 . . . . 3.71 110.113 -169.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.94 -120.91 0.3 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.803 2.041 . . . . 4.0899999999999999 106.049 172.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -78.14 -2.81 39.34 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.39 0.995 . . . . 4.6100000000000003 111.117 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.0 p -48.14 151.26 1.02 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.351 1.46 . . . . 1.3100000000000001 111.157 167.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.3 pt -77.95 -6.47 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.841 0.682 . . . . 1.97 112.841 -174.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.3 mm -32.01 116.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.1 1.36 . . . . 1.71 110.323 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.49 10.87 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 112.12 -0.392 . . . . 1.75 112.12 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -136.1 164.6 27.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.499 -1.667 . . . . 6.25 106.499 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.01 113.23 23.44 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.602 1.092 . . . . 1.8899999999999999 109.558 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 118' ' ' VAL . 2.0 tm? -69.35 145.09 53.24 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.267 -1.753 . . . . 2.3100000000000001 106.267 167.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 117' ' ' LEU . 71.5 t -130.98 135.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.137 1.775 . . . . 0.58999999999999997 109.066 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -101.79 123.65 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.756 1.223 . . . . 1.78 107.711 164.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.579 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 93.8 m-70 -95.96 165.69 12.14 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 117.378 2.362 . . . . 0.66000000000000003 117.378 -172.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.47 -66.43 0.56 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.16 -1.836 . . . . 3.4700000000000002 110.971 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -90.28 -179.5 5.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.958 0.885 . . . . 3.9700000000000002 110.566 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.87 46.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.073 -1.454 . . . . 0.54000000000000004 107.073 153.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -83.05 162.49 21.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.894 -0.78 . . . . 2.0699999999999998 108.894 161.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.74 -8.28 59.62 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.484 0.714 . . . . 3.0099999999999998 112.106 -169.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 51.18 38.78 22.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.014 0.926 . . . . 1.6299999999999999 109.101 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 48.78 33.04 11.98 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.529 1.062 . . . . 1.4399999999999999 112.798 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -77.48 -25.33 50.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.095 0.948 . . . . 4.9299999999999997 110.039 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 133.25 -130.28 5.68 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.964 -0.854 . . . . 2.6099999999999999 110.964 161.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.49 -73.72 0.02 OUTLIER Glycine 0 C--N 1.34 0.772 0 C-N-CA 126.372 1.939 . . . . 2.0699999999999998 111.414 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.21 165.46 24.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.834 1.654 . . . . 2.5699999999999998 108.286 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -79.06 -52.02 8.78 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.874 -0.787 . . . . 3.8100000000000001 108.874 162.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.18 -40.69 11.61 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.992 2.117 . . . . 4.2000000000000002 111.49 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.8 p -39.16 -64.46 0.46 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.798 2.039 . . . . 1.9299999999999999 111.003 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.7 p -71.66 -45.86 60.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.717 -0.674 . . . . 1.26 110.497 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -58.09 -50.13 74.54 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.403 0.681 . . . . 2.98 111.313 -165.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.384 1.3 p -125.63 -45.76 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.678 -0.677 . . . . 1.3799999999999999 112.665 168.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.44 0.13 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.428 1.013 . . . . 0.95999999999999996 114.803 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 54.28 55.53 8.04 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.628 1.571 . . . . 2.0899999999999999 111.557 -167.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -68.12 -3.07 9.22 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.453 0.909 . . . . 1.1799999999999999 113.453 169.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.47 -64.8 4.21 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 120.549 -1.344 . . . . 3.2400000000000002 111.127 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -165.2 168.18 17.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.163 0.985 . . . . 1.45 111.808 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.432 ' HD2' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -83.33 133.86 34.94 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.242 2.217 . . . . 2.6499999999999999 107.33 172.091 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.35 -77.93 0.56 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.158 -1.052 . . . . 0.85999999999999999 108.158 166.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.19 154.01 42.21 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.901 -1.148 . . . . 1.0700000000000001 107.901 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 16.6 p -142.8 171.51 13.95 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.352 -1.295 . . . . 1.99 108.959 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.16 142.71 5.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.744 -1.342 . . . . 0.62 109.744 174.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.34 126.91 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 108.735 -0.839 . . . . 0.94999999999999996 108.735 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.3 126.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.722 -0.844 . . . . 2.6699999999999999 108.722 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.46 -5.97 1.42 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 115.014 0.766 . . . . 0.76000000000000001 115.014 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.3 59.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 118.638 1.219 . . . . 0.78000000000000003 110.627 -156.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.39 172.07 7.2 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.661 0.743 . . . . 1.6499999999999999 111.643 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.25 1.083 0 N-CA-C 103.44 -2.8 . . . . 5.9900000000000002 103.44 144.599 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 106.217 -1.771 . . . . 6.6500000000000004 106.217 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.58 56.39 0.17 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.842 -1.54 . . . . 4.3499999999999996 106.842 -157.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 138.09 51.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.56 -0.745 . . . . 2.8100000000000001 110.803 -173.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.48 131.9 34.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.586 -1.265 . . . . 0.82999999999999996 107.586 163.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -98.52 142.12 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.688 -0.856 . . . . 0.79000000000000004 108.688 165.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.63 97.57 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.581 -0.896 . . . . 0.48999999999999999 108.581 154.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.02 107.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.207 -1.405 . . . . 0.73999999999999999 107.207 163.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.3 mt -93.96 133.19 37.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.911 -0.774 . . . . 0.92000000000000004 108.911 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -138.08 -56.52 0.66 Allowed 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.541 -0.911 . . . . 4.1399999999999997 108.541 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.04 -121.34 24.89 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.789 -1.096 . . . . 0.83999999999999997 111.957 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.08 -49.27 1.71 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.903 0.881 . . . . 3.48 109.497 -155.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.36 164.19 20.27 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 109.841 -1.303 . . . . 0.80000000000000004 109.841 167.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.61 40.92 0.9 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.614 2.876 . . . . 1.0700000000000001 112.617 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.2 t -94.51 155.11 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.539 1.535 . . . . 0.92000000000000004 109.846 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.38 123.24 8.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.231 -1.396 . . . . 2.2200000000000002 107.231 168.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.94 167.32 33.73 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.543 -1.023 . . . . 0.60999999999999999 110.543 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.19 118.28 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.767 -1.568 . . . . 1.2 106.767 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -85.02 128.55 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.259 -1.756 . . . . 0.78000000000000003 106.259 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -111.59 113.68 26.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.366 -1.716 . . . . 2.2999999999999998 106.366 166.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CE1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -102.88 115.6 30.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.613 -1.625 . . . . 2.8100000000000001 106.613 173.279 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -139.14 160.37 39.96 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.054 0.843 . . . . 3.3700000000000001 109.609 170.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -155.26 145.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.594 -2.002 . . . . 3.1400000000000001 105.594 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -45.5 44.25 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.008 -0.738 . . . . 4.9000000000000004 109.008 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -78.73 178.2 8.07 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.118 1.767 . . . . 3.8100000000000001 109.189 168.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.3 p -123.8 21.47 9.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.98 0.912 . . . . 2.3799999999999999 111.382 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -167.41 38.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.593 0.633 . . . . 3.6000000000000001 111.557 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.69 -157.84 7.66 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.042 -1.623 . . . . 1.1299999999999999 109.042 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.36 135.41 33.9 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.161 2.574 . . . . 1.1699999999999999 110.348 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -78.97 164.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.394 -0.965 . . . . 0.84999999999999998 108.394 173.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -115.57 125.21 52.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.634 -1.987 . . . . 3.04 105.634 167.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG22 ' CE1' ' A' ' 20' ' ' PHE . 59.0 t -117.1 114.75 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.586 1.554 . . . . 0.93999999999999995 107.352 -171.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -125.9 133.53 51.87 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.189 0.93 . . . . 0.83999999999999997 110.408 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.2 160.16 33.73 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.385 -1.086 . . . . 0.79000000000000004 110.385 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 p -135.29 107.17 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.229 -1.397 . . . . 2.02 107.229 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.78 119.91 59.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.559 -1.645 . . . . 1.23 106.559 -159.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -124.35 152.21 43.43 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.946 0.498 . . . . 4.96 110.062 -160.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.58 27.04 64.0 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.444 -0.344 . . . . 0.82999999999999996 113.823 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -67.0 -169.41 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.581 -0.952 . . . . 0.97999999999999998 108.478 157.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.51 165.94 10.81 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 105.518 -2.03 . . . . 3.5600000000000001 105.518 146.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 178.9 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.83 2.052 . . . . 3.3599999999999999 112.43 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.58 -169.45 53.38 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.357 -0.838 . . . . 0.45000000000000001 111.933 169.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.77 147.17 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.475 0.71 . . . . 1.98 111.493 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -143.92 121.16 11.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.945 1.698 . . . . 0.48999999999999999 108.473 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.07 149.03 7.59 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.519 -1.433 . . . . 0.46000000000000002 109.519 169.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -143.25 83.48 1.79 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.644 -1.243 . . . . 2.2999999999999998 107.644 -169.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -124.64 146.38 49.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.885 -1.052 . . . . 0.82999999999999996 109.071 -160.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.22 106.44 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.436 -0.95 . . . . 2.3799999999999999 108.436 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -82.35 150.21 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.903 -0.777 . . . . 0.89000000000000001 108.903 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.26 19.84 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.376 1.471 . . . . 3.96 113.374 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' CD ' HH22 ' A' ' 143' ' ' ARG . 1.5 tt0 -88.57 67.09 8.41 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.648 -1.283 . . . . 3.1600000000000001 110.138 -167.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -75.3 60.18 1.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.498 0.666 . . . . 4.9100000000000001 109.514 160.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.7 t0 178.42 155.09 0.39 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.456 2.302 . . . . 5.2999999999999998 106.512 164.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -158.37 34.99 0.24 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.83 1.652 . . . . 5.3399999999999999 111.985 157.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.6 t -74.59 33.28 0.09 Allowed 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.971 -1.081 . . . . 5.5700000000000003 113.759 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -168.82 -50.39 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.089 1.756 . . . . 6.7999999999999998 107.839 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -169.47 157.72 29.65 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.488 -1.845 . . . . 4.6200000000000001 108.488 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.8 t -76.53 56.41 1.11 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.937 1.295 . . . . 2.3700000000000001 109.582 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.5 m -148.49 78.68 1.42 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.478 -0.489 . . . . 3.98 111.402 -152.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -174.28 -51.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.709 1.744 . . . . 2.5 115.709 -146.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.17 100.31 10.52 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.622 1.169 . . . . 2.5800000000000001 110.589 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.9 -65.89 3.14 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.987 -0.896 . . . . 1.02 111.661 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.85 172.72 2.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.771 1.647 . . . . 1.8999999999999999 115.016 -166.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -83.01 56.68 3.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 113.121 -1.854 . . . . 2.1299999999999999 110.559 -172.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 53.32 80.09 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.406 0.682 . . . . 1.96 109.476 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -107.85 103.85 51.1 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.181 0.993 . . . . 2.3799999999999999 110.425 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.82 -30.98 39.95 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.997 1.798 . . . . 1.1200000000000001 112.251 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.0 tp -155.93 -67.4 0.11 Allowed 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.554 0.616 . . . . 2.8999999999999999 110.038 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 p -151.99 60.72 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.21 0.529 . . . . 2.1899999999999999 110.621 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -77.51 165.99 23.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.384 -0.598 . . . . 3.8399999999999999 109.384 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -137.83 162.68 33.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.068 1.347 . . . . 7.2400000000000002 107.819 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -94.27 153.23 18.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.135 1.374 . . . . 0.79000000000000004 113.374 -158.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.48 171.93 45.0 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 107.763 -2.135 . . . . 2.4399999999999999 107.763 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.84 -171.23 30.75 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.165 0.412 . . . . 1.1499999999999999 112.832 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.49 -31.18 51.64 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.515 2.144 . . . . 1.6699999999999999 109.582 172.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.63 -43.1 73.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.915 0.486 . . . . 4.4500000000000002 111.496 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -69.22 161.96 28.12 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.673 0.749 . . . . 2.4300000000000002 112.144 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -75.5 -46.89 29.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.896 2.078 . . . . 4.3200000000000003 109.33 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -77.05 159.45 29.86 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.1 -1.074 . . . . 4.3099999999999996 108.1 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 158.98 127.1 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.463 2.305 . . . . 3.1099999999999999 106.441 -163.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 45.4 m80 -62.29 150.8 38.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.963 -1.495 . . . . 0.52000000000000002 106.963 163.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.82 -16.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 120.255 -0.578 . . . . 1.1499999999999999 110.38 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.56 56.58 0.46 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.959 0.79 . . . . 0.65000000000000002 113.336 161.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -123.59 117.99 26.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.022 1.411 . . . . 2.4199999999999999 108.771 158.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.6 -56.66 3.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.068 -1.086 . . . . 1.5700000000000001 108.068 164.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.65 -121.95 1.05 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.319 -0.712 . . . . 0.65000000000000002 111.319 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -143.11 165.28 27.83 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.895 1.678 . . . . 1.55 108.112 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.31 166.74 28.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.699 -1.223 . . . . 0.45000000000000001 107.699 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.3 m -123.41 116.42 23.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.234 1.014 . . . . 1.96 108.67 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.58 139.3 35.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.033 0.379 . . . . 0.62 111.076 171.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.07 -84.16 0.12 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.956 0.502 . . . . 4.0999999999999996 111.053 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 -53.19 0.93 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.231 0.612 . . . . 4.6100000000000003 112.082 -161.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.18 30.12 1.0 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 124.53 2.11 . . . . 3.3100000000000001 109.972 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 57.69 27.66 59.16 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 113.619 -1.628 . . . . 0.71999999999999997 110.833 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.27 103.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.56 1.144 . . . . 0.89000000000000001 108.101 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.92 166.77 12.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.336 1.054 . . . . 0.82999999999999996 108.267 160.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.7 141.82 47.73 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.452 -2.425 . . . . 2.8500000000000001 104.452 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.16 116.6 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.881 -1.525 . . . . 1.3899999999999999 106.881 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -137.46 80.29 1.8 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.068 1.747 . . . . 0.93999999999999995 106.738 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.2 mm -125.75 156.95 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.135 0.574 . . . . 2.2999999999999998 109.57 -170.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -151.36 71.54 1.01 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.733 0.813 . . . . 2.8900000000000001 110.93 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.96 119.23 22.52 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.126 -0.359 . . . . 3.29 111.738 -168.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.6 p -79.4 65.19 4.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.159 0.984 . . . . 2.8900000000000001 110.391 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.3 t -141.56 -52.32 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.622 1.169 . . . . 1.26 109.083 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -102.96 168.7 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.079 0.952 . . . . 1.0900000000000001 111.321 -172.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.2 m -137.91 168.92 18.71 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.077 1.351 . . . . 2.0299999999999998 109.217 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' H ' ' CD2' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -100.84 17.04 23.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.477 1.511 . . . . 2.71 113.068 -178.241 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.9 t -157.78 162.84 38.49 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.148 0.979 . . . . 2.96 108.737 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.45 157.29 14.96 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.02 -0.832 . . . . 2.6200000000000001 111.02 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.22 -43.11 42.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.175 1.79 . . . . 5.1299999999999999 112.182 -172.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -79.27 0.64 27.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.15 0.98 . . . . 3.3999999999999999 112.364 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.4 p -66.94 174.31 3.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.589 -1.32 . . . . 1.49 111.345 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -18.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.684 -1.144 . . . . 2.8100000000000001 111.782 174.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.1 mm -47.0 119.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.174 0.99 . . . . 2.2400000000000002 110.758 -162.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.46 -32.47 5.2 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.519 0.58 . . . . 1.99 112.553 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -76.52 177.01 7.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.547 1.673 . . . . 10.15 114.031 -163.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 m -104.15 120.99 42.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.436 1.095 . . . . 1.1000000000000001 110.322 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.71 138.25 39.87 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.465 -1.309 . . . . 1.8600000000000001 107.465 164.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.48 127.84 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.272 1.429 . . . . 0.57999999999999996 107.88 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.6 m -97.47 122.45 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.125 -1.806 . . . . 1.55 106.125 162.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -93.97 158.19 15.75 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 115.319 1.6 . . . . 0.57999999999999996 115.319 -171.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -25.56 -83.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.183 2.993 . . . . 3.5800000000000001 112.388 162.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -106.73 -177.34 3.33 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.819 0.848 . . . . 2.6400000000000001 110.215 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.1 157.44 3.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.498 -0.774 . . . . 0.75 109.987 162.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.26 176.58 5.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.951 -0.759 . . . . 1.95 108.951 160.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.53 -9.59 59.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 3.9500000000000002 111.183 -167.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.7 11.93 4.29 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.694 1.598 . . . . 2.4300000000000002 111.928 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.86 102.03 1.0 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 108.538 -1.825 . . . . 3.4399999999999999 108.538 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.55 -56.49 0.08 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.953 -1.499 . . . . 4.7300000000000004 106.953 174.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.47 50.49 0.97 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.165 -1.174 . . . . 2.6400000000000001 110.165 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.52 37.29 0.84 Allowed Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.165 0.982 . . . . 3.96 112.984 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.3 p30 175.66 -108.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.862 2.865 . . . . 2.8999999999999999 106.266 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.416 ' OE1' ' NZ ' ' A' ' 136' ' ' LYS . 15.9 tm-20 -153.13 -39.61 0.1 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.456 1.102 . . . . 4.29 109.07 161.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -44.09 -37.63 3.17 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.423 1.489 . . . . 2.8900000000000001 111.784 170.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.9 t -45.71 -58.25 3.6 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.417 1.087 . . . . 2.25 110.903 168.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -44.63 67.63 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.101 -1.0 . . . . 1.3100000000000001 110.015 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.416 ' NZ ' ' OE1' ' A' ' 132' ' ' GLU . 1.5 ttmp? -55.68 -50.65 69.69 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.355 1.062 . . . . 2.7799999999999998 112.239 -172.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.502 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.309 2.0 p -124.33 -50.33 1.78 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.834 -0.603 . . . . 1.21 111.759 171.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 157.27 -26.81 0.49 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.139 -0.784 . . . . 0.98999999999999999 111.139 -173.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 49.41 53.93 11.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.876 1.27 . . . . 2.3700000000000001 110.338 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.62 -51.93 13.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.858 0.837 . . . . 1.53 109.53 170.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.32 -157.84 22.18 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.623 -2.191 . . . . 1.0 107.623 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.1 m -61.0 151.35 30.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.307 1.443 . . . . 1.28 113.217 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.406 HH22 ' CD ' ' A' ' 50' ' ' GLU . 13.1 mmt85 -61.33 138.23 58.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.101 1.36 . . . . 2.98 109.046 168.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.9 mt -112.17 -67.35 1.0 Allowed 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.44 -0.948 . . . . 0.64000000000000001 108.44 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -106.37 156.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.072 0.549 . . . . 0.89000000000000001 110.384 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.2 p -165.0 162.21 20.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.018 0.927 . . . . 1.4399999999999999 110.17 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.27 140.96 3.33 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.861 2.172 . . . . 0.88 107.688 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.79 134.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.668 1.187 . . . . 0.89000000000000001 109.756 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.5 tt -91.1 136.59 23.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 C-N-CA 123.101 0.561 . . . . 0.83999999999999997 112.512 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.9 4.56 0.83 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.839 1.209 . . . . 0.65000000000000002 114.078 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.7 mm -102.24 57.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 119.192 1.496 . . . . 1.01 110.147 -150.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.96 175.41 13.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.146 0.498 . . . . 1.6000000000000001 111.142 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.439 0 N-CA-C 102.962 -2.977 . . . . 5.0499999999999998 102.962 160.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 121.083 0.468 . . . . 5.7800000000000002 109.754 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -165.42 105.54 0.75 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.261 -2.126 . . . . 2.8900000000000001 105.261 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER -78.92 143.46 35.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.048 -0.723 . . . . 3.5299999999999998 109.048 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.68 139.31 33.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.884 -1.525 . . . . 0.67000000000000004 106.884 164.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.79 144.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.547 -2.02 . . . . 1.0 105.547 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.74 93.55 3.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.271 -1.011 . . . . 0.44 108.271 161.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.91 104.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.22 -1.03 . . . . 0.56999999999999995 108.22 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -87.98 136.71 32.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.56 0.344 . . . . 0.93999999999999995 110.213 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -149.82 -54.72 0.17 Allowed 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.322 0.649 . . . . 4.2999999999999998 110.49 168.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.32 -126.55 27.87 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.603 0.621 . . . . 1.0 113.815 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.09 -53.99 2.63 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.672 1.189 . . . . 4.2199999999999998 110.138 -165.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.19 154.28 10.95 Favored Glycine 0 CA--C 1.536 1.353 0 N-CA-C 110.008 -1.237 . . . . 0.92000000000000004 110.008 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.24 52.04 3.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.84 3.027 . . . . 1.3400000000000001 112.279 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 74.7 t -110.78 156.65 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.302 2.241 . . . . 0.75 107.875 -175.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -155.84 136.48 13.36 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.621 -0.881 . . . . 2.7599999999999998 108.621 166.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.57 176.49 46.16 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.175 -0.77 . . . . 0.62 111.175 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.68 123.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.494 -1.298 . . . . 1.01 107.494 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.621 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.8 mp -80.66 136.65 22.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.66 -1.978 . . . . 1.51 105.66 161.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -120.6 119.24 32.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.444 -2.058 . . . . 2.0600000000000001 105.444 161.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 5.9 t80 -132.57 126.96 34.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.385 -0.969 . . . . 2.9399999999999999 108.385 -166.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -148.07 158.83 44.28 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.074 0.949 . . . . 4.3399999999999999 110.321 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -152.44 142.52 22.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.36 1.864 . . . . 3.0 106.964 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -44.94 -74.07 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.14 0.576 . . . . 4.6299999999999999 111.342 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -81.47 -172.9 4.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.1 1.36 . . . . 3.7400000000000002 110.929 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.7 m -83.43 -64.67 1.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.232 1.413 . . . . 2.3500000000000001 111.133 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -102.97 75.62 1.4 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.065 1.346 . . . . 3.75 110.229 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.04 -167.15 12.85 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.585 -1.406 . . . . 1.1000000000000001 109.585 166.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.02 113.58 3.82 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.242 1.962 . . . . 1.1699999999999999 111.32 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 4.0 t -87.17 138.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.312 -0.403 . . . . 0.93000000000000005 110.556 -172.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -94.11 116.48 28.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.929 -1.137 . . . . 2.6299999999999999 107.929 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG22 ' CD1' ' A' ' 20' ' ' PHE . 11.6 t -89.72 132.71 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.703 -1.962 . . . . 1.25 105.703 162.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -133.53 151.8 51.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.986 -1.487 . . . . 0.94999999999999996 106.986 156.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.76 134.54 2.91 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.131 -1.188 . . . . 0.92000000000000004 110.131 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.5 p -109.57 94.75 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.54 -1.652 . . . . 1.9299999999999999 106.54 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 mm -96.99 148.59 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.623 -1.251 . . . . 1.3700000000000001 107.623 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.36 165.39 22.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.298 0.571 . . . . 4.2199999999999998 111.45 165.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.19 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 114.462 -1.245 . . . . 0.60999999999999999 114.171 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.88 158.92 17.82 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.266 1.533 . . . . 0.68999999999999995 108.861 167.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.36 158.01 24.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.2 -1.407 . . . . 1.6799999999999999 107.2 154.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.94 174.31 0.51 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.952 1.251 . . . . 3.2799999999999998 112.327 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.14 -160.65 52.5 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.956 -1.02 . . . . 0.67000000000000004 112.29 168.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.7 140.69 57.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.956 1.303 . . . . 2.1000000000000001 113.105 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -144.41 117.69 9.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.647 1.579 . . . . 0.44 109.257 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.19 145.91 5.56 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.362 -1.095 . . . . 0.46000000000000002 110.362 172.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.6 102.08 5.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.776 -1.565 . . . . 2.9100000000000001 106.776 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -133.48 168.22 19.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.156 -1.794 . . . . 0.69999999999999996 106.156 -173.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.88 130.2 48.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.867 -0.79 . . . . 1.77 108.867 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -114.62 147.34 39.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.466 1.507 . . . . 0.83999999999999997 110.413 -160.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.14 -9.35 0.26 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.059 1.744 . . . . 4.25 114.638 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' CD ' HH21 ' A' ' 143' ' ' ARG . 4.5 mt-10 -52.28 89.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.47 1.108 . . . . 3.3300000000000001 109.794 164.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -100.07 -45.89 5.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.422 1.489 . . . . 4.8300000000000001 111.356 169.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.32 56.42 2.1 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.278 -0.889 . . . . 6.3099999999999996 111.666 -167.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -90.5 44.57 1.21 Allowed 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.426 -1.421 . . . . 4.0700000000000003 112.004 -163.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 t -81.62 42.92 0.72 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.249 0.619 . . . . 4.3499999999999996 111.12 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 177.12 -54.87 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.321 1.449 . . . . 5.0899999999999999 109.992 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.41 -163.58 22.63 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.764 -1.334 . . . . 3.1899999999999999 109.764 -171.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.6 p -151.75 72.11 1.01 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 124.347 1.059 . . . . 2.6400000000000001 109.136 -167.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -155.03 71.67 0.8 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.024 -1.473 . . . . 4.9500000000000002 107.024 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.8 m -167.19 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.63 1.344 . . . . 2.6000000000000001 114.63 -136.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.1 -116.05 0.08 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.48 -1.304 . . . . 2.4300000000000002 107.48 166.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.92 -87.63 0.08 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.322 -1.511 . . . . 1.01 109.322 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.91 176.84 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.965 3.777 . . . . 1.2 113.569 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -75.48 58.49 1.02 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.885 1.674 . . . . 2.29 111.615 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.84 80.3 0.16 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.994 0.917 . . . . 2.0800000000000001 108.628 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -112.88 86.66 9.18 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.55 1.14 . . . . 2.4199999999999999 109.415 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.13 -17.95 45.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.3 2.0 . . . . 2.3100000000000001 112.7 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 tt -154.28 -68.0 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.676 0.671 . . . . 2.1000000000000001 109.838 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -162.92 96.0 0.89 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.757 -1.201 . . . . 1.72 107.757 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.27 173.68 6.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.147 1.379 . . . . 5.2800000000000002 109.703 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -137.3 151.33 48.53 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 125.61 1.564 . . . . 3.71 108.032 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -91.24 139.97 30.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.828 0.677 . . . . 0.80000000000000004 112.828 -170.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.02 -88.75 0.07 OUTLIER Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.539 -2.625 . . . . 1.8600000000000001 106.539 163.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.67 -102.58 0.38 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.973 -0.904 . . . . 1.8 112.289 159.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -90.63 -47.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.508 2.139 . . . . 1.47 110.774 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.27 -46.01 10.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.233 1.413 . . . . 4.96 110.388 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.03 175.58 10.24 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.889 -1.05 . . . . 2.7599999999999998 111.424 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.06 -55.22 8.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.399 1.479 . . . . 3.79 109.596 -174.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.89 175.28 10.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.462 -0.79 . . . . 3.8100000000000001 110.967 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.36 141.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.248 2.219 . . . . 3.52 107.876 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.411 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 16.0 m80 -64.21 160.72 17.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 118.468 -1.293 . . . . 0.60999999999999999 108.669 162.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -28.66 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 121.289 -0.882 . . . . 1.23 110.69 -177.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.56 70.11 0.22 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.65000000000000002 110.973 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -163.3 104.74 0.98 Allowed 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.782 -0.834 . . . . 2.0499999999999998 108.914 -169.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.54 -54.81 3.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.686 -0.688 . . . . 1.78 109.156 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 -108.38 0.34 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.603 -0.999 . . . . 0.65000000000000002 110.603 -176.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -152.06 167.5 28.26 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.938 1.695 . . . . 1.5700000000000001 109.874 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -123.35 175.78 5.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.476 -1.675 . . . . 0.64000000000000001 106.476 164.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 t -116.76 149.76 39.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.377 -0.971 . . . . 2.0800000000000001 108.377 167.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.68 140.48 45.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.174 1.39 . . . . 0.78000000000000003 112.333 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.01 -90.17 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 O-C-N 124.46 1.1 . . . . 2.5899999999999999 111.11 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -156.22 -31.75 0.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.652 2.093 . . . . 4.5300000000000002 116.652 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -8.96 58.14 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.993 0.901 . . . . 3.7200000000000002 109.119 164.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.57 23.16 10.4 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.701 1.62 . . . . 0.83999999999999997 109.593 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.2 t -78.0 123.39 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.289 -1.375 . . . . 0.83999999999999997 107.289 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.19 159.32 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.055 0.942 . . . . 0.91000000000000003 109.231 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.77 95.59 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.763 -1.569 . . . . 2.8500000000000001 106.763 -159.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.36 57.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.715 -0.476 . . . . 1.8100000000000001 109.715 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.2 m -85.49 91.66 8.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.813 0.845 . . . . 0.90000000000000002 109.231 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 mt -124.33 148.19 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.893 -0.78 . . . . 2.0099999999999998 108.893 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -134.39 101.97 5.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.279 -0.638 . . . . 2.9500000000000002 109.279 164.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.16 140.74 31.21 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.918 0.887 . . . . 2.27 109.073 173.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 t -110.85 19.23 18.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.407 1.083 . . . . 2.6699999999999999 112.406 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.99 -48.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 108.098 -1.075 . . . . 1.53 108.098 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.35 177.01 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 122.813 0.445 . . . . 1.1899999999999999 111.289 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.5 p -155.4 178.8 9.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.429 1.892 . . . . 2.29 108.23 -164.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.14 69.9 1.44 Allowed 'General case' 0 C--N 1.339 0.151 0 CA-C-O 122.917 1.342 . . . . 2.25 110.466 162.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p -119.19 156.14 30.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.721 2.008 . . . . 4.1900000000000004 110.348 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.28 62.68 2.2 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.652 -1.379 . . . . 3.73 109.652 168.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -148.26 -124.87 0.05 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.143 1.777 . . . . 4.7999999999999998 107.054 -172.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -78.67 -9.01 59.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.445 1.02 . . . . 5.46 113.085 -176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.2 p -60.37 163.89 4.79 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 123.213 1.482 . . . . 1.49 113.682 -165.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.839 -1.528 . . . . 1.8400000000000001 111.112 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mm -49.03 118.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.795 0.725 . . . . 1.8300000000000001 109.118 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.53 -20.32 34.83 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.468 1.508 . . . . 1.5700000000000001 112.759 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.59 165.34 18.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.416 1.608 . . . . 4.7199999999999998 110.279 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -86.95 117.9 25.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.801 0.841 . . . . 1.0700000000000001 109.159 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 140.33 58.28 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.393 -1.336 . . . . 2.3599999999999999 107.393 167.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -128.26 126.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.945 -1.132 . . . . 0.42999999999999999 107.945 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.627 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 2.1 p -99.17 116.95 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.219 -1.771 . . . . 1.77 106.219 166.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -89.54 160.11 16.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 115.808 1.781 . . . . 0.58999999999999997 115.808 -172.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -44.87 -72.27 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.708 2.003 . . . . 3.3900000000000001 112.362 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -98.26 -177.19 3.63 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.33 1.052 . . . . 3.1200000000000001 111.097 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.08 157.56 7.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.375 0.67 . . . . 0.72999999999999998 109.703 162.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.24 175.67 8.8 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.484 -0.561 . . . . 2.1200000000000001 109.484 164.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.03 -35.61 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.989 0.916 . . . . 3.3100000000000001 112.669 -152.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp 66.72 32.77 6.7 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.894 1.678 . . . . 3.4199999999999999 111.402 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.37 45.82 92.3 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.227 0.917 . . . . 1.76 112.255 163.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -127.07 -28.82 2.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.234 2.213 . . . . 5.2300000000000004 111.493 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.34 126.22 33.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.812 -0.915 . . . . 2.0600000000000001 110.812 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.1 -30.58 76.05 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.327 0.489 . . . . 3.1400000000000001 111.88 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -55.6 115.29 2.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.843 0.857 . . . . 2.0299999999999998 109.26 170.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -38.29 -48.23 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.814 1.246 . . . . 3.5 113.217 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -46.93 -33.84 4.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.244 1.418 . . . . 3.1800000000000002 112.647 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 m -62.49 -56.88 13.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.976 0.51 . . . . 2.3300000000000001 111.976 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -71.21 -45.81 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.0 -1.687 . . . . 1.3500000000000001 110.215 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -58.08 -39.4 78.45 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.052 0.941 . . . . 3.1800000000000002 111.728 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.411 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 6.8 p -128.95 -54.92 1.21 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.762 0.71 . . . . 1.55 112.632 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 140.48 -18.55 2.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 125.936 1.732 . . . . 0.89000000000000001 111.385 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.76 56.95 2.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.333 1.453 . . . . 2.3500000000000001 111.757 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.66 -5.02 48.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.226 -0.59 . . . . 1.27 111.435 171.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.6 -173.68 40.54 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 108.899 -1.681 . . . . 1.03 108.899 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -55.82 153.33 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.752 1.621 . . . . 1.27 114.086 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.475 HH21 ' CD ' ' A' ' 50' ' ' GLU . 6.4 mmt-85 -60.02 139.8 57.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.775 -1.557 . . . . 3.0699999999999998 107.963 166.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.07 -74.74 0.59 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.047 -1.094 . . . . 0.51000000000000001 108.047 173.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -103.47 151.18 23.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.334 -1.358 . . . . 0.68999999999999995 107.334 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 p -151.45 160.54 43.67 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.042 0.839 . . . . 1.8300000000000001 109.246 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.09 140.75 3.25 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 125.596 1.81 . . . . 0.58999999999999997 109.61 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -77.88 134.67 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.044 1.338 . . . . 0.68000000000000005 109.878 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 16.6 tt -90.66 131.28 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.081 0.553 . . . . 0.78000000000000003 111.342 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.08 -8.17 2.68 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 124.377 0.989 . . . . 0.56999999999999995 113.762 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.4 mm -91.07 59.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 118.026 0.913 . . . . 1.0900000000000001 111.448 -154.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.68 168.09 9.48 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.218 0.533 . . . . 1.98 111.587 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.424 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 20.9 mm-40 . . . . . 0 C--O 1.256 1.397 0 N-CA-C 101.643 -3.465 . . . . 4.1699999999999999 101.643 139.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' H3 ' ' CD ' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 106.89 -1.522 . . . . 5.8600000000000003 106.89 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 m -81.17 94.21 6.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.491 -1.3 . . . . 2.6699999999999999 107.491 167.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER -77.45 161.4 27.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.012 -0.54 . . . . 3.0899999999999999 110.416 -175.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -109.72 136.6 48.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.547 -2.02 . . . . 0.69999999999999996 105.547 152.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.94 140.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.378 -1.712 . . . . 0.81000000000000005 106.378 169.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.56 96.61 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.371 -0.974 . . . . 0.41999999999999998 108.371 156.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.83 108.26 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.656 -1.609 . . . . 0.56000000000000005 106.656 161.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.7 mt -97.37 127.97 43.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.204 -1.036 . . . . 0.91000000000000003 108.204 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -149.39 -56.13 0.19 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.191 -1.04 . . . . 3.4199999999999999 108.191 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.49 -117.61 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.504 -1.225 . . . . 0.93000000000000005 111.19 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -123.37 -41.17 2.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.883 0.873 . . . . 3.7000000000000002 110.056 -163.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.72 161.42 51.36 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.732 -0.605 . . . . 0.84999999999999998 111.762 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.86 30.82 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.984 3.123 . . . . 1.04 113.436 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 52.1 t -99.24 155.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.575 1.95 . . . . 0.70999999999999996 107.424 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 129.37 9.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.739 -0.837 . . . . 3.3900000000000001 108.739 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.27 171.07 41.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.793 -0.718 . . . . 0.47999999999999998 114.383 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.6 118.64 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.477 1.111 . . . . 1.0 108.482 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -83.84 129.57 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.459 -1.312 . . . . 0.66000000000000003 107.459 164.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -106.13 115.68 30.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.328 -1.36 . . . . 1.6899999999999999 107.328 160.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -95.9 112.64 24.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.126 -1.805 . . . . 2.6400000000000001 106.126 171.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' CD ' ' H3 ' ' A' ' 1' ' ' ALA . 2.8 mm-40 -124.94 144.79 50.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.668 0.747 . . . . 3.3399999999999999 109.436 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -156.99 158.68 37.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.155 1.382 . . . . 4.1799999999999997 109.15 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.01 -74.95 0.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.134 0.973 . . . . 4.7300000000000004 109.634 170.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -90.83 130.08 36.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.539 1.136 . . . . 3.8300000000000001 110.377 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 p -66.43 1.28 1.72 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.931 1.456 . . . . 2.4100000000000001 114.931 -169.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -140.19 54.18 1.64 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 126.518 1.927 . . . . 4.2699999999999996 107.161 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.64 175.07 32.87 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 107.509 -2.237 . . . . 1.0700000000000001 107.509 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.08 134.62 46.87 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.728 2.285 . . . . 1.23 110.63 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.86 141.5 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.124 -0.695 . . . . 0.90000000000000002 109.124 -171.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -97.34 107.2 19.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.419 -1.326 . . . . 2.6699999999999999 107.419 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.493 HG22 ' CE1' ' A' ' 20' ' ' PHE . 23.8 t -96.25 116.09 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.532 -1.655 . . . . 1.1299999999999999 106.532 -177.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -123.4 107.11 11.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.131 -1.062 . . . . 1.28 108.131 164.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.76 152.95 16.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.66000000000000003 111.805 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -132.06 85.39 2.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.737 2.015 . . . . 2.7599999999999998 106.575 -165.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 mp -111.31 126.02 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 107.017 -1.475 . . . . 0.83999999999999997 107.017 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 162.69 16.51 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.327 1.051 . . . . 3.8799999999999999 110.973 171.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.24 1.8 74.91 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.341 -0.7 . . . . 0.70999999999999996 114.768 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -53.35 157.22 2.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.099 1.449 . . . . 0.77000000000000002 110.815 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.68 163.37 9.26 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.124 -1.065 . . . . 1.8999999999999999 108.124 156.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.34 173.74 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 2.3700000000000001 111.038 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.71 -159.73 34.6 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.049 0.833 . . . . 0.44 113.843 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.57 145.12 55.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.246 1.818 . . . . 1.8999999999999999 113.79 -171.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -147.34 118.55 7.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.326 1.85 . . . . 0.42999999999999999 109.777 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.66 147.6 8.14 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.515 -1.034 . . . . 0.40000000000000002 110.515 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE2' HD21 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -136.39 91.23 2.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.268 -1.382 . . . . 2.3199999999999998 107.268 -174.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.75 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 40.2 m170 -125.8 172.36 9.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.015 -0.735 . . . . 0.81000000000000005 109.015 -163.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.4 133.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.527 -1.286 . . . . 2.1800000000000002 107.527 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -119.43 140.97 49.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.152 1.381 . . . . 0.81999999999999995 107.738 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -45.16 -58.15 3.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.767 2.027 . . . . 5.0999999999999996 111.107 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 25.41 66.49 0.05 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.082 2.153 . . . . 3.4100000000000001 116.153 164.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -49.27 -53.21 22.82 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.283 1.833 . . . . 5.5899999999999999 112.322 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -124.62 118.58 26.84 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.79 0.836 . . . . 5.3099999999999996 109.667 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -137.22 42.17 2.4 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.052 1.741 . . . . 4.5300000000000002 109.117 166.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.3 m -63.44 -40.83 98.22 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.15 0.5 . . . . 4.1699999999999999 111.066 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.94 -42.9 62.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.807 0.843 . . . . 5.1900000000000004 111.69 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.73 173.55 42.41 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 106.041 -2.824 . . . . 3.3700000000000001 106.041 -174.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 85.3 m -75.62 83.17 2.64 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 119.169 1.485 . . . . 2.1899999999999999 112.246 -171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 m -29.47 94.28 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.208 1.403 . . . . 5.75 113.063 157.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.296 1.4 m 51.78 16.49 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 118.539 2.792 . . . . 4.7699999999999996 118.539 82.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.33 -118.33 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.078 -1.823 . . . . 2.3500000000000001 106.078 165.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.12 -91.58 0.08 OUTLIER Glycine 0 CA--C 1.524 0.605 0 CA-C-O 117.86 -1.522 . . . . 1.1100000000000001 111.756 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.03 -177.47 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 1 C-N-CA 126.911 5.074 . . . . 1.01 113.351 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -89.33 62.39 6.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.916 1.286 . . . . 1.8100000000000001 111.363 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 56.41 64.29 1.73 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.45 -0.944 . . . . 1.8899999999999999 108.45 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -90.45 113.8 58.86 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 2.3199999999999998 110.4 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.66 -37.39 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.134 1.889 . . . . 1.3400000000000001 111.294 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 tp -156.17 -64.74 0.11 Allowed 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.376 -0.601 . . . . 3.1600000000000001 109.376 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -153.81 69.47 0.8 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 1.77 109.68 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -76.92 166.49 23.26 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.49 -0.559 . . . . 3.6899999999999999 109.49 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.8 156.2 33.7 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.647 1.579 . . . . 3.7999999999999998 107.008 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -92.79 153.81 18.66 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.657 0.614 . . . . 1.03 112.657 -172.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.3 38.79 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 108.95 -1.66 . . . . 2.5800000000000001 108.95 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.82 -156.06 9.87 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 108.662 -1.775 . . . . 1.3400000000000001 108.662 170.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.33 -35.06 92.76 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.987 1.791 . . . . 1.74 110.853 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -51.63 68.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.066 0.946 . . . . 7.0 110.944 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.88 156.57 20.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.594 1.702 . . . . 2.4500000000000002 115.594 -145.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.64 -48.84 74.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.716 2.006 . . . . 6.4100000000000001 112.367 -169.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -135.51 162.42 32.72 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.049 1.34 . . . . 5.5800000000000001 107.759 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -163.4 161.2 24.26 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.4 0.68 . . . . 3.6299999999999999 111.081 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 62.6 m80 -68.16 141.5 56.0 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 107.949 -1.13 . . . . 0.66000000000000003 107.949 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.41 -30.23 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.625 -0.262 . . . . 1.21 110.716 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 57.37 0.43 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.745 -0.475 . . . . 0.64000000000000001 113.802 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.4 146.75 33.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.918 1.859 . . . . 2.3799999999999999 110.226 149.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 mt -97.1 -51.83 4.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.572 -0.899 . . . . 2.3300000000000001 108.572 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.04 -107.92 0.31 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.5 -1.04 . . . . 0.56999999999999995 110.5 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -147.08 171.98 14.46 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.184 1.794 . . . . 1.48 109.493 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -132.78 171.4 18.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 106.644 -1.614 . . . . 0.77000000000000002 106.644 166.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -103.99 144.48 31.49 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.404 -0.961 . . . . 2.2400000000000002 108.404 163.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.05 159.51 27.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.983 0.913 . . . . 0.88 110.004 158.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.37 -92.06 0.05 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.033 1.733 . . . . 4.3799999999999999 108.858 162.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 93' ' ' GLY . 13.7 tttt -176.07 -31.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.619 1.168 . . . . 3.5899999999999999 112.0 -159.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -76.84 15.49 0.65 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 124.243 1.973 . . . . 3.3500000000000001 109.477 151.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 63.05 24.75 67.33 Favored Glycine 0 N--CA 1.44 -1.069 0 O-C-N 119.933 -1.729 . . . . 1.1000000000000001 110.347 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.0 t -83.89 118.88 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.306 -0.998 . . . . 1.05 108.306 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.79 153.26 17.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.331 -0.989 . . . . 1.1299999999999999 108.331 166.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -112.32 83.72 1.85 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 104.16 -2.533 . . . . 3.7400000000000002 104.16 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.412 HG11 ' CE2' ' A' ' 45' ' ' PHE . 2.4 t -86.96 60.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.722 -0.844 . . . . 1.1899999999999999 108.722 -167.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -96.43 86.93 4.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.694 1.597 . . . . 1.01 108.027 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.76 150.69 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.894 -0.78 . . . . 1.8100000000000001 108.894 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.47 134.27 33.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.218 -1.771 . . . . 3.1099999999999999 106.218 158.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -145.77 164.25 32.44 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.603 -1.258 . . . . 3.8199999999999998 107.603 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.3 p -112.59 -5.31 14.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.741 2.016 . . . . 1.5800000000000001 111.915 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.24 -37.06 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 119.065 0.848 . . . . 2.1200000000000001 109.26 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.4 pp -96.02 177.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.586 0.754 . . . . 1.22 110.655 176.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.6 m -158.53 175.96 13.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.702 1.601 . . . . 2.25 108.3 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.34 14.18 31.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.214 1.405 . . . . 2.5299999999999998 111.546 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m -84.5 135.79 34.09 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 120.738 -1.226 . . . . 3.0800000000000001 109.632 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.13 65.7 1.24 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 109.414 -1.475 . . . . 3.9100000000000001 109.414 170.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -144.33 -127.04 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.053 1.741 . . . . 3.9100000000000001 107.421 -169.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -79.13 -19.87 50.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.245 0.93 . . . . 4.0499999999999998 111.04 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.83 172.77 0.49 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.13 0.972 . . . . 2.4199999999999999 112.034 172.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.433 HD11 ' CE2' ' A' ' 20' ' ' PHE . 2.5 pp -81.0 -8.14 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 113.537 0.94 . . . . 1.47 113.537 -166.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 mm -50.79 120.12 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.922 0.889 . . . . 2.4500000000000002 109.175 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.16 22.05 66.32 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.916 -0.935 . . . . 1.5800000000000001 113.498 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 174.28 5.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.139 1.469 . . . . 5.5700000000000003 107.982 160.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -86.61 126.74 34.71 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 118.086 -0.959 . . . . 0.96999999999999997 108.943 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.454 HD21 ' CE2' ' A' ' 45' ' ' PHE . 5.0 tt -82.56 137.17 34.65 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.557 -1.275 . . . . 2.0600000000000001 107.557 159.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.86 135.16 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.733 1.613 . . . . 0.48999999999999999 108.082 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.32 130.48 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.178 -1.045 . . . . 1.8400000000000001 108.178 165.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.556 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 72.8 m-70 -106.79 160.51 15.43 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 117.632 2.456 . . . . 0.46999999999999997 117.632 -167.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -33.84 -84.51 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.265 3.026 . . . . 3.6200000000000001 112.736 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -99.4 -174.67 2.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.292 0.951 . . . . 2.71 109.592 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.24 157.95 2.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.087 0.555 . . . . 0.84999999999999998 110.11 164.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 152.17 35.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.675 -1.232 . . . . 2.1000000000000001 107.675 158.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -77.16 -6.81 54.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.439 0.903 . . . . 3.3599999999999999 113.439 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 68.65 -9.37 0.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.34 1.456 . . . . 2.2799999999999998 112.851 -167.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.72 6.1 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.935 0.789 . . . . 1.98 111.537 168.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.37 38.78 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.2 -0.667 . . . . 7.0599999999999996 109.2 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -103.73 160.62 16.21 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.497 -0.641 . . . . 1.96 111.497 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.79 59.51 3.0 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.156 0.884 . . . . 2.6499999999999999 110.972 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -178.42 109.22 0.05 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 105.254 -2.128 . . . . 2.6600000000000001 105.254 -170.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -33.51 66.34 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.164 -0.335 . . . . 3.3799999999999999 111.637 -171.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -34.47 -44.4 0.2 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.355 1.862 . . . . 3.2000000000000002 113.18 165.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.84 -63.38 1.17 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.868 -0.79 . . . . 2.1600000000000001 108.868 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 p -60.14 -46.59 89.16 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.904 -0.497 . . . . 1.22 110.946 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.67 -43.72 75.55 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.826 0.851 . . . . 2.6600000000000001 112.181 -167.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.288 1.1 p -124.72 -52.83 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.239 -0.886 . . . . 1.22 111.734 172.333 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 146.53 -14.31 1.6 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.528 1.058 . . . . 0.90000000000000002 113.598 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.95 54.86 9.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.535 1.134 . . . . 1.8899999999999999 110.649 173.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -68.21 -40.85 81.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.172 0.987 . . . . 1.01 110.665 173.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.92 -168.66 30.36 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 108.407 -1.877 . . . . 1.01 108.407 -159.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -55.42 148.23 15.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.111 1.764 . . . . 1.1699999999999999 113.924 -167.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.1 mmt-85 -59.52 134.57 57.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.361 1.464 . . . . 2.9199999999999999 107.972 165.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -110.51 -80.01 0.58 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.016 1.28 . . . . 0.59999999999999998 109.837 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.6 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -114.48 149.42 36.37 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.548 -0.908 . . . . 1.1699999999999999 108.548 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.96 160.43 12.16 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.729 -2.032 . . . . 1.75 107.013 -163.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.07 156.12 13.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.748 -2.141 . . . . 0.73999999999999999 107.748 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.14 140.07 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 117.75 0.775 . . . . 0.98999999999999999 109.646 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.6 tt -97.04 132.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.839 -0.619 . . . . 0.71999999999999997 111.126 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.413 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 140.52 -6.66 2.73 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 123.902 0.763 . . . . 0.56999999999999995 114.519 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -90.33 59.83 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 118.487 1.144 . . . . 1.29 109.873 -157.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.69 149.2 24.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.268 -0.878 . . . . 2.1000000000000001 112.411 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.404 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 85.2 mt-30 . . . . . 0 C--O 1.256 1.409 0 N-CA-C 102.691 -3.077 . . . . 5.7400000000000002 102.691 129.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 109.915 -0.402 . . . . 5.8700000000000001 109.915 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.7 155.55 30.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.178 -1.416 . . . . 2.5899999999999999 107.178 -167.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.3 153.63 30.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 124.315 1.009 . . . . 3.4100000000000001 109.805 167.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.57 154.85 17.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.426 -1.694 . . . . 0.82999999999999996 106.426 153.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.99 147.89 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 104.859 -2.274 . . . . 0.90000000000000002 104.859 161.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -134.39 102.59 5.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.08 -1.822 . . . . 0.54000000000000004 106.08 166.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.57 99.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.907 -1.146 . . . . 0.81999999999999995 107.907 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.447 HD22 ' O ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -86.79 120.68 28.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.777 -1.194 . . . . 2.6000000000000001 107.777 -178.417 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -139.99 -50.17 0.48 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 122.888 0.475 . . . . 3.54 110.811 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.37 -117.35 2.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.113 0.864 . . . . 0.84999999999999998 112.667 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.14 -50.65 1.68 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.977 0.911 . . . . 3.3799999999999999 110.165 -155.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.85 165.13 11.85 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 110.667 -0.973 . . . . 0.90000000000000002 110.667 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.23 41.91 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.911 3.074 . . . . 1.3400000000000001 112.063 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 72.2 t -110.89 150.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 126.79 2.036 . . . . 0.89000000000000001 108.154 -174.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.12 129.4 8.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.892 -1.151 . . . . 2.73 107.892 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.85 172.18 44.54 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.027 -0.829 . . . . 0.65000000000000002 111.027 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.87 126.67 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.061 -1.088 . . . . 1.4399999999999999 108.061 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 2.4 mm -86.31 132.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.268 -1.753 . . . . 1.48 106.268 159.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -112.16 124.62 52.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.741 -1.948 . . . . 1.99 105.741 159.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -133.42 103.82 6.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.576 -2.009 . . . . 3.46 105.576 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.52 161.28 29.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.396 0.679 . . . . 3.4500000000000002 112.114 -169.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.407 HE22 ' N ' ' A' ' 27' ' ' GLY . 16.5 tt0 -154.97 147.15 23.78 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.972 -1.122 . . . . 3.0 107.972 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -79.5 -35.56 39.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.415 -1.266 . . . . 6.7699999999999996 110.134 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -85.37 -144.94 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.063 -1.828 . . . . 6.3700000000000001 106.063 158.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 p -147.72 -1.87 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.634 1.106 . . . . 3.25 112.984 162.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -123.57 49.76 1.68 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.217 1.007 . . . . 3.4500000000000002 109.612 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' HE22 ' A' ' 22' ' ' GLN . . . -159.69 -162.81 12.55 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.007 -1.237 . . . . 1.25 110.007 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.19 111.9 2.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.256 1.97 . . . . 1.3200000000000001 112.434 -168.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.66 150.15 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.959 0.904 . . . . 1.04 109.535 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -105.69 106.62 17.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.532 -1.655 . . . . 3.9100000000000001 106.532 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -104.24 116.98 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -130.08 142.39 50.61 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.133 -0.691 . . . . 0.96999999999999997 109.133 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.85 159.45 32.68 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.65 -1.78 . . . . 0.69999999999999996 108.65 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -140.14 108.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.841 -2.281 . . . . 2.4199999999999999 104.841 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.28 142.46 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.961 -1.866 . . . . 0.81999999999999995 105.961 -163.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.455 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -140.31 159.06 43.02 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 115.328 1.603 . . . . 4.4900000000000002 115.328 173.065 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.98 53.87 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.828 1.68 . . . . 0.90000000000000002 112.815 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.44 159.98 9.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.187 0.993 . . . . 0.78000000000000003 109.568 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.59 162.02 13.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.597 -1.261 . . . . 1.6599999999999999 107.597 156.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.47 172.44 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.172 0.897 . . . . 2.5899999999999999 110.757 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.5 -163.29 54.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 116.079 -0.51 . . . . 0.47999999999999998 113.122 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.77 146.59 47.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.959 0.904 . . . . 2.1200000000000001 111.913 -172.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -146.56 119.97 9.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.729 1.612 . . . . 0.60999999999999999 109.145 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.81 152.12 4.99 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.405 -0.678 . . . . 0.37 111.405 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE2' HG12 ' A' ' 119' ' ' VAL . 16.7 t80 -146.04 101.84 3.57 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.329 -1.36 . . . . 2.3799999999999999 107.329 -174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 26.5 m80 -143.15 160.22 40.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.322 -0.992 . . . . 0.81000000000000005 108.322 -163.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.62 127.83 75.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 CA-C-O 121.899 0.857 . . . . 1.8 110.058 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -99.68 137.49 38.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.715 1.606 . . . . 0.78000000000000003 107.627 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.02 -38.21 56.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.409 1.084 . . . . 4.3099999999999996 111.749 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 2.8 tt0 0.1 103.53 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.596 2.759 . . . . 3.0899999999999999 113.199 156.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.77 -177.82 0.08 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 129.833 3.253 . . . . 6.8600000000000003 113.305 -162.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -74.52 59.65 0.83 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.46 1.504 . . . . 7.4800000000000004 109.808 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -55.21 -59.3 4.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.941 1.696 . . . . 5.1799999999999997 111.246 -171.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m 179.5 -52.25 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 127.539 2.336 . . . . 6.2400000000000002 106.573 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.33 -65.16 0.09 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.943 -1.026 . . . . 6.8600000000000003 110.215 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.59 170.75 53.67 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 121.278 0.376 . . . . 4.1900000000000004 113.879 -170.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.7 p -91.45 137.47 32.34 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 126.381 1.872 . . . . 2.52 107.123 167.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -159.92 20.45 0.16 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.134 0.879 . . . . 4.1699999999999999 113.029 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.272 66.5 m -169.0 -21.59 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 118.043 2.608 . . . . 2.96 118.043 -128.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . . . -132.72 176.75 8.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.229 0.922 . . . . 1.8100000000000001 111.347 168.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.62 -95.67 2.42 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.125 -1.375 . . . . 1.01 109.767 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.69 -179.87 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.545 4.163 . . . . 1.1799999999999999 113.833 -175.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -52.01 126.3 18.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.514 1.526 . . . . 1.3999999999999999 108.793 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -39.7 117.3 0.72 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.353 1.061 . . . . 2.4199999999999999 111.742 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -124.71 143.28 43.08 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 130.397 3.479 . . . . 3.5099999999999998 107.578 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.99 -36.21 3.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.124 2.55 . . . . 1.27 110.148 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 tt -151.42 -66.72 0.18 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.254 -1.387 . . . . 2.9300000000000002 107.254 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.4 m -154.39 84.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.091 -1.005 . . . . 2.3700000000000001 109.848 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -79.39 174.99 11.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.182 0.515 . . . . 4.79 110.131 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -127.79 163.84 23.48 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.521 1.928 . . . . 6.75 106.951 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -102.9 152.9 20.76 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 123.707 0.803 . . . . 0.97999999999999998 110.881 -172.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 -35.56 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.777 -0.529 . . . . 2.8199999999999998 111.777 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.52 -150.5 20.12 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.682 1.611 . . . . 1.2 111.386 167.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.1 -26.98 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.566 2.844 . . . . 2.2400000000000002 110.374 -176.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -48.35 82.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.585 -0.524 . . . . 5.9100000000000001 109.585 170.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.83 175.55 6.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.29 113.41 -166.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.34 -43.73 60.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.299 1.439 . . . . 4.6399999999999997 108.401 164.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.95 157.73 31.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.639 -0.71 . . . . 3.27 111.344 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 164.66 147.93 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.89 2.076 . . . . 3.3500000000000001 111.777 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 18.4 m80 -62.79 153.61 32.4 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.319 -0.993 . . . . 0.65000000000000002 108.319 167.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.06 -36.64 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 119.794 -0.762 . . . . 1.3600000000000001 109.3 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.98 60.87 1.38 Allowed Glycine 0 CA--C 1.529 0.969 0 O-C-N 122.003 -0.436 . . . . 0.59999999999999998 113.175 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.84 96.71 1.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.367 -0.975 . . . . 2.1699999999999999 108.367 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.37 -52.28 8.3 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.319 -0.993 . . . . 2.1299999999999999 108.319 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.53 -109.06 0.35 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.834 -0.698 . . . . 0.53000000000000003 112.645 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -155.49 170.18 22.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.599 1.56 . . . . 1.52 109.758 -168.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.8 169.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.004 -1.48 . . . . 0.52000000000000002 107.004 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.2 m -123.87 123.47 40.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.58 -1.267 . . . . 2.0 107.58 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.36 141.4 31.79 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.568 0.347 . . . . 0.60999999999999999 111.149 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.25 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.348 1.03 . . . . 2.71 109.277 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.4 tttt -155.29 -34.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.102 1.519 . . . . 3.7599999999999998 115.102 -172.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.455 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 24.7 t0 -89.19 40.05 0.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.216 1.96 . . . . 2.8599999999999999 109.284 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 56.58 20.58 31.76 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 129.15 3.262 . . . . 0.88 112.562 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.49 119.92 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.947 0.899 . . . . 0.93999999999999995 108.928 -168.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.46 156.87 27.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.568 1.147 . . . . 0.67000000000000004 108.591 168.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.61 147.42 33.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.485 -2.413 . . . . 3.2799999999999998 104.485 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.67 59.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.827 0.704 . . . . 1.6599999999999999 112.024 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.5 m -86.62 96.02 9.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.371 1.068 . . . . 0.96999999999999997 110.429 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.51 152.17 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.546 1.138 . . . . 2.0099999999999998 109.931 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.37 141.9 51.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.324 -0.991 . . . . 2.8300000000000001 108.324 150.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -135.14 163.76 29.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.133 -0.691 . . . . 2.0600000000000001 109.133 162.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -111.24 -16.04 13.5 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.463 2.305 . . . . 1.8600000000000001 112.781 -173.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.37 -36.29 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.888 0.767 . . . . 1.28 109.478 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.8 pp -91.56 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.767 0.827 . . . . 1.1599999999999999 110.477 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.2 p -159.28 176.95 11.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.654 1.981 . . . . 2.6000000000000001 106.967 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.87 37.74 4.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.918 1.235 . . . . 2.3700000000000001 112.498 166.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 m -94.56 -63.44 1.18 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.968 -0.753 . . . . 3.3799999999999999 108.968 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.58 167.3 37.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.218 -0.753 . . . . 2.5 111.218 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.96 -78.59 0.02 OUTLIER 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.045 2.138 . . . . 4.6799999999999997 112.831 165.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -79.54 -24.98 41.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.478 1.111 . . . . 3.8399999999999999 110.443 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.8 p -55.85 151.95 10.66 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.179 -0.675 . . . . 1.3200000000000001 109.179 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.9 pt -78.61 -5.13 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.044 -0.503 . . . . 1.78 111.918 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 mm -32.01 127.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.762 1.225 . . . . 1.6599999999999999 110.716 170.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.78 33.3 83.79 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.378 -0.679 . . . . 1.5600000000000001 112.928 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -116.29 169.13 9.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.088 0.944 . . . . 4.1500000000000004 108.487 166.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m -100.88 110.4 22.46 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-N 118.867 0.758 . . . . 1.3300000000000001 110.247 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt -68.04 148.98 50.26 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.427 -0.953 . . . . 1.76 108.427 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.71 138.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.103 1.761 . . . . 0.40000000000000002 108.135 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.444 HG12 ' CE2' ' A' ' 45' ' ' PHE . 1.3 m -109.15 129.1 64.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.147 -1.057 . . . . 1.53 108.147 162.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.455 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 50.5 m-70 -101.98 160.18 14.71 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 116.366 1.987 . . . . 0.37 116.366 -168.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 7.3 tt0 -44.05 -75.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.68 2.392 . . . . 3.0299999999999998 112.228 172.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -94.24 179.0 5.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.222 0.534 . . . . 2.8399999999999999 110.353 -168.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.13 142.62 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.382 -1.34 . . . . 0.73999999999999999 107.382 155.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -82.25 164.23 21.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.207 1.003 . . . . 2.0099999999999998 109.094 165.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -28.12 47.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.0 -1.0 . . . . 2.8399999999999999 111.722 -160.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.16 46.4 21.51 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.876 0.87 . . . . 1.9399999999999999 109.793 -168.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.71 34.63 64.99 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 124.696 1.141 . . . . 1.6299999999999999 113.04 165.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -78.45 -17.18 56.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.409 0.604 . . . . 6.21 109.712 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.28 -118.25 5.25 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.593 -1.003 . . . . 2.5499999999999998 110.593 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.36 -69.52 0.68 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.503 -1.439 . . . . 2.48 109.503 -168.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -92.6 160.34 15.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.19 0.996 . . . . 2.79 108.453 164.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -72.94 -47.97 40.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.253 -0.88 . . . . 5.1100000000000003 110.819 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -44.22 -39.78 4.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.795 1.634 . . . . 2.7799999999999998 114.463 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 t -39.41 -64.16 0.5 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.944 1.298 . . . . 2.1099999999999999 111.035 166.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.271 1.6 t -73.38 -44.53 58.37 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.6 0.76 . . . . 2.0800000000000001 111.1 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -55.03 -49.64 71.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 119.495 1.043 . . . . 2.6600000000000001 111.921 -174.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 19.5 p -127.62 -45.98 1.46 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 119.08 -0.486 . . . . 1.72 111.403 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.42 -14.56 1.25 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.191 0.9 . . . . 0.98999999999999999 114.327 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.265 0.3 OUTLIER 28.24 56.05 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.041 1.337 . . . . 3.2599999999999998 113.944 -156.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.499 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -55.3 -35.65 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.603 1.161 . . . . 1.0600000000000001 112.337 167.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.86 -176.55 45.95 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.751 -1.74 . . . . 0.94999999999999996 108.751 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 m -61.21 154.28 23.84 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.612 1.165 . . . . 1.28 113.809 -166.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -56.18 136.56 52.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.126 1.37 . . . . 2.5699999999999998 109.022 168.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.5 mt -111.13 -76.24 0.6 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.294 -1.002 . . . . 0.55000000000000004 108.294 168.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.531 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.79 150.85 26.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.821 -1.177 . . . . 0.78000000000000003 107.821 170.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.5 p -153.34 156.68 38.8 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.301 -1.318 . . . . 1.3600000000000001 108.49 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 136.68 4.31 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 125.036 1.46 . . . . 0.60999999999999999 112.091 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.51 125.06 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 125.192 1.397 . . . . 0.90000000000000002 109.544 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.425 ' CB ' ' HB2' ' A' ' 6' ' ' ALA . 12.6 tt -90.29 128.74 42.02 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.227 0.537 . . . . 0.77000000000000002 111.233 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 152.08 -11.62 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.151 0.881 . . . . 0.76000000000000001 114.901 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -93.76 59.43 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 122.557 1.17 . . . . 1.5 109.275 -152.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.28 148.53 25.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.71 -0.677 . . . . 2.23 111.6 172.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 C--O 1.252 1.195 0 N-CA-C 101.967 -3.345 . . . . 6.8099999999999996 101.967 142.32 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 113.733 1.012 . . . . 8.4600000000000009 113.733 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m 52.53 58.8 5.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.626 1.17 . . . . 4.5899999999999999 113.031 157.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 21.1 pttp -154.99 163.74 39.88 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.14 0.976 . . . . 4.5300000000000002 109.086 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.06 168.93 16.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.253 1.025 . . . . 2.1600000000000001 111.428 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.644 HG23 ' HB2' ' A' ' 152' ' ' ALA . 27.3 t -128.78 147.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.532 -2.396 . . . . 1.6000000000000001 104.532 155.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.43 99.18 4.02 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 108.525 -0.916 . . . . 0.82999999999999996 108.525 153.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.4 t -68.58 94.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.868 -1.16 . . . . 1.02 107.868 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 147' ' ' GLY . 34.8 mt -79.52 122.96 27.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.597 -0.89 . . . . 1.8600000000000001 108.597 175.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -136.33 -60.01 0.72 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.242 -1.022 . . . . 4.0199999999999996 108.242 174.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.83 -139.79 9.73 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.894 -1.682 . . . . 1.23 108.894 -156.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.83 21.78 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.142 0.577 . . . . 5.9400000000000004 111.534 168.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.32 165.57 46.37 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 107.97 -2.052 . . . . 0.95999999999999996 107.97 148.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.62 72.42 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.798 2.332 . . . . 2.6299999999999999 109.845 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.0 t -139.64 144.64 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.818 0.847 . . . . 0.76000000000000001 109.287 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -145.44 120.61 10.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.575 -1.268 . . . . 3.0099999999999998 107.575 166.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.88 163.56 32.78 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.588 -0.695 . . . . 0.52000000000000002 111.941 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.1 mt -127.16 127.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.474 -1.306 . . . . 1.3400000000000001 107.474 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 30.2 mm -87.85 142.6 12.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 N-CA-C 106.383 -1.71 . . . . 0.77000000000000002 106.383 158.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -139.04 82.25 1.89 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.165 -1.05 . . . . 2.7000000000000002 108.165 168.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.407 ' CD1' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -77.85 152.53 33.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 118.641 -1.224 . . . . 5.29 108.992 175.147 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -139.3 148.22 42.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.905 -1.887 . . . . 3.5600000000000001 105.905 166.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -156.94 116.96 3.51 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.208 1.403 . . . . 4.0700000000000003 108.173 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -63.6 -60.23 3.6 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.274 0.63 . . . . 4.6699999999999999 110.681 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -77.9 107.02 10.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.244 -0.91 . . . . 4.0499999999999998 108.919 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -57.76 6.08 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.593 2.357 . . . . 3.29 116.922 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.44 60.85 0.75 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.116 -1.068 . . . . 3.6099999999999999 108.116 168.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.79 179.97 19.37 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 108.389 -1.884 . . . . 0.93999999999999995 108.389 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.67 116.78 3.57 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 1.02 111.302 -171.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 20' ' ' PHE . 7.8 t -80.95 135.37 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.367 -0.825 . . . . 1.4199999999999999 109.958 -169.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.83 88.03 4.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.293 0.951 . . . . 3.9700000000000002 109.855 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.96 88.66 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.634 1.174 . . . . 1.8400000000000001 109.03 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -102.62 157.3 17.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 123.52 0.513 . . . . 0.93999999999999995 111.581 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.17 164.24 35.37 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.652 -0.579 . . . . 0.67000000000000004 111.652 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -130.08 70.44 1.44 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.161 1.384 . . . . 2.2599999999999998 108.999 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.0 132.59 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.191 0.996 . . . . 0.75 110.124 -168.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -130.91 163.03 28.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.618 0.767 . . . . 3.7999999999999998 111.494 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.6 -16.89 59.82 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.077 -0.846 . . . . 1.3899999999999999 113.862 173.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.41 159.25 2.09 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.55 1.175 . . . . 0.79000000000000004 111.389 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 154.67 23.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.722 -1.214 . . . . 1.72 107.722 153.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.2 171.42 0.27 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.065 0.935 . . . . 3.3100000000000001 111.302 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.05 -161.58 54.32 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.307 -0.86 . . . . 0.73999999999999999 112.75 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.92 136.24 52.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.085 1.354 . . . . 1.99 112.401 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -140.6 121.75 14.76 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.581 1.552 . . . . 0.53000000000000003 108.86 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.66 149.98 9.87 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.73 -0.948 . . . . 0.48999999999999999 110.73 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.11 96.62 3.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.487 -1.672 . . . . 2.4700000000000002 106.487 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.624 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 27.9 m80 -134.86 161.52 34.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.997 -1.112 . . . . 0.68000000000000005 107.997 -169.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 t -114.09 128.05 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.845 -1.169 . . . . 2.1800000000000002 107.845 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -112.47 137.98 49.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.099 -1.445 . . . . 0.96999999999999997 107.099 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -72.34 63.95 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.418 0.687 . . . . 4.1600000000000001 112.725 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -113.29 115.32 27.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.228 -1.397 . . . . 3.5099999999999998 107.228 171.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -72.62 -173.65 1.22 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 127.381 2.272 . . . . 4.6399999999999997 111.861 -167.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -76.66 70.71 3.19 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.376 1.87 . . . . 8.2200000000000006 110.709 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.58 -25.26 0.57 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.856 1.058 . . . . 5.7599999999999998 113.856 -175.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -161.33 -167.18 1.7 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.318 -1.364 . . . . 5.6500000000000004 107.318 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.45 84.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.053 0.541 . . . . 6.9299999999999997 109.758 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.405 ' O ' HG21 ' A' ' 116' ' ' THR . . . 100.48 65.63 0.81 Allowed Glycine 0 CA--C 1.523 0.553 0 CA-C-O 123.707 1.726 . . . . 5.1699999999999999 111.512 165.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 p -151.76 56.31 0.85 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.706 -1.22 . . . . 2.8900000000000001 107.706 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -148.78 32.61 0.77 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.065 0.765 . . . . 3.9300000000000002 113.065 171.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.298 15.1 m -170.06 -50.99 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 117.309 2.337 . . . . 2.6899999999999999 117.309 -144.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.09 134.2 49.59 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.659 0.784 . . . . 1.9199999999999999 108.949 176.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.01 -94.38 0.9 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.393 -1.483 . . . . 1.02 109.393 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.17 178.25 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.902 3.068 . . . . 1.23 112.819 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -63.85 130.0 42.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.693 -1.14 . . . . 1.3799999999999999 110.608 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -31.92 113.83 0.13 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.196 1.184 . . . . 1.99 114.196 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.47 154.86 49.39 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 126.517 1.927 . . . . 2.6400000000000001 106.722 160.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.9 -42.33 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.61 1.54 . . . . 1.28 111.666 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 -71.95 0.43 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.257 0.623 . . . . 2.7400000000000002 109.556 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 m -145.47 72.56 1.32 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.562 0.745 . . . . 1.6599999999999999 111.512 -164.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -79.43 175.5 10.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.599 -1.26 . . . . 4.75 107.599 153.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -128.89 174.97 9.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.333 1.453 . . . . 4.0700000000000003 107.224 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -108.02 129.85 55.1 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.285 1.034 . . . . 1.3899999999999999 112.658 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.79 21.71 1.29 Allowed Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.68 -0.568 . . . . 3.0 111.68 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.58 -169.71 4.02 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.074 0.845 . . . . 1.3999999999999999 113.348 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.94 -6.13 12.12 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.056 3.171 . . . . 1.47 114.256 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.04 -50.06 5.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.916 -1.115 . . . . 6.0499999999999998 110.612 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.81 169.46 18.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.989 0.899 . . . . 2.5099999999999998 111.552 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.26 -37.84 84.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 5.21 109.51 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.343 12.1 pt-20 -78.57 149.68 32.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.028 0.918 . . . . 4.9299999999999997 110.915 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 151.87 127.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 131.405 3.882 . . . . 2.98 104.03 -162.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.523 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.0 m80 -60.62 152.34 26.61 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.649 -1.241 . . . . 0.64000000000000001 107.649 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -30.25 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 120.117 -0.633 . . . . 1.3500000000000001 110.239 -167.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.52 59.56 0.5 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.385 -0.675 . . . . 0.66000000000000003 112.756 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -123.03 108.67 13.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.682 1.241 . . . . 2.6400000000000001 109.049 165.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.82 -47.46 15.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.088 -0.708 . . . . 1.5600000000000001 109.088 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.52 -104.17 0.25 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.916 0.78 . . . . 0.70999999999999996 112.677 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -155.66 167.42 30.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.484 1.914 . . . . 1.5600000000000001 108.629 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.4 160.19 40.26 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.205 -1.035 . . . . 0.85999999999999999 108.205 171.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -109.32 111.93 23.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 2.1899999999999999 108.669 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.38 139.37 37.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.304 0.502 . . . . 0.62 110.802 169.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.02 -90.31 0.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.532 0.52 . . . . 3.9300000000000002 110.649 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 -56.95 1.16 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.844 0.857 . . . . 4.6299999999999999 112.142 -159.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.7 21.16 0.85 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.074 1.749 . . . . 3.2999999999999998 110.155 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.08 18.47 69.03 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 124.593 1.092 . . . . 0.78000000000000003 111.597 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -79.74 110.14 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.534 -1.284 . . . . 0.97999999999999998 107.534 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.75 175.71 6.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.873 -1.158 . . . . 0.80000000000000004 107.873 161.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -131.34 136.39 48.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 102.67 -3.085 . . . . 2.9100000000000001 102.67 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.83 131.86 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.784 -1.932 . . . . 1.5700000000000001 105.784 167.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.6 m -160.78 61.04 0.31 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.868 1.667 . . . . 1.3 108.245 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -108.22 152.78 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.414 0.686 . . . . 1.8500000000000001 109.705 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -137.64 142.83 41.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.308 -0.627 . . . . 3.27 109.308 149.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -124.6 145.21 49.74 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.614 -1.625 . . . . 2.5499999999999998 106.614 166.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -79.58 -18.11 52.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.036 2.134 . . . . 1.4199999999999999 111.394 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.4 t -77.17 -39.91 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.772 -0.455 . . . . 1.1100000000000001 109.772 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -77.46 176.79 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.672 0.749 . . . . 1.1200000000000001 110.985 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 t -161.51 179.89 7.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.613 1.965 . . . . 2.2999999999999998 105.871 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.54 41.86 3.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.846 1.259 . . . . 3.1899999999999999 110.74 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.4 t -155.92 -64.73 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.015 -0.735 . . . . 3.27 109.015 -174.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.75 157.14 48.53 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.147 -0.781 . . . . 3.1699999999999999 111.147 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -45.44 -43.02 11.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.128 0.964 . . . . 6.5499999999999998 112.135 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -74.76 1.79 11.6 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.987 -0.445 . . . . 4.6299999999999999 111.721 -172.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.0 p -57.14 164.41 1.71 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 123.01 1.386 . . . . 1.6699999999999999 111.533 158.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.628 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -83.52 -8.68 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 113.695 -1.593 . . . . 2.3399999999999999 111.98 169.298 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.1 mm -49.75 123.85 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 119.471 1.032 . . . . 1.6899999999999999 110.34 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.75 -9.46 55.92 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.614 -1.103 . . . . 1.6799999999999999 112.974 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.444 ' O ' HG22 ' A' ' 149' ' ' ILE . 90.5 mtt-85 -88.6 164.54 15.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.519 1.659 . . . . 4.2199999999999998 110.171 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 56' ' ' GLY . 24.3 m -94.11 118.41 31.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.233 -0.292 . . . . 0.89000000000000001 110.698 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.76 142.53 54.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.356 -0.979 . . . . 2.4900000000000002 108.356 163.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.6 t -127.91 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.24 1.416 . . . . 0.38 107.648 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.39 120.95 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 106.187 -1.783 . . . . 2.2999999999999998 106.187 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.501 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 55.1 m-70 -98.29 159.42 14.95 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.751 2.13 . . . . 0.40999999999999998 116.751 -174.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -29.59 -83.44 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.363 3.065 . . . . 3.71 112.352 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -96.98 -175.35 3.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.472 1.109 . . . . 3.3300000000000001 109.728 -175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.15 157.6 3.37 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.701 -0.481 . . . . 0.94999999999999996 109.701 159.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.27 160.79 23.65 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.44 -0.578 . . . . 2.1899999999999999 109.44 161.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.05 -25.21 59.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.96 1.096 . . . . 3.0800000000000001 113.96 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.78 13.11 2.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.839 0.856 . . . . 1.4399999999999999 113.127 -165.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.39 47.49 42.92 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.831 1.196 . . . . 1.55 111.554 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -142.03 -22.71 0.7 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.807 2.043 . . . . 4.96 112.925 -173.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.2 136.72 40.2 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 120.315 1.416 . . . . 2.5600000000000001 111.02 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.28 67.68 0.92 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.691 1.139 . . . . 2.6400000000000001 111.26 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -144.07 -179.22 6.36 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.025 2.13 . . . . 3.1400000000000001 105.424 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -39.47 15.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.387 -0.968 . . . . 4.2000000000000002 108.387 159.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -47.48 -28.25 2.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.336 2.254 . . . . 4.9299999999999997 113.622 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.6 p -58.21 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.734 1.214 . . . . 2.3999999999999999 109.116 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.5 t -60.83 -31.74 71.15 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.23 -0.919 . . . . 2.79 111.592 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -59.09 -49.36 78.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.281 -0.887 . . . . 3.3900000000000001 111.948 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.523 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.335 9.9 t -134.08 -51.81 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.325 -0.845 . . . . 1.77 111.343 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.54 30.0 0.07 OUTLIER Glycine 0 C--N 1.336 0.579 0 CA-C-O 116.989 -2.006 . . . . 1.1699999999999999 115.572 168.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 9.03 57.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.683 2.393 . . . . 2.3100000000000001 114.674 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.624 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.25 -38.34 88.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.2 1.0 . . . . 1.0 108.998 166.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.73 36.44 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 108.074 -2.011 . . . . 1.04 108.074 -165.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 158.81 20.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.985 0.914 . . . . 2.21 113.106 -166.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -63.15 132.02 50.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.243 1.817 . . . . 3.0699999999999998 108.487 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.84 -63.23 1.37 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.256 -1.016 . . . . 0.64000000000000001 108.256 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.45 158.66 16.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.15 -0.932 . . . . 1.04 109.716 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 139.36 23.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.356 -1.72 . . . . 1.78 106.356 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.469 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -160.12 131.05 2.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.553 -1.819 . . . . 0.68999999999999995 108.553 170.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.42 139.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.722 -0.844 . . . . 0.80000000000000004 108.722 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.628 HG21 HG12 ' A' ' 112' ' ' ILE . 7.8 tt -102.31 142.68 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.779 0.831 . . . . 0.88 112.692 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.23 6.72 8.8 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.016 1.294 . . . . 0.76000000000000001 112.658 172.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.33 58.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.685 1.242 . . . . 0.78000000000000003 111.315 -163.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.644 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -155.57 175.54 13.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.052 0.941 . . . . 1.45 108.79 164.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.501 0 C-N-CA 126.361 1.864 . . . . 4.2999999999999998 106.127 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 120.8 0.333 . . . . 4.7999999999999998 110.654 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.65 78.34 3.31 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.872 1.269 . . . . 2.4700000000000002 110.655 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.24 145.67 37.4 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.648 -0.871 . . . . 3.3500000000000001 108.648 168.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.58 139.99 37.32 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.873 -1.529 . . . . 0.69999999999999996 106.873 156.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -99.46 146.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.373 -1.714 . . . . 0.75 106.373 161.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -133.2 92.76 3.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.875 -0.787 . . . . 0.58999999999999997 108.875 163.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.24 110.22 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.69999999999999996 108.163 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.42 140.31 30.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.04 0.536 . . . . 0.85999999999999999 110.355 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -144.94 -54.45 0.31 Allowed 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.204 1.002 . . . . 6.0199999999999996 109.877 165.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.46 -134.93 51.6 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.421 1.01 . . . . 0.98999999999999999 114.185 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.79 -51.32 2.92 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.79 1.236 . . . . 4.0099999999999998 109.481 -166.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.14 156.1 15.14 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 109.192 -1.563 . . . . 0.85999999999999999 109.192 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.72 46.38 2.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 0.96999999999999997 112.045 -172.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 30.3 t -89.91 158.16 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 125.353 1.461 . . . . 0.88 108.643 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.62 120.85 4.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.536 -1.653 . . . . 3.1200000000000001 106.536 173.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.06 40.38 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.528 -0.844 . . . . 0.59999999999999998 111.864 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.11 128.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.035 -1.098 . . . . 1.01 108.035 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.8 mp -93.91 141.94 14.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.009 -1.849 . . . . 1.47 106.009 162.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.32 115.65 20.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.414 -2.069 . . . . 1.6100000000000001 105.414 163.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' CD2' HG22 ' A' ' 31' ' ' VAL . 31.8 t80 -129.91 107.45 9.38 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.445 -2.057 . . . . 2.9500000000000002 105.445 -163.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -136.1 153.72 51.23 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.422 0.63 . . . . 3.3199999999999998 110.58 -166.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -140.18 143.63 36.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.18 -1.785 . . . . 3.75 106.18 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -85.31 -35.87 21.18 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.932 0.893 . . . . 5.1900000000000004 110.675 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -137.24 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.437 1.095 . . . . 5.25 108.52 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 t -129.61 -69.53 0.68 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.95 1.7 . . . . 2.7599999999999998 108.715 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -109.68 61.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.93 1.292 . . . . 4.2599999999999998 107.865 -172.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.11 175.07 21.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.961 -1.256 . . . . 1.0600000000000001 109.961 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 115.35 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.789 2.993 . . . . 1.2 111.259 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -78.51 150.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.921 -0.77 . . . . 0.80000000000000004 108.921 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -100.13 113.79 26.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.311 -1.366 . . . . 3.6899999999999999 107.311 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 20' ' ' PHE . 3.5 t -104.54 128.59 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.131 -1.433 . . . . 1.3300000000000001 107.131 175.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -130.41 146.54 51.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.851 -1.907 . . . . 1.0600000000000001 105.851 162.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.23 20.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.046 -1.622 . . . . 0.68999999999999995 109.046 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 p -132.12 118.22 19.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.574 -1.639 . . . . 1.9199999999999999 106.574 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.36 148.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 125.588 1.555 . . . . 1.1299999999999999 108.462 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -141.09 176.45 8.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 119.017 -1.073 . . . . 5.7000000000000002 112.548 149.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.99 13.89 57.08 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.203 1.858 . . . . 0.69999999999999996 113.191 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 119' ' ' VAL . 2.3 mm? -65.25 166.01 10.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 117.713 0.757 . . . . 1.3799999999999999 109.968 166.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 164.95 23.65 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.988 -1.115 . . . . 1.8999999999999999 107.988 156.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -58.92 174.11 0.38 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.266 0.939 . . . . 2.4300000000000002 111.476 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.08 -166.38 54.85 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.677 0.656 . . . . 0.56999999999999995 113.756 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.05 153.26 40.93 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.241 1.017 . . . . 2.1899999999999999 110.41 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CD2' HD12 ' A' ' 38' ' ' LEU . 80.5 m-70 -146.55 118.62 8.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.945 1.298 . . . . 0.46000000000000002 108.878 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.96 151.58 5.5 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.335 -1.106 . . . . 0.41999999999999998 110.335 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -145.85 102.27 3.64 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 117.977 0.889 . . . . 2.25 108.716 -171.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.648 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.5 m80 -143.34 155.21 44.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.248 -1.39 . . . . 0.56000000000000005 107.248 -158.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.1 140.35 30.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 119.643 1.111 . . . . 1.8899999999999999 109.784 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -113.25 140.33 48.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.971 1.308 . . . . 1.0 107.691 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.1 74.1 0.65 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.387 1.089 . . . . 4.4699999999999998 112.193 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HA ' HD22 ' A' ' 53' ' ' ASN . 41.4 tt0 -148.56 80.94 1.45 Allowed 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 104.753 -2.314 . . . . 3.3100000000000001 104.753 -171.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -152.25 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.124 1.37 . . . . 5.04 110.698 172.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -84.58 63.84 8.13 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 120.422 -1.424 . . . . 6.6100000000000003 109.814 -174.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -100.24 -28.96 12.72 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 126.227 1.811 . . . . 5.75 110.373 -179.587 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -171.34 157.94 5.15 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.072 0.949 . . . . 5.5800000000000001 108.588 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.65 -22.23 29.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.579 0.752 . . . . 4.9500000000000002 110.161 163.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.99 71.95 1.38 Allowed Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.353 -1.499 . . . . 4.2999999999999998 109.353 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.0 t -48.39 109.61 0.26 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.009 1.723 . . . . 2.4399999999999999 112.387 -171.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 m -149.7 -117.57 0.05 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.604 -1.258 . . . . 4.0999999999999996 107.604 -173.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.3 m 69.97 -73.34 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.823 2.157 . . . . 2.46 116.823 139.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.22 142.83 27.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.891 1.277 . . . . 2.04 109.472 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.68 -91.92 1.92 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 107.879 -2.088 . . . . 1.26 107.879 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.95 178.09 6.91 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.759 2.972 . . . . 1.1599999999999999 113.281 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.31 131.74 45.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.584 -1.644 . . . . 1.47 109.868 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -35.42 109.84 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.834 1.254 . . . . 2.1200000000000001 111.907 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.38 150.7 21.17 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 126.038 1.735 . . . . 2.3599999999999999 107.199 165.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.15 -29.02 33.72 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.368 2.045 . . . . 1.1499999999999999 114.14 -170.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.93 -64.38 0.11 Allowed 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.07 0.85 . . . . 3.1200000000000001 112.152 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.6 m -154.23 83.3 1.13 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.102 -0.703 . . . . 1.8799999999999999 109.102 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 168.06 11.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.462 -0.94 . . . . 5.6100000000000003 108.462 162.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -114.7 163.16 15.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.635 -1.246 . . . . 3.0899999999999999 107.635 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -82.58 160.77 22.46 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.082 0.553 . . . . 0.80000000000000004 110.293 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.54 176.72 41.64 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 106.302 -2.719 . . . . 2.02 106.302 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.19 -168.92 23.99 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 118.927 1.364 . . . . 1.3500000000000001 112.913 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -62.36 -30.9 81.31 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.851 1.7 . . . . 1.49 109.957 163.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -78.11 -42.39 32.12 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.617 0.767 . . . . 5.5899999999999999 112.561 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.1 163.55 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.456 0.571 . . . . 2.2999999999999998 111.267 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -78.5 -50.9 10.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.638 1.575 . . . . 4.2000000000000002 109.936 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.259 16.9 pt-20 -90.48 176.82 6.56 Favored 'General case' 0 C--N 1.337 0.055 0 C-N-CA 122.554 0.342 . . . . 2.9700000000000002 111.812 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 165.05 159.06 0.02 OUTLIER 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.674 1.989 . . . . 4.7800000000000002 108.552 -166.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 55.7 m80 -61.52 139.39 58.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.094 -1.817 . . . . 0.67000000000000004 106.094 161.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.11 -32.23 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.723 -0.391 . . . . 1.3400000000000001 110.653 -163.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.62 53.32 0.65 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.123 0.392 . . . . 0.96999999999999997 113.007 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -107.9 130.14 55.04 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 2.5899999999999999 107.733 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.71 -58.75 2.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.166 -1.05 . . . . 1.6699999999999999 108.166 159.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.12 -93.14 0.13 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.701 -0.96 . . . . 0.63 110.701 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -155.09 166.52 33.33 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.945 1.698 . . . . 1.8899999999999999 111.234 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.09 178.06 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 127.31 2.244 . . . . 0.69999999999999996 105.961 165.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -136.49 145.73 45.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.921 -1.881 . . . . 2.1200000000000001 105.921 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.52 145.49 34.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.733 0.813 . . . . 0.53000000000000003 110.862 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -70.39 -84.25 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.873 0.869 . . . . 2.9500000000000002 110.79 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 93' ' ' GLY . 61.5 tttt -158.69 -47.3 0.06 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.317 1.047 . . . . 3.48 111.226 -171.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -82.44 29.62 0.43 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 124.659 2.171 . . . . 3.0699999999999998 110.277 173.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 60.07 21.31 55.94 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 113.583 -1.644 . . . . 0.71999999999999997 111.611 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.56 138.14 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.716 -1.587 . . . . 0.79000000000000004 106.716 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.73 169.37 19.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.103 -1.073 . . . . 0.85999999999999999 108.103 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.64 141.61 29.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.956 -1.868 . . . . 2.7200000000000002 105.956 -165.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.8 56.59 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 124.048 0.843 . . . . 1.6299999999999999 112.415 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.8 m -78.15 97.45 5.47 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.27 1.028 . . . . 0.96999999999999997 109.846 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 mm -136.44 153.62 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.964 0.906 . . . . 1.77 110.455 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -132.81 97.08 3.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.243 1.817 . . . . 4.0300000000000002 108.77 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.98 174.4 11.59 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.601 -0.518 . . . . 2.3199999999999998 109.601 169.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.2 m -147.84 26.52 1.01 Allowed 'General case' 0 CA--C 1.53 0.211 0 O-C-N 120.839 -1.163 . . . . 2.4300000000000002 112.069 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.15 -52.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.543 1.537 . . . . 1.04 108.532 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.21 173.22 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.107 0.48 . . . . 1.1299999999999999 111.338 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.3 t -154.43 176.48 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.679 0.792 . . . . 2.5699999999999998 110.257 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -86.88 -13.67 44.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 2.4199999999999999 111.073 160.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.1 t -126.64 177.21 6.67 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.568 1.147 . . . . 3.6400000000000001 111.349 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.42 -96.96 2.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.848 -1.301 . . . . 3.5 109.848 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -162.8 -60.47 0.04 OUTLIER 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.483 1.113 . . . . 4.2199999999999998 108.989 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -75.39 2.65 10.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.064 0.946 . . . . 5.0800000000000001 111.516 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -41.96 156.48 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.147 1.779 . . . . 1.4199999999999999 112.413 165.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.7 pt -86.04 -6.39 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 1.9199999999999999 110.855 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.6 tp -33.22 123.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 125.369 1.468 . . . . 2.3900000000000001 110.69 166.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.81 57.11 20.5 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.858 -0.897 . . . . 1.8600000000000001 110.858 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -135.56 157.93 45.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.883 -1.525 . . . . 4.3300000000000001 106.883 163.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -82.58 120.75 25.93 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.543 -1.28 . . . . 1.21 107.543 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.44 141.69 44.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.602 -1.258 . . . . 2.4300000000000002 107.602 168.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.04 134.1 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.446 -1.316 . . . . 0.35999999999999999 107.446 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.656 HG21 HD11 ' A' ' 38' ' ' LEU . 5.6 p -107.33 130.43 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 106.337 -1.727 . . . . 2.21 106.337 162.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.506 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 49.7 m-70 -104.51 163.66 12.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.773 1.397 . . . . 0.38 114.773 -168.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.72 -71.47 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.281 -0.866 . . . . 3.7599999999999998 112.287 176.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -79.56 176.68 9.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.643 1.111 . . . . 3.3300000000000001 109.08 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.3 158.66 16.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.779 -0.822 . . . . 0.66000000000000003 108.779 162.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -76.64 170.57 16.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.481 -0.562 . . . . 2.0 109.481 166.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.78 -20.84 59.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.254 1.205 . . . . 4.1500000000000004 114.254 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 66.48 -6.21 0.53 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.119 1.368 . . . . 1.97 113.471 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.84 9.34 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 120.122 1.328 . . . . 1.95 109.904 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.09 -31.09 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 5.6600000000000001 109.384 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.64 -106.73 2.12 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.761 . . . . 2.96 111.196 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.44 -72.19 0.47 Allowed Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.544 -0.974 . . . . 2.6299999999999999 112.117 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -83.23 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.688 0.744 . . . . 3.1699999999999999 110.933 -172.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 178.77 -71.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.597 1.959 . . . . 3.2200000000000002 106.908 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -40.28 -40.39 1.14 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.857 2.063 . . . . 4.5599999999999996 112.042 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.47 0.09 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.549 2.339 . . . . 2.2200000000000002 112.076 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -39.53 74.27 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.409 -1.432 . . . . 1.79 110.787 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -55.66 -48.42 75.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.78 1.232 . . . . 3.1899999999999999 111.566 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.496 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -127.7 -48.26 1.39 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.691 0.796 . . . . 1.3200000000000001 111.987 177.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.3 -11.9 0.9 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.797 -1.002 . . . . 0.89000000000000001 114.097 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 30.51 54.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.943 2.097 . . . . 2.6499999999999999 112.911 -168.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.648 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.74 -35.8 80.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.519 1.127 . . . . 1.02 111.014 169.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.96 -165.75 30.72 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 108.895 -1.682 . . . . 1.05 108.895 -166.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -58.57 154.83 13.44 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 127.751 2.421 . . . . 1.21 113.102 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -57.01 139.03 53.47 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.816 -1.084 . . . . 2.3199999999999998 108.964 166.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.73 -78.48 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.014 -1.106 . . . . 0.5 108.014 160.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.566 ' HB3' HG12 ' A' ' 119' ' ' VAL . . . -89.7 159.8 16.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.019 -0.734 . . . . 0.79000000000000004 109.019 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 72.8 m -148.01 157.84 43.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.825 -1.546 . . . . 1.75 106.825 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.14 139.96 3.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.212 -1.955 . . . . 0.65000000000000002 108.212 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.42 138.08 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.714 0.806 . . . . 0.77000000000000002 109.552 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 tt -94.82 131.03 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.104 0.478 . . . . 0.77000000000000002 111.828 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.45 0.52 0.98 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.942 1.258 . . . . 0.66000000000000003 114.689 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.96 57.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.19 1.495 . . . . 0.82999999999999996 111.54 -153.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.72 174.58 15.25 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.027 0.531 . . . . 1.6000000000000001 110.914 163.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 . . . . . 0 C--O 1.255 1.347 0 N-CA-C 102.731 -3.063 . . . . 6.1799999999999997 102.731 160.668 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 107.932 -1.136 . . . . 7.5899999999999999 107.932 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -165.89 56.24 0.1 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.304 1.441 . . . . 3.25 109.375 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -151.55 166.54 30.86 Favored 'General case' 0 C--N 1.335 -0.055 0 O-C-N 121.183 -0.948 . . . . 3.4700000000000002 113.295 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.97 155.82 23.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.39 1.076 . . . . 0.85999999999999999 109.573 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -124.18 150.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 107.981 -1.118 . . . . 0.85999999999999999 107.981 165.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -124.36 95.37 4.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.194 0.998 . . . . 0.46999999999999997 109.206 161.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.67 112.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.359 -1.348 . . . . 0.56999999999999995 107.359 161.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.48 131.83 51.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.153 0.981 . . . . 1.1299999999999999 109.769 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.63 -47.92 0.29 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.785 1.234 . . . . 4.9100000000000001 109.886 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.61 -125.05 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.543 1.068 . . . . 0.84999999999999998 111.989 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.47 -58.27 1.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.696 -0.853 . . . . 4.21 108.696 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.72 165.92 3.8 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.788 1.661 . . . . 0.72999999999999998 114.146 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.62 37.46 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 124.516 3.477 . . . . 1.4299999999999999 111.95 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 55.2 t -110.97 143.61 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.167 2.187 . . . . 0.89000000000000001 106.795 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -137.38 131.22 31.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.786 -1.931 . . . . 2.8599999999999999 105.786 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.96 165.75 33.27 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 121.687 -0.633 . . . . 0.59999999999999998 111.84 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.65 127.65 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.979 -1.86 . . . . 1.25 105.979 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 35.5 mm -98.46 138.14 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.748 -1.575 . . . . 0.73999999999999999 106.748 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -109.38 124.86 51.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.57 -1.641 . . . . 2.1699999999999999 106.57 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.517 ' CG ' HD11 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -107.21 95.99 6.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.882 -1.895 . . . . 2.4700000000000002 105.882 171.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -113.52 136.66 52.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.879 -1.526 . . . . 5.54 106.879 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -153.69 153.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.913 -1.514 . . . . 4.29 106.913 -166.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -105.5 -79.06 0.56 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 4.8799999999999999 110.121 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.46 137.07 37.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.098 0.959 . . . . 4.0 109.051 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -52.52 -68.08 0.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.02 1.728 . . . . 2.3500000000000001 112.446 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -79.7 68.54 5.79 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.814 -1.18 . . . . 3.71 107.814 170.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 167.46 31.42 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.604 -0.999 . . . . 1.3500000000000001 110.604 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.4 142.32 44.84 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.523 2.816 . . . . 1.49 111.834 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.3 165.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.617 -1.253 . . . . 1.28 107.617 171.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.37 95.09 4.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.866 -1.901 . . . . 3.1499999999999999 105.866 157.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' CE1' ' A' ' 20' ' ' PHE . 38.3 t -79.83 113.49 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.524 -1.658 . . . . 0.84999999999999998 106.524 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -124.85 142.5 51.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.177 -1.045 . . . . 0.84999999999999998 108.177 166.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.1 152.23 23.67 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.446 -0.661 . . . . 0.67000000000000004 111.446 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 p -125.33 64.56 1.16 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.484 1.514 . . . . 2.2799999999999998 108.599 -165.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -80.72 142.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.525 -1.216 . . . . 0.81000000000000005 109.099 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -149.99 161.88 41.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.324 0.861 . . . . 3.4199999999999999 113.324 174.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.81 9.1 61.43 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.702 1.62 . . . . 0.82999999999999996 112.617 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.87 162.41 16.35 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.751 -0.853 . . . . 0.81999999999999995 109.542 172.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.18 162.21 14.91 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.571 -1.27 . . . . 1.5800000000000001 107.571 152.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.69 177.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.962 0.801 . . . . 3.0699999999999998 110.959 174.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.98 -163.51 37.51 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.922 0.772 . . . . 0.59999999999999998 113.512 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.7 142.92 58.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.393 1.477 . . . . 1.9199999999999999 113.355 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -145.68 116.88 7.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 126.104 1.762 . . . . 0.53000000000000003 109.359 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.58 150.02 6.13 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.301 0.953 . . . . 0.34999999999999998 111.081 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -141.25 99.61 3.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.66 -1.237 . . . . 2.8799999999999999 107.66 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.607 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 25.5 m80 -140.02 161.95 36.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.714 -1.217 . . . . 0.68000000000000005 107.714 -165.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.89 130.0 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 119.07 0.85 . . . . 2.04 109.41 172.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -106.99 134.09 50.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.479 1.911 . . . . 1.3 105.947 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 60.64 0.61 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.16 1.541 . . . . 4.6900000000000004 115.16 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -95.75 112.12 23.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.878 -1.156 . . . . 3.1800000000000002 107.878 168.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -88.53 39.31 0.91 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.683 -1.229 . . . . 4.1600000000000001 107.683 160.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -73.9 84.88 1.72 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 122.42 1.105 . . . . 6.8799999999999999 109.009 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -101.45 38.08 1.67 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.933 -1.485 . . . . 7.2300000000000004 107.847 171.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -128.55 -47.81 1.29 Allowed 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.059 0.543 . . . . 5.0 111.784 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.35 -63.8 1.2 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.267 1.027 . . . . 5.0 109.165 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.72 -47.44 0.36 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.343 -0.703 . . . . 4.1299999999999999 111.343 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 32.2 m -147.31 135.05 21.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 104.077 -2.564 . . . . 3.29 104.077 164.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 m -140.43 -13.81 1.0 Allowed 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 114.281 1.215 . . . . 4.9400000000000004 114.281 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.3 t -179.8 55.48 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 116.697 2.11 . . . . 3.2799999999999998 116.697 -115.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -167.28 148.54 5.69 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.395 0.678 . . . . 2.0299999999999998 109.453 158.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.49 -85.5 1.85 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.819 -1.312 . . . . 1.1200000000000001 109.819 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.63 176.66 9.82 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.215 2.61 . . . . 0.89000000000000001 113.217 -174.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 m170 -66.31 123.4 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.107 -1.406 . . . . 1.45 108.119 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -37.19 113.5 0.26 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.092 1.357 . . . . 2.77 111.608 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.5 154.55 25.63 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 124.957 1.303 . . . . 2.5 107.604 168.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.36 -48.6 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.861 1.708 . . . . 1.1000000000000001 111.643 -168.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.38 -79.71 0.62 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.898 0.879 . . . . 3.1400000000000001 109.074 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.3 m -150.8 68.86 0.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.801 0.841 . . . . 1.6499999999999999 110.384 -166.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -78.95 174.92 11.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.338 0.589 . . . . 4.0999999999999996 109.417 166.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -124.8 156.01 38.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.376 -1.342 . . . . 3.04 107.376 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -83.15 162.05 21.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.099 0.476 . . . . 0.79000000000000004 111.155 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.41 -126.28 0.87 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.173 -2.771 . . . . 2.0499999999999998 106.173 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.02 -134.22 2.02 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 106.403 -2.679 . . . . 1.24 106.403 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.14 -54.18 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 120.288 2.044 . . . . 1.5600000000000001 109.869 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -60.14 -44.42 94.95 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.952 1.301 . . . . 5.2599999999999998 113.841 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.8 175.75 2.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.905 0.383 . . . . 2.0600000000000001 111.06 -170.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -77.36 -46.85 21.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.048 1.339 . . . . 5.0099999999999998 108.889 167.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.85 172.22 14.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.81 0.844 . . . . 3.1499999999999999 112.144 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 172.17 145.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.234 2.213 . . . . 4.1799999999999997 109.757 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 38.2 m80 -56.18 138.64 49.64 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.905 -1.517 . . . . 0.77000000000000002 106.905 161.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.55 -32.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.293 -0.632 . . . . 1.3799999999999999 109.293 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.87 34.45 5.34 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 116.395 1.318 . . . . 0.79000000000000004 116.395 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -107.1 148.08 29.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.861 1.83 . . . . 1.79 107.402 157.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.62 -49.95 4.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.27 -1.011 . . . . 1.5800000000000001 108.27 141.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.82 -97.16 0.17 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.794 -1.322 . . . . 0.69999999999999996 109.794 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -152.81 169.49 22.65 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.784 1.634 . . . . 1.47 109.574 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.7 175.2 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.331 -1.729 . . . . 0.60999999999999999 106.331 163.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -109.47 143.7 38.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.733 -1.21 . . . . 2.0099999999999998 107.733 162.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.25 151.32 29.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.548 -0.908 . . . . 1.01 108.548 151.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.39 -87.28 0.06 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.328 0.651 . . . . 2.8599999999999999 109.388 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -150.72 -43.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.12 1.368 . . . . 3.8700000000000001 110.848 -170.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.24 8.09 5.45 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.204 1.002 . . . . 2.6699999999999999 111.268 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.29 8.16 87.59 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.169 0.89 . . . . 0.89000000000000001 111.536 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -78.67 135.91 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.015 -1.476 . . . . 0.67000000000000004 107.015 173.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.1 174.42 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.086 0.955 . . . . 0.89000000000000001 109.424 170.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -130.0 117.56 20.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 103.241 -2.874 . . . . 3.6400000000000001 103.241 -174.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.58 112.03 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 105.039 -2.208 . . . . 1.25 105.039 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -148.89 97.23 2.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.816 1.246 . . . . 0.94999999999999996 108.433 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.1 mp -145.28 147.41 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 108.929 -0.767 . . . . 1.75 108.929 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.22 68.49 1.28 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.066 0.946 . . . . 4.21 111.964 173.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.99 157.66 31.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.375 -0.828 . . . . 2.4199999999999999 111.078 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 p -110.36 -11.8 14.49 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.775 2.03 . . . . 1.8899999999999999 113.508 -177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.05 -50.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.923 -1.14 . . . . 1.3200000000000001 107.923 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -77.78 158.95 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 122.357 1.075 . . . . 2.4199999999999999 109.808 171.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.8 p -152.17 174.68 13.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.762 2.425 . . . . 2.1499999999999999 107.553 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -42.61 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.344 1.458 . . . . 2.8599999999999999 109.45 173.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.5 m -119.02 72.21 0.88 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.301 1.44 . . . . 4.4299999999999997 110.899 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -166.63 60.14 0.23 Allowed Glycine 0 CA--C 1.526 0.724 0 CA-C-N 118.616 0.644 . . . . 4.4400000000000004 111.769 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.9 t70 56.49 -76.75 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.671 1.989 . . . . 3.8700000000000001 113.476 172.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -78.07 1.38 21.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.664 1.186 . . . . 4.5999999999999996 111.232 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.17 146.01 0.33 Allowed 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.122 0.969 . . . . 1.4299999999999999 110.824 163.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 115' ' ' ARG . 10.8 pt -79.58 -7.73 10.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 119.295 -0.962 . . . . 2.1899999999999999 111.339 -175.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 tt -44.46 140.91 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.095 1.146 . . . . 1.9399999999999999 114.095 -167.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 56.59 9.32 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.4 -1.08 . . . . 1.8 110.4 -178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 112' ' ' ILE . 0.2 OUTLIER -157.48 175.78 13.51 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.861 2.065 . . . . 4.29 105.706 -174.564 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -123.35 106.39 10.63 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.501 1.046 . . . . 0.94999999999999996 112.488 -169.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.69 150.02 42.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.194 -0.457 . . . . 1.6699999999999999 110.133 168.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.33 134.45 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.995 1.718 . . . . 0.44 107.124 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 m -103.71 124.66 58.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.265 -1.383 . . . . 1.6000000000000001 107.265 165.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.476 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 60.0 m-70 -97.81 159.42 14.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 116.859 2.17 . . . . 0.42999999999999999 116.859 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -40.62 -69.52 0.13 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.143 2.577 . . . . 3.1099999999999999 111.651 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -113.44 -176.23 2.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.66 0.664 . . . . 3.3900000000000001 109.985 -169.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.7 146.33 41.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.528 -0.545 . . . . 0.59999999999999998 109.528 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 154.47 41.61 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.244 -1.021 . . . . 2.0800000000000001 108.244 157.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -90.81 -6.02 54.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 3.54 113.663 -170.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 65.84 14.49 9.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.365 1.466 . . . . 1.5 113.44 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 39.01 3.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.94 1.257 . . . . 1.6399999999999999 110.999 167.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -141.68 -82.36 0.21 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.346 1.459 . . . . 5.3200000000000003 108.525 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.06 -46.42 0.98 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.66 1.124 . . . . 3.98 114.285 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.53 7.76 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.349 -1.5 . . . . 2.6200000000000001 109.349 -165.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -166.18 -170.39 1.69 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.138 1.775 . . . . 2.5899999999999999 107.347 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -92.87 -47.61 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.831 0.853 . . . . 3.3199999999999998 110.493 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -53.3 -33.76 54.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.929 2.092 . . . . 4.1699999999999999 112.085 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 p -49.73 -70.68 0.08 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.47 1.508 . . . . 2.1800000000000002 110.705 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.6 p -60.06 -45.65 92.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 1.4199999999999999 110.207 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.8 -48.26 75.7 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.373 1.069 . . . . 3.9100000000000001 111.577 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.45 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 54.5 p -132.07 -54.73 0.98 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.386 0.513 . . . . 1.6100000000000001 112.386 -172.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 126.99 106.96 1.45 Allowed Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 104.783 -3.327 . . . . 3.02 104.783 -167.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.45 57.55 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.679 1.592 . . . . 1.95 108.984 -172.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -58.75 -30.84 67.81 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.458 1.503 . . . . 0.89000000000000001 113.438 -176.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.08 50.62 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 107.953 -2.059 . . . . 1.05 107.953 -160.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 t -64.69 162.78 15.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.927 0.891 . . . . 1.8799999999999999 113.289 -165.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -65.75 138.03 57.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.337 1.855 . . . . 2.9300000000000002 109.144 172.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.7 mt -110.75 -78.31 0.59 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.773 1.169 . . . . 0.53000000000000003 108.91 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -109.4 151.7 26.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.878 0.871 . . . . 0.76000000000000001 109.175 174.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.0 p -160.57 173.24 15.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.426 1.89 . . . . 1.3899999999999999 107.367 -177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 167.11 170.88 32.54 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.844 -2.902 . . . . 1.45 105.844 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.6 t -87.49 143.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 119.624 1.712 . . . . 0.78000000000000003 109.082 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.517 HD11 ' CG ' ' A' ' 20' ' ' PHE . 12.8 tt -93.65 127.63 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.92 0.488 . . . . 0.78000000000000003 111.592 171.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.54 14.95 0.11 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.38 1.467 . . . . 1.1000000000000001 114.292 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 mm -101.99 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 120.178 1.989 . . . . 1.03 109.331 -159.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.73 175.11 14.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 1.24 109.278 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 104.351 -2.463 . . . . 4.2999999999999998 104.351 162.377 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 106.984 -1.487 . . . . 5.1600000000000001 106.984 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.0 p -71.98 95.33 1.57 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.064 0.946 . . . . 2.5099999999999998 108.568 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 149.46 26.6 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.656 0.662 . . . . 3.6099999999999999 111.181 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.06 138.36 34.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 0.66000000000000003 108.108 165.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.59 142.36 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.953 -1.129 . . . . 0.76000000000000001 107.953 166.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.34 96.07 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.444 -0.947 . . . . 0.47999999999999998 108.444 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.84 107.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.763 -1.569 . . . . 0.87 106.763 159.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -95.21 125.0 39.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.969 -1.123 . . . . 1.01 107.969 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -49.68 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.16 0.584 . . . . 4.8499999999999996 109.872 175.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 36.38 -120.5 0.6 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.42 1.486 . . . . 1.04 112.918 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -93.47 -59.67 1.96 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.342 -0.984 . . . . 3.4100000000000001 108.342 -173.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.39 164.2 5.43 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.512 1.53 . . . . 1.01 114.897 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -79.06 33.48 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.399 3.399 . . . . 1.3200000000000001 112.208 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 27.7 t -111.2 141.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 127.171 2.189 . . . . 1.21 105.997 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -139.61 128.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.776 -1.564 . . . . 2.4300000000000002 106.776 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.17 164.88 31.59 Favored Glycine 0 N--CA 1.45 -0.395 0 O-C-N 121.905 -0.497 . . . . 0.77000000000000002 112.064 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.98 124.57 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.863 -1.162 . . . . 1.28 107.863 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.0 mm -89.39 155.33 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.504 1.122 . . . . 0.94999999999999996 109.061 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 126.57 43.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.516 -0.92 . . . . 2.3300000000000001 108.516 153.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.592 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -106.65 123.25 47.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.462 -2.051 . . . . 2.5299999999999998 105.462 168.542 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -148.98 139.51 22.56 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.098 -0.705 . . . . 3.4199999999999999 109.098 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 164.91 37.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.618 -1.993 . . . . 3.8999999999999999 105.618 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -54.3 2.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.774 1.23 . . . . 4.4100000000000001 110.34 -177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -79.28 118.74 21.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.257 -1.386 . . . . 4.1699999999999999 107.257 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -76.02 46.09 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.738 1.154 . . . . 2.79 112.7 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.8 t30 179.85 58.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.822 2.449 . . . . 3.79 107.971 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.59 170.59 35.2 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.41 -1.076 . . . . 0.96999999999999997 110.41 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.45 140.24 86.49 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.315 2.677 . . . . 1.2 111.626 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 20' ' ' PHE . 9.6 t -93.67 158.12 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.12 -1.067 . . . . 1.27 108.12 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -107.71 111.75 24.09 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.38 -1.711 . . . . 5.6200000000000001 106.38 162.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' CE1' ' A' ' 20' ' ' PHE . 5.0 t -79.61 135.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.507 -2.034 . . . . 1.1599999999999999 105.507 170.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -139.13 159.64 41.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.644 -1.984 . . . . 0.81000000000000005 105.644 159.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.1 -166.29 14.75 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.201 -1.0 . . . . 1.9199999999999999 110.61 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.0 m -148.22 109.73 4.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.626 -1.99 . . . . 1.6499999999999999 105.626 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -114.81 146.18 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.703 -1.592 . . . . 0.82999999999999996 106.703 -170.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -154.79 170.63 21.17 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 114.127 1.158 . . . . 3.7200000000000002 114.127 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.89 80.45 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.626 1.584 . . . . 0.65000000000000002 112.616 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.1 155.77 26.93 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.833 -0.804 . . . . 0.68999999999999995 110.232 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 165.01 17.71 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.66 -1.237 . . . . 1.6899999999999999 107.66 156.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.66 175.69 0.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.013 0.824 . . . . 2.6099999999999999 111.59 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.34 -162.12 37.22 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.129 0.871 . . . . 0.45000000000000001 113.576 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.49 146.48 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.051 1.74 . . . . 1.9199999999999999 112.962 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -146.97 113.53 5.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.872 1.669 . . . . 0.51000000000000001 109.428 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.92 147.84 4.16 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.745 -0.942 . . . . 0.40999999999999998 110.745 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.54 95.32 2.85 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.791 -1.559 . . . . 2.23 106.791 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.669 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 14.7 m170 -132.18 158.37 41.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.354 -1.721 . . . . 0.64000000000000001 106.354 -165.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.302 0.8 OUTLIER -117.81 115.94 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.546 1.165 . . . . 1.77 110.681 175.527 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -79.78 158.95 26.72 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.113 1.365 . . . . 0.92000000000000004 109.15 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -28.62 -93.39 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.638 2.775 . . . . 4.9400000000000004 114.998 -158.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.69 74.13 0.05 Allowed 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.1 0.56 . . . . 12.24 110.273 -171.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -149.1 125.41 10.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.428 -0.509 . . . . 8.8800000000000008 111.82 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -90.45 134.46 34.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.64 1.576 . . . . 4.6900000000000004 109.325 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.0 53.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.048 1.339 . . . . 4.7199999999999998 107.997 -163.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -77.31 59.4 1.81 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.715 1.206 . . . . 7.1799999999999997 112.861 -166.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 175.14 -65.33 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.925 2.49 . . . . 5.1900000000000004 105.339 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.36 57.29 5.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.722 -1.351 . . . . 4.0800000000000001 109.722 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.3 t -79.62 65.95 4.95 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.219 0.51 . . . . 2.4199999999999999 112.209 -165.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.6 m -165.04 134.38 3.54 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.345 2.258 . . . . 4.96 105.881 167.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.6 m 119.82 152.86 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 104.232 -2.507 . . . . 3.7000000000000002 104.232 -101.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 53.6 93.21 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.258 1.823 . . . . 2.7999999999999998 113.188 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.82 -91.98 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.955 -0.914 . . . . 1.6000000000000001 112.204 -161.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.4 177.51 8.25 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.607 2.872 . . . . 1.3999999999999999 112.925 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -62.3 123.42 18.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.219 -1.4 . . . . 1.28 107.219 168.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -37.9 109.63 0.11 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.422 1.089 . . . . 1.8600000000000001 112.255 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -126.12 145.06 51.0 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 130.792 3.637 . . . . 3.5 107.712 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 -43.0 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.277 1.985 . . . . 1.27 109.028 168.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -155.24 -73.44 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.368 -0.975 . . . . 2.9500000000000002 108.368 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 p -129.49 58.88 1.61 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.471 1.108 . . . . 2.77 110.906 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -79.8 159.84 26.37 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.818 -0.552 . . . . 4.71 109.559 168.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.46 163.02 17.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.375 1.47 . . . . 3.8500000000000001 107.792 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -90.2 153.39 20.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.912 0.885 . . . . 0.82999999999999996 110.329 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.66 -52.4 0.01 OUTLIER Glycine 0 C--O 1.224 -0.521 0 N-CA-C 109.639 -1.384 . . . . 2.77 109.639 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.9 -166.31 21.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.948 1.261 . . . . 1.1699999999999999 111.488 171.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.91 -41.31 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.786 2.324 . . . . 1.3600000000000001 109.155 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -58.78 -58.11 10.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.267 1.427 . . . . 4.9000000000000004 109.91 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.66 152.88 29.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.036 -0.983 . . . . 1.9299999999999999 111.269 -167.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -52.18 -45.42 65.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.77 1.628 . . . . 4.0999999999999996 111.479 173.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -77.64 145.67 36.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.505 1.145 . . . . 2.6499999999999999 110.256 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.27 151.56 2.07 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.369 1.868 . . . . 3.1099999999999999 108.848 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.4 m80 -60.94 143.63 54.72 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.785 -1.561 . . . . 0.53000000000000003 106.785 163.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.97 -30.73 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.167 -0.613 . . . . 1.3700000000000001 110.947 -165.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.69 67.51 0.31 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 112.157 -0.377 . . . . 0.89000000000000001 112.157 167.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.29 114.37 3.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.419 -1.048 . . . . 2.1899999999999999 108.862 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.03 -53.93 3.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.248 0.619 . . . . 2.0600000000000001 110.121 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.76 -110.41 0.42 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.112 -0.566 . . . . 0.55000000000000004 111.822 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -148.58 167.58 25.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.04 1.736 . . . . 1.46 109.479 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.5 m -117.63 175.23 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.362 -1.718 . . . . 0.48999999999999999 106.362 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.9 t -109.43 150.48 28.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.264 -1.384 . . . . 2.2599999999999998 107.264 159.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.03 152.83 32.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.64 -0.874 . . . . 1.04 108.64 157.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -79.88 -83.47 0.1 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.781 1.232 . . . . 3.7200000000000002 108.984 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -151.29 -48.47 0.12 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.175 0.99 . . . . 3.9500000000000002 110.968 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.37 24.91 0.65 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.439 1.59 . . . . 2.7200000000000002 111.13 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.36 14.39 61.94 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.063 1.316 . . . . 0.70999999999999996 111.889 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.88 152.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 125.193 1.397 . . . . 0.92000000000000004 107.749 175.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.41 172.35 15.07 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.16 1.384 . . . . 0.88 107.729 168.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -132.85 162.66 30.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.89 -2.263 . . . . 3.3999999999999999 104.89 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.54 55.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 O-C-N 124.184 0.928 . . . . 1.8700000000000001 112.423 174.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.3 m -70.4 101.29 1.92 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.741 -0.599 . . . . 0.98999999999999999 110.845 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.07 157.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.835 -0.802 . . . . 1.76 108.835 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -139.09 129.16 25.19 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.613 -0.884 . . . . 3.6200000000000001 108.613 159.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -134.68 151.48 51.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.695 1.598 . . . . 2.3599999999999999 108.492 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 p -107.59 -3.51 19.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.275 1.83 . . . . 1.45 113.28 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.94 -42.56 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.364 -1.347 . . . . 1.1599999999999999 107.364 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.497 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.2 pp -74.69 177.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.519 0.676 . . . . 1.79 111.546 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.9 m -161.21 179.32 8.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.833 2.453 . . . . 1.9399999999999999 106.434 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 70.4 1.08 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.118 -2.179 . . . . 2.8399999999999999 105.118 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 t -145.4 -72.12 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.638 -0.71 . . . . 3.96 110.513 170.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 167.37 -146.09 10.39 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 106.924 -2.47 . . . . 3.46 106.924 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.1 t70 55.1 -101.77 0.13 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.21 1.004 . . . . 3.8599999999999999 110.417 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -76.51 -34.88 58.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.108 0.963 . . . . 4.04 110.736 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.5 p -72.75 176.56 5.47 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.486 1.136 . . . . 2.0699999999999998 112.887 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.507 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -86.95 -6.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.065 -0.971 . . . . 1.6899999999999999 112.081 -170.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.463 ' HA ' HG23 ' A' ' 149' ' ' ILE . 24.2 mm -59.38 124.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.455 -0.943 . . . . 2.6200000000000001 108.455 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.79 3.56 76.91 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.447 1.022 . . . . 1.3200000000000001 113.256 -172.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -113.03 163.48 14.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.285 1.543 . . . . 4.46 109.771 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -93.15 89.79 6.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.833 1.253 . . . . 2.54 110.252 -157.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.33 143.98 56.27 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.329 -0.857 . . . . 1.8100000000000001 109.848 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -135.19 133.45 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.281 1.832 . . . . 0.46000000000000002 109.046 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -94.38 121.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 125.858 1.663 . . . . 2.4500000000000002 107.706 163.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.568 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 90.3 m-70 -98.56 167.28 10.91 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 117.608 2.447 . . . . 0.48999999999999999 117.608 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -81.3 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.325 1.85 . . . . 4.0199999999999996 110.314 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -178.26 6.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.595 0.634 . . . . 4.6100000000000003 109.878 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.63 151.03 30.07 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.141 -1.429 . . . . 0.55000000000000004 107.141 153.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -76.74 151.7 35.93 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.473 -1.306 . . . . 1.99 107.473 158.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -70.27 -25.56 63.41 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.0 -0.437 . . . . 3.1400000000000001 111.529 -169.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 50.0 7.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.043 0.937 . . . . 2.0800000000000001 109.93 -159.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 52.53 39.72 53.73 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.306 0.955 . . . . 1.6000000000000001 113.263 167.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -80.01 -18.61 49.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.681 0.792 . . . . 5.3700000000000001 111.394 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.44 -143.09 16.3 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.83 -0.508 . . . . 2.4399999999999999 111.83 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.77 -77.05 0.4 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.577 -1.409 . . . . 2.27 109.577 -172.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.86 104.03 14.46 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.012 -1.477 . . . . 2.8399999999999999 107.012 167.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.56 -33.55 22.23 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.763 1.165 . . . . 5.1600000000000001 112.986 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -37.07 -36.71 0.13 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.319 1.048 . . . . 3.02 113.694 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.8 t -36.35 -66.99 0.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.903 2.081 . . . . 2.27 111.023 167.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.28 -46.15 51.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.145 0.978 . . . . 1.49 110.583 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -53.01 -52.27 58.96 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.585 0.754 . . . . 3.0099999999999998 111.328 -168.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.492 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.278 5.4 p -126.51 -48.51 1.54 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.675 -0.679 . . . . 1.3100000000000001 112.277 174.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 159.42 -21.06 0.28 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 120.052 1.296 . . . . 1.01 114.039 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.17 56.32 5.96 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.796 1.238 . . . . 2.1800000000000002 111.349 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -67.28 0.49 2.78 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.509 0.929 . . . . 1.0700000000000001 113.509 169.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -71.13 2.99 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.297 -1.502 . . . . 3.3799999999999999 110.315 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 t -166.33 -174.41 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.529 0.732 . . . . 1.8200000000000001 110.975 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.31 139.06 31.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.496 2.718 . . . . 2.8900000000000001 109.522 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.4 mt -113.26 -88.28 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.298 0.954 . . . . 0.93999999999999995 109.685 169.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.31 154.43 21.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.598 -0.89 . . . . 1.02 108.598 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.6 p -157.58 170.98 21.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 123.753 0.658 . . . . 1.51 110.598 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.62 155.42 11.31 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.484 -1.446 . . . . 1.0600000000000001 109.484 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.0 137.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.611 0.705 . . . . 1.48 109.459 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.507 HG21 HG12 ' A' ' 112' ' ' ILE . 13.1 tt -86.45 143.65 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.72999999999999998 110.935 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.04 5.56 3.03 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.62 1.105 . . . . 0.57999999999999996 114.219 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.4 mm -96.05 56.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 119.289 1.544 . . . . 0.94999999999999996 109.926 -156.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.49 176.52 12.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.547 0.739 . . . . 1.3 110.578 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.483 ' NE2' ' H ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.313 0 N-CA-C 103.999 -2.593 . . . . 5.0599999999999996 103.999 154.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 107.171 -1.418 . . . . 7.54 107.171 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.9 p -151.85 -178.16 6.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.934 1.294 . . . . 4.8200000000000003 107.654 -176.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -75.73 176.18 7.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.798 -1.186 . . . . 2.9900000000000002 107.798 157.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.414 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -115.39 144.8 43.26 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.055 -1.461 . . . . 0.78000000000000003 107.055 164.169 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.9 t -119.91 141.38 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 107.571 -1.27 . . . . 0.87 107.571 171.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.19 99.82 6.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.173 1.389 . . . . 0.55000000000000004 108.286 159.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.83 98.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.65 -1.241 . . . . 0.58999999999999997 107.65 163.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.0 mt -84.61 126.82 33.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.188 0.595 . . . . 0.81000000000000005 109.564 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -143.72 -48.3 0.29 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.72 0.808 . . . . 3.75 110.91 170.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.43 -123.68 5.24 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.432 -1.067 . . . . 0.82999999999999996 110.432 -171.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -107.1 -52.57 2.74 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.712 0.756 . . . . 4.0199999999999996 110.707 -173.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.56 156.58 5.71 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.913 1.244 . . . . 0.78000000000000003 111.702 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.14 39.65 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.372 3.381 . . . . 1.1899999999999999 113.23 -170.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 63.5 t -101.47 155.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.761 2.025 . . . . 0.80000000000000004 107.644 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.12 125.02 9.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.967 -1.494 . . . . 2.5 106.967 175.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.81 165.91 35.33 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.268 -0.733 . . . . 0.51000000000000001 111.268 177.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.09 115.18 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.009 -1.849 . . . . 1.6000000000000001 106.009 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.4 mm -78.65 145.83 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.273 -1.38 . . . . 0.75 107.273 168.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -123.41 107.62 11.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.878 -1.897 . . . . 2.0299999999999998 105.878 163.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CE1' HG22 ' A' ' 31' ' ' VAL . 1.3 m-85 -89.55 93.16 9.39 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.265 -2.124 . . . . 2.8999999999999999 105.265 164.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -96.11 134.87 38.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.106 -0.702 . . . . 3.5600000000000001 109.106 177.483 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -145.95 83.31 1.63 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.104 -0.953 . . . . 3.71 110.931 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -50.39 -45.13 55.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.721 -0.672 . . . . 6.7699999999999996 111.012 157.036 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -85.33 73.48 10.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.852 -1.166 . . . . 4.7400000000000002 107.852 -175.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 79.78 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.473 0.709 . . . . 4.1600000000000001 109.614 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -162.72 -53.69 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.61 1.564 . . . . 5.6299999999999999 109.513 -162.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.08 -85.31 0.06 OUTLIER Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.762 -1.209 . . . . 2.0899999999999999 112.761 -170.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.21 115.64 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.363 2.708 . . . . 1.8400000000000001 111.593 -174.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.51 HG11 ' CD2' ' A' ' 20' ' ' PHE . 23.2 t -87.5 165.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.861 -1.162 . . . . 1.0600000000000001 107.861 172.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.162 -1.792 . . . . 3.9399999999999999 106.162 168.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.525 HG22 ' CE1' ' A' ' 20' ' ' PHE . 10.0 t -89.67 131.49 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.96 -1.496 . . . . 1.0900000000000001 106.96 174.513 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -136.93 161.9 34.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.26 -1.385 . . . . 0.87 107.26 153.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.09 146.16 7.06 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.998 . . . . 0.84999999999999998 108.105 178.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -119.81 66.94 0.81 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.672 1.989 . . . . 1.6299999999999999 107.16 -171.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.73 115.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.47 -1.241 . . . . 1.21 107.96 -167.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -110.27 154.36 23.56 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.424 0.69 . . . . 3.7000000000000002 111.616 -173.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.64 68.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.641 -0.709 . . . . 0.73999999999999999 114.31 172.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -59.28 164.28 3.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.945 1.373 . . . . 0.68999999999999995 109.078 163.205 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.28 160.22 19.18 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.719 -1.238 . . . . 1.75 107.836 154.27 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -58.85 171.33 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.367 -0.833 . . . . 2.6000000000000001 110.289 175.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.0 -157.27 48.42 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 121.94 -0.475 . . . . 0.46000000000000002 112.96 167.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.98 141.92 38.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.207 1.003 . . . . 2.3999999999999999 111.059 -167.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -143.99 119.62 10.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.241 1.016 . . . . 0.45000000000000001 110.537 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.3 147.9 16.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.708 -0.957 . . . . 0.45000000000000001 110.708 172.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.41 91.85 2.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.361 1.064 . . . . 2.4100000000000001 108.167 -173.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.583 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 21.3 m170 -130.86 158.27 40.64 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.81999999999999995 109.828 -160.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.42 117.0 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.295 -0.632 . . . . 2.4700000000000002 109.295 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -107.6 139.57 41.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.959 -1.126 . . . . 1.05 107.959 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -73.01 66.16 0.79 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.242 0.83 . . . . 5.1900000000000004 113.242 -171.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' CD ' HH22 ' A' ' 143' ' ' ARG . 2.4 mt-10 -119.7 78.25 1.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 3.0 110.541 -173.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -80.93 -85.85 0.09 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.062 0.545 . . . . 5.1100000000000003 110.19 171.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -82.24 70.81 9.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.834 0.826 . . . . 6.0300000000000002 110.834 -170.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -104.67 -60.05 1.65 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.336 1.054 . . . . 4.2400000000000002 109.381 169.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 t -178.86 -46.4 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.349 1.46 . . . . 4.3200000000000003 109.935 -175.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -179.18 -42.51 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.814 1.246 . . . . 6.6100000000000003 110.83 -174.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.09 -93.18 2.11 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.04 0.829 . . . . 4.4100000000000001 111.747 -174.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m -148.43 148.75 30.66 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 117.982 -1.008 . . . . 2.54 108.442 -167.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 p -152.7 -4.91 0.22 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.522 1.304 . . . . 4.54 114.522 164.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.1 t 173.15 40.92 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.297 -1.502 . . . . 3.23 113.28 -115.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.91 146.91 16.35 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.634 -1.617 . . . . 1.9399999999999999 106.634 166.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.5 -96.27 2.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.485 -1.846 . . . . 1.1699999999999999 108.485 -177.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.47 177.8 6.34 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.281 2.654 . . . . 1.0 113.23 -177.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -69.07 131.77 45.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 115.968 -1.968 . . . . 1.6499999999999999 105.852 170.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -33.93 107.91 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.865 1.666 . . . . 3.1499999999999999 114.337 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.41 127.73 30.89 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 126.521 1.928 . . . . 3.1699999999999999 107.31 167.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.49 -40.68 13.45 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.595 1.53 . . . . 1.76 109.133 173.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 tt -146.69 -60.56 0.3 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.159 -1.793 . . . . 3.54 106.159 164.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.6 p -151.38 80.28 1.3 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.49 0.716 . . . . 2.6600000000000001 109.948 -178.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -80.03 163.58 24.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 4.7699999999999996 108.392 158.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.14 166.21 10.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.32 -1.363 . . . . 3.54 107.32 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.437 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 46.0 t60 -80.1 160.95 25.58 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.81999999999999995 110.148 175.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.19 -149.33 7.98 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 104.769 -3.332 . . . . 2.1299999999999999 104.769 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.69 -146.45 4.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.462 1.631 . . . . 1.3300000000000001 109.041 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.9 -36.88 21.59 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.321 2.014 . . . . 1.48 111.132 -177.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.61 -44.05 91.8 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.627 0.371 . . . . 4.8200000000000003 111.104 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.43 164.13 26.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.625 0.726 . . . . 1.9299999999999999 112.042 -169.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -77.74 -45.63 24.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.158 1.383 . . . . 4.1500000000000004 108.971 165.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -78.27 168.59 19.6 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.987 0.899 . . . . 3.25 109.84 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 153.62 142.75 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 130.524 3.53 . . . . 3.0 105.454 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.0 m80 -59.58 151.02 25.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.649 -0.82 . . . . 0.78000000000000003 109.313 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -71.31 -4.77 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.258 -0.901 . . . . 1.51 111.121 -172.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.99 70.2 0.44 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.995 1.283 . . . . 1.0 109.947 159.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.92 122.28 0.7 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.64 -1.244 . . . . 2.1400000000000001 107.64 -177.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.33 -38.06 8.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.772 0.829 . . . . 1.8100000000000001 110.204 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.87 -129.29 3.24 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.086 -2.006 . . . . 0.82999999999999996 108.086 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -131.05 170.6 14.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.134 1.374 . . . . 1.77 110.382 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.09 175.71 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.352 1.461 . . . . 0.79000000000000004 107.244 171.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -124.89 126.76 46.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.937 -1.135 . . . . 2.1200000000000001 107.937 175.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.48 139.53 31.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.754 0.822 . . . . 0.63 111.337 171.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -74.26 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 O-C-N 124.305 1.003 . . . . 3.0899999999999999 110.508 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 93' ' ' GLY . 46.6 tttt -149.84 -35.44 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.786 1.032 . . . . 3.23 113.786 -164.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -80.89 22.17 0.63 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 124.047 1.879 . . . . 3.9300000000000002 110.191 165.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 57.9 25.83 56.95 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 125.124 1.345 . . . . 1.0900000000000001 111.069 -170.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.9 t -83.78 106.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.396 1.079 . . . . 1.1599999999999999 108.169 -175.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.8 167.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.977 -1.12 . . . . 0.96999999999999997 107.977 158.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -128.07 139.6 52.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 103.399 -2.815 . . . . 3.0899999999999999 103.399 176.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.08 55.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 123.861 0.726 . . . . 2.02 111.775 179.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -74.89 101.57 4.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.389 0.676 . . . . 1.05 110.767 170.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.1 mt -140.94 156.01 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.93 0.786 . . . . 1.8700000000000001 109.626 177.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.27 72.22 1.37 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.345 1.458 . . . . 4.96 111.22 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.49 134.68 37.29 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.403 -0.811 . . . . 2.1699999999999999 109.454 177.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 p -92.72 -9.97 38.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.424 1.49 . . . . 1.6599999999999999 112.894 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.4 t -85.63 -46.09 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.404 -0.962 . . . . 1.48 108.404 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.6 pp -70.8 177.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.097 0.475 . . . . 1.1200000000000001 111.922 176.493 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.5 t -153.12 175.07 13.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.609 1.964 . . . . 2.98 105.808 172.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.45 0.68 17.9 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.036 0.935 . . . . 2.4100000000000001 111.399 162.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.9 m -121.94 -49.71 2.08 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.246 1.418 . . . . 3.5899999999999999 110.74 -173.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.08 158.73 37.6 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.739 -0.544 . . . . 3.3300000000000001 111.739 -174.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.46 -49.5 5.28 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.176 1.79 . . . . 4.8399999999999999 112.229 -177.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.65 4.07 19.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.108 1.363 . . . . 4.9699999999999998 113.516 -174.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 p -50.32 175.38 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.509 1.67 . . . . 1.49 115.509 -173.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.66 -14.54 12.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 114.122 -1.399 . . . . 2.73 112.392 170.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.2 tp -50.04 123.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 124.066 0.946 . . . . 2.1499999999999999 110.297 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.9 86.77 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.215 -0.769 . . . . 1.3600000000000001 114.198 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.7 175.99 9.41 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.148 1.974 . . . . 5.6699999999999999 109.341 178.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.85 123.69 50.89 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.578 1.081 . . . . 1.9399999999999999 108.594 167.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.85 144.92 40.95 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.301 -1.37 . . . . 1.52 107.301 167.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -129.75 134.93 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.195 1.798 . . . . 0.41999999999999998 107.59 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.82 128.44 58.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.729 -1.212 . . . . 1.6899999999999999 107.729 167.582 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.497 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 53.6 m-70 -104.3 158.13 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.827 2.158 . . . . 0.63 116.827 -171.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -41.33 -68.87 0.16 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.724 2.81 . . . . 3.04 111.355 172.291 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -111.27 -175.06 2.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.1 -0.704 . . . . 2.8900000000000001 109.1 -171.053 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.97 141.04 47.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.053 -1.091 . . . . 0.89000000000000001 108.053 165.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.66 165.46 14.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.994 -0.682 . . . . 2.5600000000000001 109.604 154.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.53 -48.66 74.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.525 -0.761 . . . . 3.54 113.048 -173.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 77.08 52.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.289 1.836 . . . . 1.6799999999999999 111.021 -159.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 27.16 64.42 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.408 1.004 . . . . 1.6399999999999999 114.889 152.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -85.35 -33.14 22.1 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.081 1.352 . . . . 5.9199999999999999 108.673 169.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.43 -80.67 1.6 Allowed Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.633 -1.787 . . . . 2.7200000000000002 108.633 -178.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.85 -73.92 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.294 0.95 . . . . 2.7799999999999998 110.861 -175.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -75.46 -116.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.097 -1.446 . . . . 2.8900000000000001 107.097 157.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.15 -40.3 0.06 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.069 1.304 . . . . 4.2400000000000002 112.912 173.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -43.21 -43.61 4.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.806 1.242 . . . . 3.8399999999999999 111.504 175.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.9 m -33.28 -63.66 0.23 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.095 2.558 . . . . 2.5 113.483 163.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.08 -46.28 57.44 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.119 -0.988 . . . . 1.97 112.052 175.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -53.03 -49.46 66.25 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.395 0.543 . . . . 3.5600000000000001 110.821 -173.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -129.67 -46.21 1.17 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.662 0.785 . . . . 1.45 110.991 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.21 -31.74 0.79 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.241 0.448 . . . . 1.1699999999999999 112.12 -175.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 48.19 54.66 9.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.926 1.29 . . . . 2.7799999999999998 110.259 -165.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.583 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -51.46 -35.35 39.34 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.921 1.688 . . . . 1.3899999999999999 113.71 174.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.52 -179.04 49.1 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 108.464 -1.854 . . . . 0.98999999999999999 108.464 -159.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -62.43 153.3 31.77 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.263 1.425 . . . . 1.6200000000000001 112.736 -164.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.436 HH22 ' CD ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -77.07 133.71 38.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.8 1.24 . . . . 2.6800000000000002 108.664 179.137 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.0 mt -111.02 -70.39 0.82 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.093 -1.077 . . . . 0.53000000000000003 108.093 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -131.97 148.37 52.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.614 0.766 . . . . 0.88 110.047 -173.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.3 p -160.28 173.79 15.17 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 125.191 1.557 . . . . 1.55 109.415 -176.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.64 135.04 2.5 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.71 -2.156 . . . . 0.68999999999999995 107.71 -176.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.1 t -60.5 133.79 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.495 0.718 . . . . 0.80000000000000004 109.074 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.22 136.08 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.28 0.562 . . . . 0.80000000000000004 112.204 -174.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 137.25 -3.02 3.28 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.812 1.196 . . . . 0.55000000000000004 114.029 175.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -95.3 61.26 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 122.784 1.278 . . . . 1.45 107.832 -157.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.25 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.93 -1.032 . . . . 2.6400000000000001 112.696 -173.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 C--O 1.25 1.104 0 N-CA-C 101.813 -3.403 . . . . 8.6500000000000004 101.813 150.662 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.375 -0.602 . . . . 7.5700000000000003 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.1 m -100.04 159.02 15.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.957 -1.497 . . . . 3.9399999999999999 106.957 171.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -78.13 154.28 31.38 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.946 -1.131 . . . . 4.79 107.946 167.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.53 149.12 47.27 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.856 -0.794 . . . . 0.82999999999999996 108.856 157.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 t -119.59 145.48 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.856 -1.164 . . . . 1.0600000000000001 107.856 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.11 97.14 5.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.648 -0.871 . . . . 0.65000000000000002 108.648 159.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.43 105.33 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.264 -1.384 . . . . 0.67000000000000004 107.264 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.22 124.48 37.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.99 -0.745 . . . . 0.85999999999999999 108.99 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -137.97 -60.16 0.64 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.75 0.42 . . . . 3.3100000000000001 110.001 174.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.78 -122.1 6.43 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.201 0.905 . . . . 0.79000000000000004 111.989 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -115.14 -50.48 2.75 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 124.932 1.293 . . . . 3.02 109.475 -163.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.31 153.95 9.18 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.735 -1.346 . . . . 0.71999999999999997 109.735 171.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.69 41.91 1.15 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.425 2.75 . . . . 0.98999999999999999 113.279 -166.242 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.62 155.91 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.329 1.852 . . . . 1.1499999999999999 108.945 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.39 81.57 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.133 -1.432 . . . . 2.3900000000000001 107.133 172.086 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.23 163.66 13.96 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.398 -0.681 . . . . 0.46999999999999997 111.398 -173.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.75 124.56 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.417 -0.957 . . . . 1.1200000000000001 108.417 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -88.82 135.31 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.421 1.089 . . . . 0.91000000000000003 108.326 164.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.48 110.38 22.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.801 1.64 . . . . 2.9199999999999999 108.086 159.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.42 111.88 23.57 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.11 -1.811 . . . . 2.3999999999999999 106.11 166.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -117.41 140.13 49.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.852 0.72 . . . . 2.9399999999999999 110.167 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -156.62 141.57 17.13 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.781 0.832 . . . . 4.0899999999999999 110.569 170.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -70.42 -67.06 0.52 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.44 0.696 . . . . 4.79 109.529 170.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -76.85 -178.7 5.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 120.076 1.307 . . . . 3.8100000000000001 111.854 -170.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -65.57 -65.95 0.61 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.882 1.273 . . . . 2.4399999999999999 110.401 172.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -125.65 92.52 3.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.892 0.877 . . . . 4.1699999999999999 109.526 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.25 177.35 27.5 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 108.28 -1.928 . . . . 1.0600000000000001 108.28 170.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.44 111.59 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.51 2.806 . . . . 1.3 112.094 -175.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.31 132.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.075 -1.083 . . . . 0.83999999999999997 108.075 -169.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -87.23 101.17 13.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.201 -1.777 . . . . 3.6600000000000001 106.201 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.1 124.37 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.282 -1.747 . . . . 1.23 106.282 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -131.83 136.35 47.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.047 -1.834 . . . . 1.0700000000000001 106.047 159.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.28 150.97 23.21 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.539 -1.824 . . . . 0.71999999999999997 108.539 -174.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.1 m -128.95 101.43 6.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.73 -2.322 . . . . 1.8600000000000001 104.73 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.97 144.59 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.074 -1.454 . . . . 0.81000000000000005 107.074 -169.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -154.83 143.73 20.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.475 0.546 . . . . 3.8199999999999998 112.475 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.89 25.79 8.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.877 2.179 . . . . 0.98999999999999999 112.712 -177.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.31 -155.78 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.431 -0.952 . . . . 1.1899999999999999 108.431 164.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -135.65 168.43 19.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.622 -2.733 . . . . 2.5499999999999998 103.622 165.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.16 169.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.277 1.399 . . . . 3.1899999999999999 114.099 -172.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.36 -165.98 48.9 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.592 -1.185 . . . . 0.5 113.195 169.211 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.51 143.7 57.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.403 1.481 . . . . 1.8200000000000001 113.104 -174.384 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -143.15 114.82 8.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.074 1.749 . . . . 0.44 108.69 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.61 145.16 2.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.33 -1.108 . . . . 0.33000000000000002 110.33 169.497 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.456 ' CE2' HG12 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -137.58 95.11 3.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.738 -1.579 . . . . 2.46 106.738 -176.64 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.3 m80 -134.98 154.51 51.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.362 -1.347 . . . . 0.65000000000000002 107.362 -164.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.264 2.6 p -107.08 108.66 25.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 CA-C-O 122.396 1.093 . . . . 1.8899999999999999 108.782 172.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.515 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 12.4 m-70 -77.47 156.44 31.05 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.39 -1.707 . . . . 0.97999999999999998 106.39 172.245 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -81.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.908 0.483 . . . . 5.5099999999999998 110.261 -178.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . 30.5 tt0 11.25 76.66 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 C-N-CA 127.853 2.461 . . . . 4.4900000000000002 114.403 -169.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -80.75 57.25 2.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.175 0.99 . . . . 4.2599999999999998 109.438 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -159.72 153.99 23.68 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.536 1.534 . . . . 5.29 108.46 166.064 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.75 -3.85 4.68 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.246 1.419 . . . . 5.9500000000000002 113.283 165.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.43 -40.53 61.9 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 120.546 1.521 . . . . 4.21 111.19 -177.147 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.67 78.8 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.252 0.621 . . . . 6.2800000000000002 111.623 -177.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.91 98.75 2.37 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 107.138 -2.385 . . . . 3.9900000000000002 107.138 -167.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.83 114.79 4.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.715 0.257 . . . . 3.1800000000000002 110.787 -171.168 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 m -149.73 -77.09 0.15 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.225 -0.922 . . . . 4.2999999999999998 110.826 177.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.378 0.4 OUTLIER 26.73 -61.99 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 1 N-CA-C 123.074 4.472 . . . . 2.9500000000000002 123.074 143.463 . . . . . . . . 4 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . . . -36.42 142.49 0.09 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 118.556 2.799 . . . . 2.3700000000000001 118.556 -157.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -177.66 14.05 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 114.235 -1.348 . . . . 2.0899999999999999 110.914 164.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.61 -179.99 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.977 3.785 . . . . 1.1399999999999999 113.612 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -47.07 107.19 0.1 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.844 1.258 . . . . 1.1499999999999999 109.063 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -34.27 104.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.278 1.431 . . . . 2.4100000000000001 111.935 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -122.79 141.58 35.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 129.55 3.14 . . . . 3.48 108.197 -174.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.91 -51.71 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.017 1.811 . . . . 1.01 109.085 173.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.19 -75.4 0.37 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.299 1.04 . . . . 2.6000000000000001 108.558 169.04 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -136.32 60.63 1.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.006 0.522 . . . . 1.6299999999999999 111.613 -159.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -78.74 164.04 24.89 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.702 -1.222 . . . . 4.0300000000000002 107.702 162.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -127.66 173.62 9.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.643 . . . . 4.6100000000000003 107.142 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.518 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 35.8 t60 -93.85 157.69 16.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.97 0.73 . . . . 0.81999999999999995 112.97 -167.076 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.41 -147.77 7.79 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 105.734 -2.946 . . . . 2.1099999999999999 105.734 166.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.89 -170.4 30.77 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.051 -2.42 . . . . 1.8300000000000001 107.051 176.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.29 -23.84 71.62 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.092 2.528 . . . . 2.1499999999999999 113.667 -176.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -70.37 -34.37 72.52 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.963 -0.461 . . . . 5.2400000000000002 111.264 173.592 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.52 176.65 8.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.562 1.545 . . . . 1.8899999999999999 110.585 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -83.93 -47.91 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.926 1.29 . . . . 4.3200000000000003 109.145 164.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -88.69 166.39 14.11 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.592 1.157 . . . . 3.2400000000000002 111.073 -166.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 168.95 146.1 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.51 2.324 . . . . 5.7599999999999998 108.773 -173.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 42.1 m80 -63.25 148.75 47.31 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 106.278 -1.749 . . . . 0.52000000000000002 106.278 166.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 -45.84 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 119.224 -0.99 . . . . 1.5 108.389 -176.124 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.6 59.71 4.8 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.618 -0.677 . . . . 0.78000000000000003 113.187 171.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 80' ' ' HIS . 1.3 t0 -168.94 120.22 0.75 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.656 -1.238 . . . . 2.0 107.656 -172.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.39 -51.56 3.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.18 0.992 . . . . 2.2799999999999998 109.186 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.95 -116.49 0.71 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.642 -0.983 . . . . 0.56999999999999995 110.642 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -144.66 167.5 22.4 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.876 1.27 . . . . 1.71 109.677 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 175.54 5.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 N-CA-C 106.522 -1.659 . . . . 0.53000000000000003 106.522 167.342 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -106.97 147.25 30.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.264 -1.384 . . . . 2.27 107.264 158.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.01 30.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.639 -0.875 . . . . 0.88 108.639 155.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -73.2 -78.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.227 1.011 . . . . 3.3199999999999998 109.736 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -152.95 -52.37 0.11 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.532 1.533 . . . . 4.5700000000000003 108.491 178.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.48 17.7 1.68 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.903 1.681 . . . . 4.4800000000000004 111.541 -171.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.98 15.11 81.95 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.084 1.326 . . . . 0.70999999999999996 111.337 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.77 149.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.21 -1.404 . . . . 1.0 107.21 171.228 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.77 24.85 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.232 1.013 . . . . 0.69999999999999996 108.343 169.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.33 145.91 50.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.027 -2.212 . . . . 2.79 105.027 -174.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.13 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.841 0.713 . . . . 1.8 111.3 178.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.5 m -76.07 96.78 3.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.387 1.075 . . . . 0.81000000000000005 110.85 170.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.7 mt -132.45 153.94 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 1.5900000000000001 109.064 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -126.08 84.01 2.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.103 0.561 . . . . 3.0499999999999998 110.47 166.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -79.5 121.76 25.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.89 0.476 . . . . 2.9900000000000002 109.728 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.5 p -84.6 -17.33 39.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.286 1.834 . . . . 1.79 112.57 178.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.2 t -83.64 -51.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.908 0.776 . . . . 1.03 110.05 -170.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.435 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.9 pp -75.55 177.04 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.261 0.553 . . . . 1.03 110.863 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.0 m -155.97 175.84 13.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.898 1.279 . . . . 1.98 108.1 171.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 47.66 2.09 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.891 1.276 . . . . 2.5800000000000001 111.705 -175.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -121.38 155.88 33.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.856 -1.905 . . . . 2.77 105.856 171.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.09 63.95 2.42 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.281 0.946 . . . . 3.5899999999999999 112.175 -171.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -128.27 -113.18 0.27 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.373 1.469 . . . . 6.21 108.515 -169.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -87.22 0.9 54.64 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.644 1.978 . . . . 5.7800000000000002 111.662 176.082 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 p -62.35 166.32 5.16 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.094 1.358 . . . . 1.49 113.007 -166.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -79.69 -27.41 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.943 -1.026 . . . . 1.97 110.443 172.142 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -32.12 108.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.133 2.173 . . . . 2.5600000000000001 111.247 177.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.88 -20.13 10.91 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.419 1.485 . . . . 1.55 112.816 -174.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -103.06 160.13 14.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.961 1.881 . . . . 4.6399999999999997 113.002 -165.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 146' ' ' CYS . 1.3 m -75.81 102.09 5.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.354 1.062 . . . . 1.1699999999999999 111.028 -172.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -68.71 144.96 54.25 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.335 -0.853 . . . . 1.6599999999999999 108.938 168.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -136.1 140.59 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.703 1.601 . . . . 0.44 108.99 -172.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 45' ' ' PHE . 2.2 m -111.38 125.45 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.203 1.401 . . . . 1.75 107.445 166.563 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.549 ' CD2' ' HD1' ' A' ' 46' ' ' HIS . 60.1 m-70 -101.63 165.25 11.33 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.727 1.751 . . . . 0.39000000000000001 115.727 -172.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' CG ' ' HD3' ' A' ' 122' ' ' LYS . 8.1 pt-20 -67.86 -53.41 26.94 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.469 1.108 . . . . 3.4300000000000002 112.444 -174.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.484 ' HD3' ' CG ' ' A' ' 121' ' ' GLU . 1.9 mppt? -101.09 -176.17 3.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.227 1.376 . . . . 2.8300000000000001 109.039 175.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.11 165.97 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.838 -0.801 . . . . 0.67000000000000004 108.838 156.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -84.39 167.06 16.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.421 0.688 . . . . 1.98 109.383 156.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.29 -7.15 59.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.627 1.171 . . . . 3.0299999999999998 111.881 -175.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 53.14 33.18 14.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.351 1.06 . . . . 1.3500000000000001 110.241 -170.087 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.57 20.52 52.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.798 0.713 . . . . 1.5900000000000001 112.635 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -135.14 50.3 2.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.292 1.437 . . . . 6.1500000000000004 107.446 -173.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.38 147.23 19.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 106.94 -2.464 . . . . 2.46 106.94 173.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.4 60.3 4.3 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.435 0.618 . . . . 2.2599999999999998 112.631 -167.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.88 163.22 35.76 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 107.325 -1.361 . . . . 2.8300000000000001 107.325 172.509 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.26 -52.37 62.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.004 -0.739 . . . . 3.1099999999999999 109.004 168.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -46.65 -42.57 16.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.518 1.527 . . . . 2.9300000000000002 111.847 -171.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 m -40.17 -63.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.866 2.066 . . . . 2.0299999999999998 112.113 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.2 t -74.95 -45.74 40.29 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.867 -0.521 . . . . 2.71 111.598 175.311 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.85 -48.22 67.21 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.713 1.605 . . . . 2.7999999999999998 111.492 -169.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.0 p -127.77 -46.73 1.41 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.778 0.431 . . . . 1.3899999999999999 111.493 174.763 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.518 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.54 -27.73 0.48 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 123.169 0.414 . . . . 1.0800000000000001 113.71 -178.412 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 51.6 t30 48.71 53.77 11.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 1.9199999999999999 110.216 -165.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.576 1.15 . . . . 1.0900000000000001 112.012 167.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.09 179.02 51.73 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 108.765 -1.734 . . . . 1.0 108.765 -161.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -53.79 155.72 3.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.791 -1.204 . . . . 1.6699999999999999 112.04 -175.398 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -92.93 144.49 25.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.615 1.966 . . . . 3.8500000000000001 109.519 -177.878 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt -114.43 -69.28 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.814 -1.18 . . . . 0.63 107.814 -173.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 165.21 12.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.865 -0.607 . . . . 1.28 110.133 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.532 ' HB2' HG23 ' A' ' 116' ' ' THR . 4.1 p -151.07 154.9 37.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.248 -0.887 . . . . 1.76 109.234 164.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.11 131.45 2.29 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.111 -1.996 . . . . 0.56000000000000005 108.111 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.94 125.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.433 -0.951 . . . . 0.81000000000000005 108.433 175.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.02 138.07 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 120.381 0.134 . . . . 0.93000000000000005 111.088 178.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.19 6.87 1.16 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.622 1.106 . . . . 0.67000000000000004 114.409 174.563 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.5 58.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 119.584 1.692 . . . . 0.92000000000000004 110.635 -160.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.94 175.67 12.68 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.891 0.876 . . . . 1.6100000000000001 108.646 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 103.603 -2.74 . . . . 4.7699999999999996 103.603 161.815 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 112.861 0.689 . . . . 8.3699999999999992 112.861 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m 46.04 59.44 3.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.007 1.723 . . . . 4.3700000000000001 114.319 172.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 161.75 29.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.534 -0.913 . . . . 3.7200000000000002 108.534 158.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.457 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -88.63 154.95 19.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.198 -1.408 . . . . 0.97999999999999998 107.198 154.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.1 t -123.39 142.81 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.788 -0.819 . . . . 0.72999999999999998 108.788 169.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.38 93.14 4.26 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.114 -0.698 . . . . 0.5 109.114 158.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.62 103.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.73 -1.211 . . . . 0.68999999999999995 107.73 158.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.86 134.71 34.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.974 -0.751 . . . . 0.87 108.974 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -145.81 -57.64 0.31 Allowed 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.602 1.161 . . . . 3.1800000000000002 108.824 169.137 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.63 -124.3 31.25 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.804 0.716 . . . . 0.94999999999999996 112.432 -176.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -113.18 -54.15 2.64 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.618 1.167 . . . . 4.25 109.939 -164.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.02 160.55 7.07 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.202 -1.159 . . . . 0.95999999999999996 110.202 173.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.21 40.63 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.441 2.761 . . . . 1.04 112.349 -172.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.48 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.441 1.897 . . . . 0.68000000000000005 108.848 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.5 128.84 8.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.085 -1.82 . . . . 2.52 106.085 170.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.43 171.12 41.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.798 . . . . 0.46999999999999997 111.57 -177.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 mm -128.92 129.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.143 -1.428 . . . . 1.8999999999999999 107.143 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.3 mm -101.07 137.29 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 N-CA-C 107.126 -1.435 . . . . 0.71999999999999997 107.126 161.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 127.15 45.23 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.274 -1.38 . . . . 1.78 107.274 160.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.25 91.82 5.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.619 -1.993 . . . . 2.2400000000000002 105.619 158.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -122.03 134.76 54.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.119 -1.067 . . . . 4.1399999999999997 108.119 175.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.39 -62.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.512 -1.222 . . . . 3.5299999999999998 108.193 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? 58.79 48.89 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.299 1.44 . . . . 9.0099999999999998 112.958 169.397 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -147.67 160.76 42.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.042 0.937 . . . . 5.4199999999999999 109.387 160.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.3 p -75.93 56.23 0.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.216 -0.661 . . . . 5.8300000000000001 109.216 167.077 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -110.59 -56.91 2.29 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.527 1.531 . . . . 9.5899999999999999 107.688 176.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.65 0.35 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 117.974 -1.459 . . . . 2.0899999999999999 110.161 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -50.65 122.93 10.49 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.912 3.075 . . . . 2.0800000000000001 113.869 -168.402 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.23 143.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.623 -0.717 . . . . 1.0600000000000001 110.25 -165.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -92.16 83.81 5.16 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.082 -1.822 . . . . 2.77 106.082 171.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.43 83.52 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.945 -1.132 . . . . 1.05 107.945 -172.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -92.49 135.18 34.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.267 0.556 . . . . 1.02 110.03 169.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.27 164.61 35.04 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.079 -1.609 . . . . 0.80000000000000004 109.079 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -154.09 129.22 9.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.369 -1.345 . . . . 2.29 107.369 -174.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -128.78 147.92 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 125.689 1.596 . . . . 1.0800000000000001 108.932 -163.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -136.86 156.2 48.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.291 0.496 . . . . 3.96 112.202 164.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.83 13.09 41.41 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.382 1.944 . . . . 0.57999999999999996 112.916 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.69 157.15 36.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.709 -0.848 . . . . 0.76000000000000001 108.709 168.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -78.55 157.02 28.91 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.984 -1.487 . . . . 2.0499999999999998 106.984 156.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.36 174.2 0.1 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.951 . . . . 3.1899999999999999 112.637 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.75 -169.19 53.12 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.623 -0.717 . . . . 0.56000000000000005 112.564 169.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 42' ' ' LEU . 3.6 tp -75.18 146.82 40.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.351 1.06 . . . . 2.46 110.753 -177.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.59 116.26 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.331 1.452 . . . . 0.59999999999999998 108.468 -178.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.72 146.72 7.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.63 -1.388 . . . . 0.56000000000000005 109.63 172.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -139.1 93.75 2.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.541 -1.652 . . . . 2.5 106.541 -171.206 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -131.83 150.95 52.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.719 -1.585 . . . . 0.66000000000000003 106.719 -162.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.738 0.78 . . . . 1.6699999999999999 109.07 174.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -78.7 149.28 32.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.416 -1.698 . . . . 0.97999999999999998 106.416 170.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.55 -100.23 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.388 2.275 . . . . 5.1799999999999997 113.543 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 50.97 58.53 5.45 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.82 0.674 . . . . 3.52 112.82 174.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -62.45 -27.09 68.87 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 113.635 0.976 . . . . 6.3700000000000001 113.635 -174.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -174.64 95.52 0.08 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.507 1.123 . . . . 5.9500000000000002 108.988 -175.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -153.14 -57.29 0.13 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.464 0.542 . . . . 5.1100000000000003 112.464 -177.013 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 t -163.79 164.4 23.65 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 119.328 0.967 . . . . 5.7000000000000002 109.458 176.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.12 -18.54 60.21 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.791 0.836 . . . . 6.7300000000000004 110.703 167.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.13 -126.52 0.5 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 108.745 -1.742 . . . . 3.8999999999999999 108.745 170.02 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.0 p 179.98 138.8 0.12 Allowed 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.253 1.021 . . . . 2.1400000000000001 109.786 174.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.19 -158.82 0.75 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 104.156 -2.535 . . . . 3.77 104.156 160.422 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.6 m 69.13 23.75 6.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 116.392 -2.123 . . . . 3.0899999999999999 116.121 143.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.09 150.44 24.06 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.593 0.633 . . . . 1.8100000000000001 111.224 -166.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.42 -143.9 15.47 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.44 1.495 . . . . 1.4199999999999999 111.394 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.47 -179.43 5.42 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.798 3.665 . . . . 1.1299999999999999 113.76 -170.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -52.57 64.57 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 129.498 3.119 . . . . 1.6200000000000001 115.402 -174.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.2 t80 42.97 68.22 0.53 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.074 1.75 . . . . 2.2400000000000002 110.504 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -85.09 114.82 58.2 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.241 -0.885 . . . . 2.6400000000000001 109.808 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.84 -32.99 10.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.271 1.981 . . . . 1.3 111.593 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.43 -64.57 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.239 -0.652 . . . . 3.0899999999999999 109.239 177.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.7 t -158.94 65.34 0.41 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.062 -0.718 . . . . 2.6600000000000001 109.062 178.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 -79.23 163.39 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.931 -0.396 . . . . 5.2199999999999998 109.931 169.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.96 144.16 49.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.091 1.356 . . . . 3.8900000000000001 109.114 -169.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -77.09 155.66 32.27 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.831 0.853 . . . . 0.78000000000000003 111.707 -173.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.79 -98.27 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.499 -1.44 . . . . 2.2400000000000002 109.499 161.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.34 -146.93 9.55 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.577 -1.809 . . . . 1.2 108.577 178.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.83 -58.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.536 2.157 . . . . 1.4099999999999999 109.724 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -20.54 64.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.906 1.283 . . . . 6.4100000000000001 112.176 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 2.7 t70 -64.41 175.91 1.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.528 0.731 . . . . 3.4500000000000002 111.255 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.04 -50.97 7.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.917 1.287 . . . . 5.6299999999999999 108.551 164.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.12 174.39 8.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.954 0.502 . . . . 4.29 111.606 -173.057 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 164.58 136.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.309 3.044 . . . . 4.2199999999999998 107.78 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 32.4 m80 -66.9 156.52 35.57 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.195 -1.78 . . . . 0.68000000000000005 106.195 165.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.265 13.0 p -78.51 45.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 123.25 1.5 . . . . 2.3199999999999998 110.832 173.102 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.16 33.25 0.27 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 128.74 3.067 . . . . 0.76000000000000001 111.331 165.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -137.48 131.9 32.53 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.312 2.056 . . . . 2.1699999999999999 110.37 161.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.28 -56.38 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.114 1.365 . . . . 2.2999999999999998 109.201 176.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.34 -123.58 0.94 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.238 -0.745 . . . . 0.83999999999999997 111.238 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -139.26 172.32 13.0 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 125.28 1.432 . . . . 1.9199999999999999 110.077 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.5 163.68 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.993 1.317 . . . . 0.63 107.453 164.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.2 m -110.59 133.42 53.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.999 -1.482 . . . . 2.3199999999999998 106.999 174.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.76 137.41 32.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.766 0.426 . . . . 0.68999999999999995 110.535 169.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -73.98 -75.57 0.15 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.307 1.043 . . . . 3.3900000000000001 111.645 -166.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.37 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.668 1.187 . . . . 4.79 110.841 -168.525 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.18 8.44 4.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.278 1.431 . . . . 2.77 110.936 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.82 16.45 76.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.365 -1.094 . . . . 0.91000000000000003 110.365 -171.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -78.24 149.01 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.788 -1.56 . . . . 0.87 106.788 172.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.72 165.73 26.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.774 -1.195 . . . . 0.71999999999999997 107.774 165.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.28 140.25 51.5 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.364 -2.828 . . . . 3.0600000000000001 103.364 -172.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.61 78.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 123.971 0.795 . . . . 1.3 110.144 160.025 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.7 m -98.54 77.87 2.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.14 0.976 . . . . 1.02 108.952 166.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.58 159.11 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.554 -0.906 . . . . 1.78 108.554 176.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.32 147.29 49.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.352 -0.981 . . . . 2.52 108.352 152.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -137.62 150.56 47.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.332 1.053 . . . . 2.0800000000000001 108.218 172.348 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 p -110.17 -4.45 15.76 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.942 1.697 . . . . 1.3400000000000001 113.418 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.55 -47.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.745 -1.206 . . . . 1.0800000000000001 107.745 175.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.11 176.27 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.131 0.967 . . . . 1.1000000000000001 111.388 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.2 m -163.1 175.54 10.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.987 2.515 . . . . 1.72 104.469 -175.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.78 -1.93 45.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.896 0.771 . . . . 2.5899999999999999 112.587 173.165 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.2 m -155.71 -150.25 0.29 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.578 1.151 . . . . 3.4500000000000002 108.848 -173.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.15 -90.76 0.81 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.249 -1.141 . . . . 3.48 110.249 -178.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -160.56 -63.52 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.385 0.674 . . . . 4.1600000000000001 110.883 -175.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.02 1.11 18.84 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.809 -0.557 . . . . 3.8300000000000001 112.472 -172.069 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.1 p -53.98 155.36 3.5 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.056 1.343 . . . . 1.1399999999999999 111.931 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.2 pt -88.61 -5.72 10.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.011 -0.995 . . . . 1.99 110.738 -178.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -37.8 122.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.874 1.67 . . . . 1.6799999999999999 110.446 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.99 -21.24 40.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.895 -0.947 . . . . 1.6899999999999999 113.989 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -83.92 165.2 18.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.475 1.637 . . . . 5.29 110.961 -170.021 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -89.56 108.15 19.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.699 0.4 . . . . 0.93999999999999995 111.351 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.08 148.15 52.17 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.8 -0.815 . . . . 2.4399999999999999 108.8 168.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.16 141.47 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.525 1.53 . . . . 0.44 108.045 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.01 132.77 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.087 -1.079 . . . . 1.53 108.087 162.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -102.97 168.98 8.85 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.621 1.568 . . . . 0.66000000000000003 114.018 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -72.06 0.17 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.493 -0.776 . . . . 5.4000000000000004 111.078 177.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -79.78 178.09 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.284 0.947 . . . . 4.6100000000000003 109.498 -178.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.13 173.76 0.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.433 1.093 . . . . 1.5 111.442 172.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -70.39 165.52 22.28 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.812 0.815 . . . . 2.9399999999999999 108.94 163.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.74 -21.38 15.21 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.128 -0.942 . . . . 3.9100000000000001 112.36 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 54.69 14.36 0.85 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.904 1.282 . . . . 1.98 112.232 -173.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.61 61.67 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.11 1.338 . . . . 2.4100000000000001 111.285 -176.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 11.3 mttt -129.94 19.08 5.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.267 1.027 . . . . 5.96 110.874 -172.263 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.01 139.04 22.22 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.942 -2.063 . . . . 2.6000000000000001 107.942 164.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.36 67.13 1.88 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 117.764 0.782 . . . . 2.73 111.682 -175.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -172.99 156.27 3.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.46 1.504 . . . . 3.0699999999999998 108.195 -177.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -52.24 52.78 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.263 -0.398 . . . . 3.6200000000000001 111.28 -178.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -29.49 -46.13 0.05 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 3.0499999999999998 113.751 171.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 t -53.16 -61.74 2.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.174 0.989 . . . . 1.9099999999999999 111.548 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -71.26 -43.4 67.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.237 -0.914 . . . . 1.48 109.743 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -54.4 -39.14 66.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.337 2.255 . . . . 3.8900000000000001 112.539 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.4 t -138.1 -53.81 0.63 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.41 1.084 . . . . 1.6100000000000001 112.011 176.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 79.45 1.0 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 103.714 -3.755 . . . . 3.3599999999999999 103.714 -162.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -71.07 57.5 0.22 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.325 1.85 . . . . 3.48 110.681 -178.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -26.1 67.78 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.928 -0.483 . . . . 1.25 111.432 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 134.28 -177.34 19.24 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.397 -1.881 . . . . 0.93000000000000005 108.397 175.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -53.51 153.99 3.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.821 1.249 . . . . 1.25 111.775 175.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.24 131.16 49.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.002 -0.999 . . . . 3.0800000000000001 108.468 168.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -102.51 -74.14 0.64 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.576 -1.639 . . . . 0.67000000000000004 106.576 164.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.16 154.44 19.76 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.424 -0.954 . . . . 1.0800000000000001 108.424 173.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.0 m -144.46 156.05 44.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.909 -1.886 . . . . 2.0899999999999999 105.909 170.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.39 130.1 1.62 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.101 -0.8 . . . . 0.72999999999999998 111.101 169.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.9 131.24 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.898 0.879 . . . . 0.84999999999999998 109.004 173.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.8 tt -91.91 133.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.722 0.296 . . . . 0.70999999999999996 111.533 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.457 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 144.06 2.78 0.83 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.135 0.874 . . . . 1.1100000000000001 115.104 178.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.4 mm -95.4 57.86 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-N 119.325 1.562 . . . . 1.2 109.92 -157.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.62 176.62 12.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.668 0.787 . . . . 1.51 109.773 171.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.256 1.435 0 N-CA-C 104.068 -2.568 . . . . 4.4199999999999999 104.068 170.225 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 109.797 -0.446 . . . . 7.5300000000000002 109.797 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.3 p 47.92 60.02 3.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.658 1.583 . . . . 3.6600000000000001 112.818 169.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.613 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 6.4 ttmm -122.33 168.85 11.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.82 1.648 . . . . 4.4000000000000004 106.943 172.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -114.22 142.46 46.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.773 0.829 . . . . 0.69999999999999996 108.909 158.12 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' A' ' 152' ' ' ALA . 51.2 t -111.87 145.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.654 -1.61 . . . . 0.90000000000000002 106.654 166.232 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -118.47 97.62 5.85 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 0.54000000000000004 108.941 155.239 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.64 98.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.561 1.144 . . . . 0.71999999999999997 108.768 164.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.69 130.4 35.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.958 0.903 . . . . 2.3300000000000001 108.784 172.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -151.69 -52.12 0.12 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 122.767 0.427 . . . . 3.5800000000000001 110.961 166.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.45 -116.6 1.43 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.261 0.934 . . . . 1.1599999999999999 112.998 -175.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -117.2 -46.04 2.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.169 0.988 . . . . 3.3500000000000001 109.729 -158.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 172.36 16.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.567 1.08 . . . . 1.0 111.747 177.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.47 -24.06 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.139 2.559 . . . . 1.3100000000000001 111.594 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.2 t -49.89 139.36 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 0.97999999999999998 110.92 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.89 130.26 8.88 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.751 -1.203 . . . . 1.95 107.751 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.14 170.06 41.79 Favored Glycine 0 N--CA 1.449 -0.437 0 O-C-N 121.732 -0.605 . . . . 0.67000000000000004 111.691 -177.068 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 mm -123.83 126.14 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.287 -1.375 . . . . 1.6699999999999999 107.287 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.2 mp -95.65 147.62 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.019 -1.474 . . . . 1.3 107.019 163.234 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.53 121.39 36.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.032 1.333 . . . . 1.9099999999999999 107.494 167.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -96.73 99.03 10.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.978 -2.23 . . . . 2.4100000000000001 104.978 162.464 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -113.69 128.31 56.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.6 -0.889 . . . . 3.8999999999999999 108.6 174.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -157.22 -77.82 0.08 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.54 -1.664 . . . . 3.7799999999999998 108.963 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.2 59.85 3.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.47 -0.937 . . . . 6.5499999999999998 108.47 -174.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -113.83 -103.48 0.41 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.59 -2.374 . . . . 3.8599999999999999 104.59 168.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 t -153.03 -69.97 0.15 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.111 -1.44 . . . . 2.8999999999999999 107.111 157.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -124.19 97.85 5.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.84 -1.541 . . . . 4.04 106.84 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.89 37.43 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.345 -0.702 . . . . 1.02 111.345 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.74 115.62 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.366 3.378 . . . . 1.26 112.065 -172.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.02 164.44 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.562 0.745 . . . . 1.24 109.157 -172.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -115.1 99.18 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.938 -1.504 . . . . 3.0499999999999998 106.938 166.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -92.31 88.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.08 1.752 . . . . 1.1100000000000001 107.566 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -98.31 151.43 20.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.419 -0.586 . . . . 0.97999999999999998 109.419 169.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.9 159.04 32.18 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.369 -1.493 . . . . 0.82999999999999996 109.369 176.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.4 m -136.82 110.25 7.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.6 -1.63 . . . . 2.2200000000000002 106.6 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.411 HD11 HD12 ' A' ' 18' ' ' ILE . 1.1 mp -119.16 148.83 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.013 1.325 . . . . 0.95999999999999996 107.893 -163.338 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -148.33 166.26 28.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.978 0.732 . . . . 3.4900000000000002 112.978 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.44 19.35 62.35 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 0.67000000000000004 113.208 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -75.49 165.32 25.3 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.373 1.086 . . . . 0.79000000000000004 109.32 174.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.13 163.01 28.38 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.67 -1.233 . . . . 1.6599999999999999 107.67 155.342 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.89 165.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.79 0.805 . . . . 2.52 112.216 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 -158.31 53.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.086 -0.961 . . . . 0.58999999999999997 113.402 167.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 130.02 42.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.926 1.29 . . . . 1.9199999999999999 111.176 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -136.49 110.08 8.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.919 1.688 . . . . 1.3100000000000001 109.527 -174.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.91 149.42 11.06 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.852 1.692 . . . . 0.53000000000000003 111.563 -177.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -146.4 100.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.463 -0.94 . . . . 2.79 108.463 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.625 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.0 m80 -139.56 154.21 47.58 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.137 -1.06 . . . . 0.64000000000000001 108.137 -166.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -113.61 129.23 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 119.571 1.078 . . . . 1.8600000000000001 108.82 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -105.81 146.83 29.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.64 -1.615 . . . . 0.79000000000000004 106.64 -176.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -53.77 -61.24 2.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.591 0.557 . . . . 4.0499999999999998 110.751 -165.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 39.12 71.54 0.16 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.598 1.559 . . . . 2.98 111.535 159.205 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -73.27 -77.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.277 0.56 . . . . 4.9199999999999999 111.195 -171.523 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -80.24 126.66 31.41 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.139 -1.43 . . . . 5.2800000000000002 107.139 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -126.61 20.55 7.2 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.382 1.073 . . . . 3.9300000000000002 109.709 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 54' ' ' THR . 1.5 t -78.67 46.39 0.65 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.952 -1.093 . . . . 4.9199999999999999 111.981 -172.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -174.53 -45.89 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 125.105 1.362 . . . . 5.6500000000000004 109.584 -173.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.54 -163.39 27.05 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.566 -2.214 . . . . 3.6600000000000001 107.566 -178.068 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.01 161.46 40.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.59 -1.633 . . . . 2.3700000000000001 106.59 -177.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m 101.3 79.89 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.843 2.057 . . . . 5.3899999999999997 107.85 -178.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 t 179.77 39.68 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.641 0.734 . . . . 2.6299999999999999 111.021 -137.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.11 -69.92 0.05 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.542 1.537 . . . . 3.3900000000000001 107.497 -178.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.89 -94.52 0.34 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.256 -1.938 . . . . 0.95999999999999996 108.256 173.328 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.76 177.07 9.17 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.311 2.674 . . . . 0.82999999999999996 113.736 -176.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -60.93 130.94 48.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.582 -1.645 . . . . 1.3600000000000001 108.517 171.293 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -48.22 117.11 1.79 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.085 0.469 . . . . 1.71 110.487 176.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.22 152.57 25.28 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 126.536 1.934 . . . . 2.4500000000000002 107.158 173.052 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -24.69 12.37 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.418 2.079 . . . . 1.22 113.529 -167.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.36 -68.74 0.12 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.952 0.796 . . . . 2.9100000000000001 109.57 -176.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.7 m -155.99 77.96 0.96 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.484 0.714 . . . . 1.9199999999999999 109.67 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -77.99 169.82 17.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.785 -0.82 . . . . 5.0499999999999998 108.785 163.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -118.41 158.47 25.23 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.701 1.6 . . . . 3.4399999999999999 106.734 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.437 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 55.0 t60 -86.0 154.06 21.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.566 0.58 . . . . 0.85999999999999999 112.566 -175.252 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.41 -178.58 43.48 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 106.613 -2.595 . . . . 2.1699999999999999 106.613 160.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.49 -160.83 26.04 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 117.462 0.631 . . . . 1.45 112.616 -170.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.85 -43.19 3.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.951 1.768 . . . . 1.47 109.301 173.158 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.4 -46.57 76.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 5.1699999999999999 111.659 -176.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.68 174.45 1.79 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.425 -0.807 . . . . 2.4399999999999999 109.754 176.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.09 -37.44 11.61 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.224 1.01 . . . . 5.7300000000000004 111.082 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -75.71 155.53 35.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.04 -1.096 . . . . 2.7400000000000002 108.04 -174.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 165.57 145.46 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.905 2.082 . . . . 3.5099999999999998 112.002 -170.323 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.2 m80 -66.57 149.7 50.09 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 107.564 -1.273 . . . . 0.63 107.564 164.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.69 -37.43 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.94 -0.704 . . . . 1.5900000000000001 109.714 -171.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.17 60.86 1.59 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.611 0.624 . . . . 0.62 112.029 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 80' ' ' HIS . 1.2 t0 -168.29 114.94 0.67 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.523 -0.917 . . . . 2.0600000000000001 108.523 -172.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.13 -45.06 8.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.249 -0.648 . . . . 2.48 109.249 176.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.76 -94.11 0.15 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.289 -1.124 . . . . 1.1299999999999999 110.289 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -150.62 164.84 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.478 1.511 . . . . 1.5800000000000001 110.573 -177.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.0 m -110.0 176.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.284 -1.747 . . . . 0.52000000000000002 106.284 156.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 t -112.49 144.3 42.2 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.444 -1.317 . . . . 1.9099999999999999 107.444 160.295 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.35 153.25 29.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.289 -1.004 . . . . 1.1499999999999999 108.289 154.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.47 -89.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.781 -0.822 . . . . 2.8399999999999999 108.781 173.322 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -140.25 -57.67 0.54 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.584 1.554 . . . . 4.1799999999999997 108.981 -171.411 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -87.8 30.39 0.83 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.042 1.337 . . . . 5.0700000000000003 110.062 -170.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.63 10.65 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.205 1.86 . . . . 0.90000000000000002 112.956 179.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.71 138.3 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.393 -1.336 . . . . 0.95999999999999996 107.393 176.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.55 170.79 15.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.063 1.345 . . . . 0.60999999999999999 107.953 173.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -143.9 147.76 34.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.998 -2.223 . . . . 2.7999999999999998 104.998 -171.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.85 132.64 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.407 -1.701 . . . . 1.3799999999999999 106.407 166.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.9 m -153.02 73.19 0.98 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.013 1.325 . . . . 1.05 107.603 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.6 mm -115.85 152.51 17.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.638 -0.875 . . . . 2.5600000000000001 108.638 -177.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -145.53 91.47 2.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.522 0.729 . . . . 2.4500000000000002 109.48 167.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.42 -178.02 6.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.904 0.882 . . . . 3.5800000000000001 109.931 177.219 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.4 p -133.33 48.97 2.34 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.201 1.0 . . . . 1.6799999999999999 109.146 170.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.22 -55.86 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.918 1.287 . . . . 1.1799999999999999 108.486 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pp -88.08 177.68 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.89 0.852 . . . . 1.21 111.451 -177.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -161.64 177.88 9.56 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.921 2.088 . . . . 2.1400000000000001 107.077 -176.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.86 -3.8 24.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.888 1.07 . . . . 3.3900000000000001 113.888 -175.082 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m -155.79 166.66 32.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.091 1.357 . . . . 4.1900000000000004 109.125 176.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.58 130.14 0.37 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 109.228 -1.549 . . . . 2.7200000000000002 109.228 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -72.05 74.48 0.92 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 123.6 1.667 . . . . 5.5800000000000001 112.336 -169.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -158.0 -39.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.577 1 C-N-CA 132.115 4.166 . . . . 3.8799999999999999 105.978 174.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.1 p -42.25 147.4 0.25 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.276 0.56 . . . . 1.27 111.07 156.263 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.3 pt -78.64 -17.32 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.553 -0.737 . . . . 1.96 109.257 174.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 tp -36.91 133.06 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.606 1.562 . . . . 1.78 113.775 -170.129 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.53 37.82 45.67 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.85 -0.5 . . . . 1.51 111.85 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -134.99 160.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.894 1.278 . . . . 4.0800000000000001 107.559 172.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.4 m -94.29 112.71 24.52 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.693 0.397 . . . . 1.2 111.022 -170.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.92 149.55 50.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.117 -0.698 . . . . 1.6399999999999999 109.117 172.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t -135.47 128.93 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.346 1.459 . . . . 0.38 107.467 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.53 120.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.046 -1.835 . . . . 1.6100000000000001 106.046 163.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.462 ' CD2' ' HD1' ' A' ' 46' ' ' HIS . 51.4 m-70 -94.28 175.65 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.019 1.727 . . . . 0.69999999999999996 112.247 -174.521 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -72.67 -76.93 0.11 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 113.041 0.756 . . . . 6.0599999999999996 113.041 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -81.11 -176.79 6.14 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.21 0.913 . . . . 3.2000000000000002 110.084 -167.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.6 148.89 36.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.89 -0.782 . . . . 0.56999999999999995 108.89 167.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -67.9 170.17 8.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.051 -0.722 . . . . 1.99 109.051 159.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.32 -23.58 62.86 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.699 1.37 . . . . 3.9100000000000001 114.699 -176.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 67.03 2.01 2.56 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.811 1.244 . . . . 1.6499999999999999 113.636 -170.259 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.21 10.09 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 120.54 1.518 . . . . 1.77 112.676 166.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -106.92 -20.77 13.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.508 2.323 . . . . 5.3799999999999999 109.639 -178.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.8 -77.01 1.94 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 124.492 1.044 . . . . 2.4199999999999999 112.939 167.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.77 -70.35 0.12 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.118 -0.793 . . . . 2.48 111.118 -163.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -90.76 -92.98 0.13 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.449 1.5 . . . . 2.96 112.473 -176.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -165.39 -81.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.144 0.978 . . . . 3.25 108.693 -164.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -29.09 -45.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.282 2.633 . . . . 3.2000000000000002 113.146 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.2 m -53.65 -50.49 65.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.305 1.842 . . . . 2.9900000000000002 112.744 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 52.2 p -71.7 -48.35 47.86 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.881 -1.137 . . . . 1.5 110.615 170.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -53.25 -48.15 68.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.091 2.156 . . . . 3.4399999999999999 111.022 -168.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.431 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.1 p -128.08 -50.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.154 0.982 . . . . 1.21 110.691 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.83 -18.53 0.66 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-O 119.268 -0.74 . . . . 0.91000000000000003 114.556 -176.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 45.47 54.12 7.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.294 1.438 . . . . 2.0 110.803 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -60.83 -34.93 75.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.075 1.35 . . . . 1.01 113.213 177.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.86 173.67 31.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.404 -1.878 . . . . 1.0600000000000001 108.404 -159.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 p -61.12 153.62 25.25 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.116 1.366 . . . . 2.2799999999999998 112.426 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -81.1 147.43 30.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.151 1.78 . . . . 2.4399999999999999 110.437 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.5 mt -127.33 -76.3 0.57 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.528 -0.916 . . . . 0.72999999999999998 108.528 -168.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.82 151.54 21.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.192 -0.669 . . . . 0.84999999999999998 109.192 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.1 p -136.71 167.36 21.57 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.521 1.528 . . . . 2.4700000000000002 107.879 174.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.95 133.88 1.64 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 114.46 -1.246 . . . . 0.64000000000000001 110.195 -177.411 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.38 138.87 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.817 -0.808 . . . . 0.82999999999999996 108.817 175.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 6' ' ' ALA . 21.5 tt -93.79 127.48 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 123.42 0.45 . . . . 0.79000000000000004 111.166 175.327 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.04 -2.1 0.82 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.106 1.336 . . . . 0.54000000000000004 115.692 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -89.36 60.59 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.25 1.525 . . . . 1.1499999999999999 109.589 -160.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -131.13 175.68 8.89 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.386 -0.821 . . . . 1.24 110.881 164.095 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 . . . . . 0 C--O 1.254 1.334 0 N-CA-C 103.187 -2.894 . . . . 4.3700000000000001 103.187 163.458 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 109.454 -0.572 . . . . 6.0800000000000001 109.454 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 p -73.56 173.73 9.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.109 1.364 . . . . 2.9199999999999999 110.599 173.383 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.6 OUTLIER -104.19 152.82 21.7 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.223 0.609 . . . . 3.1099999999999999 110.478 -179.032 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.95 14.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.375 0.67 . . . . 1.49 110.359 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 152' ' ' ALA . 37.8 t -122.2 152.08 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.104 1.761 . . . . 0.92000000000000004 106.399 159.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.25 99.15 4.03 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.986 -0.746 . . . . 0.71999999999999997 108.986 154.441 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.7 t -66.15 111.88 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.221 -1.4 . . . . 0.80000000000000004 107.221 166.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -92.07 133.05 36.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.469 -0.937 . . . . 0.95999999999999996 108.469 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -149.12 -50.27 0.15 Allowed 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.487 0.551 . . . . 3.7400000000000002 112.487 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.18 -113.64 1.15 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.092 -0.838 . . . . 0.82999999999999996 113.942 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -124.09 -55.59 1.67 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.207 1.003 . . . . 3.5800000000000001 110.909 -164.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.32 165.58 12.76 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.041 -0.823 . . . . 0.72999999999999998 111.041 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.77 27.14 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.807 3.005 . . . . 1.05 113.59 -173.396 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 91.6 t -91.89 143.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.895 1.678 . . . . 0.78000000000000003 107.649 177.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -154.79 116.83 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.179 -1.045 . . . . 2.8100000000000001 108.179 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.02 171.74 32.02 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.692 -0.563 . . . . 0.59999999999999998 111.692 -172.194 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -127.99 126.65 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.46 0.704 . . . . 1.3500000000000001 109.243 178.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.6 mm -94.5 151.47 3.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 125.53 1.532 . . . . 0.78000000000000003 107.005 165.153 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.92 154.23 48.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.592 -1.633 . . . . 1.5600000000000001 106.592 164.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.8 160.11 40.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.81 -0.756 . . . . 5.25 109.131 158.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -127.82 139.51 52.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.056 2.143 . . . . 4.7300000000000004 105.386 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -143.65 146.82 33.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.949 -1.871 . . . . 4.2999999999999998 105.949 154.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -73.9 -68.8 0.48 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.151 -0.685 . . . . 4.5300000000000002 109.151 170.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -78.19 165.25 24.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.769 0.828 . . . . 3.8999999999999999 111.618 -173.038 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -77.92 2.26 17.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.548 0.739 . . . . 2.6099999999999999 112.513 173.287 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -161.32 78.22 0.57 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.877 0.762 . . . . 4.2800000000000002 109.856 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.61 164.81 30.38 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.375 -2.29 . . . . 1.3899999999999999 107.375 165.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.02 118.41 5.27 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.983 2.455 . . . . 1.5800000000000001 110.524 -176.528 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.69 176.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.769 -0.826 . . . . 1.46 108.769 -165.871 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -131.24 81.06 1.97 Allowed 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.577 -0.897 . . . . 5.0300000000000002 108.577 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.58 100.95 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.988 -1.116 . . . . 1.75 107.988 -177.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -114.02 170.39 8.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.934 0.493 . . . . 1.24 110.081 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.21 165.72 34.74 Favored Glycine 0 N--CA 1.449 -0.463 0 O-C-N 120.974 -1.079 . . . . 0.67000000000000004 112.088 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -131.18 106.66 8.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.509 -2.034 . . . . 1.8400000000000001 105.509 -177.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.64 146.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.626 -1.25 . . . . 0.96999999999999997 107.626 -166.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 161.84 41.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.485 0.92 . . . . 3.6600000000000001 113.485 168.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.85 15.56 45.27 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.758 1.647 . . . . 0.65000000000000002 113.467 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.83 -173.47 0.63 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.524 1.162 . . . . 0.81000000000000005 108.85 169.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -85.29 -100.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.077 -1.083 . . . . 2.6000000000000001 108.077 164.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -149.2 162.04 40.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.389 1.475 . . . . 2.6600000000000001 108.049 -175.3 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.57 -161.54 50.91 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.209 0.433 . . . . 0.68999999999999995 112.443 167.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.17 132.78 53.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.735 0.814 . . . . 1.98 112.521 -175.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.18 114.94 9.52 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.132 1.773 . . . . 1.23 109.131 -177.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.23 152.27 6.91 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.918 1.247 . . . . 0.68000000000000005 113.753 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 103.84 4.3 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.209 1.803 . . . . 2.8599999999999999 108.138 -177.524 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 41.9 m80 -142.06 162.07 36.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.729 . . . . 1.26 109.033 -169.146 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.43 130.43 74.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 2.3700000000000001 108.73 -178.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -113.51 154.52 26.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.116 0.967 . . . . 0.81999999999999995 108.838 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.61 33.09 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.197 1.399 . . . . 4.4199999999999999 113.495 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -83.4 95.59 8.28 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.598 -1.63 . . . . 3.1200000000000001 106.598 178.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' CD ' HH12 ' A' ' 115' ' ' ARG . 8.0 tp10 -74.69 -82.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.451 1.5 . . . . 4.2000000000000002 108.528 -179.28 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -78.52 126.66 31.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.163 -1.421 . . . . 5.0999999999999996 107.163 174.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -122.6 14.09 10.16 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.972 1.309 . . . . 4.0999999999999996 110.479 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.0 t -59.31 -39.94 84.68 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.733 0.697 . . . . 4.2199999999999998 111.447 -174.271 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.46 -55.5 7.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.414 0.685 . . . . 6.25 109.816 175.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.75 163.6 21.95 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.975 -1.25 . . . . 3.8199999999999998 109.975 176.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 90.7 m -76.57 62.2 1.89 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.719 1.207 . . . . 2.7999999999999998 110.042 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -141.49 66.11 1.37 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.423 1.106 . . . . 4.5099999999999998 110.849 -172.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.5 m -168.95 -37.4 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.459 1.651 . . . . 2.4700000000000002 115.459 -141.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.57 149.29 30.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.625 1.57 . . . . 1.8899999999999999 108.636 168.073 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.98 -99.18 2.16 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.79 -1.324 . . . . 0.94999999999999996 109.79 -173.379 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.92 178.39 5.34 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.692 2.928 . . . . 1.0700000000000001 112.524 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -61.73 136.68 58.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.432 -1.27 . . . . 1.48 108.365 172.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -23.06 105.41 0.02 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.975 1.71 . . . . 2.5099999999999998 113.814 -177.123 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -130.16 90.59 41.58 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.815 1.646 . . . . 2.5499999999999998 109.621 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.64 -36.93 13.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.836 1.69 . . . . 1.6599999999999999 111.115 -178.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -135.49 -75.06 0.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.977 0.911 . . . . 2.8399999999999999 109.557 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.6 m -156.97 81.06 0.93 Allowed 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.312 -0.868 . . . . 1.6299999999999999 109.468 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -85.35 170.93 12.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.322 0.582 . . . . 4.7800000000000002 110.598 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -125.82 161.63 26.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.944 1.698 . . . . 3.52 107.265 177.028 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -104.24 115.95 31.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.774 0.83 . . . . 1.01 110.914 173.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.87 12.9 6.48 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 124.76 1.171 . . . . 3.1400000000000001 110.621 164.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.92 -164.11 23.24 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.44 -1.035 . . . . 1.75 112.296 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.92 -23.69 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.34 2.027 . . . . 2.23 111.545 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -71.89 -53.84 11.94 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.739 0.816 . . . . 6.5 111.45 -176.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.5 171.16 7.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.73 -0.841 . . . . 4.0700000000000003 108.73 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.96 -51.11 68.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.974 -1.121 . . . . 6.2300000000000004 107.974 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -76.81 143.47 39.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.738 0.78 . . . . 3.3100000000000001 110.6 -163.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -176.3 150.89 0.95 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.388 -1.338 . . . . 3.1000000000000001 107.388 -166.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.1 m80 -63.67 147.46 51.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.848 -1.538 . . . . 0.65000000000000002 106.848 163.279 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.71 -15.22 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 120.625 -0.43 . . . . 1.3 110.672 -175.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.2 67.42 0.28 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.088 1.328 . . . . 0.68000000000000005 110.747 166.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -132.8 110.75 10.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.868 1.334 . . . . 2.4500000000000002 109.781 168.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -39.59 16.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.068 0.547 . . . . 1.78 109.94 169.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 138.59 -106.34 0.52 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.108 -0.797 . . . . 0.79000000000000004 111.108 172.015 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.09 159.8 40.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.467 1.507 . . . . 1.45 109.373 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.2 176.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 125.695 1.598 . . . . 0.77000000000000002 107.078 166.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -114.91 139.76 49.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.799 -1.185 . . . . 2.0299999999999998 107.799 163.347 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.25 141.25 31.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.242 1.417 . . . . 0.60999999999999999 110.801 169.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.25 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.194 0.998 . . . . 2.5299999999999998 111.08 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -159.38 -46.55 0.05 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.923 1.289 . . . . 3.75 110.496 -173.13 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.79 19.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.419 1.488 . . . . 3.3100000000000001 111.134 178.09 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.65 9.28 78.39 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.6 -1.111 . . . . 0.88 111.997 -177.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.0 t -77.52 141.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.59 -1.263 . . . . 1.01 107.59 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.36 168.2 21.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.531 1.132 . . . . 0.77000000000000002 108.407 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.54 144.24 50.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 103.452 -2.796 . . . . 2.9199999999999999 103.452 -174.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.89 136.06 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.055 -1.831 . . . . 1.54 106.055 169.666 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -159.98 67.39 0.37 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.141 1.376 . . . . 0.85999999999999999 107.613 -177.468 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 mm -112.64 146.66 17.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 108.485 -0.931 . . . . 2.0299999999999998 108.485 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.82 74.96 1.49 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.258 0.623 . . . . 3.4500000000000002 109.805 177.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -77.84 151.17 34.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.599 0.714 . . . . 2.48 110.356 -177.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -98.71 -26.28 14.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.018 2.127 . . . . 1.6299999999999999 110.844 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.2 -48.77 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 118.91 -0.567 . . . . 1.7 110.162 -173.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.24 162.97 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.291 0.95 . . . . 1.6899999999999999 109.97 171.395 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 m -143.13 179.85 6.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.604 1.561 . . . . 2.7400000000000002 108.316 -175.083 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -133.06 31.88 3.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.295 1.438 . . . . 4.4699999999999998 113.857 -173.648 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t -153.48 69.67 0.82 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.128 -0.983 . . . . 3.2999999999999998 110.863 178.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 167.22 172.53 34.51 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.932 -0.48 . . . . 3.4199999999999999 112.56 174.242 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.23 -46.95 46.64 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.405 1.882 . . . . 5.5800000000000001 112.507 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -95.76 0.5 52.48 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.75 1.62 . . . . 6.4500000000000002 111.878 -178.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p -75.71 161.98 28.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.128 -1.805 . . . . 1.3200000000000001 106.128 168.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.3 pt -76.94 -13.83 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 118.419 -1.312 . . . . 2.27 113.598 -168.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.4 mm -43.21 115.72 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.283 0.947 . . . . 1.8500000000000001 111.183 176.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.7 25.35 74.22 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.076 -0.847 . . . . 1.3300000000000001 112.389 178.673 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.414 HH12 ' CD ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -107.84 159.45 16.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 120.051 1.926 . . . . 4.8399999999999999 110.548 170.848 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 m -92.06 104.56 16.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 1.1499999999999999 109.592 -172.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.06 147.44 53.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.055 -1.091 . . . . 1.78 108.055 166.513 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -134.72 133.72 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 127.356 2.263 . . . . 0.40999999999999998 106.222 177.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.23 120.81 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.024 -1.472 . . . . 1.72 107.024 165.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.478 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 45.7 m-70 -95.56 176.1 6.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.58 1.552 . . . . 0.79000000000000004 112.343 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -77.58 -65.58 0.94 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.558 0.947 . . . . 6.0999999999999996 113.558 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -88.42 174.32 8.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.206 0.912 . . . . 5.9199999999999999 110.675 -175.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.84 143.29 17.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.363 -1.289 . . . . 0.96999999999999997 107.91 157.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.48 155.74 38.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.614 -0.884 . . . . 2.1099999999999999 108.614 158.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -78.76 -5.58 53.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.163 0.985 . . . . 3.3900000000000001 112.092 -172.426 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 54.46 30.59 13.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.418 1.087 . . . . 1.6699999999999999 110.542 -173.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.84 16.48 68.22 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.403 -0.665 . . . . 1.8300000000000001 112.796 177.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -98.83 -23.6 15.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.334 1.067 . . . . 5.2000000000000002 110.782 -176.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.1 131.22 45.28 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.019 -0.832 . . . . 2.2599999999999998 111.019 -176.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.03 -40.22 72.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 117.731 0.766 . . . . 2.52 111.514 179.145 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -50.72 109.29 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.87 1.268 . . . . 2.3799999999999999 109.46 164.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -61.87 -21.7 64.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.6 -0.688 . . . . 3.77 112.308 -170.215 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -41.13 -38.2 1.02 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.949 1.7 . . . . 4.3700000000000001 111.018 169.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.9 p -46.15 -67.12 0.31 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.264 1.026 . . . . 2.04 109.909 172.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.8 p -66.13 -46.84 76.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.045 0.938 . . . . 1.23 111.119 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -60.26 -38.95 85.07 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.182 0.993 . . . . 4.8200000000000003 111.633 -172.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.514 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.317 7.3 t -136.91 -55.25 0.72 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 1.8700000000000001 111.095 175.959 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.88 -25.21 0.21 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.059 0.845 . . . . 0.96999999999999997 112.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 47.79 55.53 8.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.208 1.403 . . . . 2.02 110.996 -170.238 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -78.1 -8.89 58.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.218 0.821 . . . . 1.1100000000000001 113.218 173.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.56 173.28 49.51 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.247 -1.541 . . . . 1.1599999999999999 109.247 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 m -56.36 155.13 7.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.797 1.639 . . . . 1.3600000000000001 113.344 -173.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.91 142.37 45.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.24 1.416 . . . . 3.04 110.34 177.254 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 mt -122.39 -74.83 0.6 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.897 -1.149 . . . . 0.54000000000000004 107.897 -174.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -106.6 144.32 33.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.063 -1.088 . . . . 0.78000000000000003 108.063 166.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 25.7 p -123.36 169.03 11.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.401 1.48 . . . . 2.1499999999999999 107.863 168.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.98 142.6 6.13 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 124.362 1.039 . . . . 0.75 111.234 166.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.76 133.57 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.996 0.918 . . . . 0.84999999999999998 108.692 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.466 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 8.0 tt -96.7 139.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.303 0.483 . . . . 1.0900000000000001 112.303 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 134.22 6.3 2.48 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.127 1.346 . . . . 1.0800000000000001 113.992 174.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -91.8 57.26 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.328 1.564 . . . . 1.0800000000000001 110.691 -159.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.15 176.02 13.22 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.567 0.747 . . . . 1.6799999999999999 110.552 169.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.409 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 17.6 tt0 . . . . . 0 C--O 1.251 1.168 0 N-CA-C 105.821 -1.918 . . . . 5.4900000000000002 105.821 167.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.429 ' N ' ' OXT' ' A' ' 153' ' ' GLN . . . . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 109.834 -0.432 . . . . 7.1500000000000004 109.834 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.5 p -71.3 79.29 0.73 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.292 0.637 . . . . 3.8599999999999999 109.366 177.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -140.79 146.55 37.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.994 0.918 . . . . 3.0 109.561 178.182 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.42 158.89 15.24 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.804 -0.813 . . . . 0.92000000000000004 108.804 163.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 t -124.79 150.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.36 -1.291 . . . . 0.81999999999999995 108.058 165.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.84 97.98 5.18 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.39 1.076 . . . . 0.54000000000000004 108.624 158.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.58 114.84 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.511 -1.292 . . . . 0.65000000000000002 107.511 165.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.8 mt -96.66 137.0 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.685 0.794 . . . . 1.0700000000000001 109.91 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -150.0 -52.68 0.15 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.84 0.856 . . . . 3.2999999999999998 109.358 169.345 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.59 -124.99 28.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.979 -1.01 . . . . 0.96999999999999997 111.622 -175.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.05 -48.2 2.84 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.339 1.055 . . . . 3.6499999999999999 109.365 -162.311 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.83 166.06 23.9 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.99 -0.844 . . . . 0.80000000000000004 110.99 174.478 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.11 36.78 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.822 3.015 . . . . 0.97999999999999998 112.785 -173.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 57.2 t -94.51 159.38 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.693 1.597 . . . . 0.78000000000000003 108.98 -176.46 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 132.19 9.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.082 -1.451 . . . . 2.9300000000000002 107.082 176.242 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.47 179.36 44.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.623 -0.799 . . . . 0.77000000000000002 111.575 178.571 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.77 119.54 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.212 -1.403 . . . . 1.0 107.212 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -79.07 146.44 7.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.389 -1.337 . . . . 0.77000000000000002 107.389 163.639 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -120.24 137.1 54.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.094 -1.817 . . . . 2.2000000000000002 106.094 163.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -122.93 112.82 18.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.966 1.706 . . . . 2.2799999999999998 107.452 177.277 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.55 135.27 54.06 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.67 1.188 . . . . 4.0999999999999996 108.832 177.092 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.495 ' HB3' HD21 ' A' ' 106' ' ' LEU . 5.6 tp-100 -151.45 152.63 33.3 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.541 1.537 . . . . 3.7200000000000002 108.753 170.736 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -120.31 -46.56 2.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.472 2.709 . . . . 6.1699999999999999 107.556 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.77 96.41 6.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.496 -1.298 . . . . 5.0300000000000002 107.496 173.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -21.13 -66.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.446 2.298 . . . . 2.8300000000000001 114.748 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -114.51 54.55 0.77 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.849 0.859 . . . . 3.9900000000000002 110.153 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.54 -179.71 18.73 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.328 1.442 . . . . 0.93000000000000005 110.407 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.96 115.45 3.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.536 2.824 . . . . 1.04 111.086 -178.1 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.401 HG11 ' CD2' ' A' ' 20' ' ' PHE . 48.0 t -78.73 153.24 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.02 0.528 . . . . 0.96999999999999997 109.626 -170.685 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -108.34 126.03 52.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.618 -0.882 . . . . 2.6099999999999999 108.618 174.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 ' CE1' ' A' ' 20' ' ' PHE . 48.0 t -125.63 140.84 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 125.489 1.516 . . . . 1.1200000000000001 107.593 -169.549 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -155.17 164.54 38.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.689 -0.486 . . . . 0.98999999999999999 109.689 167.196 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.19 137.14 3.21 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.363 -0.446 . . . . 1.2 112.027 175.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 p -102.22 77.3 1.65 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.78 1.232 . . . . 1.8600000000000001 109.577 -172.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.13 142.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.028 -0.73 . . . . 1.54 109.028 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -137.6 157.16 47.1 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.243 0.617 . . . . 3.7999999999999998 110.256 -176.525 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.95 12.42 66.11 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.68000000000000005 112.709 -176.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.85 157.33 30.77 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.177 0.991 . . . . 0.96999999999999997 109.308 170.543 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -74.6 156.45 36.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.114 -1.069 . . . . 1.8700000000000001 108.114 154.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.89 171.79 0.32 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.124 0.97 . . . . 2.3100000000000001 111.839 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.45 -165.13 54.76 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.614 -0.721 . . . . 0.51000000000000001 113.031 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.95 147.92 44.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.7 0.8 . . . . 1.96 111.288 -173.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -145.31 123.54 12.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.504 1.522 . . . . 0.54000000000000004 109.429 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.37 149.18 18.95 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.812 -0.915 . . . . 0.44 110.812 170.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -138.66 95.64 3.01 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.089 -1.448 . . . . 2.9700000000000002 107.089 -174.547 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -133.87 160.34 37.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.754 -1.202 . . . . 0.88 107.754 -160.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.698 HG11 ' CZ ' ' A' ' 115' ' ' ARG . 33.8 m -119.42 128.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 122.307 1.051 . . . . 2.4500000000000002 109.933 175.327 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -104.61 142.64 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.656 -1.609 . . . . 0.88 106.656 -177.394 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 74.31 0.59 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.325 -1.731 . . . . 4.8799999999999999 106.325 170.368 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -141.62 39.31 1.69 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.871 -0.604 . . . . 3.6099999999999999 109.559 -165.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -58.74 78.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.212 1.005 . . . . 5.1600000000000001 112.736 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -146.08 140.95 27.12 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 127.147 2.179 . . . . 7.4400000000000004 106.076 169.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -141.58 60.63 1.48 Allowed 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 106.57 -1.641 . . . . 6.0099999999999998 106.57 152.268 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.257 8.7 t -142.08 -43.48 0.34 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.752 1.221 . . . . 5.25 110.749 176.681 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.95 -47.36 85.23 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.659 -0.867 . . . . 6.0199999999999996 108.659 154.542 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.71 -70.6 0.39 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.648 1.594 . . . . 3.6400000000000001 109.511 172.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.4 t -179.08 176.3 0.89 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 129.231 3.012 . . . . 2.21 104.839 -179.113 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m 71.55 73.62 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.167 1.349 . . . . 6.2699999999999996 110.079 167.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.0 t 177.85 33.99 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.233 1.016 . . . . 2.48 110.013 -137.385 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 179.09 -148.04 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 128.666 2.786 . . . . 2.4199999999999999 104.87 -172.029 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.45 -115.37 1.11 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.72 -1.6 . . . . 1.0700000000000001 110.666 178.41 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 -179.22 5.03 Favored 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.808 4.339 . . . . 1.0900000000000001 113.933 -173.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -53.39 134.3 40.11 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.038 -0.983 . . . . 1.6899999999999999 111.111 176.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -50.54 117.9 2.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 123.74 0.65 . . . . 1.8700000000000001 109.567 172.179 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.8 156.54 30.74 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 106.757 -1.571 . . . . 2.79 106.757 169.632 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.14 -38.65 2.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.176 1.917 . . . . 1.4199999999999999 111.55 -165.459 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 mt -144.52 -74.54 0.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.858 0.863 . . . . 2.4100000000000001 109.347 176.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.3 m -142.51 64.85 1.36 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.47 0.708 . . . . 1.8100000000000001 111.062 -165.228 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.3 170.68 16.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.377 0.608 . . . . 4.9900000000000002 109.555 163.59 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.421 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 51.9 mttt -111.9 162.34 15.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.67 -1.974 . . . . 3.71 105.67 172.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -77.33 168.67 19.64 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.979 0.419 . . . . 1.1699999999999999 110.325 169.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.93 161.08 34.75 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 105.802 -2.919 . . . . 2.0299999999999998 105.802 156.187 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.86 -172.54 7.83 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 117.17 0.485 . . . . 1.8899999999999999 112.509 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 -18.77 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.133 2.555 . . . . 1.8700000000000001 111.376 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.2 -26.76 18.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.312 1.045 . . . . 5.9699999999999998 111.584 173.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.53 159.89 23.54 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.061 0.458 . . . . 2.0099999999999998 109.914 175.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -74.13 -51.43 15.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.387 1.475 . . . . 4.8700000000000001 108.03 170.07 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 34.9 mt-10 -80.25 168.3 19.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.87 0.843 . . . . 3.54 110.98 -175.007 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.28 150.2 0.07 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.936 2.095 . . . . 4.4900000000000002 106.53 -167.189 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 71.4 m80 -65.58 155.8 34.66 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.278 -2.119 . . . . 0.84999999999999998 105.278 162.335 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.61 48.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 123.355 1.55 . . . . 2.1099999999999999 109.618 170.637 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.73 34.97 0.06 OUTLIER Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.953 2.216 . . . . 0.85999999999999999 111.512 -175.31 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.42 136.41 37.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.333 -1.358 . . . . 2.6299999999999999 107.333 157.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.36 -54.72 4.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.649 -1.612 . . . . 1.52 106.649 168.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.97 -114.92 0.63 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.514 -1.434 . . . . 0.64000000000000001 109.514 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -140.75 162.03 36.37 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.942 1.697 . . . . 1.8500000000000001 109.329 -177.566 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.11 175.65 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.354 1.462 . . . . 0.83999999999999997 107.162 175.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.8 m -129.6 134.29 47.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.365 -0.976 . . . . 2.02 108.365 -178.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.61 137.28 34.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.35 1.06 . . . . 0.53000000000000003 109.731 169.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -87.83 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.857 2.463 . . . . 3.9100000000000001 110.736 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -173.34 -46.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.794 1.238 . . . . 6.1799999999999997 108.745 -156.997 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.403 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 2.3 m-20 -79.16 11.35 2.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.887 1.275 . . . . 4.46 110.407 172.522 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.25 64.39 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 110.789 -0.925 . . . . 1.05 110.789 -178.821 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.37 128.31 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 0.72999999999999998 108.464 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.2 114.93 22.66 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.595 -1.631 . . . . 1.3400000000000001 106.595 168.334 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -113.44 93.99 4.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.859 -1.534 . . . . 5.3399999999999999 106.859 -169.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.77 149.34 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.147 -0.933 . . . . 1.9099999999999999 110.359 -162.19 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.8 m -151.12 126.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.383 1.473 . . . . 1.28 107.413 168.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mt -143.22 155.13 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.306 1.043 . . . . 2.27 108.306 -174.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.3 101.06 3.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.573 0.225 . . . . 2.3500000000000001 110.811 157.198 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -89.25 159.71 17.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.941 0.896 . . . . 2.25 108.823 173.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 p -107.65 -15.76 14.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.303 1.841 . . . . 1.51 112.283 -175.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.81 -41.09 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.513 0.597 . . . . 1.05 109.894 -171.577 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.3 pp -98.19 170.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.312 0.645 . . . . 1.0 111.72 -173.521 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.6 m -151.34 174.61 13.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.706 1.202 . . . . 1.6000000000000001 110.265 -176.401 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 22' ' ' GLN . 1.9 pt? -126.49 29.9 5.66 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.957 0.903 . . . . 2.1600000000000001 112.243 170.046 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 t -81.16 -149.49 0.07 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.634 -0.876 . . . . 3.0299999999999998 108.634 165.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -127.61 69.67 0.52 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.955 1.264 . . . . 4.1299999999999999 109.969 175.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -159.89 -109.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.357 1.063 . . . . 5.6799999999999997 108.318 -175.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -77.44 3.14 14.07 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.22 1.408 . . . . 4.04 110.787 173.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p -59.25 162.61 4.44 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 122.835 1.302 . . . . 1.97 112.88 177.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.23 -4.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.231 -1.804 . . . . 2.25 111.466 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -38.32 129.87 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.453 1.101 . . . . 2.4199999999999999 110.211 170.718 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.7 23.72 74.32 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 118.095 0.407 . . . . 1.52 114.042 -174.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.698 ' CZ ' HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.69 176.99 8.99 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.249 1.525 . . . . 8.5999999999999996 108.517 159.744 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -109.31 120.88 43.84 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.072 -0.714 . . . . 0.90000000000000002 109.072 153.215 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.61 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.6 tm? -73.02 142.39 47.69 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 106.029 -1.841 . . . . 3.2799999999999998 106.029 168.181 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.6 134.17 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.354 1.862 . . . . 0.56000000000000005 106.94 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.62 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 1.5 p -109.19 133.82 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.309 -1.367 . . . . 2.0899999999999999 107.309 164.314 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -109.14 161.62 15.03 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 115.992 1.849 . . . . 0.42999999999999999 115.992 -161.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -34.47 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.896 2.878 . . . . 3.29 112.813 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -80.57 174.99 11.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.611 1.164 . . . . 5.2400000000000002 110.482 -170.187 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.97 142.88 49.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.631 -1.622 . . . . 0.82999999999999996 108.234 150.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.04 152.15 20.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.317 0.647 . . . . 2.8199999999999998 109.296 170.155 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.83 -4.86 53.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.488 0.586 . . . . 3.6600000000000001 112.506 -179.449 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 59.82 28.93 18.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.168 1.387 . . . . 1.8400000000000001 109.607 -177.619 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.46 25.78 68.96 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.695 0.664 . . . . 2.0499999999999998 111.598 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -145.5 45.14 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.718 0.759 . . . . 5.25 109.365 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.93 159.97 27.03 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.152 -1.179 . . . . 2.6299999999999999 110.152 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.35 61.43 3.13 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.353 -1.499 . . . . 3.54 109.353 171.632 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -177.36 164.77 2.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.487 1.515 . . . . 2.9700000000000002 107.678 -167.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -83.15 -38.39 22.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.775 0.83 . . . . 3.9399999999999999 109.389 173.201 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -42.18 -39.05 1.9 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.413 1.485 . . . . 2.77 112.774 -176.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.8 p -57.22 -61.85 2.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.707 1.203 . . . . 1.8400000000000001 111.25 178.413 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.4 p -67.68 -42.59 81.86 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.478 -0.764 . . . . 1.3500000000000001 110.187 178.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -57.35 -44.08 84.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.972 1.709 . . . . 3.0299999999999998 111.841 -177.012 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.516 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.424 8.9 t -138.23 -56.85 0.65 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 2.1400000000000001 111.839 177.918 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.19 -22.44 0.2 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 119.415 1.007 . . . . 0.87 112.231 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 45.79 55.6 6.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.064 1.746 . . . . 2.0600000000000001 111.258 -177.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.61 58.2 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 118.953 -1.099 . . . . 1.01 111.934 167.21 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.36 -161.01 33.71 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 109.063 -1.615 . . . . 0.96999999999999997 109.063 179.283 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.5 p -59.89 151.49 25.71 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.942 1.297 . . . . 1.98 112.752 -169.104 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.4 mmt-85 -68.01 130.67 43.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.864 2.066 . . . . 3.3900000000000001 108.177 176.006 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.94 -83.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.552 1.069 . . . . 0.68000000000000005 108.663 174.007 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.669 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -97.98 146.29 25.64 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.296 -1.372 . . . . 0.98999999999999999 107.296 176.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.8 m -147.43 160.56 42.43 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 124.663 1.227 . . . . 2.2200000000000002 107.991 178.771 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.03 142.18 7.06 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.752 -0.939 . . . . 0.81999999999999995 110.752 172.638 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.31 139.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.152 1.381 . . . . 0.69999999999999996 108.999 172.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.2 tt -105.65 132.49 52.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.193 0.812 . . . . 1.1399999999999999 113.193 -178.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.76 13.1 0.15 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.482 1.515 . . . . 0.68000000000000005 113.99 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.2 mm -107.72 58.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.836 1.818 . . . . 0.82999999999999996 110.081 -152.237 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 175.35 14.1 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.745 -0.661 . . . . 1.26 110.255 171.057 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.429 ' OXT' ' N ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.259 1.586 0 C-N-CA 125.09 1.356 . . . . 5.21 108.691 177.052 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.275 0.102 . . . . 6.5499999999999998 111.275 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m -159.58 105.47 1.64 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.291 -1.744 . . . . 3.25 106.291 173.535 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -77.8 143.57 37.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.898 -0.408 . . . . 3.0800000000000001 109.898 -171.017 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.32 137.63 51.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.778 -0.823 . . . . 0.79000000000000004 108.778 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -96.94 144.25 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.32 -0.993 . . . . 0.73999999999999999 108.32 167.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.08 111.57 15.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.929 -1.508 . . . . 0.67000000000000004 106.929 148.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.34 108.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.972 -1.492 . . . . 0.78000000000000003 106.972 156.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.9 125.18 31.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.765 -1.198 . . . . 1.9299999999999999 107.765 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -153.97 -45.31 0.09 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.063 0.545 . . . . 3.6000000000000001 111.561 170.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.35 -109.25 0.39 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.237 0.922 . . . . 1.1599999999999999 113.04 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.1 -55.24 2.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.817 1.247 . . . . 3.3300000000000001 110.245 -172.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 164.48 11.4 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.459 1.028 . . . . 0.93999999999999995 112.339 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.83 -19.54 58.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.567 2.845 . . . . 1.4299999999999999 112.476 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.57 143.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.945 1.298 . . . . 0.89000000000000001 110.634 175.06 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -155.39 128.4 8.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.467 -0.568 . . . . 1.97 109.467 -176.577 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.11 177.28 39.91 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.17 -0.331 . . . . 0.53000000000000003 112.354 -177.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.09 133.91 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.882 -1.155 . . . . 1.1699999999999999 107.882 172.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.426 HD13 ' HA3' ' A' ' 33' ' ' GLY . 21.1 mm -102.79 136.33 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.92 1.688 . . . . 1.1599999999999999 106.866 164.076 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.26 112.17 22.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.35 1.46 . . . . 1.74 108.22 163.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -77.57 140.72 39.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.469 1.508 . . . . 2.8199999999999998 108.698 164.739 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -149.13 168.29 23.62 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.464 -1.68 . . . . 4.5700000000000003 106.464 148.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -151.29 159.32 44.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.739 -1.948 . . . . 3.8799999999999999 105.739 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -64.08 -73.78 0.11 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.998 -1.112 . . . . 6.2599999999999998 107.998 166.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -79.85 -165.66 0.86 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.046 2.538 . . . . 4.8799999999999999 111.138 -169.559 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -106.61 3.82 27.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.112 1.765 . . . . 2.4500000000000002 110.59 162.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -160.73 78.46 0.62 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.267 2.227 . . . . 3.8999999999999999 108.681 -170.128 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.68 -170.4 41.16 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 110.258 -1.137 . . . . 1.6599999999999999 110.258 -170.06 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.79 120.74 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.157 2.571 . . . . 1.0700000000000001 114.108 -167.301 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.8 t -79.14 147.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.499 -0.773 . . . . 1.3200000000000001 109.335 175.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 100' ' ' GLU . 65.9 mttm -116.51 110.54 18.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.836 -1.172 . . . . 2.9500000000000002 107.836 159.795 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 m -95.27 132.22 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.234 -1.395 . . . . 2.25 107.234 169.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -126.83 145.09 50.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.116 -1.438 . . . . 0.92000000000000004 107.116 168.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.09 156.87 29.02 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.36 -0.924 . . . . 0.65000000000000002 112.165 -173.597 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 m -131.71 83.49 2.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.706 1.602 . . . . 1.75 107.389 -162.542 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.19 139.09 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.2 1.0 . . . . 0.88 109.13 -168.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 166.67 22.8 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.4 0.619 . . . . 3.8599999999999999 112.26 176.502 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.13 15.52 69.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.761 1.172 . . . . 0.64000000000000001 113.492 174.423 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.41 165.03 21.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.603 1.201 . . . . 0.67000000000000004 108.837 172.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -72.58 166.39 22.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.596 -1.261 . . . . 1.72 107.596 150.557 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.9 175.45 0.5 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.167 0.987 . . . . 3.3300000000000001 110.696 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.65 -156.04 51.61 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.865 -0.607 . . . . 0.5 111.643 169.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.56 145.18 33.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.793 1.637 . . . . 1.9399999999999999 112.48 -171.291 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -147.73 113.18 5.62 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.032 1.333 . . . . 0.56999999999999995 110.434 -179.083 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.0 146.26 2.91 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.493 1.044 . . . . 0.57999999999999996 111.316 173.053 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.76 96.74 3.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.909 -1.886 . . . . 2.2000000000000002 105.909 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.1 m80 -133.43 171.94 13.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.322 -1.362 . . . . 0.85999999999999999 107.322 -164.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 0.3 OUTLIER -130.54 133.44 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 122.147 0.975 . . . . 1.8200000000000001 109.938 173.163 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.406 ' CD2' HG21 ' A' ' 118' ' ' VAL . 44.0 m-70 -109.79 145.64 36.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.051 2.141 . . . . 0.98999999999999999 106.876 -175.528 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -72.31 31.52 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.981 1.474 . . . . 4.5700000000000003 114.981 -168.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.97 62.21 7.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.075 -1.083 . . . . 3.0800000000000001 108.075 -170.487 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -58.88 -26.96 64.75 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.736 0.643 . . . . 4.4900000000000002 112.736 -171.069 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -129.46 149.31 51.29 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 105.387 -2.079 . . . . 4.75 105.387 151.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -163.32 42.66 0.11 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 128.158 2.583 . . . . 4.5099999999999998 110.191 170.533 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.6 t -65.96 57.45 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.005 1.722 . . . . 4.1699999999999999 113.875 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -170.46 -44.15 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.37 1.868 . . . . 5.6799999999999997 109.238 -173.445 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.73 146.5 6.35 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.042 -1.623 . . . . 3.8100000000000001 109.042 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.7 t -75.74 54.9 0.83 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.579 1.552 . . . . 2.9199999999999999 111.98 -170.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.8 p -149.38 80.38 1.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.302 -0.629 . . . . 4.1399999999999997 109.302 -158.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.7 m -170.8 -43.3 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.248 1.203 . . . . 2.6499999999999999 114.248 -144.355 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.87 170.5 7.9 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.53 -1.285 . . . . 1.77 107.53 151.736 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.04 -92.43 2.03 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.636 -1.386 . . . . 0.98999999999999999 109.636 -178.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.08 -178.84 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 126.337 4.692 . . . . 1.02 113.21 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -52.52 128.47 26.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.031 1.332 . . . . 1.4199999999999999 109.627 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -45.46 120.24 2.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.753 1.221 . . . . 1.9099999999999999 111.273 175.154 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -118.46 163.12 26.95 Favored Pre-proline 0 C--O 1.227 -0.1 0 C-N-CA 127.314 2.246 . . . . 3.6499999999999999 109.747 164.848 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.45 -53.01 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.194 1.263 . . . . 1.6699999999999999 108.85 154.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.66 -77.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.281 1.032 . . . . 3.2200000000000002 109.998 169.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -135.5 71.03 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.306 1.042 . . . . 2.3100000000000001 110.459 -165.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -79.38 172.21 14.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.715 -1.216 . . . . 4.9800000000000004 107.715 156.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -129.11 162.89 26.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 127.019 2.128 . . . . 3.0 105.946 177.882 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -76.6 162.91 27.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.693 0.797 . . . . 1.1599999999999999 110.933 -169.452 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.14 -123.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 105.518 -3.033 . . . . 1.99 105.518 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.24 -140.48 3.06 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 107.957 -2.057 . . . . 1.8100000000000001 107.957 169.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.31 -47.78 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 120.091 1.946 . . . . 1.71 109.011 168.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -59.18 -42.15 90.17 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 126.133 1.773 . . . . 5.4299999999999997 112.987 -171.058 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.8 176.93 2.28 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.756 -1.566 . . . . 1.98 111.467 -168.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.07 -52.46 6.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.004 1.322 . . . . 5.1100000000000003 108.21 164.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 9.1 mt-10 -80.33 175.91 10.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.693 0.797 . . . . 2.75 111.424 -177.788 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 161.04 143.15 0.01 OUTLIER 'General case' 0 C--O 1.239 0.535 0 C-N-CA 129.958 3.303 . . . . 3.2200000000000002 106.498 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.2 m80 -60.06 153.26 22.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.335 -1.357 . . . . 0.69999999999999996 107.335 166.154 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.0 -37.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 117.796 -1.562 . . . . 1.3200000000000001 109.991 -169.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.82 73.11 0.87 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.229 -0.748 . . . . 0.90000000000000002 111.229 167.576 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -168.14 103.37 0.46 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.786 -0.82 . . . . 2.0899999999999999 108.786 -175.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.86 -51.39 8.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.195 0.598 . . . . 1.6699999999999999 109.541 176.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.83 -119.86 0.94 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.404 -1.478 . . . . 0.60999999999999999 109.404 -177.557 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -137.91 166.5 23.89 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 124.407 1.083 . . . . 1.5700000000000001 110.291 174.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.12 177.14 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.462 -1.681 . . . . 0.45000000000000001 106.462 166.393 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -122.51 155.26 36.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.695 -0.854 . . . . 2.0899999999999999 108.695 164.183 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.86 141.76 48.35 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.45 1.1 . . . . 0.80000000000000004 110.352 164.266 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.83 -75.28 0.12 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.1 0.96 . . . . 2.9399999999999999 111.389 -171.825 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -153.94 -44.26 0.09 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.321 1.048 . . . . 3.7200000000000002 110.973 -169.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.84 7.77 6.56 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.297 1.046 . . . . 2.6000000000000001 111.39 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.71 8.12 84.05 Favored Glycine 0 CA--C 1.524 0.636 0 O-C-N 121.266 -0.896 . . . . 0.68000000000000005 111.75 -175.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.54 128.61 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.218 1.407 . . . . 0.76000000000000001 107.713 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.89 175.24 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.213 1.405 . . . . 0.97999999999999998 109.169 173.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -121.88 145.28 48.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.964 -2.606 . . . . 3.3599999999999999 103.964 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.21 58.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.331 -0.548 . . . . 1.48 111.391 167.569 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.4 m -90.08 88.03 7.12 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.607 1.163 . . . . 0.84999999999999998 109.098 172.297 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.1 mm -125.67 156.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.942 -0.762 . . . . 2.1200000000000001 108.942 -177.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 30' ' ' LYS . 8.0 pt-20 -140.12 142.15 36.06 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.658 0.383 . . . . 2.6499999999999999 110.616 164.699 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.23 148.52 44.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.475 1.51 . . . . 2.2799999999999998 109.259 176.018 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.5 p -102.74 -4.26 25.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.789 2.036 . . . . 1.4299999999999999 113.249 -173.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.97 -45.77 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.658 1.183 . . . . 1.0800000000000001 108.807 -178.06 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -76.49 176.14 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.473 0.654 . . . . 1.3600000000000001 110.969 176.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -165.7 176.58 7.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.592 1.957 . . . . 1.9399999999999999 107.208 177.108 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -6.3 57.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.963 . . . . 3.3900000000000001 112.928 175.926 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m -154.63 161.01 41.78 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.157 2.183 . . . . 3.5899999999999999 108.498 -172.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.09 -159.13 14.08 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.673 1.13 . . . . 3.3900000000000001 111.117 178.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.44 -52.62 6.7 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.297 1.439 . . . . 4.8600000000000003 108.347 -179.147 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -80.68 -10.24 59.74 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.132 1.373 . . . . 3.9500000000000002 112.563 -170.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.1 p -60.22 154.91 18.69 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.837 0.855 . . . . 1.6899999999999999 112.055 -178.537 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.277 1.8 pp -111.8 -6.2 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.144 -0.934 . . . . 1.6699999999999999 111.833 -177.362 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.86 133.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 162.255 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.06 47.44 81.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.58 -1.008 . . . . 2.25 110.58 -173.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -142.42 168.92 18.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.906 -1.887 . . . . 4.6799999999999997 105.906 165.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 m -101.02 115.42 30.44 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.579 -0.526 . . . . 1.04 109.579 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.8 148.73 51.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.845 -0.798 . . . . 1.97 108.845 165.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 48' ' ' HIS . 92.1 t -134.01 137.9 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.94 2.096 . . . . 0.59999999999999998 106.588 175.013 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 m -113.0 129.52 68.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.74 -1.207 . . . . 1.79 107.74 169.557 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.476 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 45.3 m-70 -107.29 159.94 15.99 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 117.361 2.356 . . . . 0.65000000000000002 117.361 -163.11 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -32.02 -76.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.55 3.14 . . . . 3.5699999999999998 112.908 168.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.69 -174.36 2.44 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.913 0.885 . . . . 2.75 110.491 -171.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.58 148.79 18.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.987 -0.745 . . . . 0.55000000000000004 108.987 157.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.04 168.65 18.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.738 -0.838 . . . . 2.1899999999999999 108.738 154.4 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.46 -38.81 48.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.066 0.765 . . . . 4.2800000000000002 113.066 -168.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 82.2 46.05 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.835 2.854 . . . . 1.55 110.691 -169.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.94 43.53 98.76 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.472 1.034 . . . . 1.8600000000000001 112.051 165.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -155.11 -16.37 0.11 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.806 1.409 . . . . 5.1900000000000004 114.806 -170.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.3 146.18 47.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 120.496 1.498 . . . . 1.99 110.928 -178.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.54 -24.3 69.34 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.791 0.71 . . . . 2.6499999999999999 114.202 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 159.85 14.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.227 -1.027 . . . . 2.52 108.227 174.499 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -46.82 76.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 3.8900000000000001 107.646 167.677 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -40.39 -48.49 2.73 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.374 2.67 . . . . 4.0499999999999998 111.64 -175.231 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -63.38 0.83 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.535 1.534 . . . . 1.9199999999999999 110.702 176.093 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -71.62 -41.99 68.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.052 -1.03 . . . . 1.1899999999999999 111.597 177.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.57 -37.26 84.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.334 1.454 . . . . 3.6299999999999999 110.924 -166.318 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.431 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.257 0.7 OUTLIER -133.3 -51.97 0.88 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.232 1.013 . . . . 1.29 111.545 173.218 . . . . . . . . 4 4 . 1 . 027 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.05 -22.49 0.52 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.715 0.689 . . . . 0.93000000000000005 114.287 -177.779 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 44.71 54.42 6.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.302 1.441 . . . . 2.2999999999999998 111.561 -163.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.598 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -59.12 -39.38 82.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.568 1.147 . . . . 1.1699999999999999 111.217 166.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.89 -171.33 44.7 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 108.682 -1.767 . . . . 0.98999999999999999 108.682 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.7 m -59.17 153.07 19.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 126.028 1.731 . . . . 1.1899999999999999 114.091 -166.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -59.55 137.22 58.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.21 1.804 . . . . 2.54 108.83 168.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.9 mt -114.84 -85.26 0.61 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.775 -1.195 . . . . 0.53000000000000003 107.775 169.536 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.16 154.77 18.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.522 -0.918 . . . . 0.89000000000000001 108.522 172.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.2 m -146.22 165.11 30.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.603 -1.18 . . . . 1.96 108.408 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.39 134.46 3.09 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.498 -1.041 . . . . 0.65000000000000002 110.498 173.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.97 130.85 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.575 -1.269 . . . . 0.70999999999999996 107.575 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.2 tt -102.22 129.87 52.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.244 0.545 . . . . 0.97999999999999998 111.897 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.59 3.99 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.603 1.097 . . . . 0.56000000000000005 115.429 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -98.28 56.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 119.989 1.894 . . . . 0.90000000000000002 109.917 -156.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.24 173.57 16.76 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.27 0.628 . . . . 1.5900000000000001 110.305 169.085 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 C--O 1.255 1.378 0 N-CA-C 102.5 -3.148 . . . . 4.8200000000000003 102.5 159.919 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 108.199 -1.038 . . . . 4.7599999999999998 108.199 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 p -64.63 82.35 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.836 1.254 . . . . 2.9300000000000002 109.1 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 140.76 40.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.297 -0.631 . . . . 3.9300000000000002 109.297 179.784 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.85 18.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.875 -0.787 . . . . 1.01 108.875 168.051 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.575 HG23 ' HB2' ' A' ' 152' ' ' ALA . 60.4 t -106.71 152.61 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 105.585 -2.005 . . . . 0.93000000000000005 105.585 158.326 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.61 93.52 3.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.516 -0.92 . . . . 0.66000000000000003 108.516 158.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.66 107.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.926 -1.509 . . . . 0.73999999999999999 106.926 169.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.563 ' CD1' HD12 ' A' ' 117' ' ' LEU . 25.0 mt -92.46 128.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.368 0.667 . . . . 1.0 109.712 178.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 -48.21 0.15 Allowed 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.155 1.382 . . . . 4.6699999999999999 109.863 172.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.55 -120.47 2.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.084 1.326 . . . . 1.1399999999999999 112.808 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -97.07 -59.0 1.88 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.647 -1.242 . . . . 3.9500000000000002 107.647 -169.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.98 176.65 2.41 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.66 2.076 . . . . 1.27 115.15 -173.206 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.81 -25.95 16.35 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.742 2.961 . . . . 1.6100000000000001 111.817 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.81 141.99 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.719 1.208 . . . . 1.25 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -153.71 121.99 6.17 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.319 -0.993 . . . . 1.96 108.319 -171.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.58 172.06 37.69 Favored Glycine 0 C--N 1.333 0.372 0 O-C-N 121.832 -0.542 . . . . 0.56999999999999995 112.514 -174.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.38 125.1 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.946 -0.761 . . . . 1.29 108.946 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 17.9 mm -88.71 139.65 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 107.029 -1.471 . . . . 0.75 107.029 160.838 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -129.61 108.07 9.93 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.903 -1.517 . . . . 2.8399999999999999 106.903 171.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.521 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 35.9 t80 -130.67 120.8 24.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.879 -1.156 . . . . 3.4500000000000002 107.879 -155.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.15 159.93 41.18 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.785 0.721 . . . . 3.5600000000000001 111.35 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -145.61 141.76 28.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.018 -2.586 . . . . 3.8900000000000001 104.018 -175.374 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -107.35 -29.84 9.04 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.25 1.02 . . . . 6.0599999999999996 109.444 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -77.99 164.76 24.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 128.72 2.808 . . . . 4.8200000000000003 109.433 -178.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -77.97 -67.79 0.69 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.158 0.983 . . . . 4.54 109.176 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -111.88 85.47 2.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.346 -1.724 . . . . 3.7400000000000002 106.346 170.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.17 174.47 32.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.388 -1.485 . . . . 1.3600000000000001 109.388 178.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 140.97 47.83 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.191 2.594 . . . . 1.3500000000000001 111.647 -167.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 4.3 t -91.2 140.46 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.22 -0.659 . . . . 1.1699999999999999 109.22 -179.079 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -95.12 105.59 17.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.54 -1.652 . . . . 5.0099999999999998 106.54 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.5 85.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.378 1.471 . . . . 1.25 108.689 -169.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -99.24 145.16 27.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.206 -0.665 . . . . 0.90000000000000002 109.206 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.73 149.82 18.15 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.172 -1.171 . . . . 0.79000000000000004 110.172 -177.635 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 p -130.15 105.23 7.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.677 -1.972 . . . . 1.8999999999999999 105.677 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.68 143.75 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 106.888 -1.523 . . . . 0.90000000000000002 106.888 -169.242 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -143.7 -178.73 6.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.944 1.461 . . . . 4.79 114.944 167.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.91 76.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 113.94 -1.482 . . . . 0.69999999999999996 112.322 -179.313 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -72.61 163.14 28.54 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.264 1.032 . . . . 0.69999999999999996 108.31 172.248 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.86 163.66 25.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.701 -1.222 . . . . 1.8400000000000001 107.701 153.789 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.91 171.09 0.54 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.702 0.763 . . . . 2.5699999999999998 111.227 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.92 -158.61 53.43 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.747 -0.661 . . . . 0.48999999999999999 113.038 166.071 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.23 143.86 46.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.232 0.613 . . . . 2.0699999999999998 111.396 -171.228 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -139.42 127.0 21.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.392 1.477 . . . . 0.58999999999999997 108.697 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.51 152.04 7.51 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.344 -1.102 . . . . 0.48999999999999999 110.344 171.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -144.0 90.88 2.16 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.067 -1.457 . . . . 2.8500000000000001 107.067 -173.41 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -137.28 143.77 42.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.674 -1.232 . . . . 0.92000000000000004 107.674 -162.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.2 m -98.93 129.15 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.49 1.041 . . . . 2.1000000000000001 110.39 178.334 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -109.8 155.22 21.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.375 1.07 . . . . 1.02 108.712 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 11.77 0.39 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.795 1.638 . . . . 5.2699999999999996 113.655 -167.547 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HG2' ' HB3' ' A' ' 60' ' ' ALA . 1.2 mt-10 -77.14 66.13 2.88 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.417 1.008 . . . . 3.3399999999999999 109.855 -173.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -61.12 -52.99 62.54 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.882 -0.785 . . . . 4.7300000000000004 108.882 176.107 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -76.17 126.16 30.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.101 -1.074 . . . . 5.5800000000000001 108.101 166.741 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -145.05 42.77 1.31 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.406 1.883 . . . . 4.7800000000000002 107.278 168.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.7 m -63.11 -50.11 71.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.197 0.599 . . . . 4.0199999999999996 110.755 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -111.73 110.07 20.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.71 0.804 . . . . 5.9100000000000001 109.617 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.04 -166.41 1.39 Allowed Glycine 0 CA--C 1.532 1.151 0 CA-C-N 114.461 -1.245 . . . . 4.25 111.636 -172.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.23 -164.05 1.59 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.178 -0.675 . . . . 2.71 109.178 170.628 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.4 m 70.67 81.1 0.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.205 -1.035 . . . . 6.2800000000000002 108.205 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.7 m -177.29 30.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.232 0.826 . . . . 3.4500000000000002 113.232 -134.625 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . . . -167.39 -172.55 1.99 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.696 1.598 . . . . 1.7 107.476 166.74 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.2 -127.75 3.88 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 119.244 0.929 . . . . 1.55 112.048 -171.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.35 -179.7 5.43 Favored 'Trans proline' 0 N--CA 1.457 -0.667 1 C-N-CA 125.378 4.052 . . . . 1.3100000000000001 111.597 -176.768 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -44.8 125.92 5.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 118.856 -0.592 . . . . 1.27 109.946 171.335 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -46.62 119.58 2.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.71 0.631 . . . . 2.6899999999999999 109.939 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -156.37 157.04 30.91 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 126.544 1.938 . . . . 2.6499999999999999 106.888 174.635 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.26 -27.42 13.57 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.148 1.898 . . . . 1.49 113.502 -170.049 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.21 -63.93 0.11 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.133 0.879 . . . . 3.8399999999999999 111.569 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.5 m -158.87 81.45 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.468 1.107 . . . . 2.4300000000000002 109.287 171.836 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -74.73 167.65 21.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.26 -1.755 . . . . 4.9699999999999998 106.26 157.198 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -119.3 166.08 13.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.952 -1.499 . . . . 4.6299999999999999 106.952 -176.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -93.95 149.98 20.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 111.81 0.3 . . . . 1.0900000000000001 111.81 -175.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.37 176.74 39.51 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.31 -3.116 . . . . 1.8300000000000001 105.31 158.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.42 -172.32 47.78 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 117.856 0.828 . . . . 1.8999999999999999 111.268 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.89 -24.36 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.101 2.534 . . . . 1.78 110.624 172.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -65.84 -44.12 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.522 0.729 . . . . 5.5800000000000001 109.822 171.152 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.65 163.21 27.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.418 -0.81 . . . . 2.0299999999999998 109.716 175.53 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.06 -37.92 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.749 0.82 . . . . 5.5 108.925 163.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.18 152.15 41.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.543 -0.91 . . . . 3.02 108.543 -173.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 166.04 143.8 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.782 2.033 . . . . 3.29 111.129 -167.603 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.462 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -65.24 154.5 37.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.489 -0.93 . . . . 0.98999999999999999 108.489 166.762 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.43 -40.57 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.948 -0.76 . . . . 1.8500000000000001 108.948 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.42 62.14 1.75 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.627 0.632 . . . . 0.69999999999999996 111.849 173.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -165.67 97.93 0.67 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.398 -0.964 . . . . 2.1600000000000001 108.398 -172.581 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.38 -43.48 15.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.998 -0.547 . . . . 2.3199999999999998 109.634 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.2 -100.87 0.19 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.474 -0.87 . . . . 0.67000000000000004 112.864 177.37 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -155.53 166.33 33.87 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.747 1.619 . . . . 1.54 109.954 -169.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.49 155.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.713 1.205 . . . . 0.54000000000000004 108.34 173.44 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.9 p -107.26 109.16 20.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.772 1.629 . . . . 3.1499999999999999 108.83 -176.068 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.71 138.8 37.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.717 0.689 . . . . 0.54000000000000004 111.127 171.368 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.14 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.207 0.942 . . . . 2.6200000000000001 109.536 177.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.5 tttt -157.48 -30.23 0.08 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.827 1.417 . . . . 3.8900000000000001 114.827 -170.753 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -80.25 21.92 0.57 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.757 1.741 . . . . 2.8700000000000001 110.665 164.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 64.12 12.96 51.9 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 125.458 1.504 . . . . 0.83999999999999997 111.739 -175.089 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -78.65 133.05 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.796 -1.187 . . . . 0.72999999999999998 107.796 -176.28 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.54 155.23 46.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.447 1.499 . . . . 0.81999999999999995 107.157 168.026 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -120.44 143.23 48.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.718 -2.327 . . . . 2.7999999999999998 104.718 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.39 131.69 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.339 -1.356 . . . . 1.3200000000000001 107.339 165.263 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.5 m -148.32 73.47 1.25 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.046 1.338 . . . . 1.47 107.962 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -111.72 152.51 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.974 0.909 . . . . 2.3199999999999998 108.723 -175.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -132.39 88.23 2.51 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.635 -0.876 . . . . 4.1799999999999997 108.635 164.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.62 152.87 29.78 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.6 0.36 . . . . 2.5699999999999998 110.303 176.416 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -124.2 34.53 5.02 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.022 1.329 . . . . 1.6299999999999999 111.325 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.36 -52.0 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.434 1.093 . . . . 1.45 108.395 175.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -74.54 174.59 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.255 0.55 . . . . 1.1399999999999999 110.772 176.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -149.44 171.71 16.13 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.411 -1.329 . . . . 2.5800000000000001 107.411 170.766 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -101.8 5.44 41.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.525 0.73 . . . . 2.52 111.944 169.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 m -70.28 -160.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.124 1.77 . . . . 2.96 111.022 -177.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -113.23 74.67 0.23 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.397 -1.481 . . . . 3.8399999999999999 109.397 175.156 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -147.62 -126.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.619 -1.252 . . . . 5.1399999999999997 107.619 -176.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -79.33 4.0 16.53 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.037 1.335 . . . . 4.0899999999999999 111.371 171.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 p -46.48 151.86 0.51 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.71 2.004 . . . . 1.5900000000000001 111.931 175.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -6.4 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.212 1.005 . . . . 2.2200000000000002 111.024 -178.575 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.0 tp -19.99 117.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.718 2.007 . . . . 1.96 111.69 163.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.4 -32.34 7.64 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 119.519 -0.601 . . . . 2.4700000000000002 113.785 -177.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 177.36 8.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.752 1.776 . . . . 10.59 114.672 -153.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.489 HG23 ' HB2' ' A' ' 146' ' ' CYS . 0.9 OUTLIER -92.3 123.53 35.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.362 1.065 . . . . 1.54 111.277 169.483 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.563 HD12 ' CD1' ' A' ' 8' ' ' LEU . 3.2 tm? -80.25 132.11 35.79 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.513 -1.291 . . . . 3.8199999999999998 107.513 162.541 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.26 117.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 107.274 -1.38 . . . . 0.85999999999999999 107.274 170.252 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.07 114.98 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 104.685 -2.339 . . . . 1.8799999999999999 104.685 164.459 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -90.13 161.52 15.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 115.828 1.788 . . . . 0.64000000000000001 115.828 -164.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -40.81 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.244 2.618 . . . . 3.1800000000000002 112.532 169.486 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -89.2 -179.2 5.83 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.306 0.957 . . . . 3.3700000000000001 109.723 179.268 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 155.4 16.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.703 -0.851 . . . . 0.76000000000000001 108.703 157.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -74.66 165.9 24.46 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.233 -0.655 . . . . 2.4500000000000002 109.233 167.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -70.85 -19.5 62.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 117.829 -1.081 . . . . 3.4100000000000001 112.389 -175.73 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 59.16 39.63 22.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.664 1.12 . . . . 2.27 109.816 -160.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.18 42.66 82.69 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.025 0.821 . . . . 1.9399999999999999 111.533 172.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.94 -22.01 43.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.057 0.943 . . . . 7.4900000000000002 110.73 -171.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.3 -155.51 26.21 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.976 -0.85 . . . . 2.8799999999999999 110.976 177.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.41 -68.12 1.2 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.935 -1.666 . . . . 3.2599999999999998 108.935 -170.602 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.12 118.0 14.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.327 -1.731 . . . . 2.98 106.327 167.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -49.83 -45.33 50.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.306 1.412 . . . . 3.5299999999999998 109.602 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -35.74 -41.24 0.21 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.593 2.757 . . . . 3.1000000000000001 112.657 170.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -49.37 -65.19 0.61 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.684 1.594 . . . . 1.73 109.024 179.038 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 -41.95 69.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.36 1.064 . . . . 1.55 110.819 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -67.12 -32.31 73.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.989 0.516 . . . . 6.2300000000000004 111.556 -169.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.462 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.382 13.5 t -139.54 -58.57 0.58 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 118.132 -0.937 . . . . 2.0099999999999998 111.398 174.482 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.99 -21.26 0.2 Allowed Glycine 0 N--CA 1.463 0.436 0 CA-C-N 119.556 1.071 . . . . 0.96999999999999997 113.309 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 52.5 54.84 9.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.848 1.259 . . . . 1.8100000000000001 111.256 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.72 59.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.159 0.8 . . . . 1.1799999999999999 113.159 168.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 -159.35 34.22 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 108.526 -1.83 . . . . 0.93000000000000005 108.526 -177.316 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.4 m -62.54 151.67 36.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.959 -1.12 . . . . 1.26 113.639 -163.611 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -61.44 141.36 57.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.712 -1.585 . . . . 3.4300000000000002 108.896 166.152 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.8 mt -111.97 -82.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.728 -0.841 . . . . 0.69999999999999996 108.728 169.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.56 167.31 10.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.134 0.574 . . . . 0.88 110.411 177.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.489 ' HB2' HG23 ' A' ' 116' ' ' THR . 1.2 p -154.54 170.64 20.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.653 1.181 . . . . 2.5800000000000001 109.451 173.326 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.6 143.75 4.18 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 124.417 1.073 . . . . 0.77000000000000002 111.189 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.39 134.08 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.752 1.221 . . . . 1.8300000000000001 109.549 174.146 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 13.4 tt -89.55 126.97 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.326 -0.62 . . . . 0.93000000000000005 109.326 161.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.38 -4.32 0.49 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.785 -0.643 . . . . 0.82999999999999996 114.562 176.071 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.92 57.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 118.778 1.289 . . . . 1.1899999999999999 111.298 -157.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.575 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.98 168.91 26.08 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.739 0.816 . . . . 1.3700000000000001 110.578 160.709 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 101.658 -3.46 . . . . 6.3200000000000003 101.658 159.494 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.662 -0.125 . . . . 7.2300000000000004 110.662 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.96 156.19 17.18 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.114 -1.439 . . . . 3.9500000000000002 107.114 -177.512 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -93.73 165.38 12.73 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.505 -0.924 . . . . 2.8599999999999999 108.505 166.107 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.01 143.78 42.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.977 -1.49 . . . . 0.68999999999999995 106.977 159.871 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 152' ' ' ALA . 93.9 t -105.85 144.23 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.434 -1.691 . . . . 0.90000000000000002 106.434 165.153 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.51 97.09 5.04 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.702 -0.851 . . . . 0.48999999999999999 108.702 156.039 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.55 109.41 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.981 -1.489 . . . . 0.68000000000000005 106.981 164.099 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -93.73 122.5 36.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.564 -0.902 . . . . 0.84999999999999998 108.564 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -139.42 -53.25 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.651 -1.24 . . . . 4.3600000000000003 107.651 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.52 -113.12 2.46 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.193 0.901 . . . . 1.1899999999999999 110.88 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -109.68 -65.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.524 -1.288 . . . . 3.8100000000000001 107.524 -163.356 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.56 2.03 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 129.318 3.342 . . . . 1.23 115.068 -172.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.7 -26.16 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.797 2.998 . . . . 1.71 112.094 -176.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.18 143.67 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.753 1.221 . . . . 0.87 110.601 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -155.18 132.19 10.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.328 -0.99 . . . . 2.0099999999999998 108.328 -175.749 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.97 172.72 42.77 Favored Glycine 0 N--CA 1.451 -0.36 0 O-C-N 121.86 -0.525 . . . . 0.5 112.464 -175.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.11 129.78 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.54 -1.281 . . . . 1.1000000000000001 107.54 176.883 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mm -96.93 137.84 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.218 1.407 . . . . 0.70999999999999996 107.44 164.274 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -113.7 122.75 48.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.274 -1.38 . . . . 1.8799999999999999 107.274 160.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.468 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -105.1 130.6 53.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.407 1.883 . . . . 2.5099999999999998 106.222 172.814 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -135.75 148.21 48.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.986 0.812 . . . . 3.9500000000000002 109.906 168.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -155.3 133.63 11.72 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.255 -1.016 . . . . 3.25 108.255 166.207 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -44.17 71.7 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.572 -0.899 . . . . 4.3099999999999996 108.572 177.09 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -77.33 -177.16 4.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.438 1.495 . . . . 4.0899999999999999 109.597 -170.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.4 p -82.86 -67.92 0.75 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.502 1.521 . . . . 3.77 107.86 169.476 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -117.1 109.65 17.22 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.168 1.387 . . . . 3.9500000000000002 107.643 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.87 -155.01 7.01 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 108.511 -1.836 . . . . 1.6799999999999999 108.511 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.5 114.11 2.96 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.385 2.056 . . . . 2.0099999999999998 109.515 173.702 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.14 146.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.232 -0.655 . . . . 1.02 109.232 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -100.27 118.53 36.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.28 -1.748 . . . . 2.6499999999999999 106.28 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.468 HG22 ' CE1' ' A' ' 20' ' ' PHE . 34.0 t -117.1 122.19 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 107.794 -1.187 . . . . 1.1599999999999999 107.794 177.705 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -141.04 142.14 34.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.024 0.375 . . . . 0.85999999999999999 110.174 169.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.84 -178.22 38.01 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.535 -1.826 . . . . 0.92000000000000004 108.535 175.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.6 p -148.12 108.68 4.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.263 -2.125 . . . . 2.0499999999999998 105.263 169.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.28 126.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.128 -2.175 . . . . 1.1699999999999999 105.128 -176.653 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 157.84 24.03 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.486 0.66 . . . . 4.9500000000000002 111.45 -175.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 15.5 62.51 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 114.583 -1.19 . . . . 0.67000000000000004 114.079 176.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.98 159.08 23.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.293 1.547 . . . . 0.71999999999999997 109.57 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.18 166.61 13.71 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.288 -1.005 . . . . 1.6499999999999999 108.288 155.297 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -63.79 177.85 0.69 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.104 -0.998 . . . . 2.5 111.56 -175.041 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.78 -159.53 52.21 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.759 0.695 . . . . 0.53000000000000003 114.076 167.116 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.91 150.05 41.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.193 0.997 . . . . 2.0800000000000001 110.493 -177.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -143.58 116.92 9.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.336 1.054 . . . . 0.51000000000000001 110.086 178.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.13 141.71 19.92 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.538 -1.425 . . . . 0.45000000000000001 109.538 169.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -140.09 96.7 3.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.468 -1.308 . . . . 2.54 107.468 -172.79 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.742 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 27.9 m170 -131.79 146.42 52.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.503 -1.295 . . . . 0.57999999999999996 107.503 -160.848 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.83 113.66 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.263 1.03 . . . . 1.6399999999999999 108.446 172.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -79.63 -174.28 4.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.137 -1.392 . . . . 1.3300000000000001 108.446 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -115.84 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 118.317 -0.849 . . . . 5.3700000000000001 109.071 166.362 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 54.63 98.41 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.613 1.165 . . . . 5.0199999999999996 112.794 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -84.95 -158.7 0.38 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.818 0.818 . . . . 4.1900000000000004 110.882 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -86.15 83.38 7.75 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.037 1.335 . . . . 7.04 110.734 -164.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.57 -32.1 0.25 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.928 0.714 . . . . 6.0899999999999999 112.928 -173.118 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.9 t -161.87 173.52 14.41 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 119.758 1.163 . . . . 5.2699999999999996 109.15 168.636 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.65 -29.7 22.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.166 0.987 . . . . 6.4100000000000001 109.698 163.642 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.17 66.99 3.09 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.173 -0.793 . . . . 3.75 111.922 -171.115 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.555 ' SG ' HG21 ' A' ' 116' ' ' THR . 5.3 m -20.04 96.79 0.01 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.265 2.626 . . . . 2.3399999999999999 113.317 179.243 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.61 -4.98 58.93 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.533 0.938 . . . . 4.4900000000000002 113.533 -159.78 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 m 172.03 -6.45 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.653 2.094 . . . . 3.0099999999999998 116.653 -117.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.59 18.28 0.34 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.303 1.964 . . . . 3.3599999999999999 116.303 -145.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 42.2 -150.04 0.35 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.42 1.486 . . . . 1.3300000000000001 114.223 173.025 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.43 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.863 3.042 . . . . 1.3 111.142 173.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -66.27 59.79 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.721 2.009 . . . . 1.9099999999999999 112.252 -178.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 48.82 58.53 5.22 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.194 0.998 . . . . 1.8899999999999999 109.186 -176.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -87.62 114.95 61.25 Favored Pre-proline 0 C--N 1.34 0.153 0 CA-C-O 118.066 -0.969 . . . . 2.7599999999999998 108.481 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.16 -34.67 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.654 1.569 . . . . 1.2 111.425 -178.45 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -156.32 -76.63 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.526 -0.916 . . . . 2.5600000000000001 108.526 177.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.2 m -138.79 59.03 1.64 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.101 0.961 . . . . 1.6299999999999999 110.599 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -77.94 163.51 25.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.63 -0.878 . . . . 4.2599999999999998 108.63 162.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -125.58 153.78 43.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.299 1.839 . . . . 3.73 107.718 -171.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -76.97 164.68 25.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.032 0.444 . . . . 1.03 110.827 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.55 156.5 22.1 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 106.133 -2.787 . . . . 2.2799999999999998 106.133 168.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.18 -156.44 12.6 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 109.915 -1.274 . . . . 1.3899999999999999 109.915 173.224 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.35 -44.49 4.69 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.541 1.494 . . . . 1.49 108.936 165.294 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -59.01 -43.84 91.59 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.549 1.54 . . . . 5.5800000000000001 112.308 -173.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -55.91 166.89 0.66 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.424 1.09 . . . . 2.48 111.328 -177.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -82.32 -47.86 11.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.436 1.894 . . . . 4.71 109.665 170.268 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 175.9 10.19 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.374 1.07 . . . . 3.98 110.112 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 170.28 148.08 0.03 OUTLIER 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.422 3.089 . . . . 3.73 107.191 168.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 40.0 m80 -61.73 148.58 42.41 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 117.614 -1.634 . . . . 0.56000000000000005 106.791 171.132 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 p -53.58 -23.04 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 1.3 110.665 174.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.97 43.09 1.8 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.805 1.082 . . . . 0.77000000000000002 115.805 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -140.66 138.69 34.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.984 1.892 . . . . 2.04 111.385 153.644 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.7 -44.09 7.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.972 1.309 . . . . 3.02 108.119 166.248 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.85 -103.13 0.23 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.608 -1.397 . . . . 0.88 109.608 177.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -145.29 170.88 15.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.805 1.642 . . . . 1.52 111.516 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.07 170.95 18.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 127.055 2.142 . . . . 0.57999999999999996 107.877 174.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.77 109.67 15.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.726 1.61 . . . . 2.9300000000000002 109.718 -170.62 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.55 139.54 38.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.548 -0.72 . . . . 0.59999999999999998 111.496 174.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.02 -92.14 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.38 1.472 . . . . 4.25 109.886 172.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -175.28 -32.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.878 1.271 . . . . 3.4700000000000002 111.795 -163.044 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.91 8.12 4.1 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 123.39 1.567 . . . . 3.3999999999999999 109.64 153.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.84 72.74 Favored Glycine 0 N--CA 1.442 -0.935 0 O-C-N 120.639 -1.288 . . . . 0.95999999999999996 110.217 177.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.3 t -82.93 111.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.943 1.297 . . . . 1.04 107.611 -177.169 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.53 155.15 21.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.535 1.134 . . . . 1.1299999999999999 110.041 172.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -102.0 57.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.859 2.464 . . . . 6.2400000000000002 107.502 -165.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.07 85.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.996 -0.742 . . . . 1.52 108.996 -163.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.1 m -143.76 119.41 10.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.124 -0.695 . . . . 1.47 109.124 173.098 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.31 152.69 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.173 -1.047 . . . . 2.1800000000000002 108.173 -173.466 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -131.72 92.45 3.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.705 -1.22 . . . . 2.8799999999999999 107.705 167.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.6 151.3 21.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.259 0.624 . . . . 2.3700000000000001 110.569 176.375 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -121.06 -0.48 9.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.224 1.81 . . . . 3.3399999999999999 112.651 173.27 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -78.56 -51.21 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.752 -1.203 . . . . 1.6499999999999999 107.752 174.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.13 168.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.299 0.571 . . . . 1.2 110.319 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.8 m -131.66 178.53 6.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.127 2.171 . . . . 1.96 106.509 174.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.44 ' HA ' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -100.01 9.74 42.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.21 0.914 . . . . 3.2000000000000002 112.453 171.871 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 p -76.68 110.41 11.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.918 1.287 . . . . 4.5099999999999998 109.312 -166.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.29 72.56 0.14 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.867 1.222 . . . . 4.2699999999999996 112.393 -176.182 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -162.3 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.615 2.366 . . . . 4.0300000000000002 105.066 -172.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -77.57 -31.58 53.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.725 1.21 . . . . 3.29 110.919 178.071 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 p -66.06 179.54 0.91 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.082 1.42 . . . . 2.2000000000000002 112.83 -175.132 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -7.55 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 113.534 -1.666 . . . . 1.6699999999999999 110.893 179.453 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 106' ' ' LEU . 1.5 mp -58.74 131.79 23.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.413 0 CA-C-N 119.823 1.192 . . . . 2.6899999999999999 107.969 171.292 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.07 23.67 68.29 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.24 -0.755 . . . . 1.79 111.687 -170.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.528 ' O ' HG22 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -130.41 168.82 16.35 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.085 1.443 . . . . 5.0499999999999998 109.173 167.449 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.555 HG21 ' SG ' ' A' ' 57' ' ' CYS . 19.9 m -100.06 110.57 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.583 0.753 . . . . 0.93000000000000005 112.681 -169.065 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mt -67.05 141.9 57.36 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.219 -1.03 . . . . 1.5600000000000001 108.219 170.307 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.6 t -132.31 140.23 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.889 2.475 . . . . 0.39000000000000001 107.148 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 p -112.5 127.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.663 1.185 . . . . 1.75 108.204 167.736 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.531 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 56.9 m-70 -105.25 163.35 12.66 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.785 1.634 . . . . 0.46999999999999997 113.611 -171.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.471 ' HB2' HD21 ' A' ' 144' ' ' LEU 0.28 8.7 tt0 -76.71 -53.52 7.87 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 115.035 1.494 . . . . 6.1699999999999999 115.035 -178.005 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -78.93 177.46 8.75 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 120.476 1.489 . . . . 3.8900000000000001 108.713 -179.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.29 37.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.429 -0.952 . . . . 0.52000000000000002 108.429 160.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 164.26 20.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.039 . . . . 1.9399999999999999 108.193 156.654 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -10.47 59.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.217 1.191 . . . . 4.1299999999999999 114.217 -171.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 58.93 34.19 23.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 1.73 111.706 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.0 60.41 6.88 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.723 -0.611 . . . . 2.1800000000000002 112.712 168.138 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -138.7 -59.47 0.61 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.422 1.489 . . . . 5.1900000000000004 109.937 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 64.28 -72.06 0.06 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.844 1.688 . . . . 2.02 116.152 173.464 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.19 40.26 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 111.184 -0.766 . . . . 2.3500000000000001 111.184 -157.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -170.68 160.69 7.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.077 1.751 . . . . 2.8500000000000001 107.085 -178.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -55.13 -64.88 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.015 1.117 . . . . 3.1800000000000002 114.015 -173.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.59 -45.12 66.37 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.874 0.87 . . . . 4.2300000000000004 110.617 -156.421 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -58.85 1.99 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.039 1.735 . . . . 1.96 111.515 170.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -70.9 -48.03 55.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.195 -0.941 . . . . 1.52 110.788 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -67.33 -36.68 81.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.052 -0.499 . . . . 2.6600000000000001 112.304 -169.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.504 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.404 0.0 OUTLIER -129.49 -53.89 1.17 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.681 -1.152 . . . . 1.1499999999999999 113.518 168.428 . . . . . . . . 4 4 . 1 . 029 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.68 -10.25 0.27 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 120.408 1.458 . . . . 0.88 115.995 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 46.84 53.62 10.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.216 1.406 . . . . 1.98 111.791 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.742 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -65.18 -30.22 71.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.366 1.467 . . . . 1.0700000000000001 113.452 177.712 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.62 173.15 49.54 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.865 -1.294 . . . . 1.1599999999999999 109.865 -160.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 m -56.4 152.25 11.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.167 1.387 . . . . 1.5900000000000001 113.148 -172.454 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.44 ' O ' HD23 ' A' ' 144' ' ' LEU . 11.8 mtm105 -77.61 162.85 26.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.713 -1.585 . . . . 4.5599999999999996 111.614 176.648 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 121' ' ' GLU . 6.9 mt -138.83 -72.92 0.4 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.836 -1.913 . . . . 0.78000000000000003 105.836 -172.607 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.68 155.69 30.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.425 0.631 . . . . 0.87 109.321 172.551 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -157.23 172.12 19.19 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.543 -1.662 . . . . 1.6799999999999999 108.642 175.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.24 146.08 6.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.034 -0.985 . . . . 0.69999999999999996 111.932 176.567 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.4 t -63.32 133.49 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.489 1.116 . . . . 0.71999999999999997 109.118 175.229 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 115' ' ' ARG . 16.6 tt -96.41 136.05 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.76000000000000001 110.478 176.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.96 -1.27 2.5 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.883 0.754 . . . . 0.80000000000000004 114.427 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -89.38 58.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.906 1.353 . . . . 0.93000000000000005 110.367 -160.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.427 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -128.46 176.14 7.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.431 1.093 . . . . 1.52 110.972 176.304 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 102.047 -3.316 . . . . 4.8399999999999999 102.047 143.817 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 110.587 -0.153 . . . . 6.5599999999999996 110.587 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 p 53.19 66.15 1.31 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.068 1.347 . . . . 3.71 111.416 173.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -134.67 148.86 50.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.96 1.304 . . . . 5.8099999999999996 107.567 178.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.92 125.74 53.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.252 -1.388 . . . . 0.78000000000000003 107.252 160.22 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 152' ' ' ALA . 59.5 t -90.78 140.91 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 105.837 -1.912 . . . . 1.05 105.837 164.711 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.96 92.52 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.27 -1.011 . . . . 0.75 108.27 160.456 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.09 103.19 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 107.077 -1.453 . . . . 0.81999999999999995 107.077 165.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.73 129.96 34.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.402 -0.962 . . . . 0.93999999999999995 108.402 176.274 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -154.98 -53.86 0.09 Allowed 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.411 -0.588 . . . . 3.6000000000000001 109.411 170.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.72 -107.04 0.61 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.421 -0.809 . . . . 1.3300000000000001 113.005 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -116.37 -57.23 2.22 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.949 1.3 . . . . 2.9700000000000002 110.005 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 164.81 10.15 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.674 0.654 . . . . 1.1200000000000001 112.289 -177.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.72 -19.46 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.593 2.862 . . . . 1.47 112.336 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.88 143.24 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 124.712 1.205 . . . . 0.91000000000000003 110.562 174.304 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -155.65 126.28 6.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.732 -1.21 . . . . 1.9299999999999999 107.732 -174.248 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.7 170.8 42.51 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.957 -0.639 . . . . 0.55000000000000004 112.369 -174.366 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.4 128.17 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.491 -0.929 . . . . 1.5800000000000001 108.491 -179.358 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.29 134.71 30.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.651 -1.611 . . . . 0.93999999999999995 106.651 161.315 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.42 59.85 1.02 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.863 0.865 . . . . 3.3300000000000001 108.69 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' CD2' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -90.77 144.28 25.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.237 1.415 . . . . 2.98 110.916 -163.277 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -153.44 163.39 40.03 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.872 0.844 . . . . 3.2599999999999998 111.27 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.416 HE22 ' N ' ' A' ' 27' ' ' GLY . 34.8 tt0 -145.55 153.79 41.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.041 -2.207 . . . . 2.9399999999999999 105.041 157.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -70.71 -56.06 7.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.373 -0.602 . . . . 4.5999999999999996 109.373 172.713 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -83.08 166.46 18.71 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.798 1.239 . . . . 3.5899999999999999 109.324 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 p -90.79 -0.16 57.63 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.887 -0.508 . . . . 2.3300000000000001 111.949 176.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -144.29 47.72 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.325 0.966 . . . . 4.8899999999999997 111.843 -159.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' N ' HE22 ' A' ' 22' ' ' GLN . . . -152.56 -164.87 12.75 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.823 -1.311 . . . . 1.01 109.823 171.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.4 146.78 45.58 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.594 2.196 . . . . 1.03 110.799 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.54 143.77 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 123.849 0.718 . . . . 0.90000000000000002 110.826 -171.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -95.97 96.98 9.26 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.354 -0.609 . . . . 2.5600000000000001 109.354 -175.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG22 ' CD2' ' A' ' 20' ' ' PHE . 44.1 t -83.78 88.94 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.096 -1.076 . . . . 1.22 108.096 177.423 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -104.55 137.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.778 0.674 . . . . 1.05 109.798 164.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.85 156.83 27.86 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.957 -0.857 . . . . 0.83999999999999997 110.957 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 p -132.21 106.74 8.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.664 -1.976 . . . . 1.71 105.664 -171.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.62 150.25 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.627 -1.249 . . . . 0.83999999999999997 107.627 -167.408 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.75 -179.54 6.86 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.271 1.211 . . . . 5.0899999999999999 114.271 161.796 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.92 64.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.854 1.692 . . . . 0.59999999999999998 112.204 179.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.16 162.2 29.7 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.139 0.97 . . . . 0.65000000000000002 108.811 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.21 164.61 23.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.884 -1.154 . . . . 1.78 107.884 153.412 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.01 175.21 0.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.63 0.728 . . . . 2.4100000000000001 111.048 176.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.07 -163.67 50.63 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.295 0.474 . . . . 0.58999999999999997 113.395 170.455 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.06 147.08 47.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.131 . . . . 2.2799999999999998 112.284 -172.786 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.36 117.22 8.22 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.822 1.649 . . . . 0.44 108.987 177.223 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.16 152.61 5.09 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.917 -0.873 . . . . 0.34000000000000002 110.917 171.546 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.84 95.62 2.76 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.559 1.143 . . . . 2.4100000000000001 108.053 -174.26 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -135.24 160.61 37.86 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 108.383 -0.969 . . . . 0.52000000000000002 108.383 -160.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.37 115.94 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.98 1.264 . . . . 1.8100000000000001 110.686 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -86.9 162.42 17.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.766 -0.652 . . . . 0.87 109.564 -169.792 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.73 47.27 0.13 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.683 1.993 . . . . 4.5199999999999996 111.345 178.094 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' CD ' HH22 ' A' ' 143' ' ' ARG . 4.7 mt-10 -123.77 129.02 50.41 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.074 -1.824 . . . . 3.0899999999999999 106.074 -171.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -137.88 -70.28 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.859 1.264 . . . . 4.6699999999999999 107.999 179.002 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -79.28 61.03 3.26 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.381 2.272 . . . . 6.1299999999999999 109.673 178.688 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.81 43.6 2.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.359 0.599 . . . . 4.5099999999999998 112.291 -169.548 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 m -51.54 -22.81 3.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.072 1.349 . . . . 4.1399999999999997 113.084 174.318 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -46.97 -37.06 8.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.925 1.29 . . . . 5.9100000000000001 112.327 170.122 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.04 -90.73 0.11 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.275 -1.13 . . . . 3.2999999999999998 110.275 173.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.1 m -151.6 31.06 0.58 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.524 1.529 . . . . 3.1200000000000001 107.853 -176.563 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 m -131.22 56.35 1.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.015 -1.074 . . . . 3.7999999999999998 111.856 -138.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.6 m -167.61 -38.91 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.962 1.838 . . . . 2.4700000000000002 115.962 -143.17 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.27 154.5 26.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.637 1.575 . . . . 1.8300000000000001 109.403 167.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.93 -95.25 1.68 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 109.683 -1.367 . . . . 1.04 109.683 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.83 178.61 6.59 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.392 3.394 . . . . 0.93999999999999995 114.236 -173.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -73.03 125.35 27.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.309 -1.314 . . . . 1.52 109.226 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -4.04 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.465 2.306 . . . . 2.3399999999999999 113.754 168.344 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -123.78 99.84 38.13 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.27 1.028 . . . . 3.1400000000000001 109.105 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.81 -37.02 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.668 1.578 . . . . 1.25 110.03 -179.004 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.41 -86.02 0.54 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.59 -1.263 . . . . 3.0099999999999998 107.59 160.366 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -140.32 72.87 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.434 1.094 . . . . 1.6100000000000001 109.71 -166.071 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -77.75 164.31 25.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.8 -0.815 . . . . 4.6699999999999999 108.8 170.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -125.07 148.02 48.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.059 1.343 . . . . 3.5099999999999998 108.386 -178.974 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.479 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 44.2 t60 -81.48 156.22 25.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.719 0.407 . . . . 0.89000000000000001 111.828 -176.211 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.57 -97.78 0.13 Allowed Glycine 0 C--O 1.219 -0.784 0 N-CA-C 107.334 -2.306 . . . . 2.3300000000000001 107.334 159.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.09 -154.55 25.48 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 120.575 -1.544 . . . . 1.51 110.344 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.34 -55.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.932 2.421 . . . . 1.8700000000000001 110.394 -168.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -39.82 82.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.737 0.779 . . . . 5.6100000000000003 110.067 171.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -57.29 153.09 12.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.725 -1.579 . . . . 3.1299999999999999 112.861 -164.417 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 77' ' ' GLU . 1.8 mp0 -49.2 -47.24 46.26 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 128.144 2.578 . . . . 6.5700000000000003 109.576 170.192 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 21.6 pt-20 -133.93 178.52 6.89 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.762 1.023 . . . . 3.4300000000000002 113.762 -171.145 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 175.73 153.55 0.16 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.147 2.179 . . . . 3.1000000000000001 108.579 -173.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 58.4 m80 -62.6 156.24 23.82 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.072 -0.714 . . . . 0.80000000000000004 109.072 170.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.94 -34.24 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.45 -0.782 . . . . 1.29 110.489 -174.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.46 59.98 0.49 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.39 0.995 . . . . 0.82999999999999996 110.65 175.461 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -169.68 115.93 0.56 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.22 -1.4 . . . . 2.0699999999999998 107.22 -170.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -106.79 -48.43 3.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.37 0.668 . . . . 2.5 110.978 -173.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.76 -121.69 0.93 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 119.647 -1.263 . . . . 0.67000000000000004 112.333 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -151.03 172.02 16.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.085 1.354 . . . . 1.3600000000000001 108.925 -171.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 167.23 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.016 -1.476 . . . . 0.67000000000000004 107.016 167.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 m -120.09 123.42 43.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.217 -1.401 . . . . 2.0299999999999998 107.217 172.683 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.94 33.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.979 0.354 . . . . 0.65000000000000002 110.977 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -69.19 -84.05 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.567 1.147 . . . . 2.8799999999999999 110.449 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 93' ' ' GLY . 75.4 tttt -159.12 -46.33 0.06 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.735 1.214 . . . . 3.52 111.308 -175.127 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.41 32.98 0.45 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 124.337 2.018 . . . . 2.73 110.38 176.217 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 58.39 18.67 37.3 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 126.504 2.002 . . . . 0.62 112.228 -176.925 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.62 142.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.844 -1.539 . . . . 0.76000000000000001 106.844 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.04 163.34 33.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.89 -1.152 . . . . 0.59999999999999998 107.89 171.127 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -129.99 141.53 50.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.815 -2.661 . . . . 2.6499999999999999 103.815 -174.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.38 126.25 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 105.439 -2.06 . . . . 1.3 105.439 170.299 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.8 m -145.81 71.34 1.27 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.375 1.47 . . . . 1.26 107.974 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mm -108.56 151.16 10.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.654 0.782 . . . . 1.73 109.208 -178.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -137.67 133.96 34.88 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.737 -1.579 . . . . 3.5499999999999998 106.737 160.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.06 161.94 37.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.522 -1.659 . . . . 2.4900000000000002 106.522 175.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 p -113.17 -9.2 13.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.981 2.113 . . . . 1.8 112.487 -172.389 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.1 t -77.5 -41.85 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.339 -0.985 . . . . 1.3799999999999999 108.339 -177.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -85.68 162.75 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 123.774 0.83 . . . . 2.3799999999999999 108.996 172.722 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.437 ' N ' HD13 ' A' ' 104' ' ' ILE . 49.2 p -164.29 169.54 17.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.728 1.611 . . . . 1.8200000000000001 108.086 -175.144 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.5 42.52 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.733 1.213 . . . . 2.7400000000000002 110.046 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 m -79.85 -171.51 2.91 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.575 -1.269 . . . . 4.0800000000000001 107.575 166.409 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -141.13 64.95 0.51 Allowed Glycine 0 N--CA 1.465 0.582 0 O-C-N 120.519 -1.363 . . . . 3.9500000000000002 110.762 -169.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -166.54 -105.57 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.06 -0.348 . . . . 4.7800000000000002 110.06 -155.795 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -82.68 -21.9 34.74 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.314 2.246 . . . . 4.8799999999999999 108.858 171.213 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.7 p -42.14 156.92 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.271 1.428 . . . . 1.3500000000000001 113.026 167.136 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.489 HD12 HG21 ' A' ' 149' ' ' ILE . 1.3 pp -85.64 -8.86 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.91 -0.494 . . . . 1.48 112.05 -177.012 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mm -47.6 123.88 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.835 0.854 . . . . 2.2400000000000002 109.235 169.466 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.12 -27.72 17.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.036 0.827 . . . . 2.0299999999999998 112.645 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.85 160.4 26.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.837 1.318 . . . . 5.3300000000000001 110.936 -168.143 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.8 m -87.35 100.46 12.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.042 1.337 . . . . 1.1100000000000001 109.904 -176.253 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.9 146.77 54.48 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.139 -1.06 . . . . 1.76 108.139 169.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.9 t -134.41 140.8 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 127.898 2.479 . . . . 0.53000000000000003 107.175 -177.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.64 127.19 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.265 -1.383 . . . . 1.6200000000000001 107.265 165.327 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -98.71 162.99 12.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.573 2.064 . . . . 0.39000000000000001 116.573 -169.408 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -66.36 0.4 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.754 2.022 . . . . 2.9500000000000002 112.054 176.779 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -107.68 -178.58 3.66 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.187 0.995 . . . . 3.1899999999999999 111.549 -173.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.79 147.36 42.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.292 -0.867 . . . . 0.72999999999999998 108.798 158.093 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.95 164.23 23.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.578 0.704 . . . . 2.1699999999999999 109.776 161.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.19 -4.69 58.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.473 1.509 . . . . 3.1400000000000001 112.927 -172.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 57.08 30.36 18.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.597 1.159 . . . . 1.47 110.583 -170.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.45 20.69 59.2 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.872 -0.518 . . . . 1.97 112.587 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -131.24 50.76 2.2 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.221 -1.4 . . . . 6.21 107.221 -173.201 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.46 139.71 11.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.713 -1.755 . . . . 1.99 108.713 177.201 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.23 -37.28 79.75 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.67 0.735 . . . . 2.7599999999999998 112.604 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -56.15 109.63 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.519 1.127 . . . . 2.0800000000000001 108.995 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -38.91 20.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.163 0.985 . . . . 3.54 112.105 -178.212 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -35.36 -37.87 0.09 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 128.022 2.529 . . . . 3.0 113.227 171.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.7 p -47.7 -69.2 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.285 1.034 . . . . 2.1800000000000002 109.69 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -63.96 -43.35 96.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.334 0.654 . . . . 1.3 110.417 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -52.2 -49.83 63.1 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 126.1 1.76 . . . . 2.98 110.703 -171.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.492 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.379 10.2 t -136.2 -48.19 0.65 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 117.801 -1.095 . . . . 2.21 111.629 175.459 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.479 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 162.38 -31.32 0.3 Allowed Glycine 0 N--CA 1.463 0.483 0 CA-C-N 119.564 1.074 . . . . 0.91000000000000003 112.578 178.423 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.99 53.4 10.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.498 1.519 . . . . 1.9399999999999999 109.778 -174.724 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.18 -7.27 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.352 -0.842 . . . . 1.03 112.085 166.691 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.53 -167.57 50.55 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 108.88 -1.688 . . . . 0.95999999999999996 108.88 -174.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -54.39 151.35 7.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.087 1.755 . . . . 1.1899999999999999 113.836 -167.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.466 HH22 ' CD ' ' A' ' 50' ' ' GLU . 7.6 mmt85 -64.93 141.46 58.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.333 1.453 . . . . 2.9500000000000002 108.083 170.228 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.7 mt -108.92 -89.66 0.47 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.058 -1.089 . . . . 0.55000000000000004 108.058 169.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.74 158.08 15.85 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.953 -1.129 . . . . 0.87 107.953 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.6 p -143.64 174.84 10.43 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.214 -1.357 . . . . 1.96 108.413 166.017 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.1 139.72 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 123.943 0.777 . . . . 0.70999999999999996 111.551 176.439 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.21 129.76 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.556 1.143 . . . . 0.95999999999999996 108.861 174.006 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.489 HG21 HD12 ' A' ' 112' ' ' ILE . 7.9 tt -90.74 131.88 36.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 122.665 0.386 . . . . 0.84999999999999998 110.76 176.92 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.54 3.2 0.62 Allowed Glycine 0 CA--C 1.523 0.532 0 CA-C-O 119.389 -0.673 . . . . 0.77000000000000002 114.639 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.19 56.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.193 1.497 . . . . 1.29 110.917 -164.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.36 175.51 13.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.061 1.344 . . . . 1.3600000000000001 108.268 160.258 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 103.858 -2.645 . . . . 4.8499999999999996 103.858 163.615 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 108.989 -0.745 . . . . 6.1500000000000004 108.989 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.82 68.77 7.2 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.716 0.636 . . . . 3.8100000000000001 112.716 -165.414 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 132.82 55.22 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.52 0.728 . . . . 2.6400000000000001 110.302 162.251 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.41 153.64 21.01 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.51 -0.922 . . . . 0.70999999999999996 108.51 164.102 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.96 148.62 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 123.799 0.84 . . . . 0.91000000000000003 108.939 164.395 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.18 101.64 6.35 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.067 1.347 . . . . 0.48999999999999999 108.937 159.007 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.7 98.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.204 -1.035 . . . . 0.69999999999999996 108.204 164.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 147' ' ' GLY . 44.3 mt -81.76 123.77 29.05 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.812 0.845 . . . . 1.6799999999999999 109.564 175.05 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.76 -56.73 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.82 1.248 . . . . 4.4699999999999998 108.29 178.88 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' H ' ' A' ' 146' ' ' CYS . . . 44.54 -116.16 1.58 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.043 1.306 . . . . 0.88 112.47 -177.549 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.05 -62.03 1.33 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.642 0.721 . . . . 3.46 109.605 -173.138 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.58 161.94 1.13 Allowed Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.825 1.678 . . . . 0.81000000000000005 112.554 -178.166 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.34 38.6 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.001 3.134 . . . . 0.96999999999999997 112.75 -172.207 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.3 155.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.341 1.856 . . . . 0.98999999999999999 109.013 -177.436 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.53 116.76 4.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.892 -1.151 . . . . 2.25 107.892 171.327 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 163.68 33.02 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.969 -0.852 . . . . 0.64000000000000001 110.969 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.77 114.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.826 -1.916 . . . . 1.72 105.826 -177.607 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -78.2 148.44 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.191 -1.411 . . . . 0.72999999999999998 107.191 170.252 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -122.7 118.23 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.183 -2.154 . . . . 2.1600000000000001 105.183 163.081 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -106.54 99.94 9.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.175 -1.787 . . . . 2.7400000000000002 106.175 175.606 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -103.78 136.84 42.72 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.693 0.797 . . . . 4.6900000000000004 109.246 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -155.94 86.97 1.05 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.626 1.17 . . . . 3.8100000000000001 109.591 172.717 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.98 -52.02 59.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.377 1.071 . . . . 4.9400000000000004 110.125 174.036 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -83.56 92.46 7.64 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.265 -1.013 . . . . 4.2300000000000004 108.265 175.434 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -54.57 3.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 118.287 2.699 . . . . 3.3599999999999999 118.287 -162.831 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -159.04 64.76 0.41 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 120.004 1.275 . . . . 3.6800000000000002 109.566 170.081 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.94 -145.85 6.84 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 107.578 -2.209 . . . . 1.49 107.578 164.717 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.72 142.51 16.08 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.555 2.17 . . . . 1.1299999999999999 110.693 169.922 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG11 ' CD2' ' A' ' 20' ' ' PHE . 59.5 t -90.39 152.11 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 122.818 0.447 . . . . 0.91000000000000003 110.128 -175.559 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.6 125.76 48.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.388 -1.708 . . . . 4.1600000000000001 106.388 170.219 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' CE1' ' A' ' 20' ' ' PHE . 16.1 t -116.14 129.91 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 175.442 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -144.07 150.32 37.98 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.543 -1.28 . . . . 0.73999999999999999 107.543 162.444 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.28 142.88 5.71 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 107.748 -2.141 . . . . 1.0900000000000001 107.748 173.625 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -116.92 98.57 6.56 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.444 -1.317 . . . . 2.5299999999999998 107.444 -169.261 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.69 143.44 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.512 1.525 . . . . 1.1000000000000001 108.54 -169.119 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 160.65 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.515 -0.474 . . . . 4.75 110.619 170.807 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.57 25.16 63.62 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.796 1.665 . . . . 0.97999999999999998 113.99 -179.121 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.58 171.56 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.297 -1.001 . . . . 0.95999999999999996 108.297 160.333 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -74.45 168.47 19.65 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.995 -1.113 . . . . 2.04 107.995 152.86 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.47 172.55 0.85 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.73 1.212 . . . . 4.71 110.9 179.516 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.28 -158.75 38.33 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 115.967 -0.561 . . . . 0.84999999999999998 114.023 167.63 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.13 141.35 56.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.228 1.411 . . . . 2.4900000000000002 111.997 -168.17 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -142.48 115.86 9.02 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.168 0.987 . . . . 0.57999999999999996 110.804 176.457 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.11 146.88 9.77 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.997 -0.841 . . . . 0.38 110.997 170.515 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -138.26 105.68 5.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.848 1.259 . . . . 2.5099999999999998 107.778 -175.889 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 31.0 m80 -138.66 162.09 35.52 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.291 -1.003 . . . . 0.64000000000000001 108.291 -166.055 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.45 126.18 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.472 0.654 . . . . 1.6899999999999999 109.385 176.319 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -104.94 147.75 27.44 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.75 2.02 . . . . 0.80000000000000004 109.215 -173.314 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 67.87 0.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.681 1.192 . . . . 4.3700000000000001 111.095 177.716 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -129.35 107.92 9.89 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.383 -1.339 . . . . 3.1800000000000002 107.383 -176.254 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.73 -29.78 29.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.391 1.076 . . . . 5.2699999999999996 110.999 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -118.02 123.75 46.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.917 0.887 . . . . 5.4500000000000002 109.528 -178.226 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -138.43 46.15 2.03 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.908 0.883 . . . . 5.1600000000000001 108.782 161.439 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 t -76.6 39.61 0.21 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.559 1.144 . . . . 4.3099999999999996 112.812 -172.568 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.96 -51.93 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 124.477 1.111 . . . . 5.7599999999999998 109.551 -177.265 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.81 -168.77 35.94 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.817 -2.113 . . . . 4.0499999999999998 107.817 -176.938 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.6 m -69.32 98.11 1.03 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.775 0.788 . . . . 3.0299999999999998 110.843 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 59' ' ' SER 0.253 19.4 m -38.19 -93.37 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 127.295 2.238 . . . . 5.1699999999999999 114.66 167.252 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 58' ' ' THR 0.384 5.5 m 141.53 69.58 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 121.677 2.035 . . . . 4.3099999999999996 114.206 -113.631 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -156.7 163.29 39.45 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.906 2.082 . . . . 1.79 106.867 168.623 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.78 -122.89 2.94 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.076 -0.847 . . . . 1.0700000000000001 111.98 -158.496 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.89 179.12 6.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.416 2.744 . . . . 0.90000000000000002 113.289 -172.356 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -58.82 115.74 3.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.893 -1.503 . . . . 1.29 107.19 171.534 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -21.89 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.967 1.707 . . . . 2.3900000000000001 113.902 176.94 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -130.29 146.23 60.75 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.08 . . . . 3.2200000000000002 107.929 -173.764 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.58 -54.69 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.778 1.652 . . . . 1.8700000000000001 108.655 169.076 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -144.63 -70.37 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.449 1.499 . . . . 2.54 107.333 171.244 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.9 p -135.29 71.92 1.44 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.042 1.337 . . . . 2.5600000000000001 109.369 -168.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -78.82 175.13 10.77 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.233 -1.025 . . . . 4.2400000000000002 108.233 162.488 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -117.16 149.08 40.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.561 -2.015 . . . . 4.3099999999999996 105.561 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.427 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 82.7 t60 -66.93 146.25 54.58 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.543 -0.863 . . . . 0.83999999999999997 111.048 178.487 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.36 130.28 3.29 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 106.751 -2.54 . . . . 2.73 106.751 172.495 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.1 -155.28 12.36 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.231 -1.148 . . . . 1.8200000000000001 110.231 174.732 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.52 -33.0 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.26 1.974 . . . . 2.4199999999999999 110.786 178.91 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -44.23 90.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.437 0.637 . . . . 7.8099999999999996 110.817 175.637 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.18 139.69 56.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.218 1.562 . . . . 3.0299999999999998 115.218 -159.401 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -53.57 -59.45 4.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.752 2.421 . . . . 5.4199999999999999 110.167 170.588 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.64 -178.72 6.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 130.221 3.409 . . . . 3.8199999999999998 110.406 178.029 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 172.68 161.01 0.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.206 1.802 . . . . 2.8700000000000001 111.685 164.74 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.7 m80 -50.25 136.84 19.14 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.685 -1.968 . . . . 0.64000000000000001 105.685 154.256 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.78 -20.6 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 120.072 -0.651 . . . . 1.24 109.82 -179.96 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.91 43.29 1.75 Allowed Glycine 0 CA--C 1.535 1.338 0 N-CA-C 116.717 1.447 . . . . 0.78000000000000003 116.717 164.56 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -98.09 136.8 37.81 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 105.757 -1.942 . . . . 1.9299999999999999 105.757 147.681 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 84' ' ' LEU . 3.9 mm? -93.55 -52.29 4.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.72 -0.844 . . . . 1.5700000000000001 108.72 148.464 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.92 -108.6 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 119.597 -1.287 . . . . 0.53000000000000003 112.321 178.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -155.63 168.18 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.512 1.525 . . . . 2.0800000000000001 109.224 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.98 178.05 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.565 -1.643 . . . . 0.56999999999999995 106.565 163.21 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.5 t -113.07 146.22 39.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.562 -1.644 . . . . 2.4900000000000002 106.562 151.913 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.46 156.43 20.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.106 -1.072 . . . . 0.78000000000000003 108.106 150.755 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.57 -90.11 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.967 -0.753 . . . . 3.1299999999999999 108.967 172.314 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -139.22 -48.79 0.49 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.467 1.507 . . . . 3.7599999999999998 110.091 -167.497 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -81.88 17.0 1.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.964 1.364 . . . . 3.0800000000000001 111.343 -176.545 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.84 10.11 76.42 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.344 -0.847 . . . . 0.93999999999999995 111.7 -175.87 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.38 124.65 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.493 1.517 . . . . 0.93000000000000005 107.475 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.34 171.62 14.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.269 1.828 . . . . 0.68000000000000005 108.086 175.12 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.31 144.74 26.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.787 -1.19 . . . . 3.5899999999999999 107.787 -179.583 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.21 55.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 123.866 0.866 . . . . 2.04 111.153 -172.797 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.6 m -72.67 102.3 3.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.768 -0.634 . . . . 1.1000000000000001 110.193 169.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 100' ' ' GLU . 16.4 mt -137.4 157.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.192 0.906 . . . . 1.8999999999999999 110.147 179.077 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 99' ' ' ILE . 34.7 tt0 -137.94 123.72 19.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.659 -1.237 . . . . 3.6600000000000001 107.659 158.514 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -117.15 156.82 26.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.466 -0.939 . . . . 2.4500000000000002 108.466 164.095 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.9 p -102.03 -12.64 18.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.282 2.233 . . . . 1.5700000000000001 111.937 176.432 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.35 -25.87 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.764 0.711 . . . . 1.3100000000000001 110.872 -173.726 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.88 166.6 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.704 0.683 . . . . 1.3999999999999999 111.686 177.32 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -136.41 176.81 8.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.596 2.359 . . . . 1.8200000000000001 107.618 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.42 57.37 1.09 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.802 0.728 . . . . 2.48 112.11 167.352 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.0 m -151.08 -59.63 0.17 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.328 0.651 . . . . 2.8700000000000001 111.743 165.509 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.89 165.13 30.33 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 122.149 -0.344 . . . . 2.7599999999999998 113.395 -170.887 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -36.77 -47.8 0.69 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.936 2.095 . . . . 4.79 114.022 179.672 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -75.22 -11.39 60.06 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.078 -0.51 . . . . 5.7300000000000004 111.221 -170.745 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.9 p -61.56 171.97 1.35 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 122.695 1.236 . . . . 1.4099999999999999 112.516 -170.229 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -8.53 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 3.0800000000000001 111.942 176.066 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 33.9 mm -54.85 120.4 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.926 1.239 . . . . 1.96 109.491 -174.069 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.25 73.81 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.617 -0.546 . . . . 1.49 112.338 -177.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -102.39 177.21 4.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.313 -1.736 . . . . 4.2599999999999998 106.313 167.611 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -119.4 122.14 41.11 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.596 1.089 . . . . 1.01 111.314 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.8 mt -74.16 146.43 43.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.239 -0.652 . . . . 1.72 109.239 166.144 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.91 136.06 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.416 1.886 . . . . 0.39000000000000001 107.919 177.511 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.419 HG22 ' CE2' ' A' ' 45' ' ' PHE . 28.3 t -100.47 122.23 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 126.044 1.738 . . . . 2.27 106.9 167.005 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.486 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 65.0 m-70 -98.48 158.69 15.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.369 1.989 . . . . 0.44 116.369 -174.653 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 2.7 tt0 -46.72 -74.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.219 2.208 . . . . 2.96 112.018 174.292 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -93.76 -176.88 4.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.851 0.75 . . . . 2.8599999999999999 110.275 -171.748 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.32 152.08 30.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.588 -0.893 . . . . 0.60999999999999999 108.588 157.924 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.13 177.34 6.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.94 0.876 . . . . 2.1099999999999999 109.087 161.92 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.53 -27.4 67.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.498 1.119 . . . . 4.3899999999999997 113.83 177.824 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.288 2.9 mm? 88.73 -17.58 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 128.47 2.708 . . . . 2.8900000000000001 113.172 -175.127 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.27 3.33 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.647 -1.381 . . . . 3.6000000000000001 109.647 -171.969 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -95.44 -38.97 10.23 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 128.264 2.626 . . . . 6.1100000000000003 108.87 160.403 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.35 62.63 5.8 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 125.401 1.477 . . . . 3.6000000000000001 110.112 -167.294 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.19 -16.02 25.05 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.694 -0.503 . . . . 3.1099999999999999 113.741 178.845 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -176.68 -179.98 1.05 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.49 1.516 . . . . 2.25 108.236 -169.507 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -42.83 -82.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.772 2.029 . . . . 3.4900000000000002 113.562 178.681 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -53.18 -33.54 53.07 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.827 -0.546 . . . . 3.2000000000000002 111.709 -172.796 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.3 m -61.42 -52.78 63.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.005 1.322 . . . . 2.5099999999999998 111.161 179.266 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.9 t -71.04 -45.07 64.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.767 1.167 . . . . 2.4100000000000001 110.791 173.781 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.17 -43.13 99.36 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.175 0.59 . . . . 3.9500000000000002 111.58 -170.063 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -128.21 -47.98 1.33 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.225 0.466 . . . . 1.3600000000000001 112.107 177.104 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 147.65 -14.99 1.4 Allowed Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.786 0.721 . . . . 0.91000000000000003 114.097 -178.417 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.11 54.85 6.73 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.035 1.334 . . . . 1.8500000000000001 110.601 -174.755 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.5 -31.26 71.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.77 1.228 . . . . 1.1399999999999999 112.087 172.848 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.52 178.43 50.48 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 108.64 -1.784 . . . . 0.93999999999999995 108.64 -163.262 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 m -58.23 153.76 14.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.556 1.142 . . . . 1.28 113.648 -167.229 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -59.72 134.58 57.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.082 1.353 . . . . 3.0099999999999998 108.465 170.254 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.6 mt -110.32 -72.48 0.72 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.955 -1.498 . . . . 0.58999999999999997 106.955 168.37 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.35 155.03 16.94 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.409 -0.96 . . . . 0.93999999999999995 108.409 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.407 ' H ' ' HA3' ' A' ' 10' ' ' GLY . 73.9 m -135.96 150.51 49.3 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 106.196 -1.779 . . . . 1.8200000000000001 106.196 163.858 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.54 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -152.09 116.45 0.75 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.8 -1.72 . . . . 0.95999999999999996 108.8 172.03 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.68 132.88 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.095 -1.446 . . . . 0.77000000000000002 107.095 168.236 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.59 138.96 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.206 0.527 . . . . 0.69999999999999996 112.385 -172.537 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 137.78 5.84 1.62 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.328 1.442 . . . . 0.59999999999999998 114.221 177.563 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.75 57.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-N 119.351 1.575 . . . . 0.81000000000000005 109.89 -154.268 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 165.33 36.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.367 0.603 . . . . 1.5900000000000001 111.236 171.669 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 C--O 1.255 1.353 0 N-CA-C 102.699 -3.075 . . . . 4.5 102.699 156.139 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.418 0.628 . . . . 5.5899999999999999 112.224 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 p -78.49 83.32 4.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.975 -1.12 . . . . 2.8300000000000001 107.975 177.962 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.2 145.86 39.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.747 0.308 . . . . 3.0800000000000001 110.845 -175.508 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.76 37.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.551 -2.018 . . . . 0.87 105.551 156.147 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -100.6 142.85 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 105.558 -2.016 . . . . 0.65000000000000002 105.558 162.725 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -129.79 93.16 3.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.645 -1.243 . . . . 0.46000000000000002 107.645 166.889 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.09 98.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.299 -1.371 . . . . 0.78000000000000003 107.299 169.408 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 147' ' ' GLY . 18.2 mt -79.89 123.06 27.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.038 -0.727 . . . . 1.8300000000000001 109.038 177.741 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -150.69 -48.07 0.12 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.824 -0.625 . . . . 3.5299999999999998 111.065 167.623 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.32 -117.8 3.52 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.61 -0.996 . . . . 1.1200000000000001 110.61 -174.898 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.85 -35.04 6.07 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.319 1.048 . . . . 3.7400000000000002 110.131 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.44 168.8 30.15 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-O 121.63 0.572 . . . . 1.1200000000000001 112.577 -177.466 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.47 -26.29 47.58 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.571 2.847 . . . . 1.8700000000000001 111.758 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 56.0 t -48.04 151.61 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.639 1.976 . . . . 0.71999999999999997 111.025 -178.603 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -156.01 118.32 4.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.396 0.678 . . . . 2.02 109.254 -175.529 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.77 167.72 35.35 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.868 -0.52 . . . . 0.47999999999999998 112.286 -178.838 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.8 mt -129.95 119.95 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.736 -1.209 . . . . 1.4199999999999999 107.736 177.921 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 20.8 mm -81.27 140.51 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.903 -1.147 . . . . 0.87 107.903 164.592 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -120.38 93.5 4.07 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 105.396 -2.075 . . . . 1.71 105.396 159.299 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.665 ' CE1' HD11 ' A' ' 112' ' ' ILE . 1.1 t80 -100.3 118.93 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.881 -1.896 . . . . 3.1099999999999999 105.881 -173.481 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -155.65 175.07 14.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.028 0.918 . . . . 3.9199999999999999 113.404 -173.911 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.84 169.87 23.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.807 -1.553 . . . . 3.1099999999999999 106.807 -173.51 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -93.79 -64.66 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.596 1.558 . . . . 4.7699999999999996 108.601 171.779 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -79.95 -178.58 6.55 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.458 1.103 . . . . 4.3099999999999996 111.375 178.368 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -87.7 -66.87 0.87 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.906 -1.146 . . . . 3.3100000000000001 107.906 155.69 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -75.74 63.23 1.6 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.045 1.338 . . . . 4.4100000000000001 111.723 -173.219 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.09 -177.48 27.55 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.319 -1.912 . . . . 1.9199999999999999 108.319 169.794 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.35 152.82 44.72 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.1 2.534 . . . . 1.48 110.412 174.782 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -82.65 158.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.547 -0.908 . . . . 0.96999999999999997 108.547 176.743 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -111.57 104.88 13.3 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.382 1.087 . . . . 2.73 108.601 162.297 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.523 HG22 ' CD2' ' A' ' 20' ' ' PHE . 58.8 t -97.26 105.22 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.883 1.673 . . . . 1.24 108.206 -175.048 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -128.01 164.27 22.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.693 0.627 . . . . 0.97999999999999998 112.693 176.706 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.5 42.69 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.516 -1.034 . . . . 0.70999999999999996 110.516 179.267 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -138.74 109.32 6.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.427 -1.694 . . . . 1.96 106.427 179.025 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.53 115.87 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.865 -1.531 . . . . 1.0800000000000001 106.865 -161.934 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -105.36 162.38 13.49 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.64 0.733 . . . . 3.7200000000000002 111.954 -173.806 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.65 79.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.201 -0.908 . . . . 0.57999999999999996 113.662 168.398 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.77 165.85 9.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.82 1.31 . . . . 0.63 108.839 167.972 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.93 160.75 25.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.188 -1.412 . . . . 1.8600000000000001 107.188 152.804 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.55 173.68 0.52 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.397 -0.814 . . . . 2.73 110.6 177.359 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.92 -159.26 46.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 123.747 0.689 . . . . 0.76000000000000001 112.465 170.028 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.49 141.49 55.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.609 1.564 . . . . 2.02 114.543 -169.493 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -145.29 119.62 9.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.97 1.708 . . . . 0.5 109.703 177.24 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.37 150.44 5.57 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.883 -0.887 . . . . 0.41999999999999998 110.883 171.699 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CE2' HD21 ' A' ' 117' ' ' LEU . 1.0 OUTLIER -141.58 93.12 2.53 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.939 -1.504 . . . . 2.4300000000000002 106.939 -173.292 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -130.39 173.39 10.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.217 -1.031 . . . . 0.64000000000000001 108.217 -165.475 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.9 t -124.42 118.27 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.39 -0.967 . . . . 2.1200000000000001 108.39 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -100.2 149.61 23.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.415 1.486 . . . . 0.88 107.912 175.847 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.45 34.24 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.931 0.892 . . . . 4.7300000000000004 112.445 177.743 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.3 tt0 -91.3 55.27 2.78 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 120.579 -1.326 . . . . 3.4900000000000002 110.817 -159.408 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -48.91 -41.79 34.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.348 1.459 . . . . 4.4900000000000002 111.906 -174.868 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -76.36 95.15 3.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.96 -1.126 . . . . 6.8099999999999996 107.96 174.21 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -119.36 47.32 1.72 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.641 -1.244 . . . . 5.2199999999999998 107.641 155.188 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.8 t -112.72 32.0 5.96 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.787 0.835 . . . . 4.3399999999999999 109.309 168.439 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.88 -50.14 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.742 1.617 . . . . 5.6900000000000004 108.505 -178.122 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.58 -176.22 46.19 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.643 -1.783 . . . . 3.6200000000000001 108.643 179.429 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.4 t -113.01 64.76 0.64 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.762 1.225 . . . . 2.8399999999999999 109.474 179.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m -144.14 55.27 1.29 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.433 -0.951 . . . . 4.6399999999999997 108.433 -170.333 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 m -159.71 -26.62 0.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.467 1.654 . . . . 3.2200000000000002 115.467 -131.388 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.46 175.15 9.21 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.477 1.511 . . . . 1.6799999999999999 109.809 167.233 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.83 -119.66 4.2 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.698 -0.961 . . . . 1.1599999999999999 110.698 -172.269 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.64 178.65 7.35 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.014 3.143 . . . . 0.85999999999999999 112.333 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -54.26 124.97 17.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.977 1.311 . . . . 1.25 108.898 174.582 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -30.73 113.88 0.11 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.653 1.581 . . . . 2.5 112.23 174.499 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.7 151.73 46.99 Favored Pre-proline 0 N--CA 1.446 -0.625 0 C-N-CA 124.675 1.19 . . . . 2.29 109.152 167.369 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.48 -30.91 52.15 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.42 2.08 . . . . 1.3 111.621 -178.989 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 tp -154.54 -69.72 0.13 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.145 0.429 . . . . 3.71 109.954 173.331 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -145.94 76.41 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.144 0.978 . . . . 1.8 110.411 -172.649 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -79.67 176.55 9.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.964 -0.754 . . . . 4.4500000000000002 108.964 165.28 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.978 -1.49 . . . . 3.2799999999999998 106.978 -179.558 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -106.64 126.9 52.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.132 0.573 . . . . 1.0600000000000001 111.495 175.017 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.25 3.95 8.3 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.683 1.611 . . . . 3.2200000000000002 111.461 173.581 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 -173.29 4.25 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.468 -1.019 . . . . 1.3799999999999999 111.291 -169.546 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.09 -9.43 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.641 2.227 . . . . 1.45 111.872 173.12 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -54.51 5.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.469 0.577 . . . . 4.0599999999999996 111.397 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.26 176.58 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.033 0.444 . . . . 2.6600000000000001 110.382 -179.335 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.54 -63.12 1.21 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.684 1.194 . . . . 5.6500000000000004 109.923 -179.885 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.49 148.5 33.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.573 -0.739 . . . . 3.3100000000000001 111.333 -161.949 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -159.29 147.01 17.41 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.095 -1.003 . . . . 3.7999999999999998 108.396 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.455 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.2 m80 -54.69 135.22 47.17 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.721 -1.955 . . . . 0.69999999999999996 105.721 157.462 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -62.09 -22.02 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.788 -0.449 . . . . 1.25 109.788 -178.13 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.83 44.93 1.57 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.809 0.719 . . . . 0.56000000000000005 114.337 162.709 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.72 121.77 45.96 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 106.643 -1.614 . . . . 1.9399999999999999 106.643 158.058 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.24 -71.13 0.46 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.422 -1.696 . . . . 1.73 106.422 154.399 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.32 -110.76 0.35 Allowed Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.536 -0.626 . . . . 0.69999999999999996 111.536 -176.575 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.66 167.35 26.66 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.848 1.659 . . . . 1.49 109.086 175.967 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.03 175.06 10.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 106.848 -1.538 . . . . 0.46000000000000002 106.848 170.553 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -122.89 142.93 50.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.936 -1.135 . . . . 1.9099999999999999 107.936 169.104 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 142.13 40.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.921 1.288 . . . . 0.82999999999999996 112.629 173.525 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.31 -88.15 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.158 0.983 . . . . 2.5099999999999998 111.688 -178.652 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -146.08 -42.32 0.21 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.595 0.591 . . . . 3.52 112.595 -158.251 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -83.49 23.27 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 124.059 1.885 . . . . 4.0599999999999996 110.163 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.42 24.94 57.08 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.563 -1.199 . . . . 1.03 110.479 -168.7 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.15 107.5 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.221 -1.029 . . . . 1.1899999999999999 108.221 -175.599 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.83 154.72 18.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.904 -1.147 . . . . 0.70999999999999996 107.904 156.187 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.57 139.11 50.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 102.218 -3.252 . . . . 2.8700000000000001 102.218 174.01 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.85 131.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.041 -1.466 . . . . 1.6699999999999999 107.041 170.678 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -158.22 61.73 0.45 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.649 1.98 . . . . 1.0700000000000001 107.678 178.39 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.0 mm -105.29 157.55 6.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.904 -1.146 . . . . 2.4399999999999999 107.904 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.2 102.94 4.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.187 -0.321 . . . . 2.2000000000000002 111.617 165.397 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.46 144.75 25.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.314 1.046 . . . . 2.0299999999999998 111.045 -178.639 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -105.63 -9.14 17.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.04 2.136 . . . . 1.6699999999999999 113.142 -176.213 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.41 -43.4 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.148 -1.056 . . . . 1.1200000000000001 108.148 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 pt -86.67 176.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.714 0.768 . . . . 1.3100000000000001 111.446 175.001 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.1 m -157.16 177.67 11.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.1 2.16 . . . . 2.0899999999999999 105.78 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.76 54.83 1.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.909 1.231 . . . . 2.46 111.995 172.844 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 p -91.07 -76.99 0.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.646 1.178 . . . . 3.6800000000000002 108.524 175.083 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.33 61.53 0.01 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.075 -1.61 . . . . 2.9199999999999999 109.075 -174.118 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -162.53 -105.52 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.499 1.12 . . . . 4.9000000000000004 108.154 -167.42 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -76.98 0.09 22.43 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.043 1.337 . . . . 4.3899999999999997 110.223 174.542 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 p -74.44 172.45 11.93 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 127.028 2.131 . . . . 1.1899999999999999 112.654 -175.786 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.665 HD11 ' CE1' ' A' ' 20' ' ' PHE . 1.1 pp -93.78 -6.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.001 -1.454 . . . . 2.1499999999999999 113.228 177.994 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.9 mm -43.81 119.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.973 . . . . 1.6799999999999999 110.371 -179.214 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.63 25.54 73.83 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.707 -0.496 . . . . 1.4199999999999999 113.089 177.055 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 149' ' ' ILE . 63.1 mtt-85 -104.06 -178.86 3.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.405 -1.702 . . . . 4.1799999999999997 106.405 166.244 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 m -116.02 118.79 33.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.082 0.401 . . . . 1.0800000000000001 110.108 178.119 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.449 HD21 ' CE2' ' A' ' 45' ' ' PHE . 4.4 tt -73.34 143.46 46.89 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.506 -1.294 . . . . 2.27 107.506 170.804 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -127.24 136.81 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.808 2.043 . . . . 0.40000000000000002 107.577 177.974 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG12 ' CE1' ' A' ' 45' ' ' PHE . 1.5 m -104.19 127.15 58.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.444 -0.947 . . . . 1.6299999999999999 108.444 164.572 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.24 160.29 14.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 116.066 1.876 . . . . 0.40000000000000002 116.066 -171.217 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -36.2 -68.03 0.15 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.579 2.352 . . . . 3.1200000000000001 112.522 172.952 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -126.09 -173.8 2.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.683 1.193 . . . . 2.48 110.188 -170.462 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.78 141.76 43.17 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.468 -0.567 . . . . 0.62 109.468 169.594 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.19 160.96 28.1 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.288 -1.005 . . . . 2.0 108.288 161.502 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.53 -22.34 62.63 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.715 -0.659 . . . . 2.9900000000000002 112.189 -176.042 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 56.36 51.96 10.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.137 1.335 . . . . 1.6599999999999999 109.68 -161.607 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 50.58 44.11 46.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.334 0.969 . . . . 1.5700000000000001 113.793 169.116 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -79.5 -30.87 42.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.235 1.014 . . . . 5.8700000000000001 111.088 179.147 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.38 -146.01 25.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.259 -1.136 . . . . 2.6400000000000001 110.259 -170.369 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.37 -72.37 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.444 -1.862 . . . . 2.1400000000000001 108.444 -169.075 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 109.81 8.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 104.488 -2.412 . . . . 2.75 104.488 161.592 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -35.9 66.87 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.559 . . . . 3.6499999999999999 110.391 178.654 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -28.6 -44.96 0.03 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.58 2.752 . . . . 2.6299999999999999 113.248 162.366 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -45.68 -60.92 1.93 Allowed 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.979 1.312 . . . . 2.75 109.489 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -72.26 -43.56 64.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.499 0.32 . . . . 1.22 110.152 178.829 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -52.91 -53.02 55.41 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.822 1.649 . . . . 2.5800000000000001 110.85 -170.578 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.455 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.251 1.0 OUTLIER -125.0 -47.71 1.78 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.067 0.547 . . . . 1.3500000000000001 111.207 173.483 . . . . . . . . 4 4 . 1 . 032 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.66 -26.29 1.06 Allowed Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.533 -0.627 . . . . 1.0900000000000001 111.533 -170.916 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.64 56.51 6.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.303 1.041 . . . . 2.0299999999999998 111.249 178.281 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.22 -5.96 57.24 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.389 0.514 . . . . 1.27 112.389 168.613 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.05 -170.84 43.82 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.054 -1.619 . . . . 1.04 109.054 -173.847 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -68.48 171.22 7.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.108 -1.046 . . . . 2.6800000000000002 113.016 -167.577 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.498 HH21 ' CD ' ' A' ' 50' ' ' GLU . 5.8 mmt-85 -66.79 142.17 57.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.171 2.188 . . . . 2.8900000000000001 109.316 175.126 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.9 -78.95 0.58 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.466 -1.309 . . . . 0.46000000000000002 107.466 166.501 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.479 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -109.71 150.23 28.6 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.651 -0.87 . . . . 0.76000000000000001 108.651 171.624 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 3.3 m -137.12 150.05 47.73 Favored 'General case' 0 N--CA 1.436 -1.135 0 O-C-N 125.462 1.727 . . . . 2.0800000000000001 106.66 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.441 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -148.67 123.5 1.67 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 109.454 -1.459 . . . . 0.90000000000000002 109.454 178.263 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.08 128.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.575 -1.269 . . . . 0.83999999999999997 107.575 168.562 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 115' ' ' ARG . 10.5 tt -103.92 117.06 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.645 0.736 . . . . 0.89000000000000001 110.95 -172.012 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.24 2.63 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-N 114.954 -1.021 . . . . 0.51000000000000001 115.388 178.133 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.8 mm -94.45 58.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.732 1.766 . . . . 0.75 111.589 -155.031 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.89 176.4 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.678 0.791 . . . . 1.26 110.024 167.84 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 104.148 -2.538 . . . . 4.3899999999999997 104.148 162.294 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 106.603 -1.628 . . . . 5.3899999999999997 106.603 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m 70.37 56.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 105.958 -1.867 . . . . 2.7000000000000002 105.958 -155.221 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -103.28 146.08 28.99 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.032 -0.985 . . . . 2.5800000000000001 111.272 -170.746 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.15 133.13 33.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.03 -1.1 . . . . 0.78000000000000003 108.03 165.57 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.12 146.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 106.852 -1.536 . . . . 0.67000000000000004 106.852 158.013 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -128.86 94.77 3.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.017 -1.105 . . . . 0.42999999999999999 108.017 162.55 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.67 96.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.407 1.083 . . . . 0.69999999999999996 108.284 170.469 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -91.71 121.55 33.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.431 -0.581 . . . . 0.93000000000000005 109.431 -179.212 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -130.84 -62.12 0.92 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.822 -0.807 . . . . 3.3999999999999999 108.822 174.268 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.26 -123.83 10.33 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 114.34 -1.3 . . . . 1.02 112.22 -170.296 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.22 -43.19 1.8 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.247 0.619 . . . . 3.4300000000000002 109.974 -150.153 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.99 165.61 8.43 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 109.439 -1.464 . . . . 0.82999999999999996 109.439 164.386 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.53 35.14 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.515 2.81 . . . . 1.0 112.954 -173.681 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -93.16 153.73 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.578 1.551 . . . . 0.71999999999999997 109.992 -171.962 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -155.08 107.16 2.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.217 1.407 . . . . 2.8999999999999999 107.543 175.376 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.0 166.03 29.35 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.664 -0.574 . . . . 0.45000000000000001 111.664 179.1 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 mm -132.17 117.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.934 -1.876 . . . . 1.8600000000000001 105.934 -178.368 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.63 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 32.1 mm -85.28 140.6 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.856 -1.535 . . . . 0.69999999999999996 106.856 165.879 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -120.88 105.1 10.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.518 -2.03 . . . . 1.51 105.518 164.914 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' CD2' HG22 ' A' ' 31' ' ' VAL . 10.0 t80 -115.76 110.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.482 -2.044 . . . . 3.2200000000000002 105.482 -171.397 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.33 167.42 30.43 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.659 0.742 . . . . 3.98 112.057 -174.672 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.96 -156.7 0.71 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.181 -2.526 . . . . 4.4000000000000004 104.181 169.493 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -110.67 -62.78 1.48 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.485 1.039 . . . . 4.2400000000000002 109.497 168.899 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.17 101.45 12.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.927 -1.509 . . . . 4.6100000000000003 106.927 -171.286 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 p -73.99 53.18 0.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.177 1.391 . . . . 2.5899999999999999 111.946 -177.391 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -156.08 34.74 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.199 1.8 . . . . 3.7999999999999998 108.196 165.238 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.72 -173.26 14.36 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.042 -1.623 . . . . 1.05 109.042 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.04 169.9 6.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.346 2.698 . . . . 1.55 111.765 177.252 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.83 154.38 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.863 -0.608 . . . . 0.76000000000000001 109.622 -178.842 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -104.46 113.5 27.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.209 -1.775 . . . . 2.6600000000000001 106.209 171.662 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 20' ' ' PHE . 21.9 t -115.25 90.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.786 -1.19 . . . . 1.1899999999999999 107.786 -168.798 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -109.59 150.66 27.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 123.457 0.473 . . . . 0.70999999999999996 110.067 -179.613 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.74 168.25 41.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.221 -1.151 . . . . 0.77000000000000002 110.221 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.6 m -139.63 107.5 5.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.281 -1.748 . . . . 2.1800000000000002 106.281 -179.387 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -115.77 123.02 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.89 -1.893 . . . . 0.83999999999999997 105.89 -161.047 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 162.83 20.74 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 118.651 0.659 . . . . 4.4900000000000002 110.966 -174.371 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.91 74.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.878 0.751 . . . . 0.71999999999999997 113.692 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -69.94 164.04 24.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.48 1.14 . . . . 0.63 109.151 167.633 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.85 156.78 19.81 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.098 -1.075 . . . . 1.8799999999999999 108.098 149.02 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.78 -180.0 0.31 Allowed 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.004 -1.06 . . . . 3.9399999999999999 110.4 176.1 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.11 -158.6 51.13 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.818 -0.551 . . . . 0.71999999999999997 112.1 168.087 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.43 146.86 30.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.948 1.299 . . . . 2.6800000000000002 110.219 -170.149 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.9 121.09 10.83 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.178 0.991 . . . . 0.51000000000000001 110.213 -177.257 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.15 147.58 26.45 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.914 -1.275 . . . . 0.40000000000000002 109.914 170.71 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 38.3 t80 -136.26 97.07 3.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.63 -1.619 . . . . 3.1099999999999999 106.63 -174.084 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.1 m170 -129.31 174.88 9.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.548 -1.278 . . . . 0.82999999999999996 107.548 -169.281 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 p -134.33 115.91 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.177 -1.416 . . . . 1.6899999999999999 107.177 170.203 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -82.28 -175.74 5.84 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.836 -1.542 . . . . 1.1499999999999999 106.836 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -70.92 -106.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.433 -0.951 . . . . 4.1299999999999999 108.433 172.802 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 44.5 66.07 0.94 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.75 0.82 . . . . 3.3700000000000001 110.513 -175.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -57.16 -22.8 42.97 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.698 1.199 . . . . 5.5899999999999999 110.896 170.074 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -118.15 115.06 24.03 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.158 1.783 . . . . 4.9299999999999997 108.556 -179.15 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -128.19 52.35 1.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.435 -1.32 . . . . 4.75 107.435 159.267 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.6 m -62.52 -29.28 70.44 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.635 -0.666 . . . . 4.9199999999999999 111.577 -179.229 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.86 -57.51 0.13 Allowed 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.719 0.807 . . . . 5.2699999999999996 109.686 177.718 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.15 172.89 53.23 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.111 -0.796 . . . . 4.29 111.111 175.427 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.4 t -162.88 160.57 25.14 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.071 -1.826 . . . . 2.8700000000000001 106.071 173.182 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.321 18.1 p 101.23 65.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 128.759 2.824 . . . . 5.5499999999999998 110.993 166.229 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.4 m -164.85 27.51 0.06 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.674 -1.148 . . . . 3.0 113.057 -134.058 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -161.56 146.95 13.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.85 1.66 . . . . 2.04 107.544 170.311 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -94.44 0.18 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.785 -0.926 . . . . 1.1299999999999999 110.785 -179.59 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -81.54 178.28 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.12 2.546 . . . . 0.97999999999999998 115.405 -166.226 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -65.86 64.86 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.613 2.365 . . . . 1.6899999999999999 112.46 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.6 t80 37.77 70.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.411 1.884 . . . . 2.7999999999999998 111.025 -177.275 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -96.33 105.26 21.18 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 118.271 -0.871 . . . . 2.71 109.338 -176.727 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.2 -36.15 17.38 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.058 1.838 . . . . 1.48 111.655 -175.094 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -141.71 -75.4 0.3 Allowed 'General case' 0 C--N 1.339 0.134 0 N-CA-C 108.687 -0.857 . . . . 3.02 108.687 177.825 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.6 p -156.55 58.34 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.68 0.753 . . . . 3.2400000000000002 110.512 -171.548 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -77.41 160.57 28.64 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.163 -1.421 . . . . 4.8700000000000001 107.163 162.133 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -133.84 152.01 51.73 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.242 1.417 . . . . 3.3799999999999999 108.178 -172.62 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -76.18 153.75 35.91 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.804 0.668 . . . . 0.92000000000000004 112.804 -169.245 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.13 163.88 36.24 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.964 -2.454 . . . . 2.2799999999999998 106.964 159.086 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.5 -170.35 11.76 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 117.524 0.662 . . . . 1.3799999999999999 112.493 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.98 -39.77 30.76 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.656 2.237 . . . . 1.5 109.797 178.158 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -66.87 -51.06 60.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.083 1.353 . . . . 4.9400000000000004 111.258 175.401 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -61.5 157.55 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.516 0.932 . . . . 2.1299999999999999 113.516 -161.678 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.13 -49.77 73.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.418 1.087 . . . . 4.4100000000000001 110.333 -179.313 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -78.1 170.04 17.26 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.845 -0.428 . . . . 3.29 109.845 177.488 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 165.24 133.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.927 2.491 . . . . 3.3900000000000001 106.584 -171.882 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.552 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.8 m80 -68.31 161.37 27.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 118.594 -1.242 . . . . 0.64000000000000001 107.947 167.962 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.54 44.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 122.985 1.374 . . . . 2.6200000000000001 110.498 165.303 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -169.0 36.72 0.2 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 124.816 1.198 . . . . 0.93000000000000005 110.984 167.458 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 133.72 28.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.33 -1.1 . . . . 2.46 108.712 163.337 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.9 mt -99.74 -46.02 5.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.014 -1.106 . . . . 1.99 108.014 168.757 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.24 -111.41 0.46 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.511 -0.852 . . . . 0.60999999999999999 111.347 178.28 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -155.11 158.41 38.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.164 1.386 . . . . 1.9099999999999999 109.375 -169.83 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.66 178.14 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.686 1.995 . . . . 0.45000000000000001 106.384 172.353 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -138.32 145.92 41.76 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.562 -0.903 . . . . 2.2799999999999998 108.562 171.301 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.83 139.79 39.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.446 1.099 . . . . 0.93999999999999995 110.885 170.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.76 -79.77 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 123.784 0.678 . . . . 2.9100000000000001 111.309 -174.861 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.65 -46.33 0.15 Allowed 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.744 0.817 . . . . 3.6499999999999999 111.151 -164.739 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.02 13.58 2.19 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.803 1.287 . . . . 2.6699999999999999 111.529 177.693 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.63 16.85 74.35 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.235 -0.916 . . . . 0.60999999999999999 111.224 -173.341 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -89.06 115.21 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.051 1.34 . . . . 0.83999999999999997 108.262 -179.53 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.59 168.09 9.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.906 1.683 . . . . 0.68999999999999995 108.367 162.242 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -126.8 149.13 49.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.202 -2.888 . . . . 2.98 103.202 -179.369 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.68 135.19 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 107.197 -1.408 . . . . 1.74 107.197 166.742 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.9 m -157.59 58.75 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.298 1.839 . . . . 0.98999999999999999 107.229 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.0 mt -101.88 154.04 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 123.886 0.875 . . . . 1.71 108.861 -174.424 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -133.45 137.98 45.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.364 -1.347 . . . . 2.3900000000000001 107.364 161.393 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.42 159.74 41.64 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.151 -1.426 . . . . 2.5 107.151 170.995 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -121.74 -1.96 9.4 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.808 2.043 . . . . 3.1699999999999999 113.199 -177.549 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.02 -31.2 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.458 1.027 . . . . 1.5700000000000001 108.236 176.574 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -99.94 175.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.683 1.193 . . . . 1.22 109.286 171.129 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.1 t -158.1 179.55 9.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.347 1.859 . . . . 2.3100000000000001 106.058 175.339 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -106.2 27.74 8.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.946 0.898 . . . . 2.8399999999999999 111.922 177.9 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 p -88.76 -74.72 0.46 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.371 1.068 . . . . 4.0999999999999996 110.887 -170.922 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 174.6 -163.05 33.38 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 106.0 -2.84 . . . . 3.0600000000000001 106.0 -171.87 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t70 47.72 -107.91 0.21 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.92 1.36 . . . . 4.4800000000000004 112.028 172.048 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -76.55 -3.93 40.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.644 1.178 . . . . 4.2699999999999996 112.278 -173.502 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.9 p -62.02 172.7 1.3 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.248 1.023 . . . . 1.51 112.232 173.378 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.8 pt -100.29 -5.31 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.348 -1.296 . . . . 2.0299999999999998 111.056 171.749 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 tp -46.73 128.81 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.725 0.81 . . . . 1.5900000000000001 109.383 176.906 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.79 -14.12 62.53 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.597 -1.113 . . . . 1.4299999999999999 113.744 -178.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -94.11 163.24 13.55 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.875 1.837 . . . . 4.0099999999999998 111.561 -169.745 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -88.74 108.74 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.898 0.479 . . . . 0.85999999999999999 111.184 -177.243 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.457 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -72.75 143.25 48.04 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.927 -0.768 . . . . 2.0600000000000001 108.927 174.281 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.1 t -130.27 127.78 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.687 1.195 . . . . 0.42999999999999999 109.212 -179.105 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.67 128.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 106.48 -1.674 . . . . 2.4199999999999999 106.48 161.643 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.458 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 76.6 m-70 -101.87 158.45 16.12 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 114.627 1.343 . . . . 0.39000000000000001 114.627 -175.782 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.8 -71.73 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.397 -0.819 . . . . 5.5300000000000002 111.152 176.835 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -79.6 -179.5 6.9 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.025 0.83 . . . . 3.9300000000000002 109.353 -177.247 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.43 157.31 26.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.75 109.818 169.631 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.83 160.49 5.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.043 -0.526 . . . . 2.6299999999999999 110.326 162.324 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.01 -33.02 74.65 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.921 0.711 . . . . 3.5099999999999998 112.921 176.181 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 73.34 -9.68 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.72 2.408 . . . . 1.9399999999999999 112.532 -168.92 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.52 43.42 8.5 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.142 -1.983 . . . . 2.3700000000000001 108.142 -168.197 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.26 -20.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.575 0.954 . . . . 5.8200000000000003 113.575 -175.0 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.9 -46.21 92.18 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 108.276 -1.93 . . . . 2.6499999999999999 108.276 169.898 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.55 36.01 57.84 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.583 0.611 . . . . 3.8999999999999999 111.64 175.926 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -69.64 -61.62 1.71 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.246 -1.39 . . . . 2.8100000000000001 107.246 -179.868 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 27.5 tt0 178.96 -55.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.694 2.798 . . . . 3.2999999999999998 105.124 166.795 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -48.01 -37.7 15.39 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.937 2.095 . . . . 2.8399999999999999 111.212 173.619 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.7 m -38.09 -65.18 0.35 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.87 1.668 . . . . 1.6299999999999999 110.754 164.302 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.9 p -71.73 -42.74 66.92 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.378 -0.826 . . . . 1.76 110.77 -176.138 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 132' ' ' GLU . 60.9 mttm -52.78 -51.34 61.08 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 123.528 0.731 . . . . 2.7999999999999998 110.837 -175.248 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.552 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 15.2 t -136.92 -48.34 0.61 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.246 -1.359 . . . . 2.5099999999999998 111.906 176.162 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.11 25.7 0.08 OUTLIER Glycine 0 N--CA 1.473 1.119 0 CA-C-N 120.52 1.509 . . . . 1.21 115.642 177.107 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.28 0.4 OUTLIER 3.37 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.54 2.336 . . . . 3.4199999999999999 116.601 -167.693 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -63.22 -28.86 70.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.55 1.54 . . . . 0.96999999999999997 113.965 -177.605 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.79 171.55 44.85 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.055 -1.618 . . . . 1.1000000000000001 109.055 -160.119 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m -53.03 147.92 8.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.538 1.535 . . . . 1.51 113.923 -170.342 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -54.79 136.62 46.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.844 1.258 . . . . 2.7400000000000002 108.645 166.79 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.2 mt -107.88 -64.88 1.16 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.335 -0.987 . . . . 0.68999999999999995 108.335 167.054 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.95 162.39 13.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.057 -0.974 . . . . 1.0800000000000001 110.847 -173.691 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.57 156.3 34.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.166 0.986 . . . . 1.9199999999999999 109.552 169.119 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.82 138.95 3.53 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 106.613 -2.595 . . . . 0.71999999999999997 106.613 172.909 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.63 132.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.551 -0.907 . . . . 0.75 108.551 177.554 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.7 tt -86.17 134.12 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 122.832 0.453 . . . . 0.81000000000000005 111.252 -178.765 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 140.0 5.84 1.15 Allowed Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.166 0.889 . . . . 0.53000000000000003 114.236 175.796 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.75 55.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.713 1.757 . . . . 0.73999999999999999 110.062 -158.321 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.76 177.82 10.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.43 1.092 . . . . 1.6299999999999999 109.873 170.089 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 103.449 -2.797 . . . . 6.2599999999999998 103.449 146.837 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 107.357 -1.349 . . . . 6.0199999999999996 107.357 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -158.1 120.02 3.64 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 119.39 0.996 . . . . 3.6000000000000001 109.16 -178.083 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -102.97 161.67 13.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.124 1.369 . . . . 4.1699999999999999 109.529 178.563 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.42 156.09 44.65 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.168 0.987 . . . . 0.93000000000000005 108.945 154.867 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.45 150.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 106.674 -1.602 . . . . 0.90000000000000002 106.674 158.435 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.64 102.08 4.65 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 108.446 -0.946 . . . . 0.46999999999999997 108.446 157.102 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.15 102.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.208 -1.404 . . . . 0.60999999999999999 107.208 167.354 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -87.36 126.26 34.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.882 -1.155 . . . . 1.0 107.882 177.509 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -150.92 -53.4 0.14 Allowed 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.481 0.312 . . . . 3.3599999999999999 110.629 -175.872 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.62 -114.33 1.05 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.763 1.173 . . . . 0.72999999999999998 112.986 -177.163 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -122.54 -52.45 1.92 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.496 1.118 . . . . 3.8100000000000001 110.724 -168.489 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.78 163.76 13.84 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.705 0.669 . . . . 0.84999999999999998 112.225 -175.067 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.45 64.35 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.271 3.314 . . . . 2.1299999999999999 110.864 -176.603 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t -141.64 146.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.752 2.021 . . . . 0.80000000000000004 106.4 -171.633 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -155.59 136.75 13.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.656 -0.868 . . . . 4.0300000000000002 108.656 176.812 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.77 174.58 44.63 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.129 -0.557 . . . . 0.46999999999999997 111.92 175.374 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.84 118.3 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.082 -1.081 . . . . 1.1000000000000001 108.082 -179.119 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.1 137.49 22.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 105.804 -1.925 . . . . 0.85999999999999999 105.804 165.065 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.33 58.73 1.66 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.742 -0.836 . . . . 2.8700000000000001 108.742 178.004 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.55 168.42 19.81 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.18 -1.008 . . . . 3.6800000000000002 112.162 -168.597 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -144.72 150.31 37.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.706 -1.133 . . . . 3.98 108.146 177.912 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.427 ' NE2' ' H ' ' A' ' 27' ' ' GLY . 32.6 tt0 -151.26 93.89 1.96 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.448 -1.251 . . . . 3.5899999999999999 108.229 167.506 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -49.21 -39.85 31.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.588 1.329 . . . . 5.2000000000000002 114.588 -178.604 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -87.21 148.89 24.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.461 1.104 . . . . 5.1100000000000003 110.239 -176.356 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -0.53 18.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.203 1.801 . . . . 3.27 114.935 -173.678 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -170.13 53.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.844 1.656 . . . . 4.6900000000000004 111.218 170.96 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.427 ' H ' ' NE2' ' A' ' 22' ' ' GLN . . . -108.42 -157.7 19.12 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.116 1.341 . . . . 1.1200000000000001 110.722 178.193 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -89.34 141.37 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.06 3.84 . . . . 1.3500000000000001 111.053 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.17 136.18 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.916 -0.401 . . . . 1.1799999999999999 109.916 -175.965 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -90.29 91.92 8.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.452 -0.944 . . . . 2.54 108.452 173.815 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.4 t -90.57 86.0 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.764 0.826 . . . . 1.3500000000000001 110.419 -170.41 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -102.96 139.51 38.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.148 0.499 . . . . 0.81999999999999995 111.572 173.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.04 41.35 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.066 1.793 . . . . 0.68000000000000005 108.799 170.384 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.8 m -139.54 80.43 1.77 Allowed 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 107.702 -1.221 . . . . 2.3999999999999999 107.702 -176.752 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.78 119.42 33.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.908 -1.145 . . . . 1.22 107.908 -169.091 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.92 162.02 13.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.395 0.678 . . . . 3.6400000000000001 110.705 -175.218 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.59 -10.77 64.85 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.819 0.687 . . . . 1.4399999999999999 114.819 167.276 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.3 154.94 4.09 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.868 1.334 . . . . 1.1299999999999999 110.87 176.874 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -65.59 153.13 42.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.94 -1.1 . . . . 1.6399999999999999 108.231 158.927 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -52.74 156.24 2.01 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.344 1.057 . . . . 2.7999999999999998 112.073 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 -158.2 31.69 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.276 -0.874 . . . . 0.56999999999999995 112.683 167.964 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.91 142.54 36.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.882 0.873 . . . . 2.3799999999999999 110.891 -165.492 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -142.04 130.35 22.3 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.775 1.23 . . . . 0.56999999999999995 110.594 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 148.23 36.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.91 -0.876 . . . . 0.46999999999999997 110.91 170.783 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 52.0 t80 -146.91 96.72 2.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.275 1.43 . . . . 2.6699999999999999 107.798 -171.453 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.553 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 40.6 m80 -131.32 170.93 13.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.227 -0.657 . . . . 0.68999999999999995 109.227 -164.564 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.58 108.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.767 -1.198 . . . . 2.3500000000000001 107.767 173.919 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.421 ' CD2' HG21 ' A' ' 118' ' ' VAL . 67.6 m-70 -81.52 168.0 18.72 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.0 -1.111 . . . . 1.1000000000000001 108.0 168.57 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.02 -96.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.642 -1.244 . . . . 4.7199999999999998 107.642 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 60' ' ' ALA . 4.1 mt-10 54.99 65.06 1.6 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.354 0.662 . . . . 3.2400000000000002 112.581 160.326 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.95 -95.93 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.499 -0.751 . . . . 4.7599999999999998 110.777 176.764 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -84.87 58.81 5.2 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.825 1.25 . . . . 5.7599999999999998 110.724 -168.522 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.25 -53.3 6.16 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.404 0.621 . . . . 5.0899999999999999 109.401 -173.146 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t 179.85 -51.09 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.428 1.891 . . . . 4.7400000000000002 108.463 -179.066 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.13 -58.12 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.304 1.441 . . . . 5.8799999999999999 109.165 176.939 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.56 -163.03 36.44 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.856 -0.898 . . . . 3.8599999999999999 110.856 176.308 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 96.0 m -66.97 154.16 41.81 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.317 1.047 . . . . 2.96 109.982 175.187 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.08 15.12 0.13 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 115.214 1.561 . . . . 3.9399999999999999 115.214 167.756 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.7 m -172.82 -56.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 118.473 2.768 . . . . 2.5699999999999998 118.473 -127.891 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.407 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . -72.21 -41.62 66.69 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.953 -0.467 . . . . 3.5 111.921 -162.363 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.31 -116.22 4.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 116.954 -2.025 . . . . 1.0600000000000001 109.142 -172.417 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.99 179.95 4.42 Favored 'Trans proline' 0 C--N 1.348 0.516 1 C-N-CA 125.337 4.025 . . . . 1.1499999999999999 115.359 -170.576 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -67.74 99.27 0.79 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.384 1.474 . . . . 1.4299999999999999 108.722 -179.231 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -9.52 102.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.127 2.171 . . . . 1.9199999999999999 113.744 172.932 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -124.47 136.8 28.23 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 127.458 2.303 . . . . 3.1000000000000001 108.13 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.51 -47.43 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.101 1.868 . . . . 1.0800000000000001 109.218 174.812 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.0 -70.97 0.47 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.571 -1.27 . . . . 2.6600000000000001 107.571 170.932 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.2 t -154.6 90.79 1.34 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.345 -0.613 . . . . 2.79 109.345 -178.552 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -84.64 165.66 17.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.39 -1.337 . . . . 4.6600000000000001 107.39 146.669 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -116.93 170.46 8.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.579 -1.637 . . . . 3.1000000000000001 106.579 174.303 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -84.33 157.17 21.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.083 0.468 . . . . 0.81000000000000005 110.808 -179.531 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.62 158.5 31.47 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 104.702 -3.359 . . . . 1.97 104.702 160.83 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.91 174.59 8.54 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.325 -1.11 . . . . 1.8200000000000001 110.325 170.821 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.15 -29.7 89.7 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.045 1.83 . . . . 1.3999999999999999 110.176 169.893 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.87 -52.11 66.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.653 0.781 . . . . 3.96 110.98 171.305 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -73.83 164.81 26.15 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.718 0.636 . . . . 2.1600000000000001 111.177 -178.169 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -89.48 -36.09 15.6 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.457 1.103 . . . . 5.54 112.674 -171.607 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -75.19 166.04 24.25 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.498 -1.297 . . . . 3.04 107.498 165.857 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 152.21 127.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.387 2.675 . . . . 3.5699999999999998 104.811 -161.142 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.477 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.0 m80 -58.48 149.92 23.98 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.863 -1.162 . . . . 0.57999999999999996 107.863 174.627 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.46 -32.79 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.07 -0.652 . . . . 1.25 109.848 -175.987 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.5 52.53 2.07 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.308 -0.718 . . . . 0.59999999999999998 113.114 165.642 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -127.42 117.17 21.64 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.186 1.493 . . . . 2.4199999999999999 108.275 164.201 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 84' ' ' LEU . 3.6 mm? -81.39 -53.17 6.54 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.655 -0.869 . . . . 1.5800000000000001 108.655 161.759 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.62 -105.25 0.27 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.81 -0.71 . . . . 0.65000000000000002 112.95 175.218 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.36 155.52 32.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.876 1.271 . . . . 3.6600000000000001 109.059 -166.317 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.97 163.1 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.477 1.111 . . . . 0.65000000000000002 110.41 -175.836 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 m -116.49 103.02 10.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.967 2.107 . . . . 2.79 109.632 -169.137 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.11 135.38 36.83 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.669 -0.644 . . . . 0.56000000000000005 112.225 176.4 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.58 -92.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.741 1.616 . . . . 4.0499999999999998 110.438 175.505 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -177.21 -26.71 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.658 1.983 . . . . 3.4199999999999999 112.548 -165.112 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -76.06 9.06 2.68 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.831 1.777 . . . . 3.7999999999999998 108.442 148.599 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.67 26.63 72.98 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 119.782 -1.824 . . . . 1.1100000000000001 109.996 178.154 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -84.11 108.48 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.219 -1.4 . . . . 1.3 107.219 -175.795 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.46 155.31 28.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.022 1.329 . . . . 1.4099999999999999 109.129 171.636 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -102.81 58.49 0.78 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.325 2.25 . . . . 6.5199999999999996 107.765 -164.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.98 68.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.397 -0.819 . . . . 1.46 110.792 -161.256 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -121.45 75.45 1.18 Allowed 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.79 1.636 . . . . 0.95999999999999996 108.796 179.099 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.0 mm -106.18 155.31 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.26 1.024 . . . . 1.8100000000000001 109.476 -174.613 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -146.5 122.89 10.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.13 -1.434 . . . . 3.3700000000000001 107.13 168.375 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.88 158.45 25.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.424 1.089 . . . . 2.1000000000000001 109.241 173.14 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -127.6 29.67 5.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.069 1.348 . . . . 1.3600000000000001 111.785 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.18 -49.3 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.667 -1.234 . . . . 1.0900000000000001 107.667 171.312 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.95 174.11 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.558 0.694 . . . . 0.93999999999999995 110.178 171.255 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -156.83 -179.89 8.64 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.178 -1.786 . . . . 2.3500000000000001 106.178 175.315 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.405 HD22 ' HB3' ' A' ' 22' ' ' GLN . 0.7 OUTLIER -110.77 14.4 22.23 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 2.46 112.197 173.963 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.2 t -145.53 134.09 22.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.509 1.124 . . . . 3.02 108.929 -166.7 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.67 132.96 0.28 Allowed Glycine 0 CA--C 1.533 1.196 0 N-CA-C 109.596 -1.402 . . . . 2.5899999999999999 109.596 -168.875 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -29.03 -60.5 0.13 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.179 1.792 . . . . 6.0999999999999996 113.134 -170.724 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -74.13 1.99 9.94 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.588 0.218 . . . . 3.79 111.588 -161.672 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.7 m -47.36 173.47 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 122.919 1.342 . . . . 2.0800000000000001 112.586 149.434 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.89 -6.94 10.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 114.702 -1.136 . . . . 1.9099999999999999 111.094 175.309 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 tp -44.26 131.65 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.331 1.052 . . . . 1.6699999999999999 110.386 172.088 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.87 -25.23 7.72 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.909 0.766 . . . . 1.5900000000000001 112.65 -176.441 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -87.18 162.93 17.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.758 1.279 . . . . 4.1799999999999997 110.333 -166.855 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -94.01 113.61 25.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.087 0.555 . . . . 0.90000000000000002 110.758 -172.544 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.427 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -70.21 141.28 52.56 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.385 -1.339 . . . . 2.0699999999999998 107.385 167.403 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 48' ' ' HIS . 88.4 t -126.37 133.1 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 126.125 1.77 . . . . 0.35999999999999999 109.211 175.653 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.1 t -98.13 122.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 125.799 1.64 . . . . 2.2400000000000002 106.929 165.213 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.435 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 64.9 m-70 -97.45 156.76 16.33 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 116.284 1.957 . . . . 0.44 116.284 -174.508 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -34.18 -90.39 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 130.232 3.413 . . . . 3.7000000000000002 112.211 168.06 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -174.49 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.873 0.845 . . . . 4.5 109.418 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.54 154.93 10.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.556 -1.202 . . . . 0.97999999999999998 110.099 164.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.06 161.47 8.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.974 -1.012 . . . . 2.3500000000000001 108.93 158.182 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -86.64 -30.49 21.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.988 1.715 . . . . 3.0 111.081 177.183 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 76.16 -1.93 2.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.693 2.397 . . . . 1.9099999999999999 112.982 -172.8 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.61 30.48 4.61 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.866 1.212 . . . . 1.4399999999999999 113.123 163.151 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -129.56 -16.62 3.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.881 1.272 . . . . 4.96 112.823 -173.946 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.91 124.85 31.27 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.33 0.968 . . . . 2.0800000000000001 111.885 175.704 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.02 -29.83 62.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.604 0.621 . . . . 2.77 111.81 175.805 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -53.24 98.63 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.268 1.027 . . . . 2.4399999999999999 109.531 163.847 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -35.61 -43.26 0.27 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 127.013 2.125 . . . . 4.0199999999999996 113.458 -178.711 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -37.88 -37.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.107 1.763 . . . . 2.6400000000000001 112.668 175.31 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.2 t -50.72 -77.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.159 0.984 . . . . 2.52 110.709 169.726 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 t -58.4 -38.32 77.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.771 -1.205 . . . . 2.6099999999999999 110.959 -177.01 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -59.38 -51.43 69.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.323 1.049 . . . . 4.9900000000000002 110.887 -177.445 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.477 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.281 0.1 OUTLIER -129.72 -54.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.891 0.477 . . . . 1.1699999999999999 112.156 174.504 . . . . . . . . 4 4 . 1 . 034 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.64 -16.24 0.26 Allowed Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.073 0.851 . . . . 0.91000000000000003 113.252 179.078 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.87 52.22 9.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.316 . . . . 2.0899999999999999 110.718 -176.651 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.553 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.41 -50.45 71.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.039 0.936 . . . . 0.93000000000000005 109.921 169.356 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 115.46 -172.09 14.04 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 106.99 -2.444 . . . . 0.93999999999999995 106.99 -168.419 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.6 m -60.93 155.35 20.07 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.388 1.475 . . . . 1.26 113.049 -171.19 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -61.1 135.57 57.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.323 1.449 . . . . 2.98 108.867 169.538 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.2 mt -111.01 -76.57 0.6 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.678 1.126 . . . . 0.45000000000000001 108.753 168.859 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.05 140.41 37.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.205 -1.406 . . . . 0.68999999999999995 107.205 173.444 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 66.7 m -127.3 159.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.738 -1.578 . . . . 2.1099999999999999 106.738 173.285 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.93 132.85 2.59 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.69999999999999996 110.951 168.201 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.89 136.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.619 1.167 . . . . 0.63 109.037 171.228 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.89 144.15 14.66 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.115 0 C-N-CA 123.222 0.609 . . . . 0.92000000000000004 111.653 -179.01 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.28 0.8 5.81 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.737 0.684 . . . . 0.76000000000000001 113.451 175.116 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.8 mm -87.82 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.499 1.149 . . . . 0.83999999999999997 110.91 -161.187 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.28 175.06 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.335 1.054 . . . . 1.45 110.22 171.489 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 104.271 -2.492 . . . . 4.6299999999999999 104.271 167.244 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.786 0.291 . . . . 6.29 111.786 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.9 p -105.01 85.86 2.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.469 1.508 . . . . 3.1800000000000002 107.235 -179.248 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 153.01 29.9 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.886 0.741 . . . . 3.3999999999999999 111.353 -171.572 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.81 25.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.591 -1.262 . . . . 0.69999999999999996 107.591 161.058 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.9 t -103.88 145.11 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.778 -1.193 . . . . 0.66000000000000003 107.778 165.206 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.95 97.65 5.04 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.77 -0.826 . . . . 0.40999999999999998 108.77 155.696 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.06 107.81 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.925 -1.509 . . . . 0.66000000000000003 106.925 162.735 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.1 128.21 35.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.939 -1.134 . . . . 0.98999999999999999 107.939 175.813 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -149.34 -52.02 0.16 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.965 0.412 . . . . 3.5600000000000001 110.663 172.278 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.71 -119.22 4.86 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.52 -0.764 . . . . 0.93000000000000005 111.526 -175.648 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.38 -42.66 2.65 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.806 1.242 . . . . 3.1000000000000001 110.353 -165.821 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.49 166.99 10.69 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 123.825 0.726 . . . . 0.82999999999999996 111.309 177.411 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.38 -21.65 53.62 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.407 2.738 . . . . 1.1599999999999999 111.993 179.584 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 89.6 t -50.01 141.77 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.828 1.251 . . . . 0.97999999999999998 110.822 177.112 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.56 125.09 6.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.909 -1.145 . . . . 2.0299999999999998 107.909 -175.752 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.65 172.67 40.44 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 121.764 -0.585 . . . . 0.52000000000000002 112.52 -177.106 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.31 130.96 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.775 0.83 . . . . 1.22 108.877 176.577 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.24 137.9 23.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.497 -1.298 . . . . 0.70999999999999996 107.497 163.543 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -119.43 99.98 7.02 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.574 -1.269 . . . . 1.8 107.574 166.952 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.569 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -87.66 118.02 26.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.698 1.199 . . . . 2.52 108.566 -178.981 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -148.28 164.72 33.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.014 0.824 . . . . 3.6000000000000001 109.419 167.609 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.66 164.5 38.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.255 1.422 . . . . 4.6500000000000004 107.273 177.265 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -51.22 -46.72 62.33 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.987 0.915 . . . . 4.6799999999999997 112.076 178.728 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -114.31 164.02 14.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.715 -1.217 . . . . 5.8600000000000003 107.715 179.847 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.0 p -69.2 55.14 0.1 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.023 1.329 . . . . 3.21 109.158 163.466 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 179.4 -153.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.578 1.951 . . . . 4.8099999999999996 106.619 -165.937 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.25 -178.09 0.4 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 127.191 2.329 . . . . 1.02 115.268 175.022 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.72 110.23 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.601 2.867 . . . . 1.5600000000000001 109.917 -175.446 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 20' ' ' PHE . 4.0 t -79.63 133.03 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.818 -0.353 . . . . 1.3999999999999999 111.161 -164.655 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -95.97 101.76 13.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.99 -1.485 . . . . 3.6099999999999999 106.99 -174.381 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.569 HG22 ' CE1' ' A' ' 20' ' ' PHE . 25.4 t -89.0 90.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.77 1.228 . . . . 1.1499999999999999 107.877 -173.287 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -97.77 131.41 44.32 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 123.738 0.649 . . . . 1.45 109.271 169.425 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 163.21 30.79 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.177 -0.769 . . . . 0.78000000000000003 111.177 -179.422 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -133.4 99.82 4.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 2.25 106.522 -171.805 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.15 140.59 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.534 1.134 . . . . 0.93000000000000005 108.647 -169.775 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -145.0 -178.02 5.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.709 0.766 . . . . 3.6800000000000002 112.967 169.56 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.24 75.44 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.922 1.249 . . . . 0.58999999999999997 112.598 -179.025 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -77.62 -157.63 0.1 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.615 -0.883 . . . . 0.81000000000000005 108.615 173.185 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.6 m -143.82 144.43 31.77 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.126 -2.546 . . . . 2.7000000000000002 104.126 168.78 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -40.87 138.04 1.11 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.723 2.409 . . . . 2.6899999999999999 112.857 -168.772 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.32 -171.38 29.45 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.128 -0.487 . . . . 0.59999999999999998 111.979 174.243 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.28 153.19 40.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.663 0.986 . . . . 2.2599999999999998 113.663 -163.155 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.99 126.55 14.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.218 1.807 . . . . 0.52000000000000002 109.323 -179.261 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.65 155.58 10.98 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.658 -0.977 . . . . 0.34999999999999998 110.658 165.78 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 117' ' ' LEU . 1.8 t80 -152.38 92.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.143 1.377 . . . . 2.4199999999999999 107.655 -170.657 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -134.45 161.91 33.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.785 -0.82 . . . . 0.53000000000000003 108.785 -161.03 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.3 m -113.58 140.75 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.906 0.775 . . . . 2.0 109.11 168.99 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -111.52 172.06 7.11 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.282 1.033 . . . . 1.28 111.252 -168.825 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -58.02 -21.59 45.88 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.763 0.825 . . . . 5.9299999999999997 113.019 173.209 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -50.99 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.655 1.982 . . . . 3.3700000000000001 111.133 -179.246 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.3 174.49 2.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 129.295 3.038 . . . . 6.0300000000000002 113.671 178.871 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -90.27 117.37 28.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.815 1.246 . . . . 7.3700000000000001 109.902 172.484 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -138.78 -63.74 0.53 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.903 1.681 . . . . 5.8600000000000003 109.734 176.679 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t -174.61 -51.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.575 1.55 . . . . 3.8799999999999999 109.386 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.64 -43.06 19.09 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.97 0.908 . . . . 4.6600000000000001 109.139 175.078 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.01 -72.21 2.11 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 124.439 1.019 . . . . 5.5199999999999996 111.082 173.564 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.9 t -78.5 56.54 1.8 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.52 1.528 . . . . 3.2200000000000002 111.37 -168.989 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -117.36 -0.08 12.08 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.286 1.217 . . . . 4.9299999999999997 114.286 -163.127 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.5 t 174.29 51.28 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.176 1.917 . . . . 3.79 116.176 -120.401 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.6 164.24 16.92 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 121.249 -0.907 . . . . 1.95 110.456 176.052 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.25 -91.39 1.56 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.312 -2.315 . . . . 1.47 107.312 169.676 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 179.71 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 124.898 3.732 . . . . 1.1599999999999999 115.066 -176.872 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -82.25 60.64 5.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.297 1.439 . . . . 2.0099999999999998 110.44 -170.701 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.4 t80 53.6 72.69 0.42 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.048 1.339 . . . . 3.2599999999999998 108.323 -170.883 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -97.73 98.32 5.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 108.997 -0.742 . . . . 2.8199999999999998 108.997 175.22 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.06 -38.37 7.24 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.196 1.93 . . . . 2.0 111.468 -173.559 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.72 -65.34 0.56 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.712 0.805 . . . . 2.9900000000000002 109.456 173.409 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 m -163.22 100.45 0.95 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.108 -1.441 . . . . 1.5800000000000001 107.108 -171.303 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.6 mmt-85 -126.23 163.0 24.15 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.18 0.992 . . . . 5.8099999999999996 109.86 170.228 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -116.25 149.53 39.05 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.38 1.472 . . . . 3.48 108.362 -172.527 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -78.43 153.57 31.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 112.509 -172.57 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.64 152.26 10.58 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 105.563 -3.015 . . . . 3.02 105.563 172.081 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.89 -133.99 7.05 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.067 -1.613 . . . . 1.77 109.067 177.294 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.6 -52.3 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.768 1.646 . . . . 1.6799999999999999 110.212 173.706 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.94 -34.76 78.16 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.081 1.141 . . . . 4.9800000000000004 114.081 -167.072 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.73 175.83 2.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.698 0.285 . . . . 1.99 110.884 -174.582 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.83 -48.13 11.12 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 4.4000000000000004 109.102 168.074 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -79.64 171.04 15.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.804 0.842 . . . . 3.6699999999999999 110.439 -176.797 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 174.05 145.37 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.41 2.284 . . . . 3.5800000000000001 110.037 171.54 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.548 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.2 m80 -57.83 143.16 43.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.204 -1.776 . . . . 0.58999999999999997 106.204 160.113 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -52.59 -27.29 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.369 -0.378 . . . . 1.1499999999999999 110.589 174.545 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.55 28.76 12.38 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.49 -1.172 . . . . 0.64000000000000001 115.071 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -94.79 127.81 41.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.455 2.128 . . . . 1.8400000000000001 107.421 159.653 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.85 -54.34 4.95 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.113 -1.44 . . . . 1.8600000000000001 107.113 151.868 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 153.24 -116.44 0.74 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.394 -1.482 . . . . 0.70999999999999996 109.394 173.438 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -139.46 160.51 39.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.249 1.02 . . . . 1.9399999999999999 110.34 -174.945 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.86 178.09 5.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.451 -1.685 . . . . 0.46000000000000002 106.451 171.245 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -129.99 147.1 51.7 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.559 -0.534 . . . . 2.2400000000000002 109.559 164.897 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.93 146.6 32.02 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.46 -0.941 . . . . 0.72999999999999998 108.46 162.092 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.15 -88.47 0.09 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.524 1.14 . . . . 2.8900000000000001 109.619 177.187 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -137.54 -51.18 0.63 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.949 1.3 . . . . 4.2300000000000004 110.542 -174.399 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.92 15.49 1.79 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.846 1.308 . . . . 2.7000000000000002 111.635 -174.265 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.3 10.11 69.18 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.358 -0.838 . . . . 0.78000000000000003 111.309 -171.625 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.6 140.69 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.036 -1.468 . . . . 0.75 107.036 173.904 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.86 175.9 7.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.073 0.949 . . . . 1.0800000000000001 109.262 174.267 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -110.59 148.42 32.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 103.732 -2.692 . . . . 3.9399999999999999 103.732 176.315 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.46 94.58 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.143 -1.058 . . . . 1.1499999999999999 108.143 153.16 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.7 m -122.04 76.99 1.34 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.217 1.407 . . . . 0.88 109.287 170.818 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.42 157.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.574 -0.528 . . . . 1.5700000000000001 109.574 179.909 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -144.68 89.41 1.98 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.149 0.58 . . . . 3.0299999999999998 110.654 166.684 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.84 162.37 26.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.896 -0.409 . . . . 2.2000000000000002 109.896 172.852 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 p -124.67 7.17 8.18 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.019 1.328 . . . . 1.6499999999999999 113.159 179.321 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.88 -51.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 119.076 0.853 . . . . 1.1699999999999999 108.773 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.39 159.54 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.407 0.623 . . . . 1.01 111.23 -177.7 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.1 p -120.06 177.4 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.266 2.226 . . . . 2.9300000000000002 107.632 175.943 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -112.26 27.62 9.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.36 0.664 . . . . 2.5600000000000001 110.944 166.767 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.3 t -155.63 162.12 40.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.409 -0.589 . . . . 2.9100000000000001 109.409 177.89 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.56 148.05 0.19 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.64 1.114 . . . . 2.8799999999999999 110.515 -169.235 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -70.6 -3.18 16.94 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.854 -1.38 . . . . 7.5999999999999996 113.362 -173.328 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -76.97 -16.61 59.29 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 120.826 -1.171 . . . . 3.2599999999999998 110.047 169.936 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.6 p -67.69 175.58 2.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.776 1.274 . . . . 1.9199999999999999 111.709 176.149 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.59 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -77.48 -7.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.443 -1.708 . . . . 2.1400000000000001 110.836 170.971 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.8 mm -61.06 128.55 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 119.978 1.263 . . . . 2.0899999999999999 108.404 -177.481 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.38 33.38 84.39 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 112.036 -0.426 . . . . 1.6799999999999999 112.036 -171.373 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -105.94 163.94 12.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.262 -1.755 . . . . 4.9800000000000004 106.262 149.814 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.2 m -92.59 123.88 36.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.406 1.083 . . . . 0.88 108.434 171.795 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.532 HD21 ' CE2' ' A' ' 45' ' ' PHE . 5.6 tt -80.47 145.99 31.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.102 -1.073 . . . . 2.4199999999999999 108.102 167.087 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.73 133.47 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 127.549 2.34 . . . . 0.35999999999999999 107.107 -177.62 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.41 118.34 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.564 -1.643 . . . . 1.6699999999999999 106.564 167.367 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -90.99 159.43 16.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.1 1.889 . . . . 0.34999999999999998 116.1 -168.572 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -33.01 -83.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.693 2.797 . . . . 3.3500000000000001 112.617 166.145 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -105.27 -179.23 3.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.542 0.737 . . . . 2.73 109.591 -170.231 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.0 137.76 55.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.553 -0.906 . . . . 0.63 108.553 167.899 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 160.95 30.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.622 -0.881 . . . . 2.1800000000000002 108.622 163.436 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -15.24 54.07 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.863 1.06 . . . . 3.5800000000000001 113.863 -170.353 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 64.45 4.23 2.16 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.739 -1.226 . . . . 1.73 113.836 -173.022 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.28 60.39 1.06 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 121.242 1.837 . . . . 1.8799999999999999 111.434 167.208 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.82 -51.76 0.37 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.345 1.858 . . . . 5.7300000000000004 110.308 -175.592 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -43.84 122.69 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.619 1.58 . . . . 1.9399999999999999 113.181 -177.973 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.04 -22.99 65.47 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.365 0.507 . . . . 3.2400000000000002 112.79 179.234 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -65.43 102.83 0.74 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.982 0.891 . . . . 2.27 109.055 174.775 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -19.31 -64.34 0.02 OUTLIER 'General case' 0 C--N 1.341 0.236 0 C-N-CA 127.857 2.463 . . . . 3.48 113.899 -172.264 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -37.72 -42.98 0.61 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.549 2.34 . . . . 3.5299999999999998 112.568 -177.805 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.3 m -55.45 -55.1 35.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.198 0.999 . . . . 2.4300000000000002 111.685 177.14 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -71.18 -48.26 52.76 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.024 -1.048 . . . . 1.3 110.231 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -65.97 -28.88 69.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.856 1.262 . . . . 4.6699999999999999 111.909 -170.241 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.548 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 1.2 t -137.45 -53.89 0.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.589 -1.196 . . . . 1.51 113.14 174.143 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.38 -18.52 1.33 Allowed Glycine 0 N--CA 1.468 0.83 0 CA-C-N 120.126 1.33 . . . . 0.97999999999999998 112.562 -179.88 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 46.6 54.12 9.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.199 1.8 . . . . 2.2599999999999998 111.751 175.376 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.93 -36.74 56.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.377 0.608 . . . . 1.1000000000000001 110.591 168.728 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 -150.53 17.85 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 108.52 -1.832 . . . . 1.02 108.52 176.105 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.9 p -65.77 151.47 46.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.061 0.763 . . . . 2.2200000000000002 113.061 -164.035 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -60.81 139.46 57.93 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.809 -1.182 . . . . 2.7799999999999998 107.809 166.86 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -115.49 -77.41 0.57 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.749 -1.204 . . . . 0.60999999999999999 107.749 173.504 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.91 157.9 17.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.197 -1.409 . . . . 0.90000000000000002 107.197 165.745 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.6 p -156.83 163.27 39.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.169 -1.832 . . . . 1.3899999999999999 107.102 179.601 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.24 138.39 5.05 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.476 -1.05 . . . . 0.58999999999999997 110.476 179.418 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.06 133.9 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.368 1.067 . . . . 0.73999999999999999 108.54 172.6 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.59 HG21 HG12 ' A' ' 112' ' ' ILE . 14.7 tt -100.11 132.84 44.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 122.769 0.428 . . . . 0.72999999999999998 111.508 -177.051 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.68 2.99 1.01 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.466 1.032 . . . . 0.63 114.675 179.379 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.6 mm -92.63 57.04 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 119.541 1.671 . . . . 0.79000000000000004 110.832 -157.203 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.1 173.45 16.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.804 . . . . 1.29 109.518 166.305 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 C--O 1.255 1.388 0 N-CA-C 102.892 -3.003 . . . . 4.1299999999999999 102.892 162.918 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.702 0.287 . . . . 2.9900000000000002 111.288 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -94.97 144.75 25.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.651 -1.24 . . . . 0.67000000000000004 107.651 163.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 t -110.61 142.28 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.747 -0.835 . . . . 0.87 108.747 167.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.01 97.47 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.069 -1.086 . . . . 0.44 108.069 156.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.14 107.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.723 -1.584 . . . . 0.60999999999999999 106.723 161.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.22 124.46 38.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.081 -1.081 . . . . 0.84999999999999998 108.081 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -135.22 -52.05 0.77 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.213 0.605 . . . . 4.21 109.822 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.73 -121.97 4.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.811 -1.315 . . . . 0.78000000000000003 109.811 -170.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.89 -37.63 1.51 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.18 0.592 . . . . 3.0699999999999998 111.553 -162.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.27 162.3 18.98 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 110.972 -0.851 . . . . 0.81999999999999995 110.972 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.86 58.95 6.23 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.15 3.234 . . . . 1.78 111.22 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -132.71 152.63 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 127.353 2.261 . . . . 0.98999999999999999 107.269 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -155.04 133.77 12.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.49 -1.3 . . . . 2.5800000000000001 107.49 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.41 168.83 40.21 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.789 -0.72 . . . . 0.44 112.785 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.86 125.67 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 1.1200000000000001 107.345 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.7 136.55 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.883 -1.525 . . . . 0.68999999999999995 106.883 161.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -116.26 106.99 14.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.7 -1.593 . . . . 1.6299999999999999 106.7 165.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -92.74 120.11 32.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 2.6000000000000001 106.877 176.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.62 163.17 33.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.102 0.953 . . . . 3.46 109.935 163.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -156.85 153.82 28.85 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.979 2.112 . . . . 3.1899999999999999 105.405 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -63.42 -62.43 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.323 0.965 . . . . 5.6500000000000004 110.375 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -90.9 -162.38 0.9 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 126.802 2.041 . . . . 4.4100000000000001 111.282 -167.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 m -101.69 -68.55 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.643 1.577 . . . . 2.5899999999999999 107.215 158.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -73.58 76.55 1.48 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.526 1.131 . . . . 4.5800000000000001 110.72 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.36 179.35 43.2 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 110.343 -1.103 . . . . 1.01 110.343 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.21 126.06 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.776 2.984 . . . . 1.03 112.123 -170.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.19 140.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.427 -0.583 . . . . 0.87 109.427 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -103.74 99.04 8.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.547 -1.649 . . . . 2.8300000000000001 106.547 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG22 ' CE1' ' A' ' 20' ' ' PHE . 30.4 t -89.44 120.91 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.006 -1.479 . . . . 0.93000000000000005 107.006 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -130.92 140.34 50.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.8 -1.185 . . . . 0.93999999999999995 107.8 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.21 23.71 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.088 -1.205 . . . . 0.75 110.088 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 p -130.04 67.59 1.46 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.088 1.355 . . . . 1.8899999999999999 107.726 -163.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -81.6 139.53 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.541 -1.209 . . . . 0.82999999999999996 108.323 -175.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 7.0 ptpt -134.94 169.53 17.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.452 1.279 . . . . 4.2999999999999998 114.452 170.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 -1.68 79.1 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 114.227 -1.351 . . . . 1.04 113.803 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -56.09 158.83 3.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.668 1.234 . . . . 0.79000000000000004 110.31 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.82 160.55 11.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.375 -0.972 . . . . 1.79 108.375 154.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -60.88 174.04 0.68 Allowed 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.57 -0.706 . . . . 2.6000000000000001 110.822 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.26 -162.19 54.48 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.993 -0.549 . . . . 0.44 112.541 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.17 146.69 47.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.37 0.668 . . . . 2.1400000000000001 111.973 -171.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -144.74 119.3 9.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.486 1.515 . . . . 0.48999999999999999 109.408 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.15 147.83 8.96 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.155 -1.178 . . . . 0.32000000000000001 110.155 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.421 ' CZ ' HG12 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -140.29 96.04 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.502 -1.295 . . . . 2.6499999999999999 107.502 -174.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.773 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 33.3 m170 -130.91 146.6 52.38 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.99 -1.115 . . . . 0.56999999999999995 107.99 -162.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.75 104.91 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 122.09 0.948 . . . . 1.6799999999999999 109.542 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.71 161.87 18.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.245 -1.391 . . . . 0.82999999999999996 107.245 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 6.8 pm0 -51.3 -103.39 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.124 1.77 . . . . 5.46 112.76 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 123.366 0.666 . . . . 2.9700000000000002 112.784 170.226 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.22 0.533 . . . . 1.96 110.658 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.86 -88.32 1.27 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.152 -1.579 . . . . 1.02 109.152 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.57 179.0 4.47 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.948 3.099 . . . . 1.1299999999999999 114.06 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -84.84 59.05 5.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.308 -1.315 . . . . 1.75 109.47 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.5 t80 50.17 68.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.828 . . . . 2.3399999999999999 109.818 -172.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -83.21 115.17 57.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.218 -0.896 . . . . 2.5699999999999998 108.759 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.18 -37.12 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.148 1.898 . . . . 1.55 111.157 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 tt -155.84 -65.7 0.11 Allowed 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.945 -1.131 . . . . 3.0600000000000001 107.945 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -154.95 71.45 0.8 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.705 0.802 . . . . 1.8500000000000001 109.379 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.56 161.34 27.08 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.946 -0.761 . . . . 4.4199999999999999 108.946 165.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 28.2 mttt -109.71 155.72 21.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.809 -1.552 . . . . 3.54 106.809 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -74.85 164.06 26.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0700000000000001 110.587 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.01 148.46 9.28 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 105.447 -3.061 . . . . 2.5699999999999998 105.447 169.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.26 -155.46 4.99 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.444 -1.062 . . . . 1.1699999999999999 110.444 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.71 -46.87 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.728 1.618 . . . . 1.4399999999999999 108.756 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.62 -36.26 75.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.265 1.426 . . . . 4.4000000000000004 113.039 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.95 165.93 1.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.927 0.491 . . . . 2.6600000000000001 110.737 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -79.61 -46.96 16.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.884 1.674 . . . . 4.2699999999999996 109.512 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 44.7 mt-10 -93.47 177.1 6.14 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.209 1.404 . . . . 3.1499999999999999 110.812 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 177.33 160.57 0.44 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 128.55 2.74 . . . . 3.4900000000000002 106.82 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 51.0 m80 -71.51 152.14 43.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.241 -1.763 . . . . 0.56000000000000005 106.241 162.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.49 39.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.4 1.095 . . . . 2.2799999999999998 111.128 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.51 37.27 0.29 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 128.331 2.872 . . . . 0.64000000000000001 110.62 166.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.05 140.57 50.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.427 1.614 . . . . 2.1899999999999999 110.451 157.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.31 -51.22 4.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.708 -1.219 . . . . 1.6399999999999999 107.708 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.45 -103.41 0.23 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.649 -0.98 . . . . 0.56999999999999995 110.649 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -152.16 169.28 22.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.305 1.842 . . . . 1.71 110.461 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.06 176.04 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.649 1.58 . . . . 0.42999999999999999 107.034 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.4 m -125.33 126.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.934 -1.135 . . . . 2.0099999999999998 107.934 174.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.17 141.4 29.58 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.127 0.971 . . . . 0.66000000000000003 111.818 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.11 -90.38 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.153 0.908 . . . . 2.6499999999999999 110.855 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -158.23 -34.37 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.243 0.831 . . . . 4.0499999999999998 113.243 -161.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 38.6 t0 -79.34 17.93 0.76 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 123.797 1.761 . . . . 3.4300000000000002 110.178 158.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.78 17.22 60.24 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 125.189 1.376 . . . . 0.96999999999999997 111.808 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.38 119.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.515 -1.291 . . . . 0.84999999999999998 107.515 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.51 174.24 6.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.444 1.098 . . . . 1.01 109.292 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -132.49 91.24 2.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.196 -2.15 . . . . 3.6899999999999999 105.196 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.1 59.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.775 -0.824 . . . . 1.6100000000000001 108.775 -168.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m -96.56 104.15 16.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.758 1.223 . . . . 1.3700000000000001 109.453 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.02 153.31 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.393 -0.965 . . . . 1.8100000000000001 108.393 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -140.14 82.16 1.85 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.302 0.641 . . . . 2.4199999999999999 109.914 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.52 160.36 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.851 0.46 . . . . 2.1000000000000001 110.969 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.4 p -121.11 4.39 10.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.573 1.549 . . . . 1.3500000000000001 113.16 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.66 -50.43 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.28 0.945 . . . . 1.1599999999999999 109.065 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pp -77.57 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.425 0.631 . . . . 0.93999999999999995 111.043 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -153.66 175.1 13.64 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.746 1.618 . . . . 2.27 107.502 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.87 38.72 4.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.726 0.811 . . . . 2.54 111.144 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 124.716 1.206 . . . . 3.5099999999999998 109.782 -176.257 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.454 0.168 . . . . 2.1299999999999999 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.441 HD12 ' C ' ' A' ' 112' ' ' ILE 0.257 1.3 pp -95.97 -7.84 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.266 0.469 . . . . 1.5600000000000001 112.266 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' HG23 ' A' ' 149' ' ' ILE . 8.7 tt -45.57 137.03 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.503 0.721 . . . . 1.8999999999999999 110.494 167.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.07 -30.78 6.4 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.727 0.679 . . . . 1.5600000000000001 112.253 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.541 ' O ' HG22 ' A' ' 149' ' ' ILE . 82.8 mtt180 -81.1 166.23 20.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.734 1.267 . . . . 5.1500000000000004 109.897 -168.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.0 m -93.06 108.61 20.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.085 0.469 . . . . 0.87 110.586 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -68.45 148.74 50.19 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.704 -0.85 . . . . 1.6399999999999999 108.704 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.98 137.77 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.894 1.677 . . . . 0.38 108.342 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.421 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -108.37 128.33 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.017 -1.105 . . . . 1.6299999999999999 108.017 166.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.531 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 72.1 m-70 -104.8 160.85 14.66 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.121 2.267 . . . . 0.40000000000000002 117.121 -169.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -50.82 -71.96 0.06 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.833 2.053 . . . . 3.3399999999999999 111.902 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -94.3 -178.22 4.53 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.174 0.897 . . . . 2.9399999999999999 110.239 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.97 151.08 27.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.643 -0.873 . . . . 0.52000000000000002 108.643 161.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.53 169.02 18.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.434 -0.58 . . . . 1.97 109.434 163.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.08 -25.78 63.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.471 0.915 . . . . 3.9399999999999999 113.471 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 72.63 -13.71 0.63 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.111 2.164 . . . . 2.1899999999999999 113.006 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.54 5.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.949 1.25 . . . . 2.2000000000000002 110.666 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -91.57 -31.38 15.93 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.501 1.12 . . . . 5.6799999999999997 109.212 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.67 62.78 3.09 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.784 -1.326 . . . . 2.3500000000000001 109.784 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.52 -31.42 57.29 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.563 -1.015 . . . . 4.0499999999999998 110.563 164.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.501 ' ND2' ' H ' ' A' ' 132' ' ' GLU . 1.3 p-10 -141.42 -78.54 0.27 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.421 0.611 . . . . 2.52 111.622 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.501 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 13.5 tt0 179.56 -54.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.335 1.454 . . . . 3.5899999999999999 109.624 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -45.9 -31.4 2.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.7 0.8 . . . . 4.4000000000000004 110.735 167.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -29.57 -77.13 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.821 2.048 . . . . 1.75 113.534 155.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 p -71.63 -39.38 70.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 120.884 -1.135 . . . . 1.24 109.447 -175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -55.28 -51.37 66.88 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.104 0.411 . . . . 3.7000000000000002 111.463 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.543 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.337 1.0 OUTLIER -128.9 -47.92 1.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.361 0.874 . . . . 1.1699999999999999 113.361 175.175 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.15 -5.46 0.39 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.577 1.08 . . . . 0.91000000000000003 115.366 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.3 t30 36.25 57.13 1.05 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.274 1.83 . . . . 2.0 113.549 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.773 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -63.55 -32.75 74.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.339 0.866 . . . . 1.04 113.339 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.53 174.47 50.01 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.312 -1.515 . . . . 1.0600000000000001 109.312 -159.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 m -54.92 154.09 5.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.274 1.43 . . . . 1.46 113.961 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -77.41 142.69 39.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 2.7799999999999998 109.897 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 mt -120.32 -72.64 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.694 -0.854 . . . . 0.54000000000000004 108.694 -174.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.77 149.25 41.1 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.042 0.937 . . . . 0.77000000000000002 108.494 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.04 170.48 20.43 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.054 1.471 . . . . 1.3600000000000001 109.178 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.43 147.19 6.36 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.642 -1.383 . . . . 0.70999999999999996 109.642 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.46 135.25 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.27 1.028 . . . . 0.72999999999999998 109.065 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 115' ' ' ARG . 10.1 tt -92.63 140.03 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.144 0.424 . . . . 0.76000000000000001 112.144 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.403 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 139.68 7.42 1.03 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.579 1.085 . . . . 0.62 114.315 171.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.3 mm -98.65 57.0 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.229 -0.025 0 CA-C-N 119.55 1.675 . . . . 0.76000000000000001 109.917 -154.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.65 176.93 11.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.823 0.849 . . . . 1.4399999999999999 109.452 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 103.267 -2.864 . . . . 4.2800000000000002 103.267 154.184 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.8 pttp . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.777 0.322 . . . . 2.6299999999999999 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.27 147.18 24.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.257 -1.016 . . . . 0.77000000000000002 108.257 163.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 152' ' ' ALA . 46.4 t -104.49 152.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 106.164 -1.791 . . . . 0.81000000000000005 106.164 157.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -137.2 96.3 3.25 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.9 -0.778 . . . . 0.68000000000000005 108.9 160.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.26 110.32 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.352 -1.351 . . . . 1.0 107.352 168.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.4 mt -93.85 122.84 36.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.919 -0.771 . . . . 0.93000000000000005 108.919 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.77 -47.97 0.46 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.857 0.863 . . . . 4.2000000000000002 110.578 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.83 -123.47 1.97 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.744 1.164 . . . . 0.92000000000000004 112.779 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -59.52 1.85 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 3.7599999999999998 108.52 -172.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.03 172.19 1.77 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.074 2.274 . . . . 1.02 114.518 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.43 -25.68 48.39 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.606 2.871 . . . . 1.48 111.906 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 62.6 t -51.33 141.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.225 1.01 . . . . 0.75 110.851 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -152.25 92.75 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.83 1.652 . . . . 2.0899999999999999 107.432 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.77 21.17 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.031 0.824 . . . . 0.63 111.867 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.41 131.91 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.294 -1.002 . . . . 1.45 108.294 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 33.7 mm -102.2 147.59 8.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.632 1.573 . . . . 0.81999999999999995 107.954 165.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.64 118.51 24.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.57 -2.011 . . . . 1.6299999999999999 105.57 162.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 31' ' ' VAL . 5.7 t80 -127.95 116.53 20.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.876 -1.898 . . . . 3.2799999999999998 105.876 -168.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 163.88 39.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.274 0.559 . . . . 3.6499999999999999 111.971 -170.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 -177.84 6.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.69 -1.596 . . . . 3.8300000000000001 106.69 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -77.73 -63.22 1.43 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.861 -0.792 . . . . 6.4900000000000002 108.861 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.33 165.62 14.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.828 1.251 . . . . 4.9400000000000004 109.569 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -81.0 -0.78 41.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.765 0.654 . . . . 2.6299999999999999 112.765 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -161.47 83.04 0.61 Allowed 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 121.723 -0.611 . . . . 4.0899999999999999 110.225 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.18 169.74 42.43 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 105.827 -2.909 . . . . 1.23 105.827 171.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.42 114.82 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.587 2.858 . . . . 1.5700000000000001 112.584 -165.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 19.5 t -84.32 142.65 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.82 -0.627 . . . . 0.94999999999999996 109.951 -168.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -95.66 122.46 38.45 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.736 -0.839 . . . . 2.6400000000000001 108.736 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 20' ' ' PHE . 16.1 t -121.72 97.39 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.705 1.602 . . . . 1.0700000000000001 107.727 -169.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -113.76 148.81 35.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.273 -0.64 . . . . 0.82999999999999996 109.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.87 160.46 34.06 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 120.991 -1.068 . . . . 0.73999999999999999 110.964 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.2 p -129.77 113.51 14.8 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 105.486 -2.042 . . . . 1.8200000000000001 105.486 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.74 142.1 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.844 -1.91 . . . . 1.1000000000000001 105.844 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.56 153.49 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.875 -0.516 . . . . 5.4900000000000002 110.368 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.94 21.01 51.98 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.914 1.245 . . . . 0.64000000000000001 112.401 -171.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.14 -168.16 0.37 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.335 1.064 . . . . 0.87 108.753 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.0 m -135.93 166.32 23.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 103.814 -2.662 . . . . 3.46 103.814 159.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.24 175.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.763 1.625 . . . . 2.8999999999999999 114.649 -166.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.04 -170.66 54.72 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 114.975 -1.011 . . . . 1.1499999999999999 112.284 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.37 152.52 27.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.379 1.071 . . . . 2.3300000000000001 110.528 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -145.51 112.83 6.18 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.835 1.254 . . . . 0.52000000000000002 109.277 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.26 150.37 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.835 -0.906 . . . . 0.5 110.835 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE1' HD11 ' A' ' 117' ' ' LEU . 39.1 t80 -142.95 94.49 2.64 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.917 -1.512 . . . . 2.7400000000000002 106.917 -171.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -131.98 162.72 30.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.533 -1.284 . . . . 0.92000000000000004 107.533 -164.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 m -134.97 115.26 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.721 0.691 . . . . 2.4900000000000002 109.624 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -104.69 150.77 24.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.894 1.277 . . . . 1.1599999999999999 110.561 -164.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.78 66.83 0.37 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.071 1.748 . . . . 5.0700000000000003 112.414 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 106.577 -1.638 . . . . 3.3399999999999999 106.577 171.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.061 0 CA-C-O 120.027 -0.035 . . . . 3.3399999999999999 111.02 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.96 -178.35 44.76 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.389 -1.084 . . . . 2.1899999999999999 110.389 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.73 179.35 5.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.085 3.857 . . . . 1.6799999999999999 113.331 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -62.17 57.57 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.189 2.596 . . . . 2.0699999999999998 113.299 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.539 ' CD2' HG13 ' A' ' 81' ' ' VAL . 6.0 t80 35.88 77.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.341 1.056 . . . . 2.9399999999999999 111.016 -160.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -93.74 106.02 19.45 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 108.457 -0.942 . . . . 2.75 108.457 171.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.69 -33.37 10.5 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.286 1.99 . . . . 1.5 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -155.33 -66.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.537 -0.912 . . . . 3.6099999999999999 108.537 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.6 m -154.4 74.71 0.97 Allowed 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.63 -0.669 . . . . 1.8700000000000001 110.36 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -78.31 161.29 27.33 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.699 -0.852 . . . . 5.1799999999999997 108.699 166.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -107.62 148.53 29.21 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.452 1.101 . . . . 4.8099999999999996 108.326 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.442 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 56.8 t60 -78.18 159.64 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.767 -0.373 . . . . 1.1699999999999999 110.691 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.52 160.72 33.02 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 107.448 -2.261 . . . . 2.3300000000000001 107.448 161.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.33 -176.86 29.11 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 117.715 0.758 . . . . 1.99 111.342 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.49 -29.2 37.7 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.104 1.869 . . . . 2.9300000000000002 110.43 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -64.81 -43.45 93.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.329 0.651 . . . . 5.4900000000000002 111.202 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -63.48 147.77 50.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.299 1.047 . . . . 2.5899999999999999 112.183 -168.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.27 -50.78 71.82 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.819 -1.082 . . . . 4.2000000000000002 108.242 167.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -78.02 164.98 24.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.155 0.982 . . . . 3.8500000000000001 110.574 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.37 147.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 C-N-CA 129.255 3.022 . . . . 3.3100000000000001 108.751 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 31.4 m80 -65.44 152.51 43.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 119.504 -0.878 . . . . 0.96999999999999997 109.986 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.539 HG13 ' CD2' ' A' ' 64' ' ' PHE . 7.7 p -67.12 -5.98 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 O-C-N 121.894 -0.504 . . . . 1.8400000000000001 112.307 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.2 50.96 0.77 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.058 -1.026 . . . . 1.1799999999999999 111.772 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.25 123.06 1.88 Allowed 'General case' 0 C--O 1.227 -0.087 0 O-C-N 120.811 -1.406 . . . . 2.0299999999999998 110.089 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.13 -52.45 4.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.652 -0.499 . . . . 2.0499999999999998 109.652 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.39 -101.41 0.19 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.068 -1.063 . . . . 0.82999999999999996 111.99 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -155.11 166.03 34.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.084 1.353 . . . . 1.9299999999999999 111.327 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.9 179.71 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.308 1.843 . . . . 0.67000000000000004 106.165 162.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 t -134.32 145.17 48.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.568 -1.271 . . . . 2.2200000000000002 107.568 163.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.22 143.18 35.58 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.601 0.563 . . . . 0.72999999999999998 109.618 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.76 -69.64 0.23 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.474 0.709 . . . . 3.3300000000000001 109.918 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -168.35 -55.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.789 2.036 . . . . 4.1299999999999999 108.53 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.21 29.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.922 1.344 . . . . 4.8200000000000003 110.244 -170.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.13 17.61 72.14 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.59 1.091 . . . . 1.0800000000000001 112.386 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.4 152.33 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.461 -1.311 . . . . 1.0 107.461 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.26 167.22 22.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.495 -1.298 . . . . 0.68000000000000005 107.495 161.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.05 148.95 51.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.668 -2.345 . . . . 2.8399999999999999 104.668 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.6 136.48 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 107.614 -1.254 . . . . 1.54 107.614 164.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.0 m -156.95 70.4 0.63 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.545 1.538 . . . . 0.96999999999999997 108.168 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.58 155.3 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.942 0.897 . . . . 1.8700000000000001 109.088 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.6 134.71 29.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.393 -0.595 . . . . 2.71 109.393 145.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -128.64 165.31 21.07 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.332 1.053 . . . . 2.8399999999999999 109.539 170.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 p -104.08 8.0 36.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.078 1.751 . . . . 1.72 112.287 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.4 t -90.53 -49.15 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.368 -0.975 . . . . 1.49 108.368 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.259 0.4 OUTLIER -84.19 175.82 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.05 0.452 . . . . 1.22 111.574 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -160.97 169.12 23.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.325 1.05 . . . . 2.98 109.25 -166.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.7 mp -85.67 -25.79 26.35 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.483 1.113 . . . . 2.8999999999999999 111.907 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.326 -0.449 0 C-N-CA 125.951 1.7 . . . . 4.0599999999999996 107.47 171.667 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.0 p . . . . . 0 N--CA 1.445 -0.685 0 CA-C-O 122.082 0.944 . . . . 1.48 113.409 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 pp -91.02 -6.3 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.018 -1.446 . . . . 1.55 109.825 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 tp -43.86 123.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.897 0.879 . . . . 1.6100000000000001 109.465 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.9 32.53 84.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.926 -0.654 . . . . 1.49 113.093 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -98.32 174.96 6.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.282 -1.007 . . . . 5.5099999999999998 108.282 152.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 m -105.58 117.16 33.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.778 1.231 . . . . 1.05 108.283 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.419 HD11 ' CE1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -61.3 150.62 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.008 -0.738 . . . . 2.3999999999999999 109.008 171.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -140.7 134.6 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.918 1.287 . . . . 0.46000000000000002 107.702 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.33 128.37 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.865 -1.531 . . . . 1.71 106.865 164.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -98.32 160.02 14.56 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 115.182 1.549 . . . . 0.48999999999999999 115.182 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.16 -72.15 0.06 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.138 1.775 . . . . 4.2800000000000002 111.787 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -101.21 -177.71 3.53 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.441 0.696 . . . . 2.9700000000000002 110.038 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.89 151.35 18.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.043 -0.725 . . . . 0.75 109.043 165.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.14 176.33 4.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.321 -0.992 . . . . 1.9199999999999999 108.321 159.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.65 -28.38 66.83 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 3.98 114.351 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 81.55 -7.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.244 2.618 . . . . 2.3100000000000001 113.475 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.12 31.64 11.7 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.82 1.191 . . . . 2.6600000000000001 110.477 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -35.36 32.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 128.224 2.61 . . . . 6.9699999999999998 108.229 168.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.13 41.88 30.6 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.655 1.122 . . . . 3.1699999999999999 111.253 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.64 35.64 1.61 Allowed Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.538 1.169 . . . . 3.75 114.299 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.6 p30 177.64 -89.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.455 1.902 . . . . 3.21 108.703 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -170.38 -57.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.296 1.838 . . . . 2.9399999999999999 107.137 -173.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -56.42 -34.37 66.71 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.745 1.218 . . . . 3.25 110.883 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.1 m -41.84 -68.77 0.16 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.898 1.279 . . . . 1.8999999999999999 112.087 167.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -43.78 69.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.3 -0.875 . . . . 1.6799999999999999 110.059 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 132' ' ' GLU . 20.9 ttmt -57.81 -42.86 85.12 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.104 0.962 . . . . 2.5899999999999999 111.647 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.255 4.2 p -132.53 -52.28 0.94 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.676 0.621 . . . . 1.54 112.676 178.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.442 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 154.52 -25.13 0.66 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 124.092 0.854 . . . . 0.91000000000000003 112.171 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t30 41.55 56.2 3.32 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.92 1.688 . . . . 2.4700000000000002 111.06 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 -50.55 18.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.293 -0.963 . . . . 1.49 108.992 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 132.11 -151.95 20.02 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 107.427 -2.269 . . . . 1.54 107.427 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 t -67.76 -179.71 1.21 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.326 1.06 . . . . 3.1699999999999999 111.98 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -105.44 152.23 23.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.611 2.364 . . . . 3.2400000000000002 111.405 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.5 -85.27 0.66 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.371 -1.344 . . . . 0.75 107.371 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.497 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -94.17 155.23 17.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.173 -1.047 . . . . 1.01 108.173 164.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 18.5 p -146.93 168.09 22.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.107 -1.406 . . . . 2.02 107.776 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.99 140.93 4.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.126 -1.19 . . . . 0.67000000000000004 110.126 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.93 137.98 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.897 0.879 . . . . 0.84999999999999998 108.96 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.0 tt -101.43 125.43 55.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.205 0.526 . . . . 0.91000000000000003 111.231 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.21 8.87 0.42 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.539 1.066 . . . . 0.62 114.306 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.11 55.39 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 120.116 1.958 . . . . 1.05 110.19 -161.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -158.87 176.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.563 1.145 . . . . 1.5800000000000001 109.412 168.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 102.844 -3.021 . . . . 4.9800000000000004 102.844 150.895 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.8 pttm . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 109.505 -0.554 . . . . 2.6899999999999999 109.505 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.5 153.41 48.78 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.909 2.083 . . . . 0.68000000000000005 108.148 167.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -118.87 143.12 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.412 -1.329 . . . . 0.75 107.412 170.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.95 99.83 6.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.141 1.376 . . . . 0.48999999999999999 108.996 156.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 113.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.573 -1.269 . . . . 0.56999999999999995 107.573 159.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.71 125.12 49.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.359 1.064 . . . . 1.01 109.056 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -132.23 -53.2 0.96 Allowed 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.409 0.684 . . . . 3.9500000000000002 110.215 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.43 -124.14 13.86 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.036 0.827 . . . . 0.93000000000000005 113.832 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -114.12 -52.47 2.73 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.867 1.267 . . . . 3.7999999999999998 108.859 -158.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.05 160.52 26.45 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 110.295 -1.122 . . . . 0.90000000000000002 110.295 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.52 40.59 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.72 2.946 . . . . 1.01 112.711 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.04 156.18 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.807 1.643 . . . . 0.79000000000000004 108.934 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -153.63 93.0 1.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.523 -0.917 . . . . 2.6200000000000001 108.523 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.91 162.53 14.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 124.03 0.824 . . . . 0.60999999999999999 111.462 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.8 mt -130.95 120.56 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 106.532 -1.655 . . . . 1.28 106.532 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.4 mm -84.23 146.37 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.319 1.048 . . . . 0.75 108.221 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -124.85 101.18 6.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.244 -1.761 . . . . 2.4700000000000002 106.244 166.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -79.66 91.09 5.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.245 -2.132 . . . . 2.2999999999999998 105.245 166.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.39 140.84 31.28 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.824 -1.547 . . . . 3.6600000000000001 106.824 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -157.96 151.36 23.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.759 -1.941 . . . . 3.8999999999999999 105.759 167.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.91 -65.31 1.18 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.072 0.851 . . . . 6.9400000000000004 108.769 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -78.97 119.23 21.83 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.583 -0.895 . . . . 5.1799999999999997 108.583 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 m -35.4 -64.11 0.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.403 2.681 . . . . 2.6099999999999999 113.815 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.0 37.21 0.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.582 -0.699 . . . . 3.6299999999999999 111.114 177.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.67 167.34 22.17 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.322 0.963 . . . . 1.4399999999999999 111.291 -174.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.7 139.21 51.92 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.458 2.772 . . . . 1.52 112.019 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -89.32 126.71 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.305 -0.998 . . . . 0.93000000000000005 108.305 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -83.6 98.86 9.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.436 -1.69 . . . . 2.8900000000000001 106.436 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' A' ' 20' ' ' PHE . 41.9 t -97.25 85.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.746 1.618 . . . . 1.3400000000000001 107.387 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -98.61 162.13 13.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.204 -0.665 . . . . 1.1200000000000001 109.204 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.41 153.57 23.15 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.834 -0.906 . . . . 0.67000000000000004 110.834 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 p -121.98 79.43 1.58 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.245 1.418 . . . . 2.4500000000000002 107.488 -171.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -96.99 125.2 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.69 1.196 . . . . 0.94999999999999996 108.934 -170.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.73 158.58 43.77 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.711 -0.477 . . . . 5.0599999999999996 109.711 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.52 19.52 48.53 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.675 1.607 . . . . 0.69999999999999996 113.34 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.83 170.28 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.648 -0.913 . . . . 0.59999999999999998 108.962 170.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.1 163.39 27.98 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.711 -1.218 . . . . 1.6899999999999999 107.711 149.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -61.63 175.91 0.57 Allowed 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.382 -0.824 . . . . 3.3500000000000001 111.03 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.62 -165.54 52.2 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.272 0.939 . . . . 0.46000000000000002 112.607 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.52 141.99 58.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.802 1.241 . . . . 1.9399999999999999 113.045 -174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -143.12 118.38 10.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.756 1.622 . . . . 0.45000000000000001 108.592 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.46 149.3 2.14 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.751 -0.939 . . . . 0.35999999999999999 110.751 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -139.91 94.16 2.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.327 -1.731 . . . . 3.0699999999999998 106.327 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.566 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 26.5 m80 -138.86 153.49 48.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.723 -1.584 . . . . 0.83999999999999997 106.723 -166.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.24 121.76 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.637 0.732 . . . . 1.5600000000000001 109.792 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.438 ' CD2' HG21 ' A' ' 118' ' ' VAL . 21.3 m-70 -96.19 144.2 26.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.154 2.182 . . . . 0.84999999999999998 109.548 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -33.97 -90.87 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.539 2.736 . . . . 5.3799999999999999 112.671 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HG2' ' HB2' ' A' ' 60' ' ' ALA . 5.1 mt-10 . . . . . 0 C--N 1.331 -0.198 0 N-CA-C 115.103 1.52 . . . . 3.6899999999999999 115.103 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 114.645 1.35 . . . . 2.7000000000000002 114.645 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.82 -167.58 30.52 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.887 -1.685 . . . . 1.27 108.887 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 178.75 4.34 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.315 3.343 . . . . 1.1599999999999999 113.142 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -47.61 123.48 5.89 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.338 1.455 . . . . 1.25 110.182 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -45.86 122.92 4.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.724 0.809 . . . . 2.46 111.027 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -155.4 152.84 25.56 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 106.679 -1.601 . . . . 2.54 106.679 171.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.22 -20.33 24.81 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.228 1.952 . . . . 1.3200000000000001 113.806 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.81 -70.08 0.11 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.463 1.029 . . . . 3.0 111.195 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.9 t -157.43 69.53 0.56 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.254 0.622 . . . . 2.1200000000000001 109.488 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -79.21 175.04 10.95 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.379 0.609 . . . . 4.7800000000000002 110.374 168.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -118.55 161.24 20.36 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 106.33 -1.73 . . . . 3.21 106.33 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -85.9 165.21 16.97 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.639 0.654 . . . . 1.0600000000000001 109.382 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.53 -65.84 0.02 OUTLIER Glycine 0 C--O 1.223 -0.591 0 N-CA-C 108.201 -1.959 . . . . 2.9199999999999999 108.201 169.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.15 -171.27 27.87 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.604 1.097 . . . . 1.45 111.978 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.14 -46.85 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.743 2.295 . . . . 1.6100000000000001 109.796 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.66 -36.41 82.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.611 0.764 . . . . 4.2800000000000002 112.017 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.1 176.95 0.66 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.277 1.031 . . . . 1.8 112.042 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.69 -48.3 11.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.052 1.341 . . . . 4.6100000000000003 109.71 165.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -98.4 156.58 16.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.311 1.044 . . . . 3.5099999999999998 112.68 -166.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.69 150.0 0.64 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.768 1.627 . . . . 4.0599999999999996 110.0 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 44.5 m80 -55.84 136.6 51.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 104.979 -2.23 . . . . 0.70999999999999996 104.979 156.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -58.98 -23.17 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.185 -0.606 . . . . 1.47 109.947 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.87 39.24 2.8 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.372 1.463 . . . . 0.72999999999999998 115.083 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -102.9 136.63 42.37 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.772 1.786 . . . . 1.9099999999999999 106.831 153.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.6 -52.74 3.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.469 -0.938 . . . . 1.8600000000000001 108.469 147.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.38 -106.72 0.29 Allowed Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.964 -0.854 . . . . 0.65000000000000002 110.964 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.69 165.66 31.69 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.261 1.425 . . . . 1.6599999999999999 109.524 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.38 175.38 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 106.174 -1.788 . . . . 0.5 106.174 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -120.67 141.72 50.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.769 -1.197 . . . . 2.0699999999999998 107.769 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.3 138.84 34.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.398 0.679 . . . . 0.63 109.979 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.45 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.571 0.544 . . . . 3.3599999999999999 110.134 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -53.79 1.52 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.928 0.891 . . . . 4.6299999999999999 111.52 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.05 26.61 2.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 123.368 1.556 . . . . 2.7999999999999998 110.78 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.8 17.9 67.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 114.524 -1.217 . . . . 0.59999999999999998 111.596 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.6 t -89.02 122.63 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 125.378 1.471 . . . . 0.76000000000000001 107.306 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.16 175.99 5.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.894 1.277 . . . . 0.83999999999999997 107.662 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -133.67 148.21 51.48 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 103.62 -2.733 . . . . 2.9100000000000001 103.62 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.01 139.79 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.874 -1.528 . . . . 1.76 106.874 160.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.1 m -158.16 59.69 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.303 1.841 . . . . 1.3400000000000001 108.078 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.08 151.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 107.638 -1.245 . . . . 1.52 107.638 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -124.99 90.06 3.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.853 -0.795 . . . . 3.5899999999999999 108.853 166.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.63 152.89 31.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.461 0.573 . . . . 2.7000000000000002 110.637 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -132.07 41.9 3.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.779 1.232 . . . . 1.6299999999999999 110.295 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -127.57 -54.33 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.596 1.158 . . . . 1.3600000000000001 108.197 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -86.42 173.02 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.224 0.535 . . . . 1.3899999999999999 110.566 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.2 m -140.86 173.95 10.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.324 1.85 . . . . 1.96 106.835 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.6 -3.37 46.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.137 0.421 . . . . 3.7400000000000002 112.137 170.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 106.881 -1.526 . . . . 3.48 106.881 171.734 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 108.738 -0.838 . . . . 1.5 108.738 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.27 -12.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.534 -0.466 . . . . 1.7 110.794 -169.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.9 tp -16.85 119.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 127.877 2.471 . . . . 1.8100000000000001 113.353 164.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.59 -17.39 59.18 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.181 -1.344 . . . . 1.54 113.386 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.3 169.07 18.25 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.951 1.875 . . . . 4.0199999999999996 111.735 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.4 m -96.17 110.38 22.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.213 1.005 . . . . 0.93999999999999995 109.472 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.29 144.28 54.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.222 0.919 . . . . 1.6799999999999999 108.705 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.438 HG21 ' CD2' ' A' ' 48' ' ' HIS . 98.7 t -130.79 136.41 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.87 1.268 . . . . 0.53000000000000003 109.087 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.3 m -103.39 126.9 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.794 -1.558 . . . . 1.53 106.794 163.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.488 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 61.6 m-70 -100.97 161.0 13.9 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 116.358 1.985 . . . . 0.38 116.358 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -39.61 -70.33 0.11 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.949 2.9 . . . . 3.0 112.273 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -112.72 -172.49 2.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.426 1.012 . . . . 2.7200000000000002 108.848 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.12 160.59 9.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.917 -0.771 . . . . 0.57999999999999996 108.917 162.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.3 167.11 21.86 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.721 0.772 . . . . 1.8899999999999999 109.808 158.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.7 -6.98 57.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.463 1.905 . . . . 3.4100000000000001 111.282 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 36.06 20.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.886 2.074 . . . . 1.6399999999999999 111.068 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.49 27.43 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.44 -0.788 . . . . 1.9199999999999999 112.65 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -111.67 -34.03 6.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.063 1.345 . . . . 5.9500000000000002 109.623 -171.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -48.39 126.76 16.38 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.247 -1.141 . . . . 2.7200000000000002 110.247 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.62 64.43 2.94 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.341 0.972 . . . . 2.4900000000000002 111.69 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -163.58 117.44 1.55 Allowed 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 106.619 -1.623 . . . . 2.6200000000000001 106.619 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.15 -54.53 0.61 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.814 1.646 . . . . 3.4399999999999999 113.786 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -27.54 -49.64 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.791 2.836 . . . . 3.5699999999999998 113.983 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -44.47 -60.22 2.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.399 1.88 . . . . 2.2200000000000002 110.435 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.7 p -72.99 -42.51 63.19 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.091 -0.381 . . . . 1.29 110.579 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -51.99 -53.69 38.57 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.353 1.061 . . . . 3.6899999999999999 110.862 -172.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.451 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.3 p -123.39 -42.31 2.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.27 0.228 . . . . 1.48 111.567 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 141.19 -27.51 2.41 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.447 -1.061 . . . . 0.98999999999999999 110.447 -169.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.3 t30 55.23 54.41 8.78 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 122.665 1.222 . . . . 1.6799999999999999 110.463 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -64.69 -27.83 69.19 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.812 1.245 . . . . 0.93000000000000005 112.812 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.18 179.42 52.52 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 108.514 -1.834 . . . . 1.04 108.514 -160.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.4 m -59.21 148.94 29.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.286 1.217 . . . . 1.27 114.286 -164.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -51.38 126.09 16.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.652 2.381 . . . . 3.0299999999999998 109.346 166.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.7 mt -109.26 -71.16 0.77 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-N 120.098 1.317 . . . . 0.5 108.669 170.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -100.89 154.52 18.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.565 -0.532 . . . . 0.83999999999999997 109.565 -175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.81 160.16 16.76 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.676 0.61 . . . . 1.45 111.391 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.89 144.84 4.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 128.382 2.896 . . . . 1.04 105.954 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.23 143.36 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 118.023 0.911 . . . . 0.81999999999999995 110.671 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 tt -92.92 139.83 17.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.555 0.742 . . . . 0.73999999999999999 112.71 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.06 -4.83 1.2 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.192 0.901 . . . . 0.60999999999999999 114.777 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -90.55 58.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.715 1.258 . . . . 1.1799999999999999 109.101 -156.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.6 143.69 30.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.518 -0.739 . . . . 1.8300000000000001 112.263 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 103.511 -2.774 . . . . 6.5999999999999996 103.511 141.554 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp . . . . . 0 N--CA 1.441 -0.895 0 N-CA-C 107.858 -1.164 . . . . 3.52 107.858 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.64 138.39 34.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.338 -0.986 . . . . 0.78000000000000003 108.338 163.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 t -99.79 136.27 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 106.885 -1.524 . . . . 1.22 106.885 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -117.88 94.5 4.54 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 124.329 1.052 . . . . 0.47999999999999998 108.236 158.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -65.84 102.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.45 -1.315 . . . . 1.01 107.45 165.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.3 134.68 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.037 0.535 . . . . 0.93999999999999995 109.889 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -149.65 -50.31 0.14 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.657 0.383 . . . . 4.1299999999999999 111.618 166.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.43 -123.8 16.57 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.72 1.152 . . . . 1.0700000000000001 112.971 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.12 -51.77 2.92 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.47 1.108 . . . . 3.9900000000000002 108.621 -159.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.22 172.75 16.39 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.663 1.601 . . . . 0.91000000000000003 111.851 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 27.69 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.433 2.755 . . . . 1.05 112.674 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 15' ' ' GLN . 25.4 t -82.1 165.38 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 1.05 109.11 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.401 ' N ' HG12 ' A' ' 14' ' ' VAL . 6.3 pt20 -156.33 139.1 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.937 1.695 . . . . 3.1600000000000001 106.729 168.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.77 43.39 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.21 -0.995 . . . . 0.78000000000000003 111.651 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.21 126.45 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.071 -1.455 . . . . 1.98 107.071 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.1 mm -92.51 129.24 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.269 -1.382 . . . . 0.90000000000000002 107.269 165.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.75 108.7 21.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.875 -1.528 . . . . 2.1699999999999999 106.875 159.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CZ ' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -87.1 131.97 33.98 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.705 -1.961 . . . . 2.3599999999999999 105.705 162.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.39 165.16 36.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.226 0.921 . . . . 3.4700000000000002 111.49 158.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -155.26 145.46 21.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 104.714 -2.328 . . . . 3.0899999999999999 104.714 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -81.46 -36.91 28.78 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.875 -1.157 . . . . 7.4500000000000002 107.875 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -77.81 -167.4 0.97 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.721 2.808 . . . . 4.6299999999999999 110.037 171.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -139.83 26.56 2.27 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.877 1.271 . . . . 2.3999999999999999 109.425 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 179.03 35.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.485 1.114 . . . . 5.7199999999999998 110.202 -152.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.44 -162.27 9.73 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.628 -1.389 . . . . 0.97999999999999998 109.628 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.35 144.95 29.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.294 2.663 . . . . 1.1200000000000001 110.104 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -88.11 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.523 -0.917 . . . . 1.02 108.523 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -111.08 124.01 51.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.568 -1.641 . . . . 2.8199999999999998 106.568 165.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -120.57 124.51 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.95 -1.5 . . . . 1.3600000000000001 106.95 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -140.64 138.0 34.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.609 -0.515 . . . . 1.25 109.609 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.67 139.4 4.66 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.525 -1.43 . . . . 0.98999999999999999 109.525 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.6 m -119.17 91.16 3.49 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.34 1.056 . . . . 2.4100000000000001 108.987 -167.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.2 mm -87.47 152.74 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.091 2.156 . . . . 1.3799999999999999 109.332 -165.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.89 146.69 33.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.329 0.651 . . . . 4.1699999999999999 109.66 -172.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.65 18.99 42.47 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.008 1.289 . . . . 0.60999999999999999 112.703 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 162.58 28.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.566 -0.902 . . . . 0.89000000000000001 108.566 168.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.48 163.84 27.29 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.991 -1.114 . . . . 1.9199999999999999 107.991 155.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.53 176.39 0.5 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.435 -0.791 . . . . 2.3599999999999999 111.133 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.5 -165.95 46.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.659 0.647 . . . . 0.46999999999999997 113.648 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.87 147.94 52.59 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.649 0.78 . . . . 2.3700000000000001 112.023 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -142.52 119.91 11.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.859 1.664 . . . . 0.63 108.059 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.99 148.0 6.8 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.719 -1.352 . . . . 0.44 109.719 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.437 ' CZ ' HG11 ' A' ' 97' ' ' VAL . 24.1 t80 -141.72 95.79 2.87 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.488 -1.301 . . . . 2.46 107.488 -172.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -133.67 161.75 33.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.624 -1.25 . . . . 0.62 107.624 -163.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.83 137.72 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 108.932 -0.766 . . . . 2.0099999999999998 108.932 165.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.415 ' CD2' HG21 ' A' ' 118' ' ' VAL . 22.8 m-70 -98.8 151.11 21.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.579 1.151 . . . . 0.84999999999999998 109.422 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -36.23 -59.62 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.371 1.868 . . . . 4.7699999999999996 112.37 -174.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 CA--C 1.53 0.198 0 C-N-CA 130.041 3.337 . . . . 3.3500000000000001 116.706 171.387 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.279 0 N-CA-C 109.527 -0.546 . . . . 2.04 109.527 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.17 -85.17 0.84 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.079 -1.209 . . . . 1.22 110.079 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.61 175.4 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.309 2.673 . . . . 1.0 116.118 -161.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -83.55 57.22 3.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 113.695 -1.593 . . . . 2.04 110.996 -170.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 59.79 75.44 0.4 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.345 0.658 . . . . 1.9199999999999999 109.353 -172.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.21 87.91 0.52 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 3.29 108.939 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -62.81 -43.67 19.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.246 1.297 . . . . 1.6499999999999999 110.136 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.49 -93.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.783 -0.821 . . . . 2.4900000000000002 108.783 165.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.1 p -137.37 60.7 1.64 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.794 0.838 . . . . 3.2599999999999998 110.399 -161.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -82.16 161.64 22.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.769 -1.196 . . . . 4.5599999999999996 107.769 159.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -128.94 175.28 8.78 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.728 -1.582 . . . . 4.3499999999999996 106.728 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -106.08 132.6 51.96 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.251 -1.018 . . . . 1.3500000000000001 108.251 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -124.06 -48.88 0.22 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.437 -1.465 . . . . 3.46 109.437 173.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.54 176.14 21.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.31 1.91 . . . . 1.6699999999999999 109.029 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -57.86 -43.71 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.42 2.08 . . . . 2.0600000000000001 110.614 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -70.47 -47.47 60.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.846 1.658 . . . . 4.2400000000000002 111.817 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.44 152.46 34.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.464 0.705 . . . . 1.78 111.573 -168.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -50.99 -51.43 52.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.582 1.553 . . . . 3.9399999999999999 111.837 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.94 146.42 26.16 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 122.924 1.345 . . . . 3.4500000000000002 111.444 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -170.84 134.69 1.02 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.931 -1.486 . . . . 4.0 107.002 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.2 m80 -51.46 140.74 17.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.219 -1.4 . . . . 0.55000000000000004 107.219 158.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.69 -14.1 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.988 -0.551 . . . . 1.1599999999999999 110.291 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.22 35.22 4.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.071 0.843 . . . . 0.68000000000000005 115.143 165.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -94.89 117.85 30.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.818 1.809 . . . . 1.9299999999999999 106.619 158.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.39 -61.35 2.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.11 -1.441 . . . . 2.7400000000000002 107.11 158.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.41 -106.42 0.25 Allowed Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.387 -0.685 . . . . 0.80000000000000004 111.387 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -152.45 169.84 21.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.493 1.517 . . . . 1.6799999999999999 109.427 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.03 169.99 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.131 -1.433 . . . . 0.45000000000000001 107.131 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.4 m -122.7 120.27 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.618 -1.253 . . . . 2.2599999999999998 107.618 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 141.85 35.85 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.109 0.564 . . . . 0.62 109.888 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.51 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.309 2.244 . . . . 3.9300000000000002 110.459 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -172.88 -45.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.205 1.402 . . . . 3.79 108.855 -161.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -77.5 8.43 4.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.234 1.016 . . . . 2.73 110.929 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.46 19.44 78.13 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.123 -0.985 . . . . 0.79000000000000004 110.728 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.6 t -86.39 137.64 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.087 . . . . 0.67000000000000004 108.064 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.12 167.25 21.31 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.931 -1.507 . . . . 0.78000000000000003 106.931 167.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -148.28 138.41 22.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.176 -1.416 . . . . 3.8700000000000001 107.176 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.437 HG11 ' CZ ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -116.35 56.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 124.331 1.019 . . . . 1.53 111.349 -173.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.8 m -70.3 88.51 0.64 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.981 0.512 . . . . 1.1599999999999999 109.962 166.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.8 mm -127.56 160.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.104 0.961 . . . . 2.1400000000000001 109.611 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -146.66 76.41 1.43 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.397 0.679 . . . . 2.3700000000000001 111.177 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.1 143.73 35.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.935 0.398 . . . . 2.1299999999999999 110.156 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -106.35 -4.21 20.25 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.033 1.733 . . . . 1.55 112.843 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.06 -46.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.701 1.2 . . . . 1.1200000000000001 107.963 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.95 168.82 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.02 0.438 . . . . 1.27 110.507 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 m -146.2 167.52 23.26 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.803 1.641 . . . . 1.78 106.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 pp -99.01 -0.35 42.19 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.597 0.592 . . . . 2.3199999999999998 112.597 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.454 -0.266 0 C-N-CA 125.189 1.395 . . . . 3.1899999999999999 108.055 177.107 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.2 p . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 115.276 1.584 . . . . 1.25 115.276 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.462 HD11 ' CZ ' ' A' ' 20' ' ' PHE 0.271 2.0 pp -95.34 -4.53 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 113.335 -1.757 . . . . 1.5600000000000001 111.207 174.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tp -39.08 131.42 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.892 0.877 . . . . 1.5600000000000001 109.824 162.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.63 49.54 72.89 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.232 -0.747 . . . . 1.9399999999999999 111.232 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -137.1 163.83 29.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.58 -1.637 . . . . 3.9700000000000002 106.58 164.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 m -90.61 111.84 23.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 118.691 -0.671 . . . . 0.97999999999999998 110.121 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.36 143.16 57.32 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.556 -0.905 . . . . 1.72 108.556 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 48' ' ' HIS . 76.6 t -134.67 139.58 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.337 1.855 . . . . 0.46000000000000002 108.294 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -110.96 125.11 68.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.253 -1.017 . . . . 1.5900000000000001 108.253 162.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -94.45 163.46 13.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 115.355 1.613 . . . . 0.44 115.355 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.78 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.201 1.4 . . . . 3.5699999999999998 112.357 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -92.54 -177.85 4.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.775 0.716 . . . . 3.0099999999999998 110.601 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 151.6 16.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.447 -0.946 . . . . 0.56999999999999995 108.447 157.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.78 162.32 29.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.99 -0.744 . . . . 2.0600000000000001 108.99 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.65 -7.2 58.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.43 1.092 . . . . 3.3999999999999999 112.043 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 49.6 40.28 19.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.648 1.179 . . . . 1.8700000000000001 109.307 -168.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 51.78 34.12 36.37 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.453 -0.794 . . . . 2.0600000000000001 113.396 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -130.21 49.99 2.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.492 1.146 . . . . 4.8799999999999999 108.982 -177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.76 132.65 8.78 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.849 -1.7 . . . . 2.4300000000000002 108.849 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.59 -37.38 67.41 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.713 -0.955 . . . . 2.9300000000000002 110.713 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -50.45 103.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.694 1.198 . . . . 2.0499999999999998 109.593 159.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -35.19 10.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.246 1.018 . . . . 3.4300000000000002 111.948 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -28.08 -44.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.157 2.583 . . . . 2.96 112.671 167.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.8 p -49.62 -73.16 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 2.2000000000000002 110.292 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.6 p -61.66 -40.73 95.95 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.298 -0.876 . . . . 1.25 110.818 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.72 -53.27 59.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.392 1.477 . . . . 3.1000000000000001 110.783 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.33 1.3 p -126.07 -45.66 1.7 Allowed 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.96 0.726 . . . . 1.1599999999999999 112.96 172.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.72 -25.43 0.74 Allowed Glycine 0 N--CA 1.463 0.455 0 CA-C-N 118.965 0.802 . . . . 0.93999999999999995 112.029 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 t30 47.51 52.34 12.54 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.412 1.485 . . . . 1.75 110.987 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.37 -47.95 31.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.77 -1.196 . . . . 1.1200000000000001 107.77 162.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.22 -146.06 16.8 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 108.271 -1.932 . . . . 1.23 108.271 164.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.1 m -58.41 156.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.861 1.264 . . . . 1.49 112.77 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -60.73 141.9 56.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.109 -1.405 . . . . 2.54 109.608 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.3 mt -107.73 -71.52 0.75 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 105.992 -1.855 . . . . 0.83999999999999997 105.992 156.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.434 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -97.93 151.79 19.91 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.439 -0.949 . . . . 1.04 108.439 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 67.0 m -139.43 156.69 46.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.604 -1.999 . . . . 2.0 105.604 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.16 130.69 1.79 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.809 -0.916 . . . . 0.72999999999999998 110.809 163.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.55 130.22 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.405 0.682 . . . . 0.96999999999999997 109.578 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 tt -98.76 135.9 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.311 -0.404 . . . . 0.78000000000000003 111.592 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.68 -4.9 0.94 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.11 0.804 . . . . 0.65000000000000002 115.11 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -89.04 58.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.888 1.344 . . . . 1.24 109.559 -159.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.96 151.54 23.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.744 -0.662 . . . . 2.1099999999999999 109.553 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 . . . . . 0 C--O 1.256 1.425 0 N-CA-C 104.48 -2.415 . . . . 6.9500000000000002 104.48 166.005 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.124 -0.324 . . . . 3.0 110.124 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.81 141.21 29.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.31 1.044 . . . . 0.83999999999999997 108.885 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 t -102.61 144.37 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.437 -0.949 . . . . 0.90000000000000002 108.437 162.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.02 100.26 6.65 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 108.615 -0.883 . . . . 0.75 108.615 153.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 101.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.971 -1.122 . . . . 0.81999999999999995 107.971 164.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.44 130.84 36.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.288 -0.634 . . . . 0.90000000000000002 109.288 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -134.58 -57.37 0.83 Allowed 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.747 -0.835 . . . . 4.46 108.747 165.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.83 -143.07 48.42 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.263 0.935 . . . . 1.6200000000000001 113.518 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.51 -46.69 5.65 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.841 1.656 . . . . 4.0300000000000002 108.495 -165.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.45 158.69 22.21 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 109.968 -1.253 . . . . 1.3400000000000001 109.968 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.38 46.77 2.21 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.513 2.808 . . . . 1.0900000000000001 111.83 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.42 ' CB ' ' HB2' ' A' ' 145' ' ' ALA . 38.3 t -100.2 159.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.613 1.565 . . . . 0.90000000000000002 109.524 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.51 129.05 7.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.698 1.599 . . . . 2.4500000000000002 106.798 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.89 175.19 47.0 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.165 -0.774 . . . . 0.79000000000000004 111.165 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.4 mt -126.26 119.18 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.595 -1.632 . . . . 1.9099999999999999 106.595 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.29 134.06 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.197 -1.779 . . . . 0.76000000000000001 106.197 160.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -108.99 121.36 44.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.259 -2.126 . . . . 2.1699999999999999 105.259 162.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -113.47 114.72 26.95 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.944 1.698 . . . . 3.0699999999999998 106.647 175.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -131.33 156.2 45.9 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.294 0.952 . . . . 3.0699999999999998 109.367 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -153.99 146.8 24.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.721 -1.955 . . . . 4.2300000000000004 105.721 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -84.97 -90.26 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.905 -0.776 . . . . 4.7599999999999998 108.905 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.1 mp0 -77.06 149.8 35.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.831 -1.174 . . . . 3.8700000000000001 107.831 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -73.65 -2.17 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.132 -0.98 . . . . 2.2799999999999998 113.001 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -119.12 24.91 10.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.307 1.843 . . . . 4.8099999999999996 109.482 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.42 169.04 18.08 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 108.654 -1.778 . . . . 1.4399999999999999 108.654 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -65.63 139.48 58.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.681 1.587 . . . . 1.45 110.563 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.74 153.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.75 -1.204 . . . . 1.1100000000000001 107.75 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -129.21 131.67 47.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.417 -1.697 . . . . 2.8399999999999999 106.417 172.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.45 139.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.208 1.403 . . . . 1.4399999999999999 107.755 -169.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.22 138.75 21.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.274 -1.01 . . . . 1.1399999999999999 108.274 168.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.93 130.74 2.24 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.388 -1.885 . . . . 1.03 108.388 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.4 p -105.92 85.99 2.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.698 -1.964 . . . . 1.99 105.698 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mm -88.1 153.29 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.309 -1.367 . . . . 1.3999999999999999 107.309 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -147.54 158.19 43.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.128 1.158 . . . . 3.6099999999999999 114.128 168.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.24 9.96 43.28 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.87 2.176 . . . . 0.62 112.481 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 119' ' ' VAL . 1.3 mm? -63.84 160.86 16.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.588 0.755 . . . . 1.1399999999999999 109.369 168.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.57 159.2 26.94 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 107.468 -1.308 . . . . 1.6899999999999999 107.468 155.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.47 177.9 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.947 0.879 . . . . 3.0699999999999998 111.681 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.65 -164.55 54.05 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.02 -0.536 . . . . 0.5 112.036 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.81 148.4 40.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.895 1.678 . . . . 1.95 112.305 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.414 ' CD2' HD12 ' A' ' 38' ' ' LEU . 82.5 m-70 -150.59 111.35 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.239 1.416 . . . . 0.47999999999999998 110.29 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.25 147.4 2.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.549 -0.62 . . . . 0.37 111.549 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.572 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -136.36 96.71 3.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.875 -1.157 . . . . 2.6299999999999999 107.875 -178.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -133.28 156.53 47.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.813 -1.551 . . . . 0.62 106.813 -167.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.7 119.46 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.434 1.016 . . . . 1.8200000000000001 109.491 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.43 ' CD2' HG21 ' A' ' 118' ' ' VAL . 16.4 m-70 -91.25 138.46 31.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.659 -1.608 . . . . 0.84999999999999998 106.659 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -40.76 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.684 1.594 . . . . 4.4100000000000001 110.935 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 6.1 tt0 . . . . . 0 N--CA 1.454 -0.234 0 C-N-CA 124.18 0.992 . . . . 3.2400000000000002 112.457 152.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.719 0.295 . . . . 2.04 110.486 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.63 -86.5 1.75 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.288 -1.925 . . . . 1.21 108.288 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.25 177.42 8.8 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.621 2.881 . . . . 0.93000000000000005 113.326 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -64.8 134.81 54.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.821 -1.536 . . . . 1.47 108.136 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -37.89 106.66 0.05 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.301 1.041 . . . . 1.77 111.129 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -127.14 143.54 47.41 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 130.817 3.647 . . . . 3.7599999999999998 108.037 -175.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.14 -51.82 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.644 1.563 . . . . 1.2 109.256 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -143.53 -82.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.891 1.276 . . . . 3.0899999999999999 108.08 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -123.59 60.53 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.494 1.118 . . . . 1.8999999999999999 109.751 -164.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -79.01 166.35 22.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.469 0.652 . . . . 3.4500000000000002 110.354 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -118.67 159.29 23.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.644 1.578 . . . . 3.3700000000000001 107.906 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 40.7 t60 -86.94 168.47 13.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.023 0.529 . . . . 0.96999999999999997 112.064 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.7 -126.59 1.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.431 -3.068 . . . . 1.8600000000000001 105.431 165.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.49 -176.74 45.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.929 -2.068 . . . . 1.73 107.929 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.01 -40.43 84.03 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.012 2.475 . . . . 2.3700000000000001 111.463 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -32.61 71.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.166 0.586 . . . . 4.9800000000000004 112.474 174.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -89.09 177.66 6.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.716 0.769 . . . . 2.8599999999999999 112.66 -164.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -55.75 -66.41 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.619 1.168 . . . . 7.2999999999999998 111.405 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -118.23 179.6 4.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.663 2.385 . . . . 3.1099999999999999 112.263 -166.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.83 157.45 1.96 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.7 2.4 . . . . 4.1500000000000004 108.231 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -63.56 153.89 34.33 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.844 -1.169 . . . . 0.54000000000000004 107.844 170.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.76 -37.48 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 119.902 -0.719 . . . . 1.24 110.464 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.03 71.7 0.24 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 112.026 -0.43 . . . . 0.76000000000000001 112.026 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -165.8 113.55 0.94 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.331 -0.988 . . . . 1.8300000000000001 108.331 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.13 -61.39 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.094 -0.706 . . . . 1.97 109.094 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.3 -107.05 0.27 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.139 -1.184 . . . . 0.78000000000000003 110.139 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -147.2 163.25 36.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 125.107 1.363 . . . . 1.48 110.93 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.24 -178.58 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.027 2.131 . . . . 0.51000000000000001 105.867 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.8 t -129.47 171.54 12.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.827 -1.175 . . . . 1.99 107.827 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.11 144.58 50.81 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.308 1.043 . . . . 0.56999999999999995 110.669 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.47 -90.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.386 2.274 . . . . 4.2400000000000002 110.89 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -174.23 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.278 1.031 . . . . 3.29 110.271 -158.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.04 5.0 8.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.118 0.961 . . . . 2.7799999999999998 110.183 165.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.53 23.03 71.38 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.124 -1.19 . . . . 0.85999999999999999 110.124 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.2 t -85.36 136.65 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.364 1.466 . . . . 0.68000000000000005 107.895 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.407 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . . . -131.18 166.22 21.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.691 1.596 . . . . 0.87 109.748 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -142.14 118.45 10.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.038 -2.579 . . . . 2.71 104.038 -158.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.95 55.54 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 123.691 0.62 . . . . 1.51 111.225 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.4 m -77.18 87.86 3.64 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.642 -0.661 . . . . 1.0 109.771 168.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.5 mm -125.39 157.16 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.163 0.985 . . . . 1.76 108.352 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -151.32 99.0 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.637 0.375 . . . . 2.4300000000000002 111.494 166.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -92.17 159.1 15.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.178 0.591 . . . . 2.3999999999999999 110.595 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 p -116.23 -17.52 10.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.62 1.968 . . . . 1.55 113.296 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.75 -50.91 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 119.151 0.887 . . . . 1.3500000000000001 108.656 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.55 175.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.45 0.643 . . . . 1.4299999999999999 110.915 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.1 p -146.33 178.26 8.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.425 2.69 . . . . 2.3300000000000001 105.231 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 44.84 2.9 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.767 1.167 . . . . 2.8799999999999999 111.68 167.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 112.976 0.732 . . . . 3.2400000000000002 112.976 -169.106 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.891 0.853 . . . . 1.25 112.327 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.403 HD11 ' CE2' ' A' ' 20' ' ' PHE . 1.4 pp -89.08 -8.65 10.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 CA-C-N 115.327 -0.851 . . . . 1.6799999999999999 111.001 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 tp -33.63 127.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.258 1.423 . . . . 1.98 110.569 159.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.74 -19.52 24.4 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.037 -0.868 . . . . 1.6399999999999999 113.479 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.3 mtt-85 -86.54 168.94 13.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.604 1.702 . . . . 4.1900000000000004 109.281 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 80.7 m -101.82 115.4 30.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.018 -0.427 . . . . 0.88 110.353 -172.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 149.42 45.15 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.65 -0.87 . . . . 2.4300000000000002 108.65 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 48' ' ' HIS . 76.0 t -133.78 128.55 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.454 1.102 . . . . 0.54000000000000004 109.246 171.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 45' ' ' PHE . 25.1 t -99.81 116.24 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 C-N-CA 126.346 1.858 . . . . 2.2799999999999998 106.275 168.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -94.26 160.47 14.67 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.164 1.913 . . . . 0.53000000000000003 116.164 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -41.27 -77.53 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.265 2.626 . . . . 3.2799999999999998 112.481 170.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -97.29 -179.52 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.627 1.571 . . . . 2.5899999999999999 111.147 -168.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.81 153.72 32.11 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.019 -0.734 . . . . 0.80000000000000004 109.019 158.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -85.05 153.36 22.77 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.306 0.574 . . . . 2.02 109.729 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -81.97 -3.93 55.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.617 1.567 . . . . 3.0899999999999999 113.542 -168.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 53.85 32.9 15.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.377 1.071 . . . . 2.6200000000000001 110.773 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.79 14.5 30.22 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 121.08 -1.013 . . . . 2.2200000000000002 113.567 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -127.97 -27.48 2.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.926 1.291 . . . . 6.6799999999999997 110.728 -168.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.05 134.5 40.62 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.547 -1.421 . . . . 2.6800000000000002 109.547 164.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.62 -24.75 33.18 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.152 0.882 . . . . 2.1699999999999999 114.872 -166.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -55.91 125.86 23.27 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 118.295 -0.86 . . . . 2.8500000000000001 109.267 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -47.38 -40.99 18.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.833 1.197 . . . . 3.6899999999999999 111.192 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -47.43 -31.3 4.0 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.56 1.544 . . . . 3.0 111.624 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.99 -72.16 0.07 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.369 -0.604 . . . . 2.21 109.369 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 t -63.44 -41.11 98.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 121.621 -0.674 . . . . 2.5099999999999998 109.485 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.53 -45.41 94.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.75 -0.643 . . . . 3.8599999999999999 112.27 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.467 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.339 0.2 OUTLIER -128.68 -53.08 1.24 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.476 1.034 . . . . 1.27 113.181 173.723 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.71 -22.5 0.4 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.241 0.924 . . . . 1.03 112.201 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.1 t30 49.61 54.53 10.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.651 1.18 . . . . 1.8899999999999999 111.001 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.42 -3.45 58.34 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.672 -0.811 . . . . 1.3300000000000001 111.021 162.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.35 -155.34 45.45 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.249 -1.54 . . . . 0.96999999999999997 109.249 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.8 m -65.45 150.9 47.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.444 -1.378 . . . . 1.55 113.537 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -59.2 135.72 57.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.581 1.552 . . . . 2.96 108.812 170.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 mt -116.55 -76.88 0.57 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.05 -1.092 . . . . 0.82999999999999996 108.05 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 14' ' ' VAL . . . -104.47 145.86 29.69 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.755 -0.831 . . . . 1.23 108.755 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.3 163.81 30.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 123.862 0.726 . . . . 1.53 110.221 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.47 145.87 6.01 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.456 1.979 . . . . 0.72999999999999998 109.035 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.37 139.02 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.875 1.27 . . . . 0.88 108.65 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.6 tt -101.96 139.15 23.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 123.239 0.616 . . . . 0.98999999999999999 112.22 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.35 1.63 1.92 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.395 0.998 . . . . 0.59999999999999998 114.482 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.0 mm -93.61 56.91 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.214 1.507 . . . . 0.80000000000000004 110.3 -156.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.99 168.4 27.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.148 0.579 . . . . 1.3200000000000001 110.461 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 . . . . . 0 C--O 1.256 1.412 0 N-CA-C 101.995 -3.335 . . . . 4.5999999999999996 101.995 162.117 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 108.641 -0.874 . . . . 4.0499999999999998 108.641 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.95 21.77 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.49 -0.93 . . . . 1.0700000000000001 108.49 167.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 152' ' ' ALA . 53.0 t -107.58 150.68 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 106.666 -1.605 . . . . 1.05 106.666 161.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.1 96.2 3.85 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.706 -0.85 . . . . 0.59999999999999998 108.706 158.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 109.32 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.876 -1.527 . . . . 0.79000000000000004 106.876 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.83 125.03 39.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.571 -1.27 . . . . 0.85999999999999999 107.571 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -49.27 0.14 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 110.575 -0.157 . . . . 4.75 110.575 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.86 -117.21 0.8 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.958 1.266 . . . . 0.69999999999999996 111.247 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.75 -60.15 1.59 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.181 -1.044 . . . . 3.2999999999999998 108.181 -164.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.01 168.24 0.43 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 127.089 2.28 . . . . 0.69999999999999996 113.96 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.79 -21.08 69.49 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.315 2.677 . . . . 1.23 111.657 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.4 141.41 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.736 1.214 . . . . 1.01 110.937 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.0 122.31 5.6 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.119 -1.438 . . . . 1.98 107.119 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.14 168.68 36.51 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.67 -0.572 . . . . 0.63 111.67 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.76 131.3 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.623 -0.88 . . . . 1.4299999999999999 108.623 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.3 mm -97.21 146.63 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.747 -1.575 . . . . 0.82999999999999996 106.747 161.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.86 144.51 50.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.472 -1.677 . . . . 2.1299999999999999 106.472 159.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.93 161.51 41.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.535 -0.466 . . . . 3.5499999999999998 111.758 167.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.23 170.64 15.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.541 1.136 . . . . 3.5099999999999998 108.166 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.76 165.41 36.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 104.878 -2.267 . . . . 3.4399999999999999 104.878 165.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.65 -66.14 0.85 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.326 -0.62 . . . . 4.8300000000000001 109.326 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -89.38 166.12 13.93 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.219 1.007 . . . . 3.7400000000000002 110.52 -164.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -78.31 2.26 19.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.402 0.681 . . . . 3.27 111.652 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -153.34 85.4 1.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.205 1.402 . . . . 3.7999999999999998 108.406 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.83 169.74 37.8 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.41 133.61 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.723 2.949 . . . . 1.1200000000000001 112.934 -166.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -106.93 139.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.568 0.747 . . . . 1.1299999999999999 110.115 -171.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -99.5 89.71 4.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.713 0.805 . . . . 6.1500000000000004 109.223 -170.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.2 t -76.82 105.13 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 1.0600000000000001 106.878 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -113.66 140.9 47.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.817 -0.808 . . . . 1.0900000000000001 108.817 166.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.45 156.95 28.77 Favored Glycine 0 N--CA 1.448 -0.528 0 O-C-N 121.472 -0.768 . . . . 0.66000000000000003 112.008 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 p -130.36 104.38 7.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.505 -2.035 . . . . 2.02 105.505 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.01 143.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.381 -1.34 . . . . 0.88 107.381 -168.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -147.78 174.06 12.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.581 0.705 . . . . 3.6400000000000001 112.729 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 22.26 72.38 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 114.868 -1.06 . . . . 0.66000000000000003 112.107 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -76.58 -155.38 0.06 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.475 -1.306 . . . . 0.88 107.475 168.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -146.99 146.15 29.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.848 -2.278 . . . . 3.0699999999999998 104.848 166.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -34.19 132.96 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.719 2.408 . . . . 3.3100000000000001 113.223 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.63 -172.3 20.94 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.284 0.468 . . . . 0.56000000000000005 112.612 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.28 149.03 49.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.667 1.187 . . . . 2.23 112.831 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.34 120.22 9.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 126.279 1.832 . . . . 0.46999999999999997 108.455 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.0 150.06 6.65 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 110.393 -1.083 . . . . 0.35999999999999999 110.393 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.87 95.83 2.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.417 -1.327 . . . . 2.6699999999999999 107.417 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.427 ' ND1' ' CE1' ' A' ' 63' ' ' HIS . 24.0 m170 -134.2 147.16 50.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.264 -1.013 . . . . 0.56000000000000005 108.264 -161.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.294 0.7 OUTLIER -99.43 126.46 52.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.194 0.997 . . . . 1.8600000000000001 109.993 168.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.404 ' CD2' HG21 ' A' ' 118' ' ' VAL . 30.3 m-70 -85.38 -172.97 4.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.233 -1.395 . . . . 1.74 107.233 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -112.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.105 -1.443 . . . . 4.9500000000000002 107.105 161.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.213 -1.032 . . . . 2.9900000000000002 108.213 -177.197 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 107.777 -1.194 . . . . 2.0600000000000001 107.777 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.22 -88.03 0.07 OUTLIER Glycine 0 CA--C 1.522 0.485 0 N-CA-C 108.661 -1.776 . . . . 1.2 108.661 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -71.88 179.13 5.08 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 125.057 3.838 . . . . 1.0600000000000001 112.585 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.427 ' CE1' ' ND1' ' A' ' 46' ' ' HIS . 15.4 m170 -74.23 152.7 39.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.143 -0.935 . . . . 1.5700000000000001 109.327 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -50.82 108.09 0.22 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.382 0.512 . . . . 1.99 112.382 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -121.48 135.32 24.97 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 126.246 1.818 . . . . 3.5 109.147 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.5 -50.43 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.739 1.626 . . . . 1.1599999999999999 108.991 171.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.48 -84.09 0.25 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.94 1.296 . . . . 2.3199999999999998 107.652 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.8 m -132.71 60.88 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.406 1.082 . . . . 1.5900000000000001 110.787 -168.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -77.44 158.7 29.89 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.526 -1.287 . . . . 4.0 107.526 162.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -120.41 163.44 17.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.433 1.493 . . . . 3.0099999999999998 107.713 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -81.58 157.04 24.89 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.22 0.533 . . . . 0.75 111.043 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.88 -155.84 16.54 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 104.469 -3.453 . . . . 2.3999999999999999 104.469 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.63 -131.65 1.24 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.274 -1.53 . . . . 1.5600000000000001 109.274 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.7 -40.67 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.308 2.005 . . . . 1.8400000000000001 111.872 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.29 -46.17 42.94 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.786 0.291 . . . . 4.96 111.786 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.95 176.69 6.93 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.505 -0.554 . . . . 2.4300000000000002 109.505 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.62 -33.55 10.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 5.1399999999999997 111.736 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 162.89 26.74 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 119.111 -1.036 . . . . 3.6200000000000001 110.183 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 133.05 0.05 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.782 2.033 . . . . 3.9100000000000001 108.864 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 46.5 m80 -50.01 144.61 6.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.177 -1.786 . . . . 0.70999999999999996 106.177 155.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.304 5.1 p -83.55 44.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 123.304 1.526 . . . . 1.6899999999999999 110.795 -170.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -154.63 3.68 0.24 Allowed Glycine 0 CA--C 1.545 1.926 1 C-N-CA 131.364 4.316 . . . . 1.8400000000000001 113.125 169.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.19 99.39 8.54 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 121.651 2.726 . . . . 2.0 107.753 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.5 mt -77.31 -44.96 27.77 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.064 0.847 . . . . 2.79 109.103 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.58 -107.82 0.34 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.688 -0.767 . . . . 0.73999999999999999 111.216 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -149.69 171.13 17.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.648 1.579 . . . . 1.52 109.366 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.82 172.27 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.74 -1.578 . . . . 0.55000000000000004 106.74 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.5 m -122.02 124.28 43.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.523 -1.288 . . . . 1.98 107.523 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.88 138.78 38.29 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.642 -0.503 . . . . 0.58999999999999997 109.642 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.72 -89.69 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 124.272 0.982 . . . . 2.7799999999999998 110.228 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 -57.84 1.0 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.295 1.038 . . . . 3.4300000000000002 110.085 -164.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.36 25.04 1.48 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 123.352 1.549 . . . . 2.96 110.911 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 62.91 19.71 61.4 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.917 -1.038 . . . . 0.82999999999999996 111.51 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.72 139.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.13 -1.433 . . . . 0.80000000000000004 107.13 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.99 166.18 23.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.856 1.263 . . . . 0.70999999999999996 107.887 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -128.0 143.23 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.766 -2.679 . . . . 2.8900000000000001 103.766 -173.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.39 121.7 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.381 -1.711 . . . . 1.4399999999999999 106.381 173.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -150.59 91.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.947 1.299 . . . . 0.82999999999999996 108.604 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.48 144.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 107.951 -1.129 . . . . 1.8700000000000001 107.951 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -112.51 83.44 1.81 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.656 -1.609 . . . . 3.7400000000000002 106.656 161.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.28 146.29 33.06 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.1 p -108.06 -7.95 15.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.764 2.025 . . . . 1.48 112.28 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.59 -55.53 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.78 -1.193 . . . . 1.3600000000000001 107.78 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.8 pt -70.35 176.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 122.312 1.053 . . . . 1.54 112.008 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 m -153.4 176.96 11.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.663 1.985 . . . . 2.04 106.233 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 -19.61 25.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.319 0.963 . . . . 3.04 113.434 -169.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 CA--C 1.532 0.255 0 O-C-N 121.034 -1.041 . . . . 3.8900000000000001 111.857 -168.292 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.5 p . . . . . 0 N--CA 1.445 -0.686 0 CA-C-O 121.194 0.521 . . . . 1.3799999999999999 111.113 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.38 -5.89 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.389 -0.823 . . . . 1.97 110.553 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -51.49 120.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.094 -0.706 . . . . 1.6200000000000001 109.094 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.85 39.61 95.14 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.61 -0.55 . . . . 1.77 112.8 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -120.79 167.94 11.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.265 -1.383 . . . . 5.4699999999999998 107.265 158.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.7 m -91.69 118.3 30.53 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.846 0.458 . . . . 0.95999999999999996 111.043 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 144.4 45.56 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.145 -1.057 . . . . 1.5800000000000001 108.145 164.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.404 HG21 ' CD2' ' A' ' 48' ' ' HIS . 75.0 t -131.54 140.33 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.189 1.796 . . . . 0.40000000000000002 107.818 174.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.63 127.44 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.129 -1.063 . . . . 1.55 108.129 164.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -97.08 159.61 14.81 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.474 2.028 . . . . 0.40999999999999998 116.474 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -47.57 -73.4 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.257 1.823 . . . . 3.02 112.243 172.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -97.35 179.87 4.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.002 0.921 . . . . 4.2800000000000002 110.264 -172.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.61 147.96 39.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.031 -0.729 . . . . 0.54000000000000004 109.031 160.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -77.32 162.73 27.07 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.278 -0.638 . . . . 1.97 109.278 167.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.13 -8.47 59.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.424 1.268 . . . . 3.0800000000000001 114.424 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 48.97 30.3 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.695 1.134 . . . . 1.4299999999999999 110.89 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.56 28.18 72.85 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.152 0.882 . . . . 1.8500000000000001 112.502 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -130.41 29.48 4.84 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.034 0.917 . . . . 5.4400000000000004 111.226 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -96.44 135.2 12.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 108.467 -1.853 . . . . 2.29 108.467 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.08 66.27 2.88 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 117.63 0.715 . . . . 2.25 112.43 -171.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -168.84 170.72 8.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 125.085 1.354 . . . . 3.3999999999999999 108.092 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -52.09 -71.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.062 0.545 . . . . 3.6099999999999999 110.897 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -47.72 -41.96 24.13 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.868 2.067 . . . . 3.8300000000000001 111.947 -162.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.2 m -46.09 -58.54 3.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.994 0.917 . . . . 2.5600000000000001 112.071 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -73.07 -40.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.792 -1.193 . . . . 1.49 112.511 173.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -66.25 -36.29 82.62 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.376 1.07 . . . . 5.8399999999999999 110.549 -165.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.377 13.1 t -133.47 -46.27 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.604 0.762 . . . . 2.0699999999999998 111.562 172.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.37 -18.45 1.33 Allowed Glycine 0 N--CA 1.467 0.752 0 CA-C-N 119.886 1.221 . . . . 0.89000000000000001 112.877 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 34.36 56.28 0.66 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.077 2.551 . . . . 2.5699999999999998 112.347 -174.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.44 -1.61 27.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.417 -0.513 . . . . 1.1000000000000001 111.994 167.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.81 -163.23 45.64 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.017 -1.633 . . . . 0.94999999999999996 109.017 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.4 m -60.86 148.79 38.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.026 -1.587 . . . . 1.28 113.822 -161.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -57.47 130.82 48.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.392 -1.277 . . . . 2.6699999999999999 107.799 165.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.7 mt -106.64 -73.1 0.7 Allowed 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 107.746 -1.205 . . . . 0.46999999999999997 107.746 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.25 144.45 34.04 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.705 -1.22 . . . . 0.67000000000000004 107.705 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 85.8 m -126.87 160.58 30.53 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.522 -2.029 . . . . 2.1299999999999999 105.522 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.8 131.19 1.85 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.013 -0.835 . . . . 0.68999999999999995 111.013 169.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.6 t -62.94 134.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.669 0.788 . . . . 0.69999999999999996 109.404 169.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.6 tt -95.67 134.81 31.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.714 0.293 . . . . 0.95999999999999996 111.116 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.54 3.81 0.49 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.062 0.839 . . . . 0.81000000000000005 115.033 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.8 mm -92.77 57.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.52 1.66 . . . . 1.01 110.91 -155.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.566 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -155.57 170.92 20.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.488 0.715 . . . . 1.46 110.792 167.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 83.9 mt-30 . . . . . 0 C--O 1.255 1.359 0 N-CA-C 103.065 -2.939 . . . . 4.6600000000000001 103.065 163.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.721 0.296 . . . . 3.8799999999999999 110.643 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.26 41.71 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.003 1.321 . . . . 0.92000000000000004 107.562 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.92 143.74 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 106.701 -1.592 . . . . 1.02 106.701 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.575 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -122.4 93.34 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.698 . . . . 0.56000000000000005 109.114 156.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.68 100.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.246 -1.39 . . . . 1.04 107.246 164.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.9 mt -89.13 143.16 27.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.996 0.518 . . . . 1.26 109.767 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -143.73 -64.2 0.38 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.206 -1.035 . . . . 4.0300000000000002 108.206 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.36 -122.9 13.14 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.748 -0.66 . . . . 0.96999999999999997 113.14 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -126.43 -55.98 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.387 0.613 . . . . 2.98 110.014 -152.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.31 164.15 25.07 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 110.049 -1.22 . . . . 0.73999999999999999 110.049 164.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.74 34.25 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.674 2.916 . . . . 1.1000000000000001 113.586 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.5 155.1 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.722 1.609 . . . . 1.1200000000000001 109.69 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.03 125.69 9.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.799 -1.926 . . . . 2.46 105.799 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.61 164.15 31.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.194 -0.763 . . . . 0.76000000000000001 111.194 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.636 -1.616 . . . . 1.01 106.636 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 3.0 mp -90.48 144.06 9.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.432 -1.692 . . . . 1.79 106.432 161.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.5 102.72 7.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.395 1.478 . . . . 1.78 107.104 167.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -79.77 118.76 21.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.615 -1.995 . . . . 2.46 105.615 169.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -142.67 145.84 33.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.52 1.055 . . . . 3.2799999999999998 108.902 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -157.18 146.06 19.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.223 -0.444 . . . . 4.4500000000000002 109.919 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -68.43 -61.26 1.91 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.275 1.03 . . . . 5.0099999999999998 109.755 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -78.48 -175.92 4.52 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 119.018 0.827 . . . . 4.1299999999999999 110.194 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -81.0 -68.68 0.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.035 -1.468 . . . . 2.6899999999999999 107.035 165.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -90.56 106.02 18.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.907 0.883 . . . . 4.5499999999999998 109.293 171.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.08 176.17 45.88 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 107.94 -2.064 . . . . 1.23 107.94 166.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.84 116.84 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.317 2.678 . . . . 1.46 110.635 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.8 t -78.62 147.39 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.312 -0.625 . . . . 0.98999999999999999 109.312 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -98.14 113.37 25.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.809 -1.552 . . . . 3.1899999999999999 106.809 171.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 20' ' ' PHE . 56.6 t -115.25 82.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.996 1.718 . . . . 1.1399999999999999 106.974 -169.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -98.07 158.84 15.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.078 -0.712 . . . . 0.85999999999999999 109.078 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.72 158.94 29.36 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.769 -0.933 . . . . 0.72999999999999998 110.769 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.9 p -129.16 104.07 7.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.762 -1.94 . . . . 2.52 105.762 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.7 141.95 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.082 -1.451 . . . . 0.92000000000000004 107.082 -168.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.11 159.9 41.69 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.593 1.331 . . . . 3.23 114.593 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.4 22.84 25.79 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.957 1.742 . . . . 1.1200000000000001 111.81 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.33 -156.05 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.105 -1.072 . . . . 1.27 108.105 166.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 m -146.27 152.17 38.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.749 -2.315 . . . . 3.21 104.749 165.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -37.98 141.39 0.21 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.273 2.229 . . . . 2.8599999999999999 113.77 -170.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.66 -171.87 26.76 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.238 -0.437 . . . . 0.63 112.323 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 151.47 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.286 1.035 . . . . 2.3500000000000001 112.804 -168.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -146.66 118.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.194 1.797 . . . . 0.87 108.154 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.01 154.25 3.89 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.035 -1.226 . . . . 0.57999999999999996 110.035 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -145.47 89.79 1.96 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.612 -1.255 . . . . 2.6800000000000002 107.612 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -128.72 164.58 22.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.156 -1.053 . . . . 0.84999999999999998 108.156 -160.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 134.0 66.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 122.055 0.931 . . . . 2.0499999999999998 110.488 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.497 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 21.5 m-70 -110.05 132.82 53.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.371 1.469 . . . . 0.96999999999999997 107.241 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HA ' ' HG2' ' A' ' 115' ' ' ARG . 13.4 mt-10 -74.11 65.95 1.18 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.876 1.27 . . . . 5.7699999999999996 111.19 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' CB ' ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.429 -1.521 0 CA-C-N 113.516 -1.675 . . . . 5.6500000000000004 107.446 168.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 48' ' ' HIS . . . . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 110.614 -0.143 . . . . 1.95 110.614 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.25 -126.45 3.2 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.069 -1.213 . . . . 1.0600000000000001 110.069 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.15 178.68 6.63 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.894 3.062 . . . . 0.82999999999999996 112.629 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.66 126.02 28.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.519 -1.229 . . . . 1.23 108.031 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -5.56 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.243 2.217 . . . . 2.5600000000000001 113.394 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -125.81 130.51 24.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 127.318 2.247 . . . . 3.5699999999999998 108.719 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.73 -43.77 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.8 1.666 . . . . 1.1699999999999999 109.729 173.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.54 -73.11 0.42 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.718 1.207 . . . . 2.46 107.923 172.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.5 m -154.0 83.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.423 -0.798 . . . . 2.2200000000000002 109.767 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -79.5 168.52 19.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.399 -0.593 . . . . 4.6900000000000004 109.399 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -102.93 152.93 20.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 107.264 -1.384 . . . . 3.6200000000000001 107.264 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -75.41 163.21 27.66 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.114 0.87 . . . . 0.93000000000000005 110.349 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.6 -103.54 0.17 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.846 -2.502 . . . . 1.9299999999999999 106.846 167.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.26 -121.21 2.51 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.496 1.148 . . . . 2.1000000000000001 111.547 167.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -86.58 -42.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.541 2.161 . . . . 1.6200000000000001 111.306 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -64.15 0.96 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.095 -1.076 . . . . 4.9400000000000004 108.095 174.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.87 143.09 54.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.265 -0.879 . . . . 2.0699999999999998 109.34 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -54.87 -46.93 74.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 126.449 1.899 . . . . 5.21 111.667 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.59 176.57 6.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.246 1.018 . . . . 3.4700000000000002 110.924 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 154.86 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.616 1.166 . . . . 4.5499999999999998 110.995 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.6 m80 -54.53 141.86 29.77 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.682 -1.97 . . . . 0.64000000000000001 105.682 155.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.08 -17.81 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.298 -0.561 . . . . 1.3600000000000001 110.973 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.4 52.37 0.75 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.506 -0.608 . . . . 0.76000000000000001 114.574 162.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -96.71 124.51 40.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 105.463 -2.051 . . . . 2.0699999999999998 105.463 143.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.06 -51.64 6.52 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.33 0.968 . . . . 2.4500000000000002 108.399 161.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.49 -115.35 0.64 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.713 -1.355 . . . . 0.93000000000000005 109.713 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -148.63 166.56 27.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.359 1.463 . . . . 1.8500000000000001 109.362 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.3 174.28 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.648 -1.612 . . . . 0.78000000000000003 106.648 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.4 m -129.02 129.67 45.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 2.0600000000000001 107.306 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 135.49 37.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.324 -0.621 . . . . 0.72999999999999998 109.324 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.84 -69.91 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.725 1.266 . . . . 4.0199999999999996 110.356 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -168.87 -53.94 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.95 2.1 . . . . 5.2800000000000002 108.528 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.44 23.29 1.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.934 1.293 . . . . 3.5899999999999999 110.563 -167.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.26 4.97 75.36 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.52 1.057 . . . . 1.1100000000000001 112.182 -174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.85 154.34 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.022 -1.103 . . . . 1.3999999999999999 108.022 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.64 171.32 14.21 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.525 1.13 . . . . 0.87 108.079 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.41 151.45 38.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 104.266 -2.494 . . . . 2.75 104.266 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.07 134.19 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 107.788 -1.19 . . . . 1.74 107.788 145.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.3 m -155.42 61.35 0.62 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.012 1.725 . . . . 1.1100000000000001 107.748 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -105.91 155.56 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 108.036 -1.098 . . . . 1.47 108.036 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.06 118.64 14.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.135 -0.691 . . . . 2.7000000000000002 109.135 150.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.46 -174.4 5.17 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.59 0.71 . . . . 4.0999999999999996 109.664 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.6 p -144.75 51.41 1.25 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.197 -1.038 . . . . 2.4300000000000002 108.197 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.4 -54.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.329 1.452 . . . . 1.52 108.957 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -96.32 179.76 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.165 0.986 . . . . 1.1200000000000001 109.928 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.1 m -152.31 176.82 11.22 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.192 -1.41 . . . . 2.1600000000000001 107.192 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.65 47.96 1.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.733 1.254 . . . . 2.71 110.712 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 126.742 2.017 . . . . 3.96 112.937 -169.862 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 111.647 0.24 . . . . 1.1699999999999999 111.647 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.415 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 15.2 pt -78.05 -10.28 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.538 -0.744 . . . . 1.73 111.904 174.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.4 mm -40.6 123.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 1.8200000000000001 110.68 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.14 50.89 6.02 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.558 -0.617 . . . . 2.0699999999999998 111.558 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.427 ' HG2' ' HA ' ' A' ' 49' ' ' GLU . 2.2 mtt85 -136.62 153.52 50.92 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.535 1.134 . . . . 3.8799999999999999 109.264 168.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 98.7 m -79.63 115.95 19.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 124.326 1.016 . . . . 1.1899999999999999 108.397 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tt -86.03 136.5 33.22 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 118.901 0.773 . . . . 2.1400000000000001 109.427 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -124.86 120.21 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.958 -1.127 . . . . 0.48999999999999999 107.958 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.94 118.59 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 105.523 -2.029 . . . . 1.6799999999999999 105.523 161.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -90.07 162.83 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.249 1.574 . . . . 0.53000000000000003 115.249 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -38.78 -69.13 0.13 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.068 2.547 . . . . 3.23 111.907 170.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -120.75 -177.71 3.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.622 1.169 . . . . 2.71 110.624 -167.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.62 57.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.274 -0.639 . . . . 0.54000000000000004 109.274 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -81.07 156.28 25.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.056 -0.72 . . . . 2.23 109.056 158.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -22.93 60.08 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.332 0.653 . . . . 3.5099999999999998 111.664 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.98 56.77 2.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.823 0.82 . . . . 2.3599999999999999 109.573 -168.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.87 73.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.156 -0.929 . . . . 1.6100000000000001 113.438 157.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -77.3 -23.31 51.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.932 -0.746 . . . . 6.7300000000000004 110.217 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 71.76 -118.66 7.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.415 -1.474 . . . . 3.1200000000000001 109.415 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.72 -68.44 1.57 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.334 -1.506 . . . . 2.46 109.334 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -94.41 161.61 14.16 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.79 -1.189 . . . . 2.7599999999999998 107.79 160.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.62 -53.53 46.16 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.242 -0.286 . . . . 3.5299999999999998 110.649 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -49.03 -40.94 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.818 1.647 . . . . 2.9399999999999999 113.45 -169.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.9 m -47.16 -54.27 11.03 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.77 0.828 . . . . 2.2000000000000002 112.004 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -44.6 60.96 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.46 -0.775 . . . . 1.53 111.78 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -59.62 -50.84 72.33 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.976 0.911 . . . . 2.7400000000000002 111.207 -166.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.464 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.35 0.1 OUTLIER -124.7 -46.39 1.87 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.568 -0.73 . . . . 1.1399999999999999 111.56 175.086 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.35 -2.1 0.67 Allowed Glycine 0 C--O 1.222 -0.652 0 CA-C-O 118.009 -1.439 . . . . 1.03 115.531 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 27.63 52.72 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.151 2.181 . . . . 4.2800000000000002 114.589 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.21 -16.42 60.48 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.416 -0.803 . . . . 0.89000000000000001 111.93 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.67 -171.32 36.08 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 109.142 -1.583 . . . . 0.95999999999999996 109.142 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -62.46 156.01 23.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.639 -1.28 . . . . 1.25 113.564 -164.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -73.1 148.05 44.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.959 -1.019 . . . . 2.4700000000000002 111.14 173.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mt -128.73 -69.43 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.537 -1.283 . . . . 0.78000000000000003 107.537 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.02 163.58 12.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.918 -0.771 . . . . 1.3100000000000001 108.918 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.9 p -165.07 160.45 18.86 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.678 -1.601 . . . . 1.9099999999999999 106.678 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.49 143.16 3.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 105.766 -2.933 . . . . 1.0800000000000001 105.766 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.5 t -81.37 139.85 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 117.901 0.851 . . . . 1.29 110.213 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.8 tt -86.49 131.88 33.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.899 0.38 . . . . 0.82999999999999996 110.484 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.83 -8.62 0.97 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.048 0.833 . . . . 0.93000000000000005 115.002 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mm -90.56 57.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.662 1.231 . . . . 1.03 110.546 -157.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.92 175.87 5.79 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.556 0.742 . . . . 2.04 110.465 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 C--O 1.257 1.451 0 N-CA-C 104.113 -2.551 . . . . 4.29 104.113 164.814 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 109.972 -0.381 . . . . 3.6600000000000001 109.972 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.85 148.41 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.866 1.666 . . . . 0.69999999999999996 108.367 169.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.92 144.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.39 -0.967 . . . . 0.63 108.39 165.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.93 97.03 5.3 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.841 -0.8 . . . . 0.42999999999999999 108.841 155.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.26 106.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.992 -1.485 . . . . 0.51000000000000001 106.992 161.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -90.31 133.91 34.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 0.91000000000000003 108.456 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -149.45 -50.99 0.15 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.413 0.685 . . . . 3.2200000000000002 110.527 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.06 -117.5 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.352 0.977 . . . . 0.92000000000000004 113.501 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -114.33 -54.82 2.55 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.661 1.184 . . . . 4.0700000000000003 109.69 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.77 159.73 21.42 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 110.336 -1.106 . . . . 0.85999999999999999 110.336 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.11 40.6 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.342 2.695 . . . . 1.0 112.179 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 40.6 t -92.59 159.47 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.003 1.721 . . . . 0.81000000000000005 108.616 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.81 135.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.948 -1.501 . . . . 2.3500000000000001 106.948 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 169.31 42.27 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.916 -1.274 . . . . 0.67000000000000004 109.916 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.87 110.16 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.115 -1.439 . . . . 0.97999999999999998 107.115 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.2 125.34 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.756 -1.572 . . . . 0.72999999999999998 106.756 168.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -99.36 109.56 22.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.699 -1.963 . . . . 2.0499999999999998 105.699 166.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CG ' HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -98.01 105.56 17.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.554 -2.017 . . . . 2.5499999999999998 105.554 171.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.25 138.31 49.14 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.948 1.249 . . . . 3.6600000000000001 110.264 169.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -156.67 105.71 2.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.159 -1.052 . . . . 3.7999999999999998 108.159 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -89.36 36.38 0.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.89 0.476 . . . . 7.2199999999999998 111.33 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -125.63 -138.06 0.27 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.221 -1.4 . . . . 4.8499999999999996 107.221 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -130.3 -76.62 0.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.349 0.66 . . . . 3.4300000000000002 109.345 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -101.8 86.04 2.84 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.184 -1.784 . . . . 5.0 106.184 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.64 34.68 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.597 -1.001 . . . . 1.71 110.597 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.92 132.11 29.27 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.512 2.808 . . . . 1.6200000000000001 112.297 -170.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.6 t -91.89 149.24 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.307 -0.997 . . . . 1.04 108.307 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 121.67 44.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.729 -1.582 . . . . 2.6400000000000001 106.729 163.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.412 HG22 ' CE1' ' A' ' 20' ' ' PHE . 48.8 t -115.86 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.245 1.818 . . . . 1.03 107.25 -170.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -127.23 126.88 43.52 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 123.507 0.505 . . . . 1.25 110.743 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.2 137.02 5.06 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.56 -1.416 . . . . 0.89000000000000001 109.56 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -116.53 110.25 18.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.929 -1.878 . . . . 2.77 105.929 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 mm -103.1 152.81 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.595 1.958 . . . . 1.22 108.866 -164.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -149.55 156.17 41.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.28 0.844 . . . . 3.46 113.28 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.52 15.11 33.06 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.782 2.134 . . . . 0.60999999999999999 112.458 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 43' ' ' HIS . 2.8 mm? -69.54 162.49 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.18 0.992 . . . . 1.25 110.035 170.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.49 161.63 24.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.927 -1.138 . . . . 1.6899999999999999 107.927 157.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -56.87 174.85 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.786 0.803 . . . . 2.4399999999999999 111.775 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.8 -169.52 52.4 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.986 0.803 . . . . 0.78000000000000003 113.687 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.82 153.02 44.54 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.892 1.277 . . . . 2.23 111.754 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.489 ' CD2' HD12 ' A' ' 38' ' ' LEU . 89.3 m-70 -149.36 117.72 6.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.869 1.667 . . . . 0.42999999999999999 108.365 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.37 150.44 4.32 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.712 -0.955 . . . . 0.34999999999999998 110.712 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -140.85 95.66 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.827 -1.545 . . . . 2.5699999999999998 106.827 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -134.11 155.97 49.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.033 -1.469 . . . . 0.54000000000000004 107.033 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.27 126.84 67.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.091 -0.707 . . . . 1.6299999999999999 109.091 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.453 ' CD2' HG21 ' A' ' 118' ' ' VAL . 25.7 m-70 -95.2 142.58 27.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.883 1.673 . . . . 0.75 108.376 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -46.49 -64.8 0.67 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.726 1.211 . . . . 4.2599999999999998 110.935 -171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 127.706 2.403 . . . . 3.2000000000000002 114.73 155.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.188 -0.671 . . . . 2.3500000000000001 109.188 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.74 -89.11 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 107.945 -2.062 . . . . 1.1399999999999999 107.945 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.56 177.65 8.25 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 124.823 3.682 . . . . 0.96999999999999997 112.948 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -66.43 142.02 57.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.921 1.688 . . . . 1.4199999999999999 107.551 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -49.49 115.66 1.43 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.402 0.681 . . . . 1.71 110.95 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.58 111.88 9.82 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.995 1.718 . . . . 2.8500000000000001 108.819 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.6 -10.9 29.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.85 1.7 . . . . 1.72 113.46 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -146.52 -72.64 0.23 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.745 -0.835 . . . . 2.2999999999999998 108.745 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -161.74 92.7 0.88 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.758 -1.201 . . . . 2.3900000000000001 107.758 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.29 175.53 5.68 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.048 1.739 . . . . 5.7400000000000002 108.202 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 9.9 mtpm? -133.8 153.27 51.84 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.575 1.55 . . . . 3.9700000000000002 107.397 -174.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -87.87 136.98 32.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.807 0.843 . . . . 1.28 109.908 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.68 -66.53 0.14 Allowed Glycine 0 C--O 1.222 -0.636 0 N-CA-C 107.519 -2.232 . . . . 2.7599999999999998 107.519 163.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.0 -170.21 35.37 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.007 1.289 . . . . 1.4099999999999999 111.595 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.02 -42.61 5.9 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.789 2.326 . . . . 1.6799999999999999 110.343 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.35 -54.08 7.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.546 0.738 . . . . 4.6600000000000001 111.107 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.05 149.31 50.1 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.439 -0.948 . . . . 2.02 108.439 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -49.53 -51.92 33.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.058 0.943 . . . . 3.9500000000000002 110.532 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 59.5 mt-10 -76.11 152.5 36.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.751 1.262 . . . . 3.75 110.694 -163.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -175.05 134.66 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.394 1.478 . . . . 3.3300000000000001 108.177 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 34.4 m80 -50.87 137.75 20.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.154 -2.165 . . . . 0.77000000000000002 105.154 147.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.44 -24.76 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 119.342 -0.943 . . . . 1.46 109.73 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.65 33.94 4.75 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.133 -1.371 . . . . 0.82999999999999996 116.504 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -102.81 112.95 25.98 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 120.72 2.26 . . . . 1.96 107.937 161.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 84' ' ' LEU . 4.0 mm? -78.66 -57.58 3.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.449 -1.315 . . . . 1.52 107.449 160.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.85 -110.63 0.43 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.806 -0.918 . . . . 0.58999999999999997 110.806 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -146.72 169.31 19.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.666 1.186 . . . . 1.3600000000000001 109.898 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.5 176.56 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 105.998 -1.853 . . . . 0.62 105.998 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.3 m -140.27 132.71 28.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.363 -2.088 . . . . 2.02 105.363 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.666 0.604 . . . . 0.68999999999999995 110.127 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.72 -80.98 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.119 0.968 . . . . 2.9700000000000002 109.407 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.2 tttm -160.2 -43.54 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.563 1.145 . . . . 3.96 111.878 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -81.99 30.61 0.38 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 123.739 1.733 . . . . 3.2599999999999998 110.833 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 64.72 17.73 63.02 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.002 1.763 . . . . 1.0700000000000001 112.571 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.52 147.82 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.54 -1.281 . . . . 1.1299999999999999 107.54 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.06 175.02 11.35 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.114 -1.439 . . . . 0.90000000000000002 107.114 166.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.31 149.95 29.22 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.386 -1.338 . . . . 3.2400000000000002 107.386 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.37 103.41 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 C-N-CA 125.621 1.569 . . . . 1.25 106.791 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.5 m -121.48 87.52 2.77 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.377 1.471 . . . . 1.0 107.789 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.8 mt -126.45 160.51 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.555 0.742 . . . . 1.3899999999999999 109.034 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.33 95.78 2.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.194 -0.457 . . . . 2.3300000000000001 111.503 157.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.35 154.46 25.25 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.311 0.577 . . . . 2.0499999999999998 110.243 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.1 p -107.76 -17.54 14.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.224 2.21 . . . . 1.73 112.386 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.33 -51.3 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.259 0.936 . . . . 1.02 109.426 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.415 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.4 pp -71.81 176.23 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.858 0.837 . . . . 1.0900000000000001 111.051 174.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -156.85 173.7 16.6 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.877 -1.157 . . . . 1.78 107.877 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -43.69 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.761 0.824 . . . . 2.7000000000000002 110.558 169.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.534 0.327 0 O-C-N 121.424 -0.797 . . . . 4.4500000000000002 112.389 -158.76 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.936 0 CA-C-O 121.542 0.687 . . . . 1.4199999999999999 112.829 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.4 pt -90.53 -5.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.085 0.954 . . . . 2.02 111.218 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 tp -26.55 126.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.889 1.675 . . . . 1.98 111.876 163.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.26 -19.09 37.26 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.827 -0.985 . . . . 1.5700000000000001 113.433 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -88.81 164.08 15.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.576 1.688 . . . . 4.6500000000000004 110.807 -169.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.2 m -89.06 106.17 18.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 119.226 -0.416 . . . . 0.95999999999999996 110.603 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 mt -65.72 146.37 54.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.613 -0.835 . . . . 1.6499999999999999 108.775 166.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.453 HG21 ' CD2' ' A' ' 48' ' ' HIS . 80.6 t -135.47 135.46 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.443 1.897 . . . . 0.40000000000000002 109.046 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 145' ' ' ALA . 55.1 t -102.25 119.62 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.153 1.781 . . . . 2.3700000000000001 106.412 166.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -92.96 159.32 15.38 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 116.839 2.163 . . . . 0.40000000000000002 116.839 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -33.3 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.501 3.121 . . . . 3.3700000000000001 112.364 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -107.14 -175.98 2.95 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.059 0.845 . . . . 2.8300000000000001 110.458 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.86 142.53 45.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.504 -0.924 . . . . 0.87 108.504 158.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.21 165.95 24.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.242 -0.651 . . . . 2.2200000000000002 109.242 159.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -88.45 -7.13 57.08 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.396 1.478 . . . . 3.3500000000000001 111.227 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.28 46.16 27.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.346 1.458 . . . . 1.8400000000000001 110.2 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.27 24.06 58.45 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.644 -0.531 . . . . 1.7 113.627 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -78.34 -13.66 59.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.441 1.121 . . . . 5.04 110.633 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.0 -133.34 11.74 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.588 -1.005 . . . . 2.6200000000000001 110.588 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.95 -68.32 1.33 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.221 -1.552 . . . . 2.29 109.221 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.09 150.97 19.61 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.222 -1.029 . . . . 2.6499999999999999 108.222 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.24 -48.76 79.99 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.81 -0.556 . . . . 3.5 111.248 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -51.94 -33.46 37.56 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.114 1.366 . . . . 3.1099999999999999 111.777 -168.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.2 t -39.39 -62.56 0.65 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.386 1.474 . . . . 2.1499999999999999 110.466 167.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.3 p -73.77 -46.46 45.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.762 0.425 . . . . 1.3999999999999999 110.757 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -42.92 86.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.026 0.53 . . . . 2.8999999999999999 110.858 -167.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.497 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.6 p -128.33 -48.07 1.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.355 0.662 . . . . 1.52 112.127 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.31 -31.85 0.71 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.103 1.335 . . . . 1.1299999999999999 111.038 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 52.99 54.68 10.06 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.628 1.971 . . . . 2.4100000000000001 112.606 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.54 -43.11 33.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.12 0.962 . . . . 1.1899999999999999 108.875 162.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 116.05 -143.42 18.07 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 107.986 -2.046 . . . . 1.0700000000000001 107.986 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.5 m -60.61 149.6 34.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.574 1.149 . . . . 1.1899999999999999 112.459 -169.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -60.5 135.01 57.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 2.6400000000000001 108.878 168.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -112.19 -82.27 0.59 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.887 -1.153 . . . . 0.71999999999999997 107.887 165.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . . . -83.04 145.42 29.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.672 -1.233 . . . . 1.1599999999999999 107.672 171.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 77.7 m -141.24 154.29 45.7 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.137 -1.431 . . . . 2.21 107.137 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.06 128.64 1.5 Allowed Glycine 0 CA--C 1.527 0.796 0 O-C-N 123.614 0.571 . . . . 0.72999999999999998 111.735 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.95 132.28 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.676 1.19 . . . . 0.68999999999999995 109.223 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.417 HD11 ' CG ' ' A' ' 20' ' ' PHE . 8.1 tt -95.7 138.79 20.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 111.688 0.255 . . . . 0.69999999999999996 111.688 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.69 0.03 1.6 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.062 0.839 . . . . 0.56999999999999995 115.048 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.62 57.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 119.11 1.455 . . . . 0.76000000000000001 110.914 -157.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.39 169.07 25.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.196 0.598 . . . . 1.29 110.547 168.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 . . . . . 0 C--O 1.253 1.272 0 N-CA-C 102.057 -3.312 . . . . 4.4000000000000004 102.057 162.701 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 108.369 -0.975 . . . . 2.9100000000000001 108.369 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.79 139.9 34.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.933 -1.506 . . . . 0.77000000000000002 106.933 153.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -98.2 147.26 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.132 -1.803 . . . . 0.67000000000000004 106.132 159.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.77 96.13 3.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.404 -0.962 . . . . 0.54000000000000004 108.404 160.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.06 109.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.381 -1.34 . . . . 0.70999999999999996 107.381 168.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.52 128.77 42.65 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.176 0.591 . . . . 0.84999999999999998 109.901 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -140.15 -65.05 0.47 Allowed 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.848 0.859 . . . . 3.9700000000000002 110.858 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.58 -122.74 5.81 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.791 1.186 . . . . 1.05 112.94 -170.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -118.89 -49.81 2.41 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.179 0.991 . . . . 3.0800000000000001 109.67 -155.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.3 154.96 8.06 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 108.803 -1.719 . . . . 0.83999999999999997 108.803 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.33 42.8 1.29 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.175 2.583 . . . . 1.0600000000000001 113.385 -165.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -84.98 153.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.191 1.396 . . . . 1.1799999999999999 110.298 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.61 75.69 1.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.37 -0.974 . . . . 3.0099999999999998 108.37 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 165.27 16.89 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.56999999999999995 112.522 -171.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.51 133.22 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.11 0.964 . . . . 1.1799999999999999 109.546 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 26.6 mm -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.513 1.525 . . . . 0.79000000000000004 107.708 161.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -121.45 119.09 31.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.554 -1.646 . . . . 1.76 106.554 158.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.461 ' CD1' HG22 ' A' ' 31' ' ' VAL . 9.4 t80 -128.07 120.54 27.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.442 -1.318 . . . . 2.9500000000000002 107.442 -169.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.81 165.07 37.62 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.45 0.643 . . . . 4.3700000000000001 112.191 -166.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -153.84 157.04 38.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.501 -2.037 . . . . 2.9100000000000001 105.501 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.26 -29.77 64.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.043 0.383 . . . . 5.1900000000000004 110.894 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.52 -150.5 0.43 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.946 -1.501 . . . . 5.6200000000000001 106.946 174.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.0 m -146.17 1.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.708 -1.245 . . . . 4.2699999999999996 113.866 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -124.26 39.93 3.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.067 1.747 . . . . 3.46 109.728 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.84 -162.23 10.81 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.377 -1.089 . . . . 1.3799999999999999 110.377 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.98 114.5 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.155 2.57 . . . . 1.3600000000000001 111.139 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.1 158.54 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.089 -0.708 . . . . 0.91000000000000003 109.089 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -106.37 112.54 25.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.18 -1.045 . . . . 2.6600000000000001 108.18 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 20' ' ' PHE . 60.0 t -80.55 122.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.198 -1.778 . . . . 1.23 106.198 164.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -125.98 145.54 50.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.675 -0.861 . . . . 1.1399999999999999 108.675 154.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.41 155.4 26.68 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.673 -0.971 . . . . 0.72999999999999998 110.673 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -134.62 108.19 7.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.099 -2.186 . . . . 2.04 105.099 -173.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.3 149.01 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.014 -1.476 . . . . 0.92000000000000004 107.014 -167.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -155.32 157.28 36.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.957 -0.464 . . . . 3.8399999999999999 110.509 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.38 22.08 30.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.832 1.682 . . . . 0.90000000000000002 111.909 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.02 168.11 19.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.109 -1.071 . . . . 0.65000000000000002 108.109 168.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -74.85 169.17 18.45 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.216 -1.031 . . . . 1.6699999999999999 108.216 153.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.11 174.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.275 1.43 . . . . 3.9100000000000001 111.044 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -162.83 37.14 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.822 -0.626 . . . . 0.56000000000000005 113.531 167.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.67 141.23 57.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.929 1.292 . . . . 2.0299999999999998 113.27 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.3 114.64 7.53 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.486 1.514 . . . . 0.53000000000000003 109.751 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.46 145.14 2.81 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.497 1.046 . . . . 0.42999999999999999 110.665 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.18 93.57 3.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 2.4399999999999999 106.972 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.669 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 23.4 m170 -131.35 154.48 48.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.24 -0.437 . . . . 0.63 109.862 -161.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.02 116.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.375 -1.342 . . . . 2.1200000000000001 107.375 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -103.84 139.67 38.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.24 -1.393 . . . . 1.1000000000000001 107.24 170.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.35 35.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.802 1.408 . . . . 5.3399999999999999 114.802 -171.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.7 mt-10 . . . . . 0 C--O 1.234 0.278 0 O-C-N 120.507 -1.371 . . . . 3.3700000000000001 112.365 -159.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.058 0 N-CA-C 108.284 -1.006 . . . . 1.8100000000000001 108.284 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.15 -91.84 1.63 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.726 -1.75 . . . . 1.01 108.726 173.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.74 -179.06 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 125.843 4.362 . . . . 1.0700000000000001 112.7 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -53.1 131.6 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.615 1.566 . . . . 1.4399999999999999 110.236 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -42.44 114.03 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.771 1.228 . . . . 2.6200000000000001 109.712 170.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -156.29 165.95 17.51 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 106.671 -1.603 . . . . 2.5299999999999998 106.671 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.39 -35.09 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.549 1.499 . . . . 1.1399999999999999 111.487 -167.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -147.22 -82.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.876 0.87 . . . . 2.7999999999999998 109.194 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.4 m -139.03 64.94 1.46 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.383 1.073 . . . . 2.04 110.617 -168.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -77.67 175.27 10.07 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.532 0.682 . . . . 4.0300000000000002 109.3 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 8.5 mttp -120.83 146.47 46.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.473 1.509 . . . . 3.2799999999999998 107.189 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -72.31 167.31 20.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.568 0.747 . . . . 1.29 110.873 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.03 -138.45 2.68 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 106.699 -2.56 . . . . 2.0099999999999998 106.699 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.75 -144.26 4.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.882 -2.087 . . . . 1.6699999999999999 107.882 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.57 -41.24 6.47 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.176 1.988 . . . . 1.8400000000000001 109.901 174.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -58.03 7.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.724 0.81 . . . . 5.5499999999999998 111.802 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.16 145.44 37.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.576 -0.528 . . . . 2.04 109.576 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -55.97 -44.54 78.6 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.77 1.628 . . . . 4.1200000000000001 111.156 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 7.1 mt-10 -78.92 179.45 7.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.012 0.925 . . . . 2.8700000000000001 111.243 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 157.67 144.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.391 3.076 . . . . 2.9300000000000002 106.369 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.478 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.4 m80 -59.96 141.23 55.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 105.536 -2.024 . . . . 0.53000000000000003 105.536 156.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.68 71.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 123.117 1.437 . . . . 2.4300000000000002 108.165 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.26 26.73 0.26 Allowed Glycine 0 CA--C 1.542 1.774 0 C-N-CA 126.779 2.133 . . . . 0.85999999999999999 113.59 -155.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -130.51 145.75 51.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 120.518 2.159 . . . . 2.27 108.032 146.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -104.95 -42.36 5.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.794 0.837 . . . . 1.79 108.79 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.28 -121.82 1.11 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 109.076 -1.61 . . . . 0.56999999999999995 109.076 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -139.82 169.22 18.12 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.381 1.473 . . . . 1.6399999999999999 109.076 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.34 175.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 0.58999999999999997 106.653 163.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -106.68 142.63 36.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.967 -1.494 . . . . 2.3900000000000001 106.967 156.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.75 152.05 31.7 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.24 -1.022 . . . . 0.66000000000000003 108.24 152.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.32 -78.9 0.09 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.666 0.786 . . . . 2.8599999999999999 110.303 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -154.39 -52.43 0.09 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.716 1.606 . . . . 4.6900000000000004 107.948 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.63 4.03 17.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.084 1.754 . . . . 5.0099999999999998 111.748 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.07 10.16 72.25 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.907 1.241 . . . . 0.84999999999999998 111.682 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -79.17 147.38 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 0.98999999999999999 107.694 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.05 167.76 21.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.244 1.018 . . . . 0.66000000000000003 108.755 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -130.64 144.59 51.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 103.901 -2.629 . . . . 2.7000000000000002 103.901 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.06 111.04 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 106.704 -1.591 . . . . 1.1499999999999999 106.704 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -140.17 104.82 4.9 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.952 0.901 . . . . 1.4099999999999999 108.773 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.04 151.9 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.662 -0.866 . . . . 1.6599999999999999 108.662 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.32 98.55 3.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.626 0.37 . . . . 2.5899999999999999 110.152 158.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.58 160.12 20.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.512 0.325 . . . . 2.6400000000000001 110.155 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -116.95 57.18 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.353 1.461 . . . . 2.5099999999999998 109.312 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -139.56 -64.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 108.025 -1.102 . . . . 1.1200000000000001 108.025 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.7 pp -75.88 175.58 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.345 0.593 . . . . 1.4199999999999999 110.905 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -153.94 176.0 12.7 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.554 1.541 . . . . 2.04 107.01 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 11.78 33.63 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.676 1.58 . . . . 2.3300000000000001 114.486 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.464 0.261 0 CA-C-N 118.362 0.528 . . . . 3.1600000000000001 111.654 -170.919 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 110.528 -0.175 . . . . 1.3700000000000001 110.528 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.5 pt -78.96 -7.05 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.208 -0.308 . . . . 1.8899999999999999 110.28 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -44.98 129.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.267 0.627 . . . . 1.46 109.744 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.21 -5.36 84.47 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 118.143 -1.365 . . . . 1.3400000000000001 113.839 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -98.26 162.3 13.26 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 120.199 2.0 . . . . 4.1100000000000003 111.655 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.0 m -94.65 107.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.059 0.943 . . . . 1.01 109.319 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.83 133.52 45.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.398 -0.964 . . . . 1.6499999999999999 108.398 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.94 134.23 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 126.846 2.058 . . . . 0.44 106.516 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -101.47 128.84 53.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.624 -1.621 . . . . 1.6599999999999999 106.624 165.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.529 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 48.3 m-70 -104.86 161.13 14.45 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 116.037 1.865 . . . . 0.52000000000000002 116.037 -169.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -37.32 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.41 2.684 . . . . 3.4100000000000001 112.06 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -101.27 -174.85 2.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.599 0.636 . . . . 2.6800000000000002 109.905 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.11 156.94 11.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.722 -0.844 . . . . 0.62 108.722 157.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -80.4 164.59 22.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.902 0.858 . . . . 2.1600000000000001 109.14 152.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -88.06 -4.61 58.76 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.321 1.448 . . . . 3.2400000000000002 112.354 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 56.16 33.79 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.638 1.175 . . . . 1.6299999999999999 110.561 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.98 25.33 65.93 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.392 -0.671 . . . . 1.4399999999999999 112.46 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -131.97 21.11 4.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.261 1.031 . . . . 5.1799999999999997 111.731 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.32 147.04 18.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.707 -0.957 . . . . 2.48 110.707 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.73 60.07 2.95 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.874 -0.89 . . . . 2.8799999999999999 110.874 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -176.67 106.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 105.232 -2.136 . . . . 2.8300000000000001 105.232 -169.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -31.92 46.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.021 0.749 . . . . 3.8199999999999998 113.021 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -36.01 -43.61 0.33 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.076 1.75 . . . . 2.9399999999999999 112.783 166.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t -43.78 -63.91 0.76 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.954 1.701 . . . . 2.7200000000000002 110.205 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.39 -46.11 61.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.818 -0.551 . . . . 1.6699999999999999 110.988 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -56.06 -45.75 79.18 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 123.642 0.777 . . . . 3.25 110.875 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.478 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 2.7 p -130.81 -47.88 1.04 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 119.127 -0.463 . . . . 1.49 112.022 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.41 -31.2 0.86 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.699 0.682 . . . . 1.0 112.647 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.41 54.21 5.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.098 1.359 . . . . 1.9399999999999999 110.09 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.83 -36.03 81.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.23 1.412 . . . . 1.1799999999999999 112.792 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 -174.05 49.77 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.396 -1.882 . . . . 0.91000000000000003 108.396 -160.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.1 m -59.53 151.61 23.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.439 1.495 . . . . 1.3200000000000001 113.385 -166.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 50' ' ' GLU . 4.8 mmt-85 -60.6 135.0 57.63 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.114 1.366 . . . . 3.0800000000000001 108.522 168.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.4 mt -112.19 -68.93 0.9 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.618 -1.253 . . . . 0.45000000000000001 107.618 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.6 166.41 11.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.185 -0.461 . . . . 1.1100000000000001 110.209 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.2 p -146.81 161.12 41.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.953 -1.021 . . . . 2.5299999999999998 108.507 165.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.94 131.62 1.57 Allowed Glycine 0 CA--C 1.526 0.779 0 O-C-N 125.07 1.481 . . . . 0.66000000000000003 110.288 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.13 134.6 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 123.743 0.817 . . . . 0.87 109.433 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.4 tt -91.8 126.37 44.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 C-N-CA 123.236 0.615 . . . . 0.90000000000000002 111.439 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.74 -5.75 0.84 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.467 1.032 . . . . 0.70999999999999996 114.911 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.5 mp -90.82 59.54 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.816 1.308 . . . . 1.1499999999999999 110.297 -155.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.49 175.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.866 0.841 . . . . 2.0699999999999998 113.181 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 C--O 1.248 1.001 0 N-CA-C 104.555 -2.387 . . . . 6.7000000000000002 104.555 160.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 pttt . . . . . 0 N--CA 1.457 -0.098 0 N-CA-C 112.002 0.371 . . . . 4.2800000000000002 112.002 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.42 155.09 19.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.718 1.207 . . . . 0.75 109.043 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.24 151.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.614 -1.254 . . . . 0.82999999999999996 107.614 162.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.75 102.39 6.07 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.86 0.864 . . . . 0.77000000000000002 108.765 157.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.61 105.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.149 -1.426 . . . . 0.80000000000000004 107.149 161.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -86.18 129.7 34.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.005 -1.109 . . . . 0.93000000000000005 108.005 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -151.58 -51.69 0.12 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.958 0.408 . . . . 3.1699999999999999 110.552 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.24 -111.16 1.06 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.472 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.99 -48.44 2.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.483 1.113 . . . . 3.6299999999999999 109.429 -161.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.65 171.65 33.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.212 1.387 . . . . 0.84999999999999998 112.048 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -69.64 -19.05 37.2 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.587 2.858 . . . . 1.3799999999999999 111.961 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.68 146.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.203 1.401 . . . . 1.0 111.072 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.11 122.05 5.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.783 -0.821 . . . . 2.0600000000000001 108.783 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.41 169.75 32.79 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.843 -0.503 . . . . 0.68000000000000005 111.843 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.84 113.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.059 -1.089 . . . . 1.4399999999999999 108.059 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -79.49 137.16 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.936 -1.135 . . . . 0.76000000000000001 107.936 167.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -109.66 118.46 36.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.008 -1.849 . . . . 1.4399999999999999 106.008 157.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.586 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -108.04 98.04 7.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.575 1.55 . . . . 3.23 106.89 176.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -109.13 137.13 47.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.441 -0.948 . . . . 5.1699999999999999 108.441 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -147.42 -62.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.54 -0.911 . . . . 4.0599999999999996 108.54 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 tttp 72.82 -48.41 0.68 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.834 1.654 . . . . 8.75 112.243 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 99.75 5.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.69 -1.226 . . . . 3.7799999999999998 107.69 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.4 t -19.36 -66.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.854 2.461 . . . . 2.8999999999999999 114.954 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -109.61 27.16 9.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.564 0.746 . . . . 3.5899999999999999 110.579 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.42 171.49 33.67 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.562 -1.015 . . . . 1.1799999999999999 110.562 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.13 139.5 66.99 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.948 1.766 . . . . 1.1200000000000001 110.257 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.81 159.86 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.274 -1.01 . . . . 1.26 108.274 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 110.85 13.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.28 -1.378 . . . . 3.2400000000000002 107.28 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.586 HG22 ' CE1' ' A' ' 20' ' ' PHE . 59.4 t -100.73 118.04 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 127.124 2.17 . . . . 1.1699999999999999 107.139 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -139.03 167.22 22.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.935 -0.395 . . . . 1.0800000000000001 109.935 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.15 175.31 38.95 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.699 -1.76 . . . . 0.88 108.699 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.1 p -130.15 113.84 14.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.807 -2.294 . . . . 2.46 104.807 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.31 109.81 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.283 -2.117 . . . . 1.51 105.283 -166.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -111.38 162.61 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.731 0.645 . . . . 3.7999999999999998 111.731 -166.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.55 80.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.219 -0.901 . . . . 0.78000000000000003 112.95 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -69.44 160.51 31.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.588 1.194 . . . . 0.83999999999999997 108.488 172.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.42 163.88 17.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.949 -1.13 . . . . 1.9399999999999999 107.949 154.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -58.61 170.11 0.82 Allowed 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.443 -0.786 . . . . 2.8900000000000001 111.295 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.58 -158.87 53.66 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.655 -0.702 . . . . 0.66000000000000003 112.693 165.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -70.86 144.44 50.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.849 1.259 . . . . 2.5600000000000001 112.59 -171.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -146.36 118.5 8.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.909 1.684 . . . . 0.63 109.294 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.99 149.86 4.18 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.923 -0.871 . . . . 0.34000000000000002 110.923 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -142.84 94.91 2.69 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.834 -1.543 . . . . 2.27 106.834 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -136.6 144.82 44.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.704 -1.221 . . . . 0.54000000000000004 107.704 -164.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.2 p -99.63 127.03 52.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 119.17 0.896 . . . . 1.8 109.894 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -97.1 136.23 37.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.356 -1.35 . . . . 0.77000000000000002 107.356 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.76 -32.29 59.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.169 0.988 . . . . 4.3200000000000003 112.111 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 7.3 tt0 . . . . . 0 CA--C 1.535 0.382 0 C-N-CA 128.525 2.73 . . . . 3.0299999999999998 113.068 158.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.612 0.244 . . . . 1.8500000000000001 110.606 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.55 -85.31 1.15 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.684 -1.767 . . . . 1.05 108.684 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.1 178.88 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.607 1 C-N-CA 125.774 4.316 . . . . 0.90000000000000002 113.308 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -67.96 132.88 48.13 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.572 1.549 . . . . 1.3100000000000001 110.106 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -44.99 114.03 0.66 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.942 0.897 . . . . 2.8999999999999999 111.68 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.92 157.36 31.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.634 1.574 . . . . 2.6000000000000001 106.875 168.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.06 -24.13 13.03 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.958 1.772 . . . . 1.3300000000000001 113.609 -168.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.0 tp -156.2 -72.32 0.11 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.03 0.832 . . . . 3.1800000000000002 110.856 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.6 m -154.09 63.21 0.7 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.266 0.555 . . . . 1.9199999999999999 110.21 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -78.09 168.76 19.38 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.353 -0.98 . . . . 3.8999999999999999 108.353 162.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -128.76 165.11 21.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.026 1.331 . . . . 4.6500000000000004 108.214 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -94.66 132.25 39.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.665 -0.865 . . . . 1.1699999999999999 108.665 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.92 -56.84 0.08 OUTLIER Glycine 0 C--O 1.224 -0.522 0 N-CA-C 108.095 -2.002 . . . . 2.96 108.095 171.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 140.33 173.41 13.34 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.457 1.503 . . . . 1.54 110.083 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.04 -31.13 66.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.902 2.402 . . . . 1.9199999999999999 111.037 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -73.84 -40.63 63.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.099 0.96 . . . . 4.0700000000000003 111.059 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -70.42 176.12 4.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.91 0.884 . . . . 1.8500000000000001 111.288 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.48 -48.96 20.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.386 1.074 . . . . 4.4299999999999997 109.734 168.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.38 149.85 26.45 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.654 1.216 . . . . 3.4700000000000002 112.185 -171.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -168.1 129.28 1.38 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.977 2.111 . . . . 5.71 107.488 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.491 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 50.1 m80 -51.62 131.58 29.88 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.463 -2.421 . . . . 0.59999999999999998 104.463 145.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.09 -35.47 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.933 -0.765 . . . . 1.9299999999999999 108.933 -169.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.76 38.95 2.98 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.537 1.065 . . . . 0.78000000000000003 115.289 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -90.16 129.21 36.46 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.206 -2.146 . . . . 1.8200000000000001 105.206 152.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.67 -51.75 6.25 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.735 -1.209 . . . . 1.8500000000000001 107.735 156.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.35 -104.63 0.26 Allowed Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.977 -1.249 . . . . 0.56999999999999995 109.977 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -148.49 170.64 17.59 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.799 1.64 . . . . 1.4099999999999999 109.57 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.81 162.32 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.069 -1.456 . . . . 0.56999999999999995 107.069 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.6 m -109.4 129.79 55.53 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 108.012 -1.107 . . . . 2.1600000000000001 108.012 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.51 139.26 34.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.744 0.818 . . . . 0.64000000000000001 111.513 168.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.13 -90.67 0.08 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 124.045 0.841 . . . . 3.0800000000000001 110.574 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -141.2 -34.38 0.49 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.395 0.887 . . . . 4.04 113.395 -162.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -78.81 14.75 1.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.911 1.339 . . . . 3.6699999999999999 110.385 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 62.33 20.88 61.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.115 -1.194 . . . . 0.72999999999999998 110.115 -166.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -92.24 117.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 123.995 0.918 . . . . 1.04 108.573 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.21 143.81 26.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.899 -1.889 . . . . 0.87 105.899 149.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.35 108.1 8.97 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 105.44 -2.059 . . . . 5.21 105.44 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.85 141.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.84 -1.073 . . . . 2.1600000000000001 110.601 -148.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.7 t -146.13 113.29 6.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.188 -1.412 . . . . 3.1800000000000002 107.188 162.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.4 mt -137.15 144.86 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 105.88 -1.896 . . . . 1.6299999999999999 105.88 166.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -125.71 96.36 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.945 0.35 . . . . 2.46 111.945 165.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.9 145.39 34.13 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.274 0.559 . . . . 2.6299999999999999 110.719 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.6 p -98.35 -20.52 17.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.394 1.878 . . . . 1.53 111.27 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.42 -49.6 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.305 0.502 . . . . 0.94999999999999996 109.875 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.2 pt -75.43 177.74 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.761 0.791 . . . . 1.4399999999999999 111.438 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.8 m -157.41 175.76 13.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.78 1.632 . . . . 1.76 107.417 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.417 HD21 ' HD2' ' A' ' 20' ' ' PHE . 77.1 mt -124.31 54.99 1.32 Allowed 'General case' 0 C--N 1.338 0.08 0 C-N-CA 124.534 1.133 . . . . 4.3300000000000001 108.754 174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 126.203 1.801 . . . . 3.0699999999999998 107.351 174.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.2 m . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 108.591 -0.892 . . . . 2.29 108.591 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.565 ' CD1' HG21 ' A' ' 149' ' ' ILE . 2.6 pp -78.78 -24.36 13.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.693 -0.403 . . . . 1.96 110.449 -163.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 tp -1.79 113.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.33 2.652 . . . . 1.8500000000000001 114.099 161.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.59 37.62 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.971 0.796 . . . . 1.74 113.183 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.485 ' O ' HG22 ' A' ' 149' ' ' ILE . 81.3 mtt85 -83.0 169.48 15.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.542 1.171 . . . . 4.0499999999999998 110.24 -171.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.2 m -95.45 108.81 21.05 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.735 -0.603 . . . . 0.92000000000000004 110.459 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.84 131.32 44.3 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.368 -1.345 . . . . 1.5700000000000001 107.368 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.09 139.89 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 127.265 2.226 . . . . 0.39000000000000001 107.845 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 m -108.86 130.19 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.85 -0.796 . . . . 1.6100000000000001 108.85 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -99.09 159.79 14.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 116.01 1.856 . . . . 0.38 116.01 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -40.65 -74.66 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.302 2.241 . . . . 3.0899999999999999 112.562 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -97.13 -179.34 4.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.198 1.399 . . . . 2.6099999999999999 110.637 -171.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.38 149.96 5.2 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 0.54000000000000004 109.473 156.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.5 149.04 26.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.152 -1.055 . . . . 2.1400000000000001 108.152 162.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.72 -8.6 59.34 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.233 0.827 . . . . 3.4199999999999999 113.233 -164.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 47.48 38.12 7.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.169 0.985 . . . . 2.2799999999999998 110.413 -165.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.25 25.48 57.42 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.533 -0.758 . . . . 2.0 113.001 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -113.85 40.38 2.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.22 1.01 . . . . 5.1799999999999997 108.655 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.0 134.6 9.0 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.895 -1.682 . . . . 2.23 108.895 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.67 -35.51 92.13 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 117.509 0.655 . . . . 2.4399999999999999 111.756 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -58.71 107.94 0.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.961 0.904 . . . . 2.1000000000000001 108.719 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -41.93 -42.65 2.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 3.8999999999999999 112.817 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -36.43 -41.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.73 2.012 . . . . 2.8100000000000001 113.978 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.5 m -54.93 -48.26 73.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.452 0.701 . . . . 2.4500000000000002 111.631 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.7 p -73.08 -46.33 52.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.361 -0.837 . . . . 1.23 110.482 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -51.83 -49.74 62.23 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.685 1.194 . . . . 2.54 111.264 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.491 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.9 OUTLIER -125.0 -46.52 1.82 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.607 0.763 . . . . 1.3100000000000001 111.142 175.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.91 2.02 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 119.086 0.857 . . . . 0.93999999999999995 112.197 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.64 54.28 9.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.187 1.795 . . . . 1.98 111.181 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.01 -5.36 58.28 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.26 -0.9 . . . . 1.1499999999999999 111.804 169.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.74 -165.23 45.71 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.083 -1.607 . . . . 0.93999999999999995 109.083 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.1 m -57.94 150.85 19.56 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.554 1.542 . . . . 1.22 113.678 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.1 mmt-85 -54.7 135.79 46.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.082 -1.417 . . . . 2.6600000000000001 108.275 164.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.5 mt -106.89 -76.63 0.61 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.953 -1.499 . . . . 0.52000000000000002 106.953 166.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 144.98 32.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.477 -0.934 . . . . 0.70999999999999996 108.477 170.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.46 150.36 48.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.119 -1.808 . . . . 1.71 106.119 172.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.48 119.94 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.424 -1.07 . . . . 0.75 110.424 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.47 130.21 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.046 1.338 . . . . 1.21 108.923 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.565 HG21 ' CD1' ' A' ' 112' ' ' ILE . 6.7 tt -105.65 133.12 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.962 0.727 . . . . 1.1399999999999999 112.962 -169.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.87 8.43 0.47 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.313 0.959 . . . . 0.82999999999999996 114.205 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.7 mm -91.88 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 120.045 1.922 . . . . 1.1299999999999999 109.867 -162.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.7 176.83 12.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.952 1.301 . . . . 1.3400000000000001 108.333 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--O 1.254 1.331 0 N-CA-C 107.014 -1.476 . . . . 4.7599999999999998 107.014 166.703 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 108.502 -0.925 . . . . 3.5299999999999998 108.502 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.63 141.19 49.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.948 -1.131 . . . . 0.88 107.948 159.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.581 HG23 ' HB2' ' A' ' 152' ' ' ALA . 71.0 t -103.81 142.83 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.195 -1.409 . . . . 0.70999999999999996 107.195 163.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -122.35 96.9 5.22 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.13 0.972 . . . . 0.51000000000000001 108.418 158.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.41 106.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.083 -1.451 . . . . 0.62 107.083 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 mt -99.17 133.95 42.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.166 0.986 . . . . 1.1000000000000001 109.196 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -143.47 -52.27 0.35 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.108 0.563 . . . . 3.3599999999999999 110.066 172.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.7 -121.67 27.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.878 0.751 . . . . 0.88 113.286 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -120.28 -54.66 2.09 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 125.128 1.371 . . . . 3.9900000000000002 110.008 -164.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.5 162.96 13.66 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.756 -1.338 . . . . 0.83999999999999997 109.756 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.52 33.54 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.389 2.726 . . . . 0.95999999999999996 113.141 -172.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 47.4 t -83.17 155.79 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.784 1.234 . . . . 0.83999999999999997 108.956 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -154.98 122.21 5.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.507 1.523 . . . . 2.5 107.243 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.41 169.09 38.36 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.883 -0.887 . . . . 0.47999999999999998 110.883 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.06 109.07 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.784 -1.562 . . . . 1.05 106.784 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 39.0 mm -79.03 126.45 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.531 -1.655 . . . . 0.73999999999999999 106.531 168.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -101.99 109.08 20.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.63 -1.618 . . . . 1.6299999999999999 106.63 160.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.42 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -90.31 96.43 10.66 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.028 -1.842 . . . . 2.8999999999999999 106.028 168.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.58 165.37 15.51 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.425 -0.954 . . . . 3.23 108.425 163.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -157.24 -50.39 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.279 0.632 . . . . 3.8999999999999999 109.411 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt 70.99 -61.33 0.48 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 127.594 2.358 . . . . 4.25 111.156 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -80.89 118.86 22.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.083 -0.71 . . . . 4.1600000000000001 109.083 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 m -20.24 -66.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.233 3.013 . . . . 3.3599999999999999 116.05 -172.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -123.9 52.55 1.45 Allowed 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 107.623 -1.251 . . . . 3.6899999999999999 107.623 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.98 178.09 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.761 -1.336 . . . . 1.46 109.761 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.01 132.7 30.92 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.107 1.871 . . . . 1.6399999999999999 111.283 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.6 124.2 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 108.747 -0.834 . . . . 1.1200000000000001 108.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -99.3 89.99 4.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.434 2.694 . . . . 5.04 105.538 -170.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 20' ' ' PHE . 12.6 t -83.54 126.1 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.138 1.775 . . . . 1.28 107.161 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -140.69 140.23 34.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.715 -0.846 . . . . 0.84999999999999998 108.715 158.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.48 145.75 8.75 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 105.806 -2.918 . . . . 0.82999999999999996 105.806 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.4 m -127.13 78.49 1.81 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.2 -1.778 . . . . 2.6899999999999999 106.2 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.38 134.15 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 128.38 2.672 . . . . 0.88 108.48 -162.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -129.48 163.01 26.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 118.741 0.701 . . . . 4.3600000000000003 111.475 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.09 24.27 52.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.113 0.863 . . . . 0.89000000000000001 111.993 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.16 -150.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.497 -1.297 . . . . 1.1399999999999999 107.497 163.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 m -147.34 152.35 38.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.36 -2.459 . . . . 3.3300000000000001 104.36 164.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -32.8 138.1 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.484 2.314 . . . . 2.7999999999999998 113.862 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.77 -166.4 28.92 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.212 0.434 . . . . 0.67000000000000004 112.995 167.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.29 147.24 53.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.091 1.356 . . . . 2.3399999999999999 112.829 -166.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -149.39 115.57 5.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.796 1.639 . . . . 0.46999999999999997 109.002 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.23 155.83 2.51 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.749 0.704 . . . . 0.54000000000000004 111.449 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.533 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 31.6 t80 -149.25 100.6 3.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.69 -0.855 . . . . 2.6899999999999999 108.69 -169.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -137.59 175.42 9.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.596 -1.261 . . . . 0.69999999999999996 107.596 -166.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.76 137.73 56.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.837 0.827 . . . . 1.8100000000000001 109.135 165.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -101.3 178.76 4.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.673 1.589 . . . . 0.93000000000000005 107.224 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -107.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.251 -1.018 . . . . 5.54 108.251 174.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 CA--C 1.529 0.163 0 C-N-CA 125.194 1.397 . . . . 3.2000000000000002 111.591 174.25 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 121.586 0.708 . . . . 1.99 110.723 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.44 -89.56 0.97 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.356 -1.898 . . . . 1.4299999999999999 108.356 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.87 179.02 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 125.136 3.89 . . . . 1.3300000000000001 112.919 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.416 ' HB2' ' CG ' ' A' ' 80' ' ' HIS . 24.2 m170 -65.46 138.4 58.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.16 1.784 . . . . 1.53 111.694 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -45.18 108.45 0.12 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.085 1.754 . . . . 2.5 111.993 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -150.24 154.82 36.73 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 125.727 1.611 . . . . 2.4300000000000002 107.454 166.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.51 -42.0 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.17 1.913 . . . . 1.29 112.667 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -142.33 -68.07 0.37 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.029 0.531 . . . . 3.3199999999999998 110.937 -175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -154.12 64.92 0.7 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.632 -0.668 . . . . 2.0499999999999998 111.532 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -78.02 166.25 23.05 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.952 -1.129 . . . . 4.0099999999999998 107.952 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -123.71 176.93 5.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.26 1.824 . . . . 5.2599999999999998 106.846 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -101.63 148.62 25.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.982 -0.449 . . . . 1.1599999999999999 111.515 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.58 -61.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.465 -1.054 . . . . 2.9700000000000002 110.465 173.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.23 -172.55 29.28 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.904 1.24 . . . . 1.6200000000000001 114.206 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 -41.49 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.769 2.313 . . . . 1.95 109.787 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -70.64 -47.55 59.47 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.735 0.814 . . . . 5.2199999999999998 111.239 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.84 175.21 1.56 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.108 -0.496 . . . . 2.5600000000000001 109.681 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.6 -39.92 21.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.986 -0.746 . . . . 8.0 108.986 165.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 147.14 39.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 117.237 -1.785 . . . . 3.8100000000000001 110.576 -165.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 167.58 127.89 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.548 2.339 . . . . 3.2799999999999998 108.262 -167.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 53.7 m80 -49.25 127.63 15.2 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 106.815 -1.55 . . . . 1.1000000000000001 106.815 163.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 p -52.69 -34.62 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.544 0.572 . . . . 1.55 112.544 -154.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.76 83.42 0.77 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.967 -0.853 . . . . 0.89000000000000001 110.967 166.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -161.98 111.74 1.54 Allowed 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.789 -0.83 . . . . 2.1200000000000001 108.84 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -90.02 -53.01 4.67 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.883 0.473 . . . . 2.1299999999999999 110.743 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.62 -102.74 0.22 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.572 -0.823 . . . . 0.73999999999999999 111.998 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.18 166.79 27.77 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.92 1.288 . . . . 1.8300000000000001 110.176 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.62 175.58 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.865 1.666 . . . . 0.48999999999999999 106.612 167.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 t -127.36 134.43 49.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.624 -0.88 . . . . 2.0699999999999998 108.624 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.74 135.99 36.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 123.227 0.611 . . . . 0.56999999999999995 110.411 165.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.19 -92.16 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.795 1.638 . . . . 3.1899999999999999 110.238 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -115.03 -67.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.616 0.767 . . . . 5.9100000000000001 110.864 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.3 -32.44 49.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 122.062 0.934 . . . . 3.4700000000000002 110.262 -168.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.24 46.41 0.07 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.597 -2.201 . . . . 0.83999999999999997 107.597 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.51 111.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.36 1.864 . . . . 0.83999999999999997 106.901 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.33 174.29 5.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.091 -1.078 . . . . 0.66000000000000003 108.091 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -145.52 149.61 34.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.787 -1.56 . . . . 3.1000000000000001 106.787 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG11 ' CZ ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -127.16 54.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.288 0.992 . . . . 1.6799999999999999 111.293 -178.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.3 m -70.07 91.8 0.71 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.839 -0.538 . . . . 1.1200000000000001 110.717 165.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.62 149.83 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.926 0.89 . . . . 1.45 108.646 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -113.23 89.6 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.729 -0.841 . . . . 3.2200000000000002 108.729 160.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -77.88 148.54 34.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.224 0.92 . . . . 2.3500000000000001 109.77 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.3 p -115.01 -6.69 12.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.926 1.69 . . . . 1.73 112.729 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.4 t -78.79 -54.73 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 119.546 1.066 . . . . 1.6899999999999999 109.615 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -86.85 176.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.977 0.894 . . . . 0.98999999999999999 111.403 178.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -145.17 160.94 40.66 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.093 -1.817 . . . . 1.8999999999999999 106.093 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.93 24.9 7.9 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.064 0.946 . . . . 2.5499999999999998 111.644 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 CA--C 1.534 0.349 0 C-N-CA 123.069 0.548 . . . . 3.02 109.657 -178.239 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 121.786 0.803 . . . . 1.3100000000000001 112.408 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.2 pt -84.12 -5.72 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.961 -0.563 . . . . 2.1800000000000002 111.429 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -51.0 136.59 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 O-C-N 122.016 -0.427 . . . . 1.75 110.207 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.88 30.01 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.614 -1.103 . . . . 1.76 112.45 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -89.59 166.06 13.87 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.8 1.8 . . . . 4.79 112.614 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 146' ' ' CYS . 1.8 m -85.54 104.09 14.98 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.537 0.735 . . . . 1.1299999999999999 109.878 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 2.3 tt -69.42 147.8 50.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.585 -0.894 . . . . 2.0699999999999998 108.585 170.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.56 128.85 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.339 1.056 . . . . 0.54000000000000004 109.088 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 1.3 p -100.66 125.7 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 106.429 -1.693 . . . . 2.1000000000000001 106.429 162.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -98.29 174.17 6.63 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.316 1.846 . . . . 0.44 115.035 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.497 -1.229 . . . . 4.96 111.984 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -178.42 6.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 121.079 1.763 . . . . 3.6600000000000001 110.98 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.38 156.25 13.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.213 -0.903 . . . . 0.92000000000000004 109.671 164.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.39 151.24 28.02 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.256 1.023 . . . . 2.6299999999999999 110.027 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.55 -10.64 58.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.623 0.769 . . . . 3.1499999999999999 112.679 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 49.06 35.57 7.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.394 1.478 . . . . 1.8200000000000001 110.904 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.96 22.28 54.54 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 121.494 -0.754 . . . . 1.99 112.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -116.88 -33.5 4.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.871 0.836 . . . . 5.0999999999999996 110.967 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.64 137.15 39.64 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.474 -0.65 . . . . 2.6899999999999999 111.474 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.04 69.31 1.6 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.082 0.849 . . . . 2.7000000000000002 112.27 -170.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -162.33 155.47 20.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.74 1.616 . . . . 2.6299999999999999 107.096 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.42 -40.8 97.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.227 0.467 . . . . 3.21 112.237 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -57.55 -30.94 65.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.032 0.533 . . . . 2.77 111.37 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -49.44 -69.68 0.11 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.965 0.906 . . . . 2.1899999999999999 110.277 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.2 p -69.28 -42.42 75.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.461 -0.774 . . . . 1.3300000000000001 110.422 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -61.42 -35.62 78.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.31 0.505 . . . . 3.3500000000000001 111.892 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.516 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.416 1.3 t -139.11 -58.3 0.6 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.919 -1.039 . . . . 1.8500000000000001 113.203 177.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.06 -18.19 0.47 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 120.194 1.361 . . . . 1.05 111.8 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.6 t30 51.09 54.64 10.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.654 1.582 . . . . 2.0 111.107 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.88 -52.62 5.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.531 0.682 . . . . 1.3799999999999999 110.473 170.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.63 -169.46 32.89 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.836 -1.706 . . . . 0.93999999999999995 108.836 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -58.4 161.55 4.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.744 1.618 . . . . 1.8899999999999999 111.293 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmt-85 -58.66 137.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.938 -1.028 . . . . 2.9199999999999999 108.356 166.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.82 -70.65 0.8 Allowed 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.134 -1.432 . . . . 0.45000000000000001 107.134 163.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -99.32 157.22 16.55 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.672 -0.695 . . . . 0.88 109.322 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.421 ' HB2' HG23 ' A' ' 116' ' ' THR . 0.7 OUTLIER -165.65 159.53 16.54 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 124.02 0.825 . . . . 1.5 109.129 171.436 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.58 141.39 3.42 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 107.068 -2.413 . . . . 0.88 107.068 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.7 133.15 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 123.999 0.919 . . . . 0.77000000000000002 110.174 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.8 tt -89.17 138.68 18.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 122.766 0.426 . . . . 0.79000000000000004 110.903 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.85 1.39 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.15 0.881 . . . . 0.69999999999999996 114.687 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.93 59.42 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.062 1.431 . . . . 0.84999999999999998 110.686 -161.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.581 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -144.08 177.64 8.43 Favored 'General case' 0 C--N 1.335 -0.022 0 N-CA-C 113.502 0.927 . . . . 1.6100000000000001 113.502 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.255 1.384 0 N-CA-C 103.098 -2.927 . . . . 6.3799999999999999 103.098 150.787 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 108.595 -0.891 . . . . 3.8100000000000001 108.595 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.9 154.8 36.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.453 -1.314 . . . . 0.78000000000000003 107.453 163.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.78 144.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 104.883 -2.266 . . . . 0.75 104.883 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -126.69 94.53 4.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.129 0.893 . . . . 0.5 108.887 159.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.55 108.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.162 -1.421 . . . . 0.65000000000000002 107.162 164.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.13 125.06 36.65 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.416 -0.587 . . . . 0.88 109.416 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -143.7 -55.5 0.38 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.067 0.547 . . . . 3.5699999999999998 110.263 165.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.7 -110.57 0.85 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.783 -0.927 . . . . 1.1399999999999999 110.783 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.76 -48.11 1.92 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.45 1.1 . . . . 3.6699999999999999 109.9 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.54 161.43 12.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 112.086 -0.406 . . . . 1.03 112.086 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.37 29.98 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.097 3.198 . . . . 1.04 114.215 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.04 160.88 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.142 1.377 . . . . 1.1599999999999999 108.787 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 97.8 1.93 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.786 -1.931 . . . . 3.0 105.786 168.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.45 167.17 24.84 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.933 -0.467 . . . . 0.5 111.933 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.33 121.44 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.555 -0.906 . . . . 1.1000000000000001 108.555 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 31.3 mm -87.7 142.35 13.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 107.413 -1.328 . . . . 0.81999999999999995 107.413 162.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.48 129.73 47.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.92 1.288 . . . . 1.5900000000000001 107.525 169.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -122.0 131.03 53.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.226 1.81 . . . . 3.0299999999999998 107.197 -172.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 153.98 48.9 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.522 -0.918 . . . . 4.0700000000000003 108.522 162.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.71 81.5 0.88 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.424 1.89 . . . . 3.98 107.486 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -40.44 -57.21 1.85 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.261 1.425 . . . . 4.6900000000000004 112.437 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.07 126.53 35.15 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.43 1.092 . . . . 3.8700000000000001 109.271 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -19.49 -66.68 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.277 2.631 . . . . 3.1299999999999999 114.57 174.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -118.5 42.2 2.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.391 1.076 . . . . 3.6099999999999999 109.214 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 175.29 48.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.333 -1.507 . . . . 1.1899999999999999 109.333 168.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.66 142.9 72.61 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.024 1.816 . . . . 1.0600000000000001 109.592 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.31 151.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.096 -1.075 . . . . 1.27 108.096 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -126.75 120.4 29.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.599 -1.26 . . . . 4.1699999999999999 107.599 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 20' ' ' PHE . 47.1 t -115.02 134.28 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.613 1.965 . . . . 1.22 107.261 -171.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -133.22 156.02 48.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.415 -2.068 . . . . 0.81999999999999995 105.415 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 145.78 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.939 -1.664 . . . . 0.70999999999999996 108.939 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -122.96 94.46 4.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.823 -2.288 . . . . 1.6799999999999999 104.823 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.71 142.03 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.765 -1.198 . . . . 0.77000000000000002 107.765 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -152.3 147.59 26.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 115.112 1.523 . . . . 3.4100000000000001 115.112 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.65 23.17 8.97 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.834 2.159 . . . . 0.93000000000000005 111.999 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -74.6 166.49 23.46 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.851 -1.166 . . . . 0.70999999999999996 107.851 167.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.24 165.45 20.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.889 -1.152 . . . . 1.8400000000000001 107.889 152.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.04 173.73 0.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.412 -0.805 . . . . 2.3399999999999999 110.513 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.14 -161.37 53.22 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.251 -0.431 . . . . 0.59999999999999998 113.053 165.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.29 140.27 58.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.481 1.112 . . . . 2.02 113.357 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -144.24 116.03 8.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.543 1.537 . . . . 0.54000000000000004 109.85 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.7 148.57 4.63 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.685 0.659 . . . . 0.55000000000000004 111.792 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 100.01 4.67 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.891 1.676 . . . . 3.04 107.334 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 12.6 m170 -133.98 160.49 37.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.396 -2.076 . . . . 0.68999999999999995 105.396 -169.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.11 125.92 74.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.482 -0.933 . . . . 1.8400000000000001 108.482 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.39 -161.35 0.73 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.316 1.046 . . . . 1.55 108.819 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -73.75 -129.01 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.083 0.953 . . . . 3.75 109.917 163.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.451 -0.407 0 C-N-CA 124.727 1.211 . . . . 3.0600000000000001 112.723 168.523 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 110.267 -0.271 . . . . 2.8399999999999999 110.267 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.53 -173.81 25.77 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 106.733 -2.547 . . . . 1.52 106.733 -158.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.92 178.27 6.67 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.658 3.572 . . . . 1.3400000000000001 113.958 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -74.01 58.22 0.66 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.145 1.778 . . . . 2.1600000000000001 111.606 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 51.92 69.02 0.72 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.255 1.022 . . . . 1.78 109.639 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -90.85 115.31 64.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.016 -0.992 . . . . 2.5899999999999999 108.482 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.29 -43.8 1.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.842 1.695 . . . . 1.3200000000000001 110.685 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -146.22 -67.25 0.28 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.232 1.013 . . . . 2.25 108.884 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.5 m -153.39 63.99 0.75 Allowed 'General case' 0 N--CA 1.457 -0.125 0 O-C-N 121.524 -0.735 . . . . 1.78 110.488 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -78.19 165.47 23.89 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.253 -0.647 . . . . 3.6099999999999999 109.253 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 6.7 mtmp? -133.66 154.26 51.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.148 1.379 . . . . 3.1200000000000001 109.012 -174.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -89.53 169.64 11.18 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.124 . . . . 0.81999999999999995 110.245 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.93 -40.21 0.17 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 107.761 -2.136 . . . . 2.6600000000000001 107.761 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.29 -175.63 54.54 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.706 1.622 . . . . 1.53 110.842 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.05 -8.9 23.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.584 2.856 . . . . 1.8300000000000001 114.167 -171.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -27.07 42.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.779 0.718 . . . . 6.4199999999999999 111.435 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.26 176.6 5.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.77 1.628 . . . . 2.7000000000000002 109.428 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.9 -47.04 40.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.962 -0.755 . . . . 4.7999999999999998 108.962 162.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 74.5 mt-10 -78.43 138.35 38.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.674 1.226 . . . . 3.0499999999999998 111.536 -169.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -160.45 154.35 22.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.36 -2.83 . . . . 5.1900000000000004 103.36 173.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.1 m80 -64.92 159.66 22.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 117.794 -1.563 . . . . 0.54000000000000004 106.88 162.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.08 40.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 122.984 1.373 . . . . 1.9199999999999999 110.876 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -170.73 42.2 0.19 Allowed Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 128.257 2.837 . . . . 0.59999999999999998 108.563 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -126.12 109.07 11.95 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.795 -1.187 . . . . 2.46 107.795 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.82 -50.3 10.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.419 -0.956 . . . . 1.8300000000000001 108.419 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.8 -120.69 0.99 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.43 -1.068 . . . . 0.96999999999999997 110.43 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -155.19 166.3 34.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.127 1.371 . . . . 1.5700000000000001 108.672 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.98 171.77 16.38 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 N-CA-C 108.206 -1.035 . . . . 0.69999999999999996 108.206 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 m -114.87 118.57 33.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.477 -1.305 . . . . 1.8899999999999999 107.477 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.81 140.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.375 0.534 . . . . 0.66000000000000003 110.319 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.2 -80.93 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.309 1.044 . . . . 3.0299999999999998 111.739 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -157.39 -48.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.107 1.363 . . . . 3.71 109.898 -170.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.76 13.78 1.56 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.012 1.325 . . . . 2.79 111.214 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.02 14.64 76.21 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.197 0.903 . . . . 0.75 111.256 -175.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.4 145.18 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.226 1.41 . . . . 0.93000000000000005 107.73 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.67 164.83 29.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.652 1.181 . . . . 0.71999999999999997 108.516 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.12 143.85 51.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.959 -2.608 . . . . 2.73 103.959 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.99 56.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 123.801 0.688 . . . . 1.6200000000000001 112.096 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.0 m -74.39 91.61 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.712 -0.617 . . . . 0.97999999999999998 110.935 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.2 mt -129.46 159.05 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.588 0.755 . . . . 1.6399999999999999 108.984 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.76 93.66 2.54 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 3.0299999999999998 111.392 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.9 126.09 30.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.717 0.807 . . . . 2.54 109.582 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 p -95.54 1.73 53.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.249 1.42 . . . . 1.8400000000000001 112.567 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.54 -44.82 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.519 0.727 . . . . 1.21 109.795 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pt -74.65 175.75 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.845 -0.742 . . . . 1.1799999999999999 109.762 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 p -151.96 176.94 10.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.918 1.287 . . . . 2.1499999999999999 107.784 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.0 mt -131.95 57.8 1.76 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.374 1.87 . . . . 4.1500000000000004 110.725 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.722 0.638 . . . . 3.4300000000000002 112.722 174.829 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 120.237 0.065 . . . . 1.3100000000000001 111.157 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.3 pt -77.95 -6.47 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.841 0.682 . . . . 1.97 112.841 -174.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.3 mm -32.01 116.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.1 1.36 . . . . 1.71 110.323 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.49 10.87 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 112.12 -0.392 . . . . 1.75 112.12 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -136.1 164.6 27.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.499 -1.667 . . . . 6.25 106.499 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.01 113.23 23.44 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.602 1.092 . . . . 1.8899999999999999 109.558 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 118' ' ' VAL . 2.0 tm? -69.35 145.09 53.24 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.267 -1.753 . . . . 2.3100000000000001 106.267 167.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 117' ' ' LEU . 71.5 t -130.98 135.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.137 1.775 . . . . 0.58999999999999997 109.066 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -101.79 123.65 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.756 1.223 . . . . 1.78 107.711 164.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.579 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 93.8 m-70 -95.96 165.69 12.14 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 117.378 2.362 . . . . 0.66000000000000003 117.378 -172.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.47 -66.43 0.56 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.16 -1.836 . . . . 3.4700000000000002 110.971 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -90.28 -179.5 5.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.958 0.885 . . . . 3.9700000000000002 110.566 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.87 46.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.073 -1.454 . . . . 0.54000000000000004 107.073 153.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -83.05 162.49 21.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.894 -0.78 . . . . 2.0699999999999998 108.894 161.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.74 -8.28 59.62 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.484 0.714 . . . . 3.0099999999999998 112.106 -169.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 51.18 38.78 22.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.014 0.926 . . . . 1.6299999999999999 109.101 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 48.78 33.04 11.98 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.529 1.062 . . . . 1.4399999999999999 112.798 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -77.48 -25.33 50.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.095 0.948 . . . . 4.9299999999999997 110.039 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 133.25 -130.28 5.68 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.964 -0.854 . . . . 2.6099999999999999 110.964 161.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.49 -73.72 0.02 OUTLIER Glycine 0 C--N 1.34 0.772 0 C-N-CA 126.372 1.939 . . . . 2.0699999999999998 111.414 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.21 165.46 24.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.834 1.654 . . . . 2.5699999999999998 108.286 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -79.06 -52.02 8.78 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.874 -0.787 . . . . 3.8100000000000001 108.874 162.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.18 -40.69 11.61 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.992 2.117 . . . . 4.2000000000000002 111.49 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.8 p -39.16 -64.46 0.46 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.798 2.039 . . . . 1.9299999999999999 111.003 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.7 p -71.66 -45.86 60.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.717 -0.674 . . . . 1.26 110.497 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -58.09 -50.13 74.54 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.403 0.681 . . . . 2.98 111.313 -165.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.384 1.3 p -125.63 -45.76 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.678 -0.677 . . . . 1.3799999999999999 112.665 168.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.44 0.13 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.428 1.013 . . . . 0.95999999999999996 114.803 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 54.28 55.53 8.04 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.628 1.571 . . . . 2.0899999999999999 111.557 -167.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -68.12 -3.07 9.22 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.453 0.909 . . . . 1.1799999999999999 113.453 169.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.47 -64.8 4.21 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 120.549 -1.344 . . . . 3.2400000000000002 111.127 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -165.2 168.18 17.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.163 0.985 . . . . 1.45 111.808 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.432 ' HD2' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -83.33 133.86 34.94 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.242 2.217 . . . . 2.6499999999999999 107.33 172.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.35 -77.93 0.56 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.158 -1.052 . . . . 0.85999999999999999 108.158 166.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.19 154.01 42.21 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.901 -1.148 . . . . 1.0700000000000001 107.901 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 16.6 p -142.8 171.51 13.95 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.352 -1.295 . . . . 1.99 108.959 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.16 142.71 5.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.744 -1.342 . . . . 0.62 109.744 174.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.34 126.91 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 108.735 -0.839 . . . . 0.94999999999999996 108.735 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.3 126.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.722 -0.844 . . . . 2.6699999999999999 108.722 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.46 -5.97 1.42 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 115.014 0.766 . . . . 0.76000000000000001 115.014 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.3 59.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 118.638 1.219 . . . . 0.78000000000000003 110.627 -156.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.39 172.07 7.2 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.661 0.743 . . . . 1.6499999999999999 111.643 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.25 1.083 0 N-CA-C 103.44 -2.8 . . . . 5.9900000000000002 103.44 144.599 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.2 0 N-CA-C 110.803 -0.073 . . . . 2.8100000000000001 110.803 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.48 131.9 34.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.586 -1.265 . . . . 0.82999999999999996 107.586 163.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -98.52 142.12 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.688 -0.856 . . . . 0.79000000000000004 108.688 165.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.63 97.57 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.581 -0.896 . . . . 0.48999999999999999 108.581 154.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.02 107.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.207 -1.405 . . . . 0.73999999999999999 107.207 163.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.3 mt -93.96 133.19 37.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.911 -0.774 . . . . 0.92000000000000004 108.911 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -138.08 -56.52 0.66 Allowed 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.541 -0.911 . . . . 4.1399999999999997 108.541 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.04 -121.34 24.89 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.789 -1.096 . . . . 0.83999999999999997 111.957 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.08 -49.27 1.71 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.903 0.881 . . . . 3.48 109.497 -155.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.36 164.19 20.27 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 109.841 -1.303 . . . . 0.80000000000000004 109.841 167.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.61 40.92 0.9 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.614 2.876 . . . . 1.0700000000000001 112.617 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.2 t -94.51 155.11 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.539 1.535 . . . . 0.92000000000000004 109.846 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.38 123.24 8.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.231 -1.396 . . . . 2.2200000000000002 107.231 168.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.94 167.32 33.73 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.543 -1.023 . . . . 0.60999999999999999 110.543 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.19 118.28 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.767 -1.568 . . . . 1.2 106.767 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -85.02 128.55 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.259 -1.756 . . . . 0.78000000000000003 106.259 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -111.59 113.68 26.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.366 -1.716 . . . . 2.2999999999999998 106.366 166.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CE1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -102.88 115.6 30.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.613 -1.625 . . . . 2.8100000000000001 106.613 173.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -139.14 160.37 39.96 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.054 0.843 . . . . 3.3700000000000001 109.609 170.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -155.26 145.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.594 -2.002 . . . . 3.1400000000000001 105.594 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -45.5 44.25 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.008 -0.738 . . . . 4.9000000000000004 109.008 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -78.73 178.2 8.07 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.118 1.767 . . . . 3.8100000000000001 109.189 168.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.3 p -123.8 21.47 9.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.98 0.912 . . . . 2.3799999999999999 111.382 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -167.41 38.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.593 0.633 . . . . 3.6000000000000001 111.557 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.69 -157.84 7.66 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.042 -1.623 . . . . 1.1299999999999999 109.042 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.36 135.41 33.9 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.161 2.574 . . . . 1.1699999999999999 110.348 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -78.97 164.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.394 -0.965 . . . . 0.84999999999999998 108.394 173.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -115.57 125.21 52.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.634 -1.987 . . . . 3.04 105.634 167.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG22 ' CE1' ' A' ' 20' ' ' PHE . 59.0 t -117.1 114.75 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.586 1.554 . . . . 0.93999999999999995 107.352 -171.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -125.9 133.53 51.87 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.189 0.93 . . . . 0.83999999999999997 110.408 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.2 160.16 33.73 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.385 -1.086 . . . . 0.79000000000000004 110.385 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 p -135.29 107.17 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.229 -1.397 . . . . 2.02 107.229 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.78 119.91 59.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.559 -1.645 . . . . 1.23 106.559 -159.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -124.35 152.21 43.43 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.946 0.498 . . . . 4.96 110.062 -160.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.58 27.04 64.0 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.444 -0.344 . . . . 0.82999999999999996 113.823 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -67.0 -169.41 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.581 -0.952 . . . . 0.97999999999999998 108.478 157.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.51 165.94 10.81 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 105.518 -2.03 . . . . 3.5600000000000001 105.518 146.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 178.9 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.83 2.052 . . . . 3.3599999999999999 112.43 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.58 -169.45 53.38 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.357 -0.838 . . . . 0.45000000000000001 111.933 169.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.77 147.17 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.475 0.71 . . . . 1.98 111.493 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -143.92 121.16 11.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.945 1.698 . . . . 0.48999999999999999 108.473 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.07 149.03 7.59 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.519 -1.433 . . . . 0.46000000000000002 109.519 169.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -143.25 83.48 1.79 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.644 -1.243 . . . . 2.2999999999999998 107.644 -169.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -124.64 146.38 49.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.885 -1.052 . . . . 0.82999999999999996 109.071 -160.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.22 106.44 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.436 -0.95 . . . . 2.3799999999999999 108.436 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -82.35 150.21 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.903 -0.777 . . . . 0.89000000000000001 108.903 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.26 19.84 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.376 1.471 . . . . 3.96 113.374 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.406 ' CD ' HH22 ' A' ' 143' ' ' ARG . 1.5 tt0 . . . . . 0 CA--C 1.53 0.201 0 O-C-N 120.648 -1.283 . . . . 3.1600000000000001 110.138 -167.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.409 0 CA-C-O 121.29 0.567 . . . . 2.5800000000000001 110.589 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.9 -65.89 3.14 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.987 -0.896 . . . . 1.02 111.661 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.85 172.72 2.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.771 1.647 . . . . 1.8999999999999999 115.016 -166.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -83.01 56.68 3.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 113.121 -1.854 . . . . 2.1299999999999999 110.559 -172.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 53.32 80.09 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.406 0.682 . . . . 1.96 109.476 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -107.85 103.85 51.1 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.181 0.993 . . . . 2.3799999999999999 110.425 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.82 -30.98 39.95 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.997 1.798 . . . . 1.1200000000000001 112.251 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.0 tp -155.93 -67.4 0.11 Allowed 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.554 0.616 . . . . 2.8999999999999999 110.038 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 p -151.99 60.72 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.21 0.529 . . . . 2.1899999999999999 110.621 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -77.51 165.99 23.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.384 -0.598 . . . . 3.8399999999999999 109.384 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -137.83 162.68 33.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.068 1.347 . . . . 7.2400000000000002 107.819 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -94.27 153.23 18.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.135 1.374 . . . . 0.79000000000000004 113.374 -158.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.48 171.93 45.0 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 107.763 -2.135 . . . . 2.4399999999999999 107.763 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.84 -171.23 30.75 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.165 0.412 . . . . 1.1499999999999999 112.832 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.49 -31.18 51.64 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.515 2.144 . . . . 1.6699999999999999 109.582 172.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.63 -43.1 73.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.915 0.486 . . . . 4.4500000000000002 111.496 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -69.22 161.96 28.12 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.673 0.749 . . . . 2.4300000000000002 112.144 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -75.5 -46.89 29.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.896 2.078 . . . . 4.3200000000000003 109.33 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -77.05 159.45 29.86 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.1 -1.074 . . . . 4.3099999999999996 108.1 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 158.98 127.1 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.463 2.305 . . . . 3.1099999999999999 106.441 -163.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 45.4 m80 -62.29 150.8 38.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.963 -1.495 . . . . 0.52000000000000002 106.963 163.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.82 -16.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 120.255 -0.578 . . . . 1.1499999999999999 110.38 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.56 56.58 0.46 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.959 0.79 . . . . 0.65000000000000002 113.336 161.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -123.59 117.99 26.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.022 1.411 . . . . 2.4199999999999999 108.771 158.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.6 -56.66 3.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.068 -1.086 . . . . 1.5700000000000001 108.068 164.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.65 -121.95 1.05 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.319 -0.712 . . . . 0.65000000000000002 111.319 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -143.11 165.28 27.83 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.895 1.678 . . . . 1.55 108.112 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.31 166.74 28.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.699 -1.223 . . . . 0.45000000000000001 107.699 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.3 m -123.41 116.42 23.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.234 1.014 . . . . 1.96 108.67 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.58 139.3 35.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.033 0.379 . . . . 0.62 111.076 171.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.07 -84.16 0.12 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.956 0.502 . . . . 4.0999999999999996 111.053 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 -53.19 0.93 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.231 0.612 . . . . 4.6100000000000003 112.082 -161.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.18 30.12 1.0 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 124.53 2.11 . . . . 3.3100000000000001 109.972 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 57.69 27.66 59.16 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 113.619 -1.628 . . . . 0.71999999999999997 110.833 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.27 103.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.56 1.144 . . . . 0.89000000000000001 108.101 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.92 166.77 12.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.336 1.054 . . . . 0.82999999999999996 108.267 160.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.7 141.82 47.73 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.452 -2.425 . . . . 2.8500000000000001 104.452 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.16 116.6 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.881 -1.525 . . . . 1.3899999999999999 106.881 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -137.46 80.29 1.8 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.068 1.747 . . . . 0.93999999999999995 106.738 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.2 mm -125.75 156.95 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.135 0.574 . . . . 2.2999999999999998 109.57 -170.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -151.36 71.54 1.01 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.733 0.813 . . . . 2.8900000000000001 110.93 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.96 119.23 22.52 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.126 -0.359 . . . . 3.29 111.738 -168.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.6 p -79.4 65.19 4.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.159 0.984 . . . . 2.8900000000000001 110.391 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.3 t -141.56 -52.32 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.622 1.169 . . . . 1.26 109.083 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -102.96 168.7 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.079 0.952 . . . . 1.0900000000000001 111.321 -172.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.2 m -137.91 168.92 18.71 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.077 1.351 . . . . 2.0299999999999998 109.217 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' H ' ' CD2' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -100.84 17.04 23.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.477 1.511 . . . . 2.71 113.068 -178.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 C--O 1.233 0.231 0 C-N-CA 124.148 0.979 . . . . 2.96 108.737 179.372 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 122.381 1.086 . . . . 1.49 111.345 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -18.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.684 -1.144 . . . . 2.8100000000000001 111.782 174.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.1 mm -47.0 119.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.174 0.99 . . . . 2.2400000000000002 110.758 -162.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.46 -32.47 5.2 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.519 0.58 . . . . 1.99 112.553 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -76.52 177.01 7.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.547 1.673 . . . . 10.15 114.031 -163.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 m -104.15 120.99 42.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.436 1.095 . . . . 1.1000000000000001 110.322 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.71 138.25 39.87 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.465 -1.309 . . . . 1.8600000000000001 107.465 164.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.48 127.84 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.272 1.429 . . . . 0.57999999999999996 107.88 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.6 m -97.47 122.45 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.125 -1.806 . . . . 1.55 106.125 162.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -93.97 158.19 15.75 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 115.319 1.6 . . . . 0.57999999999999996 115.319 -171.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -25.56 -83.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.183 2.993 . . . . 3.5800000000000001 112.388 162.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -106.73 -177.34 3.33 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.819 0.848 . . . . 2.6400000000000001 110.215 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.1 157.44 3.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.498 -0.774 . . . . 0.75 109.987 162.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.26 176.58 5.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.951 -0.759 . . . . 1.95 108.951 160.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.53 -9.59 59.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 3.9500000000000002 111.183 -167.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.7 11.93 4.29 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.694 1.598 . . . . 2.4300000000000002 111.928 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.86 102.03 1.0 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 108.538 -1.825 . . . . 3.4399999999999999 108.538 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.55 -56.49 0.08 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.953 -1.499 . . . . 4.7300000000000004 106.953 174.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.47 50.49 0.97 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.165 -1.174 . . . . 2.6400000000000001 110.165 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.52 37.29 0.84 Allowed Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.165 0.982 . . . . 3.96 112.984 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.3 p30 175.66 -108.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.862 2.865 . . . . 2.8999999999999999 106.266 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.416 ' OE1' ' NZ ' ' A' ' 136' ' ' LYS . 15.9 tm-20 -153.13 -39.61 0.1 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.456 1.102 . . . . 4.29 109.07 161.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -44.09 -37.63 3.17 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.423 1.489 . . . . 2.8900000000000001 111.784 170.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.9 t -45.71 -58.25 3.6 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.417 1.087 . . . . 2.25 110.903 168.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -44.63 67.63 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.101 -1.0 . . . . 1.3100000000000001 110.015 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.416 ' NZ ' ' OE1' ' A' ' 132' ' ' GLU . 1.5 ttmp? -55.68 -50.65 69.69 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.355 1.062 . . . . 2.7799999999999998 112.239 -172.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.502 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.309 2.0 p -124.33 -50.33 1.78 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.834 -0.603 . . . . 1.21 111.759 171.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 157.27 -26.81 0.49 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.139 -0.784 . . . . 0.98999999999999999 111.139 -173.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 49.41 53.93 11.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.876 1.27 . . . . 2.3700000000000001 110.338 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.62 -51.93 13.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.858 0.837 . . . . 1.53 109.53 170.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.32 -157.84 22.18 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.623 -2.191 . . . . 1.0 107.623 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.1 m -61.0 151.35 30.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.307 1.443 . . . . 1.28 113.217 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.406 HH22 ' CD ' ' A' ' 50' ' ' GLU . 13.1 mmt85 -61.33 138.23 58.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.101 1.36 . . . . 2.98 109.046 168.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.9 mt -112.17 -67.35 1.0 Allowed 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.44 -0.948 . . . . 0.64000000000000001 108.44 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -106.37 156.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.072 0.549 . . . . 0.89000000000000001 110.384 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.2 p -165.0 162.21 20.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.018 0.927 . . . . 1.4399999999999999 110.17 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.27 140.96 3.33 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.861 2.172 . . . . 0.88 107.688 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.79 134.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.668 1.187 . . . . 0.89000000000000001 109.756 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.5 tt -91.1 136.59 23.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 C-N-CA 123.101 0.561 . . . . 0.83999999999999997 112.512 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.9 4.56 0.83 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.839 1.209 . . . . 0.65000000000000002 114.078 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.7 mm -102.24 57.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 119.192 1.496 . . . . 1.01 110.147 -150.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.96 175.41 13.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.146 0.498 . . . . 1.6000000000000001 111.142 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.439 0 N-CA-C 102.962 -2.977 . . . . 5.0499999999999998 102.962 160.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.424 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.048 -0.723 . . . . 3.5299999999999998 109.048 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.68 139.31 33.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.884 -1.525 . . . . 0.67000000000000004 106.884 164.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.79 144.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.547 -2.02 . . . . 1.0 105.547 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.74 93.55 3.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.271 -1.011 . . . . 0.44 108.271 161.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.91 104.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.22 -1.03 . . . . 0.56999999999999995 108.22 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -87.98 136.71 32.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.56 0.344 . . . . 0.93999999999999995 110.213 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -149.82 -54.72 0.17 Allowed 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.322 0.649 . . . . 4.2999999999999998 110.49 168.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.32 -126.55 27.87 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.603 0.621 . . . . 1.0 113.815 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.09 -53.99 2.63 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.672 1.189 . . . . 4.2199999999999998 110.138 -165.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.19 154.28 10.95 Favored Glycine 0 CA--C 1.536 1.353 0 N-CA-C 110.008 -1.237 . . . . 0.92000000000000004 110.008 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.24 52.04 3.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.84 3.027 . . . . 1.3400000000000001 112.279 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 74.7 t -110.78 156.65 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.302 2.241 . . . . 0.75 107.875 -175.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -155.84 136.48 13.36 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.621 -0.881 . . . . 2.7599999999999998 108.621 166.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.57 176.49 46.16 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.175 -0.77 . . . . 0.62 111.175 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.68 123.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.494 -1.298 . . . . 1.01 107.494 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.621 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.8 mp -80.66 136.65 22.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.66 -1.978 . . . . 1.51 105.66 161.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -120.6 119.24 32.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.444 -2.058 . . . . 2.0600000000000001 105.444 161.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 5.9 t80 -132.57 126.96 34.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.385 -0.969 . . . . 2.9399999999999999 108.385 -166.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -148.07 158.83 44.28 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.074 0.949 . . . . 4.3399999999999999 110.321 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -152.44 142.52 22.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.36 1.864 . . . . 3.0 106.964 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -44.94 -74.07 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.14 0.576 . . . . 4.6299999999999999 111.342 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -81.47 -172.9 4.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.1 1.36 . . . . 3.7400000000000002 110.929 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.7 m -83.43 -64.67 1.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.232 1.413 . . . . 2.3500000000000001 111.133 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -102.97 75.62 1.4 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.065 1.346 . . . . 3.75 110.229 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.04 -167.15 12.85 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.585 -1.406 . . . . 1.1000000000000001 109.585 166.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.02 113.58 3.82 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.242 1.962 . . . . 1.1699999999999999 111.32 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 4.0 t -87.17 138.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.312 -0.403 . . . . 0.93000000000000005 110.556 -172.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -94.11 116.48 28.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.929 -1.137 . . . . 2.6299999999999999 107.929 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG22 ' CD1' ' A' ' 20' ' ' PHE . 11.6 t -89.72 132.71 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.703 -1.962 . . . . 1.25 105.703 162.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -133.53 151.8 51.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.986 -1.487 . . . . 0.94999999999999996 106.986 156.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.76 134.54 2.91 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.131 -1.188 . . . . 0.92000000000000004 110.131 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.5 p -109.57 94.75 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.54 -1.652 . . . . 1.9299999999999999 106.54 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 mm -96.99 148.59 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.623 -1.251 . . . . 1.3700000000000001 107.623 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.36 165.39 22.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.298 0.571 . . . . 4.2199999999999998 111.45 165.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.19 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 114.462 -1.245 . . . . 0.60999999999999999 114.171 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.88 158.92 17.82 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.266 1.533 . . . . 0.68999999999999995 108.861 167.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.36 158.01 24.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.2 -1.407 . . . . 1.6799999999999999 107.2 154.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.94 174.31 0.51 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.952 1.251 . . . . 3.2799999999999998 112.327 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.14 -160.65 52.5 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.956 -1.02 . . . . 0.67000000000000004 112.29 168.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.7 140.69 57.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.956 1.303 . . . . 2.1000000000000001 113.105 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -144.41 117.69 9.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.647 1.579 . . . . 0.44 109.257 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.19 145.91 5.56 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.362 -1.095 . . . . 0.46000000000000002 110.362 172.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.6 102.08 5.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.776 -1.565 . . . . 2.9100000000000001 106.776 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -133.48 168.22 19.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.156 -1.794 . . . . 0.69999999999999996 106.156 -173.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.88 130.2 48.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.867 -0.79 . . . . 1.77 108.867 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -114.62 147.34 39.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.466 1.507 . . . . 0.83999999999999997 110.413 -160.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.14 -9.35 0.26 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.059 1.744 . . . . 4.25 114.638 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.475 ' CD ' HH21 ' A' ' 143' ' ' ARG . 4.5 mt-10 . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.47 1.108 . . . . 3.3300000000000001 109.794 164.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 107.48 -1.304 . . . . 2.4300000000000002 107.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.92 -87.63 0.08 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.322 -1.511 . . . . 1.01 109.322 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.91 176.84 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.965 3.777 . . . . 1.2 113.569 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -75.48 58.49 1.02 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.885 1.674 . . . . 2.29 111.615 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.84 80.3 0.16 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.994 0.917 . . . . 2.0800000000000001 108.628 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -112.88 86.66 9.18 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.55 1.14 . . . . 2.4199999999999999 109.415 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.13 -17.95 45.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.3 2.0 . . . . 2.3100000000000001 112.7 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 tt -154.28 -68.0 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.676 0.671 . . . . 2.1000000000000001 109.838 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -162.92 96.0 0.89 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.757 -1.201 . . . . 1.72 107.757 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.27 173.68 6.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.147 1.379 . . . . 5.2800000000000002 109.703 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -137.3 151.33 48.53 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 125.61 1.564 . . . . 3.71 108.032 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -91.24 139.97 30.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.828 0.677 . . . . 0.80000000000000004 112.828 -170.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.02 -88.75 0.07 OUTLIER Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.539 -2.625 . . . . 1.8600000000000001 106.539 163.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.67 -102.58 0.38 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.973 -0.904 . . . . 1.8 112.289 159.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -90.63 -47.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.508 2.139 . . . . 1.47 110.774 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.27 -46.01 10.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.233 1.413 . . . . 4.96 110.388 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.03 175.58 10.24 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.889 -1.05 . . . . 2.7599999999999998 111.424 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.06 -55.22 8.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.399 1.479 . . . . 3.79 109.596 -174.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.89 175.28 10.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.462 -0.79 . . . . 3.8100000000000001 110.967 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.36 141.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.248 2.219 . . . . 3.52 107.876 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.411 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 16.0 m80 -64.21 160.72 17.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 118.468 -1.293 . . . . 0.60999999999999999 108.669 162.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -28.66 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 121.289 -0.882 . . . . 1.23 110.69 -177.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.56 70.11 0.22 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.65000000000000002 110.973 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -163.3 104.74 0.98 Allowed 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.782 -0.834 . . . . 2.0499999999999998 108.914 -169.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.54 -54.81 3.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.686 -0.688 . . . . 1.78 109.156 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 -108.38 0.34 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.603 -0.999 . . . . 0.65000000000000002 110.603 -176.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -152.06 167.5 28.26 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.938 1.695 . . . . 1.5700000000000001 109.874 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -123.35 175.78 5.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.476 -1.675 . . . . 0.64000000000000001 106.476 164.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 t -116.76 149.76 39.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.377 -0.971 . . . . 2.0800000000000001 108.377 167.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.68 140.48 45.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.174 1.39 . . . . 0.78000000000000003 112.333 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.01 -90.17 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 O-C-N 124.46 1.1 . . . . 2.5899999999999999 111.11 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -156.22 -31.75 0.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.652 2.093 . . . . 4.5300000000000002 116.652 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -8.96 58.14 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.993 0.901 . . . . 3.7200000000000002 109.119 164.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.57 23.16 10.4 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.701 1.62 . . . . 0.83999999999999997 109.593 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.2 t -78.0 123.39 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.289 -1.375 . . . . 0.83999999999999997 107.289 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.19 159.32 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.055 0.942 . . . . 0.91000000000000003 109.231 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.77 95.59 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.763 -1.569 . . . . 2.8500000000000001 106.763 -159.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.36 57.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.715 -0.476 . . . . 1.8100000000000001 109.715 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.2 m -85.49 91.66 8.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.813 0.845 . . . . 0.90000000000000002 109.231 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 mt -124.33 148.19 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.893 -0.78 . . . . 2.0099999999999998 108.893 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -134.39 101.97 5.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.279 -0.638 . . . . 2.9500000000000002 109.279 164.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.16 140.74 31.21 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.918 0.887 . . . . 2.27 109.073 173.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 t -110.85 19.23 18.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.407 1.083 . . . . 2.6699999999999999 112.406 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.99 -48.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 108.098 -1.075 . . . . 1.53 108.098 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.35 177.01 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 122.813 0.445 . . . . 1.1899999999999999 111.289 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.5 p -155.4 178.8 9.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.429 1.892 . . . . 2.29 108.23 -164.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.14 69.9 1.44 Allowed 'General case' 0 C--N 1.339 0.151 0 CA-C-O 122.917 1.342 . . . . 2.25 110.466 162.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.326 -0.428 0 C-N-CA 126.721 2.008 . . . . 4.1900000000000004 110.348 -177.849 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 123.213 1.482 . . . . 1.49 113.682 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.839 -1.528 . . . . 1.8400000000000001 111.112 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mm -49.03 118.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.795 0.725 . . . . 1.8300000000000001 109.118 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.53 -20.32 34.83 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.468 1.508 . . . . 1.5700000000000001 112.759 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.59 165.34 18.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.416 1.608 . . . . 4.7199999999999998 110.279 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -86.95 117.9 25.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.801 0.841 . . . . 1.0700000000000001 109.159 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 140.33 58.28 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.393 -1.336 . . . . 2.3599999999999999 107.393 167.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -128.26 126.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.945 -1.132 . . . . 0.42999999999999999 107.945 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.627 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 2.1 p -99.17 116.95 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.219 -1.771 . . . . 1.77 106.219 166.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -89.54 160.11 16.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 115.808 1.781 . . . . 0.58999999999999997 115.808 -172.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -44.87 -72.27 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.708 2.003 . . . . 3.3900000000000001 112.362 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -98.26 -177.19 3.63 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.33 1.052 . . . . 3.1200000000000001 111.097 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.08 157.56 7.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.375 0.67 . . . . 0.72999999999999998 109.703 162.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.24 175.67 8.8 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.484 -0.561 . . . . 2.1200000000000001 109.484 164.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.03 -35.61 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.989 0.916 . . . . 3.3100000000000001 112.669 -152.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp 66.72 32.77 6.7 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.894 1.678 . . . . 3.4199999999999999 111.402 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.37 45.82 92.3 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.227 0.917 . . . . 1.76 112.255 163.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -127.07 -28.82 2.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.234 2.213 . . . . 5.2300000000000004 111.493 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.34 126.22 33.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.812 -0.915 . . . . 2.0600000000000001 110.812 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.1 -30.58 76.05 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.327 0.489 . . . . 3.1400000000000001 111.88 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -55.6 115.29 2.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.843 0.857 . . . . 2.0299999999999998 109.26 170.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -38.29 -48.23 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.814 1.246 . . . . 3.5 113.217 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -46.93 -33.84 4.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.244 1.418 . . . . 3.1800000000000002 112.647 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 m -62.49 -56.88 13.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.976 0.51 . . . . 2.3300000000000001 111.976 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -71.21 -45.81 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.0 -1.687 . . . . 1.3500000000000001 110.215 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -58.08 -39.4 78.45 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.052 0.941 . . . . 3.1800000000000002 111.728 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.411 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 6.8 p -128.95 -54.92 1.21 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.762 0.71 . . . . 1.55 112.632 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 140.48 -18.55 2.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 125.936 1.732 . . . . 0.89000000000000001 111.385 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.76 56.95 2.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.333 1.453 . . . . 2.3500000000000001 111.757 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.66 -5.02 48.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.226 -0.59 . . . . 1.27 111.435 171.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.6 -173.68 40.54 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 108.899 -1.681 . . . . 1.03 108.899 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -55.82 153.33 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.752 1.621 . . . . 1.27 114.086 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.475 HH21 ' CD ' ' A' ' 50' ' ' GLU . 6.4 mmt-85 -60.02 139.8 57.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.775 -1.557 . . . . 3.0699999999999998 107.963 166.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.07 -74.74 0.59 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.047 -1.094 . . . . 0.51000000000000001 108.047 173.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -103.47 151.18 23.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.334 -1.358 . . . . 0.68999999999999995 107.334 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 p -151.45 160.54 43.67 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.042 0.839 . . . . 1.8300000000000001 109.246 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.09 140.75 3.25 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 125.596 1.81 . . . . 0.58999999999999997 109.61 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -77.88 134.67 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.044 1.338 . . . . 0.68000000000000005 109.878 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 16.6 tt -90.66 131.28 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.081 0.553 . . . . 0.78000000000000003 111.342 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.08 -8.17 2.68 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 124.377 0.989 . . . . 0.56999999999999995 113.762 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.4 mm -91.07 59.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 118.026 0.913 . . . . 1.0900000000000001 111.448 -154.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.68 168.09 9.48 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.218 0.533 . . . . 1.98 111.587 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.424 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 20.9 mm-40 . . . . . 0 C--O 1.256 1.397 0 N-CA-C 101.643 -3.465 . . . . 4.1699999999999999 101.643 139.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.011 0.434 . . . . 3.0899999999999999 110.416 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -109.72 136.6 48.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.547 -2.02 . . . . 0.69999999999999996 105.547 152.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.94 140.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.378 -1.712 . . . . 0.81000000000000005 106.378 169.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.56 96.61 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.371 -0.974 . . . . 0.41999999999999998 108.371 156.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.83 108.26 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.656 -1.609 . . . . 0.56000000000000005 106.656 161.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.7 mt -97.37 127.97 43.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.204 -1.036 . . . . 0.91000000000000003 108.204 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -149.39 -56.13 0.19 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.191 -1.04 . . . . 3.4199999999999999 108.191 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.49 -117.61 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.504 -1.225 . . . . 0.93000000000000005 111.19 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -123.37 -41.17 2.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.883 0.873 . . . . 3.7000000000000002 110.056 -163.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.72 161.42 51.36 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.732 -0.605 . . . . 0.84999999999999998 111.762 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.86 30.82 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.984 3.123 . . . . 1.04 113.436 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 52.1 t -99.24 155.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.575 1.95 . . . . 0.70999999999999996 107.424 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 129.37 9.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.739 -0.837 . . . . 3.3900000000000001 108.739 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.27 171.07 41.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.793 -0.718 . . . . 0.47999999999999998 114.383 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.6 118.64 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.477 1.111 . . . . 1.0 108.482 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -83.84 129.57 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.459 -1.312 . . . . 0.66000000000000003 107.459 164.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -106.13 115.68 30.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.328 -1.36 . . . . 1.6899999999999999 107.328 160.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -95.9 112.64 24.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.126 -1.805 . . . . 2.6400000000000001 106.126 171.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -124.94 144.79 50.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.668 0.747 . . . . 3.3399999999999999 109.436 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -156.99 158.68 37.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.155 1.382 . . . . 4.1799999999999997 109.15 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.01 -74.95 0.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.134 0.973 . . . . 4.7300000000000004 109.634 170.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -90.83 130.08 36.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.539 1.136 . . . . 3.8300000000000001 110.377 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 p -66.43 1.28 1.72 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.931 1.456 . . . . 2.4100000000000001 114.931 -169.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -140.19 54.18 1.64 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 126.518 1.927 . . . . 4.2699999999999996 107.161 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.64 175.07 32.87 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 107.509 -2.237 . . . . 1.0700000000000001 107.509 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.08 134.62 46.87 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.728 2.285 . . . . 1.23 110.63 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.86 141.5 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.124 -0.695 . . . . 0.90000000000000002 109.124 -171.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -97.34 107.2 19.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.419 -1.326 . . . . 2.6699999999999999 107.419 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.493 HG22 ' CE1' ' A' ' 20' ' ' PHE . 23.8 t -96.25 116.09 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.532 -1.655 . . . . 1.1299999999999999 106.532 -177.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -123.4 107.11 11.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.131 -1.062 . . . . 1.28 108.131 164.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.76 152.95 16.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.66000000000000003 111.805 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -132.06 85.39 2.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.737 2.015 . . . . 2.7599999999999998 106.575 -165.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 mp -111.31 126.02 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 107.017 -1.475 . . . . 0.83999999999999997 107.017 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 162.69 16.51 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.327 1.051 . . . . 3.8799999999999999 110.973 171.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.24 1.8 74.91 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.341 -0.7 . . . . 0.70999999999999996 114.768 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -53.35 157.22 2.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.099 1.449 . . . . 0.77000000000000002 110.815 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.68 163.37 9.26 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.124 -1.065 . . . . 1.8999999999999999 108.124 156.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.34 173.74 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 2.3700000000000001 111.038 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.71 -159.73 34.6 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.049 0.833 . . . . 0.44 113.843 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.57 145.12 55.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.246 1.818 . . . . 1.8999999999999999 113.79 -171.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -147.34 118.55 7.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.326 1.85 . . . . 0.42999999999999999 109.777 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.66 147.6 8.14 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.515 -1.034 . . . . 0.40000000000000002 110.515 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE2' HD21 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -136.39 91.23 2.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.268 -1.382 . . . . 2.3199999999999998 107.268 -174.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.75 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 40.2 m170 -125.8 172.36 9.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.015 -0.735 . . . . 0.81000000000000005 109.015 -163.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.4 133.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.527 -1.286 . . . . 2.1800000000000002 107.527 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -119.43 140.97 49.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.152 1.381 . . . . 0.81999999999999995 107.738 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -45.16 -58.15 3.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.767 2.027 . . . . 5.0999999999999996 111.107 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 127.082 2.153 . . . . 3.4100000000000001 116.153 164.477 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 106.078 -1.823 . . . . 2.3500000000000001 106.078 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.12 -91.58 0.08 OUTLIER Glycine 0 CA--C 1.524 0.605 0 CA-C-O 117.86 -1.522 . . . . 1.1100000000000001 111.756 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.03 -177.47 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 1 C-N-CA 126.911 5.074 . . . . 1.01 113.351 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -89.33 62.39 6.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.916 1.286 . . . . 1.8100000000000001 111.363 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 56.41 64.29 1.73 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.45 -0.944 . . . . 1.8899999999999999 108.45 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -90.45 113.8 58.86 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 2.3199999999999998 110.4 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.66 -37.39 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.134 1.889 . . . . 1.3400000000000001 111.294 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 tp -156.17 -64.74 0.11 Allowed 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.376 -0.601 . . . . 3.1600000000000001 109.376 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -153.81 69.47 0.8 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 1.77 109.68 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -76.92 166.49 23.26 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.49 -0.559 . . . . 3.6899999999999999 109.49 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.8 156.2 33.7 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.647 1.579 . . . . 3.7999999999999998 107.008 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -92.79 153.81 18.66 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.657 0.614 . . . . 1.03 112.657 -172.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.3 38.79 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 108.95 -1.66 . . . . 2.5800000000000001 108.95 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.82 -156.06 9.87 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 108.662 -1.775 . . . . 1.3400000000000001 108.662 170.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.33 -35.06 92.76 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.987 1.791 . . . . 1.74 110.853 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -51.63 68.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.066 0.946 . . . . 7.0 110.944 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.88 156.57 20.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.594 1.702 . . . . 2.4500000000000002 115.594 -145.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.64 -48.84 74.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.716 2.006 . . . . 6.4100000000000001 112.367 -169.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -135.51 162.42 32.72 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.049 1.34 . . . . 5.5800000000000001 107.759 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -163.4 161.2 24.26 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.4 0.68 . . . . 3.6299999999999999 111.081 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 62.6 m80 -68.16 141.5 56.0 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 107.949 -1.13 . . . . 0.66000000000000003 107.949 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.41 -30.23 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.625 -0.262 . . . . 1.21 110.716 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 57.37 0.43 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.745 -0.475 . . . . 0.64000000000000001 113.802 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.4 146.75 33.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.918 1.859 . . . . 2.3799999999999999 110.226 149.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 mt -97.1 -51.83 4.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.572 -0.899 . . . . 2.3300000000000001 108.572 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.04 -107.92 0.31 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.5 -1.04 . . . . 0.56999999999999995 110.5 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -147.08 171.98 14.46 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.184 1.794 . . . . 1.48 109.493 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -132.78 171.4 18.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 106.644 -1.614 . . . . 0.77000000000000002 106.644 166.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -103.99 144.48 31.49 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.404 -0.961 . . . . 2.2400000000000002 108.404 163.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.05 159.51 27.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.983 0.913 . . . . 0.88 110.004 158.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.37 -92.06 0.05 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.033 1.733 . . . . 4.3799999999999999 108.858 162.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 93' ' ' GLY . 13.7 tttt -176.07 -31.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.619 1.168 . . . . 3.5899999999999999 112.0 -159.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -76.84 15.49 0.65 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 124.243 1.973 . . . . 3.3500000000000001 109.477 151.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 63.05 24.75 67.33 Favored Glycine 0 N--CA 1.44 -1.069 0 O-C-N 119.933 -1.729 . . . . 1.1000000000000001 110.347 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.0 t -83.89 118.88 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.306 -0.998 . . . . 1.05 108.306 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.79 153.26 17.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.331 -0.989 . . . . 1.1299999999999999 108.331 166.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -112.32 83.72 1.85 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 104.16 -2.533 . . . . 3.7400000000000002 104.16 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.412 HG11 ' CE2' ' A' ' 45' ' ' PHE . 2.4 t -86.96 60.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.722 -0.844 . . . . 1.1899999999999999 108.722 -167.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -96.43 86.93 4.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.694 1.597 . . . . 1.01 108.027 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.76 150.69 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.894 -0.78 . . . . 1.8100000000000001 108.894 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.47 134.27 33.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.218 -1.771 . . . . 3.1099999999999999 106.218 158.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -145.77 164.25 32.44 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.603 -1.258 . . . . 3.8199999999999998 107.603 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.3 p -112.59 -5.31 14.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.741 2.016 . . . . 1.5800000000000001 111.915 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.24 -37.06 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 119.065 0.848 . . . . 2.1200000000000001 109.26 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.4 pp -96.02 177.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.586 0.754 . . . . 1.22 110.655 176.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.6 m -158.53 175.96 13.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.702 1.601 . . . . 2.25 108.3 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.34 14.18 31.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.214 1.405 . . . . 2.5299999999999998 111.546 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.455 -0.201 0 O-C-N 120.738 -1.226 . . . . 3.0800000000000001 109.632 -179.643 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 121.882 0.848 . . . . 2.4199999999999999 112.034 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.433 HD11 ' CE2' ' A' ' 20' ' ' PHE . 2.5 pp -81.0 -8.14 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 113.537 0.94 . . . . 1.47 113.537 -166.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 mm -50.79 120.12 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.922 0.889 . . . . 2.4500000000000002 109.175 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.16 22.05 66.32 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.916 -0.935 . . . . 1.5800000000000001 113.498 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 174.28 5.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.139 1.469 . . . . 5.5700000000000003 107.982 160.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -86.61 126.74 34.71 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 118.086 -0.959 . . . . 0.96999999999999997 108.943 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.454 HD21 ' CE2' ' A' ' 45' ' ' PHE . 5.0 tt -82.56 137.17 34.65 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.557 -1.275 . . . . 2.0600000000000001 107.557 159.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.86 135.16 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.733 1.613 . . . . 0.48999999999999999 108.082 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.32 130.48 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.178 -1.045 . . . . 1.8400000000000001 108.178 165.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.556 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 72.8 m-70 -106.79 160.51 15.43 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 117.632 2.456 . . . . 0.46999999999999997 117.632 -167.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -33.84 -84.51 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.265 3.026 . . . . 3.6200000000000001 112.736 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -99.4 -174.67 2.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.292 0.951 . . . . 2.71 109.592 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.24 157.95 2.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.087 0.555 . . . . 0.84999999999999998 110.11 164.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 152.17 35.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.675 -1.232 . . . . 2.1000000000000001 107.675 158.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -77.16 -6.81 54.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.439 0.903 . . . . 3.3599999999999999 113.439 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 68.65 -9.37 0.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.34 1.456 . . . . 2.2799999999999998 112.851 -167.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.72 6.1 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.935 0.789 . . . . 1.98 111.537 168.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.37 38.78 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.2 -0.667 . . . . 7.0599999999999996 109.2 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -103.73 160.62 16.21 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.497 -0.641 . . . . 1.96 111.497 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.79 59.51 3.0 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.156 0.884 . . . . 2.6499999999999999 110.972 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -178.42 109.22 0.05 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 105.254 -2.128 . . . . 2.6600000000000001 105.254 -170.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -33.51 66.34 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.164 -0.335 . . . . 3.3799999999999999 111.637 -171.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -34.47 -44.4 0.2 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.355 1.862 . . . . 3.2000000000000002 113.18 165.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.84 -63.38 1.17 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.868 -0.79 . . . . 2.1600000000000001 108.868 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 p -60.14 -46.59 89.16 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.904 -0.497 . . . . 1.22 110.946 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.67 -43.72 75.55 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.826 0.851 . . . . 2.6600000000000001 112.181 -167.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.288 1.1 p -124.72 -52.83 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.239 -0.886 . . . . 1.22 111.734 172.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 146.53 -14.31 1.6 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.528 1.058 . . . . 0.90000000000000002 113.598 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.95 54.86 9.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.535 1.134 . . . . 1.8899999999999999 110.649 173.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -68.21 -40.85 81.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.172 0.987 . . . . 1.01 110.665 173.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.92 -168.66 30.36 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 108.407 -1.877 . . . . 1.01 108.407 -159.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -55.42 148.23 15.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.111 1.764 . . . . 1.1699999999999999 113.924 -167.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.1 mmt-85 -59.52 134.57 57.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.361 1.464 . . . . 2.9199999999999999 107.972 165.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -110.51 -80.01 0.58 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.016 1.28 . . . . 0.59999999999999998 109.837 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.6 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -114.48 149.42 36.37 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.548 -0.908 . . . . 1.1699999999999999 108.548 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.96 160.43 12.16 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.729 -2.032 . . . . 1.75 107.013 -163.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.07 156.12 13.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.748 -2.141 . . . . 0.73999999999999999 107.748 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.14 140.07 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 117.75 0.775 . . . . 0.98999999999999999 109.646 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.6 tt -97.04 132.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.839 -0.619 . . . . 0.71999999999999997 111.126 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.413 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 140.52 -6.66 2.73 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 123.902 0.763 . . . . 0.56999999999999995 114.519 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -90.33 59.83 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 118.487 1.144 . . . . 1.29 109.873 -157.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.69 149.2 24.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.268 -0.878 . . . . 2.1000000000000001 112.411 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.404 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 85.2 mt-30 . . . . . 0 C--O 1.256 1.409 0 N-CA-C 102.691 -3.077 . . . . 5.7400000000000002 102.691 129.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 109.805 -0.442 . . . . 3.4100000000000001 109.805 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.57 154.85 17.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.426 -1.694 . . . . 0.82999999999999996 106.426 153.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.99 147.89 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 104.859 -2.274 . . . . 0.90000000000000002 104.859 161.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.447 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -134.39 102.59 5.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.08 -1.822 . . . . 0.54000000000000004 106.08 166.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.57 99.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.907 -1.146 . . . . 0.81999999999999995 107.907 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.447 HD22 ' O ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -86.79 120.68 28.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.777 -1.194 . . . . 2.6000000000000001 107.777 -178.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -139.99 -50.17 0.48 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 122.888 0.475 . . . . 3.54 110.811 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.37 -117.35 2.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.113 0.864 . . . . 0.84999999999999998 112.667 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.14 -50.65 1.68 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.977 0.911 . . . . 3.3799999999999999 110.165 -155.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.85 165.13 11.85 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 110.667 -0.973 . . . . 0.90000000000000002 110.667 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.23 41.91 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.911 3.074 . . . . 1.3400000000000001 112.063 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 72.2 t -110.89 150.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 126.79 2.036 . . . . 0.89000000000000001 108.154 -174.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.12 129.4 8.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.892 -1.151 . . . . 2.73 107.892 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.85 172.18 44.54 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.027 -0.829 . . . . 0.65000000000000002 111.027 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.87 126.67 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.061 -1.088 . . . . 1.4399999999999999 108.061 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 2.4 mm -86.31 132.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.268 -1.753 . . . . 1.48 106.268 159.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -112.16 124.62 52.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.741 -1.948 . . . . 1.99 105.741 159.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -133.42 103.82 6.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.576 -2.009 . . . . 3.46 105.576 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.52 161.28 29.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.396 0.679 . . . . 3.4500000000000002 112.114 -169.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.407 HE22 ' N ' ' A' ' 27' ' ' GLY . 16.5 tt0 -154.97 147.15 23.78 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.972 -1.122 . . . . 3.0 107.972 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -79.5 -35.56 39.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.415 -1.266 . . . . 6.7699999999999996 110.134 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -85.37 -144.94 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.063 -1.828 . . . . 6.3700000000000001 106.063 158.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 p -147.72 -1.87 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.634 1.106 . . . . 3.25 112.984 162.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -123.57 49.76 1.68 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.217 1.007 . . . . 3.4500000000000002 109.612 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' HE22 ' A' ' 22' ' ' GLN . . . -159.69 -162.81 12.55 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.007 -1.237 . . . . 1.25 110.007 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.19 111.9 2.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.256 1.97 . . . . 1.3200000000000001 112.434 -168.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.66 150.15 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.959 0.904 . . . . 1.04 109.535 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -105.69 106.62 17.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.532 -1.655 . . . . 3.9100000000000001 106.532 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -104.24 116.98 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -130.08 142.39 50.61 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.133 -0.691 . . . . 0.96999999999999997 109.133 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.85 159.45 32.68 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.65 -1.78 . . . . 0.69999999999999996 108.65 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -140.14 108.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.841 -2.281 . . . . 2.4199999999999999 104.841 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.28 142.46 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.961 -1.866 . . . . 0.81999999999999995 105.961 -163.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.455 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -140.31 159.06 43.02 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 115.328 1.603 . . . . 4.4900000000000002 115.328 173.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.98 53.87 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.828 1.68 . . . . 0.90000000000000002 112.815 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.44 159.98 9.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.187 0.993 . . . . 0.78000000000000003 109.568 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.59 162.02 13.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.597 -1.261 . . . . 1.6599999999999999 107.597 156.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.47 172.44 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.172 0.897 . . . . 2.5899999999999999 110.757 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.5 -163.29 54.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 116.079 -0.51 . . . . 0.47999999999999998 113.122 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.77 146.59 47.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.959 0.904 . . . . 2.1200000000000001 111.913 -172.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -146.56 119.97 9.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.729 1.612 . . . . 0.60999999999999999 109.145 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.81 152.12 4.99 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.405 -0.678 . . . . 0.37 111.405 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE2' HG12 ' A' ' 119' ' ' VAL . 16.7 t80 -146.04 101.84 3.57 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.329 -1.36 . . . . 2.3799999999999999 107.329 -174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 26.5 m80 -143.15 160.22 40.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.322 -0.992 . . . . 0.81000000000000005 108.322 -163.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.62 127.83 75.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 CA-C-O 121.899 0.857 . . . . 1.8 110.058 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -99.68 137.49 38.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.715 1.606 . . . . 0.78000000000000003 107.627 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.02 -38.21 56.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.409 1.084 . . . . 4.3099999999999996 111.749 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 2.8 tt0 . . . . . 0 N--CA 1.454 -0.274 0 C-N-CA 128.596 2.759 . . . . 3.0899999999999999 113.199 156.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.066 0.46 . . . . 1.8100000000000001 111.347 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.62 -95.67 2.42 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.125 -1.375 . . . . 1.01 109.767 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.69 -179.87 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.545 4.163 . . . . 1.1799999999999999 113.833 -175.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -52.01 126.3 18.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.514 1.526 . . . . 1.3999999999999999 108.793 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -39.7 117.3 0.72 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.353 1.061 . . . . 2.4199999999999999 111.742 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -124.71 143.28 43.08 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 130.397 3.479 . . . . 3.5099999999999998 107.578 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.99 -36.21 3.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.124 2.55 . . . . 1.27 110.148 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 tt -151.42 -66.72 0.18 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.254 -1.387 . . . . 2.9300000000000002 107.254 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.4 m -154.39 84.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.091 -1.005 . . . . 2.3700000000000001 109.848 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -79.39 174.99 11.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.182 0.515 . . . . 4.79 110.131 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -127.79 163.84 23.48 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.521 1.928 . . . . 6.75 106.951 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -102.9 152.9 20.76 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 123.707 0.803 . . . . 0.97999999999999998 110.881 -172.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 -35.56 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.777 -0.529 . . . . 2.8199999999999998 111.777 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.52 -150.5 20.12 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.682 1.611 . . . . 1.2 111.386 167.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.1 -26.98 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.566 2.844 . . . . 2.2400000000000002 110.374 -176.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -48.35 82.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.585 -0.524 . . . . 5.9100000000000001 109.585 170.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.83 175.55 6.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.29 113.41 -166.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.34 -43.73 60.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.299 1.439 . . . . 4.6399999999999997 108.401 164.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.95 157.73 31.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.639 -0.71 . . . . 3.27 111.344 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 164.66 147.93 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.89 2.076 . . . . 3.3500000000000001 111.777 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 18.4 m80 -62.79 153.61 32.4 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.319 -0.993 . . . . 0.65000000000000002 108.319 167.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.06 -36.64 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 119.794 -0.762 . . . . 1.3600000000000001 109.3 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.98 60.87 1.38 Allowed Glycine 0 CA--C 1.529 0.969 0 O-C-N 122.003 -0.436 . . . . 0.59999999999999998 113.175 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.84 96.71 1.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.367 -0.975 . . . . 2.1699999999999999 108.367 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.37 -52.28 8.3 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.319 -0.993 . . . . 2.1299999999999999 108.319 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.53 -109.06 0.35 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.834 -0.698 . . . . 0.53000000000000003 112.645 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -155.49 170.18 22.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.599 1.56 . . . . 1.52 109.758 -168.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.8 169.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.004 -1.48 . . . . 0.52000000000000002 107.004 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.2 m -123.87 123.47 40.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.58 -1.267 . . . . 2.0 107.58 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.36 141.4 31.79 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.568 0.347 . . . . 0.60999999999999999 111.149 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.25 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.348 1.03 . . . . 2.71 109.277 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.4 tttt -155.29 -34.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.102 1.519 . . . . 3.7599999999999998 115.102 -172.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.455 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 24.7 t0 -89.19 40.05 0.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.216 1.96 . . . . 2.8599999999999999 109.284 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 56.58 20.58 31.76 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 129.15 3.262 . . . . 0.88 112.562 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.49 119.92 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.947 0.899 . . . . 0.93999999999999995 108.928 -168.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.46 156.87 27.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.568 1.147 . . . . 0.67000000000000004 108.591 168.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.61 147.42 33.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.485 -2.413 . . . . 3.2799999999999998 104.485 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.67 59.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.827 0.704 . . . . 1.6599999999999999 112.024 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.5 m -86.62 96.02 9.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.371 1.068 . . . . 0.96999999999999997 110.429 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.51 152.17 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.546 1.138 . . . . 2.0099999999999998 109.931 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.37 141.9 51.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.324 -0.991 . . . . 2.8300000000000001 108.324 150.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -135.14 163.76 29.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.133 -0.691 . . . . 2.0600000000000001 109.133 162.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -111.24 -16.04 13.5 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.463 2.305 . . . . 1.8600000000000001 112.781 -173.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.37 -36.29 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.888 0.767 . . . . 1.28 109.478 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.8 pp -91.56 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.767 0.827 . . . . 1.1599999999999999 110.477 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.2 p -159.28 176.95 11.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.654 1.981 . . . . 2.6000000000000001 106.967 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.87 37.74 4.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.918 1.235 . . . . 2.3700000000000001 112.498 166.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 108.968 -0.753 . . . . 3.3799999999999999 108.968 178.293 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.8 p . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 109.179 -0.675 . . . . 1.3200000000000001 109.179 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.9 pt -78.61 -5.13 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.044 -0.503 . . . . 1.78 111.918 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 mm -32.01 127.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.762 1.225 . . . . 1.6599999999999999 110.716 170.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.78 33.3 83.79 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.378 -0.679 . . . . 1.5600000000000001 112.928 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -116.29 169.13 9.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.088 0.944 . . . . 4.1500000000000004 108.487 166.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m -100.88 110.4 22.46 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-N 118.867 0.758 . . . . 1.3300000000000001 110.247 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt -68.04 148.98 50.26 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.427 -0.953 . . . . 1.76 108.427 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.71 138.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.103 1.761 . . . . 0.40000000000000002 108.135 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.444 HG12 ' CE2' ' A' ' 45' ' ' PHE . 1.3 m -109.15 129.1 64.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.147 -1.057 . . . . 1.53 108.147 162.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.455 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 50.5 m-70 -101.98 160.18 14.71 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 116.366 1.987 . . . . 0.37 116.366 -168.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 7.3 tt0 -44.05 -75.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.68 2.392 . . . . 3.0299999999999998 112.228 172.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -94.24 179.0 5.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.222 0.534 . . . . 2.8399999999999999 110.353 -168.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.13 142.62 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.382 -1.34 . . . . 0.73999999999999999 107.382 155.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -82.25 164.23 21.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.207 1.003 . . . . 2.0099999999999998 109.094 165.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -28.12 47.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.0 -1.0 . . . . 2.8399999999999999 111.722 -160.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.16 46.4 21.51 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.876 0.87 . . . . 1.9399999999999999 109.793 -168.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.71 34.63 64.99 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 124.696 1.141 . . . . 1.6299999999999999 113.04 165.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -78.45 -17.18 56.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.409 0.604 . . . . 6.21 109.712 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.28 -118.25 5.25 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.593 -1.003 . . . . 2.5499999999999998 110.593 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.36 -69.52 0.68 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.503 -1.439 . . . . 2.48 109.503 -168.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -92.6 160.34 15.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.19 0.996 . . . . 2.79 108.453 164.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -72.94 -47.97 40.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.253 -0.88 . . . . 5.1100000000000003 110.819 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -44.22 -39.78 4.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.795 1.634 . . . . 2.7799999999999998 114.463 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 t -39.41 -64.16 0.5 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.944 1.298 . . . . 2.1099999999999999 111.035 166.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.271 1.6 t -73.38 -44.53 58.37 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.6 0.76 . . . . 2.0800000000000001 111.1 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -55.03 -49.64 71.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 119.495 1.043 . . . . 2.6600000000000001 111.921 -174.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 19.5 p -127.62 -45.98 1.46 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 119.08 -0.486 . . . . 1.72 111.403 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.42 -14.56 1.25 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.191 0.9 . . . . 0.98999999999999999 114.327 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.265 0.3 OUTLIER 28.24 56.05 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.041 1.337 . . . . 3.2599999999999998 113.944 -156.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.499 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -55.3 -35.65 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.603 1.161 . . . . 1.0600000000000001 112.337 167.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.86 -176.55 45.95 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.751 -1.74 . . . . 0.94999999999999996 108.751 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 m -61.21 154.28 23.84 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.612 1.165 . . . . 1.28 113.809 -166.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -56.18 136.56 52.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.126 1.37 . . . . 2.5699999999999998 109.022 168.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.5 mt -111.13 -76.24 0.6 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.294 -1.002 . . . . 0.55000000000000004 108.294 168.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.531 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.79 150.85 26.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.821 -1.177 . . . . 0.78000000000000003 107.821 170.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.5 p -153.34 156.68 38.8 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.301 -1.318 . . . . 1.3600000000000001 108.49 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 136.68 4.31 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 125.036 1.46 . . . . 0.60999999999999999 112.091 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.51 125.06 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 125.192 1.397 . . . . 0.90000000000000002 109.544 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.425 ' CB ' ' HB2' ' A' ' 6' ' ' ALA . 12.6 tt -90.29 128.74 42.02 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.227 0.537 . . . . 0.77000000000000002 111.233 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 152.08 -11.62 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.151 0.881 . . . . 0.76000000000000001 114.901 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -93.76 59.43 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 122.557 1.17 . . . . 1.5 109.275 -152.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.28 148.53 25.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.71 -0.677 . . . . 2.23 111.6 172.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 C--O 1.252 1.195 0 N-CA-C 101.967 -3.345 . . . . 6.8099999999999996 101.967 142.32 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 21.1 pttp . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.086 -0.709 . . . . 4.5300000000000002 109.086 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.06 168.93 16.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.253 1.025 . . . . 2.1600000000000001 111.428 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.644 HG23 ' HB2' ' A' ' 152' ' ' ALA . 27.3 t -128.78 147.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.532 -2.396 . . . . 1.6000000000000001 104.532 155.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.43 99.18 4.02 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 108.525 -0.916 . . . . 0.82999999999999996 108.525 153.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.4 t -68.58 94.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.868 -1.16 . . . . 1.02 107.868 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 147' ' ' GLY . 34.8 mt -79.52 122.96 27.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.597 -0.89 . . . . 1.8600000000000001 108.597 175.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -136.33 -60.01 0.72 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.242 -1.022 . . . . 4.0199999999999996 108.242 174.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.83 -139.79 9.73 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.894 -1.682 . . . . 1.23 108.894 -156.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.83 21.78 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.142 0.577 . . . . 5.9400000000000004 111.534 168.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.32 165.57 46.37 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 107.97 -2.052 . . . . 0.95999999999999996 107.97 148.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.62 72.42 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.798 2.332 . . . . 2.6299999999999999 109.845 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.0 t -139.64 144.64 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.818 0.847 . . . . 0.76000000000000001 109.287 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -145.44 120.61 10.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.575 -1.268 . . . . 3.0099999999999998 107.575 166.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.88 163.56 32.78 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.588 -0.695 . . . . 0.52000000000000002 111.941 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.1 mt -127.16 127.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.474 -1.306 . . . . 1.3400000000000001 107.474 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 30.2 mm -87.85 142.6 12.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 N-CA-C 106.383 -1.71 . . . . 0.77000000000000002 106.383 158.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.472 HD21 HG22 ' A' ' 5' ' ' VAL . 14.1 m120 -139.04 82.25 1.89 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.165 -1.05 . . . . 2.7000000000000002 108.165 168.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.407 ' CD1' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -77.85 152.53 33.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 118.641 -1.224 . . . . 5.29 108.992 175.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -139.3 148.22 42.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.905 -1.887 . . . . 3.5600000000000001 105.905 166.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -156.94 116.96 3.51 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.208 1.403 . . . . 4.0700000000000003 108.173 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -63.6 -60.23 3.6 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.274 0.63 . . . . 4.6699999999999999 110.681 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -77.9 107.02 10.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.244 -0.91 . . . . 4.0499999999999998 108.919 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -57.76 6.08 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.593 2.357 . . . . 3.29 116.922 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.44 60.85 0.75 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.116 -1.068 . . . . 3.6099999999999999 108.116 168.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.79 179.97 19.37 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 108.389 -1.884 . . . . 0.93999999999999995 108.389 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.67 116.78 3.57 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 1.02 111.302 -171.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 20' ' ' PHE . 7.8 t -80.95 135.37 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.367 -0.825 . . . . 1.4199999999999999 109.958 -169.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.83 88.03 4.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.293 0.951 . . . . 3.9700000000000002 109.855 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.96 88.66 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.634 1.174 . . . . 1.8400000000000001 109.03 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -102.62 157.3 17.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 123.52 0.513 . . . . 0.93999999999999995 111.581 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.17 164.24 35.37 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.652 -0.579 . . . . 0.67000000000000004 111.652 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -130.08 70.44 1.44 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.161 1.384 . . . . 2.2599999999999998 108.999 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.0 132.59 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.191 0.996 . . . . 0.75 110.124 -168.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -130.91 163.03 28.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.618 0.767 . . . . 3.7999999999999998 111.494 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.6 -16.89 59.82 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.077 -0.846 . . . . 1.3899999999999999 113.862 173.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.41 159.25 2.09 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.55 1.175 . . . . 0.79000000000000004 111.389 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 154.67 23.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.722 -1.214 . . . . 1.72 107.722 153.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.2 171.42 0.27 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.065 0.935 . . . . 3.3100000000000001 111.302 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.05 -161.58 54.32 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.307 -0.86 . . . . 0.73999999999999999 112.75 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.92 136.24 52.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.085 1.354 . . . . 1.99 112.401 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -140.6 121.75 14.76 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.581 1.552 . . . . 0.53000000000000003 108.86 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.66 149.98 9.87 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.73 -0.948 . . . . 0.48999999999999999 110.73 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.11 96.62 3.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.487 -1.672 . . . . 2.4700000000000002 106.487 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.624 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 27.9 m80 -134.86 161.52 34.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.997 -1.112 . . . . 0.68000000000000005 107.997 -169.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 t -114.09 128.05 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.845 -1.169 . . . . 2.1800000000000002 107.845 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -112.47 137.98 49.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.099 -1.445 . . . . 0.96999999999999997 107.099 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -72.34 63.95 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.418 0.687 . . . . 4.1600000000000001 112.725 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 107.228 -1.397 . . . . 3.5099999999999998 107.228 171.463 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 N-CA-C 108.949 -0.759 . . . . 1.9199999999999999 108.949 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.01 -94.38 0.9 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.393 -1.483 . . . . 1.02 109.393 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.17 178.25 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.902 3.068 . . . . 1.23 112.819 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -63.85 130.0 42.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.693 -1.14 . . . . 1.3799999999999999 110.608 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -31.92 113.83 0.13 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.196 1.184 . . . . 1.99 114.196 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.47 154.86 49.39 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 126.517 1.927 . . . . 2.6400000000000001 106.722 160.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.9 -42.33 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.61 1.54 . . . . 1.28 111.666 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 -71.95 0.43 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.257 0.623 . . . . 2.7400000000000002 109.556 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 m -145.47 72.56 1.32 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.562 0.745 . . . . 1.6599999999999999 111.512 -164.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -79.43 175.5 10.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.599 -1.26 . . . . 4.75 107.599 153.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -128.89 174.97 9.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.333 1.453 . . . . 4.0700000000000003 107.224 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -108.02 129.85 55.1 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.285 1.034 . . . . 1.3899999999999999 112.658 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.79 21.71 1.29 Allowed Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.68 -0.568 . . . . 3.0 111.68 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.58 -169.71 4.02 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.074 0.845 . . . . 1.3999999999999999 113.348 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.94 -6.13 12.12 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.056 3.171 . . . . 1.47 114.256 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.04 -50.06 5.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.916 -1.115 . . . . 6.0499999999999998 110.612 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.81 169.46 18.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.989 0.899 . . . . 2.5099999999999998 111.552 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.26 -37.84 84.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 5.21 109.51 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.343 12.1 pt-20 -78.57 149.68 32.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.028 0.918 . . . . 4.9299999999999997 110.915 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 151.87 127.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 131.405 3.882 . . . . 2.98 104.03 -162.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.523 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.0 m80 -60.62 152.34 26.61 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.649 -1.241 . . . . 0.64000000000000001 107.649 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -30.25 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 120.117 -0.633 . . . . 1.3500000000000001 110.239 -167.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.52 59.56 0.5 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.385 -0.675 . . . . 0.66000000000000003 112.756 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -123.03 108.67 13.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.682 1.241 . . . . 2.6400000000000001 109.049 165.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.82 -47.46 15.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.088 -0.708 . . . . 1.5600000000000001 109.088 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.52 -104.17 0.25 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.916 0.78 . . . . 0.70999999999999996 112.677 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -155.66 167.42 30.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.484 1.914 . . . . 1.5600000000000001 108.629 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.4 160.19 40.26 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.205 -1.035 . . . . 0.85999999999999999 108.205 171.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -109.32 111.93 23.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 2.1899999999999999 108.669 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.38 139.37 37.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.304 0.502 . . . . 0.62 110.802 169.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.02 -90.31 0.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.532 0.52 . . . . 3.9300000000000002 110.649 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 -56.95 1.16 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.844 0.857 . . . . 4.6299999999999999 112.142 -159.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.7 21.16 0.85 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.074 1.749 . . . . 3.2999999999999998 110.155 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.08 18.47 69.03 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 124.593 1.092 . . . . 0.78000000000000003 111.597 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -79.74 110.14 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.534 -1.284 . . . . 0.97999999999999998 107.534 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.75 175.71 6.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.873 -1.158 . . . . 0.80000000000000004 107.873 161.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -131.34 136.39 48.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 102.67 -3.085 . . . . 2.9100000000000001 102.67 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.83 131.86 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.784 -1.932 . . . . 1.5700000000000001 105.784 167.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.6 m -160.78 61.04 0.31 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.868 1.667 . . . . 1.3 108.245 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -108.22 152.78 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.414 0.686 . . . . 1.8500000000000001 109.705 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -137.64 142.83 41.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.308 -0.627 . . . . 3.27 109.308 149.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -124.6 145.21 49.74 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.614 -1.625 . . . . 2.5499999999999998 106.614 166.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -79.58 -18.11 52.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.036 2.134 . . . . 1.4199999999999999 111.394 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.4 t -77.17 -39.91 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.772 -0.455 . . . . 1.1100000000000001 109.772 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -77.46 176.79 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.672 0.749 . . . . 1.1200000000000001 110.985 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 t -161.51 179.89 7.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.613 1.965 . . . . 2.2999999999999998 105.871 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.54 41.86 3.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.846 1.259 . . . . 3.1899999999999999 110.74 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 C--N 1.332 -0.166 0 N-CA-C 109.015 -0.735 . . . . 3.27 109.015 -174.779 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 N--CA 1.44 -0.935 0 CA-C-O 123.01 1.386 . . . . 1.6699999999999999 111.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.628 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -83.52 -8.68 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 113.695 -1.593 . . . . 2.3399999999999999 111.98 169.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.1 mm -49.75 123.85 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 119.471 1.032 . . . . 1.6899999999999999 110.34 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.75 -9.46 55.92 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.614 -1.103 . . . . 1.6799999999999999 112.974 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.444 ' O ' HG22 ' A' ' 149' ' ' ILE . 90.5 mtt-85 -88.6 164.54 15.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.519 1.659 . . . . 4.2199999999999998 110.171 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 m -94.11 118.41 31.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.233 -0.292 . . . . 0.89000000000000001 110.698 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.76 142.53 54.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.356 -0.979 . . . . 2.4900000000000002 108.356 163.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.6 t -127.91 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.24 1.416 . . . . 0.38 107.648 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.39 120.95 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 106.187 -1.783 . . . . 2.2999999999999998 106.187 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.501 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 55.1 m-70 -98.29 159.42 14.95 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.751 2.13 . . . . 0.40999999999999998 116.751 -174.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -29.59 -83.44 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.363 3.065 . . . . 3.71 112.352 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -96.98 -175.35 3.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.472 1.109 . . . . 3.3300000000000001 109.728 -175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.15 157.6 3.37 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.701 -0.481 . . . . 0.94999999999999996 109.701 159.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.27 160.79 23.65 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.44 -0.578 . . . . 2.1899999999999999 109.44 161.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.05 -25.21 59.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.96 1.096 . . . . 3.0800000000000001 113.96 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.78 13.11 2.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.839 0.856 . . . . 1.4399999999999999 113.127 -165.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.39 47.49 42.92 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.831 1.196 . . . . 1.55 111.554 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -142.03 -22.71 0.7 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.807 2.043 . . . . 4.96 112.925 -173.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.2 136.72 40.2 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 120.315 1.416 . . . . 2.5600000000000001 111.02 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.28 67.68 0.92 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.691 1.139 . . . . 2.6400000000000001 111.26 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -144.07 -179.22 6.36 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.025 2.13 . . . . 3.1400000000000001 105.424 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -39.47 15.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.387 -0.968 . . . . 4.2000000000000002 108.387 159.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -47.48 -28.25 2.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.336 2.254 . . . . 4.9299999999999997 113.622 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.6 p -58.21 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.734 1.214 . . . . 2.3999999999999999 109.116 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.5 t -60.83 -31.74 71.15 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.23 -0.919 . . . . 2.79 111.592 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -59.09 -49.36 78.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.281 -0.887 . . . . 3.3900000000000001 111.948 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.523 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.335 9.9 t -134.08 -51.81 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.325 -0.845 . . . . 1.77 111.343 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.54 30.0 0.07 OUTLIER Glycine 0 C--N 1.336 0.579 0 CA-C-O 116.989 -2.006 . . . . 1.1699999999999999 115.572 168.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 9.03 57.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.683 2.393 . . . . 2.3100000000000001 114.674 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.624 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.25 -38.34 88.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.2 1.0 . . . . 1.0 108.998 166.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.73 36.44 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 108.074 -2.011 . . . . 1.04 108.074 -165.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 158.81 20.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.985 0.914 . . . . 2.21 113.106 -166.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -63.15 132.02 50.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.243 1.817 . . . . 3.0699999999999998 108.487 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.84 -63.23 1.37 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.256 -1.016 . . . . 0.64000000000000001 108.256 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.45 158.66 16.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.15 -0.932 . . . . 1.04 109.716 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 139.36 23.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.356 -1.72 . . . . 1.78 106.356 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.469 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -160.12 131.05 2.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.553 -1.819 . . . . 0.68999999999999995 108.553 170.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.42 139.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.722 -0.844 . . . . 0.80000000000000004 108.722 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.628 HG21 HG12 ' A' ' 112' ' ' ILE . 7.8 tt -102.31 142.68 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.779 0.831 . . . . 0.88 112.692 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.23 6.72 8.8 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.016 1.294 . . . . 0.76000000000000001 112.658 172.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.33 58.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.685 1.242 . . . . 0.78000000000000003 111.315 -163.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.644 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -155.57 175.54 13.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.052 0.941 . . . . 1.45 108.79 164.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.501 0 C-N-CA 126.361 1.864 . . . . 4.2999999999999998 106.127 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 108.648 -0.871 . . . . 3.3500000000000001 108.648 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.58 139.99 37.32 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.873 -1.529 . . . . 0.69999999999999996 106.873 156.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -99.46 146.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.373 -1.714 . . . . 0.75 106.373 161.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -133.2 92.76 3.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.875 -0.787 . . . . 0.58999999999999997 108.875 163.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.24 110.22 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.69999999999999996 108.163 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.42 140.31 30.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.04 0.536 . . . . 0.85999999999999999 110.355 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -144.94 -54.45 0.31 Allowed 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.204 1.002 . . . . 6.0199999999999996 109.877 165.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.46 -134.93 51.6 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.421 1.01 . . . . 0.98999999999999999 114.185 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.79 -51.32 2.92 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.79 1.236 . . . . 4.0099999999999998 109.481 -166.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.14 156.1 15.14 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 109.192 -1.563 . . . . 0.85999999999999999 109.192 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.72 46.38 2.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 0.96999999999999997 112.045 -172.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 30.3 t -89.91 158.16 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 125.353 1.461 . . . . 0.88 108.643 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.62 120.85 4.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.536 -1.653 . . . . 3.1200000000000001 106.536 173.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.06 40.38 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.528 -0.844 . . . . 0.59999999999999998 111.864 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.11 128.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.035 -1.098 . . . . 1.01 108.035 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.8 mp -93.91 141.94 14.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.009 -1.849 . . . . 1.47 106.009 162.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.32 115.65 20.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.414 -2.069 . . . . 1.6100000000000001 105.414 163.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.485 ' CD2' HG22 ' A' ' 31' ' ' VAL . 31.8 t80 -129.91 107.45 9.38 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.445 -2.057 . . . . 2.9500000000000002 105.445 -163.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -136.1 153.72 51.23 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.422 0.63 . . . . 3.3199999999999998 110.58 -166.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -140.18 143.63 36.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.18 -1.785 . . . . 3.75 106.18 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -85.31 -35.87 21.18 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.932 0.893 . . . . 5.1900000000000004 110.675 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -137.24 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.437 1.095 . . . . 5.25 108.52 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 t -129.61 -69.53 0.68 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.95 1.7 . . . . 2.7599999999999998 108.715 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -109.68 61.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.93 1.292 . . . . 4.2599999999999998 107.865 -172.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.11 175.07 21.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.961 -1.256 . . . . 1.0600000000000001 109.961 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 115.35 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.789 2.993 . . . . 1.2 111.259 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -78.51 150.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.921 -0.77 . . . . 0.80000000000000004 108.921 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -100.13 113.79 26.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.311 -1.366 . . . . 3.6899999999999999 107.311 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 20' ' ' PHE . 3.5 t -104.54 128.59 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.131 -1.433 . . . . 1.3300000000000001 107.131 175.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -130.41 146.54 51.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.851 -1.907 . . . . 1.0600000000000001 105.851 162.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.23 20.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.046 -1.622 . . . . 0.68999999999999995 109.046 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 p -132.12 118.22 19.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.574 -1.639 . . . . 1.9199999999999999 106.574 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.36 148.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 125.588 1.555 . . . . 1.1299999999999999 108.462 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -141.09 176.45 8.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 119.017 -1.073 . . . . 5.7000000000000002 112.548 149.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.99 13.89 57.08 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.203 1.858 . . . . 0.69999999999999996 113.191 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 119' ' ' VAL . 2.3 mm? -65.25 166.01 10.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 117.713 0.757 . . . . 1.3799999999999999 109.968 166.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 164.95 23.65 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.988 -1.115 . . . . 1.8999999999999999 107.988 156.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -58.92 174.11 0.38 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.266 0.939 . . . . 2.4300000000000002 111.476 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.08 -166.38 54.85 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.677 0.656 . . . . 0.56999999999999995 113.756 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.05 153.26 40.93 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.241 1.017 . . . . 2.1899999999999999 110.41 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CD2' HD12 ' A' ' 38' ' ' LEU . 80.5 m-70 -146.55 118.62 8.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.945 1.298 . . . . 0.46000000000000002 108.878 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.96 151.58 5.5 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.335 -1.106 . . . . 0.41999999999999998 110.335 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -145.85 102.27 3.64 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 117.977 0.889 . . . . 2.25 108.716 -171.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.648 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.5 m80 -143.34 155.21 44.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.248 -1.39 . . . . 0.56000000000000005 107.248 -158.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.1 140.35 30.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 119.643 1.111 . . . . 1.8899999999999999 109.784 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -113.25 140.33 48.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.971 1.308 . . . . 1.0 107.691 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.1 74.1 0.65 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.387 1.089 . . . . 4.4699999999999998 112.193 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 104.753 -2.314 . . . . 3.3100000000000001 104.753 -171.978 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.474 0.654 . . . . 2.04 109.472 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.68 -91.92 1.92 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 107.879 -2.088 . . . . 1.26 107.879 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.95 178.09 6.91 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.759 2.972 . . . . 1.1599999999999999 113.281 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.31 131.74 45.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.584 -1.644 . . . . 1.47 109.868 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -35.42 109.84 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.834 1.254 . . . . 2.1200000000000001 111.907 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.38 150.7 21.17 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 126.038 1.735 . . . . 2.3599999999999999 107.199 165.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.15 -29.02 33.72 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.368 2.045 . . . . 1.1499999999999999 114.14 -170.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.93 -64.38 0.11 Allowed 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.07 0.85 . . . . 3.1200000000000001 112.152 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.6 m -154.23 83.3 1.13 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.102 -0.703 . . . . 1.8799999999999999 109.102 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 168.06 11.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.462 -0.94 . . . . 5.6100000000000003 108.462 162.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -114.7 163.16 15.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.635 -1.246 . . . . 3.0899999999999999 107.635 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -82.58 160.77 22.46 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.082 0.553 . . . . 0.80000000000000004 110.293 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.54 176.72 41.64 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 106.302 -2.719 . . . . 2.02 106.302 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.19 -168.92 23.99 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 118.927 1.364 . . . . 1.3500000000000001 112.913 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -62.36 -30.9 81.31 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.851 1.7 . . . . 1.49 109.957 163.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -78.11 -42.39 32.12 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.617 0.767 . . . . 5.5899999999999999 112.561 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.1 163.55 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.456 0.571 . . . . 2.2999999999999998 111.267 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -78.5 -50.9 10.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.638 1.575 . . . . 4.2000000000000002 109.936 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.259 16.9 pt-20 -90.48 176.82 6.56 Favored 'General case' 0 C--N 1.337 0.055 0 C-N-CA 122.554 0.342 . . . . 2.9700000000000002 111.812 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 165.05 159.06 0.02 OUTLIER 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.674 1.989 . . . . 4.7800000000000002 108.552 -166.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 55.7 m80 -61.52 139.39 58.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.094 -1.817 . . . . 0.67000000000000004 106.094 161.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.11 -32.23 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.723 -0.391 . . . . 1.3400000000000001 110.653 -163.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.62 53.32 0.65 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.123 0.392 . . . . 0.96999999999999997 113.007 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -107.9 130.14 55.04 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 2.5899999999999999 107.733 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.71 -58.75 2.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.166 -1.05 . . . . 1.6699999999999999 108.166 159.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.12 -93.14 0.13 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.701 -0.96 . . . . 0.63 110.701 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -155.09 166.52 33.33 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.945 1.698 . . . . 1.8899999999999999 111.234 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.09 178.06 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 127.31 2.244 . . . . 0.69999999999999996 105.961 165.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -136.49 145.73 45.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.921 -1.881 . . . . 2.1200000000000001 105.921 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.52 145.49 34.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.733 0.813 . . . . 0.53000000000000003 110.862 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -70.39 -84.25 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.873 0.869 . . . . 2.9500000000000002 110.79 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 93' ' ' GLY . 61.5 tttt -158.69 -47.3 0.06 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.317 1.047 . . . . 3.48 111.226 -171.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -82.44 29.62 0.43 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 124.659 2.171 . . . . 3.0699999999999998 110.277 173.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 60.07 21.31 55.94 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 113.583 -1.644 . . . . 0.71999999999999997 111.611 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.56 138.14 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.716 -1.587 . . . . 0.79000000000000004 106.716 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.73 169.37 19.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.103 -1.073 . . . . 0.85999999999999999 108.103 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.64 141.61 29.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.956 -1.868 . . . . 2.7200000000000002 105.956 -165.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.8 56.59 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 124.048 0.843 . . . . 1.6299999999999999 112.415 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.8 m -78.15 97.45 5.47 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.27 1.028 . . . . 0.96999999999999997 109.846 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 mm -136.44 153.62 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.964 0.906 . . . . 1.77 110.455 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -132.81 97.08 3.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.243 1.817 . . . . 4.0300000000000002 108.77 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.98 174.4 11.59 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.601 -0.518 . . . . 2.3199999999999998 109.601 169.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.2 m -147.84 26.52 1.01 Allowed 'General case' 0 CA--C 1.53 0.211 0 O-C-N 120.839 -1.163 . . . . 2.4300000000000002 112.069 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.15 -52.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.543 1.537 . . . . 1.04 108.532 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.21 173.22 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.107 0.48 . . . . 1.1299999999999999 111.338 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.3 t -154.43 176.48 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.679 0.792 . . . . 2.5699999999999998 110.257 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -86.88 -13.67 44.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 2.4199999999999999 111.073 160.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 124.568 1.147 . . . . 3.6400000000000001 111.349 -172.184 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.44 -0.963 0 CA-C-O 121.375 0.607 . . . . 1.4199999999999999 112.413 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.7 pt -86.04 -6.39 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 1.9199999999999999 110.855 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.6 tp -33.22 123.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 125.369 1.468 . . . . 2.3900000000000001 110.69 166.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.81 57.11 20.5 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.858 -0.897 . . . . 1.8600000000000001 110.858 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -135.56 157.93 45.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.883 -1.525 . . . . 4.3300000000000001 106.883 163.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -82.58 120.75 25.93 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.543 -1.28 . . . . 1.21 107.543 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.44 141.69 44.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.602 -1.258 . . . . 2.4300000000000002 107.602 168.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.04 134.1 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.446 -1.316 . . . . 0.35999999999999999 107.446 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.656 HG21 HD11 ' A' ' 38' ' ' LEU . 5.6 p -107.33 130.43 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 106.337 -1.727 . . . . 2.21 106.337 162.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.506 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 49.7 m-70 -104.51 163.66 12.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.773 1.397 . . . . 0.38 114.773 -168.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.72 -71.47 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.281 -0.866 . . . . 3.7599999999999998 112.287 176.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -79.56 176.68 9.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.643 1.111 . . . . 3.3300000000000001 109.08 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.3 158.66 16.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.779 -0.822 . . . . 0.66000000000000003 108.779 162.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -76.64 170.57 16.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.481 -0.562 . . . . 2.0 109.481 166.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.78 -20.84 59.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.254 1.205 . . . . 4.1500000000000004 114.254 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 66.48 -6.21 0.53 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.119 1.368 . . . . 1.97 113.471 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.84 9.34 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 120.122 1.328 . . . . 1.95 109.904 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.09 -31.09 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 5.6600000000000001 109.384 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.64 -106.73 2.12 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.761 . . . . 2.96 111.196 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.44 -72.19 0.47 Allowed Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.544 -0.974 . . . . 2.6299999999999999 112.117 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -83.23 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.688 0.744 . . . . 3.1699999999999999 110.933 -172.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 178.77 -71.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.597 1.959 . . . . 3.2200000000000002 106.908 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -40.28 -40.39 1.14 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.857 2.063 . . . . 4.5599999999999996 112.042 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.47 0.09 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.549 2.339 . . . . 2.2200000000000002 112.076 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -39.53 74.27 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.409 -1.432 . . . . 1.79 110.787 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -55.66 -48.42 75.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.78 1.232 . . . . 3.1899999999999999 111.566 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.496 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -127.7 -48.26 1.39 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.691 0.796 . . . . 1.3200000000000001 111.987 177.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.3 -11.9 0.9 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.797 -1.002 . . . . 0.89000000000000001 114.097 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 30.51 54.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.943 2.097 . . . . 2.6499999999999999 112.911 -168.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.648 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.74 -35.8 80.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.519 1.127 . . . . 1.02 111.014 169.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.96 -165.75 30.72 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 108.895 -1.682 . . . . 1.05 108.895 -166.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -58.57 154.83 13.44 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 127.751 2.421 . . . . 1.21 113.102 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -57.01 139.03 53.47 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.816 -1.084 . . . . 2.3199999999999998 108.964 166.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.73 -78.48 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.014 -1.106 . . . . 0.5 108.014 160.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.566 ' HB3' HG12 ' A' ' 119' ' ' VAL . . . -89.7 159.8 16.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.019 -0.734 . . . . 0.79000000000000004 109.019 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 72.8 m -148.01 157.84 43.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.825 -1.546 . . . . 1.75 106.825 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.14 139.96 3.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.212 -1.955 . . . . 0.65000000000000002 108.212 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.42 138.08 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.714 0.806 . . . . 0.77000000000000002 109.552 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 tt -94.82 131.03 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.104 0.478 . . . . 0.77000000000000002 111.828 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.45 0.52 0.98 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.942 1.258 . . . . 0.66000000000000003 114.689 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.96 57.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.19 1.495 . . . . 0.82999999999999996 111.54 -153.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.72 174.58 15.25 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.027 0.531 . . . . 1.6000000000000001 110.914 163.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 . . . . . 0 C--O 1.255 1.347 0 N-CA-C 102.731 -3.063 . . . . 6.1799999999999997 102.731 160.668 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.1 pttt . . . . . 0 C--O 1.229 -0.017 0 N-CA-C 113.295 0.85 . . . . 3.4700000000000002 113.295 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.97 155.82 23.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.39 1.076 . . . . 0.85999999999999999 109.573 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -124.18 150.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 107.981 -1.118 . . . . 0.85999999999999999 107.981 165.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -124.36 95.37 4.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.194 0.998 . . . . 0.46999999999999997 109.206 161.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.67 112.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.359 -1.348 . . . . 0.56999999999999995 107.359 161.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.48 131.83 51.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.153 0.981 . . . . 1.1299999999999999 109.769 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.63 -47.92 0.29 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.785 1.234 . . . . 4.9100000000000001 109.886 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.61 -125.05 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.543 1.068 . . . . 0.84999999999999998 111.989 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.47 -58.27 1.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.696 -0.853 . . . . 4.21 108.696 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.72 165.92 3.8 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.788 1.661 . . . . 0.72999999999999998 114.146 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.62 37.46 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 124.516 3.477 . . . . 1.4299999999999999 111.95 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 55.2 t -110.97 143.61 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.167 2.187 . . . . 0.89000000000000001 106.795 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -137.38 131.22 31.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.786 -1.931 . . . . 2.8599999999999999 105.786 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.96 165.75 33.27 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 121.687 -0.633 . . . . 0.59999999999999998 111.84 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.65 127.65 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.979 -1.86 . . . . 1.25 105.979 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 35.5 mm -98.46 138.14 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.748 -1.575 . . . . 0.73999999999999999 106.748 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -109.38 124.86 51.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.57 -1.641 . . . . 2.1699999999999999 106.57 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.517 ' CG ' HD11 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -107.21 95.99 6.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.882 -1.895 . . . . 2.4700000000000002 105.882 171.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -113.52 136.66 52.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.879 -1.526 . . . . 5.54 106.879 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -153.69 153.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.913 -1.514 . . . . 4.29 106.913 -166.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -105.5 -79.06 0.56 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 4.8799999999999999 110.121 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.46 137.07 37.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.098 0.959 . . . . 4.0 109.051 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -52.52 -68.08 0.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.02 1.728 . . . . 2.3500000000000001 112.446 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -79.7 68.54 5.79 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.814 -1.18 . . . . 3.71 107.814 170.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 167.46 31.42 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.604 -0.999 . . . . 1.3500000000000001 110.604 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.4 142.32 44.84 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.523 2.816 . . . . 1.49 111.834 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.3 165.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.617 -1.253 . . . . 1.28 107.617 171.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.37 95.09 4.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.866 -1.901 . . . . 3.1499999999999999 105.866 157.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' CE1' ' A' ' 20' ' ' PHE . 38.3 t -79.83 113.49 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.524 -1.658 . . . . 0.84999999999999998 106.524 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -124.85 142.5 51.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.177 -1.045 . . . . 0.84999999999999998 108.177 166.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.1 152.23 23.67 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.446 -0.661 . . . . 0.67000000000000004 111.446 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 p -125.33 64.56 1.16 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.484 1.514 . . . . 2.2799999999999998 108.599 -165.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -80.72 142.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.525 -1.216 . . . . 0.81000000000000005 109.099 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -149.99 161.88 41.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.324 0.861 . . . . 3.4199999999999999 113.324 174.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.81 9.1 61.43 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.702 1.62 . . . . 0.82999999999999996 112.617 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.87 162.41 16.35 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.751 -0.853 . . . . 0.81999999999999995 109.542 172.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.18 162.21 14.91 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.571 -1.27 . . . . 1.5800000000000001 107.571 152.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.69 177.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.962 0.801 . . . . 3.0699999999999998 110.959 174.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.98 -163.51 37.51 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.922 0.772 . . . . 0.59999999999999998 113.512 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.7 142.92 58.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.393 1.477 . . . . 1.9199999999999999 113.355 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -145.68 116.88 7.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 126.104 1.762 . . . . 0.53000000000000003 109.359 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.58 150.02 6.13 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.301 0.953 . . . . 0.34999999999999998 111.081 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -141.25 99.61 3.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.66 -1.237 . . . . 2.8799999999999999 107.66 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.607 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 25.5 m80 -140.02 161.95 36.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.714 -1.217 . . . . 0.68000000000000005 107.714 -165.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.89 130.0 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 119.07 0.85 . . . . 2.04 109.41 172.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -106.99 134.09 50.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.479 1.911 . . . . 1.3 105.947 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 60.64 0.61 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.16 1.541 . . . . 4.6900000000000004 115.16 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 107.878 -1.156 . . . . 3.1800000000000002 107.878 168.543 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.453 -0.573 . . . . 2.0299999999999998 109.453 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.49 -85.5 1.85 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.819 -1.312 . . . . 1.1200000000000001 109.819 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.63 176.66 9.82 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.215 2.61 . . . . 0.89000000000000001 113.217 -174.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 m170 -66.31 123.4 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.107 -1.406 . . . . 1.45 108.119 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -37.19 113.5 0.26 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.092 1.357 . . . . 2.77 111.608 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.5 154.55 25.63 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 124.957 1.303 . . . . 2.5 107.604 168.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.36 -48.6 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.861 1.708 . . . . 1.1000000000000001 111.643 -168.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.38 -79.71 0.62 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.898 0.879 . . . . 3.1400000000000001 109.074 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.3 m -150.8 68.86 0.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.801 0.841 . . . . 1.6499999999999999 110.384 -166.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -78.95 174.92 11.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.338 0.589 . . . . 4.0999999999999996 109.417 166.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -124.8 156.01 38.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.376 -1.342 . . . . 3.04 107.376 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -83.15 162.05 21.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.099 0.476 . . . . 0.79000000000000004 111.155 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.41 -126.28 0.87 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.173 -2.771 . . . . 2.0499999999999998 106.173 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.02 -134.22 2.02 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 106.403 -2.679 . . . . 1.24 106.403 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.14 -54.18 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 120.288 2.044 . . . . 1.5600000000000001 109.869 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -60.14 -44.42 94.95 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.952 1.301 . . . . 5.2599999999999998 113.841 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.8 175.75 2.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.905 0.383 . . . . 2.0600000000000001 111.06 -170.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -77.36 -46.85 21.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.048 1.339 . . . . 5.0099999999999998 108.889 167.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.85 172.22 14.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.81 0.844 . . . . 3.1499999999999999 112.144 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 172.17 145.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.234 2.213 . . . . 4.1799999999999997 109.757 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 38.2 m80 -56.18 138.64 49.64 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.905 -1.517 . . . . 0.77000000000000002 106.905 161.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.55 -32.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.293 -0.632 . . . . 1.3799999999999999 109.293 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.87 34.45 5.34 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 116.395 1.318 . . . . 0.79000000000000004 116.395 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -107.1 148.08 29.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.861 1.83 . . . . 1.79 107.402 157.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.62 -49.95 4.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.27 -1.011 . . . . 1.5800000000000001 108.27 141.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.82 -97.16 0.17 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.794 -1.322 . . . . 0.69999999999999996 109.794 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -152.81 169.49 22.65 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.784 1.634 . . . . 1.47 109.574 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.7 175.2 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.331 -1.729 . . . . 0.60999999999999999 106.331 163.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -109.47 143.7 38.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.733 -1.21 . . . . 2.0099999999999998 107.733 162.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.25 151.32 29.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.548 -0.908 . . . . 1.01 108.548 151.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.39 -87.28 0.06 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.328 0.651 . . . . 2.8599999999999999 109.388 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -150.72 -43.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.12 1.368 . . . . 3.8700000000000001 110.848 -170.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.24 8.09 5.45 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.204 1.002 . . . . 2.6699999999999999 111.268 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.29 8.16 87.59 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.169 0.89 . . . . 0.89000000000000001 111.536 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -78.67 135.91 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.015 -1.476 . . . . 0.67000000000000004 107.015 173.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.1 174.42 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.086 0.955 . . . . 0.89000000000000001 109.424 170.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -130.0 117.56 20.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 103.241 -2.874 . . . . 3.6400000000000001 103.241 -174.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.58 112.03 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 105.039 -2.208 . . . . 1.25 105.039 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -148.89 97.23 2.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.816 1.246 . . . . 0.94999999999999996 108.433 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.1 mp -145.28 147.41 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 108.929 -0.767 . . . . 1.75 108.929 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.22 68.49 1.28 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.066 0.946 . . . . 4.21 111.964 173.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.99 157.66 31.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.375 -0.828 . . . . 2.4199999999999999 111.078 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 p -110.36 -11.8 14.49 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.775 2.03 . . . . 1.8899999999999999 113.508 -177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.05 -50.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.923 -1.14 . . . . 1.3200000000000001 107.923 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -77.78 158.95 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 122.357 1.075 . . . . 2.4199999999999999 109.808 171.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.8 p -152.17 174.68 13.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.762 2.425 . . . . 2.1499999999999999 107.553 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -42.61 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.344 1.458 . . . . 2.8599999999999999 109.45 173.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 125.301 1.44 . . . . 4.4299999999999997 110.899 178.127 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.806 0 N-CA-C 110.824 -0.065 . . . . 1.4299999999999999 110.824 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 115' ' ' ARG . 10.8 pt -79.58 -7.73 10.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 119.295 -0.962 . . . . 2.1899999999999999 111.339 -175.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 tt -44.46 140.91 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.095 1.146 . . . . 1.9399999999999999 114.095 -167.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 56.59 9.32 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.4 -1.08 . . . . 1.8 110.4 -178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 112' ' ' ILE . 0.2 OUTLIER -157.48 175.78 13.51 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.861 2.065 . . . . 4.29 105.706 -174.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -123.35 106.39 10.63 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.501 1.046 . . . . 0.94999999999999996 112.488 -169.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.69 150.02 42.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.194 -0.457 . . . . 1.6699999999999999 110.133 168.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.33 134.45 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.995 1.718 . . . . 0.44 107.124 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 m -103.71 124.66 58.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.265 -1.383 . . . . 1.6000000000000001 107.265 165.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.476 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 60.0 m-70 -97.81 159.42 14.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 116.859 2.17 . . . . 0.42999999999999999 116.859 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -40.62 -69.52 0.13 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.143 2.577 . . . . 3.1099999999999999 111.651 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -113.44 -176.23 2.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.66 0.664 . . . . 3.3900000000000001 109.985 -169.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.7 146.33 41.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.528 -0.545 . . . . 0.59999999999999998 109.528 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 154.47 41.61 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.244 -1.021 . . . . 2.0800000000000001 108.244 157.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -90.81 -6.02 54.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 3.54 113.663 -170.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 65.84 14.49 9.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.365 1.466 . . . . 1.5 113.44 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 39.01 3.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.94 1.257 . . . . 1.6399999999999999 110.999 167.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -141.68 -82.36 0.21 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.346 1.459 . . . . 5.3200000000000003 108.525 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.06 -46.42 0.98 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.66 1.124 . . . . 3.98 114.285 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.53 7.76 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.349 -1.5 . . . . 2.6200000000000001 109.349 -165.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -166.18 -170.39 1.69 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.138 1.775 . . . . 2.5899999999999999 107.347 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -92.87 -47.61 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.831 0.853 . . . . 3.3199999999999998 110.493 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -53.3 -33.76 54.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.929 2.092 . . . . 4.1699999999999999 112.085 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 p -49.73 -70.68 0.08 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.47 1.508 . . . . 2.1800000000000002 110.705 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.6 p -60.06 -45.65 92.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 1.4199999999999999 110.207 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.8 -48.26 75.7 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.373 1.069 . . . . 3.9100000000000001 111.577 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.45 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 54.5 p -132.07 -54.73 0.98 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.386 0.513 . . . . 1.6100000000000001 112.386 -172.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 126.99 106.96 1.45 Allowed Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 104.783 -3.327 . . . . 3.02 104.783 -167.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.45 57.55 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.679 1.592 . . . . 1.95 108.984 -172.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -58.75 -30.84 67.81 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.458 1.503 . . . . 0.89000000000000001 113.438 -176.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.08 50.62 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 107.953 -2.059 . . . . 1.05 107.953 -160.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 t -64.69 162.78 15.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.927 0.891 . . . . 1.8799999999999999 113.289 -165.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -65.75 138.03 57.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.337 1.855 . . . . 2.9300000000000002 109.144 172.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.7 mt -110.75 -78.31 0.59 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.773 1.169 . . . . 0.53000000000000003 108.91 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -109.4 151.7 26.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.878 0.871 . . . . 0.76000000000000001 109.175 174.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.0 p -160.57 173.24 15.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.426 1.89 . . . . 1.3899999999999999 107.367 -177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 167.11 170.88 32.54 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.844 -2.902 . . . . 1.45 105.844 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.6 t -87.49 143.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 119.624 1.712 . . . . 0.78000000000000003 109.082 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.517 HD11 ' CG ' ' A' ' 20' ' ' PHE . 12.8 tt -93.65 127.63 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.92 0.488 . . . . 0.78000000000000003 111.592 171.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.54 14.95 0.11 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.38 1.467 . . . . 1.1000000000000001 114.292 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 mm -101.99 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 120.178 1.989 . . . . 1.03 109.331 -159.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.73 175.11 14.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 1.24 109.278 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 104.351 -2.463 . . . . 4.2999999999999998 104.351 162.377 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.749 0.309 . . . . 3.6099999999999999 111.181 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.06 138.36 34.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 0.66000000000000003 108.108 165.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.59 142.36 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.953 -1.129 . . . . 0.76000000000000001 107.953 166.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.34 96.07 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.444 -0.947 . . . . 0.47999999999999998 108.444 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.84 107.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.763 -1.569 . . . . 0.87 106.763 159.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -95.21 125.0 39.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.969 -1.123 . . . . 1.01 107.969 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -49.68 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.16 0.584 . . . . 4.8499999999999996 109.872 175.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 36.38 -120.5 0.6 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.42 1.486 . . . . 1.04 112.918 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -93.47 -59.67 1.96 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.342 -0.984 . . . . 3.4100000000000001 108.342 -173.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.39 164.2 5.43 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.512 1.53 . . . . 1.01 114.897 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -79.06 33.48 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.399 3.399 . . . . 1.3200000000000001 112.208 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 27.7 t -111.2 141.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 127.171 2.189 . . . . 1.21 105.997 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -139.61 128.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.776 -1.564 . . . . 2.4300000000000002 106.776 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.17 164.88 31.59 Favored Glycine 0 N--CA 1.45 -0.395 0 O-C-N 121.905 -0.497 . . . . 0.77000000000000002 112.064 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.98 124.57 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.863 -1.162 . . . . 1.28 107.863 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.0 mm -89.39 155.33 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.504 1.122 . . . . 0.94999999999999996 109.061 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 126.57 43.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.516 -0.92 . . . . 2.3300000000000001 108.516 153.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.592 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -106.65 123.25 47.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.462 -2.051 . . . . 2.5299999999999998 105.462 168.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -148.98 139.51 22.56 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.098 -0.705 . . . . 3.4199999999999999 109.098 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 164.91 37.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.618 -1.993 . . . . 3.8999999999999999 105.618 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -54.3 2.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.774 1.23 . . . . 4.4100000000000001 110.34 -177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -79.28 118.74 21.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.257 -1.386 . . . . 4.1699999999999999 107.257 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -76.02 46.09 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.738 1.154 . . . . 2.79 112.7 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.8 t30 179.85 58.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.822 2.449 . . . . 3.79 107.971 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.59 170.59 35.2 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.41 -1.076 . . . . 0.96999999999999997 110.41 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.45 140.24 86.49 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.315 2.677 . . . . 1.2 111.626 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 20' ' ' PHE . 9.6 t -93.67 158.12 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.12 -1.067 . . . . 1.27 108.12 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -107.71 111.75 24.09 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.38 -1.711 . . . . 5.6200000000000001 106.38 162.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' CE1' ' A' ' 20' ' ' PHE . 5.0 t -79.61 135.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.507 -2.034 . . . . 1.1599999999999999 105.507 170.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -139.13 159.64 41.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.644 -1.984 . . . . 0.81000000000000005 105.644 159.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.1 -166.29 14.75 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.201 -1.0 . . . . 1.9199999999999999 110.61 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.0 m -148.22 109.73 4.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.626 -1.99 . . . . 1.6499999999999999 105.626 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -114.81 146.18 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.703 -1.592 . . . . 0.82999999999999996 106.703 -170.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -154.79 170.63 21.17 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 114.127 1.158 . . . . 3.7200000000000002 114.127 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.89 80.45 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.626 1.584 . . . . 0.65000000000000002 112.616 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.1 155.77 26.93 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.833 -0.804 . . . . 0.68999999999999995 110.232 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 165.01 17.71 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.66 -1.237 . . . . 1.6899999999999999 107.66 156.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.66 175.69 0.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.013 0.824 . . . . 2.6099999999999999 111.59 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.34 -162.12 37.22 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.129 0.871 . . . . 0.45000000000000001 113.576 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.49 146.48 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.051 1.74 . . . . 1.9199999999999999 112.962 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -146.97 113.53 5.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.872 1.669 . . . . 0.51000000000000001 109.428 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.92 147.84 4.16 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.745 -0.942 . . . . 0.40999999999999998 110.745 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.54 95.32 2.85 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.791 -1.559 . . . . 2.23 106.791 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.669 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 14.7 m170 -132.18 158.37 41.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.354 -1.721 . . . . 0.64000000000000001 106.354 -165.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.302 0.8 OUTLIER -117.81 115.94 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.546 1.165 . . . . 1.77 110.681 175.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -79.78 158.95 26.72 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.113 1.365 . . . . 0.92000000000000004 109.15 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -28.62 -93.39 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.638 2.775 . . . . 4.9400000000000004 114.998 -158.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.517 -0.301 0 C-N-CA 123.1 0.56 . . . . 12.24 110.273 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 113.188 0.81 . . . . 2.7999999999999998 113.188 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.82 -91.98 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.955 -0.914 . . . . 1.6000000000000001 112.204 -161.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.4 177.51 8.25 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.607 2.872 . . . . 1.3999999999999999 112.925 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -62.3 123.42 18.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.219 -1.4 . . . . 1.28 107.219 168.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -37.9 109.63 0.11 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.422 1.089 . . . . 1.8600000000000001 112.255 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -126.12 145.06 51.0 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 130.792 3.637 . . . . 3.5 107.712 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 -43.0 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.277 1.985 . . . . 1.27 109.028 168.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -155.24 -73.44 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.368 -0.975 . . . . 2.9500000000000002 108.368 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 p -129.49 58.88 1.61 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.471 1.108 . . . . 2.77 110.906 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -79.8 159.84 26.37 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.818 -0.552 . . . . 4.71 109.559 168.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.46 163.02 17.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.375 1.47 . . . . 3.8500000000000001 107.792 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -90.2 153.39 20.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.912 0.885 . . . . 0.82999999999999996 110.329 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.66 -52.4 0.01 OUTLIER Glycine 0 C--O 1.224 -0.521 0 N-CA-C 109.639 -1.384 . . . . 2.77 109.639 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.9 -166.31 21.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.948 1.261 . . . . 1.1699999999999999 111.488 171.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.91 -41.31 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.786 2.324 . . . . 1.3600000000000001 109.155 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -58.78 -58.11 10.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.267 1.427 . . . . 4.9000000000000004 109.91 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.66 152.88 29.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.036 -0.983 . . . . 1.9299999999999999 111.269 -167.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -52.18 -45.42 65.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.77 1.628 . . . . 4.0999999999999996 111.479 173.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -77.64 145.67 36.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.505 1.145 . . . . 2.6499999999999999 110.256 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.27 151.56 2.07 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.369 1.868 . . . . 3.1099999999999999 108.848 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.4 m80 -60.94 143.63 54.72 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.785 -1.561 . . . . 0.53000000000000003 106.785 163.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.97 -30.73 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.167 -0.613 . . . . 1.3700000000000001 110.947 -165.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.69 67.51 0.31 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 112.157 -0.377 . . . . 0.89000000000000001 112.157 167.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.29 114.37 3.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.419 -1.048 . . . . 2.1899999999999999 108.862 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.03 -53.93 3.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.248 0.619 . . . . 2.0600000000000001 110.121 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.76 -110.41 0.42 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.112 -0.566 . . . . 0.55000000000000004 111.822 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -148.58 167.58 25.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.04 1.736 . . . . 1.46 109.479 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.5 m -117.63 175.23 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.362 -1.718 . . . . 0.48999999999999999 106.362 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.9 t -109.43 150.48 28.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.264 -1.384 . . . . 2.2599999999999998 107.264 159.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.03 152.83 32.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.64 -0.874 . . . . 1.04 108.64 157.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -79.88 -83.47 0.1 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.781 1.232 . . . . 3.7200000000000002 108.984 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -151.29 -48.47 0.12 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.175 0.99 . . . . 3.9500000000000002 110.968 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.37 24.91 0.65 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.439 1.59 . . . . 2.7200000000000002 111.13 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.36 14.39 61.94 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.063 1.316 . . . . 0.70999999999999996 111.889 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.88 152.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 125.193 1.397 . . . . 0.92000000000000004 107.749 175.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.41 172.35 15.07 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.16 1.384 . . . . 0.88 107.729 168.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -132.85 162.66 30.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.89 -2.263 . . . . 3.3999999999999999 104.89 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.54 55.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 O-C-N 124.184 0.928 . . . . 1.8700000000000001 112.423 174.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.3 m -70.4 101.29 1.92 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.741 -0.599 . . . . 0.98999999999999999 110.845 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.07 157.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.835 -0.802 . . . . 1.76 108.835 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -139.09 129.16 25.19 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.613 -0.884 . . . . 3.6200000000000001 108.613 159.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -134.68 151.48 51.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.695 1.598 . . . . 2.3599999999999999 108.492 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 p -107.59 -3.51 19.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.275 1.83 . . . . 1.45 113.28 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.94 -42.56 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.364 -1.347 . . . . 1.1599999999999999 107.364 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.497 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.2 pp -74.69 177.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.519 0.676 . . . . 1.79 111.546 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.9 m -161.21 179.32 8.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.833 2.453 . . . . 1.9399999999999999 106.434 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 70.4 1.08 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.118 -2.179 . . . . 2.8399999999999999 105.118 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 115.638 -0.71 . . . . 3.96 110.513 170.019 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.445 -0.692 0 CA-C-O 122.486 1.136 . . . . 2.0699999999999998 112.887 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.507 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -86.95 -6.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.065 -0.971 . . . . 1.6899999999999999 112.081 -170.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.463 ' HA ' HG23 ' A' ' 149' ' ' ILE . 24.2 mm -59.38 124.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.455 -0.943 . . . . 2.6200000000000001 108.455 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.79 3.56 76.91 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.447 1.022 . . . . 1.3200000000000001 113.256 -172.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -113.03 163.48 14.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.285 1.543 . . . . 4.46 109.771 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -93.15 89.79 6.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.833 1.253 . . . . 2.54 110.252 -157.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.33 143.98 56.27 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.329 -0.857 . . . . 1.8100000000000001 109.848 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -135.19 133.45 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.281 1.832 . . . . 0.46000000000000002 109.046 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -94.38 121.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 125.858 1.663 . . . . 2.4500000000000002 107.706 163.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.568 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 90.3 m-70 -98.56 167.28 10.91 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 117.608 2.447 . . . . 0.48999999999999999 117.608 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -81.3 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.325 1.85 . . . . 4.0199999999999996 110.314 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -178.26 6.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.595 0.634 . . . . 4.6100000000000003 109.878 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.63 151.03 30.07 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.141 -1.429 . . . . 0.55000000000000004 107.141 153.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -76.74 151.7 35.93 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.473 -1.306 . . . . 1.99 107.473 158.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -70.27 -25.56 63.41 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.0 -0.437 . . . . 3.1400000000000001 111.529 -169.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 50.0 7.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.043 0.937 . . . . 2.0800000000000001 109.93 -159.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 52.53 39.72 53.73 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.306 0.955 . . . . 1.6000000000000001 113.263 167.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -80.01 -18.61 49.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.681 0.792 . . . . 5.3700000000000001 111.394 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.44 -143.09 16.3 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.83 -0.508 . . . . 2.4399999999999999 111.83 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.77 -77.05 0.4 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.577 -1.409 . . . . 2.27 109.577 -172.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.86 104.03 14.46 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.012 -1.477 . . . . 2.8399999999999999 107.012 167.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.56 -33.55 22.23 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.763 1.165 . . . . 5.1600000000000001 112.986 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -37.07 -36.71 0.13 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.319 1.048 . . . . 3.02 113.694 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.8 t -36.35 -66.99 0.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.903 2.081 . . . . 2.27 111.023 167.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.28 -46.15 51.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.145 0.978 . . . . 1.49 110.583 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -53.01 -52.27 58.96 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.585 0.754 . . . . 3.0099999999999998 111.328 -168.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.492 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.278 5.4 p -126.51 -48.51 1.54 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.675 -0.679 . . . . 1.3100000000000001 112.277 174.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 159.42 -21.06 0.28 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 120.052 1.296 . . . . 1.01 114.039 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.17 56.32 5.96 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.796 1.238 . . . . 2.1800000000000002 111.349 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -67.28 0.49 2.78 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.509 0.929 . . . . 1.0700000000000001 113.509 169.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -71.13 2.99 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.297 -1.502 . . . . 3.3799999999999999 110.315 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 t -166.33 -174.41 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.529 0.732 . . . . 1.8200000000000001 110.975 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.31 139.06 31.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.496 2.718 . . . . 2.8900000000000001 109.522 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.4 mt -113.26 -88.28 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.298 0.954 . . . . 0.93999999999999995 109.685 169.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.31 154.43 21.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.598 -0.89 . . . . 1.02 108.598 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.6 p -157.58 170.98 21.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 123.753 0.658 . . . . 1.51 110.598 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.62 155.42 11.31 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.484 -1.446 . . . . 1.0600000000000001 109.484 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.0 137.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.611 0.705 . . . . 1.48 109.459 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.507 HG21 HG12 ' A' ' 112' ' ' ILE . 13.1 tt -86.45 143.65 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.72999999999999998 110.935 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.04 5.56 3.03 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.62 1.105 . . . . 0.57999999999999996 114.219 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.4 mm -96.05 56.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 119.289 1.544 . . . . 0.94999999999999996 109.926 -156.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.49 176.52 12.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.547 0.739 . . . . 1.3 110.578 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.483 ' NE2' ' H ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.313 0 N-CA-C 103.999 -2.593 . . . . 5.0599999999999996 103.999 154.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 pttm . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 107.798 -1.186 . . . . 2.9900000000000002 107.798 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.414 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -115.39 144.8 43.26 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.055 -1.461 . . . . 0.78000000000000003 107.055 164.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.9 t -119.91 141.38 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 107.571 -1.27 . . . . 0.87 107.571 171.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.19 99.82 6.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.173 1.389 . . . . 0.55000000000000004 108.286 159.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.83 98.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.65 -1.241 . . . . 0.58999999999999997 107.65 163.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.0 mt -84.61 126.82 33.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.188 0.595 . . . . 0.81000000000000005 109.564 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -143.72 -48.3 0.29 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.72 0.808 . . . . 3.75 110.91 170.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.43 -123.68 5.24 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.432 -1.067 . . . . 0.82999999999999996 110.432 -171.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -107.1 -52.57 2.74 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.712 0.756 . . . . 4.0199999999999996 110.707 -173.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.56 156.58 5.71 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.913 1.244 . . . . 0.78000000000000003 111.702 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.14 39.65 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.372 3.381 . . . . 1.1899999999999999 113.23 -170.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 63.5 t -101.47 155.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.761 2.025 . . . . 0.80000000000000004 107.644 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.12 125.02 9.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.967 -1.494 . . . . 2.5 106.967 175.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.81 165.91 35.33 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.268 -0.733 . . . . 0.51000000000000001 111.268 177.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.09 115.18 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.009 -1.849 . . . . 1.6000000000000001 106.009 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.4 mm -78.65 145.83 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.273 -1.38 . . . . 0.75 107.273 168.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -123.41 107.62 11.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.878 -1.897 . . . . 2.0299999999999998 105.878 163.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CE1' HG22 ' A' ' 31' ' ' VAL . 1.3 m-85 -89.55 93.16 9.39 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.265 -2.124 . . . . 2.8999999999999999 105.265 164.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -96.11 134.87 38.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.106 -0.702 . . . . 3.5600000000000001 109.106 177.483 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -145.95 83.31 1.63 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.104 -0.953 . . . . 3.71 110.931 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -50.39 -45.13 55.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.721 -0.672 . . . . 6.7699999999999996 111.012 157.036 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -85.33 73.48 10.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.852 -1.166 . . . . 4.7400000000000002 107.852 -175.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 79.78 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.473 0.709 . . . . 4.1600000000000001 109.614 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -162.72 -53.69 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.61 1.564 . . . . 5.6299999999999999 109.513 -162.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.08 -85.31 0.06 OUTLIER Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.762 -1.209 . . . . 2.0899999999999999 112.761 -170.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.21 115.64 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.363 2.708 . . . . 1.8400000000000001 111.593 -174.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.51 HG11 ' CD2' ' A' ' 20' ' ' PHE . 23.2 t -87.5 165.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.861 -1.162 . . . . 1.0600000000000001 107.861 172.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.162 -1.792 . . . . 3.9399999999999999 106.162 168.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.525 HG22 ' CE1' ' A' ' 20' ' ' PHE . 10.0 t -89.67 131.49 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.96 -1.496 . . . . 1.0900000000000001 106.96 174.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -136.93 161.9 34.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.26 -1.385 . . . . 0.87 107.26 153.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.09 146.16 7.06 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.998 . . . . 0.84999999999999998 108.105 178.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -119.81 66.94 0.81 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.672 1.989 . . . . 1.6299999999999999 107.16 -171.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.73 115.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.47 -1.241 . . . . 1.21 107.96 -167.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -110.27 154.36 23.56 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.424 0.69 . . . . 3.7000000000000002 111.616 -173.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.64 68.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.641 -0.709 . . . . 0.73999999999999999 114.31 172.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -59.28 164.28 3.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.945 1.373 . . . . 0.68999999999999995 109.078 163.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.28 160.22 19.18 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.719 -1.238 . . . . 1.75 107.836 154.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -58.85 171.33 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.367 -0.833 . . . . 2.6000000000000001 110.289 175.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.0 -157.27 48.42 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 121.94 -0.475 . . . . 0.46000000000000002 112.96 167.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.98 141.92 38.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.207 1.003 . . . . 2.3999999999999999 111.059 -167.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -143.99 119.62 10.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.241 1.016 . . . . 0.45000000000000001 110.537 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.3 147.9 16.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.708 -0.957 . . . . 0.45000000000000001 110.708 172.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.41 91.85 2.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.361 1.064 . . . . 2.4100000000000001 108.167 -173.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.583 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 21.3 m170 -130.86 158.27 40.64 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.81999999999999995 109.828 -160.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.42 117.0 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.295 -0.632 . . . . 2.4700000000000002 109.295 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -107.6 139.57 41.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.959 -1.126 . . . . 1.05 107.959 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -73.01 66.16 0.79 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.242 0.83 . . . . 5.1900000000000004 113.242 -171.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' CD ' HH22 ' A' ' 143' ' ' ARG . 2.4 mt-10 . . . . . 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 3.0 110.541 -173.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.367 0 N-CA-C 106.634 -1.617 . . . . 1.9399999999999999 106.634 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.5 -96.27 2.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.485 -1.846 . . . . 1.1699999999999999 108.485 -177.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.47 177.8 6.34 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.281 2.654 . . . . 1.0 113.23 -177.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -69.07 131.77 45.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 115.968 -1.968 . . . . 1.6499999999999999 105.852 170.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -33.93 107.91 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.865 1.666 . . . . 3.1499999999999999 114.337 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.41 127.73 30.89 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 126.521 1.928 . . . . 3.1699999999999999 107.31 167.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.49 -40.68 13.45 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.595 1.53 . . . . 1.76 109.133 173.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 tt -146.69 -60.56 0.3 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.159 -1.793 . . . . 3.54 106.159 164.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.6 p -151.38 80.28 1.3 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.49 0.716 . . . . 2.6600000000000001 109.948 -178.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -80.03 163.58 24.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 4.7699999999999996 108.392 158.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.14 166.21 10.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.32 -1.363 . . . . 3.54 107.32 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.437 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 46.0 t60 -80.1 160.95 25.58 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.81999999999999995 110.148 175.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.19 -149.33 7.98 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 104.769 -3.332 . . . . 2.1299999999999999 104.769 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.69 -146.45 4.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.462 1.631 . . . . 1.3300000000000001 109.041 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.9 -36.88 21.59 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.321 2.014 . . . . 1.48 111.132 -177.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.61 -44.05 91.8 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.627 0.371 . . . . 4.8200000000000003 111.104 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.43 164.13 26.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.625 0.726 . . . . 1.9299999999999999 112.042 -169.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -77.74 -45.63 24.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.158 1.383 . . . . 4.1500000000000004 108.971 165.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -78.27 168.59 19.6 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.987 0.899 . . . . 3.25 109.84 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 153.62 142.75 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 130.524 3.53 . . . . 3.0 105.454 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.0 m80 -59.58 151.02 25.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.649 -0.82 . . . . 0.78000000000000003 109.313 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -71.31 -4.77 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.258 -0.901 . . . . 1.51 111.121 -172.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.99 70.2 0.44 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.995 1.283 . . . . 1.0 109.947 159.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.92 122.28 0.7 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.64 -1.244 . . . . 2.1400000000000001 107.64 -177.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.33 -38.06 8.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.772 0.829 . . . . 1.8100000000000001 110.204 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.87 -129.29 3.24 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.086 -2.006 . . . . 0.82999999999999996 108.086 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -131.05 170.6 14.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.134 1.374 . . . . 1.77 110.382 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.09 175.71 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.352 1.461 . . . . 0.79000000000000004 107.244 171.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -124.89 126.76 46.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.937 -1.135 . . . . 2.1200000000000001 107.937 175.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.48 139.53 31.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.754 0.822 . . . . 0.63 111.337 171.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -74.26 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 O-C-N 124.305 1.003 . . . . 3.0899999999999999 110.508 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 93' ' ' GLY . 46.6 tttt -149.84 -35.44 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.786 1.032 . . . . 3.23 113.786 -164.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -80.89 22.17 0.63 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 124.047 1.879 . . . . 3.9300000000000002 110.191 165.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 57.9 25.83 56.95 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 125.124 1.345 . . . . 1.0900000000000001 111.069 -170.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.9 t -83.78 106.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.396 1.079 . . . . 1.1599999999999999 108.169 -175.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.8 167.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.977 -1.12 . . . . 0.96999999999999997 107.977 158.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -128.07 139.6 52.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 103.399 -2.815 . . . . 3.0899999999999999 103.399 176.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.08 55.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 123.861 0.726 . . . . 2.02 111.775 179.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -74.89 101.57 4.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.389 0.676 . . . . 1.05 110.767 170.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.1 mt -140.94 156.01 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.93 0.786 . . . . 1.8700000000000001 109.626 177.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.27 72.22 1.37 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.345 1.458 . . . . 4.96 111.22 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.49 134.68 37.29 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.403 -0.811 . . . . 2.1699999999999999 109.454 177.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 p -92.72 -9.97 38.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.424 1.49 . . . . 1.6599999999999999 112.894 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.4 t -85.63 -46.09 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.404 -0.962 . . . . 1.48 108.404 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.6 pp -70.8 177.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.097 0.475 . . . . 1.1200000000000001 111.922 176.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.5 t -153.12 175.07 13.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.609 1.964 . . . . 2.98 105.808 172.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.45 0.68 17.9 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.036 0.935 . . . . 2.4100000000000001 111.399 162.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 CA--C 1.53 0.184 0 C-N-CA 125.246 1.418 . . . . 3.5899999999999999 110.74 -173.243 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 p . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 115.509 1.67 . . . . 1.49 115.509 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.66 -14.54 12.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 114.122 -1.399 . . . . 2.73 112.392 170.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.2 tp -50.04 123.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 124.066 0.946 . . . . 2.1499999999999999 110.297 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.9 86.77 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.215 -0.769 . . . . 1.3600000000000001 114.198 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.7 175.99 9.41 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.148 1.974 . . . . 5.6699999999999999 109.341 178.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.85 123.69 50.89 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.578 1.081 . . . . 1.9399999999999999 108.594 167.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.85 144.92 40.95 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.301 -1.37 . . . . 1.52 107.301 167.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -129.75 134.93 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.195 1.798 . . . . 0.41999999999999998 107.59 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.82 128.44 58.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.729 -1.212 . . . . 1.6899999999999999 107.729 167.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.497 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 53.6 m-70 -104.3 158.13 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.827 2.158 . . . . 0.63 116.827 -171.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -41.33 -68.87 0.16 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.724 2.81 . . . . 3.04 111.355 172.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -111.27 -175.06 2.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.1 -0.704 . . . . 2.8900000000000001 109.1 -171.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.97 141.04 47.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.053 -1.091 . . . . 0.89000000000000001 108.053 165.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.66 165.46 14.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.994 -0.682 . . . . 2.5600000000000001 109.604 154.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.53 -48.66 74.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.525 -0.761 . . . . 3.54 113.048 -173.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 77.08 52.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.289 1.836 . . . . 1.6799999999999999 111.021 -159.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 27.16 64.42 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.408 1.004 . . . . 1.6399999999999999 114.889 152.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -85.35 -33.14 22.1 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.081 1.352 . . . . 5.9199999999999999 108.673 169.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.43 -80.67 1.6 Allowed Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.633 -1.787 . . . . 2.7200000000000002 108.633 -178.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.85 -73.92 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.294 0.95 . . . . 2.7799999999999998 110.861 -175.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -75.46 -116.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.097 -1.446 . . . . 2.8900000000000001 107.097 157.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.15 -40.3 0.06 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.069 1.304 . . . . 4.2400000000000002 112.912 173.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -43.21 -43.61 4.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.806 1.242 . . . . 3.8399999999999999 111.504 175.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.9 m -33.28 -63.66 0.23 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.095 2.558 . . . . 2.5 113.483 163.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.08 -46.28 57.44 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.119 -0.988 . . . . 1.97 112.052 175.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -53.03 -49.46 66.25 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.395 0.543 . . . . 3.5600000000000001 110.821 -173.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -129.67 -46.21 1.17 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.662 0.785 . . . . 1.45 110.991 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.21 -31.74 0.79 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.241 0.448 . . . . 1.1699999999999999 112.12 -175.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 48.19 54.66 9.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.926 1.29 . . . . 2.7799999999999998 110.259 -165.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.583 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -51.46 -35.35 39.34 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.921 1.688 . . . . 1.3899999999999999 113.71 174.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.52 -179.04 49.1 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 108.464 -1.854 . . . . 0.98999999999999999 108.464 -159.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -62.43 153.3 31.77 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.263 1.425 . . . . 1.6200000000000001 112.736 -164.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.436 HH22 ' CD ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -77.07 133.71 38.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.8 1.24 . . . . 2.6800000000000002 108.664 179.137 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.0 mt -111.02 -70.39 0.82 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.093 -1.077 . . . . 0.53000000000000003 108.093 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -131.97 148.37 52.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.614 0.766 . . . . 0.88 110.047 -173.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.3 p -160.28 173.79 15.17 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 125.191 1.557 . . . . 1.55 109.415 -176.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.64 135.04 2.5 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.71 -2.156 . . . . 0.68999999999999995 107.71 -176.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.1 t -60.5 133.79 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.495 0.718 . . . . 0.80000000000000004 109.074 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.22 136.08 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.28 0.562 . . . . 0.80000000000000004 112.204 -174.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 137.25 -3.02 3.28 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.812 1.196 . . . . 0.55000000000000004 114.029 175.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -95.3 61.26 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 122.784 1.278 . . . . 1.45 107.832 -157.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.25 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.93 -1.032 . . . . 2.6400000000000001 112.696 -173.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 C--O 1.25 1.104 0 N-CA-C 101.813 -3.403 . . . . 8.6500000000000004 101.813 150.662 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 107.946 -1.131 . . . . 4.79 107.946 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.53 149.12 47.27 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.856 -0.794 . . . . 0.82999999999999996 108.856 157.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 t -119.59 145.48 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.856 -1.164 . . . . 1.0600000000000001 107.856 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.11 97.14 5.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.648 -0.871 . . . . 0.65000000000000002 108.648 159.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.43 105.33 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.264 -1.384 . . . . 0.67000000000000004 107.264 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.22 124.48 37.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.99 -0.745 . . . . 0.85999999999999999 108.99 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -137.97 -60.16 0.64 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.75 0.42 . . . . 3.3100000000000001 110.001 174.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.78 -122.1 6.43 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.201 0.905 . . . . 0.79000000000000004 111.989 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -115.14 -50.48 2.75 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 124.932 1.293 . . . . 3.02 109.475 -163.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.31 153.95 9.18 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.735 -1.346 . . . . 0.71999999999999997 109.735 171.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.69 41.91 1.15 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.425 2.75 . . . . 0.98999999999999999 113.279 -166.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.62 155.91 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.329 1.852 . . . . 1.1499999999999999 108.945 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.39 81.57 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.133 -1.432 . . . . 2.3900000000000001 107.133 172.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.23 163.66 13.96 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.398 -0.681 . . . . 0.46999999999999997 111.398 -173.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.75 124.56 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.417 -0.957 . . . . 1.1200000000000001 108.417 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -88.82 135.31 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.421 1.089 . . . . 0.91000000000000003 108.326 164.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.48 110.38 22.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.801 1.64 . . . . 2.9199999999999999 108.086 159.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.42 111.88 23.57 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.11 -1.811 . . . . 2.3999999999999999 106.11 166.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -117.41 140.13 49.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.852 0.72 . . . . 2.9399999999999999 110.167 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -156.62 141.57 17.13 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.781 0.832 . . . . 4.0899999999999999 110.569 170.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -70.42 -67.06 0.52 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.44 0.696 . . . . 4.79 109.529 170.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -76.85 -178.7 5.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 120.076 1.307 . . . . 3.8100000000000001 111.854 -170.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -65.57 -65.95 0.61 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.882 1.273 . . . . 2.4399999999999999 110.401 172.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -125.65 92.52 3.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.892 0.877 . . . . 4.1699999999999999 109.526 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.25 177.35 27.5 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 108.28 -1.928 . . . . 1.0600000000000001 108.28 170.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.44 111.59 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.51 2.806 . . . . 1.3 112.094 -175.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.31 132.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.075 -1.083 . . . . 0.83999999999999997 108.075 -169.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -87.23 101.17 13.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.201 -1.777 . . . . 3.6600000000000001 106.201 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.1 124.37 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.282 -1.747 . . . . 1.23 106.282 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -131.83 136.35 47.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.047 -1.834 . . . . 1.0700000000000001 106.047 159.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.28 150.97 23.21 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.539 -1.824 . . . . 0.71999999999999997 108.539 -174.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.1 m -128.95 101.43 6.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.73 -2.322 . . . . 1.8600000000000001 104.73 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.97 144.59 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.074 -1.454 . . . . 0.81000000000000005 107.074 -169.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -154.83 143.73 20.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.475 0.546 . . . . 3.8199999999999998 112.475 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.89 25.79 8.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.877 2.179 . . . . 0.98999999999999999 112.712 -177.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.31 -155.78 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.431 -0.952 . . . . 1.1899999999999999 108.431 164.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -135.65 168.43 19.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.622 -2.733 . . . . 2.5499999999999998 103.622 165.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.16 169.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.277 1.399 . . . . 3.1899999999999999 114.099 -172.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.36 -165.98 48.9 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.592 -1.185 . . . . 0.5 113.195 169.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.51 143.7 57.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.403 1.481 . . . . 1.8200000000000001 113.104 -174.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -143.15 114.82 8.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.074 1.749 . . . . 0.44 108.69 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.61 145.16 2.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.33 -1.108 . . . . 0.33000000000000002 110.33 169.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.456 ' CE2' HG12 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -137.58 95.11 3.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.738 -1.579 . . . . 2.46 106.738 -176.64 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.3 m80 -134.98 154.51 51.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.362 -1.347 . . . . 0.65000000000000002 107.362 -164.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.264 2.6 p -107.08 108.66 25.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 CA-C-O 122.396 1.093 . . . . 1.8899999999999999 108.782 172.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.515 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 12.4 m-70 -77.47 156.44 31.05 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.39 -1.707 . . . . 0.97999999999999998 106.39 172.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -81.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.908 0.483 . . . . 5.5099999999999998 110.261 -178.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . 30.5 tt0 . . . . . 0 C--O 1.233 0.203 0 C-N-CA 127.853 2.461 . . . . 4.4900000000000002 114.403 -169.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . . . . . . . . 0 C--O 1.232 0.137 0 N-CA-C 118.556 2.799 . . . . 2.3700000000000001 118.556 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -177.66 14.05 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 114.235 -1.348 . . . . 2.0899999999999999 110.914 164.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.61 -179.99 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.977 3.785 . . . . 1.1399999999999999 113.612 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -47.07 107.19 0.1 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.844 1.258 . . . . 1.1499999999999999 109.063 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -34.27 104.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.278 1.431 . . . . 2.4100000000000001 111.935 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -122.79 141.58 35.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 129.55 3.14 . . . . 3.48 108.197 -174.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.91 -51.71 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.017 1.811 . . . . 1.01 109.085 173.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.19 -75.4 0.37 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.299 1.04 . . . . 2.6000000000000001 108.558 169.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -136.32 60.63 1.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.006 0.522 . . . . 1.6299999999999999 111.613 -159.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -78.74 164.04 24.89 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.702 -1.222 . . . . 4.0300000000000002 107.702 162.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -127.66 173.62 9.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.643 . . . . 4.6100000000000003 107.142 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.518 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 35.8 t60 -93.85 157.69 16.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.97 0.73 . . . . 0.81999999999999995 112.97 -167.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.41 -147.77 7.79 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 105.734 -2.946 . . . . 2.1099999999999999 105.734 166.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.89 -170.4 30.77 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.051 -2.42 . . . . 1.8300000000000001 107.051 176.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.29 -23.84 71.62 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.092 2.528 . . . . 2.1499999999999999 113.667 -176.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -70.37 -34.37 72.52 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.963 -0.461 . . . . 5.2400000000000002 111.264 173.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.52 176.65 8.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.562 1.545 . . . . 1.8899999999999999 110.585 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -83.93 -47.91 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.926 1.29 . . . . 4.3200000000000003 109.145 164.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -88.69 166.39 14.11 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.592 1.157 . . . . 3.2400000000000002 111.073 -166.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 168.95 146.1 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.51 2.324 . . . . 5.7599999999999998 108.773 -173.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 42.1 m80 -63.25 148.75 47.31 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 106.278 -1.749 . . . . 0.52000000000000002 106.278 166.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 -45.84 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 119.224 -0.99 . . . . 1.5 108.389 -176.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.6 59.71 4.8 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.618 -0.677 . . . . 0.78000000000000003 113.187 171.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 80' ' ' HIS . 1.3 t0 -168.94 120.22 0.75 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.656 -1.238 . . . . 2.0 107.656 -172.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.39 -51.56 3.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.18 0.992 . . . . 2.2799999999999998 109.186 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.95 -116.49 0.71 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.642 -0.983 . . . . 0.56999999999999995 110.642 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -144.66 167.5 22.4 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.876 1.27 . . . . 1.71 109.677 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 175.54 5.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 N-CA-C 106.522 -1.659 . . . . 0.53000000000000003 106.522 167.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -106.97 147.25 30.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.264 -1.384 . . . . 2.27 107.264 158.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.01 30.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.639 -0.875 . . . . 0.88 108.639 155.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -73.2 -78.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.227 1.011 . . . . 3.3199999999999998 109.736 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -152.95 -52.37 0.11 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.532 1.533 . . . . 4.5700000000000003 108.491 178.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.48 17.7 1.68 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.903 1.681 . . . . 4.4800000000000004 111.541 -171.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.98 15.11 81.95 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.084 1.326 . . . . 0.70999999999999996 111.337 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.77 149.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.21 -1.404 . . . . 1.0 107.21 171.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.77 24.85 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.232 1.013 . . . . 0.69999999999999996 108.343 169.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.33 145.91 50.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.027 -2.212 . . . . 2.79 105.027 -174.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.13 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.841 0.713 . . . . 1.8 111.3 178.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.5 m -76.07 96.78 3.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.387 1.075 . . . . 0.81000000000000005 110.85 170.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.7 mt -132.45 153.94 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 1.5900000000000001 109.064 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -126.08 84.01 2.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.103 0.561 . . . . 3.0499999999999998 110.47 166.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -79.5 121.76 25.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.89 0.476 . . . . 2.9900000000000002 109.728 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.5 p -84.6 -17.33 39.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.286 1.834 . . . . 1.79 112.57 178.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.2 t -83.64 -51.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.908 0.776 . . . . 1.03 110.05 -170.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.435 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.9 pp -75.55 177.04 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.261 0.553 . . . . 1.03 110.863 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.0 m -155.97 175.84 13.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.898 1.279 . . . . 1.98 108.1 171.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 47.66 2.09 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.891 1.276 . . . . 2.5800000000000001 111.705 -175.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 105.856 -1.905 . . . . 2.77 105.856 171.808 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 p . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 122.375 1.083 . . . . 1.49 113.007 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -79.69 -27.41 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.943 -1.026 . . . . 1.97 110.443 172.142 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -32.12 108.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.133 2.173 . . . . 2.5600000000000001 111.247 177.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.88 -20.13 10.91 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.419 1.485 . . . . 1.55 112.816 -174.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -103.06 160.13 14.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.961 1.881 . . . . 4.6399999999999997 113.002 -165.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 146' ' ' CYS . 1.3 m -75.81 102.09 5.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.354 1.062 . . . . 1.1699999999999999 111.028 -172.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -68.71 144.96 54.25 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.335 -0.853 . . . . 1.6599999999999999 108.938 168.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -136.1 140.59 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.703 1.601 . . . . 0.44 108.99 -172.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 45' ' ' PHE . 2.2 m -111.38 125.45 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.203 1.401 . . . . 1.75 107.445 166.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.529 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 60.1 m-70 -101.63 165.25 11.33 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.727 1.751 . . . . 0.39000000000000001 115.727 -172.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' CG ' ' HD3' ' A' ' 122' ' ' LYS . 8.1 pt-20 -67.86 -53.41 26.94 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.469 1.108 . . . . 3.4300000000000002 112.444 -174.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.484 ' HD3' ' CG ' ' A' ' 121' ' ' GLU . 1.9 mppt? -101.09 -176.17 3.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.227 1.376 . . . . 2.8300000000000001 109.039 175.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.11 165.97 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.838 -0.801 . . . . 0.67000000000000004 108.838 156.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -84.39 167.06 16.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.421 0.688 . . . . 1.98 109.383 156.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.29 -7.15 59.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.627 1.171 . . . . 3.0299999999999998 111.881 -175.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 53.14 33.18 14.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.351 1.06 . . . . 1.3500000000000001 110.241 -170.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.57 20.52 52.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.798 0.713 . . . . 1.5900000000000001 112.635 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -135.14 50.3 2.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.292 1.437 . . . . 6.1500000000000004 107.446 -173.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.38 147.23 19.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 106.94 -2.464 . . . . 2.46 106.94 173.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.4 60.3 4.3 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.435 0.618 . . . . 2.2599999999999998 112.631 -167.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.88 163.22 35.76 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 107.325 -1.361 . . . . 2.8300000000000001 107.325 172.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.26 -52.37 62.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.004 -0.739 . . . . 3.1099999999999999 109.004 168.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -46.65 -42.57 16.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.518 1.527 . . . . 2.9300000000000002 111.847 -171.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 m -40.17 -63.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.866 2.066 . . . . 2.0299999999999998 112.113 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.2 t -74.95 -45.74 40.29 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.867 -0.521 . . . . 2.71 111.598 175.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.85 -48.22 67.21 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.713 1.605 . . . . 2.7999999999999998 111.492 -169.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.0 p -127.77 -46.73 1.41 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.778 0.431 . . . . 1.3899999999999999 111.493 174.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.518 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.54 -27.73 0.48 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 123.169 0.414 . . . . 1.0800000000000001 113.71 -178.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 51.6 t30 48.71 53.77 11.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 1.9199999999999999 110.216 -165.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.576 1.15 . . . . 1.0900000000000001 112.012 167.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.09 179.02 51.73 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 108.765 -1.734 . . . . 1.0 108.765 -161.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -53.79 155.72 3.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.791 -1.204 . . . . 1.6699999999999999 112.04 -175.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -92.93 144.49 25.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.615 1.966 . . . . 3.8500000000000001 109.519 -177.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt -114.43 -69.28 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.814 -1.18 . . . . 0.63 107.814 -173.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 165.21 12.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.865 -0.607 . . . . 1.28 110.133 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.532 ' HB2' HG23 ' A' ' 116' ' ' THR . 4.1 p -151.07 154.9 37.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.248 -0.887 . . . . 1.76 109.234 164.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.11 131.45 2.29 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.111 -1.996 . . . . 0.56000000000000005 108.111 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.94 125.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.433 -0.951 . . . . 0.81000000000000005 108.433 175.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.02 138.07 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 120.381 0.134 . . . . 0.93000000000000005 111.088 178.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.19 6.87 1.16 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.622 1.106 . . . . 0.67000000000000004 114.409 174.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.5 58.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 119.584 1.692 . . . . 0.92000000000000004 110.635 -160.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.94 175.67 12.68 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.891 0.876 . . . . 1.6100000000000001 108.646 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 103.603 -2.74 . . . . 4.7699999999999996 103.603 161.815 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 108.534 -0.913 . . . . 3.7200000000000002 108.534 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.457 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -88.63 154.95 19.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.198 -1.408 . . . . 0.97999999999999998 107.198 154.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.1 t -123.39 142.81 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.788 -0.819 . . . . 0.72999999999999998 108.788 169.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.38 93.14 4.26 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.114 -0.698 . . . . 0.5 109.114 158.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.62 103.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.73 -1.211 . . . . 0.68999999999999995 107.73 158.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.86 134.71 34.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.974 -0.751 . . . . 0.87 108.974 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -145.81 -57.64 0.31 Allowed 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.602 1.161 . . . . 3.1800000000000002 108.824 169.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.63 -124.3 31.25 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.804 0.716 . . . . 0.94999999999999996 112.432 -176.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -113.18 -54.15 2.64 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.618 1.167 . . . . 4.25 109.939 -164.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.02 160.55 7.07 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.202 -1.159 . . . . 0.95999999999999996 110.202 173.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.21 40.63 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.441 2.761 . . . . 1.04 112.349 -172.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.48 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.441 1.897 . . . . 0.68000000000000005 108.848 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.5 128.84 8.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.085 -1.82 . . . . 2.52 106.085 170.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.43 171.12 41.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.798 . . . . 0.46999999999999997 111.57 -177.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 mm -128.92 129.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.143 -1.428 . . . . 1.8999999999999999 107.143 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.3 mm -101.07 137.29 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 N-CA-C 107.126 -1.435 . . . . 0.71999999999999997 107.126 161.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 127.15 45.23 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.274 -1.38 . . . . 1.78 107.274 160.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.25 91.82 5.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.619 -1.993 . . . . 2.2400000000000002 105.619 158.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -122.03 134.76 54.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.119 -1.067 . . . . 4.1399999999999997 108.119 175.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.39 -62.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.512 -1.222 . . . . 3.5299999999999998 108.193 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? 58.79 48.89 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.299 1.44 . . . . 9.0099999999999998 112.958 169.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -147.67 160.76 42.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.042 0.937 . . . . 5.4199999999999999 109.387 160.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.3 p -75.93 56.23 0.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.216 -0.661 . . . . 5.8300000000000001 109.216 167.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -110.59 -56.91 2.29 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.527 1.531 . . . . 9.5899999999999999 107.688 176.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.65 0.35 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 117.974 -1.459 . . . . 2.0899999999999999 110.161 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -50.65 122.93 10.49 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.912 3.075 . . . . 2.0800000000000001 113.869 -168.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.23 143.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.623 -0.717 . . . . 1.0600000000000001 110.25 -165.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -92.16 83.81 5.16 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.082 -1.822 . . . . 2.77 106.082 171.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.43 83.52 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.945 -1.132 . . . . 1.05 107.945 -172.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -92.49 135.18 34.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.267 0.556 . . . . 1.02 110.03 169.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.27 164.61 35.04 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.079 -1.609 . . . . 0.80000000000000004 109.079 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -154.09 129.22 9.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.369 -1.345 . . . . 2.29 107.369 -174.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -128.78 147.92 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 125.689 1.596 . . . . 1.0800000000000001 108.932 -163.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -136.86 156.2 48.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.291 0.496 . . . . 3.96 112.202 164.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.83 13.09 41.41 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.382 1.944 . . . . 0.57999999999999996 112.916 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.69 157.15 36.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.709 -0.848 . . . . 0.76000000000000001 108.709 168.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -78.55 157.02 28.91 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.984 -1.487 . . . . 2.0499999999999998 106.984 156.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.36 174.2 0.1 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.951 . . . . 3.1899999999999999 112.637 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.75 -169.19 53.12 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.623 -0.717 . . . . 0.56000000000000005 112.564 169.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 42' ' ' LEU . 3.6 tp -75.18 146.82 40.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.351 1.06 . . . . 2.46 110.753 -177.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.59 116.26 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.331 1.452 . . . . 0.59999999999999998 108.468 -178.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.72 146.72 7.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.63 -1.388 . . . . 0.56000000000000005 109.63 172.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -139.1 93.75 2.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.541 -1.652 . . . . 2.5 106.541 -171.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -131.83 150.95 52.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.719 -1.585 . . . . 0.66000000000000003 106.719 -162.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.738 0.78 . . . . 1.6699999999999999 109.07 174.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -78.7 149.28 32.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.416 -1.698 . . . . 0.97999999999999998 106.416 170.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.55 -100.23 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.388 2.275 . . . . 5.1799999999999997 113.543 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 112.82 0.674 . . . . 3.52 112.82 174.806 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 111.224 0.083 . . . . 1.8100000000000001 111.224 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.42 -143.9 15.47 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.44 1.495 . . . . 1.4199999999999999 111.394 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.47 -179.43 5.42 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.798 3.665 . . . . 1.1299999999999999 113.76 -170.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -52.57 64.57 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 129.498 3.119 . . . . 1.6200000000000001 115.402 -174.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.2 t80 42.97 68.22 0.53 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.074 1.75 . . . . 2.2400000000000002 110.504 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -85.09 114.82 58.2 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.241 -0.885 . . . . 2.6400000000000001 109.808 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.84 -32.99 10.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.271 1.981 . . . . 1.3 111.593 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.43 -64.57 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.239 -0.652 . . . . 3.0899999999999999 109.239 177.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.7 t -158.94 65.34 0.41 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.062 -0.718 . . . . 2.6600000000000001 109.062 178.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 -79.23 163.39 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.931 -0.396 . . . . 5.2199999999999998 109.931 169.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.96 144.16 49.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.091 1.356 . . . . 3.8900000000000001 109.114 -169.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -77.09 155.66 32.27 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.831 0.853 . . . . 0.78000000000000003 111.707 -173.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.79 -98.27 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.499 -1.44 . . . . 2.2400000000000002 109.499 161.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.34 -146.93 9.55 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.577 -1.809 . . . . 1.2 108.577 178.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.83 -58.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.536 2.157 . . . . 1.4099999999999999 109.724 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -20.54 64.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.906 1.283 . . . . 6.4100000000000001 112.176 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 2.7 t70 -64.41 175.91 1.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.528 0.731 . . . . 3.4500000000000002 111.255 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.04 -50.97 7.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.917 1.287 . . . . 5.6299999999999999 108.551 164.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.12 174.39 8.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.954 0.502 . . . . 4.29 111.606 -173.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 164.58 136.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.309 3.044 . . . . 4.2199999999999998 107.78 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 32.4 m80 -66.9 156.52 35.57 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.195 -1.78 . . . . 0.68000000000000005 106.195 165.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.265 13.0 p -78.51 45.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 123.25 1.5 . . . . 2.3199999999999998 110.832 173.102 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.16 33.25 0.27 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 128.74 3.067 . . . . 0.76000000000000001 111.331 165.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -137.48 131.9 32.53 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.312 2.056 . . . . 2.1699999999999999 110.37 161.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.28 -56.38 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.114 1.365 . . . . 2.2999999999999998 109.201 176.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.34 -123.58 0.94 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.238 -0.745 . . . . 0.83999999999999997 111.238 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -139.26 172.32 13.0 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 125.28 1.432 . . . . 1.9199999999999999 110.077 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.5 163.68 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.993 1.317 . . . . 0.63 107.453 164.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.2 m -110.59 133.42 53.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.999 -1.482 . . . . 2.3199999999999998 106.999 174.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.76 137.41 32.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.766 0.426 . . . . 0.68999999999999995 110.535 169.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -73.98 -75.57 0.15 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.307 1.043 . . . . 3.3900000000000001 111.645 -166.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.37 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.668 1.187 . . . . 4.79 110.841 -168.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.18 8.44 4.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.278 1.431 . . . . 2.77 110.936 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.82 16.45 76.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.365 -1.094 . . . . 0.91000000000000003 110.365 -171.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -78.24 149.01 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.788 -1.56 . . . . 0.87 106.788 172.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.72 165.73 26.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.774 -1.195 . . . . 0.71999999999999997 107.774 165.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.28 140.25 51.5 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.364 -2.828 . . . . 3.0600000000000001 103.364 -172.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.61 78.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 123.971 0.795 . . . . 1.3 110.144 160.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.7 m -98.54 77.87 2.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.14 0.976 . . . . 1.02 108.952 166.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.58 159.11 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.554 -0.906 . . . . 1.78 108.554 176.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.32 147.29 49.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.352 -0.981 . . . . 2.52 108.352 152.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -137.62 150.56 47.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.332 1.053 . . . . 2.0800000000000001 108.218 172.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 p -110.17 -4.45 15.76 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.942 1.697 . . . . 1.3400000000000001 113.418 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.55 -47.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.745 -1.206 . . . . 1.0800000000000001 107.745 175.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.11 176.27 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.131 0.967 . . . . 1.1000000000000001 111.388 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.2 m -163.1 175.54 10.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.987 2.515 . . . . 1.72 104.469 -175.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.78 -1.93 45.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.896 0.771 . . . . 2.5899999999999999 112.587 173.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.535 0.399 0 C-N-CA 124.578 1.151 . . . . 3.4500000000000002 108.848 -173.852 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 121.948 0.88 . . . . 1.1399999999999999 111.931 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.2 pt -88.61 -5.72 10.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.011 -0.995 . . . . 1.99 110.738 -178.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -37.8 122.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.874 1.67 . . . . 1.6799999999999999 110.446 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.99 -21.24 40.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.895 -0.947 . . . . 1.6899999999999999 113.989 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -83.92 165.2 18.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.475 1.637 . . . . 5.29 110.961 -170.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -89.56 108.15 19.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.699 0.4 . . . . 0.93999999999999995 111.351 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.08 148.15 52.17 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.8 -0.815 . . . . 2.4399999999999999 108.8 168.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.16 141.47 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.525 1.53 . . . . 0.44 108.045 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.01 132.77 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.087 -1.079 . . . . 1.53 108.087 162.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -102.97 168.98 8.85 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.621 1.568 . . . . 0.66000000000000003 114.018 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -72.06 0.17 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.493 -0.776 . . . . 5.4000000000000004 111.078 177.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -79.78 178.09 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.284 0.947 . . . . 4.6100000000000003 109.498 -178.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.13 173.76 0.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.433 1.093 . . . . 1.5 111.442 172.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -70.39 165.52 22.28 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.812 0.815 . . . . 2.9399999999999999 108.94 163.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.74 -21.38 15.21 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.128 -0.942 . . . . 3.9100000000000001 112.36 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 54.69 14.36 0.85 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.904 1.282 . . . . 1.98 112.232 -173.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.61 61.67 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.11 1.338 . . . . 2.4100000000000001 111.285 -176.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 11.3 mttt -129.94 19.08 5.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.267 1.027 . . . . 5.96 110.874 -172.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.01 139.04 22.22 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.942 -2.063 . . . . 2.6000000000000001 107.942 164.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.36 67.13 1.88 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 117.764 0.782 . . . . 2.73 111.682 -175.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -172.99 156.27 3.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.46 1.504 . . . . 3.0699999999999998 108.195 -177.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -52.24 52.78 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.263 -0.398 . . . . 3.6200000000000001 111.28 -178.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -29.49 -46.13 0.05 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 3.0499999999999998 113.751 171.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 t -53.16 -61.74 2.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.174 0.989 . . . . 1.9099999999999999 111.548 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -71.26 -43.4 67.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.237 -0.914 . . . . 1.48 109.743 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -54.4 -39.14 66.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.337 2.255 . . . . 3.8900000000000001 112.539 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.4 t -138.1 -53.81 0.63 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.41 1.084 . . . . 1.6100000000000001 112.011 176.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 79.45 1.0 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 103.714 -3.755 . . . . 3.3599999999999999 103.714 -162.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -71.07 57.5 0.22 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.325 1.85 . . . . 3.48 110.681 -178.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -26.1 67.78 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.928 -0.483 . . . . 1.25 111.432 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 134.28 -177.34 19.24 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.397 -1.881 . . . . 0.93000000000000005 108.397 175.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -53.51 153.99 3.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.821 1.249 . . . . 1.25 111.775 175.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.24 131.16 49.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.002 -0.999 . . . . 3.0800000000000001 108.468 168.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -102.51 -74.14 0.64 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.576 -1.639 . . . . 0.67000000000000004 106.576 164.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.16 154.44 19.76 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.424 -0.954 . . . . 1.0800000000000001 108.424 173.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.0 m -144.46 156.05 44.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.909 -1.886 . . . . 2.0899999999999999 105.909 170.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.39 130.1 1.62 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.101 -0.8 . . . . 0.72999999999999998 111.101 169.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.9 131.24 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.898 0.879 . . . . 0.84999999999999998 109.004 173.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.8 tt -91.91 133.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.722 0.296 . . . . 0.70999999999999996 111.533 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.457 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 144.06 2.78 0.83 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.135 0.874 . . . . 1.1100000000000001 115.104 178.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.4 mm -95.4 57.86 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-N 119.325 1.562 . . . . 1.2 109.92 -157.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.62 176.62 12.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.668 0.787 . . . . 1.51 109.773 171.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.256 1.435 0 N-CA-C 104.068 -2.568 . . . . 4.4199999999999999 104.068 170.225 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.613 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 6.4 ttmm . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 106.943 -1.503 . . . . 4.4000000000000004 106.943 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -114.22 142.46 46.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.773 0.829 . . . . 0.69999999999999996 108.909 158.12 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' A' ' 152' ' ' ALA . 51.2 t -111.87 145.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.654 -1.61 . . . . 0.90000000000000002 106.654 166.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -118.47 97.62 5.85 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 0.54000000000000004 108.941 155.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.64 98.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.561 1.144 . . . . 0.71999999999999997 108.768 164.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.69 130.4 35.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.958 0.903 . . . . 2.3300000000000001 108.784 172.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -151.69 -52.12 0.12 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 122.767 0.427 . . . . 3.5800000000000001 110.961 166.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.45 -116.6 1.43 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.261 0.934 . . . . 1.1599999999999999 112.998 -175.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -117.2 -46.04 2.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.169 0.988 . . . . 3.3500000000000001 109.729 -158.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 172.36 16.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.567 1.08 . . . . 1.0 111.747 177.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.47 -24.06 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.139 2.559 . . . . 1.3100000000000001 111.594 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.2 t -49.89 139.36 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 0.97999999999999998 110.92 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.89 130.26 8.88 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.751 -1.203 . . . . 1.95 107.751 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.14 170.06 41.79 Favored Glycine 0 N--CA 1.449 -0.437 0 O-C-N 121.732 -0.605 . . . . 0.67000000000000004 111.691 -177.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 mm -123.83 126.14 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.287 -1.375 . . . . 1.6699999999999999 107.287 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.2 mp -95.65 147.62 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.019 -1.474 . . . . 1.3 107.019 163.234 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.53 121.39 36.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.032 1.333 . . . . 1.9099999999999999 107.494 167.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -96.73 99.03 10.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.978 -2.23 . . . . 2.4100000000000001 104.978 162.464 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -113.69 128.31 56.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.6 -0.889 . . . . 3.8999999999999999 108.6 174.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -157.22 -77.82 0.08 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.54 -1.664 . . . . 3.7799999999999998 108.963 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.2 59.85 3.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.47 -0.937 . . . . 6.5499999999999998 108.47 -174.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -113.83 -103.48 0.41 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.59 -2.374 . . . . 3.8599999999999999 104.59 168.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 t -153.03 -69.97 0.15 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.111 -1.44 . . . . 2.8999999999999999 107.111 157.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -124.19 97.85 5.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.84 -1.541 . . . . 4.04 106.84 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.89 37.43 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.345 -0.702 . . . . 1.02 111.345 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.74 115.62 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.366 3.378 . . . . 1.26 112.065 -172.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.02 164.44 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.562 0.745 . . . . 1.24 109.157 -172.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -115.1 99.18 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.938 -1.504 . . . . 3.0499999999999998 106.938 166.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -92.31 88.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.08 1.752 . . . . 1.1100000000000001 107.566 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -98.31 151.43 20.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.419 -0.586 . . . . 0.97999999999999998 109.419 169.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.9 159.04 32.18 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.369 -1.493 . . . . 0.82999999999999996 109.369 176.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.4 m -136.82 110.25 7.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.6 -1.63 . . . . 2.2200000000000002 106.6 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.411 HD11 HD12 ' A' ' 18' ' ' ILE . 1.1 mp -119.16 148.83 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.013 1.325 . . . . 0.95999999999999996 107.893 -163.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -148.33 166.26 28.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.978 0.732 . . . . 3.4900000000000002 112.978 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.44 19.35 62.35 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 0.67000000000000004 113.208 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -75.49 165.32 25.3 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.373 1.086 . . . . 0.79000000000000004 109.32 174.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.13 163.01 28.38 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.67 -1.233 . . . . 1.6599999999999999 107.67 155.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.89 165.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.79 0.805 . . . . 2.52 112.216 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 -158.31 53.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.086 -0.961 . . . . 0.58999999999999997 113.402 167.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 130.02 42.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.926 1.29 . . . . 1.9199999999999999 111.176 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -136.49 110.08 8.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.919 1.688 . . . . 1.3100000000000001 109.527 -174.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.91 149.42 11.06 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.852 1.692 . . . . 0.53000000000000003 111.563 -177.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -146.4 100.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.463 -0.94 . . . . 2.79 108.463 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.625 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.0 m80 -139.56 154.21 47.58 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.137 -1.06 . . . . 0.64000000000000001 108.137 -166.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -113.61 129.23 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 119.571 1.078 . . . . 1.8600000000000001 108.82 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -105.81 146.83 29.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.64 -1.615 . . . . 0.79000000000000004 106.64 -176.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -53.77 -61.24 2.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.591 0.557 . . . . 4.0499999999999998 110.751 -165.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 . . . . . 0 CA--C 1.54 0.568 0 C-N-CA 125.598 1.559 . . . . 2.98 111.535 159.205 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 107.497 -1.297 . . . . 3.3900000000000001 107.497 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.89 -94.52 0.34 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.256 -1.938 . . . . 0.95999999999999996 108.256 173.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.76 177.07 9.17 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.311 2.674 . . . . 0.82999999999999996 113.736 -176.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -60.93 130.94 48.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.582 -1.645 . . . . 1.3600000000000001 108.517 171.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -48.22 117.11 1.79 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.085 0.469 . . . . 1.71 110.487 176.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.22 152.57 25.28 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 126.536 1.934 . . . . 2.4500000000000002 107.158 173.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -24.69 12.37 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.418 2.079 . . . . 1.22 113.529 -167.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.36 -68.74 0.12 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.952 0.796 . . . . 2.9100000000000001 109.57 -176.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.7 m -155.99 77.96 0.96 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.484 0.714 . . . . 1.9199999999999999 109.67 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -77.99 169.82 17.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.785 -0.82 . . . . 5.0499999999999998 108.785 163.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -118.41 158.47 25.23 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.701 1.6 . . . . 3.4399999999999999 106.734 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.437 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 55.0 t60 -86.0 154.06 21.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.566 0.58 . . . . 0.85999999999999999 112.566 -175.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.41 -178.58 43.48 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 106.613 -2.595 . . . . 2.1699999999999999 106.613 160.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.49 -160.83 26.04 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 117.462 0.631 . . . . 1.45 112.616 -170.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.85 -43.19 3.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.951 1.768 . . . . 1.47 109.301 173.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.4 -46.57 76.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 5.1699999999999999 111.659 -176.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.68 174.45 1.79 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.425 -0.807 . . . . 2.4399999999999999 109.754 176.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.09 -37.44 11.61 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.224 1.01 . . . . 5.7300000000000004 111.082 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -75.71 155.53 35.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.04 -1.096 . . . . 2.7400000000000002 108.04 -174.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 165.57 145.46 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.905 2.082 . . . . 3.5099999999999998 112.002 -170.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.2 m80 -66.57 149.7 50.09 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 107.564 -1.273 . . . . 0.63 107.564 164.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.69 -37.43 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.94 -0.704 . . . . 1.5900000000000001 109.714 -171.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.17 60.86 1.59 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.611 0.624 . . . . 0.62 112.029 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 80' ' ' HIS . 1.2 t0 -168.29 114.94 0.67 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.523 -0.917 . . . . 2.0600000000000001 108.523 -172.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.13 -45.06 8.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.249 -0.648 . . . . 2.48 109.249 176.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.76 -94.11 0.15 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.289 -1.124 . . . . 1.1299999999999999 110.289 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -150.62 164.84 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.478 1.511 . . . . 1.5800000000000001 110.573 -177.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.0 m -110.0 176.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.284 -1.747 . . . . 0.52000000000000002 106.284 156.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 t -112.49 144.3 42.2 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.444 -1.317 . . . . 1.9099999999999999 107.444 160.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.35 153.25 29.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.289 -1.004 . . . . 1.1499999999999999 108.289 154.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.47 -89.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.781 -0.822 . . . . 2.8399999999999999 108.781 173.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -140.25 -57.67 0.54 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.584 1.554 . . . . 4.1799999999999997 108.981 -171.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -87.8 30.39 0.83 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.042 1.337 . . . . 5.0700000000000003 110.062 -170.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.63 10.65 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.205 1.86 . . . . 0.90000000000000002 112.956 179.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.71 138.3 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.393 -1.336 . . . . 0.95999999999999996 107.393 176.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.55 170.79 15.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.063 1.345 . . . . 0.60999999999999999 107.953 173.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -143.9 147.76 34.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.998 -2.223 . . . . 2.7999999999999998 104.998 -171.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.85 132.64 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.407 -1.701 . . . . 1.3799999999999999 106.407 166.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.9 m -153.02 73.19 0.98 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.013 1.325 . . . . 1.05 107.603 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.6 mm -115.85 152.51 17.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.638 -0.875 . . . . 2.5600000000000001 108.638 -177.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -145.53 91.47 2.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.522 0.729 . . . . 2.4500000000000002 109.48 167.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.42 -178.02 6.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.904 0.882 . . . . 3.5800000000000001 109.931 177.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.4 p -133.33 48.97 2.34 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.201 1.0 . . . . 1.6799999999999999 109.146 170.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.22 -55.86 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.918 1.287 . . . . 1.1799999999999999 108.486 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pp -88.08 177.68 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.89 0.852 . . . . 1.21 111.451 -177.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -161.64 177.88 9.56 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.921 2.088 . . . . 2.1400000000000001 107.077 -176.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.86 -3.8 24.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.888 1.07 . . . . 3.3900000000000001 113.888 -175.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 125.091 1.357 . . . . 4.1900000000000004 109.125 176.836 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.276 0.56 . . . . 1.27 111.07 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.3 pt -78.64 -17.32 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.553 -0.737 . . . . 1.96 109.257 174.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 tp -36.91 133.06 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.606 1.562 . . . . 1.78 113.775 -170.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.53 37.82 45.67 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.85 -0.5 . . . . 1.51 111.85 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -134.99 160.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.894 1.278 . . . . 4.0800000000000001 107.559 172.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.4 m -94.29 112.71 24.52 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.693 0.397 . . . . 1.2 111.022 -170.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.92 149.55 50.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.117 -0.698 . . . . 1.6399999999999999 109.117 172.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t -135.47 128.93 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.346 1.459 . . . . 0.38 107.467 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.53 120.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.046 -1.835 . . . . 1.6100000000000001 106.046 163.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.462 ' CD2' ' HD1' ' A' ' 46' ' ' HIS . 51.4 m-70 -94.28 175.65 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.019 1.727 . . . . 0.69999999999999996 112.247 -174.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -72.67 -76.93 0.11 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 113.041 0.756 . . . . 6.0599999999999996 113.041 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -81.11 -176.79 6.14 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.21 0.913 . . . . 3.2000000000000002 110.084 -167.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.6 148.89 36.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.89 -0.782 . . . . 0.56999999999999995 108.89 167.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -67.9 170.17 8.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.051 -0.722 . . . . 1.99 109.051 159.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.32 -23.58 62.86 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.699 1.37 . . . . 3.9100000000000001 114.699 -176.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 67.03 2.01 2.56 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.811 1.244 . . . . 1.6499999999999999 113.636 -170.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.21 10.09 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 120.54 1.518 . . . . 1.77 112.676 166.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -106.92 -20.77 13.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.508 2.323 . . . . 5.3799999999999999 109.639 -178.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.8 -77.01 1.94 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 124.492 1.044 . . . . 2.4199999999999999 112.939 167.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.77 -70.35 0.12 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.118 -0.793 . . . . 2.48 111.118 -163.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -90.76 -92.98 0.13 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.449 1.5 . . . . 2.96 112.473 -176.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -165.39 -81.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.144 0.978 . . . . 3.25 108.693 -164.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -29.09 -45.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.282 2.633 . . . . 3.2000000000000002 113.146 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.2 m -53.65 -50.49 65.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.305 1.842 . . . . 2.9900000000000002 112.744 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 52.2 p -71.7 -48.35 47.86 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.881 -1.137 . . . . 1.5 110.615 170.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -53.25 -48.15 68.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.091 2.156 . . . . 3.4399999999999999 111.022 -168.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.431 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.1 p -128.08 -50.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.154 0.982 . . . . 1.21 110.691 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.83 -18.53 0.66 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-O 119.268 -0.74 . . . . 0.91000000000000003 114.556 -176.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 45.47 54.12 7.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.294 1.438 . . . . 2.0 110.803 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -60.83 -34.93 75.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.075 1.35 . . . . 1.01 113.213 177.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.86 173.67 31.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.404 -1.878 . . . . 1.0600000000000001 108.404 -159.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 p -61.12 153.62 25.25 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.116 1.366 . . . . 2.2799999999999998 112.426 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -81.1 147.43 30.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.151 1.78 . . . . 2.4399999999999999 110.437 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.5 mt -127.33 -76.3 0.57 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.528 -0.916 . . . . 0.72999999999999998 108.528 -168.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.82 151.54 21.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.192 -0.669 . . . . 0.84999999999999998 109.192 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.1 p -136.71 167.36 21.57 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.521 1.528 . . . . 2.4700000000000002 107.879 174.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.95 133.88 1.64 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 114.46 -1.246 . . . . 0.64000000000000001 110.195 -177.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.38 138.87 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.817 -0.808 . . . . 0.82999999999999996 108.817 175.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 6' ' ' ALA . 21.5 tt -93.79 127.48 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 123.42 0.45 . . . . 0.79000000000000004 111.166 175.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.04 -2.1 0.82 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.106 1.336 . . . . 0.54000000000000004 115.692 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -89.36 60.59 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.25 1.525 . . . . 1.1499999999999999 109.589 -160.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -131.13 175.68 8.89 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.386 -0.821 . . . . 1.24 110.881 164.095 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 . . . . . 0 C--O 1.254 1.334 0 N-CA-C 103.187 -2.894 . . . . 4.3700000000000001 103.187 163.458 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 110.478 -0.193 . . . . 3.1099999999999999 110.478 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.95 14.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.375 0.67 . . . . 1.49 110.359 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 152' ' ' ALA . 37.8 t -122.2 152.08 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.104 1.761 . . . . 0.92000000000000004 106.399 159.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.25 99.15 4.03 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.986 -0.746 . . . . 0.71999999999999997 108.986 154.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.7 t -66.15 111.88 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.221 -1.4 . . . . 0.80000000000000004 107.221 166.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -92.07 133.05 36.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.469 -0.937 . . . . 0.95999999999999996 108.469 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -149.12 -50.27 0.15 Allowed 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.487 0.551 . . . . 3.7400000000000002 112.487 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.18 -113.64 1.15 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.092 -0.838 . . . . 0.82999999999999996 113.942 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -124.09 -55.59 1.67 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.207 1.003 . . . . 3.5800000000000001 110.909 -164.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.32 165.58 12.76 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.041 -0.823 . . . . 0.72999999999999998 111.041 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.77 27.14 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.807 3.005 . . . . 1.05 113.59 -173.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 91.6 t -91.89 143.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.895 1.678 . . . . 0.78000000000000003 107.649 177.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -154.79 116.83 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.179 -1.045 . . . . 2.8100000000000001 108.179 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.02 171.74 32.02 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.692 -0.563 . . . . 0.59999999999999998 111.692 -172.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -127.99 126.65 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.46 0.704 . . . . 1.3500000000000001 109.243 178.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.6 mm -94.5 151.47 3.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 125.53 1.532 . . . . 0.78000000000000003 107.005 165.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.92 154.23 48.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.592 -1.633 . . . . 1.5600000000000001 106.592 164.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.8 160.11 40.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.81 -0.756 . . . . 5.25 109.131 158.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -127.82 139.51 52.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.056 2.143 . . . . 4.7300000000000004 105.386 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -143.65 146.82 33.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.949 -1.871 . . . . 4.2999999999999998 105.949 154.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -73.9 -68.8 0.48 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.151 -0.685 . . . . 4.5300000000000002 109.151 170.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -78.19 165.25 24.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.769 0.828 . . . . 3.8999999999999999 111.618 -173.038 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -77.92 2.26 17.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.548 0.739 . . . . 2.6099999999999999 112.513 173.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -161.32 78.22 0.57 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.877 0.762 . . . . 4.2800000000000002 109.856 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.61 164.81 30.38 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.375 -2.29 . . . . 1.3899999999999999 107.375 165.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.02 118.41 5.27 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.983 2.455 . . . . 1.5800000000000001 110.524 -176.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.69 176.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.769 -0.826 . . . . 1.46 108.769 -165.871 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -131.24 81.06 1.97 Allowed 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.577 -0.897 . . . . 5.0300000000000002 108.577 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.58 100.95 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.988 -1.116 . . . . 1.75 107.988 -177.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -114.02 170.39 8.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.934 0.493 . . . . 1.24 110.081 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.21 165.72 34.74 Favored Glycine 0 N--CA 1.449 -0.463 0 O-C-N 120.974 -1.079 . . . . 0.67000000000000004 112.088 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -131.18 106.66 8.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.509 -2.034 . . . . 1.8400000000000001 105.509 -177.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.64 146.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.626 -1.25 . . . . 0.96999999999999997 107.626 -166.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 161.84 41.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.485 0.92 . . . . 3.6600000000000001 113.485 168.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.85 15.56 45.27 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.758 1.647 . . . . 0.65000000000000002 113.467 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.83 -173.47 0.63 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.524 1.162 . . . . 0.81000000000000005 108.85 169.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -85.29 -100.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.077 -1.083 . . . . 2.6000000000000001 108.077 164.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -149.2 162.04 40.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.389 1.475 . . . . 2.6600000000000001 108.049 -175.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.57 -161.54 50.91 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.209 0.433 . . . . 0.68999999999999995 112.443 167.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.17 132.78 53.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.735 0.814 . . . . 1.98 112.521 -175.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.18 114.94 9.52 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.132 1.773 . . . . 1.23 109.131 -177.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.23 152.27 6.91 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.918 1.247 . . . . 0.68000000000000005 113.753 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 103.84 4.3 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.209 1.803 . . . . 2.8599999999999999 108.138 -177.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 41.9 m80 -142.06 162.07 36.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.729 . . . . 1.26 109.033 -169.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.43 130.43 74.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 2.3700000000000001 108.73 -178.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -113.51 154.52 26.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.116 0.967 . . . . 0.81999999999999995 108.838 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.61 33.09 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.197 1.399 . . . . 4.4199999999999999 113.495 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 106.598 -1.63 . . . . 3.1200000000000001 106.598 178.744 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 108.636 -0.875 . . . . 1.8899999999999999 108.636 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.98 -99.18 2.16 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.79 -1.324 . . . . 0.94999999999999996 109.79 -173.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.92 178.39 5.34 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.692 2.928 . . . . 1.0700000000000001 112.524 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -61.73 136.68 58.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.432 -1.27 . . . . 1.48 108.365 172.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -23.06 105.41 0.02 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.975 1.71 . . . . 2.5099999999999998 113.814 -177.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -130.16 90.59 41.58 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.815 1.646 . . . . 2.5499999999999998 109.621 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.64 -36.93 13.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.836 1.69 . . . . 1.6599999999999999 111.115 -178.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -135.49 -75.06 0.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.977 0.911 . . . . 2.8399999999999999 109.557 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.6 m -156.97 81.06 0.93 Allowed 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.312 -0.868 . . . . 1.6299999999999999 109.468 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -85.35 170.93 12.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.322 0.582 . . . . 4.7800000000000002 110.598 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -125.82 161.63 26.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.944 1.698 . . . . 3.52 107.265 177.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -104.24 115.95 31.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.774 0.83 . . . . 1.01 110.914 173.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.87 12.9 6.48 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 124.76 1.171 . . . . 3.1400000000000001 110.621 164.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.92 -164.11 23.24 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.44 -1.035 . . . . 1.75 112.296 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.92 -23.69 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.34 2.027 . . . . 2.23 111.545 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -71.89 -53.84 11.94 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.739 0.816 . . . . 6.5 111.45 -176.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.5 171.16 7.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.73 -0.841 . . . . 4.0700000000000003 108.73 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.96 -51.11 68.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.974 -1.121 . . . . 6.2300000000000004 107.974 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -76.81 143.47 39.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.738 0.78 . . . . 3.3100000000000001 110.6 -163.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -176.3 150.89 0.95 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.388 -1.338 . . . . 3.1000000000000001 107.388 -166.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.1 m80 -63.67 147.46 51.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.848 -1.538 . . . . 0.65000000000000002 106.848 163.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.71 -15.22 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 120.625 -0.43 . . . . 1.3 110.672 -175.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.2 67.42 0.28 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.088 1.328 . . . . 0.68000000000000005 110.747 166.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -132.8 110.75 10.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.868 1.334 . . . . 2.4500000000000002 109.781 168.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -39.59 16.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.068 0.547 . . . . 1.78 109.94 169.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 138.59 -106.34 0.52 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.108 -0.797 . . . . 0.79000000000000004 111.108 172.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.09 159.8 40.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.467 1.507 . . . . 1.45 109.373 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.2 176.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 125.695 1.598 . . . . 0.77000000000000002 107.078 166.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -114.91 139.76 49.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.799 -1.185 . . . . 2.0299999999999998 107.799 163.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.25 141.25 31.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.242 1.417 . . . . 0.60999999999999999 110.801 169.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.25 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.194 0.998 . . . . 2.5299999999999998 111.08 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -159.38 -46.55 0.05 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.923 1.289 . . . . 3.75 110.496 -173.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.79 19.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.419 1.488 . . . . 3.3100000000000001 111.134 178.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.65 9.28 78.39 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.6 -1.111 . . . . 0.88 111.997 -177.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.0 t -77.52 141.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.59 -1.263 . . . . 1.01 107.59 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.36 168.2 21.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.531 1.132 . . . . 0.77000000000000002 108.407 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.54 144.24 50.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 103.452 -2.796 . . . . 2.9199999999999999 103.452 -174.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.89 136.06 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.055 -1.831 . . . . 1.54 106.055 169.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -159.98 67.39 0.37 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.141 1.376 . . . . 0.85999999999999999 107.613 -177.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 mm -112.64 146.66 17.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 108.485 -0.931 . . . . 2.0299999999999998 108.485 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.82 74.96 1.49 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.258 0.623 . . . . 3.4500000000000002 109.805 177.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -77.84 151.17 34.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.599 0.714 . . . . 2.48 110.356 -177.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -98.71 -26.28 14.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.018 2.127 . . . . 1.6299999999999999 110.844 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.2 -48.77 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 118.91 -0.567 . . . . 1.7 110.162 -173.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.24 162.97 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.291 0.95 . . . . 1.6899999999999999 109.97 171.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 m -143.13 179.85 6.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.604 1.561 . . . . 2.7400000000000002 108.316 -175.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -133.06 31.88 3.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.295 1.438 . . . . 4.4699999999999998 113.857 -173.648 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.536 0.429 0 O-C-N 121.128 -0.983 . . . . 3.2999999999999998 110.863 178.261 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 106.128 -1.805 . . . . 1.3200000000000001 106.128 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.3 pt -76.94 -13.83 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 118.419 -1.312 . . . . 2.27 113.598 -168.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.4 mm -43.21 115.72 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.283 0.947 . . . . 1.8500000000000001 111.183 176.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.7 25.35 74.22 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.076 -0.847 . . . . 1.3300000000000001 112.389 178.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.84 159.45 16.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 120.051 1.926 . . . . 4.8399999999999999 110.548 170.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 m -92.06 104.56 16.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 1.1499999999999999 109.592 -172.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.06 147.44 53.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.055 -1.091 . . . . 1.78 108.055 166.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -134.72 133.72 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 127.356 2.263 . . . . 0.40999999999999998 106.222 177.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.23 120.81 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.024 -1.472 . . . . 1.72 107.024 165.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.478 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 45.7 m-70 -95.56 176.1 6.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.58 1.552 . . . . 0.79000000000000004 112.343 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -77.58 -65.58 0.94 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.558 0.947 . . . . 6.0999999999999996 113.558 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -88.42 174.32 8.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.206 0.912 . . . . 5.9199999999999999 110.675 -175.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.84 143.29 17.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.363 -1.289 . . . . 0.96999999999999997 107.91 157.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.48 155.74 38.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.614 -0.884 . . . . 2.1099999999999999 108.614 158.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -78.76 -5.58 53.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.163 0.985 . . . . 3.3900000000000001 112.092 -172.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 54.46 30.59 13.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.418 1.087 . . . . 1.6699999999999999 110.542 -173.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.84 16.48 68.22 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.403 -0.665 . . . . 1.8300000000000001 112.796 177.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -98.83 -23.6 15.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.334 1.067 . . . . 5.2000000000000002 110.782 -176.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.1 131.22 45.28 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.019 -0.832 . . . . 2.2599999999999998 111.019 -176.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.03 -40.22 72.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 117.731 0.766 . . . . 2.52 111.514 179.145 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -50.72 109.29 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.87 1.268 . . . . 2.3799999999999999 109.46 164.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -61.87 -21.7 64.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.6 -0.688 . . . . 3.77 112.308 -170.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -41.13 -38.2 1.02 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.949 1.7 . . . . 4.3700000000000001 111.018 169.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.9 p -46.15 -67.12 0.31 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.264 1.026 . . . . 2.04 109.909 172.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.8 p -66.13 -46.84 76.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.045 0.938 . . . . 1.23 111.119 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -60.26 -38.95 85.07 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.182 0.993 . . . . 4.8200000000000003 111.633 -172.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.514 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.317 7.3 t -136.91 -55.25 0.72 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 1.8700000000000001 111.095 175.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.88 -25.21 0.21 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.059 0.845 . . . . 0.96999999999999997 112.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 47.79 55.53 8.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.208 1.403 . . . . 2.02 110.996 -170.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -78.1 -8.89 58.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.218 0.821 . . . . 1.1100000000000001 113.218 173.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.56 173.28 49.51 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.247 -1.541 . . . . 1.1599999999999999 109.247 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 m -56.36 155.13 7.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.797 1.639 . . . . 1.3600000000000001 113.344 -173.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.91 142.37 45.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.24 1.416 . . . . 3.04 110.34 177.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 mt -122.39 -74.83 0.6 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.897 -1.149 . . . . 0.54000000000000004 107.897 -174.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -106.6 144.32 33.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.063 -1.088 . . . . 0.78000000000000003 108.063 166.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 25.7 p -123.36 169.03 11.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.401 1.48 . . . . 2.1499999999999999 107.863 168.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.98 142.6 6.13 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 124.362 1.039 . . . . 0.75 111.234 166.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.76 133.57 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.996 0.918 . . . . 0.84999999999999998 108.692 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.466 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 8.0 tt -96.7 139.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.303 0.483 . . . . 1.0900000000000001 112.303 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 134.22 6.3 2.48 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.127 1.346 . . . . 1.0800000000000001 113.992 174.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -91.8 57.26 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.328 1.564 . . . . 1.0800000000000001 110.691 -159.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.15 176.02 13.22 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.567 0.747 . . . . 1.6799999999999999 110.552 169.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.409 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 17.6 tt0 . . . . . 0 C--O 1.251 1.168 0 N-CA-C 105.821 -1.918 . . . . 5.4900000000000002 105.821 167.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.561 -0.533 . . . . 3.0 109.561 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.42 158.89 15.24 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.804 -0.813 . . . . 0.92000000000000004 108.804 163.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 t -124.79 150.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.36 -1.291 . . . . 0.81999999999999995 108.058 165.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.84 97.98 5.18 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.39 1.076 . . . . 0.54000000000000004 108.624 158.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.58 114.84 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.511 -1.292 . . . . 0.65000000000000002 107.511 165.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.8 mt -96.66 137.0 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.685 0.794 . . . . 1.0700000000000001 109.91 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -150.0 -52.68 0.15 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.84 0.856 . . . . 3.2999999999999998 109.358 169.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.59 -124.99 28.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.979 -1.01 . . . . 0.96999999999999997 111.622 -175.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.05 -48.2 2.84 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.339 1.055 . . . . 3.6499999999999999 109.365 -162.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.83 166.06 23.9 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.99 -0.844 . . . . 0.80000000000000004 110.99 174.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.11 36.78 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.822 3.015 . . . . 0.97999999999999998 112.785 -173.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 57.2 t -94.51 159.38 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.693 1.597 . . . . 0.78000000000000003 108.98 -176.46 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 132.19 9.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.082 -1.451 . . . . 2.9300000000000002 107.082 176.242 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.47 179.36 44.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.623 -0.799 . . . . 0.77000000000000002 111.575 178.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.77 119.54 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.212 -1.403 . . . . 1.0 107.212 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -79.07 146.44 7.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.389 -1.337 . . . . 0.77000000000000002 107.389 163.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -120.24 137.1 54.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.094 -1.817 . . . . 2.2000000000000002 106.094 163.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -122.93 112.82 18.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.966 1.706 . . . . 2.2799999999999998 107.452 177.277 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.55 135.27 54.06 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.67 1.188 . . . . 4.0999999999999996 108.832 177.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.495 ' HB3' HD21 ' A' ' 106' ' ' LEU . 5.6 tp-100 -151.45 152.63 33.3 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.541 1.537 . . . . 3.7200000000000002 108.753 170.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -120.31 -46.56 2.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.472 2.709 . . . . 6.1699999999999999 107.556 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.77 96.41 6.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.496 -1.298 . . . . 5.0300000000000002 107.496 173.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -21.13 -66.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.446 2.298 . . . . 2.8300000000000001 114.748 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -114.51 54.55 0.77 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.849 0.859 . . . . 3.9900000000000002 110.153 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.54 -179.71 18.73 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.328 1.442 . . . . 0.93000000000000005 110.407 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.96 115.45 3.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.536 2.824 . . . . 1.04 111.086 -178.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.401 HG11 ' CD2' ' A' ' 20' ' ' PHE . 48.0 t -78.73 153.24 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.02 0.528 . . . . 0.96999999999999997 109.626 -170.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -108.34 126.03 52.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.618 -0.882 . . . . 2.6099999999999999 108.618 174.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 ' CE1' ' A' ' 20' ' ' PHE . 48.0 t -125.63 140.84 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 125.489 1.516 . . . . 1.1200000000000001 107.593 -169.549 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -155.17 164.54 38.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.689 -0.486 . . . . 0.98999999999999999 109.689 167.196 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.19 137.14 3.21 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.363 -0.446 . . . . 1.2 112.027 175.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 p -102.22 77.3 1.65 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.78 1.232 . . . . 1.8600000000000001 109.577 -172.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.13 142.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.028 -0.73 . . . . 1.54 109.028 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -137.6 157.16 47.1 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.243 0.617 . . . . 3.7999999999999998 110.256 -176.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.95 12.42 66.11 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.68000000000000005 112.709 -176.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.85 157.33 30.77 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.177 0.991 . . . . 0.96999999999999997 109.308 170.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -74.6 156.45 36.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.114 -1.069 . . . . 1.8700000000000001 108.114 154.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.89 171.79 0.32 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.124 0.97 . . . . 2.3100000000000001 111.839 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.45 -165.13 54.76 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.614 -0.721 . . . . 0.51000000000000001 113.031 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.95 147.92 44.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.7 0.8 . . . . 1.96 111.288 -173.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -145.31 123.54 12.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.504 1.522 . . . . 0.54000000000000004 109.429 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.37 149.18 18.95 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.812 -0.915 . . . . 0.44 110.812 170.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -138.66 95.64 3.01 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.089 -1.448 . . . . 2.9700000000000002 107.089 -174.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -133.87 160.34 37.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.754 -1.202 . . . . 0.88 107.754 -160.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.698 HG11 ' CZ ' ' A' ' 115' ' ' ARG . 33.8 m -119.42 128.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 122.307 1.051 . . . . 2.4500000000000002 109.933 175.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -104.61 142.64 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.656 -1.609 . . . . 0.88 106.656 -177.394 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 74.31 0.59 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.325 -1.731 . . . . 4.8799999999999999 106.325 170.368 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.444 -0.737 0 CA-C-N 115.871 -0.604 . . . . 3.6099999999999999 109.559 -165.823 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 104.87 -2.27 . . . . 2.4199999999999999 104.87 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.45 -115.37 1.11 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.72 -1.6 . . . . 1.0700000000000001 110.666 178.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 -179.22 5.03 Favored 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.808 4.339 . . . . 1.0900000000000001 113.933 -173.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -53.39 134.3 40.11 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.038 -0.983 . . . . 1.6899999999999999 111.111 176.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -50.54 117.9 2.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 123.74 0.65 . . . . 1.8700000000000001 109.567 172.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.8 156.54 30.74 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 106.757 -1.571 . . . . 2.79 106.757 169.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.14 -38.65 2.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.176 1.917 . . . . 1.4199999999999999 111.55 -165.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 mt -144.52 -74.54 0.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.858 0.863 . . . . 2.4100000000000001 109.347 176.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.3 m -142.51 64.85 1.36 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.47 0.708 . . . . 1.8100000000000001 111.062 -165.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.3 170.68 16.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.377 0.608 . . . . 4.9900000000000002 109.555 163.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.421 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 51.9 mttt -111.9 162.34 15.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.67 -1.974 . . . . 3.71 105.67 172.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -77.33 168.67 19.64 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.979 0.419 . . . . 1.1699999999999999 110.325 169.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.93 161.08 34.75 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 105.802 -2.919 . . . . 2.0299999999999998 105.802 156.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.86 -172.54 7.83 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 117.17 0.485 . . . . 1.8899999999999999 112.509 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 -18.77 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.133 2.555 . . . . 1.8700000000000001 111.376 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.2 -26.76 18.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.312 1.045 . . . . 5.9699999999999998 111.584 173.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.53 159.89 23.54 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.061 0.458 . . . . 2.0099999999999998 109.914 175.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -74.13 -51.43 15.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.387 1.475 . . . . 4.8700000000000001 108.03 170.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.421 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 34.9 mt-10 -80.25 168.3 19.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.87 0.843 . . . . 3.54 110.98 -175.007 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.28 150.2 0.07 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.936 2.095 . . . . 4.4900000000000002 106.53 -167.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 71.4 m80 -65.58 155.8 34.66 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.278 -2.119 . . . . 0.84999999999999998 105.278 162.335 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.61 48.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 123.355 1.55 . . . . 2.1099999999999999 109.618 170.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.73 34.97 0.06 OUTLIER Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.953 2.216 . . . . 0.85999999999999999 111.512 -175.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.42 136.41 37.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.333 -1.358 . . . . 2.6299999999999999 107.333 157.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.36 -54.72 4.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.649 -1.612 . . . . 1.52 106.649 168.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.97 -114.92 0.63 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.514 -1.434 . . . . 0.64000000000000001 109.514 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -140.75 162.03 36.37 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.942 1.697 . . . . 1.8500000000000001 109.329 -177.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.11 175.65 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.354 1.462 . . . . 0.83999999999999997 107.162 175.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.8 m -129.6 134.29 47.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.365 -0.976 . . . . 2.02 108.365 -178.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.61 137.28 34.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.35 1.06 . . . . 0.53000000000000003 109.731 169.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -87.83 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.857 2.463 . . . . 3.9100000000000001 110.736 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -173.34 -46.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.794 1.238 . . . . 6.1799999999999997 108.745 -156.997 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.403 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 2.3 m-20 -79.16 11.35 2.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.887 1.275 . . . . 4.46 110.407 172.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.25 64.39 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 110.789 -0.925 . . . . 1.05 110.789 -178.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.37 128.31 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 0.72999999999999998 108.464 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.2 114.93 22.66 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.595 -1.631 . . . . 1.3400000000000001 106.595 168.334 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -113.44 93.99 4.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.859 -1.534 . . . . 5.3399999999999999 106.859 -169.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.77 149.34 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.147 -0.933 . . . . 1.9099999999999999 110.359 -162.19 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.8 m -151.12 126.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.383 1.473 . . . . 1.28 107.413 168.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mt -143.22 155.13 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.306 1.043 . . . . 2.27 108.306 -174.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.3 101.06 3.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.573 0.225 . . . . 2.3500000000000001 110.811 157.198 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -89.25 159.71 17.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.941 0.896 . . . . 2.25 108.823 173.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 p -107.65 -15.76 14.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.303 1.841 . . . . 1.51 112.283 -175.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.81 -41.09 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.513 0.597 . . . . 1.05 109.894 -171.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.3 pp -98.19 170.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.312 0.645 . . . . 1.0 111.72 -173.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.6 m -151.34 174.61 13.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.706 1.202 . . . . 1.6000000000000001 110.265 -176.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 22' ' ' GLN . 1.9 pt? -126.49 29.9 5.66 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.957 0.903 . . . . 2.1600000000000001 112.243 170.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.634 -0.876 . . . . 3.0299999999999998 108.634 165.805 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.426 -1.641 0 CA-C-O 122.835 1.302 . . . . 1.97 112.88 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.23 -4.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.231 -1.804 . . . . 2.25 111.466 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -38.32 129.87 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.453 1.101 . . . . 2.4199999999999999 110.211 170.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.7 23.72 74.32 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 118.095 0.407 . . . . 1.52 114.042 -174.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.698 ' CZ ' HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.69 176.99 8.99 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.249 1.525 . . . . 8.5999999999999996 108.517 159.744 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -109.31 120.88 43.84 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.072 -0.714 . . . . 0.90000000000000002 109.072 153.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.61 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.6 tm? -73.02 142.39 47.69 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 106.029 -1.841 . . . . 3.2799999999999998 106.029 168.181 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.6 134.17 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.354 1.862 . . . . 0.56000000000000005 106.94 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.62 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 1.5 p -109.19 133.82 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.309 -1.367 . . . . 2.0899999999999999 107.309 164.314 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -109.14 161.62 15.03 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 115.992 1.849 . . . . 0.42999999999999999 115.992 -161.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -34.47 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.896 2.878 . . . . 3.29 112.813 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -80.57 174.99 11.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.611 1.164 . . . . 5.2400000000000002 110.482 -170.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.97 142.88 49.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.631 -1.622 . . . . 0.82999999999999996 108.234 150.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.04 152.15 20.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.317 0.647 . . . . 2.8199999999999998 109.296 170.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.83 -4.86 53.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.488 0.586 . . . . 3.6600000000000001 112.506 -179.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 59.82 28.93 18.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.168 1.387 . . . . 1.8400000000000001 109.607 -177.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.46 25.78 68.96 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.695 0.664 . . . . 2.0499999999999998 111.598 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -145.5 45.14 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.718 0.759 . . . . 5.25 109.365 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.93 159.97 27.03 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.152 -1.179 . . . . 2.6299999999999999 110.152 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.35 61.43 3.13 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.353 -1.499 . . . . 3.54 109.353 171.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -177.36 164.77 2.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.487 1.515 . . . . 2.9700000000000002 107.678 -167.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -83.15 -38.39 22.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.775 0.83 . . . . 3.9399999999999999 109.389 173.201 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -42.18 -39.05 1.9 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.413 1.485 . . . . 2.77 112.774 -176.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.8 p -57.22 -61.85 2.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.707 1.203 . . . . 1.8400000000000001 111.25 178.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.4 p -67.68 -42.59 81.86 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.478 -0.764 . . . . 1.3500000000000001 110.187 178.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -57.35 -44.08 84.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.972 1.709 . . . . 3.0299999999999998 111.841 -177.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.516 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.424 8.9 t -138.23 -56.85 0.65 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 2.1400000000000001 111.839 177.918 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.19 -22.44 0.2 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 119.415 1.007 . . . . 0.87 112.231 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 45.79 55.6 6.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.064 1.746 . . . . 2.0600000000000001 111.258 -177.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.61 58.2 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 118.953 -1.099 . . . . 1.01 111.934 167.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.36 -161.01 33.71 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 109.063 -1.615 . . . . 0.96999999999999997 109.063 179.283 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.5 p -59.89 151.49 25.71 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.942 1.297 . . . . 1.98 112.752 -169.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.4 mmt-85 -68.01 130.67 43.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.864 2.066 . . . . 3.3900000000000001 108.177 176.006 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.94 -83.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.552 1.069 . . . . 0.68000000000000005 108.663 174.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.669 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -97.98 146.29 25.64 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.296 -1.372 . . . . 0.98999999999999999 107.296 176.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.8 m -147.43 160.56 42.43 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 124.663 1.227 . . . . 2.2200000000000002 107.991 178.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.03 142.18 7.06 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.752 -0.939 . . . . 0.81999999999999995 110.752 172.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.31 139.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.152 1.381 . . . . 0.69999999999999996 108.999 172.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.2 tt -105.65 132.49 52.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.193 0.812 . . . . 1.1399999999999999 113.193 -178.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.76 13.1 0.15 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.482 1.515 . . . . 0.68000000000000005 113.99 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.2 mm -107.72 58.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.836 1.818 . . . . 0.82999999999999996 110.081 -152.237 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 175.35 14.1 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.745 -0.661 . . . . 1.26 110.255 171.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.259 1.586 0 C-N-CA 125.09 1.356 . . . . 5.21 108.691 177.052 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.898 -0.408 . . . . 3.0800000000000001 109.898 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.32 137.63 51.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.778 -0.823 . . . . 0.79000000000000004 108.778 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -96.94 144.25 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.32 -0.993 . . . . 0.73999999999999999 108.32 167.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.08 111.57 15.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.929 -1.508 . . . . 0.67000000000000004 106.929 148.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.34 108.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.972 -1.492 . . . . 0.78000000000000003 106.972 156.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.9 125.18 31.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.765 -1.198 . . . . 1.9299999999999999 107.765 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -153.97 -45.31 0.09 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.063 0.545 . . . . 3.6000000000000001 111.561 170.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.35 -109.25 0.39 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.237 0.922 . . . . 1.1599999999999999 113.04 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.1 -55.24 2.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.817 1.247 . . . . 3.3300000000000001 110.245 -172.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 164.48 11.4 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.459 1.028 . . . . 0.93999999999999995 112.339 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.83 -19.54 58.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.567 2.845 . . . . 1.4299999999999999 112.476 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.57 143.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.945 1.298 . . . . 0.89000000000000001 110.634 175.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -155.39 128.4 8.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.467 -0.568 . . . . 1.97 109.467 -176.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.11 177.28 39.91 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.17 -0.331 . . . . 0.53000000000000003 112.354 -177.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.09 133.91 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.882 -1.155 . . . . 1.1699999999999999 107.882 172.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.426 HD13 ' HA3' ' A' ' 33' ' ' GLY . 21.1 mm -102.79 136.33 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.92 1.688 . . . . 1.1599999999999999 106.866 164.076 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.26 112.17 22.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.35 1.46 . . . . 1.74 108.22 163.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -77.57 140.72 39.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.469 1.508 . . . . 2.8199999999999998 108.698 164.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -149.13 168.29 23.62 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.464 -1.68 . . . . 4.5700000000000003 106.464 148.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -151.29 159.32 44.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.739 -1.948 . . . . 3.8799999999999999 105.739 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -64.08 -73.78 0.11 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.998 -1.112 . . . . 6.2599999999999998 107.998 166.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -79.85 -165.66 0.86 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.046 2.538 . . . . 4.8799999999999999 111.138 -169.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -106.61 3.82 27.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.112 1.765 . . . . 2.4500000000000002 110.59 162.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -160.73 78.46 0.62 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.267 2.227 . . . . 3.8999999999999999 108.681 -170.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.68 -170.4 41.16 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 110.258 -1.137 . . . . 1.6599999999999999 110.258 -170.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.79 120.74 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.157 2.571 . . . . 1.0700000000000001 114.108 -167.301 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.8 t -79.14 147.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.499 -0.773 . . . . 1.3200000000000001 109.335 175.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 100' ' ' GLU . 65.9 mttm -116.51 110.54 18.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.836 -1.172 . . . . 2.9500000000000002 107.836 159.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 m -95.27 132.22 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.234 -1.395 . . . . 2.25 107.234 169.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -126.83 145.09 50.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.116 -1.438 . . . . 0.92000000000000004 107.116 168.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.09 156.87 29.02 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.36 -0.924 . . . . 0.65000000000000002 112.165 -173.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 m -131.71 83.49 2.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.706 1.602 . . . . 1.75 107.389 -162.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.19 139.09 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.2 1.0 . . . . 0.88 109.13 -168.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 166.67 22.8 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.4 0.619 . . . . 3.8599999999999999 112.26 176.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.13 15.52 69.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.761 1.172 . . . . 0.64000000000000001 113.492 174.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.41 165.03 21.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.603 1.201 . . . . 0.67000000000000004 108.837 172.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -72.58 166.39 22.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.596 -1.261 . . . . 1.72 107.596 150.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.9 175.45 0.5 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.167 0.987 . . . . 3.3300000000000001 110.696 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.65 -156.04 51.61 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.865 -0.607 . . . . 0.5 111.643 169.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.56 145.18 33.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.793 1.637 . . . . 1.9399999999999999 112.48 -171.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -147.73 113.18 5.62 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.032 1.333 . . . . 0.56999999999999995 110.434 -179.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.0 146.26 2.91 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.493 1.044 . . . . 0.57999999999999996 111.316 173.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.76 96.74 3.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.909 -1.886 . . . . 2.2000000000000002 105.909 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.1 m80 -133.43 171.94 13.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.322 -1.362 . . . . 0.85999999999999999 107.322 -164.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 0.3 OUTLIER -130.54 133.44 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 122.147 0.975 . . . . 1.8200000000000001 109.938 173.163 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.406 ' CD2' HG21 ' A' ' 118' ' ' VAL . 44.0 m-70 -109.79 145.64 36.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.051 2.141 . . . . 0.98999999999999999 106.876 -175.528 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -72.31 31.52 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.981 1.474 . . . . 4.5700000000000003 114.981 -168.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 108.075 -1.083 . . . . 3.0800000000000001 108.075 -170.487 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 N-CA-C 107.53 -1.285 . . . . 1.77 107.53 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.04 -92.43 2.03 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.636 -1.386 . . . . 0.98999999999999999 109.636 -178.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.08 -178.84 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 126.337 4.692 . . . . 1.02 113.21 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -52.52 128.47 26.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.031 1.332 . . . . 1.4199999999999999 109.627 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -45.46 120.24 2.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.753 1.221 . . . . 1.9099999999999999 111.273 175.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -118.46 163.12 26.95 Favored Pre-proline 0 C--O 1.227 -0.1 0 C-N-CA 127.314 2.246 . . . . 3.6499999999999999 109.747 164.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.45 -53.01 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.194 1.263 . . . . 1.6699999999999999 108.85 154.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.66 -77.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.281 1.032 . . . . 3.2200000000000002 109.998 169.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -135.5 71.03 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.306 1.042 . . . . 2.3100000000000001 110.459 -165.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -79.38 172.21 14.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.715 -1.216 . . . . 4.9800000000000004 107.715 156.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -129.11 162.89 26.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 127.019 2.128 . . . . 3.0 105.946 177.882 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -76.6 162.91 27.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.693 0.797 . . . . 1.1599999999999999 110.933 -169.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.14 -123.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 105.518 -3.033 . . . . 1.99 105.518 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.24 -140.48 3.06 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 107.957 -2.057 . . . . 1.8100000000000001 107.957 169.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.31 -47.78 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 120.091 1.946 . . . . 1.71 109.011 168.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -59.18 -42.15 90.17 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 126.133 1.773 . . . . 5.4299999999999997 112.987 -171.058 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.8 176.93 2.28 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.756 -1.566 . . . . 1.98 111.467 -168.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.07 -52.46 6.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.004 1.322 . . . . 5.1100000000000003 108.21 164.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 9.1 mt-10 -80.33 175.91 10.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.693 0.797 . . . . 2.75 111.424 -177.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 161.04 143.15 0.01 OUTLIER 'General case' 0 C--O 1.239 0.535 0 C-N-CA 129.958 3.303 . . . . 3.2200000000000002 106.498 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.2 m80 -60.06 153.26 22.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.335 -1.357 . . . . 0.69999999999999996 107.335 166.154 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.0 -37.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 117.796 -1.562 . . . . 1.3200000000000001 109.991 -169.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.82 73.11 0.87 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.229 -0.748 . . . . 0.90000000000000002 111.229 167.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -168.14 103.37 0.46 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.786 -0.82 . . . . 2.0899999999999999 108.786 -175.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.86 -51.39 8.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.195 0.598 . . . . 1.6699999999999999 109.541 176.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.83 -119.86 0.94 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.404 -1.478 . . . . 0.60999999999999999 109.404 -177.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -137.91 166.5 23.89 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 124.407 1.083 . . . . 1.5700000000000001 110.291 174.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.12 177.14 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.462 -1.681 . . . . 0.45000000000000001 106.462 166.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -122.51 155.26 36.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.695 -0.854 . . . . 2.0899999999999999 108.695 164.183 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.86 141.76 48.35 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.45 1.1 . . . . 0.80000000000000004 110.352 164.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.83 -75.28 0.12 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.1 0.96 . . . . 2.9399999999999999 111.389 -171.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -153.94 -44.26 0.09 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.321 1.048 . . . . 3.7200000000000002 110.973 -169.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.84 7.77 6.56 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.297 1.046 . . . . 2.6000000000000001 111.39 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.71 8.12 84.05 Favored Glycine 0 CA--C 1.524 0.636 0 O-C-N 121.266 -0.896 . . . . 0.68000000000000005 111.75 -175.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.54 128.61 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.218 1.407 . . . . 0.76000000000000001 107.713 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.89 175.24 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.213 1.405 . . . . 0.97999999999999998 109.169 173.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -121.88 145.28 48.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.964 -2.606 . . . . 3.3599999999999999 103.964 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.21 58.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.331 -0.548 . . . . 1.48 111.391 167.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.4 m -90.08 88.03 7.12 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.607 1.163 . . . . 0.84999999999999998 109.098 172.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.1 mm -125.67 156.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.942 -0.762 . . . . 2.1200000000000001 108.942 -177.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 30' ' ' LYS . 8.0 pt-20 -140.12 142.15 36.06 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.658 0.383 . . . . 2.6499999999999999 110.616 164.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.23 148.52 44.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.475 1.51 . . . . 2.2799999999999998 109.259 176.018 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.5 p -102.74 -4.26 25.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.789 2.036 . . . . 1.4299999999999999 113.249 -173.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.97 -45.77 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.658 1.183 . . . . 1.0800000000000001 108.807 -178.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -76.49 176.14 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.473 0.654 . . . . 1.3600000000000001 110.969 176.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -165.7 176.58 7.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.592 1.957 . . . . 1.9399999999999999 107.208 177.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -6.3 57.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.963 . . . . 3.3900000000000001 112.928 175.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 127.157 2.183 . . . . 3.5899999999999999 108.498 -172.782 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.445 -0.716 0 CA-C-O 121.005 0.431 . . . . 1.6899999999999999 112.055 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.277 1.8 pp -111.8 -6.2 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.144 -0.934 . . . . 1.6699999999999999 111.833 -177.362 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.86 133.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 162.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.06 47.44 81.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.58 -1.008 . . . . 2.25 110.58 -173.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -142.42 168.92 18.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.906 -1.887 . . . . 4.6799999999999997 105.906 165.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 m -101.02 115.42 30.44 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.579 -0.526 . . . . 1.04 109.579 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.8 148.73 51.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.845 -0.798 . . . . 1.97 108.845 165.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 48' ' ' HIS . 92.1 t -134.01 137.9 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.94 2.096 . . . . 0.59999999999999998 106.588 175.013 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 m -113.0 129.52 68.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.74 -1.207 . . . . 1.79 107.74 169.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.476 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 45.3 m-70 -107.29 159.94 15.99 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 117.361 2.356 . . . . 0.65000000000000002 117.361 -163.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -32.02 -76.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.55 3.14 . . . . 3.5699999999999998 112.908 168.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.69 -174.36 2.44 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.913 0.885 . . . . 2.75 110.491 -171.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.58 148.79 18.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.987 -0.745 . . . . 0.55000000000000004 108.987 157.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.04 168.65 18.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.738 -0.838 . . . . 2.1899999999999999 108.738 154.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.46 -38.81 48.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.066 0.765 . . . . 4.2800000000000002 113.066 -168.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 82.2 46.05 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.835 2.854 . . . . 1.55 110.691 -169.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.94 43.53 98.76 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.472 1.034 . . . . 1.8600000000000001 112.051 165.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -155.11 -16.37 0.11 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.806 1.409 . . . . 5.1900000000000004 114.806 -170.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.3 146.18 47.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 120.496 1.498 . . . . 1.99 110.928 -178.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.54 -24.3 69.34 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.791 0.71 . . . . 2.6499999999999999 114.202 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 159.85 14.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.227 -1.027 . . . . 2.52 108.227 174.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -46.82 76.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 3.8900000000000001 107.646 167.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -40.39 -48.49 2.73 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.374 2.67 . . . . 4.0499999999999998 111.64 -175.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -63.38 0.83 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.535 1.534 . . . . 1.9199999999999999 110.702 176.093 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -71.62 -41.99 68.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.052 -1.03 . . . . 1.1899999999999999 111.597 177.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.57 -37.26 84.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.334 1.454 . . . . 3.6299999999999999 110.924 -166.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.431 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.257 0.7 OUTLIER -133.3 -51.97 0.88 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.232 1.013 . . . . 1.29 111.545 173.218 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.05 -22.49 0.52 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.715 0.689 . . . . 0.93000000000000005 114.287 -177.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 44.71 54.42 6.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.302 1.441 . . . . 2.2999999999999998 111.561 -163.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.598 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -59.12 -39.38 82.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.568 1.147 . . . . 1.1699999999999999 111.217 166.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.89 -171.33 44.7 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 108.682 -1.767 . . . . 0.98999999999999999 108.682 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.7 m -59.17 153.07 19.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 126.028 1.731 . . . . 1.1899999999999999 114.091 -166.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -59.55 137.22 58.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.21 1.804 . . . . 2.54 108.83 168.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.9 mt -114.84 -85.26 0.61 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.775 -1.195 . . . . 0.53000000000000003 107.775 169.536 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.16 154.77 18.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.522 -0.918 . . . . 0.89000000000000001 108.522 172.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.2 m -146.22 165.11 30.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.603 -1.18 . . . . 1.96 108.408 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.39 134.46 3.09 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.498 -1.041 . . . . 0.65000000000000002 110.498 173.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.97 130.85 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.575 -1.269 . . . . 0.70999999999999996 107.575 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.2 tt -102.22 129.87 52.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.244 0.545 . . . . 0.97999999999999998 111.897 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.59 3.99 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.603 1.097 . . . . 0.56000000000000005 115.429 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -98.28 56.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 119.989 1.894 . . . . 0.90000000000000002 109.917 -156.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.24 173.57 16.76 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.27 0.628 . . . . 1.5900000000000001 110.305 169.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 C--O 1.255 1.378 0 N-CA-C 102.5 -3.148 . . . . 4.8200000000000003 102.5 159.919 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.297 -0.631 . . . . 3.9300000000000002 109.297 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.85 18.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.875 -0.787 . . . . 1.01 108.875 168.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.575 HG23 ' HB2' ' A' ' 152' ' ' ALA . 60.4 t -106.71 152.61 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 105.585 -2.005 . . . . 0.93000000000000005 105.585 158.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.61 93.52 3.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.516 -0.92 . . . . 0.66000000000000003 108.516 158.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.66 107.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.926 -1.509 . . . . 0.73999999999999999 106.926 169.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.563 ' CD1' HD12 ' A' ' 117' ' ' LEU . 25.0 mt -92.46 128.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.368 0.667 . . . . 1.0 109.712 178.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 -48.21 0.15 Allowed 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.155 1.382 . . . . 4.6699999999999999 109.863 172.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.55 -120.47 2.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.084 1.326 . . . . 1.1399999999999999 112.808 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -97.07 -59.0 1.88 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.647 -1.242 . . . . 3.9500000000000002 107.647 -169.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.98 176.65 2.41 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.66 2.076 . . . . 1.27 115.15 -173.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.81 -25.95 16.35 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.742 2.961 . . . . 1.6100000000000001 111.817 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.81 141.99 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.719 1.208 . . . . 1.25 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -153.71 121.99 6.17 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.319 -0.993 . . . . 1.96 108.319 -171.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.58 172.06 37.69 Favored Glycine 0 C--N 1.333 0.372 0 O-C-N 121.832 -0.542 . . . . 0.56999999999999995 112.514 -174.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.38 125.1 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.946 -0.761 . . . . 1.29 108.946 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 17.9 mm -88.71 139.65 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 107.029 -1.471 . . . . 0.75 107.029 160.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -129.61 108.07 9.93 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.903 -1.517 . . . . 2.8399999999999999 106.903 171.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.521 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 35.9 t80 -130.67 120.8 24.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.879 -1.156 . . . . 3.4500000000000002 107.879 -155.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.15 159.93 41.18 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.785 0.721 . . . . 3.5600000000000001 111.35 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -145.61 141.76 28.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.018 -2.586 . . . . 3.8900000000000001 104.018 -175.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -107.35 -29.84 9.04 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.25 1.02 . . . . 6.0599999999999996 109.444 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -77.99 164.76 24.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 128.72 2.808 . . . . 4.8200000000000003 109.433 -178.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -77.97 -67.79 0.69 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.158 0.983 . . . . 4.54 109.176 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -111.88 85.47 2.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.346 -1.724 . . . . 3.7400000000000002 106.346 170.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.17 174.47 32.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.388 -1.485 . . . . 1.3600000000000001 109.388 178.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 140.97 47.83 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.191 2.594 . . . . 1.3500000000000001 111.647 -167.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 4.3 t -91.2 140.46 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.22 -0.659 . . . . 1.1699999999999999 109.22 -179.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -95.12 105.59 17.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.54 -1.652 . . . . 5.0099999999999998 106.54 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.5 85.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.378 1.471 . . . . 1.25 108.689 -169.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -99.24 145.16 27.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.206 -0.665 . . . . 0.90000000000000002 109.206 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.73 149.82 18.15 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.172 -1.171 . . . . 0.79000000000000004 110.172 -177.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 p -130.15 105.23 7.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.677 -1.972 . . . . 1.8999999999999999 105.677 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.68 143.75 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 106.888 -1.523 . . . . 0.90000000000000002 106.888 -169.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -143.7 -178.73 6.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.944 1.461 . . . . 4.79 114.944 167.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.91 76.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 113.94 -1.482 . . . . 0.69999999999999996 112.322 -179.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -72.61 163.14 28.54 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.264 1.032 . . . . 0.69999999999999996 108.31 172.248 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.86 163.66 25.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.701 -1.222 . . . . 1.8400000000000001 107.701 153.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.91 171.09 0.54 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.702 0.763 . . . . 2.5699999999999998 111.227 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.92 -158.61 53.43 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.747 -0.661 . . . . 0.48999999999999999 113.038 166.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.23 143.86 46.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.232 0.613 . . . . 2.0699999999999998 111.396 -171.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -139.42 127.0 21.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.392 1.477 . . . . 0.58999999999999997 108.697 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.51 152.04 7.51 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.344 -1.102 . . . . 0.48999999999999999 110.344 171.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -144.0 90.88 2.16 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.067 -1.457 . . . . 2.8500000000000001 107.067 -173.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -137.28 143.77 42.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.674 -1.232 . . . . 0.92000000000000004 107.674 -162.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.2 m -98.93 129.15 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.49 1.041 . . . . 2.1000000000000001 110.39 178.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -109.8 155.22 21.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.375 1.07 . . . . 1.02 108.712 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 11.77 0.39 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.795 1.638 . . . . 5.2699999999999996 113.655 -167.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HG2' ' HB3' ' A' ' 60' ' ' ALA . 1.2 mt-10 . . . . . 0 CA--C 1.534 0.352 0 CA-C-N 119.417 1.008 . . . . 3.3399999999999999 109.855 -173.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . . . . . . . . 0 C--O 1.235 0.317 0 N-CA-C 107.476 -1.305 . . . . 1.7 107.476 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.2 -127.75 3.88 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 119.244 0.929 . . . . 1.55 112.048 -171.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.35 -179.7 5.43 Favored 'Trans proline' 0 N--CA 1.457 -0.667 1 C-N-CA 125.378 4.052 . . . . 1.3100000000000001 111.597 -176.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -44.8 125.92 5.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 118.856 -0.592 . . . . 1.27 109.946 171.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -46.62 119.58 2.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.71 0.631 . . . . 2.6899999999999999 109.939 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -156.37 157.04 30.91 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 126.544 1.938 . . . . 2.6499999999999999 106.888 174.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.26 -27.42 13.57 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.148 1.898 . . . . 1.49 113.502 -170.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.21 -63.93 0.11 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.133 0.879 . . . . 3.8399999999999999 111.569 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.5 m -158.87 81.45 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.468 1.107 . . . . 2.4300000000000002 109.287 171.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -74.73 167.65 21.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.26 -1.755 . . . . 4.9699999999999998 106.26 157.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -119.3 166.08 13.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.952 -1.499 . . . . 4.6299999999999999 106.952 -176.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -93.95 149.98 20.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 111.81 0.3 . . . . 1.0900000000000001 111.81 -175.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.37 176.74 39.51 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.31 -3.116 . . . . 1.8300000000000001 105.31 158.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.42 -172.32 47.78 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 117.856 0.828 . . . . 1.8999999999999999 111.268 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.89 -24.36 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.101 2.534 . . . . 1.78 110.624 172.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -65.84 -44.12 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.522 0.729 . . . . 5.5800000000000001 109.822 171.152 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.65 163.21 27.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.418 -0.81 . . . . 2.0299999999999998 109.716 175.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.06 -37.92 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.749 0.82 . . . . 5.5 108.925 163.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.18 152.15 41.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.543 -0.91 . . . . 3.02 108.543 -173.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 166.04 143.8 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.782 2.033 . . . . 3.29 111.129 -167.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.462 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -65.24 154.5 37.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.489 -0.93 . . . . 0.98999999999999999 108.489 166.762 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.43 -40.57 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.948 -0.76 . . . . 1.8500000000000001 108.948 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.42 62.14 1.75 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.627 0.632 . . . . 0.69999999999999996 111.849 173.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -165.67 97.93 0.67 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.398 -0.964 . . . . 2.1600000000000001 108.398 -172.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.38 -43.48 15.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.998 -0.547 . . . . 2.3199999999999998 109.634 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.2 -100.87 0.19 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.474 -0.87 . . . . 0.67000000000000004 112.864 177.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -155.53 166.33 33.87 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.747 1.619 . . . . 1.54 109.954 -169.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.49 155.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.713 1.205 . . . . 0.54000000000000004 108.34 173.44 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.9 p -107.26 109.16 20.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.772 1.629 . . . . 3.1499999999999999 108.83 -176.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.71 138.8 37.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.717 0.689 . . . . 0.54000000000000004 111.127 171.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.14 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.207 0.942 . . . . 2.6200000000000001 109.536 177.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.5 tttt -157.48 -30.23 0.08 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.827 1.417 . . . . 3.8900000000000001 114.827 -170.753 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -80.25 21.92 0.57 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.757 1.741 . . . . 2.8700000000000001 110.665 164.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 64.12 12.96 51.9 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 125.458 1.504 . . . . 0.83999999999999997 111.739 -175.089 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -78.65 133.05 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.796 -1.187 . . . . 0.72999999999999998 107.796 -176.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.54 155.23 46.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.447 1.499 . . . . 0.81999999999999995 107.157 168.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -120.44 143.23 48.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.718 -2.327 . . . . 2.7999999999999998 104.718 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.39 131.69 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.339 -1.356 . . . . 1.3200000000000001 107.339 165.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.5 m -148.32 73.47 1.25 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.046 1.338 . . . . 1.47 107.962 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -111.72 152.51 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.974 0.909 . . . . 2.3199999999999998 108.723 -175.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -132.39 88.23 2.51 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.635 -0.876 . . . . 4.1799999999999997 108.635 164.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.62 152.87 29.78 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.6 0.36 . . . . 2.5699999999999998 110.303 176.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -124.2 34.53 5.02 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.022 1.329 . . . . 1.6299999999999999 111.325 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.36 -52.0 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.434 1.093 . . . . 1.45 108.395 175.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -74.54 174.59 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.255 0.55 . . . . 1.1399999999999999 110.772 176.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -149.44 171.71 16.13 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.411 -1.329 . . . . 2.5800000000000001 107.411 170.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -101.8 5.44 41.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.525 0.73 . . . . 2.52 111.944 169.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 CA--C 1.537 0.476 0 C-N-CA 126.124 1.77 . . . . 2.96 111.022 -177.876 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.44 -0.962 0 CA-C-O 121.735 0.778 . . . . 1.5900000000000001 111.931 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -6.4 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.212 1.005 . . . . 2.2200000000000002 111.024 -178.575 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.0 tp -19.99 117.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.718 2.007 . . . . 1.96 111.69 163.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.4 -32.34 7.64 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 119.519 -0.601 . . . . 2.4700000000000002 113.785 -177.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 177.36 8.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.752 1.776 . . . . 10.59 114.672 -153.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.489 HG23 ' HB2' ' A' ' 146' ' ' CYS . 0.9 OUTLIER -92.3 123.53 35.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.362 1.065 . . . . 1.54 111.277 169.483 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.563 HD12 ' CD1' ' A' ' 8' ' ' LEU . 3.2 tm? -80.25 132.11 35.79 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.513 -1.291 . . . . 3.8199999999999998 107.513 162.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.26 117.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 107.274 -1.38 . . . . 0.85999999999999999 107.274 170.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.07 114.98 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 104.685 -2.339 . . . . 1.8799999999999999 104.685 164.459 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -90.13 161.52 15.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 115.828 1.788 . . . . 0.64000000000000001 115.828 -164.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -40.81 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.244 2.618 . . . . 3.1800000000000002 112.532 169.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -89.2 -179.2 5.83 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.306 0.957 . . . . 3.3700000000000001 109.723 179.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 155.4 16.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.703 -0.851 . . . . 0.76000000000000001 108.703 157.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -74.66 165.9 24.46 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.233 -0.655 . . . . 2.4500000000000002 109.233 167.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -70.85 -19.5 62.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 117.829 -1.081 . . . . 3.4100000000000001 112.389 -175.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 59.16 39.63 22.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.664 1.12 . . . . 2.27 109.816 -160.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.18 42.66 82.69 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.025 0.821 . . . . 1.9399999999999999 111.533 172.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.94 -22.01 43.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.057 0.943 . . . . 7.4900000000000002 110.73 -171.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.3 -155.51 26.21 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.976 -0.85 . . . . 2.8799999999999999 110.976 177.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.41 -68.12 1.2 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.935 -1.666 . . . . 3.2599999999999998 108.935 -170.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.12 118.0 14.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.327 -1.731 . . . . 2.98 106.327 167.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -49.83 -45.33 50.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.306 1.412 . . . . 3.5299999999999998 109.602 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -35.74 -41.24 0.21 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.593 2.757 . . . . 3.1000000000000001 112.657 170.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -49.37 -65.19 0.61 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.684 1.594 . . . . 1.73 109.024 179.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 -41.95 69.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.36 1.064 . . . . 1.55 110.819 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -67.12 -32.31 73.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.989 0.516 . . . . 6.2300000000000004 111.556 -169.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.462 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.382 13.5 t -139.54 -58.57 0.58 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 118.132 -0.937 . . . . 2.0099999999999998 111.398 174.482 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.99 -21.26 0.2 Allowed Glycine 0 N--CA 1.463 0.436 0 CA-C-N 119.556 1.071 . . . . 0.96999999999999997 113.309 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 52.5 54.84 9.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.848 1.259 . . . . 1.8100000000000001 111.256 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.72 59.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.159 0.8 . . . . 1.1799999999999999 113.159 168.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 -159.35 34.22 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 108.526 -1.83 . . . . 0.93000000000000005 108.526 -177.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.4 m -62.54 151.67 36.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.959 -1.12 . . . . 1.26 113.639 -163.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -61.44 141.36 57.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.712 -1.585 . . . . 3.4300000000000002 108.896 166.152 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.8 mt -111.97 -82.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.728 -0.841 . . . . 0.69999999999999996 108.728 169.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.56 167.31 10.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.134 0.574 . . . . 0.88 110.411 177.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.489 ' HB2' HG23 ' A' ' 116' ' ' THR . 1.2 p -154.54 170.64 20.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.653 1.181 . . . . 2.5800000000000001 109.451 173.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.6 143.75 4.18 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 124.417 1.073 . . . . 0.77000000000000002 111.189 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.39 134.08 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.752 1.221 . . . . 1.8300000000000001 109.549 174.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 13.4 tt -89.55 126.97 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.326 -0.62 . . . . 0.93000000000000005 109.326 161.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.38 -4.32 0.49 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.785 -0.643 . . . . 0.82999999999999996 114.562 176.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.92 57.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 118.778 1.289 . . . . 1.1899999999999999 111.298 -157.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.575 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.98 168.91 26.08 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.739 0.816 . . . . 1.3700000000000001 110.578 160.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 101.658 -3.46 . . . . 6.3200000000000003 101.658 159.494 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.505 -0.924 . . . . 2.8599999999999999 108.505 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.01 143.78 42.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.977 -1.49 . . . . 0.68999999999999995 106.977 159.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 152' ' ' ALA . 93.9 t -105.85 144.23 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.434 -1.691 . . . . 0.90000000000000002 106.434 165.153 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.51 97.09 5.04 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.702 -0.851 . . . . 0.48999999999999999 108.702 156.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.55 109.41 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.981 -1.489 . . . . 0.68000000000000005 106.981 164.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -93.73 122.5 36.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.564 -0.902 . . . . 0.84999999999999998 108.564 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -139.42 -53.25 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.651 -1.24 . . . . 4.3600000000000003 107.651 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.52 -113.12 2.46 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.193 0.901 . . . . 1.1899999999999999 110.88 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -109.68 -65.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.524 -1.288 . . . . 3.8100000000000001 107.524 -163.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.56 2.03 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 129.318 3.342 . . . . 1.23 115.068 -172.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.7 -26.16 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.797 2.998 . . . . 1.71 112.094 -176.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.18 143.67 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.753 1.221 . . . . 0.87 110.601 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -155.18 132.19 10.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.328 -0.99 . . . . 2.0099999999999998 108.328 -175.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.97 172.72 42.77 Favored Glycine 0 N--CA 1.451 -0.36 0 O-C-N 121.86 -0.525 . . . . 0.5 112.464 -175.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.11 129.78 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.54 -1.281 . . . . 1.1000000000000001 107.54 176.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mm -96.93 137.84 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.218 1.407 . . . . 0.70999999999999996 107.44 164.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -113.7 122.75 48.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.274 -1.38 . . . . 1.8799999999999999 107.274 160.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.468 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -105.1 130.6 53.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.407 1.883 . . . . 2.5099999999999998 106.222 172.814 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -135.75 148.21 48.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.986 0.812 . . . . 3.9500000000000002 109.906 168.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -155.3 133.63 11.72 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.255 -1.016 . . . . 3.25 108.255 166.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -44.17 71.7 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.572 -0.899 . . . . 4.3099999999999996 108.572 177.09 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -77.33 -177.16 4.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.438 1.495 . . . . 4.0899999999999999 109.597 -170.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.4 p -82.86 -67.92 0.75 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.502 1.521 . . . . 3.77 107.86 169.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -117.1 109.65 17.22 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.168 1.387 . . . . 3.9500000000000002 107.643 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.87 -155.01 7.01 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 108.511 -1.836 . . . . 1.6799999999999999 108.511 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.5 114.11 2.96 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.385 2.056 . . . . 2.0099999999999998 109.515 173.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.14 146.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.232 -0.655 . . . . 1.02 109.232 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -100.27 118.53 36.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.28 -1.748 . . . . 2.6499999999999999 106.28 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.468 HG22 ' CE1' ' A' ' 20' ' ' PHE . 34.0 t -117.1 122.19 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 107.794 -1.187 . . . . 1.1599999999999999 107.794 177.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -141.04 142.14 34.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.024 0.375 . . . . 0.85999999999999999 110.174 169.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.84 -178.22 38.01 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.535 -1.826 . . . . 0.92000000000000004 108.535 175.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.6 p -148.12 108.68 4.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.263 -2.125 . . . . 2.0499999999999998 105.263 169.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.28 126.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.128 -2.175 . . . . 1.1699999999999999 105.128 -176.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 157.84 24.03 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.486 0.66 . . . . 4.9500000000000002 111.45 -175.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 15.5 62.51 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 114.583 -1.19 . . . . 0.67000000000000004 114.079 176.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.98 159.08 23.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.293 1.547 . . . . 0.71999999999999997 109.57 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.18 166.61 13.71 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.288 -1.005 . . . . 1.6499999999999999 108.288 155.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -63.79 177.85 0.69 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.104 -0.998 . . . . 2.5 111.56 -175.041 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.78 -159.53 52.21 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.759 0.695 . . . . 0.53000000000000003 114.076 167.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.91 150.05 41.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.193 0.997 . . . . 2.0800000000000001 110.493 -177.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -143.58 116.92 9.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.336 1.054 . . . . 0.51000000000000001 110.086 178.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.13 141.71 19.92 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.538 -1.425 . . . . 0.45000000000000001 109.538 169.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -140.09 96.7 3.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.468 -1.308 . . . . 2.54 107.468 -172.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.742 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 27.9 m170 -131.79 146.42 52.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.503 -1.295 . . . . 0.57999999999999996 107.503 -160.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.83 113.66 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.263 1.03 . . . . 1.6399999999999999 108.446 172.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -79.63 -174.28 4.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.137 -1.392 . . . . 1.3300000000000001 108.446 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -115.84 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 118.317 -0.849 . . . . 5.3700000000000001 109.071 166.362 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 124.613 1.165 . . . . 5.0199999999999996 112.794 -179.146 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 116.303 1.964 . . . . 3.3599999999999999 116.303 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 42.2 -150.04 0.35 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.42 1.486 . . . . 1.3300000000000001 114.223 173.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.43 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.863 3.042 . . . . 1.3 111.142 173.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -66.27 59.79 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.721 2.009 . . . . 1.9099999999999999 112.252 -178.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 48.82 58.53 5.22 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.194 0.998 . . . . 1.8899999999999999 109.186 -176.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -87.62 114.95 61.25 Favored Pre-proline 0 C--N 1.34 0.153 0 CA-C-O 118.066 -0.969 . . . . 2.7599999999999998 108.481 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.16 -34.67 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.654 1.569 . . . . 1.2 111.425 -178.45 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -156.32 -76.63 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.526 -0.916 . . . . 2.5600000000000001 108.526 177.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.2 m -138.79 59.03 1.64 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.101 0.961 . . . . 1.6299999999999999 110.599 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -77.94 163.51 25.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.63 -0.878 . . . . 4.2599999999999998 108.63 162.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -125.58 153.78 43.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.299 1.839 . . . . 3.73 107.718 -171.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -76.97 164.68 25.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.032 0.444 . . . . 1.03 110.827 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.55 156.5 22.1 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 106.133 -2.787 . . . . 2.2799999999999998 106.133 168.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.18 -156.44 12.6 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 109.915 -1.274 . . . . 1.3899999999999999 109.915 173.224 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.35 -44.49 4.69 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.541 1.494 . . . . 1.49 108.936 165.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -59.01 -43.84 91.59 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.549 1.54 . . . . 5.5800000000000001 112.308 -173.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -55.91 166.89 0.66 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.424 1.09 . . . . 2.48 111.328 -177.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -82.32 -47.86 11.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.436 1.894 . . . . 4.71 109.665 170.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 175.9 10.19 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.374 1.07 . . . . 3.98 110.112 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 170.28 148.08 0.03 OUTLIER 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.422 3.089 . . . . 3.73 107.191 168.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 40.0 m80 -61.73 148.58 42.41 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 117.614 -1.634 . . . . 0.56000000000000005 106.791 171.132 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 p -53.58 -23.04 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 1.3 110.665 174.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.97 43.09 1.8 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.805 1.082 . . . . 0.77000000000000002 115.805 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -140.66 138.69 34.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.984 1.892 . . . . 2.04 111.385 153.644 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.7 -44.09 7.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.972 1.309 . . . . 3.02 108.119 166.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.85 -103.13 0.23 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.608 -1.397 . . . . 0.88 109.608 177.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -145.29 170.88 15.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.805 1.642 . . . . 1.52 111.516 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.07 170.95 18.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 127.055 2.142 . . . . 0.57999999999999996 107.877 174.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.77 109.67 15.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.726 1.61 . . . . 2.9300000000000002 109.718 -170.62 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.55 139.54 38.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.548 -0.72 . . . . 0.59999999999999998 111.496 174.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.02 -92.14 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.38 1.472 . . . . 4.25 109.886 172.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -175.28 -32.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.878 1.271 . . . . 3.4700000000000002 111.795 -163.044 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.91 8.12 4.1 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 123.39 1.567 . . . . 3.3999999999999999 109.64 153.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.84 72.74 Favored Glycine 0 N--CA 1.442 -0.935 0 O-C-N 120.639 -1.288 . . . . 0.95999999999999996 110.217 177.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.3 t -82.93 111.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.943 1.297 . . . . 1.04 107.611 -177.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.53 155.15 21.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.535 1.134 . . . . 1.1299999999999999 110.041 172.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -102.0 57.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.859 2.464 . . . . 6.2400000000000002 107.502 -165.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.07 85.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.996 -0.742 . . . . 1.52 108.996 -163.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.1 m -143.76 119.41 10.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.124 -0.695 . . . . 1.47 109.124 173.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.31 152.69 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.173 -1.047 . . . . 2.1800000000000002 108.173 -173.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -131.72 92.45 3.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.705 -1.22 . . . . 2.8799999999999999 107.705 167.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.6 151.3 21.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.259 0.624 . . . . 2.3700000000000001 110.569 176.375 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -121.06 -0.48 9.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.224 1.81 . . . . 3.3399999999999999 112.651 173.27 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -78.56 -51.21 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.752 -1.203 . . . . 1.6499999999999999 107.752 174.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.13 168.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.299 0.571 . . . . 1.2 110.319 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.8 m -131.66 178.53 6.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.127 2.171 . . . . 1.96 106.509 174.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.44 ' HA ' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -100.01 9.74 42.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.21 0.914 . . . . 3.2000000000000002 112.453 171.871 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.451 -0.392 0 C-N-CA 124.918 1.287 . . . . 4.5099999999999998 109.312 -166.189 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 123.082 1.42 . . . . 2.2000000000000002 112.83 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -7.55 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 113.534 -1.666 . . . . 1.6699999999999999 110.893 179.453 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 106' ' ' LEU . 1.5 mp -58.74 131.79 23.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.413 0 CA-C-N 119.823 1.192 . . . . 2.6899999999999999 107.969 171.292 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.07 23.67 68.29 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.24 -0.755 . . . . 1.79 111.687 -170.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.528 ' O ' HG22 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -130.41 168.82 16.35 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.085 1.443 . . . . 5.0499999999999998 109.173 167.449 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.9 m -100.06 110.57 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.583 0.753 . . . . 0.93000000000000005 112.681 -169.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mt -67.05 141.9 57.36 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.219 -1.03 . . . . 1.5600000000000001 108.219 170.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.6 t -132.31 140.23 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.889 2.475 . . . . 0.39000000000000001 107.148 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 p -112.5 127.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.663 1.185 . . . . 1.75 108.204 167.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.531 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 56.9 m-70 -105.25 163.35 12.66 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.785 1.634 . . . . 0.46999999999999997 113.611 -171.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.471 ' HB2' HD21 ' A' ' 144' ' ' LEU 0.28 8.7 tt0 -76.71 -53.52 7.87 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 115.035 1.494 . . . . 6.1699999999999999 115.035 -178.005 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -78.93 177.46 8.75 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 120.476 1.489 . . . . 3.8900000000000001 108.713 -179.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.29 37.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.429 -0.952 . . . . 0.52000000000000002 108.429 160.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 164.26 20.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.039 . . . . 1.9399999999999999 108.193 156.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -10.47 59.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.217 1.191 . . . . 4.1299999999999999 114.217 -171.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 58.93 34.19 23.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 1.73 111.706 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.0 60.41 6.88 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.723 -0.611 . . . . 2.1800000000000002 112.712 168.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -138.7 -59.47 0.61 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.422 1.489 . . . . 5.1900000000000004 109.937 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 64.28 -72.06 0.06 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.844 1.688 . . . . 2.02 116.152 173.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.19 40.26 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 111.184 -0.766 . . . . 2.3500000000000001 111.184 -157.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -170.68 160.69 7.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.077 1.751 . . . . 2.8500000000000001 107.085 -178.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -55.13 -64.88 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.015 1.117 . . . . 3.1800000000000002 114.015 -173.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -45.12 66.37 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.874 0.87 . . . . 4.2300000000000004 110.617 -156.421 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -58.85 1.99 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.039 1.735 . . . . 1.96 111.515 170.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -70.9 -48.03 55.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.195 -0.941 . . . . 1.52 110.788 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -67.33 -36.68 81.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.052 -0.499 . . . . 2.6600000000000001 112.304 -169.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.504 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.404 0.0 OUTLIER -129.49 -53.89 1.17 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.681 -1.152 . . . . 1.1499999999999999 113.518 168.428 . . . . . . . . 4 4 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.68 -10.25 0.27 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 120.408 1.458 . . . . 0.88 115.995 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 46.84 53.62 10.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.216 1.406 . . . . 1.98 111.791 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.742 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -65.18 -30.22 71.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.366 1.467 . . . . 1.0700000000000001 113.452 177.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.62 173.15 49.54 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.865 -1.294 . . . . 1.1599999999999999 109.865 -160.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 m -56.4 152.25 11.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.167 1.387 . . . . 1.5900000000000001 113.148 -172.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.44 ' O ' HD23 ' A' ' 144' ' ' LEU . 11.8 mtm105 -77.61 162.85 26.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.713 -1.585 . . . . 4.5599999999999996 111.614 176.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 121' ' ' GLU . 6.9 mt -138.83 -72.92 0.4 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.836 -1.913 . . . . 0.78000000000000003 105.836 -172.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.68 155.69 30.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.425 0.631 . . . . 0.87 109.321 172.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -157.23 172.12 19.19 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.543 -1.662 . . . . 1.6799999999999999 108.642 175.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.24 146.08 6.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.034 -0.985 . . . . 0.69999999999999996 111.932 176.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.4 t -63.32 133.49 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.489 1.116 . . . . 0.71999999999999997 109.118 175.229 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 115' ' ' ARG . 16.6 tt -96.41 136.05 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.76000000000000001 110.478 176.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.96 -1.27 2.5 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.883 0.754 . . . . 0.80000000000000004 114.427 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -89.38 58.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.906 1.353 . . . . 0.93000000000000005 110.367 -160.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.427 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -128.46 176.14 7.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.431 1.093 . . . . 1.52 110.972 176.304 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 102.047 -3.316 . . . . 4.8399999999999999 102.047 143.817 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 107.567 -1.272 . . . . 5.8099999999999996 107.567 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.92 125.74 53.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.252 -1.388 . . . . 0.78000000000000003 107.252 160.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 152' ' ' ALA . 59.5 t -90.78 140.91 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 105.837 -1.912 . . . . 1.05 105.837 164.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.96 92.52 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.27 -1.011 . . . . 0.75 108.27 160.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.09 103.19 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 107.077 -1.453 . . . . 0.81999999999999995 107.077 165.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.73 129.96 34.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.402 -0.962 . . . . 0.93999999999999995 108.402 176.274 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -154.98 -53.86 0.09 Allowed 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.411 -0.588 . . . . 3.6000000000000001 109.411 170.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.72 -107.04 0.61 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.421 -0.809 . . . . 1.3300000000000001 113.005 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -116.37 -57.23 2.22 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.949 1.3 . . . . 2.9700000000000002 110.005 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 164.81 10.15 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.674 0.654 . . . . 1.1200000000000001 112.289 -177.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.72 -19.46 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.593 2.862 . . . . 1.47 112.336 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.88 143.24 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 124.712 1.205 . . . . 0.91000000000000003 110.562 174.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -155.65 126.28 6.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.732 -1.21 . . . . 1.9299999999999999 107.732 -174.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.7 170.8 42.51 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.957 -0.639 . . . . 0.55000000000000004 112.369 -174.366 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.4 128.17 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.491 -0.929 . . . . 1.5800000000000001 108.491 -179.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.29 134.71 30.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.651 -1.611 . . . . 0.93999999999999995 106.651 161.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.42 59.85 1.02 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.863 0.865 . . . . 3.3300000000000001 108.69 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.491 ' CD2' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -90.77 144.28 25.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.237 1.415 . . . . 2.98 110.916 -163.277 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -153.44 163.39 40.03 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.872 0.844 . . . . 3.2599999999999998 111.27 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.416 HE22 ' N ' ' A' ' 27' ' ' GLY . 34.8 tt0 -145.55 153.79 41.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.041 -2.207 . . . . 2.9399999999999999 105.041 157.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -70.71 -56.06 7.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.373 -0.602 . . . . 4.5999999999999996 109.373 172.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -83.08 166.46 18.71 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.798 1.239 . . . . 3.5899999999999999 109.324 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 p -90.79 -0.16 57.63 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.887 -0.508 . . . . 2.3300000000000001 111.949 176.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -144.29 47.72 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.325 0.966 . . . . 4.8899999999999997 111.843 -159.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' N ' HE22 ' A' ' 22' ' ' GLN . . . -152.56 -164.87 12.75 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.823 -1.311 . . . . 1.01 109.823 171.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.4 146.78 45.58 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.594 2.196 . . . . 1.03 110.799 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.54 143.77 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 123.849 0.718 . . . . 0.90000000000000002 110.826 -171.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -95.97 96.98 9.26 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.354 -0.609 . . . . 2.5600000000000001 109.354 -175.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG22 ' CD2' ' A' ' 20' ' ' PHE . 44.1 t -83.78 88.94 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.096 -1.076 . . . . 1.22 108.096 177.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -104.55 137.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.778 0.674 . . . . 1.05 109.798 164.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.85 156.83 27.86 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.957 -0.857 . . . . 0.83999999999999997 110.957 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 p -132.21 106.74 8.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.664 -1.976 . . . . 1.71 105.664 -171.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.62 150.25 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.627 -1.249 . . . . 0.83999999999999997 107.627 -167.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.75 -179.54 6.86 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.271 1.211 . . . . 5.0899999999999999 114.271 161.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.92 64.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.854 1.692 . . . . 0.59999999999999998 112.204 179.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.16 162.2 29.7 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.139 0.97 . . . . 0.65000000000000002 108.811 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.21 164.61 23.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.884 -1.154 . . . . 1.78 107.884 153.412 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.01 175.21 0.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.63 0.728 . . . . 2.4100000000000001 111.048 176.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.07 -163.67 50.63 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.295 0.474 . . . . 0.58999999999999997 113.395 170.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.06 147.08 47.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.131 . . . . 2.2799999999999998 112.284 -172.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.36 117.22 8.22 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.822 1.649 . . . . 0.44 108.987 177.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.16 152.61 5.09 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.917 -0.873 . . . . 0.34000000000000002 110.917 171.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.84 95.62 2.76 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.559 1.143 . . . . 2.4100000000000001 108.053 -174.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -135.24 160.61 37.86 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 108.383 -0.969 . . . . 0.52000000000000002 108.383 -160.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.37 115.94 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.98 1.264 . . . . 1.8100000000000001 110.686 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -86.9 162.42 17.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.766 -0.652 . . . . 0.87 109.564 -169.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.73 47.27 0.13 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.683 1.993 . . . . 4.5199999999999996 111.345 178.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' CD ' HH22 ' A' ' 143' ' ' ARG . 4.7 mt-10 . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 106.074 -1.824 . . . . 3.0899999999999999 106.074 -171.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.403 -0.591 . . . . 1.8300000000000001 109.403 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.93 -95.25 1.68 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 109.683 -1.367 . . . . 1.04 109.683 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.83 178.61 6.59 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.392 3.394 . . . . 0.93999999999999995 114.236 -173.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -73.03 125.35 27.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.309 -1.314 . . . . 1.52 109.226 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -4.04 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.465 2.306 . . . . 2.3399999999999999 113.754 168.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -123.78 99.84 38.13 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.27 1.028 . . . . 3.1400000000000001 109.105 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.81 -37.02 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.668 1.578 . . . . 1.25 110.03 -179.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.41 -86.02 0.54 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.59 -1.263 . . . . 3.0099999999999998 107.59 160.366 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -140.32 72.87 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.434 1.094 . . . . 1.6100000000000001 109.71 -166.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -77.75 164.31 25.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.8 -0.815 . . . . 4.6699999999999999 108.8 170.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -125.07 148.02 48.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.059 1.343 . . . . 3.5099999999999998 108.386 -178.974 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.479 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 44.2 t60 -81.48 156.22 25.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.719 0.407 . . . . 0.89000000000000001 111.828 -176.211 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.57 -97.78 0.13 Allowed Glycine 0 C--O 1.219 -0.784 0 N-CA-C 107.334 -2.306 . . . . 2.3300000000000001 107.334 159.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.09 -154.55 25.48 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 120.575 -1.544 . . . . 1.51 110.344 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.34 -55.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.932 2.421 . . . . 1.8700000000000001 110.394 -168.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -39.82 82.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.737 0.779 . . . . 5.6100000000000003 110.067 171.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -57.29 153.09 12.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.725 -1.579 . . . . 3.1299999999999999 112.861 -164.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 77' ' ' GLU . 1.8 mp0 -49.2 -47.24 46.26 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 128.144 2.578 . . . . 6.5700000000000003 109.576 170.192 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 21.6 pt-20 -133.93 178.52 6.89 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.762 1.023 . . . . 3.4300000000000002 113.762 -171.145 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 175.73 153.55 0.16 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.147 2.179 . . . . 3.1000000000000001 108.579 -173.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 58.4 m80 -62.6 156.24 23.82 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.072 -0.714 . . . . 0.80000000000000004 109.072 170.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.94 -34.24 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.45 -0.782 . . . . 1.29 110.489 -174.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.46 59.98 0.49 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.39 0.995 . . . . 0.82999999999999996 110.65 175.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -169.68 115.93 0.56 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.22 -1.4 . . . . 2.0699999999999998 107.22 -170.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -106.79 -48.43 3.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.37 0.668 . . . . 2.5 110.978 -173.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.76 -121.69 0.93 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 119.647 -1.263 . . . . 0.67000000000000004 112.333 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -151.03 172.02 16.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.085 1.354 . . . . 1.3600000000000001 108.925 -171.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 167.23 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.016 -1.476 . . . . 0.67000000000000004 107.016 167.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 m -120.09 123.42 43.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.217 -1.401 . . . . 2.0299999999999998 107.217 172.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.94 33.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.979 0.354 . . . . 0.65000000000000002 110.977 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -69.19 -84.05 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.567 1.147 . . . . 2.8799999999999999 110.449 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 93' ' ' GLY . 75.4 tttt -159.12 -46.33 0.06 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.735 1.214 . . . . 3.52 111.308 -175.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.41 32.98 0.45 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 124.337 2.018 . . . . 2.73 110.38 176.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 58.39 18.67 37.3 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 126.504 2.002 . . . . 0.62 112.228 -176.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.62 142.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.844 -1.539 . . . . 0.76000000000000001 106.844 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.04 163.34 33.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.89 -1.152 . . . . 0.59999999999999998 107.89 171.127 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -129.99 141.53 50.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.815 -2.661 . . . . 2.6499999999999999 103.815 -174.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.38 126.25 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 105.439 -2.06 . . . . 1.3 105.439 170.299 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.8 m -145.81 71.34 1.27 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.375 1.47 . . . . 1.26 107.974 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mm -108.56 151.16 10.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.654 0.782 . . . . 1.73 109.208 -178.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -137.67 133.96 34.88 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.737 -1.579 . . . . 3.5499999999999998 106.737 160.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.06 161.94 37.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.522 -1.659 . . . . 2.4900000000000002 106.522 175.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 p -113.17 -9.2 13.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.981 2.113 . . . . 1.8 112.487 -172.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.1 t -77.5 -41.85 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.339 -0.985 . . . . 1.3799999999999999 108.339 -177.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -85.68 162.75 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 123.774 0.83 . . . . 2.3799999999999999 108.996 172.722 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.437 ' N ' HD13 ' A' ' 104' ' ' ILE . 49.2 p -164.29 169.54 17.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.728 1.611 . . . . 1.8200000000000001 108.086 -175.144 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.5 42.52 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.733 1.213 . . . . 2.7400000000000002 110.046 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 107.575 -1.269 . . . . 4.0800000000000001 107.575 166.409 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 113.026 0.75 . . . . 1.3500000000000001 113.026 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.489 HD12 HG21 ' A' ' 149' ' ' ILE . 1.3 pp -85.64 -8.86 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.91 -0.494 . . . . 1.48 112.05 -177.012 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mm -47.6 123.88 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.835 0.854 . . . . 2.2400000000000002 109.235 169.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.12 -27.72 17.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.036 0.827 . . . . 2.0299999999999998 112.645 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.85 160.4 26.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.837 1.318 . . . . 5.3300000000000001 110.936 -168.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.8 m -87.35 100.46 12.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.042 1.337 . . . . 1.1100000000000001 109.904 -176.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.9 146.77 54.48 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.139 -1.06 . . . . 1.76 108.139 169.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.9 t -134.41 140.8 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 127.898 2.479 . . . . 0.53000000000000003 107.175 -177.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.64 127.19 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.265 -1.383 . . . . 1.6200000000000001 107.265 165.327 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -98.71 162.99 12.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.573 2.064 . . . . 0.39000000000000001 116.573 -169.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -66.36 0.4 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.754 2.022 . . . . 2.9500000000000002 112.054 176.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -107.68 -178.58 3.66 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.187 0.995 . . . . 3.1899999999999999 111.549 -173.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.79 147.36 42.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.292 -0.867 . . . . 0.72999999999999998 108.798 158.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.95 164.23 23.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.578 0.704 . . . . 2.1699999999999999 109.776 161.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.19 -4.69 58.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.473 1.509 . . . . 3.1400000000000001 112.927 -172.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 57.08 30.36 18.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.597 1.159 . . . . 1.47 110.583 -170.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.45 20.69 59.2 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.872 -0.518 . . . . 1.97 112.587 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -131.24 50.76 2.2 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.221 -1.4 . . . . 6.21 107.221 -173.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.46 139.71 11.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.713 -1.755 . . . . 1.99 108.713 177.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.23 -37.28 79.75 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.67 0.735 . . . . 2.7599999999999998 112.604 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -56.15 109.63 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.519 1.127 . . . . 2.0800000000000001 108.995 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -38.91 20.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.163 0.985 . . . . 3.54 112.105 -178.212 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -35.36 -37.87 0.09 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 128.022 2.529 . . . . 3.0 113.227 171.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.7 p -47.7 -69.2 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.285 1.034 . . . . 2.1800000000000002 109.69 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -63.96 -43.35 96.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.334 0.654 . . . . 1.3 110.417 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -52.2 -49.83 63.1 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 126.1 1.76 . . . . 2.98 110.703 -171.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.492 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.379 10.2 t -136.2 -48.19 0.65 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 117.801 -1.095 . . . . 2.21 111.629 175.459 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.479 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 162.38 -31.32 0.3 Allowed Glycine 0 N--CA 1.463 0.483 0 CA-C-N 119.564 1.074 . . . . 0.91000000000000003 112.578 178.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.99 53.4 10.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.498 1.519 . . . . 1.9399999999999999 109.778 -174.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.18 -7.27 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.352 -0.842 . . . . 1.03 112.085 166.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.53 -167.57 50.55 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 108.88 -1.688 . . . . 0.95999999999999996 108.88 -174.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -54.39 151.35 7.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.087 1.755 . . . . 1.1899999999999999 113.836 -167.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.466 HH22 ' CD ' ' A' ' 50' ' ' GLU . 7.6 mmt85 -64.93 141.46 58.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.333 1.453 . . . . 2.9500000000000002 108.083 170.228 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.7 mt -108.92 -89.66 0.47 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.058 -1.089 . . . . 0.55000000000000004 108.058 169.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.74 158.08 15.85 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.953 -1.129 . . . . 0.87 107.953 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.6 p -143.64 174.84 10.43 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.214 -1.357 . . . . 1.96 108.413 166.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.1 139.72 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 123.943 0.777 . . . . 0.70999999999999996 111.551 176.439 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.21 129.76 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.556 1.143 . . . . 0.95999999999999996 108.861 174.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.489 HG21 HD12 ' A' ' 112' ' ' ILE . 7.9 tt -90.74 131.88 36.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 122.665 0.386 . . . . 0.84999999999999998 110.76 176.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.54 3.2 0.62 Allowed Glycine 0 CA--C 1.523 0.532 0 CA-C-O 119.389 -0.673 . . . . 0.77000000000000002 114.639 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.19 56.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.193 1.497 . . . . 1.29 110.917 -164.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.36 175.51 13.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.061 1.344 . . . . 1.3600000000000001 108.268 160.258 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 103.858 -2.645 . . . . 4.8499999999999996 103.858 163.615 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 110.302 -0.259 . . . . 2.6400000000000001 110.302 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.41 153.64 21.01 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.51 -0.922 . . . . 0.70999999999999996 108.51 164.102 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.96 148.62 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 123.799 0.84 . . . . 0.91000000000000003 108.939 164.395 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.18 101.64 6.35 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.067 1.347 . . . . 0.48999999999999999 108.937 159.007 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.7 98.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.204 -1.035 . . . . 0.69999999999999996 108.204 164.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 147' ' ' GLY . 44.3 mt -81.76 123.77 29.05 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.812 0.845 . . . . 1.6799999999999999 109.564 175.05 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.76 -56.73 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.82 1.248 . . . . 4.4699999999999998 108.29 178.88 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' H ' ' A' ' 146' ' ' CYS . . . 44.54 -116.16 1.58 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.043 1.306 . . . . 0.88 112.47 -177.549 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.05 -62.03 1.33 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.642 0.721 . . . . 3.46 109.605 -173.138 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.58 161.94 1.13 Allowed Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.825 1.678 . . . . 0.81000000000000005 112.554 -178.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.34 38.6 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.001 3.134 . . . . 0.96999999999999997 112.75 -172.207 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.3 155.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.341 1.856 . . . . 0.98999999999999999 109.013 -177.436 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.53 116.76 4.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.892 -1.151 . . . . 2.25 107.892 171.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 163.68 33.02 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.969 -0.852 . . . . 0.64000000000000001 110.969 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.77 114.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.826 -1.916 . . . . 1.72 105.826 -177.607 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -78.2 148.44 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.191 -1.411 . . . . 0.72999999999999998 107.191 170.252 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -122.7 118.23 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.183 -2.154 . . . . 2.1600000000000001 105.183 163.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -106.54 99.94 9.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.175 -1.787 . . . . 2.7400000000000002 106.175 175.606 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -103.78 136.84 42.72 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.693 0.797 . . . . 4.6900000000000004 109.246 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -155.94 86.97 1.05 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.626 1.17 . . . . 3.8100000000000001 109.591 172.717 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.98 -52.02 59.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.377 1.071 . . . . 4.9400000000000004 110.125 174.036 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -83.56 92.46 7.64 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.265 -1.013 . . . . 4.2300000000000004 108.265 175.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -54.57 3.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 118.287 2.699 . . . . 3.3599999999999999 118.287 -162.831 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -159.04 64.76 0.41 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 120.004 1.275 . . . . 3.6800000000000002 109.566 170.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.94 -145.85 6.84 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 107.578 -2.209 . . . . 1.49 107.578 164.717 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.72 142.51 16.08 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.555 2.17 . . . . 1.1299999999999999 110.693 169.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG11 ' CD2' ' A' ' 20' ' ' PHE . 59.5 t -90.39 152.11 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 122.818 0.447 . . . . 0.91000000000000003 110.128 -175.559 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.6 125.76 48.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.388 -1.708 . . . . 4.1600000000000001 106.388 170.219 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' CE1' ' A' ' 20' ' ' PHE . 16.1 t -116.14 129.91 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 175.442 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -144.07 150.32 37.98 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.543 -1.28 . . . . 0.73999999999999999 107.543 162.444 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.28 142.88 5.71 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 107.748 -2.141 . . . . 1.0900000000000001 107.748 173.625 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -116.92 98.57 6.56 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.444 -1.317 . . . . 2.5299999999999998 107.444 -169.261 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.69 143.44 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.512 1.525 . . . . 1.1000000000000001 108.54 -169.119 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 160.65 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.515 -0.474 . . . . 4.75 110.619 170.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.57 25.16 63.62 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.796 1.665 . . . . 0.97999999999999998 113.99 -179.121 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.58 171.56 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.297 -1.001 . . . . 0.95999999999999996 108.297 160.333 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -74.45 168.47 19.65 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.995 -1.113 . . . . 2.04 107.995 152.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.47 172.55 0.85 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.73 1.212 . . . . 4.71 110.9 179.516 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.28 -158.75 38.33 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 115.967 -0.561 . . . . 0.84999999999999998 114.023 167.63 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.13 141.35 56.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.228 1.411 . . . . 2.4900000000000002 111.997 -168.17 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -142.48 115.86 9.02 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.168 0.987 . . . . 0.57999999999999996 110.804 176.457 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.11 146.88 9.77 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.997 -0.841 . . . . 0.38 110.997 170.515 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -138.26 105.68 5.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.848 1.259 . . . . 2.5099999999999998 107.778 -175.889 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 31.0 m80 -138.66 162.09 35.52 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.291 -1.003 . . . . 0.64000000000000001 108.291 -166.055 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.45 126.18 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.472 0.654 . . . . 1.6899999999999999 109.385 176.319 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -104.94 147.75 27.44 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.75 2.02 . . . . 0.80000000000000004 109.215 -173.314 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 67.87 0.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.681 1.192 . . . . 4.3700000000000001 111.095 177.716 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 107.383 -1.339 . . . . 3.1800000000000002 107.383 -176.254 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.386 0 N-CA-C 106.867 -1.531 . . . . 1.79 106.867 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.78 -122.89 2.94 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.076 -0.847 . . . . 1.0700000000000001 111.98 -158.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.89 179.12 6.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.416 2.744 . . . . 0.90000000000000002 113.289 -172.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -58.82 115.74 3.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.893 -1.503 . . . . 1.29 107.19 171.534 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -21.89 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.967 1.707 . . . . 2.3900000000000001 113.902 176.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -130.29 146.23 60.75 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.08 . . . . 3.2200000000000002 107.929 -173.764 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.58 -54.69 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.778 1.652 . . . . 1.8700000000000001 108.655 169.076 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -144.63 -70.37 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.449 1.499 . . . . 2.54 107.333 171.244 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.9 p -135.29 71.92 1.44 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.042 1.337 . . . . 2.5600000000000001 109.369 -168.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -78.82 175.13 10.77 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.233 -1.025 . . . . 4.2400000000000002 108.233 162.488 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -117.16 149.08 40.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.561 -2.015 . . . . 4.3099999999999996 105.561 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.427 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 82.7 t60 -66.93 146.25 54.58 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.543 -0.863 . . . . 0.83999999999999997 111.048 178.487 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.36 130.28 3.29 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 106.751 -2.54 . . . . 2.73 106.751 172.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.1 -155.28 12.36 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.231 -1.148 . . . . 1.8200000000000001 110.231 174.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.52 -33.0 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.26 1.974 . . . . 2.4199999999999999 110.786 178.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -44.23 90.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.437 0.637 . . . . 7.8099999999999996 110.817 175.637 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.18 139.69 56.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.218 1.562 . . . . 3.0299999999999998 115.218 -159.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -53.57 -59.45 4.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.752 2.421 . . . . 5.4199999999999999 110.167 170.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.64 -178.72 6.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 130.221 3.409 . . . . 3.8199999999999998 110.406 178.029 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 172.68 161.01 0.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.206 1.802 . . . . 2.8700000000000001 111.685 164.74 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.7 m80 -50.25 136.84 19.14 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.685 -1.968 . . . . 0.64000000000000001 105.685 154.256 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.78 -20.6 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 120.072 -0.651 . . . . 1.24 109.82 -179.96 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.91 43.29 1.75 Allowed Glycine 0 CA--C 1.535 1.338 0 N-CA-C 116.717 1.447 . . . . 0.78000000000000003 116.717 164.56 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -98.09 136.8 37.81 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 105.757 -1.942 . . . . 1.9299999999999999 105.757 147.681 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 84' ' ' LEU . 3.9 mm? -93.55 -52.29 4.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.72 -0.844 . . . . 1.5700000000000001 108.72 148.464 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.92 -108.6 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 119.597 -1.287 . . . . 0.53000000000000003 112.321 178.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -155.63 168.18 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.512 1.525 . . . . 2.0800000000000001 109.224 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.98 178.05 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.565 -1.643 . . . . 0.56999999999999995 106.565 163.21 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.5 t -113.07 146.22 39.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.562 -1.644 . . . . 2.4900000000000002 106.562 151.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.46 156.43 20.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.106 -1.072 . . . . 0.78000000000000003 108.106 150.755 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.57 -90.11 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.967 -0.753 . . . . 3.1299999999999999 108.967 172.314 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -139.22 -48.79 0.49 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.467 1.507 . . . . 3.7599999999999998 110.091 -167.497 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -81.88 17.0 1.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.964 1.364 . . . . 3.0800000000000001 111.343 -176.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.84 10.11 76.42 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.344 -0.847 . . . . 0.93999999999999995 111.7 -175.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.38 124.65 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.493 1.517 . . . . 0.93000000000000005 107.475 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.34 171.62 14.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.269 1.828 . . . . 0.68000000000000005 108.086 175.12 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.31 144.74 26.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.787 -1.19 . . . . 3.5899999999999999 107.787 -179.583 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.21 55.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 123.866 0.866 . . . . 2.04 111.153 -172.797 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.6 m -72.67 102.3 3.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.768 -0.634 . . . . 1.1000000000000001 110.193 169.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 100' ' ' GLU . 16.4 mt -137.4 157.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.192 0.906 . . . . 1.8999999999999999 110.147 179.077 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 99' ' ' ILE . 34.7 tt0 -137.94 123.72 19.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.659 -1.237 . . . . 3.6600000000000001 107.659 158.514 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -117.15 156.82 26.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.466 -0.939 . . . . 2.4500000000000002 108.466 164.095 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.9 p -102.03 -12.64 18.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.282 2.233 . . . . 1.5700000000000001 111.937 176.432 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.35 -25.87 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.764 0.711 . . . . 1.3100000000000001 110.872 -173.726 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.88 166.6 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.704 0.683 . . . . 1.3999999999999999 111.686 177.32 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -136.41 176.81 8.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.596 2.359 . . . . 1.8200000000000001 107.618 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.42 57.37 1.09 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.802 0.728 . . . . 2.48 112.11 167.352 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 123.328 0.651 . . . . 2.8700000000000001 111.743 165.509 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.443 -0.776 0 CA-C-O 122.695 1.236 . . . . 1.4099999999999999 112.516 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -8.53 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 3.0800000000000001 111.942 176.066 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 33.9 mm -54.85 120.4 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.926 1.239 . . . . 1.96 109.491 -174.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.25 73.81 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.617 -0.546 . . . . 1.49 112.338 -177.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -102.39 177.21 4.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.313 -1.736 . . . . 4.2599999999999998 106.313 167.611 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -119.4 122.14 41.11 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.596 1.089 . . . . 1.01 111.314 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.8 mt -74.16 146.43 43.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.239 -0.652 . . . . 1.72 109.239 166.144 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.91 136.06 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.416 1.886 . . . . 0.39000000000000001 107.919 177.511 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.419 HG22 ' CE2' ' A' ' 45' ' ' PHE . 28.3 t -100.47 122.23 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 126.044 1.738 . . . . 2.27 106.9 167.005 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.486 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 65.0 m-70 -98.48 158.69 15.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.369 1.989 . . . . 0.44 116.369 -174.653 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 2.7 tt0 -46.72 -74.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.219 2.208 . . . . 2.96 112.018 174.292 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -93.76 -176.88 4.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.851 0.75 . . . . 2.8599999999999999 110.275 -171.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.32 152.08 30.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.588 -0.893 . . . . 0.60999999999999999 108.588 157.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.13 177.34 6.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.94 0.876 . . . . 2.1099999999999999 109.087 161.92 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.53 -27.4 67.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.498 1.119 . . . . 4.3899999999999997 113.83 177.824 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.288 2.9 mm? 88.73 -17.58 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 128.47 2.708 . . . . 2.8900000000000001 113.172 -175.127 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.27 3.33 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.647 -1.381 . . . . 3.6000000000000001 109.647 -171.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -95.44 -38.97 10.23 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 128.264 2.626 . . . . 6.1100000000000003 108.87 160.403 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.35 62.63 5.8 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 125.401 1.477 . . . . 3.6000000000000001 110.112 -167.294 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.19 -16.02 25.05 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.694 -0.503 . . . . 3.1099999999999999 113.741 178.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -176.68 -179.98 1.05 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.49 1.516 . . . . 2.25 108.236 -169.507 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -42.83 -82.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.772 2.029 . . . . 3.4900000000000002 113.562 178.681 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -53.18 -33.54 53.07 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.827 -0.546 . . . . 3.2000000000000002 111.709 -172.796 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.3 m -61.42 -52.78 63.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.005 1.322 . . . . 2.5099999999999998 111.161 179.266 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.9 t -71.04 -45.07 64.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.767 1.167 . . . . 2.4100000000000001 110.791 173.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.17 -43.13 99.36 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.175 0.59 . . . . 3.9500000000000002 111.58 -170.063 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -128.21 -47.98 1.33 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.225 0.466 . . . . 1.3600000000000001 112.107 177.104 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 147.65 -14.99 1.4 Allowed Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.786 0.721 . . . . 0.91000000000000003 114.097 -178.417 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.11 54.85 6.73 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.035 1.334 . . . . 1.8500000000000001 110.601 -174.755 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.5 -31.26 71.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.77 1.228 . . . . 1.1399999999999999 112.087 172.848 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.52 178.43 50.48 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 108.64 -1.784 . . . . 0.93999999999999995 108.64 -163.262 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 m -58.23 153.76 14.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.556 1.142 . . . . 1.28 113.648 -167.229 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -59.72 134.58 57.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.082 1.353 . . . . 3.0099999999999998 108.465 170.254 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.6 mt -110.32 -72.48 0.72 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.955 -1.498 . . . . 0.58999999999999997 106.955 168.37 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.35 155.03 16.94 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.409 -0.96 . . . . 0.93999999999999995 108.409 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.407 ' H ' ' HA3' ' A' ' 10' ' ' GLY . 73.9 m -135.96 150.51 49.3 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 106.196 -1.779 . . . . 1.8200000000000001 106.196 163.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.54 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -152.09 116.45 0.75 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.8 -1.72 . . . . 0.95999999999999996 108.8 172.03 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.68 132.88 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.095 -1.446 . . . . 0.77000000000000002 107.095 168.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.59 138.96 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.206 0.527 . . . . 0.69999999999999996 112.385 -172.537 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 137.78 5.84 1.62 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.328 1.442 . . . . 0.59999999999999998 114.221 177.563 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.75 57.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-N 119.351 1.575 . . . . 0.81000000000000005 109.89 -154.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 165.33 36.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.367 0.603 . . . . 1.5900000000000001 111.236 171.669 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 C--O 1.255 1.353 0 N-CA-C 102.699 -3.075 . . . . 4.5 102.699 156.139 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.747 0.308 . . . . 3.0800000000000001 110.845 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.76 37.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.551 -2.018 . . . . 0.87 105.551 156.147 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -100.6 142.85 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 105.558 -2.016 . . . . 0.65000000000000002 105.558 162.725 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -129.79 93.16 3.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.645 -1.243 . . . . 0.46000000000000002 107.645 166.889 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.09 98.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.299 -1.371 . . . . 0.78000000000000003 107.299 169.408 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 147' ' ' GLY . 18.2 mt -79.89 123.06 27.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.038 -0.727 . . . . 1.8300000000000001 109.038 177.741 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -150.69 -48.07 0.12 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.824 -0.625 . . . . 3.5299999999999998 111.065 167.623 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.32 -117.8 3.52 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.61 -0.996 . . . . 1.1200000000000001 110.61 -174.898 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.85 -35.04 6.07 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.319 1.048 . . . . 3.7400000000000002 110.131 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.44 168.8 30.15 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-O 121.63 0.572 . . . . 1.1200000000000001 112.577 -177.466 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.47 -26.29 47.58 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.571 2.847 . . . . 1.8700000000000001 111.758 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 56.0 t -48.04 151.61 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.639 1.976 . . . . 0.71999999999999997 111.025 -178.603 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -156.01 118.32 4.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.396 0.678 . . . . 2.02 109.254 -175.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.77 167.72 35.35 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.868 -0.52 . . . . 0.47999999999999998 112.286 -178.838 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.8 mt -129.95 119.95 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.736 -1.209 . . . . 1.4199999999999999 107.736 177.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 20.8 mm -81.27 140.51 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.903 -1.147 . . . . 0.87 107.903 164.592 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -120.38 93.5 4.07 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 105.396 -2.075 . . . . 1.71 105.396 159.299 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.665 ' CE1' HD11 ' A' ' 112' ' ' ILE . 1.1 t80 -100.3 118.93 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.881 -1.896 . . . . 3.1099999999999999 105.881 -173.481 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -155.65 175.07 14.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.028 0.918 . . . . 3.9199999999999999 113.404 -173.911 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.84 169.87 23.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.807 -1.553 . . . . 3.1099999999999999 106.807 -173.51 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -93.79 -64.66 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.596 1.558 . . . . 4.7699999999999996 108.601 171.779 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -79.95 -178.58 6.55 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.458 1.103 . . . . 4.3099999999999996 111.375 178.368 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -87.7 -66.87 0.87 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.906 -1.146 . . . . 3.3100000000000001 107.906 155.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -75.74 63.23 1.6 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.045 1.338 . . . . 4.4100000000000001 111.723 -173.219 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.09 -177.48 27.55 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.319 -1.912 . . . . 1.9199999999999999 108.319 169.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.35 152.82 44.72 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.1 2.534 . . . . 1.48 110.412 174.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -82.65 158.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.547 -0.908 . . . . 0.96999999999999997 108.547 176.743 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -111.57 104.88 13.3 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.382 1.087 . . . . 2.73 108.601 162.297 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.523 HG22 ' CD2' ' A' ' 20' ' ' PHE . 58.8 t -97.26 105.22 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.883 1.673 . . . . 1.24 108.206 -175.048 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -128.01 164.27 22.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.693 0.627 . . . . 0.97999999999999998 112.693 176.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.5 42.69 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.516 -1.034 . . . . 0.70999999999999996 110.516 179.267 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -138.74 109.32 6.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.427 -1.694 . . . . 1.96 106.427 179.025 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.53 115.87 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.865 -1.531 . . . . 1.0800000000000001 106.865 -161.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -105.36 162.38 13.49 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.64 0.733 . . . . 3.7200000000000002 111.954 -173.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.65 79.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.201 -0.908 . . . . 0.57999999999999996 113.662 168.398 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.77 165.85 9.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.82 1.31 . . . . 0.63 108.839 167.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.93 160.75 25.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.188 -1.412 . . . . 1.8600000000000001 107.188 152.804 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.55 173.68 0.52 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.397 -0.814 . . . . 2.73 110.6 177.359 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.92 -159.26 46.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 123.747 0.689 . . . . 0.76000000000000001 112.465 170.028 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.49 141.49 55.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.609 1.564 . . . . 2.02 114.543 -169.493 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -145.29 119.62 9.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.97 1.708 . . . . 0.5 109.703 177.24 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.37 150.44 5.57 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.883 -0.887 . . . . 0.41999999999999998 110.883 171.699 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CE2' HD21 ' A' ' 117' ' ' LEU . 1.0 OUTLIER -141.58 93.12 2.53 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.939 -1.504 . . . . 2.4300000000000002 106.939 -173.292 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -130.39 173.39 10.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.217 -1.031 . . . . 0.64000000000000001 108.217 -165.475 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.9 t -124.42 118.27 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.39 -0.967 . . . . 2.1200000000000001 108.39 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -100.2 149.61 23.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.415 1.486 . . . . 0.88 107.912 175.847 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.45 34.24 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.931 0.892 . . . . 4.7300000000000004 112.445 177.743 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.3 tt0 . . . . . 0 N--CA 1.456 -0.151 0 O-C-N 120.579 -1.326 . . . . 3.4900000000000002 110.817 -159.408 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 121.256 0.55 . . . . 1.6799999999999999 109.809 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.83 -119.66 4.2 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.698 -0.961 . . . . 1.1599999999999999 110.698 -172.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.64 178.65 7.35 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.014 3.143 . . . . 0.85999999999999999 112.333 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -54.26 124.97 17.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.977 1.311 . . . . 1.25 108.898 174.582 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -30.73 113.88 0.11 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.653 1.581 . . . . 2.5 112.23 174.499 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.7 151.73 46.99 Favored Pre-proline 0 N--CA 1.446 -0.625 0 C-N-CA 124.675 1.19 . . . . 2.29 109.152 167.369 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.48 -30.91 52.15 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.42 2.08 . . . . 1.3 111.621 -178.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 tp -154.54 -69.72 0.13 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.145 0.429 . . . . 3.71 109.954 173.331 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -145.94 76.41 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.144 0.978 . . . . 1.8 110.411 -172.649 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -79.67 176.55 9.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.964 -0.754 . . . . 4.4500000000000002 108.964 165.28 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.978 -1.49 . . . . 3.2799999999999998 106.978 -179.558 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -106.64 126.9 52.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.132 0.573 . . . . 1.0600000000000001 111.495 175.017 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.25 3.95 8.3 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.683 1.611 . . . . 3.2200000000000002 111.461 173.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 -173.29 4.25 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.468 -1.019 . . . . 1.3799999999999999 111.291 -169.546 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.09 -9.43 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.641 2.227 . . . . 1.45 111.872 173.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -54.51 5.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.469 0.577 . . . . 4.0599999999999996 111.397 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.26 176.58 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.033 0.444 . . . . 2.6600000000000001 110.382 -179.335 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.54 -63.12 1.21 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.684 1.194 . . . . 5.6500000000000004 109.923 -179.885 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.49 148.5 33.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.573 -0.739 . . . . 3.3100000000000001 111.333 -161.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -159.29 147.01 17.41 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.095 -1.003 . . . . 3.7999999999999998 108.396 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.455 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.2 m80 -54.69 135.22 47.17 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.721 -1.955 . . . . 0.69999999999999996 105.721 157.462 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -62.09 -22.02 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.788 -0.449 . . . . 1.25 109.788 -178.13 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.83 44.93 1.57 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.809 0.719 . . . . 0.56000000000000005 114.337 162.709 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.72 121.77 45.96 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 106.643 -1.614 . . . . 1.9399999999999999 106.643 158.058 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.24 -71.13 0.46 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.422 -1.696 . . . . 1.73 106.422 154.399 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.32 -110.76 0.35 Allowed Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.536 -0.626 . . . . 0.69999999999999996 111.536 -176.575 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.66 167.35 26.66 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.848 1.659 . . . . 1.49 109.086 175.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.03 175.06 10.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 106.848 -1.538 . . . . 0.46000000000000002 106.848 170.553 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -122.89 142.93 50.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.936 -1.135 . . . . 1.9099999999999999 107.936 169.104 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 142.13 40.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.921 1.288 . . . . 0.82999999999999996 112.629 173.525 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.31 -88.15 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.158 0.983 . . . . 2.5099999999999998 111.688 -178.652 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -146.08 -42.32 0.21 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.595 0.591 . . . . 3.52 112.595 -158.251 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -83.49 23.27 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 124.059 1.885 . . . . 4.0599999999999996 110.163 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.42 24.94 57.08 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.563 -1.199 . . . . 1.03 110.479 -168.7 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.15 107.5 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.221 -1.029 . . . . 1.1899999999999999 108.221 -175.599 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.83 154.72 18.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.904 -1.147 . . . . 0.70999999999999996 107.904 156.187 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.57 139.11 50.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 102.218 -3.252 . . . . 2.8700000000000001 102.218 174.01 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.85 131.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.041 -1.466 . . . . 1.6699999999999999 107.041 170.678 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -158.22 61.73 0.45 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.649 1.98 . . . . 1.0700000000000001 107.678 178.39 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.0 mm -105.29 157.55 6.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.904 -1.146 . . . . 2.4399999999999999 107.904 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.2 102.94 4.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.187 -0.321 . . . . 2.2000000000000002 111.617 165.397 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.46 144.75 25.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.314 1.046 . . . . 2.0299999999999998 111.045 -178.639 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -105.63 -9.14 17.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.04 2.136 . . . . 1.6699999999999999 113.142 -176.213 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.41 -43.4 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.148 -1.056 . . . . 1.1200000000000001 108.148 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 pt -86.67 176.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.714 0.768 . . . . 1.3100000000000001 111.446 175.001 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.1 m -157.16 177.67 11.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.1 2.16 . . . . 2.0899999999999999 105.78 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.76 54.83 1.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.909 1.231 . . . . 2.46 111.995 172.844 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 124.646 1.178 . . . . 3.6800000000000002 108.524 175.083 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.437 -1.121 0 CA-C-O 122.498 1.142 . . . . 1.1899999999999999 112.654 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.665 HD11 ' CE1' ' A' ' 20' ' ' PHE . 1.1 pp -93.78 -6.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.001 -1.454 . . . . 2.1499999999999999 113.228 177.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.9 mm -43.81 119.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.973 . . . . 1.6799999999999999 110.371 -179.214 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.63 25.54 73.83 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.707 -0.496 . . . . 1.4199999999999999 113.089 177.055 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 149' ' ' ILE . 63.1 mtt-85 -104.06 -178.86 3.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.405 -1.702 . . . . 4.1799999999999997 106.405 166.244 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 m -116.02 118.79 33.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.082 0.401 . . . . 1.0800000000000001 110.108 178.119 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.449 HD21 ' CE2' ' A' ' 45' ' ' PHE . 4.4 tt -73.34 143.46 46.89 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.506 -1.294 . . . . 2.27 107.506 170.804 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -127.24 136.81 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.808 2.043 . . . . 0.40000000000000002 107.577 177.974 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG12 ' CE1' ' A' ' 45' ' ' PHE . 1.5 m -104.19 127.15 58.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.444 -0.947 . . . . 1.6299999999999999 108.444 164.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.24 160.29 14.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 116.066 1.876 . . . . 0.40000000000000002 116.066 -171.217 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -36.2 -68.03 0.15 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.579 2.352 . . . . 3.1200000000000001 112.522 172.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -126.09 -173.8 2.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.683 1.193 . . . . 2.48 110.188 -170.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.78 141.76 43.17 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.468 -0.567 . . . . 0.62 109.468 169.594 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.19 160.96 28.1 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.288 -1.005 . . . . 2.0 108.288 161.502 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.53 -22.34 62.63 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.715 -0.659 . . . . 2.9900000000000002 112.189 -176.042 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 56.36 51.96 10.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.137 1.335 . . . . 1.6599999999999999 109.68 -161.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 50.58 44.11 46.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.334 0.969 . . . . 1.5700000000000001 113.793 169.116 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -79.5 -30.87 42.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.235 1.014 . . . . 5.8700000000000001 111.088 179.147 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.38 -146.01 25.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.259 -1.136 . . . . 2.6400000000000001 110.259 -170.369 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.37 -72.37 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.444 -1.862 . . . . 2.1400000000000001 108.444 -169.075 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 109.81 8.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 104.488 -2.412 . . . . 2.75 104.488 161.592 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -35.9 66.87 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.559 . . . . 3.6499999999999999 110.391 178.654 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -28.6 -44.96 0.03 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.58 2.752 . . . . 2.6299999999999999 113.248 162.366 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -45.68 -60.92 1.93 Allowed 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.979 1.312 . . . . 2.75 109.489 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -72.26 -43.56 64.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.499 0.32 . . . . 1.22 110.152 178.829 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -52.91 -53.02 55.41 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.822 1.649 . . . . 2.5800000000000001 110.85 -170.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.455 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.251 1.0 OUTLIER -125.0 -47.71 1.78 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.067 0.547 . . . . 1.3500000000000001 111.207 173.483 . . . . . . . . 4 4 . 1 . 032 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.66 -26.29 1.06 Allowed Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.533 -0.627 . . . . 1.0900000000000001 111.533 -170.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.64 56.51 6.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.303 1.041 . . . . 2.0299999999999998 111.249 178.281 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.22 -5.96 57.24 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.389 0.514 . . . . 1.27 112.389 168.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.05 -170.84 43.82 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.054 -1.619 . . . . 1.04 109.054 -173.847 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -68.48 171.22 7.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.108 -1.046 . . . . 2.6800000000000002 113.016 -167.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.498 HH21 ' CD ' ' A' ' 50' ' ' GLU . 5.8 mmt-85 -66.79 142.17 57.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.171 2.188 . . . . 2.8900000000000001 109.316 175.126 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.9 -78.95 0.58 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.466 -1.309 . . . . 0.46000000000000002 107.466 166.501 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.479 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -109.71 150.23 28.6 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.651 -0.87 . . . . 0.76000000000000001 108.651 171.624 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 3.3 m -137.12 150.05 47.73 Favored 'General case' 0 N--CA 1.436 -1.135 0 O-C-N 125.462 1.727 . . . . 2.0800000000000001 106.66 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.441 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -148.67 123.5 1.67 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 109.454 -1.459 . . . . 0.90000000000000002 109.454 178.263 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.08 128.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.575 -1.269 . . . . 0.83999999999999997 107.575 168.562 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 115' ' ' ARG . 10.5 tt -103.92 117.06 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.645 0.736 . . . . 0.89000000000000001 110.95 -172.012 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.24 2.63 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-N 114.954 -1.021 . . . . 0.51000000000000001 115.388 178.133 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.8 mm -94.45 58.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.732 1.766 . . . . 0.75 111.589 -155.031 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.89 176.4 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.678 0.791 . . . . 1.26 110.024 167.84 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 104.148 -2.538 . . . . 4.3899999999999997 104.148 162.294 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 pttm . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 111.272 0.101 . . . . 2.5800000000000001 111.272 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.15 133.13 33.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.03 -1.1 . . . . 0.78000000000000003 108.03 165.57 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.12 146.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 106.852 -1.536 . . . . 0.67000000000000004 106.852 158.013 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -128.86 94.77 3.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.017 -1.105 . . . . 0.42999999999999999 108.017 162.55 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.67 96.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.407 1.083 . . . . 0.69999999999999996 108.284 170.469 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -91.71 121.55 33.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.431 -0.581 . . . . 0.93000000000000005 109.431 -179.212 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -130.84 -62.12 0.92 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.822 -0.807 . . . . 3.3999999999999999 108.822 174.268 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.26 -123.83 10.33 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 114.34 -1.3 . . . . 1.02 112.22 -170.296 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.22 -43.19 1.8 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.247 0.619 . . . . 3.4300000000000002 109.974 -150.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.99 165.61 8.43 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 109.439 -1.464 . . . . 0.82999999999999996 109.439 164.386 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.53 35.14 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.515 2.81 . . . . 1.0 112.954 -173.681 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -93.16 153.73 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.578 1.551 . . . . 0.71999999999999997 109.992 -171.962 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -155.08 107.16 2.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.217 1.407 . . . . 2.8999999999999999 107.543 175.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.0 166.03 29.35 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.664 -0.574 . . . . 0.45000000000000001 111.664 179.1 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 mm -132.17 117.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.934 -1.876 . . . . 1.8600000000000001 105.934 -178.368 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.63 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 32.1 mm -85.28 140.6 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.856 -1.535 . . . . 0.69999999999999996 106.856 165.879 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -120.88 105.1 10.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.518 -2.03 . . . . 1.51 105.518 164.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.443 ' CD2' HG22 ' A' ' 31' ' ' VAL . 10.0 t80 -115.76 110.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.482 -2.044 . . . . 3.2200000000000002 105.482 -171.397 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.33 167.42 30.43 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.659 0.742 . . . . 3.98 112.057 -174.672 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.96 -156.7 0.71 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.181 -2.526 . . . . 4.4000000000000004 104.181 169.493 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -110.67 -62.78 1.48 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.485 1.039 . . . . 4.2400000000000002 109.497 168.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.17 101.45 12.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.927 -1.509 . . . . 4.6100000000000003 106.927 -171.286 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 p -73.99 53.18 0.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.177 1.391 . . . . 2.5899999999999999 111.946 -177.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -156.08 34.74 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.199 1.8 . . . . 3.7999999999999998 108.196 165.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.72 -173.26 14.36 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.042 -1.623 . . . . 1.05 109.042 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.04 169.9 6.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.346 2.698 . . . . 1.55 111.765 177.252 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.83 154.38 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.863 -0.608 . . . . 0.76000000000000001 109.622 -178.842 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -104.46 113.5 27.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.209 -1.775 . . . . 2.6600000000000001 106.209 171.662 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 20' ' ' PHE . 21.9 t -115.25 90.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.786 -1.19 . . . . 1.1899999999999999 107.786 -168.798 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -109.59 150.66 27.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 123.457 0.473 . . . . 0.70999999999999996 110.067 -179.613 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.74 168.25 41.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.221 -1.151 . . . . 0.77000000000000002 110.221 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.6 m -139.63 107.5 5.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.281 -1.748 . . . . 2.1800000000000002 106.281 -179.387 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -115.77 123.02 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.89 -1.893 . . . . 0.83999999999999997 105.89 -161.047 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 162.83 20.74 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 118.651 0.659 . . . . 4.4900000000000002 110.966 -174.371 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.91 74.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.878 0.751 . . . . 0.71999999999999997 113.692 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -69.94 164.04 24.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.48 1.14 . . . . 0.63 109.151 167.633 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.85 156.78 19.81 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.098 -1.075 . . . . 1.8799999999999999 108.098 149.02 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.78 -180.0 0.31 Allowed 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.004 -1.06 . . . . 3.9399999999999999 110.4 176.1 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.11 -158.6 51.13 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.818 -0.551 . . . . 0.71999999999999997 112.1 168.087 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.43 146.86 30.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.948 1.299 . . . . 2.6800000000000002 110.219 -170.149 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.9 121.09 10.83 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.178 0.991 . . . . 0.51000000000000001 110.213 -177.257 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.15 147.58 26.45 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.914 -1.275 . . . . 0.40000000000000002 109.914 170.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 38.3 t80 -136.26 97.07 3.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.63 -1.619 . . . . 3.1099999999999999 106.63 -174.084 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.1 m170 -129.31 174.88 9.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.548 -1.278 . . . . 0.82999999999999996 107.548 -169.281 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 p -134.33 115.91 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.177 -1.416 . . . . 1.6899999999999999 107.177 170.203 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -82.28 -175.74 5.84 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.836 -1.542 . . . . 1.1499999999999999 106.836 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -70.92 -106.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.433 -0.951 . . . . 4.1299999999999999 108.433 172.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 . . . . . 0 CA--C 1.532 0.253 0 C-N-CA 123.75 0.82 . . . . 3.3700000000000001 110.513 -175.976 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 107.544 -1.28 . . . . 2.04 107.544 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -94.44 0.18 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.785 -0.926 . . . . 1.1299999999999999 110.785 -179.59 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -81.54 178.28 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.12 2.546 . . . . 0.97999999999999998 115.405 -166.226 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -65.86 64.86 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.613 2.365 . . . . 1.6899999999999999 112.46 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.6 t80 37.77 70.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.411 1.884 . . . . 2.7999999999999998 111.025 -177.275 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -96.33 105.26 21.18 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 118.271 -0.871 . . . . 2.71 109.338 -176.727 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.2 -36.15 17.38 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.058 1.838 . . . . 1.48 111.655 -175.094 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -141.71 -75.4 0.3 Allowed 'General case' 0 C--N 1.339 0.134 0 N-CA-C 108.687 -0.857 . . . . 3.02 108.687 177.825 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.6 p -156.55 58.34 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.68 0.753 . . . . 3.2400000000000002 110.512 -171.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -77.41 160.57 28.64 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.163 -1.421 . . . . 4.8700000000000001 107.163 162.133 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -133.84 152.01 51.73 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.242 1.417 . . . . 3.3799999999999999 108.178 -172.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -76.18 153.75 35.91 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.804 0.668 . . . . 0.92000000000000004 112.804 -169.245 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.13 163.88 36.24 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.964 -2.454 . . . . 2.2799999999999998 106.964 159.086 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.5 -170.35 11.76 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 117.524 0.662 . . . . 1.3799999999999999 112.493 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.98 -39.77 30.76 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.656 2.237 . . . . 1.5 109.797 178.158 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -66.87 -51.06 60.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.083 1.353 . . . . 4.9400000000000004 111.258 175.401 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -61.5 157.55 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.516 0.932 . . . . 2.1299999999999999 113.516 -161.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.13 -49.77 73.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.418 1.087 . . . . 4.4100000000000001 110.333 -179.313 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -78.1 170.04 17.26 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.845 -0.428 . . . . 3.29 109.845 177.488 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 165.24 133.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.927 2.491 . . . . 3.3900000000000001 106.584 -171.882 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.552 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.8 m80 -68.31 161.37 27.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 118.594 -1.242 . . . . 0.64000000000000001 107.947 167.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.54 44.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 122.985 1.374 . . . . 2.6200000000000001 110.498 165.303 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -169.0 36.72 0.2 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 124.816 1.198 . . . . 0.93000000000000005 110.984 167.458 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 133.72 28.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.33 -1.1 . . . . 2.46 108.712 163.337 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.9 mt -99.74 -46.02 5.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.014 -1.106 . . . . 1.99 108.014 168.757 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.24 -111.41 0.46 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.511 -0.852 . . . . 0.60999999999999999 111.347 178.28 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -155.11 158.41 38.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.164 1.386 . . . . 1.9099999999999999 109.375 -169.83 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.66 178.14 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.686 1.995 . . . . 0.45000000000000001 106.384 172.353 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -138.32 145.92 41.76 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.562 -0.903 . . . . 2.2799999999999998 108.562 171.301 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.83 139.79 39.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.446 1.099 . . . . 0.93999999999999995 110.885 170.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.76 -79.77 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 123.784 0.678 . . . . 2.9100000000000001 111.309 -174.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.65 -46.33 0.15 Allowed 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.744 0.817 . . . . 3.6499999999999999 111.151 -164.739 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.02 13.58 2.19 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.803 1.287 . . . . 2.6699999999999999 111.529 177.693 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.63 16.85 74.35 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.235 -0.916 . . . . 0.60999999999999999 111.224 -173.341 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -89.06 115.21 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.051 1.34 . . . . 0.83999999999999997 108.262 -179.53 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.59 168.09 9.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.906 1.683 . . . . 0.68999999999999995 108.367 162.242 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -126.8 149.13 49.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.202 -2.888 . . . . 2.98 103.202 -179.369 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.68 135.19 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 107.197 -1.408 . . . . 1.74 107.197 166.742 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.9 m -157.59 58.75 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.298 1.839 . . . . 0.98999999999999999 107.229 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.0 mt -101.88 154.04 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 123.886 0.875 . . . . 1.71 108.861 -174.424 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -133.45 137.98 45.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.364 -1.347 . . . . 2.3900000000000001 107.364 161.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.42 159.74 41.64 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.151 -1.426 . . . . 2.5 107.151 170.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -121.74 -1.96 9.4 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.808 2.043 . . . . 3.1699999999999999 113.199 -177.549 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.02 -31.2 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.458 1.027 . . . . 1.5700000000000001 108.236 176.574 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -99.94 175.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.683 1.193 . . . . 1.22 109.286 171.129 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.1 t -158.1 179.55 9.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.347 1.859 . . . . 2.3100000000000001 106.058 175.339 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -106.2 27.74 8.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.946 0.898 . . . . 2.8399999999999999 111.922 177.9 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 124.371 1.068 . . . . 4.0999999999999996 110.887 -170.922 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.9 p . . . . . 0 C--O 1.237 0.428 0 CA-C-O 122.248 1.023 . . . . 1.51 112.232 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.8 pt -100.29 -5.31 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.348 -1.296 . . . . 2.0299999999999998 111.056 171.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 tp -46.73 128.81 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.725 0.81 . . . . 1.5900000000000001 109.383 176.906 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.79 -14.12 62.53 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.597 -1.113 . . . . 1.4299999999999999 113.744 -178.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -94.11 163.24 13.55 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.875 1.837 . . . . 4.0099999999999998 111.561 -169.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -88.74 108.74 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.898 0.479 . . . . 0.85999999999999999 111.184 -177.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.457 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -72.75 143.25 48.04 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.927 -0.768 . . . . 2.0600000000000001 108.927 174.281 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.1 t -130.27 127.78 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.687 1.195 . . . . 0.42999999999999999 109.212 -179.105 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.67 128.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 106.48 -1.674 . . . . 2.4199999999999999 106.48 161.643 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.458 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 76.6 m-70 -101.87 158.45 16.12 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 114.627 1.343 . . . . 0.39000000000000001 114.627 -175.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.8 -71.73 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.397 -0.819 . . . . 5.5300000000000002 111.152 176.835 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -79.6 -179.5 6.9 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.025 0.83 . . . . 3.9300000000000002 109.353 -177.247 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.43 157.31 26.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.75 109.818 169.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.83 160.49 5.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.043 -0.526 . . . . 2.6299999999999999 110.326 162.324 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.01 -33.02 74.65 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.921 0.711 . . . . 3.5099999999999998 112.921 176.181 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 73.34 -9.68 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.72 2.408 . . . . 1.9399999999999999 112.532 -168.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.52 43.42 8.5 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.142 -1.983 . . . . 2.3700000000000001 108.142 -168.197 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.26 -20.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.575 0.954 . . . . 5.8200000000000003 113.575 -175.0 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.9 -46.21 92.18 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 108.276 -1.93 . . . . 2.6499999999999999 108.276 169.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.55 36.01 57.84 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.583 0.611 . . . . 3.8999999999999999 111.64 175.926 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -69.64 -61.62 1.71 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.246 -1.39 . . . . 2.8100000000000001 107.246 -179.868 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 27.5 tt0 178.96 -55.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.694 2.798 . . . . 3.2999999999999998 105.124 166.795 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -48.01 -37.7 15.39 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.937 2.095 . . . . 2.8399999999999999 111.212 173.619 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.7 m -38.09 -65.18 0.35 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.87 1.668 . . . . 1.6299999999999999 110.754 164.302 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.9 p -71.73 -42.74 66.92 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.378 -0.826 . . . . 1.76 110.77 -176.138 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 132' ' ' GLU . 60.9 mttm -52.78 -51.34 61.08 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 123.528 0.731 . . . . 2.7999999999999998 110.837 -175.248 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.552 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 15.2 t -136.92 -48.34 0.61 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.246 -1.359 . . . . 2.5099999999999998 111.906 176.162 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.11 25.7 0.08 OUTLIER Glycine 0 N--CA 1.473 1.119 0 CA-C-N 120.52 1.509 . . . . 1.21 115.642 177.107 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.28 0.4 OUTLIER 3.37 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.54 2.336 . . . . 3.4199999999999999 116.601 -167.693 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -63.22 -28.86 70.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.55 1.54 . . . . 0.96999999999999997 113.965 -177.605 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.79 171.55 44.85 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.055 -1.618 . . . . 1.1000000000000001 109.055 -160.119 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m -53.03 147.92 8.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.538 1.535 . . . . 1.51 113.923 -170.342 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -54.79 136.62 46.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.844 1.258 . . . . 2.7400000000000002 108.645 166.79 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.2 mt -107.88 -64.88 1.16 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.335 -0.987 . . . . 0.68999999999999995 108.335 167.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.95 162.39 13.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.057 -0.974 . . . . 1.0800000000000001 110.847 -173.691 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.57 156.3 34.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.166 0.986 . . . . 1.9199999999999999 109.552 169.119 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.82 138.95 3.53 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 106.613 -2.595 . . . . 0.71999999999999997 106.613 172.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.63 132.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.551 -0.907 . . . . 0.75 108.551 177.554 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.7 tt -86.17 134.12 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 122.832 0.453 . . . . 0.81000000000000005 111.252 -178.765 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 140.0 5.84 1.15 Allowed Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.166 0.889 . . . . 0.53000000000000003 114.236 175.796 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.75 55.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.713 1.757 . . . . 0.73999999999999999 110.062 -158.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.76 177.82 10.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.43 1.092 . . . . 1.6299999999999999 109.873 170.089 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 103.449 -2.797 . . . . 6.2599999999999998 103.449 146.837 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.9 tttt . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 109.529 -0.545 . . . . 4.1699999999999999 109.529 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.42 156.09 44.65 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.168 0.987 . . . . 0.93000000000000005 108.945 154.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.45 150.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 106.674 -1.602 . . . . 0.90000000000000002 106.674 158.435 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.64 102.08 4.65 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 108.446 -0.946 . . . . 0.46999999999999997 108.446 157.102 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.15 102.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.208 -1.404 . . . . 0.60999999999999999 107.208 167.354 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -87.36 126.26 34.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.882 -1.155 . . . . 1.0 107.882 177.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -150.92 -53.4 0.14 Allowed 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.481 0.312 . . . . 3.3599999999999999 110.629 -175.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.62 -114.33 1.05 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.763 1.173 . . . . 0.72999999999999998 112.986 -177.163 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -122.54 -52.45 1.92 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.496 1.118 . . . . 3.8100000000000001 110.724 -168.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.78 163.76 13.84 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.705 0.669 . . . . 0.84999999999999998 112.225 -175.067 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.45 64.35 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.271 3.314 . . . . 2.1299999999999999 110.864 -176.603 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t -141.64 146.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.752 2.021 . . . . 0.80000000000000004 106.4 -171.633 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -155.59 136.75 13.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.656 -0.868 . . . . 4.0300000000000002 108.656 176.812 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.77 174.58 44.63 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.129 -0.557 . . . . 0.46999999999999997 111.92 175.374 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.84 118.3 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.082 -1.081 . . . . 1.1000000000000001 108.082 -179.119 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.1 137.49 22.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 105.804 -1.925 . . . . 0.85999999999999999 105.804 165.065 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.33 58.73 1.66 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.742 -0.836 . . . . 2.8700000000000001 108.742 178.004 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.55 168.42 19.81 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.18 -1.008 . . . . 3.6800000000000002 112.162 -168.597 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -144.72 150.31 37.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.706 -1.133 . . . . 3.98 108.146 177.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.427 ' NE2' ' H ' ' A' ' 27' ' ' GLY . 32.6 tt0 -151.26 93.89 1.96 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.448 -1.251 . . . . 3.5899999999999999 108.229 167.506 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -49.21 -39.85 31.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.588 1.329 . . . . 5.2000000000000002 114.588 -178.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -87.21 148.89 24.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.461 1.104 . . . . 5.1100000000000003 110.239 -176.356 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -0.53 18.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.203 1.801 . . . . 3.27 114.935 -173.678 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -170.13 53.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.844 1.656 . . . . 4.6900000000000004 111.218 170.96 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.427 ' H ' ' NE2' ' A' ' 22' ' ' GLN . . . -108.42 -157.7 19.12 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.116 1.341 . . . . 1.1200000000000001 110.722 178.193 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -89.34 141.37 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.06 3.84 . . . . 1.3500000000000001 111.053 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.17 136.18 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.916 -0.401 . . . . 1.1799999999999999 109.916 -175.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -90.29 91.92 8.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.452 -0.944 . . . . 2.54 108.452 173.815 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.4 t -90.57 86.0 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.764 0.826 . . . . 1.3500000000000001 110.419 -170.41 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -102.96 139.51 38.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.148 0.499 . . . . 0.81999999999999995 111.572 173.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.04 41.35 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.066 1.793 . . . . 0.68000000000000005 108.799 170.384 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.8 m -139.54 80.43 1.77 Allowed 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 107.702 -1.221 . . . . 2.3999999999999999 107.702 -176.752 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.78 119.42 33.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.908 -1.145 . . . . 1.22 107.908 -169.091 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.92 162.02 13.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.395 0.678 . . . . 3.6400000000000001 110.705 -175.218 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.59 -10.77 64.85 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.819 0.687 . . . . 1.4399999999999999 114.819 167.276 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.3 154.94 4.09 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.868 1.334 . . . . 1.1299999999999999 110.87 176.874 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -65.59 153.13 42.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.94 -1.1 . . . . 1.6399999999999999 108.231 158.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -52.74 156.24 2.01 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.344 1.057 . . . . 2.7999999999999998 112.073 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 -158.2 31.69 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.276 -0.874 . . . . 0.56999999999999995 112.683 167.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.91 142.54 36.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.882 0.873 . . . . 2.3799999999999999 110.891 -165.492 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -142.04 130.35 22.3 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.775 1.23 . . . . 0.56999999999999995 110.594 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 148.23 36.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.91 -0.876 . . . . 0.46999999999999997 110.91 170.783 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.427 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 52.0 t80 -146.91 96.72 2.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.275 1.43 . . . . 2.6699999999999999 107.798 -171.453 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.553 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 40.6 m80 -131.32 170.93 13.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.227 -0.657 . . . . 0.68999999999999995 109.227 -164.564 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.58 108.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.767 -1.198 . . . . 2.3500000000000001 107.767 173.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.421 ' CD2' HG21 ' A' ' 118' ' ' VAL . 67.6 m-70 -81.52 168.0 18.72 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.0 -1.111 . . . . 1.1000000000000001 108.0 168.57 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.02 -96.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.642 -1.244 . . . . 4.7199999999999998 107.642 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.533 0.32 0 C-N-CA 123.354 0.662 . . . . 3.2400000000000002 112.581 160.326 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.937 0.399 . . . . 3.5 111.921 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.31 -116.22 4.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 116.954 -2.025 . . . . 1.0600000000000001 109.142 -172.417 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.99 179.95 4.42 Favored 'Trans proline' 0 C--N 1.348 0.516 1 C-N-CA 125.337 4.025 . . . . 1.1499999999999999 115.359 -170.576 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -67.74 99.27 0.79 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.384 1.474 . . . . 1.4299999999999999 108.722 -179.231 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -9.52 102.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.127 2.171 . . . . 1.9199999999999999 113.744 172.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -124.47 136.8 28.23 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 127.458 2.303 . . . . 3.1000000000000001 108.13 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.51 -47.43 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.101 1.868 . . . . 1.0800000000000001 109.218 174.812 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.0 -70.97 0.47 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.571 -1.27 . . . . 2.6600000000000001 107.571 170.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.2 t -154.6 90.79 1.34 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.345 -0.613 . . . . 2.79 109.345 -178.552 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -84.64 165.66 17.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.39 -1.337 . . . . 4.6600000000000001 107.39 146.669 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -116.93 170.46 8.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.579 -1.637 . . . . 3.1000000000000001 106.579 174.303 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -84.33 157.17 21.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.083 0.468 . . . . 0.81000000000000005 110.808 -179.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.62 158.5 31.47 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 104.702 -3.359 . . . . 1.97 104.702 160.83 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.91 174.59 8.54 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.325 -1.11 . . . . 1.8200000000000001 110.325 170.821 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.15 -29.7 89.7 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.045 1.83 . . . . 1.3999999999999999 110.176 169.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.87 -52.11 66.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.653 0.781 . . . . 3.96 110.98 171.305 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -73.83 164.81 26.15 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.718 0.636 . . . . 2.1600000000000001 111.177 -178.169 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -89.48 -36.09 15.6 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.457 1.103 . . . . 5.54 112.674 -171.607 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -75.19 166.04 24.25 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.498 -1.297 . . . . 3.04 107.498 165.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 152.21 127.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.387 2.675 . . . . 3.5699999999999998 104.811 -161.142 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.477 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.0 m80 -58.48 149.92 23.98 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.863 -1.162 . . . . 0.57999999999999996 107.863 174.627 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.46 -32.79 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.07 -0.652 . . . . 1.25 109.848 -175.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.5 52.53 2.07 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.308 -0.718 . . . . 0.59999999999999998 113.114 165.642 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -127.42 117.17 21.64 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.186 1.493 . . . . 2.4199999999999999 108.275 164.201 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 84' ' ' LEU . 3.6 mm? -81.39 -53.17 6.54 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.655 -0.869 . . . . 1.5800000000000001 108.655 161.759 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.62 -105.25 0.27 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.81 -0.71 . . . . 0.65000000000000002 112.95 175.218 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.36 155.52 32.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.876 1.271 . . . . 3.6600000000000001 109.059 -166.317 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.97 163.1 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.477 1.111 . . . . 0.65000000000000002 110.41 -175.836 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 m -116.49 103.02 10.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.967 2.107 . . . . 2.79 109.632 -169.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.11 135.38 36.83 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.669 -0.644 . . . . 0.56000000000000005 112.225 176.4 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.58 -92.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.741 1.616 . . . . 4.0499999999999998 110.438 175.505 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -177.21 -26.71 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.658 1.983 . . . . 3.4199999999999999 112.548 -165.112 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -76.06 9.06 2.68 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.831 1.777 . . . . 3.7999999999999998 108.442 148.599 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.67 26.63 72.98 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 119.782 -1.824 . . . . 1.1100000000000001 109.996 178.154 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -84.11 108.48 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.219 -1.4 . . . . 1.3 107.219 -175.795 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.46 155.31 28.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.022 1.329 . . . . 1.4099999999999999 109.129 171.636 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -102.81 58.49 0.78 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.325 2.25 . . . . 6.5199999999999996 107.765 -164.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.98 68.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.397 -0.819 . . . . 1.46 110.792 -161.256 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -121.45 75.45 1.18 Allowed 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.79 1.636 . . . . 0.95999999999999996 108.796 179.099 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.0 mm -106.18 155.31 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.26 1.024 . . . . 1.8100000000000001 109.476 -174.613 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -146.5 122.89 10.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.13 -1.434 . . . . 3.3700000000000001 107.13 168.375 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.88 158.45 25.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.424 1.089 . . . . 2.1000000000000001 109.241 173.14 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -127.6 29.67 5.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.069 1.348 . . . . 1.3600000000000001 111.785 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.18 -49.3 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.667 -1.234 . . . . 1.0900000000000001 107.667 171.312 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.95 174.11 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.558 0.694 . . . . 0.93999999999999995 110.178 171.255 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -156.83 -179.89 8.64 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.178 -1.786 . . . . 2.3500000000000001 106.178 175.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.405 HD22 ' HB3' ' A' ' 22' ' ' GLN . 0.7 OUTLIER -110.77 14.4 22.23 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 2.46 112.197 173.963 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.455 -0.186 0 C-N-CA 124.509 1.124 . . . . 3.02 108.929 -166.7 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.442 -0.83 0 CA-C-O 122.919 1.342 . . . . 2.0800000000000001 112.586 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.89 -6.94 10.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 114.702 -1.136 . . . . 1.9099999999999999 111.094 175.309 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 tp -44.26 131.65 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.331 1.052 . . . . 1.6699999999999999 110.386 172.088 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.87 -25.23 7.72 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.909 0.766 . . . . 1.5900000000000001 112.65 -176.441 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -87.18 162.93 17.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.758 1.279 . . . . 4.1799999999999997 110.333 -166.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -94.01 113.61 25.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.087 0.555 . . . . 0.90000000000000002 110.758 -172.544 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.427 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -70.21 141.28 52.56 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.385 -1.339 . . . . 2.0699999999999998 107.385 167.403 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 48' ' ' HIS . 88.4 t -126.37 133.1 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 126.125 1.77 . . . . 0.35999999999999999 109.211 175.653 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.1 t -98.13 122.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 125.799 1.64 . . . . 2.2400000000000002 106.929 165.213 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.435 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 64.9 m-70 -97.45 156.76 16.33 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 116.284 1.957 . . . . 0.44 116.284 -174.508 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -34.18 -90.39 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 130.232 3.413 . . . . 3.7000000000000002 112.211 168.06 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -174.49 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.873 0.845 . . . . 4.5 109.418 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.54 154.93 10.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.556 -1.202 . . . . 0.97999999999999998 110.099 164.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.06 161.47 8.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.974 -1.012 . . . . 2.3500000000000001 108.93 158.182 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -86.64 -30.49 21.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.988 1.715 . . . . 3.0 111.081 177.183 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 76.16 -1.93 2.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.693 2.397 . . . . 1.9099999999999999 112.982 -172.8 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.61 30.48 4.61 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.866 1.212 . . . . 1.4399999999999999 113.123 163.151 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -129.56 -16.62 3.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.881 1.272 . . . . 4.96 112.823 -173.946 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.91 124.85 31.27 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.33 0.968 . . . . 2.0800000000000001 111.885 175.704 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.02 -29.83 62.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.604 0.621 . . . . 2.77 111.81 175.805 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -53.24 98.63 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.268 1.027 . . . . 2.4399999999999999 109.531 163.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -35.61 -43.26 0.27 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 127.013 2.125 . . . . 4.0199999999999996 113.458 -178.711 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -37.88 -37.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.107 1.763 . . . . 2.6400000000000001 112.668 175.31 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.2 t -50.72 -77.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.159 0.984 . . . . 2.52 110.709 169.726 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 t -58.4 -38.32 77.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.771 -1.205 . . . . 2.6099999999999999 110.959 -177.01 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -59.38 -51.43 69.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.323 1.049 . . . . 4.9900000000000002 110.887 -177.445 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.477 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.281 0.1 OUTLIER -129.72 -54.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.891 0.477 . . . . 1.1699999999999999 112.156 174.504 . . . . . . . . 4 4 . 1 . 034 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.64 -16.24 0.26 Allowed Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.073 0.851 . . . . 0.91000000000000003 113.252 179.078 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.87 52.22 9.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.316 . . . . 2.0899999999999999 110.718 -176.651 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.553 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.41 -50.45 71.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.039 0.936 . . . . 0.93000000000000005 109.921 169.356 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 115.46 -172.09 14.04 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 106.99 -2.444 . . . . 0.93999999999999995 106.99 -168.419 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.6 m -60.93 155.35 20.07 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.388 1.475 . . . . 1.26 113.049 -171.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -61.1 135.57 57.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.323 1.449 . . . . 2.98 108.867 169.538 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.2 mt -111.01 -76.57 0.6 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.678 1.126 . . . . 0.45000000000000001 108.753 168.859 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.05 140.41 37.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.205 -1.406 . . . . 0.68999999999999995 107.205 173.444 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 66.7 m -127.3 159.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.738 -1.578 . . . . 2.1099999999999999 106.738 173.285 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.93 132.85 2.59 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.69999999999999996 110.951 168.201 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.89 136.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.619 1.167 . . . . 0.63 109.037 171.228 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.89 144.15 14.66 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.115 0 C-N-CA 123.222 0.609 . . . . 0.92000000000000004 111.653 -179.01 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.28 0.8 5.81 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.737 0.684 . . . . 0.76000000000000001 113.451 175.116 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.8 mm -87.82 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.499 1.149 . . . . 0.83999999999999997 110.91 -161.187 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.28 175.06 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.335 1.054 . . . . 1.45 110.22 171.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 104.271 -2.492 . . . . 4.6299999999999999 104.271 167.244 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 111.353 0.131 . . . . 3.3999999999999999 111.353 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.81 25.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.591 -1.262 . . . . 0.69999999999999996 107.591 161.058 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.9 t -103.88 145.11 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.778 -1.193 . . . . 0.66000000000000003 107.778 165.206 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.95 97.65 5.04 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.77 -0.826 . . . . 0.40999999999999998 108.77 155.696 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.06 107.81 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.925 -1.509 . . . . 0.66000000000000003 106.925 162.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.1 128.21 35.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.939 -1.134 . . . . 0.98999999999999999 107.939 175.813 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -149.34 -52.02 0.16 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.965 0.412 . . . . 3.5600000000000001 110.663 172.278 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.71 -119.22 4.86 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.52 -0.764 . . . . 0.93000000000000005 111.526 -175.648 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.38 -42.66 2.65 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.806 1.242 . . . . 3.1000000000000001 110.353 -165.821 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.49 166.99 10.69 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 123.825 0.726 . . . . 0.82999999999999996 111.309 177.411 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.38 -21.65 53.62 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.407 2.738 . . . . 1.1599999999999999 111.993 179.584 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 89.6 t -50.01 141.77 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.828 1.251 . . . . 0.97999999999999998 110.822 177.112 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.56 125.09 6.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.909 -1.145 . . . . 2.0299999999999998 107.909 -175.752 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.65 172.67 40.44 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 121.764 -0.585 . . . . 0.52000000000000002 112.52 -177.106 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.31 130.96 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.775 0.83 . . . . 1.22 108.877 176.577 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.24 137.9 23.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.497 -1.298 . . . . 0.70999999999999996 107.497 163.543 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -119.43 99.98 7.02 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.574 -1.269 . . . . 1.8 107.574 166.952 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.569 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -87.66 118.02 26.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.698 1.199 . . . . 2.52 108.566 -178.981 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -148.28 164.72 33.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.014 0.824 . . . . 3.6000000000000001 109.419 167.609 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.66 164.5 38.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.255 1.422 . . . . 4.6500000000000004 107.273 177.265 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -51.22 -46.72 62.33 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.987 0.915 . . . . 4.6799999999999997 112.076 178.728 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -114.31 164.02 14.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.715 -1.217 . . . . 5.8600000000000003 107.715 179.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.0 p -69.2 55.14 0.1 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.023 1.329 . . . . 3.21 109.158 163.466 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 179.4 -153.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.578 1.951 . . . . 4.8099999999999996 106.619 -165.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.25 -178.09 0.4 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 127.191 2.329 . . . . 1.02 115.268 175.022 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.72 110.23 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.601 2.867 . . . . 1.5600000000000001 109.917 -175.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 20' ' ' PHE . 4.0 t -79.63 133.03 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.818 -0.353 . . . . 1.3999999999999999 111.161 -164.655 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -95.97 101.76 13.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.99 -1.485 . . . . 3.6099999999999999 106.99 -174.381 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.569 HG22 ' CE1' ' A' ' 20' ' ' PHE . 25.4 t -89.0 90.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.77 1.228 . . . . 1.1499999999999999 107.877 -173.287 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -97.77 131.41 44.32 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 123.738 0.649 . . . . 1.45 109.271 169.425 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 163.21 30.79 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.177 -0.769 . . . . 0.78000000000000003 111.177 -179.422 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -133.4 99.82 4.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 2.25 106.522 -171.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.15 140.59 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.534 1.134 . . . . 0.93000000000000005 108.647 -169.775 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -145.0 -178.02 5.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.709 0.766 . . . . 3.6800000000000002 112.967 169.56 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.24 75.44 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.922 1.249 . . . . 0.58999999999999997 112.598 -179.025 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -77.62 -157.63 0.1 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.615 -0.883 . . . . 0.81000000000000005 108.615 173.185 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.6 m -143.82 144.43 31.77 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.126 -2.546 . . . . 2.7000000000000002 104.126 168.78 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -40.87 138.04 1.11 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.723 2.409 . . . . 2.6899999999999999 112.857 -168.772 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.32 -171.38 29.45 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.128 -0.487 . . . . 0.59999999999999998 111.979 174.243 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.28 153.19 40.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.663 0.986 . . . . 2.2599999999999998 113.663 -163.155 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.99 126.55 14.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.218 1.807 . . . . 0.52000000000000002 109.323 -179.261 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.65 155.58 10.98 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.658 -0.977 . . . . 0.34999999999999998 110.658 165.78 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 117' ' ' LEU . 1.8 t80 -152.38 92.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.143 1.377 . . . . 2.4199999999999999 107.655 -170.657 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -134.45 161.91 33.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.785 -0.82 . . . . 0.53000000000000003 108.785 -161.03 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.3 m -113.58 140.75 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.906 0.775 . . . . 2.0 109.11 168.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -111.52 172.06 7.11 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.282 1.033 . . . . 1.28 111.252 -168.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -58.02 -21.59 45.88 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.763 0.825 . . . . 5.9299999999999997 113.019 173.209 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 N--CA 1.452 -0.364 0 C-N-CA 126.655 1.982 . . . . 3.3700000000000001 111.133 -179.246 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 110.456 -0.201 . . . . 1.95 110.456 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.25 -91.39 1.56 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.312 -2.315 . . . . 1.47 107.312 169.676 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 179.71 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 124.898 3.732 . . . . 1.1599999999999999 115.066 -176.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -82.25 60.64 5.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.297 1.439 . . . . 2.0099999999999998 110.44 -170.701 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.4 t80 53.6 72.69 0.42 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.048 1.339 . . . . 3.2599999999999998 108.323 -170.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -97.73 98.32 5.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 108.997 -0.742 . . . . 2.8199999999999998 108.997 175.22 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.06 -38.37 7.24 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.196 1.93 . . . . 2.0 111.468 -173.559 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.72 -65.34 0.56 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.712 0.805 . . . . 2.9900000000000002 109.456 173.409 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 m -163.22 100.45 0.95 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.108 -1.441 . . . . 1.5800000000000001 107.108 -171.303 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.6 mmt-85 -126.23 163.0 24.15 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.18 0.992 . . . . 5.8099999999999996 109.86 170.228 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -116.25 149.53 39.05 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.38 1.472 . . . . 3.48 108.362 -172.527 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -78.43 153.57 31.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 112.509 -172.57 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.64 152.26 10.58 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 105.563 -3.015 . . . . 3.02 105.563 172.081 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.89 -133.99 7.05 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.067 -1.613 . . . . 1.77 109.067 177.294 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.6 -52.3 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.768 1.646 . . . . 1.6799999999999999 110.212 173.706 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.94 -34.76 78.16 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.081 1.141 . . . . 4.9800000000000004 114.081 -167.072 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.73 175.83 2.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.698 0.285 . . . . 1.99 110.884 -174.582 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.83 -48.13 11.12 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 4.4000000000000004 109.102 168.074 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -79.64 171.04 15.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.804 0.842 . . . . 3.6699999999999999 110.439 -176.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 174.05 145.37 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.41 2.284 . . . . 3.5800000000000001 110.037 171.54 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.548 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.2 m80 -57.83 143.16 43.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.204 -1.776 . . . . 0.58999999999999997 106.204 160.113 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -52.59 -27.29 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.369 -0.378 . . . . 1.1499999999999999 110.589 174.545 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.55 28.76 12.38 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.49 -1.172 . . . . 0.64000000000000001 115.071 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -94.79 127.81 41.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.455 2.128 . . . . 1.8400000000000001 107.421 159.653 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.85 -54.34 4.95 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.113 -1.44 . . . . 1.8600000000000001 107.113 151.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 153.24 -116.44 0.74 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.394 -1.482 . . . . 0.70999999999999996 109.394 173.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -139.46 160.51 39.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.249 1.02 . . . . 1.9399999999999999 110.34 -174.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.86 178.09 5.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.451 -1.685 . . . . 0.46000000000000002 106.451 171.245 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -129.99 147.1 51.7 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.559 -0.534 . . . . 2.2400000000000002 109.559 164.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.93 146.6 32.02 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.46 -0.941 . . . . 0.72999999999999998 108.46 162.092 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.15 -88.47 0.09 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.524 1.14 . . . . 2.8900000000000001 109.619 177.187 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -137.54 -51.18 0.63 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.949 1.3 . . . . 4.2300000000000004 110.542 -174.399 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.92 15.49 1.79 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.846 1.308 . . . . 2.7000000000000002 111.635 -174.265 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.3 10.11 69.18 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.358 -0.838 . . . . 0.78000000000000003 111.309 -171.625 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.6 140.69 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.036 -1.468 . . . . 0.75 107.036 173.904 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.86 175.9 7.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.073 0.949 . . . . 1.0800000000000001 109.262 174.267 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -110.59 148.42 32.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 103.732 -2.692 . . . . 3.9399999999999999 103.732 176.315 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.46 94.58 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.143 -1.058 . . . . 1.1499999999999999 108.143 153.16 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.7 m -122.04 76.99 1.34 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.217 1.407 . . . . 0.88 109.287 170.818 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.42 157.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.574 -0.528 . . . . 1.5700000000000001 109.574 179.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -144.68 89.41 1.98 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.149 0.58 . . . . 3.0299999999999998 110.654 166.684 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.84 162.37 26.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.896 -0.409 . . . . 2.2000000000000002 109.896 172.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 p -124.67 7.17 8.18 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.019 1.328 . . . . 1.6499999999999999 113.159 179.321 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.88 -51.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 119.076 0.853 . . . . 1.1699999999999999 108.773 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.39 159.54 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.407 0.623 . . . . 1.01 111.23 -177.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.1 p -120.06 177.4 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.266 2.226 . . . . 2.9300000000000002 107.632 175.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -112.26 27.62 9.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.36 0.664 . . . . 2.5600000000000001 110.944 166.767 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.409 -0.589 . . . . 2.9100000000000001 109.409 177.89 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 122.776 1.274 . . . . 1.9199999999999999 111.709 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.59 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -77.48 -7.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.443 -1.708 . . . . 2.1400000000000001 110.836 170.971 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.8 mm -61.06 128.55 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 119.978 1.263 . . . . 2.0899999999999999 108.404 -177.481 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.38 33.38 84.39 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 112.036 -0.426 . . . . 1.6799999999999999 112.036 -171.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -105.94 163.94 12.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.262 -1.755 . . . . 4.9800000000000004 106.262 149.814 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.2 m -92.59 123.88 36.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.406 1.083 . . . . 0.88 108.434 171.795 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.532 HD21 ' CE2' ' A' ' 45' ' ' PHE . 5.6 tt -80.47 145.99 31.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.102 -1.073 . . . . 2.4199999999999999 108.102 167.087 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.73 133.47 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 127.549 2.34 . . . . 0.35999999999999999 107.107 -177.62 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.41 118.34 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.564 -1.643 . . . . 1.6699999999999999 106.564 167.367 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -90.99 159.43 16.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.1 1.889 . . . . 0.34999999999999998 116.1 -168.572 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -33.01 -83.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.693 2.797 . . . . 3.3500000000000001 112.617 166.145 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -105.27 -179.23 3.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.542 0.737 . . . . 2.73 109.591 -170.231 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.0 137.76 55.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.553 -0.906 . . . . 0.63 108.553 167.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 160.95 30.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.622 -0.881 . . . . 2.1800000000000002 108.622 163.436 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -15.24 54.07 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.863 1.06 . . . . 3.5800000000000001 113.863 -170.353 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 64.45 4.23 2.16 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.739 -1.226 . . . . 1.73 113.836 -173.022 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.28 60.39 1.06 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 121.242 1.837 . . . . 1.8799999999999999 111.434 167.208 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.82 -51.76 0.37 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.345 1.858 . . . . 5.7300000000000004 110.308 -175.592 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -43.84 122.69 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.619 1.58 . . . . 1.9399999999999999 113.181 -177.973 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.04 -22.99 65.47 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.365 0.507 . . . . 3.2400000000000002 112.79 179.234 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -65.43 102.83 0.74 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.982 0.891 . . . . 2.27 109.055 174.775 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -19.31 -64.34 0.02 OUTLIER 'General case' 0 C--N 1.341 0.236 0 C-N-CA 127.857 2.463 . . . . 3.48 113.899 -172.264 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -37.72 -42.98 0.61 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.549 2.34 . . . . 3.5299999999999998 112.568 -177.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.3 m -55.45 -55.1 35.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.198 0.999 . . . . 2.4300000000000002 111.685 177.14 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -71.18 -48.26 52.76 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.024 -1.048 . . . . 1.3 110.231 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -65.97 -28.88 69.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.856 1.262 . . . . 4.6699999999999999 111.909 -170.241 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.548 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 1.2 t -137.45 -53.89 0.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.589 -1.196 . . . . 1.51 113.14 174.143 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.38 -18.52 1.33 Allowed Glycine 0 N--CA 1.468 0.83 0 CA-C-N 120.126 1.33 . . . . 0.97999999999999998 112.562 -179.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 46.6 54.12 9.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.199 1.8 . . . . 2.2599999999999998 111.751 175.376 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.93 -36.74 56.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.377 0.608 . . . . 1.1000000000000001 110.591 168.728 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 -150.53 17.85 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 108.52 -1.832 . . . . 1.02 108.52 176.105 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.9 p -65.77 151.47 46.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.061 0.763 . . . . 2.2200000000000002 113.061 -164.035 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -60.81 139.46 57.93 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.809 -1.182 . . . . 2.7799999999999998 107.809 166.86 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -115.49 -77.41 0.57 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.749 -1.204 . . . . 0.60999999999999999 107.749 173.504 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.91 157.9 17.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.197 -1.409 . . . . 0.90000000000000002 107.197 165.745 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.6 p -156.83 163.27 39.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.169 -1.832 . . . . 1.3899999999999999 107.102 179.601 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.24 138.39 5.05 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.476 -1.05 . . . . 0.58999999999999997 110.476 179.418 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.06 133.9 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.368 1.067 . . . . 0.73999999999999999 108.54 172.6 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.59 HG21 HG12 ' A' ' 112' ' ' ILE . 14.7 tt -100.11 132.84 44.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 122.769 0.428 . . . . 0.72999999999999998 111.508 -177.051 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.68 2.99 1.01 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.466 1.032 . . . . 0.63 114.675 179.379 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.6 mm -92.63 57.04 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 119.541 1.671 . . . . 0.79000000000000004 110.832 -157.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.1 173.45 16.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.804 . . . . 1.29 109.518 166.305 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 C--O 1.255 1.388 0 N-CA-C 102.892 -3.003 . . . . 4.1299999999999999 102.892 162.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 105.385 -2.08 . . . . 5.7999999999999998 105.385 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.9 m 92.53 121.38 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 126.656 1.982 . . . . 2.7200000000000002 105.887 -162.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.32 144.97 26.57 Favored 'General case' 0 N--CA 1.458 -0.068 0 CA-C-N 118.149 0.431 . . . . 2.9900000000000002 111.288 -173.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -94.97 144.75 25.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.651 -1.24 . . . . 0.67000000000000004 107.651 163.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 t -110.61 142.28 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.747 -0.835 . . . . 0.87 108.747 167.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.01 97.47 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.069 -1.086 . . . . 0.44 108.069 156.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.14 107.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.723 -1.584 . . . . 0.60999999999999999 106.723 161.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.22 124.46 38.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.081 -1.081 . . . . 0.84999999999999998 108.081 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -135.22 -52.05 0.77 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.213 0.605 . . . . 4.21 109.822 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.73 -121.97 4.58 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.811 -1.315 . . . . 0.78000000000000003 109.811 -170.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.89 -37.63 1.51 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.18 0.592 . . . . 3.0699999999999998 111.553 -162.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.27 162.3 18.98 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 110.972 -0.851 . . . . 0.81999999999999995 110.972 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.86 58.95 6.23 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.15 3.234 . . . . 1.78 111.22 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -132.71 152.63 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 127.353 2.261 . . . . 0.98999999999999999 107.269 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -155.04 133.77 12.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.49 -1.3 . . . . 2.5800000000000001 107.49 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.41 168.83 40.21 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.789 -0.72 . . . . 0.44 112.785 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.86 125.67 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 1.1200000000000001 107.345 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.7 136.55 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.883 -1.525 . . . . 0.68999999999999995 106.883 161.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -116.26 106.99 14.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.7 -1.593 . . . . 1.6299999999999999 106.7 165.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -92.74 120.11 32.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 2.6000000000000001 106.877 176.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.62 163.17 33.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.102 0.953 . . . . 3.46 109.935 163.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -156.85 153.82 28.85 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.979 2.112 . . . . 3.1899999999999999 105.405 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -63.42 -62.43 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.323 0.965 . . . . 5.6500000000000004 110.375 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -90.9 -162.38 0.9 Allowed 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 126.802 2.041 . . . . 4.4100000000000001 111.282 -167.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 m -101.69 -68.55 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.643 1.577 . . . . 2.5899999999999999 107.215 158.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -73.58 76.55 1.48 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.526 1.131 . . . . 4.5800000000000001 110.72 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.36 179.35 43.2 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 110.343 -1.103 . . . . 1.01 110.343 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.21 126.06 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.776 2.984 . . . . 1.03 112.123 -170.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.19 140.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.427 -0.583 . . . . 0.87 109.427 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -103.74 99.04 8.82 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.547 -1.649 . . . . 2.8300000000000001 106.547 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG22 ' CE1' ' A' ' 20' ' ' PHE . 30.4 t -89.44 120.91 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.006 -1.479 . . . . 0.93000000000000005 107.006 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -130.92 140.34 50.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.8 -1.185 . . . . 0.93999999999999995 107.8 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.72 153.21 23.71 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.088 -1.205 . . . . 0.75 110.088 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 p -130.04 67.59 1.46 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.088 1.355 . . . . 1.8899999999999999 107.726 -163.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -81.6 139.53 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.541 -1.209 . . . . 0.82999999999999996 108.323 -175.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 7.0 ptpt -134.94 169.53 17.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.452 1.279 . . . . 4.2999999999999998 114.452 170.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 -1.68 79.1 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 114.227 -1.351 . . . . 1.04 113.803 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -56.09 158.83 3.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.668 1.234 . . . . 0.79000000000000004 110.31 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.82 160.55 11.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.375 -0.972 . . . . 1.79 108.375 154.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -60.88 174.04 0.68 Allowed 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.57 -0.706 . . . . 2.6000000000000001 110.822 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.26 -162.19 54.48 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.993 -0.549 . . . . 0.44 112.541 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.17 146.69 47.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.37 0.668 . . . . 2.1400000000000001 111.973 -171.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -144.74 119.3 9.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.486 1.515 . . . . 0.48999999999999999 109.408 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.15 147.83 8.96 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.155 -1.178 . . . . 0.32000000000000001 110.155 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.421 ' CZ ' HG12 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -140.29 96.04 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.502 -1.295 . . . . 2.6499999999999999 107.502 -174.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.773 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 33.3 m170 -130.91 146.6 52.38 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.99 -1.115 . . . . 0.56999999999999995 107.99 -162.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.75 104.91 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 122.09 0.948 . . . . 1.6799999999999999 109.542 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.71 161.87 18.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.245 -1.391 . . . . 0.82999999999999996 107.245 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 6.8 pm0 -51.3 -103.39 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.124 1.77 . . . . 5.46 112.76 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 50.21 67.11 0.97 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.366 0.666 . . . . 2.9700000000000002 112.784 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -73.99 -107.39 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.48 1.112 . . . . 5.1299999999999999 111.138 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -85.12 59.37 5.58 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.135 1.774 . . . . 6.4400000000000004 110.482 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.01 -53.91 6.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.435 0.636 . . . . 5.3200000000000003 110.13 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -170.22 -55.21 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.321 2.248 . . . . 4.5599999999999996 106.783 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -170.37 -53.01 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.16 1.384 . . . . 6.3200000000000003 109.632 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.25 -148.89 12.91 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.328 -1.109 . . . . 4.1100000000000003 110.328 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.5 m -58.4 149.1 25.77 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.084 0.954 . . . . 3.0499999999999998 110.406 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.41 7.74 0.2 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.117 1.525 . . . . 4.8499999999999996 115.117 161.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.4 m -176.0 -40.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 118.54 2.793 . . . . 2.73 118.54 -126.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.16 154.13 20.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.215 1.006 . . . . 1.96 110.658 -170.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.86 -88.32 1.27 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.152 -1.579 . . . . 1.02 109.152 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.57 179.0 4.47 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.948 3.099 . . . . 1.1299999999999999 114.06 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -84.84 59.05 5.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.308 -1.315 . . . . 1.75 109.47 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.5 t80 50.17 68.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.828 . . . . 2.3399999999999999 109.818 -172.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -83.21 115.17 57.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.218 -0.896 . . . . 2.5699999999999998 108.759 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.18 -37.12 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.148 1.898 . . . . 1.55 111.157 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 tt -155.84 -65.7 0.11 Allowed 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.945 -1.131 . . . . 3.0600000000000001 107.945 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -154.95 71.45 0.8 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.705 0.802 . . . . 1.8500000000000001 109.379 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.56 161.34 27.08 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.946 -0.761 . . . . 4.4199999999999999 108.946 165.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 28.2 mttt -109.71 155.72 21.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.809 -1.552 . . . . 3.54 106.809 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -74.85 164.06 26.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0700000000000001 110.587 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.01 148.46 9.28 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 105.447 -3.061 . . . . 2.5699999999999998 105.447 169.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.26 -155.46 4.99 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.444 -1.062 . . . . 1.1699999999999999 110.444 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.71 -46.87 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.728 1.618 . . . . 1.4399999999999999 108.756 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.62 -36.26 75.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.265 1.426 . . . . 4.4000000000000004 113.039 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.95 165.93 1.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.927 0.491 . . . . 2.6600000000000001 110.737 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -79.61 -46.96 16.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.884 1.674 . . . . 4.2699999999999996 109.512 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 44.7 mt-10 -93.47 177.1 6.14 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.209 1.404 . . . . 3.1499999999999999 110.812 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 177.33 160.57 0.44 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 128.55 2.74 . . . . 3.4900000000000002 106.82 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 51.0 m80 -71.51 152.14 43.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.241 -1.763 . . . . 0.56000000000000005 106.241 162.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.49 39.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.4 1.095 . . . . 2.2799999999999998 111.128 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.51 37.27 0.29 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 128.331 2.872 . . . . 0.64000000000000001 110.62 166.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.05 140.57 50.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.427 1.614 . . . . 2.1899999999999999 110.451 157.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.31 -51.22 4.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.708 -1.219 . . . . 1.6399999999999999 107.708 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.45 -103.41 0.23 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.649 -0.98 . . . . 0.56999999999999995 110.649 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -152.16 169.28 22.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.305 1.842 . . . . 1.71 110.461 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.06 176.04 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.649 1.58 . . . . 0.42999999999999999 107.034 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.4 m -125.33 126.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.934 -1.135 . . . . 2.0099999999999998 107.934 174.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.17 141.4 29.58 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.127 0.971 . . . . 0.66000000000000003 111.818 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.11 -90.38 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.153 0.908 . . . . 2.6499999999999999 110.855 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -158.23 -34.37 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.243 0.831 . . . . 4.0499999999999998 113.243 -161.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 38.6 t0 -79.34 17.93 0.76 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 123.797 1.761 . . . . 3.4300000000000002 110.178 158.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.78 17.22 60.24 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 125.189 1.376 . . . . 0.96999999999999997 111.808 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.38 119.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.515 -1.291 . . . . 0.84999999999999998 107.515 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.51 174.24 6.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.444 1.098 . . . . 1.01 109.292 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -132.49 91.24 2.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.196 -2.15 . . . . 3.6899999999999999 105.196 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.1 59.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.775 -0.824 . . . . 1.6100000000000001 108.775 -168.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m -96.56 104.15 16.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.758 1.223 . . . . 1.3700000000000001 109.453 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.02 153.31 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.393 -0.965 . . . . 1.8100000000000001 108.393 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -140.14 82.16 1.85 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.302 0.641 . . . . 2.4199999999999999 109.914 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.52 160.36 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.851 0.46 . . . . 2.1000000000000001 110.969 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.4 p -121.11 4.39 10.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.573 1.549 . . . . 1.3500000000000001 113.16 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.66 -50.43 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.28 0.945 . . . . 1.1599999999999999 109.065 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pp -77.57 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.425 0.631 . . . . 0.93999999999999995 111.043 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -153.66 175.1 13.64 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.746 1.618 . . . . 2.27 107.502 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.87 38.72 4.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.726 0.811 . . . . 2.54 111.144 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 t -99.1 -58.39 1.95 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.716 1.206 . . . . 3.5099999999999998 109.782 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.53 -176.72 40.36 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 108.42 -1.872 . . . . 2.79 108.42 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 55.1 -105.6 0.28 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 117.882 0.841 . . . . 3.7000000000000002 110.93 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -76.9 -13.38 59.99 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.753 1.16 . . . . 4.5899999999999999 111.814 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.6 m -53.35 158.36 1.7 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 119.092 0.86 . . . . 2.1299999999999999 111.279 167.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.441 HD12 ' C ' ' A' ' 112' ' ' ILE 0.257 1.3 pp -95.97 -7.84 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.266 0.469 . . . . 1.5600000000000001 112.266 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' HG23 ' A' ' 149' ' ' ILE . 8.7 tt -45.57 137.03 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.503 0.721 . . . . 1.8999999999999999 110.494 167.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.07 -30.78 6.4 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.727 0.679 . . . . 1.5600000000000001 112.253 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.541 ' O ' HG22 ' A' ' 149' ' ' ILE . 82.8 mtt180 -81.1 166.23 20.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.734 1.267 . . . . 5.1500000000000004 109.897 -168.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.0 m -93.06 108.61 20.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.085 0.469 . . . . 0.87 110.586 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -68.45 148.74 50.19 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.704 -0.85 . . . . 1.6399999999999999 108.704 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.98 137.77 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 125.894 1.677 . . . . 0.38 108.342 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.421 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -108.37 128.33 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.017 -1.105 . . . . 1.6299999999999999 108.017 166.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.531 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 72.1 m-70 -104.8 160.85 14.66 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.121 2.267 . . . . 0.40000000000000002 117.121 -169.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -50.82 -71.96 0.06 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.833 2.053 . . . . 3.3399999999999999 111.902 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -94.3 -178.22 4.53 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.174 0.897 . . . . 2.9399999999999999 110.239 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.97 151.08 27.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.643 -0.873 . . . . 0.52000000000000002 108.643 161.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.53 169.02 18.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.434 -0.58 . . . . 1.97 109.434 163.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.08 -25.78 63.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.471 0.915 . . . . 3.9399999999999999 113.471 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 72.63 -13.71 0.63 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.111 2.164 . . . . 2.1899999999999999 113.006 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.12 33.54 5.7 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.949 1.25 . . . . 2.2000000000000002 110.666 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -91.57 -31.38 15.93 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.501 1.12 . . . . 5.6799999999999997 109.212 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.67 62.78 3.09 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.784 -1.326 . . . . 2.3500000000000001 109.784 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.52 -31.42 57.29 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.563 -1.015 . . . . 4.0499999999999998 110.563 164.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.501 ' ND2' ' H ' ' A' ' 132' ' ' GLU . 1.3 p-10 -141.42 -78.54 0.27 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.421 0.611 . . . . 2.52 111.622 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.501 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 13.5 tt0 179.56 -54.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.335 1.454 . . . . 3.5899999999999999 109.624 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -45.9 -31.4 2.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.7 0.8 . . . . 4.4000000000000004 110.735 167.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -29.57 -77.13 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.821 2.048 . . . . 1.75 113.534 155.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 p -71.63 -39.38 70.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 120.884 -1.135 . . . . 1.24 109.447 -175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -55.28 -51.37 66.88 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.104 0.411 . . . . 3.7000000000000002 111.463 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.543 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.337 1.0 OUTLIER -128.9 -47.92 1.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.361 0.874 . . . . 1.1699999999999999 113.361 175.175 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.15 -5.46 0.39 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.577 1.08 . . . . 0.91000000000000003 115.366 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.3 t30 36.25 57.13 1.05 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.274 1.83 . . . . 2.0 113.549 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.773 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -63.55 -32.75 74.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.339 0.866 . . . . 1.04 113.339 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.53 174.47 50.01 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.312 -1.515 . . . . 1.0600000000000001 109.312 -159.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 m -54.92 154.09 5.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.274 1.43 . . . . 1.46 113.961 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -77.41 142.69 39.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 2.7799999999999998 109.897 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 mt -120.32 -72.64 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.694 -0.854 . . . . 0.54000000000000004 108.694 -174.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.77 149.25 41.1 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.042 0.937 . . . . 0.77000000000000002 108.494 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.04 170.48 20.43 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.054 1.471 . . . . 1.3600000000000001 109.178 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.43 147.19 6.36 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.642 -1.383 . . . . 0.70999999999999996 109.642 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.46 135.25 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.27 1.028 . . . . 0.72999999999999998 109.065 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 115' ' ' ARG . 10.1 tt -92.63 140.03 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.144 0.424 . . . . 0.76000000000000001 112.144 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.403 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 139.68 7.42 1.03 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.579 1.085 . . . . 0.62 114.315 171.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.3 mm -98.65 57.0 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.229 -0.025 0 CA-C-N 119.55 1.675 . . . . 0.76000000000000001 109.917 -154.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.65 176.93 11.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.823 0.849 . . . . 1.4399999999999999 109.452 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 103.267 -2.864 . . . . 4.2800000000000002 103.267 154.184 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 108.426 -0.953 . . . . 5.8200000000000003 108.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m -59.45 133.01 55.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.64 -0.874 . . . . 2.71 108.64 170.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -125.63 141.41 52.04 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.917 0.887 . . . . 2.6299999999999999 111.09 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.27 147.18 24.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.257 -1.016 . . . . 0.77000000000000002 108.257 163.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 152' ' ' ALA . 46.4 t -104.49 152.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 106.164 -1.791 . . . . 0.81000000000000005 106.164 157.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -137.2 96.3 3.25 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.9 -0.778 . . . . 0.68000000000000005 108.9 160.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.26 110.32 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.352 -1.351 . . . . 1.0 107.352 168.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.4 mt -93.85 122.84 36.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.919 -0.771 . . . . 0.93000000000000005 108.919 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.77 -47.97 0.46 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.857 0.863 . . . . 4.2000000000000002 110.578 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.83 -123.47 1.97 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.744 1.164 . . . . 0.92000000000000004 112.779 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -59.52 1.85 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.52 -0.919 . . . . 3.7599999999999998 108.52 -172.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.03 172.19 1.77 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.074 2.274 . . . . 1.02 114.518 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.43 -25.68 48.39 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.606 2.871 . . . . 1.48 111.906 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 62.6 t -51.33 141.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.225 1.01 . . . . 0.75 110.851 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -152.25 92.75 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.83 1.652 . . . . 2.0899999999999999 107.432 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.77 21.17 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.031 0.824 . . . . 0.63 111.867 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.41 131.91 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.294 -1.002 . . . . 1.45 108.294 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 33.7 mm -102.2 147.59 8.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.632 1.573 . . . . 0.81999999999999995 107.954 165.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.64 118.51 24.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.57 -2.011 . . . . 1.6299999999999999 105.57 162.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 31' ' ' VAL . 5.7 t80 -127.95 116.53 20.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.876 -1.898 . . . . 3.2799999999999998 105.876 -168.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 163.88 39.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.274 0.559 . . . . 3.6499999999999999 111.971 -170.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 -177.84 6.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.69 -1.596 . . . . 3.8300000000000001 106.69 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -77.73 -63.22 1.43 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.861 -0.792 . . . . 6.4900000000000002 108.861 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.33 165.62 14.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.828 1.251 . . . . 4.9400000000000004 109.569 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -81.0 -0.78 41.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.765 0.654 . . . . 2.6299999999999999 112.765 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -161.47 83.04 0.61 Allowed 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 121.723 -0.611 . . . . 4.0899999999999999 110.225 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.18 169.74 42.43 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 105.827 -2.909 . . . . 1.23 105.827 171.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.42 114.82 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.587 2.858 . . . . 1.5700000000000001 112.584 -165.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 19.5 t -84.32 142.65 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.82 -0.627 . . . . 0.94999999999999996 109.951 -168.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -95.66 122.46 38.45 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.736 -0.839 . . . . 2.6400000000000001 108.736 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 20' ' ' PHE . 16.1 t -121.72 97.39 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.705 1.602 . . . . 1.0700000000000001 107.727 -169.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -113.76 148.81 35.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.273 -0.64 . . . . 0.82999999999999996 109.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.87 160.46 34.06 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 120.991 -1.068 . . . . 0.73999999999999999 110.964 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.2 p -129.77 113.51 14.8 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 105.486 -2.042 . . . . 1.8200000000000001 105.486 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.74 142.1 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.844 -1.91 . . . . 1.1000000000000001 105.844 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.56 153.49 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.875 -0.516 . . . . 5.4900000000000002 110.368 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.94 21.01 51.98 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.914 1.245 . . . . 0.64000000000000001 112.401 -171.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.14 -168.16 0.37 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.335 1.064 . . . . 0.87 108.753 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.0 m -135.93 166.32 23.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 103.814 -2.662 . . . . 3.46 103.814 159.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.24 175.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.763 1.625 . . . . 2.8999999999999999 114.649 -166.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.04 -170.66 54.72 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 114.975 -1.011 . . . . 1.1499999999999999 112.284 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.37 152.52 27.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.379 1.071 . . . . 2.3300000000000001 110.528 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -145.51 112.83 6.18 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.835 1.254 . . . . 0.52000000000000002 109.277 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.26 150.37 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.835 -0.906 . . . . 0.5 110.835 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE1' HD11 ' A' ' 117' ' ' LEU . 39.1 t80 -142.95 94.49 2.64 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.917 -1.512 . . . . 2.7400000000000002 106.917 -171.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -131.98 162.72 30.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.533 -1.284 . . . . 0.92000000000000004 107.533 -164.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 m -134.97 115.26 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.721 0.691 . . . . 2.4900000000000002 109.624 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -104.69 150.77 24.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.894 1.277 . . . . 1.1599999999999999 110.561 -164.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.78 66.83 0.37 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.071 1.748 . . . . 5.0700000000000003 112.414 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.5 110.51 11.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.577 -1.638 . . . . 3.3399999999999999 106.577 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -153.31 0.09 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.31 0.644 . . . . 5.8799999999999999 109.753 171.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -88.84 115.22 26.23 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.825 1.193 . . . . 7.4699999999999998 110.035 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -152.79 -84.15 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.066 0.946 . . . . 5.3499999999999996 111.245 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.8 m -145.31 133.5 21.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.314 -1.365 . . . . 4.6699999999999999 107.314 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 127.94 34.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.184 -0.672 . . . . 4.9500000000000002 109.184 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.01 52.0 0.05 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.566 -1.413 . . . . 4.5999999999999996 109.566 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.5 m -74.79 29.49 0.09 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.034 0.934 . . . . 3.3599999999999999 113.313 -164.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -79.3 -12.32 59.94 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 119.859 -1.775 . . . . 5.3200000000000003 113.69 -175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.3 m 177.69 68.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 118.861 -1.135 . . . . 6.2800000000000002 112.288 -115.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.61 -86.49 0.17 Allowed 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 122.588 0.355 . . . . 3.3399999999999999 111.02 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.96 -178.35 44.76 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.389 -1.084 . . . . 2.1899999999999999 110.389 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.73 179.35 5.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.085 3.857 . . . . 1.6799999999999999 113.331 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -62.17 57.57 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.189 2.596 . . . . 2.0699999999999998 113.299 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.539 ' CD2' HG13 ' A' ' 81' ' ' VAL . 6.0 t80 35.88 77.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.341 1.056 . . . . 2.9399999999999999 111.016 -160.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -93.74 106.02 19.45 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 108.457 -0.942 . . . . 2.75 108.457 171.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.69 -33.37 10.5 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.286 1.99 . . . . 1.5 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -155.33 -66.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.537 -0.912 . . . . 3.6099999999999999 108.537 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.6 m -154.4 74.71 0.97 Allowed 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.63 -0.669 . . . . 1.8700000000000001 110.36 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -78.31 161.29 27.33 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.699 -0.852 . . . . 5.1799999999999997 108.699 166.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -107.62 148.53 29.21 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.452 1.101 . . . . 4.8099999999999996 108.326 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.442 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 56.8 t60 -78.18 159.64 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.767 -0.373 . . . . 1.1699999999999999 110.691 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.52 160.72 33.02 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 107.448 -2.261 . . . . 2.3300000000000001 107.448 161.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.33 -176.86 29.11 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 117.715 0.758 . . . . 1.99 111.342 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.49 -29.2 37.7 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.104 1.869 . . . . 2.9300000000000002 110.43 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -64.81 -43.45 93.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.329 0.651 . . . . 5.4900000000000002 111.202 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -63.48 147.77 50.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.299 1.047 . . . . 2.5899999999999999 112.183 -168.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.27 -50.78 71.82 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.819 -1.082 . . . . 4.2000000000000002 108.242 167.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -78.02 164.98 24.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.155 0.982 . . . . 3.8500000000000001 110.574 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.37 147.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 C-N-CA 129.255 3.022 . . . . 3.3100000000000001 108.751 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 31.4 m80 -65.44 152.51 43.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 119.504 -0.878 . . . . 0.96999999999999997 109.986 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.539 HG13 ' CD2' ' A' ' 64' ' ' PHE . 7.7 p -67.12 -5.98 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 O-C-N 121.894 -0.504 . . . . 1.8400000000000001 112.307 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.2 50.96 0.77 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.058 -1.026 . . . . 1.1799999999999999 111.772 161.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.25 123.06 1.88 Allowed 'General case' 0 C--O 1.227 -0.087 0 O-C-N 120.811 -1.406 . . . . 2.0299999999999998 110.089 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.13 -52.45 4.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.652 -0.499 . . . . 2.0499999999999998 109.652 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.39 -101.41 0.19 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.068 -1.063 . . . . 0.82999999999999996 111.99 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -155.11 166.03 34.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.084 1.353 . . . . 1.9299999999999999 111.327 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.9 179.71 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.308 1.843 . . . . 0.67000000000000004 106.165 162.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 t -134.32 145.17 48.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.568 -1.271 . . . . 2.2200000000000002 107.568 163.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.22 143.18 35.58 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.601 0.563 . . . . 0.72999999999999998 109.618 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.76 -69.64 0.23 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.474 0.709 . . . . 3.3300000000000001 109.918 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -168.35 -55.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.789 2.036 . . . . 4.1299999999999999 108.53 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.21 29.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.922 1.344 . . . . 4.8200000000000003 110.244 -170.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.13 17.61 72.14 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.59 1.091 . . . . 1.0800000000000001 112.386 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.4 152.33 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.461 -1.311 . . . . 1.0 107.461 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.26 167.22 22.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.495 -1.298 . . . . 0.68000000000000005 107.495 161.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.05 148.95 51.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.668 -2.345 . . . . 2.8399999999999999 104.668 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.6 136.48 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 107.614 -1.254 . . . . 1.54 107.614 164.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.0 m -156.95 70.4 0.63 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.545 1.538 . . . . 0.96999999999999997 108.168 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.58 155.3 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 123.942 0.897 . . . . 1.8700000000000001 109.088 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.6 134.71 29.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.393 -0.595 . . . . 2.71 109.393 145.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -128.64 165.31 21.07 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.332 1.053 . . . . 2.8399999999999999 109.539 170.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 p -104.08 8.0 36.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.078 1.751 . . . . 1.72 112.287 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.4 t -90.53 -49.15 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.368 -0.975 . . . . 1.49 108.368 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.259 0.4 OUTLIER -84.19 175.82 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.05 0.452 . . . . 1.22 111.574 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -160.97 169.12 23.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.325 1.05 . . . . 2.98 109.25 -166.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.7 mp -85.67 -25.79 26.35 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.483 1.113 . . . . 2.8999999999999999 111.907 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.0 t -154.98 -176.18 5.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.951 1.7 . . . . 4.0599999999999996 107.47 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.86 168.06 24.61 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.969 0.795 . . . . 3.4300000000000002 111.696 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -32.27 -53.45 0.3 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 128.828 2.851 . . . . 5.1500000000000004 114.676 -169.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -79.13 -23.27 44.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.575 -0.726 . . . . 3.8399999999999999 112.608 -171.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.0 p -51.3 147.01 6.15 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 122.082 0.944 . . . . 1.48 113.409 -165.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 pp -91.02 -6.3 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.018 -1.446 . . . . 1.55 109.825 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 tp -43.86 123.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 123.897 0.879 . . . . 1.6100000000000001 109.465 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.9 32.53 84.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.926 -0.654 . . . . 1.49 113.093 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -98.32 174.96 6.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.282 -1.007 . . . . 5.5099999999999998 108.282 152.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 m -105.58 117.16 33.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.778 1.231 . . . . 1.05 108.283 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.419 HD11 ' CE1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -61.3 150.62 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.008 -0.738 . . . . 2.3999999999999999 109.008 171.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -140.7 134.6 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.918 1.287 . . . . 0.46000000000000002 107.702 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.33 128.37 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.865 -1.531 . . . . 1.71 106.865 164.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -98.32 160.02 14.56 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 115.182 1.549 . . . . 0.48999999999999999 115.182 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.16 -72.15 0.06 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.138 1.775 . . . . 4.2800000000000002 111.787 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -101.21 -177.71 3.53 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.441 0.696 . . . . 2.9700000000000002 110.038 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.89 151.35 18.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.043 -0.725 . . . . 0.75 109.043 165.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.14 176.33 4.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.321 -0.992 . . . . 1.9199999999999999 108.321 159.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.65 -28.38 66.83 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 3.98 114.351 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 81.55 -7.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.244 2.618 . . . . 2.3100000000000001 113.475 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.12 31.64 11.7 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.82 1.191 . . . . 2.6600000000000001 110.477 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -35.36 32.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 128.224 2.61 . . . . 6.9699999999999998 108.229 168.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.13 41.88 30.6 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.655 1.122 . . . . 3.1699999999999999 111.253 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.64 35.64 1.61 Allowed Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.538 1.169 . . . . 3.75 114.299 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.6 p30 177.64 -89.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.455 1.902 . . . . 3.21 108.703 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -170.38 -57.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.296 1.838 . . . . 2.9399999999999999 107.137 -173.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -56.42 -34.37 66.71 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.745 1.218 . . . . 3.25 110.883 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.1 m -41.84 -68.77 0.16 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.898 1.279 . . . . 1.8999999999999999 112.087 167.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -43.78 69.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.3 -0.875 . . . . 1.6799999999999999 110.059 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 132' ' ' GLU . 20.9 ttmt -57.81 -42.86 85.12 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.104 0.962 . . . . 2.5899999999999999 111.647 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.255 4.2 p -132.53 -52.28 0.94 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.676 0.621 . . . . 1.54 112.676 178.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.442 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 154.52 -25.13 0.66 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 124.092 0.854 . . . . 0.91000000000000003 112.171 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t30 41.55 56.2 3.32 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.92 1.688 . . . . 2.4700000000000002 111.06 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.3 -50.55 18.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.293 -0.963 . . . . 1.49 108.992 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 132.11 -151.95 20.02 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 107.427 -2.269 . . . . 1.54 107.427 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 t -67.76 -179.71 1.21 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.326 1.06 . . . . 3.1699999999999999 111.98 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -105.44 152.23 23.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.611 2.364 . . . . 3.2400000000000002 111.405 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.5 -85.27 0.66 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.371 -1.344 . . . . 0.75 107.371 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.497 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -94.17 155.23 17.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.173 -1.047 . . . . 1.01 108.173 164.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 18.5 p -146.93 168.09 22.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.107 -1.406 . . . . 2.02 107.776 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.99 140.93 4.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.126 -1.19 . . . . 0.67000000000000004 110.126 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.93 137.98 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.897 0.879 . . . . 0.84999999999999998 108.96 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.0 tt -101.43 125.43 55.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.205 0.526 . . . . 0.91000000000000003 111.231 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.21 8.87 0.42 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.539 1.066 . . . . 0.62 114.306 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.11 55.39 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 120.116 1.958 . . . . 1.05 110.19 -161.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -158.87 176.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.563 1.145 . . . . 1.5800000000000001 109.412 168.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 102.844 -3.021 . . . . 4.9800000000000004 102.844 150.895 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 118.736 -0.649 . . . . 8.1500000000000004 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.3 p -70.85 -177.05 1.48 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.566 1.146 . . . . 4.0099999999999998 110.279 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.8 pttm -78.51 175.09 10.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.505 -0.554 . . . . 2.6899999999999999 109.505 158.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.5 153.41 48.78 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.909 2.083 . . . . 0.68000000000000005 108.148 167.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -118.87 143.12 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.412 -1.329 . . . . 0.75 107.412 170.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.95 99.83 6.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.141 1.376 . . . . 0.48999999999999999 108.996 156.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 113.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.573 -1.269 . . . . 0.56999999999999995 107.573 159.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.71 125.12 49.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.359 1.064 . . . . 1.01 109.056 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -132.23 -53.2 0.96 Allowed 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.409 0.684 . . . . 3.9500000000000002 110.215 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.43 -124.14 13.86 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.036 0.827 . . . . 0.93000000000000005 113.832 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -114.12 -52.47 2.73 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.867 1.267 . . . . 3.7999999999999998 108.859 -158.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.05 160.52 26.45 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 110.295 -1.122 . . . . 0.90000000000000002 110.295 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.52 40.59 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.72 2.946 . . . . 1.01 112.711 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.04 156.18 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.807 1.643 . . . . 0.79000000000000004 108.934 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -153.63 93.0 1.63 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.523 -0.917 . . . . 2.6200000000000001 108.523 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.91 162.53 14.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 124.03 0.824 . . . . 0.60999999999999999 111.462 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.8 mt -130.95 120.56 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 106.532 -1.655 . . . . 1.28 106.532 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.4 mm -84.23 146.37 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.319 1.048 . . . . 0.75 108.221 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -124.85 101.18 6.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.244 -1.761 . . . . 2.4700000000000002 106.244 166.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -79.66 91.09 5.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.245 -2.132 . . . . 2.2999999999999998 105.245 166.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.39 140.84 31.28 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.824 -1.547 . . . . 3.6600000000000001 106.824 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -157.96 151.36 23.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.759 -1.941 . . . . 3.8999999999999999 105.759 167.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.91 -65.31 1.18 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.072 0.851 . . . . 6.9400000000000004 108.769 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -78.97 119.23 21.83 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.583 -0.895 . . . . 5.1799999999999997 108.583 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 m -35.4 -64.11 0.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.403 2.681 . . . . 2.6099999999999999 113.815 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.0 37.21 0.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.582 -0.699 . . . . 3.6299999999999999 111.114 177.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.67 167.34 22.17 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.322 0.963 . . . . 1.4399999999999999 111.291 -174.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.7 139.21 51.92 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.458 2.772 . . . . 1.52 112.019 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -89.32 126.71 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.305 -0.998 . . . . 0.93000000000000005 108.305 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -83.6 98.86 9.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.436 -1.69 . . . . 2.8900000000000001 106.436 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' A' ' 20' ' ' PHE . 41.9 t -97.25 85.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.746 1.618 . . . . 1.3400000000000001 107.387 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -98.61 162.13 13.3 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.204 -0.665 . . . . 1.1200000000000001 109.204 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.41 153.57 23.15 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.834 -0.906 . . . . 0.67000000000000004 110.834 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 p -121.98 79.43 1.58 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.245 1.418 . . . . 2.4500000000000002 107.488 -171.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -96.99 125.2 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.69 1.196 . . . . 0.94999999999999996 108.934 -170.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.73 158.58 43.77 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.711 -0.477 . . . . 5.0599999999999996 109.711 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.52 19.52 48.53 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.675 1.607 . . . . 0.69999999999999996 113.34 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.83 170.28 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.648 -0.913 . . . . 0.59999999999999998 108.962 170.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.1 163.39 27.98 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.711 -1.218 . . . . 1.6899999999999999 107.711 149.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -61.63 175.91 0.57 Allowed 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.382 -0.824 . . . . 3.3500000000000001 111.03 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.62 -165.54 52.2 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.272 0.939 . . . . 0.46000000000000002 112.607 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.52 141.99 58.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.802 1.241 . . . . 1.9399999999999999 113.045 -174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -143.12 118.38 10.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.756 1.622 . . . . 0.45000000000000001 108.592 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.46 149.3 2.14 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.751 -0.939 . . . . 0.35999999999999999 110.751 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -139.91 94.16 2.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.327 -1.731 . . . . 3.0699999999999998 106.327 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.566 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 26.5 m80 -138.86 153.49 48.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.723 -1.584 . . . . 0.83999999999999997 106.723 -166.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.24 121.76 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.637 0.732 . . . . 1.5600000000000001 109.792 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.438 ' CD2' HG21 ' A' ' 118' ' ' VAL . 21.3 m-70 -96.19 144.2 26.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.154 2.182 . . . . 0.84999999999999998 109.548 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -33.97 -90.87 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.539 2.736 . . . . 5.3799999999999999 112.671 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HG2' ' HB2' ' A' ' 60' ' ' ALA . 5.1 mt-10 43.34 56.1 4.44 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.103 1.52 . . . . 3.6899999999999999 115.103 170.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -78.71 43.69 0.5 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.73 -0.606 . . . . 5.1500000000000004 110.35 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 t70 179.1 135.37 0.09 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 129.556 3.142 . . . . 4.8300000000000001 105.451 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.41 48.6 2.04 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.054 -1.091 . . . . 4.4500000000000002 108.054 165.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.3 t -62.34 -46.2 89.76 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.544 -0.722 . . . . 4.6699999999999999 111.395 -171.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.59 -47.19 13.37 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.751 0.82 . . . . 5.29 109.3 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.9 -171.27 37.79 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 106.289 -2.724 . . . . 3.4900000000000002 106.289 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.8 p -74.05 154.87 39.04 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 117.805 0.802 . . . . 2.6000000000000001 111.133 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.2 p -134.0 163.14 30.21 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.058 1.343 . . . . 4.7699999999999996 111.381 -166.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.421 0.7 OUTLIER 45.18 -96.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 118.041 2.608 . . . . 4.4900000000000002 118.041 105.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . . . 28.67 -118.42 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.04 2.536 . . . . 2.7000000000000002 114.645 -173.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.82 -167.58 30.52 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.887 -1.685 . . . . 1.27 108.887 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 178.75 4.34 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.315 3.343 . . . . 1.1599999999999999 113.142 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -47.61 123.48 5.89 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.338 1.455 . . . . 1.25 110.182 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -45.86 122.92 4.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.724 0.809 . . . . 2.46 111.027 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -155.4 152.84 25.56 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 106.679 -1.601 . . . . 2.54 106.679 171.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.22 -20.33 24.81 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.228 1.952 . . . . 1.3200000000000001 113.806 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.81 -70.08 0.11 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.463 1.029 . . . . 3.0 111.195 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.9 t -157.43 69.53 0.56 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.254 0.622 . . . . 2.1200000000000001 109.488 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -79.21 175.04 10.95 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.379 0.609 . . . . 4.7800000000000002 110.374 168.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -118.55 161.24 20.36 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 106.33 -1.73 . . . . 3.21 106.33 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -85.9 165.21 16.97 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.639 0.654 . . . . 1.0600000000000001 109.382 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.53 -65.84 0.02 OUTLIER Glycine 0 C--O 1.223 -0.591 0 N-CA-C 108.201 -1.959 . . . . 2.9199999999999999 108.201 169.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.15 -171.27 27.87 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.604 1.097 . . . . 1.45 111.978 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.14 -46.85 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.743 2.295 . . . . 1.6100000000000001 109.796 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.66 -36.41 82.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.611 0.764 . . . . 4.2800000000000002 112.017 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.1 176.95 0.66 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.277 1.031 . . . . 1.8 112.042 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.69 -48.3 11.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.052 1.341 . . . . 4.6100000000000003 109.71 165.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -98.4 156.58 16.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.311 1.044 . . . . 3.5099999999999998 112.68 -166.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.69 150.0 0.64 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.768 1.627 . . . . 4.0599999999999996 110.0 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 44.5 m80 -55.84 136.6 51.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 104.979 -2.23 . . . . 0.70999999999999996 104.979 156.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -58.98 -23.17 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.185 -0.606 . . . . 1.47 109.947 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.87 39.24 2.8 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.372 1.463 . . . . 0.72999999999999998 115.083 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -102.9 136.63 42.37 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.772 1.786 . . . . 1.9099999999999999 106.831 153.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.6 -52.74 3.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.469 -0.938 . . . . 1.8600000000000001 108.469 147.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.38 -106.72 0.29 Allowed Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.964 -0.854 . . . . 0.65000000000000002 110.964 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.69 165.66 31.69 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.261 1.425 . . . . 1.6599999999999999 109.524 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.38 175.38 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 106.174 -1.788 . . . . 0.5 106.174 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -120.67 141.72 50.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.769 -1.197 . . . . 2.0699999999999998 107.769 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.3 138.84 34.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.398 0.679 . . . . 0.63 109.979 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.45 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.571 0.544 . . . . 3.3599999999999999 110.134 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -53.79 1.52 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.928 0.891 . . . . 4.6299999999999999 111.52 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.05 26.61 2.08 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 123.368 1.556 . . . . 2.7999999999999998 110.78 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.8 17.9 67.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 114.524 -1.217 . . . . 0.59999999999999998 111.596 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.6 t -89.02 122.63 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 125.378 1.471 . . . . 0.76000000000000001 107.306 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.16 175.99 5.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.894 1.277 . . . . 0.83999999999999997 107.662 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -133.67 148.21 51.48 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 103.62 -2.733 . . . . 2.9100000000000001 103.62 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.01 139.79 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.874 -1.528 . . . . 1.76 106.874 160.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.1 m -158.16 59.69 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.303 1.841 . . . . 1.3400000000000001 108.078 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.08 151.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 107.638 -1.245 . . . . 1.52 107.638 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -124.99 90.06 3.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.853 -0.795 . . . . 3.5899999999999999 108.853 166.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.63 152.89 31.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.461 0.573 . . . . 2.7000000000000002 110.637 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -132.07 41.9 3.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.779 1.232 . . . . 1.6299999999999999 110.295 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -127.57 -54.33 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.596 1.158 . . . . 1.3600000000000001 108.197 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -86.42 173.02 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.224 0.535 . . . . 1.3899999999999999 110.566 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.2 m -140.86 173.95 10.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.324 1.85 . . . . 1.96 106.835 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.6 -3.37 46.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.137 0.421 . . . . 3.7400000000000002 112.137 170.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t -150.87 153.14 34.78 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.881 -1.526 . . . . 3.48 106.881 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.41 -155.78 22.08 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 107.412 -2.275 . . . . 2.6600000000000001 107.412 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.71 -73.74 0.42 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.382 -0.97 . . . . 4.2599999999999998 108.382 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.15 4.73 9.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.645 1.178 . . . . 4.5999999999999996 113.141 -173.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.7 p -49.96 137.56 16.78 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 119.233 0.924 . . . . 1.5 108.738 167.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.27 -12.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.534 -0.466 . . . . 1.7 110.794 -169.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.9 tp -16.85 119.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 127.877 2.471 . . . . 1.8100000000000001 113.353 164.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.59 -17.39 59.18 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.181 -1.344 . . . . 1.54 113.386 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.3 169.07 18.25 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.951 1.875 . . . . 4.0199999999999996 111.735 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.4 m -96.17 110.38 22.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.213 1.005 . . . . 0.93999999999999995 109.472 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.29 144.28 54.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.222 0.919 . . . . 1.6799999999999999 108.705 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.438 HG21 ' CD2' ' A' ' 48' ' ' HIS . 98.7 t -130.79 136.41 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 124.87 1.268 . . . . 0.53000000000000003 109.087 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.3 m -103.39 126.9 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.794 -1.558 . . . . 1.53 106.794 163.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.488 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 61.6 m-70 -100.97 161.0 13.9 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 116.358 1.985 . . . . 0.38 116.358 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -39.61 -70.33 0.11 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.949 2.9 . . . . 3.0 112.273 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -112.72 -172.49 2.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.426 1.012 . . . . 2.7200000000000002 108.848 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.12 160.59 9.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.917 -0.771 . . . . 0.57999999999999996 108.917 162.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.3 167.11 21.86 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.721 0.772 . . . . 1.8899999999999999 109.808 158.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.7 -6.98 57.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.463 1.905 . . . . 3.4100000000000001 111.282 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 36.06 20.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.886 2.074 . . . . 1.6399999999999999 111.068 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.49 27.43 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.44 -0.788 . . . . 1.9199999999999999 112.65 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -111.67 -34.03 6.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.063 1.345 . . . . 5.9500000000000002 109.623 -171.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -48.39 126.76 16.38 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.247 -1.141 . . . . 2.7200000000000002 110.247 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.62 64.43 2.94 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.341 0.972 . . . . 2.4900000000000002 111.69 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -163.58 117.44 1.55 Allowed 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 106.619 -1.623 . . . . 2.6200000000000001 106.619 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.15 -54.53 0.61 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.814 1.646 . . . . 3.4399999999999999 113.786 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -27.54 -49.64 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.791 2.836 . . . . 3.5699999999999998 113.983 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -44.47 -60.22 2.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.399 1.88 . . . . 2.2200000000000002 110.435 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.7 p -72.99 -42.51 63.19 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.091 -0.381 . . . . 1.29 110.579 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -51.99 -53.69 38.57 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.353 1.061 . . . . 3.6899999999999999 110.862 -172.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.451 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.3 p -123.39 -42.31 2.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.27 0.228 . . . . 1.48 111.567 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 141.19 -27.51 2.41 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.447 -1.061 . . . . 0.98999999999999999 110.447 -169.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.3 t30 55.23 54.41 8.78 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 122.665 1.222 . . . . 1.6799999999999999 110.463 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -64.69 -27.83 69.19 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.812 1.245 . . . . 0.93000000000000005 112.812 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.18 179.42 52.52 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 108.514 -1.834 . . . . 1.04 108.514 -160.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.4 m -59.21 148.94 29.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.286 1.217 . . . . 1.27 114.286 -164.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -51.38 126.09 16.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.652 2.381 . . . . 3.0299999999999998 109.346 166.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.7 mt -109.26 -71.16 0.77 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-N 120.098 1.317 . . . . 0.5 108.669 170.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -100.89 154.52 18.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.565 -0.532 . . . . 0.83999999999999997 109.565 -175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.81 160.16 16.76 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.676 0.61 . . . . 1.45 111.391 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.89 144.84 4.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 128.382 2.896 . . . . 1.04 105.954 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.23 143.36 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 118.023 0.911 . . . . 0.81999999999999995 110.671 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 tt -92.92 139.83 17.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.555 0.742 . . . . 0.73999999999999999 112.71 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.06 -4.83 1.2 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.192 0.901 . . . . 0.60999999999999999 114.777 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -90.55 58.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.715 1.258 . . . . 1.1799999999999999 109.101 -156.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.6 143.69 30.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.518 -0.739 . . . . 1.8300000000000001 112.263 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 103.511 -2.774 . . . . 6.5999999999999996 103.511 141.554 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 117.819 -1.086 . . . . 6.6100000000000003 108.085 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.02 141.74 3.99 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.182 1.393 . . . . 3.8599999999999999 112.024 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.93 175.51 9.98 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.858 -1.164 . . . . 3.52 107.858 170.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.64 138.39 34.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.338 -0.986 . . . . 0.78000000000000003 108.338 163.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 t -99.79 136.27 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 106.885 -1.524 . . . . 1.22 106.885 169.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -117.88 94.5 4.54 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 124.329 1.052 . . . . 0.47999999999999998 108.236 158.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -65.84 102.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.45 -1.315 . . . . 1.01 107.45 165.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.3 134.68 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.037 0.535 . . . . 0.93999999999999995 109.889 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -149.65 -50.31 0.14 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.657 0.383 . . . . 4.1299999999999999 111.618 166.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.43 -123.8 16.57 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.72 1.152 . . . . 1.0700000000000001 112.971 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.12 -51.77 2.92 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.47 1.108 . . . . 3.9900000000000002 108.621 -159.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.22 172.75 16.39 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.663 1.601 . . . . 0.91000000000000003 111.851 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 27.69 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.433 2.755 . . . . 1.05 112.674 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 15' ' ' GLN . 25.4 t -82.1 165.38 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 1.05 109.11 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.401 ' N ' HG12 ' A' ' 14' ' ' VAL . 6.3 pt20 -156.33 139.1 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.937 1.695 . . . . 3.1600000000000001 106.729 168.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.77 43.39 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.21 -0.995 . . . . 0.78000000000000003 111.651 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.21 126.45 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.071 -1.455 . . . . 1.98 107.071 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.1 mm -92.51 129.24 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.269 -1.382 . . . . 0.90000000000000002 107.269 165.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.75 108.7 21.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.875 -1.528 . . . . 2.1699999999999999 106.875 159.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CZ ' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -87.1 131.97 33.98 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.705 -1.961 . . . . 2.3599999999999999 105.705 162.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.39 165.16 36.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.226 0.921 . . . . 3.4700000000000002 111.49 158.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -155.26 145.46 21.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 104.714 -2.328 . . . . 3.0899999999999999 104.714 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -81.46 -36.91 28.78 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.875 -1.157 . . . . 7.4500000000000002 107.875 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -77.81 -167.4 0.97 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.721 2.808 . . . . 4.6299999999999999 110.037 171.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -139.83 26.56 2.27 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.877 1.271 . . . . 2.3999999999999999 109.425 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 179.03 35.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.485 1.114 . . . . 5.7199999999999998 110.202 -152.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.44 -162.27 9.73 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.628 -1.389 . . . . 0.97999999999999998 109.628 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.35 144.95 29.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.294 2.663 . . . . 1.1200000000000001 110.104 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -88.11 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.523 -0.917 . . . . 1.02 108.523 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -111.08 124.01 51.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.568 -1.641 . . . . 2.8199999999999998 106.568 165.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -120.57 124.51 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.95 -1.5 . . . . 1.3600000000000001 106.95 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -140.64 138.0 34.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.609 -0.515 . . . . 1.25 109.609 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.67 139.4 4.66 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.525 -1.43 . . . . 0.98999999999999999 109.525 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.6 m -119.17 91.16 3.49 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.34 1.056 . . . . 2.4100000000000001 108.987 -167.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.2 mm -87.47 152.74 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.091 2.156 . . . . 1.3799999999999999 109.332 -165.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.89 146.69 33.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.329 0.651 . . . . 4.1699999999999999 109.66 -172.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.65 18.99 42.47 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.008 1.289 . . . . 0.60999999999999999 112.703 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 162.58 28.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.566 -0.902 . . . . 0.89000000000000001 108.566 168.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.48 163.84 27.29 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.991 -1.114 . . . . 1.9199999999999999 107.991 155.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.53 176.39 0.5 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.435 -0.791 . . . . 2.3599999999999999 111.133 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.5 -165.95 46.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.659 0.647 . . . . 0.46999999999999997 113.648 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.87 147.94 52.59 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.649 0.78 . . . . 2.3700000000000001 112.023 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -142.52 119.91 11.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.859 1.664 . . . . 0.63 108.059 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.99 148.0 6.8 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.719 -1.352 . . . . 0.44 109.719 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.437 ' CZ ' HG11 ' A' ' 97' ' ' VAL . 24.1 t80 -141.72 95.79 2.87 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.488 -1.301 . . . . 2.46 107.488 -172.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -133.67 161.75 33.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.624 -1.25 . . . . 0.62 107.624 -163.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.83 137.72 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 108.932 -0.766 . . . . 2.0099999999999998 108.932 165.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.415 ' CD2' HG21 ' A' ' 118' ' ' VAL . 22.8 m-70 -98.8 151.11 21.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.579 1.151 . . . . 0.84999999999999998 109.422 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -36.23 -59.62 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.371 1.868 . . . . 4.7699999999999996 112.37 -174.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 2.21 87.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.041 3.337 . . . . 3.3500000000000001 116.706 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.66 -51.72 68.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.12 0.418 . . . . 4.7300000000000004 111.431 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 t0 178.69 92.85 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 126.021 1.729 . . . . 5.25 109.121 167.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -40.28 71.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.377 -0.829 . . . . 4.0899999999999999 112.754 165.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 t 178.47 -42.31 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.014 1.326 . . . . 4.3799999999999999 110.292 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 169.34 -46.93 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 126.712 2.005 . . . . 6.54 109.753 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.31 -106.65 0.23 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 125.045 1.307 . . . . 4.2400000000000002 111.546 -172.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 20.5 p -169.06 -129.37 0.01 OUTLIER 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.006 0.743 . . . . 2.79 113.006 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p 52.47 68.19 0.86 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.361 2.264 . . . . 4.4900000000000002 111.892 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.2 t -172.33 -10.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 117.32 2.341 . . . . 3.3900000000000001 117.32 -141.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.9 155.6 10.24 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.488 1.04 . . . . 2.04 109.527 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.17 -85.17 0.84 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.079 -1.209 . . . . 1.22 110.079 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.61 175.4 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.309 2.673 . . . . 1.0 116.118 -161.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -83.55 57.22 3.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 113.695 -1.593 . . . . 2.04 110.996 -170.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 59.79 75.44 0.4 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.345 0.658 . . . . 1.9199999999999999 109.353 -172.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.21 87.91 0.52 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 3.29 108.939 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -62.81 -43.67 19.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.246 1.297 . . . . 1.6499999999999999 110.136 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.49 -93.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.783 -0.821 . . . . 2.4900000000000002 108.783 165.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.1 p -137.37 60.7 1.64 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.794 0.838 . . . . 3.2599999999999998 110.399 -161.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -82.16 161.64 22.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.769 -1.196 . . . . 4.5599999999999996 107.769 159.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -128.94 175.28 8.78 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.728 -1.582 . . . . 4.3499999999999996 106.728 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -106.08 132.6 51.96 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.251 -1.018 . . . . 1.3500000000000001 108.251 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -124.06 -48.88 0.22 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.437 -1.465 . . . . 3.46 109.437 173.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.54 176.14 21.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.31 1.91 . . . . 1.6699999999999999 109.029 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -57.86 -43.71 46.84 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.42 2.08 . . . . 2.0600000000000001 110.614 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -70.47 -47.47 60.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.846 1.658 . . . . 4.2400000000000002 111.817 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -62.44 152.46 34.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.464 0.705 . . . . 1.78 111.573 -168.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -50.99 -51.43 52.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.582 1.553 . . . . 3.9399999999999999 111.837 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.94 146.42 26.16 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 122.924 1.345 . . . . 3.4500000000000002 111.444 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -170.84 134.69 1.02 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.931 -1.486 . . . . 4.0 107.002 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.2 m80 -51.46 140.74 17.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.219 -1.4 . . . . 0.55000000000000004 107.219 158.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.69 -14.1 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.988 -0.551 . . . . 1.1599999999999999 110.291 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.22 35.22 4.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.071 0.843 . . . . 0.68000000000000005 115.143 165.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -94.89 117.85 30.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.818 1.809 . . . . 1.9299999999999999 106.619 158.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.39 -61.35 2.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.11 -1.441 . . . . 2.7400000000000002 107.11 158.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.41 -106.42 0.25 Allowed Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.387 -0.685 . . . . 0.80000000000000004 111.387 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -152.45 169.84 21.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.493 1.517 . . . . 1.6799999999999999 109.427 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.03 169.99 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.131 -1.433 . . . . 0.45000000000000001 107.131 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.4 m -122.7 120.27 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.618 -1.253 . . . . 2.2599999999999998 107.618 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 141.85 35.85 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.109 0.564 . . . . 0.62 109.888 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.51 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.309 2.244 . . . . 3.9300000000000002 110.459 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -172.88 -45.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.205 1.402 . . . . 3.79 108.855 -161.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -77.5 8.43 4.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 122.234 1.016 . . . . 2.73 110.929 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.46 19.44 78.13 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.123 -0.985 . . . . 0.79000000000000004 110.728 -176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.6 t -86.39 137.64 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.087 . . . . 0.67000000000000004 108.064 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.12 167.25 21.31 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.931 -1.507 . . . . 0.78000000000000003 106.931 167.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -148.28 138.41 22.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.176 -1.416 . . . . 3.8700000000000001 107.176 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.437 HG11 ' CZ ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -116.35 56.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 124.331 1.019 . . . . 1.53 111.349 -173.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.8 m -70.3 88.51 0.64 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.981 0.512 . . . . 1.1599999999999999 109.962 166.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.8 mm -127.56 160.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.104 0.961 . . . . 2.1400000000000001 109.611 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -146.66 76.41 1.43 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.397 0.679 . . . . 2.3700000000000001 111.177 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.1 143.73 35.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.935 0.398 . . . . 2.1299999999999999 110.156 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -106.35 -4.21 20.25 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.033 1.733 . . . . 1.55 112.843 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.06 -46.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.701 1.2 . . . . 1.1200000000000001 107.963 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.95 168.82 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.02 0.438 . . . . 1.27 110.507 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 m -146.2 167.52 23.26 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.803 1.641 . . . . 1.78 106.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 pp -99.01 -0.35 42.19 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.597 0.592 . . . . 2.3199999999999998 112.597 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p -155.04 167.41 30.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.189 1.395 . . . . 3.1899999999999999 108.055 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.34 155.12 15.86 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.403 -0.679 . . . . 2.8300000000000001 111.403 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.43 55.57 0.23 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.314 2.645 . . . . 4.2400000000000002 112.192 -169.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -158.4 -36.05 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 128.336 2.655 . . . . 4.4900000000000002 109.6 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.2 p -44.47 155.03 0.1 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.276 1.584 . . . . 1.25 115.276 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.462 HD11 ' CZ ' ' A' ' 20' ' ' PHE 0.271 2.0 pp -95.34 -4.53 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 113.335 -1.757 . . . . 1.5600000000000001 111.207 174.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tp -39.08 131.42 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.892 0.877 . . . . 1.5600000000000001 109.824 162.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.63 49.54 72.89 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.232 -0.747 . . . . 1.9399999999999999 111.232 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -137.1 163.83 29.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.58 -1.637 . . . . 3.9700000000000002 106.58 164.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 m -90.61 111.84 23.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 118.691 -0.671 . . . . 0.97999999999999998 110.121 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.36 143.16 57.32 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.556 -0.905 . . . . 1.72 108.556 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 48' ' ' HIS . 76.6 t -134.67 139.58 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.337 1.855 . . . . 0.46000000000000002 108.294 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -110.96 125.11 68.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.253 -1.017 . . . . 1.5900000000000001 108.253 162.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -94.45 163.46 13.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 115.355 1.613 . . . . 0.44 115.355 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.78 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.201 1.4 . . . . 3.5699999999999998 112.357 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -92.54 -177.85 4.72 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.775 0.716 . . . . 3.0099999999999998 110.601 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 151.6 16.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.447 -0.946 . . . . 0.56999999999999995 108.447 157.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.78 162.32 29.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.99 -0.744 . . . . 2.0600000000000001 108.99 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.65 -7.2 58.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.43 1.092 . . . . 3.3999999999999999 112.043 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 49.6 40.28 19.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.648 1.179 . . . . 1.8700000000000001 109.307 -168.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 51.78 34.12 36.37 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.453 -0.794 . . . . 2.0600000000000001 113.396 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -130.21 49.99 2.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.492 1.146 . . . . 4.8799999999999999 108.982 -177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.76 132.65 8.78 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.849 -1.7 . . . . 2.4300000000000002 108.849 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.59 -37.38 67.41 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.713 -0.955 . . . . 2.9300000000000002 110.713 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -50.45 103.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.694 1.198 . . . . 2.0499999999999998 109.593 159.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -35.19 10.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.246 1.018 . . . . 3.4300000000000002 111.948 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -28.08 -44.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.157 2.583 . . . . 2.96 112.671 167.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.8 p -49.62 -73.16 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 2.2000000000000002 110.292 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.6 p -61.66 -40.73 95.95 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.298 -0.876 . . . . 1.25 110.818 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.72 -53.27 59.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.392 1.477 . . . . 3.1000000000000001 110.783 -172.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.33 1.3 p -126.07 -45.66 1.7 Allowed 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.96 0.726 . . . . 1.1599999999999999 112.96 172.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 153.72 -25.43 0.74 Allowed Glycine 0 N--CA 1.463 0.455 0 CA-C-N 118.965 0.802 . . . . 0.93999999999999995 112.029 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 t30 47.51 52.34 12.54 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.412 1.485 . . . . 1.75 110.987 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.37 -47.95 31.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.77 -1.196 . . . . 1.1200000000000001 107.77 162.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.22 -146.06 16.8 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 108.271 -1.932 . . . . 1.23 108.271 164.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.1 m -58.41 156.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.861 1.264 . . . . 1.49 112.77 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -60.73 141.9 56.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.109 -1.405 . . . . 2.54 109.608 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.3 mt -107.73 -71.52 0.75 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 105.992 -1.855 . . . . 0.83999999999999997 105.992 156.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.434 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -97.93 151.79 19.91 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.439 -0.949 . . . . 1.04 108.439 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 67.0 m -139.43 156.69 46.8 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.604 -1.999 . . . . 2.0 105.604 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.16 130.69 1.79 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.809 -0.916 . . . . 0.72999999999999998 110.809 163.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.55 130.22 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.405 0.682 . . . . 0.96999999999999997 109.578 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 tt -98.76 135.9 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.311 -0.404 . . . . 0.78000000000000003 111.592 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.68 -4.9 0.94 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.11 0.804 . . . . 0.65000000000000002 115.11 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -89.04 58.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.888 1.344 . . . . 1.24 109.559 -159.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.96 151.54 23.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.744 -0.662 . . . . 2.1099999999999999 109.553 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 . . . . . 0 C--O 1.256 1.425 0 N-CA-C 104.48 -2.415 . . . . 6.9500000000000002 104.48 166.005 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.521 -0.918 . . . . 4.9100000000000001 108.521 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 m -70.77 81.09 0.62 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.877 0.871 . . . . 2.9199999999999999 109.935 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' CD ' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -76.14 146.82 38.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 3.0 110.124 -175.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.81 141.21 29.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.31 1.044 . . . . 0.83999999999999997 108.885 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 t -102.61 144.37 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.437 -0.949 . . . . 0.90000000000000002 108.437 162.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.02 100.26 6.65 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 108.615 -0.883 . . . . 0.75 108.615 153.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 101.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.971 -1.122 . . . . 0.81999999999999995 107.971 164.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.44 130.84 36.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.288 -0.634 . . . . 0.90000000000000002 109.288 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -134.58 -57.37 0.83 Allowed 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.747 -0.835 . . . . 4.46 108.747 165.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.83 -143.07 48.42 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.263 0.935 . . . . 1.6200000000000001 113.518 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.51 -46.69 5.65 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.841 1.656 . . . . 4.0300000000000002 108.495 -165.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.45 158.69 22.21 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 109.968 -1.253 . . . . 1.3400000000000001 109.968 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.38 46.77 2.21 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.513 2.808 . . . . 1.0900000000000001 111.83 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.42 ' CB ' ' HB2' ' A' ' 145' ' ' ALA . 38.3 t -100.2 159.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.613 1.565 . . . . 0.90000000000000002 109.524 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.51 129.05 7.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.698 1.599 . . . . 2.4500000000000002 106.798 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.89 175.19 47.0 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.165 -0.774 . . . . 0.79000000000000004 111.165 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.4 mt -126.26 119.18 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.595 -1.632 . . . . 1.9099999999999999 106.595 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.29 134.06 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.197 -1.779 . . . . 0.76000000000000001 106.197 160.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -108.99 121.36 44.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.259 -2.126 . . . . 2.1699999999999999 105.259 162.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -113.47 114.72 26.95 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.944 1.698 . . . . 3.0699999999999998 106.647 175.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -131.33 156.2 45.9 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.294 0.952 . . . . 3.0699999999999998 109.367 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -153.99 146.8 24.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.721 -1.955 . . . . 4.2300000000000004 105.721 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -84.97 -90.26 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.905 -0.776 . . . . 4.7599999999999998 108.905 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.1 mp0 -77.06 149.8 35.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.831 -1.174 . . . . 3.8700000000000001 107.831 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -73.65 -2.17 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.132 -0.98 . . . . 2.2799999999999998 113.001 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -119.12 24.91 10.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.307 1.843 . . . . 4.8099999999999996 109.482 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.42 169.04 18.08 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 108.654 -1.778 . . . . 1.4399999999999999 108.654 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -65.63 139.48 58.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.681 1.587 . . . . 1.45 110.563 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.74 153.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.75 -1.204 . . . . 1.1100000000000001 107.75 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -129.21 131.67 47.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.417 -1.697 . . . . 2.8399999999999999 106.417 172.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.45 139.58 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.208 1.403 . . . . 1.4399999999999999 107.755 -169.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.22 138.75 21.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.274 -1.01 . . . . 1.1399999999999999 108.274 168.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.93 130.74 2.24 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.388 -1.885 . . . . 1.03 108.388 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.4 p -105.92 85.99 2.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.698 -1.964 . . . . 1.99 105.698 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mm -88.1 153.29 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.309 -1.367 . . . . 1.3999999999999999 107.309 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -147.54 158.19 43.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.128 1.158 . . . . 3.6099999999999999 114.128 168.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.24 9.96 43.28 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.87 2.176 . . . . 0.62 112.481 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 119' ' ' VAL . 1.3 mm? -63.84 160.86 16.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.588 0.755 . . . . 1.1399999999999999 109.369 168.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.57 159.2 26.94 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 107.468 -1.308 . . . . 1.6899999999999999 107.468 155.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.47 177.9 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.947 0.879 . . . . 3.0699999999999998 111.681 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.65 -164.55 54.05 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.02 -0.536 . . . . 0.5 112.036 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.81 148.4 40.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.895 1.678 . . . . 1.95 112.305 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.414 ' CD2' HD12 ' A' ' 38' ' ' LEU . 82.5 m-70 -150.59 111.35 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.239 1.416 . . . . 0.47999999999999998 110.29 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.25 147.4 2.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.549 -0.62 . . . . 0.37 111.549 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.572 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -136.36 96.71 3.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.875 -1.157 . . . . 2.6299999999999999 107.875 -178.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -133.28 156.53 47.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.813 -1.551 . . . . 0.62 106.813 -167.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.7 119.46 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.434 1.016 . . . . 1.8200000000000001 109.491 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.43 ' CD2' HG21 ' A' ' 118' ' ' VAL . 16.4 m-70 -91.25 138.46 31.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.659 -1.608 . . . . 0.84999999999999998 106.659 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -40.76 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.684 1.594 . . . . 4.4100000000000001 110.935 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 6.1 tt0 45.62 56.71 5.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.18 0.992 . . . . 3.2400000000000002 112.457 152.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -83.61 15.85 2.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.656 -1.156 . . . . 4.5099999999999998 110.762 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.42 81.71 0.56 Allowed 'General case' 0 C--N 1.342 0.271 0 CA-C-O 122.699 1.237 . . . . 5.5999999999999996 108.705 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -80.09 23.43 0.47 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.727 1.211 . . . . 7.7999999999999998 110.54 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -106.58 -55.56 2.31 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.906 0.882 . . . . 5.8200000000000003 109.162 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.97 -16.98 12.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.209 1.404 . . . . 4.7699999999999996 112.665 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.5 -116.57 5.49 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 118.817 0.735 . . . . 4.79 112.58 167.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.4 t -84.11 60.04 5.67 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.72 0.808 . . . . 2.8900000000000001 111.092 -163.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 p -112.38 0.24 15.58 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.085 1.513 . . . . 5.5999999999999996 115.085 -162.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -177.76 40.25 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 116.831 -1.948 . . . . 3.6400000000000001 115.191 -119.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.83 158.74 6.04 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.487 -0.758 . . . . 2.04 110.486 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.63 -86.5 1.75 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.288 -1.925 . . . . 1.21 108.288 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.25 177.42 8.8 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.621 2.881 . . . . 0.93000000000000005 113.326 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -64.8 134.81 54.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.821 -1.536 . . . . 1.47 108.136 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -37.89 106.66 0.05 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.301 1.041 . . . . 1.77 111.129 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -127.14 143.54 47.41 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 130.817 3.647 . . . . 3.7599999999999998 108.037 -175.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.14 -51.82 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.644 1.563 . . . . 1.2 109.256 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -143.53 -82.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.891 1.276 . . . . 3.0899999999999999 108.08 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -123.59 60.53 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.494 1.118 . . . . 1.8999999999999999 109.751 -164.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -79.01 166.35 22.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.469 0.652 . . . . 3.4500000000000002 110.354 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -118.67 159.29 23.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.644 1.578 . . . . 3.3700000000000001 107.906 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 40.7 t60 -86.94 168.47 13.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.023 0.529 . . . . 0.96999999999999997 112.064 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.7 -126.59 1.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.431 -3.068 . . . . 1.8600000000000001 105.431 165.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.49 -176.74 45.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.929 -2.068 . . . . 1.73 107.929 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.01 -40.43 84.03 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.012 2.475 . . . . 2.3700000000000001 111.463 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -32.61 71.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.166 0.586 . . . . 4.9800000000000004 112.474 174.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -89.09 177.66 6.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.716 0.769 . . . . 2.8599999999999999 112.66 -164.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -55.75 -66.41 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.619 1.168 . . . . 7.2999999999999998 111.405 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -118.23 179.6 4.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.663 2.385 . . . . 3.1099999999999999 112.263 -166.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.83 157.45 1.96 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.7 2.4 . . . . 4.1500000000000004 108.231 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -63.56 153.89 34.33 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.844 -1.169 . . . . 0.54000000000000004 107.844 170.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.76 -37.48 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 119.902 -0.719 . . . . 1.24 110.464 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.03 71.7 0.24 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 112.026 -0.43 . . . . 0.76000000000000001 112.026 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -165.8 113.55 0.94 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.331 -0.988 . . . . 1.8300000000000001 108.331 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.13 -61.39 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.094 -0.706 . . . . 1.97 109.094 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.3 -107.05 0.27 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.139 -1.184 . . . . 0.78000000000000003 110.139 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -147.2 163.25 36.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 125.107 1.363 . . . . 1.48 110.93 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.24 -178.58 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 127.027 2.131 . . . . 0.51000000000000001 105.867 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.8 t -129.47 171.54 12.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.827 -1.175 . . . . 1.99 107.827 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.11 144.58 50.81 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.308 1.043 . . . . 0.56999999999999995 110.669 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.47 -90.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.386 2.274 . . . . 4.2400000000000002 110.89 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -174.23 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.278 1.031 . . . . 3.29 110.271 -158.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.04 5.0 8.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.118 0.961 . . . . 2.7799999999999998 110.183 165.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.53 23.03 71.38 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.124 -1.19 . . . . 0.85999999999999999 110.124 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.2 t -85.36 136.65 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.364 1.466 . . . . 0.68000000000000005 107.895 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.407 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . . . -131.18 166.22 21.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.691 1.596 . . . . 0.87 109.748 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -142.14 118.45 10.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.038 -2.579 . . . . 2.71 104.038 -158.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.95 55.54 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 123.691 0.62 . . . . 1.51 111.225 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.4 m -77.18 87.86 3.64 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.642 -0.661 . . . . 1.0 109.771 168.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.5 mm -125.39 157.16 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.163 0.985 . . . . 1.76 108.352 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -151.32 99.0 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.637 0.375 . . . . 2.4300000000000002 111.494 166.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -92.17 159.1 15.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.178 0.591 . . . . 2.3999999999999999 110.595 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 p -116.23 -17.52 10.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.62 1.968 . . . . 1.55 113.296 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.75 -50.91 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 119.151 0.887 . . . . 1.3500000000000001 108.656 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.55 175.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.45 0.643 . . . . 1.4299999999999999 110.915 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.1 p -146.33 178.26 8.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.425 2.69 . . . . 2.3300000000000001 105.231 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 44.84 2.9 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.767 1.167 . . . . 2.8799999999999999 111.68 167.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 p -156.87 38.6 0.31 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.976 0.732 . . . . 3.2400000000000002 112.976 -169.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.6 174.96 39.86 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.989 -0.845 . . . . 2.98 110.989 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.56 -44.86 62.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.409 1.483 . . . . 5.8600000000000003 110.741 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -78.61 -23.38 45.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.463 1.105 . . . . 3.1800000000000002 112.53 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.08 176.76 1.17 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.891 0.853 . . . . 1.25 112.327 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.403 HD11 ' CE2' ' A' ' 20' ' ' PHE . 1.4 pp -89.08 -8.65 10.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 CA-C-N 115.327 -0.851 . . . . 1.6799999999999999 111.001 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 tp -33.63 127.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.258 1.423 . . . . 1.98 110.569 159.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.74 -19.52 24.4 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.037 -0.868 . . . . 1.6399999999999999 113.479 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.3 mtt-85 -86.54 168.94 13.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.604 1.702 . . . . 4.1900000000000004 109.281 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 80.7 m -101.82 115.4 30.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.018 -0.427 . . . . 0.88 110.353 -172.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 149.42 45.15 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.65 -0.87 . . . . 2.4300000000000002 108.65 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 48' ' ' HIS . 76.0 t -133.78 128.55 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.454 1.102 . . . . 0.54000000000000004 109.246 171.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 45' ' ' PHE . 25.1 t -99.81 116.24 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 C-N-CA 126.346 1.858 . . . . 2.2799999999999998 106.275 168.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -94.26 160.47 14.67 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.164 1.913 . . . . 0.53000000000000003 116.164 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -41.27 -77.53 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.265 2.626 . . . . 3.2799999999999998 112.481 170.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -97.29 -179.52 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.627 1.571 . . . . 2.5899999999999999 111.147 -168.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.81 153.72 32.11 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.019 -0.734 . . . . 0.80000000000000004 109.019 158.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -85.05 153.36 22.77 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.306 0.574 . . . . 2.02 109.729 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -81.97 -3.93 55.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.617 1.567 . . . . 3.0899999999999999 113.542 -168.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 53.85 32.9 15.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.377 1.071 . . . . 2.6200000000000001 110.773 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.79 14.5 30.22 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 121.08 -1.013 . . . . 2.2200000000000002 113.567 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -127.97 -27.48 2.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.926 1.291 . . . . 6.6799999999999997 110.728 -168.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.05 134.5 40.62 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.547 -1.421 . . . . 2.6800000000000002 109.547 164.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.62 -24.75 33.18 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.152 0.882 . . . . 2.1699999999999999 114.872 -166.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -55.91 125.86 23.27 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 118.295 -0.86 . . . . 2.8500000000000001 109.267 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -47.38 -40.99 18.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.833 1.197 . . . . 3.6899999999999999 111.192 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -47.43 -31.3 4.0 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.56 1.544 . . . . 3.0 111.624 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.99 -72.16 0.07 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.369 -0.604 . . . . 2.21 109.369 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.9 t -63.44 -41.11 98.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 121.621 -0.674 . . . . 2.5099999999999998 109.485 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.53 -45.41 94.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.75 -0.643 . . . . 3.8599999999999999 112.27 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.467 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.339 0.2 OUTLIER -128.68 -53.08 1.24 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.476 1.034 . . . . 1.27 113.181 173.723 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.71 -22.5 0.4 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.241 0.924 . . . . 1.03 112.201 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.1 t30 49.61 54.53 10.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.651 1.18 . . . . 1.8899999999999999 111.001 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.42 -3.45 58.34 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.672 -0.811 . . . . 1.3300000000000001 111.021 162.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.35 -155.34 45.45 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.249 -1.54 . . . . 0.96999999999999997 109.249 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.8 m -65.45 150.9 47.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.444 -1.378 . . . . 1.55 113.537 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -59.2 135.72 57.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.581 1.552 . . . . 2.96 108.812 170.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 mt -116.55 -76.88 0.57 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.05 -1.092 . . . . 0.82999999999999996 108.05 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 14' ' ' VAL . . . -104.47 145.86 29.69 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.755 -0.831 . . . . 1.23 108.755 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.3 163.81 30.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 123.862 0.726 . . . . 1.53 110.221 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.47 145.87 6.01 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.456 1.979 . . . . 0.72999999999999998 109.035 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.37 139.02 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.875 1.27 . . . . 0.88 108.65 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 7.6 tt -101.96 139.15 23.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 123.239 0.616 . . . . 0.98999999999999999 112.22 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.35 1.63 1.92 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.395 0.998 . . . . 0.59999999999999998 114.482 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.0 mm -93.61 56.91 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.214 1.507 . . . . 0.80000000000000004 110.3 -156.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.99 168.4 27.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.148 0.579 . . . . 1.3200000000000001 110.461 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 . . . . . 0 C--O 1.256 1.412 0 N-CA-C 101.995 -3.335 . . . . 4.5999999999999996 101.995 162.117 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 107.102 -1.444 . . . . 5.3600000000000003 107.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.3 p -54.54 138.32 40.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.991 -1.115 . . . . 2.6000000000000001 107.991 161.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER -140.65 153.92 46.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.091 0.956 . . . . 4.0499999999999998 108.641 -175.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.95 21.77 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.49 -0.93 . . . . 1.0700000000000001 108.49 167.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 152' ' ' ALA . 53.0 t -107.58 150.68 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 106.666 -1.605 . . . . 1.05 106.666 161.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.1 96.2 3.85 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.706 -0.85 . . . . 0.59999999999999998 108.706 158.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 109.32 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.876 -1.527 . . . . 0.79000000000000004 106.876 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -94.83 125.03 39.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.571 -1.27 . . . . 0.85999999999999999 107.571 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -49.27 0.14 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 110.575 -0.157 . . . . 4.75 110.575 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.86 -117.21 0.8 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.958 1.266 . . . . 0.69999999999999996 111.247 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.75 -60.15 1.59 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.181 -1.044 . . . . 3.2999999999999998 108.181 -164.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.01 168.24 0.43 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 127.089 2.28 . . . . 0.69999999999999996 113.96 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.79 -21.08 69.49 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.315 2.677 . . . . 1.23 111.657 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.4 141.41 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.736 1.214 . . . . 1.01 110.937 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.0 122.31 5.6 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.119 -1.438 . . . . 1.98 107.119 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.14 168.68 36.51 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.67 -0.572 . . . . 0.63 111.67 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.76 131.3 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.623 -0.88 . . . . 1.4299999999999999 108.623 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.3 mm -97.21 146.63 7.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.747 -1.575 . . . . 0.82999999999999996 106.747 161.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.86 144.51 50.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.472 -1.677 . . . . 2.1299999999999999 106.472 159.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.93 161.51 41.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.535 -0.466 . . . . 3.5499999999999998 111.758 167.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -140.23 170.64 15.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.541 1.136 . . . . 3.5099999999999998 108.166 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.76 165.41 36.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 104.878 -2.267 . . . . 3.4399999999999999 104.878 165.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.65 -66.14 0.85 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.326 -0.62 . . . . 4.8300000000000001 109.326 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -89.38 166.12 13.93 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.219 1.007 . . . . 3.7400000000000002 110.52 -164.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -78.31 2.26 19.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.402 0.681 . . . . 3.27 111.652 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -153.34 85.4 1.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.205 1.402 . . . . 3.7999999999999998 108.406 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.83 169.74 37.8 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.41 133.61 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.723 2.949 . . . . 1.1200000000000001 112.934 -166.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -106.93 139.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.568 0.747 . . . . 1.1299999999999999 110.115 -171.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -99.5 89.71 4.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.713 0.805 . . . . 6.1500000000000004 109.223 -170.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.2 t -76.82 105.13 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 1.0600000000000001 106.878 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -113.66 140.9 47.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.817 -0.808 . . . . 1.0900000000000001 108.817 166.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.45 156.95 28.77 Favored Glycine 0 N--CA 1.448 -0.528 0 O-C-N 121.472 -0.768 . . . . 0.66000000000000003 112.008 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 p -130.36 104.38 7.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.505 -2.035 . . . . 2.02 105.505 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.01 143.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.381 -1.34 . . . . 0.88 107.381 -168.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -147.78 174.06 12.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.581 0.705 . . . . 3.6400000000000001 112.729 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 22.26 72.38 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 114.868 -1.06 . . . . 0.66000000000000003 112.107 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -76.58 -155.38 0.06 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.475 -1.306 . . . . 0.88 107.475 168.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -146.99 146.15 29.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.848 -2.278 . . . . 3.0699999999999998 104.848 166.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -34.19 132.96 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.719 2.408 . . . . 3.3100000000000001 113.223 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.63 -172.3 20.94 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.284 0.468 . . . . 0.56000000000000005 112.612 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.28 149.03 49.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.667 1.187 . . . . 2.23 112.831 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.34 120.22 9.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 126.279 1.832 . . . . 0.46999999999999997 108.455 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.0 150.06 6.65 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 110.393 -1.083 . . . . 0.35999999999999999 110.393 169.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.87 95.83 2.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.417 -1.327 . . . . 2.6699999999999999 107.417 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.427 ' ND1' ' CE1' ' A' ' 63' ' ' HIS . 24.0 m170 -134.2 147.16 50.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.264 -1.013 . . . . 0.56000000000000005 108.264 -161.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.294 0.7 OUTLIER -99.43 126.46 52.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.194 0.997 . . . . 1.8600000000000001 109.993 168.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.404 ' CD2' HG21 ' A' ' 118' ' ' VAL . 30.3 m-70 -85.38 -172.97 4.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.233 -1.395 . . . . 1.74 107.233 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -112.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.105 -1.443 . . . . 4.9500000000000002 107.105 161.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 54.4 63.61 2.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.213 -1.032 . . . . 2.9900000000000002 108.213 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -48.63 -48.07 39.8 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.895 -1.048 . . . . 4.4299999999999997 110.412 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -175.91 95.88 0.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.197 1.799 . . . . 5.1900000000000004 109.224 163.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.488 ' ND2' ' H ' ' A' ' 53' ' ' ASN . 2.2 p30 -60.55 -40.82 92.99 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.027 1.731 . . . . 4.2300000000000004 111.941 166.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m 177.48 -49.99 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.321 2.248 . . . . 3.96 107.255 -163.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 179.44 -41.09 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.466 1.507 . . . . 6.7599999999999998 111.011 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.11 -105.6 2.72 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.264 -1.134 . . . . 4.3499999999999996 110.264 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.3 p -161.59 147.23 13.74 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.535 1.534 . . . . 2.3199999999999998 107.098 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.96 8.58 0.08 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.142 1.164 . . . . 3.7599999999999998 114.142 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 p -167.9 -43.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 117.672 2.471 . . . . 2.7400000000000002 117.672 -121.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.06 -145.04 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.777 -1.194 . . . . 2.0600000000000001 107.777 167.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.22 -88.03 0.07 OUTLIER Glycine 0 CA--C 1.522 0.485 0 N-CA-C 108.661 -1.776 . . . . 1.2 108.661 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -71.88 179.13 5.08 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 125.057 3.838 . . . . 1.0600000000000001 112.585 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.427 ' CE1' ' ND1' ' A' ' 46' ' ' HIS . 15.4 m170 -74.23 152.7 39.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.143 -0.935 . . . . 1.5700000000000001 109.327 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -50.82 108.09 0.22 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.382 0.512 . . . . 1.99 112.382 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -121.48 135.32 24.97 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 126.246 1.818 . . . . 3.5 109.147 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.5 -50.43 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.739 1.626 . . . . 1.1599999999999999 108.991 171.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.48 -84.09 0.25 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.94 1.296 . . . . 2.3199999999999998 107.652 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.8 m -132.71 60.88 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.406 1.082 . . . . 1.5900000000000001 110.787 -168.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -77.44 158.7 29.89 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.526 -1.287 . . . . 4.0 107.526 162.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -120.41 163.44 17.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.433 1.493 . . . . 3.0099999999999998 107.713 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -81.58 157.04 24.89 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.22 0.533 . . . . 0.75 111.043 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.88 -155.84 16.54 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 104.469 -3.453 . . . . 2.3999999999999999 104.469 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.63 -131.65 1.24 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.274 -1.53 . . . . 1.5600000000000001 109.274 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.7 -40.67 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.308 2.005 . . . . 1.8400000000000001 111.872 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.29 -46.17 42.94 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.786 0.291 . . . . 4.96 111.786 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.95 176.69 6.93 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.505 -0.554 . . . . 2.4300000000000002 109.505 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.62 -33.55 10.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 5.1399999999999997 111.736 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 162.89 26.74 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 119.111 -1.036 . . . . 3.6200000000000001 110.183 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 133.05 0.05 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.782 2.033 . . . . 3.9100000000000001 108.864 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 46.5 m80 -50.01 144.61 6.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.177 -1.786 . . . . 0.70999999999999996 106.177 155.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.304 5.1 p -83.55 44.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 123.304 1.526 . . . . 1.6899999999999999 110.795 -170.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -154.63 3.68 0.24 Allowed Glycine 0 CA--C 1.545 1.926 1 C-N-CA 131.364 4.316 . . . . 1.8400000000000001 113.125 169.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.19 99.39 8.54 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 121.651 2.726 . . . . 2.0 107.753 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.5 mt -77.31 -44.96 27.77 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.064 0.847 . . . . 2.79 109.103 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.58 -107.82 0.34 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.688 -0.767 . . . . 0.73999999999999999 111.216 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -149.69 171.13 17.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.648 1.579 . . . . 1.52 109.366 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.82 172.27 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.74 -1.578 . . . . 0.55000000000000004 106.74 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.5 m -122.02 124.28 43.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.523 -1.288 . . . . 1.98 107.523 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.88 138.78 38.29 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.642 -0.503 . . . . 0.58999999999999997 109.642 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.72 -89.69 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 124.272 0.982 . . . . 2.7799999999999998 110.228 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 -57.84 1.0 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.295 1.038 . . . . 3.4300000000000002 110.085 -164.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.36 25.04 1.48 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 123.352 1.549 . . . . 2.96 110.911 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 62.91 19.71 61.4 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.917 -1.038 . . . . 0.82999999999999996 111.51 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.72 139.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.13 -1.433 . . . . 0.80000000000000004 107.13 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.99 166.18 23.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.856 1.263 . . . . 0.70999999999999996 107.887 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -128.0 143.23 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.766 -2.679 . . . . 2.8900000000000001 103.766 -173.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.39 121.7 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.381 -1.711 . . . . 1.4399999999999999 106.381 173.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -150.59 91.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.947 1.299 . . . . 0.82999999999999996 108.604 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.48 144.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 107.951 -1.129 . . . . 1.8700000000000001 107.951 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -112.51 83.44 1.81 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.656 -1.609 . . . . 3.7400000000000002 106.656 161.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.28 146.29 33.06 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.1 p -108.06 -7.95 15.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.764 2.025 . . . . 1.48 112.28 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.59 -55.53 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.78 -1.193 . . . . 1.3600000000000001 107.78 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.8 pt -70.35 176.95 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 122.312 1.053 . . . . 1.54 112.008 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 m -153.4 176.96 11.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.663 1.985 . . . . 2.04 106.233 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 -19.61 25.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.319 0.963 . . . . 3.04 113.434 -169.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 m -159.7 90.32 0.93 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.034 -1.041 . . . . 3.8900000000000001 111.857 -168.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 167.63 179.06 40.14 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.148 -1.181 . . . . 3.2200000000000002 110.148 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -36.14 -52.7 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.601 1.191 . . . . 5.6100000000000003 111.761 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -76.96 -23.78 52.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.503 -1.226 . . . . 5.0999999999999996 110.428 -169.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.5 p -63.95 151.1 43.61 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.542 0.61 . . . . 1.3799999999999999 111.113 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.38 -5.89 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.389 -0.823 . . . . 1.97 110.553 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -51.49 120.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.094 -0.706 . . . . 1.6200000000000001 109.094 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.85 39.61 95.14 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.61 -0.55 . . . . 1.77 112.8 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -120.79 167.94 11.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.265 -1.383 . . . . 5.4699999999999998 107.265 158.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.7 m -91.69 118.3 30.53 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.846 0.458 . . . . 0.95999999999999996 111.043 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 144.4 45.56 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.145 -1.057 . . . . 1.5800000000000001 108.145 164.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.404 HG21 ' CD2' ' A' ' 48' ' ' HIS . 75.0 t -131.54 140.33 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.189 1.796 . . . . 0.40000000000000002 107.818 174.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.63 127.44 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.129 -1.063 . . . . 1.55 108.129 164.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -97.08 159.61 14.81 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.474 2.028 . . . . 0.40999999999999998 116.474 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -47.57 -73.4 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.257 1.823 . . . . 3.02 112.243 172.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -97.35 179.87 4.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.002 0.921 . . . . 4.2800000000000002 110.264 -172.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.61 147.96 39.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.031 -0.729 . . . . 0.54000000000000004 109.031 160.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -77.32 162.73 27.07 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.278 -0.638 . . . . 1.97 109.278 167.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.13 -8.47 59.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.424 1.268 . . . . 3.0800000000000001 114.424 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 48.97 30.3 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.695 1.134 . . . . 1.4299999999999999 110.89 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.56 28.18 72.85 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.152 0.882 . . . . 1.8500000000000001 112.502 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -130.41 29.48 4.84 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.034 0.917 . . . . 5.4400000000000004 111.226 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -96.44 135.2 12.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 108.467 -1.853 . . . . 2.29 108.467 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.08 66.27 2.88 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 117.63 0.715 . . . . 2.25 112.43 -171.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -168.84 170.72 8.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 125.085 1.354 . . . . 3.3999999999999999 108.092 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -52.09 -71.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.062 0.545 . . . . 3.6099999999999999 110.897 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -47.72 -41.96 24.13 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.868 2.067 . . . . 3.8300000000000001 111.947 -162.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.2 m -46.09 -58.54 3.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.994 0.917 . . . . 2.5600000000000001 112.071 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.8 p -73.07 -40.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.792 -1.193 . . . . 1.49 112.511 173.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -66.25 -36.29 82.62 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.376 1.07 . . . . 5.8399999999999999 110.549 -165.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.377 13.1 t -133.47 -46.27 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.604 0.762 . . . . 2.0699999999999998 111.562 172.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.37 -18.45 1.33 Allowed Glycine 0 N--CA 1.467 0.752 0 CA-C-N 119.886 1.221 . . . . 0.89000000000000001 112.877 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 34.36 56.28 0.66 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.077 2.551 . . . . 2.5699999999999998 112.347 -174.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.44 -1.61 27.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.417 -0.513 . . . . 1.1000000000000001 111.994 167.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.81 -163.23 45.64 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.017 -1.633 . . . . 0.94999999999999996 109.017 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.4 m -60.86 148.79 38.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.026 -1.587 . . . . 1.28 113.822 -161.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -57.47 130.82 48.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.392 -1.277 . . . . 2.6699999999999999 107.799 165.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.7 mt -106.64 -73.1 0.7 Allowed 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 107.746 -1.205 . . . . 0.46999999999999997 107.746 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.25 144.45 34.04 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.705 -1.22 . . . . 0.67000000000000004 107.705 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 85.8 m -126.87 160.58 30.53 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.522 -2.029 . . . . 2.1299999999999999 105.522 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.8 131.19 1.85 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.013 -0.835 . . . . 0.68999999999999995 111.013 169.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.6 t -62.94 134.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.669 0.788 . . . . 0.69999999999999996 109.404 169.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.6 tt -95.67 134.81 31.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.714 0.293 . . . . 0.95999999999999996 111.116 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.54 3.81 0.49 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.062 0.839 . . . . 0.81000000000000005 115.033 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.8 mm -92.77 57.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.52 1.66 . . . . 1.01 110.91 -155.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.566 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -155.57 170.92 20.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.488 0.715 . . . . 1.46 110.792 167.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 83.9 mt-30 . . . . . 0 C--O 1.255 1.359 0 N-CA-C 103.065 -2.939 . . . . 4.6600000000000001 103.065 163.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 107.352 -1.351 . . . . 7.4500000000000002 107.352 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 m -45.25 141.86 2.29 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.313 1.445 . . . . 3.5899999999999999 111.906 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -78.57 174.93 10.85 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.474 0.31 . . . . 3.8799999999999999 110.643 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.26 41.71 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.003 1.321 . . . . 0.92000000000000004 107.562 170.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.92 143.74 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 106.701 -1.592 . . . . 1.02 106.701 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.575 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -122.4 93.34 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.698 . . . . 0.56000000000000005 109.114 156.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.68 100.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.246 -1.39 . . . . 1.04 107.246 164.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.9 mt -89.13 143.16 27.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.996 0.518 . . . . 1.26 109.767 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -143.73 -64.2 0.38 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.206 -1.035 . . . . 4.0300000000000002 108.206 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.36 -122.9 13.14 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.748 -0.66 . . . . 0.96999999999999997 113.14 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -126.43 -55.98 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.387 0.613 . . . . 2.98 110.014 -152.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.31 164.15 25.07 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 110.049 -1.22 . . . . 0.73999999999999999 110.049 164.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.74 34.25 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.674 2.916 . . . . 1.1000000000000001 113.586 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.5 155.1 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.722 1.609 . . . . 1.1200000000000001 109.69 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.03 125.69 9.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.799 -1.926 . . . . 2.46 105.799 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.61 164.15 31.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.194 -0.763 . . . . 0.76000000000000001 111.194 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.636 -1.616 . . . . 1.01 106.636 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 3.0 mp -90.48 144.06 9.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.432 -1.692 . . . . 1.79 106.432 161.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.5 102.72 7.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.395 1.478 . . . . 1.78 107.104 167.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -79.77 118.76 21.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.615 -1.995 . . . . 2.46 105.615 169.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -142.67 145.84 33.82 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.52 1.055 . . . . 3.2799999999999998 108.902 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -157.18 146.06 19.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.223 -0.444 . . . . 4.4500000000000002 109.919 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -68.43 -61.26 1.91 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.275 1.03 . . . . 5.0099999999999998 109.755 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -78.48 -175.92 4.52 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 119.018 0.827 . . . . 4.1299999999999999 110.194 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -81.0 -68.68 0.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.035 -1.468 . . . . 2.6899999999999999 107.035 165.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -90.56 106.02 18.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.907 0.883 . . . . 4.5499999999999998 109.293 171.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.08 176.17 45.88 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 107.94 -2.064 . . . . 1.23 107.94 166.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.84 116.84 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.317 2.678 . . . . 1.46 110.635 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.8 t -78.62 147.39 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.312 -0.625 . . . . 0.98999999999999999 109.312 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -98.14 113.37 25.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.809 -1.552 . . . . 3.1899999999999999 106.809 171.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 20' ' ' PHE . 56.6 t -115.25 82.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.996 1.718 . . . . 1.1399999999999999 106.974 -169.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -98.07 158.84 15.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.078 -0.712 . . . . 0.85999999999999999 109.078 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.72 158.94 29.36 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.769 -0.933 . . . . 0.72999999999999998 110.769 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.9 p -129.16 104.07 7.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.762 -1.94 . . . . 2.52 105.762 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.7 141.95 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.082 -1.451 . . . . 0.92000000000000004 107.082 -168.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.11 159.9 41.69 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 114.593 1.331 . . . . 3.23 114.593 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.4 22.84 25.79 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.957 1.742 . . . . 1.1200000000000001 111.81 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.33 -156.05 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.105 -1.072 . . . . 1.27 108.105 166.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 m -146.27 152.17 38.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.749 -2.315 . . . . 3.21 104.749 165.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -37.98 141.39 0.21 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.273 2.229 . . . . 2.8599999999999999 113.77 -170.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.66 -171.87 26.76 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.238 -0.437 . . . . 0.63 112.323 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.83 151.47 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.286 1.035 . . . . 2.3500000000000001 112.804 -168.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -146.66 118.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.194 1.797 . . . . 0.87 108.154 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.01 154.25 3.89 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.035 -1.226 . . . . 0.57999999999999996 110.035 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -145.47 89.79 1.96 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.612 -1.255 . . . . 2.6800000000000002 107.612 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -128.72 164.58 22.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.156 -1.053 . . . . 0.84999999999999998 108.156 -160.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 134.0 66.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 122.055 0.931 . . . . 2.0499999999999998 110.488 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.497 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 21.5 m-70 -110.05 132.82 53.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.371 1.469 . . . . 0.96999999999999997 107.241 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HA ' ' HG2' ' A' ' 115' ' ' ARG . 13.4 mt-10 -74.11 65.95 1.18 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.876 1.27 . . . . 5.7699999999999996 111.19 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' CB ' ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -138.4 171.58 14.16 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.516 -1.675 . . . . 5.6500000000000004 107.446 168.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -105.73 35.73 2.78 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 128.486 2.714 . . . . 6.3399999999999999 109.681 169.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.86 75.14 0.62 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.778 2.031 . . . . 9.9299999999999997 107.863 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -90.05 -52.19 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.206 -0.934 . . . . 6.2400000000000002 110.132 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -56.55 136.15 54.43 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.715 1.206 . . . . 6.4000000000000004 111.495 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.32 145.4 6.27 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.16 -0.682 . . . . 7.3399999999999999 109.16 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.36 56.0 4.87 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.784 -1.727 . . . . 5.9199999999999999 108.784 -162.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.6 m -75.08 59.75 0.97 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.119 1.367 . . . . 3.3900000000000001 109.475 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -118.78 75.55 1.04 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.926 0.891 . . . . 5.0599999999999996 108.666 -154.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 t 179.29 -68.07 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.455 -0.793 . . . . 2.6600000000000001 111.043 -142.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 48' ' ' HIS . . . -60.03 134.4 57.01 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.945 -0.472 . . . . 1.95 110.614 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.25 -126.45 3.2 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.069 -1.213 . . . . 1.0600000000000001 110.069 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.15 178.68 6.63 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.894 3.062 . . . . 0.82999999999999996 112.629 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -71.66 126.02 28.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.519 -1.229 . . . . 1.23 108.031 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -5.56 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.243 2.217 . . . . 2.5600000000000001 113.394 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -125.81 130.51 24.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 127.318 2.247 . . . . 3.5699999999999998 108.719 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.73 -43.77 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.8 1.666 . . . . 1.1699999999999999 109.729 173.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.54 -73.11 0.42 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.718 1.207 . . . . 2.46 107.923 172.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.5 m -154.0 83.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.423 -0.798 . . . . 2.2200000000000002 109.767 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -79.5 168.52 19.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.399 -0.593 . . . . 4.6900000000000004 109.399 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -102.93 152.93 20.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 107.264 -1.384 . . . . 3.6200000000000001 107.264 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -75.41 163.21 27.66 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.114 0.87 . . . . 0.93000000000000005 110.349 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.6 -103.54 0.17 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.846 -2.502 . . . . 1.9299999999999999 106.846 167.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.26 -121.21 2.51 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.496 1.148 . . . . 2.1000000000000001 111.547 167.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -86.58 -42.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.541 2.161 . . . . 1.6200000000000001 111.306 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -64.15 0.96 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.095 -1.076 . . . . 4.9400000000000004 108.095 174.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -68.87 143.09 54.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.265 -0.879 . . . . 2.0699999999999998 109.34 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -54.87 -46.93 74.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 126.449 1.899 . . . . 5.21 111.667 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.59 176.57 6.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.246 1.018 . . . . 3.4700000000000002 110.924 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 154.86 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.616 1.166 . . . . 4.5499999999999998 110.995 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.6 m80 -54.53 141.86 29.77 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.682 -1.97 . . . . 0.64000000000000001 105.682 155.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.08 -17.81 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.298 -0.561 . . . . 1.3600000000000001 110.973 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.4 52.37 0.75 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.506 -0.608 . . . . 0.76000000000000001 114.574 162.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -96.71 124.51 40.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 105.463 -2.051 . . . . 2.0699999999999998 105.463 143.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 mt -85.06 -51.64 6.52 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.33 0.968 . . . . 2.4500000000000002 108.399 161.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.49 -115.35 0.64 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.713 -1.355 . . . . 0.93000000000000005 109.713 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -148.63 166.56 27.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.359 1.463 . . . . 1.8500000000000001 109.362 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.3 174.28 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.648 -1.612 . . . . 0.78000000000000003 106.648 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.4 m -129.02 129.67 45.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 2.0600000000000001 107.306 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 135.49 37.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.324 -0.621 . . . . 0.72999999999999998 109.324 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.84 -69.91 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.725 1.266 . . . . 4.0199999999999996 110.356 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -168.87 -53.94 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.95 2.1 . . . . 5.2800000000000002 108.528 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.44 23.29 1.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.934 1.293 . . . . 3.5899999999999999 110.563 -167.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.26 4.97 75.36 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.52 1.057 . . . . 1.1100000000000001 112.182 -174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.85 154.34 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.022 -1.103 . . . . 1.3999999999999999 108.022 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.64 171.32 14.21 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.525 1.13 . . . . 0.87 108.079 166.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -119.41 151.45 38.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 104.266 -2.494 . . . . 2.75 104.266 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.07 134.19 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 107.788 -1.19 . . . . 1.74 107.788 145.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.3 m -155.42 61.35 0.62 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.012 1.725 . . . . 1.1100000000000001 107.748 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -105.91 155.56 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 108.036 -1.098 . . . . 1.47 108.036 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.06 118.64 14.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.135 -0.691 . . . . 2.7000000000000002 109.135 150.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.46 -174.4 5.17 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.59 0.71 . . . . 4.0999999999999996 109.664 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.6 p -144.75 51.41 1.25 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.197 -1.038 . . . . 2.4300000000000002 108.197 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.4 -54.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.329 1.452 . . . . 1.52 108.957 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -96.32 179.76 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.165 0.986 . . . . 1.1200000000000001 109.928 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.1 m -152.31 176.82 11.22 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.192 -1.41 . . . . 2.1600000000000001 107.192 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.65 47.96 1.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.733 1.254 . . . . 2.71 110.712 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p -95.95 -29.95 13.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.742 2.017 . . . . 3.96 112.937 -169.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.55 -179.52 30.55 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 108.008 -2.037 . . . . 2.77 108.008 -152.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.0 t70 55.52 -106.9 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.533 1.133 . . . . 4.0899999999999999 110.518 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.01 -11.55 59.97 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.869 0.868 . . . . 4.1600000000000001 111.409 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -58.5 156.95 9.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.277 -0.889 . . . . 1.1699999999999999 111.647 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.415 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 15.2 pt -78.05 -10.28 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.538 -0.744 . . . . 1.73 111.904 174.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.4 mm -40.6 123.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 1.8200000000000001 110.68 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.14 50.89 6.02 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.558 -0.617 . . . . 2.0699999999999998 111.558 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.427 ' HG2' ' HA ' ' A' ' 49' ' ' GLU . 2.2 mtt85 -136.62 153.52 50.92 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.535 1.134 . . . . 3.8799999999999999 109.264 168.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 98.7 m -79.63 115.95 19.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 124.326 1.016 . . . . 1.1899999999999999 108.397 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 tt -86.03 136.5 33.22 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 118.901 0.773 . . . . 2.1400000000000001 109.427 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.7 t -124.86 120.21 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.958 -1.127 . . . . 0.48999999999999999 107.958 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.94 118.59 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 105.523 -2.029 . . . . 1.6799999999999999 105.523 161.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -90.07 162.83 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.249 1.574 . . . . 0.53000000000000003 115.249 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -38.78 -69.13 0.13 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.068 2.547 . . . . 3.23 111.907 170.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -120.75 -177.71 3.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.622 1.169 . . . . 2.71 110.624 -167.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.62 57.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.274 -0.639 . . . . 0.54000000000000004 109.274 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -81.07 156.28 25.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.056 -0.72 . . . . 2.23 109.056 158.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -22.93 60.08 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.332 0.653 . . . . 3.5099999999999998 111.664 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.98 56.77 2.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.823 0.82 . . . . 2.3599999999999999 109.573 -168.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.87 73.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.156 -0.929 . . . . 1.6100000000000001 113.438 157.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -77.3 -23.31 51.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.932 -0.746 . . . . 6.7300000000000004 110.217 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 71.76 -118.66 7.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.415 -1.474 . . . . 3.1200000000000001 109.415 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.72 -68.44 1.57 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.334 -1.506 . . . . 2.46 109.334 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -94.41 161.61 14.16 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.79 -1.189 . . . . 2.7599999999999998 107.79 160.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.62 -53.53 46.16 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.242 -0.286 . . . . 3.5299999999999998 110.649 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -49.03 -40.94 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.818 1.647 . . . . 2.9399999999999999 113.45 -169.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.9 m -47.16 -54.27 11.03 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.77 0.828 . . . . 2.2000000000000002 112.004 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -44.6 60.96 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.46 -0.775 . . . . 1.53 111.78 172.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -59.62 -50.84 72.33 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.976 0.911 . . . . 2.7400000000000002 111.207 -166.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.464 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.35 0.1 OUTLIER -124.7 -46.39 1.87 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.568 -0.73 . . . . 1.1399999999999999 111.56 175.086 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.35 -2.1 0.67 Allowed Glycine 0 C--O 1.222 -0.652 0 CA-C-O 118.009 -1.439 . . . . 1.03 115.531 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 27.63 52.72 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.151 2.181 . . . . 4.2800000000000002 114.589 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.21 -16.42 60.48 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.416 -0.803 . . . . 0.89000000000000001 111.93 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.67 -171.32 36.08 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 109.142 -1.583 . . . . 0.95999999999999996 109.142 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -62.46 156.01 23.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.639 -1.28 . . . . 1.25 113.564 -164.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -73.1 148.05 44.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.959 -1.019 . . . . 2.4700000000000002 111.14 173.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mt -128.73 -69.43 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.537 -1.283 . . . . 0.78000000000000003 107.537 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.02 163.58 12.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.918 -0.771 . . . . 1.3100000000000001 108.918 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.9 p -165.07 160.45 18.86 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.678 -1.601 . . . . 1.9099999999999999 106.678 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.49 143.16 3.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 105.766 -2.933 . . . . 1.0800000000000001 105.766 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.5 t -81.37 139.85 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 117.901 0.851 . . . . 1.29 110.213 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.8 tt -86.49 131.88 33.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.899 0.38 . . . . 0.82999999999999996 110.484 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.83 -8.62 0.97 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.048 0.833 . . . . 0.93000000000000005 115.002 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mm -90.56 57.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.662 1.231 . . . . 1.03 110.546 -157.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.92 175.87 5.79 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.556 0.742 . . . . 2.04 110.465 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 C--O 1.257 1.451 0 N-CA-C 104.113 -2.551 . . . . 4.29 104.113 164.814 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.333 -0.365 . . . . 7.1500000000000004 110.856 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 p -70.25 177.58 3.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.08 0.952 . . . . 3.6800000000000002 110.538 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 148.77 23.98 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.584 0.754 . . . . 3.6600000000000001 109.972 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.85 148.41 25.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.866 1.666 . . . . 0.69999999999999996 108.367 169.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.92 144.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.39 -0.967 . . . . 0.63 108.39 165.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.93 97.03 5.3 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.841 -0.8 . . . . 0.42999999999999999 108.841 155.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.26 106.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.992 -1.485 . . . . 0.51000000000000001 106.992 161.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -90.31 133.91 34.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 0.91000000000000003 108.456 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -149.45 -50.99 0.15 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.413 0.685 . . . . 3.2200000000000002 110.527 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.06 -117.5 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.352 0.977 . . . . 0.92000000000000004 113.501 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -114.33 -54.82 2.55 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.661 1.184 . . . . 4.0700000000000003 109.69 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.77 159.73 21.42 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 110.336 -1.106 . . . . 0.85999999999999999 110.336 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.11 40.6 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.342 2.695 . . . . 1.0 112.179 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 40.6 t -92.59 159.47 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.003 1.721 . . . . 0.81000000000000005 108.616 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.81 135.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.948 -1.501 . . . . 2.3500000000000001 106.948 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 169.31 42.27 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.916 -1.274 . . . . 0.67000000000000004 109.916 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.87 110.16 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.115 -1.439 . . . . 0.97999999999999998 107.115 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.2 125.34 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.756 -1.572 . . . . 0.72999999999999998 106.756 168.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -99.36 109.56 22.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.699 -1.963 . . . . 2.0499999999999998 105.699 166.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CG ' HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -98.01 105.56 17.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.554 -2.017 . . . . 2.5499999999999998 105.554 171.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.25 138.31 49.14 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.948 1.249 . . . . 3.6600000000000001 110.264 169.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -156.67 105.71 2.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.159 -1.052 . . . . 3.7999999999999998 108.159 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -89.36 36.38 0.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.89 0.476 . . . . 7.2199999999999998 111.33 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -125.63 -138.06 0.27 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.221 -1.4 . . . . 4.8499999999999996 107.221 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -130.3 -76.62 0.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.349 0.66 . . . . 3.4300000000000002 109.345 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -101.8 86.04 2.84 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.184 -1.784 . . . . 5.0 106.184 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.64 34.68 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.597 -1.001 . . . . 1.71 110.597 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.92 132.11 29.27 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.512 2.808 . . . . 1.6200000000000001 112.297 -170.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.6 t -91.89 149.24 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.307 -0.997 . . . . 1.04 108.307 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 121.67 44.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.729 -1.582 . . . . 2.6400000000000001 106.729 163.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.412 HG22 ' CE1' ' A' ' 20' ' ' PHE . 48.8 t -115.86 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.245 1.818 . . . . 1.03 107.25 -170.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -127.23 126.88 43.52 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 123.507 0.505 . . . . 1.25 110.743 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.2 137.02 5.06 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.56 -1.416 . . . . 0.89000000000000001 109.56 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -116.53 110.25 18.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.929 -1.878 . . . . 2.77 105.929 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 mm -103.1 152.81 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.595 1.958 . . . . 1.22 108.866 -164.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -149.55 156.17 41.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.28 0.844 . . . . 3.46 113.28 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.52 15.11 33.06 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.782 2.134 . . . . 0.60999999999999999 112.458 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 43' ' ' HIS . 2.8 mm? -69.54 162.49 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.18 0.992 . . . . 1.25 110.035 170.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.49 161.63 24.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.927 -1.138 . . . . 1.6899999999999999 107.927 157.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -56.87 174.85 0.14 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.786 0.803 . . . . 2.4399999999999999 111.775 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.8 -169.52 52.4 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.986 0.803 . . . . 0.78000000000000003 113.687 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.82 153.02 44.54 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.892 1.277 . . . . 2.23 111.754 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.489 ' CD2' HD12 ' A' ' 38' ' ' LEU . 89.3 m-70 -149.36 117.72 6.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.869 1.667 . . . . 0.42999999999999999 108.365 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.37 150.44 4.32 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.712 -0.955 . . . . 0.34999999999999998 110.712 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -140.85 95.66 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.827 -1.545 . . . . 2.5699999999999998 106.827 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -134.11 155.97 49.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.033 -1.469 . . . . 0.54000000000000004 107.033 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.27 126.84 67.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.091 -0.707 . . . . 1.6299999999999999 109.091 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.453 ' CD2' HG21 ' A' ' 118' ' ' VAL . 25.7 m-70 -95.2 142.58 27.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.883 1.673 . . . . 0.75 108.376 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -46.49 -64.8 0.67 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.726 1.211 . . . . 4.2599999999999998 110.935 -171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 38.91 54.6 2.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.706 2.403 . . . . 3.2000000000000002 114.73 155.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -50.0 -59.42 3.9 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 127.142 2.177 . . . . 5.6699999999999999 112.787 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -141.71 55.88 1.5 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.741 1.616 . . . . 6.9699999999999998 108.812 -156.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -77.96 -66.64 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.803 -1.09 . . . . 4.4199999999999999 110.767 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.5 t 179.47 -47.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.976 1.71 . . . . 4.79 109.781 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 177.25 -48.28 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.322 1.849 . . . . 6.8600000000000003 109.494 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.18 -118.11 2.92 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.549 -1.02 . . . . 4.7000000000000002 110.549 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.1 p -126.85 155.68 42.54 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.307 2.243 . . . . 2.8599999999999999 105.675 172.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.75 -1.81 0.07 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.033 1.494 . . . . 3.7200000000000002 115.033 164.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.2 t -160.3 -48.18 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 116.405 -2.118 . . . . 2.9199999999999999 114.245 -110.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.04 -114.19 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.188 -0.671 . . . . 2.3500000000000001 109.188 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.74 -89.11 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 107.945 -2.062 . . . . 1.1399999999999999 107.945 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.56 177.65 8.25 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 124.823 3.682 . . . . 0.96999999999999997 112.948 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -66.43 142.02 57.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.921 1.688 . . . . 1.4199999999999999 107.551 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -49.49 115.66 1.43 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.402 0.681 . . . . 1.71 110.95 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.58 111.88 9.82 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.995 1.718 . . . . 2.8500000000000001 108.819 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.6 -10.9 29.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.85 1.7 . . . . 1.72 113.46 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -146.52 -72.64 0.23 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.745 -0.835 . . . . 2.2999999999999998 108.745 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -161.74 92.7 0.88 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.758 -1.201 . . . . 2.3900000000000001 107.758 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.29 175.53 5.68 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.048 1.739 . . . . 5.7400000000000002 108.202 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 9.9 mtpm? -133.8 153.27 51.84 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.575 1.55 . . . . 3.9700000000000002 107.397 -174.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -87.87 136.98 32.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.807 0.843 . . . . 1.28 109.908 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.68 -66.53 0.14 Allowed Glycine 0 C--O 1.222 -0.636 0 N-CA-C 107.519 -2.232 . . . . 2.7599999999999998 107.519 163.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.0 -170.21 35.37 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.007 1.289 . . . . 1.4099999999999999 111.595 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.02 -42.61 5.9 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.789 2.326 . . . . 1.6799999999999999 110.343 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.35 -54.08 7.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.546 0.738 . . . . 4.6600000000000001 111.107 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.05 149.31 50.1 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.439 -0.948 . . . . 2.02 108.439 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -49.53 -51.92 33.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.058 0.943 . . . . 3.9500000000000002 110.532 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 59.5 mt-10 -76.11 152.5 36.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.751 1.262 . . . . 3.75 110.694 -163.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -175.05 134.66 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.394 1.478 . . . . 3.3300000000000001 108.177 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 34.4 m80 -50.87 137.75 20.15 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.154 -2.165 . . . . 0.77000000000000002 105.154 147.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.44 -24.76 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 119.342 -0.943 . . . . 1.46 109.73 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.65 33.94 4.75 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.133 -1.371 . . . . 0.82999999999999996 116.504 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -102.81 112.95 25.98 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 120.72 2.26 . . . . 1.96 107.937 161.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 84' ' ' LEU . 4.0 mm? -78.66 -57.58 3.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.449 -1.315 . . . . 1.52 107.449 160.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.85 -110.63 0.43 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.806 -0.918 . . . . 0.58999999999999997 110.806 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -146.72 169.31 19.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.666 1.186 . . . . 1.3600000000000001 109.898 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.5 176.56 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 105.998 -1.853 . . . . 0.62 105.998 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.3 m -140.27 132.71 28.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.363 -2.088 . . . . 2.02 105.363 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.666 0.604 . . . . 0.68999999999999995 110.127 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.72 -80.98 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.119 0.968 . . . . 2.9700000000000002 109.407 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.2 tttm -160.2 -43.54 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.563 1.145 . . . . 3.96 111.878 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -81.99 30.61 0.38 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 123.739 1.733 . . . . 3.2599999999999998 110.833 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 64.72 17.73 63.02 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.002 1.763 . . . . 1.0700000000000001 112.571 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.52 147.82 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.54 -1.281 . . . . 1.1299999999999999 107.54 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.06 175.02 11.35 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.114 -1.439 . . . . 0.90000000000000002 107.114 166.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.31 149.95 29.22 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.386 -1.338 . . . . 3.2400000000000002 107.386 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.37 103.41 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 C-N-CA 125.621 1.569 . . . . 1.25 106.791 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.5 m -121.48 87.52 2.77 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.377 1.471 . . . . 1.0 107.789 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.8 mt -126.45 160.51 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.555 0.742 . . . . 1.3899999999999999 109.034 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.33 95.78 2.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.194 -0.457 . . . . 2.3300000000000001 111.503 157.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.35 154.46 25.25 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.311 0.577 . . . . 2.0499999999999998 110.243 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.1 p -107.76 -17.54 14.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.224 2.21 . . . . 1.73 112.386 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.33 -51.3 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.259 0.936 . . . . 1.02 109.426 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.415 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.4 pp -71.81 176.23 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.858 0.837 . . . . 1.0900000000000001 111.051 174.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -156.85 173.7 16.6 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.877 -1.157 . . . . 1.78 107.877 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 -43.69 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.761 0.824 . . . . 2.7000000000000002 110.558 169.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.0 t -101.72 35.25 2.37 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.424 -0.797 . . . . 4.4500000000000002 112.389 -158.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -149.65 -137.53 2.78 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 118.805 0.729 . . . . 3.1499999999999999 112.232 -169.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -100.14 -67.97 0.83 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.177 0.991 . . . . 5.9199999999999999 109.338 -166.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -79.87 2.76 22.02 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.24 1.016 . . . . 3.3900000000000001 111.684 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.64 157.42 0.77 Allowed 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.651 1.58 . . . . 1.4199999999999999 112.829 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.4 pt -90.53 -5.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.085 0.954 . . . . 2.02 111.218 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 tp -26.55 126.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.889 1.675 . . . . 1.98 111.876 163.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.26 -19.09 37.26 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.827 -0.985 . . . . 1.5700000000000001 113.433 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -88.81 164.08 15.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.576 1.688 . . . . 4.6500000000000004 110.807 -169.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.2 m -89.06 106.17 18.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 119.226 -0.416 . . . . 0.95999999999999996 110.603 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 mt -65.72 146.37 54.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.613 -0.835 . . . . 1.6499999999999999 108.775 166.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.453 HG21 ' CD2' ' A' ' 48' ' ' HIS . 80.6 t -135.47 135.46 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.443 1.897 . . . . 0.40000000000000002 109.046 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 145' ' ' ALA . 55.1 t -102.25 119.62 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.153 1.781 . . . . 2.3700000000000001 106.412 166.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -92.96 159.32 15.38 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 116.839 2.163 . . . . 0.40000000000000002 116.839 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -33.3 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.501 3.121 . . . . 3.3700000000000001 112.364 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -107.14 -175.98 2.95 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.059 0.845 . . . . 2.8300000000000001 110.458 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.86 142.53 45.62 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.504 -0.924 . . . . 0.87 108.504 158.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.21 165.95 24.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.242 -0.651 . . . . 2.2200000000000002 109.242 159.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -88.45 -7.13 57.08 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.396 1.478 . . . . 3.3500000000000001 111.227 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.28 46.16 27.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.346 1.458 . . . . 1.8400000000000001 110.2 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.27 24.06 58.45 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.644 -0.531 . . . . 1.7 113.627 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -78.34 -13.66 59.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.441 1.121 . . . . 5.04 110.633 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.0 -133.34 11.74 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.588 -1.005 . . . . 2.6200000000000001 110.588 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.95 -68.32 1.33 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.221 -1.552 . . . . 2.29 109.221 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.09 150.97 19.61 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.222 -1.029 . . . . 2.6499999999999999 108.222 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.24 -48.76 79.99 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.81 -0.556 . . . . 3.5 111.248 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -51.94 -33.46 37.56 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.114 1.366 . . . . 3.1099999999999999 111.777 -168.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.2 t -39.39 -62.56 0.65 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.386 1.474 . . . . 2.1499999999999999 110.466 167.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.3 p -73.77 -46.46 45.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.762 0.425 . . . . 1.3999999999999999 110.757 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -42.92 86.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.026 0.53 . . . . 2.8999999999999999 110.858 -167.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.497 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.6 p -128.33 -48.07 1.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.355 0.662 . . . . 1.52 112.127 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 154.31 -31.85 0.71 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.103 1.335 . . . . 1.1299999999999999 111.038 -173.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 52.99 54.68 10.06 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.628 1.971 . . . . 2.4100000000000001 112.606 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.54 -43.11 33.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.12 0.962 . . . . 1.1899999999999999 108.875 162.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 116.05 -143.42 18.07 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 107.986 -2.046 . . . . 1.0700000000000001 107.986 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.5 m -60.61 149.6 34.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.574 1.149 . . . . 1.1899999999999999 112.459 -169.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -60.5 135.01 57.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 2.6400000000000001 108.878 168.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -112.19 -82.27 0.59 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.887 -1.153 . . . . 0.71999999999999997 107.887 165.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . . . -83.04 145.42 29.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.672 -1.233 . . . . 1.1599999999999999 107.672 171.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 77.7 m -141.24 154.29 45.7 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.137 -1.431 . . . . 2.21 107.137 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.06 128.64 1.5 Allowed Glycine 0 CA--C 1.527 0.796 0 O-C-N 123.614 0.571 . . . . 0.72999999999999998 111.735 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.95 132.28 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.676 1.19 . . . . 0.68999999999999995 109.223 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.417 HD11 ' CG ' ' A' ' 20' ' ' PHE . 8.1 tt -95.7 138.79 20.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 111.688 0.255 . . . . 0.69999999999999996 111.688 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.69 0.03 1.6 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.062 0.839 . . . . 0.56999999999999995 115.048 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.62 57.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 119.11 1.455 . . . . 0.76000000000000001 110.914 -157.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.39 169.07 25.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.196 0.598 . . . . 1.29 110.547 168.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 . . . . . 0 C--O 1.253 1.272 0 N-CA-C 102.057 -3.312 . . . . 4.4000000000000004 102.057 162.701 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 107.664 -1.236 . . . . 7.5899999999999999 107.664 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.99 86.84 2.17 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.796 0.839 . . . . 3.8700000000000001 109.805 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.11 177.35 8.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.753 1.221 . . . . 2.9100000000000001 108.369 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.79 139.9 34.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.933 -1.506 . . . . 0.77000000000000002 106.933 153.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -98.2 147.26 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.132 -1.803 . . . . 0.67000000000000004 106.132 159.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.77 96.13 3.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.404 -0.962 . . . . 0.54000000000000004 108.404 160.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.06 109.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.381 -1.34 . . . . 0.70999999999999996 107.381 168.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.9 mt -95.52 128.77 42.65 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.176 0.591 . . . . 0.84999999999999998 109.901 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -140.15 -65.05 0.47 Allowed 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.848 0.859 . . . . 3.9700000000000002 110.858 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.58 -122.74 5.81 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.791 1.186 . . . . 1.05 112.94 -170.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -118.89 -49.81 2.41 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.179 0.991 . . . . 3.0800000000000001 109.67 -155.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.3 154.96 8.06 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 108.803 -1.719 . . . . 0.83999999999999997 108.803 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.33 42.8 1.29 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.175 2.583 . . . . 1.0600000000000001 113.385 -165.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -84.98 153.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.191 1.396 . . . . 1.1799999999999999 110.298 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.61 75.69 1.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.37 -0.974 . . . . 3.0099999999999998 108.37 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 165.27 16.89 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.56999999999999995 112.522 -171.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.51 133.22 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.11 0.964 . . . . 1.1799999999999999 109.546 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 26.6 mm -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.513 1.525 . . . . 0.79000000000000004 107.708 161.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -121.45 119.09 31.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.554 -1.646 . . . . 1.76 106.554 158.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.461 ' CD1' HG22 ' A' ' 31' ' ' VAL . 9.4 t80 -128.07 120.54 27.65 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.442 -1.318 . . . . 2.9500000000000002 107.442 -169.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.81 165.07 37.62 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.45 0.643 . . . . 4.3700000000000001 112.191 -166.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -153.84 157.04 38.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.501 -2.037 . . . . 2.9100000000000001 105.501 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.26 -29.77 64.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.043 0.383 . . . . 5.1900000000000004 110.894 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.52 -150.5 0.43 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.946 -1.501 . . . . 5.6200000000000001 106.946 174.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.0 m -146.17 1.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.708 -1.245 . . . . 4.2699999999999996 113.866 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -124.26 39.93 3.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.067 1.747 . . . . 3.46 109.728 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.84 -162.23 10.81 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.377 -1.089 . . . . 1.3799999999999999 110.377 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.98 114.5 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.155 2.57 . . . . 1.3600000000000001 111.139 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.1 158.54 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.089 -0.708 . . . . 0.91000000000000003 109.089 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -106.37 112.54 25.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.18 -1.045 . . . . 2.6600000000000001 108.18 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 20' ' ' PHE . 60.0 t -80.55 122.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.198 -1.778 . . . . 1.23 106.198 164.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -125.98 145.54 50.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.675 -0.861 . . . . 1.1399999999999999 108.675 154.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.41 155.4 26.68 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.673 -0.971 . . . . 0.72999999999999998 110.673 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -134.62 108.19 7.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.099 -2.186 . . . . 2.04 105.099 -173.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.3 149.01 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.014 -1.476 . . . . 0.92000000000000004 107.014 -167.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -155.32 157.28 36.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.957 -0.464 . . . . 3.8399999999999999 110.509 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.38 22.08 30.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.832 1.682 . . . . 0.90000000000000002 111.909 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.02 168.11 19.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.109 -1.071 . . . . 0.65000000000000002 108.109 168.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -74.85 169.17 18.45 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.216 -1.031 . . . . 1.6699999999999999 108.216 153.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.11 174.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.275 1.43 . . . . 3.9100000000000001 111.044 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -162.83 37.14 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.822 -0.626 . . . . 0.56000000000000005 113.531 167.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.67 141.23 57.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.929 1.292 . . . . 2.0299999999999998 113.27 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.3 114.64 7.53 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.486 1.514 . . . . 0.53000000000000003 109.751 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.46 145.14 2.81 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.497 1.046 . . . . 0.42999999999999999 110.665 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.18 93.57 3.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 2.4399999999999999 106.972 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.669 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 23.4 m170 -131.35 154.48 48.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.24 -0.437 . . . . 0.63 109.862 -161.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.02 116.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.375 -1.342 . . . . 2.1200000000000001 107.375 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -103.84 139.67 38.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.24 -1.393 . . . . 1.1000000000000001 107.24 170.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.35 35.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.802 1.408 . . . . 5.3399999999999999 114.802 -171.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.7 mt-10 -90.78 59.98 4.32 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.507 -1.371 . . . . 3.3700000000000001 112.365 -159.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.74 73.23 7.73 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.266 -0.642 . . . . 6.8300000000000001 109.266 173.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -123.0 56.8 1.15 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.228 -1.027 . . . . 7.54 108.228 162.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -51.98 -40.23 60.6 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.594 -0.691 . . . . 6.0599999999999996 110.956 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -77.3 43.58 0.38 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.873 0.869 . . . . 5.8600000000000003 112.105 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -172.98 -53.57 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 125.951 1.7 . . . . 6.21 108.038 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.28 -100.84 0.14 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.918 -1.273 . . . . 3.73 109.918 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.5 p 178.92 54.22 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.721 2.008 . . . . 2.9300000000000002 107.088 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.73 70.53 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.188 0.595 . . . . 3.77 109.628 -142.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.8 t -175.82 5.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 117.14 2.274 . . . . 4.1699999999999999 117.14 -143.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -134.98 168.76 18.53 Favored 'General case' 0 C--O 1.228 -0.058 0 N-CA-C 108.284 -1.006 . . . . 1.8100000000000001 108.284 160.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.15 -91.84 1.63 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.726 -1.75 . . . . 1.01 108.726 173.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.74 -179.06 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 125.843 4.362 . . . . 1.0700000000000001 112.7 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -53.1 131.6 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.615 1.566 . . . . 1.4399999999999999 110.236 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -42.44 114.03 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.771 1.228 . . . . 2.6200000000000001 109.712 170.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -156.29 165.95 17.51 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 106.671 -1.603 . . . . 2.5299999999999998 106.671 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.39 -35.09 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.549 1.499 . . . . 1.1399999999999999 111.487 -167.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -147.22 -82.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.876 0.87 . . . . 2.7999999999999998 109.194 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.4 m -139.03 64.94 1.46 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.383 1.073 . . . . 2.04 110.617 -168.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -77.67 175.27 10.07 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.532 0.682 . . . . 4.0300000000000002 109.3 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 8.5 mttp -120.83 146.47 46.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.473 1.509 . . . . 3.2799999999999998 107.189 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -72.31 167.31 20.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.568 0.747 . . . . 1.29 110.873 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.03 -138.45 2.68 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 106.699 -2.56 . . . . 2.0099999999999998 106.699 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.75 -144.26 4.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.882 -2.087 . . . . 1.6699999999999999 107.882 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.57 -41.24 6.47 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.176 1.988 . . . . 1.8400000000000001 109.901 174.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -58.03 7.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.724 0.81 . . . . 5.5499999999999998 111.802 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.16 145.44 37.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.576 -0.528 . . . . 2.04 109.576 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -55.97 -44.54 78.6 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.77 1.628 . . . . 4.1200000000000001 111.156 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 7.1 mt-10 -78.92 179.45 7.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.012 0.925 . . . . 2.8700000000000001 111.243 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 157.67 144.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.391 3.076 . . . . 2.9300000000000002 106.369 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.478 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.4 m80 -59.96 141.23 55.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 105.536 -2.024 . . . . 0.53000000000000003 105.536 156.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.68 71.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 123.117 1.437 . . . . 2.4300000000000002 108.165 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.26 26.73 0.26 Allowed Glycine 0 CA--C 1.542 1.774 0 C-N-CA 126.779 2.133 . . . . 0.85999999999999999 113.59 -155.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -130.51 145.75 51.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 120.518 2.159 . . . . 2.27 108.032 146.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -104.95 -42.36 5.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.794 0.837 . . . . 1.79 108.79 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.28 -121.82 1.11 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 109.076 -1.61 . . . . 0.56999999999999995 109.076 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -139.82 169.22 18.12 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.381 1.473 . . . . 1.6399999999999999 109.076 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.34 175.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 0.58999999999999997 106.653 163.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -106.68 142.63 36.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.967 -1.494 . . . . 2.3900000000000001 106.967 156.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.75 152.05 31.7 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.24 -1.022 . . . . 0.66000000000000003 108.24 152.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.32 -78.9 0.09 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.666 0.786 . . . . 2.8599999999999999 110.303 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -154.39 -52.43 0.09 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.716 1.606 . . . . 4.6900000000000004 107.948 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.63 4.03 17.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.084 1.754 . . . . 5.0099999999999998 111.748 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.07 10.16 72.25 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.907 1.241 . . . . 0.84999999999999998 111.682 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.2 t -79.17 147.38 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 0.98999999999999999 107.694 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.05 167.76 21.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.244 1.018 . . . . 0.66000000000000003 108.755 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -130.64 144.59 51.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 103.901 -2.629 . . . . 2.7000000000000002 103.901 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -128.06 111.04 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 106.704 -1.591 . . . . 1.1499999999999999 106.704 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -140.17 104.82 4.9 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.952 0.901 . . . . 1.4099999999999999 108.773 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.04 151.9 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.662 -0.866 . . . . 1.6599999999999999 108.662 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.32 98.55 3.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.626 0.37 . . . . 2.5899999999999999 110.152 158.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.58 160.12 20.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.512 0.325 . . . . 2.6400000000000001 110.155 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -116.95 57.18 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.353 1.461 . . . . 2.5099999999999998 109.312 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -139.56 -64.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 108.025 -1.102 . . . . 1.1200000000000001 108.025 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.7 pp -75.88 175.58 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.345 0.593 . . . . 1.4199999999999999 110.905 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -153.94 176.0 12.7 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.554 1.541 . . . . 2.04 107.01 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 11.78 33.63 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.676 1.58 . . . . 2.3300000000000001 114.486 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.3 t -73.99 -73.28 0.23 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.362 0.528 . . . . 3.1600000000000001 111.654 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -171.15 171.94 44.18 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.665 -0.974 . . . . 2.5600000000000001 110.665 -172.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 51.87 -80.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.164 0 C-N-CA 128.273 2.629 . . . . 5.25 113.162 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -77.43 -25.4 50.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.275 1.83 . . . . 3.9500000000000002 110.304 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -53.83 160.24 1.46 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.891 0.477 . . . . 1.3700000000000001 110.528 171.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.5 pt -78.96 -7.05 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.208 -0.308 . . . . 1.8899999999999999 110.28 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tp -44.98 129.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.267 0.627 . . . . 1.46 109.744 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.21 -5.36 84.47 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 118.143 -1.365 . . . . 1.3400000000000001 113.839 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -98.26 162.3 13.26 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 120.199 2.0 . . . . 4.1100000000000003 111.655 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.0 m -94.65 107.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.059 0.943 . . . . 1.01 109.319 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.83 133.52 45.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.398 -0.964 . . . . 1.6499999999999999 108.398 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.94 134.23 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 126.846 2.058 . . . . 0.44 106.516 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -101.47 128.84 53.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.624 -1.621 . . . . 1.6599999999999999 106.624 165.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.529 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 48.3 m-70 -104.86 161.13 14.45 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 116.037 1.865 . . . . 0.52000000000000002 116.037 -169.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -37.32 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.41 2.684 . . . . 3.4100000000000001 112.06 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -101.27 -174.85 2.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.599 0.636 . . . . 2.6800000000000002 109.905 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.11 156.94 11.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.722 -0.844 . . . . 0.62 108.722 157.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -80.4 164.59 22.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.902 0.858 . . . . 2.1600000000000001 109.14 152.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -88.06 -4.61 58.76 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.321 1.448 . . . . 3.2400000000000002 112.354 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 56.16 33.79 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.638 1.175 . . . . 1.6299999999999999 110.561 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.98 25.33 65.93 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.392 -0.671 . . . . 1.4399999999999999 112.46 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -131.97 21.11 4.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.261 1.031 . . . . 5.1799999999999997 111.731 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.32 147.04 18.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.707 -0.957 . . . . 2.48 110.707 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.73 60.07 2.95 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.874 -0.89 . . . . 2.8799999999999999 110.874 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -176.67 106.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 105.232 -2.136 . . . . 2.8300000000000001 105.232 -169.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -31.92 46.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.021 0.749 . . . . 3.8199999999999998 113.021 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -36.01 -43.61 0.33 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.076 1.75 . . . . 2.9399999999999999 112.783 166.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t -43.78 -63.91 0.76 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.954 1.701 . . . . 2.7200000000000002 110.205 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.39 -46.11 61.12 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.818 -0.551 . . . . 1.6699999999999999 110.988 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -56.06 -45.75 79.18 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 123.642 0.777 . . . . 3.25 110.875 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.478 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 2.7 p -130.81 -47.88 1.04 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 119.127 -0.463 . . . . 1.49 112.022 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.41 -31.2 0.86 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.699 0.682 . . . . 1.0 112.647 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.41 54.21 5.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.098 1.359 . . . . 1.9399999999999999 110.09 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.83 -36.03 81.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.23 1.412 . . . . 1.1799999999999999 112.792 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 -174.05 49.77 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.396 -1.882 . . . . 0.91000000000000003 108.396 -160.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.1 m -59.53 151.61 23.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.439 1.495 . . . . 1.3200000000000001 113.385 -166.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 50' ' ' GLU . 4.8 mmt-85 -60.6 135.0 57.63 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.114 1.366 . . . . 3.0800000000000001 108.522 168.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.4 mt -112.19 -68.93 0.9 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.618 -1.253 . . . . 0.45000000000000001 107.618 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.6 166.41 11.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.185 -0.461 . . . . 1.1100000000000001 110.209 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.2 p -146.81 161.12 41.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.953 -1.021 . . . . 2.5299999999999998 108.507 165.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.94 131.62 1.57 Allowed Glycine 0 CA--C 1.526 0.779 0 O-C-N 125.07 1.481 . . . . 0.66000000000000003 110.288 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.13 134.6 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 123.743 0.817 . . . . 0.87 109.433 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.4 tt -91.8 126.37 44.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 C-N-CA 123.236 0.615 . . . . 0.90000000000000002 111.439 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.74 -5.75 0.84 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.467 1.032 . . . . 0.70999999999999996 114.911 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.5 mp -90.82 59.54 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.816 1.308 . . . . 1.1499999999999999 110.297 -155.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.49 175.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.866 0.841 . . . . 2.0699999999999998 113.181 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 C--O 1.248 1.001 0 N-CA-C 104.555 -2.387 . . . . 6.7000000000000002 104.555 160.571 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 112.989 0.737 . . . . 6.4800000000000004 112.989 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m 66.82 58.87 0.59 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.52 1.928 . . . . 2.9500000000000002 110.223 -162.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -139.16 167.74 21.39 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.826 0.45 . . . . 4.2800000000000002 112.002 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.42 155.09 19.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.718 1.207 . . . . 0.75 109.043 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.24 151.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.614 -1.254 . . . . 0.82999999999999996 107.614 162.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.75 102.39 6.07 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.86 0.864 . . . . 0.77000000000000002 108.765 157.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.61 105.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.149 -1.426 . . . . 0.80000000000000004 107.149 161.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -86.18 129.7 34.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.005 -1.109 . . . . 0.93000000000000005 108.005 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -151.58 -51.69 0.12 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.958 0.408 . . . . 3.1699999999999999 110.552 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.24 -111.16 1.06 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.472 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.99 -48.44 2.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.483 1.113 . . . . 3.6299999999999999 109.429 -161.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.65 171.65 33.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.212 1.387 . . . . 0.84999999999999998 112.048 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -69.64 -19.05 37.2 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.587 2.858 . . . . 1.3799999999999999 111.961 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.68 146.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.203 1.401 . . . . 1.0 111.072 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.11 122.05 5.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.783 -0.821 . . . . 2.0600000000000001 108.783 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.41 169.75 32.79 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.843 -0.503 . . . . 0.68000000000000005 111.843 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.84 113.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.059 -1.089 . . . . 1.4399999999999999 108.059 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.7 mm -79.49 137.16 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.936 -1.135 . . . . 0.76000000000000001 107.936 167.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -109.66 118.46 36.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.008 -1.849 . . . . 1.4399999999999999 106.008 157.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.586 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -108.04 98.04 7.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.575 1.55 . . . . 3.23 106.89 176.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -109.13 137.13 47.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.441 -0.948 . . . . 5.1699999999999999 108.441 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -147.42 -62.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.54 -0.911 . . . . 4.0599999999999996 108.54 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 tttp 72.82 -48.41 0.68 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.834 1.654 . . . . 8.75 112.243 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 99.75 5.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.69 -1.226 . . . . 3.7799999999999998 107.69 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.4 t -19.36 -66.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.854 2.461 . . . . 2.8999999999999999 114.954 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -109.61 27.16 9.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.564 0.746 . . . . 3.5899999999999999 110.579 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.42 171.49 33.67 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.562 -1.015 . . . . 1.1799999999999999 110.562 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.13 139.5 66.99 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.948 1.766 . . . . 1.1200000000000001 110.257 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.81 159.86 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.274 -1.01 . . . . 1.26 108.274 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 110.85 13.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.28 -1.378 . . . . 3.2400000000000002 107.28 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.586 HG22 ' CE1' ' A' ' 20' ' ' PHE . 59.4 t -100.73 118.04 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 127.124 2.17 . . . . 1.1699999999999999 107.139 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -139.03 167.22 22.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.935 -0.395 . . . . 1.0800000000000001 109.935 163.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.15 175.31 38.95 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.699 -1.76 . . . . 0.88 108.699 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.1 p -130.15 113.84 14.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.807 -2.294 . . . . 2.46 104.807 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.31 109.81 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.283 -2.117 . . . . 1.51 105.283 -166.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -111.38 162.61 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.731 0.645 . . . . 3.7999999999999998 111.731 -166.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.55 80.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.219 -0.901 . . . . 0.78000000000000003 112.95 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -69.44 160.51 31.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.588 1.194 . . . . 0.83999999999999997 108.488 172.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.42 163.88 17.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.949 -1.13 . . . . 1.9399999999999999 107.949 154.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -58.61 170.11 0.82 Allowed 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.443 -0.786 . . . . 2.8900000000000001 111.295 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.58 -158.87 53.66 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.655 -0.702 . . . . 0.66000000000000003 112.693 165.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -70.86 144.44 50.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.849 1.259 . . . . 2.5600000000000001 112.59 -171.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -146.36 118.5 8.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.909 1.684 . . . . 0.63 109.294 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.99 149.86 4.18 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.923 -0.871 . . . . 0.34000000000000002 110.923 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -142.84 94.91 2.69 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.834 -1.543 . . . . 2.27 106.834 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -136.6 144.82 44.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.704 -1.221 . . . . 0.54000000000000004 107.704 -164.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.2 p -99.63 127.03 52.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 119.17 0.896 . . . . 1.8 109.894 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -97.1 136.23 37.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.356 -1.35 . . . . 0.77000000000000002 107.356 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.76 -32.29 59.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.169 0.988 . . . . 4.3200000000000003 112.111 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 7.3 tt0 -4.58 100.64 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.525 2.73 . . . . 3.0299999999999998 113.068 158.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.63 178.44 6.04 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.067 1.747 . . . . 5.54 112.348 -163.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -80.19 58.64 3.09 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.553 1.941 . . . . 7.0899999999999999 110.19 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.92 -18.36 22.02 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.452 1.901 . . . . 5.5199999999999996 111.83 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.0 t -169.92 -163.16 0.35 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.414 -1.699 . . . . 5.3799999999999999 106.414 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.63 -53.99 6.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.357 0.663 . . . . 6.8799999999999999 110.605 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.13 -166.19 39.36 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.87 0.748 . . . . 4.3399999999999999 112.546 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 65.1 m -59.2 151.86 21.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.377 0.671 . . . . 2.98 109.818 173.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 m -151.38 -8.56 0.23 Allowed 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 114.018 1.118 . . . . 5.9299999999999997 114.018 163.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.298 2.4 p -173.8 2.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 119.497 3.147 . . . . 3.8900000000000001 119.497 -117.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . . . -152.31 178.72 9.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.322 0.965 . . . . 1.8500000000000001 110.606 164.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.55 -85.31 1.15 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.684 -1.767 . . . . 1.05 108.684 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.1 178.88 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.607 1 C-N-CA 125.774 4.316 . . . . 0.90000000000000002 113.308 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -67.96 132.88 48.13 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.572 1.549 . . . . 1.3100000000000001 110.106 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -44.99 114.03 0.66 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.942 0.897 . . . . 2.8999999999999999 111.68 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.92 157.36 31.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 125.634 1.574 . . . . 2.6000000000000001 106.875 168.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.06 -24.13 13.03 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.958 1.772 . . . . 1.3300000000000001 113.609 -168.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.0 tp -156.2 -72.32 0.11 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.03 0.832 . . . . 3.1800000000000002 110.856 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.6 m -154.09 63.21 0.7 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.266 0.555 . . . . 1.9199999999999999 110.21 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -78.09 168.76 19.38 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.353 -0.98 . . . . 3.8999999999999999 108.353 162.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -128.76 165.11 21.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.026 1.331 . . . . 4.6500000000000004 108.214 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -94.66 132.25 39.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.665 -0.865 . . . . 1.1699999999999999 108.665 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.92 -56.84 0.08 OUTLIER Glycine 0 C--O 1.224 -0.522 0 N-CA-C 108.095 -2.002 . . . . 2.96 108.095 171.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 140.33 173.41 13.34 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.457 1.503 . . . . 1.54 110.083 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.04 -31.13 66.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.902 2.402 . . . . 1.9199999999999999 111.037 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -73.84 -40.63 63.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.099 0.96 . . . . 4.0700000000000003 111.059 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -70.42 176.12 4.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.91 0.884 . . . . 1.8500000000000001 111.288 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.48 -48.96 20.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.386 1.074 . . . . 4.4299999999999997 109.734 168.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.38 149.85 26.45 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.654 1.216 . . . . 3.4700000000000002 112.185 -171.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -168.1 129.28 1.38 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.977 2.111 . . . . 5.71 107.488 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.491 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 50.1 m80 -51.62 131.58 29.88 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.463 -2.421 . . . . 0.59999999999999998 104.463 145.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.09 -35.47 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.933 -0.765 . . . . 1.9299999999999999 108.933 -169.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.76 38.95 2.98 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.537 1.065 . . . . 0.78000000000000003 115.289 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -90.16 129.21 36.46 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.206 -2.146 . . . . 1.8200000000000001 105.206 152.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.67 -51.75 6.25 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.735 -1.209 . . . . 1.8500000000000001 107.735 156.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.35 -104.63 0.26 Allowed Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.977 -1.249 . . . . 0.56999999999999995 109.977 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -148.49 170.64 17.59 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.799 1.64 . . . . 1.4099999999999999 109.57 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.81 162.32 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.069 -1.456 . . . . 0.56999999999999995 107.069 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.6 m -109.4 129.79 55.53 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 108.012 -1.107 . . . . 2.1600000000000001 108.012 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.51 139.26 34.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.744 0.818 . . . . 0.64000000000000001 111.513 168.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.13 -90.67 0.08 Allowed 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 124.045 0.841 . . . . 3.0800000000000001 110.574 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -141.2 -34.38 0.49 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.395 0.887 . . . . 4.04 113.395 -162.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -78.81 14.75 1.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.911 1.339 . . . . 3.6699999999999999 110.385 170.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 62.33 20.88 61.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.115 -1.194 . . . . 0.72999999999999998 110.115 -166.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -92.24 117.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 123.995 0.918 . . . . 1.04 108.573 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.21 143.81 26.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.899 -1.889 . . . . 0.87 105.899 149.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.35 108.1 8.97 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 105.44 -2.059 . . . . 5.21 105.44 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.85 141.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.84 -1.073 . . . . 2.1600000000000001 110.601 -148.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.7 t -146.13 113.29 6.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.188 -1.412 . . . . 3.1800000000000002 107.188 162.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.4 mt -137.15 144.86 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 105.88 -1.896 . . . . 1.6299999999999999 105.88 166.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -125.71 96.36 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.945 0.35 . . . . 2.46 111.945 165.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.9 145.39 34.13 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.274 0.559 . . . . 2.6299999999999999 110.719 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.6 p -98.35 -20.52 17.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.394 1.878 . . . . 1.53 111.27 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.42 -49.6 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.305 0.502 . . . . 0.94999999999999996 109.875 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.2 pt -75.43 177.74 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.761 0.791 . . . . 1.4399999999999999 111.438 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.8 m -157.41 175.76 13.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.78 1.632 . . . . 1.76 107.417 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.417 HD21 ' HD2' ' A' ' 20' ' ' PHE . 77.1 mt -124.31 54.99 1.32 Allowed 'General case' 0 C--N 1.338 0.08 0 C-N-CA 124.534 1.133 . . . . 4.3300000000000001 108.754 174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t -134.72 -127.12 0.16 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.203 1.801 . . . . 3.0699999999999998 107.351 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.75 156.89 48.41 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 114.498 0.559 . . . . 2.8799999999999999 114.498 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.2 t70 52.76 -88.66 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.642 2.377 . . . . 4.5700000000000003 114.521 155.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -73.54 -20.85 60.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.49 1.116 . . . . 5.8600000000000003 110.448 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.2 m -50.43 130.81 24.2 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.591 -0.892 . . . . 2.29 108.591 167.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.565 ' CD1' HG21 ' A' ' 149' ' ' ILE . 2.6 pp -78.78 -24.36 13.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.693 -0.403 . . . . 1.96 110.449 -163.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 tp -1.79 113.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.33 2.652 . . . . 1.8500000000000001 114.099 161.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.59 37.62 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.971 0.796 . . . . 1.74 113.183 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.485 ' O ' HG22 ' A' ' 149' ' ' ILE . 81.3 mtt85 -83.0 169.48 15.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.542 1.171 . . . . 4.0499999999999998 110.24 -171.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.2 m -95.45 108.81 21.05 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.735 -0.603 . . . . 0.92000000000000004 110.459 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.84 131.32 44.3 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.368 -1.345 . . . . 1.5700000000000001 107.368 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.09 139.89 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 127.265 2.226 . . . . 0.39000000000000001 107.845 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 m -108.86 130.19 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.85 -0.796 . . . . 1.6100000000000001 108.85 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -99.09 159.79 14.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 116.01 1.856 . . . . 0.38 116.01 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -40.65 -74.66 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.302 2.241 . . . . 3.0899999999999999 112.562 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -97.13 -179.34 4.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.198 1.399 . . . . 2.6099999999999999 110.637 -171.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.38 149.96 5.2 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 0.54000000000000004 109.473 156.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.5 149.04 26.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.152 -1.055 . . . . 2.1400000000000001 108.152 162.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.72 -8.6 59.34 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.233 0.827 . . . . 3.4199999999999999 113.233 -164.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 47.48 38.12 7.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.169 0.985 . . . . 2.2799999999999998 110.413 -165.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.25 25.48 57.42 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.533 -0.758 . . . . 2.0 113.001 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -113.85 40.38 2.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.22 1.01 . . . . 5.1799999999999997 108.655 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.0 134.6 9.0 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.895 -1.682 . . . . 2.23 108.895 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.67 -35.51 92.13 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 117.509 0.655 . . . . 2.4399999999999999 111.756 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -58.71 107.94 0.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.961 0.904 . . . . 2.1000000000000001 108.719 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -41.93 -42.65 2.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 3.8999999999999999 112.817 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -36.43 -41.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.73 2.012 . . . . 2.8100000000000001 113.978 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.5 m -54.93 -48.26 73.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.452 0.701 . . . . 2.4500000000000002 111.631 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.7 p -73.08 -46.33 52.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.361 -0.837 . . . . 1.23 110.482 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -51.83 -49.74 62.23 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.685 1.194 . . . . 2.54 111.264 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.491 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.9 OUTLIER -125.0 -46.52 1.82 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.607 0.763 . . . . 1.3100000000000001 111.142 175.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.91 2.02 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 119.086 0.857 . . . . 0.93999999999999995 112.197 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.64 54.28 9.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.187 1.795 . . . . 1.98 111.181 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.01 -5.36 58.28 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.26 -0.9 . . . . 1.1499999999999999 111.804 169.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.74 -165.23 45.71 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.083 -1.607 . . . . 0.93999999999999995 109.083 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.1 m -57.94 150.85 19.56 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.554 1.542 . . . . 1.22 113.678 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.1 mmt-85 -54.7 135.79 46.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.082 -1.417 . . . . 2.6600000000000001 108.275 164.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.5 mt -106.89 -76.63 0.61 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.953 -1.499 . . . . 0.52000000000000002 106.953 166.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 144.98 32.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.477 -0.934 . . . . 0.70999999999999996 108.477 170.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.46 150.36 48.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.119 -1.808 . . . . 1.71 106.119 172.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.48 119.94 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.424 -1.07 . . . . 0.75 110.424 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -58.47 130.21 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.046 1.338 . . . . 1.21 108.923 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.565 HG21 ' CD1' ' A' ' 112' ' ' ILE . 6.7 tt -105.65 133.12 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.962 0.727 . . . . 1.1399999999999999 112.962 -169.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.87 8.43 0.47 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.313 0.959 . . . . 0.82999999999999996 114.205 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.7 mm -91.88 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 120.045 1.922 . . . . 1.1299999999999999 109.867 -162.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.7 176.83 12.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.952 1.301 . . . . 1.3400000000000001 108.333 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--O 1.254 1.331 0 N-CA-C 107.014 -1.476 . . . . 4.7599999999999998 107.014 166.703 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 108.146 -1.057 . . . . 4.9100000000000001 108.146 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 m 54.76 56.04 7.17 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.928 -1.878 . . . . 3.9199999999999999 105.928 -161.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -89.96 173.51 8.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.155 -1.384 . . . . 3.5299999999999998 108.502 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.63 141.19 49.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.948 -1.131 . . . . 0.88 107.948 159.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.581 HG23 ' HB2' ' A' ' 152' ' ' ALA . 71.0 t -103.81 142.83 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 107.195 -1.409 . . . . 0.70999999999999996 107.195 163.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -122.35 96.9 5.22 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.13 0.972 . . . . 0.51000000000000001 108.418 158.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.41 106.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.083 -1.451 . . . . 0.62 107.083 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 mt -99.17 133.95 42.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.166 0.986 . . . . 1.1000000000000001 109.196 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -143.47 -52.27 0.35 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.108 0.563 . . . . 3.3599999999999999 110.066 172.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.7 -121.67 27.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.878 0.751 . . . . 0.88 113.286 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -120.28 -54.66 2.09 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 125.128 1.371 . . . . 3.9900000000000002 110.008 -164.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.5 162.96 13.66 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.756 -1.338 . . . . 0.83999999999999997 109.756 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.52 33.54 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.389 2.726 . . . . 0.95999999999999996 113.141 -172.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 47.4 t -83.17 155.79 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.784 1.234 . . . . 0.83999999999999997 108.956 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -154.98 122.21 5.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.507 1.523 . . . . 2.5 107.243 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.41 169.09 38.36 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.883 -0.887 . . . . 0.47999999999999998 110.883 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.06 109.07 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.784 -1.562 . . . . 1.05 106.784 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 39.0 mm -79.03 126.45 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.531 -1.655 . . . . 0.73999999999999999 106.531 168.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -101.99 109.08 20.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.63 -1.618 . . . . 1.6299999999999999 106.63 160.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.42 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -90.31 96.43 10.66 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.028 -1.842 . . . . 2.8999999999999999 106.028 168.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.58 165.37 15.51 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.425 -0.954 . . . . 3.23 108.425 163.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -157.24 -50.39 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.279 0.632 . . . . 3.8999999999999999 109.411 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt 70.99 -61.33 0.48 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 127.594 2.358 . . . . 4.25 111.156 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -80.89 118.86 22.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.083 -0.71 . . . . 4.1600000000000001 109.083 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 m -20.24 -66.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.233 3.013 . . . . 3.3599999999999999 116.05 -172.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -123.9 52.55 1.45 Allowed 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 107.623 -1.251 . . . . 3.6899999999999999 107.623 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.98 178.09 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.761 -1.336 . . . . 1.46 109.761 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.01 132.7 30.92 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.107 1.871 . . . . 1.6399999999999999 111.283 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.6 124.2 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 108.747 -0.834 . . . . 1.1200000000000001 108.747 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -99.3 89.99 4.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.434 2.694 . . . . 5.04 105.538 -170.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 20' ' ' PHE . 12.6 t -83.54 126.1 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.138 1.775 . . . . 1.28 107.161 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -140.69 140.23 34.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.715 -0.846 . . . . 0.84999999999999998 108.715 158.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.48 145.75 8.75 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 105.806 -2.918 . . . . 0.82999999999999996 105.806 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.4 m -127.13 78.49 1.81 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.2 -1.778 . . . . 2.6899999999999999 106.2 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.38 134.15 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 128.38 2.672 . . . . 0.88 108.48 -162.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -129.48 163.01 26.81 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 118.741 0.701 . . . . 4.3600000000000003 111.475 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.09 24.27 52.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.113 0.863 . . . . 0.89000000000000001 111.993 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.16 -150.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.497 -1.297 . . . . 1.1399999999999999 107.497 163.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 m -147.34 152.35 38.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.36 -2.459 . . . . 3.3300000000000001 104.36 164.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -32.8 138.1 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.484 2.314 . . . . 2.7999999999999998 113.862 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.77 -166.4 28.92 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.212 0.434 . . . . 0.67000000000000004 112.995 167.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.29 147.24 53.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.091 1.356 . . . . 2.3399999999999999 112.829 -166.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -149.39 115.57 5.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.796 1.639 . . . . 0.46999999999999997 109.002 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.23 155.83 2.51 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.749 0.704 . . . . 0.54000000000000004 111.449 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.533 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 31.6 t80 -149.25 100.6 3.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.69 -0.855 . . . . 2.6899999999999999 108.69 -169.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -137.59 175.42 9.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.596 -1.261 . . . . 0.69999999999999996 107.596 -166.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.76 137.73 56.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.837 0.827 . . . . 1.8100000000000001 109.135 165.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -101.3 178.76 4.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.673 1.589 . . . . 0.93000000000000005 107.224 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -107.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.251 -1.018 . . . . 5.54 108.251 174.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 46.61 59.29 3.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.194 1.397 . . . . 3.2000000000000002 111.591 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.76 -105.89 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.132 0.973 . . . . 5.1399999999999997 110.8 -177.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -84.06 63.61 7.72 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.523 -1.361 . . . . 6.7199999999999998 110.786 -169.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -60.17 1.61 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.83 0.852 . . . . 5.3899999999999997 109.674 -174.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.6 m -159.09 -56.45 0.06 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.959 0.904 . . . . 4.1399999999999997 109.532 -173.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -165.35 -43.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.453 1.101 . . . . 6.5099999999999998 110.716 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.14 -138.99 2.6 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.391 -1.084 . . . . 4.54 110.391 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 71.0 m -47.16 128.19 11.35 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 124.927 1.291 . . . . 2.54 111.27 -172.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.99 0.34 0.22 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.19 1.552 . . . . 5.3200000000000003 115.19 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.7 m -172.33 -59.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 118.653 2.834 . . . . 2.8399999999999999 118.653 -123.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.49 -179.39 4.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.586 0.708 . . . . 1.99 110.723 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.44 -89.56 0.97 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.356 -1.898 . . . . 1.4299999999999999 108.356 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.87 179.02 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 125.136 3.89 . . . . 1.3300000000000001 112.919 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.416 ' HB2' ' CG ' ' A' ' 80' ' ' HIS . 24.2 m170 -65.46 138.4 58.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.16 1.784 . . . . 1.53 111.694 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -45.18 108.45 0.12 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.085 1.754 . . . . 2.5 111.993 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -150.24 154.82 36.73 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 125.727 1.611 . . . . 2.4300000000000002 107.454 166.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.51 -42.0 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.17 1.913 . . . . 1.29 112.667 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -142.33 -68.07 0.37 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.029 0.531 . . . . 3.3199999999999998 110.937 -175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -154.12 64.92 0.7 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.632 -0.668 . . . . 2.0499999999999998 111.532 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -78.02 166.25 23.05 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.952 -1.129 . . . . 4.0099999999999998 107.952 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -123.71 176.93 5.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.26 1.824 . . . . 5.2599999999999998 106.846 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -101.63 148.62 25.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.982 -0.449 . . . . 1.1599999999999999 111.515 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.58 -61.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.465 -1.054 . . . . 2.9700000000000002 110.465 173.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.23 -172.55 29.28 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.904 1.24 . . . . 1.6200000000000001 114.206 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 -41.49 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.769 2.313 . . . . 1.95 109.787 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -70.64 -47.55 59.47 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.735 0.814 . . . . 5.2199999999999998 111.239 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.84 175.21 1.56 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.108 -0.496 . . . . 2.5600000000000001 109.681 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.6 -39.92 21.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.986 -0.746 . . . . 8.0 108.986 165.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 147.14 39.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 117.237 -1.785 . . . . 3.8100000000000001 110.576 -165.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 167.58 127.89 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.548 2.339 . . . . 3.2799999999999998 108.262 -167.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 53.7 m80 -49.25 127.63 15.2 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 106.815 -1.55 . . . . 1.1000000000000001 106.815 163.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 p -52.69 -34.62 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.544 0.572 . . . . 1.55 112.544 -154.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.76 83.42 0.77 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.967 -0.853 . . . . 0.89000000000000001 110.967 166.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -161.98 111.74 1.54 Allowed 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.789 -0.83 . . . . 2.1200000000000001 108.84 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -90.02 -53.01 4.67 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.883 0.473 . . . . 2.1299999999999999 110.743 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.62 -102.74 0.22 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.572 -0.823 . . . . 0.73999999999999999 111.998 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.18 166.79 27.77 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.92 1.288 . . . . 1.8300000000000001 110.176 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.62 175.58 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.865 1.666 . . . . 0.48999999999999999 106.612 167.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 t -127.36 134.43 49.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.624 -0.88 . . . . 2.0699999999999998 108.624 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.74 135.99 36.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 123.227 0.611 . . . . 0.56999999999999995 110.411 165.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.19 -92.16 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.795 1.638 . . . . 3.1899999999999999 110.238 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -115.03 -67.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.616 0.767 . . . . 5.9100000000000001 110.864 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.3 -32.44 49.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 122.062 0.934 . . . . 3.4700000000000002 110.262 -168.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.24 46.41 0.07 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.597 -2.201 . . . . 0.83999999999999997 107.597 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.51 111.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.36 1.864 . . . . 0.83999999999999997 106.901 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.33 174.29 5.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.091 -1.078 . . . . 0.66000000000000003 108.091 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -145.52 149.61 34.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.787 -1.56 . . . . 3.1000000000000001 106.787 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG11 ' CZ ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -127.16 54.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 124.288 0.992 . . . . 1.6799999999999999 111.293 -178.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.3 m -70.07 91.8 0.71 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.839 -0.538 . . . . 1.1200000000000001 110.717 165.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.62 149.83 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.926 0.89 . . . . 1.45 108.646 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -113.23 89.6 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.729 -0.841 . . . . 3.2200000000000002 108.729 160.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -77.88 148.54 34.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.224 0.92 . . . . 2.3500000000000001 109.77 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.3 p -115.01 -6.69 12.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.926 1.69 . . . . 1.73 112.729 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.4 t -78.79 -54.73 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 119.546 1.066 . . . . 1.6899999999999999 109.615 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -86.85 176.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.977 0.894 . . . . 0.98999999999999999 111.403 178.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -145.17 160.94 40.66 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.093 -1.817 . . . . 1.8999999999999999 106.093 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.93 24.9 7.9 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.064 0.946 . . . . 2.5499999999999998 111.644 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 t -76.8 -162.97 0.3 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.069 0.548 . . . . 3.02 109.657 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.75 67.75 0.23 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.859 -1.696 . . . . 3.4100000000000001 108.859 172.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -142.44 -129.49 0.09 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.852 -1.166 . . . . 4.79 107.852 -172.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -79.19 2.23 21.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.122 1.369 . . . . 4.5499999999999998 111.155 171.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p -50.48 158.01 0.66 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.836 2.454 . . . . 1.3100000000000001 112.408 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.2 pt -84.12 -5.72 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.961 -0.563 . . . . 2.1800000000000002 111.429 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -51.0 136.59 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 O-C-N 122.016 -0.427 . . . . 1.75 110.207 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.88 30.01 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.614 -1.103 . . . . 1.76 112.45 -173.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -89.59 166.06 13.87 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.8 1.8 . . . . 4.79 112.614 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 146' ' ' CYS . 1.8 m -85.54 104.09 14.98 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.537 0.735 . . . . 1.1299999999999999 109.878 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 2.3 tt -69.42 147.8 50.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.585 -0.894 . . . . 2.0699999999999998 108.585 170.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.56 128.85 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.339 1.056 . . . . 0.54000000000000004 109.088 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 1.3 p -100.66 125.7 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 106.429 -1.693 . . . . 2.1000000000000001 106.429 162.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -98.29 174.17 6.63 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.316 1.846 . . . . 0.44 115.035 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.497 -1.229 . . . . 4.96 111.984 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -178.42 6.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 121.079 1.763 . . . . 3.6600000000000001 110.98 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.38 156.25 13.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.213 -0.903 . . . . 0.92000000000000004 109.671 164.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -81.39 151.24 28.02 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.256 1.023 . . . . 2.6299999999999999 110.027 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.55 -10.64 58.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.623 0.769 . . . . 3.1499999999999999 112.679 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 49.06 35.57 7.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.394 1.478 . . . . 1.8200000000000001 110.904 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.96 22.28 54.54 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 121.494 -0.754 . . . . 1.99 112.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -116.88 -33.5 4.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.871 0.836 . . . . 5.0999999999999996 110.967 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.64 137.15 39.64 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.474 -0.65 . . . . 2.6899999999999999 111.474 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.04 69.31 1.6 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.082 0.849 . . . . 2.7000000000000002 112.27 -170.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -162.33 155.47 20.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.74 1.616 . . . . 2.6299999999999999 107.096 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.42 -40.8 97.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.227 0.467 . . . . 3.21 112.237 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -57.55 -30.94 65.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.032 0.533 . . . . 2.77 111.37 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -49.44 -69.68 0.11 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.965 0.906 . . . . 2.1899999999999999 110.277 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.2 p -69.28 -42.42 75.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.461 -0.774 . . . . 1.3300000000000001 110.422 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -61.42 -35.62 78.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.31 0.505 . . . . 3.3500000000000001 111.892 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.516 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.416 1.3 t -139.11 -58.3 0.6 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.919 -1.039 . . . . 1.8500000000000001 113.203 177.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.06 -18.19 0.47 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 120.194 1.361 . . . . 1.05 111.8 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.6 t30 51.09 54.64 10.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.654 1.582 . . . . 2.0 111.107 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.88 -52.62 5.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.531 0.682 . . . . 1.3799999999999999 110.473 170.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.63 -169.46 32.89 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.836 -1.706 . . . . 0.93999999999999995 108.836 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -58.4 161.55 4.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.744 1.618 . . . . 1.8899999999999999 111.293 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmt-85 -58.66 137.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.938 -1.028 . . . . 2.9199999999999999 108.356 166.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.82 -70.65 0.8 Allowed 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.134 -1.432 . . . . 0.45000000000000001 107.134 163.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -99.32 157.22 16.55 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.672 -0.695 . . . . 0.88 109.322 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.421 ' HB2' HG23 ' A' ' 116' ' ' THR . 0.7 OUTLIER -165.65 159.53 16.54 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 124.02 0.825 . . . . 1.5 109.129 171.436 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.58 141.39 3.42 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 107.068 -2.413 . . . . 0.88 107.068 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.7 133.15 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 123.999 0.919 . . . . 0.77000000000000002 110.174 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.8 tt -89.17 138.68 18.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 122.766 0.426 . . . . 0.79000000000000004 110.903 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.85 1.39 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.15 0.881 . . . . 0.69999999999999996 114.687 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.93 59.42 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.062 1.431 . . . . 0.84999999999999998 110.686 -161.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.581 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -144.08 177.64 8.43 Favored 'General case' 0 C--N 1.335 -0.022 0 N-CA-C 113.502 0.927 . . . . 1.6100000000000001 113.502 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.255 1.384 0 N-CA-C 103.098 -2.927 . . . . 6.3799999999999999 103.098 150.787 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 107.481 -1.303 . . . . 5.5599999999999996 107.481 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.9 m -74.5 114.9 13.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.931 -1.137 . . . . 2.8700000000000001 107.931 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 166.99 22.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.595 -0.891 . . . . 3.8100000000000001 108.595 177.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.9 154.8 36.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.453 -1.314 . . . . 0.78000000000000003 107.453 163.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.78 144.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 104.883 -2.266 . . . . 0.75 104.883 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -126.69 94.53 4.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.129 0.893 . . . . 0.5 108.887 159.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.55 108.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.162 -1.421 . . . . 0.65000000000000002 107.162 164.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.13 125.06 36.65 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.416 -0.587 . . . . 0.88 109.416 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -143.7 -55.5 0.38 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.067 0.547 . . . . 3.5699999999999998 110.263 165.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.7 -110.57 0.85 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.783 -0.927 . . . . 1.1399999999999999 110.783 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.76 -48.11 1.92 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.45 1.1 . . . . 3.6699999999999999 109.9 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.54 161.43 12.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 112.086 -0.406 . . . . 1.03 112.086 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.37 29.98 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.097 3.198 . . . . 1.04 114.215 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.04 160.88 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.142 1.377 . . . . 1.1599999999999999 108.787 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 97.8 1.93 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.786 -1.931 . . . . 3.0 105.786 168.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.45 167.17 24.84 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.933 -0.467 . . . . 0.5 111.933 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.33 121.44 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.555 -0.906 . . . . 1.1000000000000001 108.555 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 31.3 mm -87.7 142.35 13.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 107.413 -1.328 . . . . 0.81999999999999995 107.413 162.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.48 129.73 47.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.92 1.288 . . . . 1.5900000000000001 107.525 169.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -122.0 131.03 53.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.226 1.81 . . . . 3.0299999999999998 107.197 -172.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 153.98 48.9 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.522 -0.918 . . . . 4.0700000000000003 108.522 162.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.71 81.5 0.88 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.424 1.89 . . . . 3.98 107.486 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -40.44 -57.21 1.85 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.261 1.425 . . . . 4.6900000000000004 112.437 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.07 126.53 35.15 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.43 1.092 . . . . 3.8700000000000001 109.271 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -19.49 -66.68 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.277 2.631 . . . . 3.1299999999999999 114.57 174.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -118.5 42.2 2.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.391 1.076 . . . . 3.6099999999999999 109.214 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 175.29 48.59 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.333 -1.507 . . . . 1.1899999999999999 109.333 168.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.66 142.9 72.61 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.024 1.816 . . . . 1.0600000000000001 109.592 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.31 151.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.096 -1.075 . . . . 1.27 108.096 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -126.75 120.4 29.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.599 -1.26 . . . . 4.1699999999999999 107.599 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 20' ' ' PHE . 47.1 t -115.02 134.28 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.613 1.965 . . . . 1.22 107.261 -171.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -133.22 156.02 48.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.415 -2.068 . . . . 0.81999999999999995 105.415 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 145.78 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.939 -1.664 . . . . 0.70999999999999996 108.939 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -122.96 94.46 4.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.823 -2.288 . . . . 1.6799999999999999 104.823 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.71 142.03 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.765 -1.198 . . . . 0.77000000000000002 107.765 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -152.3 147.59 26.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 115.112 1.523 . . . . 3.4100000000000001 115.112 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.65 23.17 8.97 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.834 2.159 . . . . 0.93000000000000005 111.999 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -74.6 166.49 23.46 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.851 -1.166 . . . . 0.70999999999999996 107.851 167.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.24 165.45 20.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.889 -1.152 . . . . 1.8400000000000001 107.889 152.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.04 173.73 0.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.412 -0.805 . . . . 2.3399999999999999 110.513 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.14 -161.37 53.22 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.251 -0.431 . . . . 0.59999999999999998 113.053 165.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.29 140.27 58.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.481 1.112 . . . . 2.02 113.357 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -144.24 116.03 8.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.543 1.537 . . . . 0.54000000000000004 109.85 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.7 148.57 4.63 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.685 0.659 . . . . 0.55000000000000004 111.792 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 100.01 4.67 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.891 1.676 . . . . 3.04 107.334 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 12.6 m170 -133.98 160.49 37.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.396 -2.076 . . . . 0.68999999999999995 105.396 -169.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.11 125.92 74.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.482 -0.933 . . . . 1.8400000000000001 108.482 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.39 -161.35 0.73 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.316 1.046 . . . . 1.55 108.819 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -73.75 -129.01 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.083 0.953 . . . . 3.75 109.917 163.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 59.05 65.84 1.14 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.727 1.211 . . . . 3.0600000000000001 112.723 168.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -51.63 -42.51 62.08 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.797 0.839 . . . . 4.5800000000000001 110.652 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -125.59 128.12 47.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.511 -1.292 . . . . 4.8700000000000001 107.511 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.76 29.14 2.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.814 2.046 . . . . 4.6299999999999999 109.702 170.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 m -74.08 72.63 1.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.905 0.882 . . . . 4.79 110.322 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -173.92 -44.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.096 1.758 . . . . 5.6200000000000001 108.924 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.84 144.42 3.91 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 107.339 -2.305 . . . . 3.7400000000000002 107.339 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.02 41.81 0.99 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.31 1.055 . . . . 2.6000000000000001 109.968 -171.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -86.28 50.27 1.95 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.446 1.098 . . . . 4.9100000000000001 111.488 -161.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.2 p 166.58 172.93 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.035 -1.098 . . . . 4.8300000000000001 108.035 -133.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 134.94 -112.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 130.523 3.529 . . . . 2.8399999999999999 110.267 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.53 -173.81 25.77 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 106.733 -2.547 . . . . 1.52 106.733 -158.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.92 178.27 6.67 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.658 3.572 . . . . 1.3400000000000001 113.958 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -74.01 58.22 0.66 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.145 1.778 . . . . 2.1600000000000001 111.606 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 51.92 69.02 0.72 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.255 1.022 . . . . 1.78 109.639 -168.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -90.85 115.31 64.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.016 -0.992 . . . . 2.5899999999999999 108.482 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.29 -43.8 1.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.842 1.695 . . . . 1.3200000000000001 110.685 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -146.22 -67.25 0.28 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.232 1.013 . . . . 2.25 108.884 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.5 m -153.39 63.99 0.75 Allowed 'General case' 0 N--CA 1.457 -0.125 0 O-C-N 121.524 -0.735 . . . . 1.78 110.488 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -78.19 165.47 23.89 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.253 -0.647 . . . . 3.6099999999999999 109.253 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 6.7 mtmp? -133.66 154.26 51.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.148 1.379 . . . . 3.1200000000000001 109.012 -174.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -89.53 169.64 11.18 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.124 . . . . 0.81999999999999995 110.245 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.93 -40.21 0.17 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 107.761 -2.136 . . . . 2.6600000000000001 107.761 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.29 -175.63 54.54 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.706 1.622 . . . . 1.53 110.842 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.05 -8.9 23.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.584 2.856 . . . . 1.8300000000000001 114.167 -171.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -27.07 42.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.779 0.718 . . . . 6.4199999999999999 111.435 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.26 176.6 5.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.77 1.628 . . . . 2.7000000000000002 109.428 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.9 -47.04 40.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.962 -0.755 . . . . 4.7999999999999998 108.962 162.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 74.5 mt-10 -78.43 138.35 38.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.674 1.226 . . . . 3.0499999999999998 111.536 -169.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -160.45 154.35 22.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.36 -2.83 . . . . 5.1900000000000004 103.36 173.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.1 m80 -64.92 159.66 22.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 117.794 -1.563 . . . . 0.54000000000000004 106.88 162.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.08 40.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 122.984 1.373 . . . . 1.9199999999999999 110.876 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -170.73 42.2 0.19 Allowed Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 128.257 2.837 . . . . 0.59999999999999998 108.563 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -126.12 109.07 11.95 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.795 -1.187 . . . . 2.46 107.795 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.82 -50.3 10.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.419 -0.956 . . . . 1.8300000000000001 108.419 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.8 -120.69 0.99 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.43 -1.068 . . . . 0.96999999999999997 110.43 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -155.19 166.3 34.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.127 1.371 . . . . 1.5700000000000001 108.672 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.98 171.77 16.38 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 N-CA-C 108.206 -1.035 . . . . 0.69999999999999996 108.206 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 m -114.87 118.57 33.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.477 -1.305 . . . . 1.8899999999999999 107.477 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.81 140.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.375 0.534 . . . . 0.66000000000000003 110.319 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.2 -80.93 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.309 1.044 . . . . 3.0299999999999998 111.739 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -157.39 -48.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.107 1.363 . . . . 3.71 109.898 -170.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.76 13.78 1.56 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.012 1.325 . . . . 2.79 111.214 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.02 14.64 76.21 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.197 0.903 . . . . 0.75 111.256 -175.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.4 145.18 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.226 1.41 . . . . 0.93000000000000005 107.73 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.67 164.83 29.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.652 1.181 . . . . 0.71999999999999997 108.516 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.12 143.85 51.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.959 -2.608 . . . . 2.73 103.959 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.99 56.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 123.801 0.688 . . . . 1.6200000000000001 112.096 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.0 m -74.39 91.61 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.712 -0.617 . . . . 0.97999999999999998 110.935 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.2 mt -129.46 159.05 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.588 0.755 . . . . 1.6399999999999999 108.984 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.76 93.66 2.54 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 3.0299999999999998 111.392 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.9 126.09 30.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.717 0.807 . . . . 2.54 109.582 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 p -95.54 1.73 53.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.249 1.42 . . . . 1.8400000000000001 112.567 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.54 -44.82 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.519 0.727 . . . . 1.21 109.795 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pt -74.65 175.75 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.845 -0.742 . . . . 1.1799999999999999 109.762 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 p -151.96 176.94 10.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.918 1.287 . . . . 2.1499999999999999 107.784 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.0 mt -131.95 57.8 1.76 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.374 1.87 . . . . 4.1500000000000004 110.725 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.6 m -96.04 -22.04 17.61 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.722 0.638 . . . . 3.4300000000000002 112.722 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.86 38.76 10.05 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.113 -1.195 . . . . 3.71 110.113 -169.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.94 -120.91 0.3 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.803 2.041 . . . . 4.0899999999999999 106.049 172.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -78.14 -2.81 39.34 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.39 0.995 . . . . 4.6100000000000003 111.117 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.0 p -48.14 151.26 1.02 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.351 1.46 . . . . 1.3100000000000001 111.157 167.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.3 pt -77.95 -6.47 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.841 0.682 . . . . 1.97 112.841 -174.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.3 mm -32.01 116.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.1 1.36 . . . . 1.71 110.323 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.49 10.87 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 112.12 -0.392 . . . . 1.75 112.12 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -136.1 164.6 27.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.499 -1.667 . . . . 6.25 106.499 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.01 113.23 23.44 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.602 1.092 . . . . 1.8899999999999999 109.558 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 118' ' ' VAL . 2.0 tm? -69.35 145.09 53.24 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.267 -1.753 . . . . 2.3100000000000001 106.267 167.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 117' ' ' LEU . 71.5 t -130.98 135.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.137 1.775 . . . . 0.58999999999999997 109.066 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -101.79 123.65 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.756 1.223 . . . . 1.78 107.711 164.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.579 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 93.8 m-70 -95.96 165.69 12.14 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 117.378 2.362 . . . . 0.66000000000000003 117.378 -172.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -67.47 -66.43 0.56 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.16 -1.836 . . . . 3.4700000000000002 110.971 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -90.28 -179.5 5.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.958 0.885 . . . . 3.9700000000000002 110.566 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.87 46.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.073 -1.454 . . . . 0.54000000000000004 107.073 153.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -83.05 162.49 21.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.894 -0.78 . . . . 2.0699999999999998 108.894 161.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.74 -8.28 59.62 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.484 0.714 . . . . 3.0099999999999998 112.106 -169.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 51.18 38.78 22.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.014 0.926 . . . . 1.6299999999999999 109.101 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 48.78 33.04 11.98 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.529 1.062 . . . . 1.4399999999999999 112.798 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -77.48 -25.33 50.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.095 0.948 . . . . 4.9299999999999997 110.039 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 133.25 -130.28 5.68 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.964 -0.854 . . . . 2.6099999999999999 110.964 161.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.49 -73.72 0.02 OUTLIER Glycine 0 C--N 1.34 0.772 0 C-N-CA 126.372 1.939 . . . . 2.0699999999999998 111.414 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.21 165.46 24.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.834 1.654 . . . . 2.5699999999999998 108.286 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -79.06 -52.02 8.78 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.874 -0.787 . . . . 3.8100000000000001 108.874 162.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.18 -40.69 11.61 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.992 2.117 . . . . 4.2000000000000002 111.49 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.8 p -39.16 -64.46 0.46 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.798 2.039 . . . . 1.9299999999999999 111.003 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.7 p -71.66 -45.86 60.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.717 -0.674 . . . . 1.26 110.497 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -58.09 -50.13 74.54 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.403 0.681 . . . . 2.98 111.313 -165.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.538 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.384 1.3 p -125.63 -45.76 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.678 -0.677 . . . . 1.3799999999999999 112.665 168.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 166.83 -24.44 0.13 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.428 1.013 . . . . 0.95999999999999996 114.803 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 54.28 55.53 8.04 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.628 1.571 . . . . 2.0899999999999999 111.557 -167.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -68.12 -3.07 9.22 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.453 0.909 . . . . 1.1799999999999999 113.453 169.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.47 -64.8 4.21 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 120.549 -1.344 . . . . 3.2400000000000002 111.127 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -165.2 168.18 17.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.163 0.985 . . . . 1.45 111.808 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.432 ' HD2' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -83.33 133.86 34.94 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.242 2.217 . . . . 2.6499999999999999 107.33 172.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.35 -77.93 0.56 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.158 -1.052 . . . . 0.85999999999999999 108.158 166.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.19 154.01 42.21 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.901 -1.148 . . . . 1.0700000000000001 107.901 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 16.6 p -142.8 171.51 13.95 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.352 -1.295 . . . . 1.99 108.959 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.16 142.71 5.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.744 -1.342 . . . . 0.62 109.744 174.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.34 126.91 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 108.735 -0.839 . . . . 0.94999999999999996 108.735 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.3 126.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.722 -0.844 . . . . 2.6699999999999999 108.722 173.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.46 -5.97 1.42 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 115.014 0.766 . . . . 0.76000000000000001 115.014 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.3 59.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 118.638 1.219 . . . . 0.78000000000000003 110.627 -156.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.39 172.07 7.2 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.661 0.743 . . . . 1.6499999999999999 111.643 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.25 1.083 0 N-CA-C 103.44 -2.8 . . . . 5.9900000000000002 103.44 144.599 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 106.217 -1.771 . . . . 6.6500000000000004 106.217 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.58 56.39 0.17 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.842 -1.54 . . . . 4.3499999999999996 106.842 -157.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 138.09 51.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.56 -0.745 . . . . 2.8100000000000001 110.803 -173.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.48 131.9 34.98 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.586 -1.265 . . . . 0.82999999999999996 107.586 163.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -98.52 142.12 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.688 -0.856 . . . . 0.79000000000000004 108.688 165.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.63 97.57 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.581 -0.896 . . . . 0.48999999999999999 108.581 154.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.02 107.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.207 -1.405 . . . . 0.73999999999999999 107.207 163.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.3 mt -93.96 133.19 37.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.911 -0.774 . . . . 0.92000000000000004 108.911 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -138.08 -56.52 0.66 Allowed 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.541 -0.911 . . . . 4.1399999999999997 108.541 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.04 -121.34 24.89 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.789 -1.096 . . . . 0.83999999999999997 111.957 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.08 -49.27 1.71 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.903 0.881 . . . . 3.48 109.497 -155.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.36 164.19 20.27 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 109.841 -1.303 . . . . 0.80000000000000004 109.841 167.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.61 40.92 0.9 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.614 2.876 . . . . 1.0700000000000001 112.617 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.2 t -94.51 155.11 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.539 1.535 . . . . 0.92000000000000004 109.846 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.38 123.24 8.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.231 -1.396 . . . . 2.2200000000000002 107.231 168.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.94 167.32 33.73 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.543 -1.023 . . . . 0.60999999999999999 110.543 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.19 118.28 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.767 -1.568 . . . . 1.2 106.767 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -85.02 128.55 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.259 -1.756 . . . . 0.78000000000000003 106.259 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -111.59 113.68 26.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.366 -1.716 . . . . 2.2999999999999998 106.366 166.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CE1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -102.88 115.6 30.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.613 -1.625 . . . . 2.8100000000000001 106.613 173.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -139.14 160.37 39.96 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.054 0.843 . . . . 3.3700000000000001 109.609 170.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -155.26 145.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.594 -2.002 . . . . 3.1400000000000001 105.594 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -45.5 44.25 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.008 -0.738 . . . . 4.9000000000000004 109.008 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -78.73 178.2 8.07 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.118 1.767 . . . . 3.8100000000000001 109.189 168.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.3 p -123.8 21.47 9.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.98 0.912 . . . . 2.3799999999999999 111.382 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -167.41 38.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.593 0.633 . . . . 3.6000000000000001 111.557 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.69 -157.84 7.66 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.042 -1.623 . . . . 1.1299999999999999 109.042 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.36 135.41 33.9 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.161 2.574 . . . . 1.1699999999999999 110.348 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -78.97 164.05 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.394 -0.965 . . . . 0.84999999999999998 108.394 173.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -115.57 125.21 52.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.634 -1.987 . . . . 3.04 105.634 167.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG22 ' CE1' ' A' ' 20' ' ' PHE . 59.0 t -117.1 114.75 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.586 1.554 . . . . 0.93999999999999995 107.352 -171.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -125.9 133.53 51.87 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.189 0.93 . . . . 0.83999999999999997 110.408 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.2 160.16 33.73 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.385 -1.086 . . . . 0.79000000000000004 110.385 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 p -135.29 107.17 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.229 -1.397 . . . . 2.02 107.229 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.78 119.91 59.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.559 -1.645 . . . . 1.23 106.559 -159.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -124.35 152.21 43.43 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.946 0.498 . . . . 4.96 110.062 -160.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.58 27.04 64.0 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.444 -0.344 . . . . 0.82999999999999996 113.823 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -67.0 -169.41 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.581 -0.952 . . . . 0.97999999999999998 108.478 157.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.51 165.94 10.81 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 105.518 -2.03 . . . . 3.5600000000000001 105.518 146.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 178.9 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.83 2.052 . . . . 3.3599999999999999 112.43 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.58 -169.45 53.38 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.357 -0.838 . . . . 0.45000000000000001 111.933 169.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.77 147.17 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.475 0.71 . . . . 1.98 111.493 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -143.92 121.16 11.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.945 1.698 . . . . 0.48999999999999999 108.473 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.07 149.03 7.59 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.519 -1.433 . . . . 0.46000000000000002 109.519 169.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -143.25 83.48 1.79 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.644 -1.243 . . . . 2.2999999999999998 107.644 -169.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -124.64 146.38 49.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.885 -1.052 . . . . 0.82999999999999996 109.071 -160.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.22 106.44 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.436 -0.95 . . . . 2.3799999999999999 108.436 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -82.35 150.21 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.903 -0.777 . . . . 0.89000000000000001 108.903 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.26 19.84 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.376 1.471 . . . . 3.96 113.374 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' CD ' HH22 ' A' ' 143' ' ' ARG . 1.5 tt0 -88.57 67.09 8.41 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.648 -1.283 . . . . 3.1600000000000001 110.138 -167.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -75.3 60.18 1.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.498 0.666 . . . . 4.9100000000000001 109.514 160.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.7 t0 178.42 155.09 0.39 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.456 2.302 . . . . 5.2999999999999998 106.512 164.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -158.37 34.99 0.24 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.83 1.652 . . . . 5.3399999999999999 111.985 157.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.6 t -74.59 33.28 0.09 Allowed 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.971 -1.081 . . . . 5.5700000000000003 113.759 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -168.82 -50.39 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.089 1.756 . . . . 6.7999999999999998 107.839 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -169.47 157.72 29.65 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.488 -1.845 . . . . 4.6200000000000001 108.488 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.8 t -76.53 56.41 1.11 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.937 1.295 . . . . 2.3700000000000001 109.582 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.5 m -148.49 78.68 1.42 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.478 -0.489 . . . . 3.98 111.402 -152.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -174.28 -51.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.709 1.744 . . . . 2.5 115.709 -146.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.17 100.31 10.52 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.622 1.169 . . . . 2.5800000000000001 110.589 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.9 -65.89 3.14 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.987 -0.896 . . . . 1.02 111.661 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.85 172.72 2.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.771 1.647 . . . . 1.8999999999999999 115.016 -166.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -83.01 56.68 3.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 113.121 -1.854 . . . . 2.1299999999999999 110.559 -172.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 53.32 80.09 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.406 0.682 . . . . 1.96 109.476 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -107.85 103.85 51.1 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.181 0.993 . . . . 2.3799999999999999 110.425 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.82 -30.98 39.95 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.997 1.798 . . . . 1.1200000000000001 112.251 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.0 tp -155.93 -67.4 0.11 Allowed 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.554 0.616 . . . . 2.8999999999999999 110.038 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 p -151.99 60.72 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.21 0.529 . . . . 2.1899999999999999 110.621 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -77.51 165.99 23.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.384 -0.598 . . . . 3.8399999999999999 109.384 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -137.83 162.68 33.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.068 1.347 . . . . 7.2400000000000002 107.819 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -94.27 153.23 18.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.135 1.374 . . . . 0.79000000000000004 113.374 -158.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.48 171.93 45.0 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 107.763 -2.135 . . . . 2.4399999999999999 107.763 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.84 -171.23 30.75 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.165 0.412 . . . . 1.1499999999999999 112.832 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.49 -31.18 51.64 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.515 2.144 . . . . 1.6699999999999999 109.582 172.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.63 -43.1 73.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.915 0.486 . . . . 4.4500000000000002 111.496 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -69.22 161.96 28.12 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.673 0.749 . . . . 2.4300000000000002 112.144 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -75.5 -46.89 29.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.896 2.078 . . . . 4.3200000000000003 109.33 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -77.05 159.45 29.86 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.1 -1.074 . . . . 4.3099999999999996 108.1 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 158.98 127.1 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.463 2.305 . . . . 3.1099999999999999 106.441 -163.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 45.4 m80 -62.29 150.8 38.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.963 -1.495 . . . . 0.52000000000000002 106.963 163.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.82 -16.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 120.255 -0.578 . . . . 1.1499999999999999 110.38 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.56 56.58 0.46 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.959 0.79 . . . . 0.65000000000000002 113.336 161.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -123.59 117.99 26.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.022 1.411 . . . . 2.4199999999999999 108.771 158.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.6 -56.66 3.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.068 -1.086 . . . . 1.5700000000000001 108.068 164.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.65 -121.95 1.05 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.319 -0.712 . . . . 0.65000000000000002 111.319 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -143.11 165.28 27.83 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.895 1.678 . . . . 1.55 108.112 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.31 166.74 28.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.699 -1.223 . . . . 0.45000000000000001 107.699 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.3 m -123.41 116.42 23.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.234 1.014 . . . . 1.96 108.67 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.58 139.3 35.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.033 0.379 . . . . 0.62 111.076 171.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.07 -84.16 0.12 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.956 0.502 . . . . 4.0999999999999996 111.053 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 -53.19 0.93 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.231 0.612 . . . . 4.6100000000000003 112.082 -161.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.18 30.12 1.0 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 124.53 2.11 . . . . 3.3100000000000001 109.972 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 57.69 27.66 59.16 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 113.619 -1.628 . . . . 0.71999999999999997 110.833 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.27 103.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.56 1.144 . . . . 0.89000000000000001 108.101 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.92 166.77 12.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.336 1.054 . . . . 0.82999999999999996 108.267 160.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.7 141.82 47.73 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.452 -2.425 . . . . 2.8500000000000001 104.452 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.16 116.6 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.881 -1.525 . . . . 1.3899999999999999 106.881 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -137.46 80.29 1.8 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.068 1.747 . . . . 0.93999999999999995 106.738 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.2 mm -125.75 156.95 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.135 0.574 . . . . 2.2999999999999998 109.57 -170.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -151.36 71.54 1.01 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.733 0.813 . . . . 2.8900000000000001 110.93 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.96 119.23 22.52 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.126 -0.359 . . . . 3.29 111.738 -168.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.6 p -79.4 65.19 4.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.159 0.984 . . . . 2.8900000000000001 110.391 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.3 t -141.56 -52.32 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.622 1.169 . . . . 1.26 109.083 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -102.96 168.7 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.079 0.952 . . . . 1.0900000000000001 111.321 -172.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.2 m -137.91 168.92 18.71 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.077 1.351 . . . . 2.0299999999999998 109.217 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' H ' ' CD2' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -100.84 17.04 23.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.477 1.511 . . . . 2.71 113.068 -178.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.9 t -157.78 162.84 38.49 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.148 0.979 . . . . 2.96 108.737 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.45 157.29 14.96 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.02 -0.832 . . . . 2.6200000000000001 111.02 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.22 -43.11 42.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.175 1.79 . . . . 5.1299999999999999 112.182 -172.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -79.27 0.64 27.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.15 0.98 . . . . 3.3999999999999999 112.364 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.4 p -66.94 174.31 3.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.589 -1.32 . . . . 1.49 111.345 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -18.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.684 -1.144 . . . . 2.8100000000000001 111.782 174.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.1 mm -47.0 119.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.174 0.99 . . . . 2.2400000000000002 110.758 -162.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.46 -32.47 5.2 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.519 0.58 . . . . 1.99 112.553 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -76.52 177.01 7.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.547 1.673 . . . . 10.15 114.031 -163.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 m -104.15 120.99 42.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.436 1.095 . . . . 1.1000000000000001 110.322 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.71 138.25 39.87 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.465 -1.309 . . . . 1.8600000000000001 107.465 164.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.48 127.84 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.272 1.429 . . . . 0.57999999999999996 107.88 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 145' ' ' ALA . 1.6 m -97.47 122.45 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.125 -1.806 . . . . 1.55 106.125 162.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -93.97 158.19 15.75 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 115.319 1.6 . . . . 0.57999999999999996 115.319 -171.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -25.56 -83.21 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.183 2.993 . . . . 3.5800000000000001 112.388 162.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -106.73 -177.34 3.33 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.819 0.848 . . . . 2.6400000000000001 110.215 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.1 157.44 3.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.498 -0.774 . . . . 0.75 109.987 162.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.26 176.58 5.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.951 -0.759 . . . . 1.95 108.951 160.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.53 -9.59 59.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 3.9500000000000002 111.183 -167.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.7 11.93 4.29 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.694 1.598 . . . . 2.4300000000000002 111.928 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.86 102.03 1.0 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 108.538 -1.825 . . . . 3.4399999999999999 108.538 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.55 -56.49 0.08 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.953 -1.499 . . . . 4.7300000000000004 106.953 174.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.47 50.49 0.97 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.165 -1.174 . . . . 2.6400000000000001 110.165 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.52 37.29 0.84 Allowed Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.165 0.982 . . . . 3.96 112.984 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.3 p30 175.66 -108.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.862 2.865 . . . . 2.8999999999999999 106.266 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.416 ' OE1' ' NZ ' ' A' ' 136' ' ' LYS . 15.9 tm-20 -153.13 -39.61 0.1 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.456 1.102 . . . . 4.29 109.07 161.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -44.09 -37.63 3.17 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.423 1.489 . . . . 2.8900000000000001 111.784 170.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.9 t -45.71 -58.25 3.6 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.417 1.087 . . . . 2.25 110.903 168.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -44.63 67.63 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.101 -1.0 . . . . 1.3100000000000001 110.015 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.416 ' NZ ' ' OE1' ' A' ' 132' ' ' GLU . 1.5 ttmp? -55.68 -50.65 69.69 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.355 1.062 . . . . 2.7799999999999998 112.239 -172.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.502 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.309 2.0 p -124.33 -50.33 1.78 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.834 -0.603 . . . . 1.21 111.759 171.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 157.27 -26.81 0.49 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.139 -0.784 . . . . 0.98999999999999999 111.139 -173.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 49.41 53.93 11.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.876 1.27 . . . . 2.3700000000000001 110.338 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.62 -51.93 13.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.858 0.837 . . . . 1.53 109.53 170.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.32 -157.84 22.18 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.623 -2.191 . . . . 1.0 107.623 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.1 m -61.0 151.35 30.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.307 1.443 . . . . 1.28 113.217 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.406 HH22 ' CD ' ' A' ' 50' ' ' GLU . 13.1 mmt85 -61.33 138.23 58.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.101 1.36 . . . . 2.98 109.046 168.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.9 mt -112.17 -67.35 1.0 Allowed 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.44 -0.948 . . . . 0.64000000000000001 108.44 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -106.37 156.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.072 0.549 . . . . 0.89000000000000001 110.384 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.2 p -165.0 162.21 20.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.018 0.927 . . . . 1.4399999999999999 110.17 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.27 140.96 3.33 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.861 2.172 . . . . 0.88 107.688 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.79 134.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.668 1.187 . . . . 0.89000000000000001 109.756 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.5 tt -91.1 136.59 23.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 C-N-CA 123.101 0.561 . . . . 0.83999999999999997 112.512 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.9 4.56 0.83 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.839 1.209 . . . . 0.65000000000000002 114.078 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.7 mm -102.24 57.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 119.192 1.496 . . . . 1.01 110.147 -150.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.96 175.41 13.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.146 0.498 . . . . 1.6000000000000001 111.142 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.439 0 N-CA-C 102.962 -2.977 . . . . 5.0499999999999998 102.962 160.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 121.083 0.468 . . . . 5.7800000000000002 109.754 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -165.42 105.54 0.75 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.261 -2.126 . . . . 2.8900000000000001 105.261 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER -78.92 143.46 35.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.048 -0.723 . . . . 3.5299999999999998 109.048 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.68 139.31 33.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.884 -1.525 . . . . 0.67000000000000004 106.884 164.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.79 144.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.547 -2.02 . . . . 1.0 105.547 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.74 93.55 3.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.271 -1.011 . . . . 0.44 108.271 161.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.91 104.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.22 -1.03 . . . . 0.56999999999999995 108.22 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -87.98 136.71 32.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.56 0.344 . . . . 0.93999999999999995 110.213 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -149.82 -54.72 0.17 Allowed 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.322 0.649 . . . . 4.2999999999999998 110.49 168.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.32 -126.55 27.87 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.603 0.621 . . . . 1.0 113.815 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.09 -53.99 2.63 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.672 1.189 . . . . 4.2199999999999998 110.138 -165.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.19 154.28 10.95 Favored Glycine 0 CA--C 1.536 1.353 0 N-CA-C 110.008 -1.237 . . . . 0.92000000000000004 110.008 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.24 52.04 3.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.84 3.027 . . . . 1.3400000000000001 112.279 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 74.7 t -110.78 156.65 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.302 2.241 . . . . 0.75 107.875 -175.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -155.84 136.48 13.36 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.621 -0.881 . . . . 2.7599999999999998 108.621 166.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.57 176.49 46.16 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.175 -0.77 . . . . 0.62 111.175 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.68 123.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.494 -1.298 . . . . 1.01 107.494 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.621 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.8 mp -80.66 136.65 22.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.66 -1.978 . . . . 1.51 105.66 161.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -120.6 119.24 32.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.444 -2.058 . . . . 2.0600000000000001 105.444 161.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 5.9 t80 -132.57 126.96 34.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.385 -0.969 . . . . 2.9399999999999999 108.385 -166.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -148.07 158.83 44.28 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.074 0.949 . . . . 4.3399999999999999 110.321 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -152.44 142.52 22.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.36 1.864 . . . . 3.0 106.964 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -44.94 -74.07 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.14 0.576 . . . . 4.6299999999999999 111.342 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -81.47 -172.9 4.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.1 1.36 . . . . 3.7400000000000002 110.929 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.7 m -83.43 -64.67 1.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.232 1.413 . . . . 2.3500000000000001 111.133 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -102.97 75.62 1.4 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.065 1.346 . . . . 3.75 110.229 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.04 -167.15 12.85 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.585 -1.406 . . . . 1.1000000000000001 109.585 166.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.02 113.58 3.82 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.242 1.962 . . . . 1.1699999999999999 111.32 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 4.0 t -87.17 138.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.312 -0.403 . . . . 0.93000000000000005 110.556 -172.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -94.11 116.48 28.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.929 -1.137 . . . . 2.6299999999999999 107.929 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG22 ' CD1' ' A' ' 20' ' ' PHE . 11.6 t -89.72 132.71 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.703 -1.962 . . . . 1.25 105.703 162.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -133.53 151.8 51.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.986 -1.487 . . . . 0.94999999999999996 106.986 156.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.76 134.54 2.91 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.131 -1.188 . . . . 0.92000000000000004 110.131 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.5 p -109.57 94.75 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.54 -1.652 . . . . 1.9299999999999999 106.54 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 mm -96.99 148.59 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.623 -1.251 . . . . 1.3700000000000001 107.623 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.36 165.39 22.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.298 0.571 . . . . 4.2199999999999998 111.45 165.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.19 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 114.462 -1.245 . . . . 0.60999999999999999 114.171 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.88 158.92 17.82 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.266 1.533 . . . . 0.68999999999999995 108.861 167.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.36 158.01 24.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.2 -1.407 . . . . 1.6799999999999999 107.2 154.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.94 174.31 0.51 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.952 1.251 . . . . 3.2799999999999998 112.327 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.14 -160.65 52.5 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.956 -1.02 . . . . 0.67000000000000004 112.29 168.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.7 140.69 57.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.956 1.303 . . . . 2.1000000000000001 113.105 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -144.41 117.69 9.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.647 1.579 . . . . 0.44 109.257 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.19 145.91 5.56 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.362 -1.095 . . . . 0.46000000000000002 110.362 172.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.6 102.08 5.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.776 -1.565 . . . . 2.9100000000000001 106.776 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -133.48 168.22 19.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.156 -1.794 . . . . 0.69999999999999996 106.156 -173.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.88 130.2 48.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.867 -0.79 . . . . 1.77 108.867 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -114.62 147.34 39.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.466 1.507 . . . . 0.83999999999999997 110.413 -160.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.14 -9.35 0.26 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.059 1.744 . . . . 4.25 114.638 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' CD ' HH21 ' A' ' 143' ' ' ARG . 4.5 mt-10 -52.28 89.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.47 1.108 . . . . 3.3300000000000001 109.794 164.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -100.07 -45.89 5.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.422 1.489 . . . . 4.8300000000000001 111.356 169.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.32 56.42 2.1 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.278 -0.889 . . . . 6.3099999999999996 111.666 -167.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -90.5 44.57 1.21 Allowed 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.426 -1.421 . . . . 4.0700000000000003 112.004 -163.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 t -81.62 42.92 0.72 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.249 0.619 . . . . 4.3499999999999996 111.12 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 177.12 -54.87 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.321 1.449 . . . . 5.0899999999999999 109.992 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.41 -163.58 22.63 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.764 -1.334 . . . . 3.1899999999999999 109.764 -171.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.6 p -151.75 72.11 1.01 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 124.347 1.059 . . . . 2.6400000000000001 109.136 -167.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -155.03 71.67 0.8 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.024 -1.473 . . . . 4.9500000000000002 107.024 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.8 m -167.19 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.63 1.344 . . . . 2.6000000000000001 114.63 -136.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.1 -116.05 0.08 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.48 -1.304 . . . . 2.4300000000000002 107.48 166.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.92 -87.63 0.08 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.322 -1.511 . . . . 1.01 109.322 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.91 176.84 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.965 3.777 . . . . 1.2 113.569 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -75.48 58.49 1.02 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.885 1.674 . . . . 2.29 111.615 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.84 80.3 0.16 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.994 0.917 . . . . 2.0800000000000001 108.628 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -112.88 86.66 9.18 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.55 1.14 . . . . 2.4199999999999999 109.415 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.13 -17.95 45.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.3 2.0 . . . . 2.3100000000000001 112.7 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 tt -154.28 -68.0 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.676 0.671 . . . . 2.1000000000000001 109.838 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.2 m -162.92 96.0 0.89 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.757 -1.201 . . . . 1.72 107.757 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.27 173.68 6.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.147 1.379 . . . . 5.2800000000000002 109.703 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -137.3 151.33 48.53 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 125.61 1.564 . . . . 3.71 108.032 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -91.24 139.97 30.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.828 0.677 . . . . 0.80000000000000004 112.828 -170.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.02 -88.75 0.07 OUTLIER Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.539 -2.625 . . . . 1.8600000000000001 106.539 163.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.67 -102.58 0.38 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.973 -0.904 . . . . 1.8 112.289 159.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -90.63 -47.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.508 2.139 . . . . 1.47 110.774 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.27 -46.01 10.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.233 1.413 . . . . 4.96 110.388 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.03 175.58 10.24 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.889 -1.05 . . . . 2.7599999999999998 111.424 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.06 -55.22 8.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.399 1.479 . . . . 3.79 109.596 -174.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.89 175.28 10.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.462 -0.79 . . . . 3.8100000000000001 110.967 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.36 141.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.248 2.219 . . . . 3.52 107.876 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.411 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 16.0 m80 -64.21 160.72 17.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 118.468 -1.293 . . . . 0.60999999999999999 108.669 162.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -28.66 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 121.289 -0.882 . . . . 1.23 110.69 -177.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.56 70.11 0.22 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.65000000000000002 110.973 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -163.3 104.74 0.98 Allowed 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.782 -0.834 . . . . 2.0499999999999998 108.914 -169.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.54 -54.81 3.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.686 -0.688 . . . . 1.78 109.156 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.03 -108.38 0.34 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.603 -0.999 . . . . 0.65000000000000002 110.603 -176.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -152.06 167.5 28.26 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.938 1.695 . . . . 1.5700000000000001 109.874 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -123.35 175.78 5.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.476 -1.675 . . . . 0.64000000000000001 106.476 164.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 t -116.76 149.76 39.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.377 -0.971 . . . . 2.0800000000000001 108.377 167.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.68 140.48 45.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.174 1.39 . . . . 0.78000000000000003 112.333 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -68.01 -90.17 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 O-C-N 124.46 1.1 . . . . 2.5899999999999999 111.11 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -156.22 -31.75 0.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.652 2.093 . . . . 4.5300000000000002 116.652 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -8.96 58.14 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.993 0.901 . . . . 3.7200000000000002 109.119 164.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.57 23.16 10.4 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.701 1.62 . . . . 0.83999999999999997 109.593 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.2 t -78.0 123.39 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.289 -1.375 . . . . 0.83999999999999997 107.289 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.19 159.32 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.055 0.942 . . . . 0.91000000000000003 109.231 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.77 95.59 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.763 -1.569 . . . . 2.8500000000000001 106.763 -159.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.36 57.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.715 -0.476 . . . . 1.8100000000000001 109.715 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.2 m -85.49 91.66 8.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.813 0.845 . . . . 0.90000000000000002 109.231 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 mt -124.33 148.19 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.893 -0.78 . . . . 2.0099999999999998 108.893 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -134.39 101.97 5.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.279 -0.638 . . . . 2.9500000000000002 109.279 164.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.16 140.74 31.21 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.918 0.887 . . . . 2.27 109.073 173.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 t -110.85 19.23 18.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.407 1.083 . . . . 2.6699999999999999 112.406 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.99 -48.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 108.098 -1.075 . . . . 1.53 108.098 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.35 177.01 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 122.813 0.445 . . . . 1.1899999999999999 111.289 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.5 p -155.4 178.8 9.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.429 1.892 . . . . 2.29 108.23 -164.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.14 69.9 1.44 Allowed 'General case' 0 C--N 1.339 0.151 0 CA-C-O 122.917 1.342 . . . . 2.25 110.466 162.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p -119.19 156.14 30.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.721 2.008 . . . . 4.1900000000000004 110.348 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.28 62.68 2.2 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.652 -1.379 . . . . 3.73 109.652 168.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -148.26 -124.87 0.05 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.143 1.777 . . . . 4.7999999999999998 107.054 -172.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -78.67 -9.01 59.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.445 1.02 . . . . 5.46 113.085 -176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.2 p -60.37 163.89 4.79 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 123.213 1.482 . . . . 1.49 113.682 -165.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.839 -1.528 . . . . 1.8400000000000001 111.112 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mm -49.03 118.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.795 0.725 . . . . 1.8300000000000001 109.118 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.53 -20.32 34.83 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.468 1.508 . . . . 1.5700000000000001 112.759 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.59 165.34 18.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.416 1.608 . . . . 4.7199999999999998 110.279 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -86.95 117.9 25.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.801 0.841 . . . . 1.0700000000000001 109.159 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 140.33 58.28 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.393 -1.336 . . . . 2.3599999999999999 107.393 167.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -128.26 126.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.945 -1.132 . . . . 0.42999999999999999 107.945 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.627 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 2.1 p -99.17 116.95 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.219 -1.771 . . . . 1.77 106.219 166.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -89.54 160.11 16.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 115.808 1.781 . . . . 0.58999999999999997 115.808 -172.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -44.87 -72.27 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.708 2.003 . . . . 3.3900000000000001 112.362 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -98.26 -177.19 3.63 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.33 1.052 . . . . 3.1200000000000001 111.097 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.08 157.56 7.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.375 0.67 . . . . 0.72999999999999998 109.703 162.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.24 175.67 8.8 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.484 -0.561 . . . . 2.1200000000000001 109.484 164.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.03 -35.61 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.989 0.916 . . . . 3.3100000000000001 112.669 -152.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp 66.72 32.77 6.7 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.894 1.678 . . . . 3.4199999999999999 111.402 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.37 45.82 92.3 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.227 0.917 . . . . 1.76 112.255 163.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -127.07 -28.82 2.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.234 2.213 . . . . 5.2300000000000004 111.493 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.34 126.22 33.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.812 -0.915 . . . . 2.0600000000000001 110.812 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.1 -30.58 76.05 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.327 0.489 . . . . 3.1400000000000001 111.88 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -55.6 115.29 2.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.843 0.857 . . . . 2.0299999999999998 109.26 170.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -38.29 -48.23 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.814 1.246 . . . . 3.5 113.217 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -46.93 -33.84 4.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.244 1.418 . . . . 3.1800000000000002 112.647 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 m -62.49 -56.88 13.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.976 0.51 . . . . 2.3300000000000001 111.976 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -71.21 -45.81 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.0 -1.687 . . . . 1.3500000000000001 110.215 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -58.08 -39.4 78.45 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.052 0.941 . . . . 3.1800000000000002 111.728 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.411 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 6.8 p -128.95 -54.92 1.21 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.762 0.71 . . . . 1.55 112.632 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 140.48 -18.55 2.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 125.936 1.732 . . . . 0.89000000000000001 111.385 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.76 56.95 2.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.333 1.453 . . . . 2.3500000000000001 111.757 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.66 -5.02 48.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.226 -0.59 . . . . 1.27 111.435 171.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.6 -173.68 40.54 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 108.899 -1.681 . . . . 1.03 108.899 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -55.82 153.33 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.752 1.621 . . . . 1.27 114.086 -167.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.475 HH21 ' CD ' ' A' ' 50' ' ' GLU . 6.4 mmt-85 -60.02 139.8 57.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.775 -1.557 . . . . 3.0699999999999998 107.963 166.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.07 -74.74 0.59 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.047 -1.094 . . . . 0.51000000000000001 108.047 173.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -103.47 151.18 23.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.334 -1.358 . . . . 0.68999999999999995 107.334 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 p -151.45 160.54 43.67 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.042 0.839 . . . . 1.8300000000000001 109.246 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.09 140.75 3.25 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 125.596 1.81 . . . . 0.58999999999999997 109.61 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -77.88 134.67 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.044 1.338 . . . . 0.68000000000000005 109.878 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 16.6 tt -90.66 131.28 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.081 0.553 . . . . 0.78000000000000003 111.342 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.08 -8.17 2.68 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 124.377 0.989 . . . . 0.56999999999999995 113.762 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.4 mm -91.07 59.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 118.026 0.913 . . . . 1.0900000000000001 111.448 -154.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.68 168.09 9.48 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.218 0.533 . . . . 1.98 111.587 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.424 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 20.9 mm-40 . . . . . 0 C--O 1.256 1.397 0 N-CA-C 101.643 -3.465 . . . . 4.1699999999999999 101.643 139.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' H3 ' ' CD ' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 106.89 -1.522 . . . . 5.8600000000000003 106.89 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 m -81.17 94.21 6.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.491 -1.3 . . . . 2.6699999999999999 107.491 167.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER -77.45 161.4 27.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.012 -0.54 . . . . 3.0899999999999999 110.416 -175.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -109.72 136.6 48.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.547 -2.02 . . . . 0.69999999999999996 105.547 152.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.94 140.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.378 -1.712 . . . . 0.81000000000000005 106.378 169.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.56 96.61 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.371 -0.974 . . . . 0.41999999999999998 108.371 156.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.83 108.26 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.656 -1.609 . . . . 0.56000000000000005 106.656 161.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.7 mt -97.37 127.97 43.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.204 -1.036 . . . . 0.91000000000000003 108.204 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -149.39 -56.13 0.19 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.191 -1.04 . . . . 3.4199999999999999 108.191 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.49 -117.61 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.504 -1.225 . . . . 0.93000000000000005 111.19 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -123.37 -41.17 2.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.883 0.873 . . . . 3.7000000000000002 110.056 -163.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.72 161.42 51.36 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.732 -0.605 . . . . 0.84999999999999998 111.762 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.86 30.82 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.984 3.123 . . . . 1.04 113.436 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 52.1 t -99.24 155.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.575 1.95 . . . . 0.70999999999999996 107.424 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 129.37 9.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.739 -0.837 . . . . 3.3900000000000001 108.739 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.27 171.07 41.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.793 -0.718 . . . . 0.47999999999999998 114.383 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.6 118.64 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.477 1.111 . . . . 1.0 108.482 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -83.84 129.57 37.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.459 -1.312 . . . . 0.66000000000000003 107.459 164.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -106.13 115.68 30.64 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.328 -1.36 . . . . 1.6899999999999999 107.328 160.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -95.9 112.64 24.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.126 -1.805 . . . . 2.6400000000000001 106.126 171.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' CD ' ' H3 ' ' A' ' 1' ' ' ALA . 2.8 mm-40 -124.94 144.79 50.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.668 0.747 . . . . 3.3399999999999999 109.436 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -156.99 158.68 37.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.155 1.382 . . . . 4.1799999999999997 109.15 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.01 -74.95 0.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.134 0.973 . . . . 4.7300000000000004 109.634 170.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -90.83 130.08 36.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.539 1.136 . . . . 3.8300000000000001 110.377 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 p -66.43 1.28 1.72 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.931 1.456 . . . . 2.4100000000000001 114.931 -169.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -140.19 54.18 1.64 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 126.518 1.927 . . . . 4.2699999999999996 107.161 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.64 175.07 32.87 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 107.509 -2.237 . . . . 1.0700000000000001 107.509 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.08 134.62 46.87 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.728 2.285 . . . . 1.23 110.63 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.86 141.5 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.124 -0.695 . . . . 0.90000000000000002 109.124 -171.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -97.34 107.2 19.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.419 -1.326 . . . . 2.6699999999999999 107.419 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.493 HG22 ' CE1' ' A' ' 20' ' ' PHE . 23.8 t -96.25 116.09 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.532 -1.655 . . . . 1.1299999999999999 106.532 -177.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -123.4 107.11 11.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.131 -1.062 . . . . 1.28 108.131 164.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.76 152.95 16.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.66000000000000003 111.805 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 p -132.06 85.39 2.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.737 2.015 . . . . 2.7599999999999998 106.575 -165.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 mp -111.31 126.02 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 107.017 -1.475 . . . . 0.83999999999999997 107.017 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 162.69 16.51 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.327 1.051 . . . . 3.8799999999999999 110.973 171.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.24 1.8 74.91 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.341 -0.7 . . . . 0.70999999999999996 114.768 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -53.35 157.22 2.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.099 1.449 . . . . 0.77000000000000002 110.815 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.68 163.37 9.26 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.124 -1.065 . . . . 1.8999999999999999 108.124 156.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.34 173.74 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 2.3700000000000001 111.038 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.71 -159.73 34.6 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.049 0.833 . . . . 0.44 113.843 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.57 145.12 55.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.246 1.818 . . . . 1.8999999999999999 113.79 -171.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -147.34 118.55 7.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.326 1.85 . . . . 0.42999999999999999 109.777 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.66 147.6 8.14 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.515 -1.034 . . . . 0.40000000000000002 110.515 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE2' HD21 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -136.39 91.23 2.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.268 -1.382 . . . . 2.3199999999999998 107.268 -174.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.75 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 40.2 m170 -125.8 172.36 9.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.015 -0.735 . . . . 0.81000000000000005 109.015 -163.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.4 133.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.527 -1.286 . . . . 2.1800000000000002 107.527 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -119.43 140.97 49.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.152 1.381 . . . . 0.81999999999999995 107.738 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -45.16 -58.15 3.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.767 2.027 . . . . 5.0999999999999996 111.107 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 25.41 66.49 0.05 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.082 2.153 . . . . 3.4100000000000001 116.153 164.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -49.27 -53.21 22.82 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.283 1.833 . . . . 5.5899999999999999 112.322 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -124.62 118.58 26.84 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.79 0.836 . . . . 5.3099999999999996 109.667 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.22 42.17 2.4 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.052 1.741 . . . . 4.5300000000000002 109.117 166.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.3 m -63.44 -40.83 98.22 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.15 0.5 . . . . 4.1699999999999999 111.066 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.94 -42.9 62.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.807 0.843 . . . . 5.1900000000000004 111.69 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.73 173.55 42.41 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 106.041 -2.824 . . . . 3.3700000000000001 106.041 -174.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 85.3 m -75.62 83.17 2.64 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 119.169 1.485 . . . . 2.1899999999999999 112.246 -171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 m -29.47 94.28 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.208 1.403 . . . . 5.75 113.063 157.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.296 1.4 m 51.78 16.49 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 118.539 2.792 . . . . 4.7699999999999996 118.539 82.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.33 -118.33 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.078 -1.823 . . . . 2.3500000000000001 106.078 165.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.12 -91.58 0.08 OUTLIER Glycine 0 CA--C 1.524 0.605 0 CA-C-O 117.86 -1.522 . . . . 1.1100000000000001 111.756 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.03 -177.47 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 1 C-N-CA 126.911 5.074 . . . . 1.01 113.351 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -89.33 62.39 6.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.916 1.286 . . . . 1.8100000000000001 111.363 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 56.41 64.29 1.73 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.45 -0.944 . . . . 1.8899999999999999 108.45 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -90.45 113.8 58.86 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 2.3199999999999998 110.4 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.66 -37.39 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.134 1.889 . . . . 1.3400000000000001 111.294 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 tp -156.17 -64.74 0.11 Allowed 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.376 -0.601 . . . . 3.1600000000000001 109.376 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -153.81 69.47 0.8 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 1.77 109.68 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -76.92 166.49 23.26 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.49 -0.559 . . . . 3.6899999999999999 109.49 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.8 156.2 33.7 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.647 1.579 . . . . 3.7999999999999998 107.008 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -92.79 153.81 18.66 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.657 0.614 . . . . 1.03 112.657 -172.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.3 38.79 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 108.95 -1.66 . . . . 2.5800000000000001 108.95 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.82 -156.06 9.87 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 108.662 -1.775 . . . . 1.3400000000000001 108.662 170.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -60.33 -35.06 92.76 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.987 1.791 . . . . 1.74 110.853 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -51.63 68.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.066 0.946 . . . . 7.0 110.944 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.88 156.57 20.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.594 1.702 . . . . 2.4500000000000002 115.594 -145.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.64 -48.84 74.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.716 2.006 . . . . 6.4100000000000001 112.367 -169.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -135.51 162.42 32.72 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.049 1.34 . . . . 5.5800000000000001 107.759 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -163.4 161.2 24.26 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.4 0.68 . . . . 3.6299999999999999 111.081 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 62.6 m80 -68.16 141.5 56.0 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 107.949 -1.13 . . . . 0.66000000000000003 107.949 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.41 -30.23 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.625 -0.262 . . . . 1.21 110.716 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 57.37 0.43 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.745 -0.475 . . . . 0.64000000000000001 113.802 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.4 146.75 33.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.918 1.859 . . . . 2.3799999999999999 110.226 149.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 mt -97.1 -51.83 4.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.572 -0.899 . . . . 2.3300000000000001 108.572 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.04 -107.92 0.31 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.5 -1.04 . . . . 0.56999999999999995 110.5 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -147.08 171.98 14.46 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 126.184 1.794 . . . . 1.48 109.493 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -132.78 171.4 18.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 106.644 -1.614 . . . . 0.77000000000000002 106.644 166.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -103.99 144.48 31.49 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.404 -0.961 . . . . 2.2400000000000002 108.404 163.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.05 159.51 27.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.983 0.913 . . . . 0.88 110.004 158.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.37 -92.06 0.05 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.033 1.733 . . . . 4.3799999999999999 108.858 162.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 93' ' ' GLY . 13.7 tttt -176.07 -31.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.619 1.168 . . . . 3.5899999999999999 112.0 -159.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -76.84 15.49 0.65 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 124.243 1.973 . . . . 3.3500000000000001 109.477 151.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 63.05 24.75 67.33 Favored Glycine 0 N--CA 1.44 -1.069 0 O-C-N 119.933 -1.729 . . . . 1.1000000000000001 110.347 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.0 t -83.89 118.88 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.306 -0.998 . . . . 1.05 108.306 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.79 153.26 17.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.331 -0.989 . . . . 1.1299999999999999 108.331 166.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -112.32 83.72 1.85 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 104.16 -2.533 . . . . 3.7400000000000002 104.16 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.412 HG11 ' CE2' ' A' ' 45' ' ' PHE . 2.4 t -86.96 60.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.722 -0.844 . . . . 1.1899999999999999 108.722 -167.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -96.43 86.93 4.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.694 1.597 . . . . 1.01 108.027 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.76 150.69 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.894 -0.78 . . . . 1.8100000000000001 108.894 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.47 134.27 33.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.218 -1.771 . . . . 3.1099999999999999 106.218 158.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -145.77 164.25 32.44 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.603 -1.258 . . . . 3.8199999999999998 107.603 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.3 p -112.59 -5.31 14.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.741 2.016 . . . . 1.5800000000000001 111.915 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.24 -37.06 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 119.065 0.848 . . . . 2.1200000000000001 109.26 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.4 pp -96.02 177.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.586 0.754 . . . . 1.22 110.655 176.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.6 m -158.53 175.96 13.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.702 1.601 . . . . 2.25 108.3 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.34 14.18 31.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.214 1.405 . . . . 2.5299999999999998 111.546 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m -84.5 135.79 34.09 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 120.738 -1.226 . . . . 3.0800000000000001 109.632 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.13 65.7 1.24 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 109.414 -1.475 . . . . 3.9100000000000001 109.414 170.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -144.33 -127.04 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.053 1.741 . . . . 3.9100000000000001 107.421 -169.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -79.13 -19.87 50.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.245 0.93 . . . . 4.0499999999999998 111.04 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.83 172.77 0.49 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.13 0.972 . . . . 2.4199999999999999 112.034 172.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.433 HD11 ' CE2' ' A' ' 20' ' ' PHE . 2.5 pp -81.0 -8.14 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 113.537 0.94 . . . . 1.47 113.537 -166.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 mm -50.79 120.12 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.922 0.889 . . . . 2.4500000000000002 109.175 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.16 22.05 66.32 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.916 -0.935 . . . . 1.5800000000000001 113.498 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 174.28 5.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.139 1.469 . . . . 5.5700000000000003 107.982 160.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -86.61 126.74 34.71 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 118.086 -0.959 . . . . 0.96999999999999997 108.943 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.454 HD21 ' CE2' ' A' ' 45' ' ' PHE . 5.0 tt -82.56 137.17 34.65 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.557 -1.275 . . . . 2.0600000000000001 107.557 159.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.86 135.16 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.733 1.613 . . . . 0.48999999999999999 108.082 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.32 130.48 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.178 -1.045 . . . . 1.8400000000000001 108.178 165.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.556 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 72.8 m-70 -106.79 160.51 15.43 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 117.632 2.456 . . . . 0.46999999999999997 117.632 -167.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -33.84 -84.51 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.265 3.026 . . . . 3.6200000000000001 112.736 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -99.4 -174.67 2.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.292 0.951 . . . . 2.71 109.592 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.24 157.95 2.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.087 0.555 . . . . 0.84999999999999998 110.11 164.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 152.17 35.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.675 -1.232 . . . . 2.1000000000000001 107.675 158.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -77.16 -6.81 54.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.439 0.903 . . . . 3.3599999999999999 113.439 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 68.65 -9.37 0.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.34 1.456 . . . . 2.2799999999999998 112.851 -167.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.72 6.1 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.935 0.789 . . . . 1.98 111.537 168.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.37 38.78 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.2 -0.667 . . . . 7.0599999999999996 109.2 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -103.73 160.62 16.21 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.497 -0.641 . . . . 1.96 111.497 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -75.79 59.51 3.0 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.156 0.884 . . . . 2.6499999999999999 110.972 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -178.42 109.22 0.05 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 105.254 -2.128 . . . . 2.6600000000000001 105.254 -170.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -33.51 66.34 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.164 -0.335 . . . . 3.3799999999999999 111.637 -171.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -34.47 -44.4 0.2 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.355 1.862 . . . . 3.2000000000000002 113.18 165.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -54.84 -63.38 1.17 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.868 -0.79 . . . . 2.1600000000000001 108.868 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 p -60.14 -46.59 89.16 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.904 -0.497 . . . . 1.22 110.946 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -68.67 -43.72 75.55 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.826 0.851 . . . . 2.6600000000000001 112.181 -167.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.288 1.1 p -124.72 -52.83 1.68 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.239 -0.886 . . . . 1.22 111.734 172.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 146.53 -14.31 1.6 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.528 1.058 . . . . 0.90000000000000002 113.598 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.95 54.86 9.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.535 1.134 . . . . 1.8899999999999999 110.649 173.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -68.21 -40.85 81.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.172 0.987 . . . . 1.01 110.665 173.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.92 -168.66 30.36 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 108.407 -1.877 . . . . 1.01 108.407 -159.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -55.42 148.23 15.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.111 1.764 . . . . 1.1699999999999999 113.924 -167.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.1 mmt-85 -59.52 134.57 57.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.361 1.464 . . . . 2.9199999999999999 107.972 165.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -110.51 -80.01 0.58 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.016 1.28 . . . . 0.59999999999999998 109.837 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.6 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -114.48 149.42 36.37 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.548 -0.908 . . . . 1.1699999999999999 108.548 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.96 160.43 12.16 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.729 -2.032 . . . . 1.75 107.013 -163.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.07 156.12 13.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.748 -2.141 . . . . 0.73999999999999999 107.748 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.14 140.07 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 117.75 0.775 . . . . 0.98999999999999999 109.646 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.6 tt -97.04 132.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.839 -0.619 . . . . 0.71999999999999997 111.126 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.413 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 140.52 -6.66 2.73 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 123.902 0.763 . . . . 0.56999999999999995 114.519 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -90.33 59.83 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 118.487 1.144 . . . . 1.29 109.873 -157.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.69 149.2 24.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.268 -0.878 . . . . 2.1000000000000001 112.411 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.404 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 85.2 mt-30 . . . . . 0 C--O 1.256 1.409 0 N-CA-C 102.691 -3.077 . . . . 5.7400000000000002 102.691 129.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 109.915 -0.402 . . . . 5.8700000000000001 109.915 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.7 155.55 30.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.178 -1.416 . . . . 2.5899999999999999 107.178 -167.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.3 153.63 30.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 124.315 1.009 . . . . 3.4100000000000001 109.805 167.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.57 154.85 17.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.426 -1.694 . . . . 0.82999999999999996 106.426 153.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.99 147.89 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 104.859 -2.274 . . . . 0.90000000000000002 104.859 161.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -134.39 102.59 5.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.08 -1.822 . . . . 0.54000000000000004 106.08 166.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.57 99.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.907 -1.146 . . . . 0.81999999999999995 107.907 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.447 HD22 ' O ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -86.79 120.68 28.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.777 -1.194 . . . . 2.6000000000000001 107.777 -178.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -139.99 -50.17 0.48 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 122.888 0.475 . . . . 3.54 110.811 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.37 -117.35 2.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.113 0.864 . . . . 0.84999999999999998 112.667 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.14 -50.65 1.68 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.977 0.911 . . . . 3.3799999999999999 110.165 -155.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.85 165.13 11.85 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 110.667 -0.973 . . . . 0.90000000000000002 110.667 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.23 41.91 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.911 3.074 . . . . 1.3400000000000001 112.063 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 72.2 t -110.89 150.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 126.79 2.036 . . . . 0.89000000000000001 108.154 -174.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.12 129.4 8.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.892 -1.151 . . . . 2.73 107.892 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.85 172.18 44.54 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.027 -0.829 . . . . 0.65000000000000002 111.027 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.87 126.67 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.061 -1.088 . . . . 1.4399999999999999 108.061 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 2.4 mm -86.31 132.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.268 -1.753 . . . . 1.48 106.268 159.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -112.16 124.62 52.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.741 -1.948 . . . . 1.99 105.741 159.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -133.42 103.82 6.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.576 -2.009 . . . . 3.46 105.576 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.52 161.28 29.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.396 0.679 . . . . 3.4500000000000002 112.114 -169.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.407 HE22 ' N ' ' A' ' 27' ' ' GLY . 16.5 tt0 -154.97 147.15 23.78 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.972 -1.122 . . . . 3.0 107.972 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -79.5 -35.56 39.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.415 -1.266 . . . . 6.7699999999999996 110.134 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -85.37 -144.94 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.063 -1.828 . . . . 6.3700000000000001 106.063 158.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 p -147.72 -1.87 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.634 1.106 . . . . 3.25 112.984 162.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -123.57 49.76 1.68 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.217 1.007 . . . . 3.4500000000000002 109.612 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' HE22 ' A' ' 22' ' ' GLN . . . -159.69 -162.81 12.55 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.007 -1.237 . . . . 1.25 110.007 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.19 111.9 2.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.256 1.97 . . . . 1.3200000000000001 112.434 -168.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.66 150.15 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.959 0.904 . . . . 1.04 109.535 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -105.69 106.62 17.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.532 -1.655 . . . . 3.9100000000000001 106.532 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -104.24 116.98 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -130.08 142.39 50.61 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.133 -0.691 . . . . 0.96999999999999997 109.133 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.85 159.45 32.68 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.65 -1.78 . . . . 0.69999999999999996 108.65 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -140.14 108.65 5.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.841 -2.281 . . . . 2.4199999999999999 104.841 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.28 142.46 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.961 -1.866 . . . . 0.81999999999999995 105.961 -163.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.455 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -140.31 159.06 43.02 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 115.328 1.603 . . . . 4.4900000000000002 115.328 173.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.98 53.87 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.828 1.68 . . . . 0.90000000000000002 112.815 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.44 159.98 9.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.187 0.993 . . . . 0.78000000000000003 109.568 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.59 162.02 13.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.597 -1.261 . . . . 1.6599999999999999 107.597 156.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.47 172.44 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.172 0.897 . . . . 2.5899999999999999 110.757 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.5 -163.29 54.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 116.079 -0.51 . . . . 0.47999999999999998 113.122 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.77 146.59 47.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.959 0.904 . . . . 2.1200000000000001 111.913 -172.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -146.56 119.97 9.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.729 1.612 . . . . 0.60999999999999999 109.145 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.81 152.12 4.99 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.405 -0.678 . . . . 0.37 111.405 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE2' HG12 ' A' ' 119' ' ' VAL . 16.7 t80 -146.04 101.84 3.57 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.329 -1.36 . . . . 2.3799999999999999 107.329 -174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 26.5 m80 -143.15 160.22 40.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.322 -0.992 . . . . 0.81000000000000005 108.322 -163.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.62 127.83 75.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 CA-C-O 121.899 0.857 . . . . 1.8 110.058 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -99.68 137.49 38.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.715 1.606 . . . . 0.78000000000000003 107.627 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.02 -38.21 56.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.409 1.084 . . . . 4.3099999999999996 111.749 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 2.8 tt0 0.1 103.53 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.596 2.759 . . . . 3.0899999999999999 113.199 156.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.77 -177.82 0.08 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 129.833 3.253 . . . . 6.8600000000000003 113.305 -162.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -74.52 59.65 0.83 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.46 1.504 . . . . 7.4800000000000004 109.808 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -55.21 -59.3 4.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.941 1.696 . . . . 5.1799999999999997 111.246 -171.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m 179.5 -52.25 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 127.539 2.336 . . . . 6.2400000000000002 106.573 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.33 -65.16 0.09 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.943 -1.026 . . . . 6.8600000000000003 110.215 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.59 170.75 53.67 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 121.278 0.376 . . . . 4.1900000000000004 113.879 -170.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.7 p -91.45 137.47 32.34 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 126.381 1.872 . . . . 2.52 107.123 167.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -159.92 20.45 0.16 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.134 0.879 . . . . 4.1699999999999999 113.029 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.272 66.5 m -169.0 -21.59 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 118.043 2.608 . . . . 2.96 118.043 -128.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . . . -132.72 176.75 8.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.229 0.922 . . . . 1.8100000000000001 111.347 168.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.62 -95.67 2.42 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.125 -1.375 . . . . 1.01 109.767 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.69 -179.87 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.545 4.163 . . . . 1.1799999999999999 113.833 -175.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -52.01 126.3 18.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.514 1.526 . . . . 1.3999999999999999 108.793 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -39.7 117.3 0.72 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.353 1.061 . . . . 2.4199999999999999 111.742 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -124.71 143.28 43.08 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 130.397 3.479 . . . . 3.5099999999999998 107.578 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.99 -36.21 3.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.124 2.55 . . . . 1.27 110.148 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 tt -151.42 -66.72 0.18 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.254 -1.387 . . . . 2.9300000000000002 107.254 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.4 m -154.39 84.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.091 -1.005 . . . . 2.3700000000000001 109.848 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -79.39 174.99 11.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.182 0.515 . . . . 4.79 110.131 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -127.79 163.84 23.48 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.521 1.928 . . . . 6.75 106.951 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -102.9 152.9 20.76 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 123.707 0.803 . . . . 0.97999999999999998 110.881 -172.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 -35.56 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.777 -0.529 . . . . 2.8199999999999998 111.777 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.52 -150.5 20.12 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.682 1.611 . . . . 1.2 111.386 167.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.1 -26.98 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.566 2.844 . . . . 2.2400000000000002 110.374 -176.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -48.35 82.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.585 -0.524 . . . . 5.9100000000000001 109.585 170.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.83 175.55 6.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.29 113.41 -166.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.34 -43.73 60.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.299 1.439 . . . . 4.6399999999999997 108.401 164.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.95 157.73 31.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.639 -0.71 . . . . 3.27 111.344 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 164.66 147.93 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.89 2.076 . . . . 3.3500000000000001 111.777 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 18.4 m80 -62.79 153.61 32.4 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.319 -0.993 . . . . 0.65000000000000002 108.319 167.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.06 -36.64 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 119.794 -0.762 . . . . 1.3600000000000001 109.3 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.98 60.87 1.38 Allowed Glycine 0 CA--C 1.529 0.969 0 O-C-N 122.003 -0.436 . . . . 0.59999999999999998 113.175 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.84 96.71 1.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.367 -0.975 . . . . 2.1699999999999999 108.367 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.37 -52.28 8.3 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.319 -0.993 . . . . 2.1299999999999999 108.319 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.53 -109.06 0.35 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.834 -0.698 . . . . 0.53000000000000003 112.645 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -155.49 170.18 22.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.599 1.56 . . . . 1.52 109.758 -168.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.8 169.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.004 -1.48 . . . . 0.52000000000000002 107.004 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.2 m -123.87 123.47 40.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.58 -1.267 . . . . 2.0 107.58 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.36 141.4 31.79 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.568 0.347 . . . . 0.60999999999999999 111.149 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.25 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.348 1.03 . . . . 2.71 109.277 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.4 tttt -155.29 -34.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.102 1.519 . . . . 3.7599999999999998 115.102 -172.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.455 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 24.7 t0 -89.19 40.05 0.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 124.216 1.96 . . . . 2.8599999999999999 109.284 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 56.58 20.58 31.76 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 129.15 3.262 . . . . 0.88 112.562 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.49 119.92 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.947 0.899 . . . . 0.93999999999999995 108.928 -168.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.46 156.87 27.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.568 1.147 . . . . 0.67000000000000004 108.591 168.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.61 147.42 33.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.485 -2.413 . . . . 3.2799999999999998 104.485 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.67 59.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.827 0.704 . . . . 1.6599999999999999 112.024 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.5 m -86.62 96.02 9.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.371 1.068 . . . . 0.96999999999999997 110.429 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.51 152.17 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.546 1.138 . . . . 2.0099999999999998 109.931 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.37 141.9 51.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.324 -0.991 . . . . 2.8300000000000001 108.324 150.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -135.14 163.76 29.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.133 -0.691 . . . . 2.0600000000000001 109.133 162.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -111.24 -16.04 13.5 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.463 2.305 . . . . 1.8600000000000001 112.781 -173.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.37 -36.29 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.888 0.767 . . . . 1.28 109.478 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.8 pp -91.56 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.767 0.827 . . . . 1.1599999999999999 110.477 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.2 p -159.28 176.95 11.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.654 1.981 . . . . 2.6000000000000001 106.967 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.87 37.74 4.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.918 1.235 . . . . 2.3700000000000001 112.498 166.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 m -94.56 -63.44 1.18 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.968 -0.753 . . . . 3.3799999999999999 108.968 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.58 167.3 37.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.218 -0.753 . . . . 2.5 111.218 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.96 -78.59 0.02 OUTLIER 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.045 2.138 . . . . 4.6799999999999997 112.831 165.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -79.54 -24.98 41.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.478 1.111 . . . . 3.8399999999999999 110.443 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.8 p -55.85 151.95 10.66 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.179 -0.675 . . . . 1.3200000000000001 109.179 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.9 pt -78.61 -5.13 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.044 -0.503 . . . . 1.78 111.918 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 mm -32.01 127.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.762 1.225 . . . . 1.6599999999999999 110.716 170.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.78 33.3 83.79 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.378 -0.679 . . . . 1.5600000000000001 112.928 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -116.29 169.13 9.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.088 0.944 . . . . 4.1500000000000004 108.487 166.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m -100.88 110.4 22.46 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-N 118.867 0.758 . . . . 1.3300000000000001 110.247 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt -68.04 148.98 50.26 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.427 -0.953 . . . . 1.76 108.427 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.71 138.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.103 1.761 . . . . 0.40000000000000002 108.135 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.444 HG12 ' CE2' ' A' ' 45' ' ' PHE . 1.3 m -109.15 129.1 64.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.147 -1.057 . . . . 1.53 108.147 162.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.455 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 50.5 m-70 -101.98 160.18 14.71 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 116.366 1.987 . . . . 0.37 116.366 -168.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 7.3 tt0 -44.05 -75.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.68 2.392 . . . . 3.0299999999999998 112.228 172.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -94.24 179.0 5.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.222 0.534 . . . . 2.8399999999999999 110.353 -168.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.13 142.62 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.382 -1.34 . . . . 0.73999999999999999 107.382 155.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -82.25 164.23 21.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.207 1.003 . . . . 2.0099999999999998 109.094 165.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -28.12 47.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.0 -1.0 . . . . 2.8399999999999999 111.722 -160.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.16 46.4 21.51 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.876 0.87 . . . . 1.9399999999999999 109.793 -168.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.71 34.63 64.99 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 124.696 1.141 . . . . 1.6299999999999999 113.04 165.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -78.45 -17.18 56.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.409 0.604 . . . . 6.21 109.712 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.28 -118.25 5.25 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.593 -1.003 . . . . 2.5499999999999998 110.593 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.36 -69.52 0.68 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.503 -1.439 . . . . 2.48 109.503 -168.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -92.6 160.34 15.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.19 0.996 . . . . 2.79 108.453 164.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -72.94 -47.97 40.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.253 -0.88 . . . . 5.1100000000000003 110.819 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -44.22 -39.78 4.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.795 1.634 . . . . 2.7799999999999998 114.463 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 t -39.41 -64.16 0.5 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.944 1.298 . . . . 2.1099999999999999 111.035 166.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.271 1.6 t -73.38 -44.53 58.37 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.6 0.76 . . . . 2.0800000000000001 111.1 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -55.03 -49.64 71.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 119.495 1.043 . . . . 2.6600000000000001 111.921 -174.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 19.5 p -127.62 -45.98 1.46 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 119.08 -0.486 . . . . 1.72 111.403 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.42 -14.56 1.25 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.191 0.9 . . . . 0.98999999999999999 114.327 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.265 0.3 OUTLIER 28.24 56.05 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.041 1.337 . . . . 3.2599999999999998 113.944 -156.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.499 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -55.3 -35.65 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.603 1.161 . . . . 1.0600000000000001 112.337 167.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.86 -176.55 45.95 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.751 -1.74 . . . . 0.94999999999999996 108.751 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 m -61.21 154.28 23.84 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.612 1.165 . . . . 1.28 113.809 -166.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -56.18 136.56 52.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.126 1.37 . . . . 2.5699999999999998 109.022 168.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.5 mt -111.13 -76.24 0.6 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.294 -1.002 . . . . 0.55000000000000004 108.294 168.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.531 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.79 150.85 26.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.821 -1.177 . . . . 0.78000000000000003 107.821 170.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.5 p -153.34 156.68 38.8 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.301 -1.318 . . . . 1.3600000000000001 108.49 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 136.68 4.31 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 125.036 1.46 . . . . 0.60999999999999999 112.091 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.51 125.06 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 125.192 1.397 . . . . 0.90000000000000002 109.544 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.425 ' CB ' ' HB2' ' A' ' 6' ' ' ALA . 12.6 tt -90.29 128.74 42.02 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.227 0.537 . . . . 0.77000000000000002 111.233 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 152.08 -11.62 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.151 0.881 . . . . 0.76000000000000001 114.901 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -93.76 59.43 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 122.557 1.17 . . . . 1.5 109.275 -152.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.28 148.53 25.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.71 -0.677 . . . . 2.23 111.6 172.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 C--O 1.252 1.195 0 N-CA-C 101.967 -3.345 . . . . 6.8099999999999996 101.967 142.32 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 113.733 1.012 . . . . 8.4600000000000009 113.733 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m 52.53 58.8 5.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.626 1.17 . . . . 4.5899999999999999 113.031 157.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 21.1 pttp -154.99 163.74 39.88 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.14 0.976 . . . . 4.5300000000000002 109.086 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.06 168.93 16.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.253 1.025 . . . . 2.1600000000000001 111.428 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.644 HG23 ' HB2' ' A' ' 152' ' ' ALA . 27.3 t -128.78 147.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.532 -2.396 . . . . 1.6000000000000001 104.532 155.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.43 99.18 4.02 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 108.525 -0.916 . . . . 0.82999999999999996 108.525 153.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.4 t -68.58 94.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.868 -1.16 . . . . 1.02 107.868 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 147' ' ' GLY . 34.8 mt -79.52 122.96 27.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.597 -0.89 . . . . 1.8600000000000001 108.597 175.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -136.33 -60.01 0.72 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.242 -1.022 . . . . 4.0199999999999996 108.242 174.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.83 -139.79 9.73 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.894 -1.682 . . . . 1.23 108.894 -156.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.83 21.78 2.48 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.142 0.577 . . . . 5.9400000000000004 111.534 168.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.32 165.57 46.37 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 107.97 -2.052 . . . . 0.95999999999999996 107.97 148.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.62 72.42 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.798 2.332 . . . . 2.6299999999999999 109.845 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.0 t -139.64 144.64 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.818 0.847 . . . . 0.76000000000000001 109.287 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -145.44 120.61 10.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.575 -1.268 . . . . 3.0099999999999998 107.575 166.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.88 163.56 32.78 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.588 -0.695 . . . . 0.52000000000000002 111.941 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.1 mt -127.16 127.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.474 -1.306 . . . . 1.3400000000000001 107.474 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 30.2 mm -87.85 142.6 12.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 N-CA-C 106.383 -1.71 . . . . 0.77000000000000002 106.383 158.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.472 HD21 HG22 ' A' ' 5' ' ' VAL . 14.1 m120 -139.04 82.25 1.89 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.165 -1.05 . . . . 2.7000000000000002 108.165 168.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.407 ' CD1' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -77.85 152.53 33.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 118.641 -1.224 . . . . 5.29 108.992 175.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -139.3 148.22 42.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.905 -1.887 . . . . 3.5600000000000001 105.905 166.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -156.94 116.96 3.51 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.208 1.403 . . . . 4.0700000000000003 108.173 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -63.6 -60.23 3.6 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.274 0.63 . . . . 4.6699999999999999 110.681 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -77.9 107.02 10.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.244 -0.91 . . . . 4.0499999999999998 108.919 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -57.76 6.08 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.593 2.357 . . . . 3.29 116.922 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.44 60.85 0.75 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.116 -1.068 . . . . 3.6099999999999999 108.116 168.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.79 179.97 19.37 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 108.389 -1.884 . . . . 0.93999999999999995 108.389 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.67 116.78 3.57 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 1.02 111.302 -171.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 20' ' ' PHE . 7.8 t -80.95 135.37 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.367 -0.825 . . . . 1.4199999999999999 109.958 -169.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.83 88.03 4.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.293 0.951 . . . . 3.9700000000000002 109.855 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.96 88.66 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.634 1.174 . . . . 1.8400000000000001 109.03 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -102.62 157.3 17.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 123.52 0.513 . . . . 0.93999999999999995 111.581 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.17 164.24 35.37 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.652 -0.579 . . . . 0.67000000000000004 111.652 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -130.08 70.44 1.44 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.161 1.384 . . . . 2.2599999999999998 108.999 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.0 132.59 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.191 0.996 . . . . 0.75 110.124 -168.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -130.91 163.03 28.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.618 0.767 . . . . 3.7999999999999998 111.494 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.6 -16.89 59.82 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.077 -0.846 . . . . 1.3899999999999999 113.862 173.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.41 159.25 2.09 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.55 1.175 . . . . 0.79000000000000004 111.389 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 154.67 23.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.722 -1.214 . . . . 1.72 107.722 153.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.2 171.42 0.27 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.065 0.935 . . . . 3.3100000000000001 111.302 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.05 -161.58 54.32 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.307 -0.86 . . . . 0.73999999999999999 112.75 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.92 136.24 52.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.085 1.354 . . . . 1.99 112.401 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -140.6 121.75 14.76 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.581 1.552 . . . . 0.53000000000000003 108.86 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.66 149.98 9.87 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.73 -0.948 . . . . 0.48999999999999999 110.73 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.11 96.62 3.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.487 -1.672 . . . . 2.4700000000000002 106.487 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.624 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 27.9 m80 -134.86 161.52 34.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.997 -1.112 . . . . 0.68000000000000005 107.997 -169.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 t -114.09 128.05 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.845 -1.169 . . . . 2.1800000000000002 107.845 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -112.47 137.98 49.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.099 -1.445 . . . . 0.96999999999999997 107.099 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -72.34 63.95 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.418 0.687 . . . . 4.1600000000000001 112.725 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -113.29 115.32 27.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.228 -1.397 . . . . 3.5099999999999998 107.228 171.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -72.62 -173.65 1.22 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 127.381 2.272 . . . . 4.6399999999999997 111.861 -167.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -76.66 70.71 3.19 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.376 1.87 . . . . 8.2200000000000006 110.709 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.58 -25.26 0.57 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.856 1.058 . . . . 5.7599999999999998 113.856 -175.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -161.33 -167.18 1.7 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.318 -1.364 . . . . 5.6500000000000004 107.318 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.45 84.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.053 0.541 . . . . 6.9299999999999997 109.758 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.405 ' O ' HG21 ' A' ' 116' ' ' THR . . . 100.48 65.63 0.81 Allowed Glycine 0 CA--C 1.523 0.553 0 CA-C-O 123.707 1.726 . . . . 5.1699999999999999 111.512 165.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 p -151.76 56.31 0.85 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.706 -1.22 . . . . 2.8900000000000001 107.706 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -148.78 32.61 0.77 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.065 0.765 . . . . 3.9300000000000002 113.065 171.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.298 15.1 m -170.06 -50.99 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 117.309 2.337 . . . . 2.6899999999999999 117.309 -144.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.09 134.2 49.59 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.659 0.784 . . . . 1.9199999999999999 108.949 176.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.01 -94.38 0.9 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.393 -1.483 . . . . 1.02 109.393 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.17 178.25 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.902 3.068 . . . . 1.23 112.819 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -63.85 130.0 42.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.693 -1.14 . . . . 1.3799999999999999 110.608 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -31.92 113.83 0.13 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.196 1.184 . . . . 1.99 114.196 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.47 154.86 49.39 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 126.517 1.927 . . . . 2.6400000000000001 106.722 160.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.9 -42.33 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.61 1.54 . . . . 1.28 111.666 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 -71.95 0.43 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.257 0.623 . . . . 2.7400000000000002 109.556 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 m -145.47 72.56 1.32 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.562 0.745 . . . . 1.6599999999999999 111.512 -164.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -79.43 175.5 10.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.599 -1.26 . . . . 4.75 107.599 153.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -128.89 174.97 9.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.333 1.453 . . . . 4.0700000000000003 107.224 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -108.02 129.85 55.1 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.285 1.034 . . . . 1.3899999999999999 112.658 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -148.79 21.71 1.29 Allowed Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.68 -0.568 . . . . 3.0 111.68 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.58 -169.71 4.02 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.074 0.845 . . . . 1.3999999999999999 113.348 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.94 -6.13 12.12 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.056 3.171 . . . . 1.47 114.256 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.04 -50.06 5.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.916 -1.115 . . . . 6.0499999999999998 110.612 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -75.81 169.46 18.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.989 0.899 . . . . 2.5099999999999998 111.552 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.26 -37.84 84.14 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.498 1.119 . . . . 5.21 109.51 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.343 12.1 pt-20 -78.57 149.68 32.96 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.028 0.918 . . . . 4.9299999999999997 110.915 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 151.87 127.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 131.405 3.882 . . . . 2.98 104.03 -162.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.523 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.0 m80 -60.62 152.34 26.61 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.649 -1.241 . . . . 0.64000000000000001 107.649 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -30.25 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 120.117 -0.633 . . . . 1.3500000000000001 110.239 -167.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.52 59.56 0.5 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.385 -0.675 . . . . 0.66000000000000003 112.756 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -123.03 108.67 13.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.682 1.241 . . . . 2.6400000000000001 109.049 165.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.82 -47.46 15.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.088 -0.708 . . . . 1.5600000000000001 109.088 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.52 -104.17 0.25 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.916 0.78 . . . . 0.70999999999999996 112.677 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -155.66 167.42 30.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.484 1.914 . . . . 1.5600000000000001 108.629 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.4 160.19 40.26 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.205 -1.035 . . . . 0.85999999999999999 108.205 171.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -109.32 111.93 23.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 2.1899999999999999 108.669 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.38 139.37 37.76 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.304 0.502 . . . . 0.62 110.802 169.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.02 -90.31 0.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.532 0.52 . . . . 3.9300000000000002 110.649 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 -56.95 1.16 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.844 0.857 . . . . 4.6299999999999999 112.142 -159.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.7 21.16 0.85 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.074 1.749 . . . . 3.2999999999999998 110.155 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.08 18.47 69.03 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 124.593 1.092 . . . . 0.78000000000000003 111.597 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -79.74 110.14 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.534 -1.284 . . . . 0.97999999999999998 107.534 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.75 175.71 6.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.873 -1.158 . . . . 0.80000000000000004 107.873 161.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -131.34 136.39 48.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 102.67 -3.085 . . . . 2.9100000000000001 102.67 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.83 131.86 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.784 -1.932 . . . . 1.5700000000000001 105.784 167.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.6 m -160.78 61.04 0.31 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.868 1.667 . . . . 1.3 108.245 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -108.22 152.78 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.414 0.686 . . . . 1.8500000000000001 109.705 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -137.64 142.83 41.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.308 -0.627 . . . . 3.27 109.308 149.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -124.6 145.21 49.74 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.614 -1.625 . . . . 2.5499999999999998 106.614 166.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -79.58 -18.11 52.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.036 2.134 . . . . 1.4199999999999999 111.394 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.4 t -77.17 -39.91 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.772 -0.455 . . . . 1.1100000000000001 109.772 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -77.46 176.79 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.672 0.749 . . . . 1.1200000000000001 110.985 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 t -161.51 179.89 7.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.613 1.965 . . . . 2.2999999999999998 105.871 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.54 41.86 3.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.846 1.259 . . . . 3.1899999999999999 110.74 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.4 t -155.92 -64.73 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.015 -0.735 . . . . 3.27 109.015 -174.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.75 157.14 48.53 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.147 -0.781 . . . . 3.1699999999999999 111.147 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -45.44 -43.02 11.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.128 0.964 . . . . 6.5499999999999998 112.135 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -74.76 1.79 11.6 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.987 -0.445 . . . . 4.6299999999999999 111.721 -172.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.0 p -57.14 164.41 1.71 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 123.01 1.386 . . . . 1.6699999999999999 111.533 158.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.628 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -83.52 -8.68 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 113.695 -1.593 . . . . 2.3399999999999999 111.98 169.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.1 mm -49.75 123.85 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 119.471 1.032 . . . . 1.6899999999999999 110.34 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.75 -9.46 55.92 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.614 -1.103 . . . . 1.6799999999999999 112.974 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.444 ' O ' HG22 ' A' ' 149' ' ' ILE . 90.5 mtt-85 -88.6 164.54 15.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.519 1.659 . . . . 4.2199999999999998 110.171 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 56' ' ' GLY . 24.3 m -94.11 118.41 31.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.233 -0.292 . . . . 0.89000000000000001 110.698 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.76 142.53 54.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.356 -0.979 . . . . 2.4900000000000002 108.356 163.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.6 t -127.91 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.24 1.416 . . . . 0.38 107.648 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.39 120.95 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 106.187 -1.783 . . . . 2.2999999999999998 106.187 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.501 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 55.1 m-70 -98.29 159.42 14.95 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.751 2.13 . . . . 0.40999999999999998 116.751 -174.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -29.59 -83.44 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.363 3.065 . . . . 3.71 112.352 165.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -96.98 -175.35 3.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.472 1.109 . . . . 3.3300000000000001 109.728 -175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.15 157.6 3.37 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.701 -0.481 . . . . 0.94999999999999996 109.701 159.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.27 160.79 23.65 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.44 -0.578 . . . . 2.1899999999999999 109.44 161.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.05 -25.21 59.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.96 1.096 . . . . 3.0800000000000001 113.96 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.78 13.11 2.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.839 0.856 . . . . 1.4399999999999999 113.127 -165.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.39 47.49 42.92 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.831 1.196 . . . . 1.55 111.554 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -142.03 -22.71 0.7 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.807 2.043 . . . . 4.96 112.925 -173.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.2 136.72 40.2 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 120.315 1.416 . . . . 2.5600000000000001 111.02 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.28 67.68 0.92 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.691 1.139 . . . . 2.6400000000000001 111.26 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -144.07 -179.22 6.36 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.025 2.13 . . . . 3.1400000000000001 105.424 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -39.47 15.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.387 -0.968 . . . . 4.2000000000000002 108.387 159.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -47.48 -28.25 2.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.336 2.254 . . . . 4.9299999999999997 113.622 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.6 p -58.21 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.734 1.214 . . . . 2.3999999999999999 109.116 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.5 t -60.83 -31.74 71.15 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.23 -0.919 . . . . 2.79 111.592 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -59.09 -49.36 78.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.281 -0.887 . . . . 3.3900000000000001 111.948 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.523 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.335 9.9 t -134.08 -51.81 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.325 -0.845 . . . . 1.77 111.343 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.54 30.0 0.07 OUTLIER Glycine 0 C--N 1.336 0.579 0 CA-C-O 116.989 -2.006 . . . . 1.1699999999999999 115.572 168.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 9.03 57.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.683 2.393 . . . . 2.3100000000000001 114.674 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.624 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.25 -38.34 88.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.2 1.0 . . . . 1.0 108.998 166.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.73 36.44 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 108.074 -2.011 . . . . 1.04 108.074 -165.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -63.68 158.81 20.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.985 0.914 . . . . 2.21 113.106 -166.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -63.15 132.02 50.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.243 1.817 . . . . 3.0699999999999998 108.487 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.84 -63.23 1.37 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.256 -1.016 . . . . 0.64000000000000001 108.256 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.45 158.66 16.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.15 -0.932 . . . . 1.04 109.716 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 139.36 23.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.356 -1.72 . . . . 1.78 106.356 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.469 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -160.12 131.05 2.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.553 -1.819 . . . . 0.68999999999999995 108.553 170.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.42 139.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.722 -0.844 . . . . 0.80000000000000004 108.722 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.628 HG21 HG12 ' A' ' 112' ' ' ILE . 7.8 tt -102.31 142.68 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.779 0.831 . . . . 0.88 112.692 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.23 6.72 8.8 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.016 1.294 . . . . 0.76000000000000001 112.658 172.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.33 58.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.685 1.242 . . . . 0.78000000000000003 111.315 -163.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.644 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -155.57 175.54 13.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.052 0.941 . . . . 1.45 108.79 164.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.501 0 C-N-CA 126.361 1.864 . . . . 4.2999999999999998 106.127 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 120.8 0.333 . . . . 4.7999999999999998 110.654 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.65 78.34 3.31 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.872 1.269 . . . . 2.4700000000000002 110.655 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.24 145.67 37.4 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.648 -0.871 . . . . 3.3500000000000001 108.648 168.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.58 139.99 37.32 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.873 -1.529 . . . . 0.69999999999999996 106.873 156.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -99.46 146.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.373 -1.714 . . . . 0.75 106.373 161.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -133.2 92.76 3.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.875 -0.787 . . . . 0.58999999999999997 108.875 163.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.24 110.22 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.69999999999999996 108.163 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.42 140.31 30.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.04 0.536 . . . . 0.85999999999999999 110.355 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -144.94 -54.45 0.31 Allowed 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.204 1.002 . . . . 6.0199999999999996 109.877 165.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.46 -134.93 51.6 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.421 1.01 . . . . 0.98999999999999999 114.185 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.79 -51.32 2.92 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.79 1.236 . . . . 4.0099999999999998 109.481 -166.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.14 156.1 15.14 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 109.192 -1.563 . . . . 0.85999999999999999 109.192 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.72 46.38 2.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 0.96999999999999997 112.045 -172.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 30.3 t -89.91 158.16 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 125.353 1.461 . . . . 0.88 108.643 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.62 120.85 4.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.536 -1.653 . . . . 3.1200000000000001 106.536 173.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.06 40.38 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.528 -0.844 . . . . 0.59999999999999998 111.864 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.11 128.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.035 -1.098 . . . . 1.01 108.035 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.8 mp -93.91 141.94 14.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.009 -1.849 . . . . 1.47 106.009 162.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.32 115.65 20.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.414 -2.069 . . . . 1.6100000000000001 105.414 163.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' CD2' HG22 ' A' ' 31' ' ' VAL . 31.8 t80 -129.91 107.45 9.38 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.445 -2.057 . . . . 2.9500000000000002 105.445 -163.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -136.1 153.72 51.23 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.422 0.63 . . . . 3.3199999999999998 110.58 -166.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -140.18 143.63 36.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.18 -1.785 . . . . 3.75 106.18 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -85.31 -35.87 21.18 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.932 0.893 . . . . 5.1900000000000004 110.675 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -137.24 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.437 1.095 . . . . 5.25 108.52 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 t -129.61 -69.53 0.68 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.95 1.7 . . . . 2.7599999999999998 108.715 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -109.68 61.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.93 1.292 . . . . 4.2599999999999998 107.865 -172.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.11 175.07 21.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.961 -1.256 . . . . 1.0600000000000001 109.961 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 115.35 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.789 2.993 . . . . 1.2 111.259 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -78.51 150.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.921 -0.77 . . . . 0.80000000000000004 108.921 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -100.13 113.79 26.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.311 -1.366 . . . . 3.6899999999999999 107.311 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 20' ' ' PHE . 3.5 t -104.54 128.59 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.131 -1.433 . . . . 1.3300000000000001 107.131 175.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -130.41 146.54 51.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.851 -1.907 . . . . 1.0600000000000001 105.851 162.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.23 20.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.046 -1.622 . . . . 0.68999999999999995 109.046 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 p -132.12 118.22 19.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.574 -1.639 . . . . 1.9199999999999999 106.574 -174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.36 148.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 C-N-CA 125.588 1.555 . . . . 1.1299999999999999 108.462 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -141.09 176.45 8.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 119.017 -1.073 . . . . 5.7000000000000002 112.548 149.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.99 13.89 57.08 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.203 1.858 . . . . 0.69999999999999996 113.191 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 119' ' ' VAL . 2.3 mm? -65.25 166.01 10.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 117.713 0.757 . . . . 1.3799999999999999 109.968 166.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 164.95 23.65 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.988 -1.115 . . . . 1.8999999999999999 107.988 156.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -58.92 174.11 0.38 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.266 0.939 . . . . 2.4300000000000002 111.476 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.08 -166.38 54.85 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.677 0.656 . . . . 0.56999999999999995 113.756 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.05 153.26 40.93 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.241 1.017 . . . . 2.1899999999999999 110.41 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CD2' HD12 ' A' ' 38' ' ' LEU . 80.5 m-70 -146.55 118.62 8.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.945 1.298 . . . . 0.46000000000000002 108.878 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.96 151.58 5.5 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.335 -1.106 . . . . 0.41999999999999998 110.335 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -145.85 102.27 3.64 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 117.977 0.889 . . . . 2.25 108.716 -171.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.648 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.5 m80 -143.34 155.21 44.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.248 -1.39 . . . . 0.56000000000000005 107.248 -158.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.1 140.35 30.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 119.643 1.111 . . . . 1.8899999999999999 109.784 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -113.25 140.33 48.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.971 1.308 . . . . 1.0 107.691 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.1 74.1 0.65 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.387 1.089 . . . . 4.4699999999999998 112.193 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -148.56 80.94 1.45 Allowed 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 104.753 -2.314 . . . . 3.3100000000000001 104.753 -171.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -152.25 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.124 1.37 . . . . 5.04 110.698 172.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -84.58 63.84 8.13 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 120.422 -1.424 . . . . 6.6100000000000003 109.814 -174.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.24 -28.96 12.72 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 126.227 1.811 . . . . 5.75 110.373 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -171.34 157.94 5.15 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.072 0.949 . . . . 5.5800000000000001 108.588 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.65 -22.23 29.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.579 0.752 . . . . 4.9500000000000002 110.161 163.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.99 71.95 1.38 Allowed Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.353 -1.499 . . . . 4.2999999999999998 109.353 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.0 t -48.39 109.61 0.26 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.009 1.723 . . . . 2.4399999999999999 112.387 -171.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 m -149.7 -117.57 0.05 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.604 -1.258 . . . . 4.0999999999999996 107.604 -173.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.3 m 69.97 -73.34 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.823 2.157 . . . . 2.46 116.823 139.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.22 142.83 27.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.891 1.277 . . . . 2.04 109.472 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.68 -91.92 1.92 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 107.879 -2.088 . . . . 1.26 107.879 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.95 178.09 6.91 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.759 2.972 . . . . 1.1599999999999999 113.281 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.31 131.74 45.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.584 -1.644 . . . . 1.47 109.868 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -35.42 109.84 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.834 1.254 . . . . 2.1200000000000001 111.907 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.38 150.7 21.17 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 126.038 1.735 . . . . 2.3599999999999999 107.199 165.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.15 -29.02 33.72 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.368 2.045 . . . . 1.1499999999999999 114.14 -170.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.93 -64.38 0.11 Allowed 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.07 0.85 . . . . 3.1200000000000001 112.152 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.6 m -154.23 83.3 1.13 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.102 -0.703 . . . . 1.8799999999999999 109.102 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 168.06 11.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.462 -0.94 . . . . 5.6100000000000003 108.462 162.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -114.7 163.16 15.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.635 -1.246 . . . . 3.0899999999999999 107.635 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -82.58 160.77 22.46 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.082 0.553 . . . . 0.80000000000000004 110.293 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.54 176.72 41.64 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 106.302 -2.719 . . . . 2.02 106.302 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.19 -168.92 23.99 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 118.927 1.364 . . . . 1.3500000000000001 112.913 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -62.36 -30.9 81.31 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.851 1.7 . . . . 1.49 109.957 163.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -78.11 -42.39 32.12 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.617 0.767 . . . . 5.5899999999999999 112.561 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.1 163.55 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.456 0.571 . . . . 2.2999999999999998 111.267 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -78.5 -50.9 10.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.638 1.575 . . . . 4.2000000000000002 109.936 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.259 16.9 pt-20 -90.48 176.82 6.56 Favored 'General case' 0 C--N 1.337 0.055 0 C-N-CA 122.554 0.342 . . . . 2.9700000000000002 111.812 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 165.05 159.06 0.02 OUTLIER 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.674 1.989 . . . . 4.7800000000000002 108.552 -166.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 55.7 m80 -61.52 139.39 58.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.094 -1.817 . . . . 0.67000000000000004 106.094 161.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.11 -32.23 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.723 -0.391 . . . . 1.3400000000000001 110.653 -163.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.62 53.32 0.65 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.123 0.392 . . . . 0.96999999999999997 113.007 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -107.9 130.14 55.04 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 2.5899999999999999 107.733 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.71 -58.75 2.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.166 -1.05 . . . . 1.6699999999999999 108.166 159.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.12 -93.14 0.13 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.701 -0.96 . . . . 0.63 110.701 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -155.09 166.52 33.33 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.945 1.698 . . . . 1.8899999999999999 111.234 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.09 178.06 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 127.31 2.244 . . . . 0.69999999999999996 105.961 165.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -136.49 145.73 45.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.921 -1.881 . . . . 2.1200000000000001 105.921 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.52 145.49 34.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.733 0.813 . . . . 0.53000000000000003 110.862 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -70.39 -84.25 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.873 0.869 . . . . 2.9500000000000002 110.79 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 93' ' ' GLY . 61.5 tttt -158.69 -47.3 0.06 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.317 1.047 . . . . 3.48 111.226 -171.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -82.44 29.62 0.43 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 124.659 2.171 . . . . 3.0699999999999998 110.277 173.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 60.07 21.31 55.94 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 113.583 -1.644 . . . . 0.71999999999999997 111.611 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.56 138.14 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.716 -1.587 . . . . 0.79000000000000004 106.716 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.73 169.37 19.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.103 -1.073 . . . . 0.85999999999999999 108.103 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.64 141.61 29.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.956 -1.868 . . . . 2.7200000000000002 105.956 -165.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.8 56.59 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 124.048 0.843 . . . . 1.6299999999999999 112.415 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.8 m -78.15 97.45 5.47 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.27 1.028 . . . . 0.96999999999999997 109.846 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 mm -136.44 153.62 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.964 0.906 . . . . 1.77 110.455 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -132.81 97.08 3.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.243 1.817 . . . . 4.0300000000000002 108.77 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.98 174.4 11.59 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.601 -0.518 . . . . 2.3199999999999998 109.601 169.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.2 m -147.84 26.52 1.01 Allowed 'General case' 0 CA--C 1.53 0.211 0 O-C-N 120.839 -1.163 . . . . 2.4300000000000002 112.069 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.15 -52.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.543 1.537 . . . . 1.04 108.532 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.21 173.22 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.107 0.48 . . . . 1.1299999999999999 111.338 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.3 t -154.43 176.48 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.679 0.792 . . . . 2.5699999999999998 110.257 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -86.88 -13.67 44.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 2.4199999999999999 111.073 160.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.1 t -126.64 177.21 6.67 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.568 1.147 . . . . 3.6400000000000001 111.349 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.42 -96.96 2.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.848 -1.301 . . . . 3.5 109.848 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -162.8 -60.47 0.04 OUTLIER 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.483 1.113 . . . . 4.2199999999999998 108.989 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -75.39 2.65 10.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.064 0.946 . . . . 5.0800000000000001 111.516 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -41.96 156.48 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.147 1.779 . . . . 1.4199999999999999 112.413 165.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.7 pt -86.04 -6.39 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 1.9199999999999999 110.855 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.6 tp -33.22 123.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 125.369 1.468 . . . . 2.3900000000000001 110.69 166.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.81 57.11 20.5 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.858 -0.897 . . . . 1.8600000000000001 110.858 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -135.56 157.93 45.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.883 -1.525 . . . . 4.3300000000000001 106.883 163.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -82.58 120.75 25.93 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.543 -1.28 . . . . 1.21 107.543 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.44 141.69 44.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.602 -1.258 . . . . 2.4300000000000002 107.602 168.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.04 134.1 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.446 -1.316 . . . . 0.35999999999999999 107.446 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.656 HG21 HD11 ' A' ' 38' ' ' LEU . 5.6 p -107.33 130.43 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 106.337 -1.727 . . . . 2.21 106.337 162.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.506 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 49.7 m-70 -104.51 163.66 12.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.773 1.397 . . . . 0.38 114.773 -168.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.72 -71.47 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.281 -0.866 . . . . 3.7599999999999998 112.287 176.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -79.56 176.68 9.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.643 1.111 . . . . 3.3300000000000001 109.08 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.3 158.66 16.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.779 -0.822 . . . . 0.66000000000000003 108.779 162.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -76.64 170.57 16.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.481 -0.562 . . . . 2.0 109.481 166.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.78 -20.84 59.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.254 1.205 . . . . 4.1500000000000004 114.254 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 66.48 -6.21 0.53 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.119 1.368 . . . . 1.97 113.471 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.84 9.34 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 120.122 1.328 . . . . 1.95 109.904 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.09 -31.09 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.321 1.448 . . . . 5.6600000000000001 109.384 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.64 -106.73 2.12 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.761 . . . . 2.96 111.196 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.44 -72.19 0.47 Allowed Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.544 -0.974 . . . . 2.6299999999999999 112.117 -175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -83.23 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.688 0.744 . . . . 3.1699999999999999 110.933 -172.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 178.77 -71.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.597 1.959 . . . . 3.2200000000000002 106.908 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -40.28 -40.39 1.14 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.857 2.063 . . . . 4.5599999999999996 112.042 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.47 0.09 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.549 2.339 . . . . 2.2200000000000002 112.076 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -39.53 74.27 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.409 -1.432 . . . . 1.79 110.787 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -55.66 -48.42 75.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.78 1.232 . . . . 3.1899999999999999 111.566 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.496 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -127.7 -48.26 1.39 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.691 0.796 . . . . 1.3200000000000001 111.987 177.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.3 -11.9 0.9 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.797 -1.002 . . . . 0.89000000000000001 114.097 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 30.51 54.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.943 2.097 . . . . 2.6499999999999999 112.911 -168.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.648 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.74 -35.8 80.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.519 1.127 . . . . 1.02 111.014 169.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.96 -165.75 30.72 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 108.895 -1.682 . . . . 1.05 108.895 -166.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -58.57 154.83 13.44 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 127.751 2.421 . . . . 1.21 113.102 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -57.01 139.03 53.47 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.816 -1.084 . . . . 2.3199999999999998 108.964 166.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 mt -107.73 -78.48 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.014 -1.106 . . . . 0.5 108.014 160.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.566 ' HB3' HG12 ' A' ' 119' ' ' VAL . . . -89.7 159.8 16.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.019 -0.734 . . . . 0.79000000000000004 109.019 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 72.8 m -148.01 157.84 43.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.825 -1.546 . . . . 1.75 106.825 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.14 139.96 3.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.212 -1.955 . . . . 0.65000000000000002 108.212 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.42 138.08 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 123.714 0.806 . . . . 0.77000000000000002 109.552 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 tt -94.82 131.03 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.104 0.478 . . . . 0.77000000000000002 111.828 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.45 0.52 0.98 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.942 1.258 . . . . 0.66000000000000003 114.689 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.96 57.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.19 1.495 . . . . 0.82999999999999996 111.54 -153.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.72 174.58 15.25 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.027 0.531 . . . . 1.6000000000000001 110.914 163.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 . . . . . 0 C--O 1.255 1.347 0 N-CA-C 102.731 -3.063 . . . . 6.1799999999999997 102.731 160.668 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 107.932 -1.136 . . . . 7.5899999999999999 107.932 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -165.89 56.24 0.1 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.304 1.441 . . . . 3.25 109.375 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -151.55 166.54 30.86 Favored 'General case' 0 C--N 1.335 -0.055 0 O-C-N 121.183 -0.948 . . . . 3.4700000000000002 113.295 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.97 155.82 23.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.39 1.076 . . . . 0.85999999999999999 109.573 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 t -124.18 150.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 107.981 -1.118 . . . . 0.85999999999999999 107.981 165.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -124.36 95.37 4.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.194 0.998 . . . . 0.46999999999999997 109.206 161.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.67 112.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.359 -1.348 . . . . 0.56999999999999995 107.359 161.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.48 131.83 51.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.153 0.981 . . . . 1.1299999999999999 109.769 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.63 -47.92 0.29 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.785 1.234 . . . . 4.9100000000000001 109.886 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.61 -125.05 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.543 1.068 . . . . 0.84999999999999998 111.989 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.47 -58.27 1.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.696 -0.853 . . . . 4.21 108.696 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.72 165.92 3.8 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.788 1.661 . . . . 0.72999999999999998 114.146 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -77.62 37.46 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 124.516 3.477 . . . . 1.4299999999999999 111.95 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 55.2 t -110.97 143.61 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.167 2.187 . . . . 0.89000000000000001 106.795 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -137.38 131.22 31.76 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.786 -1.931 . . . . 2.8599999999999999 105.786 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.96 165.75 33.27 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 121.687 -0.633 . . . . 0.59999999999999998 111.84 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.65 127.65 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.979 -1.86 . . . . 1.25 105.979 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 35.5 mm -98.46 138.14 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.748 -1.575 . . . . 0.73999999999999999 106.748 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -109.38 124.86 51.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.57 -1.641 . . . . 2.1699999999999999 106.57 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.517 ' CG ' HD11 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -107.21 95.99 6.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.882 -1.895 . . . . 2.4700000000000002 105.882 171.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -113.52 136.66 52.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.879 -1.526 . . . . 5.54 106.879 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -153.69 153.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.913 -1.514 . . . . 4.29 106.913 -166.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -105.5 -79.06 0.56 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 4.8799999999999999 110.121 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.46 137.07 37.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.098 0.959 . . . . 4.0 109.051 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -52.52 -68.08 0.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.02 1.728 . . . . 2.3500000000000001 112.446 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -79.7 68.54 5.79 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.814 -1.18 . . . . 3.71 107.814 170.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 167.46 31.42 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.604 -0.999 . . . . 1.3500000000000001 110.604 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.4 142.32 44.84 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.523 2.816 . . . . 1.49 111.834 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.3 165.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.617 -1.253 . . . . 1.28 107.617 171.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.37 95.09 4.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.866 -1.901 . . . . 3.1499999999999999 105.866 157.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' CE1' ' A' ' 20' ' ' PHE . 38.3 t -79.83 113.49 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.524 -1.658 . . . . 0.84999999999999998 106.524 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -124.85 142.5 51.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.177 -1.045 . . . . 0.84999999999999998 108.177 166.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.1 152.23 23.67 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.446 -0.661 . . . . 0.67000000000000004 111.446 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 p -125.33 64.56 1.16 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.484 1.514 . . . . 2.2799999999999998 108.599 -165.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -80.72 142.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.525 -1.216 . . . . 0.81000000000000005 109.099 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -149.99 161.88 41.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.324 0.861 . . . . 3.4199999999999999 113.324 174.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.81 9.1 61.43 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.702 1.62 . . . . 0.82999999999999996 112.617 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.87 162.41 16.35 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.751 -0.853 . . . . 0.81999999999999995 109.542 172.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.18 162.21 14.91 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.571 -1.27 . . . . 1.5800000000000001 107.571 152.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.69 177.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.962 0.801 . . . . 3.0699999999999998 110.959 174.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.98 -163.51 37.51 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.922 0.772 . . . . 0.59999999999999998 113.512 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.7 142.92 58.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.393 1.477 . . . . 1.9199999999999999 113.355 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -145.68 116.88 7.89 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 126.104 1.762 . . . . 0.53000000000000003 109.359 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.58 150.02 6.13 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.301 0.953 . . . . 0.34999999999999998 111.081 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -141.25 99.61 3.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.66 -1.237 . . . . 2.8799999999999999 107.66 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.607 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 25.5 m80 -140.02 161.95 36.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.714 -1.217 . . . . 0.68000000000000005 107.714 -165.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.89 130.0 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 119.07 0.85 . . . . 2.04 109.41 172.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -106.99 134.09 50.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.479 1.911 . . . . 1.3 105.947 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 60.64 0.61 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.16 1.541 . . . . 4.6900000000000004 115.16 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -95.75 112.12 23.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.878 -1.156 . . . . 3.1800000000000002 107.878 168.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -88.53 39.31 0.91 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.683 -1.229 . . . . 4.1600000000000001 107.683 160.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -73.9 84.88 1.72 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 122.42 1.105 . . . . 6.8799999999999999 109.009 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -101.45 38.08 1.67 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.933 -1.485 . . . . 7.2300000000000004 107.847 171.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -128.55 -47.81 1.29 Allowed 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.059 0.543 . . . . 5.0 111.784 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.35 -63.8 1.2 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.267 1.027 . . . . 5.0 109.165 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.72 -47.44 0.36 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.343 -0.703 . . . . 4.1299999999999999 111.343 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 32.2 m -147.31 135.05 21.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 104.077 -2.564 . . . . 3.29 104.077 164.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 m -140.43 -13.81 1.0 Allowed 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 114.281 1.215 . . . . 4.9400000000000004 114.281 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.3 t -179.8 55.48 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 116.697 2.11 . . . . 3.2799999999999998 116.697 -115.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -167.28 148.54 5.69 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.395 0.678 . . . . 2.0299999999999998 109.453 158.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.49 -85.5 1.85 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.819 -1.312 . . . . 1.1200000000000001 109.819 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.63 176.66 9.82 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.215 2.61 . . . . 0.89000000000000001 113.217 -174.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 m170 -66.31 123.4 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.107 -1.406 . . . . 1.45 108.119 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -37.19 113.5 0.26 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.092 1.357 . . . . 2.77 111.608 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.5 154.55 25.63 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 124.957 1.303 . . . . 2.5 107.604 168.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.36 -48.6 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.861 1.708 . . . . 1.1000000000000001 111.643 -168.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.38 -79.71 0.62 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.898 0.879 . . . . 3.1400000000000001 109.074 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.3 m -150.8 68.86 0.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.801 0.841 . . . . 1.6499999999999999 110.384 -166.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -78.95 174.92 11.04 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.338 0.589 . . . . 4.0999999999999996 109.417 166.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -124.8 156.01 38.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.376 -1.342 . . . . 3.04 107.376 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -83.15 162.05 21.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.099 0.476 . . . . 0.79000000000000004 111.155 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.41 -126.28 0.87 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.173 -2.771 . . . . 2.0499999999999998 106.173 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.02 -134.22 2.02 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 106.403 -2.679 . . . . 1.24 106.403 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.14 -54.18 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 120.288 2.044 . . . . 1.5600000000000001 109.869 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -60.14 -44.42 94.95 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.952 1.301 . . . . 5.2599999999999998 113.841 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.8 175.75 2.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.905 0.383 . . . . 2.0600000000000001 111.06 -170.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -77.36 -46.85 21.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.048 1.339 . . . . 5.0099999999999998 108.889 167.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.85 172.22 14.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.81 0.844 . . . . 3.1499999999999999 112.144 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 172.17 145.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.234 2.213 . . . . 4.1799999999999997 109.757 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 38.2 m80 -56.18 138.64 49.64 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.905 -1.517 . . . . 0.77000000000000002 106.905 161.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.55 -32.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.293 -0.632 . . . . 1.3799999999999999 109.293 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.87 34.45 5.34 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 116.395 1.318 . . . . 0.79000000000000004 116.395 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -107.1 148.08 29.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.861 1.83 . . . . 1.79 107.402 157.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.62 -49.95 4.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.27 -1.011 . . . . 1.5800000000000001 108.27 141.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.82 -97.16 0.17 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.794 -1.322 . . . . 0.69999999999999996 109.794 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -152.81 169.49 22.65 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.784 1.634 . . . . 1.47 109.574 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.7 175.2 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.331 -1.729 . . . . 0.60999999999999999 106.331 163.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -109.47 143.7 38.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.733 -1.21 . . . . 2.0099999999999998 107.733 162.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.25 151.32 29.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.548 -0.908 . . . . 1.01 108.548 151.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.39 -87.28 0.06 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.328 0.651 . . . . 2.8599999999999999 109.388 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -150.72 -43.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.12 1.368 . . . . 3.8700000000000001 110.848 -170.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.24 8.09 5.45 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.204 1.002 . . . . 2.6699999999999999 111.268 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.29 8.16 87.59 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.169 0.89 . . . . 0.89000000000000001 111.536 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -78.67 135.91 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.015 -1.476 . . . . 0.67000000000000004 107.015 173.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.1 174.42 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.086 0.955 . . . . 0.89000000000000001 109.424 170.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -130.0 117.56 20.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 103.241 -2.874 . . . . 3.6400000000000001 103.241 -174.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.58 112.03 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 105.039 -2.208 . . . . 1.25 105.039 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -148.89 97.23 2.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.816 1.246 . . . . 0.94999999999999996 108.433 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.1 mp -145.28 147.41 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 108.929 -0.767 . . . . 1.75 108.929 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.22 68.49 1.28 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.066 0.946 . . . . 4.21 111.964 173.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.99 157.66 31.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.375 -0.828 . . . . 2.4199999999999999 111.078 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 p -110.36 -11.8 14.49 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.775 2.03 . . . . 1.8899999999999999 113.508 -177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.05 -50.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.923 -1.14 . . . . 1.3200000000000001 107.923 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -77.78 158.95 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 122.357 1.075 . . . . 2.4199999999999999 109.808 171.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.8 p -152.17 174.68 13.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.762 2.425 . . . . 2.1499999999999999 107.553 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -42.61 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.344 1.458 . . . . 2.8599999999999999 109.45 173.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.5 m -119.02 72.21 0.88 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.301 1.44 . . . . 4.4299999999999997 110.899 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -166.63 60.14 0.23 Allowed Glycine 0 CA--C 1.526 0.724 0 CA-C-N 118.616 0.644 . . . . 4.4400000000000004 111.769 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.9 t70 56.49 -76.75 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.671 1.989 . . . . 3.8700000000000001 113.476 172.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -78.07 1.38 21.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.664 1.186 . . . . 4.5999999999999996 111.232 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.17 146.01 0.33 Allowed 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.122 0.969 . . . . 1.4299999999999999 110.824 163.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 115' ' ' ARG . 10.8 pt -79.58 -7.73 10.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 119.295 -0.962 . . . . 2.1899999999999999 111.339 -175.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 tt -44.46 140.91 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.095 1.146 . . . . 1.9399999999999999 114.095 -167.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 56.59 9.32 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.4 -1.08 . . . . 1.8 110.4 -178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 112' ' ' ILE . 0.2 OUTLIER -157.48 175.78 13.51 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.861 2.065 . . . . 4.29 105.706 -174.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -123.35 106.39 10.63 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.501 1.046 . . . . 0.94999999999999996 112.488 -169.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.69 150.02 42.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.194 -0.457 . . . . 1.6699999999999999 110.133 168.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.33 134.45 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.995 1.718 . . . . 0.44 107.124 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 m -103.71 124.66 58.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.265 -1.383 . . . . 1.6000000000000001 107.265 165.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.476 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 60.0 m-70 -97.81 159.42 14.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 116.859 2.17 . . . . 0.42999999999999999 116.859 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -40.62 -69.52 0.13 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.143 2.577 . . . . 3.1099999999999999 111.651 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -113.44 -176.23 2.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.66 0.664 . . . . 3.3900000000000001 109.985 -169.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.7 146.33 41.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.528 -0.545 . . . . 0.59999999999999998 109.528 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 154.47 41.61 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.244 -1.021 . . . . 2.0800000000000001 108.244 157.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -90.81 -6.02 54.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 3.54 113.663 -170.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 65.84 14.49 9.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.365 1.466 . . . . 1.5 113.44 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 39.01 3.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.94 1.257 . . . . 1.6399999999999999 110.999 167.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -141.68 -82.36 0.21 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.346 1.459 . . . . 5.3200000000000003 108.525 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.06 -46.42 0.98 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.66 1.124 . . . . 3.98 114.285 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.53 7.76 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.349 -1.5 . . . . 2.6200000000000001 109.349 -165.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -166.18 -170.39 1.69 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.138 1.775 . . . . 2.5899999999999999 107.347 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -92.87 -47.61 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.831 0.853 . . . . 3.3199999999999998 110.493 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -53.3 -33.76 54.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.929 2.092 . . . . 4.1699999999999999 112.085 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 p -49.73 -70.68 0.08 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.47 1.508 . . . . 2.1800000000000002 110.705 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.6 p -60.06 -45.65 92.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 1.4199999999999999 110.207 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.8 -48.26 75.7 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.373 1.069 . . . . 3.9100000000000001 111.577 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.45 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 54.5 p -132.07 -54.73 0.98 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.386 0.513 . . . . 1.6100000000000001 112.386 -172.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 126.99 106.96 1.45 Allowed Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 104.783 -3.327 . . . . 3.02 104.783 -167.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.45 57.55 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.679 1.592 . . . . 1.95 108.984 -172.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -58.75 -30.84 67.81 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.458 1.503 . . . . 0.89000000000000001 113.438 -176.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.08 50.62 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 107.953 -2.059 . . . . 1.05 107.953 -160.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 t -64.69 162.78 15.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.927 0.891 . . . . 1.8799999999999999 113.289 -165.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -65.75 138.03 57.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.337 1.855 . . . . 2.9300000000000002 109.144 172.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.7 mt -110.75 -78.31 0.59 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.773 1.169 . . . . 0.53000000000000003 108.91 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -109.4 151.7 26.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.878 0.871 . . . . 0.76000000000000001 109.175 174.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.0 p -160.57 173.24 15.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.426 1.89 . . . . 1.3899999999999999 107.367 -177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 167.11 170.88 32.54 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.844 -2.902 . . . . 1.45 105.844 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.6 t -87.49 143.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 119.624 1.712 . . . . 0.78000000000000003 109.082 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.517 HD11 ' CG ' ' A' ' 20' ' ' PHE . 12.8 tt -93.65 127.63 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.92 0.488 . . . . 0.78000000000000003 111.592 171.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.54 14.95 0.11 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.38 1.467 . . . . 1.1000000000000001 114.292 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 mm -101.99 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 120.178 1.989 . . . . 1.03 109.331 -159.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.73 175.11 14.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.836 0.855 . . . . 1.24 109.278 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 104.351 -2.463 . . . . 4.2999999999999998 104.351 162.377 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 106.984 -1.487 . . . . 5.1600000000000001 106.984 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.0 p -71.98 95.33 1.57 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.064 0.946 . . . . 2.5099999999999998 108.568 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 149.46 26.6 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.656 0.662 . . . . 3.6099999999999999 111.181 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.06 138.36 34.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.108 -1.071 . . . . 0.66000000000000003 108.108 165.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.59 142.36 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.953 -1.129 . . . . 0.76000000000000001 107.953 166.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.34 96.07 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.444 -0.947 . . . . 0.47999999999999998 108.444 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.84 107.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.763 -1.569 . . . . 0.87 106.763 159.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -95.21 125.0 39.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.969 -1.123 . . . . 1.01 107.969 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -49.68 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.16 0.584 . . . . 4.8499999999999996 109.872 175.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 36.38 -120.5 0.6 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.42 1.486 . . . . 1.04 112.918 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -93.47 -59.67 1.96 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.342 -0.984 . . . . 3.4100000000000001 108.342 -173.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.39 164.2 5.43 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.512 1.53 . . . . 1.01 114.897 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -79.06 33.48 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.399 3.399 . . . . 1.3200000000000001 112.208 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 27.7 t -111.2 141.61 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 127.171 2.189 . . . . 1.21 105.997 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -139.61 128.89 24.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.776 -1.564 . . . . 2.4300000000000002 106.776 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.17 164.88 31.59 Favored Glycine 0 N--CA 1.45 -0.395 0 O-C-N 121.905 -0.497 . . . . 0.77000000000000002 112.064 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.98 124.57 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.863 -1.162 . . . . 1.28 107.863 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.0 mm -89.39 155.33 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.504 1.122 . . . . 0.94999999999999996 109.061 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 126.57 43.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.516 -0.92 . . . . 2.3300000000000001 108.516 153.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.592 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -106.65 123.25 47.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.462 -2.051 . . . . 2.5299999999999998 105.462 168.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -148.98 139.51 22.56 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.098 -0.705 . . . . 3.4199999999999999 109.098 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 164.91 37.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.618 -1.993 . . . . 3.8999999999999999 105.618 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -54.3 2.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.774 1.23 . . . . 4.4100000000000001 110.34 -177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -79.28 118.74 21.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.257 -1.386 . . . . 4.1699999999999999 107.257 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -76.02 46.09 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.738 1.154 . . . . 2.79 112.7 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.8 t30 179.85 58.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.822 2.449 . . . . 3.79 107.971 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.59 170.59 35.2 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.41 -1.076 . . . . 0.96999999999999997 110.41 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.45 140.24 86.49 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.315 2.677 . . . . 1.2 111.626 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 20' ' ' PHE . 9.6 t -93.67 158.12 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.12 -1.067 . . . . 1.27 108.12 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -107.71 111.75 24.09 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.38 -1.711 . . . . 5.6200000000000001 106.38 162.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' CE1' ' A' ' 20' ' ' PHE . 5.0 t -79.61 135.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.507 -2.034 . . . . 1.1599999999999999 105.507 170.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -139.13 159.64 41.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.644 -1.984 . . . . 0.81000000000000005 105.644 159.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.1 -166.29 14.75 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.201 -1.0 . . . . 1.9199999999999999 110.61 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.0 m -148.22 109.73 4.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.626 -1.99 . . . . 1.6499999999999999 105.626 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -114.81 146.18 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.703 -1.592 . . . . 0.82999999999999996 106.703 -170.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -154.79 170.63 21.17 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 114.127 1.158 . . . . 3.7200000000000002 114.127 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.89 80.45 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.626 1.584 . . . . 0.65000000000000002 112.616 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.1 155.77 26.93 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.833 -0.804 . . . . 0.68999999999999995 110.232 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 165.01 17.71 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.66 -1.237 . . . . 1.6899999999999999 107.66 156.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.66 175.69 0.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.013 0.824 . . . . 2.6099999999999999 111.59 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.34 -162.12 37.22 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.129 0.871 . . . . 0.45000000000000001 113.576 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.49 146.48 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.051 1.74 . . . . 1.9199999999999999 112.962 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -146.97 113.53 5.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.872 1.669 . . . . 0.51000000000000001 109.428 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.92 147.84 4.16 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.745 -0.942 . . . . 0.40999999999999998 110.745 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.54 95.32 2.85 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.791 -1.559 . . . . 2.23 106.791 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.669 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 14.7 m170 -132.18 158.37 41.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.354 -1.721 . . . . 0.64000000000000001 106.354 -165.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.302 0.8 OUTLIER -117.81 115.94 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.546 1.165 . . . . 1.77 110.681 175.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -79.78 158.95 26.72 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.113 1.365 . . . . 0.92000000000000004 109.15 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -28.62 -93.39 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.638 2.775 . . . . 4.9400000000000004 114.998 -158.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.69 74.13 0.05 Allowed 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.1 0.56 . . . . 12.24 110.273 -171.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -149.1 125.41 10.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.428 -0.509 . . . . 8.8800000000000008 111.82 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -90.45 134.46 34.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.64 1.576 . . . . 4.6900000000000004 109.325 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -173.0 53.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.048 1.339 . . . . 4.7199999999999998 107.997 -163.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -77.31 59.4 1.81 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.715 1.206 . . . . 7.1799999999999997 112.861 -166.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 175.14 -65.33 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.925 2.49 . . . . 5.1900000000000004 105.339 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.36 57.29 5.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.722 -1.351 . . . . 4.0800000000000001 109.722 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.3 t -79.62 65.95 4.95 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.219 0.51 . . . . 2.4199999999999999 112.209 -165.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.6 m -165.04 134.38 3.54 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.345 2.258 . . . . 4.96 105.881 167.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.6 m 119.82 152.86 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 104.232 -2.507 . . . . 3.7000000000000002 104.232 -101.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 53.6 93.21 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.258 1.823 . . . . 2.7999999999999998 113.188 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.82 -91.98 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.955 -0.914 . . . . 1.6000000000000001 112.204 -161.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.4 177.51 8.25 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.607 2.872 . . . . 1.3999999999999999 112.925 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -62.3 123.42 18.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.219 -1.4 . . . . 1.28 107.219 168.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -37.9 109.63 0.11 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.422 1.089 . . . . 1.8600000000000001 112.255 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -126.12 145.06 51.0 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 130.792 3.637 . . . . 3.5 107.712 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 -43.0 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.277 1.985 . . . . 1.27 109.028 168.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -155.24 -73.44 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.368 -0.975 . . . . 2.9500000000000002 108.368 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 p -129.49 58.88 1.61 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.471 1.108 . . . . 2.77 110.906 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -79.8 159.84 26.37 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.818 -0.552 . . . . 4.71 109.559 168.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.46 163.02 17.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.375 1.47 . . . . 3.8500000000000001 107.792 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -90.2 153.39 20.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.912 0.885 . . . . 0.82999999999999996 110.329 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.66 -52.4 0.01 OUTLIER Glycine 0 C--O 1.224 -0.521 0 N-CA-C 109.639 -1.384 . . . . 2.77 109.639 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.9 -166.31 21.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.948 1.261 . . . . 1.1699999999999999 111.488 171.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.91 -41.31 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.786 2.324 . . . . 1.3600000000000001 109.155 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -58.78 -58.11 10.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.267 1.427 . . . . 4.9000000000000004 109.91 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.66 152.88 29.72 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.036 -0.983 . . . . 1.9299999999999999 111.269 -167.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -52.18 -45.42 65.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.77 1.628 . . . . 4.0999999999999996 111.479 173.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -77.64 145.67 36.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.505 1.145 . . . . 2.6499999999999999 110.256 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.27 151.56 2.07 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.369 1.868 . . . . 3.1099999999999999 108.848 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 49.4 m80 -60.94 143.63 54.72 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.785 -1.561 . . . . 0.53000000000000003 106.785 163.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.97 -30.73 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.167 -0.613 . . . . 1.3700000000000001 110.947 -165.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.69 67.51 0.31 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 112.157 -0.377 . . . . 0.89000000000000001 112.157 167.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.29 114.37 3.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.419 -1.048 . . . . 2.1899999999999999 108.862 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.03 -53.93 3.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.248 0.619 . . . . 2.0600000000000001 110.121 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.76 -110.41 0.42 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.112 -0.566 . . . . 0.55000000000000004 111.822 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -148.58 167.58 25.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.04 1.736 . . . . 1.46 109.479 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.5 m -117.63 175.23 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.362 -1.718 . . . . 0.48999999999999999 106.362 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.9 t -109.43 150.48 28.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.264 -1.384 . . . . 2.2599999999999998 107.264 159.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.03 152.83 32.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.64 -0.874 . . . . 1.04 108.64 157.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -79.88 -83.47 0.1 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.781 1.232 . . . . 3.7200000000000002 108.984 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -151.29 -48.47 0.12 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.175 0.99 . . . . 3.9500000000000002 110.968 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.37 24.91 0.65 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.439 1.59 . . . . 2.7200000000000002 111.13 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.36 14.39 61.94 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.063 1.316 . . . . 0.70999999999999996 111.889 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.88 152.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 125.193 1.397 . . . . 0.92000000000000004 107.749 175.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.41 172.35 15.07 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.16 1.384 . . . . 0.88 107.729 168.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -132.85 162.66 30.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.89 -2.263 . . . . 3.3999999999999999 104.89 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.54 55.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 O-C-N 124.184 0.928 . . . . 1.8700000000000001 112.423 174.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.3 m -70.4 101.29 1.92 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.741 -0.599 . . . . 0.98999999999999999 110.845 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.07 157.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.835 -0.802 . . . . 1.76 108.835 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -139.09 129.16 25.19 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.613 -0.884 . . . . 3.6200000000000001 108.613 159.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -134.68 151.48 51.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.695 1.598 . . . . 2.3599999999999999 108.492 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 p -107.59 -3.51 19.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.275 1.83 . . . . 1.45 113.28 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.94 -42.56 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.364 -1.347 . . . . 1.1599999999999999 107.364 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.497 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.2 pp -74.69 177.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.519 0.676 . . . . 1.79 111.546 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.9 m -161.21 179.32 8.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.833 2.453 . . . . 1.9399999999999999 106.434 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 70.4 1.08 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.118 -2.179 . . . . 2.8399999999999999 105.118 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 t -145.4 -72.12 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.638 -0.71 . . . . 3.96 110.513 170.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 167.37 -146.09 10.39 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 106.924 -2.47 . . . . 3.46 106.924 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.1 t70 55.1 -101.77 0.13 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.21 1.004 . . . . 3.8599999999999999 110.417 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -76.51 -34.88 58.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.108 0.963 . . . . 4.04 110.736 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.5 p -72.75 176.56 5.47 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.486 1.136 . . . . 2.0699999999999998 112.887 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.507 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -86.95 -6.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.065 -0.971 . . . . 1.6899999999999999 112.081 -170.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.463 ' HA ' HG23 ' A' ' 149' ' ' ILE . 24.2 mm -59.38 124.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.455 -0.943 . . . . 2.6200000000000001 108.455 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.79 3.56 76.91 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.447 1.022 . . . . 1.3200000000000001 113.256 -172.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -113.03 163.48 14.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.285 1.543 . . . . 4.46 109.771 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -93.15 89.79 6.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.833 1.253 . . . . 2.54 110.252 -157.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.33 143.98 56.27 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.329 -0.857 . . . . 1.8100000000000001 109.848 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -135.19 133.45 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.281 1.832 . . . . 0.46000000000000002 109.046 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -94.38 121.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 125.858 1.663 . . . . 2.4500000000000002 107.706 163.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.568 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 90.3 m-70 -98.56 167.28 10.91 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 117.608 2.447 . . . . 0.48999999999999999 117.608 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -81.3 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.325 1.85 . . . . 4.0199999999999996 110.314 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -178.26 6.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.595 0.634 . . . . 4.6100000000000003 109.878 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.63 151.03 30.07 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.141 -1.429 . . . . 0.55000000000000004 107.141 153.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -76.74 151.7 35.93 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.473 -1.306 . . . . 1.99 107.473 158.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -70.27 -25.56 63.41 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.0 -0.437 . . . . 3.1400000000000001 111.529 -169.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 50.0 7.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.043 0.937 . . . . 2.0800000000000001 109.93 -159.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 52.53 39.72 53.73 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.306 0.955 . . . . 1.6000000000000001 113.263 167.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -80.01 -18.61 49.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.681 0.792 . . . . 5.3700000000000001 111.394 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.44 -143.09 16.3 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.83 -0.508 . . . . 2.4399999999999999 111.83 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.77 -77.05 0.4 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.577 -1.409 . . . . 2.27 109.577 -172.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.86 104.03 14.46 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.012 -1.477 . . . . 2.8399999999999999 107.012 167.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.56 -33.55 22.23 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.763 1.165 . . . . 5.1600000000000001 112.986 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -37.07 -36.71 0.13 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.319 1.048 . . . . 3.02 113.694 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.8 t -36.35 -66.99 0.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.903 2.081 . . . . 2.27 111.023 167.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.28 -46.15 51.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.145 0.978 . . . . 1.49 110.583 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -53.01 -52.27 58.96 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.585 0.754 . . . . 3.0099999999999998 111.328 -168.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.492 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.278 5.4 p -126.51 -48.51 1.54 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.675 -0.679 . . . . 1.3100000000000001 112.277 174.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 159.42 -21.06 0.28 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 120.052 1.296 . . . . 1.01 114.039 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.17 56.32 5.96 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.796 1.238 . . . . 2.1800000000000002 111.349 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -67.28 0.49 2.78 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.509 0.929 . . . . 1.0700000000000001 113.509 169.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -71.13 2.99 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.297 -1.502 . . . . 3.3799999999999999 110.315 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 t -166.33 -174.41 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.529 0.732 . . . . 1.8200000000000001 110.975 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.31 139.06 31.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.496 2.718 . . . . 2.8900000000000001 109.522 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.4 mt -113.26 -88.28 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.298 0.954 . . . . 0.93999999999999995 109.685 169.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.31 154.43 21.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.598 -0.89 . . . . 1.02 108.598 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.6 p -157.58 170.98 21.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 123.753 0.658 . . . . 1.51 110.598 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 172.62 155.42 11.31 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.484 -1.446 . . . . 1.0600000000000001 109.484 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.0 137.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.611 0.705 . . . . 1.48 109.459 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.507 HG21 HG12 ' A' ' 112' ' ' ILE . 13.1 tt -86.45 143.65 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.72999999999999998 110.935 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.04 5.56 3.03 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.62 1.105 . . . . 0.57999999999999996 114.219 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.4 mm -96.05 56.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 119.289 1.544 . . . . 0.94999999999999996 109.926 -156.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.49 176.52 12.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.547 0.739 . . . . 1.3 110.578 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.483 ' NE2' ' H ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.313 0 N-CA-C 103.999 -2.593 . . . . 5.0599999999999996 103.999 154.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 107.171 -1.418 . . . . 7.54 107.171 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.9 p -151.85 -178.16 6.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.934 1.294 . . . . 4.8200000000000003 107.654 -176.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -75.73 176.18 7.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.798 -1.186 . . . . 2.9900000000000002 107.798 157.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.414 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -115.39 144.8 43.26 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.055 -1.461 . . . . 0.78000000000000003 107.055 164.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.9 t -119.91 141.38 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 107.571 -1.27 . . . . 0.87 107.571 171.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.19 99.82 6.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.173 1.389 . . . . 0.55000000000000004 108.286 159.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.83 98.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.65 -1.241 . . . . 0.58999999999999997 107.65 163.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.0 mt -84.61 126.82 33.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.188 0.595 . . . . 0.81000000000000005 109.564 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -143.72 -48.3 0.29 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.72 0.808 . . . . 3.75 110.91 170.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.43 -123.68 5.24 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.432 -1.067 . . . . 0.82999999999999996 110.432 -171.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -107.1 -52.57 2.74 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.712 0.756 . . . . 4.0199999999999996 110.707 -173.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.56 156.58 5.71 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.913 1.244 . . . . 0.78000000000000003 111.702 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.14 39.65 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.372 3.381 . . . . 1.1899999999999999 113.23 -170.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 63.5 t -101.47 155.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.761 2.025 . . . . 0.80000000000000004 107.644 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.12 125.02 9.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.967 -1.494 . . . . 2.5 106.967 175.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.81 165.91 35.33 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.268 -0.733 . . . . 0.51000000000000001 111.268 177.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.09 115.18 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.009 -1.849 . . . . 1.6000000000000001 106.009 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.4 mm -78.65 145.83 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.273 -1.38 . . . . 0.75 107.273 168.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -123.41 107.62 11.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.878 -1.897 . . . . 2.0299999999999998 105.878 163.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CE1' HG22 ' A' ' 31' ' ' VAL . 1.3 m-85 -89.55 93.16 9.39 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.265 -2.124 . . . . 2.8999999999999999 105.265 164.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -96.11 134.87 38.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.106 -0.702 . . . . 3.5600000000000001 109.106 177.483 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -145.95 83.31 1.63 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.104 -0.953 . . . . 3.71 110.931 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -50.39 -45.13 55.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.721 -0.672 . . . . 6.7699999999999996 111.012 157.036 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -85.33 73.48 10.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.852 -1.166 . . . . 4.7400000000000002 107.852 -175.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 79.78 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.473 0.709 . . . . 4.1600000000000001 109.614 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -162.72 -53.69 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.61 1.564 . . . . 5.6299999999999999 109.513 -162.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.08 -85.31 0.06 OUTLIER Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.762 -1.209 . . . . 2.0899999999999999 112.761 -170.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.21 115.64 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.363 2.708 . . . . 1.8400000000000001 111.593 -174.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.51 HG11 ' CD2' ' A' ' 20' ' ' PHE . 23.2 t -87.5 165.48 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.861 -1.162 . . . . 1.0600000000000001 107.861 172.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.162 -1.792 . . . . 3.9399999999999999 106.162 168.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.525 HG22 ' CE1' ' A' ' 20' ' ' PHE . 10.0 t -89.67 131.49 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.96 -1.496 . . . . 1.0900000000000001 106.96 174.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -136.93 161.9 34.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.26 -1.385 . . . . 0.87 107.26 153.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.09 146.16 7.06 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.998 . . . . 0.84999999999999998 108.105 178.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -119.81 66.94 0.81 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.672 1.989 . . . . 1.6299999999999999 107.16 -171.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.73 115.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.47 -1.241 . . . . 1.21 107.96 -167.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -110.27 154.36 23.56 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.424 0.69 . . . . 3.7000000000000002 111.616 -173.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.64 68.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.641 -0.709 . . . . 0.73999999999999999 114.31 172.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -59.28 164.28 3.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.945 1.373 . . . . 0.68999999999999995 109.078 163.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.28 160.22 19.18 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.719 -1.238 . . . . 1.75 107.836 154.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -58.85 171.33 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.367 -0.833 . . . . 2.6000000000000001 110.289 175.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.0 -157.27 48.42 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 121.94 -0.475 . . . . 0.46000000000000002 112.96 167.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.98 141.92 38.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.207 1.003 . . . . 2.3999999999999999 111.059 -167.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -143.99 119.62 10.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.241 1.016 . . . . 0.45000000000000001 110.537 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.3 147.9 16.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.708 -0.957 . . . . 0.45000000000000001 110.708 172.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.41 91.85 2.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.361 1.064 . . . . 2.4100000000000001 108.167 -173.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.583 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 21.3 m170 -130.86 158.27 40.64 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.81999999999999995 109.828 -160.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.42 117.0 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.295 -0.632 . . . . 2.4700000000000002 109.295 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -107.6 139.57 41.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.959 -1.126 . . . . 1.05 107.959 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -73.01 66.16 0.79 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.242 0.83 . . . . 5.1900000000000004 113.242 -171.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' CD ' HH22 ' A' ' 143' ' ' ARG . 2.4 mt-10 -119.7 78.25 1.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.123 0.969 . . . . 3.0 110.541 -173.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -80.93 -85.85 0.09 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.062 0.545 . . . . 5.1100000000000003 110.19 171.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -82.24 70.81 9.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.834 0.826 . . . . 6.0300000000000002 110.834 -170.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -104.67 -60.05 1.65 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.336 1.054 . . . . 4.2400000000000002 109.381 169.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 t -178.86 -46.4 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.349 1.46 . . . . 4.3200000000000003 109.935 -175.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -179.18 -42.51 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.814 1.246 . . . . 6.6100000000000003 110.83 -174.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.09 -93.18 2.11 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.04 0.829 . . . . 4.4100000000000001 111.747 -174.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m -148.43 148.75 30.66 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 117.982 -1.008 . . . . 2.54 108.442 -167.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 p -152.7 -4.91 0.22 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.522 1.304 . . . . 4.54 114.522 164.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.1 t 173.15 40.92 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.297 -1.502 . . . . 3.23 113.28 -115.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.91 146.91 16.35 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.634 -1.617 . . . . 1.9399999999999999 106.634 166.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.5 -96.27 2.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.485 -1.846 . . . . 1.1699999999999999 108.485 -177.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.47 177.8 6.34 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.281 2.654 . . . . 1.0 113.23 -177.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -69.07 131.77 45.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 115.968 -1.968 . . . . 1.6499999999999999 105.852 170.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -33.93 107.91 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.865 1.666 . . . . 3.1499999999999999 114.337 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.41 127.73 30.89 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 126.521 1.928 . . . . 3.1699999999999999 107.31 167.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.49 -40.68 13.45 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.595 1.53 . . . . 1.76 109.133 173.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 tt -146.69 -60.56 0.3 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.159 -1.793 . . . . 3.54 106.159 164.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.6 p -151.38 80.28 1.3 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.49 0.716 . . . . 2.6600000000000001 109.948 -178.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -80.03 163.58 24.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.392 -0.966 . . . . 4.7699999999999996 108.392 158.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -108.14 166.21 10.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.32 -1.363 . . . . 3.54 107.32 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.437 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 46.0 t60 -80.1 160.95 25.58 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.81999999999999995 110.148 175.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.19 -149.33 7.98 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 104.769 -3.332 . . . . 2.1299999999999999 104.769 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.69 -146.45 4.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.462 1.631 . . . . 1.3300000000000001 109.041 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.9 -36.88 21.59 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.321 2.014 . . . . 1.48 111.132 -177.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.61 -44.05 91.8 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.627 0.371 . . . . 4.8200000000000003 111.104 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.43 164.13 26.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.625 0.726 . . . . 1.9299999999999999 112.042 -169.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -77.74 -45.63 24.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.158 1.383 . . . . 4.1500000000000004 108.971 165.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -78.27 168.59 19.6 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.987 0.899 . . . . 3.25 109.84 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 153.62 142.75 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 130.524 3.53 . . . . 3.0 105.454 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 61.0 m80 -59.58 151.02 25.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.649 -0.82 . . . . 0.78000000000000003 109.313 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -71.31 -4.77 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.258 -0.901 . . . . 1.51 111.121 -172.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -122.99 70.2 0.44 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.995 1.283 . . . . 1.0 109.947 159.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.92 122.28 0.7 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.64 -1.244 . . . . 2.1400000000000001 107.64 -177.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.33 -38.06 8.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.772 0.829 . . . . 1.8100000000000001 110.204 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.87 -129.29 3.24 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.086 -2.006 . . . . 0.82999999999999996 108.086 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -131.05 170.6 14.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.134 1.374 . . . . 1.77 110.382 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.09 175.71 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.352 1.461 . . . . 0.79000000000000004 107.244 171.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -124.89 126.76 46.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.937 -1.135 . . . . 2.1200000000000001 107.937 175.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.48 139.53 31.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.754 0.822 . . . . 0.63 111.337 171.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -74.26 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 O-C-N 124.305 1.003 . . . . 3.0899999999999999 110.508 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 93' ' ' GLY . 46.6 tttt -149.84 -35.44 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.786 1.032 . . . . 3.23 113.786 -164.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -80.89 22.17 0.63 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 124.047 1.879 . . . . 3.9300000000000002 110.191 165.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 57.9 25.83 56.95 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 125.124 1.345 . . . . 1.0900000000000001 111.069 -170.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.9 t -83.78 106.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.396 1.079 . . . . 1.1599999999999999 108.169 -175.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.8 167.66 11.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.977 -1.12 . . . . 0.96999999999999997 107.977 158.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -128.07 139.6 52.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 103.399 -2.815 . . . . 3.0899999999999999 103.399 176.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.08 55.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 123.861 0.726 . . . . 2.02 111.775 179.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.6 m -74.89 101.57 4.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.389 0.676 . . . . 1.05 110.767 170.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.1 mt -140.94 156.01 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.93 0.786 . . . . 1.8700000000000001 109.626 177.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.27 72.22 1.37 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.345 1.458 . . . . 4.96 111.22 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.49 134.68 37.29 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.403 -0.811 . . . . 2.1699999999999999 109.454 177.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 p -92.72 -9.97 38.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.424 1.49 . . . . 1.6599999999999999 112.894 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.4 t -85.63 -46.09 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.404 -0.962 . . . . 1.48 108.404 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.6 pp -70.8 177.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.097 0.475 . . . . 1.1200000000000001 111.922 176.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.5 t -153.12 175.07 13.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.609 1.964 . . . . 2.98 105.808 172.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.45 0.68 17.9 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.036 0.935 . . . . 2.4100000000000001 111.399 162.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.9 m -121.94 -49.71 2.08 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.246 1.418 . . . . 3.5899999999999999 110.74 -173.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.08 158.73 37.6 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.739 -0.544 . . . . 3.3300000000000001 111.739 -174.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.46 -49.5 5.28 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.176 1.79 . . . . 4.8399999999999999 112.229 -177.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.65 4.07 19.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.108 1.363 . . . . 4.9699999999999998 113.516 -174.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 p -50.32 175.38 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.509 1.67 . . . . 1.49 115.509 -173.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.66 -14.54 12.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 114.122 -1.399 . . . . 2.73 112.392 170.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.2 tp -50.04 123.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 124.066 0.946 . . . . 2.1499999999999999 110.297 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.9 86.77 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.215 -0.769 . . . . 1.3600000000000001 114.198 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.7 175.99 9.41 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.148 1.974 . . . . 5.6699999999999999 109.341 178.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.85 123.69 50.89 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.578 1.081 . . . . 1.9399999999999999 108.594 167.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.85 144.92 40.95 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.301 -1.37 . . . . 1.52 107.301 167.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -129.75 134.93 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.195 1.798 . . . . 0.41999999999999998 107.59 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.82 128.44 58.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.729 -1.212 . . . . 1.6899999999999999 107.729 167.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.497 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 53.6 m-70 -104.3 158.13 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 116.827 2.158 . . . . 0.63 116.827 -171.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -41.33 -68.87 0.16 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.724 2.81 . . . . 3.04 111.355 172.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -111.27 -175.06 2.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.1 -0.704 . . . . 2.8900000000000001 109.1 -171.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.97 141.04 47.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.053 -1.091 . . . . 0.89000000000000001 108.053 165.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.66 165.46 14.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.994 -0.682 . . . . 2.5600000000000001 109.604 154.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.53 -48.66 74.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.525 -0.761 . . . . 3.54 113.048 -173.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 77.08 52.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.289 1.836 . . . . 1.6799999999999999 111.021 -159.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 27.16 64.42 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.408 1.004 . . . . 1.6399999999999999 114.889 152.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -85.35 -33.14 22.1 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.081 1.352 . . . . 5.9199999999999999 108.673 169.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.43 -80.67 1.6 Allowed Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.633 -1.787 . . . . 2.7200000000000002 108.633 -178.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.85 -73.92 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.294 0.95 . . . . 2.7799999999999998 110.861 -175.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -75.46 -116.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.097 -1.446 . . . . 2.8900000000000001 107.097 157.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.15 -40.3 0.06 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.069 1.304 . . . . 4.2400000000000002 112.912 173.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -43.21 -43.61 4.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.806 1.242 . . . . 3.8399999999999999 111.504 175.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.9 m -33.28 -63.66 0.23 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.095 2.558 . . . . 2.5 113.483 163.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.08 -46.28 57.44 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.119 -0.988 . . . . 1.97 112.052 175.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -53.03 -49.46 66.25 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.395 0.543 . . . . 3.5600000000000001 110.821 -173.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -129.67 -46.21 1.17 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.662 0.785 . . . . 1.45 110.991 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.21 -31.74 0.79 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.241 0.448 . . . . 1.1699999999999999 112.12 -175.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 48.19 54.66 9.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.926 1.29 . . . . 2.7799999999999998 110.259 -165.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.583 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -51.46 -35.35 39.34 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.921 1.688 . . . . 1.3899999999999999 113.71 174.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.52 -179.04 49.1 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 108.464 -1.854 . . . . 0.98999999999999999 108.464 -159.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -62.43 153.3 31.77 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.263 1.425 . . . . 1.6200000000000001 112.736 -164.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.436 HH22 ' CD ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -77.07 133.71 38.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.8 1.24 . . . . 2.6800000000000002 108.664 179.137 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.0 mt -111.02 -70.39 0.82 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.093 -1.077 . . . . 0.53000000000000003 108.093 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -131.97 148.37 52.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.614 0.766 . . . . 0.88 110.047 -173.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.3 p -160.28 173.79 15.17 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 125.191 1.557 . . . . 1.55 109.415 -176.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.64 135.04 2.5 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.71 -2.156 . . . . 0.68999999999999995 107.71 -176.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.1 t -60.5 133.79 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.495 0.718 . . . . 0.80000000000000004 109.074 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.22 136.08 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.28 0.562 . . . . 0.80000000000000004 112.204 -174.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 137.25 -3.02 3.28 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.812 1.196 . . . . 0.55000000000000004 114.029 175.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.4 mp -95.3 61.26 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 122.784 1.278 . . . . 1.45 107.832 -157.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.25 37.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.93 -1.032 . . . . 2.6400000000000001 112.696 -173.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 C--O 1.25 1.104 0 N-CA-C 101.813 -3.403 . . . . 8.6500000000000004 101.813 150.662 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.375 -0.602 . . . . 7.5700000000000003 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.1 m -100.04 159.02 15.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.957 -1.497 . . . . 3.9399999999999999 106.957 171.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -78.13 154.28 31.38 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.946 -1.131 . . . . 4.79 107.946 167.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.53 149.12 47.27 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.856 -0.794 . . . . 0.82999999999999996 108.856 157.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 t -119.59 145.48 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.856 -1.164 . . . . 1.0600000000000001 107.856 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.11 97.14 5.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.648 -0.871 . . . . 0.65000000000000002 108.648 159.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.43 105.33 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.264 -1.384 . . . . 0.67000000000000004 107.264 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.22 124.48 37.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.99 -0.745 . . . . 0.85999999999999999 108.99 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -137.97 -60.16 0.64 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.75 0.42 . . . . 3.3100000000000001 110.001 174.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.78 -122.1 6.43 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.201 0.905 . . . . 0.79000000000000004 111.989 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -115.14 -50.48 2.75 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 124.932 1.293 . . . . 3.02 109.475 -163.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.31 153.95 9.18 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.735 -1.346 . . . . 0.71999999999999997 109.735 171.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.69 41.91 1.15 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.425 2.75 . . . . 0.98999999999999999 113.279 -166.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.62 155.91 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.329 1.852 . . . . 1.1499999999999999 108.945 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.39 81.57 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.133 -1.432 . . . . 2.3900000000000001 107.133 172.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.23 163.66 13.96 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.398 -0.681 . . . . 0.46999999999999997 111.398 -173.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.75 124.56 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.417 -0.957 . . . . 1.1200000000000001 108.417 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -88.82 135.31 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.421 1.089 . . . . 0.91000000000000003 108.326 164.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.48 110.38 22.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.801 1.64 . . . . 2.9199999999999999 108.086 159.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.42 111.88 23.57 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.11 -1.811 . . . . 2.3999999999999999 106.11 166.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -117.41 140.13 49.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.852 0.72 . . . . 2.9399999999999999 110.167 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -156.62 141.57 17.13 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.781 0.832 . . . . 4.0899999999999999 110.569 170.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -70.42 -67.06 0.52 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.44 0.696 . . . . 4.79 109.529 170.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -76.85 -178.7 5.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 120.076 1.307 . . . . 3.8100000000000001 111.854 -170.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -65.57 -65.95 0.61 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.882 1.273 . . . . 2.4399999999999999 110.401 172.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -125.65 92.52 3.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.892 0.877 . . . . 4.1699999999999999 109.526 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.25 177.35 27.5 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 108.28 -1.928 . . . . 1.0600000000000001 108.28 170.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.44 111.59 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.51 2.806 . . . . 1.3 112.094 -175.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.31 132.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.075 -1.083 . . . . 0.83999999999999997 108.075 -169.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -87.23 101.17 13.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.201 -1.777 . . . . 3.6600000000000001 106.201 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.1 124.37 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.282 -1.747 . . . . 1.23 106.282 176.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -131.83 136.35 47.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.047 -1.834 . . . . 1.0700000000000001 106.047 159.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.28 150.97 23.21 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.539 -1.824 . . . . 0.71999999999999997 108.539 -174.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.1 m -128.95 101.43 6.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.73 -2.322 . . . . 1.8600000000000001 104.73 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.97 144.59 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.074 -1.454 . . . . 0.81000000000000005 107.074 -169.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -154.83 143.73 20.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.475 0.546 . . . . 3.8199999999999998 112.475 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.89 25.79 8.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.877 2.179 . . . . 0.98999999999999999 112.712 -177.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.31 -155.78 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.431 -0.952 . . . . 1.1899999999999999 108.431 164.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -135.65 168.43 19.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.622 -2.733 . . . . 2.5499999999999998 103.622 165.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.16 169.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.277 1.399 . . . . 3.1899999999999999 114.099 -172.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.36 -165.98 48.9 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.592 -1.185 . . . . 0.5 113.195 169.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.51 143.7 57.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.403 1.481 . . . . 1.8200000000000001 113.104 -174.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -143.15 114.82 8.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.074 1.749 . . . . 0.44 108.69 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.61 145.16 2.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.33 -1.108 . . . . 0.33000000000000002 110.33 169.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.456 ' CE2' HG12 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -137.58 95.11 3.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.738 -1.579 . . . . 2.46 106.738 -176.64 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.3 m80 -134.98 154.51 51.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.362 -1.347 . . . . 0.65000000000000002 107.362 -164.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.264 2.6 p -107.08 108.66 25.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 CA-C-O 122.396 1.093 . . . . 1.8899999999999999 108.782 172.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.515 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 12.4 m-70 -77.47 156.44 31.05 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.39 -1.707 . . . . 0.97999999999999998 106.39 172.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -81.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.908 0.483 . . . . 5.5099999999999998 110.261 -178.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . 30.5 tt0 11.25 76.66 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 C-N-CA 127.853 2.461 . . . . 4.4900000000000002 114.403 -169.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -80.75 57.25 2.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.175 0.99 . . . . 4.2599999999999998 109.438 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -159.72 153.99 23.68 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.536 1.534 . . . . 5.29 108.46 166.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.75 -3.85 4.68 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.246 1.419 . . . . 5.9500000000000002 113.283 165.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.43 -40.53 61.9 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 120.546 1.521 . . . . 4.21 111.19 -177.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.67 78.8 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.252 0.621 . . . . 6.2800000000000002 111.623 -177.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.91 98.75 2.37 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 107.138 -2.385 . . . . 3.9900000000000002 107.138 -167.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.83 114.79 4.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.715 0.257 . . . . 3.1800000000000002 110.787 -171.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 m -149.73 -77.09 0.15 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.225 -0.922 . . . . 4.2999999999999998 110.826 177.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.378 0.4 OUTLIER 26.73 -61.99 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 1 N-CA-C 123.074 4.472 . . . . 2.9500000000000002 123.074 143.463 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . . . -36.42 142.49 0.09 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 118.556 2.799 . . . . 2.3700000000000001 118.556 -157.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.48 -177.66 14.05 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 114.235 -1.348 . . . . 2.0899999999999999 110.914 164.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.61 -179.99 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.977 3.785 . . . . 1.1399999999999999 113.612 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -47.07 107.19 0.1 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.844 1.258 . . . . 1.1499999999999999 109.063 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -34.27 104.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.278 1.431 . . . . 2.4100000000000001 111.935 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -122.79 141.58 35.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 129.55 3.14 . . . . 3.48 108.197 -174.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.91 -51.71 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.017 1.811 . . . . 1.01 109.085 173.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.19 -75.4 0.37 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.299 1.04 . . . . 2.6000000000000001 108.558 169.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -136.32 60.63 1.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.006 0.522 . . . . 1.6299999999999999 111.613 -159.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -78.74 164.04 24.89 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.702 -1.222 . . . . 4.0300000000000002 107.702 162.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -127.66 173.62 9.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.643 . . . . 4.6100000000000003 107.142 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.518 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 35.8 t60 -93.85 157.69 16.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.97 0.73 . . . . 0.81999999999999995 112.97 -167.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.41 -147.77 7.79 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 105.734 -2.946 . . . . 2.1099999999999999 105.734 166.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.89 -170.4 30.77 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.051 -2.42 . . . . 1.8300000000000001 107.051 176.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.29 -23.84 71.62 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.092 2.528 . . . . 2.1499999999999999 113.667 -176.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -70.37 -34.37 72.52 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.963 -0.461 . . . . 5.2400000000000002 111.264 173.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.52 176.65 8.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.562 1.545 . . . . 1.8899999999999999 110.585 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -83.93 -47.91 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.926 1.29 . . . . 4.3200000000000003 109.145 164.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -88.69 166.39 14.11 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.592 1.157 . . . . 3.2400000000000002 111.073 -166.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 168.95 146.1 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.51 2.324 . . . . 5.7599999999999998 108.773 -173.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 42.1 m80 -63.25 148.75 47.31 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 106.278 -1.749 . . . . 0.52000000000000002 106.278 166.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 -45.84 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 119.224 -0.99 . . . . 1.5 108.389 -176.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.6 59.71 4.8 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.618 -0.677 . . . . 0.78000000000000003 113.187 171.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 80' ' ' HIS . 1.3 t0 -168.94 120.22 0.75 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.656 -1.238 . . . . 2.0 107.656 -172.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.39 -51.56 3.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.18 0.992 . . . . 2.2799999999999998 109.186 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.95 -116.49 0.71 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.642 -0.983 . . . . 0.56999999999999995 110.642 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -144.66 167.5 22.4 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.876 1.27 . . . . 1.71 109.677 177.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.11 175.54 5.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 N-CA-C 106.522 -1.659 . . . . 0.53000000000000003 106.522 167.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -106.97 147.25 30.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.264 -1.384 . . . . 2.27 107.264 158.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.01 30.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.639 -0.875 . . . . 0.88 108.639 155.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -73.2 -78.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.227 1.011 . . . . 3.3199999999999998 109.736 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -152.95 -52.37 0.11 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.532 1.533 . . . . 4.5700000000000003 108.491 178.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.48 17.7 1.68 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.903 1.681 . . . . 4.4800000000000004 111.541 -171.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.98 15.11 81.95 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.084 1.326 . . . . 0.70999999999999996 111.337 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.77 149.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.21 -1.404 . . . . 1.0 107.21 171.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.77 24.85 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.232 1.013 . . . . 0.69999999999999996 108.343 169.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.33 145.91 50.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.027 -2.212 . . . . 2.79 105.027 -174.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.13 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.841 0.713 . . . . 1.8 111.3 178.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.5 m -76.07 96.78 3.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.387 1.075 . . . . 0.81000000000000005 110.85 170.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.7 mt -132.45 153.94 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 1.5900000000000001 109.064 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -126.08 84.01 2.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.103 0.561 . . . . 3.0499999999999998 110.47 166.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -79.5 121.76 25.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.89 0.476 . . . . 2.9900000000000002 109.728 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.5 p -84.6 -17.33 39.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.286 1.834 . . . . 1.79 112.57 178.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.2 t -83.64 -51.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.908 0.776 . . . . 1.03 110.05 -170.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.435 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.9 pp -75.55 177.04 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.261 0.553 . . . . 1.03 110.863 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.0 m -155.97 175.84 13.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.898 1.279 . . . . 1.98 108.1 171.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 47.66 2.09 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.891 1.276 . . . . 2.5800000000000001 111.705 -175.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -121.38 155.88 33.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.856 -1.905 . . . . 2.77 105.856 171.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.09 63.95 2.42 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.281 0.946 . . . . 3.5899999999999999 112.175 -171.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -128.27 -113.18 0.27 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.373 1.469 . . . . 6.21 108.515 -169.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -87.22 0.9 54.64 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.644 1.978 . . . . 5.7800000000000002 111.662 176.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 p -62.35 166.32 5.16 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.094 1.358 . . . . 1.49 113.007 -166.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -79.69 -27.41 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.943 -1.026 . . . . 1.97 110.443 172.142 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -32.12 108.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.133 2.173 . . . . 2.5600000000000001 111.247 177.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.88 -20.13 10.91 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.419 1.485 . . . . 1.55 112.816 -174.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -103.06 160.13 14.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.961 1.881 . . . . 4.6399999999999997 113.002 -165.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 146' ' ' CYS . 1.3 m -75.81 102.09 5.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.354 1.062 . . . . 1.1699999999999999 111.028 -172.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -68.71 144.96 54.25 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.335 -0.853 . . . . 1.6599999999999999 108.938 168.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -136.1 140.59 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.703 1.601 . . . . 0.44 108.99 -172.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 45' ' ' PHE . 2.2 m -111.38 125.45 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.203 1.401 . . . . 1.75 107.445 166.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.529 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 60.1 m-70 -101.63 165.25 11.33 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.727 1.751 . . . . 0.39000000000000001 115.727 -172.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' CG ' ' HD3' ' A' ' 122' ' ' LYS . 8.1 pt-20 -67.86 -53.41 26.94 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.469 1.108 . . . . 3.4300000000000002 112.444 -174.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.484 ' HD3' ' CG ' ' A' ' 121' ' ' GLU . 1.9 mppt? -101.09 -176.17 3.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.227 1.376 . . . . 2.8300000000000001 109.039 175.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.11 165.97 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.838 -0.801 . . . . 0.67000000000000004 108.838 156.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -84.39 167.06 16.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.421 0.688 . . . . 1.98 109.383 156.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.29 -7.15 59.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.627 1.171 . . . . 3.0299999999999998 111.881 -175.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 53.14 33.18 14.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.351 1.06 . . . . 1.3500000000000001 110.241 -170.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.57 20.52 52.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.798 0.713 . . . . 1.5900000000000001 112.635 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -135.14 50.3 2.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.292 1.437 . . . . 6.1500000000000004 107.446 -173.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.38 147.23 19.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 106.94 -2.464 . . . . 2.46 106.94 173.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.4 60.3 4.3 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.435 0.618 . . . . 2.2599999999999998 112.631 -167.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.88 163.22 35.76 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 107.325 -1.361 . . . . 2.8300000000000001 107.325 172.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.26 -52.37 62.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.004 -0.739 . . . . 3.1099999999999999 109.004 168.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -46.65 -42.57 16.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.518 1.527 . . . . 2.9300000000000002 111.847 -171.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 m -40.17 -63.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.866 2.066 . . . . 2.0299999999999998 112.113 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.2 t -74.95 -45.74 40.29 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.867 -0.521 . . . . 2.71 111.598 175.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.85 -48.22 67.21 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.713 1.605 . . . . 2.7999999999999998 111.492 -169.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.0 p -127.77 -46.73 1.41 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.778 0.431 . . . . 1.3899999999999999 111.493 174.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.518 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 157.54 -27.73 0.48 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 123.169 0.414 . . . . 1.0800000000000001 113.71 -178.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 51.6 t30 48.71 53.77 11.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 1.9199999999999999 110.216 -165.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.576 1.15 . . . . 1.0900000000000001 112.012 167.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.09 179.02 51.73 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 108.765 -1.734 . . . . 1.0 108.765 -161.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -53.79 155.72 3.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.791 -1.204 . . . . 1.6699999999999999 112.04 -175.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -92.93 144.49 25.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.615 1.966 . . . . 3.8500000000000001 109.519 -177.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt -114.43 -69.28 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.814 -1.18 . . . . 0.63 107.814 -173.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 165.21 12.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.865 -0.607 . . . . 1.28 110.133 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.532 ' HB2' HG23 ' A' ' 116' ' ' THR . 4.1 p -151.07 154.9 37.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.248 -0.887 . . . . 1.76 109.234 164.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.11 131.45 2.29 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.111 -1.996 . . . . 0.56000000000000005 108.111 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.94 125.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.433 -0.951 . . . . 0.81000000000000005 108.433 175.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.02 138.07 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 120.381 0.134 . . . . 0.93000000000000005 111.088 178.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.19 6.87 1.16 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.622 1.106 . . . . 0.67000000000000004 114.409 174.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.5 58.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 119.584 1.692 . . . . 0.92000000000000004 110.635 -160.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.94 175.67 12.68 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.891 0.876 . . . . 1.6100000000000001 108.646 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 103.603 -2.74 . . . . 4.7699999999999996 103.603 161.815 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 112.861 0.689 . . . . 8.3699999999999992 112.861 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m 46.04 59.44 3.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.007 1.723 . . . . 4.3700000000000001 114.319 172.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 161.75 29.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.534 -0.913 . . . . 3.7200000000000002 108.534 158.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.457 ' HB1' ' HA2' ' A' ' 150' ' ' GLY . . . -88.63 154.95 19.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.198 -1.408 . . . . 0.97999999999999998 107.198 154.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.1 t -123.39 142.81 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.788 -0.819 . . . . 0.72999999999999998 108.788 169.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.38 93.14 4.26 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.114 -0.698 . . . . 0.5 109.114 158.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.62 103.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.73 -1.211 . . . . 0.68999999999999995 107.73 158.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.86 134.71 34.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.974 -0.751 . . . . 0.87 108.974 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -145.81 -57.64 0.31 Allowed 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.602 1.161 . . . . 3.1800000000000002 108.824 169.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.63 -124.3 31.25 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.804 0.716 . . . . 0.94999999999999996 112.432 -176.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -113.18 -54.15 2.64 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.618 1.167 . . . . 4.25 109.939 -164.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.02 160.55 7.07 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.202 -1.159 . . . . 0.95999999999999996 110.202 173.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.21 40.63 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.441 2.761 . . . . 1.04 112.349 -172.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.48 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.441 1.897 . . . . 0.68000000000000005 108.848 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.5 128.84 8.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.085 -1.82 . . . . 2.52 106.085 170.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.43 171.12 41.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.798 . . . . 0.46999999999999997 111.57 -177.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 mm -128.92 129.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.143 -1.428 . . . . 1.8999999999999999 107.143 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.3 mm -101.07 137.29 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 N-CA-C 107.126 -1.435 . . . . 0.71999999999999997 107.126 161.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 127.15 45.23 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.274 -1.38 . . . . 1.78 107.274 160.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.25 91.82 5.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.619 -1.993 . . . . 2.2400000000000002 105.619 158.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -122.03 134.76 54.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.119 -1.067 . . . . 4.1399999999999997 108.119 175.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.39 -62.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.512 -1.222 . . . . 3.5299999999999998 108.193 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? 58.79 48.89 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.299 1.44 . . . . 9.0099999999999998 112.958 169.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -147.67 160.76 42.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.042 0.937 . . . . 5.4199999999999999 109.387 160.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.3 p -75.93 56.23 0.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.216 -0.661 . . . . 5.8300000000000001 109.216 167.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -110.59 -56.91 2.29 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.527 1.531 . . . . 9.5899999999999999 107.688 176.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.65 0.35 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 117.974 -1.459 . . . . 2.0899999999999999 110.161 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -50.65 122.93 10.49 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.912 3.075 . . . . 2.0800000000000001 113.869 -168.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.23 143.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.623 -0.717 . . . . 1.0600000000000001 110.25 -165.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -92.16 83.81 5.16 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.082 -1.822 . . . . 2.77 106.082 171.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.43 83.52 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.945 -1.132 . . . . 1.05 107.945 -172.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -92.49 135.18 34.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.267 0.556 . . . . 1.02 110.03 169.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.27 164.61 35.04 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.079 -1.609 . . . . 0.80000000000000004 109.079 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -154.09 129.22 9.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.369 -1.345 . . . . 2.29 107.369 -174.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -128.78 147.92 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 125.689 1.596 . . . . 1.0800000000000001 108.932 -163.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -136.86 156.2 48.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.291 0.496 . . . . 3.96 112.202 164.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.83 13.09 41.41 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.382 1.944 . . . . 0.57999999999999996 112.916 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.69 157.15 36.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.709 -0.848 . . . . 0.76000000000000001 108.709 168.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.8 m -78.55 157.02 28.91 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.984 -1.487 . . . . 2.0499999999999998 106.984 156.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.36 174.2 0.1 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.951 . . . . 3.1899999999999999 112.637 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.75 -169.19 53.12 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.623 -0.717 . . . . 0.56000000000000005 112.564 169.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 42' ' ' LEU . 3.6 tp -75.18 146.82 40.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.351 1.06 . . . . 2.46 110.753 -177.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.59 116.26 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.331 1.452 . . . . 0.59999999999999998 108.468 -178.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.72 146.72 7.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.63 -1.388 . . . . 0.56000000000000005 109.63 172.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -139.1 93.75 2.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.541 -1.652 . . . . 2.5 106.541 -171.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -131.83 150.95 52.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.719 -1.585 . . . . 0.66000000000000003 106.719 -162.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.738 0.78 . . . . 1.6699999999999999 109.07 174.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -78.7 149.28 32.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.416 -1.698 . . . . 0.97999999999999998 106.416 170.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.55 -100.23 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.388 2.275 . . . . 5.1799999999999997 113.543 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 50.97 58.53 5.45 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.82 0.674 . . . . 3.52 112.82 174.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -62.45 -27.09 68.87 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 113.635 0.976 . . . . 6.3700000000000001 113.635 -174.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -174.64 95.52 0.08 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.507 1.123 . . . . 5.9500000000000002 108.988 -175.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -153.14 -57.29 0.13 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.464 0.542 . . . . 5.1100000000000003 112.464 -177.013 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 t -163.79 164.4 23.65 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 119.328 0.967 . . . . 5.7000000000000002 109.458 176.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.12 -18.54 60.21 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.791 0.836 . . . . 6.7300000000000004 110.703 167.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.13 -126.52 0.5 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 108.745 -1.742 . . . . 3.8999999999999999 108.745 170.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.0 p 179.98 138.8 0.12 Allowed 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.253 1.021 . . . . 2.1400000000000001 109.786 174.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.19 -158.82 0.75 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 104.156 -2.535 . . . . 3.77 104.156 160.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.6 m 69.13 23.75 6.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 116.392 -2.123 . . . . 3.0899999999999999 116.121 143.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.09 150.44 24.06 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.593 0.633 . . . . 1.8100000000000001 111.224 -166.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.42 -143.9 15.47 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.44 1.495 . . . . 1.4199999999999999 111.394 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.47 -179.43 5.42 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.798 3.665 . . . . 1.1299999999999999 113.76 -170.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -52.57 64.57 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 129.498 3.119 . . . . 1.6200000000000001 115.402 -174.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.2 t80 42.97 68.22 0.53 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.074 1.75 . . . . 2.2400000000000002 110.504 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -85.09 114.82 58.2 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.241 -0.885 . . . . 2.6400000000000001 109.808 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.84 -32.99 10.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.271 1.981 . . . . 1.3 111.593 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.43 -64.57 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.239 -0.652 . . . . 3.0899999999999999 109.239 177.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.7 t -158.94 65.34 0.41 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.062 -0.718 . . . . 2.6600000000000001 109.062 178.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 -79.23 163.39 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.931 -0.396 . . . . 5.2199999999999998 109.931 169.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.96 144.16 49.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.091 1.356 . . . . 3.8900000000000001 109.114 -169.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -77.09 155.66 32.27 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.831 0.853 . . . . 0.78000000000000003 111.707 -173.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.79 -98.27 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.499 -1.44 . . . . 2.2400000000000002 109.499 161.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.34 -146.93 9.55 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.577 -1.809 . . . . 1.2 108.577 178.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.83 -58.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.536 2.157 . . . . 1.4099999999999999 109.724 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -20.54 64.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.906 1.283 . . . . 6.4100000000000001 112.176 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 2.7 t70 -64.41 175.91 1.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.528 0.731 . . . . 3.4500000000000002 111.255 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.04 -50.97 7.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.917 1.287 . . . . 5.6299999999999999 108.551 164.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.12 174.39 8.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.954 0.502 . . . . 4.29 111.606 -173.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 164.58 136.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.309 3.044 . . . . 4.2199999999999998 107.78 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 32.4 m80 -66.9 156.52 35.57 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.195 -1.78 . . . . 0.68000000000000005 106.195 165.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.265 13.0 p -78.51 45.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 123.25 1.5 . . . . 2.3199999999999998 110.832 173.102 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -164.16 33.25 0.27 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 128.74 3.067 . . . . 0.76000000000000001 111.331 165.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -137.48 131.9 32.53 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.312 2.056 . . . . 2.1699999999999999 110.37 161.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.28 -56.38 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.114 1.365 . . . . 2.2999999999999998 109.201 176.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.34 -123.58 0.94 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.238 -0.745 . . . . 0.83999999999999997 111.238 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -139.26 172.32 13.0 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 125.28 1.432 . . . . 1.9199999999999999 110.077 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.5 163.68 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.993 1.317 . . . . 0.63 107.453 164.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.2 m -110.59 133.42 53.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.999 -1.482 . . . . 2.3199999999999998 106.999 174.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.76 137.41 32.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.766 0.426 . . . . 0.68999999999999995 110.535 169.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -73.98 -75.57 0.15 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.307 1.043 . . . . 3.3900000000000001 111.645 -166.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.37 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.668 1.187 . . . . 4.79 110.841 -168.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.18 8.44 4.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.278 1.431 . . . . 2.77 110.936 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.82 16.45 76.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.365 -1.094 . . . . 0.91000000000000003 110.365 -171.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -78.24 149.01 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 106.788 -1.56 . . . . 0.87 106.788 172.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.72 165.73 26.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.774 -1.195 . . . . 0.71999999999999997 107.774 165.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.28 140.25 51.5 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.364 -2.828 . . . . 3.0600000000000001 103.364 -172.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.61 78.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 123.971 0.795 . . . . 1.3 110.144 160.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.7 m -98.54 77.87 2.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.14 0.976 . . . . 1.02 108.952 166.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.58 159.11 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.554 -0.906 . . . . 1.78 108.554 176.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.32 147.29 49.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.352 -0.981 . . . . 2.52 108.352 152.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -137.62 150.56 47.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.332 1.053 . . . . 2.0800000000000001 108.218 172.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 p -110.17 -4.45 15.76 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.942 1.697 . . . . 1.3400000000000001 113.418 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.55 -47.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.745 -1.206 . . . . 1.0800000000000001 107.745 175.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.11 176.27 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.131 0.967 . . . . 1.1000000000000001 111.388 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.2 m -163.1 175.54 10.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.987 2.515 . . . . 1.72 104.469 -175.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.78 -1.93 45.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.896 0.771 . . . . 2.5899999999999999 112.587 173.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.2 m -155.71 -150.25 0.29 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.578 1.151 . . . . 3.4500000000000002 108.848 -173.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.15 -90.76 0.81 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.249 -1.141 . . . . 3.48 110.249 -178.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -160.56 -63.52 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.385 0.674 . . . . 4.1600000000000001 110.883 -175.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.02 1.11 18.84 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.809 -0.557 . . . . 3.8300000000000001 112.472 -172.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.1 p -53.98 155.36 3.5 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.056 1.343 . . . . 1.1399999999999999 111.931 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.2 pt -88.61 -5.72 10.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.011 -0.995 . . . . 1.99 110.738 -178.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -37.8 122.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.874 1.67 . . . . 1.6799999999999999 110.446 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.99 -21.24 40.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.895 -0.947 . . . . 1.6899999999999999 113.989 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -83.92 165.2 18.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.475 1.637 . . . . 5.29 110.961 -170.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -89.56 108.15 19.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.699 0.4 . . . . 0.93999999999999995 111.351 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.08 148.15 52.17 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.8 -0.815 . . . . 2.4399999999999999 108.8 168.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.16 141.47 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.525 1.53 . . . . 0.44 108.045 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.01 132.77 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.087 -1.079 . . . . 1.53 108.087 162.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -102.97 168.98 8.85 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.621 1.568 . . . . 0.66000000000000003 114.018 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -72.06 0.17 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.493 -0.776 . . . . 5.4000000000000004 111.078 177.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -79.78 178.09 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.284 0.947 . . . . 4.6100000000000003 109.498 -178.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.13 173.76 0.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.433 1.093 . . . . 1.5 111.442 172.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -70.39 165.52 22.28 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.812 0.815 . . . . 2.9399999999999999 108.94 163.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.74 -21.38 15.21 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.128 -0.942 . . . . 3.9100000000000001 112.36 -154.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 54.69 14.36 0.85 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.904 1.282 . . . . 1.98 112.232 -173.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.61 61.67 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.11 1.338 . . . . 2.4100000000000001 111.285 -176.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 11.3 mttt -129.94 19.08 5.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.267 1.027 . . . . 5.96 110.874 -172.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.01 139.04 22.22 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.942 -2.063 . . . . 2.6000000000000001 107.942 164.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.36 67.13 1.88 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 117.764 0.782 . . . . 2.73 111.682 -175.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -172.99 156.27 3.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.46 1.504 . . . . 3.0699999999999998 108.195 -177.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -52.24 52.78 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.263 -0.398 . . . . 3.6200000000000001 111.28 -178.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -29.49 -46.13 0.05 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 3.0499999999999998 113.751 171.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 t -53.16 -61.74 2.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.174 0.989 . . . . 1.9099999999999999 111.548 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -71.26 -43.4 67.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.237 -0.914 . . . . 1.48 109.743 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -54.4 -39.14 66.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.337 2.255 . . . . 3.8900000000000001 112.539 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 4.4 t -138.1 -53.81 0.63 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.41 1.084 . . . . 1.6100000000000001 112.011 176.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 79.45 1.0 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 103.714 -3.755 . . . . 3.3599999999999999 103.714 -162.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -71.07 57.5 0.22 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.325 1.85 . . . . 3.48 110.681 -178.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -26.1 67.78 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.928 -0.483 . . . . 1.25 111.432 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 134.28 -177.34 19.24 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.397 -1.881 . . . . 0.93000000000000005 108.397 175.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -53.51 153.99 3.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.821 1.249 . . . . 1.25 111.775 175.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.24 131.16 49.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.002 -0.999 . . . . 3.0800000000000001 108.468 168.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -102.51 -74.14 0.64 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.576 -1.639 . . . . 0.67000000000000004 106.576 164.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.16 154.44 19.76 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.424 -0.954 . . . . 1.0800000000000001 108.424 173.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.0 m -144.46 156.05 44.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.909 -1.886 . . . . 2.0899999999999999 105.909 170.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.39 130.1 1.62 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.101 -0.8 . . . . 0.72999999999999998 111.101 169.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.9 131.24 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.898 0.879 . . . . 0.84999999999999998 109.004 173.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.8 tt -91.91 133.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.722 0.296 . . . . 0.70999999999999996 111.533 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.457 ' HA2' ' HB1' ' A' ' 4' ' ' ALA . . . 144.06 2.78 0.83 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.135 0.874 . . . . 1.1100000000000001 115.104 178.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.4 mm -95.4 57.86 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-N 119.325 1.562 . . . . 1.2 109.92 -157.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.62 176.62 12.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.668 0.787 . . . . 1.51 109.773 171.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.256 1.435 0 N-CA-C 104.068 -2.568 . . . . 4.4199999999999999 104.068 170.225 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 109.797 -0.446 . . . . 7.5300000000000002 109.797 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.3 p 47.92 60.02 3.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.658 1.583 . . . . 3.6600000000000001 112.818 169.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.613 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 6.4 ttmm -122.33 168.85 11.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.82 1.648 . . . . 4.4000000000000004 106.943 172.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -114.22 142.46 46.24 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.773 0.829 . . . . 0.69999999999999996 108.909 158.12 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' A' ' 152' ' ' ALA . 51.2 t -111.87 145.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.654 -1.61 . . . . 0.90000000000000002 106.654 166.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -118.47 97.62 5.85 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.941 -0.763 . . . . 0.54000000000000004 108.941 155.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.64 98.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.561 1.144 . . . . 0.71999999999999997 108.768 164.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.69 130.4 35.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.958 0.903 . . . . 2.3300000000000001 108.784 172.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -151.69 -52.12 0.12 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 122.767 0.427 . . . . 3.5800000000000001 110.961 166.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.45 -116.6 1.43 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.261 0.934 . . . . 1.1599999999999999 112.998 -175.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -117.2 -46.04 2.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.169 0.988 . . . . 3.3500000000000001 109.729 -158.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 172.36 16.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.567 1.08 . . . . 1.0 111.747 177.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.47 -24.06 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.139 2.559 . . . . 1.3100000000000001 111.594 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.2 t -49.89 139.36 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.019 1.328 . . . . 0.97999999999999998 110.92 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.89 130.26 8.88 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.751 -1.203 . . . . 1.95 107.751 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.14 170.06 41.79 Favored Glycine 0 N--CA 1.449 -0.437 0 O-C-N 121.732 -0.605 . . . . 0.67000000000000004 111.691 -177.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 mm -123.83 126.14 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.287 -1.375 . . . . 1.6699999999999999 107.287 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 1.2 mp -95.65 147.62 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.019 -1.474 . . . . 1.3 107.019 163.234 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.53 121.39 36.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.032 1.333 . . . . 1.9099999999999999 107.494 167.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -96.73 99.03 10.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.978 -2.23 . . . . 2.4100000000000001 104.978 162.464 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -113.69 128.31 56.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.6 -0.889 . . . . 3.8999999999999999 108.6 174.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -157.22 -77.82 0.08 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.54 -1.664 . . . . 3.7799999999999998 108.963 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.2 59.85 3.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.47 -0.937 . . . . 6.5499999999999998 108.47 -174.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -113.83 -103.48 0.41 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.59 -2.374 . . . . 3.8599999999999999 104.59 168.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 t -153.03 -69.97 0.15 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.111 -1.44 . . . . 2.8999999999999999 107.111 157.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -124.19 97.85 5.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.84 -1.541 . . . . 4.04 106.84 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.89 37.43 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.345 -0.702 . . . . 1.02 111.345 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.74 115.62 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.366 3.378 . . . . 1.26 112.065 -172.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.02 164.44 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.562 0.745 . . . . 1.24 109.157 -172.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -115.1 99.18 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.938 -1.504 . . . . 3.0499999999999998 106.938 166.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -92.31 88.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.08 1.752 . . . . 1.1100000000000001 107.566 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -98.31 151.43 20.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.419 -0.586 . . . . 0.97999999999999998 109.419 169.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.9 159.04 32.18 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.369 -1.493 . . . . 0.82999999999999996 109.369 176.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.4 m -136.82 110.25 7.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.6 -1.63 . . . . 2.2200000000000002 106.6 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.411 HD11 HD12 ' A' ' 18' ' ' ILE . 1.1 mp -119.16 148.83 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.013 1.325 . . . . 0.95999999999999996 107.893 -163.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -148.33 166.26 28.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.978 0.732 . . . . 3.4900000000000002 112.978 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.44 19.35 62.35 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 0.67000000000000004 113.208 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mt -75.49 165.32 25.3 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.373 1.086 . . . . 0.79000000000000004 109.32 174.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.13 163.01 28.38 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.67 -1.233 . . . . 1.6599999999999999 107.67 155.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.89 165.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.79 0.805 . . . . 2.52 112.216 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 -158.31 53.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.086 -0.961 . . . . 0.58999999999999997 113.402 167.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 130.02 42.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.926 1.29 . . . . 1.9199999999999999 111.176 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -136.49 110.08 8.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.919 1.688 . . . . 1.3100000000000001 109.527 -174.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.91 149.42 11.06 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.852 1.692 . . . . 0.53000000000000003 111.563 -177.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -146.4 100.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.463 -0.94 . . . . 2.79 108.463 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.625 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.0 m80 -139.56 154.21 47.58 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.137 -1.06 . . . . 0.64000000000000001 108.137 -166.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -113.61 129.23 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 119.571 1.078 . . . . 1.8600000000000001 108.82 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -105.81 146.83 29.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.64 -1.615 . . . . 0.79000000000000004 106.64 -176.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -53.77 -61.24 2.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.591 0.557 . . . . 4.0499999999999998 110.751 -165.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 39.12 71.54 0.16 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.598 1.559 . . . . 2.98 111.535 159.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -73.27 -77.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.277 0.56 . . . . 4.9199999999999999 111.195 -171.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -80.24 126.66 31.41 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.139 -1.43 . . . . 5.2800000000000002 107.139 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -126.61 20.55 7.2 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.382 1.073 . . . . 3.9300000000000002 109.709 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 54' ' ' THR . 1.5 t -78.67 46.39 0.65 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.952 -1.093 . . . . 4.9199999999999999 111.981 -172.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -174.53 -45.89 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 125.105 1.362 . . . . 5.6500000000000004 109.584 -173.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.54 -163.39 27.05 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.566 -2.214 . . . . 3.6600000000000001 107.566 -178.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.01 161.46 40.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.59 -1.633 . . . . 2.3700000000000001 106.59 -177.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m 101.3 79.89 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.843 2.057 . . . . 5.3899999999999997 107.85 -178.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 t 179.77 39.68 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.641 0.734 . . . . 2.6299999999999999 111.021 -137.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.11 -69.92 0.05 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.542 1.537 . . . . 3.3900000000000001 107.497 -178.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.89 -94.52 0.34 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.256 -1.938 . . . . 0.95999999999999996 108.256 173.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.76 177.07 9.17 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.311 2.674 . . . . 0.82999999999999996 113.736 -176.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -60.93 130.94 48.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.582 -1.645 . . . . 1.3600000000000001 108.517 171.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -48.22 117.11 1.79 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.085 0.469 . . . . 1.71 110.487 176.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.22 152.57 25.28 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 126.536 1.934 . . . . 2.4500000000000002 107.158 173.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -24.69 12.37 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.418 2.079 . . . . 1.22 113.529 -167.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.36 -68.74 0.12 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.952 0.796 . . . . 2.9100000000000001 109.57 -176.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.7 m -155.99 77.96 0.96 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.484 0.714 . . . . 1.9199999999999999 109.67 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -77.99 169.82 17.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.785 -0.82 . . . . 5.0499999999999998 108.785 163.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -118.41 158.47 25.23 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.701 1.6 . . . . 3.4399999999999999 106.734 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.437 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 55.0 t60 -86.0 154.06 21.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.566 0.58 . . . . 0.85999999999999999 112.566 -175.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.41 -178.58 43.48 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 106.613 -2.595 . . . . 2.1699999999999999 106.613 160.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.49 -160.83 26.04 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 117.462 0.631 . . . . 1.45 112.616 -170.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.85 -43.19 3.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.951 1.768 . . . . 1.47 109.301 173.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.4 -46.57 76.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 5.1699999999999999 111.659 -176.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.68 174.45 1.79 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.425 -0.807 . . . . 2.4399999999999999 109.754 176.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.09 -37.44 11.61 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.224 1.01 . . . . 5.7300000000000004 111.082 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -75.71 155.53 35.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.04 -1.096 . . . . 2.7400000000000002 108.04 -174.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 165.57 145.46 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.905 2.082 . . . . 3.5099999999999998 112.002 -170.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.2 m80 -66.57 149.7 50.09 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 107.564 -1.273 . . . . 0.63 107.564 164.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.69 -37.43 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 119.94 -0.704 . . . . 1.5900000000000001 109.714 -171.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.17 60.86 1.59 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.611 0.624 . . . . 0.62 112.029 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 80' ' ' HIS . 1.2 t0 -168.29 114.94 0.67 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.523 -0.917 . . . . 2.0600000000000001 108.523 -172.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.13 -45.06 8.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.249 -0.648 . . . . 2.48 109.249 176.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.76 -94.11 0.15 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.289 -1.124 . . . . 1.1299999999999999 110.289 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -150.62 164.84 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.478 1.511 . . . . 1.5800000000000001 110.573 -177.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.0 m -110.0 176.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.284 -1.747 . . . . 0.52000000000000002 106.284 156.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 t -112.49 144.3 42.2 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.444 -1.317 . . . . 1.9099999999999999 107.444 160.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.35 153.25 29.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.289 -1.004 . . . . 1.1499999999999999 108.289 154.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.47 -89.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.781 -0.822 . . . . 2.8399999999999999 108.781 173.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -140.25 -57.67 0.54 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.584 1.554 . . . . 4.1799999999999997 108.981 -171.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -87.8 30.39 0.83 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.042 1.337 . . . . 5.0700000000000003 110.062 -170.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.63 10.65 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.205 1.86 . . . . 0.90000000000000002 112.956 179.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.71 138.3 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.393 -1.336 . . . . 0.95999999999999996 107.393 176.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.55 170.79 15.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.063 1.345 . . . . 0.60999999999999999 107.953 173.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -143.9 147.76 34.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.998 -2.223 . . . . 2.7999999999999998 104.998 -171.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.85 132.64 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.407 -1.701 . . . . 1.3799999999999999 106.407 166.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.9 m -153.02 73.19 0.98 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.013 1.325 . . . . 1.05 107.603 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.6 mm -115.85 152.51 17.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.638 -0.875 . . . . 2.5600000000000001 108.638 -177.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -145.53 91.47 2.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.522 0.729 . . . . 2.4500000000000002 109.48 167.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.42 -178.02 6.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.904 0.882 . . . . 3.5800000000000001 109.931 177.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.4 p -133.33 48.97 2.34 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.201 1.0 . . . . 1.6799999999999999 109.146 170.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.22 -55.86 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.918 1.287 . . . . 1.1799999999999999 108.486 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pp -88.08 177.68 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.89 0.852 . . . . 1.21 111.451 -177.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -161.64 177.88 9.56 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.921 2.088 . . . . 2.1400000000000001 107.077 -176.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.86 -3.8 24.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.888 1.07 . . . . 3.3900000000000001 113.888 -175.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m -155.79 166.66 32.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.091 1.357 . . . . 4.1900000000000004 109.125 176.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.58 130.14 0.37 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 109.228 -1.549 . . . . 2.7200000000000002 109.228 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -72.05 74.48 0.92 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 123.6 1.667 . . . . 5.5800000000000001 112.336 -169.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -158.0 -39.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.577 1 C-N-CA 132.115 4.166 . . . . 3.8799999999999999 105.978 174.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.1 p -42.25 147.4 0.25 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.276 0.56 . . . . 1.27 111.07 156.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.3 pt -78.64 -17.32 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.553 -0.737 . . . . 1.96 109.257 174.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 tp -36.91 133.06 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.606 1.562 . . . . 1.78 113.775 -170.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.53 37.82 45.67 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.85 -0.5 . . . . 1.51 111.85 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -134.99 160.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.894 1.278 . . . . 4.0800000000000001 107.559 172.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.4 m -94.29 112.71 24.52 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.693 0.397 . . . . 1.2 111.022 -170.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.92 149.55 50.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.117 -0.698 . . . . 1.6399999999999999 109.117 172.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t -135.47 128.93 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.346 1.459 . . . . 0.38 107.467 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.53 120.38 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.046 -1.835 . . . . 1.6100000000000001 106.046 163.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.462 ' CD2' ' HD1' ' A' ' 46' ' ' HIS . 51.4 m-70 -94.28 175.65 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.019 1.727 . . . . 0.69999999999999996 112.247 -174.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -72.67 -76.93 0.11 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 113.041 0.756 . . . . 6.0599999999999996 113.041 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -81.11 -176.79 6.14 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.21 0.913 . . . . 3.2000000000000002 110.084 -167.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.6 148.89 36.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.89 -0.782 . . . . 0.56999999999999995 108.89 167.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -67.9 170.17 8.6 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.051 -0.722 . . . . 1.99 109.051 159.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.32 -23.58 62.86 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.699 1.37 . . . . 3.9100000000000001 114.699 -176.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 67.03 2.01 2.56 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.811 1.244 . . . . 1.6499999999999999 113.636 -170.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.21 10.09 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 120.54 1.518 . . . . 1.77 112.676 166.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -106.92 -20.77 13.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.508 2.323 . . . . 5.3799999999999999 109.639 -178.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.8 -77.01 1.94 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 124.492 1.044 . . . . 2.4199999999999999 112.939 167.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.77 -70.35 0.12 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.118 -0.793 . . . . 2.48 111.118 -163.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -90.76 -92.98 0.13 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.449 1.5 . . . . 2.96 112.473 -176.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -165.39 -81.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.144 0.978 . . . . 3.25 108.693 -164.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -29.09 -45.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.282 2.633 . . . . 3.2000000000000002 113.146 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.2 m -53.65 -50.49 65.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.305 1.842 . . . . 2.9900000000000002 112.744 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 52.2 p -71.7 -48.35 47.86 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.881 -1.137 . . . . 1.5 110.615 170.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -53.25 -48.15 68.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.091 2.156 . . . . 3.4399999999999999 111.022 -168.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.431 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.1 p -128.08 -50.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.154 0.982 . . . . 1.21 110.691 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 153.83 -18.53 0.66 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-O 119.268 -0.74 . . . . 0.91000000000000003 114.556 -176.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 45.47 54.12 7.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.294 1.438 . . . . 2.0 110.803 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -60.83 -34.93 75.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.075 1.35 . . . . 1.01 113.213 177.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.86 173.67 31.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.404 -1.878 . . . . 1.0600000000000001 108.404 -159.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 p -61.12 153.62 25.25 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.116 1.366 . . . . 2.2799999999999998 112.426 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -81.1 147.43 30.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.151 1.78 . . . . 2.4399999999999999 110.437 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.5 mt -127.33 -76.3 0.57 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.528 -0.916 . . . . 0.72999999999999998 108.528 -168.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.82 151.54 21.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.192 -0.669 . . . . 0.84999999999999998 109.192 170.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.1 p -136.71 167.36 21.57 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.521 1.528 . . . . 2.4700000000000002 107.879 174.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.95 133.88 1.64 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 114.46 -1.246 . . . . 0.64000000000000001 110.195 -177.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.38 138.87 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.817 -0.808 . . . . 0.82999999999999996 108.817 175.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 6' ' ' ALA . 21.5 tt -93.79 127.48 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 123.42 0.45 . . . . 0.79000000000000004 111.166 175.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.04 -2.1 0.82 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.106 1.336 . . . . 0.54000000000000004 115.692 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 151' ' ' ILE . 1.3 mp -89.36 60.59 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.25 1.525 . . . . 1.1499999999999999 109.589 -160.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -131.13 175.68 8.89 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.386 -0.821 . . . . 1.24 110.881 164.095 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 . . . . . 0 C--O 1.254 1.334 0 N-CA-C 103.187 -2.894 . . . . 4.3700000000000001 103.187 163.458 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 109.454 -0.572 . . . . 6.0800000000000001 109.454 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 p -73.56 173.73 9.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.109 1.364 . . . . 2.9199999999999999 110.599 173.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 153' ' ' GLN . 0.6 OUTLIER -104.19 152.82 21.7 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.223 0.609 . . . . 3.1099999999999999 110.478 -179.032 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.95 14.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.375 0.67 . . . . 1.49 110.359 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 152' ' ' ALA . 37.8 t -122.2 152.08 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.104 1.761 . . . . 0.92000000000000004 106.399 159.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.25 99.15 4.03 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.986 -0.746 . . . . 0.71999999999999997 108.986 154.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.7 t -66.15 111.88 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.221 -1.4 . . . . 0.80000000000000004 107.221 166.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -92.07 133.05 36.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.469 -0.937 . . . . 0.95999999999999996 108.469 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -149.12 -50.27 0.15 Allowed 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.487 0.551 . . . . 3.7400000000000002 112.487 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 46.18 -113.64 1.15 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.092 -0.838 . . . . 0.82999999999999996 113.942 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -124.09 -55.59 1.67 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.207 1.003 . . . . 3.5800000000000001 110.909 -164.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.32 165.58 12.76 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.041 -0.823 . . . . 0.72999999999999998 111.041 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.77 27.14 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.807 3.005 . . . . 1.05 113.59 -173.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 91.6 t -91.89 143.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.895 1.678 . . . . 0.78000000000000003 107.649 177.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -154.79 116.83 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.179 -1.045 . . . . 2.8100000000000001 108.179 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.02 171.74 32.02 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.692 -0.563 . . . . 0.59999999999999998 111.692 -172.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -127.99 126.65 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.46 0.704 . . . . 1.3500000000000001 109.243 178.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 21.6 mm -94.5 151.47 3.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 125.53 1.532 . . . . 0.78000000000000003 107.005 165.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.92 154.23 48.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.592 -1.633 . . . . 1.5600000000000001 106.592 164.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.8 160.11 40.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.81 -0.756 . . . . 5.25 109.131 158.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -127.82 139.51 52.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.056 2.143 . . . . 4.7300000000000004 105.386 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -143.65 146.82 33.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.949 -1.871 . . . . 4.2999999999999998 105.949 154.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -73.9 -68.8 0.48 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.151 -0.685 . . . . 4.5300000000000002 109.151 170.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -78.19 165.25 24.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.769 0.828 . . . . 3.8999999999999999 111.618 -173.038 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -77.92 2.26 17.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.548 0.739 . . . . 2.6099999999999999 112.513 173.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -161.32 78.22 0.57 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.877 0.762 . . . . 4.2800000000000002 109.856 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.61 164.81 30.38 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.375 -2.29 . . . . 1.3899999999999999 107.375 165.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.02 118.41 5.27 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.983 2.455 . . . . 1.5800000000000001 110.524 -176.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -76.69 176.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.769 -0.826 . . . . 1.46 108.769 -165.871 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -131.24 81.06 1.97 Allowed 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.577 -0.897 . . . . 5.0300000000000002 108.577 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.58 100.95 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.988 -1.116 . . . . 1.75 107.988 -177.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -114.02 170.39 8.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.934 0.493 . . . . 1.24 110.081 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.21 165.72 34.74 Favored Glycine 0 N--CA 1.449 -0.463 0 O-C-N 120.974 -1.079 . . . . 0.67000000000000004 112.088 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -131.18 106.66 8.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.509 -2.034 . . . . 1.8400000000000001 105.509 -177.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.64 146.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.626 -1.25 . . . . 0.96999999999999997 107.626 -166.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 161.84 41.22 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.485 0.92 . . . . 3.6600000000000001 113.485 168.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.85 15.56 45.27 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.758 1.647 . . . . 0.65000000000000002 113.467 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.83 -173.47 0.63 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.524 1.162 . . . . 0.81000000000000005 108.85 169.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -85.29 -100.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.077 -1.083 . . . . 2.6000000000000001 108.077 164.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -149.2 162.04 40.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.389 1.475 . . . . 2.6600000000000001 108.049 -175.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.57 -161.54 50.91 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.209 0.433 . . . . 0.68999999999999995 112.443 167.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.17 132.78 53.91 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.735 0.814 . . . . 1.98 112.521 -175.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.18 114.94 9.52 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.132 1.773 . . . . 1.23 109.131 -177.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.23 152.27 6.91 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.918 1.247 . . . . 0.68000000000000005 113.753 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 103.84 4.3 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.209 1.803 . . . . 2.8599999999999999 108.138 -177.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 41.9 m80 -142.06 162.07 36.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.729 . . . . 1.26 109.033 -169.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.43 130.43 74.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 2.3700000000000001 108.73 -178.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -113.51 154.52 26.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.116 0.967 . . . . 0.81999999999999995 108.838 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.61 33.09 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.197 1.399 . . . . 4.4199999999999999 113.495 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -83.4 95.59 8.28 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.598 -1.63 . . . . 3.1200000000000001 106.598 178.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' CD ' HH12 ' A' ' 115' ' ' ARG . 8.0 tp10 -74.69 -82.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.451 1.5 . . . . 4.2000000000000002 108.528 -179.28 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -78.52 126.66 31.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.163 -1.421 . . . . 5.0999999999999996 107.163 174.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -122.6 14.09 10.16 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.972 1.309 . . . . 4.0999999999999996 110.479 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.0 t -59.31 -39.94 84.68 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.733 0.697 . . . . 4.2199999999999998 111.447 -174.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.46 -55.5 7.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.414 0.685 . . . . 6.25 109.816 175.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.75 163.6 21.95 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.975 -1.25 . . . . 3.8199999999999998 109.975 176.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 90.7 m -76.57 62.2 1.89 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.719 1.207 . . . . 2.7999999999999998 110.042 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -141.49 66.11 1.37 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.423 1.106 . . . . 4.5099999999999998 110.849 -172.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.5 m -168.95 -37.4 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.459 1.651 . . . . 2.4700000000000002 115.459 -141.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.57 149.29 30.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.625 1.57 . . . . 1.8899999999999999 108.636 168.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.98 -99.18 2.16 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.79 -1.324 . . . . 0.94999999999999996 109.79 -173.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.92 178.39 5.34 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.692 2.928 . . . . 1.0700000000000001 112.524 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -61.73 136.68 58.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.432 -1.27 . . . . 1.48 108.365 172.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -23.06 105.41 0.02 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.975 1.71 . . . . 2.5099999999999998 113.814 -177.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -130.16 90.59 41.58 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.815 1.646 . . . . 2.5499999999999998 109.621 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.64 -36.93 13.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.836 1.69 . . . . 1.6599999999999999 111.115 -178.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -135.49 -75.06 0.45 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.977 0.911 . . . . 2.8399999999999999 109.557 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.6 m -156.97 81.06 0.93 Allowed 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.312 -0.868 . . . . 1.6299999999999999 109.468 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -85.35 170.93 12.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.322 0.582 . . . . 4.7800000000000002 110.598 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -125.82 161.63 26.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.944 1.698 . . . . 3.52 107.265 177.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -104.24 115.95 31.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.774 0.83 . . . . 1.01 110.914 173.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.87 12.9 6.48 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 124.76 1.171 . . . . 3.1400000000000001 110.621 164.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.92 -164.11 23.24 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.44 -1.035 . . . . 1.75 112.296 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.92 -23.69 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.34 2.027 . . . . 2.23 111.545 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -71.89 -53.84 11.94 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.739 0.816 . . . . 6.5 111.45 -176.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.5 171.16 7.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.73 -0.841 . . . . 4.0700000000000003 108.73 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.96 -51.11 68.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.974 -1.121 . . . . 6.2300000000000004 107.974 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -76.81 143.47 39.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.738 0.78 . . . . 3.3100000000000001 110.6 -163.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -176.3 150.89 0.95 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.388 -1.338 . . . . 3.1000000000000001 107.388 -166.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.1 m80 -63.67 147.46 51.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.848 -1.538 . . . . 0.65000000000000002 106.848 163.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.71 -15.22 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 120.625 -0.43 . . . . 1.3 110.672 -175.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.2 67.42 0.28 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.088 1.328 . . . . 0.68000000000000005 110.747 166.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -132.8 110.75 10.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.868 1.334 . . . . 2.4500000000000002 109.781 168.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -39.59 16.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.068 0.547 . . . . 1.78 109.94 169.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 138.59 -106.34 0.52 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.108 -0.797 . . . . 0.79000000000000004 111.108 172.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.09 159.8 40.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.467 1.507 . . . . 1.45 109.373 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.2 176.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 125.695 1.598 . . . . 0.77000000000000002 107.078 166.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -114.91 139.76 49.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.799 -1.185 . . . . 2.0299999999999998 107.799 163.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.25 141.25 31.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.242 1.417 . . . . 0.60999999999999999 110.801 169.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.25 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.194 0.998 . . . . 2.5299999999999998 111.08 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -159.38 -46.55 0.05 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.923 1.289 . . . . 3.75 110.496 -173.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.79 19.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.419 1.488 . . . . 3.3100000000000001 111.134 178.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.65 9.28 78.39 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.6 -1.111 . . . . 0.88 111.997 -177.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.0 t -77.52 141.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.59 -1.263 . . . . 1.01 107.59 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.36 168.2 21.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.531 1.132 . . . . 0.77000000000000002 108.407 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.54 144.24 50.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 103.452 -2.796 . . . . 2.9199999999999999 103.452 -174.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.89 136.06 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.055 -1.831 . . . . 1.54 106.055 169.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -159.98 67.39 0.37 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.141 1.376 . . . . 0.85999999999999999 107.613 -177.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 mm -112.64 146.66 17.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 108.485 -0.931 . . . . 2.0299999999999998 108.485 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.82 74.96 1.49 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.258 0.623 . . . . 3.4500000000000002 109.805 177.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -77.84 151.17 34.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.599 0.714 . . . . 2.48 110.356 -177.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -98.71 -26.28 14.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.018 2.127 . . . . 1.6299999999999999 110.844 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.2 -48.77 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 118.91 -0.567 . . . . 1.7 110.162 -173.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.24 162.97 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.291 0.95 . . . . 1.6899999999999999 109.97 171.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 m -143.13 179.85 6.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.604 1.561 . . . . 2.7400000000000002 108.316 -175.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -133.06 31.88 3.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.295 1.438 . . . . 4.4699999999999998 113.857 -173.648 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.5 t -153.48 69.67 0.82 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.128 -0.983 . . . . 3.2999999999999998 110.863 178.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 167.22 172.53 34.51 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.932 -0.48 . . . . 3.4199999999999999 112.56 174.242 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.23 -46.95 46.64 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.405 1.882 . . . . 5.5800000000000001 112.507 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -95.76 0.5 52.48 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.75 1.62 . . . . 6.4500000000000002 111.878 -178.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p -75.71 161.98 28.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.128 -1.805 . . . . 1.3200000000000001 106.128 168.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.3 pt -76.94 -13.83 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 118.419 -1.312 . . . . 2.27 113.598 -168.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.4 mm -43.21 115.72 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.283 0.947 . . . . 1.8500000000000001 111.183 176.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.7 25.35 74.22 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.076 -0.847 . . . . 1.3300000000000001 112.389 178.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.414 HH12 ' CD ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -107.84 159.45 16.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 120.051 1.926 . . . . 4.8399999999999999 110.548 170.848 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 m -92.06 104.56 16.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 1.1499999999999999 109.592 -172.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.06 147.44 53.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.055 -1.091 . . . . 1.78 108.055 166.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -134.72 133.72 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 127.356 2.263 . . . . 0.40999999999999998 106.222 177.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.23 120.81 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.024 -1.472 . . . . 1.72 107.024 165.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.478 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 45.7 m-70 -95.56 176.1 6.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.58 1.552 . . . . 0.79000000000000004 112.343 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -77.58 -65.58 0.94 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 113.558 0.947 . . . . 6.0999999999999996 113.558 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -88.42 174.32 8.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.206 0.912 . . . . 5.9199999999999999 110.675 -175.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.84 143.29 17.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.363 -1.289 . . . . 0.96999999999999997 107.91 157.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.48 155.74 38.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.614 -0.884 . . . . 2.1099999999999999 108.614 158.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -78.76 -5.58 53.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.163 0.985 . . . . 3.3900000000000001 112.092 -172.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 54.46 30.59 13.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.418 1.087 . . . . 1.6699999999999999 110.542 -173.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.84 16.48 68.22 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.403 -0.665 . . . . 1.8300000000000001 112.796 177.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -98.83 -23.6 15.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.334 1.067 . . . . 5.2000000000000002 110.782 -176.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.1 131.22 45.28 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.019 -0.832 . . . . 2.2599999999999998 111.019 -176.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.03 -40.22 72.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 117.731 0.766 . . . . 2.52 111.514 179.145 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -50.72 109.29 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.87 1.268 . . . . 2.3799999999999999 109.46 164.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -61.87 -21.7 64.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.6 -0.688 . . . . 3.77 112.308 -170.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -41.13 -38.2 1.02 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.949 1.7 . . . . 4.3700000000000001 111.018 169.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 79.9 p -46.15 -67.12 0.31 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.264 1.026 . . . . 2.04 109.909 172.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.8 p -66.13 -46.84 76.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.045 0.938 . . . . 1.23 111.119 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -60.26 -38.95 85.07 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.182 0.993 . . . . 4.8200000000000003 111.633 -172.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.514 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.317 7.3 t -136.91 -55.25 0.72 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 1.8700000000000001 111.095 175.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.88 -25.21 0.21 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.059 0.845 . . . . 0.96999999999999997 112.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 47.79 55.53 8.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.208 1.403 . . . . 2.02 110.996 -170.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -78.1 -8.89 58.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.218 0.821 . . . . 1.1100000000000001 113.218 173.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.56 173.28 49.51 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.247 -1.541 . . . . 1.1599999999999999 109.247 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 m -56.36 155.13 7.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.797 1.639 . . . . 1.3600000000000001 113.344 -173.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.91 142.37 45.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.24 1.416 . . . . 3.04 110.34 177.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 mt -122.39 -74.83 0.6 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.897 -1.149 . . . . 0.54000000000000004 107.897 -174.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -106.6 144.32 33.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.063 -1.088 . . . . 0.78000000000000003 108.063 166.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 25.7 p -123.36 169.03 11.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.401 1.48 . . . . 2.1499999999999999 107.863 168.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -175.98 142.6 6.13 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 124.362 1.039 . . . . 0.75 111.234 166.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.76 133.57 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.996 0.918 . . . . 0.84999999999999998 108.692 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.466 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 8.0 tt -96.7 139.48 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.303 0.483 . . . . 1.0900000000000001 112.303 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 134.22 6.3 2.48 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.127 1.346 . . . . 1.0800000000000001 113.992 174.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -91.8 57.26 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.328 1.564 . . . . 1.0800000000000001 110.691 -159.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.15 176.02 13.22 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.567 0.747 . . . . 1.6799999999999999 110.552 169.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.409 ' O ' ' NZ ' ' A' ' 3' ' ' LYS . 17.6 tt0 . . . . . 0 C--O 1.251 1.168 0 N-CA-C 105.821 -1.918 . . . . 5.4900000000000002 105.821 167.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.429 ' N ' ' OXT' ' A' ' 153' ' ' GLN . . . . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 109.834 -0.432 . . . . 7.1500000000000004 109.834 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.5 p -71.3 79.29 0.73 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.292 0.637 . . . . 3.8599999999999999 109.366 177.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -140.79 146.55 37.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.994 0.918 . . . . 3.0 109.561 178.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.42 158.89 15.24 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.804 -0.813 . . . . 0.92000000000000004 108.804 163.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 t -124.79 150.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.36 -1.291 . . . . 0.81999999999999995 108.058 165.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.84 97.98 5.18 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.39 1.076 . . . . 0.54000000000000004 108.624 158.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.58 114.84 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.511 -1.292 . . . . 0.65000000000000002 107.511 165.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.8 mt -96.66 137.0 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.685 0.794 . . . . 1.0700000000000001 109.91 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -150.0 -52.68 0.15 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.84 0.856 . . . . 3.2999999999999998 109.358 169.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.59 -124.99 28.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.979 -1.01 . . . . 0.96999999999999997 111.622 -175.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.05 -48.2 2.84 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.339 1.055 . . . . 3.6499999999999999 109.365 -162.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.83 166.06 23.9 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.99 -0.844 . . . . 0.80000000000000004 110.99 174.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.11 36.78 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.822 3.015 . . . . 0.97999999999999998 112.785 -173.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 57.2 t -94.51 159.38 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.693 1.597 . . . . 0.78000000000000003 108.98 -176.46 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 132.19 9.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.082 -1.451 . . . . 2.9300000000000002 107.082 176.242 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.47 179.36 44.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.623 -0.799 . . . . 0.77000000000000002 111.575 178.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.77 119.54 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.212 -1.403 . . . . 1.0 107.212 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 mm -79.07 146.44 7.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.389 -1.337 . . . . 0.77000000000000002 107.389 163.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -120.24 137.1 54.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.094 -1.817 . . . . 2.2000000000000002 106.094 163.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -122.93 112.82 18.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.966 1.706 . . . . 2.2799999999999998 107.452 177.277 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.55 135.27 54.06 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.67 1.188 . . . . 4.0999999999999996 108.832 177.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.495 ' HB3' HD21 ' A' ' 106' ' ' LEU . 5.6 tp-100 -151.45 152.63 33.3 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.541 1.537 . . . . 3.7200000000000002 108.753 170.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -120.31 -46.56 2.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.472 2.709 . . . . 6.1699999999999999 107.556 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.77 96.41 6.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.496 -1.298 . . . . 5.0300000000000002 107.496 173.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -21.13 -66.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.446 2.298 . . . . 2.8300000000000001 114.748 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -114.51 54.55 0.77 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.849 0.859 . . . . 3.9900000000000002 110.153 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.54 -179.71 18.73 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.328 1.442 . . . . 0.93000000000000005 110.407 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.96 115.45 3.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.536 2.824 . . . . 1.04 111.086 -178.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.401 HG11 ' CD2' ' A' ' 20' ' ' PHE . 48.0 t -78.73 153.24 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.02 0.528 . . . . 0.96999999999999997 109.626 -170.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -108.34 126.03 52.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.618 -0.882 . . . . 2.6099999999999999 108.618 174.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 ' CE1' ' A' ' 20' ' ' PHE . 48.0 t -125.63 140.84 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 125.489 1.516 . . . . 1.1200000000000001 107.593 -169.549 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -155.17 164.54 38.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.689 -0.486 . . . . 0.98999999999999999 109.689 167.196 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.19 137.14 3.21 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.363 -0.446 . . . . 1.2 112.027 175.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 p -102.22 77.3 1.65 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.78 1.232 . . . . 1.8600000000000001 109.577 -172.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.13 142.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.028 -0.73 . . . . 1.54 109.028 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -137.6 157.16 47.1 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.243 0.617 . . . . 3.7999999999999998 110.256 -176.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.95 12.42 66.11 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.68000000000000005 112.709 -176.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.85 157.33 30.77 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.177 0.991 . . . . 0.96999999999999997 109.308 170.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -74.6 156.45 36.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.114 -1.069 . . . . 1.8700000000000001 108.114 154.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.89 171.79 0.32 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.124 0.97 . . . . 2.3100000000000001 111.839 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.45 -165.13 54.76 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.614 -0.721 . . . . 0.51000000000000001 113.031 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.95 147.92 44.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.7 0.8 . . . . 1.96 111.288 -173.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -145.31 123.54 12.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.504 1.522 . . . . 0.54000000000000004 109.429 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.37 149.18 18.95 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.812 -0.915 . . . . 0.44 110.812 170.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -138.66 95.64 3.01 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.089 -1.448 . . . . 2.9700000000000002 107.089 -174.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -133.87 160.34 37.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.754 -1.202 . . . . 0.88 107.754 -160.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.698 HG11 ' CZ ' ' A' ' 115' ' ' ARG . 33.8 m -119.42 128.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 122.307 1.051 . . . . 2.4500000000000002 109.933 175.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -104.61 142.64 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.656 -1.609 . . . . 0.88 106.656 -177.394 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 74.31 0.59 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.325 -1.731 . . . . 4.8799999999999999 106.325 170.368 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -141.62 39.31 1.69 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.871 -0.604 . . . . 3.6099999999999999 109.559 -165.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -58.74 78.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.212 1.005 . . . . 5.1600000000000001 112.736 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -146.08 140.95 27.12 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 127.147 2.179 . . . . 7.4400000000000004 106.076 169.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -141.58 60.63 1.48 Allowed 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 106.57 -1.641 . . . . 6.0099999999999998 106.57 152.268 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.257 8.7 t -142.08 -43.48 0.34 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.752 1.221 . . . . 5.25 110.749 176.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.95 -47.36 85.23 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.659 -0.867 . . . . 6.0199999999999996 108.659 154.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.71 -70.6 0.39 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.648 1.594 . . . . 3.6400000000000001 109.511 172.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.4 t -179.08 176.3 0.89 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 129.231 3.012 . . . . 2.21 104.839 -179.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m 71.55 73.62 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.167 1.349 . . . . 6.2699999999999996 110.079 167.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.0 t 177.85 33.99 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.233 1.016 . . . . 2.48 110.013 -137.385 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 179.09 -148.04 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 128.666 2.786 . . . . 2.4199999999999999 104.87 -172.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.45 -115.37 1.11 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.72 -1.6 . . . . 1.0700000000000001 110.666 178.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 -179.22 5.03 Favored 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.808 4.339 . . . . 1.0900000000000001 113.933 -173.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -53.39 134.3 40.11 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.038 -0.983 . . . . 1.6899999999999999 111.111 176.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -50.54 117.9 2.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 123.74 0.65 . . . . 1.8700000000000001 109.567 172.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.8 156.54 30.74 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 106.757 -1.571 . . . . 2.79 106.757 169.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.14 -38.65 2.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.176 1.917 . . . . 1.4199999999999999 111.55 -165.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 mt -144.52 -74.54 0.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.858 0.863 . . . . 2.4100000000000001 109.347 176.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.3 m -142.51 64.85 1.36 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.47 0.708 . . . . 1.8100000000000001 111.062 -165.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.3 170.68 16.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.377 0.608 . . . . 4.9900000000000002 109.555 163.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.421 ' NZ ' ' OE1' ' A' ' 78' ' ' GLU . 51.9 mttt -111.9 162.34 15.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.67 -1.974 . . . . 3.71 105.67 172.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -77.33 168.67 19.64 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.979 0.419 . . . . 1.1699999999999999 110.325 169.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.93 161.08 34.75 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 105.802 -2.919 . . . . 2.0299999999999998 105.802 156.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.86 -172.54 7.83 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 117.17 0.485 . . . . 1.8899999999999999 112.509 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 -18.77 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.133 2.555 . . . . 1.8700000000000001 111.376 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.2 -26.76 18.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.312 1.045 . . . . 5.9699999999999998 111.584 173.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.53 159.89 23.54 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.061 0.458 . . . . 2.0099999999999998 109.914 175.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -74.13 -51.43 15.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.387 1.475 . . . . 4.8700000000000001 108.03 170.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 34.9 mt-10 -80.25 168.3 19.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.87 0.843 . . . . 3.54 110.98 -175.007 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.28 150.2 0.07 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.936 2.095 . . . . 4.4900000000000002 106.53 -167.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 71.4 m80 -65.58 155.8 34.66 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 105.278 -2.119 . . . . 0.84999999999999998 105.278 162.335 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.61 48.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 123.355 1.55 . . . . 2.1099999999999999 109.618 170.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.73 34.97 0.06 OUTLIER Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.953 2.216 . . . . 0.85999999999999999 111.512 -175.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.42 136.41 37.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.333 -1.358 . . . . 2.6299999999999999 107.333 157.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.36 -54.72 4.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.649 -1.612 . . . . 1.52 106.649 168.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.97 -114.92 0.63 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.514 -1.434 . . . . 0.64000000000000001 109.514 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -140.75 162.03 36.37 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.942 1.697 . . . . 1.8500000000000001 109.329 -177.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.11 175.65 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.354 1.462 . . . . 0.83999999999999997 107.162 175.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.8 m -129.6 134.29 47.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.365 -0.976 . . . . 2.02 108.365 -178.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.61 137.28 34.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.35 1.06 . . . . 0.53000000000000003 109.731 169.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -87.83 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.857 2.463 . . . . 3.9100000000000001 110.736 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -173.34 -46.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.794 1.238 . . . . 6.1799999999999997 108.745 -156.997 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.403 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 2.3 m-20 -79.16 11.35 2.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.887 1.275 . . . . 4.46 110.407 172.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.25 64.39 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 110.789 -0.925 . . . . 1.05 110.789 -178.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.37 128.31 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 0.72999999999999998 108.464 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.2 114.93 22.66 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.595 -1.631 . . . . 1.3400000000000001 106.595 168.334 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -113.44 93.99 4.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.859 -1.534 . . . . 5.3399999999999999 106.859 -169.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.77 149.34 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.147 -0.933 . . . . 1.9099999999999999 110.359 -162.19 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.8 m -151.12 126.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.383 1.473 . . . . 1.28 107.413 168.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mt -143.22 155.13 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.306 1.043 . . . . 2.27 108.306 -174.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.3 101.06 3.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.573 0.225 . . . . 2.3500000000000001 110.811 157.198 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -89.25 159.71 17.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.941 0.896 . . . . 2.25 108.823 173.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 p -107.65 -15.76 14.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.303 1.841 . . . . 1.51 112.283 -175.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.81 -41.09 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.513 0.597 . . . . 1.05 109.894 -171.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.3 pp -98.19 170.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.312 0.645 . . . . 1.0 111.72 -173.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.6 m -151.34 174.61 13.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.706 1.202 . . . . 1.6000000000000001 110.265 -176.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 22' ' ' GLN . 1.9 pt? -126.49 29.9 5.66 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.957 0.903 . . . . 2.1600000000000001 112.243 170.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 t -81.16 -149.49 0.07 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.634 -0.876 . . . . 3.0299999999999998 108.634 165.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -127.61 69.67 0.52 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.955 1.264 . . . . 4.1299999999999999 109.969 175.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -159.89 -109.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.357 1.063 . . . . 5.6799999999999997 108.318 -175.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -77.44 3.14 14.07 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.22 1.408 . . . . 4.04 110.787 173.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 p -59.25 162.61 4.44 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 122.835 1.302 . . . . 1.97 112.88 177.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.23 -4.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.231 -1.804 . . . . 2.25 111.466 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 tt -38.32 129.87 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.453 1.101 . . . . 2.4199999999999999 110.211 170.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.7 23.72 74.32 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 118.095 0.407 . . . . 1.52 114.042 -174.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.698 ' CZ ' HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.69 176.99 8.99 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.249 1.525 . . . . 8.5999999999999996 108.517 159.744 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -109.31 120.88 43.84 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.072 -0.714 . . . . 0.90000000000000002 109.072 153.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.61 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.6 tm? -73.02 142.39 47.69 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 106.029 -1.841 . . . . 3.2799999999999998 106.029 168.181 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.6 134.17 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.354 1.862 . . . . 0.56000000000000005 106.94 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.62 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 1.5 p -109.19 133.82 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.309 -1.367 . . . . 2.0899999999999999 107.309 164.314 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -109.14 161.62 15.03 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 115.992 1.849 . . . . 0.42999999999999999 115.992 -161.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -34.47 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.896 2.878 . . . . 3.29 112.813 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -80.57 174.99 11.07 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.611 1.164 . . . . 5.2400000000000002 110.482 -170.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.97 142.88 49.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.631 -1.622 . . . . 0.82999999999999996 108.234 150.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.04 152.15 20.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.317 0.647 . . . . 2.8199999999999998 109.296 170.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.83 -4.86 53.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.488 0.586 . . . . 3.6600000000000001 112.506 -179.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 59.82 28.93 18.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.168 1.387 . . . . 1.8400000000000001 109.607 -177.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.46 25.78 68.96 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.695 0.664 . . . . 2.0499999999999998 111.598 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -145.5 45.14 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.718 0.759 . . . . 5.25 109.365 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.93 159.97 27.03 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.152 -1.179 . . . . 2.6299999999999999 110.152 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.35 61.43 3.13 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.353 -1.499 . . . . 3.54 109.353 171.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -177.36 164.77 2.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.487 1.515 . . . . 2.9700000000000002 107.678 -167.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -83.15 -38.39 22.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.775 0.83 . . . . 3.9399999999999999 109.389 173.201 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -42.18 -39.05 1.9 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.413 1.485 . . . . 2.77 112.774 -176.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.8 p -57.22 -61.85 2.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.707 1.203 . . . . 1.8400000000000001 111.25 178.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.4 p -67.68 -42.59 81.86 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.478 -0.764 . . . . 1.3500000000000001 110.187 178.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -57.35 -44.08 84.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.972 1.709 . . . . 3.0299999999999998 111.841 -177.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.516 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.424 8.9 t -138.23 -56.85 0.65 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 2.1400000000000001 111.839 177.918 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 162.19 -22.44 0.2 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 119.415 1.007 . . . . 0.87 112.231 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 45.79 55.6 6.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.064 1.746 . . . . 2.0600000000000001 111.258 -177.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.61 58.2 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 118.953 -1.099 . . . . 1.01 111.934 167.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.36 -161.01 33.71 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 109.063 -1.615 . . . . 0.96999999999999997 109.063 179.283 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.5 p -59.89 151.49 25.71 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.942 1.297 . . . . 1.98 112.752 -169.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.4 mmt-85 -68.01 130.67 43.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.864 2.066 . . . . 3.3900000000000001 108.177 176.006 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.94 -83.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.552 1.069 . . . . 0.68000000000000005 108.663 174.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.669 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -97.98 146.29 25.64 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.296 -1.372 . . . . 0.98999999999999999 107.296 176.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.8 m -147.43 160.56 42.43 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 124.663 1.227 . . . . 2.2200000000000002 107.991 178.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.03 142.18 7.06 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.752 -0.939 . . . . 0.81999999999999995 110.752 172.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.31 139.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.152 1.381 . . . . 0.69999999999999996 108.999 172.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.2 tt -105.65 132.49 52.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.193 0.812 . . . . 1.1399999999999999 113.193 -178.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.76 13.1 0.15 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.482 1.515 . . . . 0.68000000000000005 113.99 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.2 mm -107.72 58.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.836 1.818 . . . . 0.82999999999999996 110.081 -152.237 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 175.35 14.1 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.745 -0.661 . . . . 1.26 110.255 171.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.429 ' OXT' ' N ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.259 1.586 0 C-N-CA 125.09 1.356 . . . . 5.21 108.691 177.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.275 0.102 . . . . 6.5499999999999998 111.275 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m -159.58 105.47 1.64 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.291 -1.744 . . . . 3.25 106.291 173.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -77.8 143.57 37.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.898 -0.408 . . . . 3.0800000000000001 109.898 -171.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.32 137.63 51.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.778 -0.823 . . . . 0.79000000000000004 108.778 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -96.94 144.25 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.32 -0.993 . . . . 0.73999999999999999 108.32 167.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.08 111.57 15.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.929 -1.508 . . . . 0.67000000000000004 106.929 148.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.34 108.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.972 -1.492 . . . . 0.78000000000000003 106.972 156.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.9 125.18 31.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.765 -1.198 . . . . 1.9299999999999999 107.765 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -153.97 -45.31 0.09 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.063 0.545 . . . . 3.6000000000000001 111.561 170.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.35 -109.25 0.39 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.237 0.922 . . . . 1.1599999999999999 113.04 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.1 -55.24 2.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.817 1.247 . . . . 3.3300000000000001 110.245 -172.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 164.48 11.4 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.459 1.028 . . . . 0.93999999999999995 112.339 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.83 -19.54 58.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.567 2.845 . . . . 1.4299999999999999 112.476 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.57 143.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.945 1.298 . . . . 0.89000000000000001 110.634 175.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -155.39 128.4 8.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.467 -0.568 . . . . 1.97 109.467 -176.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.11 177.28 39.91 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.17 -0.331 . . . . 0.53000000000000003 112.354 -177.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.09 133.91 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.882 -1.155 . . . . 1.1699999999999999 107.882 172.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.426 HD13 ' HA3' ' A' ' 33' ' ' GLY . 21.1 mm -102.79 136.33 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.92 1.688 . . . . 1.1599999999999999 106.866 164.076 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.26 112.17 22.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.35 1.46 . . . . 1.74 108.22 163.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -77.57 140.72 39.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.469 1.508 . . . . 2.8199999999999998 108.698 164.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -149.13 168.29 23.62 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.464 -1.68 . . . . 4.5700000000000003 106.464 148.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -151.29 159.32 44.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.739 -1.948 . . . . 3.8799999999999999 105.739 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -64.08 -73.78 0.11 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.998 -1.112 . . . . 6.2599999999999998 107.998 166.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -79.85 -165.66 0.86 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.046 2.538 . . . . 4.8799999999999999 111.138 -169.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -106.61 3.82 27.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.112 1.765 . . . . 2.4500000000000002 110.59 162.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -160.73 78.46 0.62 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.267 2.227 . . . . 3.8999999999999999 108.681 -170.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.68 -170.4 41.16 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 110.258 -1.137 . . . . 1.6599999999999999 110.258 -170.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.79 120.74 7.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.157 2.571 . . . . 1.0700000000000001 114.108 -167.301 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.8 t -79.14 147.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.499 -0.773 . . . . 1.3200000000000001 109.335 175.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 100' ' ' GLU . 65.9 mttm -116.51 110.54 18.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.836 -1.172 . . . . 2.9500000000000002 107.836 159.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 m -95.27 132.22 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.234 -1.395 . . . . 2.25 107.234 169.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -126.83 145.09 50.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.116 -1.438 . . . . 0.92000000000000004 107.116 168.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.09 156.87 29.02 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.36 -0.924 . . . . 0.65000000000000002 112.165 -173.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 m -131.71 83.49 2.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.706 1.602 . . . . 1.75 107.389 -162.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.19 139.09 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.2 1.0 . . . . 0.88 109.13 -168.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 166.67 22.8 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.4 0.619 . . . . 3.8599999999999999 112.26 176.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.13 15.52 69.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.761 1.172 . . . . 0.64000000000000001 113.492 174.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.41 165.03 21.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.603 1.201 . . . . 0.67000000000000004 108.837 172.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -72.58 166.39 22.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.596 -1.261 . . . . 1.72 107.596 150.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.9 175.45 0.5 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.167 0.987 . . . . 3.3300000000000001 110.696 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.65 -156.04 51.61 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.865 -0.607 . . . . 0.5 111.643 169.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.56 145.18 33.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.793 1.637 . . . . 1.9399999999999999 112.48 -171.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -147.73 113.18 5.62 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.032 1.333 . . . . 0.56999999999999995 110.434 -179.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.0 146.26 2.91 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.493 1.044 . . . . 0.57999999999999996 111.316 173.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.76 96.74 3.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.909 -1.886 . . . . 2.2000000000000002 105.909 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.1 m80 -133.43 171.94 13.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.322 -1.362 . . . . 0.85999999999999999 107.322 -164.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 0.3 OUTLIER -130.54 133.44 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 122.147 0.975 . . . . 1.8200000000000001 109.938 173.163 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.406 ' CD2' HG21 ' A' ' 118' ' ' VAL . 44.0 m-70 -109.79 145.64 36.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.051 2.141 . . . . 0.98999999999999999 106.876 -175.528 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -72.31 31.52 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.981 1.474 . . . . 4.5700000000000003 114.981 -168.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.97 62.21 7.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.075 -1.083 . . . . 3.0800000000000001 108.075 -170.487 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -58.88 -26.96 64.75 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.736 0.643 . . . . 4.4900000000000002 112.736 -171.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -129.46 149.31 51.29 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 105.387 -2.079 . . . . 4.75 105.387 151.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -163.32 42.66 0.11 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 128.158 2.583 . . . . 4.5099999999999998 110.191 170.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.6 t -65.96 57.45 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.005 1.722 . . . . 4.1699999999999999 113.875 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -170.46 -44.15 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.37 1.868 . . . . 5.6799999999999997 109.238 -173.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.73 146.5 6.35 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.042 -1.623 . . . . 3.8100000000000001 109.042 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.7 t -75.74 54.9 0.83 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.579 1.552 . . . . 2.9199999999999999 111.98 -170.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.8 p -149.38 80.38 1.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.302 -0.629 . . . . 4.1399999999999997 109.302 -158.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.7 m -170.8 -43.3 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.248 1.203 . . . . 2.6499999999999999 114.248 -144.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.87 170.5 7.9 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.53 -1.285 . . . . 1.77 107.53 151.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.04 -92.43 2.03 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.636 -1.386 . . . . 0.98999999999999999 109.636 -178.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.08 -178.84 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 126.337 4.692 . . . . 1.02 113.21 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -52.52 128.47 26.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.031 1.332 . . . . 1.4199999999999999 109.627 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -45.46 120.24 2.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.753 1.221 . . . . 1.9099999999999999 111.273 175.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -118.46 163.12 26.95 Favored Pre-proline 0 C--O 1.227 -0.1 0 C-N-CA 127.314 2.246 . . . . 3.6499999999999999 109.747 164.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.45 -53.01 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.194 1.263 . . . . 1.6699999999999999 108.85 154.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.66 -77.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.281 1.032 . . . . 3.2200000000000002 109.998 169.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -135.5 71.03 1.43 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.306 1.042 . . . . 2.3100000000000001 110.459 -165.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -79.38 172.21 14.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.715 -1.216 . . . . 4.9800000000000004 107.715 156.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -129.11 162.89 26.7 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 127.019 2.128 . . . . 3.0 105.946 177.882 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -76.6 162.91 27.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.693 0.797 . . . . 1.1599999999999999 110.933 -169.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.14 -123.17 0.67 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 105.518 -3.033 . . . . 1.99 105.518 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.24 -140.48 3.06 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 107.957 -2.057 . . . . 1.8100000000000001 107.957 169.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.31 -47.78 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 CA-C-N 120.091 1.946 . . . . 1.71 109.011 168.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -59.18 -42.15 90.17 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 126.133 1.773 . . . . 5.4299999999999997 112.987 -171.058 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.8 176.93 2.28 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.756 -1.566 . . . . 1.98 111.467 -168.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.07 -52.46 6.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.004 1.322 . . . . 5.1100000000000003 108.21 164.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 9.1 mt-10 -80.33 175.91 10.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.693 0.797 . . . . 2.75 111.424 -177.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 161.04 143.15 0.01 OUTLIER 'General case' 0 C--O 1.239 0.535 0 C-N-CA 129.958 3.303 . . . . 3.2200000000000002 106.498 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 64.2 m80 -60.06 153.26 22.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.335 -1.357 . . . . 0.69999999999999996 107.335 166.154 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.0 -37.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 117.796 -1.562 . . . . 1.3200000000000001 109.991 -169.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.82 73.11 0.87 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.229 -0.748 . . . . 0.90000000000000002 111.229 167.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -168.14 103.37 0.46 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.786 -0.82 . . . . 2.0899999999999999 108.786 -175.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.86 -51.39 8.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.195 0.598 . . . . 1.6699999999999999 109.541 176.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.83 -119.86 0.94 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.404 -1.478 . . . . 0.60999999999999999 109.404 -177.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -137.91 166.5 23.89 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 124.407 1.083 . . . . 1.5700000000000001 110.291 174.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.12 177.14 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.462 -1.681 . . . . 0.45000000000000001 106.462 166.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.1 t -122.51 155.26 36.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.695 -0.854 . . . . 2.0899999999999999 108.695 164.183 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.86 141.76 48.35 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.45 1.1 . . . . 0.80000000000000004 110.352 164.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.83 -75.28 0.12 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.1 0.96 . . . . 2.9399999999999999 111.389 -171.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -153.94 -44.26 0.09 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.321 1.048 . . . . 3.7200000000000002 110.973 -169.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.84 7.77 6.56 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.297 1.046 . . . . 2.6000000000000001 111.39 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.71 8.12 84.05 Favored Glycine 0 CA--C 1.524 0.636 0 O-C-N 121.266 -0.896 . . . . 0.68000000000000005 111.75 -175.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.54 128.61 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.218 1.407 . . . . 0.76000000000000001 107.713 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.89 175.24 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.213 1.405 . . . . 0.97999999999999998 109.169 173.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -121.88 145.28 48.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.964 -2.606 . . . . 3.3599999999999999 103.964 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.21 58.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.331 -0.548 . . . . 1.48 111.391 167.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.4 m -90.08 88.03 7.12 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.607 1.163 . . . . 0.84999999999999998 109.098 172.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.1 mm -125.67 156.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 108.942 -0.762 . . . . 2.1200000000000001 108.942 -177.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 30' ' ' LYS . 8.0 pt-20 -140.12 142.15 36.06 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.658 0.383 . . . . 2.6499999999999999 110.616 164.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.23 148.52 44.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.475 1.51 . . . . 2.2799999999999998 109.259 176.018 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.5 p -102.74 -4.26 25.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.789 2.036 . . . . 1.4299999999999999 113.249 -173.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.97 -45.77 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.658 1.183 . . . . 1.0800000000000001 108.807 -178.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -76.49 176.14 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.473 0.654 . . . . 1.3600000000000001 110.969 176.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -165.7 176.58 7.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.592 1.957 . . . . 1.9399999999999999 107.208 177.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -6.3 57.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.963 . . . . 3.3900000000000001 112.928 175.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m -154.63 161.01 41.78 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.157 2.183 . . . . 3.5899999999999999 108.498 -172.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.09 -159.13 14.08 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.673 1.13 . . . . 3.3900000000000001 111.117 178.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.44 -52.62 6.7 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.297 1.439 . . . . 4.8600000000000003 108.347 -179.147 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -80.68 -10.24 59.74 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.132 1.373 . . . . 3.9500000000000002 112.563 -170.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.1 p -60.22 154.91 18.69 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.837 0.855 . . . . 1.6899999999999999 112.055 -178.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.277 1.8 pp -111.8 -6.2 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.144 -0.934 . . . . 1.6699999999999999 111.833 -177.362 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.86 133.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 162.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.06 47.44 81.99 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.58 -1.008 . . . . 2.25 110.58 -173.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -142.42 168.92 18.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.906 -1.887 . . . . 4.6799999999999997 105.906 165.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 m -101.02 115.42 30.44 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.579 -0.526 . . . . 1.04 109.579 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.5 mt -66.8 148.73 51.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.845 -0.798 . . . . 1.97 108.845 165.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 48' ' ' HIS . 92.1 t -134.01 137.9 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.94 2.096 . . . . 0.59999999999999998 106.588 175.013 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 m -113.0 129.52 68.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.74 -1.207 . . . . 1.79 107.74 169.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.476 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 45.3 m-70 -107.29 159.94 15.99 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 117.361 2.356 . . . . 0.65000000000000002 117.361 -163.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -32.02 -76.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.55 3.14 . . . . 3.5699999999999998 112.908 168.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.69 -174.36 2.44 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.913 0.885 . . . . 2.75 110.491 -171.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.58 148.79 18.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.987 -0.745 . . . . 0.55000000000000004 108.987 157.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.04 168.65 18.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.738 -0.838 . . . . 2.1899999999999999 108.738 154.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.46 -38.81 48.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.066 0.765 . . . . 4.2800000000000002 113.066 -168.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 82.2 46.05 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.835 2.854 . . . . 1.55 110.691 -169.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.94 43.53 98.76 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.472 1.034 . . . . 1.8600000000000001 112.051 165.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -155.11 -16.37 0.11 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.806 1.409 . . . . 5.1900000000000004 114.806 -170.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.3 146.18 47.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 120.496 1.498 . . . . 1.99 110.928 -178.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.54 -24.3 69.34 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.791 0.71 . . . . 2.6499999999999999 114.202 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 159.85 14.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.227 -1.027 . . . . 2.52 108.227 174.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -46.82 76.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 3.8900000000000001 107.646 167.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -40.39 -48.49 2.73 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.374 2.67 . . . . 4.0499999999999998 111.64 -175.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -63.38 0.83 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.535 1.534 . . . . 1.9199999999999999 110.702 176.093 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -71.62 -41.99 68.2 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.052 -1.03 . . . . 1.1899999999999999 111.597 177.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.57 -37.26 84.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.334 1.454 . . . . 3.6299999999999999 110.924 -166.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.431 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.257 0.7 OUTLIER -133.3 -51.97 0.88 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.232 1.013 . . . . 1.29 111.545 173.218 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.05 -22.49 0.52 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.715 0.689 . . . . 0.93000000000000005 114.287 -177.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 44.71 54.42 6.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.302 1.441 . . . . 2.2999999999999998 111.561 -163.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.598 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -59.12 -39.38 82.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.568 1.147 . . . . 1.1699999999999999 111.217 166.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.89 -171.33 44.7 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 108.682 -1.767 . . . . 0.98999999999999999 108.682 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.7 m -59.17 153.07 19.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 126.028 1.731 . . . . 1.1899999999999999 114.091 -166.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -59.55 137.22 58.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.21 1.804 . . . . 2.54 108.83 168.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.9 mt -114.84 -85.26 0.61 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.775 -1.195 . . . . 0.53000000000000003 107.775 169.536 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.16 154.77 18.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.522 -0.918 . . . . 0.89000000000000001 108.522 172.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.2 m -146.22 165.11 30.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.603 -1.18 . . . . 1.96 108.408 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.39 134.46 3.09 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.498 -1.041 . . . . 0.65000000000000002 110.498 173.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.97 130.85 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.575 -1.269 . . . . 0.70999999999999996 107.575 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.2 tt -102.22 129.87 52.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.244 0.545 . . . . 0.97999999999999998 111.897 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.59 3.99 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.603 1.097 . . . . 0.56000000000000005 115.429 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mm -98.28 56.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 119.989 1.894 . . . . 0.90000000000000002 109.917 -156.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.24 173.57 16.76 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.27 0.628 . . . . 1.5900000000000001 110.305 169.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 C--O 1.255 1.378 0 N-CA-C 102.5 -3.148 . . . . 4.8200000000000003 102.5 159.919 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 108.199 -1.038 . . . . 4.7599999999999998 108.199 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 p -64.63 82.35 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.836 1.254 . . . . 2.9300000000000002 109.1 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 140.76 40.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.297 -0.631 . . . . 3.9300000000000002 109.297 179.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.85 18.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.875 -0.787 . . . . 1.01 108.875 168.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.575 HG23 ' HB2' ' A' ' 152' ' ' ALA . 60.4 t -106.71 152.61 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 105.585 -2.005 . . . . 0.93000000000000005 105.585 158.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -132.61 93.52 3.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.516 -0.92 . . . . 0.66000000000000003 108.516 158.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -70.66 107.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.926 -1.509 . . . . 0.73999999999999999 106.926 169.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.563 ' CD1' HD12 ' A' ' 117' ' ' LEU . 25.0 mt -92.46 128.23 38.24 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.368 0.667 . . . . 1.0 109.712 178.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 -48.21 0.15 Allowed 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.155 1.382 . . . . 4.6699999999999999 109.863 172.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.55 -120.47 2.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.084 1.326 . . . . 1.1399999999999999 112.808 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -97.07 -59.0 1.88 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.647 -1.242 . . . . 3.9500000000000002 107.647 -169.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.98 176.65 2.41 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.66 2.076 . . . . 1.27 115.15 -173.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.81 -25.95 16.35 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.742 2.961 . . . . 1.6100000000000001 111.817 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.81 141.99 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.719 1.208 . . . . 1.25 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -153.71 121.99 6.17 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.319 -0.993 . . . . 1.96 108.319 -171.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.58 172.06 37.69 Favored Glycine 0 C--N 1.333 0.372 0 O-C-N 121.832 -0.542 . . . . 0.56999999999999995 112.514 -174.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.38 125.1 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.946 -0.761 . . . . 1.29 108.946 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 17.9 mm -88.71 139.65 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 107.029 -1.471 . . . . 0.75 107.029 160.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -129.61 108.07 9.93 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.903 -1.517 . . . . 2.8399999999999999 106.903 171.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.521 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 35.9 t80 -130.67 120.8 24.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.879 -1.156 . . . . 3.4500000000000002 107.879 -155.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.15 159.93 41.18 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.785 0.721 . . . . 3.5600000000000001 111.35 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -145.61 141.76 28.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.018 -2.586 . . . . 3.8900000000000001 104.018 -175.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -107.35 -29.84 9.04 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.25 1.02 . . . . 6.0599999999999996 109.444 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -77.99 164.76 24.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 128.72 2.808 . . . . 4.8200000000000003 109.433 -178.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -77.97 -67.79 0.69 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.158 0.983 . . . . 4.54 109.176 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -111.88 85.47 2.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.346 -1.724 . . . . 3.7400000000000002 106.346 170.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.17 174.47 32.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.388 -1.485 . . . . 1.3600000000000001 109.388 178.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 140.97 47.83 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.191 2.594 . . . . 1.3500000000000001 111.647 -167.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 4.3 t -91.2 140.46 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.22 -0.659 . . . . 1.1699999999999999 109.22 -179.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -95.12 105.59 17.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.54 -1.652 . . . . 5.0099999999999998 106.54 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.5 85.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.378 1.471 . . . . 1.25 108.689 -169.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -99.24 145.16 27.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.206 -0.665 . . . . 0.90000000000000002 109.206 169.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.73 149.82 18.15 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.172 -1.171 . . . . 0.79000000000000004 110.172 -177.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 p -130.15 105.23 7.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.677 -1.972 . . . . 1.8999999999999999 105.677 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.68 143.75 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 106.888 -1.523 . . . . 0.90000000000000002 106.888 -169.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -143.7 -178.73 6.05 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.944 1.461 . . . . 4.79 114.944 167.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.91 76.81 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 113.94 -1.482 . . . . 0.69999999999999996 112.322 -179.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -72.61 163.14 28.54 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.264 1.032 . . . . 0.69999999999999996 108.31 172.248 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.86 163.66 25.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.701 -1.222 . . . . 1.8400000000000001 107.701 153.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.91 171.09 0.54 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.702 0.763 . . . . 2.5699999999999998 111.227 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.92 -158.61 53.43 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.747 -0.661 . . . . 0.48999999999999999 113.038 166.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.23 143.86 46.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.232 0.613 . . . . 2.0699999999999998 111.396 -171.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -139.42 127.0 21.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.392 1.477 . . . . 0.58999999999999997 108.697 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.51 152.04 7.51 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.344 -1.102 . . . . 0.48999999999999999 110.344 171.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -144.0 90.88 2.16 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.067 -1.457 . . . . 2.8500000000000001 107.067 -173.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -137.28 143.77 42.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.674 -1.232 . . . . 0.92000000000000004 107.674 -162.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.2 m -98.93 129.15 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.49 1.041 . . . . 2.1000000000000001 110.39 178.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -109.8 155.22 21.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.375 1.07 . . . . 1.02 108.712 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 11.77 0.39 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.795 1.638 . . . . 5.2699999999999996 113.655 -167.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HG2' ' HB3' ' A' ' 60' ' ' ALA . 1.2 mt-10 -77.14 66.13 2.88 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.417 1.008 . . . . 3.3399999999999999 109.855 -173.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -61.12 -52.99 62.54 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.882 -0.785 . . . . 4.7300000000000004 108.882 176.107 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -76.17 126.16 30.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.101 -1.074 . . . . 5.5800000000000001 108.101 166.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -145.05 42.77 1.31 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.406 1.883 . . . . 4.7800000000000002 107.278 168.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.7 m -63.11 -50.11 71.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.197 0.599 . . . . 4.0199999999999996 110.755 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -111.73 110.07 20.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.71 0.804 . . . . 5.9100000000000001 109.617 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.04 -166.41 1.39 Allowed Glycine 0 CA--C 1.532 1.151 0 CA-C-N 114.461 -1.245 . . . . 4.25 111.636 -172.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.23 -164.05 1.59 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.178 -0.675 . . . . 2.71 109.178 170.628 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.4 m 70.67 81.1 0.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.205 -1.035 . . . . 6.2800000000000002 108.205 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.7 m -177.29 30.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.232 0.826 . . . . 3.4500000000000002 113.232 -134.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . . . -167.39 -172.55 1.99 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.696 1.598 . . . . 1.7 107.476 166.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.2 -127.75 3.88 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 119.244 0.929 . . . . 1.55 112.048 -171.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.35 -179.7 5.43 Favored 'Trans proline' 0 N--CA 1.457 -0.667 1 C-N-CA 125.378 4.052 . . . . 1.3100000000000001 111.597 -176.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -44.8 125.92 5.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 118.856 -0.592 . . . . 1.27 109.946 171.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -46.62 119.58 2.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.71 0.631 . . . . 2.6899999999999999 109.939 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -156.37 157.04 30.91 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 126.544 1.938 . . . . 2.6499999999999999 106.888 174.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.26 -27.42 13.57 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.148 1.898 . . . . 1.49 113.502 -170.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.21 -63.93 0.11 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.133 0.879 . . . . 3.8399999999999999 111.569 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.5 m -158.87 81.45 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.468 1.107 . . . . 2.4300000000000002 109.287 171.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -74.73 167.65 21.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.26 -1.755 . . . . 4.9699999999999998 106.26 157.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -119.3 166.08 13.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.952 -1.499 . . . . 4.6299999999999999 106.952 -176.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -93.95 149.98 20.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 111.81 0.3 . . . . 1.0900000000000001 111.81 -175.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.37 176.74 39.51 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 105.31 -3.116 . . . . 1.8300000000000001 105.31 158.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.42 -172.32 47.78 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 117.856 0.828 . . . . 1.8999999999999999 111.268 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.89 -24.36 21.12 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.101 2.534 . . . . 1.78 110.624 172.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -65.84 -44.12 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.522 0.729 . . . . 5.5800000000000001 109.822 171.152 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.65 163.21 27.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.418 -0.81 . . . . 2.0299999999999998 109.716 175.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.06 -37.92 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.749 0.82 . . . . 5.5 108.925 163.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.18 152.15 41.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.543 -0.91 . . . . 3.02 108.543 -173.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 166.04 143.8 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.782 2.033 . . . . 3.29 111.129 -167.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.462 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 57.6 m80 -65.24 154.5 37.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.489 -0.93 . . . . 0.98999999999999999 108.489 166.762 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.43 -40.57 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.948 -0.76 . . . . 1.8500000000000001 108.948 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.42 62.14 1.75 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.627 0.632 . . . . 0.69999999999999996 111.849 173.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -165.67 97.93 0.67 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.398 -0.964 . . . . 2.1600000000000001 108.398 -172.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.38 -43.48 15.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.998 -0.547 . . . . 2.3199999999999998 109.634 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.2 -100.87 0.19 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.474 -0.87 . . . . 0.67000000000000004 112.864 177.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -155.53 166.33 33.87 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.747 1.619 . . . . 1.54 109.954 -169.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.49 155.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.713 1.205 . . . . 0.54000000000000004 108.34 173.44 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.9 p -107.26 109.16 20.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.772 1.629 . . . . 3.1499999999999999 108.83 -176.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.71 138.8 37.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.717 0.689 . . . . 0.54000000000000004 111.127 171.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.14 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.207 0.942 . . . . 2.6200000000000001 109.536 177.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 93' ' ' GLY . 16.5 tttt -157.48 -30.23 0.08 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.827 1.417 . . . . 3.8900000000000001 114.827 -170.753 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -80.25 21.92 0.57 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.757 1.741 . . . . 2.8700000000000001 110.665 164.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 64.12 12.96 51.9 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 125.458 1.504 . . . . 0.83999999999999997 111.739 -175.089 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.8 t -78.65 133.05 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.796 -1.187 . . . . 0.72999999999999998 107.796 -176.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.54 155.23 46.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.447 1.499 . . . . 0.81999999999999995 107.157 168.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -120.44 143.23 48.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.718 -2.327 . . . . 2.7999999999999998 104.718 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.39 131.69 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.339 -1.356 . . . . 1.3200000000000001 107.339 165.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.5 m -148.32 73.47 1.25 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.046 1.338 . . . . 1.47 107.962 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -111.72 152.51 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.974 0.909 . . . . 2.3199999999999998 108.723 -175.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -132.39 88.23 2.51 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.635 -0.876 . . . . 4.1799999999999997 108.635 164.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.62 152.87 29.78 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.6 0.36 . . . . 2.5699999999999998 110.303 176.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -124.2 34.53 5.02 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.022 1.329 . . . . 1.6299999999999999 111.325 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.36 -52.0 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.434 1.093 . . . . 1.45 108.395 175.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -74.54 174.59 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.255 0.55 . . . . 1.1399999999999999 110.772 176.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -149.44 171.71 16.13 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.411 -1.329 . . . . 2.5800000000000001 107.411 170.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -101.8 5.44 41.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.525 0.73 . . . . 2.52 111.944 169.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 m -70.28 -160.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.124 1.77 . . . . 2.96 111.022 -177.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -113.23 74.67 0.23 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.397 -1.481 . . . . 3.8399999999999999 109.397 175.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -147.62 -126.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.619 -1.252 . . . . 5.1399999999999997 107.619 -176.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -79.33 4.0 16.53 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.037 1.335 . . . . 4.0899999999999999 111.371 171.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 p -46.48 151.86 0.51 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.71 2.004 . . . . 1.5900000000000001 111.931 175.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -6.4 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.212 1.005 . . . . 2.2200000000000002 111.024 -178.575 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.0 tp -19.99 117.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 126.718 2.007 . . . . 1.96 111.69 163.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.4 -32.34 7.64 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 119.519 -0.601 . . . . 2.4700000000000002 113.785 -177.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 177.36 8.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.752 1.776 . . . . 10.59 114.672 -153.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.489 HG23 ' HB2' ' A' ' 146' ' ' CYS . 0.9 OUTLIER -92.3 123.53 35.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.362 1.065 . . . . 1.54 111.277 169.483 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.563 HD12 ' CD1' ' A' ' 8' ' ' LEU . 3.2 tm? -80.25 132.11 35.79 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.513 -1.291 . . . . 3.8199999999999998 107.513 162.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.26 117.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 107.274 -1.38 . . . . 0.85999999999999999 107.274 170.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.07 114.98 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 104.685 -2.339 . . . . 1.8799999999999999 104.685 164.459 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -90.13 161.52 15.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 115.828 1.788 . . . . 0.64000000000000001 115.828 -164.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -40.81 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.244 2.618 . . . . 3.1800000000000002 112.532 169.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -89.2 -179.2 5.83 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.306 0.957 . . . . 3.3700000000000001 109.723 179.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 155.4 16.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.703 -0.851 . . . . 0.76000000000000001 108.703 157.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -74.66 165.9 24.46 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.233 -0.655 . . . . 2.4500000000000002 109.233 167.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -70.85 -19.5 62.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 117.829 -1.081 . . . . 3.4100000000000001 112.389 -175.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 59.16 39.63 22.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.664 1.12 . . . . 2.27 109.816 -160.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.18 42.66 82.69 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.025 0.821 . . . . 1.9399999999999999 111.533 172.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.94 -22.01 43.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.057 0.943 . . . . 7.4900000000000002 110.73 -171.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.3 -155.51 26.21 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.976 -0.85 . . . . 2.8799999999999999 110.976 177.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.41 -68.12 1.2 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.935 -1.666 . . . . 3.2599999999999998 108.935 -170.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.12 118.0 14.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.327 -1.731 . . . . 2.98 106.327 167.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -49.83 -45.33 50.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.306 1.412 . . . . 3.5299999999999998 109.602 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -35.74 -41.24 0.21 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.593 2.757 . . . . 3.1000000000000001 112.657 170.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -49.37 -65.19 0.61 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.684 1.594 . . . . 1.73 109.024 179.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 -41.95 69.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.36 1.064 . . . . 1.55 110.819 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -67.12 -32.31 73.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.989 0.516 . . . . 6.2300000000000004 111.556 -169.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.462 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.382 13.5 t -139.54 -58.57 0.58 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 118.132 -0.937 . . . . 2.0099999999999998 111.398 174.482 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.99 -21.26 0.2 Allowed Glycine 0 N--CA 1.463 0.436 0 CA-C-N 119.556 1.071 . . . . 0.96999999999999997 113.309 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.6 t30 52.5 54.84 9.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.848 1.259 . . . . 1.8100000000000001 111.256 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.72 59.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.159 0.8 . . . . 1.1799999999999999 113.159 168.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 -159.35 34.22 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 108.526 -1.83 . . . . 0.93000000000000005 108.526 -177.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.4 m -62.54 151.67 36.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.959 -1.12 . . . . 1.26 113.639 -163.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt-85 -61.44 141.36 57.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.712 -1.585 . . . . 3.4300000000000002 108.896 166.152 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.8 mt -111.97 -82.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.728 -0.841 . . . . 0.69999999999999996 108.728 169.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.56 167.31 10.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.134 0.574 . . . . 0.88 110.411 177.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.489 ' HB2' HG23 ' A' ' 116' ' ' THR . 1.2 p -154.54 170.64 20.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.653 1.181 . . . . 2.5800000000000001 109.451 173.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.6 143.75 4.18 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 124.417 1.073 . . . . 0.77000000000000002 111.189 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.39 134.08 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.752 1.221 . . . . 1.8300000000000001 109.549 174.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 13.4 tt -89.55 126.97 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.326 -0.62 . . . . 0.93000000000000005 109.326 161.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.38 -4.32 0.49 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.785 -0.643 . . . . 0.82999999999999996 114.562 176.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.92 57.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 118.778 1.289 . . . . 1.1899999999999999 111.298 -157.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.575 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.98 168.91 26.08 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.739 0.816 . . . . 1.3700000000000001 110.578 160.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 101.658 -3.46 . . . . 6.3200000000000003 101.658 159.494 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.662 -0.125 . . . . 7.2300000000000004 110.662 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.96 156.19 17.18 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.114 -1.439 . . . . 3.9500000000000002 107.114 -177.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -93.73 165.38 12.73 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.505 -0.924 . . . . 2.8599999999999999 108.505 166.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.01 143.78 42.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.977 -1.49 . . . . 0.68999999999999995 106.977 159.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 152' ' ' ALA . 93.9 t -105.85 144.23 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.434 -1.691 . . . . 0.90000000000000002 106.434 165.153 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.51 97.09 5.04 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.702 -0.851 . . . . 0.48999999999999999 108.702 156.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.6 t -67.55 109.41 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.981 -1.489 . . . . 0.68000000000000005 106.981 164.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -93.73 122.5 36.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.564 -0.902 . . . . 0.84999999999999998 108.564 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -139.42 -53.25 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.651 -1.24 . . . . 4.3600000000000003 107.651 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.52 -113.12 2.46 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.193 0.901 . . . . 1.1899999999999999 110.88 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -109.68 -65.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.524 -1.288 . . . . 3.8100000000000001 107.524 -163.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.56 2.03 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 129.318 3.342 . . . . 1.23 115.068 -172.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.7 -26.16 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.797 2.998 . . . . 1.71 112.094 -176.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.18 143.67 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.753 1.221 . . . . 0.87 110.601 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -155.18 132.19 10.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.328 -0.99 . . . . 2.0099999999999998 108.328 -175.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.97 172.72 42.77 Favored Glycine 0 N--CA 1.451 -0.36 0 O-C-N 121.86 -0.525 . . . . 0.5 112.464 -175.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.11 129.78 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.54 -1.281 . . . . 1.1000000000000001 107.54 176.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mm -96.93 137.84 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.218 1.407 . . . . 0.70999999999999996 107.44 164.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -113.7 122.75 48.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.274 -1.38 . . . . 1.8799999999999999 107.274 160.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.468 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -105.1 130.6 53.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.407 1.883 . . . . 2.5099999999999998 106.222 172.814 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -135.75 148.21 48.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.986 0.812 . . . . 3.9500000000000002 109.906 168.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -155.3 133.63 11.72 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.255 -1.016 . . . . 3.25 108.255 166.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -44.17 71.7 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.572 -0.899 . . . . 4.3099999999999996 108.572 177.09 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -77.33 -177.16 4.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.438 1.495 . . . . 4.0899999999999999 109.597 -170.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.4 p -82.86 -67.92 0.75 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.502 1.521 . . . . 3.77 107.86 169.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -117.1 109.65 17.22 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.168 1.387 . . . . 3.9500000000000002 107.643 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.87 -155.01 7.01 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 108.511 -1.836 . . . . 1.6799999999999999 108.511 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.5 114.11 2.96 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.385 2.056 . . . . 2.0099999999999998 109.515 173.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.14 146.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.232 -0.655 . . . . 1.02 109.232 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -100.27 118.53 36.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.28 -1.748 . . . . 2.6499999999999999 106.28 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.468 HG22 ' CE1' ' A' ' 20' ' ' PHE . 34.0 t -117.1 122.19 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 107.794 -1.187 . . . . 1.1599999999999999 107.794 177.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -141.04 142.14 34.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.024 0.375 . . . . 0.85999999999999999 110.174 169.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.84 -178.22 38.01 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 108.535 -1.826 . . . . 0.92000000000000004 108.535 175.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.6 p -148.12 108.68 4.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.263 -2.125 . . . . 2.0499999999999998 105.263 169.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.28 126.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.128 -2.175 . . . . 1.1699999999999999 105.128 -176.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 157.84 24.03 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.486 0.66 . . . . 4.9500000000000002 111.45 -175.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 15.5 62.51 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 114.583 -1.19 . . . . 0.67000000000000004 114.079 176.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.98 159.08 23.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.293 1.547 . . . . 0.71999999999999997 109.57 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.18 166.61 13.71 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.288 -1.005 . . . . 1.6499999999999999 108.288 155.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -63.79 177.85 0.69 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.104 -0.998 . . . . 2.5 111.56 -175.041 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.78 -159.53 52.21 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.759 0.695 . . . . 0.53000000000000003 114.076 167.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.91 150.05 41.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.193 0.997 . . . . 2.0800000000000001 110.493 -177.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -143.58 116.92 9.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.336 1.054 . . . . 0.51000000000000001 110.086 178.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.13 141.71 19.92 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.538 -1.425 . . . . 0.45000000000000001 109.538 169.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -140.09 96.7 3.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.468 -1.308 . . . . 2.54 107.468 -172.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.742 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 27.9 m170 -131.79 146.42 52.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.503 -1.295 . . . . 0.57999999999999996 107.503 -160.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.83 113.66 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.263 1.03 . . . . 1.6399999999999999 108.446 172.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -79.63 -174.28 4.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.137 -1.392 . . . . 1.3300000000000001 108.446 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -115.84 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 118.317 -0.849 . . . . 5.3700000000000001 109.071 166.362 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 54.63 98.41 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.613 1.165 . . . . 5.0199999999999996 112.794 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -84.95 -158.7 0.38 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.818 0.818 . . . . 4.1900000000000004 110.882 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -86.15 83.38 7.75 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.037 1.335 . . . . 7.04 110.734 -164.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.57 -32.1 0.25 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.928 0.714 . . . . 6.0899999999999999 112.928 -173.118 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.9 t -161.87 173.52 14.41 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 119.758 1.163 . . . . 5.2699999999999996 109.15 168.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.65 -29.7 22.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.166 0.987 . . . . 6.4100000000000001 109.698 163.642 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.17 66.99 3.09 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.173 -0.793 . . . . 3.75 111.922 -171.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.555 ' SG ' HG21 ' A' ' 116' ' ' THR . 5.3 m -20.04 96.79 0.01 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.265 2.626 . . . . 2.3399999999999999 113.317 179.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.61 -4.98 58.93 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.533 0.938 . . . . 4.4900000000000002 113.533 -159.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 m 172.03 -6.45 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.653 2.094 . . . . 3.0099999999999998 116.653 -117.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.59 18.28 0.34 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.303 1.964 . . . . 3.3599999999999999 116.303 -145.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 42.2 -150.04 0.35 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.42 1.486 . . . . 1.3300000000000001 114.223 173.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.43 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.863 3.042 . . . . 1.3 111.142 173.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -66.27 59.79 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.721 2.009 . . . . 1.9099999999999999 112.252 -178.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 48.82 58.53 5.22 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.194 0.998 . . . . 1.8899999999999999 109.186 -176.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -87.62 114.95 61.25 Favored Pre-proline 0 C--N 1.34 0.153 0 CA-C-O 118.066 -0.969 . . . . 2.7599999999999998 108.481 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.16 -34.67 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.654 1.569 . . . . 1.2 111.425 -178.45 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -156.32 -76.63 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.526 -0.916 . . . . 2.5600000000000001 108.526 177.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.2 m -138.79 59.03 1.64 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.101 0.961 . . . . 1.6299999999999999 110.599 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -77.94 163.51 25.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.63 -0.878 . . . . 4.2599999999999998 108.63 162.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -125.58 153.78 43.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.299 1.839 . . . . 3.73 107.718 -171.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -76.97 164.68 25.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.032 0.444 . . . . 1.03 110.827 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.55 156.5 22.1 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 106.133 -2.787 . . . . 2.2799999999999998 106.133 168.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.18 -156.44 12.6 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 109.915 -1.274 . . . . 1.3899999999999999 109.915 173.224 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.35 -44.49 4.69 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.541 1.494 . . . . 1.49 108.936 165.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -59.01 -43.84 91.59 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.549 1.54 . . . . 5.5800000000000001 112.308 -173.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -55.91 166.89 0.66 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.424 1.09 . . . . 2.48 111.328 -177.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -82.32 -47.86 11.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.436 1.894 . . . . 4.71 109.665 170.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.46 175.9 10.19 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.374 1.07 . . . . 3.98 110.112 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 170.28 148.08 0.03 OUTLIER 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.422 3.089 . . . . 3.73 107.191 168.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 40.0 m80 -61.73 148.58 42.41 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 117.614 -1.634 . . . . 0.56000000000000005 106.791 171.132 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 p -53.58 -23.04 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.236 -0.438 . . . . 1.3 110.665 174.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.97 43.09 1.8 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.805 1.082 . . . . 0.77000000000000002 115.805 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -140.66 138.69 34.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.984 1.892 . . . . 2.04 111.385 153.644 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.7 -44.09 7.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.972 1.309 . . . . 3.02 108.119 166.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.85 -103.13 0.23 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.608 -1.397 . . . . 0.88 109.608 177.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -145.29 170.88 15.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.805 1.642 . . . . 1.52 111.516 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.07 170.95 18.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 127.055 2.142 . . . . 0.57999999999999996 107.877 174.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.77 109.67 15.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.726 1.61 . . . . 2.9300000000000002 109.718 -170.62 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.55 139.54 38.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.548 -0.72 . . . . 0.59999999999999998 111.496 174.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.02 -92.14 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.38 1.472 . . . . 4.25 109.886 172.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -175.28 -32.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.878 1.271 . . . . 3.4700000000000002 111.795 -163.044 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.91 8.12 4.1 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 123.39 1.567 . . . . 3.3999999999999999 109.64 153.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.84 72.74 Favored Glycine 0 N--CA 1.442 -0.935 0 O-C-N 120.639 -1.288 . . . . 0.95999999999999996 110.217 177.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.3 t -82.93 111.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.943 1.297 . . . . 1.04 107.611 -177.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.53 155.15 21.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.535 1.134 . . . . 1.1299999999999999 110.041 172.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -102.0 57.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.859 2.464 . . . . 6.2400000000000002 107.502 -165.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.07 85.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.996 -0.742 . . . . 1.52 108.996 -163.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.1 m -143.76 119.41 10.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.124 -0.695 . . . . 1.47 109.124 173.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.31 152.69 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.173 -1.047 . . . . 2.1800000000000002 108.173 -173.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -131.72 92.45 3.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.705 -1.22 . . . . 2.8799999999999999 107.705 167.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.6 151.3 21.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.259 0.624 . . . . 2.3700000000000001 110.569 176.375 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -121.06 -0.48 9.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.224 1.81 . . . . 3.3399999999999999 112.651 173.27 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.0 t -78.56 -51.21 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.752 -1.203 . . . . 1.6499999999999999 107.752 174.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.13 168.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.299 0.571 . . . . 1.2 110.319 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.8 m -131.66 178.53 6.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.127 2.171 . . . . 1.96 106.509 174.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.44 ' HA ' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -100.01 9.74 42.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.21 0.914 . . . . 3.2000000000000002 112.453 171.871 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 p -76.68 110.41 11.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.918 1.287 . . . . 4.5099999999999998 109.312 -166.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.29 72.56 0.14 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.867 1.222 . . . . 4.2699999999999996 112.393 -176.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -162.3 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.615 2.366 . . . . 4.0300000000000002 105.066 -172.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -77.57 -31.58 53.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.725 1.21 . . . . 3.29 110.919 178.071 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.9 p -66.06 179.54 0.91 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.082 1.42 . . . . 2.2000000000000002 112.83 -175.132 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -7.55 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 113.534 -1.666 . . . . 1.6699999999999999 110.893 179.453 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 106' ' ' LEU . 1.5 mp -58.74 131.79 23.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.413 0 CA-C-N 119.823 1.192 . . . . 2.6899999999999999 107.969 171.292 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.07 23.67 68.29 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.24 -0.755 . . . . 1.79 111.687 -170.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.528 ' O ' HG22 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -130.41 168.82 16.35 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.085 1.443 . . . . 5.0499999999999998 109.173 167.449 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.555 HG21 ' SG ' ' A' ' 57' ' ' CYS . 19.9 m -100.06 110.57 22.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.583 0.753 . . . . 0.93000000000000005 112.681 -169.065 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mt -67.05 141.9 57.36 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.219 -1.03 . . . . 1.5600000000000001 108.219 170.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.6 t -132.31 140.23 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 127.889 2.475 . . . . 0.39000000000000001 107.148 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 p -112.5 127.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.663 1.185 . . . . 1.75 108.204 167.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.531 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 56.9 m-70 -105.25 163.35 12.66 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.785 1.634 . . . . 0.46999999999999997 113.611 -171.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.471 ' HB2' HD21 ' A' ' 144' ' ' LEU 0.28 8.7 tt0 -76.71 -53.52 7.87 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 115.035 1.494 . . . . 6.1699999999999999 115.035 -178.005 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -78.93 177.46 8.75 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 120.476 1.489 . . . . 3.8900000000000001 108.713 -179.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.29 37.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.429 -0.952 . . . . 0.52000000000000002 108.429 160.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 164.26 20.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.039 . . . . 1.9399999999999999 108.193 156.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -10.47 59.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.217 1.191 . . . . 4.1299999999999999 114.217 -171.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 58.93 34.19 23.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 1.73 111.706 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.0 60.41 6.88 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.723 -0.611 . . . . 2.1800000000000002 112.712 168.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -138.7 -59.47 0.61 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.422 1.489 . . . . 5.1900000000000004 109.937 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 64.28 -72.06 0.06 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.844 1.688 . . . . 2.02 116.152 173.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.19 40.26 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 111.184 -0.766 . . . . 2.3500000000000001 111.184 -157.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -170.68 160.69 7.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.077 1.751 . . . . 2.8500000000000001 107.085 -178.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -55.13 -64.88 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 114.015 1.117 . . . . 3.1800000000000002 114.015 -173.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -45.12 66.37 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.874 0.87 . . . . 4.2300000000000004 110.617 -156.421 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -58.85 1.99 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.039 1.735 . . . . 1.96 111.515 170.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -70.9 -48.03 55.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.195 -0.941 . . . . 1.52 110.788 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -67.33 -36.68 81.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.052 -0.499 . . . . 2.6600000000000001 112.304 -169.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.504 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.404 0.0 OUTLIER -129.49 -53.89 1.17 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.681 -1.152 . . . . 1.1499999999999999 113.518 168.428 . . . . . . . . 4 4 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.68 -10.25 0.27 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 120.408 1.458 . . . . 0.88 115.995 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 46.84 53.62 10.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.216 1.406 . . . . 1.98 111.791 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.742 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -65.18 -30.22 71.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.366 1.467 . . . . 1.0700000000000001 113.452 177.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.62 173.15 49.54 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.865 -1.294 . . . . 1.1599999999999999 109.865 -160.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 m -56.4 152.25 11.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.167 1.387 . . . . 1.5900000000000001 113.148 -172.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.44 ' O ' HD23 ' A' ' 144' ' ' LEU . 11.8 mtm105 -77.61 162.85 26.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.713 -1.585 . . . . 4.5599999999999996 111.614 176.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 121' ' ' GLU . 6.9 mt -138.83 -72.92 0.4 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.836 -1.913 . . . . 0.78000000000000003 105.836 -172.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.68 155.69 30.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.425 0.631 . . . . 0.87 109.321 172.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -157.23 172.12 19.19 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.543 -1.662 . . . . 1.6799999999999999 108.642 175.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.24 146.08 6.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.034 -0.985 . . . . 0.69999999999999996 111.932 176.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.4 t -63.32 133.49 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.489 1.116 . . . . 0.71999999999999997 109.118 175.229 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 115' ' ' ARG . 16.6 tt -96.41 136.05 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.76000000000000001 110.478 176.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.96 -1.27 2.5 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.883 0.754 . . . . 0.80000000000000004 114.427 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.9 mm -89.38 58.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.906 1.353 . . . . 0.93000000000000005 110.367 -160.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.427 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -128.46 176.14 7.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.431 1.093 . . . . 1.52 110.972 176.304 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 102.047 -3.316 . . . . 4.8399999999999999 102.047 143.817 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 110.587 -0.153 . . . . 6.5599999999999996 110.587 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 p 53.19 66.15 1.31 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.068 1.347 . . . . 3.71 111.416 173.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -134.67 148.86 50.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.96 1.304 . . . . 5.8099999999999996 107.567 178.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.92 125.74 53.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.252 -1.388 . . . . 0.78000000000000003 107.252 160.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 152' ' ' ALA . 59.5 t -90.78 140.91 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 105.837 -1.912 . . . . 1.05 105.837 164.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.96 92.52 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.27 -1.011 . . . . 0.75 108.27 160.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.09 103.19 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 107.077 -1.453 . . . . 0.81999999999999995 107.077 165.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.73 129.96 34.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.402 -0.962 . . . . 0.93999999999999995 108.402 176.274 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -154.98 -53.86 0.09 Allowed 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.411 -0.588 . . . . 3.6000000000000001 109.411 170.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.72 -107.04 0.61 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.421 -0.809 . . . . 1.3300000000000001 113.005 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -116.37 -57.23 2.22 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.949 1.3 . . . . 2.9700000000000002 110.005 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 164.81 10.15 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 123.674 0.654 . . . . 1.1200000000000001 112.289 -177.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.72 -19.46 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.593 2.862 . . . . 1.47 112.336 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.88 143.24 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 124.712 1.205 . . . . 0.91000000000000003 110.562 174.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -155.65 126.28 6.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.732 -1.21 . . . . 1.9299999999999999 107.732 -174.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.7 170.8 42.51 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.957 -0.639 . . . . 0.55000000000000004 112.369 -174.366 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.4 128.17 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.491 -0.929 . . . . 1.5800000000000001 108.491 -179.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.29 134.71 30.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.651 -1.611 . . . . 0.93999999999999995 106.651 161.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.42 59.85 1.02 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.863 0.865 . . . . 3.3300000000000001 108.69 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' CD2' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -90.77 144.28 25.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.237 1.415 . . . . 2.98 110.916 -163.277 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -153.44 163.39 40.03 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.872 0.844 . . . . 3.2599999999999998 111.27 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.416 HE22 ' N ' ' A' ' 27' ' ' GLY . 34.8 tt0 -145.55 153.79 41.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.041 -2.207 . . . . 2.9399999999999999 105.041 157.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -70.71 -56.06 7.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.373 -0.602 . . . . 4.5999999999999996 109.373 172.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -83.08 166.46 18.71 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.798 1.239 . . . . 3.5899999999999999 109.324 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 p -90.79 -0.16 57.63 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.887 -0.508 . . . . 2.3300000000000001 111.949 176.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -144.29 47.72 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.325 0.966 . . . . 4.8899999999999997 111.843 -159.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' N ' HE22 ' A' ' 22' ' ' GLN . . . -152.56 -164.87 12.75 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.823 -1.311 . . . . 1.01 109.823 171.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.4 146.78 45.58 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.594 2.196 . . . . 1.03 110.799 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.54 143.77 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 123.849 0.718 . . . . 0.90000000000000002 110.826 -171.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -95.97 96.98 9.26 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.354 -0.609 . . . . 2.5600000000000001 109.354 -175.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG22 ' CD2' ' A' ' 20' ' ' PHE . 44.1 t -83.78 88.94 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.096 -1.076 . . . . 1.22 108.096 177.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -104.55 137.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.778 0.674 . . . . 1.05 109.798 164.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.85 156.83 27.86 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.957 -0.857 . . . . 0.83999999999999997 110.957 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 p -132.21 106.74 8.14 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.664 -1.976 . . . . 1.71 105.664 -171.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.62 150.25 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.627 -1.249 . . . . 0.83999999999999997 107.627 -167.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.75 -179.54 6.86 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.271 1.211 . . . . 5.0899999999999999 114.271 161.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.92 64.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.854 1.692 . . . . 0.59999999999999998 112.204 179.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.16 162.2 29.7 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.139 0.97 . . . . 0.65000000000000002 108.811 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.21 164.61 23.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.884 -1.154 . . . . 1.78 107.884 153.412 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.01 175.21 0.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.63 0.728 . . . . 2.4100000000000001 111.048 176.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.07 -163.67 50.63 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.295 0.474 . . . . 0.58999999999999997 113.395 170.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.06 147.08 47.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.131 . . . . 2.2799999999999998 112.284 -172.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.36 117.22 8.22 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.822 1.649 . . . . 0.44 108.987 177.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.16 152.61 5.09 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.917 -0.873 . . . . 0.34000000000000002 110.917 171.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.84 95.62 2.76 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.559 1.143 . . . . 2.4100000000000001 108.053 -174.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -135.24 160.61 37.86 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 108.383 -0.969 . . . . 0.52000000000000002 108.383 -160.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.37 115.94 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.98 1.264 . . . . 1.8100000000000001 110.686 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -86.9 162.42 17.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.766 -0.652 . . . . 0.87 109.564 -169.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.73 47.27 0.13 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.683 1.993 . . . . 4.5199999999999996 111.345 178.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' CD ' HH22 ' A' ' 143' ' ' ARG . 4.7 mt-10 -123.77 129.02 50.41 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.074 -1.824 . . . . 3.0899999999999999 106.074 -171.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -137.88 -70.28 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.859 1.264 . . . . 4.6699999999999999 107.999 179.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -79.28 61.03 3.26 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.381 2.272 . . . . 6.1299999999999999 109.673 178.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.81 43.6 2.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.359 0.599 . . . . 4.5099999999999998 112.291 -169.548 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 m -51.54 -22.81 3.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.072 1.349 . . . . 4.1399999999999997 113.084 174.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -46.97 -37.06 8.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.925 1.29 . . . . 5.9100000000000001 112.327 170.122 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.04 -90.73 0.11 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.275 -1.13 . . . . 3.2999999999999998 110.275 173.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.1 m -151.6 31.06 0.58 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.524 1.529 . . . . 3.1200000000000001 107.853 -176.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 m -131.22 56.35 1.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.015 -1.074 . . . . 3.7999999999999998 111.856 -138.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.6 m -167.61 -38.91 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.962 1.838 . . . . 2.4700000000000002 115.962 -143.17 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.27 154.5 26.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.637 1.575 . . . . 1.8300000000000001 109.403 167.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.93 -95.25 1.68 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 109.683 -1.367 . . . . 1.04 109.683 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.83 178.61 6.59 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.392 3.394 . . . . 0.93999999999999995 114.236 -173.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -73.03 125.35 27.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.309 -1.314 . . . . 1.52 109.226 174.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -4.04 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.465 2.306 . . . . 2.3399999999999999 113.754 168.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -123.78 99.84 38.13 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.27 1.028 . . . . 3.1400000000000001 109.105 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.81 -37.02 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.668 1.578 . . . . 1.25 110.03 -179.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.41 -86.02 0.54 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.59 -1.263 . . . . 3.0099999999999998 107.59 160.366 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -140.32 72.87 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.434 1.094 . . . . 1.6100000000000001 109.71 -166.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -77.75 164.31 25.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.8 -0.815 . . . . 4.6699999999999999 108.8 170.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -125.07 148.02 48.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.059 1.343 . . . . 3.5099999999999998 108.386 -178.974 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.479 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 44.2 t60 -81.48 156.22 25.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.719 0.407 . . . . 0.89000000000000001 111.828 -176.211 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.57 -97.78 0.13 Allowed Glycine 0 C--O 1.219 -0.784 0 N-CA-C 107.334 -2.306 . . . . 2.3300000000000001 107.334 159.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.09 -154.55 25.48 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 120.575 -1.544 . . . . 1.51 110.344 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.34 -55.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.932 2.421 . . . . 1.8700000000000001 110.394 -168.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -39.82 82.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.737 0.779 . . . . 5.6100000000000003 110.067 171.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -57.29 153.09 12.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.725 -1.579 . . . . 3.1299999999999999 112.861 -164.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 77' ' ' GLU . 1.8 mp0 -49.2 -47.24 46.26 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 128.144 2.578 . . . . 6.5700000000000003 109.576 170.192 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 21.6 pt-20 -133.93 178.52 6.89 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.762 1.023 . . . . 3.4300000000000002 113.762 -171.145 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 175.73 153.55 0.16 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.147 2.179 . . . . 3.1000000000000001 108.579 -173.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 58.4 m80 -62.6 156.24 23.82 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.072 -0.714 . . . . 0.80000000000000004 109.072 170.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.94 -34.24 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.45 -0.782 . . . . 1.29 110.489 -174.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.46 59.98 0.49 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.39 0.995 . . . . 0.82999999999999996 110.65 175.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -169.68 115.93 0.56 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.22 -1.4 . . . . 2.0699999999999998 107.22 -170.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -106.79 -48.43 3.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.37 0.668 . . . . 2.5 110.978 -173.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.76 -121.69 0.93 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 119.647 -1.263 . . . . 0.67000000000000004 112.333 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -151.03 172.02 16.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.085 1.354 . . . . 1.3600000000000001 108.925 -171.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 167.23 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.016 -1.476 . . . . 0.67000000000000004 107.016 167.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 m -120.09 123.42 43.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.217 -1.401 . . . . 2.0299999999999998 107.217 172.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.94 33.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.979 0.354 . . . . 0.65000000000000002 110.977 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -69.19 -84.05 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.567 1.147 . . . . 2.8799999999999999 110.449 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 93' ' ' GLY . 75.4 tttt -159.12 -46.33 0.06 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.735 1.214 . . . . 3.52 111.308 -175.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.41 32.98 0.45 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 124.337 2.018 . . . . 2.73 110.38 176.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 91' ' ' LYS . . . 58.39 18.67 37.3 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 126.504 2.002 . . . . 0.62 112.228 -176.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.62 142.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.844 -1.539 . . . . 0.76000000000000001 106.844 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.04 163.34 33.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.89 -1.152 . . . . 0.59999999999999998 107.89 171.127 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -129.99 141.53 50.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.815 -2.661 . . . . 2.6499999999999999 103.815 -174.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.38 126.25 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 105.439 -2.06 . . . . 1.3 105.439 170.299 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.8 m -145.81 71.34 1.27 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.375 1.47 . . . . 1.26 107.974 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mm -108.56 151.16 10.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.654 0.782 . . . . 1.73 109.208 -178.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -137.67 133.96 34.88 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.737 -1.579 . . . . 3.5499999999999998 106.737 160.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.06 161.94 37.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.522 -1.659 . . . . 2.4900000000000002 106.522 175.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 p -113.17 -9.2 13.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.981 2.113 . . . . 1.8 112.487 -172.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.1 t -77.5 -41.85 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.339 -0.985 . . . . 1.3799999999999999 108.339 -177.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -85.68 162.75 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 123.774 0.83 . . . . 2.3799999999999999 108.996 172.722 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.437 ' N ' HD13 ' A' ' 104' ' ' ILE . 49.2 p -164.29 169.54 17.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.728 1.611 . . . . 1.8200000000000001 108.086 -175.144 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.5 42.52 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.733 1.213 . . . . 2.7400000000000002 110.046 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 m -79.85 -171.51 2.91 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.575 -1.269 . . . . 4.0800000000000001 107.575 166.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -141.13 64.95 0.51 Allowed Glycine 0 N--CA 1.465 0.582 0 O-C-N 120.519 -1.363 . . . . 3.9500000000000002 110.762 -169.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -166.54 -105.57 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.06 -0.348 . . . . 4.7800000000000002 110.06 -155.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -82.68 -21.9 34.74 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.314 2.246 . . . . 4.8799999999999999 108.858 171.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.7 p -42.14 156.92 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.271 1.428 . . . . 1.3500000000000001 113.026 167.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.489 HD12 HG21 ' A' ' 149' ' ' ILE . 1.3 pp -85.64 -8.86 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.91 -0.494 . . . . 1.48 112.05 -177.012 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mm -47.6 123.88 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.835 0.854 . . . . 2.2400000000000002 109.235 169.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.12 -27.72 17.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.036 0.827 . . . . 2.0299999999999998 112.645 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.85 160.4 26.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.837 1.318 . . . . 5.3300000000000001 110.936 -168.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.8 m -87.35 100.46 12.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.042 1.337 . . . . 1.1100000000000001 109.904 -176.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.9 146.77 54.48 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.139 -1.06 . . . . 1.76 108.139 169.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.9 t -134.41 140.8 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 127.898 2.479 . . . . 0.53000000000000003 107.175 -177.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.64 127.19 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.265 -1.383 . . . . 1.6200000000000001 107.265 165.327 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -98.71 162.99 12.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.573 2.064 . . . . 0.39000000000000001 116.573 -169.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -66.36 0.4 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.754 2.022 . . . . 2.9500000000000002 112.054 176.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -107.68 -178.58 3.66 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.187 0.995 . . . . 3.1899999999999999 111.549 -173.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.79 147.36 42.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.292 -0.867 . . . . 0.72999999999999998 108.798 158.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.95 164.23 23.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.578 0.704 . . . . 2.1699999999999999 109.776 161.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.19 -4.69 58.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.473 1.509 . . . . 3.1400000000000001 112.927 -172.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 57.08 30.36 18.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.597 1.159 . . . . 1.47 110.583 -170.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.45 20.69 59.2 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.872 -0.518 . . . . 1.97 112.587 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -131.24 50.76 2.2 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.221 -1.4 . . . . 6.21 107.221 -173.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.46 139.71 11.17 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.713 -1.755 . . . . 1.99 108.713 177.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.23 -37.28 79.75 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.67 0.735 . . . . 2.7599999999999998 112.604 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -56.15 109.63 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.519 1.127 . . . . 2.0800000000000001 108.995 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -38.91 20.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.163 0.985 . . . . 3.54 112.105 -178.212 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -35.36 -37.87 0.09 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 128.022 2.529 . . . . 3.0 113.227 171.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.7 p -47.7 -69.2 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.285 1.034 . . . . 2.1800000000000002 109.69 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -63.96 -43.35 96.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.334 0.654 . . . . 1.3 110.417 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -52.2 -49.83 63.1 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 126.1 1.76 . . . . 2.98 110.703 -171.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.492 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.379 10.2 t -136.2 -48.19 0.65 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 117.801 -1.095 . . . . 2.21 111.629 175.459 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.479 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 162.38 -31.32 0.3 Allowed Glycine 0 N--CA 1.463 0.483 0 CA-C-N 119.564 1.074 . . . . 0.91000000000000003 112.578 178.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.99 53.4 10.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.498 1.519 . . . . 1.9399999999999999 109.778 -174.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.18 -7.27 59.53 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.352 -0.842 . . . . 1.03 112.085 166.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.53 -167.57 50.55 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 108.88 -1.688 . . . . 0.95999999999999996 108.88 -174.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -54.39 151.35 7.7 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.087 1.755 . . . . 1.1899999999999999 113.836 -167.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.466 HH22 ' CD ' ' A' ' 50' ' ' GLU . 7.6 mmt85 -64.93 141.46 58.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.333 1.453 . . . . 2.9500000000000002 108.083 170.228 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.7 mt -108.92 -89.66 0.47 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.058 -1.089 . . . . 0.55000000000000004 108.058 169.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.74 158.08 15.85 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.953 -1.129 . . . . 0.87 107.953 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 14.6 p -143.64 174.84 10.43 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.214 -1.357 . . . . 1.96 108.413 166.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.1 139.72 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 123.943 0.777 . . . . 0.70999999999999996 111.551 176.439 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.21 129.76 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.556 1.143 . . . . 0.95999999999999996 108.861 174.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.489 HG21 HD12 ' A' ' 112' ' ' ILE . 7.9 tt -90.74 131.88 36.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 122.665 0.386 . . . . 0.84999999999999998 110.76 176.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.54 3.2 0.62 Allowed Glycine 0 CA--C 1.523 0.532 0 CA-C-O 119.389 -0.673 . . . . 0.77000000000000002 114.639 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.19 56.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.193 1.497 . . . . 1.29 110.917 -164.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 5' ' ' VAL . . . -156.36 175.51 13.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.061 1.344 . . . . 1.3600000000000001 108.268 160.258 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 103.858 -2.645 . . . . 4.8499999999999996 103.858 163.615 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 108.989 -0.745 . . . . 6.1500000000000004 108.989 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.82 68.77 7.2 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.716 0.636 . . . . 3.8100000000000001 112.716 -165.414 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 132.82 55.22 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.52 0.728 . . . . 2.6400000000000001 110.302 162.251 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.41 153.64 21.01 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.51 -0.922 . . . . 0.70999999999999996 108.51 164.102 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.96 148.62 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 123.799 0.84 . . . . 0.91000000000000003 108.939 164.395 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.18 101.64 6.35 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.067 1.347 . . . . 0.48999999999999999 108.937 159.007 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.7 98.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.204 -1.035 . . . . 0.69999999999999996 108.204 164.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 147' ' ' GLY . 44.3 mt -81.76 123.77 29.05 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.812 0.845 . . . . 1.6799999999999999 109.564 175.05 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.76 -56.73 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.82 1.248 . . . . 4.4699999999999998 108.29 178.88 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' H ' ' A' ' 146' ' ' CYS . . . 44.54 -116.16 1.58 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.043 1.306 . . . . 0.88 112.47 -177.549 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.05 -62.03 1.33 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.642 0.721 . . . . 3.46 109.605 -173.138 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.58 161.94 1.13 Allowed Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.825 1.678 . . . . 0.81000000000000005 112.554 -178.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.34 38.6 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.001 3.134 . . . . 0.96999999999999997 112.75 -172.207 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.3 155.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.341 1.856 . . . . 0.98999999999999999 109.013 -177.436 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.53 116.76 4.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.892 -1.151 . . . . 2.25 107.892 171.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 163.68 33.02 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.969 -0.852 . . . . 0.64000000000000001 110.969 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.77 114.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.826 -1.916 . . . . 1.72 105.826 -177.607 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -78.2 148.44 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.191 -1.411 . . . . 0.72999999999999998 107.191 170.252 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -122.7 118.23 27.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.183 -2.154 . . . . 2.1600000000000001 105.183 163.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -106.54 99.94 9.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.175 -1.787 . . . . 2.7400000000000002 106.175 175.606 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -103.78 136.84 42.72 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.693 0.797 . . . . 4.6900000000000004 109.246 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -155.94 86.97 1.05 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.626 1.17 . . . . 3.8100000000000001 109.591 172.717 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.98 -52.02 59.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.377 1.071 . . . . 4.9400000000000004 110.125 174.036 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -83.56 92.46 7.64 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.265 -1.013 . . . . 4.2300000000000004 108.265 175.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -54.57 3.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 118.287 2.699 . . . . 3.3599999999999999 118.287 -162.831 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -159.04 64.76 0.41 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 120.004 1.275 . . . . 3.6800000000000002 109.566 170.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.94 -145.85 6.84 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 107.578 -2.209 . . . . 1.49 107.578 164.717 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.72 142.51 16.08 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.555 2.17 . . . . 1.1299999999999999 110.693 169.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG11 ' CD2' ' A' ' 20' ' ' PHE . 59.5 t -90.39 152.11 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 122.818 0.447 . . . . 0.91000000000000003 110.128 -175.559 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.6 125.76 48.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.388 -1.708 . . . . 4.1600000000000001 106.388 170.219 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' CE1' ' A' ' 20' ' ' PHE . 16.1 t -116.14 129.91 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 175.442 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -144.07 150.32 37.98 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.543 -1.28 . . . . 0.73999999999999999 107.543 162.444 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.28 142.88 5.71 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 107.748 -2.141 . . . . 1.0900000000000001 107.748 173.625 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -116.92 98.57 6.56 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.444 -1.317 . . . . 2.5299999999999998 107.444 -169.261 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.69 143.44 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.512 1.525 . . . . 1.1000000000000001 108.54 -169.119 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 160.65 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.515 -0.474 . . . . 4.75 110.619 170.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.57 25.16 63.62 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.796 1.665 . . . . 0.97999999999999998 113.99 -179.121 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.58 171.56 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.297 -1.001 . . . . 0.95999999999999996 108.297 160.333 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -74.45 168.47 19.65 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.995 -1.113 . . . . 2.04 107.995 152.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.47 172.55 0.85 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.73 1.212 . . . . 4.71 110.9 179.516 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.28 -158.75 38.33 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 115.967 -0.561 . . . . 0.84999999999999998 114.023 167.63 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.13 141.35 56.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.228 1.411 . . . . 2.4900000000000002 111.997 -168.17 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -142.48 115.86 9.02 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.168 0.987 . . . . 0.57999999999999996 110.804 176.457 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.11 146.88 9.77 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.997 -0.841 . . . . 0.38 110.997 170.515 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -138.26 105.68 5.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.848 1.259 . . . . 2.5099999999999998 107.778 -175.889 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 31.0 m80 -138.66 162.09 35.52 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.291 -1.003 . . . . 0.64000000000000001 108.291 -166.055 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.45 126.18 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.472 0.654 . . . . 1.6899999999999999 109.385 176.319 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -104.94 147.75 27.44 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.75 2.02 . . . . 0.80000000000000004 109.215 -173.314 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 67.87 0.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.681 1.192 . . . . 4.3700000000000001 111.095 177.716 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -129.35 107.92 9.89 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.383 -1.339 . . . . 3.1800000000000002 107.383 -176.254 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.73 -29.78 29.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.391 1.076 . . . . 5.2699999999999996 110.999 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -118.02 123.75 46.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.917 0.887 . . . . 5.4500000000000002 109.528 -178.226 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -138.43 46.15 2.03 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.908 0.883 . . . . 5.1600000000000001 108.782 161.439 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 t -76.6 39.61 0.21 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.559 1.144 . . . . 4.3099999999999996 112.812 -172.568 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.96 -51.93 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 124.477 1.111 . . . . 5.7599999999999998 109.551 -177.265 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.81 -168.77 35.94 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.817 -2.113 . . . . 4.0499999999999998 107.817 -176.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.6 m -69.32 98.11 1.03 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.775 0.788 . . . . 3.0299999999999998 110.843 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 59' ' ' SER 0.253 19.4 m -38.19 -93.37 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 127.295 2.238 . . . . 5.1699999999999999 114.66 167.252 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 58' ' ' THR 0.384 5.5 m 141.53 69.58 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 121.677 2.035 . . . . 4.3099999999999996 114.206 -113.631 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -156.7 163.29 39.45 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.906 2.082 . . . . 1.79 106.867 168.623 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.78 -122.89 2.94 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.076 -0.847 . . . . 1.0700000000000001 111.98 -158.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.89 179.12 6.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.416 2.744 . . . . 0.90000000000000002 113.289 -172.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -58.82 115.74 3.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.893 -1.503 . . . . 1.29 107.19 171.534 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -21.89 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.967 1.707 . . . . 2.3900000000000001 113.902 176.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -130.29 146.23 60.75 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.08 . . . . 3.2200000000000002 107.929 -173.764 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.58 -54.69 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.778 1.652 . . . . 1.8700000000000001 108.655 169.076 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -144.63 -70.37 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.449 1.499 . . . . 2.54 107.333 171.244 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.9 p -135.29 71.92 1.44 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.042 1.337 . . . . 2.5600000000000001 109.369 -168.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -78.82 175.13 10.77 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.233 -1.025 . . . . 4.2400000000000002 108.233 162.488 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -117.16 149.08 40.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.561 -2.015 . . . . 4.3099999999999996 105.561 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.427 ' CG ' ' HA2' ' A' ' 138' ' ' GLY . 82.7 t60 -66.93 146.25 54.58 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.543 -0.863 . . . . 0.83999999999999997 111.048 178.487 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.36 130.28 3.29 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 106.751 -2.54 . . . . 2.73 106.751 172.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.1 -155.28 12.36 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.231 -1.148 . . . . 1.8200000000000001 110.231 174.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.52 -33.0 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.26 1.974 . . . . 2.4199999999999999 110.786 178.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -44.23 90.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.437 0.637 . . . . 7.8099999999999996 110.817 175.637 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.18 139.69 56.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.218 1.562 . . . . 3.0299999999999998 115.218 -159.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -53.57 -59.45 4.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.752 2.421 . . . . 5.4199999999999999 110.167 170.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.64 -178.72 6.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 130.221 3.409 . . . . 3.8199999999999998 110.406 178.029 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 172.68 161.01 0.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.206 1.802 . . . . 2.8700000000000001 111.685 164.74 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.7 m80 -50.25 136.84 19.14 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.685 -1.968 . . . . 0.64000000000000001 105.685 154.256 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.78 -20.6 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 120.072 -0.651 . . . . 1.24 109.82 -179.96 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.91 43.29 1.75 Allowed Glycine 0 CA--C 1.535 1.338 0 N-CA-C 116.717 1.447 . . . . 0.78000000000000003 116.717 164.56 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -98.09 136.8 37.81 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 105.757 -1.942 . . . . 1.9299999999999999 105.757 147.681 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 84' ' ' LEU . 3.9 mm? -93.55 -52.29 4.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.72 -0.844 . . . . 1.5700000000000001 108.72 148.464 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.92 -108.6 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 119.597 -1.287 . . . . 0.53000000000000003 112.321 178.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -155.63 168.18 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.512 1.525 . . . . 2.0800000000000001 109.224 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.98 178.05 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.565 -1.643 . . . . 0.56999999999999995 106.565 163.21 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.5 t -113.07 146.22 39.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.562 -1.644 . . . . 2.4900000000000002 106.562 151.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.46 156.43 20.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.106 -1.072 . . . . 0.78000000000000003 108.106 150.755 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.57 -90.11 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.967 -0.753 . . . . 3.1299999999999999 108.967 172.314 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -139.22 -48.79 0.49 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.467 1.507 . . . . 3.7599999999999998 110.091 -167.497 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -81.88 17.0 1.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.964 1.364 . . . . 3.0800000000000001 111.343 -176.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.84 10.11 76.42 Favored Glycine 0 CA--C 1.526 0.738 0 O-C-N 121.344 -0.847 . . . . 0.93999999999999995 111.7 -175.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.38 124.65 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.493 1.517 . . . . 0.93000000000000005 107.475 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.34 171.62 14.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.269 1.828 . . . . 0.68000000000000005 108.086 175.12 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.31 144.74 26.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.787 -1.19 . . . . 3.5899999999999999 107.787 -179.583 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.21 55.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 123.866 0.866 . . . . 2.04 111.153 -172.797 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.6 m -72.67 102.3 3.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.768 -0.634 . . . . 1.1000000000000001 110.193 169.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 100' ' ' GLU . 16.4 mt -137.4 157.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.192 0.906 . . . . 1.8999999999999999 110.147 179.077 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 99' ' ' ILE . 34.7 tt0 -137.94 123.72 19.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.659 -1.237 . . . . 3.6600000000000001 107.659 158.514 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -117.15 156.82 26.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.466 -0.939 . . . . 2.4500000000000002 108.466 164.095 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.9 p -102.03 -12.64 18.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.282 2.233 . . . . 1.5700000000000001 111.937 176.432 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.35 -25.87 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.764 0.711 . . . . 1.3100000000000001 110.872 -173.726 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.88 166.6 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.704 0.683 . . . . 1.3999999999999999 111.686 177.32 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -136.41 176.81 8.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.596 2.359 . . . . 1.8200000000000001 107.618 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.42 57.37 1.09 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.802 0.728 . . . . 2.48 112.11 167.352 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.0 m -151.08 -59.63 0.17 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.328 0.651 . . . . 2.8700000000000001 111.743 165.509 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.89 165.13 30.33 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 122.149 -0.344 . . . . 2.7599999999999998 113.395 -170.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -36.77 -47.8 0.69 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.936 2.095 . . . . 4.79 114.022 179.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -75.22 -11.39 60.06 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.078 -0.51 . . . . 5.7300000000000004 111.221 -170.745 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.9 p -61.56 171.97 1.35 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 122.695 1.236 . . . . 1.4099999999999999 112.516 -170.229 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -8.53 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 3.0800000000000001 111.942 176.066 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 33.9 mm -54.85 120.4 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.926 1.239 . . . . 1.96 109.491 -174.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.25 73.81 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.617 -0.546 . . . . 1.49 112.338 -177.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -102.39 177.21 4.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.313 -1.736 . . . . 4.2599999999999998 106.313 167.611 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -119.4 122.14 41.11 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.596 1.089 . . . . 1.01 111.314 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.8 mt -74.16 146.43 43.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.239 -0.652 . . . . 1.72 109.239 166.144 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.91 136.06 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.416 1.886 . . . . 0.39000000000000001 107.919 177.511 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.419 HG22 ' CE2' ' A' ' 45' ' ' PHE . 28.3 t -100.47 122.23 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 126.044 1.738 . . . . 2.27 106.9 167.005 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.486 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 65.0 m-70 -98.48 158.69 15.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.369 1.989 . . . . 0.44 116.369 -174.653 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 122' ' ' LYS . 2.7 tt0 -46.72 -74.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.219 2.208 . . . . 2.96 112.018 174.292 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 121' ' ' GLU . 16.0 mttm -93.76 -176.88 4.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.851 0.75 . . . . 2.8599999999999999 110.275 -171.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.32 152.08 30.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.588 -0.893 . . . . 0.60999999999999999 108.588 157.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.13 177.34 6.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.94 0.876 . . . . 2.1099999999999999 109.087 161.92 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.53 -27.4 67.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.498 1.119 . . . . 4.3899999999999997 113.83 177.824 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.288 2.9 mm? 88.73 -17.58 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 128.47 2.708 . . . . 2.8900000000000001 113.172 -175.127 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.27 3.33 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.647 -1.381 . . . . 3.6000000000000001 109.647 -171.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -95.44 -38.97 10.23 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 128.264 2.626 . . . . 6.1100000000000003 108.87 160.403 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.35 62.63 5.8 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 125.401 1.477 . . . . 3.6000000000000001 110.112 -167.294 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.19 -16.02 25.05 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.694 -0.503 . . . . 3.1099999999999999 113.741 178.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -176.68 -179.98 1.05 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.49 1.516 . . . . 2.25 108.236 -169.507 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -42.83 -82.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.772 2.029 . . . . 3.4900000000000002 113.562 178.681 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -53.18 -33.54 53.07 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.827 -0.546 . . . . 3.2000000000000002 111.709 -172.796 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.3 m -61.42 -52.78 63.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.005 1.322 . . . . 2.5099999999999998 111.161 179.266 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.9 t -71.04 -45.07 64.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.767 1.167 . . . . 2.4100000000000001 110.791 173.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.17 -43.13 99.36 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.175 0.59 . . . . 3.9500000000000002 111.58 -170.063 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 80' ' ' HIS . 1.2 p -128.21 -47.98 1.33 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.225 0.466 . . . . 1.3600000000000001 112.107 177.104 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 71' ' ' HIS . . . 147.65 -14.99 1.4 Allowed Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.786 0.721 . . . . 0.91000000000000003 114.097 -178.417 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.11 54.85 6.73 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.035 1.334 . . . . 1.8500000000000001 110.601 -174.755 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.5 -31.26 71.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.77 1.228 . . . . 1.1399999999999999 112.087 172.848 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.52 178.43 50.48 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 108.64 -1.784 . . . . 0.93999999999999995 108.64 -163.262 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 m -58.23 153.76 14.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.556 1.142 . . . . 1.28 113.648 -167.229 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -59.72 134.58 57.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.082 1.353 . . . . 3.0099999999999998 108.465 170.254 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.6 mt -110.32 -72.48 0.72 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.955 -1.498 . . . . 0.58999999999999997 106.955 168.37 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.35 155.03 16.94 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.409 -0.96 . . . . 0.93999999999999995 108.409 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.407 ' H ' ' HA3' ' A' ' 10' ' ' GLY . 73.9 m -135.96 150.51 49.3 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 106.196 -1.779 . . . . 1.8200000000000001 106.196 163.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.54 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -152.09 116.45 0.75 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.8 -1.72 . . . . 0.95999999999999996 108.8 172.03 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.68 132.88 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.095 -1.446 . . . . 0.77000000000000002 107.095 168.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.59 138.96 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.206 0.527 . . . . 0.69999999999999996 112.385 -172.537 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 137.78 5.84 1.62 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.328 1.442 . . . . 0.59999999999999998 114.221 177.563 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.75 57.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-N 119.351 1.575 . . . . 0.81000000000000005 109.89 -154.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.13 165.33 36.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.367 0.603 . . . . 1.5900000000000001 111.236 171.669 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 C--O 1.255 1.353 0 N-CA-C 102.699 -3.075 . . . . 4.5 102.699 156.139 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.418 0.628 . . . . 5.5899999999999999 112.224 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 p -78.49 83.32 4.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.975 -1.12 . . . . 2.8300000000000001 107.975 177.962 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.2 145.86 39.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.747 0.308 . . . . 3.0800000000000001 110.845 -175.508 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.76 37.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.551 -2.018 . . . . 0.87 105.551 156.147 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -100.6 142.85 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 105.558 -2.016 . . . . 0.65000000000000002 105.558 162.725 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -129.79 93.16 3.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.645 -1.243 . . . . 0.46000000000000002 107.645 166.889 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.09 98.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.299 -1.371 . . . . 0.78000000000000003 107.299 169.408 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 147' ' ' GLY . 18.2 mt -79.89 123.06 27.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.038 -0.727 . . . . 1.8300000000000001 109.038 177.741 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -150.69 -48.07 0.12 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.824 -0.625 . . . . 3.5299999999999998 111.065 167.623 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.32 -117.8 3.52 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.61 -0.996 . . . . 1.1200000000000001 110.61 -174.898 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.85 -35.04 6.07 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.319 1.048 . . . . 3.7400000000000002 110.131 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.44 168.8 30.15 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-O 121.63 0.572 . . . . 1.1200000000000001 112.577 -177.466 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.47 -26.29 47.58 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.571 2.847 . . . . 1.8700000000000001 111.758 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 56.0 t -48.04 151.61 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.639 1.976 . . . . 0.71999999999999997 111.025 -178.603 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -156.01 118.32 4.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.396 0.678 . . . . 2.02 109.254 -175.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.77 167.72 35.35 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.868 -0.52 . . . . 0.47999999999999998 112.286 -178.838 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.8 mt -129.95 119.95 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.736 -1.209 . . . . 1.4199999999999999 107.736 177.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 20.8 mm -81.27 140.51 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.903 -1.147 . . . . 0.87 107.903 164.592 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -120.38 93.5 4.07 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 105.396 -2.075 . . . . 1.71 105.396 159.299 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.665 ' CE1' HD11 ' A' ' 112' ' ' ILE . 1.1 t80 -100.3 118.93 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.881 -1.896 . . . . 3.1099999999999999 105.881 -173.481 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -155.65 175.07 14.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.028 0.918 . . . . 3.9199999999999999 113.404 -173.911 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.84 169.87 23.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.807 -1.553 . . . . 3.1099999999999999 106.807 -173.51 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -93.79 -64.66 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.596 1.558 . . . . 4.7699999999999996 108.601 171.779 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -79.95 -178.58 6.55 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.458 1.103 . . . . 4.3099999999999996 111.375 178.368 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -87.7 -66.87 0.87 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.906 -1.146 . . . . 3.3100000000000001 107.906 155.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -75.74 63.23 1.6 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.045 1.338 . . . . 4.4100000000000001 111.723 -173.219 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.09 -177.48 27.55 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.319 -1.912 . . . . 1.9199999999999999 108.319 169.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.35 152.82 44.72 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.1 2.534 . . . . 1.48 110.412 174.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -82.65 158.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.547 -0.908 . . . . 0.96999999999999997 108.547 176.743 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -111.57 104.88 13.3 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.382 1.087 . . . . 2.73 108.601 162.297 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.523 HG22 ' CD2' ' A' ' 20' ' ' PHE . 58.8 t -97.26 105.22 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 125.883 1.673 . . . . 1.24 108.206 -175.048 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -128.01 164.27 22.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.693 0.627 . . . . 0.97999999999999998 112.693 176.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.5 42.69 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.516 -1.034 . . . . 0.70999999999999996 110.516 179.267 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -138.74 109.32 6.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.427 -1.694 . . . . 1.96 106.427 179.025 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.53 115.87 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.865 -1.531 . . . . 1.0800000000000001 106.865 -161.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -105.36 162.38 13.49 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.64 0.733 . . . . 3.7200000000000002 111.954 -173.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.65 79.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.201 -0.908 . . . . 0.57999999999999996 113.662 168.398 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.77 165.85 9.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.82 1.31 . . . . 0.63 108.839 167.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.93 160.75 25.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.188 -1.412 . . . . 1.8600000000000001 107.188 152.804 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -59.55 173.68 0.52 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.397 -0.814 . . . . 2.73 110.6 177.359 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.92 -159.26 46.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 123.747 0.689 . . . . 0.76000000000000001 112.465 170.028 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.49 141.49 55.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.609 1.564 . . . . 2.02 114.543 -169.493 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -145.29 119.62 9.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.97 1.708 . . . . 0.5 109.703 177.24 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.37 150.44 5.57 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.883 -0.887 . . . . 0.41999999999999998 110.883 171.699 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CE2' HD21 ' A' ' 117' ' ' LEU . 1.0 OUTLIER -141.58 93.12 2.53 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.939 -1.504 . . . . 2.4300000000000002 106.939 -173.292 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -130.39 173.39 10.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.217 -1.031 . . . . 0.64000000000000001 108.217 -165.475 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.9 t -124.42 118.27 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.39 -0.967 . . . . 2.1200000000000001 108.39 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -100.2 149.61 23.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.415 1.486 . . . . 0.88 107.912 175.847 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.45 34.24 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.931 0.892 . . . . 4.7300000000000004 112.445 177.743 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CD ' HH21 ' A' ' 143' ' ' ARG . 3.3 tt0 -91.3 55.27 2.78 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 120.579 -1.326 . . . . 3.4900000000000002 110.817 -159.408 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -48.91 -41.79 34.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.348 1.459 . . . . 4.4900000000000002 111.906 -174.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -76.36 95.15 3.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.96 -1.126 . . . . 6.8099999999999996 107.96 174.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -119.36 47.32 1.72 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.641 -1.244 . . . . 5.2199999999999998 107.641 155.188 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.8 t -112.72 32.0 5.96 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.787 0.835 . . . . 4.3399999999999999 109.309 168.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.88 -50.14 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.742 1.617 . . . . 5.6900000000000004 108.505 -178.122 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.58 -176.22 46.19 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.643 -1.783 . . . . 3.6200000000000001 108.643 179.429 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.4 t -113.01 64.76 0.64 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.762 1.225 . . . . 2.8399999999999999 109.474 179.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m -144.14 55.27 1.29 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.433 -0.951 . . . . 4.6399999999999997 108.433 -170.333 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 m -159.71 -26.62 0.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.467 1.654 . . . . 3.2200000000000002 115.467 -131.388 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.46 175.15 9.21 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.477 1.511 . . . . 1.6799999999999999 109.809 167.233 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.83 -119.66 4.2 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.698 -0.961 . . . . 1.1599999999999999 110.698 -172.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.64 178.65 7.35 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.014 3.143 . . . . 0.85999999999999999 112.333 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -54.26 124.97 17.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.977 1.311 . . . . 1.25 108.898 174.582 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -30.73 113.88 0.11 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.653 1.581 . . . . 2.5 112.23 174.499 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.7 151.73 46.99 Favored Pre-proline 0 N--CA 1.446 -0.625 0 C-N-CA 124.675 1.19 . . . . 2.29 109.152 167.369 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.48 -30.91 52.15 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.42 2.08 . . . . 1.3 111.621 -178.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 tp -154.54 -69.72 0.13 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.145 0.429 . . . . 3.71 109.954 173.331 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -145.94 76.41 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.144 0.978 . . . . 1.8 110.411 -172.649 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -79.67 176.55 9.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.964 -0.754 . . . . 4.4500000000000002 108.964 165.28 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.978 -1.49 . . . . 3.2799999999999998 106.978 -179.558 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -106.64 126.9 52.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.132 0.573 . . . . 1.0600000000000001 111.495 175.017 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.25 3.95 8.3 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.683 1.611 . . . . 3.2200000000000002 111.461 173.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 -173.29 4.25 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.468 -1.019 . . . . 1.3799999999999999 111.291 -169.546 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.09 -9.43 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.641 2.227 . . . . 1.45 111.872 173.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -54.51 5.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.469 0.577 . . . . 4.0599999999999996 111.397 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.26 176.58 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.033 0.444 . . . . 2.6600000000000001 110.382 -179.335 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.54 -63.12 1.21 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.684 1.194 . . . . 5.6500000000000004 109.923 -179.885 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.49 148.5 33.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.573 -0.739 . . . . 3.3100000000000001 111.333 -161.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -159.29 147.01 17.41 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.095 -1.003 . . . . 3.7999999999999998 108.396 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.455 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 41.2 m80 -54.69 135.22 47.17 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.721 -1.955 . . . . 0.69999999999999996 105.721 157.462 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -62.09 -22.02 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.788 -0.449 . . . . 1.25 109.788 -178.13 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.83 44.93 1.57 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.809 0.719 . . . . 0.56000000000000005 114.337 162.709 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.72 121.77 45.96 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 106.643 -1.614 . . . . 1.9399999999999999 106.643 158.058 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.24 -71.13 0.46 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.422 -1.696 . . . . 1.73 106.422 154.399 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.32 -110.76 0.35 Allowed Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.536 -0.626 . . . . 0.69999999999999996 111.536 -176.575 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -149.66 167.35 26.66 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.848 1.659 . . . . 1.49 109.086 175.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.03 175.06 10.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 106.848 -1.538 . . . . 0.46000000000000002 106.848 170.553 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -122.89 142.93 50.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.936 -1.135 . . . . 1.9099999999999999 107.936 169.104 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 142.13 40.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.921 1.288 . . . . 0.82999999999999996 112.629 173.525 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.31 -88.15 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.158 0.983 . . . . 2.5099999999999998 111.688 -178.652 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -146.08 -42.32 0.21 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.595 0.591 . . . . 3.52 112.595 -158.251 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -83.49 23.27 0.95 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 124.059 1.885 . . . . 4.0599999999999996 110.163 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.42 24.94 57.08 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.563 -1.199 . . . . 1.03 110.479 -168.7 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.15 107.5 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.221 -1.029 . . . . 1.1899999999999999 108.221 -175.599 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.83 154.72 18.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.904 -1.147 . . . . 0.70999999999999996 107.904 156.187 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.57 139.11 50.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 102.218 -3.252 . . . . 2.8700000000000001 102.218 174.01 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.85 131.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.041 -1.466 . . . . 1.6699999999999999 107.041 170.678 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -158.22 61.73 0.45 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.649 1.98 . . . . 1.0700000000000001 107.678 178.39 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.0 mm -105.29 157.55 6.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.904 -1.146 . . . . 2.4399999999999999 107.904 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.2 102.94 4.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.187 -0.321 . . . . 2.2000000000000002 111.617 165.397 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.46 144.75 25.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.314 1.046 . . . . 2.0299999999999998 111.045 -178.639 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -105.63 -9.14 17.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.04 2.136 . . . . 1.6699999999999999 113.142 -176.213 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.41 -43.4 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.148 -1.056 . . . . 1.1200000000000001 108.148 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 pt -86.67 176.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.714 0.768 . . . . 1.3100000000000001 111.446 175.001 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.1 m -157.16 177.67 11.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.1 2.16 . . . . 2.0899999999999999 105.78 179.159 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.76 54.83 1.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.909 1.231 . . . . 2.46 111.995 172.844 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 p -91.07 -76.99 0.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.646 1.178 . . . . 3.6800000000000002 108.524 175.083 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.33 61.53 0.01 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.075 -1.61 . . . . 2.9199999999999999 109.075 -174.118 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -162.53 -105.52 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.499 1.12 . . . . 4.9000000000000004 108.154 -167.42 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -76.98 0.09 22.43 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.043 1.337 . . . . 4.3899999999999997 110.223 174.542 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 p -74.44 172.45 11.93 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 127.028 2.131 . . . . 1.1899999999999999 112.654 -175.786 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.665 HD11 ' CE1' ' A' ' 20' ' ' PHE . 1.1 pp -93.78 -6.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.001 -1.454 . . . . 2.1499999999999999 113.228 177.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.9 mm -43.81 119.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.973 . . . . 1.6799999999999999 110.371 -179.214 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.63 25.54 73.83 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.707 -0.496 . . . . 1.4199999999999999 113.089 177.055 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 149' ' ' ILE . 63.1 mtt-85 -104.06 -178.86 3.78 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.405 -1.702 . . . . 4.1799999999999997 106.405 166.244 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 m -116.02 118.79 33.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.082 0.401 . . . . 1.0800000000000001 110.108 178.119 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.449 HD21 ' CE2' ' A' ' 45' ' ' PHE . 4.4 tt -73.34 143.46 46.89 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.506 -1.294 . . . . 2.27 107.506 170.804 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -127.24 136.81 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.808 2.043 . . . . 0.40000000000000002 107.577 177.974 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG12 ' CE1' ' A' ' 45' ' ' PHE . 1.5 m -104.19 127.15 58.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.444 -0.947 . . . . 1.6299999999999999 108.444 164.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.24 160.29 14.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 116.066 1.876 . . . . 0.40000000000000002 116.066 -171.217 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -36.2 -68.03 0.15 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.579 2.352 . . . . 3.1200000000000001 112.522 172.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -126.09 -173.8 2.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.683 1.193 . . . . 2.48 110.188 -170.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.78 141.76 43.17 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.468 -0.567 . . . . 0.62 109.468 169.594 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.19 160.96 28.1 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.288 -1.005 . . . . 2.0 108.288 161.502 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.53 -22.34 62.63 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.715 -0.659 . . . . 2.9900000000000002 112.189 -176.042 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 56.36 51.96 10.76 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.137 1.335 . . . . 1.6599999999999999 109.68 -161.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 50.58 44.11 46.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.334 0.969 . . . . 1.5700000000000001 113.793 169.116 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -79.5 -30.87 42.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.235 1.014 . . . . 5.8700000000000001 111.088 179.147 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.38 -146.01 25.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.259 -1.136 . . . . 2.6400000000000001 110.259 -170.369 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.37 -72.37 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.444 -1.862 . . . . 2.1400000000000001 108.444 -169.075 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 109.81 8.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 104.488 -2.412 . . . . 2.75 104.488 161.592 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -35.9 66.87 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.559 . . . . 3.6499999999999999 110.391 178.654 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -28.6 -44.96 0.03 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.58 2.752 . . . . 2.6299999999999999 113.248 162.366 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -45.68 -60.92 1.93 Allowed 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.979 1.312 . . . . 2.75 109.489 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -72.26 -43.56 64.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.499 0.32 . . . . 1.22 110.152 178.829 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -52.91 -53.02 55.41 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.822 1.649 . . . . 2.5800000000000001 110.85 -170.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.455 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.251 1.0 OUTLIER -125.0 -47.71 1.78 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.067 0.547 . . . . 1.3500000000000001 111.207 173.483 . . . . . . . . 4 4 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 150.66 -26.29 1.06 Allowed Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.533 -0.627 . . . . 1.0900000000000001 111.533 -170.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 54.64 56.51 6.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.303 1.041 . . . . 2.0299999999999998 111.249 178.281 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.22 -5.96 57.24 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.389 0.514 . . . . 1.27 112.389 168.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.05 -170.84 43.82 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.054 -1.619 . . . . 1.04 109.054 -173.847 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -68.48 171.22 7.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.108 -1.046 . . . . 2.6800000000000002 113.016 -167.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.498 HH21 ' CD ' ' A' ' 50' ' ' GLU . 5.8 mmt-85 -66.79 142.17 57.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.171 2.188 . . . . 2.8900000000000001 109.316 175.126 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.9 -78.95 0.58 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.466 -1.309 . . . . 0.46000000000000002 107.466 166.501 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.479 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -109.71 150.23 28.6 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.651 -0.87 . . . . 0.76000000000000001 108.651 171.624 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 3.3 m -137.12 150.05 47.73 Favored 'General case' 0 N--CA 1.436 -1.135 0 O-C-N 125.462 1.727 . . . . 2.0800000000000001 106.66 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.441 ' N ' HD23 ' A' ' 8' ' ' LEU . . . -148.67 123.5 1.67 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 109.454 -1.459 . . . . 0.90000000000000002 109.454 178.263 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.08 128.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.575 -1.269 . . . . 0.83999999999999997 107.575 168.562 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 115' ' ' ARG . 10.5 tt -103.92 117.06 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.645 0.736 . . . . 0.89000000000000001 110.95 -172.012 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.24 2.63 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-N 114.954 -1.021 . . . . 0.51000000000000001 115.388 178.133 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.8 mm -94.45 58.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.732 1.766 . . . . 0.75 111.589 -155.031 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.89 176.4 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.678 0.791 . . . . 1.26 110.024 167.84 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 104.148 -2.538 . . . . 4.3899999999999997 104.148 162.294 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 106.603 -1.628 . . . . 5.3899999999999997 106.603 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m 70.37 56.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 105.958 -1.867 . . . . 2.7000000000000002 105.958 -155.221 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -103.28 146.08 28.99 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.032 -0.985 . . . . 2.5800000000000001 111.272 -170.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.15 133.13 33.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.03 -1.1 . . . . 0.78000000000000003 108.03 165.57 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.12 146.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 106.852 -1.536 . . . . 0.67000000000000004 106.852 158.013 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -128.86 94.77 3.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.017 -1.105 . . . . 0.42999999999999999 108.017 162.55 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.67 96.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.407 1.083 . . . . 0.69999999999999996 108.284 170.469 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -91.71 121.55 33.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.431 -0.581 . . . . 0.93000000000000005 109.431 -179.212 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -130.84 -62.12 0.92 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.822 -0.807 . . . . 3.3999999999999999 108.822 174.268 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.26 -123.83 10.33 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 114.34 -1.3 . . . . 1.02 112.22 -170.296 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.22 -43.19 1.8 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.247 0.619 . . . . 3.4300000000000002 109.974 -150.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.99 165.61 8.43 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 109.439 -1.464 . . . . 0.82999999999999996 109.439 164.386 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.53 35.14 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.515 2.81 . . . . 1.0 112.954 -173.681 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -93.16 153.73 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.578 1.551 . . . . 0.71999999999999997 109.992 -171.962 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -155.08 107.16 2.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.217 1.407 . . . . 2.8999999999999999 107.543 175.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.0 166.03 29.35 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.664 -0.574 . . . . 0.45000000000000001 111.664 179.1 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 mm -132.17 117.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.934 -1.876 . . . . 1.8600000000000001 105.934 -178.368 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.63 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 32.1 mm -85.28 140.6 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.856 -1.535 . . . . 0.69999999999999996 106.856 165.879 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -120.88 105.1 10.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.518 -2.03 . . . . 1.51 105.518 164.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' CD2' HG22 ' A' ' 31' ' ' VAL . 10.0 t80 -115.76 110.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.482 -2.044 . . . . 3.2200000000000002 105.482 -171.397 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.33 167.42 30.43 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.659 0.742 . . . . 3.98 112.057 -174.672 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.96 -156.7 0.71 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.181 -2.526 . . . . 4.4000000000000004 104.181 169.493 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -110.67 -62.78 1.48 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.485 1.039 . . . . 4.2400000000000002 109.497 168.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.17 101.45 12.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.927 -1.509 . . . . 4.6100000000000003 106.927 -171.286 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 p -73.99 53.18 0.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.177 1.391 . . . . 2.5899999999999999 111.946 -177.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -156.08 34.74 0.34 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.199 1.8 . . . . 3.7999999999999998 108.196 165.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.72 -173.26 14.36 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.042 -1.623 . . . . 1.05 109.042 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.04 169.9 6.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.346 2.698 . . . . 1.55 111.765 177.252 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.83 154.38 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.863 -0.608 . . . . 0.76000000000000001 109.622 -178.842 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -104.46 113.5 27.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.209 -1.775 . . . . 2.6600000000000001 106.209 171.662 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 20' ' ' PHE . 21.9 t -115.25 90.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.786 -1.19 . . . . 1.1899999999999999 107.786 -168.798 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -109.59 150.66 27.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 123.457 0.473 . . . . 0.70999999999999996 110.067 -179.613 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.74 168.25 41.06 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.221 -1.151 . . . . 0.77000000000000002 110.221 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.6 m -139.63 107.5 5.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.281 -1.748 . . . . 2.1800000000000002 106.281 -179.387 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -115.77 123.02 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.89 -1.893 . . . . 0.83999999999999997 105.89 -161.047 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 162.83 20.74 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 118.651 0.659 . . . . 4.4900000000000002 110.966 -174.371 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.91 74.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.878 0.751 . . . . 0.71999999999999997 113.692 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -69.94 164.04 24.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.48 1.14 . . . . 0.63 109.151 167.633 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.85 156.78 19.81 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.098 -1.075 . . . . 1.8799999999999999 108.098 149.02 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.78 -180.0 0.31 Allowed 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.004 -1.06 . . . . 3.9399999999999999 110.4 176.1 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.11 -158.6 51.13 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.818 -0.551 . . . . 0.71999999999999997 112.1 168.087 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.43 146.86 30.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.948 1.299 . . . . 2.6800000000000002 110.219 -170.149 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -144.9 121.09 10.83 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.178 0.991 . . . . 0.51000000000000001 110.213 -177.257 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.15 147.58 26.45 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.914 -1.275 . . . . 0.40000000000000002 109.914 170.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 38.3 t80 -136.26 97.07 3.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.63 -1.619 . . . . 3.1099999999999999 106.63 -174.084 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 28.1 m170 -129.31 174.88 9.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.548 -1.278 . . . . 0.82999999999999996 107.548 -169.281 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 p -134.33 115.91 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.177 -1.416 . . . . 1.6899999999999999 107.177 170.203 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -82.28 -175.74 5.84 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.836 -1.542 . . . . 1.1499999999999999 106.836 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -70.92 -106.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.433 -0.951 . . . . 4.1299999999999999 108.433 172.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 44.5 66.07 0.94 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.75 0.82 . . . . 3.3700000000000001 110.513 -175.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -57.16 -22.8 42.97 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.698 1.199 . . . . 5.5899999999999999 110.896 170.074 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -118.15 115.06 24.03 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.158 1.783 . . . . 4.9299999999999997 108.556 -179.15 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -128.19 52.35 1.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.435 -1.32 . . . . 4.75 107.435 159.267 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.6 m -62.52 -29.28 70.44 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.635 -0.666 . . . . 4.9199999999999999 111.577 -179.229 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.86 -57.51 0.13 Allowed 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.719 0.807 . . . . 5.2699999999999996 109.686 177.718 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.15 172.89 53.23 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.111 -0.796 . . . . 4.29 111.111 175.427 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.4 t -162.88 160.57 25.14 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.071 -1.826 . . . . 2.8700000000000001 106.071 173.182 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.321 18.1 p 101.23 65.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 128.759 2.824 . . . . 5.5499999999999998 110.993 166.229 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.4 m -164.85 27.51 0.06 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.674 -1.148 . . . . 3.0 113.057 -134.058 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -161.56 146.95 13.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.85 1.66 . . . . 2.04 107.544 170.311 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.18 -94.44 0.18 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.785 -0.926 . . . . 1.1299999999999999 110.785 -179.59 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -81.54 178.28 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.12 2.546 . . . . 0.97999999999999998 115.405 -166.226 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -65.86 64.86 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.613 2.365 . . . . 1.6899999999999999 112.46 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.6 t80 37.77 70.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.411 1.884 . . . . 2.7999999999999998 111.025 -177.275 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -96.33 105.26 21.18 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 118.271 -0.871 . . . . 2.71 109.338 -176.727 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.2 -36.15 17.38 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.058 1.838 . . . . 1.48 111.655 -175.094 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -141.71 -75.4 0.3 Allowed 'General case' 0 C--N 1.339 0.134 0 N-CA-C 108.687 -0.857 . . . . 3.02 108.687 177.825 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.6 p -156.55 58.34 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.68 0.753 . . . . 3.2400000000000002 110.512 -171.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -77.41 160.57 28.64 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.163 -1.421 . . . . 4.8700000000000001 107.163 162.133 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -133.84 152.01 51.73 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.242 1.417 . . . . 3.3799999999999999 108.178 -172.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -76.18 153.75 35.91 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.804 0.668 . . . . 0.92000000000000004 112.804 -169.245 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.13 163.88 36.24 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.964 -2.454 . . . . 2.2799999999999998 106.964 159.086 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.5 -170.35 11.76 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 117.524 0.662 . . . . 1.3799999999999999 112.493 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.98 -39.77 30.76 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.656 2.237 . . . . 1.5 109.797 178.158 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -66.87 -51.06 60.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.083 1.353 . . . . 4.9400000000000004 111.258 175.401 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -61.5 157.55 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.516 0.932 . . . . 2.1299999999999999 113.516 -161.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.13 -49.77 73.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.418 1.087 . . . . 4.4100000000000001 110.333 -179.313 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -78.1 170.04 17.26 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.845 -0.428 . . . . 3.29 109.845 177.488 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 165.24 133.45 0.01 OUTLIER 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.927 2.491 . . . . 3.3900000000000001 106.584 -171.882 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.552 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 67.8 m80 -68.31 161.37 27.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 118.594 -1.242 . . . . 0.64000000000000001 107.947 167.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.54 44.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 122.985 1.374 . . . . 2.6200000000000001 110.498 165.303 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . -169.0 36.72 0.2 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 124.816 1.198 . . . . 0.93000000000000005 110.984 167.458 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 133.72 28.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.33 -1.1 . . . . 2.46 108.712 163.337 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.9 mt -99.74 -46.02 5.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.014 -1.106 . . . . 1.99 108.014 168.757 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.24 -111.41 0.46 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.511 -0.852 . . . . 0.60999999999999999 111.347 178.28 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -155.11 158.41 38.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.164 1.386 . . . . 1.9099999999999999 109.375 -169.83 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.66 178.14 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.686 1.995 . . . . 0.45000000000000001 106.384 172.353 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -138.32 145.92 41.76 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.562 -0.903 . . . . 2.2799999999999998 108.562 171.301 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.83 139.79 39.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.446 1.099 . . . . 0.93999999999999995 110.885 170.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.76 -79.77 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 123.784 0.678 . . . . 2.9100000000000001 111.309 -174.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.65 -46.33 0.15 Allowed 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.744 0.817 . . . . 3.6499999999999999 111.151 -164.739 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.02 13.58 2.19 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.803 1.287 . . . . 2.6699999999999999 111.529 177.693 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.63 16.85 74.35 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.235 -0.916 . . . . 0.60999999999999999 111.224 -173.341 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -89.06 115.21 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.051 1.34 . . . . 0.83999999999999997 108.262 -179.53 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.59 168.09 9.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.906 1.683 . . . . 0.68999999999999995 108.367 162.242 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -126.8 149.13 49.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 103.202 -2.888 . . . . 2.98 103.202 -179.369 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.68 135.19 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 107.197 -1.408 . . . . 1.74 107.197 166.742 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.9 m -157.59 58.75 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.298 1.839 . . . . 0.98999999999999999 107.229 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.0 mt -101.88 154.04 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 123.886 0.875 . . . . 1.71 108.861 -174.424 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -133.45 137.98 45.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.364 -1.347 . . . . 2.3900000000000001 107.364 161.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.42 159.74 41.64 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.151 -1.426 . . . . 2.5 107.151 170.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -121.74 -1.96 9.4 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.808 2.043 . . . . 3.1699999999999999 113.199 -177.549 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.02 -31.2 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.458 1.027 . . . . 1.5700000000000001 108.236 176.574 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -99.94 175.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.683 1.193 . . . . 1.22 109.286 171.129 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.1 t -158.1 179.55 9.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.347 1.859 . . . . 2.3100000000000001 106.058 175.339 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -106.2 27.74 8.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.946 0.898 . . . . 2.8399999999999999 111.922 177.9 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 p -88.76 -74.72 0.46 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.371 1.068 . . . . 4.0999999999999996 110.887 -170.922 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 174.6 -163.05 33.38 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 106.0 -2.84 . . . . 3.0600000000000001 106.0 -171.87 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t70 47.72 -107.91 0.21 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.92 1.36 . . . . 4.4800000000000004 112.028 172.048 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -76.55 -3.93 40.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.644 1.178 . . . . 4.2699999999999996 112.278 -173.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.9 p -62.02 172.7 1.3 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.248 1.023 . . . . 1.51 112.232 173.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.8 pt -100.29 -5.31 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.348 -1.296 . . . . 2.0299999999999998 111.056 171.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 tp -46.73 128.81 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.725 0.81 . . . . 1.5900000000000001 109.383 176.906 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.79 -14.12 62.53 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.597 -1.113 . . . . 1.4299999999999999 113.744 -178.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -94.11 163.24 13.55 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.875 1.837 . . . . 4.0099999999999998 111.561 -169.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -88.74 108.74 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 122.898 0.479 . . . . 0.85999999999999999 111.184 -177.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.457 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -72.75 143.25 48.04 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.927 -0.768 . . . . 2.0600000000000001 108.927 174.281 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.1 t -130.27 127.78 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.687 1.195 . . . . 0.42999999999999999 109.212 -179.105 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.67 128.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 106.48 -1.674 . . . . 2.4199999999999999 106.48 161.643 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.458 ' CG ' ' HB1' ' A' ' 140' ' ' ALA . 76.6 m-70 -101.87 158.45 16.12 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 114.627 1.343 . . . . 0.39000000000000001 114.627 -175.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.8 -71.73 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.397 -0.819 . . . . 5.5300000000000002 111.152 176.835 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -79.6 -179.5 6.9 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.025 0.83 . . . . 3.9300000000000002 109.353 -177.247 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.43 157.31 26.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.75 109.818 169.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.83 160.49 5.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.043 -0.526 . . . . 2.6299999999999999 110.326 162.324 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.01 -33.02 74.65 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.921 0.711 . . . . 3.5099999999999998 112.921 176.181 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 73.34 -9.68 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.72 2.408 . . . . 1.9399999999999999 112.532 -168.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.52 43.42 8.5 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.142 -1.983 . . . . 2.3700000000000001 108.142 -168.197 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.26 -20.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.575 0.954 . . . . 5.8200000000000003 113.575 -175.0 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.9 -46.21 92.18 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 108.276 -1.93 . . . . 2.6499999999999999 108.276 169.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.55 36.01 57.84 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.583 0.611 . . . . 3.8999999999999999 111.64 175.926 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -69.64 -61.62 1.71 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.246 -1.39 . . . . 2.8100000000000001 107.246 -179.868 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 27.5 tt0 178.96 -55.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.694 2.798 . . . . 3.2999999999999998 105.124 166.795 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -48.01 -37.7 15.39 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.937 2.095 . . . . 2.8399999999999999 111.212 173.619 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.7 m -38.09 -65.18 0.35 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.87 1.668 . . . . 1.6299999999999999 110.754 164.302 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.9 p -71.73 -42.74 66.92 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.378 -0.826 . . . . 1.76 110.77 -176.138 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 132' ' ' GLU . 60.9 mttm -52.78 -51.34 61.08 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 123.528 0.731 . . . . 2.7999999999999998 110.837 -175.248 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.552 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 15.2 t -136.92 -48.34 0.61 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.246 -1.359 . . . . 2.5099999999999998 111.906 176.162 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 147.11 25.7 0.08 OUTLIER Glycine 0 N--CA 1.473 1.119 0 CA-C-N 120.52 1.509 . . . . 1.21 115.642 177.107 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . 0.28 0.4 OUTLIER 3.37 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.54 2.336 . . . . 3.4199999999999999 116.601 -167.693 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -63.22 -28.86 70.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.55 1.54 . . . . 0.96999999999999997 113.965 -177.605 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.79 171.55 44.85 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.055 -1.618 . . . . 1.1000000000000001 109.055 -160.119 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m -53.03 147.92 8.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.538 1.535 . . . . 1.51 113.923 -170.342 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -54.79 136.62 46.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.844 1.258 . . . . 2.7400000000000002 108.645 166.79 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.2 mt -107.88 -64.88 1.16 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.335 -0.987 . . . . 0.68999999999999995 108.335 167.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.95 162.39 13.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.057 -0.974 . . . . 1.0800000000000001 110.847 -173.691 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.57 156.3 34.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.166 0.986 . . . . 1.9199999999999999 109.552 169.119 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.82 138.95 3.53 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 106.613 -2.595 . . . . 0.71999999999999997 106.613 172.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.63 132.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.551 -0.907 . . . . 0.75 108.551 177.554 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.7 tt -86.17 134.12 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 122.832 0.453 . . . . 0.81000000000000005 111.252 -178.765 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 140.0 5.84 1.15 Allowed Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.166 0.889 . . . . 0.53000000000000003 114.236 175.796 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.75 55.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.713 1.757 . . . . 0.73999999999999999 110.062 -158.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.76 177.82 10.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.43 1.092 . . . . 1.6299999999999999 109.873 170.089 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 103.449 -2.797 . . . . 6.2599999999999998 103.449 146.837 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 107.357 -1.349 . . . . 6.0199999999999996 107.357 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -158.1 120.02 3.64 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 119.39 0.996 . . . . 3.6000000000000001 109.16 -178.083 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -102.97 161.67 13.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.124 1.369 . . . . 4.1699999999999999 109.529 178.563 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.42 156.09 44.65 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.168 0.987 . . . . 0.93000000000000005 108.945 154.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.45 150.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 106.674 -1.602 . . . . 0.90000000000000002 106.674 158.435 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.64 102.08 4.65 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 108.446 -0.946 . . . . 0.46999999999999997 108.446 157.102 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.15 102.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.208 -1.404 . . . . 0.60999999999999999 107.208 167.354 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -87.36 126.26 34.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.882 -1.155 . . . . 1.0 107.882 177.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -150.92 -53.4 0.14 Allowed 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.481 0.312 . . . . 3.3599999999999999 110.629 -175.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.62 -114.33 1.05 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.763 1.173 . . . . 0.72999999999999998 112.986 -177.163 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -122.54 -52.45 1.92 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.496 1.118 . . . . 3.8100000000000001 110.724 -168.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.78 163.76 13.84 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.705 0.669 . . . . 0.84999999999999998 112.225 -175.067 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.45 64.35 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.271 3.314 . . . . 2.1299999999999999 110.864 -176.603 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t -141.64 146.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.752 2.021 . . . . 0.80000000000000004 106.4 -171.633 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -155.59 136.75 13.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.656 -0.868 . . . . 4.0300000000000002 108.656 176.812 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.77 174.58 44.63 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.129 -0.557 . . . . 0.46999999999999997 111.92 175.374 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.84 118.3 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.082 -1.081 . . . . 1.1000000000000001 108.082 -179.119 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.1 137.49 22.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 105.804 -1.925 . . . . 0.85999999999999999 105.804 165.065 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.33 58.73 1.66 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.742 -0.836 . . . . 2.8700000000000001 108.742 178.004 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.55 168.42 19.81 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.18 -1.008 . . . . 3.6800000000000002 112.162 -168.597 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -144.72 150.31 37.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.706 -1.133 . . . . 3.98 108.146 177.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.427 ' NE2' ' H ' ' A' ' 27' ' ' GLY . 32.6 tt0 -151.26 93.89 1.96 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.448 -1.251 . . . . 3.5899999999999999 108.229 167.506 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -49.21 -39.85 31.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.588 1.329 . . . . 5.2000000000000002 114.588 -178.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -87.21 148.89 24.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.461 1.104 . . . . 5.1100000000000003 110.239 -176.356 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -0.53 18.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.203 1.801 . . . . 3.27 114.935 -173.678 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -170.13 53.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.844 1.656 . . . . 4.6900000000000004 111.218 170.96 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.427 ' H ' ' NE2' ' A' ' 22' ' ' GLN . . . -108.42 -157.7 19.12 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.116 1.341 . . . . 1.1200000000000001 110.722 178.193 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -89.34 141.37 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.06 3.84 . . . . 1.3500000000000001 111.053 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.17 136.18 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.916 -0.401 . . . . 1.1799999999999999 109.916 -175.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -90.29 91.92 8.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.452 -0.944 . . . . 2.54 108.452 173.815 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.4 t -90.57 86.0 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.764 0.826 . . . . 1.3500000000000001 110.419 -170.41 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -102.96 139.51 38.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.148 0.499 . . . . 0.81999999999999995 111.572 173.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.04 41.35 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.066 1.793 . . . . 0.68000000000000005 108.799 170.384 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.8 m -139.54 80.43 1.77 Allowed 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 107.702 -1.221 . . . . 2.3999999999999999 107.702 -176.752 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.78 119.42 33.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.908 -1.145 . . . . 1.22 107.908 -169.091 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.92 162.02 13.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.395 0.678 . . . . 3.6400000000000001 110.705 -175.218 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.59 -10.77 64.85 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.819 0.687 . . . . 1.4399999999999999 114.819 167.276 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.3 154.94 4.09 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.868 1.334 . . . . 1.1299999999999999 110.87 176.874 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -65.59 153.13 42.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.94 -1.1 . . . . 1.6399999999999999 108.231 158.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -52.74 156.24 2.01 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.344 1.057 . . . . 2.7999999999999998 112.073 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 -158.2 31.69 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.276 -0.874 . . . . 0.56999999999999995 112.683 167.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.91 142.54 36.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.882 0.873 . . . . 2.3799999999999999 110.891 -165.492 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -142.04 130.35 22.3 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.775 1.23 . . . . 0.56999999999999995 110.594 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 148.23 36.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.91 -0.876 . . . . 0.46999999999999997 110.91 170.783 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 52.0 t80 -146.91 96.72 2.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.275 1.43 . . . . 2.6699999999999999 107.798 -171.453 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.553 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 40.6 m80 -131.32 170.93 13.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.227 -0.657 . . . . 0.68999999999999995 109.227 -164.564 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.58 108.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.767 -1.198 . . . . 2.3500000000000001 107.767 173.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.421 ' CD2' HG21 ' A' ' 118' ' ' VAL . 67.6 m-70 -81.52 168.0 18.72 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.0 -1.111 . . . . 1.1000000000000001 108.0 168.57 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.02 -96.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.642 -1.244 . . . . 4.7199999999999998 107.642 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 60' ' ' ALA . 4.1 mt-10 54.99 65.06 1.6 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.354 0.662 . . . . 3.2400000000000002 112.581 160.326 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.95 -95.93 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.499 -0.751 . . . . 4.7599999999999998 110.777 176.764 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -84.87 58.81 5.2 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.825 1.25 . . . . 5.7599999999999998 110.724 -168.522 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.25 -53.3 6.16 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.404 0.621 . . . . 5.0899999999999999 109.401 -173.146 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t 179.85 -51.09 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.428 1.891 . . . . 4.7400000000000002 108.463 -179.066 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.13 -58.12 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.304 1.441 . . . . 5.8799999999999999 109.165 176.939 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.56 -163.03 36.44 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.856 -0.898 . . . . 3.8599999999999999 110.856 176.308 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 96.0 m -66.97 154.16 41.81 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.317 1.047 . . . . 2.96 109.982 175.187 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.08 15.12 0.13 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 115.214 1.561 . . . . 3.9399999999999999 115.214 167.756 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.7 m -172.82 -56.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 118.473 2.768 . . . . 2.5699999999999998 118.473 -127.891 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.407 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . -72.21 -41.62 66.69 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.953 -0.467 . . . . 3.5 111.921 -162.363 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.31 -116.22 4.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 116.954 -2.025 . . . . 1.0600000000000001 109.142 -172.417 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.99 179.95 4.42 Favored 'Trans proline' 0 C--N 1.348 0.516 1 C-N-CA 125.337 4.025 . . . . 1.1499999999999999 115.359 -170.576 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -67.74 99.27 0.79 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.384 1.474 . . . . 1.4299999999999999 108.722 -179.231 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -9.52 102.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.127 2.171 . . . . 1.9199999999999999 113.744 172.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -124.47 136.8 28.23 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 127.458 2.303 . . . . 3.1000000000000001 108.13 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.51 -47.43 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.101 1.868 . . . . 1.0800000000000001 109.218 174.812 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.0 -70.97 0.47 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.571 -1.27 . . . . 2.6600000000000001 107.571 170.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.2 t -154.6 90.79 1.34 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.345 -0.613 . . . . 2.79 109.345 -178.552 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -84.64 165.66 17.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.39 -1.337 . . . . 4.6600000000000001 107.39 146.669 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -116.93 170.46 8.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.579 -1.637 . . . . 3.1000000000000001 106.579 174.303 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -84.33 157.17 21.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.083 0.468 . . . . 0.81000000000000005 110.808 -179.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.62 158.5 31.47 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 104.702 -3.359 . . . . 1.97 104.702 160.83 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.91 174.59 8.54 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.325 -1.11 . . . . 1.8200000000000001 110.325 170.821 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.15 -29.7 89.7 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.045 1.83 . . . . 1.3999999999999999 110.176 169.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.87 -52.11 66.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.653 0.781 . . . . 3.96 110.98 171.305 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -73.83 164.81 26.15 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.718 0.636 . . . . 2.1600000000000001 111.177 -178.169 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -89.48 -36.09 15.6 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.457 1.103 . . . . 5.54 112.674 -171.607 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -75.19 166.04 24.25 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.498 -1.297 . . . . 3.04 107.498 165.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 152.21 127.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.387 2.675 . . . . 3.5699999999999998 104.811 -161.142 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.477 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 56.0 m80 -58.48 149.92 23.98 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.863 -1.162 . . . . 0.57999999999999996 107.863 174.627 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.46 -32.79 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.07 -0.652 . . . . 1.25 109.848 -175.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.5 52.53 2.07 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.308 -0.718 . . . . 0.59999999999999998 113.114 165.642 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -127.42 117.17 21.64 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.186 1.493 . . . . 2.4199999999999999 108.275 164.201 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 84' ' ' LEU . 3.6 mm? -81.39 -53.17 6.54 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.655 -0.869 . . . . 1.5800000000000001 108.655 161.759 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.62 -105.25 0.27 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.81 -0.71 . . . . 0.65000000000000002 112.95 175.218 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -156.36 155.52 32.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.876 1.271 . . . . 3.6600000000000001 109.059 -166.317 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.97 163.1 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.477 1.111 . . . . 0.65000000000000002 110.41 -175.836 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 m -116.49 103.02 10.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.967 2.107 . . . . 2.79 109.632 -169.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.11 135.38 36.83 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.669 -0.644 . . . . 0.56000000000000005 112.225 176.4 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.58 -92.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.741 1.616 . . . . 4.0499999999999998 110.438 175.505 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -177.21 -26.71 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.658 1.983 . . . . 3.4199999999999999 112.548 -165.112 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -76.06 9.06 2.68 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.831 1.777 . . . . 3.7999999999999998 108.442 148.599 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.67 26.63 72.98 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 119.782 -1.824 . . . . 1.1100000000000001 109.996 178.154 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -84.11 108.48 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.219 -1.4 . . . . 1.3 107.219 -175.795 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.46 155.31 28.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.022 1.329 . . . . 1.4099999999999999 109.129 171.636 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -102.81 58.49 0.78 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.325 2.25 . . . . 6.5199999999999996 107.765 -164.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.98 68.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.397 -0.819 . . . . 1.46 110.792 -161.256 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -121.45 75.45 1.18 Allowed 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.79 1.636 . . . . 0.95999999999999996 108.796 179.099 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.0 mm -106.18 155.31 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.26 1.024 . . . . 1.8100000000000001 109.476 -174.613 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -146.5 122.89 10.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.13 -1.434 . . . . 3.3700000000000001 107.13 168.375 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.88 158.45 25.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.424 1.089 . . . . 2.1000000000000001 109.241 173.14 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -127.6 29.67 5.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.069 1.348 . . . . 1.3600000000000001 111.785 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.18 -49.3 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.667 -1.234 . . . . 1.0900000000000001 107.667 171.312 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.95 174.11 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.558 0.694 . . . . 0.93999999999999995 110.178 171.255 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -156.83 -179.89 8.64 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.178 -1.786 . . . . 2.3500000000000001 106.178 175.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.405 HD22 ' HB3' ' A' ' 22' ' ' GLN . 0.7 OUTLIER -110.77 14.4 22.23 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 2.46 112.197 173.963 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.2 t -145.53 134.09 22.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.509 1.124 . . . . 3.02 108.929 -166.7 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.67 132.96 0.28 Allowed Glycine 0 CA--C 1.533 1.196 0 N-CA-C 109.596 -1.402 . . . . 2.5899999999999999 109.596 -168.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -29.03 -60.5 0.13 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.179 1.792 . . . . 6.0999999999999996 113.134 -170.724 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -74.13 1.99 9.94 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.588 0.218 . . . . 3.79 111.588 -161.672 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.7 m -47.36 173.47 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 122.919 1.342 . . . . 2.0800000000000001 112.586 149.434 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.89 -6.94 10.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 114.702 -1.136 . . . . 1.9099999999999999 111.094 175.309 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 tp -44.26 131.65 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.331 1.052 . . . . 1.6699999999999999 110.386 172.088 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.87 -25.23 7.72 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.909 0.766 . . . . 1.5900000000000001 112.65 -176.441 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -87.18 162.93 17.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.758 1.279 . . . . 4.1799999999999997 110.333 -166.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -94.01 113.61 25.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.087 0.555 . . . . 0.90000000000000002 110.758 -172.544 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.427 HD21 ' CZ ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -70.21 141.28 52.56 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.385 -1.339 . . . . 2.0699999999999998 107.385 167.403 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 48' ' ' HIS . 88.4 t -126.37 133.1 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 126.125 1.77 . . . . 0.35999999999999999 109.211 175.653 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.1 t -98.13 122.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 125.799 1.64 . . . . 2.2400000000000002 106.929 165.213 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.435 ' CD2' ' ND1' ' A' ' 46' ' ' HIS . 64.9 m-70 -97.45 156.76 16.33 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 116.284 1.957 . . . . 0.44 116.284 -174.508 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -34.18 -90.39 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 130.232 3.413 . . . . 3.7000000000000002 112.211 168.06 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -174.49 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.873 0.845 . . . . 4.5 109.418 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.54 154.93 10.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.556 -1.202 . . . . 0.97999999999999998 110.099 164.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.06 161.47 8.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.974 -1.012 . . . . 2.3500000000000001 108.93 158.182 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -86.64 -30.49 21.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.988 1.715 . . . . 3.0 111.081 177.183 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 76.16 -1.93 2.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.693 2.397 . . . . 1.9099999999999999 112.982 -172.8 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.61 30.48 4.61 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.866 1.212 . . . . 1.4399999999999999 113.123 163.151 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -129.56 -16.62 3.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.881 1.272 . . . . 4.96 112.823 -173.946 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.91 124.85 31.27 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.33 0.968 . . . . 2.0800000000000001 111.885 175.704 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.02 -29.83 62.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.604 0.621 . . . . 2.77 111.81 175.805 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -53.24 98.63 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.268 1.027 . . . . 2.4399999999999999 109.531 163.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -35.61 -43.26 0.27 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 127.013 2.125 . . . . 4.0199999999999996 113.458 -178.711 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -37.88 -37.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.107 1.763 . . . . 2.6400000000000001 112.668 175.31 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.2 t -50.72 -77.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.159 0.984 . . . . 2.52 110.709 169.726 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 t -58.4 -38.32 77.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.771 -1.205 . . . . 2.6099999999999999 110.959 -177.01 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -59.38 -51.43 69.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.323 1.049 . . . . 4.9900000000000002 110.887 -177.445 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.477 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.281 0.1 OUTLIER -129.72 -54.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.891 0.477 . . . . 1.1699999999999999 112.156 174.504 . . . . . . . . 4 4 . 1 . 034 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.64 -16.24 0.26 Allowed Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.073 0.851 . . . . 0.91000000000000003 113.252 179.078 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.87 52.22 9.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.316 . . . . 2.0899999999999999 110.718 -176.651 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.553 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . . . -62.41 -50.45 71.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.039 0.936 . . . . 0.93000000000000005 109.921 169.356 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 115.46 -172.09 14.04 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 106.99 -2.444 . . . . 0.93999999999999995 106.99 -168.419 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.6 m -60.93 155.35 20.07 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.388 1.475 . . . . 1.26 113.049 -171.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -61.1 135.57 57.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.323 1.449 . . . . 2.98 108.867 169.538 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.2 mt -111.01 -76.57 0.6 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.678 1.126 . . . . 0.45000000000000001 108.753 168.859 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.05 140.41 37.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.205 -1.406 . . . . 0.68999999999999995 107.205 173.444 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 66.7 m -127.3 159.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.738 -1.578 . . . . 2.1099999999999999 106.738 173.285 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.93 132.85 2.59 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.69999999999999996 110.951 168.201 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.89 136.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.619 1.167 . . . . 0.63 109.037 171.228 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.89 144.15 14.66 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.115 0 C-N-CA 123.222 0.609 . . . . 0.92000000000000004 111.653 -179.01 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.28 0.8 5.81 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.737 0.684 . . . . 0.76000000000000001 113.451 175.116 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.8 mm -87.82 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.499 1.149 . . . . 0.83999999999999997 110.91 -161.187 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.28 175.06 5.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.335 1.054 . . . . 1.45 110.22 171.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 104.271 -2.492 . . . . 4.6299999999999999 104.271 167.244 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.786 0.291 . . . . 6.29 111.786 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.9 p -105.01 85.86 2.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.469 1.508 . . . . 3.1800000000000002 107.235 -179.248 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 153.01 29.9 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.886 0.741 . . . . 3.3999999999999999 111.353 -171.572 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.81 25.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.591 -1.262 . . . . 0.69999999999999996 107.591 161.058 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.9 t -103.88 145.11 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.778 -1.193 . . . . 0.66000000000000003 107.778 165.206 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.95 97.65 5.04 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.77 -0.826 . . . . 0.40999999999999998 108.77 155.696 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.06 107.81 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.925 -1.509 . . . . 0.66000000000000003 106.925 162.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.1 128.21 35.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.939 -1.134 . . . . 0.98999999999999999 107.939 175.813 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -149.34 -52.02 0.16 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.965 0.412 . . . . 3.5600000000000001 110.663 172.278 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.71 -119.22 4.86 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.52 -0.764 . . . . 0.93000000000000005 111.526 -175.648 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.38 -42.66 2.65 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.806 1.242 . . . . 3.1000000000000001 110.353 -165.821 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.49 166.99 10.69 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 123.825 0.726 . . . . 0.82999999999999996 111.309 177.411 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.38 -21.65 53.62 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.407 2.738 . . . . 1.1599999999999999 111.993 179.584 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 145' ' ' ALA . 89.6 t -50.01 141.77 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.828 1.251 . . . . 0.97999999999999998 110.822 177.112 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -155.56 125.09 6.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.909 -1.145 . . . . 2.0299999999999998 107.909 -175.752 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.65 172.67 40.44 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 121.764 -0.585 . . . . 0.52000000000000002 112.52 -177.106 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.31 130.96 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.775 0.83 . . . . 1.22 108.877 176.577 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.24 137.9 23.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.497 -1.298 . . . . 0.70999999999999996 107.497 163.543 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -119.43 99.98 7.02 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.574 -1.269 . . . . 1.8 107.574 166.952 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.569 ' CE1' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -87.66 118.02 26.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.698 1.199 . . . . 2.52 108.566 -178.981 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -148.28 164.72 33.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.014 0.824 . . . . 3.6000000000000001 109.419 167.609 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.66 164.5 38.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.255 1.422 . . . . 4.6500000000000004 107.273 177.265 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -51.22 -46.72 62.33 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.987 0.915 . . . . 4.6799999999999997 112.076 178.728 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -114.31 164.02 14.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.715 -1.217 . . . . 5.8600000000000003 107.715 179.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.0 p -69.2 55.14 0.1 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.023 1.329 . . . . 3.21 109.158 163.466 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 179.4 -153.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.578 1.951 . . . . 4.8099999999999996 106.619 -165.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.25 -178.09 0.4 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 127.191 2.329 . . . . 1.02 115.268 175.022 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.72 110.23 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.601 2.867 . . . . 1.5600000000000001 109.917 -175.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 20' ' ' PHE . 4.0 t -79.63 133.03 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.818 -0.353 . . . . 1.3999999999999999 111.161 -164.655 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -95.97 101.76 13.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.99 -1.485 . . . . 3.6099999999999999 106.99 -174.381 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.569 HG22 ' CE1' ' A' ' 20' ' ' PHE . 25.4 t -89.0 90.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.77 1.228 . . . . 1.1499999999999999 107.877 -173.287 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -97.77 131.41 44.32 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 123.738 0.649 . . . . 1.45 109.271 169.425 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 163.21 30.79 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.177 -0.769 . . . . 0.78000000000000003 111.177 -179.422 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -133.4 99.82 4.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 2.25 106.522 -171.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.15 140.59 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.534 1.134 . . . . 0.93000000000000005 108.647 -169.775 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -145.0 -178.02 5.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.709 0.766 . . . . 3.6800000000000002 112.967 169.56 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.24 75.44 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.922 1.249 . . . . 0.58999999999999997 112.598 -179.025 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mt -77.62 -157.63 0.1 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.615 -0.883 . . . . 0.81000000000000005 108.615 173.185 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.6 m -143.82 144.43 31.77 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.126 -2.546 . . . . 2.7000000000000002 104.126 168.78 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -40.87 138.04 1.11 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.723 2.409 . . . . 2.6899999999999999 112.857 -168.772 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.32 -171.38 29.45 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.128 -0.487 . . . . 0.59999999999999998 111.979 174.243 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -73.28 153.19 40.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.663 0.986 . . . . 2.2599999999999998 113.663 -163.155 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -145.99 126.55 14.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.218 1.807 . . . . 0.52000000000000002 109.323 -179.261 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.65 155.58 10.98 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.658 -0.977 . . . . 0.34999999999999998 110.658 165.78 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 117' ' ' LEU . 1.8 t80 -152.38 92.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.143 1.377 . . . . 2.4199999999999999 107.655 -170.657 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -134.45 161.91 33.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.785 -0.82 . . . . 0.53000000000000003 108.785 -161.03 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.3 m -113.58 140.75 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.906 0.775 . . . . 2.0 109.11 168.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -111.52 172.06 7.11 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.282 1.033 . . . . 1.28 111.252 -168.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -58.02 -21.59 45.88 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.763 0.825 . . . . 5.9299999999999997 113.019 173.209 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -50.99 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.655 1.982 . . . . 3.3700000000000001 111.133 -179.246 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.3 174.49 2.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 129.295 3.038 . . . . 6.0300000000000002 113.671 178.871 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -90.27 117.37 28.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.815 1.246 . . . . 7.3700000000000001 109.902 172.484 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -138.78 -63.74 0.53 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.903 1.681 . . . . 5.8600000000000003 109.734 176.679 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t -174.61 -51.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.575 1.55 . . . . 3.8799999999999999 109.386 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.64 -43.06 19.09 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.97 0.908 . . . . 4.6600000000000001 109.139 175.078 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.01 -72.21 2.11 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 124.439 1.019 . . . . 5.5199999999999996 111.082 173.564 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.9 t -78.5 56.54 1.8 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.52 1.528 . . . . 3.2200000000000002 111.37 -168.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -117.36 -0.08 12.08 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.286 1.217 . . . . 4.9299999999999997 114.286 -163.127 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.5 t 174.29 51.28 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.176 1.917 . . . . 3.79 116.176 -120.401 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.6 164.24 16.92 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 121.249 -0.907 . . . . 1.95 110.456 176.052 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.25 -91.39 1.56 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.312 -2.315 . . . . 1.47 107.312 169.676 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 179.71 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 124.898 3.732 . . . . 1.1599999999999999 115.066 -176.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -82.25 60.64 5.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.297 1.439 . . . . 2.0099999999999998 110.44 -170.701 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.4 t80 53.6 72.69 0.42 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.048 1.339 . . . . 3.2599999999999998 108.323 -170.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -97.73 98.32 5.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 108.997 -0.742 . . . . 2.8199999999999998 108.997 175.22 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.06 -38.37 7.24 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.196 1.93 . . . . 2.0 111.468 -173.559 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.72 -65.34 0.56 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.712 0.805 . . . . 2.9900000000000002 109.456 173.409 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 m -163.22 100.45 0.95 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.108 -1.441 . . . . 1.5800000000000001 107.108 -171.303 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.6 mmt-85 -126.23 163.0 24.15 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.18 0.992 . . . . 5.8099999999999996 109.86 170.228 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -116.25 149.53 39.05 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.38 1.472 . . . . 3.48 108.362 -172.527 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -78.43 153.57 31.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 112.509 -172.57 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.64 152.26 10.58 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 105.563 -3.015 . . . . 3.02 105.563 172.081 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.89 -133.99 7.05 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.067 -1.613 . . . . 1.77 109.067 177.294 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.6 -52.3 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.768 1.646 . . . . 1.6799999999999999 110.212 173.706 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.94 -34.76 78.16 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.081 1.141 . . . . 4.9800000000000004 114.081 -167.072 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.73 175.83 2.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.698 0.285 . . . . 1.99 110.884 -174.582 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.83 -48.13 11.12 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 4.4000000000000004 109.102 168.074 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -79.64 171.04 15.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.804 0.842 . . . . 3.6699999999999999 110.439 -176.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 174.05 145.37 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.41 2.284 . . . . 3.5800000000000001 110.037 171.54 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.548 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 72.2 m80 -57.83 143.16 43.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.204 -1.776 . . . . 0.58999999999999997 106.204 160.113 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -52.59 -27.29 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.369 -0.378 . . . . 1.1499999999999999 110.589 174.545 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.55 28.76 12.38 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.49 -1.172 . . . . 0.64000000000000001 115.071 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -94.79 127.81 41.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.455 2.128 . . . . 1.8400000000000001 107.421 159.653 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.85 -54.34 4.95 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 107.113 -1.44 . . . . 1.8600000000000001 107.113 151.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 153.24 -116.44 0.74 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.394 -1.482 . . . . 0.70999999999999996 109.394 173.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -139.46 160.51 39.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.249 1.02 . . . . 1.9399999999999999 110.34 -174.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.86 178.09 5.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.451 -1.685 . . . . 0.46000000000000002 106.451 171.245 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -129.99 147.1 51.7 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.559 -0.534 . . . . 2.2400000000000002 109.559 164.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.93 146.6 32.02 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.46 -0.941 . . . . 0.72999999999999998 108.46 162.092 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.15 -88.47 0.09 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.524 1.14 . . . . 2.8900000000000001 109.619 177.187 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -137.54 -51.18 0.63 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.949 1.3 . . . . 4.2300000000000004 110.542 -174.399 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.92 15.49 1.79 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.846 1.308 . . . . 2.7000000000000002 111.635 -174.265 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.3 10.11 69.18 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.358 -0.838 . . . . 0.78000000000000003 111.309 -171.625 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.6 140.69 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.036 -1.468 . . . . 0.75 107.036 173.904 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.86 175.9 7.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.073 0.949 . . . . 1.0800000000000001 109.262 174.267 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -110.59 148.42 32.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 103.732 -2.692 . . . . 3.9399999999999999 103.732 176.315 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.46 94.58 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.143 -1.058 . . . . 1.1499999999999999 108.143 153.16 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.7 m -122.04 76.99 1.34 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.217 1.407 . . . . 0.88 109.287 170.818 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.42 157.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.574 -0.528 . . . . 1.5700000000000001 109.574 179.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -144.68 89.41 1.98 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.149 0.58 . . . . 3.0299999999999998 110.654 166.684 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.84 162.37 26.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.896 -0.409 . . . . 2.2000000000000002 109.896 172.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 p -124.67 7.17 8.18 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.019 1.328 . . . . 1.6499999999999999 113.159 179.321 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.88 -51.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 119.076 0.853 . . . . 1.1699999999999999 108.773 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.39 159.54 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.407 0.623 . . . . 1.01 111.23 -177.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.1 p -120.06 177.4 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.266 2.226 . . . . 2.9300000000000002 107.632 175.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -112.26 27.62 9.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.36 0.664 . . . . 2.5600000000000001 110.944 166.767 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.3 t -155.63 162.12 40.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.409 -0.589 . . . . 2.9100000000000001 109.409 177.89 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.56 148.05 0.19 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.64 1.114 . . . . 2.8799999999999999 110.515 -169.235 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -70.6 -3.18 16.94 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.854 -1.38 . . . . 7.5999999999999996 113.362 -173.328 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -76.97 -16.61 59.29 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 120.826 -1.171 . . . . 3.2599999999999998 110.047 169.936 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.6 p -67.69 175.58 2.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.776 1.274 . . . . 1.9199999999999999 111.709 176.149 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.59 HG12 HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -77.48 -7.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.443 -1.708 . . . . 2.1400000000000001 110.836 170.971 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.8 mm -61.06 128.55 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 119.978 1.263 . . . . 2.0899999999999999 108.404 -177.481 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.38 33.38 84.39 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 112.036 -0.426 . . . . 1.6799999999999999 112.036 -171.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -105.94 163.94 12.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.262 -1.755 . . . . 4.9800000000000004 106.262 149.814 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.2 m -92.59 123.88 36.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.406 1.083 . . . . 0.88 108.434 171.795 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.532 HD21 ' CE2' ' A' ' 45' ' ' PHE . 5.6 tt -80.47 145.99 31.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.102 -1.073 . . . . 2.4199999999999999 108.102 167.087 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.73 133.47 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 127.549 2.34 . . . . 0.35999999999999999 107.107 -177.62 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.41 118.34 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.564 -1.643 . . . . 1.6699999999999999 106.564 167.367 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -90.99 159.43 16.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.1 1.889 . . . . 0.34999999999999998 116.1 -168.572 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -33.01 -83.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.693 2.797 . . . . 3.3500000000000001 112.617 166.145 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -105.27 -179.23 3.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.542 0.737 . . . . 2.73 109.591 -170.231 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.0 137.76 55.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.553 -0.906 . . . . 0.63 108.553 167.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 160.95 30.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.622 -0.881 . . . . 2.1800000000000002 108.622 163.436 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -15.24 54.07 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.863 1.06 . . . . 3.5800000000000001 113.863 -170.353 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 64.45 4.23 2.16 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.739 -1.226 . . . . 1.73 113.836 -173.022 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.28 60.39 1.06 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 121.242 1.837 . . . . 1.8799999999999999 111.434 167.208 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.82 -51.76 0.37 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.345 1.858 . . . . 5.7300000000000004 110.308 -175.592 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -43.84 122.69 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.619 1.58 . . . . 1.9399999999999999 113.181 -177.973 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.04 -22.99 65.47 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.365 0.507 . . . . 3.2400000000000002 112.79 179.234 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -65.43 102.83 0.74 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.982 0.891 . . . . 2.27 109.055 174.775 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -19.31 -64.34 0.02 OUTLIER 'General case' 0 C--N 1.341 0.236 0 C-N-CA 127.857 2.463 . . . . 3.48 113.899 -172.264 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -37.72 -42.98 0.61 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.549 2.34 . . . . 3.5299999999999998 112.568 -177.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.3 m -55.45 -55.1 35.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.198 0.999 . . . . 2.4300000000000002 111.685 177.14 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.3 p -71.18 -48.26 52.76 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.024 -1.048 . . . . 1.3 110.231 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -65.97 -28.88 69.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.856 1.262 . . . . 4.6699999999999999 111.909 -170.241 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.548 ' HA ' ' CE1' ' A' ' 80' ' ' HIS 0.419 1.2 t -137.45 -53.89 0.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.589 -1.196 . . . . 1.51 113.14 174.143 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 148.38 -18.52 1.33 Allowed Glycine 0 N--CA 1.468 0.83 0 CA-C-N 120.126 1.33 . . . . 0.97999999999999998 112.562 -179.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 46.6 54.12 9.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.199 1.8 . . . . 2.2599999999999998 111.751 175.376 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.93 -36.74 56.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.377 0.608 . . . . 1.1000000000000001 110.591 168.728 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 -150.53 17.85 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 108.52 -1.832 . . . . 1.02 108.52 176.105 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.9 p -65.77 151.47 46.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.061 0.763 . . . . 2.2200000000000002 113.061 -164.035 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -60.81 139.46 57.93 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.809 -1.182 . . . . 2.7799999999999998 107.809 166.86 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 mt -115.49 -77.41 0.57 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.749 -1.204 . . . . 0.60999999999999999 107.749 173.504 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . . . -107.91 157.9 17.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.197 -1.409 . . . . 0.90000000000000002 107.197 165.745 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.6 p -156.83 163.27 39.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.169 -1.832 . . . . 1.3899999999999999 107.102 179.601 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.24 138.39 5.05 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.476 -1.05 . . . . 0.58999999999999997 110.476 179.418 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.06 133.9 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.368 1.067 . . . . 0.73999999999999999 108.54 172.6 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.59 HG21 HG12 ' A' ' 112' ' ' ILE . 14.7 tt -100.11 132.84 44.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 122.769 0.428 . . . . 0.72999999999999998 111.508 -177.051 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.68 2.99 1.01 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.466 1.032 . . . . 0.63 114.675 179.379 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.6 mm -92.63 57.04 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 119.541 1.671 . . . . 0.79000000000000004 110.832 -157.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.1 173.45 16.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.804 . . . . 1.29 109.518 166.305 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 C--O 1.255 1.388 0 N-CA-C 102.892 -3.003 . . . . 4.1299999999999999 102.892 162.918 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_